data_1bxd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bxd _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.566 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 55.4 Cg_endo . . . . . 0 C--O 1.213 -0.76 0 N-CA-C 109.954 -0.825 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.543 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.1 OUTLIER 23.68 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 122.358 1.075 . . . . 0.0 111.576 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.9 mm-40 -144.42 -159.51 1.0 Allowed 'General case' 0 C--N 1.267 -3.02 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.217 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.626 ' HA ' ' HA ' ' A' ' 331' ' ' LYS . 2.1 mmt -85.2 117.06 23.91 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.109 0.957 . . . . 0.0 110.797 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -141.18 150.61 42.97 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.061 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.47 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 13.8 m-20 -85.15 136.57 33.48 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.488 -0.758 . . . . 0.0 109.205 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.581 ' CD2' ' CE ' ' A' ' 332' ' ' MET . 6.8 mt -73.68 -23.82 59.87 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.955 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 303' ' ' ALA . 47.0 p30 -83.93 -18.96 35.58 Favored 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.856 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.511 ' N ' ' OD1' ' A' ' 302' ' ' ASN . . . -82.3 -36.34 27.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 16.2 t -74.15 -39.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.542 -0.724 . . . . 0.0 109.584 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 62.7 mt -69.55 -33.47 72.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.406 -0.809 . . . . 0.0 110.052 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -67.72 -22.35 73.53 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.99 -38.47 27.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.311 -1.111 . . . . 0.0 108.52 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.462 HG13 ' CG1' ' A' ' 341' ' ' VAL . 88.8 t -77.4 -18.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.509 ' CD1' HG23 ' A' ' 319' ' ' ILE . 1.3 mm -78.31 -45.71 26.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.654 0.74 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.99 -18.39 63.33 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.692 0.758 . . . . 0.0 109.067 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.61 -36.67 14.28 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.163 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.589 ' O ' ' CD ' ' A' ' 317' ' ' ARG . 15.3 mm-40 -91.59 8.33 37.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 110.399 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 309' ' ' ILE . 78.2 p -115.67 66.36 0.7 Allowed 'General case' 0 C--N 1.274 -2.703 0 O-C-N 120.898 -1.126 . . . . 0.0 108.187 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.59 ' O ' ' CG ' ' A' ' 315' ' ' TYR . . . -113.71 -32.06 2.18 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.294 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.607 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 90.1 m-85 -155.26 74.43 0.9 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 120.111 1.956 . . . . 0.0 114.408 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.607 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 1.4 tp10 91.5 12.8 0.04 OUTLIER 'General case' 0 CA--C 1.452 -2.804 0 O-C-N 121.732 -0.605 . . . . 0.0 111.901 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.589 ' CD ' ' O ' ' A' ' 312' ' ' GLU . 0.0 OUTLIER -81.68 87.93 6.27 Favored 'General case' 0 C--N 1.259 -3.328 0 N-CA-C 101.034 -3.691 . . . . 0.0 101.034 179.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.552 ' N ' ' CD1' ' A' ' 356' ' ' ILE . 0.5 OUTLIER -65.74 73.14 0.06 Allowed 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.549 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.569 HG22 ' CG2' ' A' ' 358' ' ' VAL . 42.6 mt -99.14 116.52 42.42 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.744 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.21 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.6 110.78 21.61 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.493 ' CG2' ' CD1' ' A' ' 309' ' ' ILE . 12.8 p -88.25 130.13 35.17 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.195 -0.941 . . . . 0.0 112.284 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.73 77.73 1.29 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.551 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 4.1 mp -93.3 167.18 11.91 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.443 -0.786 . . . . 0.0 110.884 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.633 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 57.9 t80 -58.94 112.44 5.06 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 121.44 -0.787 . . . . 0.0 109.193 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.3 79.06 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.969 1.51 . . . . 0.0 111.057 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.459 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -175.81 -82.82 0.06 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 0.8 OUTLIER 171.35 107.97 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.453 -1.028 . . . . 0.0 109.443 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.554 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 5.2 mt -85.43 -179.54 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 O-C-N 121.533 -0.729 . . . . 0.0 109.352 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 0.8 OUTLIER -173.98 103.95 0.11 Allowed 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.211 -0.996 . . . . 0.0 112.505 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.475 HG13 ' HB1' ' A' ' 367' ' ' ALA . 5.6 m -142.79 142.18 26.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 298' ' ' MET . 0.0 OUTLIER -83.72 101.19 11.38 Favored 'General case' 0 C--N 1.257 -3.44 0 C-N-CA 118.512 -1.275 . . . . 0.0 108.015 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.581 ' CE ' ' CD2' ' A' ' 301' ' ' LEU 0.252 0.0 OUTLIER -135.46 -173.23 3.28 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.707 0.765 . . . . 0.0 111.515 -179.585 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.714 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 6.7 t-80 -109.24 112.27 59.6 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 37.5 Cg_endo -59.87 -18.98 52.51 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.719 1.378 . . . . 0.0 110.407 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.714 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 1.6 mt -76.3 -73.92 0.25 Allowed 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.397 -0.815 . . . . 0.0 109.674 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.492 ' O ' HD13 ' A' ' 412' ' ' ILE . 0.4 OUTLIER -45.7 -49.78 14.27 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.702 -0.623 . . . . 0.0 110.441 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.591 HD13 ' CE1' ' A' ' 416' ' ' HIS . 6.7 mm -60.19 -40.89 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.084 -1.01 . . . . 0.0 109.999 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 6.1 mtmt -55.46 -48.39 74.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 109.17 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -28.77 67.19 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.415 0.626 . . . . 0.0 110.327 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 344' ' ' MET . . . -67.1 -37.26 83.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.748 . . . . 0.0 110.6 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.462 ' CG1' HG13 ' A' ' 308' ' ' VAL . 92.8 t -78.69 -35.0 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.125 -0.984 . . . . 0.0 110.207 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.51 ' O ' HG11 ' A' ' 346' ' ' VAL . . . -64.35 -68.75 0.33 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.554 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . 0.549 ' O ' ' CG2' ' A' ' 346' ' ' VAL . 24.7 m120 -47.52 -19.28 0.17 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.296 -0.877 . . . . 0.0 111.203 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 3.4 mtt -74.92 -42.43 57.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.603 -1.31 . . . . 0.0 110.18 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.53 ' CG2' HG22 ' A' ' 356' ' ' ILE . 14.7 p -81.16 -18.69 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.844 . . . . 0.0 111.136 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 343' ' ' ASN . 17.9 m -60.02 -20.98 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.046 -1.034 . . . . 0.0 110.465 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -84.48 -30.87 24.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 110.666 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 352' ' ' GLY . . . -90.5 -19.1 24.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.946 . . . . 0.0 110.824 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -82.73 -53.58 5.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 110.451 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -72.56 0.14 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 110.365 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -70.02 -47.4 62.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 110.203 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 348' ' ' ALA . . . -79.9 162.34 46.62 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 353' ' ' ASN . 21.5 t-20 -171.68 29.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.454 -1.027 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -110.56 -33.05 2.56 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.47 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 17.0 t90 178.46 129.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.899 -1.354 . . . . 0.0 111.851 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.552 ' CD1' ' N ' ' A' ' 318' ' ' GLU . 1.7 mt -117.01 146.97 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 372' ' ' GLU . 6.9 tttt -140.42 128.2 21.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.487 -1.383 . . . . 0.0 112.087 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.569 ' CG2' HG22 ' A' ' 319' ' ' ILE . 71.9 t -120.3 108.85 24.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 39.0 t -127.35 160.03 32.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.087 -1.008 . . . . 0.0 111.366 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.551 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -144.49 142.28 30.14 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.596 -0.69 . . . . 0.0 109.679 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -134.87 -166.12 11.03 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.633 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -173.16 173.11 3.7 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.019 -1.283 . . . . 0.0 111.285 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 4.5 mt-10 -153.08 176.65 2.3 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.675 -0.641 . . . . 0.0 109.524 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.561 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.8 Cg_endo -70.28 105.41 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.684 1.36 . . . . 0.0 110.782 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 8.4 t-20 80.49 34.02 0.14 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.868 -0.52 . . . . 0.0 110.631 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.538 ' N ' HG13 ' A' ' 438' ' ' VAL . 0.0 OUTLIER 172.5 105.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.837 . . . . 0.0 111.206 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -105.79 169.08 8.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.094 -1.003 . . . . 0.0 108.504 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 37.6 p-90 -168.43 172.4 8.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.603 -1.311 . . . . 0.0 110.615 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.622 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 37.6 p90 -143.78 140.94 30.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.37 -0.832 . . . . 0.0 109.923 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.537 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 12.4 tt0 -127.0 153.98 45.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.293 -0.879 . . . . 0.0 110.741 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.537 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 88.5 t -124.39 164.37 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.437 -0.79 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 357' ' ' LYS . 45.7 mt-10 -150.52 135.33 17.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.957 . . . . 0.0 109.764 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -148.67 148.63 30.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.077 -1.014 . . . . 0.0 110.594 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -82.29 158.67 23.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.332 -0.855 . . . . 0.0 110.144 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 153.96 -167.87 32.29 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.23 -26.4 14.72 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.982 1.517 . . . . 0.0 110.589 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 88.63 -171.85 40.15 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.48 HG13 HD12 ' A' ' 430' ' ' LEU . 54.5 mt -74.91 151.62 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.293 -1.122 . . . . 0.0 110.036 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.519 ' CB ' ' HG3' ' A' ' 382' ' ' GLN . . . -73.76 169.16 19.86 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.136 -0.978 . . . . 0.0 110.011 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.19 -38.04 2.99 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.946 1.498 . . . . 0.0 110.291 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . 0.603 ' O ' ' CD2' ' A' ' 385' ' ' HIS . 0.9 OUTLIER -90.45 -37.51 13.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.314 -0.866 . . . . 0.0 110.765 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.581 ' HA ' ' NE2' ' A' ' 385' ' ' HIS . 45.5 mt-30 -62.25 -28.47 69.73 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.259 -0.901 . . . . 0.0 110.299 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -21.51 3.98 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.955 -1.09 . . . . 0.0 109.164 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -31.6 16.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.504 -0.748 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 381' ' ' GLU . 2.1 p80 -117.47 68.95 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.878 -1.139 . . . . 0.0 111.025 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.483 HD21 ' O ' ' A' ' 382' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.594 ' N ' ' CD1' ' A' ' 408' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.568 ' CG2' HG12 ' A' ' 408' ' ' ILE . 4.3 t 80.52 -59.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.947 -0.47 . . . . 0.0 110.42 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 42.0 tt0 -54.78 -58.84 5.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.99 -1.069 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -59.22 -19.56 46.63 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.293 -0.88 . . . . 0.0 110.685 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 336' ' ' SER . 11.0 mm -67.29 -70.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.156 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 419' ' ' MET . 22.5 t -60.89 -21.09 23.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.347 -0.846 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 5.0 t70 -77.54 -29.41 52.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -0.847 . . . . 0.0 109.841 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.543 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 0.9 OUTLIER -81.37 -14.78 56.82 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.209 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.591 ' CE1' HD13 ' A' ' 337' ' ' ILE . 31.6 m80 -93.36 -37.46 11.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.576 -0.702 . . . . 0.0 109.785 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 13.9 t-20 81.43 42.91 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 121.377 0.608 . . . . 0.0 110.455 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.535 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -111.8 -89.26 1.86 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.606 ' HE1' ' CD1' ' A' ' 435' ' ' TRP . 2.6 ttp -173.36 159.76 3.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.159 -1.2 . . . . 0.0 111.464 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.496 HD12 ' CG2' ' A' ' 413' ' ' VAL . 14.0 tp -151.02 109.08 3.72 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.373 -0.83 . . . . 0.0 109.387 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -130.07 161.32 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.923 -1.11 . . . . 0.0 111.083 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.404 ' CD2' ' CD1' ' A' ' 432' ' ' ILE . 2.9 mt -126.78 138.61 53.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.384 -0.823 . . . . 0.0 110.169 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.445 ' O ' HD11 ' A' ' 430' ' ' LEU . . . -135.88 161.88 24.89 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.491 ' OG1' HD11 ' A' ' 430' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.207 -1.172 . . . . 0.0 110.631 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.491 HD11 ' OG1' ' A' ' 424' ' ' THR . 15.6 tp -78.4 139.92 38.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -1.169 . . . . 0.0 110.636 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 371' ' ' VAL . 23.3 t -139.3 132.39 29.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.56 -0.713 . . . . 0.0 109.857 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.439 ' O ' ' HG3' ' A' ' 370' ' ' GLN . 29.1 mm -92.68 140.64 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.196 -0.94 . . . . 0.0 110.648 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -119.92 97.16 5.48 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.321 -0.862 . . . . 0.0 110.407 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.622 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -103.25 137.4 41.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 110.236 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 88.9 m95 -118.93 153.14 35.08 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.1 -1.0 . . . . 0.0 111.839 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.512 ' CD1' HD12 ' A' ' 301' ' ' LEU . 24.6 mt -145.35 100.15 4.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.535 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 41.4 Cg_endo -65.75 138.04 52.05 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.967 1.509 . . . . 0.0 111.592 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.584 ' CG2' ' HD2' ' A' ' 439' ' ' PRO . 2.9 p -93.24 151.2 40.19 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.706 -0.621 . . . . 0.0 109.928 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 438' ' ' VAL . 39.5 Cg_endo . . . . . 0 C--N 1.312 -1.375 0 O-C-N 123.642 1.338 . . . . 0.0 110.205 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.602 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 51.4 Cg_endo . . . . . 0 C--O 1.214 -0.705 0 CA-C-O 121.347 0.478 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.594 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -90.82 109.41 20.61 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.938 0.875 . . . . 0.0 108.98 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.2 mt-10 -134.53 -156.33 0.72 Allowed 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.73 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.551 ' HE3' ' CA ' ' A' ' 330' ' ' VAL . 0.7 OUTLIER -87.4 131.89 34.15 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.048 -1.033 . . . . 0.0 110.239 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -142.34 147.83 36.94 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 110.972 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.47 ' O ' HG22 ' A' ' 304' ' ' VAL . 1.1 m-20 -89.61 119.8 30.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.427 -0.796 . . . . 0.0 109.454 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.529 HD22 ' CE ' ' A' ' 332' ' ' MET . 6.5 mt -62.31 -21.12 65.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.008 -1.057 . . . . 0.0 109.801 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.464 ' OD1' HD21 ' A' ' 323' ' ' LEU . 51.4 t-20 -84.25 -22.1 30.91 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.084 -1.01 . . . . 0.0 109.029 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 300' ' ' ASP . . . -84.9 -33.38 22.77 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.714 -0.616 . . . . 0.0 109.823 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 300' ' ' ASP . 22.7 t -79.55 -34.72 16.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.342 -0.849 . . . . 0.0 109.407 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 94.3 mt -75.28 -31.29 60.69 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.408 -0.808 . . . . 0.0 110.161 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -63.39 -31.0 79.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -80.17 -34.07 37.86 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.39 -1.065 . . . . 0.0 109.362 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.574 ' CG1' ' CG1' ' A' ' 341' ' ' VAL . 97.7 t -74.76 -20.38 16.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.64 0.733 . . . . 0.0 109.103 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.522 ' O ' ' CB ' ' A' ' 313' ' ' SER . 1.1 mt -75.88 -50.87 21.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.59 -16.43 63.4 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.83 0.824 . . . . 0.0 108.929 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 308' ' ' VAL . . . -62.98 -66.35 0.55 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.7 -0.625 . . . . 0.0 110.765 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.93 44.54 2.88 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.884 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.554 ' CB ' ' CD1' ' A' ' 319' ' ' ILE . 3.3 p -86.63 27.12 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.866 -1.146 . . . . 0.0 110.358 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' A' ' 317' ' ' ARG . . . 43.55 42.74 6.03 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.515 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 12.7 m-85 58.86 49.37 9.91 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.702 -0.881 . . . . 0.0 109.608 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 0.7 OUTLIER 59.93 62.24 1.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.61 0.719 . . . . 0.0 110.834 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 314' ' ' GLY . 16.2 mmm180 -71.66 -82.79 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.907 0.861 . . . . 0.0 109.092 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -147.14 55.9 1.11 Allowed 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.554 ' CD1' ' CB ' ' A' ' 313' ' ' SER . 19.6 mt -97.47 131.9 43.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.75 -0.594 . . . . 0.0 110.627 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 1.1 tp10 -91.52 107.06 18.95 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.508 HG23 ' CD1' ' A' ' 309' ' ' ILE . 16.9 p -94.36 122.85 37.34 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 111.133 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . 0.424 ' C ' HD11 ' A' ' 323' ' ' LEU . . . -146.1 77.06 1.48 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.543 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 6.1 mp -95.47 140.6 30.1 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.373 -0.83 . . . . 0.0 109.977 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 9.8 t80 -42.68 121.84 2.81 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.447 -0.783 . . . . 0.0 109.826 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.14 59.88 7.21 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.974 1.513 . . . . 0.0 110.194 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . -158.74 20.4 0.31 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 53.8 m 55.29 100.12 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.253 -1.145 . . . . 0.0 110.363 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.549 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 2.7 mt -76.23 -175.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 121.532 -0.73 . . . . 0.0 109.14 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 3.4 mt-10 -171.45 110.96 0.32 Allowed 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.315 -0.866 . . . . 0.0 111.241 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.551 ' CA ' ' HE3' ' A' ' 298' ' ' MET . 29.7 m -144.44 149.95 16.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 O-C-N 121.583 -0.698 . . . . 0.0 110.092 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.7 OUTLIER -68.69 98.25 0.88 Allowed 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.571 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 4.8 ttp -144.76 159.72 42.4 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.76 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.609 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 19.5 t-160 -101.88 117.02 62.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.47 ' O ' ' HE2' ' A' ' 338' ' ' LYS . 33.8 Cg_endo -54.74 -31.59 72.38 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.458 1.241 . . . . 0.0 111.429 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.609 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 6.6 mt -69.86 -69.75 0.33 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.888 -1.133 . . . . 0.0 110.428 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 335' ' ' LEU . 23.8 m -43.28 -60.36 1.72 Allowed 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.675 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.59 HD13 ' CE1' ' A' ' 416' ' ' HIS . 8.5 mm -55.41 -35.02 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.228 -0.92 . . . . 0.0 110.676 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 1.3 mtmm -56.11 -47.39 78.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.9 -1.125 . . . . 0.0 109.11 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -37.51 76.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.805 -0.559 . . . . 0.0 110.227 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.461 ' O ' ' SD ' ' A' ' 344' ' ' MET . . . -66.56 -23.87 66.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.574 ' CG1' ' CG1' ' A' ' 308' ' ' VAL . 72.6 t -89.98 -28.13 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.804 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.527 ' O ' ' CG2' ' A' ' 346' ' ' VAL . . . -73.94 -30.24 62.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.371 -0.831 . . . . 0.0 109.937 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -69.23 -23.37 63.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.904 . . . . 0.0 109.913 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.461 ' SD ' ' O ' ' A' ' 340' ' ' ALA . 0.3 OUTLIER -90.55 -25.19 20.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.824 . . . . 0.0 110.613 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 90.2 t -90.45 -23.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.098 -1.001 . . . . 0.0 111.107 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 342' ' ' ALA . 97.0 t -68.2 -20.11 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.984 -1.072 . . . . 0.0 110.405 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 351' ' ' TYR . 2.1 m120 -63.49 -51.78 64.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.464 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 373' ' ' ASP . . . -90.84 -19.07 23.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.402 -0.811 . . . . 0.0 111.029 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.65 -81.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.967 -1.083 . . . . 0.0 110.883 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.476 ' CG ' ' N ' ' A' ' 351' ' ' TYR . 27.7 ptt180 -92.01 -44.92 8.59 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.218 -0.926 . . . . 0.0 111.392 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . 0.476 ' N ' ' CG ' ' A' ' 350' ' ' ARG . 9.0 t80 -64.11 -40.45 96.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.209 -0.932 . . . . 0.0 110.729 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 348' ' ' ALA . . . -109.6 173.71 17.21 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -159.21 28.64 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -1.039 . . . . 0.0 109.85 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -89.29 -59.85 1.52 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.568 ' CH2' ' HB2' ' A' ' 357' ' ' LYS . 19.9 t90 -176.15 132.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -1.135 . . . . 0.0 110.132 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.491 HD11 HG12 ' A' ' 319' ' ' ILE . 5.9 mt -102.0 158.53 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.422 -0.799 . . . . 0.0 109.209 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.568 ' HB2' ' CH2' ' A' ' 355' ' ' TRP . 0.5 OUTLIER -144.09 104.93 4.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.027 -1.045 . . . . 0.0 110.654 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.514 HG21 ' CG2' ' A' ' 319' ' ' ILE . 41.2 t -107.94 89.88 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 108.86 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.0 t -121.01 138.4 54.18 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.387 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.543 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.1 t -120.97 145.12 48.08 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -141.45 -172.42 13.24 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.64 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -159.85 172.07 18.3 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.196 -1.179 . . . . 0.0 110.585 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -145.34 175.57 2.68 Favored Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.526 -0.734 . . . . 0.0 109.643 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 41.5 Cg_endo -68.15 111.34 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.699 1.368 . . . . 0.0 111.133 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 3.9 t-20 72.75 29.24 1.97 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.531 -0.731 . . . . 0.0 111.118 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 19.7 ptt-85 171.64 116.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.325 -0.859 . . . . 0.0 110.773 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.4 179.98 4.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.102 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.618 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 36.8 p-90 -170.55 143.93 2.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.619 -1.301 . . . . 0.0 110.309 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.583 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 31.8 p90 -114.16 140.28 48.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.286 -0.884 . . . . 0.0 109.257 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 432' ' ' ILE . 27.0 tt0 -130.95 149.95 52.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 111.979 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 37.7 t -128.78 150.66 34.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 357' ' ' LYS . 29.3 tt0 -150.12 140.43 22.28 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.992 -1.067 . . . . 0.0 109.692 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 348' ' ' ALA . 1.7 p30 -161.12 168.95 23.32 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.976 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.3 151.89 20.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.428 -0.795 . . . . 0.0 110.32 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 162.81 -156.46 28.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.53 137.75 23.29 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.961 1.506 . . . . 0.0 110.614 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -92.03 -174.04 42.33 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.482 HD13 HD13 ' A' ' 430' ' ' LEU . 3.2 mt -110.69 97.88 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.005 -1.291 . . . . 0.0 109.891 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.515 ' CB ' ' HD2' ' A' ' 380' ' ' PRO . . . -68.56 178.83 0.76 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.28 -0.888 . . . . 0.0 110.547 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 379' ' ' ALA . 43.0 Cg_endo -70.8 -19.75 30.81 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.165 1.613 . . . . 0.0 110.012 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.46 -30.67 17.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 109.579 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -85.0 -19.22 32.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.465 -0.772 . . . . 0.0 109.829 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 385' ' ' HIS . 36.0 ttm-85 -54.25 -52.03 62.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.395 -0.815 . . . . 0.0 110.521 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -44.03 -18.57 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.692 -0.63 . . . . 0.0 111.828 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.621 ' N ' ' CD2' ' A' ' 385' ' ' HIS . 0.6 OUTLIER -111.55 42.08 1.77 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.814 -1.179 . . . . 0.0 111.642 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.54 ' CG ' ' O ' ' A' ' 385' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 O-C-N 120.158 -1.589 . . . . 0.0 114.322 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 409' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.552 ' CB ' ' O ' ' A' ' 408' ' ' ILE . 0.4 OUTLIER 79.76 -35.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 121.605 -0.684 . . . . 0.0 110.47 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.512 ' N ' HG11 ' A' ' 409' ' ' VAL . 18.5 tt0 -69.84 -54.06 15.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.0 -1.062 . . . . 0.0 110.079 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.87 -21.11 41.26 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.28 -0.887 . . . . 0.0 110.013 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' A' ' 409' ' ' VAL . 1.0 OUTLIER -66.86 -59.1 4.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 420' ' ' LEU . 21.2 t -67.94 -22.31 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.523 -0.736 . . . . 0.0 110.031 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -82.44 -23.45 34.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.551 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.463 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 58.8 m-20 -83.31 -21.91 33.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.517 -0.739 . . . . 0.0 109.203 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.594 ' CD2' ' CE ' ' A' ' 296' ' ' MET . 37.7 m80 -92.77 -37.2 12.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.701 . . . . 0.0 109.894 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.5 t-20 81.95 29.64 0.13 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.798 -0.564 . . . . 0.0 111.015 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.541 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -98.39 -90.66 1.96 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.515 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.6 tpp -175.89 161.57 2.5 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.278 -1.131 . . . . 0.0 111.168 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.482 ' HB2' HG23 ' A' ' 413' ' ' VAL . 27.0 tp -152.66 108.12 3.29 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.353 -0.842 . . . . 0.0 109.312 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.61 138.14 48.68 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.782 -1.199 . . . . 0.0 111.738 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.57 130.5 36.6 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -122.56 114.84 2.56 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 119.577 -1.296 . . . . 0.0 110.006 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 C--N 1.305 -1.345 0 O-C-N 121.406 -1.055 . . . . 0.0 108.651 179.801 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.47 ' O ' HD23 ' A' ' 430' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.482 HD13 HD13 ' A' ' 378' ' ' ILE . 2.4 mm? -130.18 152.21 49.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.885 -1.362 . . . . 0.0 113.308 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 11.3 p -142.34 113.18 7.43 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.449 HG13 ' HG2' ' A' ' 344' ' ' MET . 21.6 mm -87.09 118.15 32.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.837 -1.165 . . . . 0.0 111.112 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -105.52 95.29 5.71 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.583 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -98.82 137.52 37.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.323 -0.86 . . . . 0.0 110.998 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.618 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 92.1 m95 -109.01 155.05 21.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.848 . . . . 0.0 111.24 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.513 ' CD1' ' SD ' ' A' ' 332' ' ' MET . 53.7 mt -145.63 101.05 4.32 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.541 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 39.8 Cg_endo -63.88 136.98 55.7 Favored 'Trans proline' 0 C--N 1.297 -2.142 0 O-C-N 124.069 1.562 . . . . 0.0 111.836 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.513 ' CG1' ' HD2' ' A' ' 439' ' ' PRO . 89.7 t -81.99 146.23 55.07 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.72 -0.612 . . . . 0.0 110.158 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.513 ' HD2' ' CG1' ' A' ' 438' ' ' VAL . 56.5 Cg_endo . . . . . 0 C--N 1.3 -1.994 0 O-C-N 124.196 1.629 . . . . 0.0 110.121 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.459 ' HG2' ' ND1' ' A' ' 333' ' ' HIS . 43.3 Cg_endo . . . . . 0 C--O 1.215 -0.646 0 CA-C-O 121.432 0.513 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.587 ' HE1' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -88.37 102.92 15.35 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.435 -0.79 . . . . 0.0 109.747 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.0 mt-10 -118.53 -167.59 1.39 Allowed 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.584 -0.697 . . . . 0.0 109.347 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.489 ' HE1' ' O ' ' A' ' 330' ' ' VAL . 1.8 mmt -88.19 124.92 34.32 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.886 -1.134 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -143.33 150.32 39.01 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.441 0.638 . . . . 0.0 111.163 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.528 ' HB3' ' CB ' ' A' ' 303' ' ' ALA . 46.9 t0 -84.44 118.81 24.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.526 ' CD1' HD11 ' A' ' 436' ' ' LEU . 7.1 mt -64.46 -22.56 67.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.968 -1.082 . . . . 0.0 109.726 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.427 ' CG ' ' HB3' ' A' ' 323' ' ' LEU . 48.2 m-20 -81.24 -19.78 42.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 0.0 108.735 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -84.61 -35.9 22.4 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.695 -0.628 . . . . 0.0 109.485 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.495 ' O ' ' CG2' ' A' ' 308' ' ' VAL . 21.5 t -77.25 -34.6 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.494 -0.754 . . . . 0.0 109.267 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 91.9 mt -77.23 -28.65 53.77 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.505 -0.747 . . . . 0.0 109.68 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -63.63 -42.1 98.87 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.62 -30.46 61.67 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.477 -1.014 . . . . 0.0 109.065 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 304' ' ' VAL . 74.4 t -75.22 -21.29 16.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.537 ' CD1' HG13 ' A' ' 358' ' ' VAL . 3.2 mt -77.38 -41.36 29.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -64.07 -17.66 63.61 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -83.31 -43.91 15.48 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.351 0.596 . . . . 0.0 109.866 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.552 ' OE2' ' CG2' ' A' ' 358' ' ' VAL . 6.7 pt-20 -81.67 10.88 5.34 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.359 -0.838 . . . . 0.0 110.306 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 314' ' ' GLY . 60.5 p -117.64 69.64 0.78 Allowed 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 313' ' ' SER . . . -42.59 -30.15 0.85 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 313' ' ' SER . 28.6 t80 -162.69 36.21 0.11 Allowed 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.788 -0.831 . . . . 0.0 109.984 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.34 56.32 8.11 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.092 -1.005 . . . . 0.0 108.538 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -68.31 -55.34 12.46 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-O 121.372 0.606 . . . . 0.0 110.746 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 355' ' ' TRP . 7.4 pt-20 -170.59 58.56 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.862 0 C-N-CA 119.471 -0.892 . . . . 0.0 112.087 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.607 ' CG2' ' CG2' ' A' ' 358' ' ' VAL . 2.2 mp -106.9 125.38 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.788 -1.195 . . . . 0.0 110.225 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.19 116.77 29.18 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 7.6 p -95.25 129.91 42.2 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.418 -0.802 . . . . 0.0 111.173 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.76 79.17 1.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.479 -0.763 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.55 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 5.7 mp -95.06 160.95 14.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.444 -0.785 . . . . 0.0 110.525 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.597 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 83.9 t80 -50.42 129.06 25.16 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.171 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.05 71.76 6.87 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.767 1.404 . . . . 0.0 110.695 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -179.72 28.19 0.05 OUTLIER Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.36 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 326' ' ' GLY . 29.3 m 46.59 99.12 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.079 -1.248 . . . . 0.0 110.209 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.535 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 3.0 mt -69.23 174.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 121.431 -0.793 . . . . 0.0 110.099 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 4.9 mt-10 -168.14 105.44 0.48 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.793 0.806 . . . . 0.0 110.714 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.527 ' CG2' ' SD ' ' A' ' 332' ' ' MET . 9.9 m -133.42 171.45 18.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 O-C-N 121.749 -0.594 . . . . 0.0 109.751 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -87.25 90.9 8.53 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.981 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.527 ' SD ' ' CG2' ' A' ' 330' ' ' VAL . 16.6 ptm -142.58 162.17 36.16 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 111.15 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.587 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 23.6 t-160 -91.56 114.21 61.1 Favored Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 36.3 Cg_endo -58.35 -18.76 39.79 Favored 'Trans proline' 0 C--N 1.295 -2.243 0 O-C-N 123.388 1.204 . . . . 0.0 109.87 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.587 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -84.19 -70.62 0.56 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.392 -0.817 . . . . 0.0 110.735 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 416' ' ' HIS . 10.6 t -51.65 -36.43 46.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 110.569 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.562 HD12 ' CG ' ' A' ' 416' ' ' HIS . 37.3 mm -70.62 -43.04 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 110.091 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 4.7 tppt? -52.28 -35.03 49.11 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 120.911 -1.118 . . . . 0.0 108.866 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.15 -36.33 35.31 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.535 0.683 . . . . 0.0 109.824 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.518 ' CA ' HG12 ' A' ' 409' ' ' VAL . . . -56.0 -48.66 75.49 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.586 -0.697 . . . . 0.0 110.5 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.495 HG13 ' CG1' ' A' ' 308' ' ' VAL . 70.2 t -75.21 -38.33 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.513 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -50.42 -53.99 25.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.325 -0.86 . . . . 0.0 110.748 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -19.81 61.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.103 -0.998 . . . . 0.0 110.512 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 341' ' ' VAL . 0.5 OUTLIER -69.46 -45.17 69.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.121 -0.987 . . . . 0.0 110.529 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.463 HG13 ' HB2' ' A' ' 312' ' ' GLU . 84.4 t -80.09 -20.59 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.431 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 346' ' ' VAL . 25.4 t -60.02 -20.59 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.124 -0.985 . . . . 0.0 110.074 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 0.6 OUTLIER -69.08 -41.88 76.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.314 -0.866 . . . . 0.0 110.475 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.539 ' CB ' ' CB ' ' A' ' 373' ' ' ASP . . . -90.29 -20.39 22.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.92 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -78.3 -52.12 9.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 110.219 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -90.43 -45.61 8.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 110.482 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 347' ' ' ASN . 1.9 m-85 -89.8 -25.88 20.85 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.231 -0.918 . . . . 0.0 110.557 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 348' ' ' ALA . . . -63.96 -135.18 0.01 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -133.83 -48.83 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.205 -1.173 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 356' ' ' ILE . . . -171.48 -87.33 0.07 OUTLIER Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.213 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.444 ' N ' ' CD ' ' A' ' 318' ' ' GLU . 37.3 t90 -42.83 132.6 3.81 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.23 -1.159 . . . . 0.0 112.469 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 319' ' ' ILE . 2.8 mt -125.26 145.66 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.511 ' CB ' ' O ' ' A' ' 372' ' ' GLU . 5.9 tttt -125.54 110.67 14.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.564 -1.335 . . . . 0.0 110.372 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.607 ' CG2' ' CG2' ' A' ' 319' ' ' ILE . 22.1 t -106.24 101.74 12.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 109.266 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 33.8 m -130.02 152.49 49.42 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.55 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.2 OUTLIER -147.07 153.22 39.71 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.63 -0.669 . . . . 0.0 109.697 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -144.27 -160.67 8.59 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 108.394 -1.883 . . . . 0.0 108.394 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.597 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.2 OUTLIER -173.0 178.87 2.41 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.893 -1.357 . . . . 0.0 111.302 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.569 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 3.5 mt-10 -160.89 -178.52 0.89 Allowed Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 38.0 Cg_endo -64.41 135.34 45.72 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.245 1.129 . . . . 0.0 110.341 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.533 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 15.2 p30 39.71 33.71 0.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.764 -0.585 . . . . 0.0 110.562 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER -174.17 94.0 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.258 -0.901 . . . . 0.0 111.421 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.27 151.35 22.79 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.673 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 30.7 p-90 -144.68 174.07 11.29 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.362 -1.461 . . . . 0.0 111.247 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 369' ' ' PHE . 9.2 p90 -148.92 139.33 22.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.671 -0.643 . . . . 0.0 109.408 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 432' ' ' ILE . 50.1 tt0 -130.72 163.94 26.16 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.252 -0.905 . . . . 0.0 111.648 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 372' ' ' GLU . 32.0 t -132.17 156.05 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.607 -0.683 . . . . 0.0 110.01 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 357' ' ' LYS . 10.2 tt0 -149.83 131.46 14.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.074 -1.016 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.539 ' CB ' ' CB ' ' A' ' 348' ' ' ALA . 35.9 m-20 -136.99 162.74 32.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.003 -1.061 . . . . 0.0 110.88 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -87.96 142.17 28.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.963 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 157.63 -168.4 34.31 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.46 -176.66 2.86 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 O-C-N 124.053 1.554 . . . . 0.0 110.692 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -90.49 -131.47 4.78 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.555 HD12 ' CD2' ' A' ' 430' ' ' LEU . 3.1 mm -103.29 145.03 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.041 -1.27 . . . . 0.0 109.93 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 378' ' ' ILE . . . -39.79 160.11 0.11 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.506 -0.746 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.28 -54.23 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.055 1.555 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -75.33 -23.19 57.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.82 . . . . 0.0 110.165 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.412 ' CB ' ' HB2' ' A' ' 379' ' ' ALA . 1.1 tt0 -82.92 -23.25 33.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.953 . . . . 0.0 109.682 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.18 -22.31 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.398 -0.814 . . . . 0.0 110.091 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -87.51 -35.11 18.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 0.0 110.053 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.505 ' ND1' ' N ' ' A' ' 385' ' ' HIS . 2.3 m-70 -80.52 -69.67 0.58 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.218 -0.926 . . . . 0.0 110.647 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 422' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 409' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.526 ' CB ' ' O ' ' A' ' 408' ' ' ILE . 3.7 t 79.22 -27.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.662 0 O-C-N 121.718 -0.614 . . . . 0.0 110.699 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 19.4 tt0 -57.92 -57.53 12.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.89 -1.131 . . . . 0.0 110.139 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -63.53 -34.91 78.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 110.659 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 416' ' ' HIS . 1.4 mp -56.37 -73.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.936 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.517 HG11 ' ND2' ' A' ' 417' ' ' ASN . 85.7 t -50.92 -34.54 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.457 -0.777 . . . . 0.0 110.321 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 0.1 OUTLIER -59.28 -39.39 82.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.206 -0.934 . . . . 0.0 110.138 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.536 ' O ' ' CE ' ' A' ' 296' ' ' MET . 22.5 m-80 -110.61 7.23 22.32 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.406 -0.809 . . . . 0.0 110.304 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.587 ' CD2' ' HE1' ' A' ' 296' ' ' MET . 8.9 m80 -115.98 -56.95 2.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 111.577 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.649 ' HA ' ' CD2' ' A' ' 436' ' ' LEU . 0.0 OUTLIER -98.77 -87.7 0.34 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.986 -1.071 . . . . 0.0 110.944 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 149.74 -37.15 0.97 Allowed Glycine 0 C--N 1.263 -3.488 0 C-N-CA 117.791 -2.147 . . . . 0.0 109.824 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.559 ' HB3' ' HB2' ' A' ' 435' ' ' TRP . 2.7 ttp -117.08 145.6 43.65 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.139 -1.212 . . . . 0.0 111.354 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 420' ' ' LEU . 23.0 tp -151.91 87.13 1.33 Allowed 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -107.94 158.51 17.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.2 -0.937 . . . . 0.0 111.3 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 386' ' ' LEU . 0.3 OUTLIER -108.35 131.86 54.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.59 -0.694 . . . . 0.0 110.785 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 424' ' ' THR . . . -130.66 -177.88 15.13 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.547 ' HB ' ' N ' ' A' ' 431' ' ' SER . 5.4 m . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.152 -1.205 . . . . 0.0 111.079 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.479 ' O ' HG21 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.497 2.732 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.555 ' CD2' HD12 ' A' ' 378' ' ' ILE . 0.2 OUTLIER -141.24 160.38 40.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.55 -0.971 . . . . 0.0 109.737 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.547 ' N ' ' HB ' ' A' ' 424' ' ' THR . 5.1 p -156.48 151.29 25.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.327 -0.858 . . . . 0.0 109.66 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.464 ' O ' ' HG3' ' A' ' 370' ' ' GLN . 12.8 mt -120.35 121.94 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 110.258 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . 0.444 ' HG2' ' CD ' ' A' ' 370' ' ' GLN . 12.0 mtm180 -99.42 122.88 43.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 110.113 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -122.11 133.08 54.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.673 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 86.0 m95 -110.55 135.91 50.49 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.898 -1.126 . . . . 0.0 112.888 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.649 ' CD2' ' HA ' ' A' ' 417' ' ' ASN . 6.9 mt -115.28 87.68 16.8 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 417' ' ' ASN . 47.1 Cg_endo -83.56 121.11 2.9 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 O-C-N 124.041 1.548 . . . . 0.0 111.617 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 2.8 t -74.16 112.31 16.33 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.037 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 52.1 Cg_endo . . . . . 0 C--N 1.307 -1.641 0 O-C-N 123.84 1.442 . . . . 0.0 110.995 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo . . . . . 0 C--O 1.215 -0.657 0 N-CA-C 110.094 -0.772 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.571 ' HE3' ' CD2' ' A' ' 416' ' ' HIS . 1.0 OUTLIER -114.23 105.34 13.05 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 47.0 mt-10 -136.25 -154.06 0.54 Allowed 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.454 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.466 ' HE3' ' CA ' ' A' ' 330' ' ' VAL . 1.6 mmt -87.12 132.67 33.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.921 . . . . 0.0 110.699 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.459 ' HB2' ' SD ' ' A' ' 332' ' ' MET . . . -148.05 158.2 43.93 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.088 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.452 ' O ' HG22 ' A' ' 304' ' ' VAL . 0.7 OUTLIER -90.51 119.46 30.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.759 . . . . 0.0 109.705 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.487 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 8.4 mt -65.77 -19.9 66.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.039 -1.038 . . . . 0.0 109.645 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 302' ' ' ASN . 52.0 t-20 -84.69 -19.98 31.94 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.111 -0.993 . . . . 0.0 108.913 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.9 -36.03 21.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.598 -0.689 . . . . 0.0 109.322 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.461 HG11 ' HG3' ' A' ' 338' ' ' LYS . 22.3 t -78.16 -38.46 23.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.526 -0.734 . . . . 0.0 109.214 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 88.5 mt -76.92 -28.21 55.19 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.424 -0.798 . . . . 0.0 109.991 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.83 -25.24 75.36 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.495 ' O ' ' CB ' ' A' ' 311' ' ' ALA . 3.8 mt-10 -83.85 -33.17 24.9 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.46 -1.023 . . . . 0.0 109.272 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.589 ' CG1' ' CG1' ' A' ' 341' ' ' VAL . 40.2 t -72.45 -28.73 29.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.459 -0.776 . . . . 0.0 109.118 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.546 ' CD1' HG13 ' A' ' 358' ' ' VAL . 4.6 mt -72.58 -57.08 7.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.77 -16.5 64.3 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.82 0.819 . . . . 0.0 109.014 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 307' ' ' GLU . . . -65.94 -66.42 0.55 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.763 -0.586 . . . . 0.0 111.047 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.426 ' HG2' ' C ' ' A' ' 311' ' ' ALA . 4.5 mm-40 -127.47 42.8 3.25 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.871 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.553 ' CB ' HD12 ' A' ' 319' ' ' ILE . 7.0 p -86.11 32.1 0.62 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.878 -1.139 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 315' ' ' TYR . . . 51.68 23.15 9.56 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.548 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 0.2 OUTLIER 70.59 43.65 0.74 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.844 -0.797 . . . . 0.0 110.249 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 74.58 52.02 0.09 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.486 -0.759 . . . . 0.0 110.725 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.428 ' HG3' ' HA3' ' A' ' 314' ' ' GLY . 12.8 mmm180 -68.27 -83.05 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 122.019 0.914 . . . . 0.0 109.144 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -145.82 50.03 1.2 Allowed 'General case' 0 C--N 1.268 -2.971 0 CA-C-O 122.011 0.91 . . . . 0.0 109.886 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.553 HD12 ' CB ' ' A' ' 313' ' ' SER . 5.2 mt -99.46 135.8 33.28 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.24 102.93 14.33 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.32 -0.863 . . . . 0.0 109.43 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.469 HG21 ' CD1' ' A' ' 309' ' ' ILE . 19.0 p -91.63 129.1 37.66 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.409 -0.807 . . . . 0.0 111.293 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . 0.425 ' C ' HD11 ' A' ' 323' ' ' LEU . . . -149.38 78.5 1.38 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.542 HD11 ' N ' ' A' ' 323' ' ' LEU . 6.5 mp -95.12 154.46 17.17 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.442 -0.786 . . . . 0.0 110.277 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.585 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 20.7 t80 -40.36 120.13 1.58 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.695 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -79.18 69.42 7.93 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.878 1.462 . . . . 0.0 111.366 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . -172.23 -76.46 0.05 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.6 OUTLIER 167.52 108.96 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.525 -0.985 . . . . 0.0 109.359 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.527 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 3.8 mt -87.66 178.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 O-C-N 121.468 -0.77 . . . . 0.0 109.995 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.5 mt-10 -171.58 102.26 0.19 Allowed 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.566 0.698 . . . . 0.0 110.297 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.53 HG13 ' CG2' ' A' ' 438' ' ' VAL . 21.3 m -133.86 158.54 42.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.943 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.3 OUTLIER -79.41 98.81 6.9 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.553 ' CE ' HG13 ' A' ' 337' ' ' ILE . 4.9 ppp? -139.93 172.7 12.4 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.188 -0.945 . . . . 0.0 112.194 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.491 ' NE2' ' HB3' ' A' ' 335' ' ' LEU . 21.9 t-160 -106.92 114.62 61.4 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 37.7 Cg_endo -61.17 -21.14 70.76 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.405 1.213 . . . . 0.0 111.04 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.491 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 1.9 tp -87.78 -54.62 4.16 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.984 -1.072 . . . . 0.0 110.141 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 412' ' ' ILE . 0.4 OUTLIER -63.83 -25.13 68.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.286 -0.884 . . . . 0.0 110.661 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.595 ' CD1' ' CE1' ' A' ' 416' ' ' HIS . 32.0 mm -85.34 -42.56 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.633 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 11.9 mtmt -57.86 -34.91 70.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 108.06 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -72.43 -43.77 63.35 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.526 0.679 . . . . 0.0 109.991 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.53 ' HB3' ' CG2' ' A' ' 412' ' ' ILE . . . -60.89 -30.66 70.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.505 -0.747 . . . . 0.0 110.973 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.589 ' CG1' ' CG1' ' A' ' 308' ' ' VAL . 98.7 t -78.62 -40.18 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.069 -1.019 . . . . 0.0 110.541 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.94 98.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -0.898 . . . . 0.0 110.828 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . 0.456 ' O ' HG11 ' A' ' 346' ' ' VAL . 1.3 t30 -58.71 -20.35 48.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.258 -0.901 . . . . 0.0 110.981 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.8 mtt -84.53 -57.64 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.054 -1.029 . . . . 0.0 110.504 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.419 ' O ' ' HB1' ' A' ' 349' ' ' ALA . 5.4 p -63.73 -19.49 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.303 -0.873 . . . . 0.0 110.756 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 343' ' ' ASN . 9.5 p -64.64 -19.99 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.083 -1.011 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -74.07 -55.86 5.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.101 -0.999 . . . . 0.0 110.415 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -76.19 -19.56 58.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 110.623 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 345' ' ' VAL . . . -71.12 -50.72 30.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 0.0 109.992 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 346' ' ' VAL . 6.7 mmm180 -53.6 -69.18 0.13 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -0.936 . . . . 0.0 109.715 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.57 -53.92 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 109.888 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 86.13 65.3 1.43 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -64.57 -48.89 73.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -1.204 . . . . 0.0 110.099 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . 150.92 -7.52 0.66 Allowed Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.302 -1.428 . . . . 0.0 111.205 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 40.6 t90 -162.83 138.22 6.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.374 -1.662 . . . . 0.0 112.658 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.518 ' HB ' ' CG1' ' A' ' 319' ' ' ILE . 3.1 mt -128.3 164.87 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 372' ' ' GLU . 2.8 tttt -147.06 134.86 21.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.477 -1.389 . . . . 0.0 111.389 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.546 HG13 ' CD1' ' A' ' 309' ' ' ILE . 11.0 t -133.77 82.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 55.9 p -116.27 136.15 53.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.289 -0.882 . . . . 0.0 110.536 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.434 ' OG ' HD11 ' A' ' 305' ' ' LEU . 0.8 OUTLIER -137.38 158.69 43.85 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.622 -0.673 . . . . 0.0 109.914 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -146.74 -150.26 5.15 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.585 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -165.55 177.46 7.38 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.21 -1.171 . . . . 0.0 110.077 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -152.88 175.89 2.71 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 110.165 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.7 Cg_endo -70.18 117.24 4.99 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.895 1.471 . . . . 0.0 110.892 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 48.0 t30 71.99 19.54 4.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.381 -0.824 . . . . 0.0 110.972 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 6.5 ptt180 173.73 127.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.431 -0.793 . . . . 0.0 110.834 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -114.45 -179.55 3.66 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.611 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 28.0 p-90 -169.23 162.39 10.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.449 -1.407 . . . . 0.0 110.968 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 37.9 p90 -131.6 158.66 40.44 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.524 ' NE2' ' HG2' ' A' ' 433' ' ' ARG . 4.1 mt-30 -144.89 151.35 38.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.858 -1.151 . . . . 0.0 112.228 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.492 HG11 ' N ' ' A' ' 372' ' ' GLU . 57.2 t -129.88 155.03 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.492 ' N ' HG11 ' A' ' 371' ' ' VAL . 5.3 mt-10 -145.05 159.43 42.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.944 -1.098 . . . . 0.0 109.987 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 430' ' ' LEU . 2.5 p30 -147.09 153.04 39.48 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.019 -1.05 . . . . 0.0 110.886 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.22 135.83 51.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.343 -0.848 . . . . 0.0 110.095 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 144.17 173.02 15.24 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.28 -166.83 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.846 1.445 . . . . 0.0 110.38 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -92.65 175.01 36.82 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.538 HG13 ' CD2' ' A' ' 430' ' ' LEU . 3.4 mt -70.07 144.23 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -1.107 . . . . 0.0 110.138 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.445 ' HB2' ' HG3' ' A' ' 382' ' ' GLN . . . -74.13 153.94 88.48 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.141 -0.974 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.68 -21.75 21.5 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.861 1.453 . . . . 0.0 110.25 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . 0.414 ' O ' ' CD2' ' A' ' 385' ' ' HIS . 10.8 tt0 -90.65 -30.96 16.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.266 -0.897 . . . . 0.0 110.605 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.501 ' O ' HD11 ' A' ' 386' ' ' LEU . 1.2 mt-30 -90.16 -18.83 25.06 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.31 -0.869 . . . . 0.0 110.806 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 45.7 ttp85 -52.72 -54.59 31.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.217 -0.927 . . . . 0.0 110.769 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -19.97 8.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.129 -0.982 . . . . 0.0 110.407 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.526 ' N ' ' CD2' ' A' ' 385' ' ' HIS . 8.4 m-70 -91.51 28.43 1.72 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.275 -0.891 . . . . 0.0 111.049 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.501 HD11 ' O ' ' A' ' 382' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 O-C-N 120.934 -1.104 . . . . 0.0 110.728 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 408' ' ' ILE . 9.1 tp . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.315 0.578 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 408' ' ' ILE . 9.1 t -160.87 -37.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.183 -0.948 . . . . 0.0 109.863 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 59.4 tt0 -67.9 -57.43 6.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.128 -0.982 . . . . 0.0 109.687 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.4 OUTLIER -56.11 -18.73 10.65 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.245 -0.909 . . . . 0.0 110.297 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 340' ' ' ALA . 18.1 mm -63.47 -71.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.113 -0.992 . . . . 0.0 109.538 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 419' ' ' MET . 10.8 t -64.36 -21.3 28.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 109.23 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 4.8 t0 -81.22 -20.41 41.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.512 -0.743 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 1.4 m120 -77.5 -23.73 50.24 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.595 ' CE1' ' CD1' ' A' ' 337' ' ' ILE . 55.2 m80 -91.24 -17.14 26.49 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.703 -0.623 . . . . 0.0 109.367 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 34.4 m120 67.82 10.49 7.83 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.327 0.584 . . . . 0.0 110.317 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 435' ' ' TRP . . . -69.86 -87.55 0.11 Allowed Glycine 0 N--CA 1.482 1.726 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.55 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.3 OUTLIER 178.02 166.08 0.73 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 111.208 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 42.5 tp -151.56 118.81 5.94 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 109.324 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -129.03 147.86 50.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.969 -1.082 . . . . 0.0 111.356 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.95 127.3 45.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.433 -0.792 . . . . 0.0 109.311 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -176.85 -176.18 44.78 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.807 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 74.6 m . . . . . 0 C--N 1.299 -1.607 0 O-C-N 121.379 -1.071 . . . . 0.0 110.387 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.505 3.244 0 CA-C-O 122.426 1.015 . . . . 0.0 113.224 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.538 ' CD2' HG13 ' A' ' 378' ' ' ILE . 0.2 OUTLIER -35.19 123.21 0.6 Allowed 'General case' 0 N--CA 1.515 2.777 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.436 ' N ' HD12 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -153.76 115.22 4.18 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.406 ' C ' ' HG3' ' A' ' 433' ' ' ARG . 31.8 mt -97.55 145.59 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 110.722 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . 0.524 ' HG2' ' NE2' ' A' ' 370' ' ' GLN . 20.2 mtp180 -126.76 144.11 51.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 109.87 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -139.77 132.68 29.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.615 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.611 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 87.5 m95 -111.46 157.98 19.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.044 -1.035 . . . . 0.0 112.082 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.429 ' HG ' ' C ' ' A' ' 435' ' ' TRP . 75.4 mt -147.26 127.62 6.84 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.422 ' C ' ' HD3' ' A' ' 439' ' ' PRO . 43.1 Cg_endo -70.13 141.41 43.68 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.522 1.275 . . . . 0.0 111.845 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.53 ' CG2' HG13 ' A' ' 330' ' ' VAL . 53.7 t -110.67 74.05 0.88 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.577 -0.702 . . . . 0.0 110.416 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.422 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 49.1 Cg_endo . . . . . 0 C--N 1.305 -1.742 0 O-C-N 123.829 1.436 . . . . 0.0 110.979 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.583 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 46.3 Cg_endo . . . . . 0 CA--C 1.508 -0.804 0 N-CA-C 109.871 -0.857 . . . . 0.0 109.871 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.429 ' HE2' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -109.49 109.26 20.03 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.4 OUTLIER -148.14 -146.93 0.21 Allowed 'General case' 0 C--N 1.273 -2.737 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.468 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.1 OUTLIER -88.04 144.86 26.28 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.227 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.98 162.84 40.83 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.358 -0.839 . . . . 0.0 111.201 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -94.32 118.76 32.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.543 -0.723 . . . . 0.0 109.363 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.539 HD22 ' CE ' ' A' ' 332' ' ' MET . 5.5 mt -69.82 -21.46 63.38 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.949 -1.095 . . . . 0.0 109.765 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.481 ' HA ' HD22 ' A' ' 323' ' ' LEU . 55.9 t-20 -84.99 -20.04 31.13 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.092 -1.005 . . . . 0.0 108.86 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.32 -34.63 18.8 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.546 0.689 . . . . 0.0 109.506 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.438 ' O ' HG21 ' A' ' 308' ' ' VAL . 18.0 t -80.42 -31.43 12.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.411 -0.805 . . . . 0.0 109.245 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 62.9 mt -80.52 -30.68 37.2 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.433 -0.792 . . . . 0.0 109.969 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -69.52 -32.48 71.38 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 311' ' ' ALA . 1.2 mt-10 -78.1 -34.29 50.19 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.405 -1.056 . . . . 0.0 109.043 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.534 ' CG1' ' HB ' ' A' ' 341' ' ' VAL . 88.2 t -78.87 -19.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 121.664 0.745 . . . . 0.0 109.531 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 313' ' ' SER . 0.0 OUTLIER -75.79 -44.09 39.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 122.052 0.93 . . . . 0.0 108.617 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.502 ' N ' HG21 ' A' ' 309' ' ' ILE . . . -91.06 -16.55 27.69 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.282 -0.886 . . . . 0.0 109.735 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 307' ' ' GLU . . . -60.42 -62.38 1.9 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.668 -0.645 . . . . 0.0 110.838 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.419 ' CD ' ' HB2' ' A' ' 342' ' ' ALA . 2.7 pt-20 -145.99 38.06 1.08 Allowed 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.94 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.56 ' CB ' HD12 ' A' ' 319' ' ' ILE . 6.9 m -91.4 31.41 1.16 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 109.339 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 94.36 21.23 27.66 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 3.0 m-85 62.46 45.55 6.34 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.674 -0.898 . . . . 0.0 109.735 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 1.9 mt-10 59.44 43.24 16.6 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.562 ' CG ' ' N ' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -69.07 -84.98 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.571 0.701 . . . . 0.0 110.041 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.562 ' N ' ' CG ' ' A' ' 317' ' ' ARG . 38.8 mt-10 -136.35 67.81 1.45 Allowed 'General case' 0 C--N 1.275 -2.653 0 CA-C-O 121.608 0.718 . . . . 0.0 111.027 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.56 HD12 ' CB ' ' A' ' 313' ' ' SER . 2.6 mp -113.13 129.08 69.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.712 -0.618 . . . . 0.0 109.632 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 358' ' ' VAL . 1.5 tt0 -89.1 100.73 13.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.072 -1.018 . . . . 0.0 109.321 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.493 ' CG2' HD12 ' A' ' 309' ' ' ILE . 19.9 p -92.17 130.31 37.92 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.781 0.801 . . . . 0.0 111.697 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.12 78.61 1.34 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.546 HD11 ' N ' ' A' ' 323' ' ' LEU . 0.9 OUTLIER -89.34 160.51 16.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 111.002 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 50.8 t80 -59.49 119.4 39.45 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.548 -0.72 . . . . 0.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.22 73.0 5.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.889 1.468 . . . . 0.0 110.573 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -172.06 27.48 0.1 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 326' ' ' GLY . 0.8 OUTLIER 47.12 96.79 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.186 -1.185 . . . . 0.0 110.145 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.542 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 3.1 mt -73.06 -179.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.658 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.2 mt-10 -169.48 107.66 0.4 Allowed 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.91 0.862 . . . . 0.0 111.128 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.515 ' CG1' ' HB1' ' A' ' 367' ' ' ALA . 31.6 m -141.38 153.13 19.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 5.3 tptt -67.55 97.87 0.63 Allowed 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 118.359 -1.336 . . . . 0.0 107.9 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.539 ' CE ' HD22 ' A' ' 301' ' ' LEU . 4.9 ttp -139.69 173.6 11.37 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.469 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.59 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 23.7 t-160 -117.11 113.26 39.45 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 37.5 Cg_endo -59.9 -20.08 58.07 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.553 1.291 . . . . 0.0 110.634 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.59 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -79.24 -63.01 1.52 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.305 -0.872 . . . . 0.0 110.212 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 412' ' ' ILE . 27.1 p -55.77 -46.93 77.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.108 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.599 HD12 ' CE1' ' A' ' 416' ' ' HIS . 23.6 mm -63.34 -32.35 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.386 -0.821 . . . . 0.0 110.05 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 10.3 mttt -59.27 -45.7 90.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.041 -1.037 . . . . 0.0 109.5 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -31.82 63.59 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.843 -0.536 . . . . 0.0 110.745 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.462 ' O ' HG13 ' A' ' 409' ' ' VAL . . . -65.03 -45.24 86.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.155 -0.965 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.534 ' HB ' ' CG1' ' A' ' 308' ' ' VAL . 16.0 t -81.1 -22.21 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 110.291 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.419 ' HB2' ' CD ' ' A' ' 312' ' ' GLU . . . -71.37 -34.73 70.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.325 -0.859 . . . . 0.0 110.682 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -83.27 -19.72 35.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.204 -0.935 . . . . 0.0 110.559 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.529 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 0.1 OUTLIER -75.36 -31.32 60.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.179 -0.951 . . . . 0.0 111.063 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.468 HG12 ' HB3' ' A' ' 313' ' ' SER . 9.6 t -90.66 -20.26 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.956 -1.09 . . . . 0.0 110.608 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.408 ' O ' HG11 ' A' ' 346' ' ' VAL . 47.9 t -77.25 -20.95 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 0.0 110.908 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 344' ' ' MET . 2.8 p30 -78.11 -38.81 43.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.97 -1.081 . . . . 0.0 110.715 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 347' ' ' ASN . . . -90.24 -20.74 22.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.123 -0.986 . . . . 0.0 110.464 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -78.1 -26.66 48.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.132 -0.98 . . . . 0.0 110.68 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -89.05 -71.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -0.962 . . . . 0.0 110.694 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -75.69 -32.26 60.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 110.52 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.481 ' CA ' ' HA2' ' A' ' 375' ' ' GLY . . . -65.87 172.04 25.52 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -67.82 0.37 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -1.116 . . . . 0.0 110.052 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 318' ' ' GLU . . . 163.26 40.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -140.37 120.98 14.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.062 -1.258 . . . . 0.0 110.866 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 319' ' ' ILE . 1.8 mp -123.37 124.21 69.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.647 -0.658 . . . . 0.0 109.339 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 372' ' ' GLU . 0.0 OUTLIER -89.46 105.08 17.56 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.981 -1.075 . . . . 0.0 109.895 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.526 ' CG1' HD13 ' A' ' 309' ' ' ILE . 74.8 t -102.5 120.28 52.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.316 -0.865 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.412 ' OG ' ' HD3' ' A' ' 357' ' ' LYS . 0.9 OUTLIER -145.84 140.34 27.0 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.214 -0.929 . . . . 0.0 110.206 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 369' ' ' PHE . 8.9 t -132.49 135.5 46.06 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.466 -0.771 . . . . 0.0 109.99 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -130.88 -160.71 10.05 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.64 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -173.51 165.39 4.63 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.913 -1.346 . . . . 0.0 111.336 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.477 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 1.0 OUTLIER -147.94 178.12 1.56 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.6 Cg_endo -71.71 110.85 2.99 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.713 1.375 . . . . 0.0 110.599 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 1.4 t-20 74.96 27.15 1.2 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.383 -0.823 . . . . 0.0 110.99 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 0.2 OUTLIER 179.13 97.39 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.257 -0.902 . . . . 0.0 111.667 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -99.62 166.84 10.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.149 -0.97 . . . . 0.0 108.396 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.688 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 40.9 p-90 -164.89 174.41 10.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.437 -1.414 . . . . 0.0 111.862 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.547 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 51.8 p90 -150.11 129.36 12.82 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -112.24 155.23 24.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.146 -0.972 . . . . 0.0 111.236 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.464 HG21 ' HB ' ' A' ' 432' ' ' ILE . 0.7 OUTLIER -138.07 126.48 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.598 -0.689 . . . . 0.0 109.877 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 357' ' ' LYS . 18.9 tt0 -128.31 106.14 8.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.249 -0.907 . . . . 0.0 109.79 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 356' ' ' ILE . 15.7 p30 -120.02 167.65 11.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.957 -1.089 . . . . 0.0 110.421 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -108.06 101.21 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.385 -0.822 . . . . 0.0 110.501 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . 0.481 ' HA2' ' CA ' ' A' ' 352' ' ' GLY . . . -116.12 -138.97 6.5 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.77 -60.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.017 1.535 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 119.69 -179.56 16.6 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.545 HD12 ' CD1' ' A' ' 430' ' ' LEU . 1.4 mm -110.59 93.94 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.279 . . . . 0.0 109.998 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.52 ' HB2' ' HD2' ' A' ' 380' ' ' PRO . . . -44.38 167.11 0.1 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 379' ' ' ALA . 42.1 Cg_endo -68.19 -28.24 34.27 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.564 1.297 . . . . 0.0 110.666 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -90.88 -19.91 22.84 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.111 -0.993 . . . . 0.0 111.655 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.491 ' HG3' ' HB1' ' A' ' 379' ' ' ALA . 2.5 mt-30 -80.86 -20.01 43.24 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.84 -1.162 . . . . 0.0 111.542 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.55 -24.27 20.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.91 -1.119 . . . . 0.0 110.746 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -75.52 -33.77 60.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.005 -1.059 . . . . 0.0 110.25 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -88.32 54.4 3.05 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.176 -0.953 . . . . 0.0 110.2 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.307 -1.273 0 O-C-N 121.019 -1.05 . . . . 0.0 111.095 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.51 ' O ' ' CD1' ' A' ' 412' ' ' ILE . 2.9 mp . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.335 0.588 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.465 ' HA ' HD11 ' A' ' 412' ' ' ILE . 27.4 m -122.36 -7.94 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.319 -0.863 . . . . 0.0 109.859 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 48.2 tt0 -74.47 -50.07 19.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.196 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -20.99 66.17 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.427 -0.796 . . . . 0.0 110.157 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 408' ' ' ILE . 1.1 mp -71.19 -63.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.269 -0.894 . . . . 0.0 108.726 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' A' ' 420' ' ' LEU . 15.5 t -64.14 -21.71 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.638 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 1.9 m-20 -79.23 -32.7 43.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.408 -0.808 . . . . 0.0 109.814 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -78.72 -28.33 45.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 109.33 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.599 ' CE1' HD12 ' A' ' 337' ' ' ILE . 30.2 m80 -81.62 -38.8 25.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.414 -0.804 . . . . 0.0 109.391 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 1.0 OUTLIER 82.24 45.24 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 CA-C-O 121.364 0.602 . . . . 0.0 110.943 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.527 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -112.28 -88.62 1.78 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.571 ' CE ' ' CD1' ' A' ' 435' ' ' TRP . 28.5 ttp -178.66 157.82 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -1.205 . . . . 0.0 112.254 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.461 ' HB2' HG13 ' A' ' 413' ' ' VAL . 57.0 tp -153.02 95.6 1.99 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 0.5 OUTLIER -115.86 155.89 27.1 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.759 -1.213 . . . . 0.0 112.786 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.49 ' CD1' HG12 ' A' ' 432' ' ' ILE . 2.7 tp -106.15 140.21 39.47 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -141.81 83.01 0.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 430' ' ' LEU . 20.5 m . . . . . 0 C--N 1.302 -1.47 0 O-C-N 121.254 -1.145 . . . . 0.0 110.85 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.579 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.545 ' CD1' HD12 ' A' ' 378' ' ' ILE . 0.2 OUTLIER -70.5 121.46 17.84 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.12 -1.224 . . . . 0.0 110.151 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.54 ' O ' ' CG1' ' A' ' 432' ' ' ILE . 3.0 t -122.23 177.03 5.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.943 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.54 ' CG1' ' O ' ' A' ' 431' ' ' SER . 10.1 mt -156.92 114.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.254 -0.904 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -90.57 100.69 13.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.346 -0.846 . . . . 0.0 110.334 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.547 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -94.65 132.04 39.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.134 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.688 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.5 m95 -116.38 156.74 26.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.784 -1.198 . . . . 0.0 113.098 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.513 ' CD1' ' SD ' ' A' ' 332' ' ' MET . 67.8 mt -146.34 100.81 4.11 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.527 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 44.9 Cg_endo -71.53 143.82 43.49 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 123.961 1.506 . . . . 0.0 112.441 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 438' ' ' VAL . 5.9 p -117.5 122.78 30.51 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.304 -1.798 0 O-C-N 123.77 1.405 . . . . 0.0 110.657 -179.922 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.564 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 48.5 Cg_endo . . . . . 0 CA--C 1.51 -0.718 0 N-CA-C 110.164 -0.745 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.634 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -93.41 110.17 21.73 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.076 0.941 . . . . 0.0 108.9 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.4 mt-10 -133.27 -172.4 2.94 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.824 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.496 ' HA ' ' HA ' ' A' ' 331' ' ' LYS . 0.1 OUTLIER -87.48 140.35 29.62 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.759 0.79 . . . . 0.0 109.958 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -157.36 169.31 25.02 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.435 0.636 . . . . 0.0 110.037 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -96.14 119.51 34.75 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.561 -0.712 . . . . 0.0 109.171 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.533 ' HB2' ' CG1' ' A' ' 328' ' ' ILE . 8.1 mt -62.24 -25.6 67.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.997 -1.064 . . . . 0.0 109.299 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.439 ' HA ' ' CD2' ' A' ' 323' ' ' LEU . 55.1 t-20 -76.19 -23.24 54.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.977 -1.077 . . . . 0.0 108.503 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -82.92 -33.48 26.83 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.453 HG11 ' HD3' ' A' ' 338' ' ' LYS . 47.8 t -74.94 -38.34 43.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.616 0.722 . . . . 0.0 109.161 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.531 ' CD2' HG23 ' A' ' 341' ' ' VAL . 92.2 mt -75.13 -27.06 59.64 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.466 -0.772 . . . . 0.0 109.982 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.43 -35.9 92.52 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.52 -34.31 54.07 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.417 -1.049 . . . . 0.0 108.673 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.534 HG13 ' CG1' ' A' ' 341' ' ' VAL . 50.7 t -75.68 -18.6 15.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 121.554 0.692 . . . . 0.0 109.148 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.507 ' HA ' ' OE2' ' A' ' 312' ' ' GLU . 1.4 mt -78.77 -45.0 25.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.5 -18.27 65.19 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -91.19 -34.08 15.15 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.766 -0.584 . . . . 0.0 111.144 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.507 ' OE2' ' HA ' ' A' ' 309' ' ' ILE . 18.9 pt-20 -86.15 16.95 3.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.083 -1.011 . . . . 0.0 110.723 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 309' ' ' ILE . 3.5 m -122.57 67.66 0.95 Allowed 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -56.67 -42.63 91.16 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 0.3 OUTLIER -136.79 24.01 3.1 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.307 -1.114 . . . . 0.0 111.004 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 2.5 mt-10 60.96 57.46 2.56 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.915 -1.116 . . . . 0.0 108.441 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.417 ' HB2' HD13 ' A' ' 356' ' ' ILE . 19.4 mmm180 -66.51 -76.08 0.08 Allowed 'General case' 0 C--N 1.278 -2.526 0 CA-C-O 121.616 0.722 . . . . 0.0 109.722 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.469 ' HG3' ' HA ' ' A' ' 355' ' ' TRP . 7.1 pt-20 -170.52 56.67 0.03 OUTLIER 'General case' 0 C--N 1.265 -3.086 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.539 ' CG2' HG22 ' A' ' 358' ' ' VAL . 1.8 mp -91.28 129.76 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.444 -0.903 . . . . 0.0 109.974 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -104.3 111.05 23.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.232 -0.918 . . . . 0.0 109.673 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 17.7 p -89.01 126.9 35.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.3 -0.875 . . . . 0.0 110.702 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . 0.457 ' HB2' ' OG ' ' A' ' 359' ' ' SER . . . -149.36 79.54 1.4 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.576 -0.702 . . . . 0.0 109.341 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 323' ' ' LEU . 4.7 mp -95.33 150.22 20.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.488 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.542 ' HB2' ' HA2' ' A' ' 361' ' ' GLY . 89.6 t80 -37.33 129.88 0.82 Allowed Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.576 -0.703 . . . . 0.0 110.678 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.39 82.66 1.35 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.924 1.486 . . . . 0.0 109.515 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . 162.56 -11.13 0.1 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.682 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.2 OUTLIER 79.85 120.55 0.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.329 -1.101 . . . . 0.0 109.951 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.533 ' CG1' ' HB2' ' A' ' 301' ' ' LEU . 1.6 mm -72.29 -176.02 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 CA-C-O 121.704 0.764 . . . . 0.0 109.93 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 3.2 mt-10 -170.19 105.19 0.3 Allowed 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.561 0.696 . . . . 0.0 109.953 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 298' ' ' MET . 2.7 m -150.52 169.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-O 121.541 0.686 . . . . 0.0 110.653 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -96.63 94.02 7.09 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.58 ' HG3' ' CE1' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -148.44 133.65 18.37 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.764 0.792 . . . . 0.0 110.027 -179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.564 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 19.1 t-160 -55.48 113.17 5.12 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.722 -0.611 . . . . 0.0 109.913 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.5 -19.56 54.75 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.816 1.429 . . . . 0.0 110.096 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.559 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -74.59 -68.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 0.0 109.835 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.496 ' CB ' HD11 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -47.56 -40.9 20.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.557 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.535 HG13 ' CG ' ' A' ' 332' ' ' MET . 11.9 mm -64.15 -46.83 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 109.316 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.527 ' HG3' ' CG2' ' A' ' 308' ' ' VAL . 0.0 OUTLIER -43.72 -47.67 7.88 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.355 -0.841 . . . . 0.0 109.555 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -70.67 -35.45 72.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.569 -0.707 . . . . 0.0 110.641 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -58.66 -32.34 69.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.414 -0.804 . . . . 0.0 111.089 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.534 ' CG1' HG13 ' A' ' 308' ' ' VAL . 32.3 t -90.24 -28.24 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.97 -1.081 . . . . 0.0 111.009 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.73 -19.68 57.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.976 -1.078 . . . . 0.0 110.753 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.3 -19.74 23.72 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.116 -0.99 . . . . 0.0 110.992 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.467 ' SD ' ' HB ' ' A' ' 432' ' ' ILE . 6.3 mtt -82.23 -23.76 35.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.09 -1.006 . . . . 0.0 111.357 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.456 HG13 ' OE1' ' A' ' 312' ' ' GLU . 28.0 m -90.7 -23.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.044 -1.035 . . . . 0.0 111.395 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 347' ' ' ASN . 0.4 OUTLIER -62.88 -29.96 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.914 -1.116 . . . . 0.0 110.533 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 351' ' ' TYR . 66.3 t30 -65.77 -34.16 77.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.179 -0.951 . . . . 0.0 110.438 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 373' ' ' ASP . . . -89.72 -22.97 21.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 110.507 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.31 -51.44 60.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.108 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 351' ' ' TYR . 4.1 mmt180 -90.5 -65.28 1.03 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.299 -0.876 . . . . 0.0 110.872 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . 0.498 ' CB ' ' O ' ' A' ' 347' ' ' ASN . 0.9 OUTLIER -38.54 -72.0 0.07 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.381 -0.824 . . . . 0.0 110.74 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -129.5 100.6 0.5 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 353' ' ' ASN . 6.3 p30 -86.38 86.42 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -1.151 . . . . 0.0 109.789 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . 0.451 ' O ' ' OE1' ' A' ' 318' ' ' GLU . . . -123.16 -35.35 0.72 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.581 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 14.3 t90 179.81 124.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.031 -1.276 . . . . 0.0 110.863 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 319' ' ' ILE . 1.5 mt -105.98 143.71 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.581 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 13.4 tttt -134.43 106.44 7.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.827 -1.171 . . . . 0.0 111.359 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.539 HG22 ' CG2' ' A' ' 319' ' ' ILE . 88.8 t -98.52 83.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 370' ' ' GLN . 30.2 t -116.39 141.36 48.27 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.357 -0.839 . . . . 0.0 111.272 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.523 ' OG ' ' CD1' ' A' ' 305' ' ' LEU . 3.9 m -134.23 168.29 19.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 109.124 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -161.77 -159.47 10.18 Favored Glycine 0 C--N 1.292 -1.868 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -177.18 164.39 2.2 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.369 -1.077 . . . . 0.0 110.032 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 3.9 mt-10 -141.72 -179.83 1.06 Allowed Pre-proline 0 C--N 1.29 -2.0 0 O-C-N 121.636 -0.665 . . . . 0.0 109.522 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 44.3 Cg_endo -71.63 116.8 4.85 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.682 1.359 . . . . 0.0 111.191 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 2.2 m120 80.01 25.41 0.37 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.874 -0.517 . . . . 0.0 111.509 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.586 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 167.34 111.67 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.319 -0.863 . . . . 0.0 111.473 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -104.41 174.65 5.78 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.194 -0.941 . . . . 0.0 108.876 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.629 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 47.8 p-90 -170.84 174.76 4.73 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.402 -1.436 . . . . 0.0 111.475 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 434' ' ' ALA . 34.2 p90 -144.21 134.72 24.71 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 14.3 tt0 -127.54 149.76 50.0 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.938 -1.101 . . . . 0.0 112.432 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.507 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 98.4 t -125.23 135.04 65.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -130.03 147.16 51.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 109.946 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.504 ' HB2' ' HB3' ' A' ' 348' ' ' ALA . 40.6 p30 -143.51 157.99 44.0 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 375' ' ' GLY . 0.8 OUTLIER -91.67 159.54 15.81 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 110.077 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 374' ' ' ASP . . . 135.3 -159.4 24.05 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.65 157.48 48.37 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.894 1.471 . . . . 0.0 110.397 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . 0.415 ' HA2' ' HA2' ' A' ' 429' ' ' GLY . . . -87.59 -144.76 9.38 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 378' ' ' ILE . 0.7 OUTLIER -106.2 98.03 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.144 -1.21 . . . . 0.0 109.486 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -52.33 171.75 0.2 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.524 -0.735 . . . . 0.0 110.99 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.55 -47.38 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 124.134 1.597 . . . . 0.0 109.458 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -25.07 68.2 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.408 -0.807 . . . . 0.0 109.094 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -20.62 27.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.506 -0.746 . . . . 0.0 109.556 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 386' ' ' LEU . 0.2 OUTLIER -60.85 -32.88 72.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.467 -0.771 . . . . 0.0 109.709 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -24.29 51.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 109.599 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.512 ' ND1' ' N ' ' A' ' 385' ' ' HIS . 1.8 m-70 -100.3 49.31 0.91 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.399 -0.813 . . . . 0.0 109.656 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 383' ' ' ARG . 1.5 tp . . . . . 0 C--N 1.304 -1.412 0 O-C-N 121.307 -0.871 . . . . 0.0 109.451 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.061 0.457 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' ' 410' ' ' GLN . 10.9 m -53.58 -22.13 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.14 -0.975 . . . . 0.0 110.461 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 0.1 OUTLIER -64.52 -47.43 78.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.215 -0.928 . . . . 0.0 109.88 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.46 ' HA ' ' HB2' ' A' ' 414' ' ' ASP . 0.0 OUTLIER -66.75 -27.76 67.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -0.873 . . . . 0.0 109.683 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.496 HD11 ' CB ' ' A' ' 336' ' ' SER . 31.0 mm -63.67 -60.37 2.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.441 HG23 ' CD1' ' A' ' 420' ' ' LEU . 45.7 t -65.8 -23.08 31.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.182 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 0.5 OUTLIER -75.19 -25.87 58.58 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.44 ' OD1' ' HE1' ' A' ' 296' ' ' MET . 0.9 OUTLIER -80.47 -19.55 45.74 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.635 ' O ' ' CB ' ' A' ' 417' ' ' ASN . 32.8 m80 -96.28 -76.18 0.51 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.807 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.635 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 4.3 m-20 127.29 26.81 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.596 0 C-N-CA 123.948 0.899 . . . . 0.0 109.297 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 435' ' ' TRP . . . -86.4 -103.41 0.77 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.573 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 18.4 ttm -165.74 161.85 18.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -1.143 . . . . 0.0 110.638 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.441 ' CD1' HG23 ' A' ' 413' ' ' VAL . 4.8 tp -151.86 96.32 2.21 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.983 -1.073 . . . . 0.0 109.223 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.12 155.73 43.96 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.978 -1.076 . . . . 0.0 111.603 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.6 146.28 23.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.556 -0.715 . . . . 0.0 110.354 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -133.5 99.88 0.38 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.577 ' HA ' ' CB ' ' A' ' 430' ' ' LEU . 17.6 m . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.186 -1.185 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.486 2.009 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.631 ' CD1' ' N ' ' A' ' 430' ' ' LEU . 0.0 OUTLIER -175.33 -173.25 0.64 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.169 -1.195 . . . . 0.0 111.786 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.505 ' N ' ' CD2' ' A' ' 430' ' ' LEU . 24.9 p -154.28 150.16 27.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.467 ' HB ' ' SD ' ' A' ' 344' ' ' MET . 24.2 mm -90.52 121.01 40.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 120.717 -1.24 . . . . 0.0 111.149 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -98.3 96.15 7.86 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.551 -0.718 . . . . 0.0 109.323 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 369' ' ' PHE . . . -97.0 143.71 27.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.613 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.629 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 88.0 m95 -120.08 157.72 28.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.264 -0.897 . . . . 0.0 112.136 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 38.1 mt -145.44 125.26 7.01 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.9 139.69 43.96 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 123.59 1.31 . . . . 0.0 111.358 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.532 ' CG2' ' HD2' ' A' ' 439' ' ' PRO . 7.2 p -99.16 146.79 32.31 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.535 -0.728 . . . . 0.0 110.404 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 438' ' ' VAL . 50.3 Cg_endo . . . . . 0 C--N 1.306 -1.679 0 O-C-N 123.979 1.515 . . . . 0.0 109.773 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.485 0.971 0 CA-C-O 121.244 0.435 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.486 ' HE3' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -71.9 105.84 3.99 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 5.1 mt-10 -115.95 -169.97 1.7 Allowed 'General case' 0 C--N 1.28 -2.428 0 O-C-N 121.683 -0.636 . . . . 0.0 110.228 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.523 ' HE3' ' N ' ' A' ' 330' ' ' VAL . 0.2 OUTLIER -88.28 128.86 35.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 111.193 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.457 ' HB1' ' SD ' ' A' ' 332' ' ' MET . . . -156.48 159.22 38.43 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.66 -0.65 . . . . 0.0 111.057 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.524 ' HB3' ' CB ' ' A' ' 303' ' ' ALA . 5.9 t0 -84.08 121.37 27.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.514 -0.741 . . . . 0.0 110.13 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.564 HD22 ' CE ' ' A' ' 332' ' ' MET . 8.0 mt -68.54 -25.2 64.8 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.138 -0.976 . . . . 0.0 109.76 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 303' ' ' ALA . 22.7 p30 -79.3 -21.21 46.3 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.089 -1.007 . . . . 0.0 108.871 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -85.44 -29.65 24.17 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.761 0.791 . . . . 0.0 108.968 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.527 HG11 ' CD ' ' A' ' 338' ' ' LYS . 42.2 t -74.92 -38.46 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.55 0.69 . . . . 0.0 109.278 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 86.2 mt -73.61 -40.75 63.58 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.306 -0.871 . . . . 0.0 110.142 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -58.71 -29.42 64.27 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 311' ' ' ALA . 6.0 mt-10 -79.03 -31.16 44.51 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.394 -1.062 . . . . 0.0 108.997 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 304' ' ' VAL . 52.3 t -75.48 -21.83 16.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.667 0.746 . . . . 0.0 109.154 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.511 ' CD1' HG21 ' A' ' 321' ' ' THR . 0.7 OUTLIER -76.19 -49.68 24.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.429 ' N ' HG21 ' A' ' 309' ' ' ILE . . . -80.2 -16.72 54.17 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.815 0.816 . . . . 0.0 109.194 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 307' ' ' GLU . . . -65.14 -63.04 1.2 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.696 -0.627 . . . . 0.0 110.709 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.28 37.91 0.7 Allowed 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.715 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.543 ' O ' HD13 ' A' ' 319' ' ' ILE . 1.2 t -87.55 43.1 1.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.892 -1.13 . . . . 0.0 109.098 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 315' ' ' TYR . . . 73.66 25.22 72.77 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.511 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 51.4 t80 63.71 44.19 5.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.657 -0.908 . . . . 0.0 110.258 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 4.2 tt0 68.24 46.57 1.09 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.235 -0.916 . . . . 0.0 109.781 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.496 ' CG ' ' N ' ' A' ' 318' ' ' GLU . 0.3 OUTLIER -68.59 -88.04 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.304 0 O-C-N 121.608 -0.683 . . . . 0.0 109.844 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.496 ' N ' ' CG ' ' A' ' 317' ' ' ARG . 16.9 mt-10 -140.93 66.12 1.38 Allowed 'General case' 0 C--N 1.277 -2.574 0 O-C-N 121.399 -0.813 . . . . 0.0 111.287 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.596 ' CG2' ' CG2' ' A' ' 358' ' ' VAL . 2.7 mp -104.43 134.09 46.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 O-C-N 121.598 -0.689 . . . . 0.0 110.129 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -91.36 107.23 19.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.763 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.511 HG21 ' CD1' ' A' ' 309' ' ' ILE . 12.5 p -89.84 124.66 34.87 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 111.519 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . 0.421 ' HB1' ' OG ' ' A' ' 359' ' ' SER . . . -149.81 78.63 1.36 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.527 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 2.7 mp -94.62 169.52 10.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.453 -0.779 . . . . 0.0 110.879 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.462 ' HB2' ' HA2' ' A' ' 361' ' ' GLY . 93.8 t80 -62.11 112.39 6.24 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.764 . . . . 0.0 109.756 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.86 79.29 1.98 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.878 1.462 . . . . 0.0 110.487 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 179.73 29.65 0.05 OUTLIER Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.773 -1.203 . . . . 0.0 110.11 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 326' ' ' GLY . 1.0 OUTLIER 47.81 98.2 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.11 -1.23 . . . . 0.0 110.509 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.555 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 1.1 mt -82.11 -176.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.495 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.555 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 0.6 OUTLIER -178.14 105.43 0.05 OUTLIER 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.416 0.627 . . . . 0.0 110.376 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' A' ' 332' ' ' MET . 5.3 m -136.05 171.57 16.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-O 121.749 0.785 . . . . 0.0 110.5 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.2 OUTLIER -91.22 89.62 7.41 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.564 ' CE ' HD22 ' A' ' 301' ' ' LEU . 4.0 ppp? -140.26 148.34 41.31 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.439 -0.788 . . . . 0.0 109.894 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 21.0 t-160 -75.97 110.82 12.03 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.487 ' O ' ' HD3' ' A' ' 338' ' ' LYS . 36.7 Cg_endo -58.74 -19.33 45.68 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.476 1.251 . . . . 0.0 109.152 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.57 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -82.57 -63.9 1.28 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.529 0.681 . . . . 0.0 109.805 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.483 ' OG ' HG13 ' A' ' 412' ' ' ILE . 26.8 t -49.39 -50.54 39.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.538 -0.726 . . . . 0.0 110.132 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.543 HG13 ' CE ' ' A' ' 332' ' ' MET . 21.7 mm -59.91 -45.68 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.527 ' CD ' HG11 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -46.81 -49.03 20.6 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.7 -1.25 . . . . 0.0 109.377 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -60.97 -38.88 87.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.491 -0.756 . . . . 0.0 110.302 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.448 ' HB1' HG22 ' A' ' 412' ' ' ILE . . . -58.94 -53.25 60.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 0.0 110.83 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.499 HG22 ' CD2' ' A' ' 305' ' ' LEU . 55.2 t -70.31 -21.08 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 110.057 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 346' ' ' VAL . . . -81.65 -19.73 41.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.397 -0.815 . . . . 0.0 110.779 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -84.64 -44.67 13.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.088 -1.008 . . . . 0.0 110.777 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.423 ' HE3' HG23 ' A' ' 409' ' ' VAL . 6.1 mtm -69.15 -20.14 64.02 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.16 -0.962 . . . . 0.0 110.546 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.457 HG11 ' N ' ' A' ' 346' ' ' VAL . 8.7 p -87.86 -27.48 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.104 -0.997 . . . . 0.0 110.506 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.457 ' N ' HG11 ' A' ' 345' ' ' VAL . 53.5 t -76.85 -28.02 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 110.373 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 17.4 m120 -75.13 -32.04 61.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.105 -0.997 . . . . 0.0 110.281 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 352' ' ' GLY . . . -90.58 -18.63 24.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.123 -0.986 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -77.05 -81.21 0.09 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.033 -1.042 . . . . 0.0 111.856 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -48.41 64.95 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.381 -0.824 . . . . 0.0 112.34 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . 0.497 ' CB ' ' HG3' ' A' ' 376' ' ' PRO . 36.6 m-85 -74.79 -58.93 2.98 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.855 -1.153 . . . . 0.0 111.561 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 348' ' ' ALA . . . -108.12 59.55 0.36 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.189 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.23 93.1 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.235 . . . . 0.0 109.886 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -147.7 -67.06 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -150.13 139.19 21.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.119 -1.224 . . . . 0.0 110.657 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.403 HG21 ' N ' ' A' ' 357' ' ' LYS . 20.3 mt -123.66 162.08 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.459 -0.776 . . . . 0.0 109.832 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 372' ' ' GLU . 1.1 ttpt -136.83 111.36 8.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.069 -1.019 . . . . 0.0 110.331 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.596 ' CG2' ' CG2' ' A' ' 319' ' ' ILE . 65.1 t -110.17 88.41 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 110.034 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.421 ' OG ' ' HB1' ' A' ' 322' ' ' ALA . 1.0 OUTLIER -112.55 148.95 33.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 110.436 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.527 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -144.65 142.14 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.403 -0.81 . . . . 0.0 110.016 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -135.08 -165.9 10.92 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.7 OUTLIER -174.52 179.17 1.81 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.775 -1.426 . . . . 0.0 111.547 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 8.2 mt-10 -156.32 173.18 5.18 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 365' ' ' ASN . 39.6 Cg_endo -66.38 119.01 5.99 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.422 1.222 . . . . 0.0 110.469 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.53 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 2.3 m-80 62.88 37.3 12.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.934 -0.479 . . . . 0.0 110.969 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 10.7 ptm180 169.31 106.32 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.455 -0.778 . . . . 0.0 110.399 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -116.49 168.11 10.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.176 -0.952 . . . . 0.0 109.835 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.64 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 25.8 p-90 -154.74 169.05 24.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.86 -1.15 . . . . 0.0 110.811 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 360' ' ' SER . 32.9 p90 -144.4 136.29 26.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.456 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.508 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 9.7 tt0 -121.07 153.84 36.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.101 -0.999 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.508 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 40.6 t -137.06 143.92 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 110.181 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 2.0 mt-10 -137.29 134.45 36.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.355 -0.841 . . . . 0.0 109.779 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.462 ' OD1' ' HB1' ' A' ' 348' ' ' ALA . 3.6 p30 -151.1 163.18 39.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.894 -1.129 . . . . 0.0 110.864 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -110.04 134.13 52.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 159.54 -136.05 4.43 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.497 ' HG3' ' CB ' ' A' ' 351' ' ' TYR . 47.0 Cg_endo -72.65 106.16 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.991 1.521 . . . . 0.0 110.349 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -78.35 -157.78 10.7 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.585 HG13 ' CD1' ' A' ' 430' ' ' LEU . 9.7 mt -119.04 172.67 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.496 -1.003 . . . . 0.0 110.12 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.469 ' HB2' ' HG3' ' A' ' 382' ' ' GLN . . . -120.91 175.0 2.6 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.867 -1.146 . . . . 0.0 110.675 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . 0.466 ' O ' ' HG3' ' A' ' 383' ' ' ARG . 51.3 Cg_endo -79.94 -33.07 1.25 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 124.059 1.557 . . . . 0.0 111.349 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -89.65 -19.76 24.49 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.907 -1.121 . . . . 0.0 111.312 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.469 ' HG3' ' HB2' ' A' ' 379' ' ' ALA . 41.6 mt-30 -85.91 -26.67 25.44 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.95 -1.094 . . . . 0.0 108.846 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 385' ' ' HIS . 0.2 OUTLIER -66.97 -25.38 66.29 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.082 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 383' ' ' ARG . 32.5 mmtm -46.94 -35.69 6.81 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 383' ' ' ARG . 1.4 m-70 -100.74 -139.26 0.33 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.481 -1.691 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.533 ' O ' ' CD1' ' A' ' 412' ' ' ILE . 9.7 tp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.265 0.555 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 410' ' ' GLN . 13.2 p -120.05 -42.08 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.479 -0.763 . . . . 0.0 109.926 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.52 ' N ' HG12 ' A' ' 409' ' ' VAL . 2.6 pt20 -51.72 -29.34 18.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.433 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.423 ' CD ' HG12 ' A' ' 408' ' ' ILE . 0.4 OUTLIER -76.51 -35.88 58.08 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 408' ' ' ILE . 0.6 OUTLIER -56.84 -44.7 82.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 419' ' ' MET . 92.9 t -73.93 -22.66 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 35.2 t70 -80.02 -19.58 47.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.699 -0.626 . . . . 0.0 109.603 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -85.77 -26.83 25.58 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.382 -0.824 . . . . 0.0 109.142 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.584 ' CG ' ' CD2' ' A' ' 436' ' ' LEU . 30.6 m80 -89.78 -31.57 17.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.766 . . . . 0.0 109.083 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.4 OUTLIER 77.27 42.96 0.12 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.395 0.617 . . . . 0.0 110.6 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.589 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -106.8 -85.14 1.76 Allowed Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.547 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.0 OUTLIER -179.2 164.23 1.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.113 . . . . 0.0 111.331 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 420' ' ' LEU . 19.1 tp -151.3 92.59 1.8 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.163 -0.961 . . . . 0.0 109.258 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.502 ' HB2' ' HG3' ' A' ' 433' ' ' ARG . 0.3 OUTLIER -92.28 139.93 30.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.975 -1.078 . . . . 0.0 110.443 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.548 ' CD2' HG12 ' A' ' 432' ' ' ILE . 0.3 OUTLIER -114.98 145.7 41.98 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.43 -0.794 . . . . 0.0 111.275 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.458 ' O ' HD13 ' A' ' 430' ' ' LEU . . . -145.53 145.52 14.78 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 7.8 m . . . . . 0 N--CA 1.49 1.57 0 O-C-N 120.838 -1.39 . . . . 0.0 111.041 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.494 2.533 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.585 ' CD1' HG13 ' A' ' 378' ' ' ILE . 18.4 tp -90.59 108.78 20.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -1.132 . . . . 0.0 110.852 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 66.5 m -118.07 132.98 56.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.608 -0.682 . . . . 0.0 109.368 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.548 HG12 ' CD2' ' A' ' 422' ' ' LEU . 4.4 mt -136.7 142.26 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.935 -1.103 . . . . 0.0 111.031 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' A' ' 421' ' ' GLU . 0.0 OUTLIER -122.2 117.02 25.2 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.445 -0.785 . . . . 0.0 109.598 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -102.6 140.0 37.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.165 -0.959 . . . . 0.0 111.049 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.64 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 79.8 m95 -114.6 154.44 28.34 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.288 -0.883 . . . . 0.0 111.271 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.584 ' CD2' ' CG ' ' A' ' 416' ' ' HIS . 12.7 mt -145.87 111.08 4.46 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.589 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 49.5 Cg_endo -85.9 130.57 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.691 1.364 . . . . 0.0 110.823 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.492 HG23 ' HA ' ' A' ' 330' ' ' VAL . 60.6 t -82.79 110.08 20.5 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.408 -0.808 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 57.3 Cg_endo . . . . . 0 C--N 1.311 -1.403 0 O-C-N 123.938 1.494 . . . . 0.0 109.987 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.656 ' CB ' ' CD2' ' A' ' 333' ' ' HIS . 51.4 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 N-CA-C 109.362 -1.053 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.531 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 43.36 87.68 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 122.323 1.058 . . . . 0.0 109.99 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 1.1 mt-10 -143.06 -156.6 0.7 Allowed 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.278 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.508 ' HE3' ' CA ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -88.25 131.61 34.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.937 -1.102 . . . . 0.0 110.589 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -150.04 160.07 43.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.443 -0.786 . . . . 0.0 110.709 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.456 ' HB2' ' HB1' ' A' ' 303' ' ' ALA . 0.9 OUTLIER -102.57 120.38 40.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 110.083 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.502 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 15.3 mt -63.37 -21.27 66.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 109.751 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.443 ' HA ' HD22 ' A' ' 323' ' ' LEU . 26.0 t-20 -83.41 -21.58 32.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.064 -1.022 . . . . 0.0 108.754 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 300' ' ' ASP . . . -88.15 -26.79 22.26 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.728 0.775 . . . . 0.0 109.144 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 18.3 t -83.8 -38.38 14.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 91.0 mt -78.41 -28.42 46.86 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.408 -0.807 . . . . 0.0 110.113 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.65 -32.66 82.09 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.451 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 3.1 mm-40 -79.6 -35.26 39.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -1.141 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.523 HG12 ' CG1' ' A' ' 341' ' ' VAL . 65.4 t -77.81 -19.29 13.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.642 0.734 . . . . 0.0 109.673 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.535 ' O ' ' CB ' ' A' ' 313' ' ' SER . 0.3 OUTLIER -79.81 -43.12 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.492 -0.755 . . . . 0.0 109.25 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.2 -17.18 53.08 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.638 0.732 . . . . 0.0 109.969 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 307' ' ' GLU . . . -90.33 -53.96 4.22 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.586 -0.696 . . . . 0.0 112.034 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -112.26 45.2 1.31 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.252 -0.905 . . . . 0.0 111.227 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 309' ' ' ILE . 0.3 OUTLIER -80.65 28.56 0.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.238 -0.914 . . . . 0.0 110.79 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 53.41 42.84 65.56 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 22.2 m-85 61.69 33.07 18.23 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.681 -0.894 . . . . 0.0 110.051 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 2.8 tt0 65.31 43.94 3.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 109.378 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.58 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.8 OUTLIER -68.76 -83.18 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.606 0.717 . . . . 0.0 110.436 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.58 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.7 pt-20 -159.23 64.1 0.39 Allowed 'General case' 0 C--N 1.273 -2.754 0 O-C-N 121.672 -0.642 . . . . 0.0 110.69 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.533 HG13 ' CD1' ' A' ' 356' ' ' ILE . 2.2 mp -96.51 126.75 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 109.511 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.46 103.66 16.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.705 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.51 ' CG2' HD12 ' A' ' 309' ' ' ILE . 19.0 p -89.68 125.68 35.35 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.502 -0.749 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.36 78.97 1.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.478 -0.764 . . . . 0.0 109.249 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.506 HD11 ' N ' ' A' ' 323' ' ' LEU . 5.3 mp -89.48 149.23 23.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.384 -0.823 . . . . 0.0 110.528 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.575 ' CD1' ' HD2' ' A' ' 325' ' ' PRO . 60.4 t80 -38.37 147.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.737 -0.602 . . . . 0.0 110.321 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.575 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.8 Cg_endo -81.83 64.12 8.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.948 1.499 . . . . 0.0 110.44 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . 172.87 8.38 0.02 OUTLIER Glycine 0 N--CA 1.498 2.767 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.697 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 1.2 p 66.07 119.92 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.473 -1.604 . . . . 0.0 109.728 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.531 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 1.6 mm -74.58 -178.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.864 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.6 mt-10 -170.56 103.72 0.26 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 121.688 0.756 . . . . 0.0 109.97 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.508 ' CA ' ' HE3' ' A' ' 298' ' ' MET . 4.0 m -140.17 172.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.378 0 CA-C-O 121.646 0.736 . . . . 0.0 110.556 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.2 tptp -91.0 89.69 7.54 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.56 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 2.2 tmm? -143.79 157.3 44.47 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.401 -0.812 . . . . 0.0 110.609 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.656 ' CD2' ' CB ' ' A' ' 295' ' ' PRO . 3.3 t-80 -78.54 117.68 67.85 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 38.4 Cg_endo -62.11 -21.88 73.24 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.776 1.409 . . . . 0.0 110.341 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.557 ' HB2' ' ND1' ' A' ' 333' ' ' HIS . 12.1 mt -76.95 -63.6 1.32 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.107 0.956 . . . . 0.0 110.258 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.475 ' HB3' HG13 ' A' ' 412' ' ' ILE . 17.4 m -45.8 -53.08 10.17 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.554 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 416' ' ' HIS . 16.7 mm -57.16 -43.84 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.999 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 0.2 OUTLIER -48.8 -41.19 31.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.887 -1.133 . . . . 0.0 108.344 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 336' ' ' SER . 6.8 mtt180 -67.46 -47.71 69.32 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.488 0.661 . . . . 0.0 109.909 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -51.82 -36.2 47.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 110.641 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.523 ' CG1' HG12 ' A' ' 308' ' ' VAL . 33.6 t -89.99 -21.05 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -0.935 . . . . 0.0 110.281 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.59 -56.69 9.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.868 . . . . 0.0 110.846 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . 0.468 ' O ' HG11 ' A' ' 346' ' ' VAL . 76.1 m-20 -75.68 -19.72 58.94 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.212 -0.93 . . . . 0.0 110.724 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.516 ' CE ' HG22 ' A' ' 432' ' ' ILE . 2.0 mtt -67.48 -32.66 73.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.287 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.416 ' O ' ' CB ' ' A' ' 349' ' ' ALA . 55.9 t -90.44 -19.05 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.351 -0.843 . . . . 0.0 111.236 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 343' ' ' ASN . 0.6 OUTLIER -70.93 -30.31 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.939 -1.101 . . . . 0.0 110.685 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -60.9 -55.76 29.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.144 -0.972 . . . . 0.0 110.636 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.477 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -85.1 -19.23 32.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.173 -0.954 . . . . 0.0 110.403 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 345' ' ' VAL . . . -43.34 -72.8 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.381 -0.824 . . . . 0.0 110.811 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 61.0 mtt85 -87.0 -69.22 0.69 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.084 -1.01 . . . . 0.0 110.744 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . 0.492 ' O ' ' N ' ' A' ' 353' ' ' ASN . 2.3 t80 -49.03 -72.61 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.301 -0.874 . . . . 0.0 110.829 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -52.85 88.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 351' ' ' TYR . 6.3 p-10 -96.2 51.48 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.184 -1.186 . . . . 0.0 109.801 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -121.1 -66.93 0.26 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 2.0 t90 -176.28 140.36 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -1.182 . . . . 0.0 110.219 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.533 ' CD1' HG13 ' A' ' 319' ' ' ILE . 2.8 mt -110.41 158.96 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.651 -0.656 . . . . 0.0 109.909 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 11.8 ttpt -142.15 105.58 4.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.74 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 321' ' ' THR . 68.9 t -107.73 84.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.327 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 69.5 p -116.67 140.73 49.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.006 -1.059 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.471 ' HB3' ' HG ' ' A' ' 323' ' ' LEU . 1.9 t -125.72 158.66 34.28 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -159.07 -152.62 6.51 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -179.26 174.18 1.05 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.215 -1.168 . . . . 0.0 110.525 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.541 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 1.9 mt-10 -151.81 -175.13 0.45 Allowed Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.468 -0.77 . . . . 0.0 109.504 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 40.7 Cg_endo -69.7 116.96 4.8 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.582 1.306 . . . . 0.0 111.353 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.535 ' O ' ' HG3' ' A' ' 366' ' ' ARG . 1.9 m-20 69.65 6.09 5.53 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.679 -0.638 . . . . 0.0 111.844 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 365' ' ' ASN . 59.7 mtp85 -155.7 104.92 2.37 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.098 -1.001 . . . . 0.0 111.834 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -101.01 167.59 10.15 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 52.7 p-90 -170.9 178.79 3.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.189 -1.569 . . . . 0.0 111.905 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 27.5 p90 -147.76 141.62 25.79 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.539 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 8.8 tt0 -134.15 149.44 51.05 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.871 -1.143 . . . . 0.0 112.325 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.539 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 33.6 t -127.22 134.05 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.439 ' HG3' ' OG ' ' A' ' 431' ' ' SER . 0.7 OUTLIER -128.96 145.88 51.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.778 -1.201 . . . . 0.0 109.897 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 373' ' ' ASP . 8.0 p30 -149.92 145.98 26.81 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.69 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.33 137.36 38.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.392 -0.817 . . . . 0.0 109.917 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 169.8 -164.15 37.59 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.008 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.53 -161.63 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.156 1.608 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 424' ' ' THR . . . -146.83 166.24 28.37 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.57 ' CD1' ' CD2' ' A' ' 422' ' ' LEU . 5.5 mt -72.6 169.81 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.236 . . . . 0.0 109.787 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.524 ' CB ' ' HB2' ' A' ' 382' ' ' GLN . . . -95.25 177.8 1.68 Allowed Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.96 -1.088 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 379' ' ' ALA . 45.9 Cg_endo -73.32 -46.43 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.036 1.545 . . . . 0.0 110.78 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -90.77 -30.22 17.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.959 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.524 ' HB2' ' CB ' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -64.45 -20.18 66.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.079 -1.013 . . . . 0.0 110.338 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 382' ' ' GLN . 16.8 ttt180 -44.81 -29.22 0.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.162 -0.961 . . . . 0.0 109.872 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 385' ' ' HIS . 20.0 mttt -89.95 -33.15 16.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.352 -0.843 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 382' ' ' GLN . 5.0 m170 -40.94 -59.18 1.51 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.314 -0.866 . . . . 0.0 110.036 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.442 ' O ' ' CD1' ' A' ' 412' ' ' ILE . 27.3 mm . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.328 0.585 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.449 HG11 ' N ' ' A' ' 410' ' ' GLN . 7.0 p -129.47 -34.03 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.183 -0.948 . . . . 0.0 110.269 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 31.0 tt0 -66.4 -42.14 88.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 110.502 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -69.57 -32.31 71.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.173 -0.954 . . . . 0.0 110.033 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.537 ' O ' ' ND1' ' A' ' 416' ' ' HIS . 1.1 mp -59.64 -63.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.147 -0.971 . . . . 0.0 108.58 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 420' ' ' LEU . 35.5 t -63.32 -28.22 44.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.321 -0.862 . . . . 0.0 109.823 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 29.7 t70 -73.24 -20.54 60.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.511 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.531 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.1 m-80 -95.27 -14.31 24.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.473 -0.767 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.56 ' NE2' ' HG2' ' A' ' 332' ' ' MET . 37.3 m80 -93.03 -34.1 13.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.451 -0.781 . . . . 0.0 109.865 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 4.1 m120 72.95 47.43 0.2 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.488 0.661 . . . . 0.0 110.431 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.545 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -121.28 -87.16 0.92 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.575 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.2 OUTLIER -171.12 161.74 6.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.397 -1.061 . . . . 0.0 110.615 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.531 ' HB2' ' CG1' ' A' ' 413' ' ' VAL . 14.1 tp -150.36 90.68 1.68 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 109.989 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 433' ' ' ARG . 63.0 mm-40 -89.81 154.03 20.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.235 -0.915 . . . . 0.0 110.046 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.57 ' CD2' ' CD1' ' A' ' 378' ' ' ILE . 7.2 tt -138.31 130.64 28.9 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.983 -1.073 . . . . 0.0 111.149 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.526 ' O ' HD22 ' A' ' 430' ' ' LEU . . . -90.33 163.04 29.91 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.694 ' HA ' ' HG ' ' A' ' 430' ' ' LEU 0.258 12.9 t . . . . . 0 N--CA 1.506 2.334 0 CA-C-N 118.836 1.318 . . . . 0.0 112.397 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.499 2.862 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.694 ' HG ' ' HA ' ' A' ' 424' ' ' THR . 0.7 OUTLIER -110.93 131.93 54.64 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.579 1.69 . . . . 0.0 110.354 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.439 ' OG ' ' HG3' ' A' ' 372' ' ' GLU . 4.0 m -143.26 -177.75 5.52 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.919 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.516 HG22 ' CE ' ' A' ' 344' ' ' MET . 9.1 mm -149.94 92.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.687 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . 0.485 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.1 mtt180 -88.59 134.84 33.76 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.859 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -128.98 129.35 45.29 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.05 -1.031 . . . . 0.0 109.679 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 84.0 m95 -111.28 145.57 38.56 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.139 -0.975 . . . . 0.0 111.908 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 416' ' ' HIS . 5.9 mt -134.35 106.69 11.11 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.545 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 42.8 Cg_endo -68.78 138.82 42.1 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 O-C-N 123.911 1.479 . . . . 0.0 111.382 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.542 ' CG2' ' HD2' ' A' ' 439' ' ' PRO . 4.9 p -86.17 145.63 40.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.567 -0.708 . . . . 0.0 109.557 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 438' ' ' VAL . 47.4 Cg_endo . . . . . 0 C--N 1.303 -1.852 0 O-C-N 123.802 1.422 . . . . 0.0 110.423 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.591 ' HB3' ' CD2' ' A' ' 333' ' ' HIS . 49.4 Cg_endo . . . . . 0 C--O 1.214 -0.718 0 CA-C-O 121.24 0.433 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.508 ' C ' ' O ' ' A' ' 295' ' ' PRO . 0.0 OUTLIER 27.99 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.193 0.997 . . . . 0.0 111.104 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 18.6 pt-20 -164.25 -159.98 0.51 Allowed 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.468 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.0 OUTLIER -88.22 127.75 35.45 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.926 -1.109 . . . . 0.0 110.146 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -147.55 163.86 35.25 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.181 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.522 ' HB3' ' CB ' ' A' ' 303' ' ' ALA . 16.3 t0 -100.12 116.42 32.11 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.664 -0.647 . . . . 0.0 109.759 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.527 ' HB2' ' CB ' ' A' ' 328' ' ' ILE . 12.0 mt -60.53 -27.45 67.65 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.299 -0.875 . . . . 0.0 109.778 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.414 ' OD1' HD21 ' A' ' 323' ' ' LEU . 56.7 t-20 -76.19 -22.68 55.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.056 . . . . 0.0 108.963 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -85.56 -31.46 22.66 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.459 0.647 . . . . 0.0 109.552 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 33.2 t -79.58 -34.31 15.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.499 -0.75 . . . . 0.0 109.542 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 82.6 mt -79.92 -26.77 40.04 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.401 -0.812 . . . . 0.0 109.991 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.56 -33.86 88.36 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.81 -32.92 25.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.305 -1.115 . . . . 0.0 109.417 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.529 HG13 ' CG1' ' A' ' 341' ' ' VAL . 51.0 t -75.39 -19.24 15.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.389 -0.819 . . . . 0.0 109.189 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.563 ' O ' ' CB ' ' A' ' 313' ' ' SER . 1.0 OUTLIER -83.26 -46.01 18.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.08 -17.58 61.99 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.277 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.58 -53.57 4.37 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.97 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.506 ' HB3' HG22 ' A' ' 345' ' ' VAL . 14.9 mm-40 -100.86 35.0 2.3 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 111.045 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 309' ' ' ILE . 0.1 OUTLIER -86.18 32.15 0.63 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.082 -1.012 . . . . 0.0 110.365 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 45.24 33.2 3.93 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.686 -2.165 . . . . 0.0 107.686 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.52 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 39.8 m-85 61.86 52.07 3.57 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 122.096 -0.65 . . . . 0.0 109.95 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 16.1 mt-10 59.28 35.52 23.36 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.597 -0.689 . . . . 0.0 110.256 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.55 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.3 OUTLIER -68.84 -74.13 0.13 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.509 -0.744 . . . . 0.0 109.46 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.55 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 9.3 mt-10 -160.42 80.85 0.67 Allowed 'General case' 0 C--N 1.274 -2.7 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.542 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.518 HG13 ' CD1' ' A' ' 356' ' ' ILE . 2.7 mp -122.62 142.21 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.491 ' HB3' ' CG ' ' A' ' 357' ' ' LYS . 26.3 tt0 -109.7 103.89 12.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.446 -0.784 . . . . 0.0 109.547 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 20.0 p -90.53 123.71 34.42 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.245 -0.91 . . . . 0.0 111.411 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -144.33 78.69 1.59 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.524 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 5.7 mp -91.07 152.31 20.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.561 -0.712 . . . . 0.0 110.999 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.568 ' CD1' HG21 ' A' ' 362' ' ' THR . 19.9 t80 -41.19 136.15 1.72 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.593 -0.692 . . . . 0.0 110.058 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -83.67 57.28 5.55 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 124.027 1.54 . . . . 0.0 110.276 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -167.58 21.13 0.1 OUTLIER Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.747 -1.215 . . . . 0.0 110.505 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 326' ' ' GLY . 68.5 m 56.44 111.56 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.019 -1.283 . . . . 0.0 110.215 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.544 ' CD1' ' HB3' ' A' ' 324' ' ' TYR . 3.5 mm -69.12 -179.34 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.579 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 1.7 mt-10 -174.84 101.28 0.09 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.64 -0.663 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.593 ' CG1' ' CB ' ' A' ' 367' ' ' ALA . 8.4 m -143.41 174.17 5.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 121.62 0.724 . . . . 0.0 110.469 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.1 OUTLIER -95.05 93.63 7.49 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.559 ' CE ' HG13 ' A' ' 337' ' ' ILE . 11.2 ptm -136.47 164.76 27.41 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.973 0.892 . . . . 0.0 112.597 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.591 ' CD2' ' HB3' ' A' ' 295' ' ' PRO . 23.4 t-160 -88.06 116.44 66.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.483 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 39.3 Cg_endo -62.47 -30.23 79.75 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.637 1.335 . . . . 0.0 112.542 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.586 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 3.9 tp -82.23 -49.2 10.36 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.623 -1.298 . . . . 0.0 110.589 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.544 ' HB2' ' ND1' ' A' ' 333' ' ' HIS . 0.5 OUTLIER -60.6 -42.26 96.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.915 -1.115 . . . . 0.0 109.869 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.578 HD13 ' CE1' ' A' ' 416' ' ' HIS . 18.5 mm -65.37 -46.99 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.601 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 0.7 OUTLIER -51.54 -32.93 29.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.83 -1.169 . . . . 0.0 107.873 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.477 ' NH1' ' OD1' ' A' ' 343' ' ' ASN . 0.0 OUTLIER -77.45 -34.65 54.41 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.991 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 344' ' ' MET . . . -67.55 -29.57 68.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.454 -0.779 . . . . 0.0 110.449 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 308' ' ' VAL . 52.8 t -90.28 -25.49 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 110.423 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 346' ' ' VAL . . . -83.3 -19.95 35.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.578 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . 0.477 ' OD1' ' NH1' ' A' ' 339' ' ' ARG . 0.3 OUTLIER -83.78 -21.08 32.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -0.916 . . . . 0.0 110.779 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 3.2 mtt -90.69 -51.3 5.45 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.138 -0.976 . . . . 0.0 111.221 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 312' ' ' GLU . 27.4 m -68.22 -19.69 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -0.943 . . . . 0.0 111.505 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 342' ' ' ALA . 14.5 p -61.53 -39.64 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.843 -1.161 . . . . 0.0 110.72 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.406 ' N ' ' CG1' ' A' ' 346' ' ' VAL . 10.9 t30 -63.2 -49.78 72.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.126 -0.984 . . . . 0.0 110.806 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.482 ' O ' ' HA2' ' A' ' 352' ' ' GLY . . . -72.73 -19.91 61.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.219 -0.926 . . . . 0.0 110.612 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 345' ' ' VAL . . . -67.09 -73.18 0.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.025 -1.047 . . . . 0.0 110.253 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -55.35 -51.63 66.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.298 -0.876 . . . . 0.0 110.453 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -59.54 2.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.215 -0.928 . . . . 0.0 110.379 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 348' ' ' ALA . . . 68.09 -104.11 1.12 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 1.5 t30 55.0 17.35 1.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -1.145 . . . . 0.0 110.207 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . 0.441 ' HA3' ' HB3' ' A' ' 374' ' ' ASP . . . -168.37 -98.25 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.067 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.601 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -179.78 148.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -1.166 . . . . 0.0 109.881 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.518 ' CD1' HG13 ' A' ' 319' ' ' ILE . 0.8 OUTLIER -106.49 159.52 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.309 -0.869 . . . . 0.0 110.024 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.601 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 1.4 ttmt -150.41 112.72 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 110.692 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.532 HG13 ' CD1' ' A' ' 309' ' ' ILE . 21.9 t -103.07 88.81 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 370' ' ' GLN . 6.8 p -115.04 151.14 34.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -0.896 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.524 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.6 OUTLIER -140.14 163.53 32.47 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -155.23 -164.32 12.95 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.568 HG21 ' CD1' ' A' ' 324' ' ' TYR . 0.1 OUTLIER -176.36 144.05 0.53 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.716 -1.461 . . . . 0.0 112.048 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.552 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 39.0 mt-10 -109.03 175.61 1.89 Allowed Pre-proline 0 C--N 1.287 -2.146 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.304 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 40.1 Cg_endo -66.07 127.0 16.77 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.245 1.129 . . . . 0.0 110.087 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.552 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 6.6 m120 60.52 22.25 11.97 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.519 -0.738 . . . . 0.0 110.243 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 42.1 mtm180 -163.63 145.06 9.22 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.593 ' CB ' ' CG1' ' A' ' 330' ' ' VAL . . . -143.17 151.16 40.36 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.11 -0.994 . . . . 0.0 109.159 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.603 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 37.7 p-90 -151.67 170.38 19.85 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.905 -1.122 . . . . 0.0 110.682 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 369' ' ' PHE . 36.4 p90 -139.5 130.42 26.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.44 -0.787 . . . . 0.0 109.582 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 359' ' ' SER . 0.8 OUTLIER -116.1 150.48 37.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -0.933 . . . . 0.0 111.381 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.29 143.86 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.497 -0.752 . . . . 0.0 109.348 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.478 ' HB2' ' HD2' ' A' ' 357' ' ' LYS . 1.8 tt0 -126.36 145.51 50.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.013 -1.054 . . . . 0.0 110.198 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' ' 355' ' ' TRP . 11.1 t70 -156.65 143.66 18.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.841 . . . . 0.0 110.331 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 374' ' ' ASP . 27.6 t0 -98.39 64.47 1.59 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.37 -0.831 . . . . 0.0 110.016 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -86.88 -148.01 12.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.15 -40.59 3.15 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.008 1.531 . . . . 0.0 110.482 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 103.6 -174.85 23.06 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.597 ' CD1' HD12 ' A' ' 430' ' ' LEU . 1.9 mm -99.72 176.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.065 -1.256 . . . . 0.0 110.102 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 382' ' ' GLN . . . -109.91 165.61 12.35 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.248 -0.908 . . . . 0.0 109.752 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.07 -49.26 0.53 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.842 1.443 . . . . 0.0 110.229 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -89.53 -19.69 24.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.12 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.458 ' HB3' ' HB1' ' A' ' 379' ' ' ALA . 4.5 tt0 -82.82 -19.78 36.98 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.275 -0.89 . . . . 0.0 110.86 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 382' ' ' GLN . 2.2 ttt85 -42.32 -37.97 1.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.024 -1.047 . . . . 0.0 110.021 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.84 -27.89 19.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.203 -0.936 . . . . 0.0 110.404 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -51.81 -18.23 1.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.107 -0.996 . . . . 0.0 110.747 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 50.4 mt . . . . . 0 N--CA 1.501 2.119 0 O-C-N 120.92 -1.113 . . . . 0.0 110.731 179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.462 HG23 HG11 ' A' ' 409' ' ' VAL . 14.2 mt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.268 0.556 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.462 HG11 HG23 ' A' ' 408' ' ' ILE . 10.6 p -48.83 -22.51 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.954 . . . . 0.0 110.176 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 48.3 tt0 -62.9 -55.94 21.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.23 -0.919 . . . . 0.0 110.609 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.4 OUTLIER -59.02 -32.19 69.5 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.311 -0.868 . . . . 0.0 110.684 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 409' ' ' VAL . 1.0 OUTLIER -64.03 -58.37 7.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.092 -1.005 . . . . 0.0 109.143 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 420' ' ' LEU . 30.4 t -65.51 -21.41 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.249 -0.907 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 0.1 OUTLIER -82.41 -25.83 33.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 109.515 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 2.2 t-20 -86.41 -17.82 33.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.578 ' CE1' HD13 ' A' ' 337' ' ' ILE . 22.7 m80 -92.87 -41.2 10.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.539 -0.726 . . . . 0.0 109.664 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 6.0 t-20 79.59 36.04 0.15 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.437 0.637 . . . . 0.0 109.949 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.606 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -101.86 -90.03 2.1 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.551 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.7 OUTLIER -173.0 163.45 4.79 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.349 -1.089 . . . . 0.0 111.222 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 420' ' ' LEU . 14.3 tp -151.45 97.93 2.46 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.57 152.17 34.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.001 -1.062 . . . . 0.0 111.541 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.485 ' O ' ' CG ' ' A' ' 422' ' ' LEU . 2.9 pp -132.47 121.13 22.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.404 -0.81 . . . . 0.0 109.273 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -141.8 132.04 5.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.535 ' OG1' ' N ' ' A' ' 430' ' ' LEU . 3.5 t . . . . . 0 C--N 1.304 -1.396 0 O-C-N 121.254 -1.145 . . . . 0.0 110.703 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.498 2.822 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.597 HD12 ' CD1' ' A' ' 378' ' ' ILE . 0.3 OUTLIER -76.44 135.77 39.42 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.138 -1.213 . . . . 0.0 111.777 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.406 ' HB2' ' HG3' ' A' ' 372' ' ' GLU . 40.2 t -144.76 114.24 7.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.689 -0.632 . . . . 0.0 109.627 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.426 ' O ' ' HG2' ' A' ' 370' ' ' GLN . 1.5 tt -94.46 131.91 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.145 -0.972 . . . . 0.0 110.368 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -111.79 103.04 11.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.94 . . . . 0.0 110.407 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 368' ' ' TRP . . . -91.96 130.39 37.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.325 -0.86 . . . . 0.0 109.518 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.603 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.3 m95 -107.66 157.24 18.25 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.822 -1.174 . . . . 0.0 112.438 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.443 ' HG ' ' C ' ' A' ' 435' ' ' TRP . 19.8 mt -142.68 114.12 6.04 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.606 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 51.4 Cg_endo -78.45 129.53 9.44 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.534 1.281 . . . . 0.0 112.161 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.47 HG23 HG11 ' A' ' 330' ' ' VAL . 6.8 t -109.32 69.0 0.42 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.539 -0.725 . . . . 0.0 110.02 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 57.7 Cg_endo . . . . . 0 C--N 1.308 -1.574 0 O-C-N 123.681 1.358 . . . . 0.0 110.558 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.615 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 54.2 Cg_endo . . . . . 0 C--O 1.216 -0.609 0 CA-C-O 121.361 0.484 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.04 107.74 15.84 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 15.5 mt-10 -128.81 -162.02 1.16 Allowed 'General case' 0 C--N 1.283 -2.287 0 O-C-N 121.637 -0.664 . . . . 0.0 109.913 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.466 ' HE1' ' C ' ' A' ' 330' ' ' VAL . 0.3 OUTLIER -88.33 133.51 34.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.048 -1.033 . . . . 0.0 110.271 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.432 ' HB1' ' HG3' ' A' ' 332' ' ' MET . . . -149.68 160.7 43.31 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.447 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.528 ' HB3' ' CB ' ' A' ' 303' ' ' ALA . 4.3 t0 -90.77 121.32 32.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.801 -0.562 . . . . 0.0 109.891 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.516 HD22 ' CE ' ' A' ' 332' ' ' MET . 9.5 mt -72.18 -21.15 61.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 109.718 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 302' ' ' ASN . 8.9 t30 -83.45 -23.97 32.04 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 109.138 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -84.0 -31.59 25.4 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.515 -0.74 . . . . 0.0 109.584 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.531 ' O ' ' CG2' ' A' ' 308' ' ' VAL . 11.4 t -78.41 -35.88 19.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.401 -0.812 . . . . 0.0 109.705 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 71.1 mt -76.08 -29.56 58.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.26 -0.9 . . . . 0.0 110.924 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -65.58 -39.78 95.69 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -75.84 -32.56 59.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.203 -1.174 . . . . 0.0 109.59 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 304' ' ' VAL . 41.0 t -78.27 -19.96 13.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 109.339 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.536 ' CD1' HG13 ' A' ' 358' ' ' VAL . 1.4 mt -71.15 -50.48 41.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.79 -15.08 61.64 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.823 0.821 . . . . 0.0 108.879 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 312' ' ' GLU . . . -61.62 -63.17 1.36 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.857 -0.527 . . . . 0.0 111.817 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 311' ' ' ALA . 13.3 mt-10 -143.41 38.92 1.4 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.525 -1.27 . . . . 0.0 113.047 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.589 ' HA ' ' CG1' ' A' ' 345' ' ' VAL . 5.9 t -85.77 10.37 13.8 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.616 -1.303 . . . . 0.0 109.53 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 111.39 43.33 0.99 Allowed Glycine 0 C--N 1.291 -1.945 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.516 ' O ' ' HG3' ' A' ' 316' ' ' GLU . 23.7 m-85 59.43 41.6 19.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.918 . . . . 0.0 110.094 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 53.59 32.67 14.8 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.342 1.068 . . . . 0.0 109.096 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 0.2 OUTLIER -69.81 -81.59 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.98 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.461 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 14.3 pt-20 -126.89 72.15 1.34 Allowed 'General case' 0 C--N 1.277 -2.545 0 O-C-N 121.669 -0.644 . . . . 0.0 111.974 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.545 HD13 ' O ' ' A' ' 313' ' ' SER . 1.8 mm -104.52 123.2 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 358' ' ' VAL . 7.5 tt0 -88.98 98.15 11.6 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.426 HG23 HD12 ' A' ' 309' ' ' ILE . 20.6 p -89.46 129.22 35.99 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.893 0.854 . . . . 0.0 111.832 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.46 77.85 1.31 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 323' ' ' LEU . 0.8 OUTLIER -96.46 158.51 15.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.47 -0.768 . . . . 0.0 110.644 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.605 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 15.3 t80 -54.31 116.03 9.74 Favored Pre-proline 0 C--N 1.299 -1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.49 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -80.97 64.64 8.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.022 1.538 . . . . 0.0 110.322 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.474 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -162.52 23.04 0.2 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 4.3 p 60.26 106.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -1.136 . . . . 0.0 110.646 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.548 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 4.0 mt -84.8 175.48 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 O-C-N 121.723 -0.611 . . . . 0.0 109.646 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.548 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.7 mt-10 -169.47 109.89 0.45 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.391 -0.818 . . . . 0.0 111.352 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.57 ' CG1' ' CB ' ' A' ' 367' ' ' ALA . 12.7 m -145.03 160.68 13.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.517 0.675 . . . . 0.0 109.936 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.0 OUTLIER -82.94 95.89 8.12 Favored 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.518 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.539 ' CE ' HG13 ' A' ' 337' ' ' ILE . 19.2 ptm -140.37 -178.21 5.39 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 110.975 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.615 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 18.1 t-160 -115.13 112.23 44.39 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 36.6 Cg_endo -58.74 -19.66 47.36 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.721 1.379 . . . . 0.0 110.447 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.576 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 2.9 tm? -78.95 -63.89 1.31 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.382 -0.824 . . . . 0.0 110.123 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.479 ' N ' HD11 ' A' ' 335' ' ' LEU . 0.0 OUTLIER -54.22 -49.97 68.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.305 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.579 HD12 ' CE1' ' A' ' 416' ' ' HIS . 17.3 mm -62.91 -31.78 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 110.346 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 0.4 OUTLIER -61.03 -57.86 10.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.906 -1.121 . . . . 0.0 109.772 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 339' ' ' ARG . 4.1 tmm_? -69.45 -21.35 63.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.466 -0.771 . . . . 0.0 110.356 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.45 ' HB3' ' CD1' ' A' ' 412' ' ' ILE . . . -69.6 -44.69 70.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.014 . . . . 0.0 110.307 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.538 ' O ' ' CG2' ' A' ' 345' ' ' VAL . 46.3 t -80.42 -22.16 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.337 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -70.62 -62.24 1.46 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.137 -0.977 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . 0.422 ' O ' ' CG1' ' A' ' 346' ' ' VAL . 1.8 t30 -59.25 -43.48 92.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.074 -1.016 . . . . 0.0 110.73 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.457 ' SD ' HG23 ' A' ' 432' ' ' ILE . 2.9 ttm -57.7 -19.05 24.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.274 -0.891 . . . . 0.0 110.976 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.589 ' CG1' ' HA ' ' A' ' 313' ' ' SER . 78.0 t -88.68 -22.26 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.094 -1.004 . . . . 0.0 111.587 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.469 HG11 ' N ' ' A' ' 347' ' ' ASN . 9.0 p -64.82 -19.5 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.951 -1.093 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.469 ' N ' HG11 ' A' ' 346' ' ' VAL . 49.7 t30 -66.26 -42.63 88.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.052 -1.03 . . . . 0.0 111.536 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -89.3 -19.86 24.79 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.938 -1.101 . . . . 0.0 111.369 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -89.41 -69.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.959 -1.088 . . . . 0.0 110.822 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -65.8 -41.92 91.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.125 -0.984 . . . . 0.0 110.744 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.82 -35.73 16.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.175 -0.953 . . . . 0.0 110.56 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -97.34 156.27 20.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -141.97 53.94 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -1.12 . . . . 0.0 109.959 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 355' ' ' TRP . . . -128.04 -59.58 0.12 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.584 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.3 OUTLIER 171.78 150.25 0.05 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.151 -1.205 . . . . 0.0 109.841 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' A' ' 313' ' ' SER . 26.6 mt -116.49 164.21 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.251 -0.905 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.584 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 18.4 tttm -142.27 97.6 3.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.561 -0.712 . . . . 0.0 109.752 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.536 HG13 ' CD1' ' A' ' 309' ' ' ILE . 26.0 t -93.01 139.57 17.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.8 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.497 ' HA ' ' CD1' ' A' ' 323' ' ' LEU . 60.3 p -160.13 169.91 22.33 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.087 -1.008 . . . . 0.0 111.458 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.495 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 34.2 t -155.21 150.28 26.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.635 -0.665 . . . . 0.0 109.762 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.517 ' HA3' ' CZ2' ' A' ' 368' ' ' TRP . . . -139.1 -169.92 11.7 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.605 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.5 OUTLIER -178.21 166.16 1.91 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.926 -1.338 . . . . 0.0 111.834 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.527 ' HB3' ' CD ' ' A' ' 364' ' ' PRO . 5.1 mm-40 -128.35 -174.91 0.4 Allowed Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 45.8 Cg_endo -86.71 36.46 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.495 1.261 . . . . 0.0 110.446 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 2.8 m-20 161.29 36.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.54 ' CG ' ' HA ' ' A' ' 437' ' ' PRO . 0.2 OUTLIER 166.14 103.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.821 . . . . 0.0 109.718 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.57 ' CB ' ' CG1' ' A' ' 330' ' ' VAL . . . -103.91 157.52 17.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.023 -1.048 . . . . 0.0 110.205 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.596 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 30.2 p-90 -150.51 166.46 30.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 110.323 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.582 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 36.0 p90 -133.77 147.26 51.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -0.83 . . . . 0.0 109.499 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.525 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 24.5 tt0 -139.08 155.9 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 111.538 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.525 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 6.3 t -140.03 144.15 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 431' ' ' SER . 26.2 tt0 -142.62 147.65 36.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.824 -1.172 . . . . 0.0 110.099 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -161.4 169.68 21.5 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.068 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -79.54 166.69 21.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.388 -0.82 . . . . 0.0 110.026 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 124.58 -164.12 18.16 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.89 127.08 11.17 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.042 1.549 . . . . 0.0 110.622 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . 0.495 ' HA2' ' CD1' ' A' ' 430' ' ' LEU . . . -94.24 -169.62 37.73 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.533 HD12 ' HG ' ' A' ' 430' ' ' LEU . 3.2 mm -76.97 -172.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.942 -1.328 . . . . 0.0 110.145 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.5 ' CB ' ' HB2' ' A' ' 382' ' ' GLN . . . -155.59 160.36 30.9 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.235 -0.915 . . . . 0.0 110.101 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.84 -38.1 4.47 Favored 'Trans proline' 0 C--N 1.298 -2.101 0 O-C-N 124.087 1.572 . . . . 0.0 110.367 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -90.1 -20.91 22.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.199 -0.938 . . . . 0.0 110.284 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.5 ' HB2' ' CB ' ' A' ' 379' ' ' ALA . 5.3 tp60 -76.92 -23.57 52.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.204 -0.935 . . . . 0.0 110.343 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -52.53 -26.36 12.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.223 -0.923 . . . . 0.0 110.351 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -79.67 -32.62 41.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.308 -0.87 . . . . 0.0 110.066 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -59.0 -71.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.032 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 0.0 110.552 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.485 ' O ' HD11 ' A' ' 412' ' ' ILE . 10.7 mt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 120.936 0.398 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.468 ' HA ' HD11 ' A' ' 412' ' ' ILE . 13.6 p -46.91 -19.88 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.052 -1.03 . . . . 0.0 111.744 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 0.7 OUTLIER -58.53 -67.08 0.39 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.012 -1.055 . . . . 0.0 111.589 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.525 ' NH2' ' HG2' ' A' ' 411' ' ' ARG . 0.0 OUTLIER -60.31 -26.09 66.27 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.193 -0.942 . . . . 0.0 111.956 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.494 ' CG2' HD11 ' A' ' 337' ' ' ILE . 1.3 mp -64.79 -61.69 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 120.473 -1.392 . . . . 0.0 109.332 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 419' ' ' MET . 25.5 t -66.23 -25.14 34.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.093 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 9.1 m-20 -78.38 -23.29 46.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 109.823 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 16.6 t-20 -82.95 -15.31 51.79 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.318 -0.864 . . . . 0.0 109.285 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.579 ' CE1' HD12 ' A' ' 337' ' ' ILE . 34.1 m80 -90.89 -30.09 17.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.515 -0.74 . . . . 0.0 110.062 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 3.4 t-20 81.52 17.57 0.45 Allowed 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.814 -0.554 . . . . 0.0 110.464 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.548 ' HA2' ' CD ' ' A' ' 437' ' ' PRO . . . -84.81 -91.7 0.79 Allowed Glycine 0 N--CA 1.481 1.678 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.569 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.8 ttp -174.52 167.12 3.91 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.205 -1.174 . . . . 0.0 111.042 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.447 HD13 HD12 ' A' ' 432' ' ' ILE . 19.1 tp -150.83 112.48 4.46 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.597 -0.69 . . . . 0.0 109.181 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -123.54 133.29 54.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.893 -1.129 . . . . 0.0 111.936 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.5 ' HB3' HG13 ' A' ' 378' ' ' ILE . 10.8 mt -108.96 127.59 54.2 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 430' ' ' LEU . . . -136.59 136.83 8.62 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.073 -1.537 . . . . 0.0 110.762 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.531 ' HA ' ' CB ' ' A' ' 430' ' ' LEU . 5.9 m . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.436 -1.038 . . . . 0.0 109.674 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.47 ' O ' HG21 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.596 HD11 ' N ' ' A' ' 430' ' ' LEU . 0.0 OUTLIER -175.42 -175.71 0.83 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.038 -1.272 . . . . 0.0 112.11 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.531 ' N ' ' CD2' ' A' ' 430' ' ' LEU . 0.9 OUTLIER -153.05 -178.98 7.27 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.203 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.457 HG23 ' SD ' ' A' ' 344' ' ' MET . 0.6 OUTLIER -137.02 133.9 47.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.043 -1.035 . . . . 0.0 110.631 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -111.63 97.8 6.98 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.47 -0.769 . . . . 0.0 109.111 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.582 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -90.63 133.07 35.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.402 -0.811 . . . . 0.0 110.474 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.596 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.7 m95 -105.64 151.92 23.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.097 -1.002 . . . . 0.0 111.586 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.468 HD13 ' CD1' ' A' ' 301' ' ' LEU . 36.8 mt -144.41 83.91 9.61 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.548 ' CD ' ' HA2' ' A' ' 418' ' ' GLY . 41.7 Cg_endo -69.35 137.0 35.57 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 123.92 1.484 . . . . 0.0 111.443 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.471 HG11 ' HD2' ' A' ' 439' ' ' PRO . 40.8 t -79.35 142.96 59.19 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.78 -0.575 . . . . 0.0 109.947 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.526 ' CG ' ' HD3' ' A' ' 331' ' ' LYS . 47.3 Cg_endo . . . . . 0 C--N 1.313 -1.321 0 O-C-N 123.742 1.39 . . . . 0.0 110.425 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.525 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 49.9 Cg_endo . . . . . 0 N--CA 1.479 0.674 0 CA-C-O 121.205 0.419 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.57 ' HE1' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -80.82 108.86 14.84 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.471 -0.892 . . . . 0.0 108.937 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 52.8 mt-10 -123.47 -161.96 1.01 Allowed 'General case' 0 C--N 1.274 -2.686 0 O-C-N 121.825 -0.547 . . . . 0.0 109.748 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.412 ' HE1' ' C ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -88.01 130.01 35.1 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 110.381 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -149.26 158.65 44.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.526 -0.734 . . . . 0.0 110.852 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.498 ' CB ' ' HB1' ' A' ' 303' ' ' ALA . 7.4 m-20 -98.65 117.32 32.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.566 -0.709 . . . . 0.0 110.206 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.53 ' HB2' ' CB ' ' A' ' 328' ' ' ILE . 13.4 mt -62.27 -23.85 66.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.169 -0.957 . . . . 0.0 109.845 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 302' ' ' ASN . 44.0 t-20 -81.63 -22.27 37.71 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.177 -0.952 . . . . 0.0 109.114 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.498 ' HB1' ' CB ' ' A' ' 300' ' ' ASP . . . -84.4 -30.31 25.48 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.629 -0.669 . . . . 0.0 109.664 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.422 ' O ' HG21 ' A' ' 308' ' ' VAL . 4.4 t -80.92 -34.46 13.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 109.608 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 79.2 mt -78.71 -27.48 44.94 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.398 -0.814 . . . . 0.0 110.623 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.4 -37.15 85.58 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 1.5 mp0 -76.21 -34.46 59.25 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.271 -1.135 . . . . 0.0 109.315 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.479 HG12 ' HB ' ' A' ' 341' ' ' VAL . 95.6 t -78.71 -19.59 13.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.534 -0.729 . . . . 0.0 109.443 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.51 ' O ' ' HB2' ' A' ' 313' ' ' SER . 0.1 OUTLIER -73.67 -43.51 54.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.46 ' N ' HG21 ' A' ' 309' ' ' ILE . . . -90.44 -16.02 29.79 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.665 0.745 . . . . 0.0 109.139 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 307' ' ' GLU . . . -53.9 -61.82 2.06 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.736 -0.603 . . . . 0.0 110.503 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -150.74 37.23 0.64 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.741 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.545 ' HB3' ' CD1' ' A' ' 319' ' ' ILE . 11.3 m -89.5 43.65 1.16 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.121 -0.987 . . . . 0.0 108.948 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.494 ' O ' ' HG2' ' A' ' 317' ' ' ARG . . . 63.18 44.35 97.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.484 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 19.7 m-30 48.82 38.0 11.04 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.0 -1.294 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 2.1 mt-10 69.38 56.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.329 -0.857 . . . . 0.0 110.006 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 314' ' ' GLY . 3.1 mmt180 -68.7 -92.11 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.787 0.803 . . . . 0.0 109.869 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.426 ' CD ' ' HA ' ' A' ' 355' ' ' TRP . 15.6 pt-20 -126.55 58.05 1.41 Allowed 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.544 0.688 . . . . 0.0 109.741 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 313' ' ' SER . 3.5 mt -104.73 130.66 55.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 121.613 -0.679 . . . . 0.0 110.2 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -89.46 103.38 16.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 19.6 p -93.6 123.07 36.68 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 111.291 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.59 78.03 1.49 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 360' ' ' SER . 3.4 mp -90.47 144.84 25.41 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.517 -0.74 . . . . 0.0 110.5 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' LEU . 7.4 t80 -40.7 137.85 1.34 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.574 -0.704 . . . . 0.0 109.634 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -82.7 47.6 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.892 1.469 . . . . 0.0 110.791 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.473 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -159.8 13.59 0.19 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 3.3 p 60.05 116.33 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.997 -1.296 . . . . 0.0 109.638 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.543 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 2.7 mm -67.77 -179.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.737 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.8 mt-10 -171.25 105.76 0.23 Allowed 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.632 0.73 . . . . 0.0 110.644 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.526 ' CG2' ' HG2' ' A' ' 332' ' ' MET . 12.1 m -149.98 163.95 3.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-O 121.597 0.713 . . . . 0.0 110.343 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.2 tptm -79.59 91.44 5.2 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.543 ' CE ' HG13 ' A' ' 337' ' ' ILE . 11.1 ptm -140.56 158.9 43.31 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 110.613 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.525 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 18.1 t-160 -88.96 113.29 55.44 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.45 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 40.0 Cg_endo -64.19 -19.4 65.91 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.59 1.31 . . . . 0.0 109.894 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.523 ' HB2' ' NE2' ' A' ' 333' ' ' HIS . 0.2 OUTLIER -78.14 -53.65 7.14 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 109.995 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.459 ' O ' ' HB1' ' A' ' 340' ' ' ALA . 60.3 p -64.72 -36.25 83.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 0.0 109.937 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.547 HD12 ' CE1' ' A' ' 416' ' ' HIS . 10.1 mm -75.1 -35.99 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.114 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 0.4 OUTLIER -57.04 -50.57 72.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.971 -1.081 . . . . 0.0 108.984 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -27.29 61.14 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.636 -0.665 . . . . 0.0 109.747 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.533 ' CB ' HD11 ' A' ' 412' ' ' ILE . . . -60.25 -49.58 77.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.149 -0.97 . . . . 0.0 110.183 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.479 ' HB ' HG12 ' A' ' 308' ' ' VAL . 21.5 t -77.47 -35.4 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.0 109.952 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.421 ' O ' ' HB ' ' A' ' 346' ' ' VAL . . . -59.32 -27.05 65.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.848 . . . . 0.0 110.299 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . 0.466 ' O ' HG11 ' A' ' 346' ' ' VAL . 0.5 OUTLIER -85.37 -19.94 30.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.461 ' SD ' HG13 ' A' ' 432' ' ' ILE . 0.8 OUTLIER -84.88 -33.09 22.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.455 ' O ' ' HB1' ' A' ' 349' ' ' ALA . 7.9 p -87.75 -24.2 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.224 -0.922 . . . . 0.0 110.322 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 343' ' ' ASN . 7.6 p -65.01 -20.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.154 -0.966 . . . . 0.0 110.234 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.12 -58.84 4.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -69.05 -31.16 69.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 110.175 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 345' ' ' VAL . . . -61.27 -23.94 66.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 109.985 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.32 -41.25 49.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -62.45 1.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.217 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 111.92 -41.71 2.16 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -88.65 83.59 6.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -1.17 . . . . 0.0 110.225 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 374' ' ' ASP . . . 177.57 101.86 0.15 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.587 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.2 OUTLIER -51.56 139.41 20.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.225 -1.161 . . . . 0.0 110.355 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.473 ' HB ' ' CG1' ' A' ' 319' ' ' ILE . 17.0 mt -111.75 167.84 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.749 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 39.9 tttt -148.56 114.97 5.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.951 -1.093 . . . . 0.0 111.12 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.517 ' CG2' HG22 ' A' ' 319' ' ' ILE . 21.7 t -119.24 78.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 109.25 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 95.5 p -110.68 135.24 51.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 110.357 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.482 ' HB3' ' HG ' ' A' ' 323' ' ' LEU . 0.0 OUTLIER -121.33 149.13 43.4 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 109.794 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -147.48 -165.07 11.6 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -175.81 162.64 2.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.961 -1.317 . . . . 0.0 111.32 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 1.2 mt-10 -126.63 174.21 4.4 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 50.5 Cg_endo -77.63 31.11 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.453 1.239 . . . . 0.0 111.488 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.557 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 11.9 p-10 177.88 26.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.069 -1.02 . . . . 0.0 110.766 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 24.4 ptt180 160.61 115.15 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 121.224 0.535 . . . . 0.0 109.861 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -96.23 166.47 11.72 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.145 -0.972 . . . . 0.0 109.26 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 61.9 p-90 -161.09 148.62 15.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.736 -1.228 . . . . 0.0 111.147 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.593 ' CZ ' ' HB2' ' A' ' 434' ' ' ALA . 30.2 p90 -122.84 136.33 54.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.42 -0.8 . . . . 0.0 109.732 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 433' ' ' ARG . 1.9 tt0 -112.23 137.42 50.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.375 -0.828 . . . . 0.0 111.481 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 54.3 t -131.93 107.51 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -109.71 158.22 18.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.071 -1.018 . . . . 0.0 110.664 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 373' ' ' ASP . 5.5 p-10 -168.97 132.33 1.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.374 -0.829 . . . . 0.0 110.15 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.465 ' O ' ' HA3' ' A' ' 354' ' ' GLY . 5.9 m-20 -107.93 154.38 21.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 110.361 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -169.77 -115.09 0.32 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.47 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.789 1.415 . . . . 0.0 110.427 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 172.21 -161.86 33.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.578 HD12 ' CD1' ' A' ' 430' ' ' LEU . 16.1 mt -131.17 154.67 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -1.205 . . . . 0.0 111.219 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.533 ' N ' HG21 ' A' ' 378' ' ' ILE . . . -73.82 150.38 88.4 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.534 -0.729 . . . . 0.0 109.081 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.38 -22.76 28.78 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 O-C-N 123.84 1.442 . . . . 0.0 110.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -91.09 -26.77 18.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.3 -0.875 . . . . 0.0 111.363 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -88.81 -29.36 19.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.052 -1.03 . . . . 0.0 110.761 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -19.43 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.049 -1.032 . . . . 0.0 110.394 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.49 ' HB2' ' CE1' ' A' ' 385' ' ' HIS . 12.2 mmtt -82.48 -34.44 28.04 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.377 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.571 ' ND1' ' N ' ' A' ' 385' ' ' HIS . 0.1 OUTLIER -107.24 -74.03 0.67 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.243 -0.91 . . . . 0.0 110.743 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 385' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.498 1.958 0 O-C-N 121.806 -0.559 . . . . 0.0 111.51 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 409' ' ' VAL . 23.6 mm . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.252 0.548 . . . . 0.0 110.062 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.49 ' HA ' HD11 ' A' ' 412' ' ' ILE . 17.4 t -39.51 -56.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.259 -0.901 . . . . 0.0 111.196 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.564 ' O ' ' CB ' ' A' ' 414' ' ' ASP . 7.8 pt20 -48.7 -52.04 25.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.14 -0.975 . . . . 0.0 111.688 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.2 OUTLIER -68.8 -20.72 64.34 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.75 -1.219 . . . . 0.0 111.274 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.533 HD11 ' CB ' ' A' ' 340' ' ' ALA . 16.9 mt -73.94 -75.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.88 -1.138 . . . . 0.0 108.679 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 419' ' ' MET . 21.4 t -54.29 -21.07 5.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.488 -0.757 . . . . 0.0 109.661 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 21.0 t0 -77.34 -40.32 44.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.143 -0.973 . . . . 0.0 109.864 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 0.8 OUTLIER -68.36 -20.36 64.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.284 -0.885 . . . . 0.0 109.65 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.57 ' CD2' ' HE1' ' A' ' 296' ' ' MET . 25.5 m80 -80.36 -26.38 38.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.379 -0.826 . . . . 0.0 110.01 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 2.1 t30 79.43 47.97 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.544 0.688 . . . . 0.0 110.445 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.528 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -118.23 -86.45 1.11 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.558 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.2 OUTLIER 179.14 161.75 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.358 -1.084 . . . . 0.0 111.259 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 410' ' ' GLN . 13.3 tp -152.55 101.53 2.65 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.338 -0.851 . . . . 0.0 108.82 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -111.46 136.41 50.66 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 120.839 -1.163 . . . . 0.0 112.405 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.46 93.42 5.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.711 0.767 . . . . 0.0 109.317 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 430' ' ' LEU . . . -60.73 141.96 48.17 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 54.7 m . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.389 -1.065 . . . . 0.0 110.396 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.578 ' CD1' HD12 ' A' ' 378' ' ' ILE . 2.7 mp -99.49 110.62 23.07 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.947 -1.325 . . . . 0.0 113.129 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.456 ' OG ' ' HA3' ' A' ' 423' ' ' GLY . 0.1 OUTLIER -113.43 111.64 22.29 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.495 ' O ' ' CG ' ' A' ' 370' ' ' GLN . 21.4 mm -87.52 125.78 41.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 120.723 -1.236 . . . . 0.0 112.9 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . 0.501 ' HA ' ' HG3' ' A' ' 370' ' ' GLN . 0.0 OUTLIER -118.8 85.9 2.45 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.95 131.9 35.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.471 -0.768 . . . . 0.0 110.703 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 81.3 m95 -112.79 154.04 26.85 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.245 1.021 . . . . 0.0 111.959 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 416' ' ' HIS . 17.8 mt -143.46 117.0 6.01 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.528 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 42.2 Cg_endo -68.41 143.99 59.93 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 O-C-N 123.549 1.289 . . . . 0.0 111.284 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 367' ' ' ALA . 76.3 t -103.98 90.37 2.95 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.659 -0.651 . . . . 0.0 110.35 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 47.2 Cg_endo . . . . . 0 C--N 1.307 -1.62 0 O-C-N 123.961 1.506 . . . . 0.0 110.09 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.604 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 52.6 Cg_endo . . . . . 0 C--O 1.215 -0.631 0 N-CA-C 110.522 -0.607 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.625 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.4 OUTLIER -94.69 107.65 19.65 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 122.152 0.977 . . . . 0.0 108.37 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.2 mm-40 -123.37 -159.73 0.87 Allowed 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.835 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.62 137.37 32.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 0.0 110.918 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -156.44 153.26 28.56 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.411 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.467 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 5.2 m-20 -88.22 114.67 25.07 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.532 HD22 ' CE ' ' A' ' 332' ' ' MET . 4.8 mt -64.09 -24.88 67.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 0.0 110.599 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.541 ' CA ' HD21 ' A' ' 323' ' ' LEU . 48.5 p-10 -81.0 -19.9 42.99 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.706 -1.246 . . . . 0.0 109.033 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.513 ' N ' ' OD1' ' A' ' 302' ' ' ASN . . . -87.96 -27.75 21.9 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.577 0.703 . . . . 0.0 109.225 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.483 HG13 HG23 ' A' ' 337' ' ' ILE . 90.4 t -78.85 -36.95 19.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.554 -0.716 . . . . 0.0 109.623 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 84.4 mt -76.34 -35.38 58.76 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.404 -0.81 . . . . 0.0 110.321 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -65.29 -26.59 71.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -84.14 -32.85 24.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.235 -1.156 . . . . 0.0 109.713 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.55 ' CG1' ' CG1' ' A' ' 341' ' ' VAL . 48.0 t -75.75 -21.4 15.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.385 -0.822 . . . . 0.0 109.121 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.589 ' CD1' ' CG1' ' A' ' 358' ' ' VAL . 17.1 mt -78.74 -53.49 13.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 122.109 0.957 . . . . 0.0 108.673 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 315' ' ' TYR . . . -68.21 -15.67 63.67 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.214 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -78.32 -59.17 2.89 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.753 -0.592 . . . . 0.0 111.931 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -118.36 32.84 5.93 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.022 -1.071 . . . . 0.0 112.348 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -129.04 44.34 2.99 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.923 -1.111 . . . . 0.0 109.777 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 59.13 22.32 55.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.479 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 0.3 OUTLIER 60.32 55.18 3.65 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.392 -1.064 . . . . 0.0 109.989 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.525 ' CA ' ' OE1' ' A' ' 316' ' ' GLU . 0.5 OUTLIER 66.7 35.77 5.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.122 -0.986 . . . . 0.0 109.741 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -48.18 62.58 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.899 0.857 . . . . 0.0 109.917 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -150.28 57.05 0.95 Allowed 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 121.51 0.671 . . . . 0.0 110.213 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.544 ' CD1' ' HB3' ' A' ' 313' ' ' SER . 2.7 mp -127.47 131.43 70.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 109.795 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -90.24 105.41 17.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.077 -1.014 . . . . 0.0 109.595 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 17.3 p -90.03 120.51 31.29 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.393 -0.817 . . . . 0.0 110.721 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -140.34 77.45 1.61 Allowed 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.467 -0.77 . . . . 0.0 108.974 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 323' ' ' LEU . 1.1 mp -92.0 163.18 14.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.618 -0.676 . . . . 0.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.457 ' CD1' HG21 ' A' ' 362' ' ' THR . 5.4 t80 -49.01 131.77 15.2 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.224 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -84.74 52.79 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.951 1.501 . . . . 0.0 110.186 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.477 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -162.97 22.42 0.18 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 15.6 p 53.04 104.65 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.338 -1.095 . . . . 0.0 110.15 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.543 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 1.3 mt -74.6 -178.17 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.45 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 5.1 mt-10 -169.8 103.12 0.32 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.611 0.72 . . . . 0.0 110.77 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.471 HG12 ' HB1' ' A' ' 367' ' ' ALA . 31.1 m -137.2 153.53 29.3 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.127 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -73.31 97.73 2.54 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.532 ' CE ' HD22 ' A' ' 301' ' ' LEU . 5.9 ttp -137.27 166.12 24.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.13 -0.981 . . . . 0.0 112.105 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.604 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 22.4 t-160 -103.26 113.86 65.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.523 ' O ' ' CG ' ' A' ' 338' ' ' LYS . 38.3 Cg_endo -63.11 -22.43 73.17 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.635 1.334 . . . . 0.0 111.904 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.531 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 0.7 OUTLIER -83.54 -56.61 3.64 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.664 -1.273 . . . . 0.0 110.601 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 51.5 p -61.96 -38.15 87.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.134 -0.979 . . . . 0.0 110.636 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.561 HD13 ' CE1' ' A' ' 416' ' ' HIS . 23.1 mm -76.24 -33.93 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.11 -0.994 . . . . 0.0 110.157 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 334' ' ' PRO . 4.7 mttt -59.89 -36.25 76.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -42.93 60.26 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.032 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.416 ' CB ' HG23 ' A' ' 412' ' ' ILE . . . -61.54 -35.11 76.83 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.359 -0.838 . . . . 0.0 110.616 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.55 ' CG1' ' CG1' ' A' ' 308' ' ' VAL . 50.7 t -76.12 -34.13 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.207 -0.933 . . . . 0.0 109.646 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.464 ' O ' ' CG2' ' A' ' 346' ' ' VAL . . . -70.66 -22.38 62.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 0.0 109.805 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -80.29 -23.75 40.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 109.969 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 7.8 mtt -85.0 -41.61 15.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.406 -0.809 . . . . 0.0 110.215 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.457 HG11 ' N ' ' A' ' 346' ' ' VAL . 14.3 p -67.46 -22.79 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.885 . . . . 0.0 110.509 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 342' ' ' ALA . 65.3 t -74.16 -24.84 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.101 -0.999 . . . . 0.0 110.16 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -81.63 -31.06 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 110.248 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -89.54 -24.93 21.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 110.197 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 345' ' ' VAL . . . -74.53 -39.43 62.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 110.031 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.71 -70.15 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -48.66 -59.08 3.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -87.45 142.56 18.08 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -139.79 81.27 1.81 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -1.103 . . . . 0.0 110.187 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -159.59 -48.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.565 ' CH2' ' HB2' ' A' ' 357' ' ' LYS . 1.4 t90 -178.65 141.9 0.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.25 . . . . 0.0 110.232 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.524 ' CD1' HG13 ' A' ' 319' ' ' ILE . 3.5 mt -107.23 163.16 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.73 . . . . 0.0 109.746 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.565 ' HB2' ' CH2' ' A' ' 355' ' ' TRP . 0.1 OUTLIER -140.73 93.69 2.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 0.0 109.957 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.589 ' CG1' ' CD1' ' A' ' 309' ' ' ILE . 37.7 t -97.15 105.01 16.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.139 -0.976 . . . . 0.0 109.784 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.2 t -124.88 160.1 29.6 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 110.992 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.531 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.4 t -142.92 130.47 21.26 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.602 -0.686 . . . . 0.0 109.212 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 362' ' ' THR . . . -123.76 -174.36 14.16 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.1 OUTLIER 170.13 163.74 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -1.106 . . . . 0.0 110.801 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.553 ' HB3' ' CD ' ' A' ' 364' ' ' PRO . 3.0 mt-10 -136.64 -168.87 0.2 Allowed Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.553 ' CD ' ' HB3' ' A' ' 363' ' ' GLU . 48.2 Cg_endo -84.79 31.04 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.21 1.11 . . . . 0.0 110.742 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 366' ' ' ARG . 57.3 t-20 -178.64 27.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 0.0 110.795 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.7 OUTLIER 165.63 107.1 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.156 -0.965 . . . . 0.0 111.149 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -106.63 137.89 43.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.277 -0.889 . . . . 0.0 109.214 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.687 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 64.6 p-90 -140.55 154.78 46.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.876 -1.14 . . . . 0.0 110.655 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 434' ' ' ALA . 53.4 p90 -127.28 138.75 53.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.328 -0.857 . . . . 0.0 109.457 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 432' ' ' ILE . 2.9 pt20 -126.99 165.38 19.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.178 -0.951 . . . . 0.0 111.673 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 431' ' ' SER . 3.1 t -141.66 125.78 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 373' ' ' ASP . 30.0 tt0 -124.33 155.2 39.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.752 -1.217 . . . . 0.0 110.598 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.445 ' N ' ' HG2' ' A' ' 372' ' ' GLU . 2.4 p30 -148.14 148.26 30.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.407 -0.808 . . . . 0.0 110.492 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -86.5 95.15 9.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.2 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 168.86 162.94 22.02 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.07 124.59 10.17 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.014 1.534 . . . . 0.0 110.02 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . 0.428 ' HA3' HD11 ' A' ' 430' ' ' LEU . . . -114.14 -90.86 1.81 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.54 HG13 ' CD1' ' A' ' 430' ' ' LEU . 65.7 mt -66.5 165.85 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.234 -1.156 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.517 ' CB ' ' HD2' ' A' ' 380' ' ' PRO . . . -128.97 178.91 1.45 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.253 -0.904 . . . . 0.0 110.003 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 379' ' ' ALA . 43.1 Cg_endo -71.05 -48.92 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.94 1.495 . . . . 0.0 109.653 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . 0.426 ' OE2' ' HG2' ' A' ' 380' ' ' PRO . 1.4 mp0 -91.04 -19.87 22.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.423 -0.798 . . . . 0.0 110.393 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.555 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 59.0 tt0 -81.16 -19.44 43.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.34 -0.85 . . . . 0.0 110.919 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -27.69 61.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.067 -1.02 . . . . 0.0 110.646 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -86.81 -19.07 29.54 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.13 -0.981 . . . . 0.0 110.546 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.555 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 8.4 m170 -48.18 -56.88 6.8 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.287 -0.883 . . . . 0.0 111.492 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.008 0 O-C-N 120.96 -1.087 . . . . 0.0 111.342 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 412' ' ' ILE . 1.3 pt . . . . . 0 N--CA 1.498 1.95 0 CA-C-O 121.05 0.452 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.7 -18.43 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.395 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -62.34 -61.53 2.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.479 -0.763 . . . . 0.0 110.097 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.419 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.3 OUTLIER -54.23 -23.63 15.49 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.351 -0.843 . . . . 0.0 110.559 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 412' ' ' ILE . 29.6 mm -68.18 -59.93 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.237 -0.914 . . . . 0.0 108.718 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' A' ' 420' ' ' LEU . 38.2 t -67.55 -19.15 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.458 -0.776 . . . . 0.0 109.43 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 7.1 t70 -84.24 -25.33 29.52 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.52 -0.738 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.504 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.4 m120 -75.3 -23.63 57.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.625 ' CD2' ' CE ' ' A' ' 296' ' ' MET . 45.1 m80 -95.75 -36.84 11.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.268 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.1 OUTLIER 80.04 57.1 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 121.435 0.636 . . . . 0.0 110.838 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.531 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -123.53 -84.66 0.66 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.534 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.7 OUTLIER -179.3 165.99 1.46 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.133 . . . . 0.0 111.556 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.467 ' HB2' HG13 ' A' ' 413' ' ' VAL . 15.1 tp -152.22 83.2 1.26 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 421' ' ' GLU . 4.1 mm-40 -101.0 166.51 10.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.915 -1.116 . . . . 0.0 111.643 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.85 123.63 40.88 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.57 0.7 . . . . 0.0 110.231 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.462 ' O ' ' OG1' ' A' ' 424' ' ' THR . . . -125.98 151.66 17.89 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 91.8 m . . . . . 0 N--CA 1.49 1.56 0 O-C-N 120.874 -1.368 . . . . 0.0 111.715 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.495 2.599 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.54 ' CD1' HG13 ' A' ' 378' ' ' ILE . 1.7 tt -76.79 152.78 35.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.031 -1.276 . . . . 0.0 110.287 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 371' ' ' VAL . 53.4 p -159.7 127.27 4.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.572 -0.705 . . . . 0.0 110.126 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 370' ' ' GLN . 18.1 mm -90.1 134.89 27.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 85.96 2.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.483 -0.761 . . . . 0.0 109.522 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.573 ' HB2' ' CE1' ' A' ' 369' ' ' PHE . . . -88.68 138.43 31.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.265 -0.897 . . . . 0.0 109.87 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.687 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.4 m95 -117.81 154.6 31.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 122.458 1.123 . . . . 0.0 113.067 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.525 ' CD1' HD12 ' A' ' 301' ' ' LEU . 7.9 mt -142.08 114.9 6.46 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.531 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 47.5 Cg_endo -71.07 138.77 34.34 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 O-C-N 123.572 1.301 . . . . 0.0 112.628 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.446 HG21 HG13 ' A' ' 330' ' ' VAL . 7.0 t -112.25 64.75 0.73 Allowed Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.436 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 42.2 Cg_endo . . . . . 0 C--N 1.308 -1.604 0 O-C-N 123.924 1.486 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.599 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 48.9 Cg_endo . . . . . 0 C--O 1.215 -0.673 0 N-CA-C 110.633 -0.564 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.602 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -96.58 108.62 21.24 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.1 mt-10 -138.09 -152.55 0.43 Allowed 'General case' 0 C--N 1.276 -2.621 0 O-C-N 121.818 -0.551 . . . . 0.0 109.604 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.482 ' CE ' ' C ' ' A' ' 330' ' ' VAL . 1.5 mmt -88.4 141.12 28.8 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 110.594 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.406 ' HB1' ' HE2' ' A' ' 332' ' ' MET . . . -154.15 157.82 39.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.396 -0.815 . . . . 0.0 110.985 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.443 ' O ' HG21 ' A' ' 304' ' ' VAL . 3.1 m-20 -90.85 117.23 29.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.41 -0.807 . . . . 0.0 110.059 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 8.4 mt -67.19 -24.17 65.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 110.015 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 302' ' ' ASN . 9.0 t30 -84.77 -22.94 29.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.871 -1.143 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -83.72 -29.78 27.25 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.43 -0.794 . . . . 0.0 109.334 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 308' ' ' VAL . 19.3 t -78.7 -40.06 23.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.573 -0.705 . . . . 0.0 109.309 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 81.4 mt -72.62 -30.14 64.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.49 -0.756 . . . . 0.0 110.594 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -61.03 -36.0 91.63 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -33.7 57.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.323 -1.104 . . . . 0.0 109.419 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.525 HG12 ' CG1' ' A' ' 341' ' ' VAL . 74.5 t -75.0 -18.93 16.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.505 -0.747 . . . . 0.0 109.244 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.579 ' CG1' ' CG1' ' A' ' 358' ' ' VAL . 5.0 mt -77.16 -46.16 29.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.96 -16.65 63.79 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.626 0.727 . . . . 0.0 109.482 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -74.92 -58.74 3.09 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.677 -0.639 . . . . 0.0 110.542 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.523 ' HB2' ' CG1' ' A' ' 345' ' ' VAL . 2.5 mm-40 -111.12 46.13 1.11 Allowed 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.753 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.584 ' HA ' ' CD1' ' A' ' 319' ' ' ILE . 0.6 OUTLIER -79.1 18.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.331 -0.855 . . . . 0.0 111.302 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 53.34 53.51 34.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 22.5 m-30 46.66 43.07 12.3 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.37 -1.076 . . . . 0.0 110.222 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.3 OUTLIER 65.12 35.92 7.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.906 -1.121 . . . . 0.0 109.667 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.582 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -69.06 -73.24 0.16 Allowed 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.552 -0.718 . . . . 0.0 109.786 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.582 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.2 mt-10 -167.91 78.63 0.16 Allowed 'General case' 0 C--N 1.27 -2.88 0 CA-C-O 121.548 0.689 . . . . 0.0 111.235 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.593 ' CG2' ' CG2' ' A' ' 358' ' ' VAL . 4.2 mm -97.05 121.99 48.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.764 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.436 ' HB3' ' HG3' ' A' ' 357' ' ' LYS . 0.4 OUTLIER -88.73 101.41 13.98 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 108.462 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 16.7 p -90.28 128.28 36.38 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.779 0.8 . . . . 0.0 111.951 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.98 78.15 1.34 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 360' ' ' SER . 5.0 mp -96.94 170.91 8.83 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.462 -0.774 . . . . 0.0 110.334 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.661 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 27.8 t80 -63.22 126.1 88.47 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.321 -0.862 . . . . 0.0 109.925 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -78.71 71.06 7.1 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.938 1.494 . . . . 0.0 110.7 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 172.73 30.35 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.446 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 326' ' ' GLY . 1.7 p 45.99 100.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.162 -1.199 . . . . 0.0 110.499 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.535 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 1.7 mt -71.12 -177.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 O-C-N 121.507 -0.746 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 4.9 mt-10 -167.34 107.65 0.6 Allowed 'General case' 0 C--N 1.289 -2.034 0 O-C-N 121.391 -0.818 . . . . 0.0 111.259 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.482 ' C ' ' CE ' ' A' ' 298' ' ' MET . 7.7 m -137.49 157.45 34.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-O 121.494 0.664 . . . . 0.0 109.97 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 11.2 tptt -78.04 92.5 4.37 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.547 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 3.0 tmm? -150.03 158.74 44.47 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 110.761 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.601 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 6.5 t-160 -91.07 126.6 54.66 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 333' ' ' HIS . 39.1 Cg_endo -61.87 -19.83 67.11 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 123.527 1.277 . . . . 0.0 109.95 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.601 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 4.4 mt -75.73 -57.85 3.64 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.375 -0.828 . . . . 0.0 109.886 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 25.3 p -52.91 -47.67 67.81 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.588 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.518 ' CG1' ' HG3' ' A' ' 332' ' ' MET . 24.1 mm -63.44 -32.15 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.069 -1.02 . . . . 0.0 110.473 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 43.2 mttt -60.69 -40.31 91.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.12 -0.987 . . . . 0.0 109.546 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -42.12 65.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.802 -0.561 . . . . 0.0 111.223 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 344' ' ' MET . . . -67.2 -30.9 70.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.229 -0.92 . . . . 0.0 111.088 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.525 ' CG1' HG12 ' A' ' 308' ' ' VAL . 43.0 t -90.31 -25.4 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.525 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.539 ' O ' ' CG2' ' A' ' 346' ' ' VAL . . . -82.99 -20.22 35.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 110.469 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -88.49 -19.4 26.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.144 -0.973 . . . . 0.0 110.613 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 58.2 mtt -78.21 -36.6 46.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.224 -0.923 . . . . 0.0 110.56 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 312' ' ' GLU . 12.2 p -88.57 -23.58 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.314 -0.866 . . . . 0.0 111.045 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 342' ' ' ALA . 12.1 t -66.19 -19.57 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.997 -1.065 . . . . 0.0 110.348 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -79.74 -33.73 40.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.468 ' O ' ' HA3' ' A' ' 352' ' ' GLY . . . -88.41 -27.79 21.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.083 -1.011 . . . . 0.0 110.751 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.31 -29.61 65.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.154 -0.966 . . . . 0.0 111.329 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 15.7 mtt-85 -77.83 -66.91 0.78 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.995 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 351' ' ' TYR . 13.4 m-30 -90.22 -19.85 23.7 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.149 -0.969 . . . . 0.0 111.129 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 353' ' ' ASN . . . -76.76 -98.15 0.17 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.33 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 352' ' ' GLY . 2.1 t30 76.56 46.7 0.08 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.459 -1.024 . . . . 0.0 109.92 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -130.49 -78.0 0.18 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -137.36 127.8 26.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -1.096 . . . . 0.0 109.687 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.535 ' HB ' HD11 ' A' ' 319' ' ' ILE . 44.9 mt -115.11 159.11 15.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 108.816 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.499 ' CD ' ' HB2' ' A' ' 372' ' ' GLU . 4.2 tttp -148.0 117.51 7.0 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.838 -1.164 . . . . 0.0 111.338 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.593 ' CG2' ' CG2' ' A' ' 319' ' ' ILE . 20.8 t -109.78 135.13 49.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.468 ' HA ' HD13 ' A' ' 323' ' ' LEU . 43.4 t -157.59 164.1 37.63 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.746 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -164.56 132.55 3.35 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -136.15 -163.72 10.0 Favored Glycine 0 C--N 1.29 -2.017 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.661 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.2 OUTLIER -160.02 166.47 29.91 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.277 -1.131 . . . . 0.0 110.417 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.559 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -146.24 -175.88 0.51 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 39.1 Cg_endo -64.93 111.03 1.61 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.449 1.236 . . . . 0.0 110.501 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.544 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 16.9 m120 59.34 40.72 20.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.732 -0.605 . . . . 0.0 110.795 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 1.4 mtt85 -176.83 98.42 0.05 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.156 -0.965 . . . . 0.0 111.192 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -97.53 171.6 8.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.135 -0.978 . . . . 0.0 108.391 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.608 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 22.7 p-90 -171.35 160.8 6.26 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.343 -1.473 . . . . 0.0 111.373 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 53.7 p90 -137.85 132.61 32.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.517 -0.74 . . . . 0.0 109.24 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.591 ' HG3' ' CZ3' ' A' ' 368' ' ' TRP . 22.9 mt-30 -121.53 168.78 11.34 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.06 -1.025 . . . . 0.0 112.353 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 65.2 t -140.08 148.92 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 431' ' ' SER . 9.1 mt-10 -147.05 148.15 31.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.061 -1.024 . . . . 0.0 110.429 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.547 ' N ' ' OD1' ' A' ' 373' ' ' ASP . 0.5 OUTLIER -165.28 163.65 20.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.287 -0.883 . . . . 0.0 110.239 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -107.92 62.69 0.61 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.214 -0.928 . . . . 0.0 110.428 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -87.46 -148.5 14.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.29 -43.52 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.051 1.553 . . . . 0.0 110.211 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 112.05 -176.69 18.22 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.533 HG13 ' CD2' ' A' ' 430' ' ' LEU . 0.8 OUTLIER -99.14 134.68 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.115 -1.227 . . . . 0.0 109.551 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 382' ' ' GLN . . . -50.11 165.3 0.33 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.454 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.67 -38.9 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.079 1.568 . . . . 0.0 111.456 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . 0.475 ' O ' ' CD2' ' A' ' 385' ' ' HIS . 0.7 OUTLIER -89.33 -45.13 9.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.028 -1.045 . . . . 0.0 110.662 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.479 ' HB3' ' HB1' ' A' ' 379' ' ' ALA . 16.6 tt0 -56.52 -18.43 11.58 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -50.44 -33.04 19.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.131 -0.98 . . . . 0.0 109.802 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -90.22 -20.07 23.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.324 -0.86 . . . . 0.0 109.692 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.627 ' N ' ' CD2' ' A' ' 385' ' ' HIS . 1.4 m170 -96.05 25.15 4.99 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.6 ' CD2' ' CD2' ' A' ' 422' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.49 0 O-C-N 121.592 -0.692 . . . . 0.0 111.611 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.536 ' CD1' ' HG3' ' A' ' 410' ' ' GLN . 21.1 tt . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.331 0.586 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.509 HG21 ' N ' ' A' ' 410' ' ' GLN . 32.8 m -56.36 -25.03 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.398 -0.814 . . . . 0.0 110.501 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.536 ' HG3' ' CD1' ' A' ' 408' ' ' ILE . 2.7 mt-30 -51.41 -43.52 62.0 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.192 -0.942 . . . . 0.0 109.761 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -28.8 66.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.476 -0.765 . . . . 0.0 110.301 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.11 -63.04 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.194 -0.941 . . . . 0.0 108.802 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.524 ' CG1' ' HB2' ' A' ' 420' ' ' LEU . 59.5 t -62.6 -23.55 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 23.1 t70 -80.33 -29.95 38.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -80.84 -28.33 36.17 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.451 -0.781 . . . . 0.0 109.5 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.602 ' CD2' ' CE ' ' A' ' 296' ' ' MET . 39.1 m80 -86.95 -34.81 19.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.525 -0.735 . . . . 0.0 109.726 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.0 OUTLIER 75.42 31.57 0.77 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.558 -0.714 . . . . 0.0 111.096 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.518 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -95.9 -83.51 1.65 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.57 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.4 OUTLIER -178.86 161.02 1.17 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -1.053 . . . . 0.0 110.671 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.524 ' HB2' ' CG1' ' A' ' 413' ' ' VAL . 67.2 tp -150.87 93.86 2.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.985 -1.072 . . . . 0.0 109.976 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.557 ' O ' ' CG ' ' A' ' 433' ' ' ARG . 37.3 mt-10 -125.0 140.47 52.89 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.081 -1.012 . . . . 0.0 109.973 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.6 ' CD2' ' CD2' ' A' ' 386' ' ' LEU . 0.6 OUTLIER -121.91 150.68 41.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.908 -1.12 . . . . 0.0 111.569 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 430' ' ' LEU . . . -135.24 -165.82 10.87 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.557 ' HB ' ' HA ' ' A' ' 430' ' ' LEU . 7.3 m . . . . . 0 N--CA 1.49 1.562 0 O-C-N 120.584 -1.539 . . . . 0.0 109.888 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.404 ' C ' HG21 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.492 2.383 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.557 ' HA ' ' HB ' ' A' ' 424' ' ' THR . 0.2 OUTLIER -153.52 149.4 27.65 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.084 -1.244 . . . . 0.0 109.397 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.516 ' N ' ' HB ' ' A' ' 424' ' ' THR . 35.2 t -149.05 102.72 3.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.992 -1.068 . . . . 0.0 109.826 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.515 ' CD1' ' HB3' ' A' ' 422' ' ' LEU . 9.6 tp -89.82 150.23 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 110.877 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . 0.557 ' CG ' ' O ' ' A' ' 421' ' ' GLU . 0.1 OUTLIER -133.98 106.06 7.05 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.646 -0.659 . . . . 0.0 109.67 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -96.57 146.3 24.95 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.413 -0.805 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.608 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 93.0 m95 -121.07 153.87 36.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.134 -0.979 . . . . 0.0 111.593 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.444 ' HG ' ' C ' ' A' ' 435' ' ' TRP . 7.7 mt -141.12 124.73 10.09 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.518 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 43.5 Cg_endo -68.4 135.71 34.68 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.557 1.293 . . . . 0.0 111.266 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.476 ' CG2' ' HB1' ' A' ' 367' ' ' ALA . 3.2 t -104.13 106.91 55.51 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.931 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.306 -1.69 0 O-C-N 124.216 1.64 . . . . 0.0 109.945 -179.938 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.538 ' HG2' ' NE2' ' A' ' 333' ' ' HIS . 51.3 Cg_endo . . . . . 0 C--O 1.215 -0.643 0 CA-C-O 121.35 0.479 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.568 ' HE2' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -89.03 109.24 20.1 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 24.2 mt-10 -135.93 -157.13 0.77 Allowed 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.993 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.54 ' CG ' ' HE3' ' A' ' 331' ' ' LYS . 0.1 OUTLIER -87.64 141.91 28.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 0.0 110.624 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -155.95 163.98 39.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.64 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.407 ' O ' HG22 ' A' ' 304' ' ' VAL . 0.5 OUTLIER -101.58 114.65 28.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.339 -0.851 . . . . 0.0 110.471 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.528 HD23 ' CD1' ' A' ' 436' ' ' LEU . 14.3 mt -61.23 -25.03 66.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.84 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.517 ' HA ' HD22 ' A' ' 323' ' ' LEU . 40.4 t-20 -80.7 -23.7 39.35 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.197 -0.939 . . . . 0.0 109.365 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.76 -25.59 26.31 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.53 ' O ' ' CG2' ' A' ' 308' ' ' VAL . 5.5 t -83.69 -34.68 10.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.427 -0.795 . . . . 0.0 109.484 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 59.3 mt -79.43 -28.37 41.7 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.346 -0.846 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.14 -35.85 91.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 311' ' ' ALA . 4.3 mt-10 -80.67 -33.63 35.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.294 -1.121 . . . . 0.0 109.79 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 304' ' ' VAL . 27.7 t -77.29 -19.99 14.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 313' ' ' SER . 0.9 OUTLIER -76.11 -51.41 20.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.432 ' N ' HG21 ' A' ' 309' ' ' ILE . . . -77.41 -15.41 59.37 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.404 -0.81 . . . . 0.0 109.456 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 307' ' ' GLU . . . -70.72 -62.49 1.37 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.401 ' OE2' ' O ' ' A' ' 311' ' ' ALA . 9.8 mm-40 -123.05 31.08 6.13 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.586 -1.246 . . . . 0.0 113.351 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.538 ' CB ' HD12 ' A' ' 319' ' ' ILE . 2.6 m -111.26 44.31 1.34 Allowed 'General case' 0 C--N 1.289 -2.052 0 O-C-N 120.641 -1.287 . . . . 0.0 108.964 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 69.8 26.52 74.3 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.496 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 4.8 m-85 59.24 47.7 11.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -1.046 . . . . 0.0 110.322 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 68.42 35.61 3.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.107 -0.996 . . . . 0.0 109.621 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.453 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 14.3 tpp85 -69.06 -81.36 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.642 0.734 . . . . 0.0 110.625 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 318' ' ' GLU . 4.3 pt-20 -126.58 72.93 1.36 Allowed 'General case' 0 C--N 1.275 -2.633 0 O-C-N 121.615 -0.678 . . . . 0.0 111.149 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.538 HD12 ' CB ' ' A' ' 313' ' ' SER . 2.6 mp -132.6 138.19 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.002 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -99.48 103.88 15.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.846 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 35.7 p -89.73 122.04 32.45 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.257 -0.902 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -138.81 79.39 1.73 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 323' ' ' LEU . 1.2 mp -88.66 150.28 23.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.478 -0.764 . . . . 0.0 110.386 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.56 ' CD1' HG21 ' A' ' 362' ' ' THR . 36.6 t80 -37.21 145.3 0.27 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.599 -0.688 . . . . 0.0 109.928 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.525 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 51.7 Cg_endo -83.0 59.03 6.56 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 O-C-N 123.966 1.508 . . . . 0.0 110.444 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . 179.74 17.1 0.03 OUTLIER Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.738 -1.22 . . . . 0.0 111.242 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 2.0 m 58.47 115.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.666 -1.49 . . . . 0.0 110.018 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 324' ' ' TYR . 2.0 mm -69.48 178.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 4.9 mt-10 -170.87 106.09 0.26 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.609 0.719 . . . . 0.0 109.971 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.472 HG13 ' HB1' ' A' ' 367' ' ' ALA . 7.8 m -148.16 168.46 3.89 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-O 121.648 0.737 . . . . 0.0 110.539 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -85.09 94.26 8.81 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.554 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 4.7 tmm? -145.17 157.51 44.06 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 110.592 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.591 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 22.2 t-160 -82.79 111.65 31.26 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 37.9 Cg_endo -62.16 -19.3 66.14 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.717 1.377 . . . . 0.0 110.058 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.591 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -81.3 -47.21 13.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.937 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.441 ' O ' HG12 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -65.06 -41.33 95.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.448 -0.782 . . . . 0.0 109.982 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.481 HG13 ' HG3' ' A' ' 332' ' ' MET . 19.6 mm -71.3 -33.67 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.909 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 7.4 mttm -59.06 -60.94 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.706 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -37.15 86.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.482 -0.761 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.551 ' CB ' HG22 ' A' ' 412' ' ' ILE . . . -58.71 -35.56 72.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.92 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.502 HG13 ' CG1' ' A' ' 308' ' ' VAL . 48.2 t -88.33 -21.23 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 111.136 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.469 ' HB3' HG11 ' A' ' 308' ' ' VAL . . . -77.61 -28.74 51.59 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.092 -1.005 . . . . 0.0 111.993 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -89.7 -18.67 25.97 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.786 -1.196 . . . . 0.0 111.793 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.455 ' HG2' ' HA ' ' A' ' 341' ' ' VAL . 3.6 ptp -88.57 -20.93 24.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.73 -1.231 . . . . 0.0 111.077 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.43 ' N ' ' HG3' ' A' ' 344' ' ' MET . 8.2 p -90.6 -20.6 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.086 -1.009 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.43 -20.16 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.047 -1.033 . . . . 0.0 110.994 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -63.83 -31.28 72.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.12 -0.987 . . . . 0.0 110.516 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.483 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -89.73 -21.3 22.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 110.738 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -82.26 -68.72 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.075 -1.015 . . . . 0.0 110.656 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -57.11 -66.9 0.38 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.191 -0.943 . . . . 0.0 110.702 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.53 -39.88 36.61 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.165 -0.959 . . . . 0.0 110.491 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -71.53 163.95 54.1 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -164.38 38.18 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.34 -1.094 . . . . 0.0 109.855 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -123.11 -67.14 0.22 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.6 OUTLIER -173.0 137.26 0.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.164 -1.197 . . . . 0.0 110.386 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.483 ' HB ' HG13 ' A' ' 319' ' ' ILE . 5.3 mt -107.52 167.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -0.76 . . . . 0.0 109.274 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 2.2 tttp -148.93 116.5 6.21 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.027 -1.045 . . . . 0.0 110.822 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.505 HG13 ' CD1' ' A' ' 309' ' ' ILE . 17.5 t -115.51 75.94 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 108.974 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.3 p -104.69 132.06 51.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.818 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 28.8 t -122.0 163.58 19.11 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.55 -0.719 . . . . 0.0 109.522 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.461 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -159.45 -153.37 6.82 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.56 HG21 ' CD1' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -179.65 171.38 1.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.43 -1.041 . . . . 0.0 109.901 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.568 ' CB ' ' CD ' ' A' ' 364' ' ' PRO . 3.8 mt-10 -131.91 -169.54 0.21 Allowed Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.193 -0.942 . . . . 0.0 109.809 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 363' ' ' GLU . 48.3 Cg_endo -84.74 30.0 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.447 0 O-C-N 123.582 1.306 . . . . 0.0 110.963 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 366' ' ' ARG . 3.8 p30 167.86 34.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.31 -0.869 . . . . 0.0 110.18 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 166.75 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.383 -0.823 . . . . 0.0 109.9 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -97.74 162.35 13.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.164 -0.96 . . . . 0.0 109.313 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.674 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 45.3 p-90 -167.31 171.65 10.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.706 -1.246 . . . . 0.0 111.005 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.6 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 20.3 p90 -141.8 143.3 33.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.226 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.495 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 0.1 OUTLIER -132.88 145.62 51.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.133 -0.979 . . . . 0.0 111.725 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.495 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 21.1 t -127.11 132.62 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -123.11 158.56 30.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.945 -1.097 . . . . 0.0 110.39 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 11.2 p-10 -150.88 140.25 21.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.366 -0.834 . . . . 0.0 110.215 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.41 177.38 9.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.335 -0.853 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 107.23 -158.6 14.99 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.17 163.0 40.04 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.947 1.499 . . . . 0.0 110.987 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -105.52 -153.13 21.2 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.539 HG12 ' CD1' ' A' ' 430' ' ' LEU . 1.6 mm -89.87 93.25 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.138 -1.213 . . . . 0.0 110.112 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 383' ' ' ARG . . . -46.61 165.9 0.19 Allowed Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.808 -1.182 . . . . 0.0 109.233 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.1 -19.55 22.72 Favored 'Trans proline' 0 C--N 1.294 -2.301 0 O-C-N 123.482 1.254 . . . . 0.0 110.231 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -84.4 -43.67 14.47 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.306 -0.871 . . . . 0.0 111.331 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.582 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 0.0 OUTLIER -83.89 -34.69 24.49 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.087 -1.008 . . . . 0.0 111.189 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -60.07 -19.61 53.91 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.684 -1.26 . . . . 0.0 109.572 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.486 ' HG2' ' HD2' ' A' ' 383' ' ' ARG . 33.2 mmtt -86.86 -23.64 25.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.554 -0.716 . . . . 0.0 110.61 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.582 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 0.3 OUTLIER -118.45 29.95 7.48 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.983 -1.073 . . . . 0.0 111.49 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 13.1 tp . . . . . 0 C--N 1.303 -1.43 0 O-C-N 121.027 -1.046 . . . . 0.0 108.713 -179.98 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 412' ' ' ILE . 7.1 tp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.367 0.603 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.525 ' HA ' ' CD1' ' A' ' 412' ' ' ILE . 10.4 t -138.44 5.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 109.485 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 414' ' ' ASP . 16.6 mt-30 -90.08 -48.51 7.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.416 -0.802 . . . . 0.0 109.608 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -66.4 -20.98 66.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.444 -0.785 . . . . 0.0 109.738 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.551 HG22 ' CB ' ' A' ' 340' ' ' ALA . 1.1 mp -68.57 -72.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.248 -0.908 . . . . 0.0 108.726 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.511 ' N ' HG23 ' A' ' 412' ' ' ILE . 12.6 t -60.35 -23.22 27.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 21.5 t0 -75.9 -30.18 58.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.459 -0.775 . . . . 0.0 109.728 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.496 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 2.5 m-20 -77.18 -19.93 56.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.207 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.568 ' CD2' ' HE2' ' A' ' 296' ' ' MET . 44.0 m80 -89.79 -28.56 19.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.557 -0.714 . . . . 0.0 109.756 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.5 OUTLIER 78.14 4.6 2.77 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.677 -0.639 . . . . 0.0 110.002 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.543 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -66.52 -91.36 0.05 OUTLIER Glycine 0 N--CA 1.482 1.727 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.545 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 1.4 ttp 178.96 166.31 0.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -1.101 . . . . 0.0 111.413 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 25.1 tp -151.96 90.96 1.57 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.396 -0.815 . . . . 0.0 108.904 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -112.24 143.12 43.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.941 -1.099 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.72 111.65 24.41 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 109.747 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.465 ' O ' ' OG1' ' A' ' 424' ' ' THR . . . -98.3 162.78 20.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 423' ' ' GLY . 4.6 m . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.11 -1.229 . . . . 0.0 110.674 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.539 ' CD1' HG12 ' A' ' 378' ' ' ILE . 0.5 OUTLIER -78.62 135.46 37.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -1.209 . . . . 0.0 110.949 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 28.6 m -148.5 122.14 9.21 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.442 ' O ' ' CG2' ' A' ' 432' ' ' ILE . 1.1 tt -89.39 128.02 41.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.062 -1.024 . . . . 0.0 110.609 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . 0.436 ' HG3' ' HG3' ' A' ' 370' ' ' GLN . 0.5 OUTLIER -107.13 99.67 9.21 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.44 -0.788 . . . . 0.0 110.059 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.6 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -90.32 138.5 31.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.674 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 89.4 m95 -114.97 159.32 20.89 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.284 1.04 . . . . 0.0 113.088 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.528 ' CD1' HD23 ' A' ' 301' ' ' LEU . 32.0 mt -146.33 123.11 5.85 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.543 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 44.4 Cg_endo -74.17 141.83 29.82 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 123.479 1.252 . . . . 0.0 112.18 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.444 HG11 ' HD2' ' A' ' 439' ' ' PRO . 55.0 t -101.8 134.25 20.27 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.758 -0.588 . . . . 0.0 109.862 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.444 ' HD2' HG11 ' A' ' 438' ' ' VAL . 48.8 Cg_endo . . . . . 0 C--N 1.307 -1.637 0 O-C-N 123.803 1.422 . . . . 0.0 109.955 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.657 ' HB3' ' CD2' ' A' ' 333' ' ' HIS . 48.1 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 CA-C-O 121.323 0.468 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.551 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.8 OUTLIER 35.78 51.69 0.73 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.699 1.238 . . . . 0.0 110.16 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.4 OUTLIER -126.5 -156.98 0.77 Allowed 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.24 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.452 ' SD ' ' OE1' ' A' ' 329' ' ' GLU . 0.7 OUTLIER -86.81 125.17 33.77 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.414 -1.429 . . . . 0.0 110.626 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -137.99 158.55 44.1 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.586 0.708 . . . . 0.0 111.572 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.453 ' O ' HG22 ' A' ' 304' ' ' VAL . 0.9 OUTLIER -102.19 112.75 25.55 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.525 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 14.1 mt -60.34 -24.87 65.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.092 -1.005 . . . . 0.0 110.472 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.527 ' HA ' ' CD2' ' A' ' 323' ' ' LEU . 7.7 m-20 -79.52 -23.39 42.94 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.829 -1.17 . . . . 0.0 109.107 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -83.12 -30.37 27.96 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.479 0.657 . . . . 0.0 109.678 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 300' ' ' ASP . 2.9 t -79.02 -31.87 15.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.44 -0.787 . . . . 0.0 109.69 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 97.9 mt -77.64 -31.78 52.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 110.869 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.21 -38.36 95.81 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.471 -1.347 . . . . 0.0 109.897 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 311' ' ' ALA . 48.4 mt-10 -76.32 -34.73 59.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -1.15 . . . . 0.0 109.7 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.525 HG13 ' CG1' ' A' ' 341' ' ' VAL . 63.6 t -77.48 -19.13 14.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.687 0.756 . . . . 0.0 109.701 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.513 ' CD1' ' CG1' ' A' ' 358' ' ' VAL . 0.0 OUTLIER -75.09 -43.85 44.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -90.37 -16.8 28.44 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.506 0.669 . . . . 0.0 110.377 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 307' ' ' GLU . . . -73.25 -41.95 63.09 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.586 -0.696 . . . . 0.0 112.261 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.486 ' HG2' HG22 ' A' ' 345' ' ' VAL . 1.4 pp20? -115.82 17.24 16.14 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.753 -1.179 . . . . 0.0 112.354 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.554 ' HB2' ' CD1' ' A' ' 319' ' ' ILE . 15.4 t -102.99 -39.47 6.9 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.391 1.091 . . . . 0.0 109.621 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 118.12 -40.29 2.35 Favored Glycine 0 C--N 1.263 -3.491 0 N-CA-C 107.326 -2.31 . . . . 0.0 107.326 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 5.8 t80 174.65 37.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 0.2 OUTLIER 58.8 47.59 12.47 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -67.75 -39.7 84.15 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.449 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 317' ' ' ARG . 39.0 mt-10 -154.97 51.74 0.61 Allowed 'General case' 0 C--N 1.273 -2.751 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.437 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 313' ' ' SER . 5.5 mt -118.9 129.34 75.24 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.949 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.493 ' HB3' ' HD3' ' A' ' 357' ' ' LYS . 37.1 tt0 -97.19 103.53 15.47 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.461 HG23 HD11 ' A' ' 309' ' ' ILE . 24.2 p -89.12 128.3 35.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 111.871 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . 0.408 ' O ' ' OG ' ' A' ' 359' ' ' SER . . . -150.57 78.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' A' ' 323' ' ' LEU . 1.9 mp -95.53 159.91 14.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.471 -0.768 . . . . 0.0 111.148 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.637 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 83.5 t80 -47.94 121.44 8.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.622 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.64 78.96 1.96 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.903 1.475 . . . . 0.0 110.718 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 173.15 29.29 0.03 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.524 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 326' ' ' GLY . 2.1 p 44.28 98.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.069 -1.253 . . . . 0.0 110.001 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.547 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -72.43 -179.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.463 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.3 mt-10 -171.39 105.66 0.22 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.68 0.752 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.504 HG13 ' CB ' ' A' ' 367' ' ' ALA . 31.0 m -137.06 158.35 36.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 O-C-N 121.67 -0.644 . . . . 0.0 109.626 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.1 OUTLIER -72.36 91.81 1.37 Allowed 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.831 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.533 ' HG3' ' CD2' ' A' ' 416' ' ' HIS . 3.8 ttp -134.81 168.15 19.57 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 111.255 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.657 ' CD2' ' HB3' ' A' ' 295' ' ' PRO . 19.0 t-160 -101.85 118.09 60.2 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.66 -21.72 64.05 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.41 1.216 . . . . 0.0 110.37 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.585 ' HB2' ' NE2' ' A' ' 333' ' ' HIS . 0.3 OUTLIER -83.4 -68.2 0.73 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.461 -0.774 . . . . 0.0 110.355 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.488 ' HB3' HD11 ' A' ' 412' ' ' ILE . 0.4 OUTLIER -46.55 -44.51 17.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.484 -0.76 . . . . 0.0 110.007 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.6 HD13 ' CE1' ' A' ' 416' ' ' HIS . 37.9 mm -65.16 -46.23 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.393 -0.817 . . . . 0.0 109.53 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 337' ' ' ILE . 0.0 OUTLIER -47.04 -41.98 17.62 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.083 -1.011 . . . . 0.0 108.492 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 343' ' ' ASN . 17.2 mtt180 -73.03 -34.93 66.63 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.433 0.635 . . . . 0.0 110.314 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.472 ' HB1' HG22 ' A' ' 412' ' ' ILE . . . -62.23 -32.62 73.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.763 . . . . 0.0 110.849 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.525 ' CG1' HG13 ' A' ' 308' ' ' VAL . 44.7 t -85.19 -63.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.127 -0.983 . . . . 0.0 110.063 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.541 ' HA ' ' CG2' ' A' ' 345' ' ' VAL . . . -51.39 -19.45 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 110.687 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 339' ' ' ARG . 2.0 t30 -76.2 -42.48 46.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.137 -0.977 . . . . 0.0 111.412 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.425 ' SD ' HD12 ' A' ' 432' ' ' ILE . 5.1 mtt -79.57 -24.89 41.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.975 -1.078 . . . . 0.0 111.413 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 342' ' ' ALA . 16.7 m -88.56 -19.74 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.906 -1.121 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 342' ' ' ALA . 4.7 p -58.72 -36.16 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.916 -1.115 . . . . 0.0 110.544 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.437 ' N ' ' CG1' ' A' ' 346' ' ' VAL . 0.9 OUTLIER -65.3 -54.38 29.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.897 . . . . 0.0 110.357 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.489 ' O ' ' CA ' ' A' ' 352' ' ' GLY . . . -66.55 -19.82 65.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.891 . . . . 0.0 110.503 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -74.76 -50.32 17.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 110.485 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.08 -73.19 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.915 . . . . 0.0 110.682 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . 0.444 ' O ' ' O ' ' A' ' 352' ' ' GLY . 12.1 m-85 -82.54 -44.6 15.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.225 -0.922 . . . . 0.0 110.828 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 348' ' ' ALA . . . 55.59 103.58 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 353' ' ' ASN . 26.6 t-20 -113.24 24.74 11.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -1.194 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 355' ' ' TRP . . . 178.64 -73.56 0.07 OUTLIER Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.626 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER 178.36 164.81 0.76 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.14 -1.212 . . . . 0.0 109.78 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.537 HD11 ' CG1' ' A' ' 319' ' ' ILE . 0.9 OUTLIER -112.45 163.01 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.279 -0.888 . . . . 0.0 111.183 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.626 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -142.23 124.08 15.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.825 . . . . 0.0 110.002 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.548 ' CG2' HG22 ' A' ' 319' ' ' ILE . 21.7 t -119.92 83.15 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.406 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.458 ' HA ' HD11 ' A' ' 323' ' ' LEU . 47.2 t -113.53 166.56 11.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.319 -0.863 . . . . 0.0 110.528 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.532 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.6 t -156.77 160.07 38.89 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.52 -0.737 . . . . 0.0 109.849 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -149.22 -162.52 10.4 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.637 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -170.62 174.89 4.85 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.905 -1.35 . . . . 0.0 110.782 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.544 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 2.6 mt-10 -160.41 -178.65 0.92 Allowed Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 38.4 Cg_endo -64.11 135.31 46.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.475 1.25 . . . . 0.0 109.908 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.553 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 5.0 p-10 38.74 33.65 0.07 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.614 -0.678 . . . . 0.0 110.699 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.553 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 3.6 mtt180 -172.67 99.93 0.14 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.393 -0.817 . . . . 0.0 111.265 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -110.32 154.8 22.99 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.1 -1.0 . . . . 0.0 108.659 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.621 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 45.9 p-90 -153.4 177.49 10.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.548 -1.345 . . . . 0.0 111.649 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.528 ' CD2' HD13 ' A' ' 436' ' ' LEU . 32.7 p90 -150.44 153.56 36.14 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -145.85 152.87 40.19 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.853 -1.154 . . . . 0.0 111.673 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 432' ' ' ILE . 88.0 t -122.73 141.31 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.537 ' CG ' ' HB2' ' A' ' 431' ' ' SER . 0.8 OUTLIER -121.62 154.93 36.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.061 -1.024 . . . . 0.0 110.732 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -155.0 140.04 17.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -107.72 109.36 20.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 0.0 110.385 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -177.37 -107.32 0.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.13 -172.03 0.8 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.829 1.436 . . . . 0.0 110.671 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . 0.434 ' HA2' HD13 ' A' ' 430' ' ' LEU . . . -144.09 -150.76 5.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . . . . . . . . . 11.3 mt -118.55 161.25 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.179 -1.189 . . . . 0.0 110.076 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.425 ' CB ' ' HD2' ' A' ' 380' ' ' PRO . . . -112.02 176.47 1.49 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.094 -1.004 . . . . 0.0 110.555 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 379' ' ' ALA . 47.2 Cg_endo -75.64 -45.04 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.092 1.575 . . . . 0.0 110.643 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -81.34 -35.73 30.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 110.514 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -61.29 -21.49 63.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.268 -0.895 . . . . 0.0 110.307 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -59.58 -30.79 68.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.879 . . . . 0.0 109.987 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.56 -35.39 39.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 385' ' ' HIS . 2.8 m-70 -67.19 -25.73 66.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.203 -0.936 . . . . 0.0 110.417 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.105 -0.997 . . . . 0.0 110.21 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.526 ' CD1' HG11 ' A' ' 409' ' ' VAL . 1.7 pp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.526 HG11 ' CD1' ' A' ' 408' ' ' ILE . 1.4 p -37.73 -33.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.326 -0.859 . . . . 0.0 110.923 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.491 ' CG ' HD13 ' A' ' 408' ' ' ILE . 1.3 mm100 -65.9 -55.7 15.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.042 -1.036 . . . . 0.0 109.739 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -56.57 -20.77 22.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 336' ' ' SER . 25.4 mm -72.11 -65.91 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 108.569 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 420' ' ' LEU . 86.5 t -59.99 -19.87 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.538 -0.726 . . . . 0.0 109.703 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -82.22 -32.83 29.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.867 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.551 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.4 m-20 -78.7 -28.06 45.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.481 -0.762 . . . . 0.0 109.378 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.6 ' CE1' HD13 ' A' ' 337' ' ' ILE . 41.1 m80 -86.34 -39.03 16.86 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.881 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 1.0 OUTLIER 79.88 45.44 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.393 0.616 . . . . 0.0 110.543 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 419' ' ' MET . . . -107.85 -85.81 1.78 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.552 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.4 ttp 177.99 169.88 0.72 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.321 -1.105 . . . . 0.0 111.019 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.445 ' HB2' HG12 ' A' ' 413' ' ' VAL . 16.1 tp -151.46 89.34 1.49 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.769 . . . . 0.0 109.133 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.38 159.47 15.11 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.095 -1.003 . . . . 0.0 111.525 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.532 ' O ' ' CD1' ' A' ' 422' ' ' LEU . 3.0 pp -134.05 119.45 18.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.606 -0.684 . . . . 0.0 109.535 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.519 ' O ' HD21 ' A' ' 430' ' ' LEU . . . -131.14 170.72 21.27 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.536 ' OG1' ' CD2' ' A' ' 430' ' ' LEU . 88.0 m . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.057 -1.261 . . . . 0.0 110.448 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.536 ' CD2' ' OG1' ' A' ' 424' ' ' THR . 0.2 OUTLIER -68.06 114.89 6.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.185 -1.185 . . . . 0.0 110.298 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.537 ' HB2' ' CG ' ' A' ' 372' ' ' GLU . 14.6 t -128.32 120.87 27.93 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.429 -0.794 . . . . 0.0 110.312 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.489 ' O ' HG21 ' A' ' 432' ' ' ILE . 1.2 tt -91.73 130.68 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.52 129.46 56.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.999 -1.063 . . . . 0.0 110.771 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -120.07 128.68 53.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.273 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.621 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.8 m95 -102.44 155.62 18.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.94 -1.1 . . . . 0.0 111.591 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.528 HD13 ' CD2' ' A' ' 369' ' ' PHE . 14.6 mt -145.59 129.04 8.41 Favored Pre-proline 0 N--CA 1.485 1.276 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.02 142.23 41.91 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.721 1.38 . . . . 0.0 110.069 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.537 ' HB ' ' HD3' ' A' ' 439' ' ' PRO . 2.6 t -73.35 -47.35 7.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.152 -0.967 . . . . 0.0 110.498 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.537 ' HD3' ' HB ' ' A' ' 438' ' ' VAL . 58.0 Cg_endo . . . . . 0 C--N 1.314 -1.289 0 O-C-N 123.51 1.269 . . . . 0.0 110.333 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.539 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 53.3 Cg_endo . . . . . 0 C--O 1.214 -0.714 0 CA-C-O 121.778 0.657 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.593 ' HE3' ' CD2' ' A' ' 416' ' ' HIS . 0.3 OUTLIER 28.83 80.57 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.416 1.103 . . . . 0.0 112.015 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 14.2 mt-10 -148.63 -149.06 0.28 Allowed 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.462 ' HE3' ' N ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -87.64 128.81 35.28 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.74 -1.225 . . . . 0.0 109.527 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . -136.01 158.29 44.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.404 -0.81 . . . . 0.0 111.67 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.441 ' HB2' ' HB1' ' A' ' 303' ' ' ALA . 4.3 m-20 -95.12 117.51 30.33 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.521 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 6.7 mt -63.86 -23.64 67.43 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.05 -1.031 . . . . 0.0 110.191 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.506 ' HA ' ' CD2' ' A' ' 323' ' ' LEU . 29.9 m-20 -79.94 -19.57 47.69 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.904 -1.123 . . . . 0.0 108.569 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.441 ' HB1' ' HB2' ' A' ' 300' ' ' ASP . . . -85.94 -37.21 19.29 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.433 0.635 . . . . 0.0 109.463 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.503 ' O ' ' CG2' ' A' ' 308' ' ' VAL . 22.0 t -74.94 -30.79 24.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.528 -0.732 . . . . 0.0 109.514 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 25.2 mt -78.65 -36.38 43.96 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.285 -0.884 . . . . 0.0 110.428 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -62.06 -39.1 97.16 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 1.0 OUTLIER -71.88 -33.66 68.54 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.231 -1.158 . . . . 0.0 108.599 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.529 HG12 ' CG1' ' A' ' 341' ' ' VAL . 93.5 t -75.57 -18.77 15.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.811 0.815 . . . . 0.0 108.9 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.557 ' CD1' ' CG2' ' A' ' 321' ' ' THR . 0.3 OUTLIER -72.71 -45.1 58.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 122.021 0.915 . . . . 0.0 108.648 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . 0.447 ' N ' HG21 ' A' ' 309' ' ' ILE . . . -90.95 -15.86 29.03 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 121.4 -0.813 . . . . 0.0 109.795 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 307' ' ' GLU . . . -61.61 -64.81 0.82 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.658 -0.651 . . . . 0.0 111.297 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.421 ' HG3' ' C ' ' A' ' 311' ' ' ALA . 94.9 mt-10 -142.98 39.2 1.47 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.088 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.537 ' CB ' HD12 ' A' ' 319' ' ' ILE . 19.4 m -88.31 42.74 1.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.892 -1.13 . . . . 0.0 109.161 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' A' ' 315' ' ' TYR . . . 74.07 13.87 80.77 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.58 ' CB ' ' O ' ' A' ' 314' ' ' GLY . 4.0 t80 78.88 63.3 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.893 -0.769 . . . . 0.0 108.926 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.576 ' CG ' ' O ' ' A' ' 315' ' ' TYR . 6.2 pt-20 41.74 45.73 3.11 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.126 0.965 . . . . 0.0 109.907 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.58 ' CG ' ' O ' ' A' ' 314' ' ' GLY . 6.4 mmt180 -68.36 -89.74 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 121.771 0.796 . . . . 0.0 109.808 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.25 65.55 1.41 Allowed 'General case' 0 C--N 1.272 -2.778 0 CA-C-O 121.583 0.706 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.537 ' CG2' HG21 ' A' ' 358' ' ' VAL . 2.6 mp -101.27 148.37 7.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 121.52 -0.737 . . . . 0.0 110.113 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -114.28 105.46 13.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.164 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.557 ' CG2' ' CD1' ' A' ' 309' ' ' ILE . 28.2 p -90.55 122.04 33.02 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 111.38 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -129.69 78.36 1.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.506 ' CD2' ' HA ' ' A' ' 302' ' ' ASN . 1.8 mp -93.78 174.18 7.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 111.215 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.629 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 20.8 t80 -61.23 137.84 94.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.651 -0.656 . . . . 0.0 109.906 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.552 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 53.1 Cg_endo -82.46 61.97 7.78 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.963 1.507 . . . . 0.0 110.547 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 178.82 22.2 0.03 OUTLIER Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.777 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 326' ' ' GLY . 2.1 m 55.12 107.3 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.891 -1.358 . . . . 0.0 110.281 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.546 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -81.63 -177.51 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.122 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 1.9 mt-10 -170.92 108.79 0.31 Allowed 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.841 0.829 . . . . 0.0 111.107 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.462 ' N ' ' HE3' ' A' ' 298' ' ' MET . 25.3 m -131.3 159.17 43.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 O-C-N 121.72 -0.613 . . . . 0.0 109.463 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 3.3 tptt -76.4 93.57 3.51 Favored 'General case' 0 C--N 1.288 -2.104 0 C-N-CA 118.681 -1.208 . . . . 0.0 108.909 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.546 ' CG ' HD23 ' A' ' 436' ' ' LEU . 0.0 OUTLIER -134.73 -174.46 3.59 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.818 0.818 . . . . 0.0 111.326 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.601 ' CB ' ' NE2' ' A' ' 416' ' ' HIS . 18.6 t-160 -113.82 117.56 44.07 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 37.1 Cg_endo -59.24 -26.58 82.32 Favored 'Trans proline' 0 C--N 1.289 -2.563 0 O-C-N 123.105 1.055 . . . . 0.0 110.391 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 336' ' ' SER . 0.5 OUTLIER -83.09 -66.47 0.89 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.273 -0.892 . . . . 0.0 110.819 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.535 ' N ' ' HG ' ' A' ' 335' ' ' LEU . 3.5 m -52.88 -42.76 65.6 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.941 -1.099 . . . . 0.0 110.624 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 416' ' ' HIS . 29.6 mm -64.17 -44.45 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.591 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 0.7 OUTLIER -50.72 -46.77 59.18 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.707 -1.246 . . . . 0.0 109.284 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -43.17 93.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 0.0 110.121 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.517 ' HB3' ' CG2' ' A' ' 412' ' ' ILE . . . -47.29 -40.99 18.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.514 -0.741 . . . . 0.0 110.576 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.529 ' CG1' HG12 ' A' ' 308' ' ' VAL . 40.2 t -80.04 -32.14 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 110.47 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.531 ' O ' ' CG2' ' A' ' 346' ' ' VAL . . . -66.78 -23.65 66.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.26 -0.9 . . . . 0.0 110.364 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -66.99 -29.88 69.84 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.147 -0.971 . . . . 0.0 110.489 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.403 ' SD ' HG22 ' A' ' 371' ' ' VAL . 42.0 mtt -82.04 -42.9 18.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.208 -0.933 . . . . 0.0 110.498 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' ' 313' ' ' SER . 3.7 p -67.86 -19.6 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.474 -0.766 . . . . 0.0 110.776 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 342' ' ' ALA . 53.0 t -67.99 -20.08 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.14 -0.975 . . . . 0.0 110.657 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.2 -57.38 4.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 110.366 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.435 ' O ' ' HA2' ' A' ' 352' ' ' GLY . . . -79.72 -19.97 47.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.46 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 345' ' ' VAL . . . -74.06 -25.11 59.65 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 110.413 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -73.71 -67.94 0.55 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.204 -0.935 . . . . 0.0 110.295 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -30.45 51.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 110.217 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 348' ' ' ALA . . . 82.95 106.5 0.48 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.498 ' HB3' ' HB3' ' A' ' 374' ' ' ASP . 10.5 m120 -97.5 -57.4 2.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.285 -1.127 . . . . 0.0 110.466 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . 150.99 -17.38 0.93 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.607 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 37.7 t90 -154.37 130.87 10.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.842 -1.387 . . . . 0.0 111.666 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.458 ' HB ' ' CG1' ' A' ' 319' ' ' ILE . 82.1 mt -124.05 158.98 30.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 372' ' ' GLU . 5.9 tttp -136.4 137.95 41.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.628 -1.295 . . . . 0.0 111.672 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.537 HG21 ' CG2' ' A' ' 319' ' ' ILE . 26.0 t -132.85 81.19 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.406 ' HB3' ' HE3' ' A' ' 357' ' ' LYS . 89.1 p -112.14 160.77 17.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.161 -0.962 . . . . 0.0 111.256 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 369' ' ' PHE . 47.2 t -162.16 130.44 4.11 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -118.1 -161.47 11.95 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.629 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.8 OUTLIER -171.36 177.58 3.5 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.748 -1.442 . . . . 0.0 112.014 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 1.0 OUTLIER -156.29 175.26 3.3 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 38.0 Cg_endo -64.29 116.32 3.67 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.158 1.083 . . . . 0.0 111.289 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.513 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 6.2 m-20 63.07 18.38 10.88 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.743 -0.598 . . . . 0.0 111.147 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 26.9 mtp180 -160.23 108.02 1.64 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.437 -0.789 . . . . 0.0 110.377 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -112.7 179.19 4.04 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.864 -1.147 . . . . 0.0 108.708 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.654 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 11.5 p-90 -171.44 149.04 2.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.825 -1.172 . . . . 0.0 110.11 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 369' ' ' PHE . 4.7 p90 -138.46 142.8 39.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.963 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.518 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 11.9 tt0 -133.31 155.09 50.06 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 110.42 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.518 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 36.7 t -118.78 151.74 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.428 -0.795 . . . . 0.0 110.179 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.537 ' CB ' ' HB3' ' A' ' 357' ' ' LYS . 4.4 tt0 -139.19 117.24 11.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.269 -0.895 . . . . 0.0 109.746 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 373' ' ' ASP . 20.4 p-10 -145.88 143.48 29.61 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.04 -1.038 . . . . 0.0 110.201 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 353' ' ' ASN . 12.4 t0 -74.83 140.76 44.15 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.406 -0.809 . . . . 0.0 109.817 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -179.51 -150.29 8.96 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.07 -162.24 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.975 1.513 . . . . 0.0 110.512 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -140.22 -172.75 12.99 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.433 ' CD1' HD11 ' A' ' 422' ' ' LEU . 26.0 mt -110.39 140.16 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -1.174 . . . . 0.0 110.568 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.56 164.4 47.49 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.407 -0.808 . . . . 0.0 109.872 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.83 -30.25 9.54 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 124.087 1.572 . . . . 0.0 110.732 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -90.39 -21.29 22.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.0 110.483 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.425 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 0.1 OUTLIER -78.88 -21.65 47.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.177 -0.952 . . . . 0.0 110.466 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -49.97 -21.42 1.2 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.151 -0.968 . . . . 0.0 110.467 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.54 -32.19 16.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.24 -0.912 . . . . 0.0 110.482 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.425 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 5.4 m-70 -80.35 -10.88 59.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.319 -0.863 . . . . 0.0 110.893 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 386' ' ' LEU . 22.1 tp . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.036 -1.04 . . . . 0.0 111.445 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.533 ' O ' ' CG2' ' A' ' 408' ' ' ILE . 1.1 tp . . . . . 0 N--CA 1.511 2.622 0 CA-C-O 121.292 0.568 . . . . 0.0 111.605 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.83 1.91 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 1.3 mm100 -74.25 -55.3 6.2 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 110.237 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 1.9 mmt180 -67.8 -31.49 71.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.323 -0.861 . . . . 0.0 109.898 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.517 ' CG2' ' HB3' ' A' ' 340' ' ' ALA . 8.7 mm -67.21 -66.28 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 413' ' ' VAL . 35.4 t -57.11 -23.24 18.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.424 -0.797 . . . . 0.0 109.699 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 29.5 m-20 -78.09 -30.72 49.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.221 -0.925 . . . . 0.0 109.535 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.479 ' HB3' ' HE2' ' A' ' 296' ' ' MET . 1.2 m-20 -109.31 7.29 25.11 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.65 -0.657 . . . . 0.0 109.625 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.601 ' NE2' ' CB ' ' A' ' 333' ' ' HIS . 47.1 m80 -134.64 -62.92 0.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 111.968 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.737 ' HA ' ' CD2' ' A' ' 436' ' ' LEU . 2.4 m-20 -74.73 -99.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.808 0.814 . . . . 0.0 111.61 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 149.11 -35.04 1.08 Allowed Glycine 0 C--N 1.262 -3.551 0 N-CA-C 106.432 -2.667 . . . . 0.0 106.432 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.607 ' HB3' ' HB2' ' A' ' 435' ' ' TRP . 36.4 ttm -123.14 145.69 48.38 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.658 -0.907 . . . . 0.0 109.601 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 413' ' ' VAL . 19.7 tp -150.84 92.71 1.86 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.114 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -107.6 128.8 54.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.372 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 422' ' ' LEU . 2.0 pp -89.81 138.58 31.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.869 . . . . 0.0 109.547 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.474 ' O ' ' HG ' ' A' ' 430' ' ' LEU . . . -149.26 -168.66 15.02 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.555 -1.307 . . . . 0.0 109.903 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.57 ' CG2' ' O ' ' A' ' 429' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 O-C-N 121.577 -0.955 . . . . 0.0 111.185 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.57 ' O ' ' CG2' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 424' ' ' THR . 0.3 OUTLIER -88.68 165.23 14.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.882 -1.364 . . . . 0.0 109.876 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.516 ' N ' ' HB ' ' A' ' 424' ' ' THR . 1.7 p -146.52 162.86 37.42 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.964 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 370' ' ' GLN . 13.3 mm -123.8 121.84 63.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -98.99 100.98 12.22 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -110.35 135.05 51.67 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 111.066 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.654 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 88.0 m95 -110.14 138.35 46.64 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 121.064 -1.023 . . . . 0.0 111.255 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.737 ' CD2' ' HA ' ' A' ' 417' ' ' ASN . 9.7 mt -113.46 75.79 2.57 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 417' ' ' ASN . 37.5 Cg_endo -63.05 115.08 2.74 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 O-C-N 124.665 1.876 . . . . 0.0 110.494 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.513 ' CG1' ' HD2' ' A' ' 439' ' ' PRO . 4.6 t -69.66 143.91 93.19 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.384 -0.823 . . . . 0.0 109.682 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.513 ' HD2' ' CG1' ' A' ' 438' ' ' VAL . 53.6 Cg_endo . . . . . 0 C--N 1.301 -1.935 0 O-C-N 124.0 1.526 . . . . 0.0 110.418 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.473 ' O ' ' HG2' ' A' ' 297' ' ' GLU . 47.0 Cg_endo . . . . . 0 C--O 1.214 -0.702 0 N-CA-C 109.542 -0.984 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.52 ' HE1' ' NE2' ' A' ' 416' ' ' HIS . 0.1 OUTLIER 40.38 48.37 2.39 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.85 1.309 . . . . 0.0 109.304 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.664 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 4.3 mm-40 -127.84 -149.91 0.43 Allowed 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.193 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.532 ' HE3' ' N ' ' A' ' 330' ' ' VAL . 2.1 mmt -84.74 117.49 23.85 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 120.286 -1.508 . . . . 0.0 110.7 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.471 ' HB2' ' HE2' ' A' ' 332' ' ' MET . . . -134.09 162.01 33.29 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.528 0.68 . . . . 0.0 111.129 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 304' ' ' VAL . 4.1 m-20 -95.97 119.01 33.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.654 -0.654 . . . . 0.0 109.867 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.498 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 6.1 mt -65.51 -23.45 66.89 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.091 -1.006 . . . . 0.0 109.654 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.46 ' HA ' HD22 ' A' ' 323' ' ' LEU . 4.5 m-20 -75.68 -19.99 58.74 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.957 -1.09 . . . . 0.0 108.351 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.07 -37.24 19.08 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.524 0.678 . . . . 0.0 109.601 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.515 ' O ' ' CG2' ' A' ' 308' ' ' VAL . 2.5 t -78.8 -28.62 14.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.415 -0.803 . . . . 0.0 109.554 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 72.4 mt -82.85 -31.38 28.04 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.62 -31.99 82.72 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.82 -30.82 26.21 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.268 -1.136 . . . . 0.0 109.251 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.536 HG13 ' CG1' ' A' ' 341' ' ' VAL . 88.7 t -72.58 -26.88 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.305 -0.872 . . . . 0.0 109.32 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.532 ' O ' ' CB ' ' A' ' 313' ' ' SER . 1.0 OUTLIER -75.79 -50.2 24.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.08 -16.7 64.5 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.861 0.839 . . . . 0.0 108.762 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 308' ' ' VAL . . . -67.01 -68.03 0.41 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.453 0.644 . . . . 0.0 110.79 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.487 ' HG3' HG21 ' A' ' 346' ' ' VAL . 0.2 OUTLIER -134.82 49.35 2.23 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.553 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.549 ' HB2' ' CD1' ' A' ' 319' ' ' ILE . 6.2 p -82.32 40.46 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.001 -1.062 . . . . 0.0 109.994 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.542 ' C ' ' CD2' ' A' ' 315' ' ' TYR . . . 53.16 38.15 55.83 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.542 ' CD2' ' C ' ' A' ' 314' ' ' GLY . 3.6 m-85 67.89 34.65 4.16 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.629 -0.924 . . . . 0.0 109.279 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.407 ' OE2' ' HA ' ' A' ' 316' ' ' GLU . 4.9 mm-40 57.52 41.71 25.48 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.241 -0.912 . . . . 0.0 108.614 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.569 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 1.6 tpp180 -68.71 -86.89 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.432 0.634 . . . . 0.0 110.784 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.569 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 5.4 mt-10 -127.04 66.15 1.29 Allowed 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.637 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.549 ' CD1' ' HB2' ' A' ' 313' ' ' SER . 1.5 mp -111.48 120.77 62.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 358' ' ' VAL . 24.0 tt0 -88.33 100.45 13.03 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.343 -0.848 . . . . 0.0 109.79 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 20.7 p -88.46 122.98 32.53 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.52 0.676 . . . . 0.0 110.903 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -144.55 78.94 1.59 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 323' ' ' LEU . 1.7 mp -90.29 164.77 14.24 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 110.125 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 323' ' ' LEU . 5.2 t80 -43.24 136.76 2.95 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.631 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -83.14 51.57 3.68 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.94 1.495 . . . . 0.0 111.232 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.469 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -165.73 -87.77 0.07 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 3.3 m -178.54 105.26 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.613 -0.933 . . . . 0.0 108.98 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.534 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 2.0 mt -74.17 -179.69 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 O-C-N 121.404 -0.81 . . . . 0.0 110.006 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 3.2 mt-10 -170.82 105.63 0.26 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.585 0.707 . . . . 0.0 110.601 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.574 ' CG1' ' CB ' ' A' ' 367' ' ' ALA . 25.4 m -139.23 154.24 25.13 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.302 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.6 OUTLIER -71.7 92.35 1.18 Allowed 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.567 ' HG2' HG13 ' A' ' 337' ' ' ILE . 10.0 tmm? -143.07 158.24 43.78 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.108 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.589 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 9.9 t-160 -100.42 121.24 53.95 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.47 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 38.6 Cg_endo -64.77 -18.81 63.62 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.628 1.33 . . . . 0.0 109.697 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.589 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 0.6 OUTLIER -81.23 -80.01 0.15 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.618 -0.676 . . . . 0.0 110.692 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 96.9 p -44.37 -43.06 7.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.39 -0.819 . . . . 0.0 110.178 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.586 HD13 ' CE1' ' A' ' 416' ' ' HIS . 1.2 mm -66.32 -40.95 88.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.811 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 0.0 OUTLIER -45.45 -38.4 6.08 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -44.39 67.79 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.108 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.526 ' CB ' HG22 ' A' ' 412' ' ' ILE . . . -54.63 -47.99 72.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.61 -0.681 . . . . 0.0 111.089 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.536 ' CG1' HG13 ' A' ' 308' ' ' VAL . 33.3 t -75.62 -28.08 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.132 -0.98 . . . . 0.0 110.403 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 346' ' ' VAL . . . -69.54 -19.89 63.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 110.117 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -88.85 -19.83 25.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.311 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.4 mtt -82.59 -44.78 15.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.243 -0.911 . . . . 0.0 110.373 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.513 ' CG1' ' N ' ' A' ' 346' ' ' VAL . 6.9 p -69.84 -42.82 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.513 ' N ' ' CG1' ' A' ' 345' ' ' VAL . 19.4 t -52.05 -19.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.102 -0.999 . . . . 0.0 110.569 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -67.12 -46.4 74.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.193 -0.942 . . . . 0.0 110.635 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.461 ' HB2' HG22 ' A' ' 356' ' ' ILE . . . -88.78 -19.72 25.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.212 -0.93 . . . . 0.0 110.656 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.3 -27.16 65.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.159 -0.963 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 350' ' ' ARG . 0.0 OUTLIER -83.3 -37.09 23.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 110.123 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.85 -67.44 0.84 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 65.34 52.98 35.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -106.3 -1.94 22.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -1.153 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -145.08 -84.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.615 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -172.7 148.81 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -1.11 . . . . 0.0 109.875 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.465 ' HB ' HG13 ' A' ' 319' ' ' ILE . 1.0 OUTLIER -109.8 153.34 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.869 . . . . 0.0 109.528 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.615 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.1 OUTLIER -144.5 114.69 7.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.986 . . . . 0.0 110.745 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 321' ' ' THR . 55.3 t -109.72 138.64 36.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.488 ' HA ' ' CD1' ' A' ' 323' ' ' LEU . 97.7 p -161.18 173.96 14.35 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 120.502 -1.374 . . . . 0.0 111.507 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.502 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 6.4 p -155.04 131.3 10.33 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.488 0.661 . . . . 0.0 109.826 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 362' ' ' THR . . . -129.91 -172.47 13.16 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 107.986 -2.046 . . . . 0.0 107.986 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 361' ' ' GLY . 0.6 OUTLIER 175.96 176.26 0.25 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.867 -1.372 . . . . 0.0 111.546 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.532 ' OE1' ' CD ' ' A' ' 364' ' ' PRO . 33.3 mm-40 -141.54 175.24 3.14 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.532 ' CD ' ' OE1' ' A' ' 363' ' ' GLU . 47.3 Cg_endo -77.25 26.01 0.46 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.336 1.177 . . . . 0.0 111.388 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 21.3 p-10 -170.19 24.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.065 -1.022 . . . . 0.0 110.202 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.542 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 8.1 ptt180 162.46 109.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.789 -0.569 . . . . 0.0 110.248 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.574 ' CB ' ' CG1' ' A' ' 330' ' ' VAL . . . -100.45 168.9 9.45 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.194 -0.941 . . . . 0.0 109.085 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.688 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 34.8 p-90 -170.98 153.16 3.73 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.587 -1.321 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.632 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 54.4 p90 -121.81 157.15 31.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.175 -0.953 . . . . 0.0 108.638 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.526 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 5.8 tt0 -141.8 159.39 42.33 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.829 -1.17 . . . . 0.0 111.835 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.526 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 96.8 t -137.83 135.73 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.403 ' OE2' ' CD ' ' A' ' 370' ' ' GLN . 18.1 mt-10 -131.21 158.08 41.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.835 -1.165 . . . . 0.0 111.041 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -150.58 142.81 24.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.436 -0.79 . . . . 0.0 109.782 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.65 2.0 20.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.219 -0.926 . . . . 0.0 110.297 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . 0.404 ' O ' ' HA3' ' A' ' 429' ' ' GLY . . . -65.53 -175.15 5.28 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.09 145.69 44.98 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.942 1.496 . . . . 0.0 110.642 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -63.67 -140.34 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.593 ' CD1' ' CD2' ' A' ' 430' ' ' LEU . 0.0 OUTLIER -116.75 118.95 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.147 -1.208 . . . . 0.0 109.957 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.427 ' HB1' ' HB2' ' A' ' 382' ' ' GLN . . . -43.26 161.64 0.19 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.281 -0.887 . . . . 0.0 110.296 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.38 -24.14 16.8 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.939 1.494 . . . . 0.0 110.028 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -88.67 -21.49 23.91 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.392 -0.818 . . . . 0.0 109.876 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.427 ' HB2' ' HB1' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -86.17 -30.33 22.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -22.21 66.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.612 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -20.84 63.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.603 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -92.42 21.02 5.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.472 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.438 ' CD2' HD22 ' A' ' 422' ' ' LEU . 8.5 mt . . . . . 0 C--N 1.302 -1.488 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . . . . . . . . . 21.7 mm . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.326 0.584 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.493 ' HA ' HG13 ' A' ' 412' ' ' ILE . 14.7 p -116.45 -9.46 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.53 -0.731 . . . . 0.0 109.989 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -68.53 -62.39 1.41 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.297 -0.877 . . . . 0.0 110.315 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -19.99 6.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.241 -0.912 . . . . 0.0 110.497 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.526 HG22 ' CB ' ' A' ' 340' ' ' ALA . 24.7 mm -66.0 -69.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.105 -0.997 . . . . 0.0 108.984 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.499 ' CG2' ' HB2' ' A' ' 420' ' ' LEU . 69.6 t -62.18 -20.72 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 109.437 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.14 -26.48 42.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.469 -0.769 . . . . 0.0 109.85 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.464 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 22.7 m-20 -84.0 -22.93 31.19 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.313 -0.867 . . . . 0.0 109.292 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.586 ' CE1' HD13 ' A' ' 337' ' ' ILE . 41.4 m80 -93.18 -26.16 17.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.504 -0.747 . . . . 0.0 109.686 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 4.2 m120 66.03 59.27 0.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.687 0.756 . . . . 0.0 110.889 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.499 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -128.29 -84.04 0.42 Allowed Glycine 0 N--CA 1.481 1.656 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.557 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.1 OUTLIER -179.07 155.98 0.76 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -1.129 . . . . 0.0 112.011 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.499 ' HB2' ' CG2' ' A' ' 413' ' ' VAL . 15.7 tp -152.76 92.83 1.69 Allowed 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.458 -0.776 . . . . 0.0 108.995 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 432' ' ' ILE . 0.2 OUTLIER -115.22 123.43 48.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.007 -1.058 . . . . 0.0 110.969 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.496 ' CA ' HG13 ' A' ' 432' ' ' ILE . 0.8 OUTLIER -126.5 140.01 52.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.154 -0.966 . . . . 0.0 110.098 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.405 ' HA2' HG13 ' A' ' 378' ' ' ILE . . . 175.46 -169.76 42.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 44.3 m . . . . . 0 N--CA 1.487 1.414 0 O-C-N 121.297 -1.119 . . . . 0.0 110.003 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.503 3.109 0 CA-C-O 121.827 0.682 . . . . 0.0 112.54 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.593 ' CD2' ' CD1' ' A' ' 378' ' ' ILE . 0.9 OUTLIER -66.98 140.06 57.71 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 121.914 0.864 . . . . 0.0 113.008 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.5 ' N ' ' CD1' ' A' ' 430' ' ' LEU . 29.4 t -167.02 112.18 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.496 HG13 ' CA ' ' A' ' 422' ' ' LEU . 15.6 tt -125.83 157.33 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.162 -0.961 . . . . 0.0 110.567 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.73 127.35 18.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.405 -0.81 . . . . 0.0 109.928 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.632 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -109.69 147.27 33.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.271 -0.893 . . . . 0.0 110.129 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.688 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.3 m95 -124.22 155.91 37.73 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.398 1.094 . . . . 0.0 113.246 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.454 ' HG ' ' C ' ' A' ' 435' ' ' TRP . 19.0 mt -145.38 94.8 5.14 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.499 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 42.6 Cg_endo -67.19 146.17 75.21 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.966 1.509 . . . . 0.0 112.896 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 10.8 t -107.3 98.0 21.18 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.836 -0.54 . . . . 0.0 110.379 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 49.6 Cg_endo . . . . . 0 C--N 1.309 -1.5 0 O-C-N 123.78 1.411 . . . . 0.0 111.577 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.612 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 54.7 Cg_endo . . . . . 0 C--O 1.215 -0.665 0 N-CA-C 110.188 -0.735 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.526 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.2 OUTLIER -81.84 108.79 15.65 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 122.216 1.008 . . . . 0.0 109.239 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 20.3 mt-10 -133.71 -155.71 0.69 Allowed 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.221 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.06 139.06 30.89 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 111.037 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -155.69 160.09 40.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.576 -0.703 . . . . 0.0 110.523 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.86 114.84 29.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.382 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 328' ' ' ILE . 7.5 mt -59.92 -25.13 64.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.265 -0.897 . . . . 0.0 109.831 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.438 ' CG ' HD21 ' A' ' 323' ' ' LEU . 42.3 t-20 -82.18 -21.53 36.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.939 -1.1 . . . . 0.0 109.356 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.52 -27.54 22.56 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.604 0.716 . . . . 0.0 109.474 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.491 HG12 ' HG3' ' A' ' 338' ' ' LYS . 28.5 t -82.89 -37.05 13.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 121.582 0.706 . . . . 0.0 109.168 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 86.1 mt -79.72 -31.11 41.09 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.475 -0.766 . . . . 0.0 110.117 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.95 -26.73 73.23 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -84.44 -33.52 23.65 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.419 -1.048 . . . . 0.0 109.782 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.566 ' CG1' ' CG1' ' A' ' 341' ' ' VAL . 78.6 t -75.2 -25.42 18.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.395 -0.816 . . . . 0.0 109.469 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.556 HD12 ' CG1' ' A' ' 358' ' ' VAL . 1.6 mt -79.56 -43.45 23.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.734 0.778 . . . . 0.0 108.941 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.2 -17.3 62.52 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.73 0.776 . . . . 0.0 109.048 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -85.7 -45.62 11.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.657 -0.652 . . . . 0.0 110.67 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -99.34 28.68 4.38 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.115 -0.991 . . . . 0.0 110.599 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.474 ' O ' ' OG ' ' A' ' 313' ' ' SER . 1.6 t -97.48 38.08 1.3 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.254 -0.904 . . . . 0.0 109.93 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -99.18 -74.77 1.16 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.461 ' O ' ' HG2' ' A' ' 316' ' ' GLU . 2.7 t80 -93.32 25.78 3.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -1.094 . . . . 0.0 108.689 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.573 ' O ' ' CD1' ' A' ' 319' ' ' ILE . 48.5 mm-40 -160.03 38.21 0.18 Allowed 'General case' 0 C--O 1.192 -1.966 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.445 ' HA ' HD13 ' A' ' 319' ' ' ILE . 0.1 OUTLIER -69.52 -0.99 7.46 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 121.422 0.63 . . . . 0.0 110.002 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.05 33.92 0.45 Allowed 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.918 0.866 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.595 ' CG2' ' CG2' ' A' ' 358' ' ' VAL . 0.7 OUTLIER -89.15 134.86 27.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.432 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -95.87 110.32 22.52 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.012 -1.055 . . . . 0.0 109.119 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.473 HG21 HD12 ' A' ' 309' ' ' ILE . 10.8 p -89.52 123.28 33.48 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.351 -0.843 . . . . 0.0 111.675 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.84 78.41 1.49 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.542 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 5.2 mp -93.93 154.85 17.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.78 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.595 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 79.0 t80 -46.75 132.26 8.43 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.425 -0.797 . . . . 0.0 110.215 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.474 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 46.5 Cg_endo -72.71 78.91 1.99 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.952 1.501 . . . . 0.0 110.318 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . 167.66 7.89 0.03 OUTLIER Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.804 -1.189 . . . . 0.0 111.177 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 0.5 OUTLIER 63.38 116.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 O-C-N 120.555 -1.556 . . . . 0.0 109.57 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.544 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 4.1 mm -69.23 179.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.734 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.544 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 1.9 mt-10 -175.49 104.47 0.08 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.609 0.719 . . . . 0.0 110.674 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.518 ' CG2' ' HG2' ' A' ' 332' ' ' MET . 13.7 m -150.09 172.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 O-C-N 121.702 -0.624 . . . . 0.0 110.323 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -86.22 93.58 9.09 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 119.384 -0.927 . . . . 0.0 108.664 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.535 ' CE ' HD22 ' A' ' 301' ' ' LEU . 11.7 ptm -144.58 166.27 25.64 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.356 -0.84 . . . . 0.0 110.568 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.612 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 19.1 t-160 -92.18 112.22 54.03 Favored Pre-proline 0 C--N 1.297 -1.698 0 O-C-N 121.523 -0.736 . . . . 0.0 109.46 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 41.4 Cg_endo -66.39 -23.62 50.89 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.825 1.434 . . . . 0.0 111.128 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.539 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 1.1 tp -81.99 -62.16 1.71 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.951 -1.093 . . . . 0.0 109.817 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.5 ' OG ' HG13 ' A' ' 412' ' ' ILE . 14.7 t -53.65 -42.94 68.37 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.109 -0.995 . . . . 0.0 109.374 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.526 HG13 ' CE ' ' A' ' 332' ' ' MET . 20.5 mm -60.34 -45.71 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.195 -0.941 . . . . 0.0 109.121 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.491 ' HG3' HG12 ' A' ' 304' ' ' VAL . 20.8 mttm -46.19 -50.25 15.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.0 108.611 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.05 -44.15 78.57 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.544 0.688 . . . . 0.0 110.056 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 344' ' ' MET . . . -54.34 -29.18 47.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.407 -0.808 . . . . 0.0 111.022 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.566 ' CG1' ' CG1' ' A' ' 308' ' ' VAL . 66.3 t -88.76 -43.9 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.079 -1.013 . . . . 0.0 111.24 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.473 ' O ' ' CG2' ' A' ' 346' ' ' VAL . . . -54.4 -38.93 66.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.125 -0.984 . . . . 0.0 110.844 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.88 -34.6 29.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -0.965 . . . . 0.0 110.666 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 340' ' ' ALA . 0.0 OUTLIER -65.73 -28.17 68.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 342' ' ' ALA . 7.7 p -88.53 -22.89 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.013 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 342' ' ' ALA . 89.3 t -76.31 -22.03 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.161 -0.962 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -69.72 -41.21 75.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.158 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 352' ' ' GLY . . . -79.7 -19.9 47.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.36 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.452 ' HB3' ' HG3' ' A' ' 316' ' ' GLU . . . -83.28 -34.43 25.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.486 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -80.2 -63.7 1.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.625 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -21.72 33.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.13 -0.981 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 353' ' ' ASN . . . -109.46 176.24 19.4 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.067 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 352' ' ' GLY . 27.1 p-10 -178.62 42.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.537 -0.978 . . . . 0.0 109.808 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 355' ' ' TRP . . . -131.38 78.32 0.38 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.469 ' HB3' ' O ' ' A' ' 354' ' ' GLY . 9.9 t90 58.49 138.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -1.076 . . . . 0.0 111.043 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.526 ' CD1' ' OE1' ' A' ' 316' ' ' GLU . 6.5 mt -126.3 164.44 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.495 ' N ' HG21 ' A' ' 356' ' ' ILE . 11.9 tttt -144.38 132.5 21.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.586 -1.321 . . . . 0.0 112.351 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.595 ' CG2' ' CG2' ' A' ' 319' ' ' ILE . 98.9 t -125.54 93.14 2.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 12.8 t -120.84 160.38 23.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 111.145 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.542 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 1.0 OUTLIER -141.68 157.16 45.41 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.569 -0.707 . . . . 0.0 109.469 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.483 ' HA3' ' CZ2' ' A' ' 368' ' ' TRP . . . -146.75 -164.54 11.11 Favored Glycine 0 C--N 1.293 -1.841 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.595 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.1 OUTLIER -171.14 178.96 3.18 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.871 -1.37 . . . . 0.0 111.233 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.496 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 6.2 mt-10 -154.23 177.69 1.9 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.587 -0.695 . . . . 0.0 109.823 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 40.9 Cg_endo -67.74 107.87 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.707 1.372 . . . . 0.0 110.763 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 4.8 t-20 68.77 31.16 4.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.409 -0.807 . . . . 0.0 110.531 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 3.6 mtt180 -176.31 109.4 0.09 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.55 -0.719 . . . . 0.0 109.787 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -113.06 161.12 17.44 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.954 -1.091 . . . . 0.0 110.096 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.6 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 22.3 p-90 -153.74 171.56 18.68 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.927 -1.108 . . . . 0.0 110.886 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -150.54 144.65 25.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.529 -0.732 . . . . 0.0 109.225 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.444 ' NE2' ' HG2' ' A' ' 433' ' ' ARG . 5.2 pt20 -142.38 163.56 32.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.908 -1.12 . . . . 0.0 111.344 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.466 ' O ' ' HG3' ' A' ' 372' ' ' GLU . 17.6 t -128.6 152.83 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.55 -0.719 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 371' ' ' VAL . 1.6 mt-10 -140.23 130.69 25.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.403 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -141.26 150.73 42.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.038 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.69 120.83 43.61 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.198 -0.939 . . . . 0.0 110.762 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -175.59 -107.37 0.21 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.34 -171.08 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.938 1.494 . . . . 0.0 111.186 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -155.62 -178.8 30.18 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 378' ' ' ILE . 0.7 OUTLIER -107.31 -154.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.039 -1.271 . . . . 0.0 110.691 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 383' ' ' ARG . . . -155.8 161.11 30.17 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.85 -20.72 22.11 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 O-C-N 123.704 1.37 . . . . 0.0 110.963 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.94 -36.75 13.26 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.948 -1.095 . . . . 0.0 111.738 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.611 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 15.3 pt20 -89.65 -30.34 18.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.019 -1.051 . . . . 0.0 111.824 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 379' ' ' ALA . 19.9 ttt-85 -56.12 -18.87 11.1 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.756 -1.215 . . . . 0.0 109.841 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.97 -31.02 39.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.288 -0.883 . . . . 0.0 110.941 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.611 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 5.2 p80 -112.47 1.31 15.86 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.97 -1.081 . . . . 0.0 111.201 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.537 ' O ' ' CD2' ' A' ' 386' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.303 -1.446 0 O-C-N 121.158 -0.964 . . . . 0.0 110.173 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.51 HD11 ' O ' ' A' ' 408' ' ' ILE . 1.9 pp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.489 0.661 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.479 ' O ' ' HB ' ' A' ' 412' ' ' ILE . 6.0 p -143.04 -36.32 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 109.809 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -69.8 -51.55 32.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.093 -1.004 . . . . 0.0 109.707 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 29.1 mmt180 -56.17 -19.06 11.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.297 -0.877 . . . . 0.0 109.88 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' A' ' 413' ' ' VAL . 0.8 OUTLIER -65.42 -63.31 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.948 . . . . 0.0 108.817 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 419' ' ' MET . 7.0 t -67.13 -22.04 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.15 -0.969 . . . . 0.0 109.196 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.401 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 8.3 t70 -76.26 -27.93 56.88 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.671 -0.643 . . . . 0.0 109.648 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.526 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 0.3 OUTLIER -79.67 -12.36 59.82 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.386 -0.821 . . . . 0.0 109.322 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.539 ' O ' ' CB ' ' A' ' 417' ' ' ASN . 30.1 m80 -97.2 -29.42 13.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.544 -0.722 . . . . 0.0 109.649 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.1 t-20 77.93 13.77 1.67 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.69 -0.631 . . . . 0.0 110.483 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.548 ' HA2' ' CD ' ' A' ' 437' ' ' PRO . . . -82.48 -87.87 0.72 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.54 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 37.2 ttm -176.94 158.57 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -1.194 . . . . 0.0 111.338 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.467 ' HB2' ' CG1' ' A' ' 413' ' ' VAL . 27.4 tp -152.57 98.79 2.4 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.181 -0.949 . . . . 0.0 109.059 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -126.31 167.8 15.01 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.75 -1.219 . . . . 0.0 112.511 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 35.0 mt -89.95 141.24 28.84 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.226 0.536 . . . . 0.0 109.962 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 431' ' ' SER . . . -108.38 163.92 12.76 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 20.8 m . . . . . 0 C--N 1.295 -1.796 0 O-C-N 121.293 -1.122 . . . . 0.0 109.948 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.485 1.949 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.471 HD22 HD12 ' A' ' 378' ' ' ILE . 3.5 mm? -86.17 111.05 20.02 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.301 -1.117 . . . . 0.0 110.653 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 423' ' ' GLY . 17.7 m -125.49 102.24 7.3 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.89 122.46 40.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.966 -1.083 . . . . 0.0 111.208 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . 0.444 ' HG2' ' NE2' ' A' ' 370' ' ' GLN . 12.2 mtt180 -107.75 116.1 31.34 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.535 0.683 . . . . 0.0 110.276 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -108.0 129.27 55.13 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.6 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 82.5 m95 -103.12 153.75 20.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.882 -1.136 . . . . 0.0 112.064 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.454 ' HG ' ' C ' ' A' ' 435' ' ' TRP . 14.7 mt -143.91 81.84 11.52 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.548 ' CD ' ' HA2' ' A' ' 418' ' ' GLY . 45.6 Cg_endo -70.55 133.6 24.48 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 O-C-N 124.02 1.537 . . . . 0.0 111.737 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.51 HG23 ' HB ' ' A' ' 330' ' ' VAL . 5.8 t -92.4 120.94 67.26 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.587 -0.695 . . . . 0.0 109.903 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.304 -1.804 0 O-C-N 123.742 1.391 . . . . 0.0 109.903 179.983 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' A' ' 333' ' ' HIS . 47.6 Cg_endo . . . . . 0 C--O 1.216 -0.605 0 N-CA-C 109.887 -0.851 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.526 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 43.6 79.94 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 122.638 1.209 . . . . 0.0 109.479 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.654 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.7 OUTLIER -146.31 -147.53 0.22 Allowed 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.836 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.513 ' HE3' ' N ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -85.87 127.76 34.66 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.07 -1.019 . . . . 0.0 110.716 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -143.32 159.32 42.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.466 0.65 . . . . 0.0 110.996 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 303' ' ' ALA . 7.6 m-20 -91.13 108.55 19.95 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 2.5 mt -57.83 -30.25 65.59 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.276 -0.89 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 303' ' ' ALA . 53.1 p-10 -79.53 -19.87 48.51 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.845 -1.159 . . . . 0.0 109.883 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.522 ' N ' ' OD1' ' A' ' 302' ' ' ASN . . . -84.12 -27.95 27.81 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.377 -0.827 . . . . 0.0 109.103 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.487 HG11 ' HD3' ' A' ' 338' ' ' LYS . 62.3 t -81.04 -38.51 16.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.786 0.803 . . . . 0.0 109.352 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 71.2 mt -77.1 -26.43 53.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 110.385 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -65.82 -31.16 78.87 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -83.0 -33.13 26.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -1.153 . . . . 0.0 109.628 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 58.9 t -78.32 -19.29 13.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.439 -0.788 . . . . 0.0 109.667 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.491 ' CG1' HG12 ' A' ' 358' ' ' VAL . 0.9 OUTLIER -83.57 -42.98 17.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.674 0.749 . . . . 0.0 109.259 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.84 -18.5 60.93 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.705 0.764 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.54 -55.1 3.71 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.753 0.787 . . . . 0.0 110.51 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.406 ' HB3' HG21 ' A' ' 346' ' ' VAL . 58.1 mp0 -104.48 50.65 0.79 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.721 0.772 . . . . 0.0 109.206 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.514 ' C ' ' CD1' ' A' ' 319' ' ' ILE . 0.3 OUTLIER -76.03 32.94 0.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.77 -0.581 . . . . 0.0 111.545 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 53.76 48.46 61.62 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 1.7 t80 53.82 37.03 25.51 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.444 -1.033 . . . . 0.0 110.079 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 5.5 mt-10 61.09 37.33 17.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.792 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.555 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 19.7 tpp180 -69.05 -85.2 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.575 0.703 . . . . 0.0 109.667 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.555 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.2 pt-20 -169.2 67.21 0.06 Allowed 'General case' 0 C--N 1.273 -2.718 0 O-C-N 121.538 -0.726 . . . . 0.0 110.526 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.514 ' CD1' ' C ' ' A' ' 313' ' ' SER . 1.8 mp -90.95 129.89 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 109.707 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -89.08 103.12 15.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.663 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 18.3 p -88.81 123.81 33.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.419 -0.801 . . . . 0.0 111.094 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' A' ' 359' ' ' SER . . . -146.55 79.09 1.52 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.534 HD11 ' N ' ' A' ' 323' ' ' LEU . 5.8 mp -88.41 157.08 18.8 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.379 -0.825 . . . . 0.0 110.322 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.539 ' CD1' HG21 ' A' ' 362' ' ' THR . 21.7 t80 -40.39 141.99 0.8 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.504 -0.747 . . . . 0.0 110.422 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.411 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.0 Cg_endo -83.07 60.32 7.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.04 1.547 . . . . 0.0 111.205 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . -176.92 -75.25 0.05 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.5 OUTLIER 165.05 116.57 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.581 -0.952 . . . . 0.0 108.932 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.536 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 2.7 mm -69.27 178.17 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.061 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.5 mt-10 -173.65 101.44 0.11 Allowed 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 121.469 0.652 . . . . 0.0 110.697 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.513 ' N ' ' HE3' ' A' ' 298' ' ' MET . 16.5 m -143.65 161.26 16.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.094 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -81.13 92.4 6.27 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.552 ' HG2' HG13 ' A' ' 337' ' ' ILE . 22.0 ttp -144.79 153.99 42.23 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.712 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.578 ' CD2' ' HB2' ' A' ' 295' ' ' PRO . 7.3 t-160 -78.73 119.84 78.73 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.778 -0.577 . . . . 0.0 109.682 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.466 ' O ' ' HD3' ' A' ' 338' ' ' LYS . 43.5 Cg_endo -70.75 -21.16 29.24 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.662 1.348 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.54 ' HG ' ' N ' ' A' ' 336' ' ' SER . 0.1 OUTLIER -84.52 -63.01 1.41 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.235 -0.916 . . . . 0.0 110.188 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.54 ' N ' ' HG ' ' A' ' 335' ' ' LEU . 3.1 m -52.78 -35.4 56.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.903 -1.123 . . . . 0.0 110.096 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.618 HD13 ' CE1' ' A' ' 416' ' ' HIS . 3.1 mm -73.93 -45.88 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.221 -0.924 . . . . 0.0 110.032 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.487 ' HD3' HG11 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -43.33 -44.32 5.47 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.13 -0.981 . . . . 0.0 109.197 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -49.9 59.77 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.522 0.677 . . . . 0.0 110.315 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.48 ' HB3' HG12 ' A' ' 412' ' ' ILE . . . -52.23 -30.91 29.7 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.301 -0.874 . . . . 0.0 111.674 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 40.9 t -89.94 -23.73 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.913 -1.117 . . . . 0.0 111.424 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.51 -24.81 60.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.002 -1.061 . . . . 0.0 111.137 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -90.16 -19.0 24.76 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.024 -1.047 . . . . 0.0 111.673 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.6 ttm -82.28 -25.42 34.04 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.917 -1.114 . . . . 0.0 112.196 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.477 HG21 ' N ' ' A' ' 346' ' ' VAL . 23.3 m -90.39 -32.39 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.685 -1.259 . . . . 0.0 111.869 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.477 ' N ' HG21 ' A' ' 345' ' ' VAL . 73.4 t -74.28 -21.14 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 120.971 -1.08 . . . . 0.0 110.79 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -79.95 -19.97 46.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.041 -1.037 . . . . 0.0 110.421 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.495 ' O ' ' HA3' ' A' ' 352' ' ' GLY . . . -89.92 -20.09 23.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 0.0 110.511 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -80.79 -21.31 41.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.096 -1.002 . . . . 0.0 110.773 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 346' ' ' VAL . 4.9 mmt180 -87.76 -70.09 0.65 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.091 -1.005 . . . . 0.0 110.535 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . 0.437 ' O ' ' C ' ' A' ' 352' ' ' GLY . 0.2 OUTLIER -77.43 -35.11 54.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 110.377 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 348' ' ' ALA . . . -42.41 -51.65 5.4 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 352' ' ' GLY . 36.4 m-20 43.27 50.1 5.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.296 -1.12 . . . . 0.0 110.356 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -162.02 -80.74 0.04 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.044 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.1 OUTLIER -165.69 149.66 8.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.145 -1.209 . . . . 0.0 109.854 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.507 ' CD1' HG13 ' A' ' 319' ' ' ILE . 8.3 mt -114.41 165.67 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.218 -0.926 . . . . 0.0 110.73 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.4 OUTLIER -148.4 101.32 3.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.189 -0.944 . . . . 0.0 110.391 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 321' ' ' THR . 99.0 t -104.45 88.08 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.108 -0.995 . . . . 0.0 109.803 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.431 ' CB ' ' HB2' ' A' ' 322' ' ' ALA . 53.2 p -115.01 134.99 54.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.086 -1.008 . . . . 0.0 110.932 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.487 ' HB3' ' HG ' ' A' ' 323' ' ' LEU . 1.8 t -117.39 144.39 45.0 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.482 -0.761 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 362' ' ' THR . . . -140.66 -161.14 8.58 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER 171.12 176.9 0.06 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.14 -1.212 . . . . 0.0 110.962 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.538 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 2.4 mt-10 -147.65 178.19 1.53 Allowed Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 46.0 Cg_endo -81.45 50.28 3.47 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.636 1.335 . . . . 0.0 109.791 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 365' ' ' ASN . 10.2 p-10 165.59 -3.7 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.795 -0.566 . . . . 0.0 111.266 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 14.2 mtm-85 -166.18 109.37 0.77 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.118 -0.989 . . . . 0.0 110.976 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.19 162.08 13.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.103 -0.998 . . . . 0.0 108.765 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.66 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 31.3 p-90 -170.31 162.92 8.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.715 -1.24 . . . . 0.0 111.131 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 39.8 p90 -133.54 133.82 42.6 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -122.84 152.13 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 111.986 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 15.5 t -132.09 122.05 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.542 ' CG ' ' HB2' ' A' ' 431' ' ' SER . 2.3 mt-10 -116.75 139.34 50.68 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 110.395 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 373' ' ' ASP . 3.3 p30 -141.0 145.82 36.45 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.263 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -104.04 114.55 28.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.323 -0.861 . . . . 0.0 110.346 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -172.55 -109.84 0.23 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.1 -168.32 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.93 1.49 . . . . 0.0 110.532 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -141.72 -160.24 8.24 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.537 ' CG1' ' CD2' ' A' ' 430' ' ' LEU . 3.0 mt -111.88 159.04 12.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.24 -1.153 . . . . 0.0 109.842 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -91.01 161.24 35.93 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.931 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.77 -46.1 0.45 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.087 1.572 . . . . 0.0 110.188 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . 0.518 ' O ' ' CE1' ' A' ' 385' ' ' HIS . 0.0 OUTLIER -73.17 -53.33 11.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.833 . . . . 0.0 110.082 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.581 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 0.0 OUTLIER -56.08 -33.33 64.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.259 -0.9 . . . . 0.0 109.808 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -40.33 13.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.679 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -71.21 -41.3 70.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.501 -0.749 . . . . 0.0 109.422 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.581 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 1.2 p-80 -120.05 74.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.602 -0.686 . . . . 0.0 109.804 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.535 ' CD2' ' HG2' ' A' ' 382' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.109 -0.994 . . . . 0.0 110.386 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.52 ' O ' ' CD1' ' A' ' 412' ' ' ILE . 3.8 tp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.312 0.577 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.424 ' HA ' HD11 ' A' ' 412' ' ' ILE . 8.8 p -126.73 -2.69 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.3 -0.875 . . . . 0.0 110.079 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 1.8 mm100 -82.34 -53.33 6.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 109.91 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -19.91 62.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.381 -0.824 . . . . 0.0 109.772 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 408' ' ' ILE . 1.0 OUTLIER -69.24 -73.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.443 ' O ' HG11 ' A' ' 413' ' ' VAL . 91.8 t -57.77 -20.13 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.363 -0.835 . . . . 0.0 109.763 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 1.8 m-20 -78.74 -33.19 46.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.371 -0.83 . . . . 0.0 109.966 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.526 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 0.8 OUTLIER -74.24 -19.86 60.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.038 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.618 ' CE1' HD13 ' A' ' 337' ' ' ILE . 41.3 m80 -92.75 -35.94 13.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.57 -0.706 . . . . 0.0 109.597 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.1 t30 80.71 32.39 0.15 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.641 -0.662 . . . . 0.0 110.608 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.503 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -95.71 -89.61 1.77 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.534 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.1 OUTLIER -177.79 162.88 1.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -1.218 . . . . 0.0 112.079 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 13.8 tp -152.63 102.7 2.73 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 0.3 OUTLIER -119.37 164.28 15.94 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.685 -1.259 . . . . 0.0 113.128 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 23.3 mt -107.07 136.93 46.08 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' A' ' 431' ' ' SER . . . -97.97 154.79 20.29 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.883 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 87.0 m . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.432 -1.04 . . . . 0.0 110.01 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.666 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.537 ' CD2' ' CG1' ' A' ' 378' ' ' ILE . 12.4 mt -60.38 114.01 2.7 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.18 0.991 . . . . 0.0 111.948 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.542 ' HB2' ' CG ' ' A' ' 372' ' ' GLU . 0.3 OUTLIER -123.53 100.05 6.61 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 73.1 mt -89.31 122.53 40.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.914 -1.116 . . . . 0.0 111.496 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.76 100.17 9.58 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.686 -0.634 . . . . 0.0 109.646 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.5 128.81 36.03 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.66 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 86.9 m95 -110.36 159.23 17.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.804 -1.185 . . . . 0.0 113.382 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.467 HD13 HD12 ' A' ' 301' ' ' LEU . 51.5 mt -148.33 109.09 3.64 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.503 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 39.9 Cg_endo -64.35 139.91 67.69 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.778 1.409 . . . . 0.0 112.488 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.537 HG22 ' N ' ' A' ' 367' ' ' ALA . 22.0 t -113.12 102.23 54.51 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 C--N 1.301 -1.935 0 O-C-N 123.83 1.437 . . . . 0.0 110.57 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.654 ' CB ' ' CD2' ' A' ' 333' ' ' HIS . 53.4 Cg_endo . . . . . 0 N--CA 1.452 -0.941 0 N-CA-C 109.475 -1.01 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' MET . . . . . 0.487 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 41.25 94.98 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 122.16 0.981 . . . . 0.0 110.851 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.0 mt-10 -144.67 -164.26 1.88 Allowed 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' MET . . . . . 0.439 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.0 OUTLIER -88.7 129.36 35.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 110.108 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.465 ' HB1' ' SD ' ' A' ' 332' ' ' MET . . . -149.77 167.19 27.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.323 -0.861 . . . . 0.0 111.316 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.477 ' HB3' ' CB ' ' A' ' 303' ' ' ALA . 26.3 t70 -96.36 117.89 31.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.735 . . . . 0.0 109.551 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.536 HD22 ' CE ' ' A' ' 332' ' ' MET . 20.3 mt -65.36 -22.37 66.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.094 -1.004 . . . . 0.0 110.015 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 302' ' ' ASN . 43.7 t-20 -80.77 -22.28 40.29 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.996 -1.065 . . . . 0.0 108.755 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.477 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -84.17 -32.51 24.58 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.589 0.709 . . . . 0.0 109.454 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.448 ' O ' HG21 ' A' ' 308' ' ' VAL . 21.8 t -77.29 -37.72 25.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.587 -0.695 . . . . 0.0 109.529 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 88.4 mt -76.86 -26.64 54.49 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.69 -38.24 95.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -76.39 -35.59 58.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -1.118 . . . . 0.0 109.336 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.56 ' CG1' ' CG1' ' A' ' 341' ' ' VAL . 92.8 t -75.24 -18.8 16.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.55 0.691 . . . . 0.0 109.441 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.538 ' CD1' HG13 ' A' ' 358' ' ' VAL . 0.0 OUTLIER -77.6 -43.77 29.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.783 0.801 . . . . 0.0 109.123 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -75.17 -17.7 60.33 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.539 0.685 . . . . 0.0 109.866 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -88.11 -45.22 10.32 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 111.155 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -98.47 31.32 2.88 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.211 -0.93 . . . . 0.0 111.25 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.526 ' CA ' HD12 ' A' ' 319' ' ' ILE . 1.0 OUTLIER -82.84 -7.53 59.65 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.06 -1.025 . . . . 0.0 109.974 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 87.56 -53.95 4.38 Favored Glycine 0 C--N 1.286 -2.198 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 19.3 t80 174.54 36.16 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 1.6 tm-20 70.02 36.17 2.02 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 317' ' ' ARG . 0.0 OUTLIER -67.86 -90.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.337 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 317' ' ' ARG . 20.5 mt-10 -152.17 73.77 1.06 Allowed 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.233 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.542 ' CG2' HG22 ' A' ' 358' ' ' VAL . 3.3 mp -105.1 134.3 46.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.297 -0.877 . . . . 0.0 109.182 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' GLU . . . . . 0.481 ' HB3' ' CG ' ' A' ' 357' ' ' LYS . 3.1 tt0 -99.55 108.6 21.06 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.035 -1.041 . . . . 0.0 110.121 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.509 HG21 ' CD1' ' A' ' 309' ' ' ILE . 15.3 p -93.97 126.5 39.22 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 110.744 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -147.81 78.23 1.44 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.374 -0.829 . . . . 0.0 109.414 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' LEU . . . . . 0.523 HD11 ' N ' ' A' ' 323' ' ' LEU . 4.2 mp -91.0 156.35 18.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.393 -0.817 . . . . 0.0 110.462 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' TYR . . . . . 0.605 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 69.2 t80 -45.8 125.62 6.61 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.893 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.51 68.93 8.16 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.885 1.466 . . . . 0.0 110.217 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -173.31 24.38 0.07 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 326' ' ' GLY . 0.0 OUTLIER 50.41 101.62 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 O-C-N 121.017 -1.284 . . . . 0.0 110.432 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.555 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 1.1 mt -78.52 -176.61 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.35 -0.843 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.555 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 0.3 OUTLIER -176.54 111.26 0.09 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.791 0.805 . . . . 0.0 110.87 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.453 HG11 HG23 ' A' ' 438' ' ' VAL . 8.5 m -142.48 162.12 18.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-O 121.391 0.615 . . . . 0.0 109.955 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.3 OUTLIER -78.28 91.0 4.36 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' MET . . . . . 0.547 ' HE3' ' CB ' ' A' ' 337' ' ' ILE . 4.4 ppp? -135.83 135.36 39.76 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.643 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' HIS . . . . . 0.654 ' CD2' ' CB ' ' A' ' 295' ' ' PRO . 10.3 t-80 -67.34 116.44 36.73 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.471 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 41.0 Cg_endo -65.32 -19.53 61.88 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.62 1.326 . . . . 0.0 110.07 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.641 ' CB ' ' CE1' ' A' ' 333' ' ' HIS . 0.5 OUTLIER -81.14 -46.08 15.44 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.426 -0.797 . . . . 0.0 110.899 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.447 ' O ' HG22 ' A' ' 412' ' ' ILE . 2.2 m -72.73 -37.47 67.73 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.143 -0.973 . . . . 0.0 110.117 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.611 ' CD1' ' CE1' ' A' ' 416' ' ' HIS . 32.5 mm -71.82 -30.47 37.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.402 -0.812 . . . . 0.0 109.521 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 3.8 mttt -68.29 -43.22 78.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 108.7 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 335' ' ' LEU . 75.5 mtt-85 -72.24 -31.77 66.11 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.474 0.654 . . . . 0.0 110.723 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 344' ' ' MET . . . -73.58 -35.88 65.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 111.035 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.56 ' CG1' ' CG1' ' A' ' 308' ' ' VAL . 59.4 t -80.46 -27.85 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 110.552 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.435 ' O ' ' CG2' ' A' ' 346' ' ' VAL . . . -79.36 -28.29 41.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.183 -0.948 . . . . 0.0 110.182 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -89.77 -24.2 21.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.305 -0.872 . . . . 0.0 110.321 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 347' ' ' ASN . 1.9 mtm -71.65 -47.15 56.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.875 . . . . 0.0 110.386 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.8 t -65.43 -28.36 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.475 ' HA ' ' HB1' ' A' ' 349' ' ' ALA . 71.6 t -56.34 -25.61 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.274 -0.891 . . . . 0.0 110.329 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 344' ' ' MET . 1.0 OUTLIER -56.18 -53.59 55.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.947 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' ALA . . . . . 0.514 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -85.53 -19.13 31.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.861 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' A' ' 346' ' ' VAL . . . -68.2 -59.66 3.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.319 -0.863 . . . . 0.0 111.668 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 351' ' ' TYR . 4.4 ptt-85 -86.5 -41.11 14.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.935 -1.103 . . . . 0.0 111.876 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' TYR . . . . . 0.501 ' N ' ' HG3' ' A' ' 350' ' ' ARG . 0.3 OUTLIER -90.2 -42.44 11.03 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.762 -1.211 . . . . 0.0 110.495 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -85.27 173.54 48.31 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -168.48 72.76 0.1 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.278 -1.131 . . . . 0.0 109.873 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' GLY . . . . . 0.537 ' HA3' ' CB ' ' A' ' 374' ' ' ASP . . . -161.65 67.68 0.24 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.589 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 11.1 t90 59.77 145.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -1.04 . . . . 0.0 111.242 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 6.0 mt -123.75 162.33 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.589 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 16.6 tttt -150.44 117.73 6.03 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.782 -1.199 . . . . 0.0 111.253 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.542 HG22 ' CG2' ' A' ' 319' ' ' ILE . 3.4 t -106.25 89.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 370' ' ' GLN . 4.4 t -113.44 139.44 48.92 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.273 -0.892 . . . . 0.0 111.229 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' SER . . . . . 0.473 ' HB2' ' HG ' ' A' ' 323' ' ' LEU . 3.7 m -138.33 158.11 44.93 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.384 -0.823 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -148.3 -154.69 6.37 Favored Glycine 0 C--N 1.295 -1.713 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' THR . . . . . 0.605 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER 175.02 169.25 0.29 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.03 -1.276 . . . . 0.0 110.71 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.477 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 3.1 mm-40 -149.39 172.23 5.44 Favored Pre-proline 0 C--N 1.293 -1.887 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' PRO . . . . . 0.534 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 40.2 Cg_endo -66.24 116.28 3.94 Favored 'Trans proline' 0 C--N 1.299 -2.075 0 O-C-N 123.682 1.359 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 4.4 t-20 74.25 34.72 0.8 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.655 -0.653 . . . . 0.0 111.009 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.1 OUTLIER 165.81 97.51 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.305 -0.872 . . . . 0.0 111.214 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.41 171.34 7.42 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.158 -0.963 . . . . 0.0 109.039 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' TRP . . . . . 0.64 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 39.2 p-90 -170.96 165.37 7.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.445 -1.41 . . . . 0.0 110.813 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 35.1 p90 -139.28 131.33 27.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.485 -0.759 . . . . 0.0 109.336 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' GLN . . . . . 0.517 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 20.5 tt0 -116.08 151.33 35.78 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.246 -0.909 . . . . 0.0 111.773 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.517 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 89.0 t -127.05 142.4 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.564 -0.71 . . . . 0.0 109.636 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.422 ' HG3' ' C ' ' A' ' 371' ' ' VAL . 55.4 mt-10 -137.81 129.58 28.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.4 -0.812 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -159.55 161.55 35.25 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.536 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' ASP . . . . . 0.537 ' CB ' ' HA3' ' A' ' 354' ' ' GLY . 0.5 OUTLIER -80.46 152.64 28.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 110.494 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . 0.422 ' HA2' ' HA2' ' A' ' 352' ' ' GLY . . . 164.64 -146.33 11.23 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.89 -169.48 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.053 1.554 . . . . 0.0 110.554 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -145.22 139.4 8.34 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' ILE . . . . . 0.442 HD13 ' CD1' ' A' ' 422' ' ' LEU . 3.9 mt -81.08 170.81 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.102 -1.234 . . . . 0.0 109.923 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.473 ' CB ' ' HD2' ' A' ' 380' ' ' PRO . . . -151.32 175.99 2.58 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.252 -0.905 . . . . 0.0 110.324 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 379' ' ' ALA . 49.5 Cg_endo -71.96 -34.25 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.061 1.558 . . . . 0.0 110.236 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.71 -21.73 30.01 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.849 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' GLN . . . . . 0.56 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 1.6 mm-40 -90.75 -18.27 25.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.129 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -60.25 -19.75 55.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.126 -0.984 . . . . 0.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -20.71 26.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.868 . . . . 0.0 110.618 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' HIS . . . . . 0.56 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 20.6 m-70 -63.05 -46.63 86.6 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.147 -0.971 . . . . 0.0 111.222 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.034 -1.041 . . . . 0.0 110.94 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' ILE . . . . . 0.477 ' O ' HG13 ' A' ' 412' ' ' ILE . 6.3 tt . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.291 0.567 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 99.5 t -128.24 -31.91 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 109.868 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 2.3 mt-30 -69.42 -49.56 53.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.257 -0.902 . . . . 0.0 109.888 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.491 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.6 OUTLIER -65.88 -20.93 66.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.269 -0.894 . . . . 0.0 109.827 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 408' ' ' ILE . 18.5 mm -68.12 -69.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 108.934 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 419' ' ' MET . 87.1 t -62.76 -21.15 26.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.368 -0.833 . . . . 0.0 109.015 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.491 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 8.4 t70 -75.24 -31.71 60.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.588 -0.695 . . . . 0.0 109.403 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' ASN . . . . . 0.487 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.1 m-20 -76.97 -14.74 59.81 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.405 -0.81 . . . . 0.0 109.12 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.611 ' CE1' ' CD1' ' A' ' 337' ' ' ILE . 38.9 m80 -92.51 -34.47 14.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.579 -0.7 . . . . 0.0 109.861 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 4.7 m-20 80.58 19.89 0.51 Allowed 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.374 0.607 . . . . 0.0 110.281 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . 0.535 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -90.03 -92.01 1.23 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' MET . . . . . 0.556 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 31.6 ttm -176.9 162.01 2.04 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.189 -1.183 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.45 HD12 HG22 ' A' ' 413' ' ' VAL . 21.2 tp -151.32 104.91 3.14 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.387 -0.82 . . . . 0.0 108.832 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.473 ' O ' HG21 ' A' ' 432' ' ' ILE . 0.5 OUTLIER -112.98 143.31 44.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.974 -1.079 . . . . 0.0 111.902 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.477 HD21 ' N ' ' A' ' 422' ' ' LEU . 3.5 mm? -99.42 80.69 2.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.485 -0.759 . . . . 0.0 109.402 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 429' ' ' GLY . . . -50.98 104.51 0.14 Allowed Glycine 0 C--N 1.28 -2.532 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.255 -1.144 . . . . 0.0 109.09 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 423' ' ' GLY . . . . . . . . 0 N--CA 1.494 2.507 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' LEU . . . . . 0.442 ' HA ' HD11 ' A' ' 430' ' ' LEU . 2.7 mm? -65.82 106.37 1.51 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.196 0.998 . . . . 0.0 111.831 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' SER . . . . . 0.463 ' O ' ' HA3' ' A' ' 423' ' ' GLY . 0.0 OUTLIER -145.76 100.72 3.46 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' ILE . . . . . 0.473 HG21 ' O ' ' A' ' 421' ' ' GLU . 80.6 mt -92.0 151.9 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.067 -1.021 . . . . 0.0 112.864 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -124.45 94.86 4.33 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.23 139.83 30.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.786 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' TRP . . . . . 0.64 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 84.9 m95 -120.28 153.12 36.83 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.102 0.953 . . . . 0.0 111.707 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.486 ' CD1' HD13 ' A' ' 301' ' ' LEU . 86.0 mt -140.72 115.15 7.32 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.535 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 43.9 Cg_endo -70.69 134.24 25.59 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.834 1.439 . . . . 0.0 111.418 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.497 ' CG1' ' HD2' ' A' ' 439' ' ' PRO . 21.4 t -94.11 144.16 27.61 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.622 -0.674 . . . . 0.0 110.161 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' PRO . . . . . 0.497 ' HD2' ' CG1' ' A' ' 438' ' ' VAL . 50.8 Cg_endo . . . . . 0 C--N 1.303 -1.828 0 O-C-N 123.993 1.523 . . . . 0.0 110.457 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.281 0.563 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 292' ' ' GLN . . . 151.79 70.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 291' ' ' GLY . 11.9 mt-30 54.86 166.63 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.268 -1.137 . . . . 0.0 110.085 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 0.8 OUTLIER -165.19 40.88 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.076 -1.015 . . . . 0.0 110.714 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 6.1 mtt -73.4 111.98 14.06 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.213 -0.93 . . . . 0.0 110.201 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.566 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 55.4 Cg_endo -93.83 -163.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.972 1.512 . . . . 0.0 109.954 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.543 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.1 OUTLIER 23.68 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 122.358 1.075 . . . . 0.0 111.576 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.9 mm-40 -144.42 -159.51 1.0 Allowed 'General case' 0 C--N 1.267 -3.02 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.217 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.626 ' HA ' ' HA ' ' A' ' 331' ' ' LYS . 2.1 mmt -85.2 117.06 23.91 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.109 0.957 . . . . 0.0 110.797 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -141.18 150.61 42.97 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.061 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.47 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 13.8 m-20 -85.15 136.57 33.48 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.488 -0.758 . . . . 0.0 109.205 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.581 ' CD2' ' CE ' ' A' ' 332' ' ' MET . 6.8 mt -73.68 -23.82 59.87 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.955 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 303' ' ' ALA . 47.0 p30 -83.93 -18.96 35.58 Favored 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.856 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.511 ' N ' ' OD1' ' A' ' 302' ' ' ASN . . . -82.3 -36.34 27.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 16.2 t -74.15 -39.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.542 -0.724 . . . . 0.0 109.584 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 62.7 mt -69.55 -33.47 72.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.406 -0.809 . . . . 0.0 110.052 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -67.72 -22.35 73.53 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.99 -38.47 27.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.311 -1.111 . . . . 0.0 108.52 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.462 HG13 ' CG1' ' A' ' 341' ' ' VAL . 88.8 t -77.4 -18.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.509 ' CD1' HG23 ' A' ' 319' ' ' ILE . 1.3 mm -78.31 -45.71 26.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.654 0.74 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.99 -18.39 63.33 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.692 0.758 . . . . 0.0 109.067 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.61 -36.67 14.28 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.163 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.589 ' O ' ' CD ' ' A' ' 317' ' ' ARG . 15.3 mm-40 -91.59 8.33 37.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 110.399 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 309' ' ' ILE . 78.2 p -115.67 66.36 0.7 Allowed 'General case' 0 C--N 1.274 -2.703 0 O-C-N 120.898 -1.126 . . . . 0.0 108.187 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.59 ' O ' ' CG ' ' A' ' 315' ' ' TYR . . . -113.71 -32.06 2.18 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.294 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.607 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 90.1 m-85 -155.26 74.43 0.9 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 120.111 1.956 . . . . 0.0 114.408 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.607 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 1.4 tp10 91.5 12.8 0.04 OUTLIER 'General case' 0 CA--C 1.452 -2.804 0 O-C-N 121.732 -0.605 . . . . 0.0 111.901 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.589 ' CD ' ' O ' ' A' ' 312' ' ' GLU . 0.0 OUTLIER -81.68 87.93 6.27 Favored 'General case' 0 C--N 1.259 -3.328 0 N-CA-C 101.034 -3.691 . . . . 0.0 101.034 179.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.552 ' N ' ' CD1' ' A' ' 356' ' ' ILE . 0.5 OUTLIER -65.74 73.14 0.06 Allowed 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.549 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.569 HG22 ' CG2' ' A' ' 358' ' ' VAL . 42.6 mt -99.14 116.52 42.42 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.744 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.21 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -89.6 110.78 21.61 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.493 ' CG2' ' CD1' ' A' ' 309' ' ' ILE . 12.8 p -88.25 130.13 35.17 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.195 -0.941 . . . . 0.0 112.284 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.73 77.73 1.29 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.551 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 4.1 mp -93.3 167.18 11.91 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.443 -0.786 . . . . 0.0 110.884 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.633 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 57.9 t80 -58.94 112.44 5.06 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 121.44 -0.787 . . . . 0.0 109.193 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.3 79.06 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.969 1.51 . . . . 0.0 111.057 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.459 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -175.81 -82.82 0.06 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 0.8 OUTLIER 171.35 107.97 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.453 -1.028 . . . . 0.0 109.443 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.554 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 5.2 mt -85.43 -179.54 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 O-C-N 121.533 -0.729 . . . . 0.0 109.352 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 0.8 OUTLIER -173.98 103.95 0.11 Allowed 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.211 -0.996 . . . . 0.0 112.505 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.475 HG13 ' HB1' ' A' ' 367' ' ' ALA . 5.6 m -142.79 142.18 26.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 298' ' ' MET . 0.0 OUTLIER -83.72 101.19 11.38 Favored 'General case' 0 C--N 1.257 -3.44 0 C-N-CA 118.512 -1.275 . . . . 0.0 108.015 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.581 ' CE ' ' CD2' ' A' ' 301' ' ' LEU 0.252 0.0 OUTLIER -135.46 -173.23 3.28 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.707 0.765 . . . . 0.0 111.515 -179.585 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.714 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 6.7 t-80 -109.24 112.27 59.6 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 37.5 Cg_endo -59.87 -18.98 52.51 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.719 1.378 . . . . 0.0 110.407 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.714 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 1.6 mt -76.3 -73.92 0.25 Allowed 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.397 -0.815 . . . . 0.0 109.674 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.492 ' O ' HD13 ' A' ' 412' ' ' ILE . 0.4 OUTLIER -45.7 -49.78 14.27 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.702 -0.623 . . . . 0.0 110.441 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.591 HD13 ' CE1' ' A' ' 416' ' ' HIS . 6.7 mm -60.19 -40.89 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.084 -1.01 . . . . 0.0 109.999 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 6.1 mtmt -55.46 -48.39 74.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 109.17 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -28.77 67.19 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.415 0.626 . . . . 0.0 110.327 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 344' ' ' MET . . . -67.1 -37.26 83.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.748 . . . . 0.0 110.6 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.462 ' CG1' HG13 ' A' ' 308' ' ' VAL . 92.8 t -78.69 -35.0 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.125 -0.984 . . . . 0.0 110.207 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.51 ' O ' HG11 ' A' ' 346' ' ' VAL . . . -64.35 -68.75 0.33 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.554 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . 0.549 ' O ' ' CG2' ' A' ' 346' ' ' VAL . 24.7 m120 -47.52 -19.28 0.17 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.296 -0.877 . . . . 0.0 111.203 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 3.4 mtt -74.92 -42.43 57.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.603 -1.31 . . . . 0.0 110.18 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.53 ' CG2' HG22 ' A' ' 356' ' ' ILE . 14.7 p -81.16 -18.69 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.844 . . . . 0.0 111.136 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 343' ' ' ASN . 17.9 m -60.02 -20.98 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.046 -1.034 . . . . 0.0 110.465 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -84.48 -30.87 24.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 110.666 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 352' ' ' GLY . . . -90.5 -19.1 24.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.946 . . . . 0.0 110.824 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -82.73 -53.58 5.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 110.451 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -72.56 0.14 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 110.365 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -70.02 -47.4 62.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 110.203 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 348' ' ' ALA . . . -79.9 162.34 46.62 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 353' ' ' ASN . 21.5 t-20 -171.68 29.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.454 -1.027 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -110.56 -33.05 2.56 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.47 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 17.0 t90 178.46 129.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.899 -1.354 . . . . 0.0 111.851 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.552 ' CD1' ' N ' ' A' ' 318' ' ' GLU . 1.7 mt -117.01 146.97 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 372' ' ' GLU . 6.9 tttt -140.42 128.2 21.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.487 -1.383 . . . . 0.0 112.087 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.569 ' CG2' HG22 ' A' ' 319' ' ' ILE . 71.9 t -120.3 108.85 24.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 39.0 t -127.35 160.03 32.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.087 -1.008 . . . . 0.0 111.366 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.551 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -144.49 142.28 30.14 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.596 -0.69 . . . . 0.0 109.679 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -134.87 -166.12 11.03 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.633 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -173.16 173.11 3.7 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.019 -1.283 . . . . 0.0 111.285 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 4.5 mt-10 -153.08 176.65 2.3 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.675 -0.641 . . . . 0.0 109.524 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.561 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.8 Cg_endo -70.28 105.41 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.684 1.36 . . . . 0.0 110.782 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 8.4 t-20 80.49 34.02 0.14 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.868 -0.52 . . . . 0.0 110.631 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.538 ' N ' HG13 ' A' ' 438' ' ' VAL . 0.0 OUTLIER 172.5 105.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.837 . . . . 0.0 111.206 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -105.79 169.08 8.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.094 -1.003 . . . . 0.0 108.504 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 37.6 p-90 -168.43 172.4 8.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.603 -1.311 . . . . 0.0 110.615 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.622 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 37.6 p90 -143.78 140.94 30.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.37 -0.832 . . . . 0.0 109.923 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.537 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 12.4 tt0 -127.0 153.98 45.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.293 -0.879 . . . . 0.0 110.741 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.537 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 88.5 t -124.39 164.37 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.437 -0.79 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 357' ' ' LYS . 45.7 mt-10 -150.52 135.33 17.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.957 . . . . 0.0 109.764 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -148.67 148.63 30.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.077 -1.014 . . . . 0.0 110.594 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -82.29 158.67 23.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.332 -0.855 . . . . 0.0 110.144 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 153.96 -167.87 32.29 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 427' ' ' ARG . 45.4 Cg_endo -73.23 -26.4 14.72 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.982 1.517 . . . . 0.0 110.589 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 88.63 -171.85 40.15 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.562 HG22 " O2'" ' A' ' 451' ' ' ANP . 54.5 mt -74.91 151.62 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.293 -1.122 . . . . 0.0 110.036 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.519 ' CB ' ' HG3' ' A' ' 382' ' ' GLN . . . -73.76 169.16 19.86 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.136 -0.978 . . . . 0.0 110.011 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.19 -38.04 2.99 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.946 1.498 . . . . 0.0 110.291 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . 0.603 ' O ' ' CD2' ' A' ' 385' ' ' HIS . 0.9 OUTLIER -90.45 -37.51 13.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.314 -0.866 . . . . 0.0 110.765 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.581 ' HA ' ' NE2' ' A' ' 385' ' ' HIS . 45.5 mt-30 -62.25 -28.47 69.73 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.259 -0.901 . . . . 0.0 110.299 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -21.51 3.98 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.955 -1.09 . . . . 0.0 109.164 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -31.6 16.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.504 -0.748 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 381' ' ' GLU . 2.1 p80 -117.47 68.95 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.878 -1.139 . . . . 0.0 111.025 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.595 ' CD1' " O4'" ' A' ' 451' ' ' ANP . 0.1 OUTLIER -109.5 71.74 0.78 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.585 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 48.7 p90 44.88 45.3 8.46 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-O 121.787 0.803 . . . . 0.0 110.237 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -78.15 133.52 64.65 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.181 -0.949 . . . . 0.0 110.429 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 390' ' ' PHE . 49.4 Cg_endo -79.35 174.57 11.78 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.877 1.462 . . . . 0.0 110.831 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 389' ' ' PRO . 0.3 OUTLIER 61.04 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.376 -0.828 . . . . 0.0 110.865 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 11.7 p -124.49 170.91 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.52 -0.738 . . . . 0.0 110.097 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.05 98.42 3.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.926 . . . . 0.0 110.25 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 175.43 169.44 37.17 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.25 -5.07 22.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.286 -1.126 . . . . 0.0 110.03 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 47.0 m -145.33 140.93 28.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 110.054 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 397' ' ' ARG . . . -96.61 -31.48 12.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.916 . . . . 0.0 110.181 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 396' ' ' ALA . 5.4 ttt180 60.7 49.68 6.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 88.6 m -75.02 118.67 18.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 110.22 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.509 ' CG2' ' N ' ' A' ' 400' ' ' SER . 6.9 tt -87.89 -42.88 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 399' ' ' ILE . 8.7 t -171.23 -175.76 1.75 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 110.082 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 115.96 48.8 0.48 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 402' ' ' THR . 8.3 t -94.41 142.17 27.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.203 -1.175 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 165.62 -137.44 4.69 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.84 167.4 10.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -1.167 . . . . 0.0 110.155 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -120.17 81.57 0.33 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 3.4 mp -91.17 71.12 6.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -1.115 . . . . 0.0 110.115 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 408' ' ' ILE . . . -90.73 44.29 1.19 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.295 -0.878 . . . . 0.0 110.441 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.594 ' CD1' ' N ' ' A' ' 408' ' ' ILE . 0.2 OUTLIER -43.5 164.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.275 -0.89 . . . . 0.0 109.916 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.568 ' CG2' HG12 ' A' ' 408' ' ' ILE . 4.3 t 80.52 -59.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.947 -0.47 . . . . 0.0 110.42 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 42.0 tt0 -54.78 -58.84 5.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.99 -1.069 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -59.22 -19.56 46.63 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.293 -0.88 . . . . 0.0 110.685 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 336' ' ' SER . 11.0 mm -67.29 -70.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.156 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 419' ' ' MET . 22.5 t -60.89 -21.09 23.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.347 -0.846 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 5.0 t70 -77.54 -29.41 52.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -0.847 . . . . 0.0 109.841 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.543 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 0.9 OUTLIER -81.37 -14.78 56.82 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.209 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.591 ' CE1' HD13 ' A' ' 337' ' ' ILE . 31.6 m80 -93.36 -37.46 11.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.576 -0.702 . . . . 0.0 109.785 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 13.9 t-20 81.43 42.91 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 121.377 0.608 . . . . 0.0 110.455 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.535 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -111.8 -89.26 1.86 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.606 ' HE1' ' CD1' ' A' ' 435' ' ' TRP . 2.6 ttp -173.36 159.76 3.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.159 -1.2 . . . . 0.0 111.464 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.496 HD12 ' CG2' ' A' ' 413' ' ' VAL . 14.0 tp -151.02 109.08 3.72 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.373 -0.83 . . . . 0.0 109.387 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -130.07 161.32 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.923 -1.11 . . . . 0.0 111.083 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.404 ' CD2' ' CD1' ' A' ' 432' ' ' ILE . 2.9 mt -126.78 138.61 53.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.384 -0.823 . . . . 0.0 110.169 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.445 ' O ' HD11 ' A' ' 430' ' ' LEU . . . -135.88 161.88 24.89 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.491 ' OG1' HD11 ' A' ' 430' ' ' LEU . 0.8 OUTLIER -154.95 129.89 9.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.207 -1.172 . . . . 0.0 110.631 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 5.5 t -88.85 98.97 12.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.308 -0.87 . . . . 0.0 109.142 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 59.36 39.4 22.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.351 -0.843 . . . . 0.0 109.733 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 376' ' ' PRO . 64.9 mmt-85 46.93 35.95 3.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.276 -0.89 . . . . 0.0 109.471 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -129.18 -44.52 0.2 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -113.09 84.44 0.36 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.615 ' CD2' ' C5 ' ' A' ' 451' ' ' ANP . 15.6 tp -78.4 139.92 38.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -1.169 . . . . 0.0 110.636 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 371' ' ' VAL . 23.3 t -139.3 132.39 29.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.56 -0.713 . . . . 0.0 109.857 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.439 ' O ' ' HG3' ' A' ' 370' ' ' GLN . 29.1 mm -92.68 140.64 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.196 -0.94 . . . . 0.0 110.648 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -119.92 97.16 5.48 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.321 -0.862 . . . . 0.0 110.407 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.622 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -103.25 137.4 41.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 110.236 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 88.9 m95 -118.93 153.14 35.08 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.1 -1.0 . . . . 0.0 111.839 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.512 ' CD1' HD12 ' A' ' 301' ' ' LEU . 24.6 mt -145.35 100.15 4.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.535 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 41.4 Cg_endo -65.75 138.04 52.05 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.967 1.509 . . . . 0.0 111.592 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.584 ' CG2' ' HD2' ' A' ' 439' ' ' PRO . 2.9 p -93.24 151.2 40.19 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.706 -0.621 . . . . 0.0 109.928 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 438' ' ' VAL . 39.5 Cg_endo -64.22 161.32 34.55 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.642 1.338 . . . . 0.0 110.205 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.451 ' O ' HG21 ' A' ' 441' ' ' THR . 10.3 p -39.26 143.3 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.376 -0.828 . . . . 0.0 110.597 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 440' ' ' VAL . 40.5 p -143.64 -163.03 1.57 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.377 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 -139.45 82.92 1.91 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 109.989 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -131.3 109.58 10.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.371 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -107.44 -47.97 3.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.224 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 101.73 -170.02 20.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 15.0 t -89.47 140.03 29.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.314 -1.109 . . . . 0.0 110.315 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 4.0 t -155.72 111.94 3.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 110.172 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -82.56 161.34 22.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -98.08 -41.7 7.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.615 ' C5 ' ' CD2' ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.21 0.528 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -84.67 105.45 2.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.91 105.97 1.22 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.301 -1.117 . . . . 0.0 110.148 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 294' ' ' MET . 0.3 OUTLIER -174.25 38.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.123 -0.986 . . . . 0.0 110.509 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 293' ' ' GLU . 19.5 mtt -154.2 119.62 2.73 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.216 -0.928 . . . . 0.0 110.113 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.602 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 51.4 Cg_endo -85.84 69.26 5.03 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.875 1.46 . . . . 0.0 111.062 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.594 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -90.82 109.41 20.61 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.938 0.875 . . . . 0.0 108.98 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.2 mt-10 -134.53 -156.33 0.72 Allowed 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.73 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.551 ' HE3' ' CA ' ' A' ' 330' ' ' VAL . 0.7 OUTLIER -87.4 131.89 34.15 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.048 -1.033 . . . . 0.0 110.239 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -142.34 147.83 36.94 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 110.972 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.47 ' O ' HG22 ' A' ' 304' ' ' VAL . 1.1 m-20 -89.61 119.8 30.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.427 -0.796 . . . . 0.0 109.454 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.529 HD22 ' CE ' ' A' ' 332' ' ' MET . 6.5 mt -62.31 -21.12 65.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.008 -1.057 . . . . 0.0 109.801 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.464 ' OD1' HD21 ' A' ' 323' ' ' LEU . 51.4 t-20 -84.25 -22.1 30.91 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.084 -1.01 . . . . 0.0 109.029 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 300' ' ' ASP . . . -84.9 -33.38 22.77 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.714 -0.616 . . . . 0.0 109.823 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 300' ' ' ASP . 22.7 t -79.55 -34.72 16.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.342 -0.849 . . . . 0.0 109.407 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 94.3 mt -75.28 -31.29 60.69 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.408 -0.808 . . . . 0.0 110.161 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -63.39 -31.0 79.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -80.17 -34.07 37.86 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.39 -1.065 . . . . 0.0 109.362 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.574 ' CG1' ' CG1' ' A' ' 341' ' ' VAL . 97.7 t -74.76 -20.38 16.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.64 0.733 . . . . 0.0 109.103 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.522 ' O ' ' CB ' ' A' ' 313' ' ' SER . 1.1 mt -75.88 -50.87 21.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.59 -16.43 63.4 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.83 0.824 . . . . 0.0 108.929 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 308' ' ' VAL . . . -62.98 -66.35 0.55 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.7 -0.625 . . . . 0.0 110.765 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.93 44.54 2.88 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.884 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.554 ' CB ' ' CD1' ' A' ' 319' ' ' ILE . 3.3 p -86.63 27.12 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.866 -1.146 . . . . 0.0 110.358 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' A' ' 317' ' ' ARG . . . 43.55 42.74 6.03 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.515 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 12.7 m-85 58.86 49.37 9.91 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.702 -0.881 . . . . 0.0 109.608 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 0.7 OUTLIER 59.93 62.24 1.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.61 0.719 . . . . 0.0 110.834 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 314' ' ' GLY . 16.2 mmm180 -71.66 -82.79 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.907 0.861 . . . . 0.0 109.092 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -147.14 55.9 1.11 Allowed 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.554 ' CD1' ' CB ' ' A' ' 313' ' ' SER . 19.6 mt -97.47 131.9 43.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.75 -0.594 . . . . 0.0 110.627 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 1.1 tp10 -91.52 107.06 18.95 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.508 HG23 ' CD1' ' A' ' 309' ' ' ILE . 16.9 p -94.36 122.85 37.34 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 111.133 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . 0.424 ' C ' HD11 ' A' ' 323' ' ' LEU . . . -146.1 77.06 1.48 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.543 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 6.1 mp -95.47 140.6 30.1 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.373 -0.83 . . . . 0.0 109.977 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 9.8 t80 -42.68 121.84 2.81 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.447 -0.783 . . . . 0.0 109.826 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.14 59.88 7.21 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.974 1.513 . . . . 0.0 110.194 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . -158.74 20.4 0.31 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 53.8 m 55.29 100.12 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.253 -1.145 . . . . 0.0 110.363 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.549 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 2.7 mt -76.23 -175.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 121.532 -0.73 . . . . 0.0 109.14 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 3.4 mt-10 -171.45 110.96 0.32 Allowed 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.315 -0.866 . . . . 0.0 111.241 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.551 ' CA ' ' HE3' ' A' ' 298' ' ' MET . 29.7 m -144.44 149.95 16.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 O-C-N 121.583 -0.698 . . . . 0.0 110.092 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.7 OUTLIER -68.69 98.25 0.88 Allowed 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.571 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 4.8 ttp -144.76 159.72 42.4 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.76 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.609 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 19.5 t-160 -101.88 117.02 62.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.47 ' O ' ' HE2' ' A' ' 338' ' ' LYS . 33.8 Cg_endo -54.74 -31.59 72.38 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.458 1.241 . . . . 0.0 111.429 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.609 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 6.6 mt -69.86 -69.75 0.33 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.888 -1.133 . . . . 0.0 110.428 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 335' ' ' LEU . 23.8 m -43.28 -60.36 1.72 Allowed 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.675 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.59 HD13 ' CE1' ' A' ' 416' ' ' HIS . 8.5 mm -55.41 -35.02 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.228 -0.92 . . . . 0.0 110.676 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 1.3 mtmm -56.11 -47.39 78.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.9 -1.125 . . . . 0.0 109.11 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -37.51 76.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.805 -0.559 . . . . 0.0 110.227 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.461 ' O ' ' SD ' ' A' ' 344' ' ' MET . . . -66.56 -23.87 66.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.574 ' CG1' ' CG1' ' A' ' 308' ' ' VAL . 72.6 t -89.98 -28.13 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.804 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.527 ' O ' ' CG2' ' A' ' 346' ' ' VAL . . . -73.94 -30.24 62.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.371 -0.831 . . . . 0.0 109.937 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -69.23 -23.37 63.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.904 . . . . 0.0 109.913 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.461 ' SD ' ' O ' ' A' ' 340' ' ' ALA . 0.3 OUTLIER -90.55 -25.19 20.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.824 . . . . 0.0 110.613 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 90.2 t -90.45 -23.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.098 -1.001 . . . . 0.0 111.107 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 342' ' ' ALA . 97.0 t -68.2 -20.11 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.984 -1.072 . . . . 0.0 110.405 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 351' ' ' TYR . 2.1 m120 -63.49 -51.78 64.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.464 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 373' ' ' ASP . . . -90.84 -19.07 23.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.402 -0.811 . . . . 0.0 111.029 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.65 -81.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.967 -1.083 . . . . 0.0 110.883 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.476 ' CG ' ' N ' ' A' ' 351' ' ' TYR . 27.7 ptt180 -92.01 -44.92 8.59 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.218 -0.926 . . . . 0.0 111.392 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . 0.476 ' N ' ' CG ' ' A' ' 350' ' ' ARG . 9.0 t80 -64.11 -40.45 96.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.209 -0.932 . . . . 0.0 110.729 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 348' ' ' ALA . . . -109.6 173.71 17.21 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -159.21 28.64 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -1.039 . . . . 0.0 109.85 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -89.29 -59.85 1.52 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.568 ' CH2' ' HB2' ' A' ' 357' ' ' LYS . 19.9 t90 -176.15 132.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -1.135 . . . . 0.0 110.132 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.491 HD11 HG12 ' A' ' 319' ' ' ILE . 5.9 mt -102.0 158.53 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.422 -0.799 . . . . 0.0 109.209 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.568 ' HB2' ' CH2' ' A' ' 355' ' ' TRP . 0.5 OUTLIER -144.09 104.93 4.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.027 -1.045 . . . . 0.0 110.654 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.514 HG21 ' CG2' ' A' ' 319' ' ' ILE . 41.2 t -107.94 89.88 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 108.86 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.0 t -121.01 138.4 54.18 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.387 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.543 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.1 t -120.97 145.12 48.08 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -141.45 -172.42 13.24 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.64 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -159.85 172.07 18.3 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.196 -1.179 . . . . 0.0 110.585 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -145.34 175.57 2.68 Favored Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.526 -0.734 . . . . 0.0 109.643 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 41.5 Cg_endo -68.15 111.34 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.699 1.368 . . . . 0.0 111.133 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 3.9 t-20 72.75 29.24 1.97 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.531 -0.731 . . . . 0.0 111.118 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 19.7 ptt-85 171.64 116.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.325 -0.859 . . . . 0.0 110.773 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.4 179.98 4.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.102 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.618 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 36.8 p-90 -170.55 143.93 2.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.619 -1.301 . . . . 0.0 110.309 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.583 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 31.8 p90 -114.16 140.28 48.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.286 -0.884 . . . . 0.0 109.257 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 432' ' ' ILE . 27.0 tt0 -130.95 149.95 52.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 111.979 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 37.7 t -128.78 150.66 34.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 357' ' ' LYS . 29.3 tt0 -150.12 140.43 22.28 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.992 -1.067 . . . . 0.0 109.692 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.462 ' HB2' ' HB3' ' A' ' 348' ' ' ALA . 1.7 p30 -161.12 168.95 23.32 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.976 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.3 151.89 20.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.428 -0.795 . . . . 0.0 110.32 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 162.81 -156.46 28.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.52 ' O ' ' N7 ' ' A' ' 451' ' ' ANP . 49.9 Cg_endo -74.53 137.75 23.29 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.961 1.506 . . . . 0.0 110.614 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -92.03 -174.04 42.33 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.579 HG12 ' N9 ' ' A' ' 451' ' ' ANP . 3.2 mt -110.69 97.88 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.005 -1.291 . . . . 0.0 109.891 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.515 ' CB ' ' HD2' ' A' ' 380' ' ' PRO . . . -68.56 178.83 0.76 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.28 -0.888 . . . . 0.0 110.547 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 379' ' ' ALA . 43.0 Cg_endo -70.8 -19.75 30.81 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.165 1.613 . . . . 0.0 110.012 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.46 -30.67 17.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 109.579 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.559 ' HB3' " O2'" ' A' ' 451' ' ' ANP . 3.5 mt-30 -85.0 -19.22 32.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.465 -0.772 . . . . 0.0 109.829 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.487 ' O ' ' OE1' ' A' ' 388' ' ' GLN . 36.0 ttm-85 -54.25 -52.03 62.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.395 -0.815 . . . . 0.0 110.521 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.502 ' CA ' ' OE1' ' A' ' 388' ' ' GLN . 7.7 mmtt -44.03 -18.57 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.692 -0.63 . . . . 0.0 111.828 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' A' ' 385' ' ' HIS . 0.6 OUTLIER -111.55 42.08 1.77 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.814 -1.179 . . . . 0.0 111.642 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.54 ' CG ' ' O ' ' A' ' 385' ' ' HIS . 0.2 OUTLIER -169.08 104.08 0.39 Allowed 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.158 -1.589 . . . . 0.0 114.322 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 386' ' ' LEU . 39.2 m-85 62.61 78.3 0.3 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 388' ' ' GLN . 13.6 pt20 -172.8 69.46 0.39 Allowed Pre-proline 0 C--N 1.294 -1.814 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.974 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 390' ' ' PHE . 47.7 Cg_endo -80.75 99.75 1.16 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.98 1.516 . . . . 0.0 110.558 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . 0.516 ' C ' ' CG2' ' A' ' 391' ' ' VAL . 2.2 t80 -178.66 62.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.092 -1.005 . . . . 0.0 110.289 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.516 ' CG2' ' C ' ' A' ' 390' ' ' PHE . 4.8 t -151.37 64.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.454 -0.779 . . . . 0.0 110.547 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.0 157.05 26.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.88 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 177.01 154.37 11.91 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.71 92.56 4.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -1.105 . . . . 0.0 110.061 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 10.1 t -164.12 179.69 6.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.228 -0.92 . . . . 0.0 110.289 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . 60.57 112.93 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.262 -0.899 . . . . 0.0 110.074 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 398' ' ' THR . 11.0 tpt180 -110.44 159.83 17.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.466 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 397' ' ' ARG . 4.5 p 43.93 -170.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.367 -0.833 . . . . 0.0 110.581 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.484 HG13 ' N ' ' A' ' 400' ' ' SER . 2.9 tp -51.49 155.37 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.346 -0.846 . . . . 0.0 110.095 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.484 ' N ' HG13 ' A' ' 399' ' ' ILE . 3.2 m -102.44 -43.87 5.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.206 -0.934 . . . . 0.0 110.475 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 77.43 66.41 1.79 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 53.7 m -133.33 -51.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.225 -1.162 . . . . 0.0 110.156 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 146.24 77.08 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 1.2 mp -124.12 170.44 10.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.225 -1.162 . . . . 0.0 110.267 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 132.28 43.8 0.16 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 408' ' ' ILE . 0.6 OUTLIER -121.92 61.87 0.95 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.254 -1.144 . . . . 0.0 110.004 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -104.12 34.6 2.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.292 -0.88 . . . . 0.0 110.725 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 409' ' ' VAL . 0.0 OUTLIER -110.61 159.47 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.783 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.552 ' CB ' ' O ' ' A' ' 408' ' ' ILE . 0.4 OUTLIER 79.76 -35.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 121.605 -0.684 . . . . 0.0 110.47 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.512 ' N ' HG11 ' A' ' 409' ' ' VAL . 18.5 tt0 -69.84 -54.06 15.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.0 -1.062 . . . . 0.0 110.079 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.87 -21.11 41.26 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.28 -0.887 . . . . 0.0 110.013 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' A' ' 409' ' ' VAL . 1.0 OUTLIER -66.86 -59.1 4.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 420' ' ' LEU . 21.2 t -67.94 -22.31 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.523 -0.736 . . . . 0.0 110.031 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -82.44 -23.45 34.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.551 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.463 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 58.8 m-20 -83.31 -21.91 33.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.517 -0.739 . . . . 0.0 109.203 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.594 ' CD2' ' CE ' ' A' ' 296' ' ' MET . 37.7 m80 -92.77 -37.2 12.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.701 . . . . 0.0 109.894 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.5 t-20 81.95 29.64 0.13 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.798 -0.564 . . . . 0.0 111.015 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.541 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -98.39 -90.66 1.96 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.515 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.6 tpp -175.89 161.57 2.5 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.278 -1.131 . . . . 0.0 111.168 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.482 ' HB2' HG23 ' A' ' 413' ' ' VAL . 27.0 tp -152.66 108.12 3.29 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.353 -0.842 . . . . 0.0 109.312 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.61 138.14 48.68 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.782 -1.199 . . . . 0.0 111.738 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.57 130.5 36.6 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -122.56 114.84 2.56 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 119.577 -1.296 . . . . 0.0 110.006 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.0 m -66.0 102.12 0.76 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.406 -1.055 . . . . 0.0 108.651 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' SER . . . . . 0.514 ' CB ' ' HG3' ' A' ' 427' ' ' ARG . 33.2 t -53.63 137.29 37.44 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.274 -0.891 . . . . 0.0 110.368 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 425' ' ' SER . 6.4 pt-20 -39.23 -27.51 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.527 0.68 . . . . 0.0 109.72 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.571 ' CD ' ' HA3' ' A' ' 429' ' ' GLY . 0.3 OUTLIER -74.34 24.45 0.08 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.522 -0.736 . . . . 0.0 111.381 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 53.56 38.72 58.92 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.571 ' HA3' ' CD ' ' A' ' 427' ' ' ARG . . . -132.74 -154.14 7.47 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.604 ' HG ' ' C5 ' ' A' ' 451' ' ' ANP . 2.4 mm? -130.18 152.21 49.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.885 -1.362 . . . . 0.0 113.308 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 11.3 p -142.34 113.18 7.43 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.449 HG13 ' HG2' ' A' ' 344' ' ' MET . 21.6 mm -87.09 118.15 32.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.837 -1.165 . . . . 0.0 111.112 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -105.52 95.29 5.71 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.583 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -98.82 137.52 37.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.323 -0.86 . . . . 0.0 110.998 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.618 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 92.1 m95 -109.01 155.05 21.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.848 . . . . 0.0 111.24 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.513 ' CD1' ' SD ' ' A' ' 332' ' ' MET . 53.7 mt -145.63 101.05 4.32 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.541 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 39.8 Cg_endo -63.88 136.98 55.7 Favored 'Trans proline' 0 C--N 1.297 -2.142 0 O-C-N 124.069 1.562 . . . . 0.0 111.836 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.513 ' CG1' ' HD2' ' A' ' 439' ' ' PRO . 89.7 t -81.99 146.23 55.07 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.72 -0.612 . . . . 0.0 110.158 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.513 ' HD2' ' CG1' ' A' ' 438' ' ' VAL . 56.5 Cg_endo -76.53 -163.5 0.21 Allowed 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 124.196 1.629 . . . . 0.0 110.121 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.95 59.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 O-C-N 121.738 -0.601 . . . . 0.0 109.992 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 59.2 p -92.48 -32.17 14.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -0.873 . . . . 0.0 110.468 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -147.2 124.08 11.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.953 . . . . 0.0 110.313 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -94.9 140.26 30.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.097 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -144.36 154.59 43.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 131.49 102.24 0.89 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 35.0 p -140.72 152.83 45.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -1.107 . . . . 0.0 110.252 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 448' ' ' LYS . 67.8 p -100.36 -32.66 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 110.123 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 447' ' ' THR . 0.0 OUTLIER 37.7 -153.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.63 -0.669 . . . . 0.0 110.59 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.26 -68.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 110.321 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 CA-C-O 117.93 -1.483 . . . . 0.0 109.582 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.604 ' C5 ' ' HG ' ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 290' ' ' THR . 5.2 t . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.222 0.534 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 292' ' ' GLN . . . -96.94 -162.8 32.23 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . 0.446 ' CB ' ' O ' ' A' ' 291' ' ' GLY . 0.1 OUTLIER 66.83 32.12 6.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.174 -1.192 . . . . 0.0 110.126 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.43 62.22 0.55 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 109.723 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.587 ' CB ' ' CD ' ' A' ' 295' ' ' PRO . 1.0 OUTLIER -79.69 -172.04 0.31 Allowed Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.377 -0.827 . . . . 0.0 109.811 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 294' ' ' MET . 43.3 Cg_endo -83.21 64.77 7.82 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 O-C-N 124.026 1.54 . . . . 0.0 110.998 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.587 ' HE1' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -88.37 102.92 15.35 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.435 -0.79 . . . . 0.0 109.747 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.0 mt-10 -118.53 -167.59 1.39 Allowed 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.584 -0.697 . . . . 0.0 109.347 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.489 ' HE1' ' O ' ' A' ' 330' ' ' VAL . 1.8 mmt -88.19 124.92 34.32 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.886 -1.134 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -143.33 150.32 39.01 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.441 0.638 . . . . 0.0 111.163 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.528 ' HB3' ' CB ' ' A' ' 303' ' ' ALA . 46.9 t0 -84.44 118.81 24.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.526 ' CD1' HD11 ' A' ' 436' ' ' LEU . 7.1 mt -64.46 -22.56 67.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.968 -1.082 . . . . 0.0 109.726 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.427 ' CG ' ' HB3' ' A' ' 323' ' ' LEU . 48.2 m-20 -81.24 -19.78 42.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 0.0 108.735 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -84.61 -35.9 22.4 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.695 -0.628 . . . . 0.0 109.485 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.495 ' O ' ' CG2' ' A' ' 308' ' ' VAL . 21.5 t -77.25 -34.6 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.494 -0.754 . . . . 0.0 109.267 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 91.9 mt -77.23 -28.65 53.77 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.505 -0.747 . . . . 0.0 109.68 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -63.63 -42.1 98.87 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.62 -30.46 61.67 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.477 -1.014 . . . . 0.0 109.065 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.495 ' CG1' HG13 ' A' ' 341' ' ' VAL . 74.4 t -75.22 -21.29 16.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.537 ' CD1' HG13 ' A' ' 358' ' ' VAL . 3.2 mt -77.38 -41.36 29.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -64.07 -17.66 63.61 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -83.31 -43.91 15.48 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.351 0.596 . . . . 0.0 109.866 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.552 ' OE2' ' CG2' ' A' ' 358' ' ' VAL . 6.7 pt-20 -81.67 10.88 5.34 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.359 -0.838 . . . . 0.0 110.306 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 314' ' ' GLY . 60.5 p -117.64 69.64 0.78 Allowed 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 313' ' ' SER . . . -42.59 -30.15 0.85 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 313' ' ' SER . 28.6 t80 -162.69 36.21 0.11 Allowed 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.788 -0.831 . . . . 0.0 109.984 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.34 56.32 8.11 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.092 -1.005 . . . . 0.0 108.538 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -68.31 -55.34 12.46 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-O 121.372 0.606 . . . . 0.0 110.746 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 355' ' ' TRP . 7.4 pt-20 -170.59 58.56 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.862 0 C-N-CA 119.471 -0.892 . . . . 0.0 112.087 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.607 ' CG2' ' CG2' ' A' ' 358' ' ' VAL . 2.2 mp -106.9 125.38 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.788 -1.195 . . . . 0.0 110.225 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.19 116.77 29.18 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 7.6 p -95.25 129.91 42.2 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.418 -0.802 . . . . 0.0 111.173 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.76 79.17 1.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.479 -0.763 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.55 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 5.7 mp -95.06 160.95 14.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.444 -0.785 . . . . 0.0 110.525 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.597 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 83.9 t80 -50.42 129.06 25.16 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.171 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.05 71.76 6.87 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.767 1.404 . . . . 0.0 110.695 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -179.72 28.19 0.05 OUTLIER Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.36 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 326' ' ' GLY . 29.3 m 46.59 99.12 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.079 -1.248 . . . . 0.0 110.209 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.535 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 3.0 mt -69.23 174.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 121.431 -0.793 . . . . 0.0 110.099 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 4.9 mt-10 -168.14 105.44 0.48 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.793 0.806 . . . . 0.0 110.714 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.527 ' CG2' ' SD ' ' A' ' 332' ' ' MET . 9.9 m -133.42 171.45 18.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 O-C-N 121.749 -0.594 . . . . 0.0 109.751 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -87.25 90.9 8.53 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.981 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.527 ' SD ' ' CG2' ' A' ' 330' ' ' VAL . 16.6 ptm -142.58 162.17 36.16 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 111.15 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.587 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 23.6 t-160 -91.56 114.21 61.1 Favored Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 36.3 Cg_endo -58.35 -18.76 39.79 Favored 'Trans proline' 0 C--N 1.295 -2.243 0 O-C-N 123.388 1.204 . . . . 0.0 109.87 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.587 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -84.19 -70.62 0.56 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.392 -0.817 . . . . 0.0 110.735 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 416' ' ' HIS . 10.6 t -51.65 -36.43 46.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 110.569 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.562 HD12 ' CG ' ' A' ' 416' ' ' HIS . 37.3 mm -70.62 -43.04 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 110.091 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 4.7 tppt? -52.28 -35.03 49.11 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 120.911 -1.118 . . . . 0.0 108.866 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.15 -36.33 35.31 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.535 0.683 . . . . 0.0 109.824 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.518 ' CA ' HG12 ' A' ' 409' ' ' VAL . . . -56.0 -48.66 75.49 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.586 -0.697 . . . . 0.0 110.5 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.495 HG13 ' CG1' ' A' ' 308' ' ' VAL . 70.2 t -75.21 -38.33 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.513 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -50.42 -53.99 25.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.325 -0.86 . . . . 0.0 110.748 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -19.81 61.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.103 -0.998 . . . . 0.0 110.512 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 341' ' ' VAL . 0.5 OUTLIER -69.46 -45.17 69.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.121 -0.987 . . . . 0.0 110.529 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.463 HG13 ' HB2' ' A' ' 312' ' ' GLU . 84.4 t -80.09 -20.59 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.431 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 346' ' ' VAL . 25.4 t -60.02 -20.59 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.124 -0.985 . . . . 0.0 110.074 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 0.6 OUTLIER -69.08 -41.88 76.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.314 -0.866 . . . . 0.0 110.475 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.539 ' CB ' ' CB ' ' A' ' 373' ' ' ASP . . . -90.29 -20.39 22.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.92 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -78.3 -52.12 9.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 110.219 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -90.43 -45.61 8.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 110.482 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 347' ' ' ASN . 1.9 m-85 -89.8 -25.88 20.85 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.231 -0.918 . . . . 0.0 110.557 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 348' ' ' ALA . . . -63.96 -135.18 0.01 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -133.83 -48.83 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.205 -1.173 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 356' ' ' ILE . . . -171.48 -87.33 0.07 OUTLIER Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.213 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.444 ' N ' ' CD ' ' A' ' 318' ' ' GLU . 37.3 t90 -42.83 132.6 3.81 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.23 -1.159 . . . . 0.0 112.469 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 319' ' ' ILE . 2.8 mt -125.26 145.66 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.511 ' CB ' ' O ' ' A' ' 372' ' ' GLU . 5.9 tttt -125.54 110.67 14.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.564 -1.335 . . . . 0.0 110.372 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.607 ' CG2' ' CG2' ' A' ' 319' ' ' ILE . 22.1 t -106.24 101.74 12.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 109.266 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 33.8 m -130.02 152.49 49.42 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.55 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.2 OUTLIER -147.07 153.22 39.71 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.63 -0.669 . . . . 0.0 109.697 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -144.27 -160.67 8.59 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 108.394 -1.883 . . . . 0.0 108.394 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.597 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.2 OUTLIER -173.0 178.87 2.41 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.893 -1.357 . . . . 0.0 111.302 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.569 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 3.5 mt-10 -160.89 -178.52 0.89 Allowed Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 38.0 Cg_endo -64.41 135.34 45.72 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.245 1.129 . . . . 0.0 110.341 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.533 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 15.2 p30 39.71 33.71 0.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.764 -0.585 . . . . 0.0 110.562 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER -174.17 94.0 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.258 -0.901 . . . . 0.0 111.421 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.27 151.35 22.79 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.673 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 30.7 p-90 -144.68 174.07 11.29 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.362 -1.461 . . . . 0.0 111.247 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 369' ' ' PHE . 9.2 p90 -148.92 139.33 22.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.671 -0.643 . . . . 0.0 109.408 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 432' ' ' ILE . 50.1 tt0 -130.72 163.94 26.16 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.252 -0.905 . . . . 0.0 111.648 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 372' ' ' GLU . 32.0 t -132.17 156.05 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.607 -0.683 . . . . 0.0 110.01 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 357' ' ' LYS . 10.2 tt0 -149.83 131.46 14.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.074 -1.016 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.539 ' CB ' ' CB ' ' A' ' 348' ' ' ALA . 35.9 m-20 -136.99 162.74 32.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.003 -1.061 . . . . 0.0 110.88 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -87.96 142.17 28.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.963 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 157.63 -168.4 34.31 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.46 -176.66 2.86 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 O-C-N 124.053 1.554 . . . . 0.0 110.692 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . 0.574 ' O ' ' N3 ' ' A' ' 451' ' ' ANP . . . -90.49 -131.47 4.78 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.555 HD12 ' CD2' ' A' ' 430' ' ' LEU . 3.1 mm -103.29 145.03 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.041 -1.27 . . . . 0.0 109.93 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 378' ' ' ILE . . . -39.79 160.11 0.11 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.506 -0.746 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.28 -54.23 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.055 1.555 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -75.33 -23.19 57.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.82 . . . . 0.0 110.165 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.412 ' CB ' ' HB2' ' A' ' 379' ' ' ALA . 1.1 tt0 -82.92 -23.25 33.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.953 . . . . 0.0 109.682 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.18 -22.31 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.398 -0.814 . . . . 0.0 110.091 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -87.51 -35.11 18.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 0.0 110.053 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.505 ' ND1' ' N ' ' A' ' 385' ' ' HIS . 2.3 m-70 -80.52 -69.67 0.58 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.218 -0.926 . . . . 0.0 110.647 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 422' ' ' LEU . 0.3 OUTLIER 63.86 99.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.576 ' CD1' " O5'" ' A' ' 451' ' ' ANP . 2.0 m-85 62.38 35.13 15.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -145.97 60.99 6.92 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.024 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.496 ' O ' ' CG ' ' A' ' 390' ' ' PHE . 42.0 Cg_endo -69.3 84.27 0.59 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 124.126 1.593 . . . . 0.0 110.346 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . 0.496 ' CG ' ' O ' ' A' ' 389' ' ' PRO . 12.5 m-85 -162.96 108.79 1.15 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 109.801 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 3.2 t -106.33 144.79 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.95 . . . . 0.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.02 58.24 4.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.262 -0.898 . . . . 0.0 109.907 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -88.38 37.35 3.29 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.75 -176.7 5.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -1.139 . . . . 0.0 110.215 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 8.6 t -97.1 31.39 2.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 0.0 110.339 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . 57.45 99.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.131 -0.981 . . . . 0.0 110.366 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.9 ttt85 -120.68 -68.75 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 0.0 110.002 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -179.93 2.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.252 -0.905 . . . . 0.0 110.148 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 18.2 tt -48.75 155.5 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.877 . . . . 0.0 110.278 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 83.1 p -123.8 80.46 1.81 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.17 -0.956 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -150.24 -85.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.414 ' O ' ' CZ ' ' A' ' 390' ' ' PHE . 0.7 OUTLIER -106.46 -94.19 0.37 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -1.166 . . . . 0.0 110.596 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 404' ' ' LEU . . . 94.28 -167.74 27.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 403' ' ' GLY . 0.3 OUTLIER 176.71 162.19 0.41 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.186 -1.185 . . . . 0.0 110.338 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -140.67 -48.33 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -165.59 24.34 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -1.207 . . . . 0.0 110.25 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -109.89 125.43 52.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.189 -0.944 . . . . 0.0 110.355 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 409' ' ' VAL . 1.0 OUTLIER -113.04 -166.59 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 109.805 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.526 ' CB ' ' O ' ' A' ' 408' ' ' ILE . 3.7 t 79.22 -27.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.662 0 O-C-N 121.718 -0.614 . . . . 0.0 110.699 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 19.4 tt0 -57.92 -57.53 12.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.89 -1.131 . . . . 0.0 110.139 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -63.53 -34.91 78.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 110.659 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 416' ' ' HIS . 1.4 mp -56.37 -73.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.936 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.517 HG11 ' ND2' ' A' ' 417' ' ' ASN . 85.7 t -50.92 -34.54 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.457 -0.777 . . . . 0.0 110.321 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 0.1 OUTLIER -59.28 -39.39 82.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.206 -0.934 . . . . 0.0 110.138 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.536 ' O ' ' CE ' ' A' ' 296' ' ' MET . 22.5 m-80 -110.61 7.23 22.32 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.406 -0.809 . . . . 0.0 110.304 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.587 ' CD2' ' HE1' ' A' ' 296' ' ' MET . 8.9 m80 -115.98 -56.95 2.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 111.577 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.649 ' HA ' ' CD2' ' A' ' 436' ' ' LEU . 0.0 OUTLIER -98.77 -87.7 0.34 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.986 -1.071 . . . . 0.0 110.944 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 149.74 -37.15 0.97 Allowed Glycine 0 C--N 1.263 -3.488 0 C-N-CA 117.791 -2.147 . . . . 0.0 109.824 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.559 ' HB3' ' HB2' ' A' ' 435' ' ' TRP . 2.7 ttp -117.08 145.6 43.65 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.139 -1.212 . . . . 0.0 111.354 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.506 HD22 ' CE2' ' A' ' 387' ' ' PHE . 23.0 tp -151.91 87.13 1.33 Allowed 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -107.94 158.51 17.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.2 -0.937 . . . . 0.0 111.3 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 386' ' ' LEU . 0.3 OUTLIER -108.35 131.86 54.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.59 -0.694 . . . . 0.0 110.785 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 424' ' ' THR . . . -130.66 -177.88 15.13 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.547 ' HB ' ' N ' ' A' ' 431' ' ' SER . 5.4 m 65.5 155.83 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.152 -1.205 . . . . 0.0 111.079 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' SER . . . . . 0.551 ' HA ' ' CD2' ' A' ' 430' ' ' LEU . 0.2 OUTLIER -178.33 -143.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.57 -0.706 . . . . 0.0 109.635 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -61.55 -13.22 19.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.088 -1.008 . . . . 0.0 109.548 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.539 ' HG2' ' N ' ' A' ' 428' ' ' GLY . 0.0 OUTLIER -72.39 -27.06 62.13 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.422 -0.799 . . . . 0.0 110.433 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.539 ' N ' ' HG2' ' A' ' 427' ' ' ARG . . . -176.94 47.76 0.1 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 425' ' ' SER . . . 85.16 -146.19 21.78 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 121.142 -1.211 . . . . 0.0 110.393 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.608 ' CB ' ' C6 ' ' A' ' 451' ' ' ANP . 0.2 OUTLIER -141.24 160.38 40.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.55 -0.971 . . . . 0.0 109.737 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.547 ' N ' ' HB ' ' A' ' 424' ' ' THR . 5.1 p -156.48 151.29 25.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.327 -0.858 . . . . 0.0 109.66 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.464 ' O ' ' HG3' ' A' ' 370' ' ' GLN . 12.8 mt -120.35 121.94 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 110.258 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . 0.444 ' HG2' ' CD ' ' A' ' 370' ' ' GLN . 12.0 mtm180 -99.42 122.88 43.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 110.113 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -122.11 133.08 54.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.673 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 86.0 m95 -110.55 135.91 50.49 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.898 -1.126 . . . . 0.0 112.888 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.649 ' CD2' ' HA ' ' A' ' 417' ' ' ASN . 6.9 mt -115.28 87.68 16.8 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 417' ' ' ASN . 47.1 Cg_endo -83.56 121.11 2.9 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 O-C-N 124.041 1.548 . . . . 0.0 111.617 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 2.8 t -74.16 112.31 16.33 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.037 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 52.1 Cg_endo -71.65 -177.02 2.25 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.84 1.442 . . . . 0.0 110.995 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 37.9 t -44.0 157.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 121.682 -0.636 . . . . 0.0 110.201 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 1.6 t -134.93 -20.55 1.72 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.218 -0.926 . . . . 0.0 111.159 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -170.36 1.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.924 -1.11 . . . . 0.0 110.933 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 444' ' ' GLN . . . -129.66 93.54 3.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.449 -0.782 . . . . 0.0 110.054 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' A' ' 443' ' ' ALA . 6.1 pt20 -177.73 156.54 1.13 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 169.14 -36.62 0.2 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 3.9 t -111.44 107.17 16.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 110.05 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.01 174.33 11.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 110.135 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.98 95.18 5.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -170.23 106.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 110.434 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.498 179.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.608 ' C6 ' ' CB ' ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.205 0.526 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -122.1 48.9 0.92 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -134.68 100.49 4.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -1.133 . . . . 0.0 110.512 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -133.04 40.2 3.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.307 -0.871 . . . . 0.0 109.817 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.43 ' HE1' ' HG3' ' A' ' 296' ' ' MET . 8.4 tpt -79.8 134.2 57.47 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.432 -0.792 . . . . 0.0 110.571 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -90.36 40.61 0.41 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.849 1.447 . . . . 0.0 110.094 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.571 ' HE3' ' CD2' ' A' ' 416' ' ' HIS . 1.0 OUTLIER -114.23 105.34 13.05 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 47.0 mt-10 -136.25 -154.06 0.54 Allowed 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.454 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.466 ' HE3' ' CA ' ' A' ' 330' ' ' VAL . 1.6 mmt -87.12 132.67 33.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.921 . . . . 0.0 110.699 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.459 ' HB2' ' SD ' ' A' ' 332' ' ' MET . . . -148.05 158.2 43.93 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.088 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.452 ' O ' HG22 ' A' ' 304' ' ' VAL . 0.7 OUTLIER -90.51 119.46 30.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.759 . . . . 0.0 109.705 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.487 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 8.4 mt -65.77 -19.9 66.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.039 -1.038 . . . . 0.0 109.645 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 302' ' ' ASN . 52.0 t-20 -84.69 -19.98 31.94 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.111 -0.993 . . . . 0.0 108.913 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.9 -36.03 21.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.598 -0.689 . . . . 0.0 109.322 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.461 HG11 ' HG3' ' A' ' 338' ' ' LYS . 22.3 t -78.16 -38.46 23.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.526 -0.734 . . . . 0.0 109.214 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 88.5 mt -76.92 -28.21 55.19 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.424 -0.798 . . . . 0.0 109.991 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.83 -25.24 75.36 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.495 ' O ' ' CB ' ' A' ' 311' ' ' ALA . 3.8 mt-10 -83.85 -33.17 24.9 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.46 -1.023 . . . . 0.0 109.272 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.589 ' CG1' ' CG1' ' A' ' 341' ' ' VAL . 40.2 t -72.45 -28.73 29.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.459 -0.776 . . . . 0.0 109.118 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.546 ' CD1' HG13 ' A' ' 358' ' ' VAL . 4.6 mt -72.58 -57.08 7.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.77 -16.5 64.3 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.82 0.819 . . . . 0.0 109.014 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 307' ' ' GLU . . . -65.94 -66.42 0.55 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.763 -0.586 . . . . 0.0 111.047 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.426 ' HG2' ' C ' ' A' ' 311' ' ' ALA . 4.5 mm-40 -127.47 42.8 3.25 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.871 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.553 ' CB ' HD12 ' A' ' 319' ' ' ILE . 7.0 p -86.11 32.1 0.62 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.878 -1.139 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 315' ' ' TYR . . . 51.68 23.15 9.56 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.548 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 0.2 OUTLIER 70.59 43.65 0.74 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.844 -0.797 . . . . 0.0 110.249 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 74.58 52.02 0.09 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.486 -0.759 . . . . 0.0 110.725 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.428 ' HG3' ' HA3' ' A' ' 314' ' ' GLY . 12.8 mmm180 -68.27 -83.05 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 122.019 0.914 . . . . 0.0 109.144 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -145.82 50.03 1.2 Allowed 'General case' 0 C--N 1.268 -2.971 0 CA-C-O 122.011 0.91 . . . . 0.0 109.886 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.553 HD12 ' CB ' ' A' ' 313' ' ' SER . 5.2 mt -99.46 135.8 33.28 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.24 102.93 14.33 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.32 -0.863 . . . . 0.0 109.43 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.469 HG21 ' CD1' ' A' ' 309' ' ' ILE . 19.0 p -91.63 129.1 37.66 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.409 -0.807 . . . . 0.0 111.293 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . 0.425 ' C ' HD11 ' A' ' 323' ' ' LEU . . . -149.38 78.5 1.38 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.542 ' N ' HD11 ' A' ' 323' ' ' LEU . 6.5 mp -95.12 154.46 17.17 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.442 -0.786 . . . . 0.0 110.277 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.585 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 20.7 t80 -40.36 120.13 1.58 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.695 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -79.18 69.42 7.93 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.878 1.462 . . . . 0.0 111.366 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . -172.23 -76.46 0.05 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.6 OUTLIER 167.52 108.96 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.525 -0.985 . . . . 0.0 109.359 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.527 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 3.8 mt -87.66 178.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 O-C-N 121.468 -0.77 . . . . 0.0 109.995 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.5 mt-10 -171.58 102.26 0.19 Allowed 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.566 0.698 . . . . 0.0 110.297 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.53 HG13 ' CG2' ' A' ' 438' ' ' VAL . 21.3 m -133.86 158.54 42.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.943 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.3 OUTLIER -79.41 98.81 6.9 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.553 ' CE ' HG13 ' A' ' 337' ' ' ILE . 4.9 ppp? -139.93 172.7 12.4 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.188 -0.945 . . . . 0.0 112.194 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.491 ' NE2' ' HB3' ' A' ' 335' ' ' LEU . 21.9 t-160 -106.92 114.62 61.4 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 37.7 Cg_endo -61.17 -21.14 70.76 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.405 1.213 . . . . 0.0 111.04 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.491 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 1.9 tp -87.78 -54.62 4.16 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.984 -1.072 . . . . 0.0 110.141 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 412' ' ' ILE . 0.4 OUTLIER -63.83 -25.13 68.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.286 -0.884 . . . . 0.0 110.661 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.595 ' CD1' ' CE1' ' A' ' 416' ' ' HIS . 32.0 mm -85.34 -42.56 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.633 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 11.9 mtmt -57.86 -34.91 70.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 108.06 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -72.43 -43.77 63.35 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.526 0.679 . . . . 0.0 109.991 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.53 ' HB3' ' CG2' ' A' ' 412' ' ' ILE . . . -60.89 -30.66 70.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.505 -0.747 . . . . 0.0 110.973 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.589 ' CG1' ' CG1' ' A' ' 308' ' ' VAL . 98.7 t -78.62 -40.18 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.069 -1.019 . . . . 0.0 110.541 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.94 98.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -0.898 . . . . 0.0 110.828 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . 0.456 ' O ' HG11 ' A' ' 346' ' ' VAL . 1.3 t30 -58.71 -20.35 48.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.258 -0.901 . . . . 0.0 110.981 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.8 mtt -84.53 -57.64 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.054 -1.029 . . . . 0.0 110.504 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.419 ' O ' ' HB1' ' A' ' 349' ' ' ALA . 5.4 p -63.73 -19.49 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.303 -0.873 . . . . 0.0 110.756 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 343' ' ' ASN . 9.5 p -64.64 -19.99 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.083 -1.011 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -74.07 -55.86 5.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.101 -0.999 . . . . 0.0 110.415 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -76.19 -19.56 58.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 110.623 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 345' ' ' VAL . . . -71.12 -50.72 30.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 0.0 109.992 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 346' ' ' VAL . 6.7 mmm180 -53.6 -69.18 0.13 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -0.936 . . . . 0.0 109.715 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.57 -53.92 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 109.888 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 86.13 65.3 1.43 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -64.57 -48.89 73.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -1.204 . . . . 0.0 110.099 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . 150.92 -7.52 0.66 Allowed Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.302 -1.428 . . . . 0.0 111.205 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.549 ' CZ3' ' NH1' ' A' ' 427' ' ' ARG . 40.6 t90 -162.83 138.22 6.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.374 -1.662 . . . . 0.0 112.658 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.518 ' HB ' ' CG1' ' A' ' 319' ' ' ILE . 3.1 mt -128.3 164.87 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 372' ' ' GLU . 2.8 tttt -147.06 134.86 21.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.477 -1.389 . . . . 0.0 111.389 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.546 HG13 ' CD1' ' A' ' 309' ' ' ILE . 11.0 t -133.77 82.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 55.9 p -116.27 136.15 53.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.289 -0.882 . . . . 0.0 110.536 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 323' ' ' LEU . 0.8 OUTLIER -137.38 158.69 43.85 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.622 -0.673 . . . . 0.0 109.914 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -146.74 -150.26 5.15 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.585 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -165.55 177.46 7.38 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.21 -1.171 . . . . 0.0 110.077 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -152.88 175.89 2.71 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 110.165 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.7 Cg_endo -70.18 117.24 4.99 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.895 1.471 . . . . 0.0 110.892 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 48.0 t30 71.99 19.54 4.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.381 -0.824 . . . . 0.0 110.972 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 6.5 ptt180 173.73 127.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.431 -0.793 . . . . 0.0 110.834 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -114.45 -179.55 3.66 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.611 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 28.0 p-90 -169.23 162.39 10.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.449 -1.407 . . . . 0.0 110.968 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 37.9 p90 -131.6 158.66 40.44 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.524 ' NE2' ' HG2' ' A' ' 433' ' ' ARG . 4.1 mt-30 -144.89 151.35 38.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.858 -1.151 . . . . 0.0 112.228 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.492 HG11 ' N ' ' A' ' 372' ' ' GLU . 57.2 t -129.88 155.03 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.492 ' N ' HG11 ' A' ' 371' ' ' VAL . 5.3 mt-10 -145.05 159.43 42.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.944 -1.098 . . . . 0.0 109.987 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.425 ' OD2' ' N6 ' ' A' ' 451' ' ' ANP . 2.5 p30 -147.09 153.04 39.48 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.019 -1.05 . . . . 0.0 110.886 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.22 135.83 51.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.343 -0.848 . . . . 0.0 110.095 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 144.17 173.02 15.24 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.28 -166.83 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.846 1.445 . . . . 0.0 110.38 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -92.65 175.01 36.82 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.597 HG21 " O2'" ' A' ' 451' ' ' ANP . 3.4 mt -70.07 144.23 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -1.107 . . . . 0.0 110.138 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.445 ' HB2' ' HG3' ' A' ' 382' ' ' GLN . . . -74.13 153.94 88.48 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.141 -0.974 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.68 -21.75 21.5 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.861 1.453 . . . . 0.0 110.25 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . 0.414 ' O ' ' CD2' ' A' ' 385' ' ' HIS . 10.8 tt0 -90.65 -30.96 16.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.266 -0.897 . . . . 0.0 110.605 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.501 ' O ' HD11 ' A' ' 386' ' ' LEU . 1.2 mt-30 -90.16 -18.83 25.06 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.31 -0.869 . . . . 0.0 110.806 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 45.7 ttp85 -52.72 -54.59 31.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.217 -0.927 . . . . 0.0 110.769 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -19.97 8.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.129 -0.982 . . . . 0.0 110.407 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 385' ' ' HIS . 8.4 m-70 -91.51 28.43 1.72 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.275 -0.891 . . . . 0.0 111.049 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.564 ' C ' ' CG ' ' A' ' 387' ' ' PHE . 0.2 OUTLIER -128.5 77.14 1.75 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.934 -1.104 . . . . 0.0 110.728 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.564 ' CG ' ' C ' ' A' ' 386' ' ' LEU . 17.5 p90 38.14 49.24 1.22 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.515 -0.741 . . . . 0.0 110.61 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.497 ' HB2' ' HD2' ' A' ' 389' ' ' PRO . 3.3 pt20 -60.06 166.77 3.4 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.592 -0.693 . . . . 0.0 109.756 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 388' ' ' GLN . 44.2 Cg_endo -71.3 175.96 8.6 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.829 1.436 . . . . 0.0 110.572 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . 0.491 ' C ' ' CG2' ' A' ' 391' ' ' VAL . 22.4 p90 -131.28 124.99 31.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 110.156 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 390' ' ' PHE . 19.9 t -153.45 44.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.589 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 393' ' ' GLY . 13.0 tpp180 -44.71 160.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.086 -1.009 . . . . 0.0 109.981 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 392' ' ' ARG . . . -57.91 -119.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 394' ' ' ASP . 28.3 p-10 -48.02 141.19 6.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.119 -1.224 . . . . 0.0 110.37 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.9 m -164.09 46.05 0.11 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 110.298 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -53.84 -89.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 0.0 109.806 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.549 ' CB ' ' CZ ' ' A' ' 397' ' ' ARG . 0.1 OUTLIER -108.69 54.09 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.892 . . . . 0.0 110.152 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 7.7 p -114.29 100.9 8.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.261 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.4 mp -106.64 -35.48 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.436 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 2.1 m 52.29 -172.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -115.13 59.63 0.41 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 26.2 m -80.64 88.18 5.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -1.142 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -172.41 75.54 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 405' ' ' GLY . 0.4 OUTLIER -79.4 96.27 5.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.265 -1.138 . . . . 0.0 110.222 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.461 ' O ' HD11 ' A' ' 406' ' ' LEU . . . -43.73 103.84 0.05 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.461 HD11 ' O ' ' A' ' 405' ' ' GLY . 3.3 tp -153.85 -61.85 0.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.235 -1.156 . . . . 0.0 110.279 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -101.12 -165.31 1.19 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.241 -0.912 . . . . 0.0 110.263 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 408' ' ' ILE . 9.1 tp -168.11 88.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.122 -0.986 . . . . 0.0 110.681 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 408' ' ' ILE . 9.1 t -160.87 -37.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.183 -0.948 . . . . 0.0 109.863 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 59.4 tt0 -67.9 -57.43 6.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.128 -0.982 . . . . 0.0 109.687 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.4 OUTLIER -56.11 -18.73 10.65 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.245 -0.909 . . . . 0.0 110.297 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 340' ' ' ALA . 18.1 mm -63.47 -71.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.113 -0.992 . . . . 0.0 109.538 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 419' ' ' MET . 10.8 t -64.36 -21.3 28.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 109.23 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 4.8 t0 -81.22 -20.41 41.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.512 -0.743 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 1.4 m120 -77.5 -23.73 50.24 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.595 ' CE1' ' CD1' ' A' ' 337' ' ' ILE . 55.2 m80 -91.24 -17.14 26.49 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.703 -0.623 . . . . 0.0 109.367 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 34.4 m120 67.82 10.49 7.83 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.327 0.584 . . . . 0.0 110.317 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 435' ' ' TRP . . . -69.86 -87.55 0.11 Allowed Glycine 0 N--CA 1.482 1.726 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.55 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.3 OUTLIER 178.02 166.08 0.73 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 111.208 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 42.5 tp -151.56 118.81 5.94 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 109.324 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -129.03 147.86 50.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.969 -1.082 . . . . 0.0 111.356 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.549 HD12 ' CE1' ' A' ' 387' ' ' PHE . 0.3 OUTLIER -125.95 127.3 45.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.433 -0.792 . . . . 0.0 109.311 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -176.85 -176.18 44.78 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.807 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 74.6 m -90.07 136.28 33.14 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.379 -1.071 . . . . 0.0 110.387 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' SER . . . . . 0.563 ' CB ' ' CB ' ' A' ' 431' ' ' SER . 8.5 t -108.45 178.62 4.44 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.358 -0.838 . . . . 0.0 109.763 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 428' ' ' GLY . 2.9 pp20? -44.57 -20.14 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.032 0.444 . . . . 0.0 111.041 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.549 ' NH1' ' CZ3' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -67.45 5.26 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.004 -1.06 . . . . 0.0 110.264 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 426' ' ' GLU . . . 64.78 36.99 93.77 Favored Glycine 0 C--O 1.216 -0.976 0 N-CA-C 108.806 -1.717 . . . . 0.0 108.806 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . 170.74 -165.71 38.92 Favored Glycine 0 N--CA 1.505 3.244 0 C-N-CA 117.623 -2.227 . . . . 0.0 113.224 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.613 ' HG ' ' N6 ' ' A' ' 451' ' ' ANP . 0.2 OUTLIER -35.19 123.21 0.6 Allowed 'General case' 0 N--CA 1.515 2.777 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.563 ' CB ' ' CB ' ' A' ' 425' ' ' SER . 1.0 OUTLIER -153.76 115.22 4.18 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.588 HD13 ' N1 ' ' A' ' 451' ' ' ANP . 31.8 mt -97.55 145.59 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 110.722 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . 0.524 ' HG2' ' NE2' ' A' ' 370' ' ' GLN . 20.2 mtp180 -126.76 144.11 51.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 109.87 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -139.77 132.68 29.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.615 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.611 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 87.5 m95 -111.46 157.98 19.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.044 -1.035 . . . . 0.0 112.082 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.429 ' HG ' ' C ' ' A' ' 435' ' ' TRP . 75.4 mt -147.26 127.62 6.84 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.422 ' C ' ' HD3' ' A' ' 439' ' ' PRO . 43.1 Cg_endo -70.13 141.41 43.68 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.522 1.275 . . . . 0.0 111.845 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.53 ' CG2' HG13 ' A' ' 330' ' ' VAL . 53.7 t -110.67 74.05 0.88 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.577 -0.702 . . . . 0.0 110.416 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.422 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 49.1 Cg_endo -75.37 75.14 3.96 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.829 1.436 . . . . 0.0 110.979 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.434 HG23 ' SD ' ' A' ' 298' ' ' MET . 11.0 t -154.17 -55.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.048 -1.033 . . . . 0.0 110.506 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 10.0 t -48.15 -28.83 3.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.328 -0.857 . . . . 0.0 111.058 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.9 -176.45 3.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.988 -1.07 . . . . 0.0 110.448 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -178.71 39.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.24 -0.912 . . . . 0.0 110.2 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -84.07 -68.94 0.68 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.212 -0.93 . . . . 0.0 110.417 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 172.17 -62.07 0.15 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 15.0 t -134.77 177.06 8.09 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.208 -1.172 . . . . 0.0 110.24 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 38.3 p -132.03 44.36 2.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.371 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -138.78 88.83 2.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.94 . . . . 0.0 110.237 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -154.71 156.24 36.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.234 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.568 -179.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.613 ' N6 ' ' HG ' ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.43 HG21 ' O ' ' A' ' 290' ' ' THR . 10.0 t . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.235 0.54 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -162.31 -166.83 21.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.92 69.64 1.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -1.091 . . . . 0.0 110.021 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -131.41 35.49 3.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 0.0 110.598 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.546 ' HB3' ' CD ' ' A' ' 295' ' ' PRO . 0.0 OUTLIER -90.15 -178.23 0.93 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.28 -0.887 . . . . 0.0 109.622 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.583 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 46.3 Cg_endo -89.19 45.85 0.88 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.77 1.405 . . . . 0.0 109.871 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.429 ' HE2' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -109.49 109.26 20.03 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.4 OUTLIER -148.14 -146.93 0.21 Allowed 'General case' 0 C--N 1.273 -2.737 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.468 ' HE3' ' N ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -88.04 144.86 26.28 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.227 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.98 162.84 40.83 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.358 -0.839 . . . . 0.0 111.201 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -94.32 118.76 32.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.543 -0.723 . . . . 0.0 109.363 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.539 HD22 ' CE ' ' A' ' 332' ' ' MET . 5.5 mt -69.82 -21.46 63.38 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.949 -1.095 . . . . 0.0 109.765 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.481 ' HA ' HD22 ' A' ' 323' ' ' LEU . 55.9 t-20 -84.99 -20.04 31.13 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.092 -1.005 . . . . 0.0 108.86 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.32 -34.63 18.8 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.546 0.689 . . . . 0.0 109.506 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.438 ' O ' HG21 ' A' ' 308' ' ' VAL . 18.0 t -80.42 -31.43 12.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.411 -0.805 . . . . 0.0 109.245 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 62.9 mt -80.52 -30.68 37.2 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.433 -0.792 . . . . 0.0 109.969 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -69.52 -32.48 71.38 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 311' ' ' ALA . 1.2 mt-10 -78.1 -34.29 50.19 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.405 -1.056 . . . . 0.0 109.043 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.534 ' CG1' ' HB ' ' A' ' 341' ' ' VAL . 88.2 t -78.87 -19.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 121.664 0.745 . . . . 0.0 109.531 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 313' ' ' SER . 0.0 OUTLIER -75.79 -44.09 39.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 122.052 0.93 . . . . 0.0 108.617 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.502 ' N ' HG21 ' A' ' 309' ' ' ILE . . . -91.06 -16.55 27.69 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.282 -0.886 . . . . 0.0 109.735 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 307' ' ' GLU . . . -60.42 -62.38 1.9 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.668 -0.645 . . . . 0.0 110.838 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.419 ' CD ' ' HB2' ' A' ' 342' ' ' ALA . 2.7 pt-20 -145.99 38.06 1.08 Allowed 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.94 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.56 ' CB ' HD12 ' A' ' 319' ' ' ILE . 6.9 m -91.4 31.41 1.16 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 109.339 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 94.36 21.23 27.66 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 3.0 m-85 62.46 45.55 6.34 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.674 -0.898 . . . . 0.0 109.735 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 1.9 mt-10 59.44 43.24 16.6 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.562 ' CG ' ' N ' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -69.07 -84.98 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.571 0.701 . . . . 0.0 110.041 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.562 ' N ' ' CG ' ' A' ' 317' ' ' ARG . 38.8 mt-10 -136.35 67.81 1.45 Allowed 'General case' 0 C--N 1.275 -2.653 0 CA-C-O 121.608 0.718 . . . . 0.0 111.027 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.56 HD12 ' CB ' ' A' ' 313' ' ' SER . 2.6 mp -113.13 129.08 69.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.712 -0.618 . . . . 0.0 109.632 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 358' ' ' VAL . 1.5 tt0 -89.1 100.73 13.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.072 -1.018 . . . . 0.0 109.321 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.493 ' CG2' HD12 ' A' ' 309' ' ' ILE . 19.9 p -92.17 130.31 37.92 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.781 0.801 . . . . 0.0 111.697 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.12 78.61 1.34 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.546 ' N ' HD11 ' A' ' 323' ' ' LEU . 0.9 OUTLIER -89.34 160.51 16.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 111.002 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 50.8 t80 -59.49 119.4 39.45 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.548 -0.72 . . . . 0.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.22 73.0 5.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.889 1.468 . . . . 0.0 110.573 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -172.06 27.48 0.1 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 326' ' ' GLY . 0.8 OUTLIER 47.12 96.79 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.186 -1.185 . . . . 0.0 110.145 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.542 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 3.1 mt -73.06 -179.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.658 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.2 mt-10 -169.48 107.66 0.4 Allowed 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.91 0.862 . . . . 0.0 111.128 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.515 ' CG1' ' HB1' ' A' ' 367' ' ' ALA . 31.6 m -141.38 153.13 19.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 5.3 tptt -67.55 97.87 0.63 Allowed 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 118.359 -1.336 . . . . 0.0 107.9 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.539 ' CE ' HD22 ' A' ' 301' ' ' LEU . 4.9 ttp -139.69 173.6 11.37 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.469 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.59 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 23.7 t-160 -117.11 113.26 39.45 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 37.5 Cg_endo -59.9 -20.08 58.07 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.553 1.291 . . . . 0.0 110.634 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.59 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -79.24 -63.01 1.52 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.305 -0.872 . . . . 0.0 110.212 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 412' ' ' ILE . 27.1 p -55.77 -46.93 77.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.108 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.599 HD12 ' CE1' ' A' ' 416' ' ' HIS . 23.6 mm -63.34 -32.35 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.386 -0.821 . . . . 0.0 110.05 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 10.3 mttt -59.27 -45.7 90.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.041 -1.037 . . . . 0.0 109.5 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -31.82 63.59 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.843 -0.536 . . . . 0.0 110.745 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.462 ' O ' HG13 ' A' ' 409' ' ' VAL . . . -65.03 -45.24 86.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.155 -0.965 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.534 ' HB ' ' CG1' ' A' ' 308' ' ' VAL . 16.0 t -81.1 -22.21 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 110.291 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.419 ' HB2' ' CD ' ' A' ' 312' ' ' GLU . . . -71.37 -34.73 70.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.325 -0.859 . . . . 0.0 110.682 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -83.27 -19.72 35.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.204 -0.935 . . . . 0.0 110.559 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.529 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 0.1 OUTLIER -75.36 -31.32 60.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.179 -0.951 . . . . 0.0 111.063 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.468 HG12 ' HB3' ' A' ' 313' ' ' SER . 9.6 t -90.66 -20.26 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.956 -1.09 . . . . 0.0 110.608 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.408 ' O ' HG11 ' A' ' 346' ' ' VAL . 47.9 t -77.25 -20.95 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 0.0 110.908 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 344' ' ' MET . 2.8 p30 -78.11 -38.81 43.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.97 -1.081 . . . . 0.0 110.715 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 347' ' ' ASN . . . -90.24 -20.74 22.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.123 -0.986 . . . . 0.0 110.464 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -78.1 -26.66 48.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.132 -0.98 . . . . 0.0 110.68 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -89.05 -71.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -0.962 . . . . 0.0 110.694 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -75.69 -32.26 60.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 110.52 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.481 ' CA ' ' HA2' ' A' ' 375' ' ' GLY . . . -65.87 172.04 25.52 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -67.82 0.37 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -1.116 . . . . 0.0 110.052 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 318' ' ' GLU . . . 163.26 40.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -140.37 120.98 14.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.062 -1.258 . . . . 0.0 110.866 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 319' ' ' ILE . 1.8 mp -123.37 124.21 69.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.647 -0.658 . . . . 0.0 109.339 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 372' ' ' GLU . 0.0 OUTLIER -89.46 105.08 17.56 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.981 -1.075 . . . . 0.0 109.895 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.526 ' CG1' HD13 ' A' ' 309' ' ' ILE . 74.8 t -102.5 120.28 52.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.316 -0.865 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.412 ' OG ' ' HD3' ' A' ' 357' ' ' LYS . 0.9 OUTLIER -145.84 140.34 27.0 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.214 -0.929 . . . . 0.0 110.206 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 369' ' ' PHE . 8.9 t -132.49 135.5 46.06 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.466 -0.771 . . . . 0.0 109.99 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -130.88 -160.71 10.05 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.64 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -173.51 165.39 4.63 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.913 -1.346 . . . . 0.0 111.336 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.477 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 1.0 OUTLIER -147.94 178.12 1.56 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.6 Cg_endo -71.71 110.85 2.99 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.713 1.375 . . . . 0.0 110.599 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 1.4 t-20 74.96 27.15 1.2 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.383 -0.823 . . . . 0.0 110.99 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 0.2 OUTLIER 179.13 97.39 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.257 -0.902 . . . . 0.0 111.667 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -99.62 166.84 10.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.149 -0.97 . . . . 0.0 108.396 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.688 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 40.9 p-90 -164.89 174.41 10.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.437 -1.414 . . . . 0.0 111.862 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.547 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 51.8 p90 -150.11 129.36 12.82 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -112.24 155.23 24.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.146 -0.972 . . . . 0.0 111.236 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.464 HG21 ' HB ' ' A' ' 432' ' ' ILE . 0.7 OUTLIER -138.07 126.48 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.598 -0.689 . . . . 0.0 109.877 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 357' ' ' LYS . 18.9 tt0 -128.31 106.14 8.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.249 -0.907 . . . . 0.0 109.79 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 356' ' ' ILE . 15.7 p30 -120.02 167.65 11.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.957 -1.089 . . . . 0.0 110.421 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -108.06 101.21 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.385 -0.822 . . . . 0.0 110.501 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . 0.481 ' HA2' ' CA ' ' A' ' 352' ' ' GLY . . . -116.12 -138.97 6.5 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.77 -60.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.017 1.535 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 119.69 -179.56 16.6 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.635 ' CD1' ' N9 ' ' A' ' 451' ' ' ANP . 1.4 mm -110.59 93.94 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.279 . . . . 0.0 109.998 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.52 ' HB2' ' HD2' ' A' ' 380' ' ' PRO . . . -44.38 167.11 0.1 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 379' ' ' ALA . 42.1 Cg_endo -68.19 -28.24 34.27 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.564 1.297 . . . . 0.0 110.666 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -90.88 -19.91 22.84 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.111 -0.993 . . . . 0.0 111.655 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.611 ' HB3' " O2'" ' A' ' 451' ' ' ANP . 2.5 mt-30 -80.86 -20.01 43.24 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.84 -1.162 . . . . 0.0 111.542 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.55 -24.27 20.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.91 -1.119 . . . . 0.0 110.746 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -75.52 -33.77 60.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.005 -1.059 . . . . 0.0 110.25 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -88.32 54.4 3.05 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.176 -0.953 . . . . 0.0 110.2 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.539 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 0.1 OUTLIER -151.77 103.05 2.9 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.019 -1.05 . . . . 0.0 111.095 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.539 ' HB2' ' O ' ' A' ' 386' ' ' LEU . 30.1 m-85 65.9 75.01 0.35 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.609 0.719 . . . . 0.0 111.291 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -117.78 62.75 4.09 Favored Pre-proline 0 C--N 1.296 -1.743 0 O-C-N 121.627 -0.67 . . . . 0.0 109.553 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.565 ' O ' ' CD1' ' A' ' 390' ' ' PHE . 44.9 Cg_endo -71.38 114.48 3.94 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.975 1.513 . . . . 0.0 110.407 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 389' ' ' PRO . 49.3 m-85 -153.06 -165.81 2.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 110.062 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.39 132.54 33.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 110.211 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.55 -52.9 1.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.902 . . . . 0.0 110.355 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 116.51 172.39 16.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 394' ' ' ASP . 17.4 p30 -130.06 157.75 41.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -1.174 . . . . 0.0 110.304 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.411 ' O ' ' HB1' ' A' ' 396' ' ' ALA . 3.3 m -70.7 104.03 2.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.322 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 397' ' ' ARG . . . 55.16 -99.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.438 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 396' ' ' ALA . 0.2 OUTLIER 171.63 70.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.028 -1.045 . . . . 0.0 110.169 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 5.4 t -76.52 162.28 27.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.187 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 399' ' ' ILE . 2.1 mp -74.32 135.65 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 110.092 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 399' ' ' ILE . 0.4 OUTLIER 61.46 122.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.257 -0.902 . . . . 0.0 110.279 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 113.7 42.5 0.87 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 18.0 p -69.62 -49.44 53.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.332 -1.099 . . . . 0.0 110.203 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -117.73 173.14 14.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.31 156.68 41.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -1.134 . . . . 0.0 110.201 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -138.27 114.62 1.08 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.82 -13.62 13.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.305 -1.115 . . . . 0.0 110.252 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.426 ' CB ' ' CB ' ' A' ' 410' ' ' GLN . . . -75.89 144.82 40.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.423 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.51 ' O ' ' CD1' ' A' ' 412' ' ' ILE . 2.9 mp -99.19 -10.85 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.465 ' HA ' HD11 ' A' ' 412' ' ' ILE . 27.4 m -122.36 -7.94 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.319 -0.863 . . . . 0.0 109.859 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 48.2 tt0 -74.47 -50.07 19.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.196 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -20.99 66.17 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.427 -0.796 . . . . 0.0 110.157 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 408' ' ' ILE . 1.1 mp -71.19 -63.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.269 -0.894 . . . . 0.0 108.726 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' A' ' 420' ' ' LEU . 15.5 t -64.14 -21.71 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.638 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 1.9 m-20 -79.23 -32.7 43.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.408 -0.808 . . . . 0.0 109.814 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -78.72 -28.33 45.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 109.33 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.599 ' CE1' HD12 ' A' ' 337' ' ' ILE . 30.2 m80 -81.62 -38.8 25.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.414 -0.804 . . . . 0.0 109.391 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 1.0 OUTLIER 82.24 45.24 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 CA-C-O 121.364 0.602 . . . . 0.0 110.943 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.527 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -112.28 -88.62 1.78 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.571 ' CE ' ' CD1' ' A' ' 435' ' ' TRP . 28.5 ttp -178.66 157.82 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -1.205 . . . . 0.0 112.254 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.461 ' HB2' HG13 ' A' ' 413' ' ' VAL . 57.0 tp -153.02 95.6 1.99 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 0.5 OUTLIER -115.86 155.89 27.1 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.759 -1.213 . . . . 0.0 112.786 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.49 ' CD1' HG12 ' A' ' 432' ' ' ILE . 2.7 tp -106.15 140.21 39.47 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -141.81 83.01 0.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 430' ' ' LEU . 20.5 m -84.52 121.51 27.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.254 -1.145 . . . . 0.0 110.85 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 426' ' ' GLU . 0.5 OUTLIER -75.38 100.3 4.39 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 425' ' ' SER . 19.9 tt0 37.64 62.22 0.91 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.123 0.487 . . . . 0.0 110.601 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.477 ' HB3' ' NH1' ' A' ' 427' ' ' ARG . 0.0 OUTLIER 41.32 49.81 3.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 110.221 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -139.61 -49.42 0.05 OUTLIER Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -123.49 88.77 0.4 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.286 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.553 HD12 ' C5 ' ' A' ' 451' ' ' ANP . 0.2 OUTLIER -70.5 121.46 17.84 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.12 -1.224 . . . . 0.0 110.151 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.54 ' O ' ' CG1' ' A' ' 432' ' ' ILE . 3.0 t -122.23 177.03 5.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.943 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.54 ' CG1' ' O ' ' A' ' 431' ' ' SER . 10.1 mt -156.92 114.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.254 -0.904 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -90.57 100.69 13.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.346 -0.846 . . . . 0.0 110.334 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.547 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -94.65 132.04 39.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.134 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.688 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.5 m95 -116.38 156.74 26.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.784 -1.198 . . . . 0.0 113.098 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.513 ' CD1' ' SD ' ' A' ' 332' ' ' MET . 67.8 mt -146.34 100.81 4.11 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.527 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 44.9 Cg_endo -71.53 143.82 43.49 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 123.961 1.506 . . . . 0.0 112.441 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 438' ' ' VAL . 5.9 p -117.5 122.78 30.51 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.58 -163.85 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.77 1.405 . . . . 0.0 110.657 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.08 103.54 15.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.388 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 442' ' ' ARG . 28.7 p -110.19 163.05 13.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.387 -0.821 . . . . 0.0 109.964 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 441' ' ' THR . 0.3 OUTLIER 67.36 136.86 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.143 -0.973 . . . . 0.0 110.173 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . 61.39 177.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.194 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -128.33 5.09 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.877 . . . . 0.0 110.261 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 176.69 -69.15 0.08 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 4.4 t -174.65 139.86 0.57 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -1.145 . . . . 0.0 110.196 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 29.4 p -90.0 45.92 1.31 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.168 -0.957 . . . . 0.0 110.265 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 107.78 11.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.331 -0.856 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -103.57 138.98 39.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.304 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.635 ' N9 ' ' CD1' ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.276 0.56 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.54 55.81 1.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . 0.412 ' O ' ' HG2' ' A' ' 293' ' ' GLU . 1.0 OUTLIER -173.33 77.23 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -1.14 . . . . 0.0 110.0 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 292' ' ' GLN . 2.3 mt-10 -157.29 46.22 0.39 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 110.255 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 10.0 ptm -146.62 132.82 9.58 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.943 . . . . 0.0 110.412 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.564 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 48.5 Cg_endo -85.69 52.38 3.09 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.916 1.482 . . . . 0.0 110.164 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.634 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -93.41 110.17 21.73 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.076 0.941 . . . . 0.0 108.9 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.4 mt-10 -133.27 -172.4 2.94 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.824 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.496 ' HA ' ' HA ' ' A' ' 331' ' ' LYS . 0.1 OUTLIER -87.48 140.35 29.62 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.759 0.79 . . . . 0.0 109.958 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -157.36 169.31 25.02 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.435 0.636 . . . . 0.0 110.037 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -96.14 119.51 34.75 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.561 -0.712 . . . . 0.0 109.171 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.533 ' HB2' ' CG1' ' A' ' 328' ' ' ILE . 8.1 mt -62.24 -25.6 67.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.997 -1.064 . . . . 0.0 109.299 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.439 ' HA ' ' CD2' ' A' ' 323' ' ' LEU . 55.1 t-20 -76.19 -23.24 54.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.977 -1.077 . . . . 0.0 108.503 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -82.92 -33.48 26.83 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.453 HG11 ' HD3' ' A' ' 338' ' ' LYS . 47.8 t -74.94 -38.34 43.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.616 0.722 . . . . 0.0 109.161 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.531 ' CD2' HG23 ' A' ' 341' ' ' VAL . 92.2 mt -75.13 -27.06 59.64 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.466 -0.772 . . . . 0.0 109.982 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.43 -35.9 92.52 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.52 -34.31 54.07 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.417 -1.049 . . . . 0.0 108.673 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.534 HG13 ' CG1' ' A' ' 341' ' ' VAL . 50.7 t -75.68 -18.6 15.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 121.554 0.692 . . . . 0.0 109.148 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.507 ' HA ' ' OE2' ' A' ' 312' ' ' GLU . 1.4 mt -78.77 -45.0 25.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.5 -18.27 65.19 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -91.19 -34.08 15.15 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.766 -0.584 . . . . 0.0 111.144 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.507 ' OE2' ' HA ' ' A' ' 309' ' ' ILE . 18.9 pt-20 -86.15 16.95 3.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.083 -1.011 . . . . 0.0 110.723 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 309' ' ' ILE . 3.5 m -122.57 67.66 0.95 Allowed 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -56.67 -42.63 91.16 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 0.3 OUTLIER -136.79 24.01 3.1 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.307 -1.114 . . . . 0.0 111.004 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 2.5 mt-10 60.96 57.46 2.56 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.915 -1.116 . . . . 0.0 108.441 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.417 ' HB2' HD13 ' A' ' 356' ' ' ILE . 19.4 mmm180 -66.51 -76.08 0.08 Allowed 'General case' 0 C--N 1.278 -2.526 0 CA-C-O 121.616 0.722 . . . . 0.0 109.722 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.469 ' HG3' ' HA ' ' A' ' 355' ' ' TRP . 7.1 pt-20 -170.52 56.67 0.03 OUTLIER 'General case' 0 C--N 1.265 -3.086 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.539 ' CG2' HG22 ' A' ' 358' ' ' VAL . 1.8 mp -91.28 129.76 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.444 -0.903 . . . . 0.0 109.974 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -104.3 111.05 23.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.232 -0.918 . . . . 0.0 109.673 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 17.7 p -89.01 126.9 35.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.3 -0.875 . . . . 0.0 110.702 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . 0.457 ' HB2' ' OG ' ' A' ' 359' ' ' SER . . . -149.36 79.54 1.4 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.576 -0.702 . . . . 0.0 109.341 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 323' ' ' LEU . 4.7 mp -95.33 150.22 20.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.488 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.542 ' HB2' ' HA2' ' A' ' 361' ' ' GLY . 89.6 t80 -37.33 129.88 0.82 Allowed Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.576 -0.703 . . . . 0.0 110.678 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.39 82.66 1.35 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.924 1.486 . . . . 0.0 109.515 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . 162.56 -11.13 0.1 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.682 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.2 OUTLIER 79.85 120.55 0.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.329 -1.101 . . . . 0.0 109.951 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.533 ' CG1' ' HB2' ' A' ' 301' ' ' LEU . 1.6 mm -72.29 -176.02 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 CA-C-O 121.704 0.764 . . . . 0.0 109.93 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 3.2 mt-10 -170.19 105.19 0.3 Allowed 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.561 0.696 . . . . 0.0 109.953 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 298' ' ' MET . 2.7 m -150.52 169.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-O 121.541 0.686 . . . . 0.0 110.653 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -96.63 94.02 7.09 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.58 ' HG3' ' CE1' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -148.44 133.65 18.37 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.764 0.792 . . . . 0.0 110.027 -179.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.564 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 19.1 t-160 -55.48 113.17 5.12 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.722 -0.611 . . . . 0.0 109.913 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.5 -19.56 54.75 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.816 1.429 . . . . 0.0 110.096 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.559 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -74.59 -68.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 0.0 109.835 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.496 ' CB ' HD11 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -47.56 -40.9 20.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.557 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.535 HG13 ' CG ' ' A' ' 332' ' ' MET . 11.9 mm -64.15 -46.83 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 109.316 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.527 ' HG3' ' CG2' ' A' ' 308' ' ' VAL . 0.0 OUTLIER -43.72 -47.67 7.88 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.355 -0.841 . . . . 0.0 109.555 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -70.67 -35.45 72.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.569 -0.707 . . . . 0.0 110.641 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -58.66 -32.34 69.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.414 -0.804 . . . . 0.0 111.089 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.534 ' CG1' HG13 ' A' ' 308' ' ' VAL . 32.3 t -90.24 -28.24 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.97 -1.081 . . . . 0.0 111.009 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.73 -19.68 57.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.976 -1.078 . . . . 0.0 110.753 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.3 -19.74 23.72 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.116 -0.99 . . . . 0.0 110.992 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.467 ' SD ' ' HB ' ' A' ' 432' ' ' ILE . 6.3 mtt -82.23 -23.76 35.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.09 -1.006 . . . . 0.0 111.357 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.456 HG13 ' OE1' ' A' ' 312' ' ' GLU . 28.0 m -90.7 -23.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.044 -1.035 . . . . 0.0 111.395 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 347' ' ' ASN . 0.4 OUTLIER -62.88 -29.96 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.914 -1.116 . . . . 0.0 110.533 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 351' ' ' TYR . 66.3 t30 -65.77 -34.16 77.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.179 -0.951 . . . . 0.0 110.438 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 373' ' ' ASP . . . -89.72 -22.97 21.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 110.507 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.31 -51.44 60.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.108 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 351' ' ' TYR . 4.1 mmt180 -90.5 -65.28 1.03 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.299 -0.876 . . . . 0.0 110.872 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . 0.498 ' CB ' ' O ' ' A' ' 347' ' ' ASN . 0.9 OUTLIER -38.54 -72.0 0.07 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.381 -0.824 . . . . 0.0 110.74 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -129.5 100.6 0.5 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 353' ' ' ASN . 6.3 p30 -86.38 86.42 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -1.151 . . . . 0.0 109.789 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . 0.451 ' O ' ' OE1' ' A' ' 318' ' ' GLU . . . -123.16 -35.35 0.72 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.581 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 14.3 t90 179.81 124.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.031 -1.276 . . . . 0.0 110.863 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 319' ' ' ILE . 1.5 mt -105.98 143.71 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.581 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 13.4 tttt -134.43 106.44 7.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.827 -1.171 . . . . 0.0 111.359 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.539 HG22 ' CG2' ' A' ' 319' ' ' ILE . 88.8 t -98.52 83.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 370' ' ' GLN . 30.2 t -116.39 141.36 48.27 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.357 -0.839 . . . . 0.0 111.272 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.523 ' OG ' ' CD1' ' A' ' 305' ' ' LEU . 3.9 m -134.23 168.29 19.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 109.124 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -161.77 -159.47 10.18 Favored Glycine 0 C--N 1.292 -1.868 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -177.18 164.39 2.2 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.369 -1.077 . . . . 0.0 110.032 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 3.9 mt-10 -141.72 -179.83 1.06 Allowed Pre-proline 0 C--N 1.29 -2.0 0 O-C-N 121.636 -0.665 . . . . 0.0 109.522 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 44.3 Cg_endo -71.63 116.8 4.85 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.682 1.359 . . . . 0.0 111.191 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 2.2 m120 80.01 25.41 0.37 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.874 -0.517 . . . . 0.0 111.509 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.586 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 167.34 111.67 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.319 -0.863 . . . . 0.0 111.473 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -104.41 174.65 5.78 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.194 -0.941 . . . . 0.0 108.876 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.629 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 47.8 p-90 -170.84 174.76 4.73 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.402 -1.436 . . . . 0.0 111.475 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 434' ' ' ALA . 34.2 p90 -144.21 134.72 24.71 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 14.3 tt0 -127.54 149.76 50.0 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.938 -1.101 . . . . 0.0 112.432 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.507 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 98.4 t -125.23 135.04 65.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -130.03 147.16 51.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 109.946 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.569 ' OD2' ' N6 ' ' A' ' 451' ' ' ANP . 40.6 p30 -143.51 157.99 44.0 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 375' ' ' GLY . 0.8 OUTLIER -91.67 159.54 15.81 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 110.077 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 374' ' ' ASP . . . 135.3 -159.4 24.05 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.508 ' O ' ' C2 ' ' A' ' 451' ' ' ANP . 46.5 Cg_endo -73.65 157.48 48.37 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.894 1.471 . . . . 0.0 110.397 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . 0.415 ' HA2' ' HA2' ' A' ' 429' ' ' GLY . . . -87.59 -144.76 9.38 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 378' ' ' ILE . 0.7 OUTLIER -106.2 98.03 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.144 -1.21 . . . . 0.0 109.486 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -52.33 171.75 0.2 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.524 -0.735 . . . . 0.0 110.99 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.55 -47.38 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 124.134 1.597 . . . . 0.0 109.458 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -25.07 68.2 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.408 -0.807 . . . . 0.0 109.094 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.58 -20.62 27.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.506 -0.746 . . . . 0.0 109.556 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 386' ' ' LEU . 0.2 OUTLIER -60.85 -32.88 72.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.467 -0.771 . . . . 0.0 109.709 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -24.29 51.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 109.599 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.512 ' ND1' ' N ' ' A' ' 385' ' ' HIS . 1.8 m-70 -100.3 49.31 0.91 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.399 -0.813 . . . . 0.0 109.656 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 1.5 tp -126.18 85.44 2.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.307 -0.871 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 388' ' ' GLN . 15.6 m-85 67.95 14.98 9.49 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.407 0.622 . . . . 0.0 110.398 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.507 ' O ' ' O ' ' A' ' 387' ' ' PHE . 6.2 mt-30 51.44 116.47 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.899 -0.501 . . . . 0.0 111.72 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 390' ' ' PHE . 48.4 Cg_endo -74.39 166.66 28.96 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.629 1.331 . . . . 0.0 109.975 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER -43.08 137.06 2.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 110.436 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 392' ' ' ARG . 4.8 p -128.87 -166.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.596 -0.69 . . . . 0.0 109.786 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 391' ' ' VAL . 0.9 OUTLIER -40.51 149.04 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.047 -1.033 . . . . 0.0 110.417 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 160.33 59.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -150.66 116.43 5.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.228 -1.16 . . . . 0.0 110.365 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 26.2 t -152.51 -81.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 110.082 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 397' ' ' ARG . . . -159.57 19.41 0.17 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.309 -0.87 . . . . 0.0 110.287 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 396' ' ' ALA . 0.0 OUTLIER -141.35 179.81 6.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.272 -0.893 . . . . 0.0 110.259 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' THR . . . . . 0.568 ' O ' ' C ' ' A' ' 399' ' ' ILE . 0.2 OUTLIER -91.79 -29.07 16.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.11 -0.994 . . . . 0.0 110.599 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.568 ' C ' ' O ' ' A' ' 398' ' ' THR . 11.2 tp -2.99 105.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 CA-C-O 121.533 0.682 . . . . 0.0 112.4 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 42.4 m -137.01 158.62 44.04 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.14 -0.975 . . . . 0.0 110.336 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 402' ' ' THR . . . 83.68 -162.18 39.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.502 ' CB ' ' O ' ' A' ' 401' ' ' GLY . 0.2 OUTLIER 69.76 105.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.335 -1.097 . . . . 0.0 110.169 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -145.24 136.03 6.32 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 84.9 mt -116.53 42.85 2.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.202 -1.175 . . . . 0.0 110.343 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -61.13 -19.57 57.15 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 46.79 78.31 0.07 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.25 -1.147 . . . . 0.0 110.21 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.537 ' CB ' ' HG3' ' A' ' 410' ' ' GLN . . . -108.9 -141.91 0.38 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.28 -0.887 . . . . 0.0 110.354 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.64 -88.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.057 -1.027 . . . . 0.0 110.567 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' ' 410' ' ' GLN . 10.9 m -53.58 -22.13 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.14 -0.975 . . . . 0.0 110.461 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.537 ' HG3' ' CB ' ' A' ' 407' ' ' ALA . 0.1 OUTLIER -64.52 -47.43 78.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.215 -0.928 . . . . 0.0 109.88 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.46 ' HA ' ' HB2' ' A' ' 414' ' ' ASP . 0.0 OUTLIER -66.75 -27.76 67.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -0.873 . . . . 0.0 109.683 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.496 HD11 ' CB ' ' A' ' 336' ' ' SER . 31.0 mm -63.67 -60.37 2.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.441 HG23 ' CD1' ' A' ' 420' ' ' LEU . 45.7 t -65.8 -23.08 31.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.182 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 0.5 OUTLIER -75.19 -25.87 58.58 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.44 ' OD1' ' HE1' ' A' ' 296' ' ' MET . 0.9 OUTLIER -80.47 -19.55 45.74 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.635 ' O ' ' CB ' ' A' ' 417' ' ' ASN . 32.8 m80 -96.28 -76.18 0.51 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.807 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.635 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 4.3 m-20 127.29 26.81 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.596 0 C-N-CA 123.948 0.899 . . . . 0.0 109.297 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 435' ' ' TRP . . . -86.4 -103.41 0.77 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.573 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 18.4 ttm -165.74 161.85 18.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -1.143 . . . . 0.0 110.638 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.441 ' CD1' HG23 ' A' ' 413' ' ' VAL . 4.8 tp -151.86 96.32 2.21 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.983 -1.073 . . . . 0.0 109.223 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.12 155.73 43.96 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.978 -1.076 . . . . 0.0 111.603 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.6 146.28 23.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.556 -0.715 . . . . 0.0 110.354 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -133.5 99.88 0.38 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.577 ' HA ' ' CB ' ' A' ' 430' ' ' LEU . 17.6 m -74.56 122.58 23.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.186 -1.185 . . . . 0.0 110.735 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' SER . . . . . 0.51 ' HB3' ' CG ' ' A' ' 427' ' ' ARG . 26.6 t -90.75 147.42 23.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.309 -0.87 . . . . 0.0 109.46 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -45.81 -20.76 0.09 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.801 -0.562 . . . . 0.0 111.308 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.514 ' CB ' ' CZ ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -59.25 -5.11 0.66 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.191 -0.943 . . . . 0.0 111.599 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 90.09 21.89 37.29 Favored Glycine 0 N--CA 1.476 1.352 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -144.66 -137.9 3.24 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.631 ' CD1' ' N ' ' A' ' 430' ' ' LEU . 0.0 OUTLIER -175.33 -173.25 0.64 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.169 -1.195 . . . . 0.0 111.786 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.505 ' N ' ' CD2' ' A' ' 430' ' ' LEU . 24.9 p -154.28 150.16 27.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.467 ' HB ' ' SD ' ' A' ' 344' ' ' MET . 24.2 mm -90.52 121.01 40.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 120.717 -1.24 . . . . 0.0 111.149 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -98.3 96.15 7.86 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.551 -0.718 . . . . 0.0 109.323 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 369' ' ' PHE . . . -97.0 143.71 27.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.613 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.629 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 88.0 m95 -120.08 157.72 28.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.264 -0.897 . . . . 0.0 112.136 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . . . . . . . . . 38.1 mt -145.44 125.26 7.01 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.9 139.69 43.96 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 123.59 1.31 . . . . 0.0 111.358 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.532 ' CG2' ' HD2' ' A' ' 439' ' ' PRO . 7.2 p -99.16 146.79 32.31 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.535 -0.728 . . . . 0.0 110.404 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 438' ' ' VAL . 50.3 Cg_endo -72.35 143.63 39.52 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.979 1.515 . . . . 0.0 109.773 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.522 ' O ' ' CG1' ' A' ' 440' ' ' VAL . 72.1 t -153.3 44.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.956 -1.09 . . . . 0.0 110.645 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 440' ' ' VAL . 14.0 p -145.82 -40.63 0.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 110.092 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.468 ' O ' ' CB ' ' A' ' 443' ' ' ALA . 0.9 OUTLIER -136.9 -179.95 6.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 442' ' ' ARG . . . 67.79 104.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 443' ' ' ALA . 0.0 OUTLIER 53.7 105.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.763 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -87.85 136.64 13.97 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 23.1 p -92.41 128.95 38.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -1.231 . . . . 0.0 110.565 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 81.5 p -86.64 82.57 7.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.867 . . . . 0.0 110.149 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -126.36 72.75 1.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.046 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.43 -56.05 3.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.883 . . . . 0.0 110.36 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 CA-C-O 117.948 -1.473 . . . . 0.0 109.589 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.58 ' C5 ' HD13 ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.354 0.597 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -134.49 -116.61 1.67 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -143.75 13.6 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -1.182 . . . . 0.0 110.082 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.46 ' O ' ' SD ' ' A' ' 294' ' ' MET . 5.2 pt-20 -124.82 13.3 8.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.203 -0.936 . . . . 0.0 109.991 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 293' ' ' GLU . 11.4 mmt -142.7 61.88 11.74 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.51 79.0 0.89 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.292 1.68 . . . . 0.0 112.12 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.486 ' HE3' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -71.9 105.84 3.99 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 5.1 mt-10 -115.95 -169.97 1.7 Allowed 'General case' 0 C--N 1.28 -2.428 0 O-C-N 121.683 -0.636 . . . . 0.0 110.228 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.523 ' HE3' ' N ' ' A' ' 330' ' ' VAL . 0.2 OUTLIER -88.28 128.86 35.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 111.193 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.457 ' HB1' ' SD ' ' A' ' 332' ' ' MET . . . -156.48 159.22 38.43 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.66 -0.65 . . . . 0.0 111.057 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.524 ' HB3' ' CB ' ' A' ' 303' ' ' ALA . 5.9 t0 -84.08 121.37 27.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.514 -0.741 . . . . 0.0 110.13 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.564 HD22 ' CE ' ' A' ' 332' ' ' MET . 8.0 mt -68.54 -25.2 64.8 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.138 -0.976 . . . . 0.0 109.76 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 303' ' ' ALA . 22.7 p30 -79.3 -21.21 46.3 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.089 -1.007 . . . . 0.0 108.871 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -85.44 -29.65 24.17 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.761 0.791 . . . . 0.0 108.968 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.527 HG11 ' CD ' ' A' ' 338' ' ' LYS . 42.2 t -74.92 -38.46 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.55 0.69 . . . . 0.0 109.278 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 86.2 mt -73.61 -40.75 63.58 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.306 -0.871 . . . . 0.0 110.142 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -58.71 -29.42 64.27 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 311' ' ' ALA . 6.0 mt-10 -79.03 -31.16 44.51 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.394 -1.062 . . . . 0.0 108.997 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 304' ' ' VAL . 52.3 t -75.48 -21.83 16.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.667 0.746 . . . . 0.0 109.154 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.511 ' CD1' HG21 ' A' ' 321' ' ' THR . 0.7 OUTLIER -76.19 -49.68 24.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.429 ' N ' HG21 ' A' ' 309' ' ' ILE . . . -80.2 -16.72 54.17 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.815 0.816 . . . . 0.0 109.194 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 307' ' ' GLU . . . -65.14 -63.04 1.2 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.696 -0.627 . . . . 0.0 110.709 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.28 37.91 0.7 Allowed 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.715 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.543 ' O ' HD13 ' A' ' 319' ' ' ILE . 1.2 t -87.55 43.1 1.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.892 -1.13 . . . . 0.0 109.098 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 315' ' ' TYR . . . 73.66 25.22 72.77 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.511 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 51.4 t80 63.71 44.19 5.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.657 -0.908 . . . . 0.0 110.258 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 4.2 tt0 68.24 46.57 1.09 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.235 -0.916 . . . . 0.0 109.781 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.496 ' CG ' ' N ' ' A' ' 318' ' ' GLU . 0.3 OUTLIER -68.59 -88.04 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.304 0 O-C-N 121.608 -0.683 . . . . 0.0 109.844 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.496 ' N ' ' CG ' ' A' ' 317' ' ' ARG . 16.9 mt-10 -140.93 66.12 1.38 Allowed 'General case' 0 C--N 1.277 -2.574 0 O-C-N 121.399 -0.813 . . . . 0.0 111.287 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.596 ' CG2' ' CG2' ' A' ' 358' ' ' VAL . 2.7 mp -104.43 134.09 46.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 O-C-N 121.598 -0.689 . . . . 0.0 110.129 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -91.36 107.23 19.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.763 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.511 HG21 ' CD1' ' A' ' 309' ' ' ILE . 12.5 p -89.84 124.66 34.87 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 111.519 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . 0.421 ' HB1' ' OG ' ' A' ' 359' ' ' SER . . . -149.81 78.63 1.36 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.527 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 2.7 mp -94.62 169.52 10.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.453 -0.779 . . . . 0.0 110.879 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.462 ' HB2' ' HA2' ' A' ' 361' ' ' GLY . 93.8 t80 -62.11 112.39 6.24 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.764 . . . . 0.0 109.756 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.86 79.29 1.98 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.878 1.462 . . . . 0.0 110.487 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 179.73 29.65 0.05 OUTLIER Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.773 -1.203 . . . . 0.0 110.11 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 326' ' ' GLY . 1.0 OUTLIER 47.81 98.2 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.11 -1.23 . . . . 0.0 110.509 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.555 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 1.1 mt -82.11 -176.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.495 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.555 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 0.6 OUTLIER -178.14 105.43 0.05 OUTLIER 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.416 0.627 . . . . 0.0 110.376 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' A' ' 332' ' ' MET . 5.3 m -136.05 171.57 16.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-O 121.749 0.785 . . . . 0.0 110.5 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.2 OUTLIER -91.22 89.62 7.41 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.564 ' CE ' HD22 ' A' ' 301' ' ' LEU . 4.0 ppp? -140.26 148.34 41.31 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.439 -0.788 . . . . 0.0 109.894 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 21.0 t-160 -75.97 110.82 12.03 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.487 ' O ' ' HD3' ' A' ' 338' ' ' LYS . 36.7 Cg_endo -58.74 -19.33 45.68 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.476 1.251 . . . . 0.0 109.152 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.57 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -82.57 -63.9 1.28 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.529 0.681 . . . . 0.0 109.805 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.483 ' OG ' HG13 ' A' ' 412' ' ' ILE . 26.8 t -49.39 -50.54 39.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.538 -0.726 . . . . 0.0 110.132 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.543 HG13 ' CE ' ' A' ' 332' ' ' MET . 21.7 mm -59.91 -45.68 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.527 ' CD ' HG11 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -46.81 -49.03 20.6 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.7 -1.25 . . . . 0.0 109.377 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -60.97 -38.88 87.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.491 -0.756 . . . . 0.0 110.302 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.448 ' HB1' HG22 ' A' ' 412' ' ' ILE . . . -58.94 -53.25 60.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 0.0 110.83 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.499 HG22 ' CD2' ' A' ' 305' ' ' LEU . 55.2 t -70.31 -21.08 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 110.057 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 346' ' ' VAL . . . -81.65 -19.73 41.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.397 -0.815 . . . . 0.0 110.779 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -84.64 -44.67 13.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.088 -1.008 . . . . 0.0 110.777 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.423 ' HE3' HG23 ' A' ' 409' ' ' VAL . 6.1 mtm -69.15 -20.14 64.02 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.16 -0.962 . . . . 0.0 110.546 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.457 HG11 ' N ' ' A' ' 346' ' ' VAL . 8.7 p -87.86 -27.48 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.104 -0.997 . . . . 0.0 110.506 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.457 ' N ' HG11 ' A' ' 345' ' ' VAL . 53.5 t -76.85 -28.02 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 110.373 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 17.4 m120 -75.13 -32.04 61.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.105 -0.997 . . . . 0.0 110.281 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 352' ' ' GLY . . . -90.58 -18.63 24.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.123 -0.986 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -77.05 -81.21 0.09 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.033 -1.042 . . . . 0.0 111.856 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -48.41 64.95 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.381 -0.824 . . . . 0.0 112.34 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . 0.497 ' CB ' ' HG3' ' A' ' 376' ' ' PRO . 36.6 m-85 -74.79 -58.93 2.98 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.855 -1.153 . . . . 0.0 111.561 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 348' ' ' ALA . . . -108.12 59.55 0.36 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.189 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.23 93.1 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.235 . . . . 0.0 109.886 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -147.7 -67.06 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -150.13 139.19 21.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.119 -1.224 . . . . 0.0 110.657 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.403 HG21 ' N ' ' A' ' 357' ' ' LYS . 20.3 mt -123.66 162.08 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.459 -0.776 . . . . 0.0 109.832 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 372' ' ' GLU . 1.1 ttpt -136.83 111.36 8.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.069 -1.019 . . . . 0.0 110.331 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.596 ' CG2' ' CG2' ' A' ' 319' ' ' ILE . 65.1 t -110.17 88.41 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 110.034 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.421 ' OG ' ' HB1' ' A' ' 322' ' ' ALA . 1.0 OUTLIER -112.55 148.95 33.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 110.436 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.527 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -144.65 142.14 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.403 -0.81 . . . . 0.0 110.016 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -135.08 -165.9 10.92 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.7 OUTLIER -174.52 179.17 1.81 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.775 -1.426 . . . . 0.0 111.547 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 8.2 mt-10 -156.32 173.18 5.18 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 365' ' ' ASN . 39.6 Cg_endo -66.38 119.01 5.99 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.422 1.222 . . . . 0.0 110.469 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.53 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 2.3 m-80 62.88 37.3 12.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.934 -0.479 . . . . 0.0 110.969 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 10.7 ptm180 169.31 106.32 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.455 -0.778 . . . . 0.0 110.399 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -116.49 168.11 10.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.176 -0.952 . . . . 0.0 109.835 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.64 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 25.8 p-90 -154.74 169.05 24.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.86 -1.15 . . . . 0.0 110.811 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 360' ' ' SER . 32.9 p90 -144.4 136.29 26.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.456 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.508 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 9.7 tt0 -121.07 153.84 36.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.101 -0.999 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.508 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 40.6 t -137.06 143.92 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 110.181 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 2.0 mt-10 -137.29 134.45 36.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.355 -0.841 . . . . 0.0 109.779 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.462 ' OD1' ' HB1' ' A' ' 348' ' ' ALA . 3.6 p30 -151.1 163.18 39.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.894 -1.129 . . . . 0.0 110.864 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -110.04 134.13 52.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 159.54 -136.05 4.43 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.497 ' HG3' ' CB ' ' A' ' 351' ' ' TYR . 47.0 Cg_endo -72.65 106.16 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.991 1.521 . . . . 0.0 110.349 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 427' ' ' ARG . . . -78.35 -157.78 10.7 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.686 HG21 " O2'" ' A' ' 451' ' ' ANP . 9.7 mt -119.04 172.67 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.496 -1.003 . . . . 0.0 110.12 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.469 ' HB2' ' HG3' ' A' ' 382' ' ' GLN . . . -120.91 175.0 2.6 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.867 -1.146 . . . . 0.0 110.675 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.466 ' O ' ' HG3' ' A' ' 383' ' ' ARG . 51.3 Cg_endo -79.94 -33.07 1.25 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 124.059 1.557 . . . . 0.0 111.349 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -89.65 -19.76 24.49 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.907 -1.121 . . . . 0.0 111.312 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.525 ' HA ' ' HB2' ' A' ' 388' ' ' GLN . 41.6 mt-30 -85.91 -26.67 25.44 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.95 -1.094 . . . . 0.0 108.846 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 385' ' ' HIS . 0.2 OUTLIER -66.97 -25.38 66.29 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.082 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 383' ' ' ARG . 32.5 mmtm -46.94 -35.69 6.81 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 383' ' ' ARG . 1.4 m-70 -100.74 -139.26 0.33 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.695 ' O ' ' CG ' ' A' ' 387' ' ' PHE . 0.0 OUTLIER -66.2 -68.23 0.39 Allowed 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.695 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 37.0 m-85 -170.7 23.38 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 112.13 -2.305 . . . . 0.0 108.814 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.525 ' HB2' ' HA ' ' A' ' 382' ' ' GLN . 0.6 OUTLIER 9.73 111.29 0.0 OUTLIER Pre-proline 0 N--CA 1.518 2.947 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.551 ' HA ' HO3' ' A' ' 451' ' ' ANP . 47.3 Cg_endo -76.99 -163.38 0.2 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.514 1.271 . . . . 0.0 110.42 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . 0.476 ' C ' ' CG2' ' A' ' 391' ' ' VAL . 5.6 t80 -94.66 108.52 20.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.084 -1.01 . . . . 0.0 110.683 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.476 ' CG2' ' C ' ' A' ' 390' ' ' PHE . 31.6 t -153.9 133.3 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 110.223 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 393' ' ' GLY . 0.2 OUTLIER -112.98 155.2 25.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.955 . . . . 0.0 110.007 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 392' ' ' ARG . . . 50.93 97.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.2 80.39 1.61 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.193 -1.181 . . . . 0.0 110.298 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.2 m -105.82 -46.02 4.23 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -0.929 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 397' ' ' ARG . . . -69.16 -90.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.078 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 397' ' ' ARG . 0.5 OUTLIER 178.15 122.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.199 -0.938 . . . . 0.0 110.016 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.7 m -136.19 10.2 3.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.126 -0.984 . . . . 0.0 110.677 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.535 ' O ' ' CD1' ' A' ' 399' ' ' ILE . 0.0 OUTLIER -107.08 -0.31 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.141 -0.974 . . . . 0.0 110.087 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 399' ' ' ILE . 0.7 OUTLIER 71.19 94.06 0.08 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.254 -0.904 . . . . 0.0 110.347 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 402' ' ' THR . . . -102.2 137.47 13.37 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.462 ' CG2' ' O ' ' A' ' 402' ' ' THR . 97.9 m 55.7 41.36 30.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.345 -1.091 . . . . 0.0 110.572 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -76.35 -72.99 1.04 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 12.5 mt -138.71 -35.33 0.58 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.25 -1.147 . . . . 0.0 110.289 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 406' ' ' LEU . . . -145.91 138.61 7.65 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.445 ' CD1' HG23 ' A' ' 408' ' ' ILE . 3.3 pp -42.09 133.73 2.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -1.126 . . . . 0.0 110.227 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -99.44 74.96 1.94 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.075 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.533 ' O ' ' CD1' ' A' ' 412' ' ' ILE . 9.7 tp -155.67 155.9 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 0.0 110.774 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 410' ' ' GLN . 13.2 p -120.05 -42.08 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.479 -0.763 . . . . 0.0 109.926 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.52 ' N ' HG12 ' A' ' 409' ' ' VAL . 2.6 pt20 -51.72 -29.34 18.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.433 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.423 ' CD ' HG12 ' A' ' 408' ' ' ILE . 0.4 OUTLIER -76.51 -35.88 58.08 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 408' ' ' ILE . 0.6 OUTLIER -56.84 -44.7 82.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 419' ' ' MET . 92.9 t -73.93 -22.66 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 35.2 t70 -80.02 -19.58 47.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.699 -0.626 . . . . 0.0 109.603 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -85.77 -26.83 25.58 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.382 -0.824 . . . . 0.0 109.142 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.584 ' CG ' ' CD2' ' A' ' 436' ' ' LEU . 30.6 m80 -89.78 -31.57 17.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.766 . . . . 0.0 109.083 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.4 OUTLIER 77.27 42.96 0.12 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.395 0.617 . . . . 0.0 110.6 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.589 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -106.8 -85.14 1.76 Allowed Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.547 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.0 OUTLIER -179.2 164.23 1.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.113 . . . . 0.0 111.331 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 420' ' ' LEU . 19.1 tp -151.3 92.59 1.8 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.163 -0.961 . . . . 0.0 109.258 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.502 ' HB2' ' HG3' ' A' ' 433' ' ' ARG . 0.3 OUTLIER -92.28 139.93 30.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.975 -1.078 . . . . 0.0 110.443 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.584 ' HG ' ' CZ ' ' A' ' 387' ' ' PHE . 0.3 OUTLIER -114.98 145.7 41.98 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.43 -0.794 . . . . 0.0 111.275 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.458 ' O ' HD13 ' A' ' 430' ' ' LEU . . . -145.53 145.52 14.78 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 7.8 m -158.6 131.23 7.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.838 -1.39 . . . . 0.0 111.041 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.72 96.97 7.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 426' ' ' GLU . 41.8 tt0 52.7 49.67 19.81 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.606 -0.684 . . . . 0.0 109.959 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' A' ' 378' ' ' ILE . 0.9 OUTLIER 50.85 44.63 28.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 110.234 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -143.46 -59.08 0.02 OUTLIER Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -87.83 82.44 1.57 Allowed Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.624 HD22 ' C5 ' ' A' ' 451' ' ' ANP . 18.4 tp -90.59 108.78 20.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -1.132 . . . . 0.0 110.852 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 66.5 m -118.07 132.98 56.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.608 -0.682 . . . . 0.0 109.368 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.562 ' CD1' ' N1 ' ' A' ' 451' ' ' ANP . 4.4 mt -136.7 142.26 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.935 -1.103 . . . . 0.0 111.031 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' A' ' 421' ' ' GLU . 0.0 OUTLIER -122.2 117.02 25.2 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.445 -0.785 . . . . 0.0 109.598 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -102.6 140.0 37.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.165 -0.959 . . . . 0.0 111.049 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.64 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 79.8 m95 -114.6 154.44 28.34 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.288 -0.883 . . . . 0.0 111.271 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.584 ' CD2' ' CG ' ' A' ' 416' ' ' HIS . 12.7 mt -145.87 111.08 4.46 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.589 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 49.5 Cg_endo -85.9 130.57 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.691 1.364 . . . . 0.0 110.823 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.492 HG23 ' HA ' ' A' ' 330' ' ' VAL . 60.6 t -82.79 110.08 20.5 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.408 -0.808 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.537 ' O ' ' CG2' ' A' ' 440' ' ' VAL . 57.3 Cg_endo -78.44 169.29 20.2 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.938 1.494 . . . . 0.0 109.987 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 439' ' ' PRO . 48.7 t -157.05 94.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.137 -0.977 . . . . 0.0 110.802 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 442' ' ' ARG . 3.1 t 34.48 76.37 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.623 -0.673 . . . . 0.0 110.75 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 443' ' ' ALA . 0.0 OUTLIER 46.84 -175.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 442' ' ' ARG . . . 166.63 47.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . 0.493 ' HG3' ' N ' ' A' ' 445' ' ' GLY . 47.2 tp60 -159.08 154.11 25.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 110.358 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . 0.493 ' N ' ' HG3' ' A' ' 444' ' ' GLN . . . 146.19 46.93 0.03 OUTLIER Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 59.7 p -107.02 -142.68 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -1.161 . . . . 0.0 110.207 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 448' ' ' LYS . 72.2 p -101.77 -136.69 0.33 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.836 . . . . 0.0 110.233 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 447' ' ' THR . 13.2 mttm 56.9 169.82 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.194 -0.941 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 448' ' ' LYS . 7.4 mm-40 -42.95 144.15 0.64 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.516 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.686 " O2'" HG21 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.299 0.571 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -69.46 -101.29 0.04 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -80.47 -168.93 1.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.197 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.5 78.16 9.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.267 -0.896 . . . . 0.0 109.939 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.444 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 0.0 OUTLIER -75.06 128.63 84.58 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.352 -0.842 . . . . 0.0 110.855 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.656 ' CB ' ' CD2' ' A' ' 333' ' ' HIS . 51.4 Cg_endo -94.18 -157.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.687 1.592 . . . . 0.0 109.362 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.531 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 43.36 87.68 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 122.323 1.058 . . . . 0.0 109.99 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 1.1 mt-10 -143.06 -156.6 0.7 Allowed 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.278 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.508 ' HE3' ' CA ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -88.25 131.61 34.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.937 -1.102 . . . . 0.0 110.589 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -150.04 160.07 43.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.443 -0.786 . . . . 0.0 110.709 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.456 ' HB2' ' HB1' ' A' ' 303' ' ' ALA . 0.9 OUTLIER -102.57 120.38 40.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 110.083 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.502 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 15.3 mt -63.37 -21.27 66.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 109.751 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.443 ' HA ' HD22 ' A' ' 323' ' ' LEU . 26.0 t-20 -83.41 -21.58 32.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.064 -1.022 . . . . 0.0 108.754 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 300' ' ' ASP . . . -88.15 -26.79 22.26 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.728 0.775 . . . . 0.0 109.144 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 18.3 t -83.8 -38.38 14.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 91.0 mt -78.41 -28.42 46.86 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.408 -0.807 . . . . 0.0 110.113 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.65 -32.66 82.09 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.451 ' O ' ' HB1' ' A' ' 311' ' ' ALA . 3.1 mm-40 -79.6 -35.26 39.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -1.141 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.523 HG12 ' CG1' ' A' ' 341' ' ' VAL . 65.4 t -77.81 -19.29 13.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.642 0.734 . . . . 0.0 109.673 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.535 ' O ' ' CB ' ' A' ' 313' ' ' SER . 0.3 OUTLIER -79.81 -43.12 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.492 -0.755 . . . . 0.0 109.25 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.2 -17.18 53.08 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.638 0.732 . . . . 0.0 109.969 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 307' ' ' GLU . . . -90.33 -53.96 4.22 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.586 -0.696 . . . . 0.0 112.034 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -112.26 45.2 1.31 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.252 -0.905 . . . . 0.0 111.227 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 309' ' ' ILE . 0.3 OUTLIER -80.65 28.56 0.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.238 -0.914 . . . . 0.0 110.79 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 53.41 42.84 65.56 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 22.2 m-85 61.69 33.07 18.23 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.681 -0.894 . . . . 0.0 110.051 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 2.8 tt0 65.31 43.94 3.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 109.378 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.58 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.8 OUTLIER -68.76 -83.18 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.606 0.717 . . . . 0.0 110.436 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.58 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.7 pt-20 -159.23 64.1 0.39 Allowed 'General case' 0 C--N 1.273 -2.754 0 O-C-N 121.672 -0.642 . . . . 0.0 110.69 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.533 HG13 ' CD1' ' A' ' 356' ' ' ILE . 2.2 mp -96.51 126.75 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 109.511 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.46 103.66 16.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.705 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.51 ' CG2' HD12 ' A' ' 309' ' ' ILE . 19.0 p -89.68 125.68 35.35 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.502 -0.749 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.36 78.97 1.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.478 -0.764 . . . . 0.0 109.249 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.506 HD11 ' N ' ' A' ' 323' ' ' LEU . 5.3 mp -89.48 149.23 23.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.384 -0.823 . . . . 0.0 110.528 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.575 ' CD1' ' HD2' ' A' ' 325' ' ' PRO . 60.4 t80 -38.37 147.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.737 -0.602 . . . . 0.0 110.321 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.575 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.8 Cg_endo -81.83 64.12 8.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.948 1.499 . . . . 0.0 110.44 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . 172.87 8.38 0.02 OUTLIER Glycine 0 N--CA 1.498 2.767 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.697 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 1.2 p 66.07 119.92 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.473 -1.604 . . . . 0.0 109.728 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.531 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 1.6 mm -74.58 -178.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.864 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.6 mt-10 -170.56 103.72 0.26 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 121.688 0.756 . . . . 0.0 109.97 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.508 ' CA ' ' HE3' ' A' ' 298' ' ' MET . 4.0 m -140.17 172.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.378 0 CA-C-O 121.646 0.736 . . . . 0.0 110.556 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.2 tptp -91.0 89.69 7.54 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.56 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 2.2 tmm? -143.79 157.3 44.47 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.401 -0.812 . . . . 0.0 110.609 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.656 ' CD2' ' CB ' ' A' ' 295' ' ' PRO . 3.3 t-80 -78.54 117.68 67.85 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 38.4 Cg_endo -62.11 -21.88 73.24 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.776 1.409 . . . . 0.0 110.341 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.557 ' HB2' ' ND1' ' A' ' 333' ' ' HIS . 12.1 mt -76.95 -63.6 1.32 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.107 0.956 . . . . 0.0 110.258 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.475 ' HB3' HG13 ' A' ' 412' ' ' ILE . 17.4 m -45.8 -53.08 10.17 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.554 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 416' ' ' HIS . 16.7 mm -57.16 -43.84 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.999 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 0.2 OUTLIER -48.8 -41.19 31.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.887 -1.133 . . . . 0.0 108.344 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 336' ' ' SER . 6.8 mtt180 -67.46 -47.71 69.32 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.488 0.661 . . . . 0.0 109.909 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . . . . . . . . . . . -51.82 -36.2 47.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 110.641 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.523 ' CG1' HG12 ' A' ' 308' ' ' VAL . 33.6 t -89.99 -21.05 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -0.935 . . . . 0.0 110.281 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.59 -56.69 9.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.868 . . . . 0.0 110.846 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . 0.468 ' O ' HG11 ' A' ' 346' ' ' VAL . 76.1 m-20 -75.68 -19.72 58.94 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.212 -0.93 . . . . 0.0 110.724 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.516 ' CE ' HG22 ' A' ' 432' ' ' ILE . 2.0 mtt -67.48 -32.66 73.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.287 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.416 ' O ' ' CB ' ' A' ' 349' ' ' ALA . 55.9 t -90.44 -19.05 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.351 -0.843 . . . . 0.0 111.236 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 343' ' ' ASN . 0.6 OUTLIER -70.93 -30.31 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.939 -1.101 . . . . 0.0 110.685 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -60.9 -55.76 29.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.144 -0.972 . . . . 0.0 110.636 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.477 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -85.1 -19.23 32.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.173 -0.954 . . . . 0.0 110.403 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 345' ' ' VAL . . . -43.34 -72.8 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.381 -0.824 . . . . 0.0 110.811 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 61.0 mtt85 -87.0 -69.22 0.69 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.084 -1.01 . . . . 0.0 110.744 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . 0.492 ' O ' ' N ' ' A' ' 353' ' ' ASN . 2.3 t80 -49.03 -72.61 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.301 -0.874 . . . . 0.0 110.829 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -52.85 88.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 351' ' ' TYR . 6.3 p-10 -96.2 51.48 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.184 -1.186 . . . . 0.0 109.801 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -121.1 -66.93 0.26 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 2.0 t90 -176.28 140.36 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -1.182 . . . . 0.0 110.219 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.533 ' CD1' HG13 ' A' ' 319' ' ' ILE . 2.8 mt -110.41 158.96 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.651 -0.656 . . . . 0.0 109.909 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 11.8 ttpt -142.15 105.58 4.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.74 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 321' ' ' THR . 68.9 t -107.73 84.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.327 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 69.5 p -116.67 140.73 49.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.006 -1.059 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.471 ' HB3' ' HG ' ' A' ' 323' ' ' LEU . 1.9 t -125.72 158.66 34.28 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -159.07 -152.62 6.51 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -179.26 174.18 1.05 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.215 -1.168 . . . . 0.0 110.525 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.541 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 1.9 mt-10 -151.81 -175.13 0.45 Allowed Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.468 -0.77 . . . . 0.0 109.504 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 40.7 Cg_endo -69.7 116.96 4.8 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.582 1.306 . . . . 0.0 111.353 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.535 ' O ' ' HG3' ' A' ' 366' ' ' ARG . 1.9 m-20 69.65 6.09 5.53 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.679 -0.638 . . . . 0.0 111.844 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 365' ' ' ASN . 59.7 mtp85 -155.7 104.92 2.37 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.098 -1.001 . . . . 0.0 111.834 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -101.01 167.59 10.15 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 52.7 p-90 -170.9 178.79 3.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.189 -1.569 . . . . 0.0 111.905 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 27.5 p90 -147.76 141.62 25.79 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.539 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 8.8 tt0 -134.15 149.44 51.05 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.871 -1.143 . . . . 0.0 112.325 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.539 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 33.6 t -127.22 134.05 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.439 ' HG3' ' OG ' ' A' ' 431' ' ' SER . 0.7 OUTLIER -128.96 145.88 51.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.778 -1.201 . . . . 0.0 109.897 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 373' ' ' ASP . 8.0 p30 -149.92 145.98 26.81 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.69 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.33 137.36 38.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.392 -0.817 . . . . 0.0 109.917 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 169.8 -164.15 37.59 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.008 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.53 -161.63 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.156 1.608 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 424' ' ' THR . . . -146.83 166.24 28.37 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.614 HG21 " O2'" ' A' ' 451' ' ' ANP . 5.5 mt -72.6 169.81 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.236 . . . . 0.0 109.787 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.524 ' CB ' ' HB2' ' A' ' 382' ' ' GLN . . . -95.25 177.8 1.68 Allowed Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.96 -1.088 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 379' ' ' ALA . 45.9 Cg_endo -73.32 -46.43 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.036 1.545 . . . . 0.0 110.78 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -90.77 -30.22 17.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.959 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.524 ' HB2' ' CB ' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -64.45 -20.18 66.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.079 -1.013 . . . . 0.0 110.338 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 382' ' ' GLN . 16.8 ttt180 -44.81 -29.22 0.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.162 -0.961 . . . . 0.0 109.872 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.46 ' HD3' ' OE1' ' A' ' 388' ' ' GLN . 20.0 mttt -89.95 -33.15 16.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.352 -0.843 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 382' ' ' GLN . 5.0 m170 -40.94 -59.18 1.51 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.314 -0.866 . . . . 0.0 110.036 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 0.9 OUTLIER -113.91 64.04 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.465 ' O ' ' HG2' ' A' ' 388' ' ' GLN . 0.8 OUTLIER 176.14 62.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.33 -0.856 . . . . 0.0 110.253 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 387' ' ' PHE . 2.2 mt-30 -152.99 126.35 4.21 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.04 -1.037 . . . . 0.0 110.363 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.65 88.27 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.923 1.486 . . . . 0.0 110.544 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.05 138.57 37.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.153 -0.967 . . . . 0.0 110.146 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.94 47.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.257 -0.902 . . . . 0.0 110.666 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -113.03 138.59 49.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 394' ' ' ASP . . . 165.36 -102.72 0.2 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 393' ' ' GLY . 0.4 OUTLIER 65.47 145.76 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -1.168 . . . . 0.0 110.121 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 m -111.71 43.47 1.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.198 -0.939 . . . . 0.0 110.08 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -100.58 -0.71 37.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 52.32 89.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.163 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 2.9 m -124.24 -129.1 0.25 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 110.078 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 399' ' ' ILE . 7.8 tp -116.82 54.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.053 -1.029 . . . . 0.0 110.215 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.9 t -128.11 -169.94 2.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.408 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -110.14 -176.69 20.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.4 p -131.76 -38.44 1.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -1.149 . . . . 0.0 110.248 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 102.07 -46.87 1.21 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 13.5 tp 45.17 82.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.263 -1.139 . . . . 0.0 110.126 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -141.79 -169.65 12.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.8 60.34 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.332 -1.099 . . . . 0.0 110.114 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.84 86.48 5.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.442 ' O ' ' CD1' ' A' ' 412' ' ' ILE . 27.3 mm -119.78 35.18 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.267 -0.896 . . . . 0.0 110.175 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.449 HG11 ' N ' ' A' ' 410' ' ' GLN . 7.0 p -129.47 -34.03 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.183 -0.948 . . . . 0.0 110.269 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 31.0 tt0 -66.4 -42.14 88.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 110.502 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -69.57 -32.31 71.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.173 -0.954 . . . . 0.0 110.033 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.537 ' O ' ' ND1' ' A' ' 416' ' ' HIS . 1.1 mp -59.64 -63.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.147 -0.971 . . . . 0.0 108.58 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 420' ' ' LEU . 35.5 t -63.32 -28.22 44.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.321 -0.862 . . . . 0.0 109.823 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 29.7 t70 -73.24 -20.54 60.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.511 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.531 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.1 m-80 -95.27 -14.31 24.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.473 -0.767 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.56 ' NE2' ' HG2' ' A' ' 332' ' ' MET . 37.3 m80 -93.03 -34.1 13.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.451 -0.781 . . . . 0.0 109.865 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 4.1 m120 72.95 47.43 0.2 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.488 0.661 . . . . 0.0 110.431 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.545 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -121.28 -87.16 0.92 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.575 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.2 OUTLIER -171.12 161.74 6.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.397 -1.061 . . . . 0.0 110.615 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.531 ' HB2' ' CG1' ' A' ' 413' ' ' VAL . 14.1 tp -150.36 90.68 1.68 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 109.989 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 433' ' ' ARG . 63.0 mm-40 -89.81 154.03 20.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.235 -0.915 . . . . 0.0 110.046 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.572 HD13 ' C2 ' ' A' ' 451' ' ' ANP . 7.2 tt -138.31 130.64 28.9 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.983 -1.073 . . . . 0.0 111.149 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.526 ' O ' HD22 ' A' ' 430' ' ' LEU . . . -90.33 163.04 29.91 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.694 ' HA ' ' HG ' ' A' ' 430' ' ' LEU 0.258 12.9 t -140.7 -38.48 0.43 Allowed 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.836 1.318 . . . . 0.0 112.397 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' SER . . . . . 0.577 ' N ' ' CG2' ' A' ' 424' ' ' THR . 1.4 p 155.38 -62.19 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.19 -48.02 72.03 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.576 ' HD2' ' CG2' ' A' ' 424' ' ' THR . 0.8 OUTLIER -61.57 -29.55 70.09 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 429' ' ' GLY . . . 139.86 86.65 0.13 Allowed Glycine 0 C--O 1.215 -1.04 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' A' ' 424' ' ' THR . . . 44.55 -167.0 0.03 OUTLIER Glycine 0 N--CA 1.499 2.862 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.694 ' HG ' ' HA ' ' A' ' 424' ' ' THR . 0.7 OUTLIER -110.93 131.93 54.64 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.579 1.69 . . . . 0.0 110.354 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.439 ' OG ' ' HG3' ' A' ' 372' ' ' GLU . 4.0 m -143.26 -177.75 5.52 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.919 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.516 HG22 ' CE ' ' A' ' 344' ' ' MET . 9.1 mm -149.94 92.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.687 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . 0.485 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.1 mtt180 -88.59 134.84 33.76 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.859 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -128.98 129.35 45.29 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.05 -1.031 . . . . 0.0 109.679 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 84.0 m95 -111.28 145.57 38.56 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.139 -0.975 . . . . 0.0 111.908 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 416' ' ' HIS . 5.9 mt -134.35 106.69 11.11 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.545 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 42.8 Cg_endo -68.78 138.82 42.1 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 O-C-N 123.911 1.479 . . . . 0.0 111.382 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.542 ' CG2' ' HD2' ' A' ' 439' ' ' PRO . 4.9 p -86.17 145.63 40.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.567 -0.708 . . . . 0.0 109.557 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 438' ' ' VAL . 47.4 Cg_endo -69.23 -167.74 0.22 Allowed 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.802 1.422 . . . . 0.0 110.423 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 12.4 t -63.36 154.3 6.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.731 -0.606 . . . . 0.0 110.474 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 9.8 p -150.82 -91.98 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.971 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -118.35 -134.42 0.33 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.08 -1.013 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -151.38 129.33 11.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.044 -1.035 . . . . 0.0 110.097 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -138.05 91.55 2.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.323 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -49.4 156.41 1.71 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 20.7 p -98.52 103.28 15.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.205 -1.173 . . . . 0.0 110.17 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 60.6 p -76.03 127.2 32.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.227 -0.92 . . . . 0.0 110.176 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.44 133.06 47.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.198 -0.938 . . . . 0.0 110.389 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -74.32 -61.68 1.78 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 110.13 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.561 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.652 ' N6 ' ' CD2' ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.205 0.526 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.98 176.22 19.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -74.12 93.63 2.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -1.159 . . . . 0.0 109.974 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 42.3 tt0 -111.92 87.34 2.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.065 -1.022 . . . . 0.0 110.73 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.89 107.34 16.89 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.445 -0.784 . . . . 0.0 109.069 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.591 ' HB3' ' CD2' ' A' ' 333' ' ' HIS . 49.4 Cg_endo -97.83 -177.27 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.421 1.414 . . . . 0.0 111.252 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.508 ' C ' ' O ' ' A' ' 295' ' ' PRO . 0.0 OUTLIER 27.99 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.193 0.997 . . . . 0.0 111.104 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 18.6 pt-20 -164.25 -159.98 0.51 Allowed 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.468 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.0 OUTLIER -88.22 127.75 35.45 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.926 -1.109 . . . . 0.0 110.146 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -147.55 163.86 35.25 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.181 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.522 ' HB3' ' CB ' ' A' ' 303' ' ' ALA . 16.3 t0 -100.12 116.42 32.11 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.664 -0.647 . . . . 0.0 109.759 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.527 ' HB2' ' CB ' ' A' ' 328' ' ' ILE . 12.0 mt -60.53 -27.45 67.65 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.299 -0.875 . . . . 0.0 109.778 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.414 ' OD1' HD21 ' A' ' 323' ' ' LEU . 56.7 t-20 -76.19 -22.68 55.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.056 . . . . 0.0 108.963 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -85.56 -31.46 22.66 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.459 0.647 . . . . 0.0 109.552 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 33.2 t -79.58 -34.31 15.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.499 -0.75 . . . . 0.0 109.542 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 82.6 mt -79.92 -26.77 40.04 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.401 -0.812 . . . . 0.0 109.991 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.56 -33.86 88.36 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.81 -32.92 25.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.305 -1.115 . . . . 0.0 109.417 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.529 HG13 ' CG1' ' A' ' 341' ' ' VAL . 51.0 t -75.39 -19.24 15.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.389 -0.819 . . . . 0.0 109.189 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.563 ' O ' ' CB ' ' A' ' 313' ' ' SER . 1.0 OUTLIER -83.26 -46.01 18.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.08 -17.58 61.99 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.277 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.58 -53.57 4.37 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.97 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.506 ' HB3' HG22 ' A' ' 345' ' ' VAL . 14.9 mm-40 -100.86 35.0 2.3 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 111.045 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 309' ' ' ILE . 0.1 OUTLIER -86.18 32.15 0.63 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.082 -1.012 . . . . 0.0 110.365 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 45.24 33.2 3.93 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.686 -2.165 . . . . 0.0 107.686 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.52 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 39.8 m-85 61.86 52.07 3.57 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 122.096 -0.65 . . . . 0.0 109.95 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 16.1 mt-10 59.28 35.52 23.36 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.597 -0.689 . . . . 0.0 110.256 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.55 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.3 OUTLIER -68.84 -74.13 0.13 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.509 -0.744 . . . . 0.0 109.46 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.55 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 9.3 mt-10 -160.42 80.85 0.67 Allowed 'General case' 0 C--N 1.274 -2.7 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.542 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.518 HG13 ' CD1' ' A' ' 356' ' ' ILE . 2.7 mp -122.62 142.21 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.491 ' HB3' ' CG ' ' A' ' 357' ' ' LYS . 26.3 tt0 -109.7 103.89 12.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.446 -0.784 . . . . 0.0 109.547 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 20.0 p -90.53 123.71 34.42 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.245 -0.91 . . . . 0.0 111.411 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -144.33 78.69 1.59 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.524 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 5.7 mp -91.07 152.31 20.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.561 -0.712 . . . . 0.0 110.999 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.568 ' CD1' HG21 ' A' ' 362' ' ' THR . 19.9 t80 -41.19 136.15 1.72 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.593 -0.692 . . . . 0.0 110.058 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -83.67 57.28 5.55 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 124.027 1.54 . . . . 0.0 110.276 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -167.58 21.13 0.1 OUTLIER Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.747 -1.215 . . . . 0.0 110.505 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 326' ' ' GLY . 68.5 m 56.44 111.56 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.019 -1.283 . . . . 0.0 110.215 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.544 ' CD1' ' HB3' ' A' ' 324' ' ' TYR . 3.5 mm -69.12 -179.34 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.579 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 1.7 mt-10 -174.84 101.28 0.09 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.64 -0.663 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.593 ' CG1' ' CB ' ' A' ' 367' ' ' ALA . 8.4 m -143.41 174.17 5.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 121.62 0.724 . . . . 0.0 110.469 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.1 OUTLIER -95.05 93.63 7.49 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.559 ' CE ' HG13 ' A' ' 337' ' ' ILE . 11.2 ptm -136.47 164.76 27.41 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.973 0.892 . . . . 0.0 112.597 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.591 ' CD2' ' HB3' ' A' ' 295' ' ' PRO . 23.4 t-160 -88.06 116.44 66.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.483 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 39.3 Cg_endo -62.47 -30.23 79.75 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.637 1.335 . . . . 0.0 112.542 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.586 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 3.9 tp -82.23 -49.2 10.36 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.623 -1.298 . . . . 0.0 110.589 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.544 ' HB2' ' ND1' ' A' ' 333' ' ' HIS . 0.5 OUTLIER -60.6 -42.26 96.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.915 -1.115 . . . . 0.0 109.869 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.578 HD13 ' CE1' ' A' ' 416' ' ' HIS . 18.5 mm -65.37 -46.99 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.601 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 0.7 OUTLIER -51.54 -32.93 29.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.83 -1.169 . . . . 0.0 107.873 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.477 ' NH1' ' OD1' ' A' ' 343' ' ' ASN . 0.0 OUTLIER -77.45 -34.65 54.41 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.991 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 344' ' ' MET . . . -67.55 -29.57 68.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.454 -0.779 . . . . 0.0 110.449 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 308' ' ' VAL . 52.8 t -90.28 -25.49 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 110.423 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 346' ' ' VAL . . . -83.3 -19.95 35.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.578 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . 0.477 ' OD1' ' NH1' ' A' ' 339' ' ' ARG . 0.3 OUTLIER -83.78 -21.08 32.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -0.916 . . . . 0.0 110.779 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 3.2 mtt -90.69 -51.3 5.45 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.138 -0.976 . . . . 0.0 111.221 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 312' ' ' GLU . 27.4 m -68.22 -19.69 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -0.943 . . . . 0.0 111.505 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 342' ' ' ALA . 14.5 p -61.53 -39.64 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.843 -1.161 . . . . 0.0 110.72 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.406 ' N ' ' CG1' ' A' ' 346' ' ' VAL . 10.9 t30 -63.2 -49.78 72.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.126 -0.984 . . . . 0.0 110.806 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.482 ' O ' ' HA2' ' A' ' 352' ' ' GLY . . . -72.73 -19.91 61.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.219 -0.926 . . . . 0.0 110.612 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 345' ' ' VAL . . . -67.09 -73.18 0.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.025 -1.047 . . . . 0.0 110.253 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -55.35 -51.63 66.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.298 -0.876 . . . . 0.0 110.453 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -59.54 2.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.215 -0.928 . . . . 0.0 110.379 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 348' ' ' ALA . . . 68.09 -104.11 1.12 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 1.5 t30 55.0 17.35 1.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -1.145 . . . . 0.0 110.207 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . 0.441 ' HA3' ' HB3' ' A' ' 374' ' ' ASP . . . -168.37 -98.25 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.067 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.601 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -179.78 148.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -1.166 . . . . 0.0 109.881 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.518 ' CD1' HG13 ' A' ' 319' ' ' ILE . 0.8 OUTLIER -106.49 159.52 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.309 -0.869 . . . . 0.0 110.024 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.601 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 1.4 ttmt -150.41 112.72 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 110.692 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.532 HG13 ' CD1' ' A' ' 309' ' ' ILE . 21.9 t -103.07 88.81 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 370' ' ' GLN . 6.8 p -115.04 151.14 34.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -0.896 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.524 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.6 OUTLIER -140.14 163.53 32.47 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -155.23 -164.32 12.95 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.568 HG21 ' CD1' ' A' ' 324' ' ' TYR . 0.1 OUTLIER -176.36 144.05 0.53 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.716 -1.461 . . . . 0.0 112.048 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.552 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 39.0 mt-10 -109.03 175.61 1.89 Allowed Pre-proline 0 C--N 1.287 -2.146 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.304 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 40.1 Cg_endo -66.07 127.0 16.77 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.245 1.129 . . . . 0.0 110.087 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.552 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 6.6 m120 60.52 22.25 11.97 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.519 -0.738 . . . . 0.0 110.243 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 42.1 mtm180 -163.63 145.06 9.22 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.593 ' CB ' ' CG1' ' A' ' 330' ' ' VAL . . . -143.17 151.16 40.36 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.11 -0.994 . . . . 0.0 109.159 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.603 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 37.7 p-90 -151.67 170.38 19.85 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.905 -1.122 . . . . 0.0 110.682 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 369' ' ' PHE . 36.4 p90 -139.5 130.42 26.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.44 -0.787 . . . . 0.0 109.582 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 359' ' ' SER . 0.8 OUTLIER -116.1 150.48 37.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -0.933 . . . . 0.0 111.381 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.29 143.86 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.497 -0.752 . . . . 0.0 109.348 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.478 ' HB2' ' HD2' ' A' ' 357' ' ' LYS . 1.8 tt0 -126.36 145.51 50.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.013 -1.054 . . . . 0.0 110.198 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' ' 355' ' ' TRP . 11.1 t70 -156.65 143.66 18.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.841 . . . . 0.0 110.331 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 374' ' ' ASP . 27.6 t0 -98.39 64.47 1.59 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.37 -0.831 . . . . 0.0 110.016 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -86.88 -148.01 12.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.15 -40.59 3.15 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.008 1.531 . . . . 0.0 110.482 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 103.6 -174.85 23.06 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.642 ' CD1' ' N9 ' ' A' ' 451' ' ' ANP . 1.9 mm -99.72 176.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.065 -1.256 . . . . 0.0 110.102 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 382' ' ' GLN . . . -109.91 165.61 12.35 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.248 -0.908 . . . . 0.0 109.752 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.07 -49.26 0.53 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.842 1.443 . . . . 0.0 110.229 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -89.53 -19.69 24.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.12 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.458 ' HB3' ' HB1' ' A' ' 379' ' ' ALA . 4.5 tt0 -82.82 -19.78 36.98 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.275 -0.89 . . . . 0.0 110.86 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 382' ' ' GLN . 2.2 ttt85 -42.32 -37.97 1.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.024 -1.047 . . . . 0.0 110.021 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.84 -27.89 19.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.203 -0.936 . . . . 0.0 110.404 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -51.81 -18.23 1.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.107 -0.996 . . . . 0.0 110.747 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.609 HD13 " O2'" ' A' ' 451' ' ' ANP . 50.4 mt -86.59 23.22 1.7 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.92 -1.113 . . . . 0.0 110.731 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 57.3 m-85 -159.7 35.2 0.19 Allowed 'General case' 0 C--N 1.293 -1.87 0 O-C-N 121.483 -0.761 . . . . 0.0 109.984 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -104.49 136.75 19.13 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 110.568 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.63 147.49 35.72 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.841 1.442 . . . . 0.0 109.888 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . 0.415 ' HB2' ' OE1' ' A' ' 388' ' ' GLN . 53.7 t80 -172.89 107.23 0.16 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.031 -1.043 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 392' ' ' ARG . 2.5 t -137.06 170.07 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.259 -0.9 . . . . 0.0 109.694 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 391' ' ' VAL . 0.1 OUTLIER 44.25 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.033 -1.042 . . . . 0.0 109.964 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 150.56 58.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -145.1 139.2 27.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -1.163 . . . . 0.0 110.204 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 t -156.66 -40.81 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.911 . . . . 0.0 110.15 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -108.23 -90.26 0.45 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.903 . . . . 0.0 110.082 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -79.05 147.22 32.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -0.972 . . . . 0.0 110.166 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 4.1 m -159.96 127.91 4.75 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.114 -0.991 . . . . 0.0 110.344 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.445 HD13 ' HB2' ' A' ' 400' ' ' SER . 2.0 pp -85.54 -29.33 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.445 ' HB2' HD13 ' A' ' 399' ' ' ILE . 9.6 t -110.79 135.87 50.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.329 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 125.11 101.7 1.35 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.431 ' O ' ' CG2' ' A' ' 402' ' ' THR . 53.1 m -132.03 13.94 4.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.211 -1.17 . . . . 0.0 109.955 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 165.26 -117.42 0.75 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 45.7 tp -89.57 -73.54 0.51 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.173 -1.192 . . . . 0.0 109.995 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -164.23 55.6 0.28 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.95 170.2 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -1.124 . . . . 0.0 110.529 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -106.48 160.15 15.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 109.664 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.462 HG23 HG11 ' A' ' 409' ' ' VAL . 14.2 mt -130.01 169.47 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.042 -1.036 . . . . 0.0 110.48 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.462 HG11 HG23 ' A' ' 408' ' ' ILE . 10.6 p -48.83 -22.51 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.954 . . . . 0.0 110.176 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 48.3 tt0 -62.9 -55.94 21.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.23 -0.919 . . . . 0.0 110.609 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.4 OUTLIER -59.02 -32.19 69.5 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.311 -0.868 . . . . 0.0 110.684 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 409' ' ' VAL . 1.0 OUTLIER -64.03 -58.37 7.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.092 -1.005 . . . . 0.0 109.143 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 420' ' ' LEU . 30.4 t -65.51 -21.41 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.249 -0.907 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 0.1 OUTLIER -82.41 -25.83 33.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 109.515 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 2.2 t-20 -86.41 -17.82 33.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.578 ' CE1' HD13 ' A' ' 337' ' ' ILE . 22.7 m80 -92.87 -41.2 10.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.539 -0.726 . . . . 0.0 109.664 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 6.0 t-20 79.59 36.04 0.15 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.437 0.637 . . . . 0.0 109.949 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.606 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -101.86 -90.03 2.1 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.551 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.7 OUTLIER -173.0 163.45 4.79 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.349 -1.089 . . . . 0.0 111.222 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 420' ' ' LEU . 14.3 tp -151.45 97.93 2.46 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.57 152.17 34.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.001 -1.062 . . . . 0.0 111.541 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.485 ' O ' ' CG ' ' A' ' 422' ' ' LEU . 2.9 pp -132.47 121.13 22.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.404 -0.81 . . . . 0.0 109.273 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -141.8 132.04 5.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.553 ' CG2' ' HA ' ' A' ' 427' ' ' ARG . 3.5 t -128.45 155.1 45.32 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.254 -1.145 . . . . 0.0 110.703 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 2.6 p -85.74 112.67 21.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.309 -0.869 . . . . 0.0 109.359 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 53.02 49.3 20.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.59 -0.694 . . . . 0.0 110.038 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.553 ' HA ' ' CG2' ' A' ' 424' ' ' THR . 13.9 mmt180 45.13 46.64 9.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 110.02 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -143.68 -66.51 0.02 OUTLIER Glycine 0 N--CA 1.484 1.853 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -77.88 77.03 1.68 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.625 ' CD2' ' C6 ' ' A' ' 451' ' ' ANP . 0.3 OUTLIER -76.44 135.77 39.42 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.138 -1.213 . . . . 0.0 111.777 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.406 ' HB2' ' HG3' ' A' ' 372' ' ' GLU . 40.2 t -144.76 114.24 7.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.689 -0.632 . . . . 0.0 109.627 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.426 ' O ' ' HG2' ' A' ' 370' ' ' GLN . 1.5 tt -94.46 131.91 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.145 -0.972 . . . . 0.0 110.368 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -111.79 103.04 11.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.94 . . . . 0.0 110.407 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 368' ' ' TRP . . . -91.96 130.39 37.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.325 -0.86 . . . . 0.0 109.518 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.603 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.3 m95 -107.66 157.24 18.25 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.822 -1.174 . . . . 0.0 112.438 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.443 ' HG ' ' C ' ' A' ' 435' ' ' TRP . 19.8 mt -142.68 114.12 6.04 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.606 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 51.4 Cg_endo -78.45 129.53 9.44 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.534 1.281 . . . . 0.0 112.161 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.47 HG23 HG11 ' A' ' 330' ' ' VAL . 6.8 t -109.32 69.0 0.42 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.539 -0.725 . . . . 0.0 110.02 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 57.7 Cg_endo -75.01 -170.5 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.681 1.358 . . . . 0.0 110.558 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.408 ' O ' HG11 ' A' ' 440' ' ' VAL 0.255 9.5 p -141.2 29.65 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 O-C-N 121.907 -0.496 . . . . 0.0 110.752 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 66.2 p -51.77 111.83 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.063 -1.023 . . . . 0.0 110.398 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -116.49 -49.67 2.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.304 -0.873 . . . . 0.0 110.023 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -108.56 121.01 44.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.222 -0.923 . . . . 0.0 110.259 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -163.51 -175.83 4.39 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.246 -0.909 . . . . 0.0 110.092 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -172.1 -63.2 0.04 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 48.5 p -149.8 110.81 4.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -1.149 . . . . 0.0 110.177 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 30.7 p -47.05 169.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -76.25 -87.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.266 -0.896 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.11 138.11 20.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.276 -0.89 . . . . 0.0 110.176 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 CA-C-O 118.019 -1.434 . . . . 0.0 109.546 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.642 ' N9 ' ' CD1' ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 290' ' ' THR . 41.7 m . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.258 0.552 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -150.08 -149.96 5.14 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 292' ' ' GLN . 1.5 tm0? -80.28 6.78 11.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -1.119 . . . . 0.0 110.268 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.68 92.42 5.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 0.0 110.465 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 67.4 mtp -104.13 109.4 62.4 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.289 -0.882 . . . . 0.0 109.937 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.615 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 54.2 Cg_endo -83.79 48.74 2.67 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.874 1.46 . . . . 0.0 111.283 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.04 107.74 15.84 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 15.5 mt-10 -128.81 -162.02 1.16 Allowed 'General case' 0 C--N 1.283 -2.287 0 O-C-N 121.637 -0.664 . . . . 0.0 109.913 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.466 ' HE1' ' C ' ' A' ' 330' ' ' VAL . 0.3 OUTLIER -88.33 133.51 34.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.048 -1.033 . . . . 0.0 110.271 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.432 ' HB1' ' HG3' ' A' ' 332' ' ' MET . . . -149.68 160.7 43.31 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.447 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.528 ' HB3' ' CB ' ' A' ' 303' ' ' ALA . 4.3 t0 -90.77 121.32 32.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.801 -0.562 . . . . 0.0 109.891 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.516 HD22 ' CE ' ' A' ' 332' ' ' MET . 9.5 mt -72.18 -21.15 61.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 109.718 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 302' ' ' ASN . 8.9 t30 -83.45 -23.97 32.04 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 109.138 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -84.0 -31.59 25.4 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.515 -0.74 . . . . 0.0 109.584 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.531 ' O ' ' CG2' ' A' ' 308' ' ' VAL . 11.4 t -78.41 -35.88 19.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.401 -0.812 . . . . 0.0 109.705 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 71.1 mt -76.08 -29.56 58.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.26 -0.9 . . . . 0.0 110.924 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -65.58 -39.78 95.69 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -75.84 -32.56 59.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.203 -1.174 . . . . 0.0 109.59 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 304' ' ' VAL . 41.0 t -78.27 -19.96 13.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 109.339 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.536 ' CD1' HG13 ' A' ' 358' ' ' VAL . 1.4 mt -71.15 -50.48 41.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.79 -15.08 61.64 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.823 0.821 . . . . 0.0 108.879 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 312' ' ' GLU . . . -61.62 -63.17 1.36 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.857 -0.527 . . . . 0.0 111.817 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 311' ' ' ALA . 13.3 mt-10 -143.41 38.92 1.4 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.525 -1.27 . . . . 0.0 113.047 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.589 ' HA ' ' CG1' ' A' ' 345' ' ' VAL . 5.9 t -85.77 10.37 13.8 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.616 -1.303 . . . . 0.0 109.53 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 111.39 43.33 0.99 Allowed Glycine 0 C--N 1.291 -1.945 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.516 ' O ' ' HG3' ' A' ' 316' ' ' GLU . 23.7 m-85 59.43 41.6 19.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.918 . . . . 0.0 110.094 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 53.59 32.67 14.8 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.342 1.068 . . . . 0.0 109.096 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 0.2 OUTLIER -69.81 -81.59 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.98 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.461 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 14.3 pt-20 -126.89 72.15 1.34 Allowed 'General case' 0 C--N 1.277 -2.545 0 O-C-N 121.669 -0.644 . . . . 0.0 111.974 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.545 HD13 ' O ' ' A' ' 313' ' ' SER . 1.8 mm -104.52 123.2 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 358' ' ' VAL . 7.5 tt0 -88.98 98.15 11.6 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.426 HG23 HD12 ' A' ' 309' ' ' ILE . 20.6 p -89.46 129.22 35.99 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.893 0.854 . . . . 0.0 111.832 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.46 77.85 1.31 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 323' ' ' LEU . 0.8 OUTLIER -96.46 158.51 15.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.47 -0.768 . . . . 0.0 110.644 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.605 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 15.3 t80 -54.31 116.03 9.74 Favored Pre-proline 0 C--N 1.299 -1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.49 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -80.97 64.64 8.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.022 1.538 . . . . 0.0 110.322 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.474 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -162.52 23.04 0.2 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 4.3 p 60.26 106.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -1.136 . . . . 0.0 110.646 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.548 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 4.0 mt -84.8 175.48 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 O-C-N 121.723 -0.611 . . . . 0.0 109.646 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.548 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.7 mt-10 -169.47 109.89 0.45 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.391 -0.818 . . . . 0.0 111.352 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.57 ' CG1' ' CB ' ' A' ' 367' ' ' ALA . 12.7 m -145.03 160.68 13.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.517 0.675 . . . . 0.0 109.936 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.0 OUTLIER -82.94 95.89 8.12 Favored 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.518 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.539 ' CE ' HG13 ' A' ' 337' ' ' ILE . 19.2 ptm -140.37 -178.21 5.39 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 110.975 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.615 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 18.1 t-160 -115.13 112.23 44.39 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 36.6 Cg_endo -58.74 -19.66 47.36 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.721 1.379 . . . . 0.0 110.447 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.576 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 2.9 tm? -78.95 -63.89 1.31 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.382 -0.824 . . . . 0.0 110.123 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.479 ' N ' HD11 ' A' ' 335' ' ' LEU . 0.0 OUTLIER -54.22 -49.97 68.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.305 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.579 HD12 ' CE1' ' A' ' 416' ' ' HIS . 17.3 mm -62.91 -31.78 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 110.346 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 0.4 OUTLIER -61.03 -57.86 10.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.906 -1.121 . . . . 0.0 109.772 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 339' ' ' ARG . 4.1 tmm_? -69.45 -21.35 63.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.466 -0.771 . . . . 0.0 110.356 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.45 ' HB3' ' CD1' ' A' ' 412' ' ' ILE . . . -69.6 -44.69 70.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.014 . . . . 0.0 110.307 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.538 ' O ' ' CG2' ' A' ' 345' ' ' VAL . 46.3 t -80.42 -22.16 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.337 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -70.62 -62.24 1.46 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.137 -0.977 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . 0.422 ' O ' ' CG1' ' A' ' 346' ' ' VAL . 1.8 t30 -59.25 -43.48 92.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.074 -1.016 . . . . 0.0 110.73 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.457 ' SD ' HG23 ' A' ' 432' ' ' ILE . 2.9 ttm -57.7 -19.05 24.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.274 -0.891 . . . . 0.0 110.976 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.589 ' CG1' ' HA ' ' A' ' 313' ' ' SER . 78.0 t -88.68 -22.26 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.094 -1.004 . . . . 0.0 111.587 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.469 HG11 ' N ' ' A' ' 347' ' ' ASN . 9.0 p -64.82 -19.5 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.951 -1.093 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.469 ' N ' HG11 ' A' ' 346' ' ' VAL . 49.7 t30 -66.26 -42.63 88.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.052 -1.03 . . . . 0.0 111.536 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -89.3 -19.86 24.79 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.938 -1.101 . . . . 0.0 111.369 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -89.41 -69.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.959 -1.088 . . . . 0.0 110.822 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -65.8 -41.92 91.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.125 -0.984 . . . . 0.0 110.744 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.82 -35.73 16.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.175 -0.953 . . . . 0.0 110.56 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -97.34 156.27 20.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -141.97 53.94 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -1.12 . . . . 0.0 109.959 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 355' ' ' TRP . . . -128.04 -59.58 0.12 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.584 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.3 OUTLIER 171.78 150.25 0.05 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.151 -1.205 . . . . 0.0 109.841 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' A' ' 313' ' ' SER . 26.6 mt -116.49 164.21 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.251 -0.905 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.584 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 18.4 tttm -142.27 97.6 3.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.561 -0.712 . . . . 0.0 109.752 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.536 HG13 ' CD1' ' A' ' 309' ' ' ILE . 26.0 t -93.01 139.57 17.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.8 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.497 ' HA ' ' CD1' ' A' ' 323' ' ' LEU . 60.3 p -160.13 169.91 22.33 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.087 -1.008 . . . . 0.0 111.458 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.495 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 34.2 t -155.21 150.28 26.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.635 -0.665 . . . . 0.0 109.762 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.517 ' HA3' ' CZ2' ' A' ' 368' ' ' TRP . . . -139.1 -169.92 11.7 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.605 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.5 OUTLIER -178.21 166.16 1.91 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.926 -1.338 . . . . 0.0 111.834 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.527 ' HB3' ' CD ' ' A' ' 364' ' ' PRO . 5.1 mm-40 -128.35 -174.91 0.4 Allowed Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 45.8 Cg_endo -86.71 36.46 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.495 1.261 . . . . 0.0 110.446 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 2.8 m-20 161.29 36.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.54 ' CG ' ' HA ' ' A' ' 437' ' ' PRO . 0.2 OUTLIER 166.14 103.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.821 . . . . 0.0 109.718 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.57 ' CB ' ' CG1' ' A' ' 330' ' ' VAL . . . -103.91 157.52 17.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.023 -1.048 . . . . 0.0 110.205 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.596 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 30.2 p-90 -150.51 166.46 30.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 110.323 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.582 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 36.0 p90 -133.77 147.26 51.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -0.83 . . . . 0.0 109.499 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.525 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 24.5 tt0 -139.08 155.9 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 111.538 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.525 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 6.3 t -140.03 144.15 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 431' ' ' SER . 26.2 tt0 -142.62 147.65 36.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.824 -1.172 . . . . 0.0 110.099 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -161.4 169.68 21.5 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.068 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -79.54 166.69 21.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.388 -0.82 . . . . 0.0 110.026 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 428' ' ' GLY . . . 124.58 -164.12 18.16 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.89 127.08 11.17 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.042 1.549 . . . . 0.0 110.622 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . 0.495 ' HA2' ' CD1' ' A' ' 430' ' ' LEU . . . -94.24 -169.62 37.73 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.634 HD12 ' C8 ' ' A' ' 451' ' ' ANP . 3.2 mm -76.97 -172.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.942 -1.328 . . . . 0.0 110.145 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.5 ' CB ' ' HB2' ' A' ' 382' ' ' GLN . . . -155.59 160.36 30.9 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.235 -0.915 . . . . 0.0 110.101 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.84 -38.1 4.47 Favored 'Trans proline' 0 C--N 1.298 -2.101 0 O-C-N 124.087 1.572 . . . . 0.0 110.367 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -90.1 -20.91 22.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.199 -0.938 . . . . 0.0 110.284 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.571 ' HG2' HO3' ' A' ' 451' ' ' ANP . 5.3 tp60 -76.92 -23.57 52.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.204 -0.935 . . . . 0.0 110.343 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' A' ' 387' ' ' PHE . 2.2 ttt180 -52.53 -26.36 12.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.223 -0.923 . . . . 0.0 110.351 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -79.67 -32.62 41.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.308 -0.87 . . . . 0.0 110.066 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -59.0 -71.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.032 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.572 HD23 " O3'" ' A' ' 451' ' ' ANP . 0.5 OUTLIER -100.28 50.15 0.9 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 0.0 110.552 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 386' ' ' LEU . 0.2 OUTLIER 176.02 68.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.195 -0.94 . . . . 0.0 110.155 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 388' ' ' GLN . 25.9 pt20 -141.22 132.39 13.5 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.219 -0.925 . . . . 0.0 110.454 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -83.69 51.23 3.42 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.749 1.394 . . . . 0.0 110.183 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.9 149.01 49.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.93 171.22 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.33 -0.856 . . . . 0.0 110.803 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.41 -56.65 1.23 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.415 -0.803 . . . . 0.0 109.789 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 139.88 -122.71 2.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -144.31 78.03 1.56 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -1.136 . . . . 0.0 110.131 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.26 36.94 4.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.905 . . . . 0.0 110.35 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -54.94 154.95 4.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.488 ' O ' ' OG1' ' A' ' 398' ' ' THR . 5.8 ttm-85 -92.94 84.79 4.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.295 -0.878 . . . . 0.0 110.349 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 397' ' ' ARG . 2.0 p 58.5 133.29 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.509 -0.744 . . . . 0.0 110.388 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 399' ' ' ILE . 19.8 tt -116.93 128.43 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.323 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.4 p -102.45 20.96 16.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 110.017 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 96.75 39.09 4.22 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.434 HG21 ' O ' ' A' ' 402' ' ' THR . 4.5 t -125.67 141.32 52.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -1.15 . . . . 0.0 110.233 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -108.14 -60.95 0.55 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.74 55.99 5.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.32 -1.106 . . . . 0.0 110.187 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -143.33 108.57 0.52 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 14.3 tp -163.38 130.76 3.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -1.145 . . . . 0.0 110.287 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 410' ' ' GLN . . . -87.02 -30.35 21.27 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.891 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.485 ' O ' HD11 ' A' ' 412' ' ' ILE . 10.7 mt 64.59 -125.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.287 -0.883 . . . . 0.0 110.869 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.468 ' HA ' HD11 ' A' ' 412' ' ' ILE . 13.6 p -46.91 -19.88 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.052 -1.03 . . . . 0.0 111.744 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.553 ' HB3' ' CB ' ' A' ' 407' ' ' ALA . 0.7 OUTLIER -58.53 -67.08 0.39 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.012 -1.055 . . . . 0.0 111.589 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.525 ' HG2' ' NH2' ' A' ' 411' ' ' ARG . 0.0 OUTLIER -60.31 -26.09 66.27 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.193 -0.942 . . . . 0.0 111.956 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.494 ' CG2' HD11 ' A' ' 337' ' ' ILE . 1.3 mp -64.79 -61.69 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 120.473 -1.392 . . . . 0.0 109.332 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 419' ' ' MET . 25.5 t -66.23 -25.14 34.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.093 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 9.1 m-20 -78.38 -23.29 46.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 109.823 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 16.6 t-20 -82.95 -15.31 51.79 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.318 -0.864 . . . . 0.0 109.285 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.579 ' CE1' HD12 ' A' ' 337' ' ' ILE . 34.1 m80 -90.89 -30.09 17.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.515 -0.74 . . . . 0.0 110.062 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 3.4 t-20 81.52 17.57 0.45 Allowed 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.814 -0.554 . . . . 0.0 110.464 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.548 ' HA2' ' CD ' ' A' ' 437' ' ' PRO . . . -84.81 -91.7 0.79 Allowed Glycine 0 N--CA 1.481 1.678 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.569 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.8 ttp -174.52 167.12 3.91 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.205 -1.174 . . . . 0.0 111.042 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.447 HD13 HD12 ' A' ' 432' ' ' ILE . 19.1 tp -150.83 112.48 4.46 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.597 -0.69 . . . . 0.0 109.181 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -123.54 133.29 54.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.893 -1.129 . . . . 0.0 111.936 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.5 ' HB3' HG13 ' A' ' 378' ' ' ILE . 10.8 mt -108.96 127.59 54.2 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 430' ' ' LEU . . . -136.59 136.83 8.62 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.073 -1.537 . . . . 0.0 110.762 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.531 ' HA ' ' CB ' ' A' ' 430' ' ' LEU . 5.9 m -90.11 123.98 34.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.436 -1.038 . . . . 0.0 109.674 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' SER . . . . . 0.54 ' HB2' ' CG ' ' A' ' 427' ' ' ARG . 41.8 m -85.47 144.73 27.79 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.137 -0.977 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.55 -20.26 0.24 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.213 0.53 . . . . 0.0 110.532 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.54 ' CG ' ' HB2' ' A' ' 425' ' ' SER . 0.2 OUTLIER -57.02 -8.17 0.6 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.32 -0.862 . . . . 0.0 111.3 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 375' ' ' GLY . . . 93.53 21.26 29.64 Favored Glycine 0 N--CA 1.479 1.563 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.47 ' O ' HG21 ' A' ' 424' ' ' THR . . . -147.41 -136.7 2.84 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.596 ' N ' HD11 ' A' ' 430' ' ' LEU . 0.0 OUTLIER -175.42 -175.71 0.83 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.038 -1.272 . . . . 0.0 112.11 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.531 ' N ' ' CD2' ' A' ' 430' ' ' LEU . 0.9 OUTLIER -153.05 -178.98 7.27 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.203 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.457 HG23 ' SD ' ' A' ' 344' ' ' MET . 0.6 OUTLIER -137.02 133.9 47.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.043 -1.035 . . . . 0.0 110.631 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -111.63 97.8 6.98 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.47 -0.769 . . . . 0.0 109.111 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.582 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -90.63 133.07 35.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.402 -0.811 . . . . 0.0 110.474 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.596 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.7 m95 -105.64 151.92 23.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.097 -1.002 . . . . 0.0 111.586 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.468 HD13 ' CD1' ' A' ' 301' ' ' LEU . 36.8 mt -144.41 83.91 9.61 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.548 ' CD ' ' HA2' ' A' ' 418' ' ' GLY . 41.7 Cg_endo -69.35 137.0 35.57 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 123.92 1.484 . . . . 0.0 111.443 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.471 HG11 ' HD2' ' A' ' 439' ' ' PRO . 40.8 t -79.35 142.96 59.19 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.78 -0.575 . . . . 0.0 109.947 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.526 ' CG ' ' HD3' ' A' ' 331' ' ' LYS . 47.3 Cg_endo -74.17 167.4 27.28 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.742 1.39 . . . . 0.0 110.425 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.44 HG21 ' N ' ' A' ' 441' ' ' THR . 13.2 p -45.53 160.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 0.0 110.171 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.44 ' N ' HG21 ' A' ' 440' ' ' VAL . 3.8 t -115.64 36.0 4.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.122 -0.987 . . . . 0.0 110.211 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -135.8 -44.88 0.66 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.2 -0.937 . . . . 0.0 110.31 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -155.87 129.5 8.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.326 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -71.35 -30.63 66.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 110.046 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -170.46 173.61 44.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 15.3 p -58.28 158.01 7.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.235 -1.156 . . . . 0.0 110.233 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 3.3 t -105.11 57.78 0.68 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.228 -0.92 . . . . 0.0 110.289 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.09 159.92 14.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.271 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.28 72.1 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.332 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 CA-C-O 117.974 -1.459 . . . . 0.0 109.57 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.634 ' C8 ' HD12 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.31 0.576 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 112.62 -67.79 0.24 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -55.26 141.58 34.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.282 -1.128 . . . . 0.0 110.36 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -150.61 39.14 0.71 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.899 . . . . 0.0 110.038 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.45 ' HE3' ' OD1' ' A' ' 415' ' ' ASN . 10.2 ptp -168.55 116.24 0.59 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.992 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.525 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 49.9 Cg_endo -78.89 67.1 8.63 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 124.112 1.585 . . . . 0.0 111.305 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.57 ' HE1' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -80.82 108.86 14.84 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.471 -0.892 . . . . 0.0 108.937 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 52.8 mt-10 -123.47 -161.96 1.01 Allowed 'General case' 0 C--N 1.274 -2.686 0 O-C-N 121.825 -0.547 . . . . 0.0 109.748 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.412 ' HE1' ' C ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -88.01 130.01 35.1 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 110.381 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -149.26 158.65 44.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.526 -0.734 . . . . 0.0 110.852 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.498 ' CB ' ' HB1' ' A' ' 303' ' ' ALA . 7.4 m-20 -98.65 117.32 32.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.566 -0.709 . . . . 0.0 110.206 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.53 ' HB2' ' CB ' ' A' ' 328' ' ' ILE . 13.4 mt -62.27 -23.85 66.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.169 -0.957 . . . . 0.0 109.845 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 302' ' ' ASN . 44.0 t-20 -81.63 -22.27 37.71 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.177 -0.952 . . . . 0.0 109.114 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.498 ' HB1' ' CB ' ' A' ' 300' ' ' ASP . . . -84.4 -30.31 25.48 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.629 -0.669 . . . . 0.0 109.664 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.422 ' O ' HG21 ' A' ' 308' ' ' VAL . 4.4 t -80.92 -34.46 13.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 109.608 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 79.2 mt -78.71 -27.48 44.94 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.398 -0.814 . . . . 0.0 110.623 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.4 -37.15 85.58 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 1.5 mp0 -76.21 -34.46 59.25 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.271 -1.135 . . . . 0.0 109.315 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.479 HG12 ' HB ' ' A' ' 341' ' ' VAL . 95.6 t -78.71 -19.59 13.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.534 -0.729 . . . . 0.0 109.443 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.51 ' O ' ' HB2' ' A' ' 313' ' ' SER . 0.1 OUTLIER -73.67 -43.51 54.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.46 ' N ' HG21 ' A' ' 309' ' ' ILE . . . -90.44 -16.02 29.79 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.665 0.745 . . . . 0.0 109.139 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 307' ' ' GLU . . . -53.9 -61.82 2.06 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.736 -0.603 . . . . 0.0 110.503 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -150.74 37.23 0.64 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.741 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.545 ' HB3' ' CD1' ' A' ' 319' ' ' ILE . 11.3 m -89.5 43.65 1.16 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.121 -0.987 . . . . 0.0 108.948 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.494 ' O ' ' HG2' ' A' ' 317' ' ' ARG . . . 63.18 44.35 97.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.484 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 19.7 m-30 48.82 38.0 11.04 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.0 -1.294 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 2.1 mt-10 69.38 56.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.329 -0.857 . . . . 0.0 110.006 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 314' ' ' GLY . 3.1 mmt180 -68.7 -92.11 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.787 0.803 . . . . 0.0 109.869 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.426 ' CD ' ' HA ' ' A' ' 355' ' ' TRP . 15.6 pt-20 -126.55 58.05 1.41 Allowed 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.544 0.688 . . . . 0.0 109.741 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 313' ' ' SER . 3.5 mt -104.73 130.66 55.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 121.613 -0.679 . . . . 0.0 110.2 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -89.46 103.38 16.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 19.6 p -93.6 123.07 36.68 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 111.291 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.59 78.03 1.49 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 360' ' ' SER . 3.4 mp -90.47 144.84 25.41 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.517 -0.74 . . . . 0.0 110.5 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' LEU . 7.4 t80 -40.7 137.85 1.34 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.574 -0.704 . . . . 0.0 109.634 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -82.7 47.6 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.892 1.469 . . . . 0.0 110.791 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.473 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -159.8 13.59 0.19 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 3.3 p 60.05 116.33 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.997 -1.296 . . . . 0.0 109.638 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.543 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 2.7 mm -67.77 -179.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.737 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.8 mt-10 -171.25 105.76 0.23 Allowed 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.632 0.73 . . . . 0.0 110.644 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.526 ' CG2' ' HG2' ' A' ' 332' ' ' MET . 12.1 m -149.98 163.95 3.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-O 121.597 0.713 . . . . 0.0 110.343 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.2 tptm -79.59 91.44 5.2 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.543 ' CE ' HG13 ' A' ' 337' ' ' ILE . 11.1 ptm -140.56 158.9 43.31 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 110.613 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.525 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 18.1 t-160 -88.96 113.29 55.44 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.45 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 40.0 Cg_endo -64.19 -19.4 65.91 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.59 1.31 . . . . 0.0 109.894 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.523 ' HB2' ' NE2' ' A' ' 333' ' ' HIS . 0.2 OUTLIER -78.14 -53.65 7.14 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 109.995 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.459 ' O ' ' HB1' ' A' ' 340' ' ' ALA . 60.3 p -64.72 -36.25 83.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 0.0 109.937 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.547 HD12 ' CE1' ' A' ' 416' ' ' HIS . 10.1 mm -75.1 -35.99 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.114 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 0.4 OUTLIER -57.04 -50.57 72.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.971 -1.081 . . . . 0.0 108.984 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -27.29 61.14 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.636 -0.665 . . . . 0.0 109.747 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.533 ' CB ' HD11 ' A' ' 412' ' ' ILE . . . -60.25 -49.58 77.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.149 -0.97 . . . . 0.0 110.183 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.479 ' HB ' HG12 ' A' ' 308' ' ' VAL . 21.5 t -77.47 -35.4 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.0 109.952 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.421 ' O ' ' HB ' ' A' ' 346' ' ' VAL . . . -59.32 -27.05 65.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.848 . . . . 0.0 110.299 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . 0.466 ' O ' HG11 ' A' ' 346' ' ' VAL . 0.5 OUTLIER -85.37 -19.94 30.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.461 ' SD ' HG13 ' A' ' 432' ' ' ILE . 0.8 OUTLIER -84.88 -33.09 22.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.455 ' O ' ' HB1' ' A' ' 349' ' ' ALA . 7.9 p -87.75 -24.2 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.224 -0.922 . . . . 0.0 110.322 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 343' ' ' ASN . 7.6 p -65.01 -20.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.154 -0.966 . . . . 0.0 110.234 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.12 -58.84 4.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -69.05 -31.16 69.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 110.175 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 345' ' ' VAL . . . -61.27 -23.94 66.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 109.985 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.32 -41.25 49.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -62.45 1.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.217 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 111.92 -41.71 2.16 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -88.65 83.59 6.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -1.17 . . . . 0.0 110.225 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 374' ' ' ASP . . . 177.57 101.86 0.15 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.587 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.2 OUTLIER -51.56 139.41 20.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.225 -1.161 . . . . 0.0 110.355 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.473 ' HB ' ' CG1' ' A' ' 319' ' ' ILE . 17.0 mt -111.75 167.84 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.749 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 39.9 tttt -148.56 114.97 5.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.951 -1.093 . . . . 0.0 111.12 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.517 ' CG2' HG22 ' A' ' 319' ' ' ILE . 21.7 t -119.24 78.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 109.25 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 95.5 p -110.68 135.24 51.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 110.357 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.482 ' HB3' ' HG ' ' A' ' 323' ' ' LEU . 0.0 OUTLIER -121.33 149.13 43.4 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 109.794 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -147.48 -165.07 11.6 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -175.81 162.64 2.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.961 -1.317 . . . . 0.0 111.32 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 1.2 mt-10 -126.63 174.21 4.4 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 50.5 Cg_endo -77.63 31.11 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.453 1.239 . . . . 0.0 111.488 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.557 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 11.9 p-10 177.88 26.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.069 -1.02 . . . . 0.0 110.766 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 24.4 ptt180 160.61 115.15 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 121.224 0.535 . . . . 0.0 109.861 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -96.23 166.47 11.72 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.145 -0.972 . . . . 0.0 109.26 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 61.9 p-90 -161.09 148.62 15.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.736 -1.228 . . . . 0.0 111.147 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.593 ' CZ ' ' HB2' ' A' ' 434' ' ' ALA . 30.2 p90 -122.84 136.33 54.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.42 -0.8 . . . . 0.0 109.732 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 433' ' ' ARG . 1.9 tt0 -112.23 137.42 50.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.375 -0.828 . . . . 0.0 111.481 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 54.3 t -131.93 107.51 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -109.71 158.22 18.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.071 -1.018 . . . . 0.0 110.664 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 373' ' ' ASP . 5.5 p-10 -168.97 132.33 1.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.374 -0.829 . . . . 0.0 110.15 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.465 ' O ' ' HA3' ' A' ' 354' ' ' GLY . 5.9 m-20 -107.93 154.38 21.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 110.361 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -169.77 -115.09 0.32 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.47 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.789 1.415 . . . . 0.0 110.427 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 172.21 -161.86 33.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.586 ' HA ' " O2'" ' A' ' 451' ' ' ANP . 16.1 mt -131.17 154.67 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -1.205 . . . . 0.0 111.219 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.533 ' N ' HG21 ' A' ' 378' ' ' ILE . . . -73.82 150.38 88.4 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.534 -0.729 . . . . 0.0 109.081 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.38 -22.76 28.78 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 O-C-N 123.84 1.442 . . . . 0.0 110.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -91.09 -26.77 18.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.3 -0.875 . . . . 0.0 111.363 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -88.81 -29.36 19.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.052 -1.03 . . . . 0.0 110.761 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -19.43 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.049 -1.032 . . . . 0.0 110.394 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.49 ' HB2' ' CE1' ' A' ' 385' ' ' HIS . 12.2 mmtt -82.48 -34.44 28.04 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.377 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.571 ' ND1' ' N ' ' A' ' 385' ' ' HIS . 0.1 OUTLIER -107.24 -74.03 0.67 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.243 -0.91 . . . . 0.0 110.743 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.551 HD23 " O4'" ' A' ' 451' ' ' ANP . 0.6 OUTLIER 31.88 49.56 0.13 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.806 -0.559 . . . . 0.0 111.51 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 422' ' ' LEU . 0.2 OUTLIER -155.82 34.65 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.137 -0.977 . . . . 0.0 109.931 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -171.07 154.91 4.27 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.565 -0.709 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.15 96.94 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.798 1.42 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -52.44 158.14 1.31 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.15 -0.969 . . . . 0.0 110.342 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 392' ' ' ARG . 45.4 t -90.22 46.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -0.896 . . . . 0.0 110.28 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 391' ' ' VAL . 0.1 OUTLIER -178.95 48.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 110.195 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -131.67 -74.39 0.11 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -132.0 80.11 1.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.211 -1.17 . . . . 0.0 110.103 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.446 ' O ' ' CB ' ' A' ' 396' ' ' ALA . 42.6 p -166.66 -171.25 1.81 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 395' ' ' SER . . . 64.87 65.45 0.61 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 110.238 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.39 83.1 1.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.448 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 52.3 m 53.28 -97.92 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.269 -0.895 . . . . 0.0 110.242 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.8 tp -122.15 159.12 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.065 -1.022 . . . . 0.0 110.281 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.9 t -48.72 153.54 0.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -131.51 -74.29 0.11 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 94.0 m -73.42 131.68 42.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.33 -1.1 . . . . 0.0 110.713 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 404' ' ' LEU . . . -121.16 140.95 14.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 403' ' ' GLY . 1.7 tt 44.63 92.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.136 -1.214 . . . . 0.0 110.031 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 406' ' ' LEU . . . 146.59 73.18 0.02 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 405' ' ' GLY . 1.7 tp -177.12 67.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.325 -1.103 . . . . 0.0 110.201 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -95.58 130.41 42.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 110.281 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 409' ' ' VAL . 23.6 mm -96.73 155.58 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.062 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.49 ' HA ' HD11 ' A' ' 412' ' ' ILE . 17.4 t -39.51 -56.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.259 -0.901 . . . . 0.0 111.196 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.564 ' O ' ' CB ' ' A' ' 414' ' ' ASP . 7.8 pt20 -48.7 -52.04 25.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.14 -0.975 . . . . 0.0 111.688 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.2 OUTLIER -68.8 -20.72 64.34 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.75 -1.219 . . . . 0.0 111.274 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.533 HD11 ' CB ' ' A' ' 340' ' ' ALA . 16.9 mt -73.94 -75.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.88 -1.138 . . . . 0.0 108.679 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 419' ' ' MET . 21.4 t -54.29 -21.07 5.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.488 -0.757 . . . . 0.0 109.661 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 21.0 t0 -77.34 -40.32 44.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.143 -0.973 . . . . 0.0 109.864 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 0.8 OUTLIER -68.36 -20.36 64.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.284 -0.885 . . . . 0.0 109.65 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.57 ' CD2' ' HE1' ' A' ' 296' ' ' MET . 25.5 m80 -80.36 -26.38 38.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.379 -0.826 . . . . 0.0 110.01 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 2.1 t30 79.43 47.97 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.544 0.688 . . . . 0.0 110.445 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.528 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -118.23 -86.45 1.11 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.558 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.2 OUTLIER 179.14 161.75 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.358 -1.084 . . . . 0.0 111.259 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 410' ' ' GLN . 13.3 tp -152.55 101.53 2.65 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.338 -0.851 . . . . 0.0 108.82 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -111.46 136.41 50.66 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 120.839 -1.163 . . . . 0.0 112.405 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.593 HD13 ' CE2' ' A' ' 387' ' ' PHE . 0.8 OUTLIER -99.46 93.42 5.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.711 0.767 . . . . 0.0 109.317 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 430' ' ' LEU . . . -60.73 141.96 48.17 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.502 HG21 ' HA2' ' A' ' 428' ' ' GLY . 54.7 m -137.14 109.48 7.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.389 -1.065 . . . . 0.0 110.396 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' SER . . . . . 0.521 ' O ' ' HG3' ' A' ' 426' ' ' GLU . 0.3 OUTLIER -101.88 106.1 17.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.896 . . . . 0.0 110.367 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 428' ' ' GLY . 11.3 pt-20 41.81 -111.06 0.14 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.523 -0.735 . . . . 0.0 111.276 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.473 ' C ' ' HD3' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -34.39 -30.77 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.872 0 O-C-N 121.011 -1.056 . . . . 0.0 111.556 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.542 ' O ' ' CD1' ' A' ' 430' ' ' LEU . . . 132.56 27.16 0.62 Allowed Glycine 0 C--N 1.293 -1.832 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -44.92 119.04 2.97 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.642 ' CD2' ' C5 ' ' A' ' 451' ' ' ANP . 2.7 mp -99.49 110.62 23.07 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.947 -1.325 . . . . 0.0 113.129 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.456 ' OG ' ' HA3' ' A' ' 423' ' ' GLY . 0.1 OUTLIER -113.43 111.64 22.29 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.495 ' O ' ' CG ' ' A' ' 370' ' ' GLN . 21.4 mm -87.52 125.78 41.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 120.723 -1.236 . . . . 0.0 112.9 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . 0.501 ' HA ' ' HG3' ' A' ' 370' ' ' GLN . 0.0 OUTLIER -118.8 85.9 2.45 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.95 131.9 35.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.471 -0.768 . . . . 0.0 110.703 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 81.3 m95 -112.79 154.04 26.85 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.245 1.021 . . . . 0.0 111.959 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 416' ' ' HIS . 17.8 mt -143.46 117.0 6.01 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.528 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 42.2 Cg_endo -68.41 143.99 59.93 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 O-C-N 123.549 1.289 . . . . 0.0 111.284 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.577 ' CG1' ' CG2' ' A' ' 440' ' ' VAL . 76.3 t -103.98 90.37 2.95 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.659 -0.651 . . . . 0.0 110.35 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 47.2 Cg_endo -73.32 77.11 2.54 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.961 1.506 . . . . 0.0 110.09 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.577 ' CG2' ' CG1' ' A' ' 438' ' ' VAL . 24.4 t -115.65 152.69 17.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.158 -0.964 . . . . 0.0 110.117 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.464 ' O ' HG21 ' A' ' 441' ' ' THR . 1.3 t -44.27 113.36 0.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.218 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -50.55 -35.57 30.37 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.217 -0.927 . . . . 0.0 110.118 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -99.07 175.66 5.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 110.013 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -125.17 167.35 14.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -168.18 -130.74 1.21 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.45 ' O ' ' CG2' ' A' ' 446' ' ' THR . 9.0 t -123.89 74.55 1.29 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.293 -1.122 . . . . 0.0 110.209 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' A' ' 448' ' ' LYS . 8.4 t -69.16 -174.48 0.64 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.219 -0.926 . . . . 0.0 110.168 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 447' ' ' THR . 0.1 OUTLIER 70.52 91.47 0.09 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.199 -0.938 . . . . 0.0 110.184 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -133.57 87.39 2.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.259 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.642 ' C5 ' ' CD2' ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.217 0.532 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 292' ' ' GLN . . . -105.27 -42.44 1.76 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 291' ' ' GLY . 6.1 tp-100 58.5 128.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.479 -1.012 . . . . 0.0 110.355 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.98 79.84 1.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 110.473 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.32 81.54 37.94 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.779 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.604 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 52.6 Cg_endo -84.45 50.02 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.156 1.608 . . . . 0.0 110.522 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.625 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.4 OUTLIER -94.69 107.65 19.65 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 122.152 0.977 . . . . 0.0 108.37 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.2 mm-40 -123.37 -159.73 0.87 Allowed 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.835 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.62 137.37 32.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 0.0 110.918 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -156.44 153.26 28.56 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.411 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.467 ' HB3' ' OD1' ' A' ' 302' ' ' ASN . 5.2 m-20 -88.22 114.67 25.07 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.532 HD22 ' CE ' ' A' ' 332' ' ' MET . 4.8 mt -64.09 -24.88 67.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 0.0 110.599 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.541 ' CA ' HD21 ' A' ' 323' ' ' LEU . 48.5 p-10 -81.0 -19.9 42.99 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.706 -1.246 . . . . 0.0 109.033 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.513 ' N ' ' OD1' ' A' ' 302' ' ' ASN . . . -87.96 -27.75 21.9 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.577 0.703 . . . . 0.0 109.225 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.483 HG13 HG23 ' A' ' 337' ' ' ILE . 90.4 t -78.85 -36.95 19.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.554 -0.716 . . . . 0.0 109.623 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 84.4 mt -76.34 -35.38 58.76 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.404 -0.81 . . . . 0.0 110.321 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -65.29 -26.59 71.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -84.14 -32.85 24.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.235 -1.156 . . . . 0.0 109.713 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.55 ' CG1' ' CG1' ' A' ' 341' ' ' VAL . 48.0 t -75.75 -21.4 15.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.385 -0.822 . . . . 0.0 109.121 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.589 ' CD1' ' CG1' ' A' ' 358' ' ' VAL . 17.1 mt -78.74 -53.49 13.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 122.109 0.957 . . . . 0.0 108.673 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 315' ' ' TYR . . . -68.21 -15.67 63.67 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.214 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -78.32 -59.17 2.89 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.753 -0.592 . . . . 0.0 111.931 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -118.36 32.84 5.93 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.022 -1.071 . . . . 0.0 112.348 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -129.04 44.34 2.99 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.923 -1.111 . . . . 0.0 109.777 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 59.13 22.32 55.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.479 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 0.3 OUTLIER 60.32 55.18 3.65 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.392 -1.064 . . . . 0.0 109.989 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.525 ' CA ' ' OE1' ' A' ' 316' ' ' GLU . 0.5 OUTLIER 66.7 35.77 5.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.122 -0.986 . . . . 0.0 109.741 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -48.18 62.58 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.899 0.857 . . . . 0.0 109.917 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -150.28 57.05 0.95 Allowed 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 121.51 0.671 . . . . 0.0 110.213 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.544 ' CD1' ' HB3' ' A' ' 313' ' ' SER . 2.7 mp -127.47 131.43 70.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 109.795 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -90.24 105.41 17.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.077 -1.014 . . . . 0.0 109.595 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 17.3 p -90.03 120.51 31.29 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.393 -0.817 . . . . 0.0 110.721 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -140.34 77.45 1.61 Allowed 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.467 -0.77 . . . . 0.0 108.974 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 323' ' ' LEU . 1.1 mp -92.0 163.18 14.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.618 -0.676 . . . . 0.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.457 ' CD1' HG21 ' A' ' 362' ' ' THR . 5.4 t80 -49.01 131.77 15.2 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.224 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -84.74 52.79 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.951 1.501 . . . . 0.0 110.186 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.477 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -162.97 22.42 0.18 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 15.6 p 53.04 104.65 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.338 -1.095 . . . . 0.0 110.15 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.543 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 1.3 mt -74.6 -178.17 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.45 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 5.1 mt-10 -169.8 103.12 0.32 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.611 0.72 . . . . 0.0 110.77 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.471 HG12 ' HB1' ' A' ' 367' ' ' ALA . 31.1 m -137.2 153.53 29.3 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.127 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -73.31 97.73 2.54 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.532 ' CE ' HD22 ' A' ' 301' ' ' LEU . 5.9 ttp -137.27 166.12 24.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.13 -0.981 . . . . 0.0 112.105 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.604 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 22.4 t-160 -103.26 113.86 65.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.523 ' O ' ' CG ' ' A' ' 338' ' ' LYS . 38.3 Cg_endo -63.11 -22.43 73.17 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.635 1.334 . . . . 0.0 111.904 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.531 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 0.7 OUTLIER -83.54 -56.61 3.64 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.664 -1.273 . . . . 0.0 110.601 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 51.5 p -61.96 -38.15 87.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.134 -0.979 . . . . 0.0 110.636 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.561 HD13 ' CE1' ' A' ' 416' ' ' HIS . 23.1 mm -76.24 -33.93 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.11 -0.994 . . . . 0.0 110.157 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 334' ' ' PRO . 4.7 mttt -59.89 -36.25 76.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -42.93 60.26 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.032 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.416 ' CB ' HG23 ' A' ' 412' ' ' ILE . . . -61.54 -35.11 76.83 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.359 -0.838 . . . . 0.0 110.616 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.55 ' CG1' ' CG1' ' A' ' 308' ' ' VAL . 50.7 t -76.12 -34.13 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.207 -0.933 . . . . 0.0 109.646 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.464 ' O ' ' CG2' ' A' ' 346' ' ' VAL . . . -70.66 -22.38 62.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 0.0 109.805 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -80.29 -23.75 40.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 109.969 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 7.8 mtt -85.0 -41.61 15.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.406 -0.809 . . . . 0.0 110.215 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.457 HG11 ' N ' ' A' ' 346' ' ' VAL . 14.3 p -67.46 -22.79 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.885 . . . . 0.0 110.509 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 342' ' ' ALA . 65.3 t -74.16 -24.84 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.101 -0.999 . . . . 0.0 110.16 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -81.63 -31.06 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 110.248 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -89.54 -24.93 21.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 110.197 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 345' ' ' VAL . . . -74.53 -39.43 62.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 110.031 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.71 -70.15 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -48.66 -59.08 3.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -87.45 142.56 18.08 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -139.79 81.27 1.81 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -1.103 . . . . 0.0 110.187 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -159.59 -48.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.565 ' CH2' ' HB2' ' A' ' 357' ' ' LYS . 1.4 t90 -178.65 141.9 0.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.25 . . . . 0.0 110.232 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.524 ' CD1' HG13 ' A' ' 319' ' ' ILE . 3.5 mt -107.23 163.16 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.73 . . . . 0.0 109.746 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.565 ' HB2' ' CH2' ' A' ' 355' ' ' TRP . 0.1 OUTLIER -140.73 93.69 2.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 0.0 109.957 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.589 ' CG1' ' CD1' ' A' ' 309' ' ' ILE . 37.7 t -97.15 105.01 16.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.139 -0.976 . . . . 0.0 109.784 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.2 t -124.88 160.1 29.6 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 110.992 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.531 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.4 t -142.92 130.47 21.26 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.602 -0.686 . . . . 0.0 109.212 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 362' ' ' THR . . . -123.76 -174.36 14.16 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.1 OUTLIER 170.13 163.74 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -1.106 . . . . 0.0 110.801 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.553 ' HB3' ' CD ' ' A' ' 364' ' ' PRO . 3.0 mt-10 -136.64 -168.87 0.2 Allowed Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.553 ' CD ' ' HB3' ' A' ' 363' ' ' GLU . 48.2 Cg_endo -84.79 31.04 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.21 1.11 . . . . 0.0 110.742 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 366' ' ' ARG . 57.3 t-20 -178.64 27.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 0.0 110.795 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.7 OUTLIER 165.63 107.1 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.156 -0.965 . . . . 0.0 111.149 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -106.63 137.89 43.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.277 -0.889 . . . . 0.0 109.214 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.687 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 64.6 p-90 -140.55 154.78 46.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.876 -1.14 . . . . 0.0 110.655 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 434' ' ' ALA . 53.4 p90 -127.28 138.75 53.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.328 -0.857 . . . . 0.0 109.457 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 432' ' ' ILE . 2.9 pt20 -126.99 165.38 19.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.178 -0.951 . . . . 0.0 111.673 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 431' ' ' SER . 3.1 t -141.66 125.78 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 373' ' ' ASP . 30.0 tt0 -124.33 155.2 39.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.752 -1.217 . . . . 0.0 110.598 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.445 ' N ' ' HG2' ' A' ' 372' ' ' GLU . 2.4 p30 -148.14 148.26 30.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.407 -0.808 . . . . 0.0 110.492 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -86.5 95.15 9.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.2 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 168.86 162.94 22.02 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.07 124.59 10.17 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.014 1.534 . . . . 0.0 110.02 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . 0.428 ' HA3' HD11 ' A' ' 430' ' ' LEU . . . -114.14 -90.86 1.81 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.54 HG13 ' CD1' ' A' ' 430' ' ' LEU . 65.7 mt -66.5 165.85 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.234 -1.156 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.517 ' CB ' ' HD2' ' A' ' 380' ' ' PRO . . . -128.97 178.91 1.45 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.253 -0.904 . . . . 0.0 110.003 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 379' ' ' ALA . 43.1 Cg_endo -71.05 -48.92 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.94 1.495 . . . . 0.0 109.653 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . 0.426 ' OE2' ' HG2' ' A' ' 380' ' ' PRO . 1.4 mp0 -91.04 -19.87 22.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.423 -0.798 . . . . 0.0 110.393 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.555 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 59.0 tt0 -81.16 -19.44 43.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.34 -0.85 . . . . 0.0 110.919 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 0.2 OUTLIER -56.95 -27.69 61.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.067 -1.02 . . . . 0.0 110.646 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -86.81 -19.07 29.54 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.13 -0.981 . . . . 0.0 110.546 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.555 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 8.4 m170 -48.18 -56.88 6.8 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.287 -0.883 . . . . 0.0 111.492 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.55 HD13 ' CE2' ' A' ' 387' ' ' PHE . 0.5 OUTLIER -115.34 38.87 3.1 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.96 -1.087 . . . . 0.0 111.342 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.55 ' CE2' HD13 ' A' ' 386' ' ' LEU . 8.9 m-85 -160.63 43.78 0.19 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.175 -0.953 . . . . 0.0 110.11 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.02 140.85 86.83 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.312 -0.868 . . . . 0.0 109.911 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.82 -158.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.044 1.549 . . . . 0.0 110.31 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 390' ' ' PHE . 14.7 p90 -112.26 99.15 7.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.426 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.79 37.32 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.411 0.624 . . . . 0.0 109.904 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? 58.76 68.54 0.81 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 110.355 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -94.99 -95.54 1.68 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.59 120.45 40.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.318 -1.107 . . . . 0.0 110.161 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.467 ' O ' ' HB1' ' A' ' 396' ' ' ALA . 15.3 m -71.56 162.52 29.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 395' ' ' SER . . . 56.5 159.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 396' ' ' ALA . 0.1 OUTLIER -176.51 34.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.231 -0.918 . . . . 0.0 110.141 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 4.4 m -162.25 26.05 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.189 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 tp -123.08 -13.12 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 110.317 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 9.7 p -159.98 43.91 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.182 -0.949 . . . . 0.0 110.282 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -101.99 139.79 14.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.7 t -120.7 -2.92 9.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.266 -1.137 . . . . 0.0 110.269 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -71.57 152.83 49.82 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 4.9 tt -128.67 -61.63 1.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -1.123 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 65.15 134.51 0.02 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 1.3 mt -93.32 -17.75 23.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.226 -1.161 . . . . 0.0 110.263 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.529 ' O ' ' CG2' ' A' ' 408' ' ' ILE . . . -110.05 115.2 29.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.529 ' CG2' ' O ' ' A' ' 407' ' ' ALA . 1.3 pt -168.96 93.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.226 -0.921 . . . . 0.0 110.701 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.7 -18.43 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.395 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -62.34 -61.53 2.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.479 -0.763 . . . . 0.0 110.097 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.419 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.3 OUTLIER -54.23 -23.63 15.49 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.351 -0.843 . . . . 0.0 110.559 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 412' ' ' ILE . 29.6 mm -68.18 -59.93 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.237 -0.914 . . . . 0.0 108.718 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' A' ' 420' ' ' LEU . 38.2 t -67.55 -19.15 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.458 -0.776 . . . . 0.0 109.43 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 7.1 t70 -84.24 -25.33 29.52 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.52 -0.738 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.504 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.4 m120 -75.3 -23.63 57.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.625 ' CD2' ' CE ' ' A' ' 296' ' ' MET . 45.1 m80 -95.75 -36.84 11.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.268 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.1 OUTLIER 80.04 57.1 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 121.435 0.636 . . . . 0.0 110.838 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.531 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -123.53 -84.66 0.66 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.534 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.7 OUTLIER -179.3 165.99 1.46 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.133 . . . . 0.0 111.556 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.467 ' HB2' HG13 ' A' ' 413' ' ' VAL . 15.1 tp -152.22 83.2 1.26 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 421' ' ' GLU . 4.1 mm-40 -101.0 166.51 10.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.915 -1.116 . . . . 0.0 111.643 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.85 123.63 40.88 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.57 0.7 . . . . 0.0 110.231 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.462 ' O ' ' OG1' ' A' ' 424' ' ' THR . . . -125.98 151.66 17.89 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 91.8 m -164.83 124.55 1.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.874 -1.368 . . . . 0.0 111.715 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 427' ' ' ARG . 3.4 p -62.42 121.72 13.93 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 49.58 -96.46 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 425' ' ' SER . 12.5 tpp85 -161.68 24.19 0.12 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.077 -1.014 . . . . 0.0 109.301 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -124.36 -15.66 3.32 Favored Glycine 0 N--CA 1.48 1.597 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -117.64 78.11 0.29 Allowed Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.266 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.602 ' CD2' ' N6 ' ' A' ' 451' ' ' ANP . 1.7 tt -76.79 152.78 35.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.031 -1.276 . . . . 0.0 110.287 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 371' ' ' VAL . 53.4 p -159.7 127.27 4.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.572 -0.705 . . . . 0.0 110.126 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 370' ' ' GLN . 18.1 mm -90.1 134.89 27.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 85.96 2.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.483 -0.761 . . . . 0.0 109.522 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.573 ' HB2' ' CE1' ' A' ' 369' ' ' PHE . . . -88.68 138.43 31.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.265 -0.897 . . . . 0.0 109.87 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.687 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.4 m95 -117.81 154.6 31.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 122.458 1.123 . . . . 0.0 113.067 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.525 ' CD1' HD12 ' A' ' 301' ' ' LEU . 7.9 mt -142.08 114.9 6.46 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.531 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 47.5 Cg_endo -71.07 138.77 34.34 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 O-C-N 123.572 1.301 . . . . 0.0 112.628 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.446 HG21 HG13 ' A' ' 330' ' ' VAL . 7.0 t -112.25 64.75 0.73 Allowed Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.436 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 42.2 Cg_endo -67.34 92.52 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.924 1.486 . . . . 0.0 110.934 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.416 HG21 ' C ' ' A' ' 439' ' ' PRO . 98.8 t -132.52 -76.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.422 -0.799 . . . . 0.0 109.96 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 35.6 p -87.39 150.97 23.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.905 . . . . 0.0 109.901 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 50.34 48.6 22.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.77 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 444' ' ' GLN . . . -92.19 130.32 37.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.34 -0.85 . . . . 0.0 110.579 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 443' ' ' ALA . 13.3 mt-30 54.97 162.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.857 . . . . 0.0 110.496 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -144.16 43.03 1.01 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 3.2 t -103.29 75.42 1.35 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.352 -1.087 . . . . 0.0 110.219 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -144.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 0.0 110.286 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -133.24 165.04 25.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.34 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -79.96 133.63 36.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 110.22 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 CA-C-O 117.954 -1.47 . . . . 0.0 109.541 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.602 ' N6 ' ' CD2' ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 151.95 54.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -103.19 174.41 5.88 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.28 -1.13 . . . . 0.0 110.137 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.95 79.13 6.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.263 -0.898 . . . . 0.0 110.348 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 43.3 mtm -119.52 106.87 41.67 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.226 -0.921 . . . . 0.0 110.415 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.599 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 48.9 Cg_endo -86.9 54.55 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.948 1.499 . . . . 0.0 110.633 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.602 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -96.58 108.62 21.24 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.1 mt-10 -138.09 -152.55 0.43 Allowed 'General case' 0 C--N 1.276 -2.621 0 O-C-N 121.818 -0.551 . . . . 0.0 109.604 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.482 ' CE ' ' C ' ' A' ' 330' ' ' VAL . 1.5 mmt -88.4 141.12 28.8 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 110.594 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.406 ' HB1' ' HE2' ' A' ' 332' ' ' MET . . . -154.15 157.82 39.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.396 -0.815 . . . . 0.0 110.985 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.443 ' O ' HG21 ' A' ' 304' ' ' VAL . 3.1 m-20 -90.85 117.23 29.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.41 -0.807 . . . . 0.0 110.059 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 8.4 mt -67.19 -24.17 65.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 110.015 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 302' ' ' ASN . 9.0 t30 -84.77 -22.94 29.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.871 -1.143 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -83.72 -29.78 27.25 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.43 -0.794 . . . . 0.0 109.334 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 308' ' ' VAL . 19.3 t -78.7 -40.06 23.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.573 -0.705 . . . . 0.0 109.309 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 81.4 mt -72.62 -30.14 64.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.49 -0.756 . . . . 0.0 110.594 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -61.03 -36.0 91.63 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -33.7 57.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.323 -1.104 . . . . 0.0 109.419 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.525 HG12 ' CG1' ' A' ' 341' ' ' VAL . 74.5 t -75.0 -18.93 16.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.505 -0.747 . . . . 0.0 109.244 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.579 ' CG1' ' CG1' ' A' ' 358' ' ' VAL . 5.0 mt -77.16 -46.16 29.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.96 -16.65 63.79 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.626 0.727 . . . . 0.0 109.482 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -74.92 -58.74 3.09 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.677 -0.639 . . . . 0.0 110.542 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.523 ' HB2' ' CG1' ' A' ' 345' ' ' VAL . 2.5 mm-40 -111.12 46.13 1.11 Allowed 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.753 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.584 ' HA ' ' CD1' ' A' ' 319' ' ' ILE . 0.6 OUTLIER -79.1 18.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.331 -0.855 . . . . 0.0 111.302 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 53.34 53.51 34.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 22.5 m-30 46.66 43.07 12.3 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.37 -1.076 . . . . 0.0 110.222 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.3 OUTLIER 65.12 35.92 7.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.906 -1.121 . . . . 0.0 109.667 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.582 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -69.06 -73.24 0.16 Allowed 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.552 -0.718 . . . . 0.0 109.786 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.582 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.2 mt-10 -167.91 78.63 0.16 Allowed 'General case' 0 C--N 1.27 -2.88 0 CA-C-O 121.548 0.689 . . . . 0.0 111.235 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.593 ' CG2' ' CG2' ' A' ' 358' ' ' VAL . 4.2 mm -97.05 121.99 48.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.764 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.436 ' HB3' ' HG3' ' A' ' 357' ' ' LYS . 0.4 OUTLIER -88.73 101.41 13.98 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 108.462 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 16.7 p -90.28 128.28 36.38 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.779 0.8 . . . . 0.0 111.951 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.98 78.15 1.34 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 360' ' ' SER . 5.0 mp -96.94 170.91 8.83 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.462 -0.774 . . . . 0.0 110.334 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.661 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 27.8 t80 -63.22 126.1 88.47 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.321 -0.862 . . . . 0.0 109.925 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -78.71 71.06 7.1 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.938 1.494 . . . . 0.0 110.7 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 172.73 30.35 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.446 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 326' ' ' GLY . 1.7 p 45.99 100.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.162 -1.199 . . . . 0.0 110.499 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.535 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 1.7 mt -71.12 -177.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 O-C-N 121.507 -0.746 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 4.9 mt-10 -167.34 107.65 0.6 Allowed 'General case' 0 C--N 1.289 -2.034 0 O-C-N 121.391 -0.818 . . . . 0.0 111.259 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.482 ' C ' ' CE ' ' A' ' 298' ' ' MET . 7.7 m -137.49 157.45 34.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-O 121.494 0.664 . . . . 0.0 109.97 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 11.2 tptt -78.04 92.5 4.37 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.547 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 3.0 tmm? -150.03 158.74 44.47 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 110.761 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.601 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 6.5 t-160 -91.07 126.6 54.66 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 333' ' ' HIS . 39.1 Cg_endo -61.87 -19.83 67.11 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 123.527 1.277 . . . . 0.0 109.95 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.601 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 4.4 mt -75.73 -57.85 3.64 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.375 -0.828 . . . . 0.0 109.886 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 25.3 p -52.91 -47.67 67.81 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.588 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.518 ' CG1' ' HG3' ' A' ' 332' ' ' MET . 24.1 mm -63.44 -32.15 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.069 -1.02 . . . . 0.0 110.473 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 43.2 mttt -60.69 -40.31 91.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.12 -0.987 . . . . 0.0 109.546 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -42.12 65.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.802 -0.561 . . . . 0.0 111.223 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 344' ' ' MET . . . -67.2 -30.9 70.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.229 -0.92 . . . . 0.0 111.088 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.525 ' CG1' HG12 ' A' ' 308' ' ' VAL . 43.0 t -90.31 -25.4 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.525 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.539 ' O ' ' CG2' ' A' ' 346' ' ' VAL . . . -82.99 -20.22 35.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 110.469 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -88.49 -19.4 26.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.144 -0.973 . . . . 0.0 110.613 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 58.2 mtt -78.21 -36.6 46.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.224 -0.923 . . . . 0.0 110.56 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 312' ' ' GLU . 12.2 p -88.57 -23.58 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.314 -0.866 . . . . 0.0 111.045 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 342' ' ' ALA . 12.1 t -66.19 -19.57 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.997 -1.065 . . . . 0.0 110.348 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -79.74 -33.73 40.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.468 ' O ' ' HA3' ' A' ' 352' ' ' GLY . . . -88.41 -27.79 21.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.083 -1.011 . . . . 0.0 110.751 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.31 -29.61 65.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.154 -0.966 . . . . 0.0 111.329 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 15.7 mtt-85 -77.83 -66.91 0.78 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.995 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 351' ' ' TYR . 13.4 m-30 -90.22 -19.85 23.7 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.149 -0.969 . . . . 0.0 111.129 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 353' ' ' ASN . . . -76.76 -98.15 0.17 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.33 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 352' ' ' GLY . 2.1 t30 76.56 46.7 0.08 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.459 -1.024 . . . . 0.0 109.92 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -130.49 -78.0 0.18 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -137.36 127.8 26.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -1.096 . . . . 0.0 109.687 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.535 ' HB ' HD11 ' A' ' 319' ' ' ILE . 44.9 mt -115.11 159.11 15.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 108.816 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.499 ' CD ' ' HB2' ' A' ' 372' ' ' GLU . 4.2 tttp -148.0 117.51 7.0 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.838 -1.164 . . . . 0.0 111.338 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.593 ' CG2' ' CG2' ' A' ' 319' ' ' ILE . 20.8 t -109.78 135.13 49.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.468 ' HA ' HD13 ' A' ' 323' ' ' LEU . 43.4 t -157.59 164.1 37.63 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.746 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -164.56 132.55 3.35 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -136.15 -163.72 10.0 Favored Glycine 0 C--N 1.29 -2.017 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.661 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.2 OUTLIER -160.02 166.47 29.91 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.277 -1.131 . . . . 0.0 110.417 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.559 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -146.24 -175.88 0.51 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 39.1 Cg_endo -64.93 111.03 1.61 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.449 1.236 . . . . 0.0 110.501 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.544 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 16.9 m120 59.34 40.72 20.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.732 -0.605 . . . . 0.0 110.795 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 1.4 mtt85 -176.83 98.42 0.05 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.156 -0.965 . . . . 0.0 111.192 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -97.53 171.6 8.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.135 -0.978 . . . . 0.0 108.391 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.608 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 22.7 p-90 -171.35 160.8 6.26 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.343 -1.473 . . . . 0.0 111.373 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 53.7 p90 -137.85 132.61 32.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.517 -0.74 . . . . 0.0 109.24 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.591 ' HG3' ' CZ3' ' A' ' 368' ' ' TRP . 22.9 mt-30 -121.53 168.78 11.34 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.06 -1.025 . . . . 0.0 112.353 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 65.2 t -140.08 148.92 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 431' ' ' SER . 9.1 mt-10 -147.05 148.15 31.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.061 -1.024 . . . . 0.0 110.429 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.66 ' OD1' ' N1 ' ' A' ' 451' ' ' ANP . 0.5 OUTLIER -165.28 163.65 20.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.287 -0.883 . . . . 0.0 110.239 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 428' ' ' GLY . 36.6 t0 -107.92 62.69 0.61 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.214 -0.928 . . . . 0.0 110.428 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -87.46 -148.5 14.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.29 -43.52 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.051 1.553 . . . . 0.0 110.211 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 112.05 -176.69 18.22 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.533 HG13 ' CD2' ' A' ' 430' ' ' LEU . 0.8 OUTLIER -99.14 134.68 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.115 -1.227 . . . . 0.0 109.551 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 382' ' ' GLN . . . -50.11 165.3 0.33 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.454 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.67 -38.9 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.079 1.568 . . . . 0.0 111.456 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . 0.475 ' O ' ' CD2' ' A' ' 385' ' ' HIS . 0.7 OUTLIER -89.33 -45.13 9.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.028 -1.045 . . . . 0.0 110.662 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.479 ' HB3' ' HB1' ' A' ' 379' ' ' ALA . 16.6 tt0 -56.52 -18.43 11.58 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -50.44 -33.04 19.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.131 -0.98 . . . . 0.0 109.802 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -90.22 -20.07 23.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.324 -0.86 . . . . 0.0 109.692 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.627 ' CD2' ' N ' ' A' ' 385' ' ' HIS . 1.4 m170 -96.05 25.15 4.99 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.6 ' CD2' ' CD2' ' A' ' 422' ' ' LEU . 0.8 OUTLIER -91.38 19.51 6.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.592 -0.692 . . . . 0.0 111.611 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 29.5 m-85 -160.68 51.16 0.28 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.363 -0.836 . . . . 0.0 110.385 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -138.33 105.69 7.84 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.18 -0.95 . . . . 0.0 110.149 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 390' ' ' PHE . 46.9 Cg_endo -79.01 164.6 24.84 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.941 1.495 . . . . 0.0 110.405 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 389' ' ' PRO . 2.1 t80 -178.72 95.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.683 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 17.9 m -69.84 122.09 20.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.245 -0.909 . . . . 0.0 111.07 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -161.08 0.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.307 -0.87 . . . . 0.0 109.259 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 394' ' ' ASP . . . -130.81 138.21 10.02 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.072 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 393' ' ' GLY . 12.2 t70 56.52 160.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.496 -1.003 . . . . 0.0 110.916 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.421 ' O ' ' HB1' ' A' ' 396' ' ' ALA . 0.1 OUTLIER -135.32 -46.73 0.7 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.43 -0.794 . . . . 0.0 110.064 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 395' ' ' SER . . . 55.35 28.44 11.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.361 -0.837 . . . . 0.0 110.71 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -138.29 -89.38 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.085 -1.01 . . . . 0.0 110.213 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' THR . . . . . 0.491 ' CG2' ' O ' ' A' ' 398' ' ' THR . 13.1 t -151.97 120.19 6.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.417 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.52 ' O ' ' CG2' ' A' ' 399' ' ' ILE . 3.4 tp -98.71 122.87 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.806 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.1 m -107.48 151.69 25.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.192 -0.942 . . . . 0.0 110.326 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 95.67 175.73 36.92 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 61.0 m -81.24 104.91 12.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -1.134 . . . . 0.0 110.086 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 76.86 -102.95 1.71 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 405' ' ' GLY . 0.8 OUTLIER -114.62 81.84 1.62 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.27 -1.136 . . . . 0.0 110.492 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 406' ' ' LEU . . . -62.39 -121.2 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.427 ' CB ' ' O ' ' A' ' 405' ' ' GLY . 0.2 OUTLIER 65.21 38.33 6.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -1.157 . . . . 0.0 110.611 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' A' ' 408' ' ' ILE . . . -69.34 -168.27 0.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.138 -0.976 . . . . 0.0 109.852 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.536 ' CD1' ' HG3' ' A' ' 410' ' ' GLN . 21.1 tt -175.0 153.11 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 0.0 110.54 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.509 HG21 ' N ' ' A' ' 410' ' ' GLN . 32.8 m -56.36 -25.03 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.398 -0.814 . . . . 0.0 110.501 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.536 ' HG3' ' CD1' ' A' ' 408' ' ' ILE . 2.7 mt-30 -51.41 -43.52 62.0 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.192 -0.942 . . . . 0.0 109.761 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -28.8 66.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.476 -0.765 . . . . 0.0 110.301 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.11 -63.04 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.194 -0.941 . . . . 0.0 108.802 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.524 ' CG1' ' HB2' ' A' ' 420' ' ' LEU . 59.5 t -62.6 -23.55 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 23.1 t70 -80.33 -29.95 38.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -80.84 -28.33 36.17 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.451 -0.781 . . . . 0.0 109.5 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.602 ' CD2' ' CE ' ' A' ' 296' ' ' MET . 39.1 m80 -86.95 -34.81 19.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.525 -0.735 . . . . 0.0 109.726 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.0 OUTLIER 75.42 31.57 0.77 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.558 -0.714 . . . . 0.0 111.096 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.518 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -95.9 -83.51 1.65 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.57 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.4 OUTLIER -178.86 161.02 1.17 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -1.053 . . . . 0.0 110.671 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.524 ' HB2' ' CG1' ' A' ' 413' ' ' VAL . 67.2 tp -150.87 93.86 2.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.985 -1.072 . . . . 0.0 109.976 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.557 ' O ' ' CG ' ' A' ' 433' ' ' ARG . 37.3 mt-10 -125.0 140.47 52.89 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.081 -1.012 . . . . 0.0 109.973 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.6 ' CD2' ' CD2' ' A' ' 386' ' ' LEU . 0.6 OUTLIER -121.91 150.68 41.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.908 -1.12 . . . . 0.0 111.569 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 430' ' ' LEU . . . -135.24 -165.82 10.87 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.557 ' HB ' ' HA ' ' A' ' 430' ' ' LEU . 7.3 m 58.48 154.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.584 -1.539 . . . . 0.0 109.888 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' SER . . . . . 0.558 ' CA ' ' O ' ' A' ' 429' ' ' GLY . 60.1 p 179.35 -145.14 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.439 -0.788 . . . . 0.0 109.932 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 427' ' ' ARG . 6.6 pt-20 -50.74 -23.7 2.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.338 -0.851 . . . . 0.0 109.763 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.548 ' HD3' ' N ' ' A' ' 425' ' ' SER . 0.2 OUTLIER -51.26 -44.29 61.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.43 -0.794 . . . . 0.0 110.345 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.416 ' O ' ' OD1' ' A' ' 374' ' ' ASP . . . -155.84 -37.06 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.558 ' O ' ' CA ' ' A' ' 425' ' ' SER . . . -178.72 -131.54 1.59 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.573 ' HG ' ' C4 ' ' A' ' 451' ' ' ANP . 0.2 OUTLIER -153.52 149.4 27.65 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.084 -1.244 . . . . 0.0 109.397 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.516 ' N ' ' HB ' ' A' ' 424' ' ' THR . 35.2 t -149.05 102.72 3.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.992 -1.068 . . . . 0.0 109.826 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.515 ' CD1' ' HB3' ' A' ' 422' ' ' LEU . 9.6 tp -89.82 150.23 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 110.877 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . 0.557 ' CG ' ' O ' ' A' ' 421' ' ' GLU . 0.1 OUTLIER -133.98 106.06 7.05 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.646 -0.659 . . . . 0.0 109.67 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -96.57 146.3 24.95 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.413 -0.805 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.608 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 93.0 m95 -121.07 153.87 36.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.134 -0.979 . . . . 0.0 111.593 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.444 ' HG ' ' C ' ' A' ' 435' ' ' TRP . 7.7 mt -141.12 124.73 10.09 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.518 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 43.5 Cg_endo -68.4 135.71 34.68 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.557 1.293 . . . . 0.0 111.266 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.476 ' CG2' ' HB1' ' A' ' 367' ' ' ALA . 3.2 t -104.13 106.91 55.51 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.931 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.48 57.03 5.96 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.216 1.64 . . . . 0.0 109.945 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 6.7 p -115.11 138.22 46.11 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 O-C-N 121.442 -0.786 . . . . 0.0 110.641 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 23.3 p -76.85 169.05 19.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.461 -0.775 . . . . 0.0 110.583 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 443' ' ' ALA . 17.2 tpp180 -159.09 72.43 0.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.39 -0.819 . . . . 0.0 109.92 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 442' ' ' ARG . . . 60.47 137.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.305 -0.872 . . . . 0.0 110.308 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -127.28 77.76 1.76 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.341 -0.849 . . . . 0.0 109.989 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . 0.466 ' O ' ' OG1' ' A' ' 446' ' ' THR . . . -72.28 -16.91 77.22 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 445' ' ' GLY . 59.7 p 43.7 -142.51 0.16 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.32 -1.106 . . . . 0.0 110.26 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 67.6 p -110.78 121.89 46.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.166 -0.959 . . . . 0.0 110.306 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -155.52 152.37 28.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.327 -0.858 . . . . 0.0 110.313 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -111.31 110.84 21.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.337 -0.852 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 CA-C-O 117.995 -1.447 . . . . 0.0 109.487 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.66 ' N1 ' ' OD1' ' A' ' 373' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.253 0.549 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -82.68 148.16 25.89 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.1 129.77 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.245 -1.15 . . . . 0.0 110.413 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -69.17 87.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 110.418 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 5.3 mtt -68.91 130.32 91.67 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.309 -0.869 . . . . 0.0 109.952 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.538 ' HG2' ' NE2' ' A' ' 333' ' ' HIS . 51.3 Cg_endo -83.42 61.12 7.03 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.994 1.523 . . . . 0.0 111.071 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.568 ' HE2' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -89.03 109.24 20.1 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 24.2 mt-10 -135.93 -157.13 0.77 Allowed 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.993 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.54 ' CG ' ' HE3' ' A' ' 331' ' ' LYS . 0.1 OUTLIER -87.64 141.91 28.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 0.0 110.624 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -155.95 163.98 39.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.64 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.407 ' O ' HG22 ' A' ' 304' ' ' VAL . 0.5 OUTLIER -101.58 114.65 28.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.339 -0.851 . . . . 0.0 110.471 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.528 HD23 ' CD1' ' A' ' 436' ' ' LEU . 14.3 mt -61.23 -25.03 66.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.84 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.517 ' HA ' HD22 ' A' ' 323' ' ' LEU . 40.4 t-20 -80.7 -23.7 39.35 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.197 -0.939 . . . . 0.0 109.365 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.76 -25.59 26.31 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.53 ' O ' ' CG2' ' A' ' 308' ' ' VAL . 5.5 t -83.69 -34.68 10.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.427 -0.795 . . . . 0.0 109.484 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 59.3 mt -79.43 -28.37 41.7 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.346 -0.846 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.14 -35.85 91.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 311' ' ' ALA . 4.3 mt-10 -80.67 -33.63 35.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.294 -1.121 . . . . 0.0 109.79 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 304' ' ' VAL . 27.7 t -77.29 -19.99 14.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 313' ' ' SER . 0.9 OUTLIER -76.11 -51.41 20.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.432 ' N ' HG21 ' A' ' 309' ' ' ILE . . . -77.41 -15.41 59.37 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.404 -0.81 . . . . 0.0 109.456 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 307' ' ' GLU . . . -70.72 -62.49 1.37 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.401 ' OE2' ' O ' ' A' ' 311' ' ' ALA . 9.8 mm-40 -123.05 31.08 6.13 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.586 -1.246 . . . . 0.0 113.351 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.538 ' CB ' HD12 ' A' ' 319' ' ' ILE . 2.6 m -111.26 44.31 1.34 Allowed 'General case' 0 C--N 1.289 -2.052 0 O-C-N 120.641 -1.287 . . . . 0.0 108.964 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 69.8 26.52 74.3 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.496 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 4.8 m-85 59.24 47.7 11.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -1.046 . . . . 0.0 110.322 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 68.42 35.61 3.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.107 -0.996 . . . . 0.0 109.621 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.453 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 14.3 tpp85 -69.06 -81.36 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.642 0.734 . . . . 0.0 110.625 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.493 ' O ' ' CG ' ' A' ' 318' ' ' GLU . 4.3 pt-20 -126.58 72.93 1.36 Allowed 'General case' 0 C--N 1.275 -2.633 0 O-C-N 121.615 -0.678 . . . . 0.0 111.149 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.538 HD12 ' CB ' ' A' ' 313' ' ' SER . 2.6 mp -132.6 138.19 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.002 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -99.48 103.88 15.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.846 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 35.7 p -89.73 122.04 32.45 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.257 -0.902 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -138.81 79.39 1.73 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 323' ' ' LEU . 1.2 mp -88.66 150.28 23.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.478 -0.764 . . . . 0.0 110.386 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.56 ' CD1' HG21 ' A' ' 362' ' ' THR . 36.6 t80 -37.21 145.3 0.27 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.599 -0.688 . . . . 0.0 109.928 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.525 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 51.7 Cg_endo -83.0 59.03 6.56 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 O-C-N 123.966 1.508 . . . . 0.0 110.444 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . 179.74 17.1 0.03 OUTLIER Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.738 -1.22 . . . . 0.0 111.242 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 2.0 m 58.47 115.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.666 -1.49 . . . . 0.0 110.018 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.542 ' CD1' ' HB3' ' A' ' 324' ' ' TYR . 2.0 mm -69.48 178.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 4.9 mt-10 -170.87 106.09 0.26 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.609 0.719 . . . . 0.0 109.971 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.472 HG13 ' HB1' ' A' ' 367' ' ' ALA . 7.8 m -148.16 168.46 3.89 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-O 121.648 0.737 . . . . 0.0 110.539 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -85.09 94.26 8.81 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.554 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 4.7 tmm? -145.17 157.51 44.06 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 110.592 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.591 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 22.2 t-160 -82.79 111.65 31.26 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 37.9 Cg_endo -62.16 -19.3 66.14 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.717 1.377 . . . . 0.0 110.058 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.591 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -81.3 -47.21 13.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.937 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.441 ' O ' HG12 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -65.06 -41.33 95.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.448 -0.782 . . . . 0.0 109.982 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.481 HG13 ' HG3' ' A' ' 332' ' ' MET . 19.6 mm -71.3 -33.67 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.909 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 7.4 mttm -59.06 -60.94 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.706 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -37.15 86.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.482 -0.761 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.551 ' CB ' HG22 ' A' ' 412' ' ' ILE . . . -58.71 -35.56 72.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.92 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.502 HG13 ' CG1' ' A' ' 308' ' ' VAL . 48.2 t -88.33 -21.23 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 111.136 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.469 ' HB3' HG11 ' A' ' 308' ' ' VAL . . . -77.61 -28.74 51.59 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.092 -1.005 . . . . 0.0 111.993 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -89.7 -18.67 25.97 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.786 -1.196 . . . . 0.0 111.793 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.455 ' HG2' ' HA ' ' A' ' 341' ' ' VAL . 3.6 ptp -88.57 -20.93 24.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.73 -1.231 . . . . 0.0 111.077 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.43 ' N ' ' HG3' ' A' ' 344' ' ' MET . 8.2 p -90.6 -20.6 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.086 -1.009 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.43 -20.16 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.047 -1.033 . . . . 0.0 110.994 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -63.83 -31.28 72.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.12 -0.987 . . . . 0.0 110.516 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.483 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -89.73 -21.3 22.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 110.738 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -82.26 -68.72 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.075 -1.015 . . . . 0.0 110.656 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -57.11 -66.9 0.38 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.191 -0.943 . . . . 0.0 110.702 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.53 -39.88 36.61 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.165 -0.959 . . . . 0.0 110.491 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -71.53 163.95 54.1 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -164.38 38.18 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.34 -1.094 . . . . 0.0 109.855 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -123.11 -67.14 0.22 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.6 OUTLIER -173.0 137.26 0.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.164 -1.197 . . . . 0.0 110.386 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.483 ' HB ' HG13 ' A' ' 319' ' ' ILE . 5.3 mt -107.52 167.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -0.76 . . . . 0.0 109.274 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 2.2 tttp -148.93 116.5 6.21 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.027 -1.045 . . . . 0.0 110.822 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.505 HG13 ' CD1' ' A' ' 309' ' ' ILE . 17.5 t -115.51 75.94 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 108.974 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.3 p -104.69 132.06 51.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.818 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 28.8 t -122.0 163.58 19.11 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.55 -0.719 . . . . 0.0 109.522 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.461 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -159.45 -153.37 6.82 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.56 HG21 ' CD1' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -179.65 171.38 1.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.43 -1.041 . . . . 0.0 109.901 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.568 ' CB ' ' CD ' ' A' ' 364' ' ' PRO . 3.8 mt-10 -131.91 -169.54 0.21 Allowed Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.193 -0.942 . . . . 0.0 109.809 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 363' ' ' GLU . 48.3 Cg_endo -84.74 30.0 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.447 0 O-C-N 123.582 1.306 . . . . 0.0 110.963 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 366' ' ' ARG . 3.8 p30 167.86 34.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.31 -0.869 . . . . 0.0 110.18 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 166.75 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.383 -0.823 . . . . 0.0 109.9 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -97.74 162.35 13.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.164 -0.96 . . . . 0.0 109.313 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.674 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 45.3 p-90 -167.31 171.65 10.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.706 -1.246 . . . . 0.0 111.005 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.6 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 20.3 p90 -141.8 143.3 33.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.226 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.495 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 0.1 OUTLIER -132.88 145.62 51.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.133 -0.979 . . . . 0.0 111.725 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.495 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 21.1 t -127.11 132.62 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -123.11 158.56 30.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.945 -1.097 . . . . 0.0 110.39 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 11.2 p-10 -150.88 140.25 21.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.366 -0.834 . . . . 0.0 110.215 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.41 177.38 9.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.335 -0.853 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 107.23 -158.6 14.99 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.17 163.0 40.04 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.947 1.499 . . . . 0.0 110.987 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -105.52 -153.13 21.2 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.644 ' CD1' ' C8 ' ' A' ' 451' ' ' ANP . 1.6 mm -89.87 93.25 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.138 -1.213 . . . . 0.0 110.112 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 383' ' ' ARG . . . -46.61 165.9 0.19 Allowed Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.808 -1.182 . . . . 0.0 109.233 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.1 -19.55 22.72 Favored 'Trans proline' 0 C--N 1.294 -2.301 0 O-C-N 123.482 1.254 . . . . 0.0 110.231 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -84.4 -43.67 14.47 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.306 -0.871 . . . . 0.0 111.331 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.582 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 0.0 OUTLIER -83.89 -34.69 24.49 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.087 -1.008 . . . . 0.0 111.189 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -60.07 -19.61 53.91 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.684 -1.26 . . . . 0.0 109.572 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.486 ' HG2' ' HD2' ' A' ' 383' ' ' ARG . 33.2 mmtt -86.86 -23.64 25.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.554 -0.716 . . . . 0.0 110.61 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.582 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 0.3 OUTLIER -118.45 29.95 7.48 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.983 -1.073 . . . . 0.0 111.49 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.469 HD12 " O4'" ' A' ' 451' ' ' ANP . 13.1 tp -75.92 -123.27 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.027 -1.046 . . . . 0.0 108.713 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.83 32.91 2.46 Favored 'General case' 0 C--N 1.282 -2.355 0 O-C-N 121.068 -1.02 . . . . 0.0 109.731 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -52.06 128.52 38.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.6 -0.687 . . . . 0.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.61 160.07 44.77 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.992 1.522 . . . . 0.0 110.062 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.05 -157.93 0.71 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.08 -1.013 . . . . 0.0 110.468 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.472 ' O ' ' CG1' ' A' ' 391' ' ' VAL . 91.8 t -131.52 39.29 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 110.495 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -176.67 -73.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.164 -0.96 . . . . 0.0 110.263 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 394' ' ' ASP . . . 137.17 -132.22 5.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 394' ' ' ASP . 5.0 p-10 36.63 84.86 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.69 -0.888 . . . . 0.0 110.724 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.2 72.16 0.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.882 . . . . 0.0 110.351 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -96.99 -164.58 1.16 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 110.143 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.26 -113.2 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.99 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 399' ' ' ILE . 10.5 t -144.18 150.63 38.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.862 -1.148 . . . . 0.0 110.093 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 398' ' ' THR . 20.2 mt 42.61 -103.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.149 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 37.1 t -134.94 96.76 3.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.915 -1.115 . . . . 0.0 110.068 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -122.85 -4.8 8.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 90.8 m -129.54 158.02 40.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.134 -1.215 . . . . 0.0 110.258 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 129.11 -4.95 6.39 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.432 ' O ' HD13 ' A' ' 404' ' ' LEU . 1.7 pp -121.52 18.53 11.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -1.107 . . . . 0.0 109.944 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 162.61 126.89 0.84 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 19.1 mt -129.29 82.37 2.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.184 -1.186 . . . . 0.0 110.373 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.29 95.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 109.926 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 412' ' ' ILE . 7.1 tp -116.6 132.48 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.157 -0.964 . . . . 0.0 110.757 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.525 ' HA ' ' CD1' ' A' ' 412' ' ' ILE . 10.4 t -138.44 5.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 109.485 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 414' ' ' ASP . 16.6 mt-30 -90.08 -48.51 7.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.416 -0.802 . . . . 0.0 109.608 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -66.4 -20.98 66.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.444 -0.785 . . . . 0.0 109.738 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.551 HG22 ' CB ' ' A' ' 340' ' ' ALA . 1.1 mp -68.57 -72.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.248 -0.908 . . . . 0.0 108.726 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.511 ' N ' HG23 ' A' ' 412' ' ' ILE . 12.6 t -60.35 -23.22 27.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 21.5 t0 -75.9 -30.18 58.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.459 -0.775 . . . . 0.0 109.728 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.496 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 2.5 m-20 -77.18 -19.93 56.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.207 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.568 ' CD2' ' HE2' ' A' ' 296' ' ' MET . 44.0 m80 -89.79 -28.56 19.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.557 -0.714 . . . . 0.0 109.756 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.5 OUTLIER 78.14 4.6 2.77 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.677 -0.639 . . . . 0.0 110.002 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.543 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -66.52 -91.36 0.05 OUTLIER Glycine 0 N--CA 1.482 1.727 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.545 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 1.4 ttp 178.96 166.31 0.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -1.101 . . . . 0.0 111.413 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 25.1 tp -151.96 90.96 1.57 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.396 -0.815 . . . . 0.0 108.904 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -112.24 143.12 43.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.941 -1.099 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.427 HD22 ' C2 ' ' A' ' 451' ' ' ANP . 0.2 OUTLIER -105.72 111.65 24.41 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 109.747 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.465 ' O ' ' OG1' ' A' ' 424' ' ' THR . . . -98.3 162.78 20.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.499 ' CG2' ' HA ' ' A' ' 427' ' ' ARG . 4.6 m -165.15 116.83 1.15 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -1.229 . . . . 0.0 110.674 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 23.0 t -75.07 98.9 3.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 426' ' ' GLU . 25.7 tt0 55.48 45.84 24.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.363 -0.836 . . . . 0.0 110.111 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.511 ' NH1' ' HG3' ' A' ' 427' ' ' ARG . 10.7 mmt85 46.64 32.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.94 . . . . 0.0 109.958 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -125.02 -46.45 0.24 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -107.11 82.41 0.31 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.626 ' CD2' ' C6 ' ' A' ' 451' ' ' ANP . 0.5 OUTLIER -78.62 135.46 37.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -1.209 . . . . 0.0 110.949 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 28.6 m -148.5 122.14 9.21 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.442 ' O ' ' CG2' ' A' ' 432' ' ' ILE . 1.1 tt -89.39 128.02 41.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.062 -1.024 . . . . 0.0 110.609 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . 0.436 ' HG3' ' HG3' ' A' ' 370' ' ' GLN . 0.5 OUTLIER -107.13 99.67 9.21 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.44 -0.788 . . . . 0.0 110.059 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.6 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -90.32 138.5 31.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.674 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 89.4 m95 -114.97 159.32 20.89 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.284 1.04 . . . . 0.0 113.088 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.528 ' CD1' HD23 ' A' ' 301' ' ' LEU . 32.0 mt -146.33 123.11 5.85 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.543 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 44.4 Cg_endo -74.17 141.83 29.82 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 123.479 1.252 . . . . 0.0 112.18 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.444 HG11 ' HD2' ' A' ' 439' ' ' PRO . 55.0 t -101.8 134.25 20.27 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.758 -0.588 . . . . 0.0 109.862 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.444 ' HD2' HG11 ' A' ' 438' ' ' VAL . 48.8 Cg_endo -70.98 108.73 2.38 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.803 1.422 . . . . 0.0 109.955 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.44 ' CG2' HG13 ' A' ' 438' ' ' VAL . 21.3 t -128.99 127.19 65.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.205 -0.935 . . . . 0.0 110.736 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 442' ' ' ARG . 1.2 t -140.21 66.19 1.4 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 0.0 109.774 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 441' ' ' THR . 0.3 OUTLIER 68.03 -83.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.292 -0.88 . . . . 0.0 109.842 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 442' ' ' ARG . . . 39.84 90.06 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.273 -0.892 . . . . 0.0 110.553 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -109.7 33.9 4.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.152 -0.967 . . . . 0.0 110.115 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . 0.485 ' O ' ' CG2' ' A' ' 446' ' ' THR . . . -167.08 31.77 0.2 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 445' ' ' GLY . 30.7 p -156.47 73.91 0.8 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.223 -1.163 . . . . 0.0 110.34 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 54.7 p -83.12 -49.08 9.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -81.61 95.63 7.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.172 -0.955 . . . . 0.0 110.255 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.88 -165.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.167 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 117.955 -1.469 . . . . 0.0 109.494 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.644 ' C8 ' ' CD1' ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.296 0.57 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -171.05 166.0 39.16 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.33 87.35 4.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -1.17 . . . . 0.0 110.234 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -123.04 42.66 3.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -0.937 . . . . 0.0 110.026 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.452 ' HG2' ' HG3' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -70.85 121.17 83.14 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.336 -0.853 . . . . 0.0 110.06 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.657 ' HB3' ' CD2' ' A' ' 333' ' ' HIS . 48.1 Cg_endo -76.09 176.3 10.21 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.912 1.48 . . . . 0.0 111.078 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.551 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.8 OUTLIER 35.78 51.69 0.73 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.699 1.238 . . . . 0.0 110.16 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.4 OUTLIER -126.5 -156.98 0.77 Allowed 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.24 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.452 ' SD ' ' OE1' ' A' ' 329' ' ' GLU . 0.7 OUTLIER -86.81 125.17 33.77 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.414 -1.429 . . . . 0.0 110.626 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -137.99 158.55 44.1 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.586 0.708 . . . . 0.0 111.572 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.453 ' O ' HG22 ' A' ' 304' ' ' VAL . 0.9 OUTLIER -102.19 112.75 25.55 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.525 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 14.1 mt -60.34 -24.87 65.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.092 -1.005 . . . . 0.0 110.472 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.527 ' HA ' ' CD2' ' A' ' 323' ' ' LEU . 7.7 m-20 -79.52 -23.39 42.94 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.829 -1.17 . . . . 0.0 109.107 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -83.12 -30.37 27.96 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.479 0.657 . . . . 0.0 109.678 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 300' ' ' ASP . 2.9 t -79.02 -31.87 15.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.44 -0.787 . . . . 0.0 109.69 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 97.9 mt -77.64 -31.78 52.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 110.869 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.21 -38.36 95.81 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.471 -1.347 . . . . 0.0 109.897 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 311' ' ' ALA . 48.4 mt-10 -76.32 -34.73 59.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -1.15 . . . . 0.0 109.7 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.525 HG13 ' CG1' ' A' ' 341' ' ' VAL . 63.6 t -77.48 -19.13 14.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.687 0.756 . . . . 0.0 109.701 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.513 ' CD1' ' CG1' ' A' ' 358' ' ' VAL . 0.0 OUTLIER -75.09 -43.85 44.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -90.37 -16.8 28.44 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.506 0.669 . . . . 0.0 110.377 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 307' ' ' GLU . . . -73.25 -41.95 63.09 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.586 -0.696 . . . . 0.0 112.261 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.486 ' HG2' HG22 ' A' ' 345' ' ' VAL . 1.4 pp20? -115.82 17.24 16.14 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.753 -1.179 . . . . 0.0 112.354 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.554 ' HB2' ' CD1' ' A' ' 319' ' ' ILE . 15.4 t -102.99 -39.47 6.9 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.391 1.091 . . . . 0.0 109.621 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 118.12 -40.29 2.35 Favored Glycine 0 C--N 1.263 -3.491 0 N-CA-C 107.326 -2.31 . . . . 0.0 107.326 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 5.8 t80 174.65 37.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 0.2 OUTLIER 58.8 47.59 12.47 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -67.75 -39.7 84.15 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.449 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 317' ' ' ARG . 39.0 mt-10 -154.97 51.74 0.61 Allowed 'General case' 0 C--N 1.273 -2.751 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.437 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 313' ' ' SER . 5.5 mt -118.9 129.34 75.24 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.949 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.493 ' HB3' ' HD3' ' A' ' 357' ' ' LYS . 37.1 tt0 -97.19 103.53 15.47 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.461 HG23 HD11 ' A' ' 309' ' ' ILE . 24.2 p -89.12 128.3 35.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 111.871 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . 0.408 ' O ' ' OG ' ' A' ' 359' ' ' SER . . . -150.57 78.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' A' ' 323' ' ' LEU . 1.9 mp -95.53 159.91 14.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.471 -0.768 . . . . 0.0 111.148 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.637 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 83.5 t80 -47.94 121.44 8.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.622 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.64 78.96 1.96 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.903 1.475 . . . . 0.0 110.718 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 173.15 29.29 0.03 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.524 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 326' ' ' GLY . 2.1 p 44.28 98.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.069 -1.253 . . . . 0.0 110.001 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.547 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -72.43 -179.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.463 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.3 mt-10 -171.39 105.66 0.22 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.68 0.752 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.504 HG13 ' CB ' ' A' ' 367' ' ' ALA . 31.0 m -137.06 158.35 36.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 O-C-N 121.67 -0.644 . . . . 0.0 109.626 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.1 OUTLIER -72.36 91.81 1.37 Allowed 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.831 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.533 ' HG3' ' CD2' ' A' ' 416' ' ' HIS . 3.8 ttp -134.81 168.15 19.57 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 111.255 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.657 ' CD2' ' HB3' ' A' ' 295' ' ' PRO . 19.0 t-160 -101.85 118.09 60.2 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.66 -21.72 64.05 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.41 1.216 . . . . 0.0 110.37 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.585 ' HB2' ' NE2' ' A' ' 333' ' ' HIS . 0.3 OUTLIER -83.4 -68.2 0.73 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.461 -0.774 . . . . 0.0 110.355 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.488 ' HB3' HD11 ' A' ' 412' ' ' ILE . 0.4 OUTLIER -46.55 -44.51 17.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.484 -0.76 . . . . 0.0 110.007 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.6 HD13 ' CE1' ' A' ' 416' ' ' HIS . 37.9 mm -65.16 -46.23 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.393 -0.817 . . . . 0.0 109.53 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 337' ' ' ILE . 0.0 OUTLIER -47.04 -41.98 17.62 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.083 -1.011 . . . . 0.0 108.492 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 343' ' ' ASN . 17.2 mtt180 -73.03 -34.93 66.63 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.433 0.635 . . . . 0.0 110.314 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.472 ' HB1' HG22 ' A' ' 412' ' ' ILE . . . -62.23 -32.62 73.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.763 . . . . 0.0 110.849 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.525 ' CG1' HG13 ' A' ' 308' ' ' VAL . 44.7 t -85.19 -63.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.127 -0.983 . . . . 0.0 110.063 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.541 ' HA ' ' CG2' ' A' ' 345' ' ' VAL . . . -51.39 -19.45 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 110.687 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 339' ' ' ARG . 2.0 t30 -76.2 -42.48 46.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.137 -0.977 . . . . 0.0 111.412 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.425 ' SD ' HD12 ' A' ' 432' ' ' ILE . 5.1 mtt -79.57 -24.89 41.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.975 -1.078 . . . . 0.0 111.413 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 342' ' ' ALA . 16.7 m -88.56 -19.74 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.906 -1.121 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 342' ' ' ALA . 4.7 p -58.72 -36.16 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.916 -1.115 . . . . 0.0 110.544 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.476 ' OD1' ' O2A' ' A' ' 451' ' ' ANP . 0.9 OUTLIER -65.3 -54.38 29.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.897 . . . . 0.0 110.357 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.489 ' O ' ' CA ' ' A' ' 352' ' ' GLY . . . -66.55 -19.82 65.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.891 . . . . 0.0 110.503 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -74.76 -50.32 17.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 110.485 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.08 -73.19 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.915 . . . . 0.0 110.682 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . 0.444 ' O ' ' O ' ' A' ' 352' ' ' GLY . 12.1 m-85 -82.54 -44.6 15.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.225 -0.922 . . . . 0.0 110.828 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 348' ' ' ALA . . . 55.59 103.58 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 353' ' ' ASN . 26.6 t-20 -113.24 24.74 11.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -1.194 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 355' ' ' TRP . . . 178.64 -73.56 0.07 OUTLIER Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.626 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER 178.36 164.81 0.76 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.14 -1.212 . . . . 0.0 109.78 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.537 HD11 ' CG1' ' A' ' 319' ' ' ILE . 0.9 OUTLIER -112.45 163.01 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.279 -0.888 . . . . 0.0 111.183 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.626 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -142.23 124.08 15.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.825 . . . . 0.0 110.002 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.548 ' CG2' HG22 ' A' ' 319' ' ' ILE . 21.7 t -119.92 83.15 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.406 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.458 ' HA ' HD11 ' A' ' 323' ' ' LEU . 47.2 t -113.53 166.56 11.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.319 -0.863 . . . . 0.0 110.528 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.532 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.6 t -156.77 160.07 38.89 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.52 -0.737 . . . . 0.0 109.849 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -149.22 -162.52 10.4 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.637 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -170.62 174.89 4.85 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.905 -1.35 . . . . 0.0 110.782 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.544 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 2.6 mt-10 -160.41 -178.65 0.92 Allowed Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 38.4 Cg_endo -64.11 135.31 46.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.475 1.25 . . . . 0.0 109.908 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.553 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 5.0 p-10 38.74 33.65 0.07 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.614 -0.678 . . . . 0.0 110.699 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.553 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 3.6 mtt180 -172.67 99.93 0.14 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.393 -0.817 . . . . 0.0 111.265 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -110.32 154.8 22.99 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.1 -1.0 . . . . 0.0 108.659 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.621 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 45.9 p-90 -153.4 177.49 10.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.548 -1.345 . . . . 0.0 111.649 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.528 ' CD2' HD13 ' A' ' 436' ' ' LEU . 32.7 p90 -150.44 153.56 36.14 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -145.85 152.87 40.19 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.853 -1.154 . . . . 0.0 111.673 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 432' ' ' ILE . 88.0 t -122.73 141.31 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.537 ' CG ' ' HB2' ' A' ' 431' ' ' SER . 0.8 OUTLIER -121.62 154.93 36.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.061 -1.024 . . . . 0.0 110.732 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -155.0 140.04 17.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -107.72 109.36 20.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 0.0 110.385 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -177.37 -107.32 0.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.13 -172.03 0.8 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.829 1.436 . . . . 0.0 110.671 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . 0.434 ' HA2' HD13 ' A' ' 430' ' ' LEU . . . -144.09 -150.76 5.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.579 HG21 " O2'" ' A' ' 451' ' ' ANP . 11.3 mt -118.55 161.25 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.179 -1.189 . . . . 0.0 110.076 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.425 ' CB ' ' HD2' ' A' ' 380' ' ' PRO . . . -112.02 176.47 1.49 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.094 -1.004 . . . . 0.0 110.555 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 379' ' ' ALA . 47.2 Cg_endo -75.64 -45.04 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.092 1.575 . . . . 0.0 110.643 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -81.34 -35.73 30.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 110.514 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.415 ' HB3' HO2' ' A' ' 451' ' ' ANP . 5.2 mp0 -61.29 -21.49 63.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.268 -0.895 . . . . 0.0 110.307 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -59.58 -30.79 68.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.879 . . . . 0.0 109.987 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 388' ' ' GLN . 0.1 OUTLIER -79.56 -35.39 39.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 385' ' ' HIS . 2.8 m-70 -67.19 -25.73 66.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.203 -0.936 . . . . 0.0 110.417 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.613 ' O ' ' CG ' ' A' ' 387' ' ' PHE . 12.4 mt -88.89 1.45 55.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -0.997 . . . . 0.0 110.21 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 90.4 m-85 -160.74 52.37 0.29 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.714 -0.616 . . . . 0.0 110.389 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 384' ' ' LYS . 0.3 OUTLIER -104.81 136.63 19.14 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.019 -1.05 . . . . 0.0 110.559 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.53 124.96 8.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.877 1.461 . . . . 0.0 109.887 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -90.57 139.92 30.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 57.9 t -139.06 152.26 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.236 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -100.43 145.32 28.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 110.381 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 113.39 -12.9 23.5 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -88.78 115.8 26.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.335 -1.097 . . . . 0.0 110.086 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.55 87.13 2.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.283 -0.886 . . . . 0.0 110.113 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -82.67 -171.41 3.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.939 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -148.11 59.86 1.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.112 -0.993 . . . . 0.0 110.286 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' THR . . . . . 0.417 HG21 ' O ' ' A' ' 398' ' ' THR . 8.9 m -154.75 20.84 0.46 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.882 . . . . 0.0 110.046 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.2 mt -136.46 -66.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 110.357 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 9.1 m 57.13 56.75 5.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.961 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -91.54 -160.87 36.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.39 178.06 5.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.26 -1.141 . . . . 0.0 110.405 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -52.19 106.29 0.33 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 24.8 mt -97.68 164.82 12.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 110.425 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 118.45 33.6 1.19 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.549 ' C ' ' CD2' ' A' ' 406' ' ' LEU . 0.0 OUTLIER -90.56 174.56 7.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.34 -1.094 . . . . 0.0 110.806 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.468 ' HB3' ' HG3' ' A' ' 411' ' ' ARG . . . -109.47 133.58 52.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.638 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.526 ' CD1' HG11 ' A' ' 409' ' ' VAL . 1.7 pp -146.95 -156.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 109.933 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.526 HG11 ' CD1' ' A' ' 408' ' ' ILE . 1.4 p -37.73 -33.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.326 -0.859 . . . . 0.0 110.923 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.491 ' CG ' HD13 ' A' ' 408' ' ' ILE . 1.3 mm100 -65.9 -55.7 15.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.042 -1.036 . . . . 0.0 109.739 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -56.57 -20.77 22.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 336' ' ' SER . 25.4 mm -72.11 -65.91 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 108.569 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 420' ' ' LEU . 86.5 t -59.99 -19.87 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.538 -0.726 . . . . 0.0 109.703 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -82.22 -32.83 29.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.867 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.551 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.4 m-20 -78.7 -28.06 45.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.481 -0.762 . . . . 0.0 109.378 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.6 ' CE1' HD13 ' A' ' 337' ' ' ILE . 41.1 m80 -86.34 -39.03 16.86 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.881 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 1.0 OUTLIER 79.88 45.44 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.393 0.616 . . . . 0.0 110.543 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 419' ' ' MET . . . -107.85 -85.81 1.78 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.552 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.4 ttp 177.99 169.88 0.72 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.321 -1.105 . . . . 0.0 111.019 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.445 ' HB2' HG12 ' A' ' 413' ' ' VAL . 16.1 tp -151.46 89.34 1.49 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.769 . . . . 0.0 109.133 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.38 159.47 15.11 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.095 -1.003 . . . . 0.0 111.525 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.532 ' O ' ' CD1' ' A' ' 422' ' ' LEU . 3.0 pp -134.05 119.45 18.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.606 -0.684 . . . . 0.0 109.535 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.519 ' O ' HD21 ' A' ' 430' ' ' LEU . . . -131.14 170.72 21.27 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.536 ' OG1' ' CD2' ' A' ' 430' ' ' LEU . 88.0 m -165.05 106.9 0.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.057 -1.261 . . . . 0.0 110.448 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 426' ' ' GLU . 1.6 m -41.92 105.54 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.854 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 425' ' ' SER . 7.3 tt0 59.64 -87.04 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 425' ' ' SER . 0.0 OUTLIER -162.76 35.71 0.1 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.127 -0.983 . . . . 0.0 109.424 179.769 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -144.75 -36.55 0.07 OUTLIER Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -85.75 57.98 4.84 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.652 ' CD1' ' N7 ' ' A' ' 451' ' ' ANP . 0.2 OUTLIER -68.06 114.89 6.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.185 -1.185 . . . . 0.0 110.298 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.537 ' HB2' ' CG ' ' A' ' 372' ' ' GLU . 14.6 t -128.32 120.87 27.93 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.429 -0.794 . . . . 0.0 110.312 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.489 HG21 ' O ' ' A' ' 432' ' ' ILE . 1.2 tt -91.73 130.68 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.52 129.46 56.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.999 -1.063 . . . . 0.0 110.771 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -120.07 128.68 53.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.273 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.621 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.8 m95 -102.44 155.62 18.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.94 -1.1 . . . . 0.0 111.591 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.528 HD13 ' CD2' ' A' ' 369' ' ' PHE . 14.6 mt -145.59 129.04 8.41 Favored Pre-proline 0 N--CA 1.485 1.276 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.02 142.23 41.91 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.721 1.38 . . . . 0.0 110.069 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.537 ' HB ' ' HD3' ' A' ' 439' ' ' PRO . 2.6 t -73.35 -47.35 7.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.152 -0.967 . . . . 0.0 110.498 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.537 ' HD3' ' HB ' ' A' ' 438' ' ' VAL . 58.0 Cg_endo -89.63 -170.73 0.46 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.51 1.269 . . . . 0.0 110.333 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 12.0 p -100.5 157.71 4.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.627 -0.671 . . . . 0.0 109.926 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 4.0 p -117.38 140.2 49.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.914 -1.116 . . . . 0.0 110.096 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.13 107.9 18.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.159 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.07 125.11 24.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 110.178 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.77 149.38 49.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 110.131 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 166.15 -161.38 35.01 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 1.9 t -164.23 73.14 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -1.182 . . . . 0.0 110.207 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 447' ' ' THR . 1.6 t -147.89 125.01 11.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.038 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 449' ' ' GLU . 16.5 pttt -107.7 -143.1 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.885 . . . . 0.0 110.298 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.405 ' N ' ' HG3' ' A' ' 448' ' ' LYS . 2.5 tp10 -74.59 131.18 40.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.88 . . . . 0.0 110.178 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 CA-C-O 117.995 -1.447 . . . . 0.0 109.504 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.652 ' N7 ' ' CD1' ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.274 0.559 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -147.75 -147.04 4.45 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -144.07 119.34 10.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -1.159 . . . . 0.0 110.017 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.46 82.82 1.96 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.0 110.483 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.518 ' N ' ' HD3' ' A' ' 295' ' ' PRO . 34.1 mtp -146.39 67.59 11.8 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.154 -0.966 . . . . 0.0 110.385 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.539 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 53.3 Cg_endo -99.45 -163.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 121.948 1.765 . . . . 0.0 111.283 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.593 ' HE3' ' CD2' ' A' ' 416' ' ' HIS . 0.3 OUTLIER 28.83 80.57 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.416 1.103 . . . . 0.0 112.015 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 14.2 mt-10 -148.63 -149.06 0.28 Allowed 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.462 ' HE3' ' N ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -87.64 128.81 35.28 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.74 -1.225 . . . . 0.0 109.527 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . -136.01 158.29 44.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.404 -0.81 . . . . 0.0 111.67 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.441 ' HB2' ' HB1' ' A' ' 303' ' ' ALA . 4.3 m-20 -95.12 117.51 30.33 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.521 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 6.7 mt -63.86 -23.64 67.43 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.05 -1.031 . . . . 0.0 110.191 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.506 ' HA ' ' CD2' ' A' ' 323' ' ' LEU . 29.9 m-20 -79.94 -19.57 47.69 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.904 -1.123 . . . . 0.0 108.569 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.441 ' HB1' ' HB2' ' A' ' 300' ' ' ASP . . . -85.94 -37.21 19.29 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.433 0.635 . . . . 0.0 109.463 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.503 ' O ' ' CG2' ' A' ' 308' ' ' VAL . 22.0 t -74.94 -30.79 24.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.528 -0.732 . . . . 0.0 109.514 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 25.2 mt -78.65 -36.38 43.96 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.285 -0.884 . . . . 0.0 110.428 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -62.06 -39.1 97.16 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 311' ' ' ALA . 1.0 OUTLIER -71.88 -33.66 68.54 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.231 -1.158 . . . . 0.0 108.599 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.529 HG12 ' CG1' ' A' ' 341' ' ' VAL . 93.5 t -75.57 -18.77 15.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.811 0.815 . . . . 0.0 108.9 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.557 ' CD1' ' CG2' ' A' ' 321' ' ' THR . 0.3 OUTLIER -72.71 -45.1 58.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 122.021 0.915 . . . . 0.0 108.648 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.447 ' N ' HG21 ' A' ' 309' ' ' ILE . . . -90.95 -15.86 29.03 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 121.4 -0.813 . . . . 0.0 109.795 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 307' ' ' GLU . . . -61.61 -64.81 0.82 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.658 -0.651 . . . . 0.0 111.297 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.421 ' HG3' ' C ' ' A' ' 311' ' ' ALA . 94.9 mt-10 -142.98 39.2 1.47 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.088 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.537 ' CB ' HD12 ' A' ' 319' ' ' ILE . 19.4 m -88.31 42.74 1.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.892 -1.13 . . . . 0.0 109.161 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' A' ' 315' ' ' TYR . . . 74.07 13.87 80.77 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.58 ' CB ' ' O ' ' A' ' 314' ' ' GLY . 4.0 t80 78.88 63.3 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.893 -0.769 . . . . 0.0 108.926 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.576 ' CG ' ' O ' ' A' ' 315' ' ' TYR . 6.2 pt-20 41.74 45.73 3.11 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.126 0.965 . . . . 0.0 109.907 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.58 ' CG ' ' O ' ' A' ' 314' ' ' GLY . 6.4 mmt180 -68.36 -89.74 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 121.771 0.796 . . . . 0.0 109.808 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.25 65.55 1.41 Allowed 'General case' 0 C--N 1.272 -2.778 0 CA-C-O 121.583 0.706 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.537 HD12 ' CB ' ' A' ' 313' ' ' SER . 2.6 mp -101.27 148.37 7.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 121.52 -0.737 . . . . 0.0 110.113 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -114.28 105.46 13.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.164 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.557 ' CG2' ' CD1' ' A' ' 309' ' ' ILE . 28.2 p -90.55 122.04 33.02 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 111.38 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -129.69 78.36 1.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.506 ' CD2' ' HA ' ' A' ' 302' ' ' ASN . 1.8 mp -93.78 174.18 7.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 111.215 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.629 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 20.8 t80 -61.23 137.84 94.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.651 -0.656 . . . . 0.0 109.906 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.552 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 53.1 Cg_endo -82.46 61.97 7.78 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.963 1.507 . . . . 0.0 110.547 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 178.82 22.2 0.03 OUTLIER Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.777 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 326' ' ' GLY . 2.1 m 55.12 107.3 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.891 -1.358 . . . . 0.0 110.281 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.546 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -81.63 -177.51 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.122 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 1.9 mt-10 -170.92 108.79 0.31 Allowed 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.841 0.829 . . . . 0.0 111.107 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.462 ' N ' ' HE3' ' A' ' 298' ' ' MET . 25.3 m -131.3 159.17 43.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 O-C-N 121.72 -0.613 . . . . 0.0 109.463 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 3.3 tptt -76.4 93.57 3.51 Favored 'General case' 0 C--N 1.288 -2.104 0 C-N-CA 118.681 -1.208 . . . . 0.0 108.909 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.546 ' CG ' HD23 ' A' ' 436' ' ' LEU . 0.0 OUTLIER -134.73 -174.46 3.59 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.818 0.818 . . . . 0.0 111.326 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.601 ' CB ' ' NE2' ' A' ' 416' ' ' HIS . 18.6 t-160 -113.82 117.56 44.07 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 37.1 Cg_endo -59.24 -26.58 82.32 Favored 'Trans proline' 0 C--N 1.289 -2.563 0 O-C-N 123.105 1.055 . . . . 0.0 110.391 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 336' ' ' SER . 0.5 OUTLIER -83.09 -66.47 0.89 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.273 -0.892 . . . . 0.0 110.819 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.535 ' N ' ' HG ' ' A' ' 335' ' ' LEU . 3.5 m -52.88 -42.76 65.6 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.941 -1.099 . . . . 0.0 110.624 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 416' ' ' HIS . 29.6 mm -64.17 -44.45 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.591 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 0.7 OUTLIER -50.72 -46.77 59.18 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.707 -1.246 . . . . 0.0 109.284 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -43.17 93.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 0.0 110.121 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.517 ' HB3' ' CG2' ' A' ' 412' ' ' ILE . . . -47.29 -40.99 18.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.514 -0.741 . . . . 0.0 110.576 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.529 ' CG1' HG12 ' A' ' 308' ' ' VAL . 40.2 t -80.04 -32.14 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 110.47 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.531 ' O ' ' CG2' ' A' ' 346' ' ' VAL . . . -66.78 -23.65 66.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.26 -0.9 . . . . 0.0 110.364 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . 0.46 ' HB2' ' HB3' ' A' ' 407' ' ' ALA . 54.1 t-20 -66.99 -29.88 69.84 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.147 -0.971 . . . . 0.0 110.489 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.403 ' SD ' HG22 ' A' ' 371' ' ' VAL . 42.0 mtt -82.04 -42.9 18.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.208 -0.933 . . . . 0.0 110.498 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' ' 313' ' ' SER . 3.7 p -67.86 -19.6 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.474 -0.766 . . . . 0.0 110.776 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 342' ' ' ALA . 53.0 t -67.99 -20.08 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.14 -0.975 . . . . 0.0 110.657 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.2 -57.38 4.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 110.366 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.435 ' O ' ' HA2' ' A' ' 352' ' ' GLY . . . -79.72 -19.97 47.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.46 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 345' ' ' VAL . . . -74.06 -25.11 59.65 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 110.413 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -73.71 -67.94 0.55 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.204 -0.935 . . . . 0.0 110.295 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -30.45 51.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 110.217 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 348' ' ' ALA . . . 82.95 106.5 0.48 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.498 ' HB3' ' HB3' ' A' ' 374' ' ' ASP . 10.5 m120 -97.5 -57.4 2.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.285 -1.127 . . . . 0.0 110.466 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . 150.99 -17.38 0.93 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.607 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 37.7 t90 -154.37 130.87 10.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.842 -1.387 . . . . 0.0 111.666 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.458 ' HB ' ' CG1' ' A' ' 319' ' ' ILE . 82.1 mt -124.05 158.98 30.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 372' ' ' GLU . 5.9 tttp -136.4 137.95 41.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.628 -1.295 . . . . 0.0 111.672 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.537 HG21 ' CG2' ' A' ' 319' ' ' ILE . 26.0 t -132.85 81.19 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.406 ' HB3' ' HE3' ' A' ' 357' ' ' LYS . 89.1 p -112.14 160.77 17.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.161 -0.962 . . . . 0.0 111.256 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 369' ' ' PHE . 47.2 t -162.16 130.44 4.11 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -118.1 -161.47 11.95 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.629 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.8 OUTLIER -171.36 177.58 3.5 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.748 -1.442 . . . . 0.0 112.014 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.559 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 1.0 OUTLIER -156.29 175.26 3.3 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 38.0 Cg_endo -64.29 116.32 3.67 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.158 1.083 . . . . 0.0 111.289 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.513 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 6.2 m-20 63.07 18.38 10.88 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.743 -0.598 . . . . 0.0 111.147 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 26.9 mtp180 -160.23 108.02 1.64 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.437 -0.789 . . . . 0.0 110.377 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -112.7 179.19 4.04 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.864 -1.147 . . . . 0.0 108.708 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.654 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 11.5 p-90 -171.44 149.04 2.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.825 -1.172 . . . . 0.0 110.11 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 369' ' ' PHE . 4.7 p90 -138.46 142.8 39.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.963 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.518 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 11.9 tt0 -133.31 155.09 50.06 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 110.42 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.518 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 36.7 t -118.78 151.74 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.428 -0.795 . . . . 0.0 110.179 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.537 ' CB ' ' HB3' ' A' ' 357' ' ' LYS . 4.4 tt0 -139.19 117.24 11.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.269 -0.895 . . . . 0.0 109.746 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 373' ' ' ASP . 20.4 p-10 -145.88 143.48 29.61 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.04 -1.038 . . . . 0.0 110.201 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 353' ' ' ASN . 12.4 t0 -74.83 140.76 44.15 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.406 -0.809 . . . . 0.0 109.817 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -179.51 -150.29 8.96 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.07 -162.24 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.975 1.513 . . . . 0.0 110.512 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -140.22 -172.75 12.99 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.586 HG12 ' N9 ' ' A' ' 451' ' ' ANP . 26.0 mt -110.39 140.16 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -1.174 . . . . 0.0 110.568 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -82.56 164.4 47.49 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.407 -0.808 . . . . 0.0 109.872 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.83 -30.25 9.54 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 124.087 1.572 . . . . 0.0 110.732 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -90.39 -21.29 22.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.0 110.483 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.425 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 0.1 OUTLIER -78.88 -21.65 47.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.177 -0.952 . . . . 0.0 110.466 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -49.97 -21.42 1.2 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.151 -0.968 . . . . 0.0 110.467 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.54 -32.19 16.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.24 -0.912 . . . . 0.0 110.482 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.425 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 5.4 m-70 -80.35 -10.88 59.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.319 -0.863 . . . . 0.0 110.893 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.609 ' O ' ' CG ' ' A' ' 387' ' ' PHE . 22.1 tp -82.77 8.05 13.33 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.036 -1.04 . . . . 0.0 111.445 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.609 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 31.2 m-85 -162.53 27.21 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.496 -0.752 . . . . 0.0 110.606 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 387' ' ' PHE . 24.7 mt-30 53.89 162.83 0.05 OUTLIER Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 121.46 -0.775 . . . . 0.0 110.536 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 390' ' ' PHE . 50.5 Cg_endo -82.58 41.66 1.16 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.76 1.4 . . . . 0.0 110.549 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 389' ' ' PRO . 93.7 m-85 59.41 137.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.356 -0.84 . . . . 0.0 110.329 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 42.6 t -84.95 148.97 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.976 . . . . 0.0 110.084 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -130.12 -3.79 4.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.217 -0.927 . . . . 0.0 110.48 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 117.95 -41.28 2.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -143.35 110.64 5.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -1.175 . . . . 0.0 110.517 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.1 t -121.47 -89.34 0.6 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.15 -0.969 . . . . 0.0 110.107 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -151.45 -72.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 109.965 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.3 155.83 10.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 109.883 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.67 138.62 54.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 110.475 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.524 ' O ' ' CG2' ' A' ' 399' ' ' ILE . 0.0 OUTLIER -115.73 120.54 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 110.169 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.45 ' O ' HD11 ' A' ' 399' ' ' ILE . 0.3 OUTLIER -74.49 -141.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.107 -0.996 . . . . 0.0 110.11 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -70.51 -66.93 2.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 32.6 p -108.89 157.87 18.21 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.285 -1.126 . . . . 0.0 110.108 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -120.07 -171.49 14.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 5.7 tp -104.4 74.33 1.17 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.375 -1.074 . . . . 0.0 110.173 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -114.72 164.37 12.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.05 -56.11 1.27 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.211 -1.17 . . . . 0.0 110.214 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.526 ' O ' ' C ' ' A' ' 408' ' ' ILE . . . -105.82 -51.78 2.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.902 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.533 ' O ' ' CG2' ' A' ' 408' ' ' ILE . 1.1 tp 23.1 98.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.622 0 CA-C-O 121.292 0.568 . . . . 0.0 111.605 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.83 1.91 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 1.3 mm100 -74.25 -55.3 6.2 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 110.237 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 1.9 mmt180 -67.8 -31.49 71.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.323 -0.861 . . . . 0.0 109.898 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.517 ' CG2' ' HB3' ' A' ' 340' ' ' ALA . 8.7 mm -67.21 -66.28 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 413' ' ' VAL . 35.4 t -57.11 -23.24 18.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.424 -0.797 . . . . 0.0 109.699 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 29.5 m-20 -78.09 -30.72 49.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.221 -0.925 . . . . 0.0 109.535 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.479 ' HB3' ' HE2' ' A' ' 296' ' ' MET . 1.2 m-20 -109.31 7.29 25.11 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.65 -0.657 . . . . 0.0 109.625 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.601 ' NE2' ' CB ' ' A' ' 333' ' ' HIS . 47.1 m80 -134.64 -62.92 0.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 111.968 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.737 ' HA ' ' CD2' ' A' ' 436' ' ' LEU . 2.4 m-20 -74.73 -99.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.808 0.814 . . . . 0.0 111.61 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 149.11 -35.04 1.08 Allowed Glycine 0 C--N 1.262 -3.551 0 N-CA-C 106.432 -2.667 . . . . 0.0 106.432 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.607 ' HB3' ' HB2' ' A' ' 435' ' ' TRP . 36.4 ttm -123.14 145.69 48.38 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.658 -0.907 . . . . 0.0 109.601 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 413' ' ' VAL . 19.7 tp -150.84 92.71 1.86 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.114 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -107.6 128.8 54.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.372 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 422' ' ' LEU . 2.0 pp -89.81 138.58 31.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.869 . . . . 0.0 109.547 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.474 ' O ' ' HG ' ' A' ' 430' ' ' LEU . . . -149.26 -168.66 15.02 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.555 -1.307 . . . . 0.0 109.903 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.57 ' CG2' ' O ' ' A' ' 429' ' ' GLY . 0.2 OUTLIER 50.09 173.2 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.577 -0.955 . . . . 0.0 111.185 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 424' ' ' THR . 0.2 OUTLIER 172.06 -143.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -58.13 -34.18 69.97 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.36 -0.837 . . . . 0.0 109.893 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.556 ' HG2' ' N ' ' A' ' 428' ' ' GLY . 0.0 OUTLIER -44.65 -27.57 0.5 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.118 -0.989 . . . . 0.0 109.897 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.556 ' N ' ' HG2' ' A' ' 427' ' ' ARG . . . 178.87 54.07 0.08 OUTLIER Glycine 0 N--CA 1.484 1.9 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.57 ' O ' ' CG2' ' A' ' 424' ' ' THR . . . 69.39 144.65 0.18 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.572 HD23 ' C6 ' ' A' ' 451' ' ' ANP . 0.3 OUTLIER -88.68 165.23 14.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.882 -1.364 . . . . 0.0 109.876 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.516 ' N ' ' HB ' ' A' ' 424' ' ' THR . 1.7 p -146.52 162.86 37.42 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.964 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.587 HD13 ' N1 ' ' A' ' 451' ' ' ANP . 13.3 mm -123.8 121.84 63.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -98.99 100.98 12.22 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -110.35 135.05 51.67 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 111.066 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.654 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 88.0 m95 -110.14 138.35 46.64 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 121.064 -1.023 . . . . 0.0 111.255 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.737 ' CD2' ' HA ' ' A' ' 417' ' ' ASN . 9.7 mt -113.46 75.79 2.57 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 417' ' ' ASN . 37.5 Cg_endo -63.05 115.08 2.74 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 O-C-N 124.665 1.876 . . . . 0.0 110.494 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.513 ' CG1' ' HD2' ' A' ' 439' ' ' PRO . 4.6 t -69.66 143.91 93.19 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.384 -0.823 . . . . 0.0 109.682 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.513 ' HD2' ' CG1' ' A' ' 438' ' ' VAL . 53.6 Cg_endo -71.23 -164.26 0.15 Allowed 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.0 1.526 . . . . 0.0 110.418 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.33 39.11 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 121.314 0.578 . . . . 0.0 110.289 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 442' ' ' ARG . 14.4 t -84.53 171.54 12.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -0.892 . . . . 0.0 110.164 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 441' ' ' THR . 5.0 mmt180 54.79 94.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.108 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -151.51 -74.13 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 110.179 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.71 81.52 3.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.963 . . . . 0.0 110.292 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -125.88 84.17 0.35 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 1.8 t -55.96 167.33 0.61 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -1.115 . . . . 0.0 110.275 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 8.9 p -86.11 -48.17 8.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 110.081 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 448' ' ' LYS . 0.0 OUTLIER -150.03 131.36 14.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.906 . . . . 0.0 110.036 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.68 -17.03 61.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 0.0 110.382 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 CA-C-O 118.028 -1.429 . . . . 0.0 109.573 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.587 ' N1 ' HD13 ' A' ' 432' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.276 0.56 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -149.12 -152.63 5.78 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.22 -32.89 4.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.31 -1.112 . . . . 0.0 110.198 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -135.32 77.87 1.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.774 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -116.14 67.72 3.34 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.229 -0.919 . . . . 0.0 111.257 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.473 ' O ' ' HG2' ' A' ' 297' ' ' GLU . 47.0 Cg_endo -73.98 179.18 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.912 1.48 . . . . 0.0 109.542 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.52 ' HE1' ' NE2' ' A' ' 416' ' ' HIS . 0.1 OUTLIER 40.38 48.37 2.39 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.85 1.309 . . . . 0.0 109.304 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.664 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 4.3 mm-40 -127.84 -149.91 0.43 Allowed 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.193 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.532 ' HE3' ' N ' ' A' ' 330' ' ' VAL . 2.1 mmt -84.74 117.49 23.85 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 120.286 -1.508 . . . . 0.0 110.7 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.471 ' HB2' ' HE2' ' A' ' 332' ' ' MET . . . -134.09 162.01 33.29 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.528 0.68 . . . . 0.0 111.129 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 304' ' ' VAL . 4.1 m-20 -95.97 119.01 33.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.654 -0.654 . . . . 0.0 109.867 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.498 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 6.1 mt -65.51 -23.45 66.89 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.091 -1.006 . . . . 0.0 109.654 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.46 ' HA ' HD22 ' A' ' 323' ' ' LEU . 4.5 m-20 -75.68 -19.99 58.74 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.957 -1.09 . . . . 0.0 108.351 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.07 -37.24 19.08 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.524 0.678 . . . . 0.0 109.601 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.515 ' O ' ' CG2' ' A' ' 308' ' ' VAL . 2.5 t -78.8 -28.62 14.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.415 -0.803 . . . . 0.0 109.554 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 72.4 mt -82.85 -31.38 28.04 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.62 -31.99 82.72 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.82 -30.82 26.21 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.268 -1.136 . . . . 0.0 109.251 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.536 HG13 ' CG1' ' A' ' 341' ' ' VAL . 88.7 t -72.58 -26.88 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.305 -0.872 . . . . 0.0 109.32 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.532 ' O ' ' CB ' ' A' ' 313' ' ' SER . 1.0 OUTLIER -75.79 -50.2 24.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.08 -16.7 64.5 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.861 0.839 . . . . 0.0 108.762 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 308' ' ' VAL . . . -67.01 -68.03 0.41 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.453 0.644 . . . . 0.0 110.79 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.487 ' HG3' HG21 ' A' ' 346' ' ' VAL . 0.2 OUTLIER -134.82 49.35 2.23 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.553 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.549 ' HB2' ' CD1' ' A' ' 319' ' ' ILE . 6.2 p -82.32 40.46 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.001 -1.062 . . . . 0.0 109.994 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.542 ' C ' ' CD2' ' A' ' 315' ' ' TYR . . . 53.16 38.15 55.83 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.542 ' CD2' ' C ' ' A' ' 314' ' ' GLY . 3.6 m-85 67.89 34.65 4.16 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.629 -0.924 . . . . 0.0 109.279 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.407 ' OE2' ' HA ' ' A' ' 316' ' ' GLU . 4.9 mm-40 57.52 41.71 25.48 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.241 -0.912 . . . . 0.0 108.614 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.569 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 1.6 tpp180 -68.71 -86.89 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.432 0.634 . . . . 0.0 110.784 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.569 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 5.4 mt-10 -127.04 66.15 1.29 Allowed 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.637 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.549 ' CD1' ' HB2' ' A' ' 313' ' ' SER . 1.5 mp -111.48 120.77 62.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 358' ' ' VAL . 24.0 tt0 -88.33 100.45 13.03 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.343 -0.848 . . . . 0.0 109.79 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 20.7 p -88.46 122.98 32.53 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.52 0.676 . . . . 0.0 110.903 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -144.55 78.94 1.59 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 323' ' ' LEU . 1.7 mp -90.29 164.77 14.24 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 110.125 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 323' ' ' LEU . 5.2 t80 -43.24 136.76 2.95 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.631 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -83.14 51.57 3.68 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.94 1.495 . . . . 0.0 111.232 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.469 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -165.73 -87.77 0.07 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 3.3 m -178.54 105.26 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.613 -0.933 . . . . 0.0 108.98 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.534 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 2.0 mt -74.17 -179.69 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 O-C-N 121.404 -0.81 . . . . 0.0 110.006 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 3.2 mt-10 -170.82 105.63 0.26 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.585 0.707 . . . . 0.0 110.601 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.574 ' CG1' ' CB ' ' A' ' 367' ' ' ALA . 25.4 m -139.23 154.24 25.13 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.302 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.6 OUTLIER -71.7 92.35 1.18 Allowed 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.567 ' HG2' HG13 ' A' ' 337' ' ' ILE . 10.0 tmm? -143.07 158.24 43.78 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.108 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.589 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 9.9 t-160 -100.42 121.24 53.95 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.47 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 38.6 Cg_endo -64.77 -18.81 63.62 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.628 1.33 . . . . 0.0 109.697 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.589 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 0.6 OUTLIER -81.23 -80.01 0.15 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.618 -0.676 . . . . 0.0 110.692 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 96.9 p -44.37 -43.06 7.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.39 -0.819 . . . . 0.0 110.178 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.586 HD13 ' CE1' ' A' ' 416' ' ' HIS . 1.2 mm -66.32 -40.95 88.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.811 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 0.0 OUTLIER -45.45 -38.4 6.08 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -44.39 67.79 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.108 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.526 ' CB ' HG22 ' A' ' 412' ' ' ILE . . . -54.63 -47.99 72.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.61 -0.681 . . . . 0.0 111.089 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.536 ' CG1' HG13 ' A' ' 308' ' ' VAL . 33.3 t -75.62 -28.08 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.132 -0.98 . . . . 0.0 110.403 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 346' ' ' VAL . . . -69.54 -19.89 63.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 110.117 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -88.85 -19.83 25.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.311 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.4 mtt -82.59 -44.78 15.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.243 -0.911 . . . . 0.0 110.373 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.513 ' CG1' ' N ' ' A' ' 346' ' ' VAL . 6.9 p -69.84 -42.82 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.513 ' N ' ' CG1' ' A' ' 345' ' ' VAL . 19.4 t -52.05 -19.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.102 -0.999 . . . . 0.0 110.569 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -67.12 -46.4 74.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.193 -0.942 . . . . 0.0 110.635 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.461 ' HB2' HG22 ' A' ' 356' ' ' ILE . . . -88.78 -19.72 25.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.212 -0.93 . . . . 0.0 110.656 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.3 -27.16 65.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.159 -0.963 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 350' ' ' ARG . 0.0 OUTLIER -83.3 -37.09 23.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 110.123 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.85 -67.44 0.84 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 65.34 52.98 35.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -106.3 -1.94 22.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -1.153 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -145.08 -84.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.615 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -172.7 148.81 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -1.11 . . . . 0.0 109.875 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.465 ' HB ' HG13 ' A' ' 319' ' ' ILE . 1.0 OUTLIER -109.8 153.34 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.869 . . . . 0.0 109.528 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.615 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.1 OUTLIER -144.5 114.69 7.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.986 . . . . 0.0 110.745 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 321' ' ' THR . 55.3 t -109.72 138.64 36.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.488 ' HA ' ' CD1' ' A' ' 323' ' ' LEU . 97.7 p -161.18 173.96 14.35 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 120.502 -1.374 . . . . 0.0 111.507 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.502 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 6.4 p -155.04 131.3 10.33 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.488 0.661 . . . . 0.0 109.826 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 362' ' ' THR . . . -129.91 -172.47 13.16 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 107.986 -2.046 . . . . 0.0 107.986 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 361' ' ' GLY . 0.6 OUTLIER 175.96 176.26 0.25 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.867 -1.372 . . . . 0.0 111.546 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.532 ' OE1' ' CD ' ' A' ' 364' ' ' PRO . 33.3 mm-40 -141.54 175.24 3.14 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.532 ' CD ' ' OE1' ' A' ' 363' ' ' GLU . 47.3 Cg_endo -77.25 26.01 0.46 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.336 1.177 . . . . 0.0 111.388 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 21.3 p-10 -170.19 24.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.065 -1.022 . . . . 0.0 110.202 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.542 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 8.1 ptt180 162.46 109.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.789 -0.569 . . . . 0.0 110.248 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.574 ' CB ' ' CG1' ' A' ' 330' ' ' VAL . . . -100.45 168.9 9.45 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.194 -0.941 . . . . 0.0 109.085 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.688 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 34.8 p-90 -170.98 153.16 3.73 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.587 -1.321 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.632 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 54.4 p90 -121.81 157.15 31.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.175 -0.953 . . . . 0.0 108.638 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.526 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 5.8 tt0 -141.8 159.39 42.33 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.829 -1.17 . . . . 0.0 111.835 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.526 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 96.8 t -137.83 135.73 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.527 ' HB3' ' NH1' ' A' ' 427' ' ' ARG . 18.1 mt-10 -131.21 158.08 41.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.835 -1.165 . . . . 0.0 111.041 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -150.58 142.81 24.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.436 -0.79 . . . . 0.0 109.782 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.65 2.0 20.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.219 -0.926 . . . . 0.0 110.297 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . 0.404 ' O ' ' HA3' ' A' ' 429' ' ' GLY . . . -65.53 -175.15 5.28 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.09 145.69 44.98 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.942 1.496 . . . . 0.0 110.642 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -63.67 -140.34 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.593 ' CD1' ' CD2' ' A' ' 430' ' ' LEU . 0.0 OUTLIER -116.75 118.95 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.147 -1.208 . . . . 0.0 109.957 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.427 ' HB1' ' HB2' ' A' ' 382' ' ' GLN . . . -43.26 161.64 0.19 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.281 -0.887 . . . . 0.0 110.296 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.38 -24.14 16.8 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.939 1.494 . . . . 0.0 110.028 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -88.67 -21.49 23.91 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.392 -0.818 . . . . 0.0 109.876 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.524 ' OE1' " O2'" ' A' ' 451' ' ' ANP . 0.0 OUTLIER -86.17 -30.33 22.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -22.21 66.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.612 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -20.84 63.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.603 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -92.42 21.02 5.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.472 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.582 ' O ' ' CB ' ' A' ' 387' ' ' PHE . 8.5 mt -137.06 95.87 3.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.582 ' CB ' ' O ' ' A' ' 386' ' ' LEU . 13.5 m-85 86.73 72.51 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.769 0.795 . . . . 0.0 109.332 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -40.74 98.57 0.18 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.731 -0.606 . . . . 0.0 111.286 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 387' ' ' PHE . 48.2 Cg_endo -91.1 148.45 3.73 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.995 1.524 . . . . 0.0 109.851 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.85 -173.87 3.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.017 -1.052 . . . . 0.0 110.406 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 39.0 t -94.07 172.72 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.278 -0.889 . . . . 0.0 111.022 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.46 -68.41 0.2 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.38 -0.825 . . . . 0.0 110.148 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 394' ' ' ASP . . . 174.8 156.71 14.61 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 393' ' ' GLY . 12.9 m-20 -156.6 179.82 8.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.25 -1.147 . . . . 0.0 110.433 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 396' ' ' ALA . 1.4 m -72.61 148.81 44.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.305 -0.872 . . . . 0.0 110.268 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 395' ' ' SER . . . 54.91 106.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.314 -0.867 . . . . 0.0 110.047 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.42 138.76 29.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.259 -0.901 . . . . 0.0 110.393 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' THR . . . . . 0.468 ' O ' ' HB ' ' A' ' 399' ' ' ILE . 11.6 m -95.1 -10.81 29.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.308 -0.87 . . . . 0.0 110.04 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 398' ' ' THR . 31.1 mt 58.79 146.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 110.175 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.94 122.77 48.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.067 -1.021 . . . . 0.0 110.42 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -85.04 -158.99 30.4 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.0 m -69.29 154.16 42.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -1.195 . . . . 0.0 109.832 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -119.0 155.62 15.98 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.26 114.65 3.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -1.16 . . . . 0.0 110.339 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -140.54 -36.78 0.11 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -171.07 28.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -1.18 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.488 ' HB3' ' O3G' ' A' ' 451' ' ' ANP . . . -74.3 129.77 38.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.168 -0.957 . . . . 0.0 110.367 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . . . . . . . . . 21.7 mm -124.35 -8.46 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.34 -0.85 . . . . 0.0 109.779 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.493 ' HA ' HG13 ' A' ' 412' ' ' ILE . 14.7 p -116.45 -9.46 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.53 -0.731 . . . . 0.0 109.989 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -68.53 -62.39 1.41 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.297 -0.877 . . . . 0.0 110.315 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -19.99 6.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.241 -0.912 . . . . 0.0 110.497 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.526 HG22 ' CB ' ' A' ' 340' ' ' ALA . 24.7 mm -66.0 -69.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.105 -0.997 . . . . 0.0 108.984 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.499 ' CG2' ' HB2' ' A' ' 420' ' ' LEU . 69.6 t -62.18 -20.72 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 109.437 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.14 -26.48 42.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.469 -0.769 . . . . 0.0 109.85 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.464 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 22.7 m-20 -84.0 -22.93 31.19 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.313 -0.867 . . . . 0.0 109.292 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.586 ' CE1' HD13 ' A' ' 337' ' ' ILE . 41.4 m80 -93.18 -26.16 17.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.504 -0.747 . . . . 0.0 109.686 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 4.2 m120 66.03 59.27 0.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.687 0.756 . . . . 0.0 110.889 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.499 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -128.29 -84.04 0.42 Allowed Glycine 0 N--CA 1.481 1.656 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.557 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.1 OUTLIER -179.07 155.98 0.76 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -1.129 . . . . 0.0 112.011 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.499 ' HB2' ' CG2' ' A' ' 413' ' ' VAL . 15.7 tp -152.76 92.83 1.69 Allowed 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.458 -0.776 . . . . 0.0 108.995 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 432' ' ' ILE . 0.2 OUTLIER -115.22 123.43 48.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.007 -1.058 . . . . 0.0 110.969 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.496 ' CA ' HG13 ' A' ' 432' ' ' ILE . 0.8 OUTLIER -126.5 140.01 52.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.154 -0.966 . . . . 0.0 110.098 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.405 ' HA2' HG13 ' A' ' 378' ' ' ILE . . . 175.46 -169.76 42.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 44.3 m -78.97 154.95 29.16 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.297 -1.119 . . . . 0.0 110.003 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' SER . . . . . 0.57 ' HB2' ' CB ' ' A' ' 431' ' ' SER . 1.8 m -133.42 170.41 15.52 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -49.42 -39.67 33.59 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 120.853 0.358 . . . . 0.0 110.714 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 427' ' ' ARG . 6.8 ptp180 -39.69 -33.19 0.17 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.909 0.861 . . . . 0.0 109.334 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 426' ' ' GLU . . . 106.07 39.78 2.08 Favored Glycine 0 C--N 1.293 -1.822 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . 174.91 -145.85 8.13 Favored Glycine 0 N--CA 1.503 3.109 0 C-N-CA 118.014 -2.041 . . . . 0.0 112.54 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.593 ' CD2' ' CD1' ' A' ' 378' ' ' ILE . 0.9 OUTLIER -66.98 140.06 57.71 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 121.914 0.864 . . . . 0.0 113.008 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.57 ' CB ' ' HB2' ' A' ' 425' ' ' SER . 29.4 t -167.02 112.18 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.496 HG13 ' CA ' ' A' ' 422' ' ' LEU . 15.6 tt -125.83 157.33 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.162 -0.961 . . . . 0.0 110.567 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.73 127.35 18.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.405 -0.81 . . . . 0.0 109.928 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.632 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -109.69 147.27 33.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.271 -0.893 . . . . 0.0 110.129 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.688 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.3 m95 -124.22 155.91 37.73 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.398 1.094 . . . . 0.0 113.246 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.454 ' HG ' ' C ' ' A' ' 435' ' ' TRP . 19.0 mt -145.38 94.8 5.14 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.499 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 42.6 Cg_endo -67.19 146.17 75.21 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.966 1.509 . . . . 0.0 112.896 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 10.8 t -107.3 98.0 21.18 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.836 -0.54 . . . . 0.0 110.379 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 440' ' ' VAL . 49.6 Cg_endo -89.18 -172.02 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.78 1.411 . . . . 0.0 111.577 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.535 ' O ' ' CG1' ' A' ' 440' ' ' VAL . 4.6 p 29.07 111.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 441' ' ' THR . 14.7 t -176.09 48.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 443' ' ' ALA . 0.2 OUTLIER -132.68 -49.78 0.9 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.913 -1.117 . . . . 0.0 110.903 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 444' ' ' GLN . . . -44.26 170.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.074 -1.016 . . . . 0.0 110.815 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 443' ' ' ALA . 14.2 mm100 59.66 78.71 0.26 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.559 -0.713 . . . . 0.0 110.54 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . 0.566 ' O ' ' CG2' ' A' ' 446' ' ' THR . . . -126.56 -32.84 0.69 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.566 ' CG2' ' O ' ' A' ' 445' ' ' GLY . 1.4 t 53.61 141.08 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.688 0.756 . . . . 0.0 111.181 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 446' ' ' THR . 2.0 t 178.1 55.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.216 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -77.84 -29.7 50.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.296 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 450' ' ' GLY . 4.6 tt0 -159.91 -37.13 0.05 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.321 -0.862 . . . . 0.0 110.246 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 449' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.404 0 CA-C-O 118.027 -1.429 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.538 " O5'" HD23 ' A' ' 386' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.19 0.519 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 86.97 -57.68 4.61 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -114.62 174.88 5.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -1.069 . . . . 0.0 109.765 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.4 54.52 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.055 -1.028 . . . . 0.0 110.647 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.544 ' N ' ' HD3' ' A' ' 295' ' ' PRO . 3.3 mtt -145.95 62.51 8.35 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.039 . . . . 0.0 110.827 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.612 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 54.7 Cg_endo -89.89 58.44 1.78 Allowed 'Trans proline' 0 C--N 1.3 -1.974 0 O-C-N 124.095 1.576 . . . . 0.0 110.188 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.526 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.2 OUTLIER -81.84 108.79 15.65 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 122.216 1.008 . . . . 0.0 109.239 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 20.3 mt-10 -133.71 -155.71 0.69 Allowed 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.221 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.06 139.06 30.89 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 111.037 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -155.69 160.09 40.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.576 -0.703 . . . . 0.0 110.523 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.86 114.84 29.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.382 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 328' ' ' ILE . 7.5 mt -59.92 -25.13 64.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.265 -0.897 . . . . 0.0 109.831 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.438 ' CG ' HD21 ' A' ' 323' ' ' LEU . 42.3 t-20 -82.18 -21.53 36.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.939 -1.1 . . . . 0.0 109.356 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.52 -27.54 22.56 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.604 0.716 . . . . 0.0 109.474 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.491 HG12 ' HG3' ' A' ' 338' ' ' LYS . 28.5 t -82.89 -37.05 13.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 121.582 0.706 . . . . 0.0 109.168 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 86.1 mt -79.72 -31.11 41.09 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.475 -0.766 . . . . 0.0 110.117 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.95 -26.73 73.23 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -84.44 -33.52 23.65 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.419 -1.048 . . . . 0.0 109.782 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.566 ' CG1' ' CG1' ' A' ' 341' ' ' VAL . 78.6 t -75.2 -25.42 18.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.395 -0.816 . . . . 0.0 109.469 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.556 HD12 ' CG1' ' A' ' 358' ' ' VAL . 1.6 mt -79.56 -43.45 23.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.734 0.778 . . . . 0.0 108.941 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.2 -17.3 62.52 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.73 0.776 . . . . 0.0 109.048 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -85.7 -45.62 11.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.657 -0.652 . . . . 0.0 110.67 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -99.34 28.68 4.38 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.115 -0.991 . . . . 0.0 110.599 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.474 ' O ' ' OG ' ' A' ' 313' ' ' SER . 1.6 t -97.48 38.08 1.3 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.254 -0.904 . . . . 0.0 109.93 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -99.18 -74.77 1.16 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.461 ' O ' ' HG2' ' A' ' 316' ' ' GLU . 2.7 t80 -93.32 25.78 3.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -1.094 . . . . 0.0 108.689 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.573 ' O ' ' CD1' ' A' ' 319' ' ' ILE . 48.5 mm-40 -160.03 38.21 0.18 Allowed 'General case' 0 C--O 1.192 -1.966 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.445 ' HA ' HD13 ' A' ' 319' ' ' ILE . 0.1 OUTLIER -69.52 -0.99 7.46 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 121.422 0.63 . . . . 0.0 110.002 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.05 33.92 0.45 Allowed 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.918 0.866 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.595 ' CG2' ' CG2' ' A' ' 358' ' ' VAL . 0.7 OUTLIER -89.15 134.86 27.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.432 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -95.87 110.32 22.52 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.012 -1.055 . . . . 0.0 109.119 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.473 HG21 HD12 ' A' ' 309' ' ' ILE . 10.8 p -89.52 123.28 33.48 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.351 -0.843 . . . . 0.0 111.675 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.84 78.41 1.49 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.542 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 5.2 mp -93.93 154.85 17.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.78 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.595 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 79.0 t80 -46.75 132.26 8.43 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.425 -0.797 . . . . 0.0 110.215 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.474 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 46.5 Cg_endo -72.71 78.91 1.99 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.952 1.501 . . . . 0.0 110.318 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . 167.66 7.89 0.03 OUTLIER Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.804 -1.189 . . . . 0.0 111.177 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 0.5 OUTLIER 63.38 116.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 O-C-N 120.555 -1.556 . . . . 0.0 109.57 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.544 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 4.1 mm -69.23 179.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.734 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.544 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 1.9 mt-10 -175.49 104.47 0.08 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.609 0.719 . . . . 0.0 110.674 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.518 ' CG2' ' HG2' ' A' ' 332' ' ' MET . 13.7 m -150.09 172.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 O-C-N 121.702 -0.624 . . . . 0.0 110.323 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -86.22 93.58 9.09 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 119.384 -0.927 . . . . 0.0 108.664 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.535 ' CE ' HD22 ' A' ' 301' ' ' LEU . 11.7 ptm -144.58 166.27 25.64 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.356 -0.84 . . . . 0.0 110.568 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.612 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 19.1 t-160 -92.18 112.22 54.03 Favored Pre-proline 0 C--N 1.297 -1.698 0 O-C-N 121.523 -0.736 . . . . 0.0 109.46 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 41.4 Cg_endo -66.39 -23.62 50.89 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.825 1.434 . . . . 0.0 111.128 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.539 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 1.1 tp -81.99 -62.16 1.71 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.951 -1.093 . . . . 0.0 109.817 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.5 ' OG ' HG13 ' A' ' 412' ' ' ILE . 14.7 t -53.65 -42.94 68.37 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.109 -0.995 . . . . 0.0 109.374 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.526 HG13 ' CE ' ' A' ' 332' ' ' MET . 20.5 mm -60.34 -45.71 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.195 -0.941 . . . . 0.0 109.121 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.491 ' HG3' HG12 ' A' ' 304' ' ' VAL . 20.8 mttm -46.19 -50.25 15.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.0 108.611 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.05 -44.15 78.57 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.544 0.688 . . . . 0.0 110.056 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 344' ' ' MET . . . -54.34 -29.18 47.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.407 -0.808 . . . . 0.0 111.022 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.566 ' CG1' ' CG1' ' A' ' 308' ' ' VAL . 66.3 t -88.76 -43.9 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.079 -1.013 . . . . 0.0 111.24 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.473 ' O ' ' CG2' ' A' ' 346' ' ' VAL . . . -54.4 -38.93 66.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.125 -0.984 . . . . 0.0 110.844 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.88 -34.6 29.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -0.965 . . . . 0.0 110.666 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 340' ' ' ALA . 0.0 OUTLIER -65.73 -28.17 68.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 342' ' ' ALA . 7.7 p -88.53 -22.89 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.013 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 342' ' ' ALA . 89.3 t -76.31 -22.03 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.161 -0.962 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.458 ' CG ' ' O2A' ' A' ' 451' ' ' ANP . 12.1 t30 -69.72 -41.21 75.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.158 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 352' ' ' GLY . . . -79.7 -19.9 47.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.36 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.452 ' HB3' ' HG3' ' A' ' 316' ' ' GLU . . . -83.28 -34.43 25.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.486 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -80.2 -63.7 1.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.625 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -21.72 33.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.13 -0.981 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 353' ' ' ASN . . . -109.46 176.24 19.4 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.067 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 352' ' ' GLY . 27.1 p-10 -178.62 42.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.537 -0.978 . . . . 0.0 109.808 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 355' ' ' TRP . . . -131.38 78.32 0.38 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.469 ' HB3' ' O ' ' A' ' 354' ' ' GLY . 9.9 t90 58.49 138.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -1.076 . . . . 0.0 111.043 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.526 ' CD1' ' OE1' ' A' ' 316' ' ' GLU . 6.5 mt -126.3 164.44 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.495 ' N ' HG21 ' A' ' 356' ' ' ILE . 11.9 tttt -144.38 132.5 21.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.586 -1.321 . . . . 0.0 112.351 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.595 ' CG2' ' CG2' ' A' ' 319' ' ' ILE . 98.9 t -125.54 93.14 2.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 12.8 t -120.84 160.38 23.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 111.145 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.542 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 1.0 OUTLIER -141.68 157.16 45.41 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.569 -0.707 . . . . 0.0 109.469 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.483 ' HA3' ' CZ2' ' A' ' 368' ' ' TRP . . . -146.75 -164.54 11.11 Favored Glycine 0 C--N 1.293 -1.841 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.595 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.1 OUTLIER -171.14 178.96 3.18 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.871 -1.37 . . . . 0.0 111.233 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.496 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 6.2 mt-10 -154.23 177.69 1.9 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.587 -0.695 . . . . 0.0 109.823 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 40.9 Cg_endo -67.74 107.87 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.707 1.372 . . . . 0.0 110.763 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 4.8 t-20 68.77 31.16 4.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.409 -0.807 . . . . 0.0 110.531 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 3.6 mtt180 -176.31 109.4 0.09 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.55 -0.719 . . . . 0.0 109.787 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -113.06 161.12 17.44 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.954 -1.091 . . . . 0.0 110.096 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.6 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 22.3 p-90 -153.74 171.56 18.68 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.927 -1.108 . . . . 0.0 110.886 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -150.54 144.65 25.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.529 -0.732 . . . . 0.0 109.225 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.444 ' NE2' ' HG2' ' A' ' 433' ' ' ARG . 5.2 pt20 -142.38 163.56 32.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.908 -1.12 . . . . 0.0 111.344 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.466 ' O ' ' HG3' ' A' ' 372' ' ' GLU . 17.6 t -128.6 152.83 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.55 -0.719 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 371' ' ' VAL . 1.6 mt-10 -140.23 130.69 25.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.403 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -141.26 150.73 42.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.038 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.69 120.83 43.61 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.198 -0.939 . . . . 0.0 110.762 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -175.59 -107.37 0.21 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.34 -171.08 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.938 1.494 . . . . 0.0 111.186 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -155.62 -178.8 30.18 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.644 ' CD1' ' C8 ' ' A' ' 451' ' ' ANP . 0.7 OUTLIER -107.31 -154.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.039 -1.271 . . . . 0.0 110.691 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 383' ' ' ARG . . . -155.8 161.11 30.17 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.85 -20.72 22.11 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 O-C-N 123.704 1.37 . . . . 0.0 110.963 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.94 -36.75 13.26 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.948 -1.095 . . . . 0.0 111.738 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.611 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 15.3 pt20 -89.65 -30.34 18.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.019 -1.051 . . . . 0.0 111.824 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 379' ' ' ALA . 19.9 ttt-85 -56.12 -18.87 11.1 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.756 -1.215 . . . . 0.0 109.841 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.97 -31.02 39.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.288 -0.883 . . . . 0.0 110.941 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.611 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 5.2 p80 -112.47 1.31 15.86 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.97 -1.081 . . . . 0.0 111.201 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.622 ' CD1' HO2' ' A' ' 451' ' ' ANP . 2.1 tt -95.86 15.07 21.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.158 -0.964 . . . . 0.0 110.173 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 386' ' ' LEU . 0.2 OUTLIER -172.61 47.75 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.417 -0.802 . . . . 0.0 109.949 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -99.52 142.48 24.69 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.407 -0.808 . . . . 0.0 110.011 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 390' ' ' PHE . 48.2 Cg_endo -76.98 -175.4 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.021 1.537 . . . . 0.0 110.735 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 389' ' ' PRO . 1.1 t80 60.4 131.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.429 -0.794 . . . . 0.0 110.82 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 391' ' ' VAL . 3.2 p -73.82 137.98 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.954 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.98 129.36 55.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.144 -0.973 . . . . 0.0 110.441 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 175.45 84.02 0.06 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.74 82.59 6.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.201 -1.176 . . . . 0.0 110.114 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 397' ' ' ARG . 0.7 OUTLIER -143.72 172.87 12.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.329 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 397' ' ' ARG . . . 42.75 -94.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 110.343 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 395' ' ' SER . 0.2 OUTLIER 41.32 79.03 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.223 -0.923 . . . . 0.0 110.505 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 399' ' ' ILE . 6.0 t -155.2 -43.57 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.942 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.433 ' N ' HG22 ' A' ' 398' ' ' THR . 19.2 mm -128.07 -69.38 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.383 -0.823 . . . . 0.0 110.107 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 2.8 p -161.85 92.48 0.86 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.206 -0.934 . . . . 0.0 110.082 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -94.57 -141.05 11.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.03 -63.18 0.17 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.302 -1.116 . . . . 0.0 110.049 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 66.96 92.56 0.04 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 34.0 mt -124.56 -166.32 1.5 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.414 -1.05 . . . . 0.0 109.666 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -168.18 -172.85 35.58 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.493 -1.337 . . . . 0.0 109.931 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 18.7 mt -115.27 34.51 4.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.472 -1.017 . . . . 0.0 109.963 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -81.89 94.45 7.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.51 HD11 ' O ' ' A' ' 408' ' ' ILE . 1.9 pp -102.82 30.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.309 -0.87 . . . . 0.0 109.84 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.479 ' O ' ' HB ' ' A' ' 412' ' ' ILE . 6.0 p -143.04 -36.32 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 109.809 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -69.8 -51.55 32.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.093 -1.004 . . . . 0.0 109.707 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 29.1 mmt180 -56.17 -19.06 11.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.297 -0.877 . . . . 0.0 109.88 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' A' ' 413' ' ' VAL . 0.8 OUTLIER -65.42 -63.31 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.948 . . . . 0.0 108.817 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 419' ' ' MET . 7.0 t -67.13 -22.04 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.15 -0.969 . . . . 0.0 109.196 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.401 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 8.3 t70 -76.26 -27.93 56.88 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.671 -0.643 . . . . 0.0 109.648 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.526 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 0.3 OUTLIER -79.67 -12.36 59.82 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.386 -0.821 . . . . 0.0 109.322 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.539 ' O ' ' CB ' ' A' ' 417' ' ' ASN . 30.1 m80 -97.2 -29.42 13.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.544 -0.722 . . . . 0.0 109.649 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.1 t-20 77.93 13.77 1.67 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.69 -0.631 . . . . 0.0 110.483 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.548 ' HA2' ' CD ' ' A' ' 437' ' ' PRO . . . -82.48 -87.87 0.72 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.54 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 37.2 ttm -176.94 158.57 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -1.194 . . . . 0.0 111.338 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.467 ' HB2' ' CG1' ' A' ' 413' ' ' VAL . 27.4 tp -152.57 98.79 2.4 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.181 -0.949 . . . . 0.0 109.059 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -126.31 167.8 15.01 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.75 -1.219 . . . . 0.0 112.511 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.4 HD23 ' C2 ' ' A' ' 451' ' ' ANP . 35.0 mt -89.95 141.24 28.84 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.226 0.536 . . . . 0.0 109.962 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 431' ' ' SER . . . -108.38 163.92 12.76 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.539 ' CG2' ' HA2' ' A' ' 428' ' ' GLY . 20.8 m -138.27 131.36 30.03 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.293 -1.122 . . . . 0.0 109.948 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 2.6 m -116.4 96.85 5.72 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.903 . . . . 0.0 110.27 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 428' ' ' GLY . 20.7 tt0 52.63 -106.82 0.31 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.222 -0.924 . . . . 0.0 109.991 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.469 ' C ' ' HD3' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -42.4 -27.52 0.16 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.823 -1.173 . . . . 0.0 109.926 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.539 ' HA2' ' CG2' ' A' ' 424' ' ' THR . . . 126.79 26.85 1.09 Allowed Glycine 0 C--N 1.291 -1.928 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 428' ' ' GLY . . . -40.78 142.73 0.74 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.597 HD13 ' C5 ' ' A' ' 451' ' ' ANP . 3.5 mm? -86.17 111.05 20.02 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.301 -1.117 . . . . 0.0 110.653 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 423' ' ' GLY . 17.7 m -125.49 102.24 7.3 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.89 122.46 40.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.966 -1.083 . . . . 0.0 111.208 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . 0.444 ' HG2' ' NE2' ' A' ' 370' ' ' GLN . 12.2 mtt180 -107.75 116.1 31.34 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.535 0.683 . . . . 0.0 110.276 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -108.0 129.27 55.13 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.6 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 82.5 m95 -103.12 153.75 20.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.882 -1.136 . . . . 0.0 112.064 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.454 ' HG ' ' C ' ' A' ' 435' ' ' TRP . 14.7 mt -143.91 81.84 11.52 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.548 ' CD ' ' HA2' ' A' ' 418' ' ' GLY . 45.6 Cg_endo -70.55 133.6 24.48 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 O-C-N 124.02 1.537 . . . . 0.0 111.737 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.51 HG23 ' HB ' ' A' ' 330' ' ' VAL . 5.8 t -92.4 120.94 67.26 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.587 -0.695 . . . . 0.0 109.903 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.46 -168.6 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.742 1.391 . . . . 0.0 109.903 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.448 ' O ' ' CG1' ' A' ' 440' ' ' VAL . 6.5 p -130.61 132.31 64.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 O-C-N 121.665 -0.647 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 442' ' ' ARG . 17.0 p -122.84 126.58 47.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.283 -0.885 . . . . 0.0 110.052 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 441' ' ' THR . 0.1 OUTLIER 168.91 38.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.206 -0.933 . . . . 0.0 110.217 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -94.92 -44.02 7.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.134 -0.979 . . . . 0.0 110.246 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -146.75 158.03 43.82 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.202 -0.937 . . . . 0.0 110.323 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -163.56 111.14 0.46 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.0 p -126.06 172.43 9.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -1.19 . . . . 0.0 110.014 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 447' ' ' THR . 7.9 t -151.26 98.29 2.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.207 -0.933 . . . . 0.0 110.286 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -127.34 -54.27 1.36 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.396 -0.815 . . . . 0.0 110.105 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -47.07 111.98 0.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.418 -0.801 . . . . 0.0 110.422 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.644 ' C8 ' ' CD1' ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 290' ' ' THR . 13.9 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.316 0.579 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -163.91 36.37 0.3 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -122.79 140.06 53.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.419 -1.048 . . . . 0.0 110.448 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -84.99 84.3 7.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.898 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.03 166.09 31.74 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.307 -0.871 . . . . 0.0 110.279 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' A' ' 333' ' ' HIS . 47.6 Cg_endo -90.08 -158.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.087 1.572 . . . . 0.0 109.887 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.526 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 43.6 79.94 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 122.638 1.209 . . . . 0.0 109.479 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.654 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.7 OUTLIER -146.31 -147.53 0.22 Allowed 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.836 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.513 ' HE3' ' N ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -85.87 127.76 34.66 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.07 -1.019 . . . . 0.0 110.716 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -143.32 159.32 42.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.466 0.65 . . . . 0.0 110.996 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 303' ' ' ALA . 7.6 m-20 -91.13 108.55 19.95 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 2.5 mt -57.83 -30.25 65.59 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.276 -0.89 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 303' ' ' ALA . 53.1 p-10 -79.53 -19.87 48.51 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.845 -1.159 . . . . 0.0 109.883 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.522 ' N ' ' OD1' ' A' ' 302' ' ' ASN . . . -84.12 -27.95 27.81 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.377 -0.827 . . . . 0.0 109.103 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.487 HG11 ' HD3' ' A' ' 338' ' ' LYS . 62.3 t -81.04 -38.51 16.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.786 0.803 . . . . 0.0 109.352 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 71.2 mt -77.1 -26.43 53.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 110.385 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -65.82 -31.16 78.87 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -83.0 -33.13 26.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -1.153 . . . . 0.0 109.628 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 58.9 t -78.32 -19.29 13.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.439 -0.788 . . . . 0.0 109.667 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.491 ' CG1' HG12 ' A' ' 358' ' ' VAL . 0.9 OUTLIER -83.57 -42.98 17.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.674 0.749 . . . . 0.0 109.259 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.84 -18.5 60.93 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.705 0.764 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.54 -55.1 3.71 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.753 0.787 . . . . 0.0 110.51 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.406 ' HB3' HG21 ' A' ' 346' ' ' VAL . 58.1 mp0 -104.48 50.65 0.79 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.721 0.772 . . . . 0.0 109.206 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.514 ' C ' ' CD1' ' A' ' 319' ' ' ILE . 0.3 OUTLIER -76.03 32.94 0.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.77 -0.581 . . . . 0.0 111.545 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 53.76 48.46 61.62 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 1.7 t80 53.82 37.03 25.51 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.444 -1.033 . . . . 0.0 110.079 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 5.5 mt-10 61.09 37.33 17.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.792 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.555 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 19.7 tpp180 -69.05 -85.2 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.575 0.703 . . . . 0.0 109.667 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.555 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.2 pt-20 -169.2 67.21 0.06 Allowed 'General case' 0 C--N 1.273 -2.718 0 O-C-N 121.538 -0.726 . . . . 0.0 110.526 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.514 ' CD1' ' C ' ' A' ' 313' ' ' SER . 1.8 mp -90.95 129.89 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 109.707 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -89.08 103.12 15.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.663 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 18.3 p -88.81 123.81 33.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.419 -0.801 . . . . 0.0 111.094 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' A' ' 359' ' ' SER . . . -146.55 79.09 1.52 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.534 ' N ' HD11 ' A' ' 323' ' ' LEU . 5.8 mp -88.41 157.08 18.8 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.379 -0.825 . . . . 0.0 110.322 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.539 ' CD1' HG21 ' A' ' 362' ' ' THR . 21.7 t80 -40.39 141.99 0.8 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.504 -0.747 . . . . 0.0 110.422 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.411 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.0 Cg_endo -83.07 60.32 7.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.04 1.547 . . . . 0.0 111.205 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . -176.92 -75.25 0.05 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.5 OUTLIER 165.05 116.57 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.581 -0.952 . . . . 0.0 108.932 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.536 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 2.7 mm -69.27 178.17 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.061 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.5 mt-10 -173.65 101.44 0.11 Allowed 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 121.469 0.652 . . . . 0.0 110.697 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.513 ' N ' ' HE3' ' A' ' 298' ' ' MET . 16.5 m -143.65 161.26 16.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.094 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -81.13 92.4 6.27 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.552 ' HG2' HG13 ' A' ' 337' ' ' ILE . 22.0 ttp -144.79 153.99 42.23 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.712 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.578 ' CD2' ' HB2' ' A' ' 295' ' ' PRO . 7.3 t-160 -78.73 119.84 78.73 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.778 -0.577 . . . . 0.0 109.682 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.466 ' O ' ' HD3' ' A' ' 338' ' ' LYS . 43.5 Cg_endo -70.75 -21.16 29.24 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.662 1.348 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.54 ' HG ' ' N ' ' A' ' 336' ' ' SER . 0.1 OUTLIER -84.52 -63.01 1.41 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.235 -0.916 . . . . 0.0 110.188 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.54 ' N ' ' HG ' ' A' ' 335' ' ' LEU . 3.1 m -52.78 -35.4 56.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.903 -1.123 . . . . 0.0 110.096 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.618 HD13 ' CE1' ' A' ' 416' ' ' HIS . 3.1 mm -73.93 -45.88 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.221 -0.924 . . . . 0.0 110.032 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.487 ' HD3' HG11 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -43.33 -44.32 5.47 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.13 -0.981 . . . . 0.0 109.197 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -49.9 59.77 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.522 0.677 . . . . 0.0 110.315 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.48 ' HB3' HG12 ' A' ' 412' ' ' ILE . . . -52.23 -30.91 29.7 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.301 -0.874 . . . . 0.0 111.674 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 40.9 t -89.94 -23.73 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.913 -1.117 . . . . 0.0 111.424 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.51 -24.81 60.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.002 -1.061 . . . . 0.0 111.137 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -90.16 -19.0 24.76 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.024 -1.047 . . . . 0.0 111.673 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.6 ttm -82.28 -25.42 34.04 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.917 -1.114 . . . . 0.0 112.196 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.477 HG21 ' N ' ' A' ' 346' ' ' VAL . 23.3 m -90.39 -32.39 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.685 -1.259 . . . . 0.0 111.869 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.477 ' N ' HG21 ' A' ' 345' ' ' VAL . 73.4 t -74.28 -21.14 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 120.971 -1.08 . . . . 0.0 110.79 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -79.95 -19.97 46.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.041 -1.037 . . . . 0.0 110.421 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.495 ' O ' ' HA3' ' A' ' 352' ' ' GLY . . . -89.92 -20.09 23.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 0.0 110.511 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -80.79 -21.31 41.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.096 -1.002 . . . . 0.0 110.773 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 346' ' ' VAL . 4.9 mmt180 -87.76 -70.09 0.65 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.091 -1.005 . . . . 0.0 110.535 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . 0.437 ' O ' ' C ' ' A' ' 352' ' ' GLY . 0.2 OUTLIER -77.43 -35.11 54.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 110.377 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 348' ' ' ALA . . . -42.41 -51.65 5.4 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 352' ' ' GLY . 36.4 m-20 43.27 50.1 5.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.296 -1.12 . . . . 0.0 110.356 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -162.02 -80.74 0.04 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.044 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.1 OUTLIER -165.69 149.66 8.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.145 -1.209 . . . . 0.0 109.854 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.507 ' CD1' HG13 ' A' ' 319' ' ' ILE . 8.3 mt -114.41 165.67 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.218 -0.926 . . . . 0.0 110.73 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.4 OUTLIER -148.4 101.32 3.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.189 -0.944 . . . . 0.0 110.391 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 321' ' ' THR . 99.0 t -104.45 88.08 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.108 -0.995 . . . . 0.0 109.803 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.431 ' CB ' ' HB2' ' A' ' 322' ' ' ALA . 53.2 p -115.01 134.99 54.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.086 -1.008 . . . . 0.0 110.932 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.487 ' HB3' ' HG ' ' A' ' 323' ' ' LEU . 1.8 t -117.39 144.39 45.0 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.482 -0.761 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 362' ' ' THR . . . -140.66 -161.14 8.58 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER 171.12 176.9 0.06 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.14 -1.212 . . . . 0.0 110.962 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.538 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 2.4 mt-10 -147.65 178.19 1.53 Allowed Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 46.0 Cg_endo -81.45 50.28 3.47 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.636 1.335 . . . . 0.0 109.791 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 365' ' ' ASN . 10.2 p-10 165.59 -3.7 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.795 -0.566 . . . . 0.0 111.266 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 14.2 mtm-85 -166.18 109.37 0.77 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.118 -0.989 . . . . 0.0 110.976 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.19 162.08 13.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.103 -0.998 . . . . 0.0 108.765 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.66 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 31.3 p-90 -170.31 162.92 8.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.715 -1.24 . . . . 0.0 111.131 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 39.8 p90 -133.54 133.82 42.6 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -122.84 152.13 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 111.986 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 15.5 t -132.09 122.05 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.542 ' CG ' ' HB2' ' A' ' 431' ' ' SER . 2.3 mt-10 -116.75 139.34 50.68 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 110.395 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 373' ' ' ASP . 3.3 p30 -141.0 145.82 36.45 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.263 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -104.04 114.55 28.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.323 -0.861 . . . . 0.0 110.346 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -172.55 -109.84 0.23 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.1 -168.32 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.93 1.49 . . . . 0.0 110.532 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -141.72 -160.24 8.24 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.597 HG21 " O2'" ' A' ' 451' ' ' ANP . 3.0 mt -111.88 159.04 12.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.24 -1.153 . . . . 0.0 109.842 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.419 ' H ' HO2' ' A' ' 451' ' ' ANP . . . -91.01 161.24 35.93 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.931 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.77 -46.1 0.45 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.087 1.572 . . . . 0.0 110.188 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . 0.518 ' O ' ' CE1' ' A' ' 385' ' ' HIS . 0.0 OUTLIER -73.17 -53.33 11.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.833 . . . . 0.0 110.082 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.581 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 0.0 OUTLIER -56.08 -33.33 64.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.259 -0.9 . . . . 0.0 109.808 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -40.33 13.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.679 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -71.21 -41.3 70.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.501 -0.749 . . . . 0.0 109.422 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.581 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 1.2 p-80 -120.05 74.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.602 -0.686 . . . . 0.0 109.804 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.607 ' O ' ' CG ' ' A' ' 387' ' ' PHE . 0.4 OUTLIER -86.96 9.55 19.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.109 -0.994 . . . . 0.0 110.386 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 70.8 m-85 -161.35 21.67 0.12 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.296 0.569 . . . . 0.0 109.908 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.5 ' HA ' ' CD2' ' A' ' 404' ' ' LEU . 10.7 pt20 178.19 68.36 0.11 Allowed Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.433 -0.792 . . . . 0.0 110.408 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . 0.45 ' HA ' ' HB2' ' A' ' 385' ' ' HIS . 44.0 Cg_endo -71.49 105.49 1.76 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 O-C-N 124.021 1.537 . . . . 0.0 110.515 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . 0.451 ' O ' HG21 ' A' ' 391' ' ' VAL . 90.4 m-85 -67.08 -175.08 0.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 110.415 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 390' ' ' PHE . 41.6 t -150.2 92.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 110.103 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 8.9 mmt-85 42.67 85.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.326 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 58.25 -135.8 51.53 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.77 86.29 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -1.155 . . . . 0.0 110.244 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 19.7 t -139.68 71.76 1.38 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.327 -0.858 . . . . 0.0 110.093 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -131.67 115.63 16.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 110.417 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.445 ' O ' ' OG ' ' A' ' 400' ' ' SER . 9.3 mtp85 -74.72 130.23 39.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.154 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' THR . . . . . 0.44 ' O ' ' HB ' ' A' ' 399' ' ' ILE . 1.8 p -53.8 169.63 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 0.0 110.149 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 398' ' ' THR . 3.6 mt 56.15 -93.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 110.245 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 397' ' ' ARG . 61.5 m 55.24 -170.24 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 0.0 110.254 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -74.59 -44.75 25.44 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 48.6 m -155.45 147.36 23.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.247 -1.149 . . . . 0.0 110.274 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -105.76 -73.39 0.88 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.5 ' CD2' ' HA ' ' A' ' 388' ' ' GLN . 1.4 mt -126.87 -46.81 1.54 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.156 -1.202 . . . . 0.0 110.215 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 133.42 -178.23 18.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.2 103.92 15.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -1.208 . . . . 0.0 110.352 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -109.32 156.38 20.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 109.989 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.52 ' O ' ' CD1' ' A' ' 412' ' ' ILE . 3.8 tp -155.4 27.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.424 ' HA ' HD11 ' A' ' 412' ' ' ILE . 8.8 p -126.73 -2.69 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.3 -0.875 . . . . 0.0 110.079 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 1.8 mm100 -82.34 -53.33 6.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 109.91 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -19.91 62.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.381 -0.824 . . . . 0.0 109.772 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 408' ' ' ILE . 1.0 OUTLIER -69.24 -73.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.443 ' O ' HG11 ' A' ' 413' ' ' VAL . 91.8 t -57.77 -20.13 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.363 -0.835 . . . . 0.0 109.763 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 1.8 m-20 -78.74 -33.19 46.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.371 -0.83 . . . . 0.0 109.966 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.526 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 0.8 OUTLIER -74.24 -19.86 60.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.038 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.618 ' CE1' HD13 ' A' ' 337' ' ' ILE . 41.3 m80 -92.75 -35.94 13.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.57 -0.706 . . . . 0.0 109.597 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.1 t30 80.71 32.39 0.15 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.641 -0.662 . . . . 0.0 110.608 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.503 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -95.71 -89.61 1.77 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.534 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.1 OUTLIER -177.79 162.88 1.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -1.218 . . . . 0.0 112.079 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 13.8 tp -152.63 102.7 2.73 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 0.3 OUTLIER -119.37 164.28 15.94 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.685 -1.259 . . . . 0.0 113.128 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 23.3 mt -107.07 136.93 46.08 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' A' ' 431' ' ' SER . . . -97.97 154.79 20.29 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.883 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.549 ' CG2' ' HA2' ' A' ' 428' ' ' GLY . 87.0 m -144.08 92.78 2.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -1.04 . . . . 0.0 110.01 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' SER . . . . . 0.539 ' C ' ' CG ' ' A' ' 426' ' ' GLU . 4.4 m -91.6 108.82 20.17 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.0 -1.062 . . . . 0.0 111.368 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.539 ' CG ' ' C ' ' A' ' 425' ' ' SER . 0.1 OUTLIER 53.71 -93.58 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.356 -0.84 . . . . 0.0 110.574 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.469 ' HD3' ' C ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -63.92 -28.55 69.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.416 -1.427 . . . . 0.0 109.87 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.549 ' HA2' ' CG2' ' A' ' 424' ' ' THR . . . 136.89 26.08 0.41 Allowed Glycine 0 C--N 1.292 -1.882 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 428' ' ' GLY . . . -39.73 100.19 0.01 OUTLIER Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.695 ' CD1' ' N7 ' ' A' ' 451' ' ' ANP . 12.4 mt -60.38 114.01 2.7 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.18 0.991 . . . . 0.0 111.948 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.542 ' HB2' ' CG ' ' A' ' 372' ' ' GLU . 0.3 OUTLIER -123.53 100.05 6.61 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 73.1 mt -89.31 122.53 40.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.914 -1.116 . . . . 0.0 111.496 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.76 100.17 9.58 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.686 -0.634 . . . . 0.0 109.646 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.5 128.81 36.03 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.66 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 86.9 m95 -110.36 159.23 17.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.804 -1.185 . . . . 0.0 113.382 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.467 HD13 HD12 ' A' ' 301' ' ' LEU . 51.5 mt -148.33 109.09 3.64 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.503 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 39.9 Cg_endo -64.35 139.91 67.69 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.778 1.409 . . . . 0.0 112.488 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.537 HG22 ' N ' ' A' ' 367' ' ' ALA . 22.0 t -113.12 102.23 54.51 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.99 82.33 0.47 Allowed 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.83 1.437 . . . . 0.0 110.57 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.503 ' O ' ' CG2' ' A' ' 441' ' ' THR . 42.3 t -135.76 0.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 110.542 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.503 ' CG2' ' O ' ' A' ' 440' ' ' VAL . 17.1 p -158.84 132.21 7.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.187 -0.946 . . . . 0.0 110.593 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 441' ' ' THR . 3.2 mmm-85 38.94 58.64 1.75 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.444 -0.785 . . . . 0.0 110.56 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -103.13 125.67 49.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.45 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -112.54 -97.05 0.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . 0.49 ' O ' HG21 ' A' ' 446' ' ' THR . . . 155.04 118.77 0.65 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 445' ' ' GLY . 1.6 t 33.81 96.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.813 -0.816 . . . . 0.0 111.046 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 31.1 p -137.05 163.37 30.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.277 -0.89 . . . . 0.0 110.22 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -144.47 -144.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 110.489 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -134.26 -45.78 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.517 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.695 ' N7 ' ' CD1' ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 46.8 p . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.251 0.548 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 292' ' ' GLN . . . 138.31 -89.61 0.2 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 291' ' ' GLY . 0.0 OUTLIER 64.85 147.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.307 -1.114 . . . . 0.0 110.25 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.505 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 9.5 pt-20 -151.21 74.28 1.14 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.973 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.532 ' O ' ' HG3' ' A' ' 294' ' ' MET . 8.0 ptt? -68.82 107.41 2.02 Favored Pre-proline 0 N--CA 1.5 2.075 0 O-C-N 121.426 -0.796 . . . . 0.0 110.819 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.654 ' CB ' ' CD2' ' A' ' 333' ' ' HIS . 53.4 Cg_endo -102.2 -156.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.309 2.006 . . . . 0.0 109.475 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' MET . . . . . 0.487 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 41.25 94.98 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 122.16 0.981 . . . . 0.0 110.851 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.0 mt-10 -144.67 -164.26 1.88 Allowed 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' MET . . . . . 0.439 ' HE3' ' N ' ' A' ' 330' ' ' VAL . 0.0 OUTLIER -88.7 129.36 35.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 110.108 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.465 ' HB1' ' SD ' ' A' ' 332' ' ' MET . . . -149.77 167.19 27.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.323 -0.861 . . . . 0.0 111.316 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.477 ' HB3' ' CB ' ' A' ' 303' ' ' ALA . 26.3 t70 -96.36 117.89 31.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.735 . . . . 0.0 109.551 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.536 HD22 ' CE ' ' A' ' 332' ' ' MET . 20.3 mt -65.36 -22.37 66.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.094 -1.004 . . . . 0.0 110.015 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 302' ' ' ASN . 43.7 t-20 -80.77 -22.28 40.29 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.996 -1.065 . . . . 0.0 108.755 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.477 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -84.17 -32.51 24.58 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.589 0.709 . . . . 0.0 109.454 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.448 ' O ' HG21 ' A' ' 308' ' ' VAL . 21.8 t -77.29 -37.72 25.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.587 -0.695 . . . . 0.0 109.529 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 88.4 mt -76.86 -26.64 54.49 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.69 -38.24 95.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -76.39 -35.59 58.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -1.118 . . . . 0.0 109.336 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.56 ' CG1' ' CG1' ' A' ' 341' ' ' VAL . 92.8 t -75.24 -18.8 16.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.55 0.691 . . . . 0.0 109.441 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.538 ' CD1' HG13 ' A' ' 358' ' ' VAL . 0.0 OUTLIER -77.6 -43.77 29.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.783 0.801 . . . . 0.0 109.123 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -75.17 -17.7 60.33 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.539 0.685 . . . . 0.0 109.866 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -88.11 -45.22 10.32 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 111.155 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -98.47 31.32 2.88 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.211 -0.93 . . . . 0.0 111.25 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.526 ' CA ' HD12 ' A' ' 319' ' ' ILE . 1.0 OUTLIER -82.84 -7.53 59.65 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.06 -1.025 . . . . 0.0 109.974 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 87.56 -53.95 4.38 Favored Glycine 0 C--N 1.286 -2.198 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 19.3 t80 174.54 36.16 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 1.6 tm-20 70.02 36.17 2.02 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 317' ' ' ARG . 0.0 OUTLIER -67.86 -90.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.337 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 317' ' ' ARG . 20.5 mt-10 -152.17 73.77 1.06 Allowed 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.233 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.542 ' CG2' HG22 ' A' ' 358' ' ' VAL . 3.3 mp -105.1 134.3 46.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.297 -0.877 . . . . 0.0 109.182 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' GLU . . . . . 0.481 ' HB3' ' CG ' ' A' ' 357' ' ' LYS . 3.1 tt0 -99.55 108.6 21.06 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.035 -1.041 . . . . 0.0 110.121 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.509 HG21 ' CD1' ' A' ' 309' ' ' ILE . 15.3 p -93.97 126.5 39.22 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 110.744 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -147.81 78.23 1.44 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.374 -0.829 . . . . 0.0 109.414 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . 0.523 ' N ' HD11 ' A' ' 323' ' ' LEU . 4.2 mp -91.0 156.35 18.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.393 -0.817 . . . . 0.0 110.462 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' TYR . . . . . 0.605 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 69.2 t80 -45.8 125.62 6.61 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.893 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.51 68.93 8.16 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.885 1.466 . . . . 0.0 110.217 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -173.31 24.38 0.07 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 326' ' ' GLY . 0.0 OUTLIER 50.41 101.62 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 O-C-N 121.017 -1.284 . . . . 0.0 110.432 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.555 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 1.1 mt -78.52 -176.61 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.35 -0.843 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.555 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 0.3 OUTLIER -176.54 111.26 0.09 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.791 0.805 . . . . 0.0 110.87 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.453 HG11 HG23 ' A' ' 438' ' ' VAL . 8.5 m -142.48 162.12 18.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-O 121.391 0.615 . . . . 0.0 109.955 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.3 OUTLIER -78.28 91.0 4.36 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' MET . . . . . 0.547 ' HE3' ' CB ' ' A' ' 337' ' ' ILE . 4.4 ppp? -135.83 135.36 39.76 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.643 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' HIS . . . . . 0.654 ' CD2' ' CB ' ' A' ' 295' ' ' PRO . 10.3 t-80 -67.34 116.44 36.73 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.471 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 41.0 Cg_endo -65.32 -19.53 61.88 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.62 1.326 . . . . 0.0 110.07 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.641 ' CB ' ' CE1' ' A' ' 333' ' ' HIS . 0.5 OUTLIER -81.14 -46.08 15.44 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.426 -0.797 . . . . 0.0 110.899 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.447 ' O ' HG22 ' A' ' 412' ' ' ILE . 2.2 m -72.73 -37.47 67.73 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.143 -0.973 . . . . 0.0 110.117 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.611 ' CD1' ' CE1' ' A' ' 416' ' ' HIS . 32.5 mm -71.82 -30.47 37.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.402 -0.812 . . . . 0.0 109.521 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 3.8 mttt -68.29 -43.22 78.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 108.7 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 335' ' ' LEU . 75.5 mtt-85 -72.24 -31.77 66.11 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.474 0.654 . . . . 0.0 110.723 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 344' ' ' MET . . . -73.58 -35.88 65.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 111.035 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.56 ' CG1' ' CG1' ' A' ' 308' ' ' VAL . 59.4 t -80.46 -27.85 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 110.552 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.435 ' O ' ' CG2' ' A' ' 346' ' ' VAL . . . -79.36 -28.29 41.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.183 -0.948 . . . . 0.0 110.182 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -89.77 -24.2 21.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.305 -0.872 . . . . 0.0 110.321 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 347' ' ' ASN . 1.9 mtm -71.65 -47.15 56.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.875 . . . . 0.0 110.386 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.8 t -65.43 -28.36 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.475 ' HA ' ' HB1' ' A' ' 349' ' ' ALA . 71.6 t -56.34 -25.61 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.274 -0.891 . . . . 0.0 110.329 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 344' ' ' MET . 1.0 OUTLIER -56.18 -53.59 55.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.947 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . 0.514 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -85.53 -19.13 31.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.861 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' A' ' 346' ' ' VAL . . . -68.2 -59.66 3.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.319 -0.863 . . . . 0.0 111.668 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 351' ' ' TYR . 4.4 ptt-85 -86.5 -41.11 14.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.935 -1.103 . . . . 0.0 111.876 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' TYR . . . . . 0.501 ' N ' ' HG3' ' A' ' 350' ' ' ARG . 0.3 OUTLIER -90.2 -42.44 11.03 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.762 -1.211 . . . . 0.0 110.495 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -85.27 173.54 48.31 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -168.48 72.76 0.1 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.278 -1.131 . . . . 0.0 109.873 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' GLY . . . . . 0.537 ' HA3' ' CB ' ' A' ' 374' ' ' ASP . . . -161.65 67.68 0.24 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.589 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 11.1 t90 59.77 145.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -1.04 . . . . 0.0 111.242 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 6.0 mt -123.75 162.33 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.589 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 16.6 tttt -150.44 117.73 6.03 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.782 -1.199 . . . . 0.0 111.253 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.542 HG22 ' CG2' ' A' ' 319' ' ' ILE . 3.4 t -106.25 89.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 370' ' ' GLN . 4.4 t -113.44 139.44 48.92 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.273 -0.892 . . . . 0.0 111.229 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' SER . . . . . 0.473 ' HB2' ' HG ' ' A' ' 323' ' ' LEU . 3.7 m -138.33 158.11 44.93 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.384 -0.823 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -148.3 -154.69 6.37 Favored Glycine 0 C--N 1.295 -1.713 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.605 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER 175.02 169.25 0.29 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.03 -1.276 . . . . 0.0 110.71 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.477 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 3.1 mm-40 -149.39 172.23 5.44 Favored Pre-proline 0 C--N 1.293 -1.887 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . 0.534 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 40.2 Cg_endo -66.24 116.28 3.94 Favored 'Trans proline' 0 C--N 1.299 -2.075 0 O-C-N 123.682 1.359 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 4.4 t-20 74.25 34.72 0.8 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.655 -0.653 . . . . 0.0 111.009 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.1 OUTLIER 165.81 97.51 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.305 -0.872 . . . . 0.0 111.214 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.41 171.34 7.42 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.158 -0.963 . . . . 0.0 109.039 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' TRP . . . . . 0.64 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 39.2 p-90 -170.96 165.37 7.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.445 -1.41 . . . . 0.0 110.813 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 35.1 p90 -139.28 131.33 27.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.485 -0.759 . . . . 0.0 109.336 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . 0.517 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 20.5 tt0 -116.08 151.33 35.78 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.246 -0.909 . . . . 0.0 111.773 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.517 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 89.0 t -127.05 142.4 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.564 -0.71 . . . . 0.0 109.636 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.422 ' HG3' ' C ' ' A' ' 371' ' ' VAL . 55.4 mt-10 -137.81 129.58 28.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.4 -0.812 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -159.55 161.55 35.25 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.536 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.537 ' CB ' ' HA3' ' A' ' 354' ' ' GLY . 0.5 OUTLIER -80.46 152.64 28.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 110.494 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . 0.422 ' HA2' ' HA2' ' A' ' 352' ' ' GLY . . . 164.64 -146.33 11.23 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.89 -169.48 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.053 1.554 . . . . 0.0 110.554 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . 0.467 ' CA ' ' HA3' ' A' ' 428' ' ' GLY . . . -145.22 139.4 8.34 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' ILE . . . . . 0.59 HG21 " O2'" ' A' ' 451' ' ' ANP . 3.9 mt -81.08 170.81 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.102 -1.234 . . . . 0.0 109.923 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.473 ' CB ' ' HD2' ' A' ' 380' ' ' PRO . . . -151.32 175.99 2.58 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.252 -0.905 . . . . 0.0 110.324 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 379' ' ' ALA . 49.5 Cg_endo -71.96 -34.25 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.061 1.558 . . . . 0.0 110.236 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.71 -21.73 30.01 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.849 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . 0.56 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 1.6 mm-40 -90.75 -18.27 25.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.129 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 1.6 tpp85 -60.25 -19.75 55.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.126 -0.984 . . . . 0.0 110.095 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.493 ' HD3' ' OE1' ' A' ' 388' ' ' GLN . 0.2 OUTLIER -86.95 -20.71 26.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.868 . . . . 0.0 110.618 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' HIS . . . . . 0.56 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 20.6 m-70 -63.05 -46.63 86.6 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.147 -0.971 . . . . 0.0 111.222 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.58 ' O ' ' CG ' ' A' ' 387' ' ' PHE . 1.0 OUTLIER -128.11 49.84 2.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.034 -1.041 . . . . 0.0 110.94 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 1.7 m-85 -175.0 51.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.177 -0.952 . . . . 0.0 111.078 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.493 ' OE1' ' HD3' ' A' ' 384' ' ' LYS . 21.7 pt20 -153.74 134.76 8.43 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.033 -1.042 . . . . 0.0 110.44 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -81.9 114.55 2.61 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.793 1.418 . . . . 0.0 110.032 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -104.78 146.87 28.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 0.0 110.206 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.92 160.78 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.402 -0.811 . . . . 0.0 110.375 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 -79.82 -57.14 3.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -0.875 . . . . 0.0 110.208 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -158.87 -48.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -133.75 -58.54 0.87 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -1.195 . . . . 0.0 110.149 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.41 ' OG ' ' HG2' ' A' ' 397' ' ' ARG . 1.3 t -154.48 -75.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.204 -0.935 . . . . 0.0 109.941 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . 53.41 45.13 28.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.41 ' HG2' ' OG ' ' A' ' 395' ' ' SER . 2.6 ptp85 -127.59 108.11 10.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 0.0 110.127 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 68.7 p -60.67 145.86 47.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 110.12 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.461 HG21 ' O ' ' A' ' 399' ' ' ILE . 6.4 tp -103.1 71.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.23 -0.919 . . . . 0.0 110.463 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -48.12 24.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.251 -0.906 . . . . 0.0 110.052 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -160.1 -117.65 0.47 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.7 m -145.18 78.43 1.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -1.157 . . . . 0.0 110.237 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 170.78 94.44 0.09 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.408 HD21 ' C ' ' A' ' 404' ' ' LEU . 2.5 tt -108.77 -67.33 0.98 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -1.203 . . . . 0.0 110.347 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -111.98 92.29 0.64 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 5.7 mt -92.52 114.91 27.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -1.164 . . . . 0.0 110.258 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -78.67 -162.44 0.37 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -0.905 . . . . 0.0 110.097 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' ILE . . . . . 0.477 ' O ' HG13 ' A' ' 412' ' ' ILE . 6.3 tt -115.29 -17.02 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.108 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 99.5 t -128.24 -31.91 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 109.868 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 2.3 mt-30 -69.42 -49.56 53.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.257 -0.902 . . . . 0.0 109.888 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.491 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.6 OUTLIER -65.88 -20.93 66.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.269 -0.894 . . . . 0.0 109.827 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 408' ' ' ILE . 18.5 mm -68.12 -69.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 108.934 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 419' ' ' MET . 87.1 t -62.76 -21.15 26.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.368 -0.833 . . . . 0.0 109.015 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.491 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 8.4 t70 -75.24 -31.71 60.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.588 -0.695 . . . . 0.0 109.403 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.487 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.1 m-20 -76.97 -14.74 59.81 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.405 -0.81 . . . . 0.0 109.12 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.611 ' CE1' ' CD1' ' A' ' 337' ' ' ILE . 38.9 m80 -92.51 -34.47 14.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.579 -0.7 . . . . 0.0 109.861 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 4.7 m-20 80.58 19.89 0.51 Allowed 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.374 0.607 . . . . 0.0 110.281 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . 0.535 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -90.03 -92.01 1.23 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' MET . . . . . 0.556 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 31.6 ttm -176.9 162.01 2.04 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.189 -1.183 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.45 HD12 HG22 ' A' ' 413' ' ' VAL . 21.2 tp -151.32 104.91 3.14 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.387 -0.82 . . . . 0.0 108.832 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.473 ' O ' HG21 ' A' ' 432' ' ' ILE . 0.5 OUTLIER -112.98 143.31 44.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.974 -1.079 . . . . 0.0 111.902 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.477 ' N ' HD21 ' A' ' 422' ' ' LEU . 3.5 mm? -99.42 80.69 2.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.485 -0.759 . . . . 0.0 109.402 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 429' ' ' GLY . . . -50.98 104.51 0.14 Allowed Glycine 0 C--N 1.28 -2.532 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.519 ' CG2' ' HA2' ' A' ' 428' ' ' GLY . 30.4 m -107.97 106.14 16.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.255 -1.144 . . . . 0.0 109.09 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.89 99.46 12.49 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.057 -1.027 . . . . 0.0 111.713 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 428' ' ' GLY . 4.2 tt0 53.03 -112.27 0.68 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.184 -0.948 . . . . 0.0 110.673 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.454 ' HD3' ' C ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -40.86 -29.24 0.09 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.101 -1.0 . . . . 0.0 109.994 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' GLY . . . . . 0.534 ' O ' ' CD2' ' A' ' 430' ' ' LEU . . . 131.48 35.32 0.37 Allowed Glycine 0 C--N 1.296 -1.646 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 423' ' ' GLY . . . -43.53 98.78 0.01 OUTLIER Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.596 ' CD1' ' C6 ' ' A' ' 451' ' ' ANP . 2.7 mm? -65.82 106.37 1.51 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.196 0.998 . . . . 0.0 111.831 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' SER . . . . . 0.463 ' O ' ' HA3' ' A' ' 423' ' ' GLY . 0.0 OUTLIER -145.76 100.72 3.46 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' ILE . . . . . 0.473 HG21 ' O ' ' A' ' 421' ' ' GLU . 80.6 mt -92.0 151.9 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.067 -1.021 . . . . 0.0 112.864 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -124.45 94.86 4.33 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.23 139.83 30.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.786 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' TRP . . . . . 0.64 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 84.9 m95 -120.28 153.12 36.83 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.102 0.953 . . . . 0.0 111.707 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.486 ' CD1' HD13 ' A' ' 301' ' ' LEU . 86.0 mt -140.72 115.15 7.32 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.535 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 43.9 Cg_endo -70.69 134.24 25.59 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.834 1.439 . . . . 0.0 111.418 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.497 ' CG1' ' HD2' ' A' ' 439' ' ' PRO . 21.4 t -94.11 144.16 27.61 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.622 -0.674 . . . . 0.0 110.161 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' PRO . . . . . 0.497 ' HD2' ' CG1' ' A' ' 438' ' ' VAL . 50.8 Cg_endo -73.71 101.87 1.43 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.993 1.523 . . . . 0.0 110.457 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.503 ' O ' ' OG1' ' A' ' 441' ' ' THR . 40.7 t -137.47 179.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.144 -0.973 . . . . 0.0 109.985 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 440' ' ' VAL . 2.8 p 59.58 83.15 0.14 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.333 -0.854 . . . . 0.0 110.145 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 443' ' ' ALA . 0.6 OUTLIER -169.23 63.91 0.05 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 442' ' ' ARG . . . -51.03 -179.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.166 -0.959 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -76.41 -155.63 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.148 -0.97 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -100.65 -76.34 1.21 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' THR . . . . . 0.48 ' C ' ' CG2' ' A' ' 447' ' ' THR . 7.4 t -126.49 -7.84 6.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.235 -1.156 . . . . 0.0 110.204 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.48 ' CG2' ' C ' ' A' ' 446' ' ' THR . 2.0 t 34.55 90.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.288 0.566 . . . . 0.0 110.755 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -49.81 -48.01 51.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 0.0 109.953 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.49 147.41 45.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 110.081 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 CA-C-O 118.005 -1.442 . . . . 0.0 109.545 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' ANP . . . . . 0.596 ' C6 ' ' CD1' ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.79 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 55.4 Cg_endo . . . . . 0 C--O 1.213 -0.76 0 N-CA-C 109.954 -0.825 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.596 ' HE3' ' HB3' ' A' ' 415' ' ' ASN . 0.1 OUTLIER 23.68 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 122.358 1.075 . . . . 0.0 111.576 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.677 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.9 mm-40 -144.42 -159.51 1.0 Allowed 'General case' 0 C--N 1.267 -3.02 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.217 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.667 ' HA ' ' HA ' ' A' ' 331' ' ' LYS . 2.1 mmt -85.2 117.06 23.91 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.109 0.957 . . . . 0.0 110.797 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.732 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -141.18 150.61 42.97 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.061 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.745 ' O ' HG23 ' A' ' 304' ' ' VAL . 13.8 m-20 -85.15 136.57 33.48 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.488 -0.758 . . . . 0.0 109.205 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.691 HD21 ' CE ' ' A' ' 332' ' ' MET . 6.8 mt -73.68 -23.82 59.87 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.955 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 303' ' ' ALA . 47.0 p30 -83.93 -18.96 35.58 Favored 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.856 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.511 ' N ' ' OD1' ' A' ' 302' ' ' ASN . . . -82.3 -36.34 27.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 300' ' ' ASP . 16.2 t -74.15 -39.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.542 -0.724 . . . . 0.0 109.584 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 62.7 mt -69.55 -33.47 72.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.406 -0.809 . . . . 0.0 110.052 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -67.72 -22.35 73.53 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.99 -38.47 27.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.311 -1.111 . . . . 0.0 108.52 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.468 HG11 ' HB ' ' A' ' 341' ' ' VAL . 88.8 t -77.4 -18.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.641 HD12 ' CG2' ' A' ' 321' ' ' THR . 1.3 mm -78.31 -45.71 26.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.654 0.74 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.99 -18.39 63.33 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.692 0.758 . . . . 0.0 109.067 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.61 -36.67 14.28 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.163 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.589 ' O ' ' CD ' ' A' ' 317' ' ' ARG . 15.3 mm-40 -91.59 8.33 37.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 110.399 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 309' ' ' ILE . 78.2 p -115.67 66.36 0.7 Allowed 'General case' 0 C--N 1.274 -2.703 0 O-C-N 120.898 -1.126 . . . . 0.0 108.187 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.59 ' O ' ' CG ' ' A' ' 315' ' ' TYR . . . -113.71 -32.06 2.18 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.294 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.607 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 90.1 m-85 -155.26 74.43 0.9 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 120.111 1.956 . . . . 0.0 114.408 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.607 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 1.4 tp10 91.5 12.8 0.04 OUTLIER 'General case' 0 CA--C 1.452 -2.804 0 O-C-N 121.732 -0.605 . . . . 0.0 111.901 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.589 ' CD ' ' O ' ' A' ' 312' ' ' GLU . 0.0 OUTLIER -81.68 87.93 6.27 Favored 'General case' 0 C--N 1.259 -3.328 0 N-CA-C 101.034 -3.691 . . . . 0.0 101.034 179.017 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.713 ' N ' HD12 ' A' ' 356' ' ' ILE . 0.5 OUTLIER -65.74 73.14 0.06 Allowed 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.549 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.707 HG23 HG23 ' A' ' 358' ' ' VAL . 42.6 mt -99.14 116.52 42.42 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.744 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.21 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.433 ' H ' ' HA ' ' A' ' 357' ' ' LYS . 1.5 tp10 -89.6 110.78 21.61 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.641 ' CG2' HD12 ' A' ' 309' ' ' ILE . 12.8 p -88.25 130.13 35.17 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.195 -0.941 . . . . 0.0 112.284 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.73 77.73 1.29 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.566 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 4.1 mp -93.3 167.18 11.91 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.443 -0.786 . . . . 0.0 110.884 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CD2' HG21 ' A' ' 362' ' ' THR . 57.9 t80 -58.94 112.44 5.06 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 121.44 -0.787 . . . . 0.0 109.193 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 324' ' ' TYR . 44.3 Cg_endo -70.3 79.06 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.969 1.51 . . . . 0.0 111.057 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.459 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -175.81 -82.82 0.06 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 0.8 OUTLIER 171.35 107.97 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.453 -1.028 . . . . 0.0 109.443 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 329' ' ' GLU . 5.2 mt -85.43 -179.54 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 O-C-N 121.533 -0.729 . . . . 0.0 109.352 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.607 ' H ' HG22 ' A' ' 328' ' ' ILE . 0.8 OUTLIER -173.98 103.95 0.11 Allowed 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.211 -0.996 . . . . 0.0 112.505 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.56 HG23 ' HG2' ' A' ' 332' ' ' MET . 5.6 m -142.79 142.18 26.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -83.72 101.19 11.38 Favored 'General case' 0 C--N 1.257 -3.44 0 C-N-CA 118.512 -1.275 . . . . 0.0 108.015 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.732 ' HG3' ' HB3' ' A' ' 299' ' ' ALA 0.252 0.0 OUTLIER -135.46 -173.23 3.28 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.707 0.765 . . . . 0.0 111.515 -179.585 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.79 ' CE1' ' HB3' ' A' ' 295' ' ' PRO . 22.5 t60 -109.24 112.27 59.6 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 37.5 Cg_endo -59.87 -18.98 52.51 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.719 1.378 . . . . 0.0 110.407 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.553 ' HB2' ' NE2' ' A' ' 333' ' ' HIS . 1.6 mt -76.3 -73.92 0.25 Allowed 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.397 -0.815 . . . . 0.0 109.674 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.456 ' H ' ' CD2' ' A' ' 333' ' ' HIS . 0.4 OUTLIER -45.7 -49.78 14.27 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.702 -0.623 . . . . 0.0 110.441 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.669 HD11 ' CE1' ' A' ' 416' ' ' HIS . 6.7 mm -60.19 -40.89 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.084 -1.01 . . . . 0.0 109.999 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 6.1 mtmt -55.46 -48.39 74.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 109.17 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -28.77 67.19 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.415 0.626 . . . . 0.0 110.327 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -67.1 -37.26 83.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.748 . . . . 0.0 110.6 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' A' ' 305' ' ' LEU . 92.8 t -78.69 -35.0 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.125 -0.984 . . . . 0.0 110.207 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.714 ' O ' HG12 ' A' ' 345' ' ' VAL . . . -64.35 -68.75 0.33 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.554 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ASN . . . . . 0.916 ' O ' HG22 ' A' ' 346' ' ' VAL . 24.7 m120 -47.52 -19.28 0.17 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.296 -0.877 . . . . 0.0 111.203 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 3.4 mtt -74.92 -42.43 57.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.603 -1.31 . . . . 0.0 110.18 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.736 HG23 HG21 ' A' ' 356' ' ' ILE . 14.7 p -81.16 -18.69 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.844 . . . . 0.0 111.136 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.916 HG22 ' O ' ' A' ' 343' ' ' ASN . 17.9 m -60.02 -20.98 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.046 -1.034 . . . . 0.0 110.465 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -84.48 -30.87 24.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 110.666 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 352' ' ' GLY . . . -90.5 -19.1 24.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.946 . . . . 0.0 110.824 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -82.73 -53.58 5.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 110.451 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -72.56 0.14 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 110.365 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -70.02 -47.4 62.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 110.203 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 348' ' ' ALA . . . -79.9 162.34 46.62 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.503 ' O ' ' ND2' ' A' ' 353' ' ' ASN . 0.2 OUTLIER -171.68 29.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.454 -1.027 . . . . 0.0 109.59 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 354' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 355' ' ' TRP . . . -110.56 -33.05 2.56 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 17.0 t90 178.46 129.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.899 -1.354 . . . . 0.0 111.851 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.736 HG21 HG23 ' A' ' 345' ' ' VAL . 1.7 mt -117.01 146.97 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 372' ' ' GLU . 6.9 tttt -140.42 128.2 21.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.487 -1.383 . . . . 0.0 112.087 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.707 HG23 HG23 ' A' ' 319' ' ' ILE . 71.9 t -120.3 108.85 24.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 39.0 t -127.35 160.03 32.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.087 -1.008 . . . . 0.0 111.366 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.566 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -144.49 142.28 30.14 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.596 -0.69 . . . . 0.0 109.679 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -134.87 -166.12 11.03 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.64 HG21 ' CD2' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -173.16 173.11 3.7 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.019 -1.283 . . . . 0.0 111.285 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 4.5 mt-10 -153.08 176.65 2.3 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.675 -0.641 . . . . 0.0 109.524 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.561 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.8 Cg_endo -70.28 105.41 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.684 1.36 . . . . 0.0 110.782 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.586 ' HA ' ' CG1' ' A' ' 438' ' ' VAL . 8.4 t-20 80.49 34.02 0.14 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.868 -0.52 . . . . 0.0 110.631 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 172.5 105.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.837 . . . . 0.0 111.206 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -105.79 169.08 8.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.094 -1.003 . . . . 0.0 108.504 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 37.6 p-90 -168.43 172.4 8.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.603 -1.311 . . . . 0.0 110.615 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.628 ' CE1' ' HB3' ' A' ' 434' ' ' ALA . 37.6 p90 -143.78 140.94 30.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.37 -0.832 . . . . 0.0 109.923 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 12.4 tt0 -127.0 153.98 45.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.293 -0.879 . . . . 0.0 110.741 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.553 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 88.5 t -124.39 164.37 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.437 -0.79 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 357' ' ' LYS . 45.7 mt-10 -150.52 135.33 17.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.957 . . . . 0.0 109.764 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -148.67 148.63 30.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.077 -1.014 . . . . 0.0 110.594 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -82.29 158.67 23.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.332 -0.855 . . . . 0.0 110.144 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 153.96 -167.87 32.29 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.23 -26.4 14.72 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.982 1.517 . . . . 0.0 110.589 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 88.63 -171.85 40.15 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.572 HD11 HD11 ' A' ' 430' ' ' LEU . 54.5 mt -74.91 151.62 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.293 -1.122 . . . . 0.0 110.036 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.671 ' HB3' ' HG3' ' A' ' 382' ' ' GLN . . . -73.76 169.16 19.86 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.136 -0.978 . . . . 0.0 110.011 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.653 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 47.6 Cg_endo -73.19 -38.04 2.99 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.946 1.498 . . . . 0.0 110.291 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' GLU . . . . . 0.603 ' O ' ' CD2' ' A' ' 385' ' ' HIS . 0.9 OUTLIER -90.45 -37.51 13.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.314 -0.866 . . . . 0.0 110.765 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.671 ' HG3' ' HB3' ' A' ' 379' ' ' ALA . 45.5 mt-30 -62.25 -28.47 69.73 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.259 -0.901 . . . . 0.0 110.299 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -21.51 3.98 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.955 -1.09 . . . . 0.0 109.164 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -31.6 16.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.504 -0.748 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 381' ' ' GLU . 2.1 p80 -117.47 68.95 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.878 -1.139 . . . . 0.0 111.025 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.488 ' HA ' HD13 ' A' ' 386' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 1.028 HG12 HG23 ' A' ' 409' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 1.028 HG23 HG12 ' A' ' 408' ' ' ILE . 4.3 t 80.52 -59.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.947 -0.47 . . . . 0.0 110.42 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 42.0 tt0 -54.78 -58.84 5.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.99 -1.069 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -59.22 -19.56 46.63 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.293 -0.88 . . . . 0.0 110.685 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.532 HG21 ' HB2' ' A' ' 340' ' ' ALA . 11.0 mm -67.29 -70.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.156 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 1.04 HG21 HD13 ' A' ' 420' ' ' LEU . 22.5 t -60.89 -21.09 23.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.347 -0.846 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 5.0 t70 -77.54 -29.41 52.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -0.847 . . . . 0.0 109.841 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.596 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 0.9 OUTLIER -81.37 -14.78 56.82 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.209 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.669 ' CE1' HD11 ' A' ' 337' ' ' ILE . 31.6 m80 -93.36 -37.46 11.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.576 -0.702 . . . . 0.0 109.785 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 13.9 t-20 81.43 42.91 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 121.377 0.608 . . . . 0.0 110.455 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.578 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -111.8 -89.26 1.86 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.564 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 2.6 ttp -173.36 159.76 3.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.159 -1.2 . . . . 0.0 111.464 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 1.04 HD13 HG21 ' A' ' 413' ' ' VAL . 14.0 tp -151.02 109.08 3.72 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.373 -0.83 . . . . 0.0 109.387 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -130.07 161.32 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.923 -1.11 . . . . 0.0 111.083 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.765 HD23 ' CD1' ' A' ' 432' ' ' ILE . 2.9 mt -126.78 138.61 53.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.384 -0.823 . . . . 0.0 110.169 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.639 ' O ' HD12 ' A' ' 430' ' ' LEU . . . -135.88 161.88 24.89 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.513 ' OG1' HD12 ' A' ' 430' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.207 -1.172 . . . . 0.0 110.631 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 423' ' ' GLY . 15.6 tp -78.4 139.92 38.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -1.169 . . . . 0.0 110.636 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 371' ' ' VAL . 23.3 t -139.3 132.39 29.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.56 -0.713 . . . . 0.0 109.857 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.765 ' CD1' HD23 ' A' ' 422' ' ' LEU . 29.1 mm -92.68 140.64 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.196 -0.94 . . . . 0.0 110.648 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -119.92 97.16 5.48 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.321 -0.862 . . . . 0.0 110.407 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.628 ' HB3' ' CE1' ' A' ' 369' ' ' PHE . . . -103.25 137.4 41.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 110.236 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 88.9 m95 -118.93 153.14 35.08 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.1 -1.0 . . . . 0.0 111.839 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.589 HD12 HD11 ' A' ' 301' ' ' LEU . 24.6 mt -145.35 100.15 4.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.578 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 41.4 Cg_endo -65.75 138.04 52.05 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.967 1.509 . . . . 0.0 111.592 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.798 HG23 ' HD2' ' A' ' 439' ' ' PRO . 2.9 p -93.24 151.2 40.19 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.706 -0.621 . . . . 0.0 109.928 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.798 ' HD2' HG23 ' A' ' 438' ' ' VAL . 39.5 Cg_endo . . . . . 0 C--N 1.312 -1.375 0 O-C-N 123.642 1.338 . . . . 0.0 110.205 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.454 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 51.4 Cg_endo . . . . . 0 C--O 1.214 -0.705 0 CA-C-O 121.347 0.478 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.594 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -90.82 109.41 20.61 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.938 0.875 . . . . 0.0 108.98 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.2 mt-10 -134.53 -156.33 0.72 Allowed 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.73 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.778 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.7 OUTLIER -87.4 131.89 34.15 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.048 -1.033 . . . . 0.0 110.239 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -142.34 147.83 36.94 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 110.972 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 304' ' ' VAL . 1.1 m-20 -89.61 119.8 30.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.427 -0.796 . . . . 0.0 109.454 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 1.051 HD11 HD12 ' A' ' 436' ' ' LEU . 6.5 mt -62.31 -21.12 65.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.008 -1.057 . . . . 0.0 109.801 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.676 ' HA ' HD23 ' A' ' 323' ' ' LEU . 51.4 t-20 -84.25 -22.1 30.91 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.084 -1.01 . . . . 0.0 109.029 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.9 -33.38 22.77 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.714 -0.616 . . . . 0.0 109.823 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.625 ' O ' HG23 ' A' ' 308' ' ' VAL . 22.7 t -79.55 -34.72 16.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.342 -0.849 . . . . 0.0 109.407 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 94.3 mt -75.28 -31.29 60.69 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.408 -0.808 . . . . 0.0 110.161 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -63.39 -31.0 79.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -80.17 -34.07 37.86 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.39 -1.065 . . . . 0.0 109.362 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 1.057 HG11 ' CG1' ' A' ' 341' ' ' VAL . 97.7 t -74.76 -20.38 16.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.64 0.733 . . . . 0.0 109.103 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.648 HG13 HG11 ' A' ' 358' ' ' VAL . 1.1 mt -75.88 -50.87 21.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.59 -16.43 63.4 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.83 0.824 . . . . 0.0 108.929 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -62.98 -66.35 0.55 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.7 -0.625 . . . . 0.0 110.765 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.93 44.54 2.88 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.884 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.554 ' CB ' ' CD1' ' A' ' 319' ' ' ILE . 3.3 p -86.63 27.12 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.866 -1.146 . . . . 0.0 110.358 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.494 ' O ' ' HG2' ' A' ' 317' ' ' ARG . . . 43.55 42.74 6.03 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 12.7 m-85 58.86 49.37 9.91 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.702 -0.881 . . . . 0.0 109.608 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 0.7 OUTLIER 59.93 62.24 1.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.61 0.719 . . . . 0.0 110.834 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 314' ' ' GLY . 16.2 mmm180 -71.66 -82.79 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.907 0.861 . . . . 0.0 109.092 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -147.14 55.9 1.11 Allowed 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.83 HG13 HD12 ' A' ' 356' ' ' ILE . 19.6 mt -97.47 131.9 43.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.75 -0.594 . . . . 0.0 110.627 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.484 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 1.1 tp10 -91.52 107.06 18.95 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 16.9 p -94.36 122.85 37.34 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 111.133 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.1 77.06 1.48 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 302' ' ' ASN . 6.1 mp -95.47 140.6 30.1 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.373 -0.83 . . . . 0.0 109.977 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 9.8 t80 -42.68 121.84 2.81 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.447 -0.783 . . . . 0.0 109.826 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.14 59.88 7.21 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.974 1.513 . . . . 0.0 110.194 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . -158.74 20.4 0.31 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 53.8 m 55.29 100.12 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.253 -1.145 . . . . 0.0 110.363 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.686 HG22 ' H ' ' A' ' 329' ' ' GLU . 2.7 mt -76.23 -175.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 121.532 -0.73 . . . . 0.0 109.14 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.686 ' H ' HG22 ' A' ' 328' ' ' ILE . 3.4 mt-10 -171.45 110.96 0.32 Allowed 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.315 -0.866 . . . . 0.0 111.241 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.778 ' C ' ' HE2' ' A' ' 298' ' ' MET . 29.7 m -144.44 149.95 16.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 O-C-N 121.583 -0.698 . . . . 0.0 110.092 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.7 OUTLIER -68.69 98.25 0.88 Allowed 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.73 ' HB2' HG23 ' A' ' 330' ' ' VAL . 4.8 ttp -144.76 159.72 42.4 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.76 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.754 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 0.9 OUTLIER -101.88 117.02 62.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.483 ' O ' ' HE2' ' A' ' 338' ' ' LYS . 33.8 Cg_endo -54.74 -31.59 72.38 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.458 1.241 . . . . 0.0 111.429 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.754 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 6.6 mt -69.86 -69.75 0.33 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.888 -1.133 . . . . 0.0 110.428 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 335' ' ' LEU . 23.8 m -43.28 -60.36 1.72 Allowed 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.675 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.631 HD11 ' CE1' ' A' ' 416' ' ' HIS . 8.5 mm -55.41 -35.02 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.228 -0.92 . . . . 0.0 110.676 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 1.3 mtmm -56.11 -47.39 78.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.9 -1.125 . . . . 0.0 109.11 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -37.51 76.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.805 -0.559 . . . . 0.0 110.227 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.829 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -66.56 -23.87 66.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 1.057 ' CG1' HG11 ' A' ' 308' ' ' VAL . 72.6 t -89.98 -28.13 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.804 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.924 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -73.94 -30.24 62.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.371 -0.831 . . . . 0.0 109.937 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -69.23 -23.37 63.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.904 . . . . 0.0 109.913 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.489 ' HG2' HG13 ' A' ' 432' ' ' ILE . 0.3 OUTLIER -90.55 -25.19 20.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.824 . . . . 0.0 110.613 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 90.2 t -90.45 -23.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.098 -1.001 . . . . 0.0 111.107 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 342' ' ' ALA . 97.0 t -68.2 -20.11 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.984 -1.072 . . . . 0.0 110.405 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 351' ' ' TYR . 2.1 m120 -63.49 -51.78 64.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.464 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 373' ' ' ASP . . . -90.84 -19.07 23.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.402 -0.811 . . . . 0.0 111.029 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.65 -81.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.967 -1.083 . . . . 0.0 110.883 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.476 ' CG ' ' N ' ' A' ' 351' ' ' TYR . 27.7 ptt180 -92.01 -44.92 8.59 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.218 -0.926 . . . . 0.0 111.392 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' TYR . . . . . 0.476 ' N ' ' CG ' ' A' ' 350' ' ' ARG . 9.0 t80 -64.11 -40.45 96.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.209 -0.932 . . . . 0.0 110.729 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 348' ' ' ALA . . . -109.6 173.71 17.21 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -159.21 28.64 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -1.039 . . . . 0.0 109.85 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -89.29 -59.85 1.52 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.573 ' CH2' ' HB2' ' A' ' 357' ' ' LYS . 19.9 t90 -176.15 132.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -1.135 . . . . 0.0 110.132 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.83 HD12 HG13 ' A' ' 319' ' ' ILE . 5.9 mt -102.0 158.53 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.422 -0.799 . . . . 0.0 109.209 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.573 ' HB2' ' CH2' ' A' ' 355' ' ' TRP . 0.5 OUTLIER -144.09 104.93 4.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.027 -1.045 . . . . 0.0 110.654 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.68 HG23 HG23 ' A' ' 319' ' ' ILE . 41.2 t -107.94 89.88 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 108.86 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.0 t -121.01 138.4 54.18 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.387 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.559 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.1 t -120.97 145.12 48.08 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -141.45 -172.42 13.24 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -159.85 172.07 18.3 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.196 -1.179 . . . . 0.0 110.585 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.471 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -145.34 175.57 2.68 Favored Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.526 -0.734 . . . . 0.0 109.643 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 41.5 Cg_endo -68.15 111.34 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.699 1.368 . . . . 0.0 111.133 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 3.9 t-20 72.75 29.24 1.97 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.531 -0.731 . . . . 0.0 111.118 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 19.7 ptt-85 171.64 116.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.325 -0.859 . . . . 0.0 110.773 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.641 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.4 179.98 4.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.102 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.618 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 36.8 p-90 -170.55 143.93 2.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.619 -1.301 . . . . 0.0 110.309 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.634 ' HB3' HD13 ' A' ' 301' ' ' LEU . 31.8 p90 -114.16 140.28 48.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.286 -0.884 . . . . 0.0 109.257 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 432' ' ' ILE . 27.0 tt0 -130.95 149.95 52.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 111.979 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 37.7 t -128.78 150.66 34.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 357' ' ' LYS . 29.3 tt0 -150.12 140.43 22.28 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.992 -1.067 . . . . 0.0 109.692 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 348' ' ' ALA . 1.7 p30 -161.12 168.95 23.32 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.976 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.3 151.89 20.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.428 -0.795 . . . . 0.0 110.32 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 162.81 -156.46 28.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.53 137.75 23.29 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.961 1.506 . . . . 0.0 110.614 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -92.03 -174.04 42.33 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.572 HG13 HD21 ' A' ' 430' ' ' LEU . 3.2 mt -110.69 97.88 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.005 -1.291 . . . . 0.0 109.891 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.957 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -68.56 178.83 0.76 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.28 -0.888 . . . . 0.0 110.547 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.957 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 43.0 Cg_endo -70.8 -19.75 30.81 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.165 1.613 . . . . 0.0 110.012 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.46 -30.67 17.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 109.579 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -85.0 -19.22 32.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.465 -0.772 . . . . 0.0 109.829 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 385' ' ' HIS . 36.0 ttm-85 -54.25 -52.03 62.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.395 -0.815 . . . . 0.0 110.521 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -44.03 -18.57 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.692 -0.63 . . . . 0.0 111.828 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.608 ' O ' HD12 ' A' ' 386' ' ' LEU . 0.2 OUTLIER -111.55 42.08 1.77 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.814 -1.179 . . . . 0.0 111.642 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.608 HD12 ' O ' ' A' ' 385' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 O-C-N 120.158 -1.589 . . . . 0.0 114.322 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.665 ' O ' HG12 ' A' ' 409' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.742 ' HA ' HD13 ' A' ' 412' ' ' ILE . 0.4 OUTLIER 79.76 -35.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 121.605 -0.684 . . . . 0.0 110.47 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -69.84 -54.06 15.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.0 -1.062 . . . . 0.0 110.079 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.87 -21.11 41.26 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.28 -0.887 . . . . 0.0 110.013 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.829 HG12 ' HB2' ' A' ' 340' ' ' ALA . 1.0 OUTLIER -66.86 -59.1 4.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.822 HG11 ' HB2' ' A' ' 420' ' ' LEU . 21.2 t -67.94 -22.31 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.523 -0.736 . . . . 0.0 110.031 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -82.44 -23.45 34.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.551 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.51 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 58.8 m-20 -83.31 -21.91 33.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.517 -0.739 . . . . 0.0 109.203 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.631 ' CE1' HD11 ' A' ' 337' ' ' ILE . 37.7 m80 -92.77 -37.2 12.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.701 . . . . 0.0 109.894 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.1 OUTLIER 81.95 29.64 0.13 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.798 -0.564 . . . . 0.0 111.015 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.589 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -98.39 -90.66 1.96 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.53 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.6 tpp -175.89 161.57 2.5 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.278 -1.131 . . . . 0.0 111.168 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.822 ' HB2' HG11 ' A' ' 413' ' ' VAL . 27.0 tp -152.66 108.12 3.29 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.353 -0.842 . . . . 0.0 109.312 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.61 138.14 48.68 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.782 -1.199 . . . . 0.0 111.738 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.493 HD23 HD11 ' A' ' 378' ' ' ILE . 0.2 OUTLIER -90.57 130.5 36.6 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -122.56 114.84 2.56 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 119.577 -1.296 . . . . 0.0 110.006 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 C--N 1.305 -1.345 0 O-C-N 121.406 -1.055 . . . . 0.0 108.651 179.801 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.738 ' C ' HD22 ' A' ' 430' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.738 HD22 ' C ' ' A' ' 429' ' ' GLY . 2.4 mm? -130.18 152.21 49.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.885 -1.362 . . . . 0.0 113.308 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 11.3 p -142.34 113.18 7.43 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.489 HG13 ' HG2' ' A' ' 344' ' ' MET . 21.6 mm -87.09 118.15 32.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.837 -1.165 . . . . 0.0 111.112 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' ARG . . . . . 0.412 ' HD2' ' HE1' ' A' ' 435' ' ' TRP . 2.6 ttm180 -105.52 95.29 5.71 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.62 ' HB3' ' CE2' ' A' ' 369' ' ' PHE . . . -98.82 137.52 37.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.323 -0.86 . . . . 0.0 110.998 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.618 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 92.1 m95 -109.01 155.05 21.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.848 . . . . 0.0 111.24 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 1.051 HD12 HD11 ' A' ' 301' ' ' LEU . 53.7 mt -145.63 101.05 4.32 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.589 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 39.8 Cg_endo -63.88 136.98 55.7 Favored 'Trans proline' 0 C--N 1.297 -2.142 0 O-C-N 124.069 1.562 . . . . 0.0 111.836 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.641 HG13 ' HD2' ' A' ' 439' ' ' PRO . 89.7 t -81.99 146.23 55.07 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.72 -0.612 . . . . 0.0 110.158 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.641 ' HD2' HG13 ' A' ' 438' ' ' VAL . 56.5 Cg_endo . . . . . 0 C--N 1.3 -1.994 0 O-C-N 124.196 1.629 . . . . 0.0 110.121 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.475 ' HG2' ' ND1' ' A' ' 333' ' ' HIS . 43.3 Cg_endo . . . . . 0 C--O 1.215 -0.646 0 CA-C-O 121.432 0.513 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.565 ' HE2' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -88.37 102.92 15.35 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.435 -0.79 . . . . 0.0 109.747 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.0 mt-10 -118.53 -167.59 1.39 Allowed 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.584 -0.697 . . . . 0.0 109.347 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 1.8 mmt -88.19 124.92 34.32 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.886 -1.134 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.686 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -143.33 150.32 39.01 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.441 0.638 . . . . 0.0 111.163 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.534 ' HB3' ' CB ' ' A' ' 303' ' ' ALA . 46.9 t0 -84.44 118.81 24.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.899 HD11 HD12 ' A' ' 436' ' ' LEU . 7.1 mt -64.46 -22.56 67.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.968 -1.082 . . . . 0.0 109.726 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.795 ' HA ' HD23 ' A' ' 323' ' ' LEU . 48.2 m-20 -81.24 -19.78 42.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 0.0 108.735 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -84.61 -35.9 22.4 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.695 -0.628 . . . . 0.0 109.485 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.805 ' O ' HG23 ' A' ' 308' ' ' VAL . 21.5 t -77.25 -34.6 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.494 -0.754 . . . . 0.0 109.267 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 91.9 mt -77.23 -28.65 53.77 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.505 -0.747 . . . . 0.0 109.68 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -63.63 -42.1 98.87 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.62 -30.46 61.67 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.477 -1.014 . . . . 0.0 109.065 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 304' ' ' VAL . 74.4 t -75.22 -21.29 16.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 1.017 ' CG1' HG11 ' A' ' 358' ' ' VAL . 3.2 mt -77.38 -41.36 29.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -64.07 -17.66 63.61 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -83.31 -43.91 15.48 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.351 0.596 . . . . 0.0 109.866 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.727 ' OE2' HG21 ' A' ' 358' ' ' VAL . 6.7 pt-20 -81.67 10.88 5.34 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.359 -0.838 . . . . 0.0 110.306 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 314' ' ' GLY . 60.5 p -117.64 69.64 0.78 Allowed 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 313' ' ' SER . . . -42.59 -30.15 0.85 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 313' ' ' SER . 28.6 t80 -162.69 36.21 0.11 Allowed 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.788 -0.831 . . . . 0.0 109.984 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.34 56.32 8.11 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.092 -1.005 . . . . 0.0 108.538 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -68.31 -55.34 12.46 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-O 121.372 0.606 . . . . 0.0 110.746 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' A' ' 355' ' ' TRP . 7.4 pt-20 -170.59 58.56 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.862 0 C-N-CA 119.471 -0.892 . . . . 0.0 112.087 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.88 HG13 HD12 ' A' ' 356' ' ' ILE . 2.2 mp -106.9 125.38 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.788 -1.195 . . . . 0.0 110.225 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.19 116.77 29.18 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 7.6 p -95.25 129.91 42.2 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.418 -0.802 . . . . 0.0 111.173 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.76 79.17 1.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.479 -0.763 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.795 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.7 mp -95.06 160.95 14.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.444 -0.785 . . . . 0.0 110.525 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.597 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 83.9 t80 -50.42 129.06 25.16 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.171 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.05 71.76 6.87 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.767 1.404 . . . . 0.0 110.695 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -179.72 28.19 0.05 OUTLIER Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.36 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 326' ' ' GLY . 29.3 m 46.59 99.12 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.079 -1.248 . . . . 0.0 110.209 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.535 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 3.0 mt -69.23 174.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 121.431 -0.793 . . . . 0.0 110.099 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 4.9 mt-10 -168.14 105.44 0.48 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.793 0.806 . . . . 0.0 110.714 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.91 HG11 ' HB3' ' A' ' 367' ' ' ALA . 9.9 m -133.42 171.45 18.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 O-C-N 121.749 -0.594 . . . . 0.0 109.751 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -87.25 90.9 8.53 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.981 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.952 ' CE ' HG21 ' A' ' 337' ' ' ILE . 16.6 ptm -142.58 162.17 36.16 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 111.15 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 23.6 t-160 -91.56 114.21 61.1 Favored Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 36.3 Cg_endo -58.35 -18.76 39.79 Favored 'Trans proline' 0 C--N 1.295 -2.243 0 O-C-N 123.388 1.204 . . . . 0.0 109.87 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.615 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -84.19 -70.62 0.56 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.392 -0.817 . . . . 0.0 110.735 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.578 ' HB3' ' CE1' ' A' ' 416' ' ' HIS . 10.6 t -51.65 -36.43 46.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 110.569 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.952 HG21 ' CE ' ' A' ' 332' ' ' MET . 37.3 mm -70.62 -43.04 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 110.091 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 4.7 tppt? -52.28 -35.03 49.11 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 120.911 -1.118 . . . . 0.0 108.866 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.15 -36.33 35.31 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.535 0.683 . . . . 0.0 109.824 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 1.089 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -56.0 -48.66 75.49 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.586 -0.697 . . . . 0.0 110.5 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.793 ' CG1' HG11 ' A' ' 308' ' ' VAL . 70.2 t -75.21 -38.33 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.513 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.752 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -50.42 -53.99 25.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.325 -0.86 . . . . 0.0 110.748 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -19.81 61.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.103 -0.998 . . . . 0.0 110.512 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 0.5 OUTLIER -69.46 -45.17 69.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.121 -0.987 . . . . 0.0 110.529 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 84.4 t -80.09 -20.59 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.431 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 342' ' ' ALA . 25.4 t -60.02 -20.59 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.124 -0.985 . . . . 0.0 110.074 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 0.6 OUTLIER -69.08 -41.88 76.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.314 -0.866 . . . . 0.0 110.475 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.694 ' HB1' ' CB ' ' A' ' 373' ' ' ASP . . . -90.29 -20.39 22.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.92 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -78.3 -52.12 9.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 110.219 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -90.43 -45.61 8.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 110.482 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 347' ' ' ASN . 1.9 m-85 -89.8 -25.88 20.85 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.231 -0.918 . . . . 0.0 110.557 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -63.96 -135.18 0.01 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -133.83 -48.83 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.205 -1.173 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' GLY . . . . . 0.479 ' O ' HG13 ' A' ' 356' ' ' ILE . . . -171.48 -87.33 0.07 OUTLIER Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.213 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.448 ' HA ' ' CG ' ' A' ' 318' ' ' GLU . 37.3 t90 -42.83 132.6 3.81 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.23 -1.159 . . . . 0.0 112.469 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.88 HD12 HG13 ' A' ' 319' ' ' ILE . 2.8 mt -125.26 145.66 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.516 ' HD3' ' HB3' ' A' ' 372' ' ' GLU . 5.9 tttt -125.54 110.67 14.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.564 -1.335 . . . . 0.0 110.372 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 1.017 HG11 ' CG1' ' A' ' 309' ' ' ILE . 22.1 t -106.24 101.74 12.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 109.266 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 33.8 m -130.02 152.49 49.42 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.562 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.2 OUTLIER -147.07 153.22 39.71 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.63 -0.669 . . . . 0.0 109.697 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -144.27 -160.67 8.59 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 108.394 -1.883 . . . . 0.0 108.394 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.2 OUTLIER -173.0 178.87 2.41 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.893 -1.357 . . . . 0.0 111.302 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.561 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 3.5 mt-10 -160.89 -178.52 0.89 Allowed Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 38.0 Cg_endo -64.41 135.34 45.72 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.245 1.129 . . . . 0.0 110.341 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.533 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 15.2 p30 39.71 33.71 0.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.764 -0.585 . . . . 0.0 110.562 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER -174.17 94.0 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.258 -0.901 . . . . 0.0 111.421 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.91 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -103.27 151.35 22.79 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.673 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 30.7 p-90 -144.68 174.07 11.29 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.362 -1.461 . . . . 0.0 111.247 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 369' ' ' PHE . 9.2 p90 -148.92 139.33 22.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.671 -0.643 . . . . 0.0 109.408 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 432' ' ' ILE . 50.1 tt0 -130.72 163.94 26.16 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.252 -0.905 . . . . 0.0 111.648 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.442 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 32.0 t -132.17 156.05 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.607 -0.683 . . . . 0.0 110.01 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 357' ' ' LYS . 10.2 tt0 -149.83 131.46 14.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.074 -1.016 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.694 ' CB ' ' HB1' ' A' ' 348' ' ' ALA . 35.9 m-20 -136.99 162.74 32.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.003 -1.061 . . . . 0.0 110.88 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -87.96 142.17 28.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.963 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 157.63 -168.4 34.31 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.46 -176.66 2.86 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 O-C-N 124.053 1.554 . . . . 0.0 110.692 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' A' ' 430' ' ' LEU . . . -90.49 -131.47 4.78 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.774 HD11 HD21 ' A' ' 430' ' ' LEU . 3.1 mm -103.29 145.03 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.041 -1.27 . . . . 0.0 109.93 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.871 ' HB3' ' HB3' ' A' ' 382' ' ' GLN . . . -39.79 160.11 0.11 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.506 -0.746 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.28 -54.23 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.055 1.555 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -75.33 -23.19 57.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.82 . . . . 0.0 110.165 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.871 ' HB3' ' HB3' ' A' ' 379' ' ' ALA . 1.1 tt0 -82.92 -23.25 33.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.953 . . . . 0.0 109.682 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.18 -22.31 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.398 -0.814 . . . . 0.0 110.091 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -87.51 -35.11 18.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 0.0 110.053 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.505 ' N ' ' ND1' ' A' ' 385' ' ' HIS . 2.3 m-70 -80.52 -69.67 0.58 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.218 -0.926 . . . . 0.0 110.647 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 1.062 ' CD1' HD13 ' A' ' 422' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.778 HG23 HG23 ' A' ' 409' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.778 HG23 HG23 ' A' ' 408' ' ' ILE . 3.7 t 79.22 -27.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.662 0 O-C-N 121.718 -0.614 . . . . 0.0 110.699 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 19.4 tt0 -57.92 -57.53 12.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.89 -1.131 . . . . 0.0 110.139 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -63.53 -34.91 78.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 110.659 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 1.089 HG21 ' HB2' ' A' ' 340' ' ' ALA . 1.4 mp -56.37 -73.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.936 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.82 HG22 HD21 ' A' ' 417' ' ' ASN . 85.7 t -50.92 -34.54 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.457 -0.777 . . . . 0.0 110.321 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 0.1 OUTLIER -59.28 -39.39 82.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.206 -0.934 . . . . 0.0 110.138 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.536 ' O ' ' CE ' ' A' ' 296' ' ' MET . 22.5 m-80 -110.61 7.23 22.32 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.406 -0.809 . . . . 0.0 110.304 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.77 ' CG ' HD11 ' A' ' 337' ' ' ILE . 8.9 m80 -115.98 -56.95 2.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 111.577 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 1.098 ' HA ' HD23 ' A' ' 436' ' ' LEU . 0.0 OUTLIER -98.77 -87.7 0.34 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.986 -1.071 . . . . 0.0 110.944 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 149.74 -37.15 0.97 Allowed Glycine 0 C--N 1.263 -3.488 0 C-N-CA 117.791 -2.147 . . . . 0.0 109.824 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.612 ' HB3' ' HB2' ' A' ' 435' ' ' TRP . 2.7 ttp -117.08 145.6 43.65 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.139 -1.212 . . . . 0.0 111.354 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.48 ' O ' ' HG ' ' A' ' 420' ' ' LEU . 23.0 tp -151.91 87.13 1.33 Allowed 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -107.94 158.51 17.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.2 -0.937 . . . . 0.0 111.3 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 1.062 HD13 ' CD1' ' A' ' 386' ' ' LEU . 0.3 OUTLIER -108.35 131.86 54.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.59 -0.694 . . . . 0.0 110.785 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 424' ' ' THR . . . -130.66 -177.88 15.13 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 429' ' ' GLY . 5.4 m . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.152 -1.205 . . . . 0.0 111.079 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.738 ' O ' HG22 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.497 2.732 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.774 HD21 HD11 ' A' ' 378' ' ' ILE . 0.2 OUTLIER -141.24 160.38 40.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.55 -0.971 . . . . 0.0 109.737 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.705 ' H ' HD13 ' A' ' 430' ' ' LEU . 5.1 p -156.48 151.29 25.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.327 -0.858 . . . . 0.0 109.66 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.476 ' O ' ' HG3' ' A' ' 370' ' ' GLN . 12.8 mt -120.35 121.94 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 110.258 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' ARG . . . . . 0.455 ' HG2' ' CD ' ' A' ' 370' ' ' GLN . 12.0 mtm180 -99.42 122.88 43.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 110.113 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -122.11 133.08 54.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.673 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 86.0 m95 -110.55 135.91 50.49 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.898 -1.126 . . . . 0.0 112.888 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 1.098 HD23 ' HA ' ' A' ' 417' ' ' ASN . 6.9 mt -115.28 87.68 16.8 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 417' ' ' ASN . 47.1 Cg_endo -83.56 121.11 2.9 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 O-C-N 124.041 1.548 . . . . 0.0 111.617 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 438' ' ' VAL . 2.8 t -74.16 112.31 16.33 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.037 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 52.1 Cg_endo . . . . . 0 C--N 1.307 -1.641 0 O-C-N 123.84 1.442 . . . . 0.0 110.995 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo . . . . . 0 C--O 1.215 -0.657 0 N-CA-C 110.094 -0.772 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.608 ' HE2' ' NE2' ' A' ' 416' ' ' HIS . 1.0 OUTLIER -114.23 105.34 13.05 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.617 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 47.0 mt-10 -136.25 -154.06 0.54 Allowed 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.454 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.683 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 1.6 mmt -87.12 132.67 33.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.921 . . . . 0.0 110.699 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.726 ' HB3' ' CG ' ' A' ' 332' ' ' MET . . . -148.05 158.2 43.93 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.088 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.7 OUTLIER -90.51 119.46 30.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.759 . . . . 0.0 109.705 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.831 HD11 HD12 ' A' ' 436' ' ' LEU . 8.4 mt -65.77 -19.9 66.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.039 -1.038 . . . . 0.0 109.645 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.801 ' HA ' HD23 ' A' ' 323' ' ' LEU . 52.0 t-20 -84.69 -19.98 31.94 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.111 -0.993 . . . . 0.0 108.913 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.9 -36.03 21.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.598 -0.689 . . . . 0.0 109.322 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.743 ' O ' HG23 ' A' ' 308' ' ' VAL . 22.3 t -78.16 -38.46 23.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.526 -0.734 . . . . 0.0 109.214 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 88.5 mt -76.92 -28.21 55.19 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.424 -0.798 . . . . 0.0 109.991 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.83 -25.24 75.36 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.832 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 3.8 mt-10 -83.85 -33.17 24.9 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.46 -1.023 . . . . 0.0 109.272 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 1.049 HG11 ' CG1' ' A' ' 341' ' ' VAL . 40.2 t -72.45 -28.73 29.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.459 -0.776 . . . . 0.0 109.118 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.6 HG13 HG11 ' A' ' 358' ' ' VAL . 4.6 mt -72.58 -57.08 7.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.77 -16.5 64.3 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.82 0.819 . . . . 0.0 109.014 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.832 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -65.94 -66.42 0.55 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.763 -0.586 . . . . 0.0 111.047 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.421 ' HG2' ' C ' ' A' ' 311' ' ' ALA . 4.5 mm-40 -127.47 42.8 3.25 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.871 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.557 ' CB ' HD13 ' A' ' 319' ' ' ILE . 7.0 p -86.11 32.1 0.62 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.878 -1.139 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 51.68 23.15 9.56 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.548 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 0.2 OUTLIER 70.59 43.65 0.74 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.844 -0.797 . . . . 0.0 110.249 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 74.58 52.02 0.09 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.486 -0.759 . . . . 0.0 110.725 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.459 ' HG3' ' HA3' ' A' ' 314' ' ' GLY . 12.8 mmm180 -68.27 -83.05 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 122.019 0.914 . . . . 0.0 109.144 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -145.82 50.03 1.2 Allowed 'General case' 0 C--N 1.268 -2.971 0 CA-C-O 122.011 0.91 . . . . 0.0 109.886 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.647 HG13 HD12 ' A' ' 356' ' ' ILE . 5.2 mt -99.46 135.8 33.28 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.24 102.93 14.33 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.32 -0.863 . . . . 0.0 109.43 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.566 ' CG2' HD13 ' A' ' 309' ' ' ILE . 19.0 p -91.63 129.1 37.66 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.409 -0.807 . . . . 0.0 111.293 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.38 78.5 1.38 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.801 HD23 ' HA ' ' A' ' 302' ' ' ASN . 6.5 mp -95.12 154.46 17.17 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.442 -0.786 . . . . 0.0 110.277 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.585 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 20.7 t80 -40.36 120.13 1.58 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.695 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -79.18 69.42 7.93 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.878 1.462 . . . . 0.0 111.366 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . -172.23 -76.46 0.05 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.6 OUTLIER 167.52 108.96 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.525 -0.985 . . . . 0.0 109.359 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 329' ' ' GLU . 3.8 mt -87.66 178.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 O-C-N 121.468 -0.77 . . . . 0.0 109.995 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.632 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.5 mt-10 -171.58 102.26 0.19 Allowed 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.566 0.698 . . . . 0.0 110.297 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 1.153 HG12 HG22 ' A' ' 438' ' ' VAL . 21.3 m -133.86 158.54 42.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.943 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.3 OUTLIER -79.41 98.81 6.9 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.726 ' CG ' ' HB3' ' A' ' 299' ' ' ALA . 4.9 ppp? -139.93 172.7 12.4 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.188 -0.945 . . . . 0.0 112.194 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.5 ' NE2' ' HB3' ' A' ' 335' ' ' LEU . 21.9 t-160 -106.92 114.62 61.4 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 37.7 Cg_endo -61.17 -21.14 70.76 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.405 1.213 . . . . 0.0 111.04 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.5 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 1.9 tp -87.78 -54.62 4.16 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.984 -1.072 . . . . 0.0 110.141 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.753 ' O ' HD12 ' A' ' 412' ' ' ILE . 0.4 OUTLIER -63.83 -25.13 68.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.286 -0.884 . . . . 0.0 110.661 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 1.042 HD11 ' CE1' ' A' ' 416' ' ' HIS . 32.0 mm -85.34 -42.56 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.633 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 11.9 mtmt -57.86 -34.91 70.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 108.06 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -72.43 -43.77 63.35 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.526 0.679 . . . . 0.0 109.991 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 1.039 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -60.89 -30.66 70.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.505 -0.747 . . . . 0.0 110.973 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 1.049 ' CG1' HG11 ' A' ' 308' ' ' VAL . 98.7 t -78.62 -40.18 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.069 -1.019 . . . . 0.0 110.541 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.94 98.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -0.898 . . . . 0.0 110.828 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ASN . . . . . 0.717 ' O ' HG12 ' A' ' 346' ' ' VAL . 1.3 t30 -58.71 -20.35 48.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.258 -0.901 . . . . 0.0 110.981 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.8 mtt -84.53 -57.64 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.054 -1.029 . . . . 0.0 110.504 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.488 HG23 HG21 ' A' ' 356' ' ' ILE . 5.4 p -63.73 -19.49 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.303 -0.873 . . . . 0.0 110.756 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 343' ' ' ASN . 9.5 p -64.64 -19.99 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.083 -1.011 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -74.07 -55.86 5.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.101 -0.999 . . . . 0.0 110.415 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -76.19 -19.56 58.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 110.623 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.12 -50.72 30.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 0.0 109.992 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 346' ' ' VAL . 6.7 mmm180 -53.6 -69.18 0.13 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -0.936 . . . . 0.0 109.715 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.57 -53.92 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 109.888 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 86.13 65.3 1.43 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -64.57 -48.89 73.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -1.204 . . . . 0.0 110.099 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . 150.92 -7.52 0.66 Allowed Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.302 -1.428 . . . . 0.0 111.205 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.426 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 40.6 t90 -162.83 138.22 6.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.374 -1.662 . . . . 0.0 112.658 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.647 HD12 HG13 ' A' ' 319' ' ' ILE . 3.1 mt -128.3 164.87 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 372' ' ' GLU . 2.8 tttt -147.06 134.86 21.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.477 -1.389 . . . . 0.0 111.389 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.6 HG11 HG13 ' A' ' 309' ' ' ILE . 11.0 t -133.77 82.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 55.9 p -116.27 136.15 53.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.289 -0.882 . . . . 0.0 110.536 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 323' ' ' LEU . 0.8 OUTLIER -137.38 158.69 43.85 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.622 -0.673 . . . . 0.0 109.914 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -146.74 -150.26 5.15 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -165.55 177.46 7.38 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.21 -1.171 . . . . 0.0 110.077 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -152.88 175.89 2.71 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 110.165 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.7 Cg_endo -70.18 117.24 4.99 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.895 1.471 . . . . 0.0 110.892 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 48.0 t30 71.99 19.54 4.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.381 -0.824 . . . . 0.0 110.972 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 6.5 ptt180 173.73 127.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.431 -0.793 . . . . 0.0 110.834 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.727 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -114.45 -179.55 3.66 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.611 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 28.0 p-90 -169.23 162.39 10.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.449 -1.407 . . . . 0.0 110.968 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 37.9 p90 -131.6 158.66 40.44 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.512 ' CG ' ' HA ' ' A' ' 433' ' ' ARG . 2.1 mt-30 -144.89 151.35 38.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.858 -1.151 . . . . 0.0 112.228 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 57.2 t -129.88 155.03 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 357' ' ' LYS . 5.3 mt-10 -145.05 159.43 42.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.944 -1.098 . . . . 0.0 109.987 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.448 ' OD2' HD12 ' A' ' 430' ' ' LEU . 2.5 p30 -147.09 153.04 39.48 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.019 -1.05 . . . . 0.0 110.886 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.22 135.83 51.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.343 -0.848 . . . . 0.0 110.095 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 144.17 173.02 15.24 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.28 -166.83 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.846 1.445 . . . . 0.0 110.38 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -92.65 175.01 36.82 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.559 HG13 ' CD2' ' A' ' 430' ' ' LEU . 3.4 mt -70.07 144.23 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -1.107 . . . . 0.0 110.138 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.707 ' HB3' ' HG3' ' A' ' 382' ' ' GLN . . . -74.13 153.94 88.48 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.141 -0.974 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.68 -21.75 21.5 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.861 1.453 . . . . 0.0 110.25 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -90.65 -30.96 16.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.266 -0.897 . . . . 0.0 110.605 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.707 ' HG3' ' HB3' ' A' ' 379' ' ' ALA . 1.2 mt-30 -90.16 -18.83 25.06 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.31 -0.869 . . . . 0.0 110.806 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 379' ' ' ALA . 45.7 ttp85 -52.72 -54.59 31.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.217 -0.927 . . . . 0.0 110.769 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -19.97 8.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.129 -0.982 . . . . 0.0 110.407 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -91.51 28.43 1.72 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.275 -0.891 . . . . 0.0 111.049 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 382' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 O-C-N 120.934 -1.104 . . . . 0.0 110.728 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.787 HG23 ' O ' ' A' ' 408' ' ' ILE . 9.1 tp . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.315 0.578 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 408' ' ' ILE . 9.1 t -160.87 -37.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.183 -0.948 . . . . 0.0 109.863 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 59.4 tt0 -67.9 -57.43 6.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.128 -0.982 . . . . 0.0 109.687 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.572 ' O ' ' ND2' ' A' ' 415' ' ' ASN . 0.4 OUTLIER -56.11 -18.73 10.65 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.245 -0.909 . . . . 0.0 110.297 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 1.039 HG21 ' HB2' ' A' ' 340' ' ' ALA . 18.1 mm -63.47 -71.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.113 -0.992 . . . . 0.0 109.538 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 420' ' ' LEU . 10.8 t -64.36 -21.3 28.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 109.23 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 4.8 t0 -81.22 -20.41 41.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.512 -0.743 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 411' ' ' ARG . 1.2 m-80 -77.5 -23.73 50.24 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 1.042 ' CE1' HD11 ' A' ' 337' ' ' ILE . 55.2 m80 -91.24 -17.14 26.49 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.703 -0.623 . . . . 0.0 109.367 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.567 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 34.4 m120 67.82 10.49 7.83 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.327 0.584 . . . . 0.0 110.317 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 435' ' ' TRP . . . -69.86 -87.55 0.11 Allowed Glycine 0 N--CA 1.482 1.726 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.577 ' O ' HG11 ' A' ' 413' ' ' VAL . 0.3 OUTLIER 178.02 166.08 0.73 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 111.208 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 413' ' ' VAL . 42.5 tp -151.56 118.81 5.94 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 109.324 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -129.03 147.86 50.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.969 -1.082 . . . . 0.0 111.356 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.95 127.3 45.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.433 -0.792 . . . . 0.0 109.311 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -176.85 -176.18 44.78 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.807 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.668 HG23 ' N ' ' A' ' 429' ' ' GLY . 74.6 m . . . . . 0 C--N 1.299 -1.607 0 O-C-N 121.379 -1.071 . . . . 0.0 110.387 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.505 3.244 0 CA-C-O 122.426 1.015 . . . . 0.0 113.224 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.668 HD13 ' N ' ' A' ' 431' ' ' SER . 0.2 OUTLIER -35.19 123.21 0.6 Allowed 'General case' 0 N--CA 1.515 2.777 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.668 ' N ' HD13 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -153.76 115.22 4.18 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.412 ' C ' ' HG3' ' A' ' 433' ' ' ARG . 31.8 mt -97.55 145.59 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 110.722 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' ARG . . . . . 0.512 ' HA ' ' CG ' ' A' ' 370' ' ' GLN . 20.2 mtp180 -126.76 144.11 51.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 109.87 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -139.77 132.68 29.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.615 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.611 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 87.5 m95 -111.46 157.98 19.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.044 -1.035 . . . . 0.0 112.082 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.831 HD12 HD11 ' A' ' 301' ' ' LEU . 75.4 mt -147.26 127.62 6.84 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.446 ' C ' ' HD3' ' A' ' 439' ' ' PRO . 43.1 Cg_endo -70.13 141.41 43.68 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.522 1.275 . . . . 0.0 111.845 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 1.153 HG22 HG12 ' A' ' 330' ' ' VAL . 53.7 t -110.67 74.05 0.88 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.577 -0.702 . . . . 0.0 110.416 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.446 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 49.1 Cg_endo . . . . . 0 C--N 1.305 -1.742 0 O-C-N 123.829 1.436 . . . . 0.0 110.979 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.595 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 46.3 Cg_endo . . . . . 0 CA--C 1.508 -0.804 0 N-CA-C 109.871 -0.857 . . . . 0.0 109.871 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.471 ' HE2' ' NE2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -109.49 109.26 20.03 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.4 OUTLIER -148.14 -146.93 0.21 Allowed 'General case' 0 C--N 1.273 -2.737 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.521 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -88.04 144.86 26.28 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.227 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.98 162.84 40.83 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.358 -0.839 . . . . 0.0 111.201 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.714 ' O ' HG23 ' A' ' 304' ' ' VAL . 71.4 m-20 -94.32 118.76 32.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.543 -0.723 . . . . 0.0 109.363 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.907 HD11 HD12 ' A' ' 436' ' ' LEU . 5.5 mt -69.82 -21.46 63.38 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.949 -1.095 . . . . 0.0 109.765 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.713 ' OD1' HD23 ' A' ' 323' ' ' LEU . 55.9 t-20 -84.99 -20.04 31.13 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.092 -1.005 . . . . 0.0 108.86 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.598 ' HB3' ' HB2' ' A' ' 300' ' ' ASP . . . -87.32 -34.63 18.8 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.546 0.689 . . . . 0.0 109.506 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 300' ' ' ASP . 18.0 t -80.42 -31.43 12.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.411 -0.805 . . . . 0.0 109.245 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.534 ' CD2' HG21 ' A' ' 341' ' ' VAL . 62.9 mt -80.52 -30.68 37.2 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.433 -0.792 . . . . 0.0 109.969 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -69.52 -32.48 71.38 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.841 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 1.2 mt-10 -78.1 -34.29 50.19 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.405 -1.056 . . . . 0.0 109.043 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 1.057 HG11 ' HB ' ' A' ' 341' ' ' VAL . 88.2 t -78.87 -19.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 121.664 0.745 . . . . 0.0 109.531 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.997 HD11 ' CG1' ' A' ' 358' ' ' VAL . 0.0 OUTLIER -75.79 -44.09 39.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 122.052 0.93 . . . . 0.0 108.617 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.473 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -91.06 -16.55 27.69 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.282 -0.886 . . . . 0.0 109.735 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -60.42 -62.38 1.9 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.668 -0.645 . . . . 0.0 110.838 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.725 ' CD ' ' HB1' ' A' ' 342' ' ' ALA . 2.7 pt-20 -145.99 38.06 1.08 Allowed 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.94 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.997 ' O ' HD11 ' A' ' 319' ' ' ILE . 6.9 m -91.4 31.41 1.16 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 109.339 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 94.36 21.23 27.66 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 3.0 m-85 62.46 45.55 6.34 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.674 -0.898 . . . . 0.0 109.735 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 1.9 mt-10 59.44 43.24 16.6 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.562 ' CG ' ' N ' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -69.07 -84.98 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.571 0.701 . . . . 0.0 110.041 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.562 ' N ' ' CG ' ' A' ' 317' ' ' ARG . 38.8 mt-10 -136.35 67.81 1.45 Allowed 'General case' 0 C--N 1.275 -2.653 0 CA-C-O 121.608 0.718 . . . . 0.0 111.027 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.997 HD11 ' O ' ' A' ' 313' ' ' SER . 2.6 mp -113.13 129.08 69.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.712 -0.618 . . . . 0.0 109.632 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 358' ' ' VAL . 1.5 tt0 -89.1 100.73 13.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.072 -1.018 . . . . 0.0 109.321 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 19.9 p -92.17 130.31 37.92 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.781 0.801 . . . . 0.0 111.697 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.12 78.61 1.34 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.713 HD23 ' OD1' ' A' ' 302' ' ' ASN . 0.9 OUTLIER -89.34 160.51 16.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 111.002 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 50.8 t80 -59.49 119.4 39.45 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.548 -0.72 . . . . 0.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.22 73.0 5.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.889 1.468 . . . . 0.0 110.573 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -172.06 27.48 0.1 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 326' ' ' GLY . 0.8 OUTLIER 47.12 96.79 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.186 -1.185 . . . . 0.0 110.145 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.663 HG22 ' H ' ' A' ' 329' ' ' GLU . 3.1 mt -73.06 -179.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.658 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.663 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.2 mt-10 -169.48 107.66 0.4 Allowed 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.91 0.862 . . . . 0.0 111.128 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.811 HG11 ' HB3' ' A' ' 367' ' ' ALA . 31.6 m -141.38 153.13 19.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 5.3 tptt -67.55 97.87 0.63 Allowed 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 118.359 -1.336 . . . . 0.0 107.9 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.84 ' SD ' HD13 ' A' ' 436' ' ' LEU . 4.9 ttp -139.69 173.6 11.37 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.469 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.614 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 23.7 t-160 -117.11 113.26 39.45 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 37.5 Cg_endo -59.9 -20.08 58.07 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.553 1.291 . . . . 0.0 110.634 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.614 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -79.24 -63.01 1.52 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.305 -0.872 . . . . 0.0 110.212 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 412' ' ' ILE . 27.1 p -55.77 -46.93 77.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.108 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.741 HD11 ' CE1' ' A' ' 416' ' ' HIS . 23.6 mm -63.34 -32.35 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.386 -0.821 . . . . 0.0 110.05 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 10.3 mttt -59.27 -45.7 90.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.041 -1.037 . . . . 0.0 109.5 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -31.82 63.59 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.843 -0.536 . . . . 0.0 110.745 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.979 ' HA ' HG12 ' A' ' 409' ' ' VAL . . . -65.03 -45.24 86.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.155 -0.965 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 1.057 ' HB ' HG11 ' A' ' 308' ' ' VAL . 16.0 t -81.1 -22.21 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 110.291 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.725 ' HB1' ' CD ' ' A' ' 312' ' ' GLU . . . -71.37 -34.73 70.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.325 -0.859 . . . . 0.0 110.682 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -83.27 -19.72 35.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.204 -0.935 . . . . 0.0 110.559 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.529 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 0.1 OUTLIER -75.36 -31.32 60.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.179 -0.951 . . . . 0.0 111.063 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.745 HG13 HG21 ' A' ' 356' ' ' ILE . 9.6 t -90.66 -20.26 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.956 -1.09 . . . . 0.0 110.608 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 342' ' ' ALA . 47.9 t -77.25 -20.95 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 0.0 110.908 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 344' ' ' MET . 2.8 p30 -78.11 -38.81 43.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.97 -1.081 . . . . 0.0 110.715 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 347' ' ' ASN . . . -90.24 -20.74 22.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.123 -0.986 . . . . 0.0 110.464 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -78.1 -26.66 48.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.132 -0.98 . . . . 0.0 110.68 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -89.05 -71.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -0.962 . . . . 0.0 110.694 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -75.69 -32.26 60.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 110.52 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.507 ' HA2' ' HA2' ' A' ' 375' ' ' GLY . . . -65.87 172.04 25.52 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -67.82 0.37 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -1.116 . . . . 0.0 110.052 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 318' ' ' GLU . . . 163.26 40.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -140.37 120.98 14.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.062 -1.258 . . . . 0.0 110.866 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.745 HG21 HG13 ' A' ' 345' ' ' VAL . 1.8 mp -123.37 124.21 69.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.647 -0.658 . . . . 0.0 109.339 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 372' ' ' GLU . 0.0 OUTLIER -89.46 105.08 17.56 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.981 -1.075 . . . . 0.0 109.895 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.997 ' CG1' HD11 ' A' ' 309' ' ' ILE . 74.8 t -102.5 120.28 52.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.316 -0.865 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.429 ' OG ' ' HD3' ' A' ' 357' ' ' LYS . 0.9 OUTLIER -145.84 140.34 27.0 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.214 -0.929 . . . . 0.0 110.206 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 369' ' ' PHE . 8.9 t -132.49 135.5 46.06 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.466 -0.771 . . . . 0.0 109.99 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.474 ' C ' HG22 ' A' ' 362' ' ' THR . . . -130.88 -160.71 10.05 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.64 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -173.51 165.39 4.63 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.913 -1.346 . . . . 0.0 111.336 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.483 ' HB2' ' CD ' ' A' ' 366' ' ' ARG . 1.0 OUTLIER -147.94 178.12 1.56 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.6 Cg_endo -71.71 110.85 2.99 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.713 1.375 . . . . 0.0 110.599 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 438' ' ' VAL . 0.1 OUTLIER 74.96 27.15 1.2 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.383 -0.823 . . . . 0.0 110.99 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 437' ' ' PRO . 0.2 OUTLIER 179.13 97.39 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.257 -0.902 . . . . 0.0 111.667 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.811 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -99.62 166.84 10.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.149 -0.97 . . . . 0.0 108.396 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.688 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 40.9 p-90 -164.89 174.41 10.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.437 -1.414 . . . . 0.0 111.862 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.547 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 51.8 p90 -150.11 129.36 12.82 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -112.24 155.23 24.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.146 -0.972 . . . . 0.0 111.236 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 432' ' ' ILE . 0.7 OUTLIER -138.07 126.48 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.598 -0.689 . . . . 0.0 109.877 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 357' ' ' LYS . 18.9 tt0 -128.31 106.14 8.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.249 -0.907 . . . . 0.0 109.79 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.493 ' HB3' ' HA ' ' A' ' 356' ' ' ILE . 15.7 p30 -120.02 167.65 11.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.957 -1.089 . . . . 0.0 110.421 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -108.06 101.21 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.385 -0.822 . . . . 0.0 110.501 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' GLY . . . . . 0.507 ' HA2' ' HA2' ' A' ' 352' ' ' GLY . . . -116.12 -138.97 6.5 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.77 -60.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.017 1.535 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' A' ' 430' ' ' LEU . . . 119.69 -179.56 16.6 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 430' ' ' LEU . 1.4 mm -110.59 93.94 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.279 . . . . 0.0 109.998 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -44.38 167.11 0.1 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 42.1 Cg_endo -68.19 -28.24 34.27 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.564 1.297 . . . . 0.0 110.666 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -90.88 -19.91 22.84 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.111 -0.993 . . . . 0.0 111.655 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.492 ' HG3' ' HB3' ' A' ' 379' ' ' ALA . 2.5 mt-30 -80.86 -20.01 43.24 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.84 -1.162 . . . . 0.0 111.542 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.55 -24.27 20.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.91 -1.119 . . . . 0.0 110.746 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -75.52 -33.77 60.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.005 -1.059 . . . . 0.0 110.25 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.63 ' O ' HD12 ' A' ' 386' ' ' LEU . 2.6 m-70 -88.32 54.4 3.05 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.176 -0.953 . . . . 0.0 110.2 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.63 HD12 ' O ' ' A' ' 385' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.307 -1.273 0 O-C-N 121.019 -1.05 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.699 ' O ' HD13 ' A' ' 412' ' ' ILE . 2.9 mp . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.335 0.588 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.979 HG12 ' HA ' ' A' ' 340' ' ' ALA . 27.4 m -122.36 -7.94 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.319 -0.863 . . . . 0.0 109.859 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 48.2 tt0 -74.47 -50.07 19.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.196 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -20.99 66.17 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.427 -0.796 . . . . 0.0 110.157 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.699 HD13 ' O ' ' A' ' 408' ' ' ILE . 1.1 mp -71.19 -63.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.269 -0.894 . . . . 0.0 108.726 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 420' ' ' LEU . 15.5 t -64.14 -21.71 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.638 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 1.9 m-20 -79.23 -32.7 43.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.408 -0.808 . . . . 0.0 109.814 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -78.72 -28.33 45.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 109.33 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.741 ' CE1' HD11 ' A' ' 337' ' ' ILE . 30.2 m80 -81.62 -38.8 25.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.414 -0.804 . . . . 0.0 109.391 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 1.0 OUTLIER 82.24 45.24 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 CA-C-O 121.364 0.602 . . . . 0.0 110.943 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.589 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -112.28 -88.62 1.78 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.593 ' HE1' ' NE1' ' A' ' 435' ' ' TRP . 28.5 ttp -178.66 157.82 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -1.205 . . . . 0.0 112.254 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.666 ' HB2' HG11 ' A' ' 413' ' ' VAL . 57.0 tp -153.02 95.6 1.99 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 0.5 OUTLIER -115.86 155.89 27.1 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.759 -1.213 . . . . 0.0 112.786 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.862 HD12 HG12 ' A' ' 432' ' ' ILE . 2.7 tp -106.15 140.21 39.47 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -141.81 83.01 0.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 430' ' ' LEU . 20.5 m . . . . . 0 C--N 1.302 -1.47 0 O-C-N 121.254 -1.145 . . . . 0.0 110.85 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.579 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.76 HD11 HD11 ' A' ' 378' ' ' ILE . 0.2 OUTLIER -70.5 121.46 17.84 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.12 -1.224 . . . . 0.0 110.151 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.54 ' O ' ' CG1' ' A' ' 432' ' ' ILE . 3.0 t -122.23 177.03 5.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.943 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.862 HG12 HD12 ' A' ' 422' ' ' LEU . 10.1 mt -156.92 114.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.254 -0.904 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -90.57 100.69 13.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.346 -0.846 . . . . 0.0 110.334 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.547 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -94.65 132.04 39.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.134 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.688 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.5 m95 -116.38 156.74 26.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.784 -1.198 . . . . 0.0 113.098 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.907 HD12 HD11 ' A' ' 301' ' ' LEU . 67.8 mt -146.34 100.81 4.11 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.589 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 44.9 Cg_endo -71.53 143.82 43.49 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 123.961 1.506 . . . . 0.0 112.441 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.636 HG23 ' HA ' ' A' ' 330' ' ' VAL . 5.9 p -117.5 122.78 30.51 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.304 -1.798 0 O-C-N 123.77 1.405 . . . . 0.0 110.657 -179.922 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.581 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 48.5 Cg_endo . . . . . 0 CA--C 1.51 -0.718 0 N-CA-C 110.164 -0.745 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.634 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -93.41 110.17 21.73 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.076 0.941 . . . . 0.0 108.9 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.4 mt-10 -133.27 -172.4 2.94 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.824 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -87.48 140.35 29.62 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.759 0.79 . . . . 0.0 109.958 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -157.36 169.31 25.02 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.435 0.636 . . . . 0.0 110.037 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 304' ' ' VAL . 57.4 m-20 -96.14 119.51 34.75 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.561 -0.712 . . . . 0.0 109.171 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.812 HD21 ' SD ' ' A' ' 332' ' ' MET . 8.1 mt -62.24 -25.6 67.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.997 -1.064 . . . . 0.0 109.299 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.89 ' HA ' HD23 ' A' ' 323' ' ' LEU . 55.1 t-20 -76.19 -23.24 54.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.977 -1.077 . . . . 0.0 108.503 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -82.92 -33.48 26.83 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 308' ' ' VAL . 47.8 t -74.94 -38.34 43.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.616 0.722 . . . . 0.0 109.161 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.593 HD13 ' OG ' ' A' ' 360' ' ' SER . 92.2 mt -75.13 -27.06 59.64 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.466 -0.772 . . . . 0.0 109.982 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.43 -35.9 92.52 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.52 -34.31 54.07 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.417 -1.049 . . . . 0.0 108.673 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.859 HG11 ' HB ' ' A' ' 341' ' ' VAL . 50.7 t -75.68 -18.6 15.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 121.554 0.692 . . . . 0.0 109.148 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.527 ' HA ' ' HG2' ' A' ' 312' ' ' GLU . 1.4 mt -78.77 -45.0 25.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.5 -18.27 65.19 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -91.19 -34.08 15.15 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.766 -0.584 . . . . 0.0 111.144 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.906 ' OE2' HG21 ' A' ' 358' ' ' VAL . 18.9 pt-20 -86.15 16.95 3.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.083 -1.011 . . . . 0.0 110.723 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.5 m -122.57 67.66 0.95 Allowed 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -56.67 -42.63 91.16 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.443 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 0.3 OUTLIER -136.79 24.01 3.1 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.307 -1.114 . . . . 0.0 111.004 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 2.5 mt-10 60.96 57.46 2.56 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.915 -1.116 . . . . 0.0 108.441 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -66.51 -76.08 0.08 Allowed 'General case' 0 C--N 1.278 -2.526 0 CA-C-O 121.616 0.722 . . . . 0.0 109.722 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 355' ' ' TRP . 7.1 pt-20 -170.52 56.67 0.03 OUTLIER 'General case' 0 C--N 1.265 -3.086 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.863 HG13 HD12 ' A' ' 356' ' ' ILE . 1.8 mp -91.28 129.76 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.444 -0.903 . . . . 0.0 109.974 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -104.3 111.05 23.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.232 -0.918 . . . . 0.0 109.673 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.404 HG22 ' CD1' ' A' ' 309' ' ' ILE . 17.7 p -89.01 126.9 35.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.3 -0.875 . . . . 0.0 110.702 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ALA . . . . . 0.441 ' HB3' ' OG ' ' A' ' 359' ' ' SER . . . -149.36 79.54 1.4 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.576 -0.702 . . . . 0.0 109.341 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.89 HD23 ' HA ' ' A' ' 302' ' ' ASN . 4.7 mp -95.33 150.22 20.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.488 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.574 ' HB2' ' HA2' ' A' ' 361' ' ' GLY . 89.6 t80 -37.33 129.88 0.82 Allowed Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.576 -0.703 . . . . 0.0 110.678 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.39 82.66 1.35 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.924 1.486 . . . . 0.0 109.515 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . 162.56 -11.13 0.1 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.682 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.2 OUTLIER 79.85 120.55 0.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.329 -1.101 . . . . 0.0 109.951 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 329' ' ' GLU . 1.6 mm -72.29 -176.02 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 CA-C-O 121.704 0.764 . . . . 0.0 109.93 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 328' ' ' ILE . 3.2 mt-10 -170.19 105.19 0.3 Allowed 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.561 0.696 . . . . 0.0 109.953 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 298' ' ' MET . 2.7 m -150.52 169.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-O 121.541 0.686 . . . . 0.0 110.653 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -96.63 94.02 7.09 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.812 ' SD ' HD21 ' A' ' 301' ' ' LEU . 0.0 OUTLIER -148.44 133.65 18.37 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.764 0.792 . . . . 0.0 110.027 -179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.582 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 19.1 t-160 -55.48 113.17 5.12 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.722 -0.611 . . . . 0.0 109.913 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 40.6 Cg_endo -66.5 -19.56 54.75 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.816 1.429 . . . . 0.0 110.096 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.582 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -74.59 -68.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 0.0 109.835 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.765 ' O ' HD12 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -47.56 -40.9 20.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.557 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.724 HD11 ' CE1' ' A' ' 416' ' ' HIS . 11.9 mm -64.15 -46.83 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 109.316 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.556 ' HG3' HG22 ' A' ' 308' ' ' VAL . 0.0 OUTLIER -43.72 -47.67 7.88 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.355 -0.841 . . . . 0.0 109.555 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -70.67 -35.45 72.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.569 -0.707 . . . . 0.0 110.641 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.601 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -58.66 -32.34 69.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.414 -0.804 . . . . 0.0 111.089 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.859 ' HB ' HG11 ' A' ' 308' ' ' VAL . 32.3 t -90.24 -28.24 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.97 -1.081 . . . . 0.0 111.009 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.73 -19.68 57.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.976 -1.078 . . . . 0.0 110.753 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.3 -19.74 23.72 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.116 -0.99 . . . . 0.0 110.992 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.478 ' SD ' ' HB ' ' A' ' 432' ' ' ILE . 6.3 mtt -82.23 -23.76 35.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.09 -1.006 . . . . 0.0 111.357 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.504 HG11 ' OE1' ' A' ' 312' ' ' GLU . 28.0 m -90.7 -23.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.044 -1.035 . . . . 0.0 111.395 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.88 -29.96 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.914 -1.116 . . . . 0.0 110.533 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 66.3 t30 -65.77 -34.16 77.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.179 -0.951 . . . . 0.0 110.438 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -89.72 -22.97 21.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 110.507 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.31 -51.44 60.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.108 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 351' ' ' TYR . 4.1 mmt180 -90.5 -65.28 1.03 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.299 -0.876 . . . . 0.0 110.872 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 347' ' ' ASN . 0.9 OUTLIER -38.54 -72.0 0.07 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.381 -0.824 . . . . 0.0 110.74 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -129.5 100.6 0.5 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 353' ' ' ASN . 2.0 p-10 -86.38 86.42 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -1.151 . . . . 0.0 109.789 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 354' ' ' GLY . . . . . 0.451 ' O ' ' OE1' ' A' ' 318' ' ' GLU . . . -123.16 -35.35 0.72 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.584 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 14.3 t90 179.81 124.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.031 -1.276 . . . . 0.0 110.863 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.863 HD12 HG13 ' A' ' 319' ' ' ILE . 1.5 mt -105.98 143.71 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.584 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 13.4 tttt -134.43 106.44 7.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.827 -1.171 . . . . 0.0 111.359 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.906 HG21 ' OE2' ' A' ' 312' ' ' GLU . 88.8 t -98.52 83.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 370' ' ' GLN . 30.2 t -116.39 141.36 48.27 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.357 -0.839 . . . . 0.0 111.272 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.593 ' OG ' HD13 ' A' ' 305' ' ' LEU . 3.9 m -134.23 168.29 19.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 109.124 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -161.77 -159.47 10.18 Favored Glycine 0 C--N 1.292 -1.868 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -177.18 164.39 2.2 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.369 -1.077 . . . . 0.0 110.032 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.507 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 3.9 mt-10 -141.72 -179.83 1.06 Allowed Pre-proline 0 C--N 1.29 -2.0 0 O-C-N 121.636 -0.665 . . . . 0.0 109.522 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 44.3 Cg_endo -71.63 116.8 4.85 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.682 1.359 . . . . 0.0 111.191 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 5.4 m-20 80.01 25.41 0.37 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.874 -0.517 . . . . 0.0 111.509 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.586 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 167.34 111.67 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.319 -0.863 . . . . 0.0 111.473 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -104.41 174.65 5.78 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.194 -0.941 . . . . 0.0 108.876 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.629 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 47.8 p-90 -170.84 174.76 4.73 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.402 -1.436 . . . . 0.0 111.475 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.572 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 34.2 p90 -144.21 134.72 24.71 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.52 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 5.3 tt0 -127.54 149.76 50.0 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.938 -1.101 . . . . 0.0 112.432 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.52 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 98.4 t -125.23 135.04 65.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -130.03 147.16 51.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 109.946 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 373' ' ' ASP . 40.6 p30 -143.51 157.99 44.0 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 375' ' ' GLY . 0.8 OUTLIER -91.67 159.54 15.81 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 110.077 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 375' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 374' ' ' ASP . . . 135.3 -159.4 24.05 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.65 157.48 48.37 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.894 1.471 . . . . 0.0 110.397 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' GLY . . . . . 0.756 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -87.59 -144.76 9.38 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.851 HD11 ' HG ' ' A' ' 430' ' ' LEU . 0.7 OUTLIER -106.2 98.03 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.144 -1.21 . . . . 0.0 109.486 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -52.33 171.75 0.2 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.524 -0.735 . . . . 0.0 110.99 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 44.8 Cg_endo -72.55 -47.38 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 124.134 1.597 . . . . 0.0 109.458 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -25.07 68.2 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.408 -0.807 . . . . 0.0 109.094 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 0.3 OUTLIER -86.58 -20.62 27.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.506 -0.746 . . . . 0.0 109.556 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 386' ' ' LEU . 0.2 OUTLIER -60.85 -32.88 72.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.467 -0.771 . . . . 0.0 109.709 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -24.29 51.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 109.599 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 385' ' ' HIS . 1.8 m-70 -100.3 49.31 0.91 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.399 -0.813 . . . . 0.0 109.656 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 386' ' ' LEU . 1.5 tp . . . . . 0 C--N 1.304 -1.412 0 O-C-N 121.307 -0.871 . . . . 0.0 109.451 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' ILE . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.061 0.457 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 340' ' ' ALA . 10.9 m -53.58 -22.13 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.14 -0.975 . . . . 0.0 110.461 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 0.1 OUTLIER -64.52 -47.43 78.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.215 -0.928 . . . . 0.0 109.88 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.515 ' HA ' ' HB2' ' A' ' 414' ' ' ASP . 0.0 OUTLIER -66.75 -27.76 67.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -0.873 . . . . 0.0 109.683 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.765 HD12 ' O ' ' A' ' 336' ' ' SER . 31.0 mm -63.67 -60.37 2.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.91 HG21 HD13 ' A' ' 420' ' ' LEU . 45.7 t -65.8 -23.08 31.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.182 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.515 ' HB2' ' HA ' ' A' ' 411' ' ' ARG . 0.5 OUTLIER -75.19 -25.87 58.58 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.416 ' OD1' ' HE3' ' A' ' 296' ' ' MET . 0.9 OUTLIER -80.47 -19.55 45.74 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.724 ' CE1' HD11 ' A' ' 337' ' ' ILE . 32.8 m80 -96.28 -76.18 0.51 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.807 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.635 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 4.3 m-20 127.29 26.81 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.596 0 C-N-CA 123.948 0.899 . . . . 0.0 109.297 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 435' ' ' TRP . . . -86.4 -103.41 0.77 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.583 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 18.4 ttm -165.74 161.85 18.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -1.143 . . . . 0.0 110.638 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 413' ' ' VAL . 4.8 tp -151.86 96.32 2.21 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.983 -1.073 . . . . 0.0 109.223 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.12 155.73 43.96 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.978 -1.076 . . . . 0.0 111.603 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.6 146.28 23.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.556 -0.715 . . . . 0.0 110.354 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -133.5 99.88 0.38 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 429' ' ' GLY . 17.6 m . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.186 -1.185 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.615 ' O ' HG23 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.486 2.009 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.851 ' HG ' HD11 ' A' ' 378' ' ' ILE . 0.0 OUTLIER -175.33 -173.25 0.64 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.169 -1.195 . . . . 0.0 111.786 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.666 ' N ' HD22 ' A' ' 430' ' ' LEU . 24.9 p -154.28 150.16 27.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.478 ' HB ' ' SD ' ' A' ' 344' ' ' MET . 24.2 mm -90.52 121.01 40.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 120.717 -1.24 . . . . 0.0 111.149 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -98.3 96.15 7.86 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.551 -0.718 . . . . 0.0 109.323 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.572 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -97.0 143.71 27.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.613 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.629 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 88.0 m95 -120.08 157.72 28.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.264 -0.897 . . . . 0.0 112.136 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.572 HD13 ' SD ' ' A' ' 332' ' ' MET . 38.1 mt -145.44 125.26 7.01 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.9 139.69 43.96 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 123.59 1.31 . . . . 0.0 111.358 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.641 HG23 ' HD2' ' A' ' 439' ' ' PRO . 7.2 p -99.16 146.79 32.31 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.535 -0.728 . . . . 0.0 110.404 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.641 ' HD2' HG23 ' A' ' 438' ' ' VAL . 50.3 Cg_endo . . . . . 0 C--N 1.306 -1.679 0 O-C-N 123.979 1.515 . . . . 0.0 109.773 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.485 0.971 0 CA-C-O 121.244 0.435 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.583 ' HE3' ' NE2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -71.9 105.84 3.99 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 5.1 mt-10 -115.95 -169.97 1.7 Allowed 'General case' 0 C--N 1.28 -2.428 0 O-C-N 121.683 -0.636 . . . . 0.0 110.228 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.631 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.2 OUTLIER -88.28 128.86 35.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 111.193 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.565 ' HB3' ' SD ' ' A' ' 332' ' ' MET . . . -156.48 159.22 38.43 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.66 -0.65 . . . . 0.0 111.057 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.808 ' O ' HG23 ' A' ' 304' ' ' VAL . 5.9 t0 -84.08 121.37 27.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.514 -0.741 . . . . 0.0 110.13 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 8.0 mt -68.54 -25.2 64.8 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.138 -0.976 . . . . 0.0 109.76 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.696 ' HA ' HD23 ' A' ' 323' ' ' LEU . 22.7 p30 -79.3 -21.21 46.3 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.089 -1.007 . . . . 0.0 108.871 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -85.44 -29.65 24.17 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.761 0.791 . . . . 0.0 108.968 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 308' ' ' VAL . 42.2 t -74.92 -38.46 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.55 0.69 . . . . 0.0 109.278 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.603 ' CD2' HG21 ' A' ' 341' ' ' VAL . 86.2 mt -73.61 -40.75 63.58 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.306 -0.871 . . . . 0.0 110.142 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -58.71 -29.42 64.27 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.846 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 6.0 mt-10 -79.03 -31.16 44.51 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.394 -1.062 . . . . 0.0 108.997 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 304' ' ' VAL . 52.3 t -75.48 -21.83 16.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.667 0.746 . . . . 0.0 109.154 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.556 ' CD1' HG22 ' A' ' 321' ' ' THR . 0.7 OUTLIER -76.19 -49.68 24.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.403 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -80.2 -16.72 54.17 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.815 0.816 . . . . 0.0 109.194 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.846 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -65.14 -63.04 1.2 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.696 -0.627 . . . . 0.0 110.709 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.28 37.91 0.7 Allowed 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.715 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.629 ' O ' HD11 ' A' ' 319' ' ' ILE . 1.2 t -87.55 43.1 1.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.892 -1.13 . . . . 0.0 109.098 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 315' ' ' TYR . . . 73.66 25.22 72.77 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.511 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 51.4 t80 63.71 44.19 5.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.657 -0.908 . . . . 0.0 110.258 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 4.2 tt0 68.24 46.57 1.09 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.235 -0.916 . . . . 0.0 109.781 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.496 ' CG ' ' N ' ' A' ' 318' ' ' GLU . 0.3 OUTLIER -68.59 -88.04 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.304 0 O-C-N 121.608 -0.683 . . . . 0.0 109.844 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.496 ' N ' ' CG ' ' A' ' 317' ' ' ARG . 16.9 mt-10 -140.93 66.12 1.38 Allowed 'General case' 0 C--N 1.277 -2.574 0 O-C-N 121.399 -0.813 . . . . 0.0 111.287 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.697 HG23 HG23 ' A' ' 358' ' ' VAL . 2.7 mp -104.43 134.09 46.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 O-C-N 121.598 -0.689 . . . . 0.0 110.129 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -91.36 107.23 19.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.763 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.556 HG22 ' CD1' ' A' ' 309' ' ' ILE . 12.5 p -89.84 124.66 34.87 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 111.519 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ALA . . . . . 0.589 ' HB3' ' OG ' ' A' ' 359' ' ' SER . . . -149.81 78.63 1.36 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 302' ' ' ASN . 2.7 mp -94.62 169.52 10.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.453 -0.779 . . . . 0.0 110.879 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.476 ' HB2' ' HA2' ' A' ' 361' ' ' GLY . 93.8 t80 -62.11 112.39 6.24 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.764 . . . . 0.0 109.756 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.86 79.29 1.98 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.878 1.462 . . . . 0.0 110.487 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 179.73 29.65 0.05 OUTLIER Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.773 -1.203 . . . . 0.0 110.11 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 326' ' ' GLY . 1.0 OUTLIER 47.81 98.2 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.11 -1.23 . . . . 0.0 110.509 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.632 HG23 HG21 ' A' ' 362' ' ' THR . 1.1 mt -82.11 -176.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.495 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.575 ' H ' HG22 ' A' ' 328' ' ' ILE . 0.6 OUTLIER -178.14 105.43 0.05 OUTLIER 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.416 0.627 . . . . 0.0 110.376 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 1.021 HG11 ' HB3' ' A' ' 367' ' ' ALA . 5.3 m -136.05 171.57 16.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-O 121.749 0.785 . . . . 0.0 110.5 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.2 OUTLIER -91.22 89.62 7.41 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.573 ' CG ' HG23 ' A' ' 330' ' ' VAL . 4.0 ppp? -140.26 148.34 41.31 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.439 -0.788 . . . . 0.0 109.894 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 21.0 t-160 -75.97 110.82 12.03 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.481 ' O ' ' HD3' ' A' ' 338' ' ' LYS . 36.7 Cg_endo -58.74 -19.33 45.68 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.476 1.251 . . . . 0.0 109.152 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.593 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -82.57 -63.9 1.28 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.529 0.681 . . . . 0.0 109.805 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.507 ' OG ' HG13 ' A' ' 412' ' ' ILE . 26.8 t -49.39 -50.54 39.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.538 -0.726 . . . . 0.0 110.132 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.554 HG13 ' CE ' ' A' ' 332' ' ' MET . 21.7 mm -59.91 -45.68 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.565 ' HD3' HG13 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -46.81 -49.03 20.6 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.7 -1.25 . . . . 0.0 109.377 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -60.97 -38.88 87.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.491 -0.756 . . . . 0.0 110.302 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -58.94 -53.25 60.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 0.0 110.83 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.791 ' CG1' HG11 ' A' ' 308' ' ' VAL . 55.2 t -70.31 -21.08 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 110.057 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -81.65 -19.73 41.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.397 -0.815 . . . . 0.0 110.779 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -84.64 -44.67 13.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.088 -1.008 . . . . 0.0 110.777 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 6.1 mtm -69.15 -20.14 64.02 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.16 -0.962 . . . . 0.0 110.546 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 342' ' ' ALA . 8.7 p -87.86 -27.48 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.104 -0.997 . . . . 0.0 110.506 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 342' ' ' ALA . 53.5 t -76.85 -28.02 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 110.373 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 17.4 m120 -75.13 -32.04 61.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.105 -0.997 . . . . 0.0 110.281 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.686 ' HB2' ' OD1' ' A' ' 373' ' ' ASP . . . -90.58 -18.63 24.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.123 -0.986 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -77.05 -81.21 0.09 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.033 -1.042 . . . . 0.0 111.856 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -48.41 64.95 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.381 -0.824 . . . . 0.0 112.34 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 347' ' ' ASN . 36.6 m-85 -74.79 -58.93 2.98 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.855 -1.153 . . . . 0.0 111.561 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 348' ' ' ALA . . . -108.12 59.55 0.36 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.189 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.23 93.1 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.235 . . . . 0.0 109.886 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -147.7 -67.06 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -150.13 139.19 21.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.119 -1.224 . . . . 0.0 110.657 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.619 HD12 HG13 ' A' ' 319' ' ' ILE . 20.3 mt -123.66 162.08 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.459 -0.776 . . . . 0.0 109.832 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 372' ' ' GLU . 1.1 ttpt -136.83 111.36 8.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.069 -1.019 . . . . 0.0 110.331 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.697 HG23 HG23 ' A' ' 319' ' ' ILE . 65.1 t -110.17 88.41 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 110.034 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.589 ' OG ' ' HB3' ' A' ' 322' ' ' ALA . 1.0 OUTLIER -112.55 148.95 33.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 110.436 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.542 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -144.65 142.14 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.403 -0.81 . . . . 0.0 110.016 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -135.08 -165.9 10.92 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.7 OUTLIER -174.52 179.17 1.81 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.775 -1.426 . . . . 0.0 111.547 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 8.2 mt-10 -156.32 173.18 5.18 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.527 ' O ' ' HB2' ' A' ' 365' ' ' ASN . 39.6 Cg_endo -66.38 119.01 5.99 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.422 1.222 . . . . 0.0 110.469 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' A' ' 364' ' ' PRO . 4.1 m120 62.88 37.3 12.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.934 -0.479 . . . . 0.0 110.969 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 10.7 ptm180 169.31 106.32 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.455 -0.778 . . . . 0.0 110.399 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 1.021 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -116.49 168.11 10.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.176 -0.952 . . . . 0.0 109.835 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.64 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 25.8 p-90 -154.74 169.05 24.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.86 -1.15 . . . . 0.0 110.811 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.519 ' CE1' HD11 ' A' ' 436' ' ' LEU . 32.9 p90 -144.4 136.29 26.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.456 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.517 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 9.7 tt0 -121.07 153.84 36.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.101 -0.999 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.517 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 40.6 t -137.06 143.92 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 110.181 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 2.0 mt-10 -137.29 134.45 36.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.355 -0.841 . . . . 0.0 109.779 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.686 ' OD1' ' HB2' ' A' ' 348' ' ' ALA . 3.6 p30 -151.1 163.18 39.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.894 -1.129 . . . . 0.0 110.864 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -110.04 134.13 52.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 352' ' ' GLY . . . 159.54 -136.05 4.43 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.496 ' HG3' ' CB ' ' A' ' 351' ' ' TYR . 47.0 Cg_endo -72.65 106.16 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.991 1.521 . . . . 0.0 110.349 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -78.35 -157.78 10.7 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.607 HD12 HD12 ' A' ' 422' ' ' LEU . 9.7 mt -119.04 172.67 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.496 -1.003 . . . . 0.0 110.12 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -120.91 175.0 2.6 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.867 -1.146 . . . . 0.0 110.675 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 51.3 Cg_endo -79.94 -33.07 1.25 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 124.059 1.557 . . . . 0.0 111.349 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -89.65 -19.76 24.49 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.907 -1.121 . . . . 0.0 111.312 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.604 ' HG3' ' HB3' ' A' ' 379' ' ' ALA . 41.6 mt-30 -85.91 -26.67 25.44 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.95 -1.094 . . . . 0.0 108.846 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 385' ' ' HIS . 0.2 OUTLIER -66.97 -25.38 66.29 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.082 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 383' ' ' ARG . 32.5 mmtm -46.94 -35.69 6.81 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 383' ' ' ARG . 0.5 OUTLIER -100.74 -139.26 0.33 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.481 -1.691 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.552 ' O ' HD13 ' A' ' 412' ' ' ILE . 9.7 tp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.265 0.555 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 410' ' ' GLN . 13.2 p -120.05 -42.08 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.479 -0.763 . . . . 0.0 109.926 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.592 ' N ' HG13 ' A' ' 409' ' ' VAL . 2.6 pt20 -51.72 -29.34 18.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.433 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.478 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.4 OUTLIER -76.51 -35.88 58.08 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.827 HG21 ' HB2' ' A' ' 340' ' ' ALA . 0.6 OUTLIER -56.84 -44.7 82.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' A' ' 420' ' ' LEU . 92.9 t -73.93 -22.66 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 35.2 t70 -80.02 -19.58 47.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.699 -0.626 . . . . 0.0 109.603 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -85.77 -26.83 25.58 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.382 -0.824 . . . . 0.0 109.142 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.716 ' CB ' HD23 ' A' ' 436' ' ' LEU . 30.6 m80 -89.78 -31.57 17.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.766 . . . . 0.0 109.083 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.4 OUTLIER 77.27 42.96 0.12 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.395 0.617 . . . . 0.0 110.6 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.614 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -106.8 -85.14 1.76 Allowed Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.565 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.0 OUTLIER -179.2 164.23 1.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.113 . . . . 0.0 111.331 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.557 ' HB2' HG11 ' A' ' 413' ' ' VAL . 19.1 tp -151.3 92.59 1.8 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.163 -0.961 . . . . 0.0 109.258 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.537 ' HB2' ' HG3' ' A' ' 433' ' ' ARG . 0.3 OUTLIER -92.28 139.93 30.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.975 -1.078 . . . . 0.0 110.443 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.704 HD22 HG12 ' A' ' 432' ' ' ILE . 0.3 OUTLIER -114.98 145.7 41.98 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.43 -0.794 . . . . 0.0 111.275 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 430' ' ' LEU . . . -145.53 145.52 14.78 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.532 HG21 ' H ' ' A' ' 378' ' ' ILE . 7.8 m . . . . . 0 N--CA 1.49 1.57 0 O-C-N 120.838 -1.39 . . . . 0.0 111.041 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.494 2.533 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.601 ' CD1' HG13 ' A' ' 378' ' ' ILE . 18.4 tp -90.59 108.78 20.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -1.132 . . . . 0.0 110.852 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 66.5 m -118.07 132.98 56.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.608 -0.682 . . . . 0.0 109.368 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.704 HG12 HD22 ' A' ' 422' ' ' LEU . 4.4 mt -136.7 142.26 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.935 -1.103 . . . . 0.0 111.031 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' ARG . . . . . 0.537 ' HG3' ' HB2' ' A' ' 421' ' ' GLU . 0.0 OUTLIER -122.2 117.02 25.2 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.445 -0.785 . . . . 0.0 109.598 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 369' ' ' PHE . . . -102.6 140.0 37.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.165 -0.959 . . . . 0.0 111.049 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.64 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 79.8 m95 -114.6 154.44 28.34 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.288 -0.883 . . . . 0.0 111.271 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.716 HD23 ' CB ' ' A' ' 416' ' ' HIS . 12.7 mt -145.87 111.08 4.46 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.614 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 49.5 Cg_endo -85.9 130.57 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.691 1.364 . . . . 0.0 110.823 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.772 HG22 ' HB ' ' A' ' 330' ' ' VAL . 60.6 t -82.79 110.08 20.5 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.408 -0.808 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 57.3 Cg_endo . . . . . 0 C--N 1.311 -1.403 0 O-C-N 123.938 1.494 . . . . 0.0 109.987 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.759 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 51.4 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 N-CA-C 109.362 -1.053 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.548 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 43.36 87.68 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 122.323 1.058 . . . . 0.0 109.99 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 1.1 mt-10 -143.06 -156.6 0.7 Allowed 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.278 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.535 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -88.25 131.61 34.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.937 -1.102 . . . . 0.0 110.589 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -150.04 160.07 43.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.443 -0.786 . . . . 0.0 110.709 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.82 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.9 OUTLIER -102.57 120.38 40.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 110.083 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.526 HD11 ' CD1' ' A' ' 436' ' ' LEU . 15.3 mt -63.37 -21.27 66.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 109.751 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.666 ' HA ' HD23 ' A' ' 323' ' ' LEU . 0.2 OUTLIER -83.41 -21.58 32.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.064 -1.022 . . . . 0.0 108.754 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 307' ' ' GLU . . . -88.15 -26.79 22.26 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.728 0.775 . . . . 0.0 109.144 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 300' ' ' ASP . 18.3 t -83.8 -38.38 14.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.634 ' CD2' HG21 ' A' ' 341' ' ' VAL . 91.0 mt -78.41 -28.42 46.86 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.408 -0.807 . . . . 0.0 110.113 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.65 -32.66 82.09 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 303' ' ' ALA . 3.1 mm-40 -79.6 -35.26 39.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -1.141 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.715 HG11 ' CG1' ' A' ' 341' ' ' VAL . 65.4 t -77.81 -19.29 13.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.642 0.734 . . . . 0.0 109.673 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.579 ' CD1' HG22 ' A' ' 321' ' ' THR . 0.3 OUTLIER -79.81 -43.12 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.492 -0.755 . . . . 0.0 109.25 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -80.2 -17.18 53.08 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.638 0.732 . . . . 0.0 109.969 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.33 -53.96 4.22 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.586 -0.696 . . . . 0.0 112.034 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.442 ' O ' HG11 ' A' ' 345' ' ' VAL . 76.1 mm-40 -112.26 45.2 1.31 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.252 -0.905 . . . . 0.0 111.227 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 309' ' ' ILE . 0.3 OUTLIER -80.65 28.56 0.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.238 -0.914 . . . . 0.0 110.79 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 53.41 42.84 65.56 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 22.2 m-85 61.69 33.07 18.23 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.681 -0.894 . . . . 0.0 110.051 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 2.8 tt0 65.31 43.94 3.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 109.378 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.584 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.8 OUTLIER -68.76 -83.18 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.606 0.717 . . . . 0.0 110.436 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.584 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.7 pt-20 -159.23 64.1 0.39 Allowed 'General case' 0 C--N 1.273 -2.754 0 O-C-N 121.672 -0.642 . . . . 0.0 110.69 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.874 HG13 HD12 ' A' ' 356' ' ' ILE . 2.2 mp -96.51 126.75 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 109.511 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.46 103.66 16.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.705 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.579 HG22 ' CD1' ' A' ' 309' ' ' ILE . 19.0 p -89.68 125.68 35.35 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.502 -0.749 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.36 78.97 1.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.478 -0.764 . . . . 0.0 109.249 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.666 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.3 mp -89.48 149.23 23.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.384 -0.823 . . . . 0.0 110.528 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.599 ' CD1' ' HD2' ' A' ' 325' ' ' PRO . 60.4 t80 -38.37 147.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.737 -0.602 . . . . 0.0 110.321 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.599 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.8 Cg_endo -81.83 64.12 8.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.948 1.499 . . . . 0.0 110.44 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . 172.87 8.38 0.02 OUTLIER Glycine 0 N--CA 1.498 2.767 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.697 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 1.2 p 66.07 119.92 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.473 -1.604 . . . . 0.0 109.728 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.65 HD13 ' N ' ' A' ' 328' ' ' ILE . 1.6 mm -74.58 -178.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.864 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.586 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.6 mt-10 -170.56 103.72 0.26 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 121.688 0.756 . . . . 0.0 109.97 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.535 ' C ' ' HE2' ' A' ' 298' ' ' MET . 4.0 m -140.17 172.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.378 0 CA-C-O 121.646 0.736 . . . . 0.0 110.556 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.2 tptp -91.0 89.69 7.54 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.591 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 2.2 tmm? -143.79 157.3 44.47 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.401 -0.812 . . . . 0.0 110.609 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.777 ' CD2' ' HB2' ' A' ' 335' ' ' LEU . 17.4 t60 -78.54 117.68 67.85 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 38.4 Cg_endo -62.11 -21.88 73.24 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.776 1.409 . . . . 0.0 110.341 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.777 ' HB2' ' CD2' ' A' ' 333' ' ' HIS . 12.1 mt -76.95 -63.6 1.32 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.107 0.956 . . . . 0.0 110.258 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.488 ' HB3' HG13 ' A' ' 412' ' ' ILE . 17.4 m -45.8 -53.08 10.17 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.554 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.757 HD11 ' CE1' ' A' ' 416' ' ' HIS . 16.7 mm -57.16 -43.84 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.999 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 0.2 OUTLIER -48.8 -41.19 31.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.887 -1.133 . . . . 0.0 108.344 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 336' ' ' SER . 6.8 mtt180 -67.46 -47.71 69.32 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.488 0.661 . . . . 0.0 109.909 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.43 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -51.82 -36.2 47.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 110.641 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.715 ' CG1' HG11 ' A' ' 308' ' ' VAL . 33.6 t -89.99 -21.05 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -0.935 . . . . 0.0 110.281 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.59 -56.69 9.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.868 . . . . 0.0 110.846 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ASN . . . . . 0.556 ' O ' HG12 ' A' ' 346' ' ' VAL . 76.1 m-20 -75.68 -19.72 58.94 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.212 -0.93 . . . . 0.0 110.724 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.667 ' CE ' HG21 ' A' ' 432' ' ' ILE . 2.0 mtt -67.48 -32.66 73.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.287 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.807 ' O ' ' HB2' ' A' ' 349' ' ' ALA . 55.9 t -90.44 -19.05 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.351 -0.843 . . . . 0.0 111.236 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 343' ' ' ASN . 0.6 OUTLIER -70.93 -30.31 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.939 -1.101 . . . . 0.0 110.685 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -60.9 -55.76 29.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.144 -0.972 . . . . 0.0 110.636 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.488 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -85.1 -19.23 32.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.173 -0.954 . . . . 0.0 110.403 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.807 ' HB2' ' O ' ' A' ' 345' ' ' VAL . . . -43.34 -72.8 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.381 -0.824 . . . . 0.0 110.811 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 61.0 mtt85 -87.0 -69.22 0.69 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.084 -1.01 . . . . 0.0 110.744 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' TYR . . . . . 0.492 ' O ' ' N ' ' A' ' 353' ' ' ASN . 2.3 t80 -49.03 -72.61 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.301 -0.874 . . . . 0.0 110.829 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -52.85 88.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 351' ' ' TYR . 6.3 p-10 -96.2 51.48 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.184 -1.186 . . . . 0.0 109.801 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -121.1 -66.93 0.26 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.575 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 2.0 t90 -176.28 140.36 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -1.182 . . . . 0.0 110.219 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.874 HD12 HG13 ' A' ' 319' ' ' ILE . 2.8 mt -110.41 158.96 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.651 -0.656 . . . . 0.0 109.909 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 11.8 ttpt -142.15 105.58 4.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.74 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.648 HG23 HG23 ' A' ' 319' ' ' ILE . 68.9 t -107.73 84.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.327 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 69.5 p -116.67 140.73 49.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.006 -1.059 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.505 ' HB3' ' HG ' ' A' ' 323' ' ' LEU . 1.9 t -125.72 158.66 34.28 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.543 ' C ' HG22 ' A' ' 362' ' ' THR . . . -159.07 -152.62 6.51 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -179.26 174.18 1.05 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.215 -1.168 . . . . 0.0 110.525 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.561 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 1.9 mt-10 -151.81 -175.13 0.45 Allowed Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.468 -0.77 . . . . 0.0 109.504 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 40.7 Cg_endo -69.7 116.96 4.8 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.582 1.306 . . . . 0.0 111.353 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.563 ' O ' ' HG3' ' A' ' 366' ' ' ARG . 1.9 m-20 69.65 6.09 5.53 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.679 -0.638 . . . . 0.0 111.844 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 365' ' ' ASN . 59.7 mtp85 -155.7 104.92 2.37 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.098 -1.001 . . . . 0.0 111.834 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -101.01 167.59 10.15 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 52.7 p-90 -170.9 178.79 3.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.189 -1.569 . . . . 0.0 111.905 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 27.5 p90 -147.76 141.62 25.79 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.544 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 1.0 OUTLIER -134.15 149.44 51.05 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.871 -1.143 . . . . 0.0 112.325 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.544 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 33.6 t -127.22 134.05 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.454 ' HG3' ' OG ' ' A' ' 431' ' ' SER . 0.7 OUTLIER -128.96 145.88 51.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.778 -1.201 . . . . 0.0 109.897 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 373' ' ' ASP . 8.0 p30 -149.92 145.98 26.81 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.69 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.33 137.36 38.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.392 -0.817 . . . . 0.0 109.917 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 169.8 -164.15 37.59 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.008 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.53 -161.63 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.156 1.608 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 424' ' ' THR . . . -146.83 166.24 28.37 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.972 HD11 HD21 ' A' ' 422' ' ' LEU . 5.5 mt -72.6 169.81 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.236 . . . . 0.0 109.787 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.995 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -95.25 177.8 1.68 Allowed Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.96 -1.088 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.872 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 45.9 Cg_endo -73.32 -46.43 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.036 1.545 . . . . 0.0 110.78 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -90.77 -30.22 17.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.959 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.995 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -64.45 -20.18 66.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.079 -1.013 . . . . 0.0 110.338 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 382' ' ' GLN . 16.8 ttt180 -44.81 -29.22 0.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.162 -0.961 . . . . 0.0 109.872 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 385' ' ' HIS . 20.0 mttt -89.95 -33.15 16.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.352 -0.843 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 382' ' ' GLN . 5.0 m170 -40.94 -59.18 1.51 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.314 -0.866 . . . . 0.0 110.036 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 386' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.85 ' O ' HD13 ' A' ' 412' ' ' ILE . 27.3 mm . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.328 0.585 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 410' ' ' GLN . 7.0 p -129.47 -34.03 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.183 -0.948 . . . . 0.0 110.269 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 31.0 tt0 -66.4 -42.14 88.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 110.502 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.488 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.0 OUTLIER -69.57 -32.31 71.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.173 -0.954 . . . . 0.0 110.033 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 408' ' ' ILE . 1.1 mp -59.64 -63.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.147 -0.971 . . . . 0.0 108.58 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 1.047 HG21 HD13 ' A' ' 420' ' ' LEU . 35.5 t -63.32 -28.22 44.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.321 -0.862 . . . . 0.0 109.823 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.488 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 29.7 t70 -73.24 -20.54 60.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.511 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.548 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.1 m-80 -95.27 -14.31 24.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.473 -0.767 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.757 ' CE1' HD11 ' A' ' 337' ' ' ILE . 37.3 m80 -93.03 -34.1 13.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.451 -0.781 . . . . 0.0 109.865 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 4.1 m120 72.95 47.43 0.2 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.488 0.661 . . . . 0.0 110.431 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.575 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -121.28 -87.16 0.92 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.593 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.2 OUTLIER -171.12 161.74 6.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.397 -1.061 . . . . 0.0 110.615 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 1.047 HD13 HG21 ' A' ' 413' ' ' VAL . 14.1 tp -150.36 90.68 1.68 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 109.989 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 433' ' ' ARG . 63.0 mm-40 -89.81 154.03 20.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.235 -0.915 . . . . 0.0 110.046 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.972 HD21 HD11 ' A' ' 378' ' ' ILE . 7.2 tt -138.31 130.64 28.9 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.983 -1.073 . . . . 0.0 111.149 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.546 ' C ' ' HA ' ' A' ' 430' ' ' LEU . . . -90.33 163.04 29.91 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.773 ' HA ' ' HG ' ' A' ' 430' ' ' LEU 0.258 12.9 t . . . . . 0 N--CA 1.506 2.334 0 CA-C-N 118.836 1.318 . . . . 0.0 112.397 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.499 2.862 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.773 ' HG ' ' HA ' ' A' ' 424' ' ' THR . 0.7 OUTLIER -110.93 131.93 54.64 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.579 1.69 . . . . 0.0 110.354 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.5 ' N ' HD23 ' A' ' 430' ' ' LEU . 4.0 m -143.26 -177.75 5.52 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.919 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.667 HG21 ' CE ' ' A' ' 344' ' ' MET . 9.1 mm -149.94 92.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.687 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' ARG . . . . . 0.534 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.1 mtt180 -88.59 134.84 33.76 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.859 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -128.98 129.35 45.29 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.05 -1.031 . . . . 0.0 109.679 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 84.0 m95 -111.28 145.57 38.56 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.139 -0.975 . . . . 0.0 111.908 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.526 ' CD1' HD11 ' A' ' 301' ' ' LEU . 5.9 mt -134.35 106.69 11.11 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.575 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 42.8 Cg_endo -68.78 138.82 42.1 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 O-C-N 123.911 1.479 . . . . 0.0 111.382 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.545 ' CG2' ' HD2' ' A' ' 439' ' ' PRO . 4.9 p -86.17 145.63 40.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.567 -0.708 . . . . 0.0 109.557 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 438' ' ' VAL . 47.4 Cg_endo . . . . . 0 C--N 1.303 -1.852 0 O-C-N 123.802 1.422 . . . . 0.0 110.423 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.623 ' HB3' ' CD2' ' A' ' 333' ' ' HIS . 49.4 Cg_endo . . . . . 0 C--O 1.214 -0.718 0 CA-C-O 121.24 0.433 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.508 ' C ' ' O ' ' A' ' 295' ' ' PRO . 0.0 OUTLIER 27.99 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.193 0.997 . . . . 0.0 111.104 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 18.6 pt-20 -164.25 -159.98 0.51 Allowed 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.502 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.0 OUTLIER -88.22 127.75 35.45 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.926 -1.109 . . . . 0.0 110.146 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -147.55 163.86 35.25 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.181 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.586 ' O ' HG23 ' A' ' 304' ' ' VAL . 16.3 t0 -100.12 116.42 32.11 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.664 -0.647 . . . . 0.0 109.759 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.648 HD12 HG21 ' A' ' 328' ' ' ILE . 12.0 mt -60.53 -27.45 67.65 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.299 -0.875 . . . . 0.0 109.778 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.818 ' HA ' HD23 ' A' ' 323' ' ' LEU . 56.7 t-20 -76.19 -22.68 55.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.056 . . . . 0.0 108.963 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -85.56 -31.46 22.66 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.459 0.647 . . . . 0.0 109.552 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 300' ' ' ASP . 33.2 t -79.58 -34.31 15.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.499 -0.75 . . . . 0.0 109.542 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.774 ' O ' HD12 ' A' ' 309' ' ' ILE . 82.6 mt -79.92 -26.77 40.04 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.401 -0.812 . . . . 0.0 109.991 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.56 -33.86 88.36 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.81 -32.92 25.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.305 -1.115 . . . . 0.0 109.417 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.843 HG11 ' CG1' ' A' ' 341' ' ' VAL . 51.0 t -75.39 -19.24 15.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.389 -0.819 . . . . 0.0 109.189 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.818 HD11 ' CG1' ' A' ' 358' ' ' VAL . 1.0 OUTLIER -83.26 -46.01 18.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.08 -17.58 61.99 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.277 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.58 -53.57 4.37 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.97 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -100.86 35.0 2.3 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 111.045 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 309' ' ' ILE . 0.1 OUTLIER -86.18 32.15 0.63 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.082 -1.012 . . . . 0.0 110.365 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 45.24 33.2 3.93 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.686 -2.165 . . . . 0.0 107.686 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 39.8 m-85 61.86 52.07 3.57 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 122.096 -0.65 . . . . 0.0 109.95 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 16.1 mt-10 59.28 35.52 23.36 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.597 -0.689 . . . . 0.0 110.256 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.3 OUTLIER -68.84 -74.13 0.13 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.509 -0.744 . . . . 0.0 109.46 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 9.3 mt-10 -160.42 80.85 0.67 Allowed 'General case' 0 C--N 1.274 -2.7 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.542 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.984 HG13 HD12 ' A' ' 356' ' ' ILE . 2.7 mp -122.62 142.21 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.508 ' HB3' ' CG ' ' A' ' 357' ' ' LYS . 26.3 tt0 -109.7 103.89 12.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.446 -0.784 . . . . 0.0 109.547 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 20.0 p -90.53 123.71 34.42 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.245 -0.91 . . . . 0.0 111.411 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -144.33 78.69 1.59 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.818 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.7 mp -91.07 152.31 20.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.561 -0.712 . . . . 0.0 110.999 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.573 ' HB3' ' CD1' ' A' ' 328' ' ' ILE . 19.9 t80 -41.19 136.15 1.72 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.593 -0.692 . . . . 0.0 110.058 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 324' ' ' TYR . 51.8 Cg_endo -83.67 57.28 5.55 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 124.027 1.54 . . . . 0.0 110.276 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -167.58 21.13 0.1 OUTLIER Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.747 -1.215 . . . . 0.0 110.505 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 326' ' ' GLY . 68.5 m 56.44 111.56 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.019 -1.283 . . . . 0.0 110.215 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.648 HG21 HD12 ' A' ' 301' ' ' LEU . 3.5 mm -69.12 -179.34 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.579 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.635 ' H ' HG22 ' A' ' 328' ' ' ILE . 1.7 mt-10 -174.84 101.28 0.09 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.64 -0.663 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 1.016 HG11 ' HB3' ' A' ' 367' ' ' ALA . 8.4 m -143.41 174.17 5.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 121.62 0.724 . . . . 0.0 110.469 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.1 OUTLIER -95.05 93.63 7.49 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.624 ' HG2' HG23 ' A' ' 330' ' ' VAL . 11.2 ptm -136.47 164.76 27.41 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.973 0.892 . . . . 0.0 112.597 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.623 ' CD2' ' HB3' ' A' ' 295' ' ' PRO . 23.4 t-160 -88.06 116.44 66.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 39.3 Cg_endo -62.47 -30.23 79.75 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.637 1.335 . . . . 0.0 112.542 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.597 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 3.9 tp -82.23 -49.2 10.36 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.623 -1.298 . . . . 0.0 110.589 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.542 ' HB2' ' ND1' ' A' ' 333' ' ' HIS . 0.5 OUTLIER -60.6 -42.26 96.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.915 -1.115 . . . . 0.0 109.869 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.933 HD11 ' CE1' ' A' ' 416' ' ' HIS . 18.5 mm -65.37 -46.99 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.601 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 0.7 OUTLIER -51.54 -32.93 29.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.83 -1.169 . . . . 0.0 107.873 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.477 ' NH1' ' OD1' ' A' ' 343' ' ' ASN . 0.0 OUTLIER -77.45 -34.65 54.41 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.991 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 344' ' ' MET . . . -67.55 -29.57 68.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.454 -0.779 . . . . 0.0 110.449 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.843 ' CG1' HG11 ' A' ' 308' ' ' VAL . 52.8 t -90.28 -25.49 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 110.423 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 346' ' ' VAL . . . -83.3 -19.95 35.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.578 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ASN . . . . . 0.477 ' OD1' ' NH1' ' A' ' 339' ' ' ARG . 0.3 OUTLIER -83.78 -21.08 32.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -0.916 . . . . 0.0 110.779 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 3.2 mtt -90.69 -51.3 5.45 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.138 -0.976 . . . . 0.0 111.221 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 341' ' ' VAL . 27.4 m -68.22 -19.69 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -0.943 . . . . 0.0 111.505 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 347' ' ' ASN . 14.5 p -61.53 -39.64 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.843 -1.161 . . . . 0.0 110.72 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.52 ' N ' HG13 ' A' ' 346' ' ' VAL . 10.9 t30 -63.2 -49.78 72.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.126 -0.984 . . . . 0.0 110.806 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.488 ' O ' ' HA2' ' A' ' 352' ' ' GLY . . . -72.73 -19.91 61.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.219 -0.926 . . . . 0.0 110.612 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.09 -73.18 0.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.025 -1.047 . . . . 0.0 110.253 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -55.35 -51.63 66.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.298 -0.876 . . . . 0.0 110.453 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -59.54 2.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.215 -0.928 . . . . 0.0 110.379 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 348' ' ' ALA . . . 68.09 -104.11 1.12 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 1.5 t30 55.0 17.35 1.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -1.145 . . . . 0.0 110.207 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 374' ' ' ASP . . . -168.37 -98.25 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.067 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.612 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -179.78 148.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -1.166 . . . . 0.0 109.881 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.984 HD12 HG13 ' A' ' 319' ' ' ILE . 0.8 OUTLIER -106.49 159.52 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.309 -0.869 . . . . 0.0 110.024 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.612 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 1.4 ttmt -150.41 112.72 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 110.692 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.818 ' CG1' HD11 ' A' ' 309' ' ' ILE . 21.9 t -103.07 88.81 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 370' ' ' GLN . 6.8 p -115.04 151.14 34.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -0.896 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.536 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.6 OUTLIER -140.14 163.53 32.47 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.533 ' C ' HG22 ' A' ' 362' ' ' THR . . . -155.23 -164.32 12.95 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.545 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.1 OUTLIER -176.36 144.05 0.53 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.716 -1.461 . . . . 0.0 112.048 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 39.0 mt-10 -109.03 175.61 1.89 Allowed Pre-proline 0 C--N 1.287 -2.146 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.304 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 40.1 Cg_endo -66.07 127.0 16.77 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.245 1.129 . . . . 0.0 110.087 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.552 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 6.6 m120 60.52 22.25 11.97 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.519 -0.738 . . . . 0.0 110.243 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 42.1 mtm180 -163.63 145.06 9.22 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 1.016 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -143.17 151.16 40.36 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.11 -0.994 . . . . 0.0 109.159 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.603 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 37.7 p-90 -151.67 170.38 19.85 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.905 -1.122 . . . . 0.0 110.682 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 369' ' ' PHE . 36.4 p90 -139.5 130.42 26.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.44 -0.787 . . . . 0.0 109.582 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 359' ' ' SER . 0.8 OUTLIER -116.1 150.48 37.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -0.933 . . . . 0.0 111.381 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.29 143.86 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.497 -0.752 . . . . 0.0 109.348 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 357' ' ' LYS . 1.8 tt0 -126.36 145.51 50.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.013 -1.054 . . . . 0.0 110.198 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.451 ' OD1' ' HB1' ' A' ' 348' ' ' ALA . 11.1 t70 -156.65 143.66 18.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.841 . . . . 0.0 110.331 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 374' ' ' ASP . 27.6 t0 -98.39 64.47 1.59 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.37 -0.831 . . . . 0.0 110.016 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -86.88 -148.01 12.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.15 -40.59 3.15 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.008 1.531 . . . . 0.0 110.482 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' GLY . . . . . 0.593 ' C ' HD13 ' A' ' 378' ' ' ILE . . . 103.6 -174.85 23.06 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.768 HD11 HD11 ' A' ' 430' ' ' LEU . 1.9 mm -99.72 176.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.065 -1.256 . . . . 0.0 110.102 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.902 ' HB3' ' CB ' ' A' ' 382' ' ' GLN . . . -109.91 165.61 12.35 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.248 -0.908 . . . . 0.0 109.752 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 43.2 Cg_endo -70.07 -49.26 0.53 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.842 1.443 . . . . 0.0 110.229 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -89.53 -19.69 24.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.12 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.902 ' CB ' ' HB3' ' A' ' 379' ' ' ALA . 4.5 tt0 -82.82 -19.78 36.98 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.275 -0.89 . . . . 0.0 110.86 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 382' ' ' GLN . 2.2 ttt85 -42.32 -37.97 1.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.024 -1.047 . . . . 0.0 110.021 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.84 -27.89 19.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.203 -0.936 . . . . 0.0 110.404 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -51.81 -18.23 1.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.107 -0.996 . . . . 0.0 110.747 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 50.4 mt . . . . . 0 N--CA 1.501 2.119 0 O-C-N 120.92 -1.113 . . . . 0.0 110.731 179.972 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.589 HG22 HG12 ' A' ' 409' ' ' VAL . 14.2 mt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.268 0.556 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 408' ' ' ILE . 10.6 p -48.83 -22.51 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.954 . . . . 0.0 110.176 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 48.3 tt0 -62.9 -55.94 21.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.23 -0.919 . . . . 0.0 110.609 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.4 OUTLIER -59.02 -32.19 69.5 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.311 -0.868 . . . . 0.0 110.684 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 340' ' ' ALA . 1.0 OUTLIER -64.03 -58.37 7.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.092 -1.005 . . . . 0.0 109.143 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.653 HG11 ' HB2' ' A' ' 420' ' ' LEU . 30.4 t -65.51 -21.41 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.249 -0.907 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 0.1 OUTLIER -82.41 -25.83 33.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 109.515 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 2.2 t-20 -86.41 -17.82 33.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.933 ' CE1' HD11 ' A' ' 337' ' ' ILE . 22.7 m80 -92.87 -41.2 10.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.539 -0.726 . . . . 0.0 109.664 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.1 OUTLIER 79.59 36.04 0.15 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.437 0.637 . . . . 0.0 109.949 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.635 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -101.86 -90.03 2.1 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.565 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.7 OUTLIER -173.0 163.45 4.79 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.349 -1.089 . . . . 0.0 111.222 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.653 ' HB2' HG11 ' A' ' 413' ' ' VAL . 14.3 tp -151.45 97.93 2.46 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.57 152.17 34.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.001 -1.062 . . . . 0.0 111.541 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.602 ' O ' HD12 ' A' ' 422' ' ' LEU . 2.9 pp -132.47 121.13 22.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.404 -0.81 . . . . 0.0 109.273 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -141.8 132.04 5.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 3.5 t . . . . . 0 C--N 1.304 -1.396 0 O-C-N 121.254 -1.145 . . . . 0.0 110.703 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.498 2.822 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.768 HD11 HD11 ' A' ' 378' ' ' ILE . 0.3 OUTLIER -76.44 135.77 39.42 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.138 -1.213 . . . . 0.0 111.777 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 40.2 t -144.76 114.24 7.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.689 -0.632 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 432' ' ' ILE . 1.5 tt -94.46 131.91 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.145 -0.972 . . . . 0.0 110.368 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -111.79 103.04 11.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.94 . . . . 0.0 110.407 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 368' ' ' TRP . . . -91.96 130.39 37.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.325 -0.86 . . . . 0.0 109.518 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.603 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.3 m95 -107.66 157.24 18.25 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.822 -1.174 . . . . 0.0 112.438 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.505 HD12 HD11 ' A' ' 301' ' ' LEU . 19.8 mt -142.68 114.12 6.04 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.635 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 51.4 Cg_endo -78.45 129.53 9.44 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.534 1.281 . . . . 0.0 112.161 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.799 HG21 HG12 ' A' ' 330' ' ' VAL . 6.8 t -109.32 69.0 0.42 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.539 -0.725 . . . . 0.0 110.02 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.483 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 57.7 Cg_endo . . . . . 0 C--N 1.308 -1.574 0 O-C-N 123.681 1.358 . . . . 0.0 110.558 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.442 ' HG2' ' NE2' ' A' ' 333' ' ' HIS . 54.2 Cg_endo . . . . . 0 C--O 1.216 -0.609 0 CA-C-O 121.361 0.484 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.04 107.74 15.84 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 15.5 mt-10 -128.81 -162.02 1.16 Allowed 'General case' 0 C--N 1.283 -2.287 0 O-C-N 121.637 -0.664 . . . . 0.0 109.913 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.468 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -88.33 133.51 34.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.048 -1.033 . . . . 0.0 110.271 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.584 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -149.68 160.7 43.31 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.447 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.903 ' O ' HG23 ' A' ' 304' ' ' VAL . 4.3 t0 -90.77 121.32 32.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.801 -0.562 . . . . 0.0 109.891 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.776 HD11 HD12 ' A' ' 436' ' ' LEU . 9.5 mt -72.18 -21.15 61.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 109.718 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.645 ' OD1' HD23 ' A' ' 323' ' ' LEU . 8.9 t30 -83.45 -23.97 32.04 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 109.138 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.682 ' HB3' ' HB3' ' A' ' 300' ' ' ASP . . . -84.0 -31.59 25.4 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.515 -0.74 . . . . 0.0 109.584 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 300' ' ' ASP . 11.4 t -78.41 -35.88 19.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.401 -0.812 . . . . 0.0 109.705 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.509 ' CD2' HG21 ' A' ' 341' ' ' VAL . 71.1 mt -76.08 -29.56 58.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.26 -0.9 . . . . 0.0 110.924 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLY . . . . . 0.473 ' HA2' HD12 ' A' ' 309' ' ' ILE . . . -65.58 -39.78 95.69 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -75.84 -32.56 59.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.203 -1.174 . . . . 0.0 109.59 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 1.006 HG11 ' HB ' ' A' ' 341' ' ' VAL . 41.0 t -78.27 -19.96 13.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 109.339 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.989 ' CG1' HG11 ' A' ' 358' ' ' VAL . 1.4 mt -71.15 -50.48 41.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.79 -15.08 61.64 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.823 0.821 . . . . 0.0 108.879 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 308' ' ' VAL . . . -61.62 -63.17 1.36 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.857 -0.527 . . . . 0.0 111.817 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 311' ' ' ALA . 13.3 mt-10 -143.41 38.92 1.4 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.525 -1.27 . . . . 0.0 113.047 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.949 ' OG ' HD12 ' A' ' 319' ' ' ILE . 5.9 t -85.77 10.37 13.8 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.616 -1.303 . . . . 0.0 109.53 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 317' ' ' ARG . . . 111.39 43.33 0.99 Allowed Glycine 0 C--N 1.291 -1.945 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.536 ' O ' ' HG3' ' A' ' 316' ' ' GLU . 23.7 m-85 59.43 41.6 19.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.918 . . . . 0.0 110.094 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 53.59 32.67 14.8 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.342 1.068 . . . . 0.0 109.096 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 0.2 OUTLIER -69.81 -81.59 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.98 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.634 ' C ' HD13 ' A' ' 319' ' ' ILE . 14.3 pt-20 -126.89 72.15 1.34 Allowed 'General case' 0 C--N 1.277 -2.545 0 O-C-N 121.669 -0.644 . . . . 0.0 111.974 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.949 HD12 ' OG ' ' A' ' 313' ' ' SER . 1.8 mm -104.52 123.2 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 358' ' ' VAL . 7.5 tt0 -88.98 98.15 11.6 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.59 HG22 HD13 ' A' ' 309' ' ' ILE . 20.6 p -89.46 129.22 35.99 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.893 0.854 . . . . 0.0 111.832 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.46 77.85 1.31 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.645 HD23 ' OD1' ' A' ' 302' ' ' ASN . 0.8 OUTLIER -96.46 158.51 15.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.47 -0.768 . . . . 0.0 110.644 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.605 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 15.3 t80 -54.31 116.03 9.74 Favored Pre-proline 0 C--N 1.299 -1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.49 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -80.97 64.64 8.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.022 1.538 . . . . 0.0 110.322 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.451 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -162.52 23.04 0.2 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 4.3 p 60.26 106.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -1.136 . . . . 0.0 110.646 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.557 HG22 ' N ' ' A' ' 329' ' ' GLU . 4.0 mt -84.8 175.48 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 O-C-N 121.723 -0.611 . . . . 0.0 109.646 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.557 ' N ' HG22 ' A' ' 328' ' ' ILE . 2.7 mt-10 -169.47 109.89 0.45 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.391 -0.818 . . . . 0.0 111.352 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 1.124 HG11 ' HB3' ' A' ' 367' ' ' ALA . 12.7 m -145.03 160.68 13.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.517 0.675 . . . . 0.0 109.936 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.0 OUTLIER -82.94 95.89 8.12 Favored 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.518 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.584 ' HG3' ' HB3' ' A' ' 299' ' ' ALA . 19.2 ptm -140.37 -178.21 5.39 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 110.975 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.774 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 0.8 OUTLIER -115.13 112.23 44.39 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.506 ' HB2' ' HE3' ' A' ' 338' ' ' LYS . 36.6 Cg_endo -58.74 -19.66 47.36 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.721 1.379 . . . . 0.0 110.447 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.774 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 2.9 tm? -78.95 -63.89 1.31 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.382 -0.824 . . . . 0.0 110.123 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.47 ' O ' HG12 ' A' ' 412' ' ' ILE . 0.0 OUTLIER -54.22 -49.97 68.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.305 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.562 HD13 ' CG2' ' A' ' 412' ' ' ILE . 17.3 mm -62.91 -31.78 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 110.346 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.506 ' HE3' ' HB2' ' A' ' 334' ' ' PRO . 0.4 OUTLIER -61.03 -57.86 10.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.906 -1.121 . . . . 0.0 109.772 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.401 ' HD2' ' C ' ' A' ' 339' ' ' ARG . 4.1 tmm_? -69.45 -21.35 63.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.466 -0.771 . . . . 0.0 110.356 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.432 ' HB2' ' CG1' ' A' ' 412' ' ' ILE . . . -69.6 -44.69 70.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.014 . . . . 0.0 110.307 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 1.006 ' HB ' HG11 ' A' ' 308' ' ' VAL . 46.3 t -80.42 -22.16 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.337 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -70.62 -62.24 1.46 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.137 -0.977 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ASN . . . . . 0.923 ' O ' HG12 ' A' ' 346' ' ' VAL . 0.7 OUTLIER -59.25 -43.48 92.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.074 -1.016 . . . . 0.0 110.73 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.539 ' CE ' HG21 ' A' ' 432' ' ' ILE . 2.9 ttm -57.7 -19.05 24.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.274 -0.891 . . . . 0.0 110.976 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 341' ' ' VAL . 78.0 t -88.68 -22.26 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.094 -1.004 . . . . 0.0 111.587 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.923 HG12 ' O ' ' A' ' 343' ' ' ASN . 9.0 p -64.82 -19.5 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.951 -1.093 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -66.26 -42.63 88.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.052 -1.03 . . . . 0.0 111.536 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.495 ' HB2' ' CG ' ' A' ' 373' ' ' ASP . . . -89.3 -19.86 24.79 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.938 -1.101 . . . . 0.0 111.369 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -89.41 -69.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.959 -1.088 . . . . 0.0 110.822 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -65.8 -41.92 91.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.125 -0.984 . . . . 0.0 110.744 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.82 -35.73 16.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.175 -0.953 . . . . 0.0 110.56 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -97.34 156.27 20.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.97 53.94 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -1.12 . . . . 0.0 109.959 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 355' ' ' TRP . . . -128.04 -59.58 0.12 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.587 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.3 OUTLIER 171.78 150.25 0.05 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.151 -1.205 . . . . 0.0 109.841 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' A' ' 313' ' ' SER . 26.6 mt -116.49 164.21 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.251 -0.905 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 18.4 tttm -142.27 97.6 3.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.561 -0.712 . . . . 0.0 109.752 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.989 HG11 ' CG1' ' A' ' 309' ' ' ILE . 26.0 t -93.01 139.57 17.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.8 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.56 ' HA ' ' CD1' ' A' ' 323' ' ' LEU . 60.3 p -160.13 169.91 22.33 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.087 -1.008 . . . . 0.0 111.458 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.517 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 34.2 t -155.21 150.28 26.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.635 -0.665 . . . . 0.0 109.762 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.513 ' HA3' ' CZ2' ' A' ' 368' ' ' TRP . . . -139.1 -169.92 11.7 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.605 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.5 OUTLIER -178.21 166.16 1.91 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.926 -1.338 . . . . 0.0 111.834 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.571 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 5.1 mm-40 -128.35 -174.91 0.4 Allowed Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 45.8 Cg_endo -86.71 36.46 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.495 1.261 . . . . 0.0 110.446 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 2.8 m-20 161.29 36.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.533 ' HG2' ' HB3' ' A' ' 437' ' ' PRO . 0.2 OUTLIER 166.14 103.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.821 . . . . 0.0 109.718 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 1.124 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -103.91 157.52 17.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.023 -1.048 . . . . 0.0 110.205 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.596 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 30.2 p-90 -150.51 166.46 30.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 110.323 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 434' ' ' ALA . 36.0 p90 -133.77 147.26 51.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -0.83 . . . . 0.0 109.499 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.542 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 24.5 tt0 -139.08 155.9 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 111.538 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.542 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 6.3 t -140.03 144.15 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 431' ' ' SER . 26.2 tt0 -142.62 147.65 36.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.824 -1.172 . . . . 0.0 110.099 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.495 ' CG ' ' HB2' ' A' ' 348' ' ' ALA . 1.5 p30 -161.4 169.68 21.5 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.068 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -79.54 166.69 21.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.388 -0.82 . . . . 0.0 110.026 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 124.58 -164.12 18.16 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.89 127.08 11.17 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.042 1.549 . . . . 0.0 110.622 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' GLY . . . . . 0.644 ' HA2' HD12 ' A' ' 430' ' ' LEU . . . -94.24 -169.62 37.73 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.711 HG22 ' H ' ' A' ' 379' ' ' ALA . 3.2 mm -76.97 -172.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.942 -1.328 . . . . 0.0 110.145 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.961 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -155.59 160.36 30.9 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.235 -0.915 . . . . 0.0 110.101 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.84 -38.1 4.47 Favored 'Trans proline' 0 C--N 1.298 -2.101 0 O-C-N 124.087 1.572 . . . . 0.0 110.367 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -90.1 -20.91 22.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.199 -0.938 . . . . 0.0 110.284 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.961 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 5.3 tp60 -76.92 -23.57 52.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.204 -0.935 . . . . 0.0 110.343 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -52.53 -26.36 12.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.223 -0.923 . . . . 0.0 110.351 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -79.67 -32.62 41.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.308 -0.87 . . . . 0.0 110.066 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -59.0 -71.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.032 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 0.0 110.552 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 412' ' ' ILE . 10.7 mt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 120.936 0.398 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.502 ' HA ' HD13 ' A' ' 412' ' ' ILE . 13.6 p -46.91 -19.88 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.052 -1.03 . . . . 0.0 111.744 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 0.7 OUTLIER -58.53 -67.08 0.39 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.012 -1.055 . . . . 0.0 111.589 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.52 ' HG2' ' NH2' ' A' ' 411' ' ' ARG . 0.0 OUTLIER -60.31 -26.09 66.27 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.193 -0.942 . . . . 0.0 111.956 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.732 HD12 ' O ' ' A' ' 408' ' ' ILE . 1.3 mp -64.79 -61.69 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 120.473 -1.392 . . . . 0.0 109.332 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.568 HG21 HD13 ' A' ' 420' ' ' LEU . 25.5 t -66.23 -25.14 34.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.093 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 9.1 m-20 -78.38 -23.29 46.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 109.823 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 16.6 t-20 -82.95 -15.31 51.79 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.318 -0.864 . . . . 0.0 109.285 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.579 ' O ' ' CB ' ' A' ' 417' ' ' ASN . 34.1 m80 -90.89 -30.09 17.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.515 -0.74 . . . . 0.0 110.062 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 3.4 t-20 81.52 17.57 0.45 Allowed 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.814 -0.554 . . . . 0.0 110.464 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.577 ' HA2' ' CD ' ' A' ' 437' ' ' PRO . . . -84.81 -91.7 0.79 Allowed Glycine 0 N--CA 1.481 1.678 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.585 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.8 ttp -174.52 167.12 3.91 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.205 -1.174 . . . . 0.0 111.042 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.568 HD13 HG21 ' A' ' 413' ' ' VAL . 19.1 tp -150.83 112.48 4.46 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.597 -0.69 . . . . 0.0 109.181 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -123.54 133.29 54.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.893 -1.129 . . . . 0.0 111.936 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.541 ' CD2' HD12 ' A' ' 432' ' ' ILE . 10.8 mt -108.96 127.59 54.2 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 430' ' ' LEU . . . -136.59 136.83 8.62 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.073 -1.537 . . . . 0.0 110.762 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 429' ' ' GLY . 5.9 m . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.436 -1.038 . . . . 0.0 109.674 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.636 ' O ' HG23 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.927 HD22 ' N ' ' A' ' 431' ' ' SER . 0.0 OUTLIER -175.42 -175.71 0.83 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.038 -1.272 . . . . 0.0 112.11 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.927 ' N ' HD22 ' A' ' 430' ' ' LEU . 0.9 OUTLIER -153.05 -178.98 7.27 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.203 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.541 HD12 ' CD2' ' A' ' 422' ' ' LEU . 0.6 OUTLIER -137.02 133.9 47.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.043 -1.035 . . . . 0.0 110.631 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -111.63 97.8 6.98 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.47 -0.769 . . . . 0.0 109.111 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.592 ' HB3' ' CE2' ' A' ' 369' ' ' PHE . . . -90.63 133.07 35.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.402 -0.811 . . . . 0.0 110.474 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.596 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.7 m95 -105.64 151.92 23.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.097 -1.002 . . . . 0.0 111.586 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.776 HD12 HD11 ' A' ' 301' ' ' LEU . 36.8 mt -144.41 83.91 9.61 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.577 ' CD ' ' HA2' ' A' ' 418' ' ' GLY . 41.7 Cg_endo -69.35 137.0 35.57 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 123.92 1.484 . . . . 0.0 111.443 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 330' ' ' VAL . 40.8 t -79.35 142.96 59.19 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.78 -0.575 . . . . 0.0 109.947 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 331' ' ' LYS . 47.3 Cg_endo . . . . . 0 C--N 1.313 -1.321 0 O-C-N 123.742 1.39 . . . . 0.0 110.425 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.546 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 49.9 Cg_endo . . . . . 0 N--CA 1.479 0.674 0 CA-C-O 121.205 0.419 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.681 ' HE3' ' NE2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -80.82 108.86 14.84 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.471 -0.892 . . . . 0.0 108.937 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.617 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 52.8 mt-10 -123.47 -161.96 1.01 Allowed 'General case' 0 C--N 1.274 -2.686 0 O-C-N 121.825 -0.547 . . . . 0.0 109.748 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.424 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -88.01 130.01 35.1 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 110.381 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.811 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -149.26 158.65 44.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.526 -0.734 . . . . 0.0 110.852 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.783 ' O ' HG23 ' A' ' 304' ' ' VAL . 7.4 m-20 -98.65 117.32 32.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.566 -0.709 . . . . 0.0 110.206 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.598 HD12 HG21 ' A' ' 328' ' ' ILE . 13.4 mt -62.27 -23.85 66.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.169 -0.957 . . . . 0.0 109.845 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.495 ' OD1' HD23 ' A' ' 323' ' ' LEU . 44.0 t-20 -81.63 -22.27 37.71 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.177 -0.952 . . . . 0.0 109.114 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.403 ' O ' ' OE1' ' A' ' 307' ' ' GLU . . . -84.4 -30.31 25.48 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.629 -0.669 . . . . 0.0 109.664 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 300' ' ' ASP . 4.4 t -80.92 -34.46 13.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 109.608 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 79.2 mt -78.71 -27.48 44.94 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.398 -0.814 . . . . 0.0 110.623 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.4 -37.15 85.58 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.741 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 1.5 mp0 -76.21 -34.46 59.25 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.271 -1.135 . . . . 0.0 109.315 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.522 HG11 ' HB ' ' A' ' 341' ' ' VAL . 95.6 t -78.71 -19.59 13.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.534 -0.729 . . . . 0.0 109.443 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.534 HG13 HG11 ' A' ' 358' ' ' VAL . 0.1 OUTLIER -73.67 -43.51 54.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.422 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -90.44 -16.02 29.79 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.665 0.745 . . . . 0.0 109.139 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -53.9 -61.82 2.06 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.736 -0.603 . . . . 0.0 110.503 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -150.74 37.23 0.64 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.741 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.628 ' HB3' HD13 ' A' ' 319' ' ' ILE . 11.3 m -89.5 43.65 1.16 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.121 -0.987 . . . . 0.0 108.948 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 317' ' ' ARG . . . 63.18 44.35 97.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.484 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 19.7 m-30 48.82 38.0 11.04 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.0 -1.294 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 2.1 mt-10 69.38 56.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.329 -0.857 . . . . 0.0 110.006 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 314' ' ' GLY . 3.1 mmt180 -68.7 -92.11 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.787 0.803 . . . . 0.0 109.869 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 318' ' ' GLU . 15.6 pt-20 -126.55 58.05 1.41 Allowed 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.544 0.688 . . . . 0.0 109.741 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.774 HG23 HG23 ' A' ' 358' ' ' VAL . 3.5 mt -104.73 130.66 55.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 121.613 -0.679 . . . . 0.0 110.2 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -89.46 103.38 16.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 19.6 p -93.6 123.07 36.68 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 111.291 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.59 78.03 1.49 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 360' ' ' SER . 3.4 mp -90.47 144.84 25.41 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.517 -0.74 . . . . 0.0 110.5 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' LEU . 7.4 t80 -40.7 137.85 1.34 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.574 -0.704 . . . . 0.0 109.634 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -82.7 47.6 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.892 1.469 . . . . 0.0 110.791 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.464 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -159.8 13.59 0.19 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 3.3 p 60.05 116.33 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.997 -1.296 . . . . 0.0 109.638 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.598 HG21 HD12 ' A' ' 301' ' ' LEU . 2.7 mm -67.77 -179.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.737 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.562 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.8 mt-10 -171.25 105.76 0.23 Allowed 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.632 0.73 . . . . 0.0 110.644 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.945 HG12 HG22 ' A' ' 438' ' ' VAL . 12.1 m -149.98 163.95 3.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-O 121.597 0.713 . . . . 0.0 110.343 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.2 tptm -79.59 91.44 5.2 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.811 ' HG3' ' HB3' ' A' ' 299' ' ' ALA . 11.1 ptm -140.56 158.9 43.31 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 110.613 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.547 ' NE2' ' HB2' ' A' ' 335' ' ' LEU . 18.1 t-160 -88.96 113.29 55.44 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 40.0 Cg_endo -64.19 -19.4 65.91 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.59 1.31 . . . . 0.0 109.894 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.547 ' HB2' ' NE2' ' A' ' 333' ' ' HIS . 0.2 OUTLIER -78.14 -53.65 7.14 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 109.995 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 60.3 p -64.72 -36.25 83.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 0.0 109.937 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.748 HD11 ' CE1' ' A' ' 416' ' ' HIS . 10.1 mm -75.1 -35.99 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.114 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 0.4 OUTLIER -57.04 -50.57 72.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.971 -1.081 . . . . 0.0 108.984 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -27.29 61.14 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.636 -0.665 . . . . 0.0 109.747 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 1.06 ' HB2' HD13 ' A' ' 412' ' ' ILE . . . -60.25 -49.58 77.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.149 -0.97 . . . . 0.0 110.183 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.522 ' HB ' HG11 ' A' ' 308' ' ' VAL . 21.5 t -77.47 -35.4 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.0 109.952 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.429 ' O ' ' HB ' ' A' ' 346' ' ' VAL . . . -59.32 -27.05 65.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.848 . . . . 0.0 110.299 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ASN . . . . . 0.506 ' O ' HG12 ' A' ' 346' ' ' VAL . 0.5 OUTLIER -85.37 -19.94 30.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.477 ' SD ' HG21 ' A' ' 432' ' ' ILE . 0.8 OUTLIER -84.88 -33.09 22.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 7.9 p -87.75 -24.2 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.224 -0.922 . . . . 0.0 110.322 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 343' ' ' ASN . 7.6 p -65.01 -20.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.154 -0.966 . . . . 0.0 110.234 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.12 -58.84 4.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -69.05 -31.16 69.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 110.175 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.94 66.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 109.985 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.32 -41.25 49.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -62.45 1.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.217 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 111.92 -41.71 2.16 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -88.65 83.59 6.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -1.17 . . . . 0.0 110.225 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 374' ' ' ASP . . . 177.57 101.86 0.15 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.588 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.2 OUTLIER -51.56 139.41 20.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.225 -1.161 . . . . 0.0 110.355 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.719 HD12 HG13 ' A' ' 319' ' ' ILE . 17.0 mt -111.75 167.84 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.749 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.588 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 39.9 tttt -148.56 114.97 5.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.951 -1.093 . . . . 0.0 111.12 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.774 HG23 HG23 ' A' ' 319' ' ' ILE . 21.7 t -119.24 78.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 109.25 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 95.5 p -110.68 135.24 51.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 110.357 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.511 ' HB3' ' HG ' ' A' ' 323' ' ' LEU . 0.0 OUTLIER -121.33 149.13 43.4 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 109.794 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.526 ' C ' HG22 ' A' ' 362' ' ' THR . . . -147.48 -165.07 11.6 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -175.81 162.64 2.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.961 -1.317 . . . . 0.0 111.32 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 1.2 mt-10 -126.63 174.21 4.4 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 50.5 Cg_endo -77.63 31.11 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.453 1.239 . . . . 0.0 111.488 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.557 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 11.9 p-10 177.88 26.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.069 -1.02 . . . . 0.0 110.766 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 24.4 ptt180 160.61 115.15 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 121.224 0.535 . . . . 0.0 109.861 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.587 ' H ' HG23 ' A' ' 438' ' ' VAL . . . -96.23 166.47 11.72 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.145 -0.972 . . . . 0.0 109.26 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 61.9 p-90 -161.09 148.62 15.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.736 -1.228 . . . . 0.0 111.147 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.554 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 30.2 p90 -122.84 136.33 54.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.42 -0.8 . . . . 0.0 109.732 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.5 ' HG3' ' HA ' ' A' ' 433' ' ' ARG . 1.9 tt0 -112.23 137.42 50.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.375 -0.828 . . . . 0.0 111.481 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 54.3 t -131.93 107.51 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -109.71 158.22 18.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.071 -1.018 . . . . 0.0 110.664 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 5.5 p-10 -168.97 132.33 1.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.374 -0.829 . . . . 0.0 110.15 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.486 ' O ' ' HA3' ' A' ' 354' ' ' GLY . 5.9 m-20 -107.93 154.38 21.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 110.361 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -169.77 -115.09 0.32 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.47 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.789 1.415 . . . . 0.0 110.427 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 172.21 -161.86 33.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.848 HD11 HD11 ' A' ' 430' ' ' LEU . 16.1 mt -131.17 154.67 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -1.205 . . . . 0.0 111.219 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.82 150.38 88.4 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.534 -0.729 . . . . 0.0 109.081 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.38 -22.76 28.78 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 O-C-N 123.84 1.442 . . . . 0.0 110.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -91.09 -26.77 18.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.3 -0.875 . . . . 0.0 111.363 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -88.81 -29.36 19.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.052 -1.03 . . . . 0.0 110.761 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -19.43 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.049 -1.032 . . . . 0.0 110.394 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 385' ' ' HIS . 12.2 mmtt -82.48 -34.44 28.04 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.377 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.571 ' N ' ' ND1' ' A' ' 385' ' ' HIS . 0.1 OUTLIER -107.24 -74.03 0.67 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.243 -0.91 . . . . 0.0 110.743 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 385' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.498 1.958 0 O-C-N 121.806 -0.559 . . . . 0.0 111.51 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.482 HG21 ' OE1' ' A' ' 410' ' ' GLN . 23.6 mm . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.252 0.548 . . . . 0.0 110.062 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.638 ' HA ' HD12 ' A' ' 412' ' ' ILE . 17.4 t -39.51 -56.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.259 -0.901 . . . . 0.0 111.196 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.564 ' O ' ' CB ' ' A' ' 414' ' ' ASP . 7.8 pt20 -48.7 -52.04 25.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.14 -0.975 . . . . 0.0 111.688 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.2 OUTLIER -68.8 -20.72 64.34 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.75 -1.219 . . . . 0.0 111.274 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 1.06 HD13 ' HB2' ' A' ' 340' ' ' ALA . 16.9 mt -73.94 -75.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.88 -1.138 . . . . 0.0 108.679 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 419' ' ' MET . 21.4 t -54.29 -21.07 5.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.488 -0.757 . . . . 0.0 109.661 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 21.0 t0 -77.34 -40.32 44.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.143 -0.973 . . . . 0.0 109.864 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 0.8 OUTLIER -68.36 -20.36 64.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.284 -0.885 . . . . 0.0 109.65 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.748 ' CE1' HD11 ' A' ' 337' ' ' ILE . 25.5 m80 -80.36 -26.38 38.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.379 -0.826 . . . . 0.0 110.01 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 2.1 t30 79.43 47.97 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.544 0.688 . . . . 0.0 110.445 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.555 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -118.23 -86.45 1.11 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.572 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.2 OUTLIER 179.14 161.75 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.358 -1.084 . . . . 0.0 111.259 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 410' ' ' GLN . 13.3 tp -152.55 101.53 2.65 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.338 -0.851 . . . . 0.0 108.82 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -111.46 136.41 50.66 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 120.839 -1.163 . . . . 0.0 112.405 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.46 93.42 5.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.711 0.767 . . . . 0.0 109.317 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 430' ' ' LEU . . . -60.73 141.96 48.17 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 54.7 m . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.389 -1.065 . . . . 0.0 110.396 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.848 HD11 HD11 ' A' ' 378' ' ' ILE . 2.7 mp -99.49 110.62 23.07 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.947 -1.325 . . . . 0.0 113.129 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.454 ' OG ' ' HA3' ' A' ' 423' ' ' GLY . 0.1 OUTLIER -113.43 111.64 22.29 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.495 ' O ' ' CG ' ' A' ' 370' ' ' GLN . 21.4 mm -87.52 125.78 41.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 120.723 -1.236 . . . . 0.0 112.9 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' ARG . . . . . 0.5 ' HA ' ' HG3' ' A' ' 370' ' ' GLN . 0.0 OUTLIER -118.8 85.9 2.45 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.554 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.95 131.9 35.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.471 -0.768 . . . . 0.0 110.703 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 81.3 m95 -112.79 154.04 26.85 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.245 1.021 . . . . 0.0 111.959 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 416' ' ' HIS . 17.8 mt -143.46 117.0 6.01 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.555 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 42.2 Cg_endo -68.41 143.99 59.93 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 O-C-N 123.549 1.289 . . . . 0.0 111.284 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.945 HG22 HG12 ' A' ' 330' ' ' VAL . 76.3 t -103.98 90.37 2.95 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.659 -0.651 . . . . 0.0 110.35 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 47.2 Cg_endo . . . . . 0 C--N 1.307 -1.62 0 O-C-N 123.961 1.506 . . . . 0.0 110.09 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.632 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 52.6 Cg_endo . . . . . 0 C--O 1.215 -0.631 0 N-CA-C 110.522 -0.607 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.625 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.4 OUTLIER -94.69 107.65 19.65 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 122.152 0.977 . . . . 0.0 108.37 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.639 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.2 mm-40 -123.37 -159.73 0.87 Allowed 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.835 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.62 137.37 32.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 0.0 110.918 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -156.44 153.26 28.56 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.411 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 304' ' ' VAL . 5.2 m-20 -88.22 114.67 25.07 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.921 HD11 ' CD1' ' A' ' 436' ' ' LEU . 4.8 mt -64.09 -24.88 67.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 0.0 110.599 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.625 ' CA ' HD23 ' A' ' 323' ' ' LEU . 48.5 p-10 -81.0 -19.9 42.99 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.706 -1.246 . . . . 0.0 109.033 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.513 ' N ' ' OD1' ' A' ' 302' ' ' ASN . . . -87.96 -27.75 21.9 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.577 0.703 . . . . 0.0 109.225 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.806 ' O ' HG23 ' A' ' 308' ' ' VAL . 90.4 t -78.85 -36.95 19.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.554 -0.716 . . . . 0.0 109.623 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 84.4 mt -76.34 -35.38 58.76 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.404 -0.81 . . . . 0.0 110.321 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -65.29 -26.59 71.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 2.8 mt-10 -84.14 -32.85 24.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.235 -1.156 . . . . 0.0 109.713 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.854 HG11 HG12 ' A' ' 341' ' ' VAL . 48.0 t -75.75 -21.4 15.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.385 -0.822 . . . . 0.0 109.121 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 1.074 HD11 ' CG1' ' A' ' 358' ' ' VAL . 17.1 mt -78.74 -53.49 13.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 122.109 0.957 . . . . 0.0 108.673 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 315' ' ' TYR . . . -68.21 -15.67 63.67 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.214 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -78.32 -59.17 2.89 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.753 -0.592 . . . . 0.0 111.931 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -118.36 32.84 5.93 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.022 -1.071 . . . . 0.0 112.348 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.561 ' HB3' ' CD1' ' A' ' 319' ' ' ILE . 1.0 OUTLIER -129.04 44.34 2.99 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.923 -1.111 . . . . 0.0 109.777 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 59.13 22.32 55.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 310' ' ' ALA . 0.3 OUTLIER 60.32 55.18 3.65 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.392 -1.064 . . . . 0.0 109.989 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.525 ' OE1' ' CA ' ' A' ' 316' ' ' GLU . 0.5 OUTLIER 66.7 35.77 5.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.122 -0.986 . . . . 0.0 109.741 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -48.18 62.58 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.899 0.857 . . . . 0.0 109.917 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -150.28 57.05 0.95 Allowed 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 121.51 0.671 . . . . 0.0 110.213 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 1.001 HG13 HD12 ' A' ' 356' ' ' ILE . 2.7 mp -127.47 131.43 70.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 109.795 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -90.24 105.41 17.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.077 -1.014 . . . . 0.0 109.595 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.747 HG22 HD13 ' A' ' 309' ' ' ILE . 17.3 p -90.03 120.51 31.29 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.393 -0.817 . . . . 0.0 110.721 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -140.34 77.45 1.61 Allowed 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.467 -0.77 . . . . 0.0 108.974 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.625 HD23 ' CA ' ' A' ' 302' ' ' ASN . 1.1 mp -92.0 163.18 14.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.618 -0.676 . . . . 0.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 5.4 t80 -49.01 131.77 15.2 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.224 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 324' ' ' TYR . 50.9 Cg_endo -84.74 52.79 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.951 1.501 . . . . 0.0 110.186 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -162.97 22.42 0.18 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 326' ' ' GLY . 15.6 p 53.04 104.65 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.338 -1.095 . . . . 0.0 110.15 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.769 HG23 HG21 ' A' ' 362' ' ' THR . 1.3 mt -74.6 -178.17 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.45 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.622 ' H ' HG22 ' A' ' 328' ' ' ILE . 5.1 mt-10 -169.8 103.12 0.32 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.611 0.72 . . . . 0.0 110.77 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.721 HG11 ' HB3' ' A' ' 367' ' ' ALA . 31.1 m -137.2 153.53 29.3 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.127 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -73.31 97.73 2.54 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.756 ' SD ' HD21 ' A' ' 301' ' ' LEU . 5.9 ttp -137.27 166.12 24.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.13 -0.981 . . . . 0.0 112.105 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.632 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 22.4 t-160 -103.26 113.86 65.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.523 ' O ' ' CG ' ' A' ' 338' ' ' LYS . 38.3 Cg_endo -63.11 -22.43 73.17 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.635 1.334 . . . . 0.0 111.904 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.674 ' C ' HD12 ' A' ' 335' ' ' LEU . 0.7 OUTLIER -83.54 -56.61 3.64 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.664 -1.273 . . . . 0.0 110.601 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 51.5 p -61.96 -38.15 87.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.134 -0.979 . . . . 0.0 110.636 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.793 HD11 ' CE1' ' A' ' 416' ' ' HIS . 23.1 mm -76.24 -33.93 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.11 -0.994 . . . . 0.0 110.157 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 334' ' ' PRO . 4.7 mttt -59.89 -36.25 76.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -42.93 60.26 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.032 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.816 ' CB ' HG21 ' A' ' 412' ' ' ILE . . . -61.54 -35.11 76.83 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.359 -0.838 . . . . 0.0 110.616 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.854 HG12 HG11 ' A' ' 308' ' ' VAL . 50.7 t -76.12 -34.13 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.207 -0.933 . . . . 0.0 109.646 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.755 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -70.66 -22.38 62.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 0.0 109.805 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -80.29 -23.75 40.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 109.969 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.556 ' SD ' HG21 ' A' ' 432' ' ' ILE . 7.8 mtt -85.0 -41.61 15.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.406 -0.809 . . . . 0.0 110.215 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.46 -22.79 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.885 . . . . 0.0 110.509 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 342' ' ' ALA . 65.3 t -74.16 -24.84 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.101 -0.999 . . . . 0.0 110.16 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -81.63 -31.06 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 110.248 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -89.54 -24.93 21.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 110.197 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -74.53 -39.43 62.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 110.031 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.534 ' O ' ' ND2' ' A' ' 353' ' ' ASN . 0.0 OUTLIER -88.71 -70.15 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -48.66 -59.08 3.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -87.45 142.56 18.08 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 350' ' ' ARG . 24.5 m-80 -139.79 81.27 1.81 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -1.103 . . . . 0.0 110.187 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -159.59 -48.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.57 ' CH2' ' HB2' ' A' ' 357' ' ' LYS . 1.4 t90 -178.65 141.9 0.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.25 . . . . 0.0 110.232 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 1.001 HD12 HG13 ' A' ' 319' ' ' ILE . 3.5 mt -107.23 163.16 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.73 . . . . 0.0 109.746 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.57 ' HB2' ' CH2' ' A' ' 355' ' ' TRP . 0.1 OUTLIER -140.73 93.69 2.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 0.0 109.957 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 1.074 ' CG1' HD11 ' A' ' 309' ' ' ILE . 37.7 t -97.15 105.01 16.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.139 -0.976 . . . . 0.0 109.784 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.2 t -124.88 160.1 29.6 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 110.992 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.55 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.4 t -142.92 130.47 21.26 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.602 -0.686 . . . . 0.0 109.212 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.567 ' C ' HG22 ' A' ' 362' ' ' THR . . . -123.76 -174.36 14.16 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.769 HG21 HG23 ' A' ' 328' ' ' ILE . 0.1 OUTLIER 170.13 163.74 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -1.106 . . . . 0.0 110.801 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.569 ' HB3' ' CD ' ' A' ' 364' ' ' PRO . 3.0 mt-10 -136.64 -168.87 0.2 Allowed Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.569 ' CD ' ' HB3' ' A' ' 363' ' ' GLU . 48.2 Cg_endo -84.79 31.04 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.21 1.11 . . . . 0.0 110.742 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 366' ' ' ARG . 57.3 t-20 -178.64 27.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 0.0 110.795 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.7 OUTLIER 165.63 107.1 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.156 -0.965 . . . . 0.0 111.149 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.721 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -106.63 137.89 43.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.277 -0.889 . . . . 0.0 109.214 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.687 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 64.6 p-90 -140.55 154.78 46.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.876 -1.14 . . . . 0.0 110.655 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.417 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 53.4 p90 -127.28 138.75 53.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.328 -0.857 . . . . 0.0 109.457 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 432' ' ' ILE . 8.1 pt20 -126.99 165.38 19.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.178 -0.951 . . . . 0.0 111.673 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 431' ' ' SER . 3.1 t -141.66 125.78 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.461 ' HG2' ' N ' ' A' ' 373' ' ' ASP . 30.0 tt0 -124.33 155.2 39.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.752 -1.217 . . . . 0.0 110.598 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.461 ' N ' ' HG2' ' A' ' 372' ' ' GLU . 2.4 p30 -148.14 148.26 30.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.407 -0.808 . . . . 0.0 110.492 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -86.5 95.15 9.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.2 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 168.86 162.94 22.02 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.07 124.59 10.17 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.014 1.534 . . . . 0.0 110.02 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -114.14 -90.86 1.81 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.867 HG13 HD11 ' A' ' 430' ' ' LEU . 65.7 mt -66.5 165.85 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.234 -1.156 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.957 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -128.97 178.91 1.45 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.253 -0.904 . . . . 0.0 110.003 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.957 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 43.1 Cg_endo -71.05 -48.92 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.94 1.495 . . . . 0.0 109.653 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' GLU . . . . . 0.427 ' OE2' ' HG2' ' A' ' 380' ' ' PRO . 1.4 mp0 -91.04 -19.87 22.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.423 -0.798 . . . . 0.0 110.393 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.785 ' HB3' ' HB3' ' A' ' 379' ' ' ALA . 59.0 tt0 -81.16 -19.44 43.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.34 -0.85 . . . . 0.0 110.919 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -27.69 61.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.067 -1.02 . . . . 0.0 110.646 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -86.81 -19.07 29.54 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.13 -0.981 . . . . 0.0 110.546 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 382' ' ' GLN . 1.5 m80 -48.18 -56.88 6.8 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.287 -0.883 . . . . 0.0 111.492 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.008 0 O-C-N 120.96 -1.087 . . . . 0.0 111.342 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.438 ' O ' HG12 ' A' ' 412' ' ' ILE . 1.3 pt . . . . . 0 N--CA 1.498 1.95 0 CA-C-O 121.05 0.452 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.401 ' O ' ' HB ' ' A' ' 412' ' ' ILE . 41.0 t -65.7 -18.43 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.395 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -62.34 -61.53 2.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.479 -0.763 . . . . 0.0 110.097 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.485 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.3 OUTLIER -54.23 -23.63 15.49 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.351 -0.843 . . . . 0.0 110.559 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.816 HG21 ' CB ' ' A' ' 340' ' ' ALA . 29.6 mm -68.18 -59.93 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.237 -0.914 . . . . 0.0 108.718 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 420' ' ' LEU . 38.2 t -67.55 -19.15 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.458 -0.776 . . . . 0.0 109.43 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.485 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 7.1 t70 -84.24 -25.33 29.52 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.52 -0.738 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.52 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.4 m120 -75.3 -23.63 57.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.793 ' CE1' HD11 ' A' ' 337' ' ' ILE . 45.1 m80 -95.75 -36.84 11.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.268 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 2.5 t-20 80.04 57.1 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 121.435 0.636 . . . . 0.0 110.838 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.56 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -123.53 -84.66 0.66 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.549 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.7 OUTLIER -179.3 165.99 1.46 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.133 . . . . 0.0 111.556 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.528 ' HB2' HG11 ' A' ' 413' ' ' VAL . 15.1 tp -152.22 83.2 1.26 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.437 ' OE1' ' HA ' ' A' ' 421' ' ' GLU . 4.1 mm-40 -101.0 166.51 10.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.915 -1.116 . . . . 0.0 111.643 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.7 HD23 HD11 ' A' ' 378' ' ' ILE . 1.0 OUTLIER -123.85 123.63 40.88 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.57 0.7 . . . . 0.0 110.231 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.437 ' O ' ' OG1' ' A' ' 424' ' ' THR . . . -125.98 151.66 17.89 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 91.8 m . . . . . 0 N--CA 1.49 1.56 0 O-C-N 120.874 -1.368 . . . . 0.0 111.715 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.495 2.599 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.867 HD11 HG13 ' A' ' 378' ' ' ILE . 1.7 tt -76.79 152.78 35.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.031 -1.276 . . . . 0.0 110.287 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.688 ' N ' HD23 ' A' ' 430' ' ' LEU . 53.4 p -159.7 127.27 4.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.572 -0.705 . . . . 0.0 110.126 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.556 HG21 ' SD ' ' A' ' 344' ' ' MET . 18.1 mm -90.1 134.89 27.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 85.96 2.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.483 -0.761 . . . . 0.0 109.522 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.417 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -88.68 138.43 31.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.265 -0.897 . . . . 0.0 109.87 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.687 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.4 m95 -117.81 154.6 31.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 122.458 1.123 . . . . 0.0 113.067 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.921 ' CD1' HD11 ' A' ' 301' ' ' LEU . 7.9 mt -142.08 114.9 6.46 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.56 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 47.5 Cg_endo -71.07 138.77 34.34 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 O-C-N 123.572 1.301 . . . . 0.0 112.628 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.632 HG22 HG12 ' A' ' 330' ' ' VAL . 7.0 t -112.25 64.75 0.73 Allowed Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 42.2 Cg_endo . . . . . 0 C--N 1.308 -1.604 0 O-C-N 123.924 1.486 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.539 ' HG2' ' CD2' ' A' ' 333' ' ' HIS . 48.9 Cg_endo . . . . . 0 C--O 1.215 -0.673 0 N-CA-C 110.633 -0.564 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.602 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -96.58 108.62 21.24 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.602 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.1 mt-10 -138.09 -152.55 0.43 Allowed 'General case' 0 C--N 1.276 -2.621 0 O-C-N 121.818 -0.551 . . . . 0.0 109.604 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.678 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 1.5 mmt -88.4 141.12 28.8 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 110.594 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.594 ' HB3' ' HE3' ' A' ' 332' ' ' MET . . . -154.15 157.82 39.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.396 -0.815 . . . . 0.0 110.985 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.918 ' O ' HG23 ' A' ' 304' ' ' VAL . 3.1 m-20 -90.85 117.23 29.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.41 -0.807 . . . . 0.0 110.059 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.526 HD11 ' CD1' ' A' ' 436' ' ' LEU . 8.4 mt -67.19 -24.17 65.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 110.015 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.607 ' OD1' HD23 ' A' ' 323' ' ' LEU . 9.0 t30 -84.77 -22.94 29.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.871 -1.143 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -83.72 -29.78 27.25 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.43 -0.794 . . . . 0.0 109.334 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 300' ' ' ASP . 19.3 t -78.7 -40.06 23.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.573 -0.705 . . . . 0.0 109.309 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.606 ' CD2' HG21 ' A' ' 341' ' ' VAL . 81.4 mt -72.62 -30.14 64.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.49 -0.756 . . . . 0.0 110.594 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 309' ' ' ILE . . . -61.03 -36.0 91.63 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -33.7 57.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.323 -1.104 . . . . 0.0 109.419 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.816 HG11 HG12 ' A' ' 341' ' ' VAL . 74.5 t -75.0 -18.93 16.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.505 -0.747 . . . . 0.0 109.244 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 1.068 ' CG1' HG11 ' A' ' 358' ' ' VAL . 5.0 mt -77.16 -46.16 29.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.96 -16.65 63.79 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.626 0.727 . . . . 0.0 109.482 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -74.92 -58.74 3.09 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.677 -0.639 . . . . 0.0 110.542 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.535 ' HB2' ' CG1' ' A' ' 345' ' ' VAL . 2.5 mm-40 -111.12 46.13 1.11 Allowed 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.753 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.643 ' HA ' ' CD1' ' A' ' 319' ' ' ILE . 0.6 OUTLIER -79.1 18.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.331 -0.855 . . . . 0.0 111.302 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 53.34 53.51 34.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 22.5 m-30 46.66 43.07 12.3 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.37 -1.076 . . . . 0.0 110.222 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.3 OUTLIER 65.12 35.92 7.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.906 -1.121 . . . . 0.0 109.667 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.576 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -69.06 -73.24 0.16 Allowed 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.552 -0.718 . . . . 0.0 109.786 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.576 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.2 mt-10 -167.91 78.63 0.16 Allowed 'General case' 0 C--N 1.27 -2.88 0 CA-C-O 121.548 0.689 . . . . 0.0 111.235 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.721 ' CG2' HG23 ' A' ' 358' ' ' VAL . 4.2 mm -97.05 121.99 48.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.764 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.486 ' HB3' ' HG3' ' A' ' 357' ' ' LYS . 0.4 OUTLIER -88.73 101.41 13.98 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 108.462 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 16.7 p -90.28 128.28 36.38 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.779 0.8 . . . . 0.0 111.951 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.98 78.15 1.34 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.607 HD23 ' OD1' ' A' ' 302' ' ' ASN . 5.0 mp -96.94 170.91 8.83 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.462 -0.774 . . . . 0.0 110.334 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.661 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 27.8 t80 -63.22 126.1 88.47 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.321 -0.862 . . . . 0.0 109.925 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.402 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.9 Cg_endo -78.71 71.06 7.1 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.938 1.494 . . . . 0.0 110.7 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 172.73 30.35 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.446 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 326' ' ' GLY . 1.7 p 45.99 100.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.162 -1.199 . . . . 0.0 110.499 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.637 HG22 ' H ' ' A' ' 329' ' ' GLU . 1.7 mt -71.12 -177.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 O-C-N 121.507 -0.746 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.637 ' H ' HG22 ' A' ' 328' ' ' ILE . 4.9 mt-10 -167.34 107.65 0.6 Allowed 'General case' 0 C--N 1.289 -2.034 0 O-C-N 121.391 -0.818 . . . . 0.0 111.259 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.678 ' C ' ' HE2' ' A' ' 298' ' ' MET . 7.7 m -137.49 157.45 34.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-O 121.494 0.664 . . . . 0.0 109.97 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 11.2 tptt -78.04 92.5 4.37 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.594 ' HE3' ' HB3' ' A' ' 299' ' ' ALA . 3.0 tmm? -150.03 158.74 44.47 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 110.761 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.732 ' CD2' ' HB2' ' A' ' 335' ' ' LEU . 5.9 t60 -91.07 126.6 54.66 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.454 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 39.1 Cg_endo -61.87 -19.83 67.11 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 123.527 1.277 . . . . 0.0 109.95 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.732 ' HB2' ' CD2' ' A' ' 333' ' ' HIS . 4.4 mt -75.73 -57.85 3.64 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.375 -0.828 . . . . 0.0 109.886 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.401 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 25.3 p -52.91 -47.67 67.81 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.588 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.529 ' CG1' ' HG3' ' A' ' 332' ' ' MET . 24.1 mm -63.44 -32.15 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.069 -1.02 . . . . 0.0 110.473 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 43.2 mttt -60.69 -40.31 91.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.12 -0.987 . . . . 0.0 109.546 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -42.12 65.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.802 -0.561 . . . . 0.0 111.223 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.736 ' HA ' HG12 ' A' ' 409' ' ' VAL . . . -67.2 -30.9 70.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.229 -0.92 . . . . 0.0 111.088 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.816 HG12 HG11 ' A' ' 308' ' ' VAL . 43.0 t -90.31 -25.4 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.525 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.67 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -82.99 -20.22 35.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 110.469 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -88.49 -19.4 26.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.144 -0.973 . . . . 0.0 110.613 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.745 ' SD ' HG21 ' A' ' 432' ' ' ILE . 58.2 mtt -78.21 -36.6 46.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.224 -0.923 . . . . 0.0 110.56 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 312' ' ' GLU . 12.2 p -88.57 -23.58 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.314 -0.866 . . . . 0.0 111.045 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 342' ' ' ALA . 12.1 t -66.19 -19.57 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.997 -1.065 . . . . 0.0 110.348 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -79.74 -33.73 40.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.452 ' O ' ' HA3' ' A' ' 352' ' ' GLY . . . -88.41 -27.79 21.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.083 -1.011 . . . . 0.0 110.751 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.31 -29.61 65.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.154 -0.966 . . . . 0.0 111.329 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 15.7 mtt-85 -77.83 -66.91 0.78 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.995 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 351' ' ' TYR . 13.4 m-30 -90.22 -19.85 23.7 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.149 -0.969 . . . . 0.0 111.129 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 353' ' ' ASN . . . -76.76 -98.15 0.17 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.33 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 352' ' ' GLY . 2.1 t30 76.56 46.7 0.08 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.459 -1.024 . . . . 0.0 109.92 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -130.49 -78.0 0.18 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -137.36 127.8 26.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -1.096 . . . . 0.0 109.687 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.543 ' HB ' HD13 ' A' ' 319' ' ' ILE . 44.9 mt -115.11 159.11 15.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 108.816 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.517 ' CD ' ' HB2' ' A' ' 372' ' ' GLU . 4.2 tttp -148.0 117.51 7.0 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.838 -1.164 . . . . 0.0 111.338 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 1.068 HG11 ' CG1' ' A' ' 309' ' ' ILE . 20.8 t -109.78 135.13 49.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.505 ' HA ' HD12 ' A' ' 323' ' ' LEU . 43.4 t -157.59 164.1 37.63 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.746 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -164.56 132.55 3.35 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -136.15 -163.72 10.0 Favored Glycine 0 C--N 1.29 -2.017 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.661 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.2 OUTLIER -160.02 166.47 29.91 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.277 -1.131 . . . . 0.0 110.417 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.578 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -146.24 -175.88 0.51 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 39.1 Cg_endo -64.93 111.03 1.61 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.449 1.236 . . . . 0.0 110.501 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.544 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 16.9 m120 59.34 40.72 20.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.732 -0.605 . . . . 0.0 110.795 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 1.4 mtt85 -176.83 98.42 0.05 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.156 -0.965 . . . . 0.0 111.192 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -97.53 171.6 8.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.135 -0.978 . . . . 0.0 108.391 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.608 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 22.7 p-90 -171.35 160.8 6.26 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.343 -1.473 . . . . 0.0 111.373 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 53.7 p90 -137.85 132.61 32.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.517 -0.74 . . . . 0.0 109.24 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.603 ' HG3' ' CZ3' ' A' ' 368' ' ' TRP . 22.9 mt-30 -121.53 168.78 11.34 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.06 -1.025 . . . . 0.0 112.353 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.471 ' HB ' HG22 ' A' ' 432' ' ' ILE . 65.2 t -140.08 148.92 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.517 ' HB2' ' CD ' ' A' ' 357' ' ' LYS . 9.1 mt-10 -147.05 148.15 31.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.061 -1.024 . . . . 0.0 110.429 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 0.5 OUTLIER -165.28 163.65 20.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.287 -0.883 . . . . 0.0 110.239 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -107.92 62.69 0.61 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.214 -0.928 . . . . 0.0 110.428 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -87.46 -148.5 14.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.29 -43.52 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.051 1.553 . . . . 0.0 110.211 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 112.05 -176.69 18.22 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.696 ' CD1' HD21 ' A' ' 430' ' ' LEU . 0.8 OUTLIER -99.14 134.68 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.115 -1.227 . . . . 0.0 109.551 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' A' ' 382' ' ' GLN . . . -50.11 165.3 0.33 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.454 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 47.1 Cg_endo -72.67 -38.9 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.079 1.568 . . . . 0.0 111.456 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.33 -45.13 9.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.028 -1.045 . . . . 0.0 110.662 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.645 ' HB3' ' HB3' ' A' ' 379' ' ' ALA . 16.6 tt0 -56.52 -18.43 11.58 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -50.44 -33.04 19.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.131 -0.98 . . . . 0.0 109.802 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -90.22 -20.07 23.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.324 -0.86 . . . . 0.0 109.692 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.405 ' ND1' ' N ' ' A' ' 385' ' ' HIS . 0.2 OUTLIER -96.05 25.15 4.99 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.66 HD13 HG21 ' A' ' 378' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.49 0 O-C-N 121.592 -0.692 . . . . 0.0 111.611 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.554 ' CD1' ' HG3' ' A' ' 410' ' ' GLN . 21.1 tt . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.331 0.586 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.736 HG12 ' HA ' ' A' ' 340' ' ' ALA . 32.8 m -56.36 -25.03 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.398 -0.814 . . . . 0.0 110.501 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.554 ' HG3' ' CD1' ' A' ' 408' ' ' ILE . 2.7 mt-30 -51.41 -43.52 62.0 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.192 -0.942 . . . . 0.0 109.761 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -28.8 66.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.476 -0.765 . . . . 0.0 110.301 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.661 HG12 ' HB2' ' A' ' 340' ' ' ALA . 1.5 mp -70.11 -63.04 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.194 -0.941 . . . . 0.0 108.802 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.899 HG11 ' HB2' ' A' ' 420' ' ' LEU . 59.5 t -62.6 -23.55 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 23.1 t70 -80.33 -29.95 38.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -80.84 -28.33 36.17 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.451 -0.781 . . . . 0.0 109.5 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.602 ' CD2' ' CE ' ' A' ' 296' ' ' MET . 39.1 m80 -86.95 -34.81 19.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.525 -0.735 . . . . 0.0 109.726 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 1.3 t-20 75.42 31.57 0.77 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.558 -0.714 . . . . 0.0 111.096 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.536 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -95.9 -83.51 1.65 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.584 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.4 OUTLIER -178.86 161.02 1.17 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -1.053 . . . . 0.0 110.671 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.899 ' HB2' HG11 ' A' ' 413' ' ' VAL . 67.2 tp -150.87 93.86 2.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.985 -1.072 . . . . 0.0 109.976 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.557 ' O ' ' CG ' ' A' ' 433' ' ' ARG . 37.3 mt-10 -125.0 140.47 52.89 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.081 -1.012 . . . . 0.0 109.973 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.792 HD13 HD11 ' A' ' 430' ' ' LEU . 0.6 OUTLIER -121.91 150.68 41.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.908 -1.12 . . . . 0.0 111.569 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 424' ' ' THR . . . -135.24 -165.82 10.87 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.769 HG22 ' C ' ' A' ' 429' ' ' GLY . 7.3 m . . . . . 0 N--CA 1.49 1.562 0 O-C-N 120.584 -1.539 . . . . 0.0 109.888 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.769 ' C ' HG22 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.492 2.383 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 422' ' ' LEU . 0.2 OUTLIER -153.52 149.4 27.65 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.084 -1.244 . . . . 0.0 109.397 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.649 ' H ' HD13 ' A' ' 430' ' ' LEU . 35.2 t -149.05 102.72 3.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.992 -1.068 . . . . 0.0 109.826 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.745 HG21 ' SD ' ' A' ' 344' ' ' MET . 9.6 tp -89.82 150.23 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 110.877 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' ARG . . . . . 0.557 ' CG ' ' O ' ' A' ' 421' ' ' GLU . 0.1 OUTLIER -133.98 106.06 7.05 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.646 -0.659 . . . . 0.0 109.67 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -96.57 146.3 24.95 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.413 -0.805 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.608 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 93.0 m95 -121.07 153.87 36.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.134 -0.979 . . . . 0.0 111.593 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.561 HD23 ' HB3' ' A' ' 416' ' ' HIS . 7.7 mt -141.12 124.73 10.09 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.536 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 43.5 Cg_endo -68.4 135.71 34.68 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.557 1.293 . . . . 0.0 111.266 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.458 HG22 HG12 ' A' ' 330' ' ' VAL . 3.2 t -104.13 106.91 55.51 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.931 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.306 -1.69 0 O-C-N 124.216 1.64 . . . . 0.0 109.945 -179.938 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.559 ' HG2' ' NE2' ' A' ' 333' ' ' HIS . 51.3 Cg_endo . . . . . 0 C--O 1.215 -0.643 0 CA-C-O 121.35 0.479 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.532 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -89.03 109.24 20.1 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.611 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 24.2 mt-10 -135.93 -157.13 0.77 Allowed 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.993 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.54 ' CG ' ' HE3' ' A' ' 331' ' ' LYS . 0.1 OUTLIER -87.64 141.91 28.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 0.0 110.624 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.564 ' HB3' ' HE3' ' A' ' 332' ' ' MET . . . -155.95 163.98 39.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.64 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.883 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.5 OUTLIER -101.58 114.65 28.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.339 -0.851 . . . . 0.0 110.471 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.624 HD12 HG21 ' A' ' 328' ' ' ILE . 14.3 mt -61.23 -25.03 66.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.84 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.73 ' OD1' HD23 ' A' ' 323' ' ' LEU . 40.4 t-20 -80.7 -23.7 39.35 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.197 -0.939 . . . . 0.0 109.365 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.76 -25.59 26.31 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 300' ' ' ASP . 5.5 t -83.69 -34.68 10.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.427 -0.795 . . . . 0.0 109.484 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 309' ' ' ILE . 59.3 mt -79.43 -28.37 41.7 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.346 -0.846 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.14 -35.85 91.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.785 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 4.3 mt-10 -80.67 -33.63 35.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.294 -1.121 . . . . 0.0 109.79 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 304' ' ' VAL . 27.7 t -77.29 -19.99 14.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.785 HD11 ' CG1' ' A' ' 358' ' ' VAL . 0.9 OUTLIER -76.11 -51.41 20.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.419 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -77.41 -15.41 59.37 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.404 -0.81 . . . . 0.0 109.456 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.785 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -70.72 -62.49 1.37 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.401 ' OE2' ' O ' ' A' ' 311' ' ' ALA . 9.8 mm-40 -123.05 31.08 6.13 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.586 -1.246 . . . . 0.0 113.351 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.662 ' O ' HD11 ' A' ' 319' ' ' ILE . 2.6 m -111.26 44.31 1.34 Allowed 'General case' 0 C--N 1.289 -2.052 0 O-C-N 120.641 -1.287 . . . . 0.0 108.964 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 69.8 26.52 74.3 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.496 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 4.8 m-85 59.24 47.7 11.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -1.046 . . . . 0.0 110.322 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 68.42 35.61 3.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.107 -0.996 . . . . 0.0 109.621 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 14.3 tpp85 -69.06 -81.36 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.642 0.734 . . . . 0.0 110.625 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 318' ' ' GLU . 4.3 pt-20 -126.58 72.93 1.36 Allowed 'General case' 0 C--N 1.275 -2.633 0 O-C-N 121.615 -0.678 . . . . 0.0 111.149 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.904 HG13 HD12 ' A' ' 356' ' ' ILE . 2.6 mp -132.6 138.19 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.002 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -99.48 103.88 15.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.846 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.513 HG22 HD13 ' A' ' 309' ' ' ILE . 35.7 p -89.73 122.04 32.45 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.257 -0.902 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -138.81 79.39 1.73 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.73 HD23 ' OD1' ' A' ' 302' ' ' ASN . 1.2 mp -88.66 150.28 23.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.478 -0.764 . . . . 0.0 110.386 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.572 ' HB3' ' CD1' ' A' ' 328' ' ' ILE . 36.6 t80 -37.21 145.3 0.27 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.599 -0.688 . . . . 0.0 109.928 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.547 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 51.7 Cg_endo -83.0 59.03 6.56 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 O-C-N 123.966 1.508 . . . . 0.0 110.444 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . 179.74 17.1 0.03 OUTLIER Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.738 -1.22 . . . . 0.0 111.242 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 2.0 m 58.47 115.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.666 -1.49 . . . . 0.0 110.018 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.624 HG21 HD12 ' A' ' 301' ' ' LEU . 2.0 mm -69.48 178.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.542 ' H ' HG22 ' A' ' 328' ' ' ILE . 4.9 mt-10 -170.87 106.09 0.26 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.609 0.719 . . . . 0.0 109.971 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.722 HG12 HG22 ' A' ' 438' ' ' VAL . 7.8 m -148.16 168.46 3.89 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-O 121.648 0.737 . . . . 0.0 110.539 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -85.09 94.26 8.81 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.576 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 4.7 tmm? -145.17 157.51 44.06 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 110.592 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.616 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 22.2 t-160 -82.79 111.65 31.26 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.449 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 37.9 Cg_endo -62.16 -19.3 66.14 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.717 1.377 . . . . 0.0 110.058 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.616 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -81.3 -47.21 13.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.937 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -65.06 -41.33 95.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.448 -0.782 . . . . 0.0 109.982 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.58 HD11 ' CE1' ' A' ' 416' ' ' HIS . 19.6 mm -71.3 -33.67 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.909 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.527 ' HG3' HG13 ' A' ' 304' ' ' VAL . 7.4 mttm -59.06 -60.94 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.706 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -37.15 86.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.482 -0.761 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.551 ' CB ' HG21 ' A' ' 412' ' ' ILE . . . -58.71 -35.56 72.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.92 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.553 HG12 ' CG1' ' A' ' 308' ' ' VAL . 48.2 t -88.33 -21.23 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 111.136 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 308' ' ' VAL . . . -77.61 -28.74 51.59 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.092 -1.005 . . . . 0.0 111.993 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ASN . . . . . 0.428 HD21 ' HA ' ' A' ' 340' ' ' ALA . 21.9 p30 -89.7 -18.67 25.97 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.786 -1.196 . . . . 0.0 111.793 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.535 ' HG2' ' HA ' ' A' ' 341' ' ' VAL . 3.6 ptp -88.57 -20.93 24.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.73 -1.231 . . . . 0.0 111.077 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.432 ' N ' ' HG3' ' A' ' 344' ' ' MET . 8.2 p -90.6 -20.6 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.086 -1.009 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 342' ' ' ALA . 40.4 t -69.43 -20.16 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.047 -1.033 . . . . 0.0 110.994 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -63.83 -31.28 72.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.12 -0.987 . . . . 0.0 110.516 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.557 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -89.73 -21.3 22.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 110.738 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -82.26 -68.72 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.075 -1.015 . . . . 0.0 110.656 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -57.11 -66.9 0.38 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.191 -0.943 . . . . 0.0 110.702 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.53 -39.88 36.61 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.165 -0.959 . . . . 0.0 110.491 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -71.53 163.95 54.1 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -164.38 38.18 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.34 -1.094 . . . . 0.0 109.855 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -123.11 -67.14 0.22 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.6 OUTLIER -173.0 137.26 0.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.164 -1.197 . . . . 0.0 110.386 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.904 HD12 HG13 ' A' ' 319' ' ' ILE . 5.3 mt -107.52 167.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -0.76 . . . . 0.0 109.274 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 2.2 tttp -148.93 116.5 6.21 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.027 -1.045 . . . . 0.0 110.822 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.785 ' CG1' HD11 ' A' ' 309' ' ' ILE . 17.5 t -115.51 75.94 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 108.974 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.3 p -104.69 132.06 51.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.818 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.443 ' H ' HD12 ' A' ' 323' ' ' LEU . 28.8 t -122.0 163.58 19.11 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.55 -0.719 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.573 ' C ' HG22 ' A' ' 362' ' ' THR . . . -159.45 -153.37 6.82 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.573 HG22 ' C ' ' A' ' 361' ' ' GLY . 0.0 OUTLIER -179.65 171.38 1.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.43 -1.041 . . . . 0.0 109.901 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.568 ' CB ' ' CD ' ' A' ' 364' ' ' PRO . 3.8 mt-10 -131.91 -169.54 0.21 Allowed Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.193 -0.942 . . . . 0.0 109.809 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 363' ' ' GLU . 48.3 Cg_endo -84.74 30.0 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.447 0 O-C-N 123.582 1.306 . . . . 0.0 110.963 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 366' ' ' ARG . 3.8 p30 167.86 34.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.31 -0.869 . . . . 0.0 110.18 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 166.75 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.383 -0.823 . . . . 0.0 109.9 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.672 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -97.74 162.35 13.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.164 -0.96 . . . . 0.0 109.313 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.674 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 45.3 p-90 -167.31 171.65 10.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.706 -1.246 . . . . 0.0 111.005 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.6 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 20.3 p90 -141.8 143.3 33.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.226 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 0.1 OUTLIER -132.88 145.62 51.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.133 -0.979 . . . . 0.0 111.725 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 21.1 t -127.11 132.62 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -123.11 158.56 30.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.945 -1.097 . . . . 0.0 110.39 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 11.2 p-10 -150.88 140.25 21.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.366 -0.834 . . . . 0.0 110.215 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.41 177.38 9.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.335 -0.853 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 107.23 -158.6 14.99 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.17 163.0 40.04 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.947 1.499 . . . . 0.0 110.987 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' GLY . . . . . 0.434 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -105.52 -153.13 21.2 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.68 ' N ' HD13 ' A' ' 378' ' ' ILE . 1.6 mm -89.87 93.25 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.138 -1.213 . . . . 0.0 110.112 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.763 ' HB3' ' NE2' ' A' ' 382' ' ' GLN . . . -46.61 165.9 0.19 Allowed Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.808 -1.182 . . . . 0.0 109.233 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.489 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 46.6 Cg_endo -73.1 -19.55 22.72 Favored 'Trans proline' 0 C--N 1.294 -2.301 0 O-C-N 123.482 1.254 . . . . 0.0 110.231 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -84.4 -43.67 14.47 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.306 -0.871 . . . . 0.0 111.331 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.763 ' NE2' ' HB3' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -83.89 -34.69 24.49 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.087 -1.008 . . . . 0.0 111.189 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.623 ' CB ' HG22 ' A' ' 378' ' ' ILE . 0.0 OUTLIER -60.07 -19.61 53.91 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.684 -1.26 . . . . 0.0 109.572 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.475 ' HG2' ' HD2' ' A' ' 383' ' ' ARG . 33.2 mmtt -86.86 -23.64 25.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.554 -0.716 . . . . 0.0 110.61 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.657 ' CE1' ' HA ' ' A' ' 382' ' ' GLN . 0.0 OUTLIER -118.45 29.95 7.48 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.983 -1.073 . . . . 0.0 111.49 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 13.1 tp . . . . . 0 C--N 1.303 -1.43 0 O-C-N 121.027 -1.046 . . . . 0.0 108.713 -179.98 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 412' ' ' ILE . 7.1 tp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.367 0.603 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.645 ' HA ' HD13 ' A' ' 412' ' ' ILE . 10.4 t -138.44 5.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 109.485 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 414' ' ' ASP . 16.6 mt-30 -90.08 -48.51 7.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.416 -0.802 . . . . 0.0 109.608 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -66.4 -20.98 66.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.444 -0.785 . . . . 0.0 109.738 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.645 HD13 ' HA ' ' A' ' 409' ' ' VAL . 1.1 mp -68.57 -72.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.248 -0.908 . . . . 0.0 108.726 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 419' ' ' MET . 12.6 t -60.35 -23.22 27.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 21.5 t0 -75.9 -30.18 58.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.459 -0.775 . . . . 0.0 109.728 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.509 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 2.5 m-20 -77.18 -19.93 56.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.207 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.58 ' CE1' HD11 ' A' ' 337' ' ' ILE . 44.0 m80 -89.79 -28.56 19.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.557 -0.714 . . . . 0.0 109.756 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.5 OUTLIER 78.14 4.6 2.77 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.677 -0.639 . . . . 0.0 110.002 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.566 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -66.52 -91.36 0.05 OUTLIER Glycine 0 N--CA 1.482 1.727 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.565 ' O ' HG11 ' A' ' 413' ' ' VAL . 1.4 ttp 178.96 166.31 0.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -1.101 . . . . 0.0 111.413 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.464 ' HB2' HG11 ' A' ' 413' ' ' VAL . 25.1 tp -151.96 90.96 1.57 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.396 -0.815 . . . . 0.0 108.904 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -112.24 143.12 43.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.941 -1.099 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.506 ' HG ' HD12 ' A' ' 432' ' ' ILE . 0.2 OUTLIER -105.72 111.65 24.41 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 109.747 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.461 ' O ' ' OG1' ' A' ' 424' ' ' THR . . . -98.3 162.78 20.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 423' ' ' GLY . 4.6 m . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.11 -1.229 . . . . 0.0 110.674 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.549 ' CD1' HG12 ' A' ' 378' ' ' ILE . 0.5 OUTLIER -78.62 135.46 37.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -1.209 . . . . 0.0 110.949 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 28.6 m -148.5 122.14 9.21 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.506 HD12 ' HG ' ' A' ' 422' ' ' LEU . 1.1 tt -89.39 128.02 41.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.062 -1.024 . . . . 0.0 110.609 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' ARG . . . . . 0.464 ' HG3' ' HG3' ' A' ' 370' ' ' GLN . 0.5 OUTLIER -107.13 99.67 9.21 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.44 -0.788 . . . . 0.0 110.059 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.6 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -90.32 138.5 31.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.674 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 89.4 m95 -114.97 159.32 20.89 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.284 1.04 . . . . 0.0 113.088 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.529 ' CD1' HD11 ' A' ' 301' ' ' LEU . 32.0 mt -146.33 123.11 5.85 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.566 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 44.4 Cg_endo -74.17 141.83 29.82 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 123.479 1.252 . . . . 0.0 112.18 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.722 HG22 HG12 ' A' ' 330' ' ' VAL . 55.0 t -101.8 134.25 20.27 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.758 -0.588 . . . . 0.0 109.862 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 C--N 1.307 -1.637 0 O-C-N 123.803 1.422 . . . . 0.0 109.955 179.95 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.685 ' HB3' ' CD2' ' A' ' 333' ' ' HIS . 48.1 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 CA-C-O 121.323 0.468 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.617 ' HE1' ' HB3' ' A' ' 415' ' ' ASN . 0.8 OUTLIER 35.78 51.69 0.73 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.699 1.238 . . . . 0.0 110.16 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.654 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.4 OUTLIER -126.5 -156.98 0.77 Allowed 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.24 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.452 ' SD ' ' OE1' ' A' ' 329' ' ' GLU . 0.7 OUTLIER -86.81 125.17 33.77 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.414 -1.429 . . . . 0.0 110.626 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -137.99 158.55 44.1 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.586 0.708 . . . . 0.0 111.572 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.835 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.9 OUTLIER -102.19 112.75 25.55 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.573 ' CD2' ' HE1' ' A' ' 332' ' ' MET . 14.1 mt -60.34 -24.87 65.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.092 -1.005 . . . . 0.0 110.472 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.965 ' HA ' HD23 ' A' ' 323' ' ' LEU . 7.7 m-20 -79.52 -23.39 42.94 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.829 -1.17 . . . . 0.0 109.107 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -83.12 -30.37 27.96 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.479 0.657 . . . . 0.0 109.678 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 300' ' ' ASP . 2.9 t -79.02 -31.87 15.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.44 -0.787 . . . . 0.0 109.69 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 309' ' ' ILE . 97.9 mt -77.64 -31.78 52.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 110.869 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.21 -38.36 95.81 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.471 -1.347 . . . . 0.0 109.897 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 48.4 mt-10 -76.32 -34.73 59.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -1.15 . . . . 0.0 109.7 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.787 HG11 ' CG1' ' A' ' 341' ' ' VAL . 63.6 t -77.48 -19.13 14.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.687 0.756 . . . . 0.0 109.701 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.778 ' CD1' HG11 ' A' ' 358' ' ' VAL . 0.0 OUTLIER -75.09 -43.85 44.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -90.37 -16.8 28.44 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.506 0.669 . . . . 0.0 110.377 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -73.25 -41.95 63.09 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.586 -0.696 . . . . 0.0 112.261 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 312' ' ' GLU . 1.4 pp20? -115.82 17.24 16.14 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.753 -1.179 . . . . 0.0 112.354 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.563 ' HB2' HD11 ' A' ' 319' ' ' ILE . 15.4 t -102.99 -39.47 6.9 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.391 1.091 . . . . 0.0 109.621 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 118.12 -40.29 2.35 Favored Glycine 0 C--N 1.263 -3.491 0 N-CA-C 107.326 -2.31 . . . . 0.0 107.326 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 5.8 t80 174.65 37.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 0.2 OUTLIER 58.8 47.59 12.47 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.488 ' O ' ' HG3' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -67.75 -39.7 84.15 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.449 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 317' ' ' ARG . 39.0 mt-10 -154.97 51.74 0.61 Allowed 'General case' 0 C--N 1.273 -2.751 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.437 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.798 HG23 HG23 ' A' ' 358' ' ' VAL . 5.5 mt -118.9 129.34 75.24 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.949 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.542 ' HB3' ' HD3' ' A' ' 357' ' ' LYS . 37.1 tt0 -97.19 103.53 15.47 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.593 HG22 ' CD1' ' A' ' 309' ' ' ILE . 24.2 p -89.12 128.3 35.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 111.871 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.57 78.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.965 HD23 ' HA ' ' A' ' 302' ' ' ASN . 1.9 mp -95.53 159.91 14.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.471 -0.768 . . . . 0.0 111.148 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.637 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 83.5 t80 -47.94 121.44 8.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.622 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.64 78.96 1.96 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.903 1.475 . . . . 0.0 110.718 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 173.15 29.29 0.03 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.524 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 326' ' ' GLY . 2.1 p 44.28 98.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.069 -1.253 . . . . 0.0 110.001 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.561 HG22 ' H ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -72.43 -179.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.463 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.561 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.3 mt-10 -171.39 105.66 0.22 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.68 0.752 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 1.004 HG11 ' HB3' ' A' ' 367' ' ' ALA . 31.0 m -137.06 158.35 36.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 O-C-N 121.67 -0.644 . . . . 0.0 109.626 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.1 OUTLIER -72.36 91.81 1.37 Allowed 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.831 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.71 ' SD ' HD13 ' A' ' 436' ' ' LEU . 3.8 ttp -134.81 168.15 19.57 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 111.255 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.685 ' CD2' ' HB3' ' A' ' 295' ' ' PRO . 19.0 t-160 -101.85 118.09 60.2 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 37.2 Cg_endo -59.66 -21.72 64.05 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.41 1.216 . . . . 0.0 110.37 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.619 ' HB2' ' NE2' ' A' ' 333' ' ' HIS . 0.3 OUTLIER -83.4 -68.2 0.73 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.461 -0.774 . . . . 0.0 110.355 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 333' ' ' HIS . 0.4 OUTLIER -46.55 -44.51 17.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.484 -0.76 . . . . 0.0 110.007 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.836 HD11 ' CE1' ' A' ' 416' ' ' HIS . 37.9 mm -65.16 -46.23 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.393 -0.817 . . . . 0.0 109.53 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 337' ' ' ILE . 0.0 OUTLIER -47.04 -41.98 17.62 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.083 -1.011 . . . . 0.0 108.492 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 343' ' ' ASN . 17.2 mtt180 -73.03 -34.93 66.63 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.433 0.635 . . . . 0.0 110.314 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.816 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -62.23 -32.62 73.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.763 . . . . 0.0 110.849 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.787 ' CG1' HG11 ' A' ' 308' ' ' VAL . 44.7 t -85.19 -63.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.127 -0.983 . . . . 0.0 110.063 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.593 ' HA ' ' CG2' ' A' ' 345' ' ' VAL . . . -51.39 -19.45 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 110.687 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ASN . . . . . 0.574 ' O ' HG12 ' A' ' 346' ' ' VAL . 16.8 t-20 -76.2 -42.48 46.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.137 -0.977 . . . . 0.0 111.412 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.1 mtt -79.57 -24.89 41.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.975 -1.078 . . . . 0.0 111.413 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 341' ' ' VAL . 16.7 m -88.56 -19.74 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.906 -1.121 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 343' ' ' ASN . 4.7 p -58.72 -36.16 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.916 -1.115 . . . . 0.0 110.544 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.437 ' N ' ' CG1' ' A' ' 346' ' ' VAL . 0.9 OUTLIER -65.3 -54.38 29.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.897 . . . . 0.0 110.357 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.489 ' O ' ' CA ' ' A' ' 352' ' ' GLY . . . -66.55 -19.82 65.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.891 . . . . 0.0 110.503 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -74.76 -50.32 17.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 110.485 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.08 -73.19 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.915 . . . . 0.0 110.682 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' TYR . . . . . 0.444 ' O ' ' O ' ' A' ' 352' ' ' GLY . 12.1 m-85 -82.54 -44.6 15.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.225 -0.922 . . . . 0.0 110.828 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 348' ' ' ALA . . . 55.59 103.58 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 353' ' ' ASN . 26.6 t-20 -113.24 24.74 11.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -1.194 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 355' ' ' TRP . . . 178.64 -73.56 0.07 OUTLIER Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.642 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER 178.36 164.81 0.76 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.14 -1.212 . . . . 0.0 109.78 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.543 HD12 HG13 ' A' ' 319' ' ' ILE . 0.9 OUTLIER -112.45 163.01 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.279 -0.888 . . . . 0.0 111.183 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.642 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -142.23 124.08 15.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.825 . . . . 0.0 110.002 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.798 HG23 HG23 ' A' ' 319' ' ' ILE . 21.7 t -119.92 83.15 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.406 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.534 ' HA ' HD12 ' A' ' 323' ' ' LEU . 47.2 t -113.53 166.56 11.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.319 -0.863 . . . . 0.0 110.528 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.552 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.6 t -156.77 160.07 38.89 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.52 -0.737 . . . . 0.0 109.849 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -149.22 -162.52 10.4 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.637 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -170.62 174.89 4.85 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.905 -1.35 . . . . 0.0 110.782 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.556 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 2.6 mt-10 -160.41 -178.65 0.92 Allowed Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 38.4 Cg_endo -64.11 135.31 46.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.475 1.25 . . . . 0.0 109.908 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.553 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 5.0 p-10 38.74 33.65 0.07 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.614 -0.678 . . . . 0.0 110.699 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.553 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 3.6 mtt180 -172.67 99.93 0.14 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.393 -0.817 . . . . 0.0 111.265 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 1.004 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -110.32 154.8 22.99 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.1 -1.0 . . . . 0.0 108.659 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.621 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 45.9 p-90 -153.4 177.49 10.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.548 -1.345 . . . . 0.0 111.649 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.783 ' HE2' HD11 ' A' ' 436' ' ' LEU . 32.7 p90 -150.44 153.56 36.14 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -145.85 152.87 40.19 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.853 -1.154 . . . . 0.0 111.673 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.564 ' O ' HG22 ' A' ' 432' ' ' ILE . 88.0 t -122.73 141.31 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.529 ' HB2' ' HG2' ' A' ' 357' ' ' LYS . 0.8 OUTLIER -121.62 154.93 36.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.061 -1.024 . . . . 0.0 110.732 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -155.0 140.04 17.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -107.72 109.36 20.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 0.0 110.385 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -177.37 -107.32 0.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.13 -172.03 0.8 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.829 1.436 . . . . 0.0 110.671 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 430' ' ' LEU . . . -144.09 -150.76 5.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.454 HD11 HD21 ' A' ' 430' ' ' LEU . 11.3 mt -118.55 161.25 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.179 -1.189 . . . . 0.0 110.076 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.842 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -112.02 176.47 1.49 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.094 -1.004 . . . . 0.0 110.555 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.842 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 47.2 Cg_endo -75.64 -45.04 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.092 1.575 . . . . 0.0 110.643 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -81.34 -35.73 30.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 110.514 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.831 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 5.2 mp0 -61.29 -21.49 63.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.268 -0.895 . . . . 0.0 110.307 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -59.58 -30.79 68.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.879 . . . . 0.0 109.987 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.56 -35.39 39.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 385' ' ' HIS . 2.8 m-70 -67.19 -25.73 66.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.203 -0.936 . . . . 0.0 110.417 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.105 -0.997 . . . . 0.0 110.21 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.878 HD12 HG12 ' A' ' 409' ' ' VAL . 1.7 pp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.878 HG12 HD12 ' A' ' 408' ' ' ILE . 1.4 p -37.73 -33.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.326 -0.859 . . . . 0.0 110.923 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 408' ' ' ILE . 1.3 mm100 -65.9 -55.7 15.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.042 -1.036 . . . . 0.0 109.739 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.504 ' HD3' ' ND2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -56.57 -20.77 22.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.816 HG21 ' HB2' ' A' ' 340' ' ' ALA . 25.4 mm -72.11 -65.91 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 108.569 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.907 HG21 HD13 ' A' ' 420' ' ' LEU . 86.5 t -59.99 -19.87 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.538 -0.726 . . . . 0.0 109.703 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -82.22 -32.83 29.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.867 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.617 ' HB3' ' HE1' ' A' ' 296' ' ' MET . 1.4 m-20 -78.7 -28.06 45.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.481 -0.762 . . . . 0.0 109.378 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.836 ' CE1' HD11 ' A' ' 337' ' ' ILE . 41.1 m80 -86.34 -39.03 16.86 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.881 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 1.0 OUTLIER 79.88 45.44 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.393 0.616 . . . . 0.0 110.543 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 419' ' ' MET . . . -107.85 -85.81 1.78 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.57 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.4 ttp 177.99 169.88 0.72 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.321 -1.105 . . . . 0.0 111.019 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.907 HD13 HG21 ' A' ' 413' ' ' VAL . 16.1 tp -151.46 89.34 1.49 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.769 . . . . 0.0 109.133 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.38 159.47 15.11 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.095 -1.003 . . . . 0.0 111.525 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 422' ' ' LEU . 3.0 pp -134.05 119.45 18.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.606 -0.684 . . . . 0.0 109.535 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 430' ' ' LEU . . . -131.14 170.72 21.27 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.536 ' OG1' ' CD2' ' A' ' 430' ' ' LEU . 88.0 m . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.057 -1.261 . . . . 0.0 110.448 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 423' ' ' GLY . 0.2 OUTLIER -68.06 114.89 6.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.185 -1.185 . . . . 0.0 110.298 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.525 ' HB2' ' CG ' ' A' ' 372' ' ' GLU . 14.6 t -128.32 120.87 27.93 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.429 -0.794 . . . . 0.0 110.312 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 371' ' ' VAL . 1.2 tt -91.73 130.68 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.52 129.46 56.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.999 -1.063 . . . . 0.0 110.771 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -120.07 128.68 53.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.273 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.621 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.8 m95 -102.44 155.62 18.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.94 -1.1 . . . . 0.0 111.591 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.783 HD11 ' HE2' ' A' ' 369' ' ' PHE . 14.6 mt -145.59 129.04 8.41 Favored Pre-proline 0 N--CA 1.485 1.276 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.02 142.23 41.91 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.721 1.38 . . . . 0.0 110.069 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.616 HG22 HG12 ' A' ' 330' ' ' VAL . 2.6 t -73.35 -47.35 7.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.152 -0.967 . . . . 0.0 110.498 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 438' ' ' VAL . 58.0 Cg_endo . . . . . 0 C--N 1.314 -1.289 0 O-C-N 123.51 1.269 . . . . 0.0 110.333 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.581 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 53.3 Cg_endo . . . . . 0 C--O 1.214 -0.714 0 CA-C-O 121.778 0.657 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.688 ' HE3' ' NE2' ' A' ' 416' ' ' HIS . 0.3 OUTLIER 28.83 80.57 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.416 1.103 . . . . 0.0 112.015 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 14.2 mt-10 -148.63 -149.06 0.28 Allowed 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.507 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -87.64 128.81 35.28 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.74 -1.225 . . . . 0.0 109.527 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . -136.01 158.29 44.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.404 -0.81 . . . . 0.0 111.67 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 304' ' ' VAL . 4.3 m-20 -95.12 117.51 30.33 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.564 HD11 HD12 ' A' ' 436' ' ' LEU . 6.7 mt -63.86 -23.64 67.43 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.05 -1.031 . . . . 0.0 110.191 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.852 ' HA ' HD23 ' A' ' 323' ' ' LEU . 29.9 m-20 -79.94 -19.57 47.69 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.904 -1.123 . . . . 0.0 108.569 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.94 -37.21 19.29 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.433 0.635 . . . . 0.0 109.463 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.814 ' O ' HG23 ' A' ' 308' ' ' VAL . 22.0 t -74.94 -30.79 24.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.528 -0.732 . . . . 0.0 109.514 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 25.2 mt -78.65 -36.38 43.96 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.285 -0.884 . . . . 0.0 110.428 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -62.06 -39.1 97.16 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.683 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 1.0 OUTLIER -71.88 -33.66 68.54 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.231 -1.158 . . . . 0.0 108.599 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 304' ' ' VAL . 93.5 t -75.57 -18.77 15.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.811 0.815 . . . . 0.0 108.9 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.665 HG13 HG21 ' A' ' 321' ' ' THR . 0.3 OUTLIER -72.71 -45.1 58.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 122.021 0.915 . . . . 0.0 108.648 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.428 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -90.95 -15.86 29.03 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 121.4 -0.813 . . . . 0.0 109.795 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -61.61 -64.81 0.82 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.658 -0.651 . . . . 0.0 111.297 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.434 ' HG3' ' C ' ' A' ' 311' ' ' ALA . 94.9 mt-10 -142.98 39.2 1.47 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.088 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.642 ' O ' HD11 ' A' ' 319' ' ' ILE . 19.4 m -88.31 42.74 1.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.892 -1.13 . . . . 0.0 109.161 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.58 ' O ' ' CG ' ' A' ' 317' ' ' ARG . . . 74.07 13.87 80.77 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.58 ' CB ' ' O ' ' A' ' 314' ' ' GLY . 4.0 t80 78.88 63.3 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.893 -0.769 . . . . 0.0 108.926 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.576 ' CG ' ' O ' ' A' ' 315' ' ' TYR . 6.2 pt-20 41.74 45.73 3.11 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.126 0.965 . . . . 0.0 109.907 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.58 ' CG ' ' O ' ' A' ' 314' ' ' GLY . 6.4 mmt180 -68.36 -89.74 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 121.771 0.796 . . . . 0.0 109.808 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.25 65.55 1.41 Allowed 'General case' 0 C--N 1.272 -2.778 0 CA-C-O 121.583 0.706 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.644 ' CG2' HG23 ' A' ' 358' ' ' VAL . 2.6 mp -101.27 148.37 7.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 121.52 -0.737 . . . . 0.0 110.113 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -114.28 105.46 13.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.164 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.772 HG22 ' HB ' ' A' ' 358' ' ' VAL . 28.2 p -90.55 122.04 33.02 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 111.38 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -129.69 78.36 1.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.852 HD23 ' HA ' ' A' ' 302' ' ' ASN . 1.8 mp -93.78 174.18 7.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 111.215 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.629 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 20.8 t80 -61.23 137.84 94.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.651 -0.656 . . . . 0.0 109.906 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.569 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 53.1 Cg_endo -82.46 61.97 7.78 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.963 1.507 . . . . 0.0 110.547 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 178.82 22.2 0.03 OUTLIER Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.777 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 326' ' ' GLY . 2.1 m 55.12 107.3 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.891 -1.358 . . . . 0.0 110.281 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.546 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -81.63 -177.51 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.122 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 1.9 mt-10 -170.92 108.79 0.31 Allowed 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.841 0.829 . . . . 0.0 111.107 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 436' ' ' LEU . 25.3 m -131.3 159.17 43.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 O-C-N 121.72 -0.613 . . . . 0.0 109.463 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 3.3 tptt -76.4 93.57 3.51 Favored 'General case' 0 C--N 1.288 -2.104 0 C-N-CA 118.681 -1.208 . . . . 0.0 108.909 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.733 ' HE1' HG21 ' A' ' 337' ' ' ILE . 0.0 OUTLIER -134.73 -174.46 3.59 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.818 0.818 . . . . 0.0 111.326 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.601 ' CB ' ' NE2' ' A' ' 416' ' ' HIS . 18.6 t-160 -113.82 117.56 44.07 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 37.1 Cg_endo -59.24 -26.58 82.32 Favored 'Trans proline' 0 C--N 1.289 -2.563 0 O-C-N 123.105 1.055 . . . . 0.0 110.391 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.637 ' C ' HD12 ' A' ' 335' ' ' LEU . 0.5 OUTLIER -83.09 -66.47 0.89 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.273 -0.892 . . . . 0.0 110.819 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.546 ' N ' ' HG ' ' A' ' 335' ' ' LEU . 3.5 m -52.88 -42.76 65.6 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.941 -1.099 . . . . 0.0 110.624 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.768 HD11 ' CG ' ' A' ' 416' ' ' HIS . 29.6 mm -64.17 -44.45 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.591 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 0.7 OUTLIER -50.72 -46.77 59.18 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.707 -1.246 . . . . 0.0 109.284 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -43.17 93.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 0.0 110.121 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 1.023 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -47.29 -40.99 18.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.514 -0.741 . . . . 0.0 110.576 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.621 ' CG1' HG11 ' A' ' 308' ' ' VAL . 40.2 t -80.04 -32.14 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 110.47 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.969 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -66.78 -23.65 66.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.26 -0.9 . . . . 0.0 110.364 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -66.99 -29.88 69.84 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.147 -0.971 . . . . 0.0 110.489 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 42.0 mtt -82.04 -42.9 18.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.208 -0.933 . . . . 0.0 110.498 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.569 HG21 ' HA ' ' A' ' 313' ' ' SER . 3.7 p -67.86 -19.6 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.474 -0.766 . . . . 0.0 110.776 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 342' ' ' ALA . 53.0 t -67.99 -20.08 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.14 -0.975 . . . . 0.0 110.657 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.2 -57.38 4.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 110.366 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.422 ' O ' ' HA2' ' A' ' 352' ' ' GLY . . . -79.72 -19.97 47.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.46 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 345' ' ' VAL . . . -74.06 -25.11 59.65 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 110.413 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -73.71 -67.94 0.55 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.204 -0.935 . . . . 0.0 110.295 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -30.45 51.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 110.217 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 348' ' ' ALA . . . 82.95 106.5 0.48 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 374' ' ' ASP . 10.5 m120 -97.5 -57.4 2.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.285 -1.127 . . . . 0.0 110.466 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . 150.99 -17.38 0.93 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.607 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 37.7 t90 -154.37 130.87 10.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.842 -1.387 . . . . 0.0 111.666 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 319' ' ' ILE . 82.1 mt -124.05 158.98 30.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.559 ' HB3' ' CB ' ' A' ' 372' ' ' GLU . 5.9 tttp -136.4 137.95 41.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.628 -1.295 . . . . 0.0 111.672 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.772 ' HB ' HG22 ' A' ' 321' ' ' THR . 26.0 t -132.85 81.19 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.44 ' HB3' ' HE3' ' A' ' 357' ' ' LYS . 89.1 p -112.14 160.77 17.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.161 -0.962 . . . . 0.0 111.256 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 369' ' ' PHE . 47.2 t -162.16 130.44 4.11 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -118.1 -161.47 11.95 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.8 OUTLIER -171.36 177.58 3.5 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.748 -1.442 . . . . 0.0 112.014 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.563 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 1.0 OUTLIER -156.29 175.26 3.3 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 38.0 Cg_endo -64.29 116.32 3.67 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.158 1.083 . . . . 0.0 111.289 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.517 ' C ' ' HG3' ' A' ' 366' ' ' ARG . 6.2 m-20 63.07 18.38 10.88 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.743 -0.598 . . . . 0.0 111.147 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.517 ' HG3' ' C ' ' A' ' 365' ' ' ASN . 26.9 mtp180 -160.23 108.02 1.64 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.437 -0.789 . . . . 0.0 110.377 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.68 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -112.7 179.19 4.04 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.864 -1.147 . . . . 0.0 108.708 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.654 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 11.5 p-90 -171.44 149.04 2.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.825 -1.172 . . . . 0.0 110.11 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 369' ' ' PHE . 4.7 p90 -138.46 142.8 39.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.963 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.534 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 11.9 tt0 -133.31 155.09 50.06 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 110.42 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.534 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 36.7 t -118.78 151.74 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.428 -0.795 . . . . 0.0 110.179 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.559 ' CB ' ' HB3' ' A' ' 357' ' ' LYS . 4.4 tt0 -139.19 117.24 11.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.269 -0.895 . . . . 0.0 109.746 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 20.4 p-10 -145.88 143.48 29.61 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.04 -1.038 . . . . 0.0 110.201 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 353' ' ' ASN . 12.4 t0 -74.83 140.76 44.15 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.406 -0.809 . . . . 0.0 109.817 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -179.51 -150.29 8.96 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.07 -162.24 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.975 1.513 . . . . 0.0 110.512 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -140.22 -172.75 12.99 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.511 HD13 HD13 ' A' ' 422' ' ' LEU . 26.0 mt -110.39 140.16 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -1.174 . . . . 0.0 110.568 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -82.56 164.4 47.49 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.407 -0.808 . . . . 0.0 109.872 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 46.6 Cg_endo -73.83 -30.25 9.54 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 124.087 1.572 . . . . 0.0 110.732 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -90.39 -21.29 22.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.0 110.483 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.766 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 0.1 OUTLIER -78.88 -21.65 47.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.177 -0.952 . . . . 0.0 110.466 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -49.97 -21.42 1.2 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.151 -0.968 . . . . 0.0 110.467 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.54 -32.19 16.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.24 -0.912 . . . . 0.0 110.482 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.432 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 5.4 m-70 -80.35 -10.88 59.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.319 -0.863 . . . . 0.0 110.893 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 386' ' ' LEU . 22.1 tp . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.036 -1.04 . . . . 0.0 111.445 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 408' ' ' ILE . 1.1 tp . . . . . 0 N--CA 1.511 2.622 0 CA-C-O 121.292 0.568 . . . . 0.0 111.605 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 409' ' ' VAL . 93.6 t -79.83 1.91 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 1.3 mm100 -74.25 -55.3 6.2 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 110.237 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 1.9 mmt180 -67.8 -31.49 71.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.323 -0.861 . . . . 0.0 109.898 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 1.023 HG21 ' HB2' ' A' ' 340' ' ' ALA . 8.7 mm -67.21 -66.28 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.894 HG21 HD13 ' A' ' 420' ' ' LEU . 35.4 t -57.11 -23.24 18.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.424 -0.797 . . . . 0.0 109.699 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 29.5 m-20 -78.09 -30.72 49.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.221 -0.925 . . . . 0.0 109.535 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.51 ' HB3' ' HE1' ' A' ' 296' ' ' MET . 1.2 m-20 -109.31 7.29 25.11 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.65 -0.657 . . . . 0.0 109.625 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.768 ' CG ' HD11 ' A' ' 337' ' ' ILE . 47.1 m80 -134.64 -62.92 0.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 111.968 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.956 ' HA ' HD23 ' A' ' 436' ' ' LEU . 2.4 m-20 -74.73 -99.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.808 0.814 . . . . 0.0 111.61 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 149.11 -35.04 1.08 Allowed Glycine 0 C--N 1.262 -3.551 0 N-CA-C 106.432 -2.667 . . . . 0.0 106.432 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.669 ' HB3' ' HB2' ' A' ' 435' ' ' TRP . 36.4 ttm -123.14 145.69 48.38 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.658 -0.907 . . . . 0.0 109.601 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.894 HD13 HG21 ' A' ' 413' ' ' VAL . 19.7 tp -150.84 92.71 1.86 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.114 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -107.6 128.8 54.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.372 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.511 HD13 HD13 ' A' ' 378' ' ' ILE . 2.0 pp -89.81 138.58 31.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.869 . . . . 0.0 109.547 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.488 ' O ' ' HG ' ' A' ' 430' ' ' LEU . . . -149.26 -168.66 15.02 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.555 -1.307 . . . . 0.0 109.903 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.853 HG22 ' O ' ' A' ' 429' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 O-C-N 121.577 -0.955 . . . . 0.0 111.185 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.853 ' O ' HG22 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.571 ' HA ' ' HB ' ' A' ' 424' ' ' THR . 0.3 OUTLIER -88.68 165.23 14.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.882 -1.364 . . . . 0.0 109.876 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.541 ' N ' ' HB ' ' A' ' 424' ' ' THR . 1.7 p -146.52 162.86 37.42 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.964 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 370' ' ' GLN . 13.3 mm -123.8 121.84 63.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -98.99 100.98 12.22 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.833 ' HB1' HD22 ' A' ' 417' ' ' ASN . . . -110.35 135.05 51.67 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 111.066 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.669 ' HB2' ' HB3' ' A' ' 419' ' ' MET . 88.0 m95 -110.14 138.35 46.64 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 121.064 -1.023 . . . . 0.0 111.255 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.956 HD23 ' HA ' ' A' ' 417' ' ' ASN . 9.7 mt -113.46 75.79 2.57 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 417' ' ' ASN . 37.5 Cg_endo -63.05 115.08 2.74 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 O-C-N 124.665 1.876 . . . . 0.0 110.494 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.513 ' CG1' ' HD2' ' A' ' 439' ' ' PRO . 4.6 t -69.66 143.91 93.19 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.384 -0.823 . . . . 0.0 109.682 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.513 ' HD2' ' CG1' ' A' ' 438' ' ' VAL . 53.6 Cg_endo . . . . . 0 C--N 1.301 -1.935 0 O-C-N 124.0 1.526 . . . . 0.0 110.418 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 297' ' ' GLU . 47.0 Cg_endo . . . . . 0 C--O 1.214 -0.702 0 N-CA-C 109.542 -0.984 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.541 ' HE3' ' HB3' ' A' ' 415' ' ' ASN . 0.1 OUTLIER 40.38 48.37 2.39 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.85 1.309 . . . . 0.0 109.304 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.701 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 4.3 mm-40 -127.84 -149.91 0.43 Allowed 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.193 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.488 ' HE2' ' N ' ' A' ' 330' ' ' VAL . 2.1 mmt -84.74 117.49 23.85 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 120.286 -1.508 . . . . 0.0 110.7 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.527 ' HB3' ' HE3' ' A' ' 332' ' ' MET . . . -134.09 162.01 33.29 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.528 0.68 . . . . 0.0 111.129 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 304' ' ' VAL . 4.1 m-20 -95.97 119.01 33.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.654 -0.654 . . . . 0.0 109.867 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.653 HD11 HD12 ' A' ' 436' ' ' LEU . 6.1 mt -65.51 -23.45 66.89 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.091 -1.006 . . . . 0.0 109.654 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.692 ' HA ' HD23 ' A' ' 323' ' ' LEU . 4.5 m-20 -75.68 -19.99 58.74 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.957 -1.09 . . . . 0.0 108.351 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.07 -37.24 19.08 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.524 0.678 . . . . 0.0 109.601 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.877 ' O ' HG23 ' A' ' 308' ' ' VAL . 2.5 t -78.8 -28.62 14.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.415 -0.803 . . . . 0.0 109.554 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 309' ' ' ILE . 72.4 mt -82.85 -31.38 28.04 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.62 -31.99 82.72 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -83.82 -30.82 26.21 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.268 -1.136 . . . . 0.0 109.251 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 304' ' ' VAL . 88.7 t -72.58 -26.88 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.305 -0.872 . . . . 0.0 109.32 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 305' ' ' LEU . 1.0 OUTLIER -75.79 -50.2 24.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.08 -16.7 64.5 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.861 0.839 . . . . 0.0 108.762 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -67.01 -68.03 0.41 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.453 0.644 . . . . 0.0 110.79 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.82 49.35 2.23 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.553 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.988 ' HB2' HD13 ' A' ' 319' ' ' ILE . 6.2 p -82.32 40.46 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.001 -1.062 . . . . 0.0 109.994 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.542 ' C ' ' CD2' ' A' ' 315' ' ' TYR . . . 53.16 38.15 55.83 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.542 ' CD2' ' C ' ' A' ' 314' ' ' GLY . 3.6 m-85 67.89 34.65 4.16 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.629 -0.924 . . . . 0.0 109.279 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 4.9 mm-40 57.52 41.71 25.48 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.241 -0.912 . . . . 0.0 108.614 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.575 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 1.6 tpp180 -68.71 -86.89 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.432 0.634 . . . . 0.0 110.784 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.575 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 5.4 mt-10 -127.04 66.15 1.29 Allowed 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.637 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.988 HD13 ' HB2' ' A' ' 313' ' ' SER . 1.5 mp -111.48 120.77 62.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 358' ' ' VAL . 24.0 tt0 -88.33 100.45 13.03 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.343 -0.848 . . . . 0.0 109.79 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 20.7 p -88.46 122.98 32.53 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.52 0.676 . . . . 0.0 110.903 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -144.55 78.94 1.59 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' ' 302' ' ' ASN . 1.7 mp -90.29 164.77 14.24 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 110.125 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 323' ' ' LEU . 5.2 t80 -43.24 136.76 2.95 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.631 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -83.14 51.57 3.68 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.94 1.495 . . . . 0.0 111.232 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -165.73 -87.77 0.07 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.3 m -178.54 105.26 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.613 -0.933 . . . . 0.0 108.98 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 329' ' ' GLU . 2.0 mt -74.17 -179.69 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 O-C-N 121.404 -0.81 . . . . 0.0 110.006 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.656 ' H ' HG22 ' A' ' 328' ' ' ILE . 3.2 mt-10 -170.82 105.63 0.26 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.585 0.707 . . . . 0.0 110.601 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.983 HG11 ' HB3' ' A' ' 367' ' ' ALA . 25.4 m -139.23 154.24 25.13 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.302 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.6 OUTLIER -71.7 92.35 1.18 Allowed 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.698 ' HE1' HG21 ' A' ' 304' ' ' VAL . 10.0 tmm? -143.07 158.24 43.78 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.108 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.617 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 9.9 t-160 -100.42 121.24 53.95 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 38.6 Cg_endo -64.77 -18.81 63.62 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.628 1.33 . . . . 0.0 109.697 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.617 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 0.6 OUTLIER -81.23 -80.01 0.15 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.618 -0.676 . . . . 0.0 110.692 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 96.9 p -44.37 -43.06 7.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.39 -0.819 . . . . 0.0 110.178 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.601 HD11 ' CE1' ' A' ' 416' ' ' HIS . 1.2 mm -66.32 -40.95 88.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.811 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 0.0 OUTLIER -45.45 -38.4 6.08 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -44.39 67.79 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.108 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.911 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -54.63 -47.99 72.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.61 -0.681 . . . . 0.0 111.089 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.806 ' CG1' HG11 ' A' ' 308' ' ' VAL . 33.3 t -75.62 -28.08 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.132 -0.98 . . . . 0.0 110.403 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.54 -19.89 63.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 110.117 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -88.85 -19.83 25.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.311 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.4 mtt -82.59 -44.78 15.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.243 -0.911 . . . . 0.0 110.373 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 346' ' ' VAL . 6.9 p -69.84 -42.82 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.555 ' N ' HG13 ' A' ' 345' ' ' VAL . 19.4 t -52.05 -19.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.102 -0.999 . . . . 0.0 110.569 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -67.12 -46.4 74.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.193 -0.942 . . . . 0.0 110.635 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 356' ' ' ILE . . . -88.78 -19.72 25.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.212 -0.93 . . . . 0.0 110.656 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.3 -27.16 65.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.159 -0.963 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 350' ' ' ARG . 0.0 OUTLIER -83.3 -37.09 23.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 110.123 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.85 -67.44 0.84 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 65.34 52.98 35.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -106.3 -1.94 22.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -1.153 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -145.08 -84.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.643 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -172.7 148.81 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -1.11 . . . . 0.0 109.875 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.528 HD12 HG13 ' A' ' 319' ' ' ILE . 1.0 OUTLIER -109.8 153.34 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.869 . . . . 0.0 109.528 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.643 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.1 OUTLIER -144.5 114.69 7.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.986 . . . . 0.0 110.745 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.719 HG23 HG23 ' A' ' 319' ' ' ILE . 55.3 t -109.72 138.64 36.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.553 ' HA ' ' CD1' ' A' ' 323' ' ' LEU . 97.7 p -161.18 173.96 14.35 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 120.502 -1.374 . . . . 0.0 111.507 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.524 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 6.4 p -155.04 131.3 10.33 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.488 0.661 . . . . 0.0 109.826 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.503 ' O ' ' HB ' ' A' ' 362' ' ' THR . . . -129.91 -172.47 13.16 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 107.986 -2.046 . . . . 0.0 107.986 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.652 HG21 HG23 ' A' ' 328' ' ' ILE . 0.6 OUTLIER 175.96 176.26 0.25 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.867 -1.372 . . . . 0.0 111.546 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.532 ' OE1' ' CD ' ' A' ' 364' ' ' PRO . 33.3 mm-40 -141.54 175.24 3.14 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.532 ' CD ' ' OE1' ' A' ' 363' ' ' GLU . 47.3 Cg_endo -77.25 26.01 0.46 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.336 1.177 . . . . 0.0 111.388 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 21.3 p-10 -170.19 24.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.065 -1.022 . . . . 0.0 110.202 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.542 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 8.1 ptt180 162.46 109.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.789 -0.569 . . . . 0.0 110.248 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.983 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -100.45 168.9 9.45 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.194 -0.941 . . . . 0.0 109.085 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.688 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 34.8 p-90 -170.98 153.16 3.73 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.587 -1.321 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 434' ' ' ALA . 54.4 p90 -121.81 157.15 31.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.175 -0.953 . . . . 0.0 108.638 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.542 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 5.8 tt0 -141.8 159.39 42.33 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.829 -1.17 . . . . 0.0 111.835 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.542 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 96.8 t -137.83 135.73 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.403 ' OE2' ' CD ' ' A' ' 370' ' ' GLN . 18.1 mt-10 -131.21 158.08 41.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.835 -1.165 . . . . 0.0 111.041 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 430' ' ' LEU . 27.1 t0 -150.58 142.81 24.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.436 -0.79 . . . . 0.0 109.782 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.65 2.0 20.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.219 -0.926 . . . . 0.0 110.297 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' GLY . . . . . 0.421 ' O ' ' HA3' ' A' ' 429' ' ' GLY . . . -65.53 -175.15 5.28 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.09 145.69 44.98 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.942 1.496 . . . . 0.0 110.642 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' GLY . . . . . 0.813 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -63.67 -140.34 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.813 HD13 ' C ' ' A' ' 377' ' ' GLY . 0.0 OUTLIER -116.75 118.95 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.147 -1.208 . . . . 0.0 109.957 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -43.26 161.64 0.19 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.281 -0.887 . . . . 0.0 110.296 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.38 -24.14 16.8 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.939 1.494 . . . . 0.0 110.028 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -88.67 -21.49 23.91 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.392 -0.818 . . . . 0.0 109.876 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -86.17 -30.33 22.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -22.21 66.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.612 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -20.84 63.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.603 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -92.42 21.02 5.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.472 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 1.031 HD22 HD21 ' A' ' 422' ' ' LEU . 8.5 mt . . . . . 0 C--N 1.302 -1.488 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' ILE . . . . . . . . . . . . . 21.7 mm . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.326 0.584 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.547 ' HA ' HG13 ' A' ' 412' ' ' ILE . 14.7 p -116.45 -9.46 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.53 -0.731 . . . . 0.0 109.989 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 44.6 tt0 -68.53 -62.39 1.41 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.297 -0.877 . . . . 0.0 110.315 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -19.99 6.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.241 -0.912 . . . . 0.0 110.497 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.911 HG21 ' HB2' ' A' ' 340' ' ' ALA . 24.7 mm -66.0 -69.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.105 -0.997 . . . . 0.0 108.984 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 420' ' ' LEU . 69.6 t -62.18 -20.72 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 109.437 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 2.8 t70 -79.14 -26.48 42.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.469 -0.769 . . . . 0.0 109.85 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.541 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 22.7 m-20 -84.0 -22.93 31.19 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.313 -0.867 . . . . 0.0 109.292 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.601 ' CE1' HD11 ' A' ' 337' ' ' ILE . 41.4 m80 -93.18 -26.16 17.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.504 -0.747 . . . . 0.0 109.686 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.57 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 4.2 m120 66.03 59.27 0.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.687 0.756 . . . . 0.0 110.889 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.559 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -128.29 -84.04 0.42 Allowed Glycine 0 N--CA 1.481 1.656 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.569 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.1 OUTLIER -179.07 155.98 0.76 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -1.129 . . . . 0.0 112.011 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.826 ' HB2' HG21 ' A' ' 413' ' ' VAL . 15.7 tp -152.76 92.83 1.69 Allowed 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.458 -0.776 . . . . 0.0 108.995 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 432' ' ' ILE . 0.2 OUTLIER -115.22 123.43 48.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.007 -1.058 . . . . 0.0 110.969 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 1.031 HD21 HD22 ' A' ' 386' ' ' LEU . 0.8 OUTLIER -126.5 140.01 52.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.154 -0.966 . . . . 0.0 110.098 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.43 ' HA2' HG13 ' A' ' 378' ' ' ILE . . . 175.46 -169.76 42.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 44.3 m . . . . . 0 N--CA 1.487 1.414 0 O-C-N 121.297 -1.119 . . . . 0.0 110.003 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.503 3.109 0 CA-C-O 121.827 0.682 . . . . 0.0 112.54 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.996 HD13 ' N ' ' A' ' 431' ' ' SER . 0.9 OUTLIER -66.98 140.06 57.71 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 121.914 0.864 . . . . 0.0 113.008 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.996 ' N ' HD13 ' A' ' 430' ' ' LEU . 29.4 t -167.02 112.18 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.492 HG13 ' CA ' ' A' ' 422' ' ' LEU . 15.6 tt -125.83 157.33 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.162 -0.961 . . . . 0.0 110.567 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.73 127.35 18.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.405 -0.81 . . . . 0.0 109.928 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 369' ' ' PHE . . . -109.69 147.27 33.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.271 -0.893 . . . . 0.0 110.129 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.688 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.3 m95 -124.22 155.91 37.73 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.398 1.094 . . . . 0.0 113.246 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.653 HD12 HD11 ' A' ' 301' ' ' LEU . 19.0 mt -145.38 94.8 5.14 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.559 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 42.6 Cg_endo -67.19 146.17 75.21 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.966 1.509 . . . . 0.0 112.896 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 10.8 t -107.3 98.0 21.18 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.836 -0.54 . . . . 0.0 110.379 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 49.6 Cg_endo . . . . . 0 C--N 1.309 -1.5 0 O-C-N 123.78 1.411 . . . . 0.0 111.577 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.643 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 54.7 Cg_endo . . . . . 0 C--O 1.215 -0.665 0 N-CA-C 110.188 -0.735 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.642 ' HE3' ' HB3' ' A' ' 415' ' ' ASN . 0.2 OUTLIER -81.84 108.79 15.65 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 122.216 1.008 . . . . 0.0 109.239 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.646 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 20.3 mt-10 -133.71 -155.71 0.69 Allowed 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.221 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.06 139.06 30.89 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 111.037 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.812 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -155.69 160.09 40.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.576 -0.703 . . . . 0.0 110.523 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.668 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.6 OUTLIER -103.86 114.84 29.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.382 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.645 HD11 HD12 ' A' ' 436' ' ' LEU . 7.5 mt -59.92 -25.13 64.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.265 -0.897 . . . . 0.0 109.831 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.688 ' HA ' HD23 ' A' ' 323' ' ' LEU . 42.3 t-20 -82.18 -21.53 36.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.939 -1.1 . . . . 0.0 109.356 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.52 -27.54 22.56 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.604 0.716 . . . . 0.0 109.474 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 300' ' ' ASP . 28.5 t -82.89 -37.05 13.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 121.582 0.706 . . . . 0.0 109.168 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.552 ' CD2' HG21 ' A' ' 341' ' ' VAL . 86.1 mt -79.72 -31.11 41.09 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.475 -0.766 . . . . 0.0 110.117 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.95 -26.73 73.23 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -84.44 -33.52 23.65 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.419 -1.048 . . . . 0.0 109.782 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.949 HG11 ' CG1' ' A' ' 341' ' ' VAL . 78.6 t -75.2 -25.42 18.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.395 -0.816 . . . . 0.0 109.469 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.976 HD11 ' CG1' ' A' ' 358' ' ' VAL . 1.6 mt -79.56 -43.45 23.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.734 0.778 . . . . 0.0 108.941 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.2 -17.3 62.52 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.73 0.776 . . . . 0.0 109.048 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -85.7 -45.62 11.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.657 -0.652 . . . . 0.0 110.67 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 342' ' ' ALA . 8.6 mt-10 -99.34 28.68 4.38 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.115 -0.991 . . . . 0.0 110.599 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.474 ' O ' ' OG ' ' A' ' 313' ' ' SER . 1.6 t -97.48 38.08 1.3 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.254 -0.904 . . . . 0.0 109.93 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -99.18 -74.77 1.16 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.45 ' O ' ' CG ' ' A' ' 316' ' ' GLU . 2.7 t80 -93.32 25.78 3.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -1.094 . . . . 0.0 108.689 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.641 ' O ' HD11 ' A' ' 319' ' ' ILE . 48.5 mm-40 -160.03 38.21 0.18 Allowed 'General case' 0 C--O 1.192 -1.966 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.471 ' HA ' ' CD1' ' A' ' 319' ' ' ILE . 0.1 OUTLIER -69.52 -0.99 7.46 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 121.422 0.63 . . . . 0.0 110.002 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.05 33.92 0.45 Allowed 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.918 0.866 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.726 ' CG2' HG23 ' A' ' 358' ' ' VAL . 0.7 OUTLIER -89.15 134.86 27.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.484 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -95.87 110.32 22.52 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.012 -1.055 . . . . 0.0 109.119 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.928 HG22 HD13 ' A' ' 309' ' ' ILE . 10.8 p -89.52 123.28 33.48 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.351 -0.843 . . . . 0.0 111.675 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.84 78.41 1.49 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.688 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.2 mp -93.93 154.85 17.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.78 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.595 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 79.0 t80 -46.75 132.26 8.43 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.425 -0.797 . . . . 0.0 110.215 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.478 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 46.5 Cg_endo -72.71 78.91 1.99 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.952 1.501 . . . . 0.0 110.318 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . 167.66 7.89 0.03 OUTLIER Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.804 -1.189 . . . . 0.0 111.177 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 0.5 OUTLIER 63.38 116.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 O-C-N 120.555 -1.556 . . . . 0.0 109.57 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 329' ' ' GLU . 4.1 mm -69.23 179.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.734 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.63 ' H ' HG22 ' A' ' 328' ' ' ILE . 1.9 mt-10 -175.49 104.47 0.08 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.609 0.719 . . . . 0.0 110.674 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.839 HG23 ' HG2' ' A' ' 332' ' ' MET . 13.7 m -150.09 172.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 O-C-N 121.702 -0.624 . . . . 0.0 110.323 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.646 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -86.22 93.58 9.09 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 119.384 -0.927 . . . . 0.0 108.664 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.839 ' HG2' HG23 ' A' ' 330' ' ' VAL . 11.7 ptm -144.58 166.27 25.64 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.356 -0.84 . . . . 0.0 110.568 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.643 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 19.1 t-160 -92.18 112.22 54.03 Favored Pre-proline 0 C--N 1.297 -1.698 0 O-C-N 121.523 -0.736 . . . . 0.0 109.46 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 41.4 Cg_endo -66.39 -23.62 50.89 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.825 1.434 . . . . 0.0 111.128 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.584 ' C ' HD12 ' A' ' 335' ' ' LEU . 1.1 tp -81.99 -62.16 1.71 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.951 -1.093 . . . . 0.0 109.817 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.509 ' OG ' HG13 ' A' ' 412' ' ' ILE . 14.7 t -53.65 -42.94 68.37 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.109 -0.995 . . . . 0.0 109.374 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.868 HD11 ' CE1' ' A' ' 416' ' ' HIS . 20.5 mm -60.34 -45.71 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.195 -0.941 . . . . 0.0 109.121 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.538 ' HG3' HG13 ' A' ' 304' ' ' VAL . 20.8 mttm -46.19 -50.25 15.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.0 108.611 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.05 -44.15 78.57 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.544 0.688 . . . . 0.0 110.056 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.572 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -54.34 -29.18 47.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.407 -0.808 . . . . 0.0 111.022 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.949 ' CG1' HG11 ' A' ' 308' ' ' VAL . 66.3 t -88.76 -43.9 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.079 -1.013 . . . . 0.0 111.24 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.832 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -54.4 -38.93 66.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.125 -0.984 . . . . 0.0 110.844 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.88 -34.6 29.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -0.965 . . . . 0.0 110.666 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 340' ' ' ALA . 0.0 OUTLIER -65.73 -28.17 68.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 342' ' ' ALA . 7.7 p -88.53 -22.89 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.013 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 342' ' ' ALA . 89.3 t -76.31 -22.03 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.161 -0.962 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -69.72 -41.21 75.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.158 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 352' ' ' GLY . . . -79.7 -19.9 47.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.36 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.28 -34.43 25.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.486 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -80.2 -63.7 1.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.625 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -21.72 33.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.13 -0.981 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 353' ' ' ASN . . . -109.46 176.24 19.4 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.067 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 352' ' ' GLY . 27.1 p-10 -178.62 42.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.537 -0.978 . . . . 0.0 109.808 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 354' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 355' ' ' TRP . . . -131.38 78.32 0.38 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.465 ' HB3' ' O ' ' A' ' 354' ' ' GLY . 9.9 t90 58.49 138.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -1.076 . . . . 0.0 111.043 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.526 ' CD1' ' OE1' ' A' ' 316' ' ' GLU . 6.5 mt -126.3 164.44 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.484 ' HG2' ' HB3' ' A' ' 320' ' ' GLU . 11.9 tttt -144.38 132.5 21.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.586 -1.321 . . . . 0.0 112.351 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.976 ' CG1' HD11 ' A' ' 309' ' ' ILE . 98.9 t -125.54 93.14 2.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 12.8 t -120.84 160.38 23.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 111.145 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.557 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 1.0 OUTLIER -141.68 157.16 45.41 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.569 -0.707 . . . . 0.0 109.469 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -146.75 -164.54 11.11 Favored Glycine 0 C--N 1.293 -1.841 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.1 OUTLIER -171.14 178.96 3.18 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.871 -1.37 . . . . 0.0 111.233 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 366' ' ' ARG . 6.2 mt-10 -154.23 177.69 1.9 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.587 -0.695 . . . . 0.0 109.823 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 40.9 Cg_endo -67.74 107.87 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.707 1.372 . . . . 0.0 110.763 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 4.8 t-20 68.77 31.16 4.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.409 -0.807 . . . . 0.0 110.531 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 3.6 mtt180 -176.31 109.4 0.09 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.55 -0.719 . . . . 0.0 109.787 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.792 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -113.06 161.12 17.44 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.954 -1.091 . . . . 0.0 110.096 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.6 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 22.3 p-90 -153.74 171.56 18.68 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.927 -1.108 . . . . 0.0 110.886 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.438 ' HB3' HD13 ' A' ' 301' ' ' LEU . 14.4 p90 -150.54 144.65 25.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.529 -0.732 . . . . 0.0 109.225 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -142.38 163.56 32.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.908 -1.12 . . . . 0.0 111.344 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.471 ' O ' ' HG3' ' A' ' 372' ' ' GLU . 17.6 t -128.6 152.83 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.55 -0.719 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 371' ' ' VAL . 1.6 mt-10 -140.23 130.69 25.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.403 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -141.26 150.73 42.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.038 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.69 120.83 43.61 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.198 -0.939 . . . . 0.0 110.762 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -175.59 -107.37 0.21 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.34 -171.08 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.938 1.494 . . . . 0.0 111.186 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' GLY . . . . . 0.687 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -155.62 -178.8 30.18 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.687 HD13 ' C ' ' A' ' 377' ' ' GLY . 0.7 OUTLIER -107.31 -154.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.039 -1.271 . . . . 0.0 110.691 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 383' ' ' ARG . . . -155.8 161.11 30.17 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.85 -20.72 22.11 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 O-C-N 123.704 1.37 . . . . 0.0 110.963 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.94 -36.75 13.26 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.948 -1.095 . . . . 0.0 111.738 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.638 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 5.7 pt20 -89.65 -30.34 18.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.019 -1.051 . . . . 0.0 111.824 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 379' ' ' ALA . 19.9 ttt-85 -56.12 -18.87 11.1 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.756 -1.215 . . . . 0.0 109.841 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.97 -31.02 39.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.288 -0.883 . . . . 0.0 110.941 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.638 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 5.2 p80 -112.47 1.31 15.86 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.97 -1.081 . . . . 0.0 111.201 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 386' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.303 -1.446 0 O-C-N 121.158 -0.964 . . . . 0.0 110.173 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.598 ' O ' HD12 ' A' ' 408' ' ' ILE . 1.9 pp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.489 0.661 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 412' ' ' ILE . 6.0 p -143.04 -36.32 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 109.809 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.441 ' N ' HG13 ' A' ' 409' ' ' VAL . 14.8 tt0 -69.8 -51.55 32.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.093 -1.004 . . . . 0.0 109.707 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.471 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 29.1 mmt180 -56.17 -19.06 11.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.297 -0.877 . . . . 0.0 109.88 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.719 HG22 ' N ' ' A' ' 413' ' ' VAL . 0.8 OUTLIER -65.42 -63.31 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.948 . . . . 0.0 108.817 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.779 HG11 ' HB2' ' A' ' 420' ' ' LEU . 7.0 t -67.13 -22.04 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.15 -0.969 . . . . 0.0 109.196 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 8.3 t70 -76.26 -27.93 56.88 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.671 -0.643 . . . . 0.0 109.648 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.642 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 0.3 OUTLIER -79.67 -12.36 59.82 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.386 -0.821 . . . . 0.0 109.322 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.868 ' CE1' HD11 ' A' ' 337' ' ' ILE . 30.1 m80 -97.2 -29.42 13.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.544 -0.722 . . . . 0.0 109.649 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.1 t-20 77.93 13.77 1.67 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.69 -0.631 . . . . 0.0 110.483 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.575 ' HA2' ' CD ' ' A' ' 437' ' ' PRO . . . -82.48 -87.87 0.72 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.684 ' O ' HG11 ' A' ' 413' ' ' VAL . 37.2 ttm -176.94 158.57 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -1.194 . . . . 0.0 111.338 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.779 ' HB2' HG11 ' A' ' 413' ' ' VAL . 27.4 tp -152.57 98.79 2.4 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.181 -0.949 . . . . 0.0 109.059 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -126.31 167.8 15.01 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.75 -1.219 . . . . 0.0 112.511 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 35.0 mt -89.95 141.24 28.84 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.226 0.536 . . . . 0.0 109.962 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 431' ' ' SER . . . -108.38 163.92 12.76 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 20.8 m . . . . . 0 C--N 1.295 -1.796 0 O-C-N 121.293 -1.122 . . . . 0.0 109.948 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.485 1.949 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 378' ' ' ILE . 3.5 mm? -86.17 111.05 20.02 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.301 -1.117 . . . . 0.0 110.653 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 423' ' ' GLY . 17.7 m -125.49 102.24 7.3 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.89 122.46 40.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.966 -1.083 . . . . 0.0 111.208 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -107.75 116.1 31.34 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.535 0.683 . . . . 0.0 110.276 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.407 ' HB3' ' CE2' ' A' ' 369' ' ' PHE . . . -108.0 129.27 55.13 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.6 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 82.5 m95 -103.12 153.75 20.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.882 -1.136 . . . . 0.0 112.064 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.645 HD12 HD11 ' A' ' 301' ' ' LEU . 14.7 mt -143.91 81.84 11.52 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.575 ' CD ' ' HA2' ' A' ' 418' ' ' GLY . 45.6 Cg_endo -70.55 133.6 24.48 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 O-C-N 124.02 1.537 . . . . 0.0 111.737 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.514 HG22 ' HB ' ' A' ' 330' ' ' VAL . 5.8 t -92.4 120.94 67.26 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.587 -0.695 . . . . 0.0 109.903 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.304 -1.804 0 O-C-N 123.742 1.391 . . . . 0.0 109.903 179.983 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.606 ' HB2' ' CD2' ' A' ' 333' ' ' HIS . 47.6 Cg_endo . . . . . 0 C--O 1.216 -0.605 0 N-CA-C 109.887 -0.851 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.55 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 43.6 79.94 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 122.638 1.209 . . . . 0.0 109.479 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.708 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.7 OUTLIER -146.31 -147.53 0.22 Allowed 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.836 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.518 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -85.87 127.76 34.66 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.07 -1.019 . . . . 0.0 110.716 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -143.32 159.32 42.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.466 0.65 . . . . 0.0 110.996 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.652 ' HB2' ' HB3' ' A' ' 303' ' ' ALA . 7.6 m-20 -91.13 108.55 19.95 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.935 HD11 HD12 ' A' ' 436' ' ' LEU . 2.5 mt -57.83 -30.25 65.59 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.276 -0.89 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 303' ' ' ALA . 53.1 p-10 -79.53 -19.87 48.51 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.845 -1.159 . . . . 0.0 109.883 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.652 ' HB3' ' HB2' ' A' ' 300' ' ' ASP . . . -84.12 -27.95 27.81 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.377 -0.827 . . . . 0.0 109.103 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.535 HG13 ' HD3' ' A' ' 338' ' ' LYS . 62.3 t -81.04 -38.51 16.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.786 0.803 . . . . 0.0 109.352 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.728 HD22 HG11 ' A' ' 341' ' ' VAL . 71.2 mt -77.1 -26.43 53.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 110.385 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -65.82 -31.16 78.87 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -83.0 -33.13 26.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -1.153 . . . . 0.0 109.628 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.504 HG11 ' HB ' ' A' ' 341' ' ' VAL . 58.9 t -78.32 -19.29 13.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.439 -0.788 . . . . 0.0 109.667 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.686 HD11 ' CG1' ' A' ' 358' ' ' VAL . 0.9 OUTLIER -83.57 -42.98 17.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.674 0.749 . . . . 0.0 109.259 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.84 -18.5 60.93 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.705 0.764 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.536 ' HB3' ' OE1' ' A' ' 312' ' ' GLU . . . -90.54 -55.1 3.71 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.753 0.787 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.536 ' OE1' ' HB3' ' A' ' 311' ' ' ALA . 58.1 mp0 -104.48 50.65 0.79 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.721 0.772 . . . . 0.0 109.206 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.584 ' HA ' HD13 ' A' ' 319' ' ' ILE . 0.3 OUTLIER -76.03 32.94 0.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.77 -0.581 . . . . 0.0 111.545 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 53.76 48.46 61.62 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 1.7 t80 53.82 37.03 25.51 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.444 -1.033 . . . . 0.0 110.079 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 5.5 mt-10 61.09 37.33 17.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.792 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 19.7 tpp180 -69.05 -85.2 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.575 0.703 . . . . 0.0 109.667 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.2 pt-20 -169.2 67.21 0.06 Allowed 'General case' 0 C--N 1.273 -2.718 0 O-C-N 121.538 -0.726 . . . . 0.0 110.526 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.692 HG23 HG23 ' A' ' 358' ' ' VAL . 1.8 mp -90.95 129.89 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 109.707 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -89.08 103.12 15.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.663 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 18.3 p -88.81 123.81 33.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.419 -0.801 . . . . 0.0 111.094 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' ALA . . . . . 0.459 ' HB3' ' CB ' ' A' ' 359' ' ' SER . . . -146.55 79.09 1.52 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.539 HD12 ' H ' ' A' ' 360' ' ' SER . 5.8 mp -88.41 157.08 18.8 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.379 -0.825 . . . . 0.0 110.322 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.433 ' CD1' ' HD2' ' A' ' 325' ' ' PRO . 21.7 t80 -40.39 141.99 0.8 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.504 -0.747 . . . . 0.0 110.422 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.433 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.0 Cg_endo -83.07 60.32 7.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.04 1.547 . . . . 0.0 111.205 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . -176.92 -75.25 0.05 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.5 OUTLIER 165.05 116.57 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.581 -0.952 . . . . 0.0 108.932 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.536 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 2.7 mm -69.27 178.17 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.061 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.5 mt-10 -173.65 101.44 0.11 Allowed 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 121.469 0.652 . . . . 0.0 110.697 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 1.015 HG12 HG22 ' A' ' 438' ' ' VAL . 16.5 m -143.65 161.26 16.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.094 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -81.13 92.4 6.27 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.596 ' SD ' HD12 ' A' ' 337' ' ' ILE . 22.0 ttp -144.79 153.99 42.23 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.712 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.606 ' CD2' ' HB2' ' A' ' 295' ' ' PRO . 7.3 t-160 -78.73 119.84 78.73 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.778 -0.577 . . . . 0.0 109.682 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 43.5 Cg_endo -70.75 -21.16 29.24 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.662 1.348 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.742 ' C ' HD12 ' A' ' 335' ' ' LEU . 0.1 OUTLIER -84.52 -63.01 1.41 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.235 -0.916 . . . . 0.0 110.188 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 335' ' ' LEU . 3.1 m -52.78 -35.4 56.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.903 -1.123 . . . . 0.0 110.096 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.734 HD11 ' CE1' ' A' ' 416' ' ' HIS . 3.1 mm -73.93 -45.88 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.221 -0.924 . . . . 0.0 110.032 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.535 ' HD3' HG13 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -43.33 -44.32 5.47 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.13 -0.981 . . . . 0.0 109.197 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -49.9 59.77 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.522 0.677 . . . . 0.0 110.315 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.623 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -52.23 -30.91 29.7 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.301 -0.874 . . . . 0.0 111.674 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.728 HG11 HD22 ' A' ' 305' ' ' LEU . 40.9 t -89.94 -23.73 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.913 -1.117 . . . . 0.0 111.424 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.51 -24.81 60.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.002 -1.061 . . . . 0.0 111.137 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -90.16 -19.0 24.76 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.024 -1.047 . . . . 0.0 111.673 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.6 ttm -82.28 -25.42 34.04 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.917 -1.114 . . . . 0.0 112.196 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.448 ' H ' HG22 ' A' ' 345' ' ' VAL . 23.3 m -90.39 -32.39 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.685 -1.259 . . . . 0.0 111.869 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 312' ' ' GLU . 73.4 t -74.28 -21.14 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 120.971 -1.08 . . . . 0.0 110.79 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -79.95 -19.97 46.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.041 -1.037 . . . . 0.0 110.421 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.493 ' O ' ' HA3' ' A' ' 352' ' ' GLY . . . -89.92 -20.09 23.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 0.0 110.511 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -80.79 -21.31 41.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.096 -1.002 . . . . 0.0 110.773 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 346' ' ' VAL . 4.9 mmt180 -87.76 -70.09 0.65 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.091 -1.005 . . . . 0.0 110.535 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 351' ' ' TYR . . . . . 0.437 ' O ' ' C ' ' A' ' 352' ' ' GLY . 0.2 OUTLIER -77.43 -35.11 54.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 110.377 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 348' ' ' ALA . . . -42.41 -51.65 5.4 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 352' ' ' GLY . 36.4 m-20 43.27 50.1 5.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.296 -1.12 . . . . 0.0 110.356 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -162.02 -80.74 0.04 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.044 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.1 OUTLIER -165.69 149.66 8.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.145 -1.209 . . . . 0.0 109.854 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.603 HD12 HG13 ' A' ' 319' ' ' ILE . 8.3 mt -114.41 165.67 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.218 -0.926 . . . . 0.0 110.73 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.4 OUTLIER -148.4 101.32 3.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.189 -0.944 . . . . 0.0 110.391 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.692 HG23 HG23 ' A' ' 319' ' ' ILE . 99.0 t -104.45 88.08 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.108 -0.995 . . . . 0.0 109.803 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 322' ' ' ALA . 53.2 p -115.01 134.99 54.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.086 -1.008 . . . . 0.0 110.932 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.539 ' H ' HD12 ' A' ' 323' ' ' LEU . 1.8 t -117.39 144.39 45.0 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.482 -0.761 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.599 ' C ' HG22 ' A' ' 362' ' ' THR . . . -140.66 -161.14 8.58 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.599 HG22 ' C ' ' A' ' 361' ' ' GLY . 0.0 OUTLIER 171.12 176.9 0.06 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.14 -1.212 . . . . 0.0 110.962 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.562 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 2.4 mt-10 -147.65 178.19 1.53 Allowed Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 46.0 Cg_endo -81.45 50.28 3.47 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.636 1.335 . . . . 0.0 109.791 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 365' ' ' ASN . 10.2 p-10 165.59 -3.7 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.795 -0.566 . . . . 0.0 111.266 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 14.2 mtm-85 -166.18 109.37 0.77 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.118 -0.989 . . . . 0.0 110.976 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.715 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -103.19 162.08 13.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.103 -0.998 . . . . 0.0 108.765 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.66 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 31.3 p-90 -170.31 162.92 8.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.715 -1.24 . . . . 0.0 111.131 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 39.8 p90 -133.54 133.82 42.6 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -122.84 152.13 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 111.986 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 15.5 t -132.09 122.05 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.558 ' CG ' ' HB2' ' A' ' 431' ' ' SER . 2.3 mt-10 -116.75 139.34 50.68 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 110.395 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 373' ' ' ASP . 3.3 p30 -141.0 145.82 36.45 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.263 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -104.04 114.55 28.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.323 -0.861 . . . . 0.0 110.346 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -172.55 -109.84 0.23 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.1 -168.32 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.93 1.49 . . . . 0.0 110.532 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -141.72 -160.24 8.24 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 0.554 ' CG1' HD21 ' A' ' 430' ' ' LEU . 3.0 mt -111.88 159.04 12.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.24 -1.153 . . . . 0.0 109.842 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 382' ' ' GLN . . . -91.01 161.24 35.93 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.931 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 46.3 Cg_endo -72.77 -46.1 0.45 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.087 1.572 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' GLU . . . . . 0.518 ' O ' ' CE1' ' A' ' 385' ' ' HIS . 0.0 OUTLIER -73.17 -53.33 11.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.833 . . . . 0.0 110.082 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.592 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 0.0 OUTLIER -56.08 -33.33 64.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.259 -0.9 . . . . 0.0 109.808 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -40.33 13.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.679 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -71.21 -41.3 70.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.501 -0.749 . . . . 0.0 109.422 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' HIS . . . . . 0.592 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 1.2 p-80 -120.05 74.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.602 -0.686 . . . . 0.0 109.804 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.76 ' O ' HD13 ' A' ' 386' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.109 -0.994 . . . . 0.0 110.386 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.72 ' O ' HD13 ' A' ' 412' ' ' ILE . 3.8 tp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.312 0.577 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.584 ' HA ' HD13 ' A' ' 412' ' ' ILE . 8.8 p -126.73 -2.69 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.3 -0.875 . . . . 0.0 110.079 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 1.8 mm100 -82.34 -53.33 6.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 109.91 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.433 ' HA ' ' HB2' ' A' ' 414' ' ' ASP . 0.0 OUTLIER -61.52 -19.91 62.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.381 -0.824 . . . . 0.0 109.772 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.72 HD13 ' O ' ' A' ' 408' ' ' ILE . 1.0 OUTLIER -69.24 -73.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.653 ' N ' HG22 ' A' ' 412' ' ' ILE . 91.8 t -57.77 -20.13 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.363 -0.835 . . . . 0.0 109.763 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 1.8 m-20 -78.74 -33.19 46.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.371 -0.83 . . . . 0.0 109.966 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.55 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 5.0 m-20 -74.24 -19.86 60.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.038 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.734 ' CE1' HD11 ' A' ' 337' ' ' ILE . 41.3 m80 -92.75 -35.94 13.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.57 -0.706 . . . . 0.0 109.597 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.1 t30 80.71 32.39 0.15 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.641 -0.662 . . . . 0.0 110.608 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.565 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -95.71 -89.61 1.77 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.546 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.1 OUTLIER -177.79 162.88 1.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -1.218 . . . . 0.0 112.079 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 13.8 tp -152.63 102.7 2.73 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 0.3 OUTLIER -119.37 164.28 15.94 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.685 -1.259 . . . . 0.0 113.128 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 23.3 mt -107.07 136.93 46.08 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 431' ' ' SER . . . -97.97 154.79 20.29 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.883 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 87.0 m . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.432 -1.04 . . . . 0.0 110.01 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.666 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.554 HD21 ' CG1' ' A' ' 378' ' ' ILE . 12.4 mt -60.38 114.01 2.7 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.18 0.991 . . . . 0.0 111.948 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.558 ' HB2' ' CG ' ' A' ' 372' ' ' GLU . 0.3 OUTLIER -123.53 100.05 6.61 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 73.1 mt -89.31 122.53 40.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.914 -1.116 . . . . 0.0 111.496 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.76 100.17 9.58 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.686 -0.634 . . . . 0.0 109.646 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.5 128.81 36.03 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.66 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 86.9 m95 -110.36 159.23 17.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.804 -1.185 . . . . 0.0 113.382 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.935 HD12 HD11 ' A' ' 301' ' ' LEU . 51.5 mt -148.33 109.09 3.64 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.565 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 39.9 Cg_endo -64.35 139.91 67.69 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.778 1.409 . . . . 0.0 112.488 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 1.015 HG22 HG12 ' A' ' 330' ' ' VAL . 22.0 t -113.12 102.23 54.51 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 C--N 1.301 -1.935 0 O-C-N 123.83 1.437 . . . . 0.0 110.57 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.654 ' CB ' ' CD2' ' A' ' 333' ' ' HIS . 53.4 Cg_endo . . . . . 0 N--CA 1.452 -0.941 0 N-CA-C 109.475 -1.01 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' MET . . . . . 0.498 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 41.25 94.98 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 122.16 0.981 . . . . 0.0 110.851 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.0 mt-10 -144.67 -164.26 1.88 Allowed 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' MET . . . . . 0.446 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.0 OUTLIER -88.7 129.36 35.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 110.108 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.671 ' HB3' ' SD ' ' A' ' 332' ' ' MET . . . -149.77 167.19 27.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.323 -0.861 . . . . 0.0 111.316 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.675 ' O ' HG23 ' A' ' 304' ' ' VAL . 26.3 t70 -96.36 117.89 31.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.735 . . . . 0.0 109.551 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.669 HD11 HD12 ' A' ' 436' ' ' LEU . 20.3 mt -65.36 -22.37 66.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.094 -1.004 . . . . 0.0 110.015 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.773 ' HA ' HD23 ' A' ' 323' ' ' LEU . 43.7 t-20 -80.77 -22.28 40.29 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.996 -1.065 . . . . 0.0 108.755 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.485 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -84.17 -32.51 24.58 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.589 0.709 . . . . 0.0 109.454 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 300' ' ' ASP . 21.8 t -77.29 -37.72 25.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.587 -0.695 . . . . 0.0 109.529 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 88.4 mt -76.86 -26.64 54.49 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.69 -38.24 95.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -76.39 -35.59 58.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -1.118 . . . . 0.0 109.336 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.99 HG11 HG12 ' A' ' 341' ' ' VAL . 92.8 t -75.24 -18.8 16.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.55 0.691 . . . . 0.0 109.441 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.574 ' CD1' HG22 ' A' ' 321' ' ' THR . 0.0 OUTLIER -77.6 -43.77 29.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.783 0.801 . . . . 0.0 109.123 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ALA . . . . . 0.452 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -75.17 -17.7 60.33 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.539 0.685 . . . . 0.0 109.866 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -88.11 -45.22 10.32 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 111.155 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -98.47 31.32 2.88 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.211 -0.93 . . . . 0.0 111.25 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.654 ' OG ' HD13 ' A' ' 319' ' ' ILE . 1.0 OUTLIER -82.84 -7.53 59.65 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.06 -1.025 . . . . 0.0 109.974 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 87.56 -53.95 4.38 Favored Glycine 0 C--N 1.286 -2.198 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 19.3 t80 174.54 36.16 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 1.6 tm-20 70.02 36.17 2.02 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 317' ' ' ARG . 0.0 OUTLIER -67.86 -90.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.337 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 317' ' ' ARG . 20.5 mt-10 -152.17 73.77 1.06 Allowed 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.233 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.675 ' CG2' HG23 ' A' ' 358' ' ' VAL . 3.3 mp -105.1 134.3 46.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.297 -0.877 . . . . 0.0 109.182 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 320' ' ' GLU . . . . . 0.507 ' HB3' ' CG ' ' A' ' 357' ' ' LYS . 3.1 tt0 -99.55 108.6 21.06 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.035 -1.041 . . . . 0.0 110.121 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.574 HG22 ' CD1' ' A' ' 309' ' ' ILE . 15.3 p -93.97 126.5 39.22 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 110.744 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -147.81 78.23 1.44 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.374 -0.829 . . . . 0.0 109.414 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' LEU . . . . . 0.773 HD23 ' HA ' ' A' ' 302' ' ' ASN . 4.2 mp -91.0 156.35 18.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.393 -0.817 . . . . 0.0 110.462 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' TYR . . . . . 0.605 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 69.2 t80 -45.8 125.62 6.61 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.893 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.51 68.93 8.16 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.885 1.466 . . . . 0.0 110.217 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -173.31 24.38 0.07 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 327' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 326' ' ' GLY . 0.0 OUTLIER 50.41 101.62 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 O-C-N 121.017 -1.284 . . . . 0.0 110.432 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 329' ' ' GLU . 1.1 mt -78.52 -176.61 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.35 -0.843 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -176.54 111.26 0.09 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.791 0.805 . . . . 0.0 110.87 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.864 HG12 HG22 ' A' ' 438' ' ' VAL . 8.5 m -142.48 162.12 18.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-O 121.391 0.615 . . . . 0.0 109.955 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.3 OUTLIER -78.28 91.0 4.36 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 332' ' ' MET . . . . . 0.759 ' CE ' HG21 ' A' ' 337' ' ' ILE . 4.4 ppp? -135.83 135.36 39.76 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.643 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 333' ' ' HIS . . . . . 0.654 ' CD2' ' CB ' ' A' ' 295' ' ' PRO . 10.3 t-80 -67.34 116.44 36.73 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.461 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 41.0 Cg_endo -65.32 -19.53 61.88 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.62 1.326 . . . . 0.0 110.07 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.641 ' CB ' ' CE1' ' A' ' 333' ' ' HIS . 0.5 OUTLIER -81.14 -46.08 15.44 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.426 -0.797 . . . . 0.0 110.899 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.503 ' O ' HD12 ' A' ' 412' ' ' ILE . 2.2 m -72.73 -37.47 67.73 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.143 -0.973 . . . . 0.0 110.117 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.847 HD11 ' CE1' ' A' ' 416' ' ' HIS . 32.5 mm -71.82 -30.47 37.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.402 -0.812 . . . . 0.0 109.521 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 3.8 mttt -68.29 -43.22 78.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 108.7 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 335' ' ' LEU . 75.5 mtt-85 -72.24 -31.77 66.11 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.474 0.654 . . . . 0.0 110.723 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 340' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -73.58 -35.88 65.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 111.035 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.99 HG12 HG11 ' A' ' 308' ' ' VAL . 59.4 t -80.46 -27.85 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 110.552 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.797 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -79.36 -28.29 41.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.183 -0.948 . . . . 0.0 110.182 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -89.77 -24.2 21.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.305 -0.872 . . . . 0.0 110.321 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 347' ' ' ASN . 1.9 mtm -71.65 -47.15 56.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.875 . . . . 0.0 110.386 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.8 t -65.43 -28.36 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 342' ' ' ALA . 71.6 t -56.34 -25.61 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.274 -0.891 . . . . 0.0 110.329 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 344' ' ' MET . 1.0 OUTLIER -56.18 -53.59 55.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.947 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 348' ' ' ALA . . . . . 0.551 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -85.53 -19.13 31.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.861 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.488 ' HB3' ' HA ' ' A' ' 346' ' ' VAL . . . -68.2 -59.66 3.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.319 -0.863 . . . . 0.0 111.668 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.518 ' HG3' ' N ' ' A' ' 351' ' ' TYR . 4.4 ptt-85 -86.5 -41.11 14.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.935 -1.103 . . . . 0.0 111.876 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 351' ' ' TYR . . . . . 0.518 ' N ' ' HG3' ' A' ' 350' ' ' ARG . 0.3 OUTLIER -90.2 -42.44 11.03 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.762 -1.211 . . . . 0.0 110.495 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -85.27 173.54 48.31 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -168.48 72.76 0.1 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.278 -1.131 . . . . 0.0 109.873 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' GLY . . . . . 0.523 ' CA ' ' HB2' ' A' ' 374' ' ' ASP . . . -161.65 67.68 0.24 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.591 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 11.1 t90 59.77 145.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -1.04 . . . . 0.0 111.242 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.417 HD12 HG13 ' A' ' 319' ' ' ILE . 6.0 mt -123.75 162.33 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.591 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 16.6 tttt -150.44 117.73 6.03 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.782 -1.199 . . . . 0.0 111.253 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.675 HG23 ' CG2' ' A' ' 319' ' ' ILE . 3.4 t -106.25 89.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 370' ' ' GLN . 4.4 t -113.44 139.44 48.92 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.273 -0.892 . . . . 0.0 111.229 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 360' ' ' SER . . . . . 0.487 ' HB2' ' HG ' ' A' ' 323' ' ' LEU . 3.7 m -138.33 158.11 44.93 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.384 -0.823 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.559 ' C ' HG22 ' A' ' 362' ' ' THR . . . -148.3 -154.69 6.37 Favored Glycine 0 C--N 1.295 -1.713 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' THR . . . . . 0.605 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER 175.02 169.25 0.29 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.03 -1.276 . . . . 0.0 110.71 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.468 ' CD ' ' HD2' ' A' ' 364' ' ' PRO . 3.1 mm-40 -149.39 172.23 5.44 Favored Pre-proline 0 C--N 1.293 -1.887 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 364' ' ' PRO . . . . . 0.534 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 40.2 Cg_endo -66.24 116.28 3.94 Favored 'Trans proline' 0 C--N 1.299 -2.075 0 O-C-N 123.682 1.359 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 44.2 t30 74.25 34.72 0.8 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.655 -0.653 . . . . 0.0 111.009 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.1 OUTLIER 165.81 97.51 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.305 -0.872 . . . . 0.0 111.214 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.41 171.34 7.42 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.158 -0.963 . . . . 0.0 109.039 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' TRP . . . . . 0.64 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 39.2 p-90 -170.96 165.37 7.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.445 -1.41 . . . . 0.0 110.813 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 35.1 p90 -139.28 131.33 27.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.485 -0.759 . . . . 0.0 109.336 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 370' ' ' GLN . . . . . 0.523 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 20.5 tt0 -116.08 151.33 35.78 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.246 -0.909 . . . . 0.0 111.773 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.523 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 89.0 t -127.05 142.4 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.564 -0.71 . . . . 0.0 109.636 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.43 ' HG3' ' C ' ' A' ' 371' ' ' VAL . 55.4 mt-10 -137.81 129.58 28.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.4 -0.812 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -159.55 161.55 35.25 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.536 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' ASP . . . . . 0.523 ' HB2' ' CA ' ' A' ' 354' ' ' GLY . 0.5 OUTLIER -80.46 152.64 28.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 110.494 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 375' ' ' GLY . . . . . 0.468 ' HA2' ' HA2' ' A' ' 352' ' ' GLY . . . 164.64 -146.33 11.23 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.616 ' O ' HD23 ' A' ' 430' ' ' LEU . 42.4 Cg_endo -72.89 -169.48 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.053 1.554 . . . . 0.0 110.554 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -145.22 139.4 8.34 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' ILE . . . . . 1.049 HD11 HD12 ' A' ' 422' ' ' LEU . 3.9 mt -81.08 170.81 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.102 -1.234 . . . . 0.0 109.923 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.947 ' HB3' ' HG2' ' A' ' 382' ' ' GLN . . . -151.32 175.99 2.58 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.252 -0.905 . . . . 0.0 110.324 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.879 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 49.5 Cg_endo -71.96 -34.25 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.061 1.558 . . . . 0.0 110.236 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.71 -21.73 30.01 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.849 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' GLN . . . . . 0.947 ' HG2' ' HB3' ' A' ' 379' ' ' ALA . 1.6 mm-40 -90.75 -18.27 25.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.129 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -60.25 -19.75 55.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.126 -0.984 . . . . 0.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -20.71 26.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.868 . . . . 0.0 110.618 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -63.05 -46.63 86.6 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.147 -0.971 . . . . 0.0 111.222 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 386' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.034 -1.041 . . . . 0.0 110.94 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 408' ' ' ILE . . . . . 0.796 HG23 HG23 ' A' ' 409' ' ' VAL . 6.3 tt . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.291 0.567 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.796 HG23 HG23 ' A' ' 408' ' ' ILE . 99.5 t -128.24 -31.91 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 109.868 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 2.3 mt-30 -69.42 -49.56 53.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.257 -0.902 . . . . 0.0 109.888 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.56 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.6 OUTLIER -65.88 -20.93 66.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.269 -0.894 . . . . 0.0 109.827 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.896 HG21 ' HB2' ' A' ' 340' ' ' ALA . 18.5 mm -68.12 -69.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 108.934 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.795 HG11 ' HB2' ' A' ' 420' ' ' LEU . 87.1 t -62.76 -21.15 26.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.368 -0.833 . . . . 0.0 109.015 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 8.4 t70 -75.24 -31.71 60.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.588 -0.695 . . . . 0.0 109.403 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' ASN . . . . . 0.498 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.1 m-20 -76.97 -14.74 59.81 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.405 -0.81 . . . . 0.0 109.12 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 416' ' ' HIS . . . . . 0.847 ' CE1' HD11 ' A' ' 337' ' ' ILE . 38.9 m80 -92.51 -34.47 14.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.579 -0.7 . . . . 0.0 109.861 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 417' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 4.7 m-20 80.58 19.89 0.51 Allowed 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.374 0.607 . . . . 0.0 110.281 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 418' ' ' GLY . . . . . 0.564 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -90.03 -92.01 1.23 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' MET . . . . . 0.567 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 31.6 ttm -176.9 162.01 2.04 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.189 -1.183 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.795 ' HB2' HG11 ' A' ' 413' ' ' VAL . 21.2 tp -151.32 104.91 3.14 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.387 -0.82 . . . . 0.0 108.832 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.487 ' O ' HG23 ' A' ' 432' ' ' ILE . 0.5 OUTLIER -112.98 143.31 44.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.974 -1.079 . . . . 0.0 111.902 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 1.049 HD12 HD11 ' A' ' 378' ' ' ILE . 3.5 mm? -99.42 80.69 2.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.485 -0.759 . . . . 0.0 109.402 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 429' ' ' GLY . . . -50.98 104.51 0.14 Allowed Glycine 0 C--N 1.28 -2.532 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.255 -1.144 . . . . 0.0 109.09 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 429' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 423' ' ' GLY . . . . . . . . 0 N--CA 1.494 2.507 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 376' ' ' PRO . 2.7 mm? -65.82 106.37 1.51 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.196 0.998 . . . . 0.0 111.831 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' SER . . . . . 0.455 ' O ' ' HA3' ' A' ' 423' ' ' GLY . 0.0 OUTLIER -145.76 100.72 3.46 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 432' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 421' ' ' GLU . 80.6 mt -92.0 151.9 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.067 -1.021 . . . . 0.0 112.864 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -124.45 94.86 4.33 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.23 139.83 30.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.786 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' TRP . . . . . 0.64 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 84.9 m95 -120.28 153.12 36.83 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.102 0.953 . . . . 0.0 111.707 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.669 HD12 HD11 ' A' ' 301' ' ' LEU . 86.0 mt -140.72 115.15 7.32 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.564 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 43.9 Cg_endo -70.69 134.24 25.59 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.834 1.439 . . . . 0.0 111.418 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.864 HG22 HG12 ' A' ' 330' ' ' VAL . 21.4 t -94.11 144.16 27.61 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.622 -0.674 . . . . 0.0 110.161 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 439' ' ' PRO . . . . . 0.495 ' HD2' ' CG1' ' A' ' 438' ' ' VAL . 50.8 Cg_endo . . . . . 0 C--N 1.303 -1.828 0 O-C-N 123.993 1.523 . . . . 0.0 110.457 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.281 0.563 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 292' ' ' GLN . . . 151.79 70.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 291' ' ' GLY . 11.9 mt-30 54.86 166.63 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.268 -1.137 . . . . 0.0 110.085 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.447 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 0.8 OUTLIER -165.19 40.88 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.076 -1.015 . . . . 0.0 110.714 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 6.1 mtt -73.4 111.98 14.06 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.213 -0.93 . . . . 0.0 110.201 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.79 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 55.4 Cg_endo -93.83 -163.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.972 1.512 . . . . 0.0 109.954 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.596 ' HE3' ' HB3' ' A' ' 415' ' ' ASN . 0.1 OUTLIER 23.68 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 122.358 1.075 . . . . 0.0 111.576 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.677 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.9 mm-40 -144.42 -159.51 1.0 Allowed 'General case' 0 C--N 1.267 -3.02 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.217 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.667 ' HA ' ' HA ' ' A' ' 331' ' ' LYS . 2.1 mmt -85.2 117.06 23.91 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.109 0.957 . . . . 0.0 110.797 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.732 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -141.18 150.61 42.97 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.061 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.745 ' O ' HG23 ' A' ' 304' ' ' VAL . 13.8 m-20 -85.15 136.57 33.48 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.488 -0.758 . . . . 0.0 109.205 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.691 HD21 ' CE ' ' A' ' 332' ' ' MET . 6.8 mt -73.68 -23.82 59.87 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.955 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 303' ' ' ALA . 47.0 p30 -83.93 -18.96 35.58 Favored 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.856 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.511 ' N ' ' OD1' ' A' ' 302' ' ' ASN . . . -82.3 -36.34 27.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 300' ' ' ASP . 16.2 t -74.15 -39.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.542 -0.724 . . . . 0.0 109.584 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 62.7 mt -69.55 -33.47 72.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.406 -0.809 . . . . 0.0 110.052 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -67.72 -22.35 73.53 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.99 -38.47 27.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.311 -1.111 . . . . 0.0 108.52 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.468 HG11 ' HB ' ' A' ' 341' ' ' VAL . 88.8 t -77.4 -18.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.641 HD12 ' CG2' ' A' ' 321' ' ' THR . 1.3 mm -78.31 -45.71 26.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.654 0.74 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.99 -18.39 63.33 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.692 0.758 . . . . 0.0 109.067 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.61 -36.67 14.28 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.163 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.589 ' O ' ' CD ' ' A' ' 317' ' ' ARG . 15.3 mm-40 -91.59 8.33 37.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 110.399 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 309' ' ' ILE . 78.2 p -115.67 66.36 0.7 Allowed 'General case' 0 C--N 1.274 -2.703 0 O-C-N 120.898 -1.126 . . . . 0.0 108.187 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.59 ' O ' ' CG ' ' A' ' 315' ' ' TYR . . . -113.71 -32.06 2.18 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.294 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.607 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 90.1 m-85 -155.26 74.43 0.9 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 120.111 1.956 . . . . 0.0 114.408 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.607 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 1.4 tp10 91.5 12.8 0.04 OUTLIER 'General case' 0 CA--C 1.452 -2.804 0 O-C-N 121.732 -0.605 . . . . 0.0 111.901 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.589 ' CD ' ' O ' ' A' ' 312' ' ' GLU . 0.0 OUTLIER -81.68 87.93 6.27 Favored 'General case' 0 C--N 1.259 -3.328 0 N-CA-C 101.034 -3.691 . . . . 0.0 101.034 179.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.713 ' N ' HD12 ' A' ' 356' ' ' ILE . 0.5 OUTLIER -65.74 73.14 0.06 Allowed 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.549 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.707 HG23 HG23 ' A' ' 358' ' ' VAL . 42.6 mt -99.14 116.52 42.42 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.744 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.21 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.433 ' H ' ' HA ' ' A' ' 357' ' ' LYS . 1.5 tp10 -89.6 110.78 21.61 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.641 ' CG2' HD12 ' A' ' 309' ' ' ILE . 12.8 p -88.25 130.13 35.17 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.195 -0.941 . . . . 0.0 112.284 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.73 77.73 1.29 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.566 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 4.1 mp -93.3 167.18 11.91 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.443 -0.786 . . . . 0.0 110.884 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CD2' HG21 ' A' ' 362' ' ' THR . 57.9 t80 -58.94 112.44 5.06 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 121.44 -0.787 . . . . 0.0 109.193 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 324' ' ' TYR . 44.3 Cg_endo -70.3 79.06 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.969 1.51 . . . . 0.0 111.057 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.459 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -175.81 -82.82 0.06 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 0.8 OUTLIER 171.35 107.97 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.453 -1.028 . . . . 0.0 109.443 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 329' ' ' GLU . 5.2 mt -85.43 -179.54 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 O-C-N 121.533 -0.729 . . . . 0.0 109.352 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.607 ' H ' HG22 ' A' ' 328' ' ' ILE . 0.8 OUTLIER -173.98 103.95 0.11 Allowed 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.211 -0.996 . . . . 0.0 112.505 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.56 HG23 ' HG2' ' A' ' 332' ' ' MET . 5.6 m -142.79 142.18 26.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -83.72 101.19 11.38 Favored 'General case' 0 C--N 1.257 -3.44 0 C-N-CA 118.512 -1.275 . . . . 0.0 108.015 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.732 ' HG3' ' HB3' ' A' ' 299' ' ' ALA 0.252 0.0 OUTLIER -135.46 -173.23 3.28 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.707 0.765 . . . . 0.0 111.515 -179.585 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.79 ' CE1' ' HB3' ' A' ' 295' ' ' PRO . 22.5 t60 -109.24 112.27 59.6 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 37.5 Cg_endo -59.87 -18.98 52.51 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.719 1.378 . . . . 0.0 110.407 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.553 ' HB2' ' NE2' ' A' ' 333' ' ' HIS . 1.6 mt -76.3 -73.92 0.25 Allowed 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.397 -0.815 . . . . 0.0 109.674 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.456 ' H ' ' CD2' ' A' ' 333' ' ' HIS . 0.4 OUTLIER -45.7 -49.78 14.27 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.702 -0.623 . . . . 0.0 110.441 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.669 HD11 ' CE1' ' A' ' 416' ' ' HIS . 6.7 mm -60.19 -40.89 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.084 -1.01 . . . . 0.0 109.999 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 6.1 mtmt -55.46 -48.39 74.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 109.17 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -28.77 67.19 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.415 0.626 . . . . 0.0 110.327 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -67.1 -37.26 83.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.748 . . . . 0.0 110.6 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' A' ' 305' ' ' LEU . 92.8 t -78.69 -35.0 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.125 -0.984 . . . . 0.0 110.207 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.714 ' O ' HG12 ' A' ' 345' ' ' VAL . . . -64.35 -68.75 0.33 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.554 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ASN . . . . . 0.916 ' O ' HG22 ' A' ' 346' ' ' VAL . 24.7 m120 -47.52 -19.28 0.17 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.296 -0.877 . . . . 0.0 111.203 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 3.4 mtt -74.92 -42.43 57.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.603 -1.31 . . . . 0.0 110.18 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.736 HG23 HG21 ' A' ' 356' ' ' ILE . 14.7 p -81.16 -18.69 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.844 . . . . 0.0 111.136 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.916 HG22 ' O ' ' A' ' 343' ' ' ASN . 17.9 m -60.02 -20.98 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.046 -1.034 . . . . 0.0 110.465 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -84.48 -30.87 24.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 110.666 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 352' ' ' GLY . . . -90.5 -19.1 24.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.946 . . . . 0.0 110.824 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -82.73 -53.58 5.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 110.451 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -72.56 0.14 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 110.365 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -70.02 -47.4 62.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 110.203 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 348' ' ' ALA . . . -79.9 162.34 46.62 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.503 ' O ' ' ND2' ' A' ' 353' ' ' ASN . 0.2 OUTLIER -171.68 29.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.454 -1.027 . . . . 0.0 109.59 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 354' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 355' ' ' TRP . . . -110.56 -33.05 2.56 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 17.0 t90 178.46 129.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.899 -1.354 . . . . 0.0 111.851 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.736 HG21 HG23 ' A' ' 345' ' ' VAL . 1.7 mt -117.01 146.97 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 372' ' ' GLU . 6.9 tttt -140.42 128.2 21.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.487 -1.383 . . . . 0.0 112.087 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.707 HG23 HG23 ' A' ' 319' ' ' ILE . 71.9 t -120.3 108.85 24.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 39.0 t -127.35 160.03 32.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.087 -1.008 . . . . 0.0 111.366 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.566 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -144.49 142.28 30.14 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.596 -0.69 . . . . 0.0 109.679 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -134.87 -166.12 11.03 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.64 HG21 ' CD2' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -173.16 173.11 3.7 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.019 -1.283 . . . . 0.0 111.285 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 4.5 mt-10 -153.08 176.65 2.3 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.675 -0.641 . . . . 0.0 109.524 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.561 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.8 Cg_endo -70.28 105.41 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.684 1.36 . . . . 0.0 110.782 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.586 ' HA ' ' CG1' ' A' ' 438' ' ' VAL . 8.4 t-20 80.49 34.02 0.14 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.868 -0.52 . . . . 0.0 110.631 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 172.5 105.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.837 . . . . 0.0 111.206 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -105.79 169.08 8.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.094 -1.003 . . . . 0.0 108.504 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 37.6 p-90 -168.43 172.4 8.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.603 -1.311 . . . . 0.0 110.615 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.628 ' CE1' ' HB3' ' A' ' 434' ' ' ALA . 37.6 p90 -143.78 140.94 30.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.37 -0.832 . . . . 0.0 109.923 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 12.4 tt0 -127.0 153.98 45.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.293 -0.879 . . . . 0.0 110.741 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.553 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 88.5 t -124.39 164.37 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.437 -0.79 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 357' ' ' LYS . 45.7 mt-10 -150.52 135.33 17.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.957 . . . . 0.0 109.764 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -148.67 148.63 30.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.077 -1.014 . . . . 0.0 110.594 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -82.29 158.67 23.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.332 -0.855 . . . . 0.0 110.144 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 153.96 -167.87 32.29 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 427' ' ' ARG . 45.4 Cg_endo -73.23 -26.4 14.72 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.982 1.517 . . . . 0.0 110.589 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 88.63 -171.85 40.15 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.709 HG23 " O2'" ' A' ' 451' ' ' ANP . 54.5 mt -74.91 151.62 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.293 -1.122 . . . . 0.0 110.036 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.671 ' HB3' ' HG3' ' A' ' 382' ' ' GLN . . . -73.76 169.16 19.86 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.136 -0.978 . . . . 0.0 110.011 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.653 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 47.6 Cg_endo -73.19 -38.04 2.99 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.946 1.498 . . . . 0.0 110.291 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' GLU . . . . . 0.603 ' O ' ' CD2' ' A' ' 385' ' ' HIS . 0.9 OUTLIER -90.45 -37.51 13.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.314 -0.866 . . . . 0.0 110.765 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.671 ' HG3' ' HB3' ' A' ' 379' ' ' ALA . 45.5 mt-30 -62.25 -28.47 69.73 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.259 -0.901 . . . . 0.0 110.299 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -21.51 3.98 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.955 -1.09 . . . . 0.0 109.164 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -31.6 16.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.504 -0.748 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 381' ' ' GLU . 2.1 p80 -117.47 68.95 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.878 -1.139 . . . . 0.0 111.025 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 1.128 HD11 " O4'" ' A' ' 451' ' ' ANP . 0.1 OUTLIER -109.5 71.74 0.78 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.806 ' CE2' HD12 ' A' ' 386' ' ' LEU . 48.7 p90 44.88 45.3 8.46 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-O 121.787 0.803 . . . . 0.0 110.237 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -78.15 133.52 64.65 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.181 -0.949 . . . . 0.0 110.429 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 390' ' ' PHE . 49.4 Cg_endo -79.35 174.57 11.78 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.877 1.462 . . . . 0.0 110.831 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 389' ' ' PRO . 0.3 OUTLIER 61.04 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.376 -0.828 . . . . 0.0 110.865 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 392' ' ' ARG . 11.7 p -124.49 170.91 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.52 -0.738 . . . . 0.0 110.097 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' ARG . . . . . 0.535 ' N ' HG22 ' A' ' 391' ' ' VAL . 0.0 OUTLIER -145.05 98.42 3.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.926 . . . . 0.0 110.25 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 175.43 169.44 37.17 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.25 -5.07 22.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.286 -1.126 . . . . 0.0 110.03 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 47.0 m -145.33 140.93 28.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 110.054 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 397' ' ' ARG . . . -96.61 -31.48 12.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.916 . . . . 0.0 110.181 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 396' ' ' ALA . 5.4 ttt180 60.7 49.68 6.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 88.6 m -75.02 118.67 18.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 110.22 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.602 HG23 ' N ' ' A' ' 400' ' ' SER . 6.9 tt -87.89 -42.88 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.602 ' N ' HG23 ' A' ' 399' ' ' ILE . 8.7 t -171.23 -175.76 1.75 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 110.082 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 115.96 48.8 0.48 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 402' ' ' THR . 8.3 t -94.41 142.17 27.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.203 -1.175 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 165.62 -137.44 4.69 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.84 167.4 10.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -1.167 . . . . 0.0 110.155 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -120.17 81.57 0.33 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 3.4 mp -91.17 71.12 6.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -1.115 . . . . 0.0 110.115 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 408' ' ' ILE . . . -90.73 44.29 1.19 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.295 -0.878 . . . . 0.0 110.441 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 1.028 HG12 HG23 ' A' ' 409' ' ' VAL . 0.2 OUTLIER -43.5 164.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.275 -0.89 . . . . 0.0 109.916 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 1.028 HG23 HG12 ' A' ' 408' ' ' ILE . 4.3 t 80.52 -59.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.947 -0.47 . . . . 0.0 110.42 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 42.0 tt0 -54.78 -58.84 5.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.99 -1.069 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -59.22 -19.56 46.63 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.293 -0.88 . . . . 0.0 110.685 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.532 HG21 ' HB2' ' A' ' 340' ' ' ALA . 11.0 mm -67.29 -70.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.156 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 1.04 HG21 HD13 ' A' ' 420' ' ' LEU . 22.5 t -60.89 -21.09 23.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.347 -0.846 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 5.0 t70 -77.54 -29.41 52.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -0.847 . . . . 0.0 109.841 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.596 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 0.9 OUTLIER -81.37 -14.78 56.82 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.209 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.669 ' CE1' HD11 ' A' ' 337' ' ' ILE . 31.6 m80 -93.36 -37.46 11.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.576 -0.702 . . . . 0.0 109.785 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 13.9 t-20 81.43 42.91 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 121.377 0.608 . . . . 0.0 110.455 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.578 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -111.8 -89.26 1.86 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.564 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 2.6 ttp -173.36 159.76 3.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.159 -1.2 . . . . 0.0 111.464 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 1.04 HD13 HG21 ' A' ' 413' ' ' VAL . 14.0 tp -151.02 109.08 3.72 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.373 -0.83 . . . . 0.0 109.387 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -130.07 161.32 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.923 -1.11 . . . . 0.0 111.083 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.765 HD23 ' CD1' ' A' ' 432' ' ' ILE . 2.9 mt -126.78 138.61 53.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.384 -0.823 . . . . 0.0 110.169 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.639 ' O ' HD12 ' A' ' 430' ' ' LEU . . . -135.88 161.88 24.89 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.513 ' OG1' HD12 ' A' ' 430' ' ' LEU . 0.8 OUTLIER -154.95 129.89 9.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.207 -1.172 . . . . 0.0 110.631 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 426' ' ' GLU . 5.5 t -88.85 98.97 12.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.308 -0.87 . . . . 0.0 109.142 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 425' ' ' SER . 23.5 tt0 59.36 39.4 22.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.351 -0.843 . . . . 0.0 109.733 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 376' ' ' PRO . 64.9 mmt-85 46.93 35.95 3.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.276 -0.89 . . . . 0.0 109.471 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -129.18 -44.52 0.2 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -113.09 84.44 0.36 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 423' ' ' GLY . 15.6 tp -78.4 139.92 38.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -1.169 . . . . 0.0 110.636 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 371' ' ' VAL . 23.3 t -139.3 132.39 29.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.56 -0.713 . . . . 0.0 109.857 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.765 ' CD1' HD23 ' A' ' 422' ' ' LEU . 29.1 mm -92.68 140.64 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.196 -0.94 . . . . 0.0 110.648 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -119.92 97.16 5.48 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.321 -0.862 . . . . 0.0 110.407 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.628 ' HB3' ' CE1' ' A' ' 369' ' ' PHE . . . -103.25 137.4 41.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 110.236 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 88.9 m95 -118.93 153.14 35.08 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.1 -1.0 . . . . 0.0 111.839 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.589 HD12 HD11 ' A' ' 301' ' ' LEU . 24.6 mt -145.35 100.15 4.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.578 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 41.4 Cg_endo -65.75 138.04 52.05 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.967 1.509 . . . . 0.0 111.592 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.798 HG23 ' HD2' ' A' ' 439' ' ' PRO . 2.9 p -93.24 151.2 40.19 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.706 -0.621 . . . . 0.0 109.928 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.813 ' O ' HG23 ' A' ' 441' ' ' THR . 39.5 Cg_endo -64.22 161.32 34.55 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.642 1.338 . . . . 0.0 110.205 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 439' ' ' PRO . 10.3 p -39.26 143.3 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.376 -0.828 . . . . 0.0 110.597 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.813 HG23 ' O ' ' A' ' 439' ' ' PRO . 40.5 p -143.64 -163.03 1.57 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.377 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 -139.45 82.92 1.91 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 109.989 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -131.3 109.58 10.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.371 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -107.44 -47.97 3.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.224 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 101.73 -170.02 20.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 15.0 t -89.47 140.03 29.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.314 -1.109 . . . . 0.0 110.315 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 447' ' ' THR . 4.0 t -155.72 111.94 3.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -82.56 161.34 22.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -98.08 -41.7 7.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 1.128 " O4'" HD11 ' A' ' 386' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.21 0.528 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -84.67 105.45 2.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.91 105.97 1.22 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.301 -1.117 . . . . 0.0 110.148 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 294' ' ' MET . 0.3 OUTLIER -174.25 38.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.123 -0.986 . . . . 0.0 110.509 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 293' ' ' GLU . 19.5 mtt -154.2 119.62 2.73 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.216 -0.928 . . . . 0.0 110.113 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.454 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 51.4 Cg_endo -85.84 69.26 5.03 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.875 1.46 . . . . 0.0 111.062 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.594 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -90.82 109.41 20.61 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.938 0.875 . . . . 0.0 108.98 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.2 mt-10 -134.53 -156.33 0.72 Allowed 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.73 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.778 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.7 OUTLIER -87.4 131.89 34.15 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.048 -1.033 . . . . 0.0 110.239 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -142.34 147.83 36.94 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 110.972 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 304' ' ' VAL . 1.1 m-20 -89.61 119.8 30.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.427 -0.796 . . . . 0.0 109.454 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 1.051 HD11 HD12 ' A' ' 436' ' ' LEU . 6.5 mt -62.31 -21.12 65.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.008 -1.057 . . . . 0.0 109.801 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.676 ' HA ' HD23 ' A' ' 323' ' ' LEU . 51.4 t-20 -84.25 -22.1 30.91 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.084 -1.01 . . . . 0.0 109.029 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.9 -33.38 22.77 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.714 -0.616 . . . . 0.0 109.823 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.625 ' O ' HG23 ' A' ' 308' ' ' VAL . 22.7 t -79.55 -34.72 16.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.342 -0.849 . . . . 0.0 109.407 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 94.3 mt -75.28 -31.29 60.69 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.408 -0.808 . . . . 0.0 110.161 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -63.39 -31.0 79.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -80.17 -34.07 37.86 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.39 -1.065 . . . . 0.0 109.362 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 1.057 HG11 ' CG1' ' A' ' 341' ' ' VAL . 97.7 t -74.76 -20.38 16.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.64 0.733 . . . . 0.0 109.103 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.648 HG13 HG11 ' A' ' 358' ' ' VAL . 1.1 mt -75.88 -50.87 21.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.59 -16.43 63.4 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.83 0.824 . . . . 0.0 108.929 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -62.98 -66.35 0.55 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.7 -0.625 . . . . 0.0 110.765 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.93 44.54 2.88 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.884 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.554 ' CB ' ' CD1' ' A' ' 319' ' ' ILE . 3.3 p -86.63 27.12 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.866 -1.146 . . . . 0.0 110.358 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.494 ' O ' ' HG2' ' A' ' 317' ' ' ARG . . . 43.55 42.74 6.03 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 12.7 m-85 58.86 49.37 9.91 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.702 -0.881 . . . . 0.0 109.608 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 0.7 OUTLIER 59.93 62.24 1.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.61 0.719 . . . . 0.0 110.834 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 314' ' ' GLY . 16.2 mmm180 -71.66 -82.79 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.907 0.861 . . . . 0.0 109.092 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -147.14 55.9 1.11 Allowed 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.83 HG13 HD12 ' A' ' 356' ' ' ILE . 19.6 mt -97.47 131.9 43.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.75 -0.594 . . . . 0.0 110.627 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.484 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 1.1 tp10 -91.52 107.06 18.95 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 16.9 p -94.36 122.85 37.34 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 111.133 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.1 77.06 1.48 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 302' ' ' ASN . 6.1 mp -95.47 140.6 30.1 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.373 -0.83 . . . . 0.0 109.977 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 9.8 t80 -42.68 121.84 2.81 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.447 -0.783 . . . . 0.0 109.826 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.14 59.88 7.21 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.974 1.513 . . . . 0.0 110.194 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . -158.74 20.4 0.31 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 53.8 m 55.29 100.12 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.253 -1.145 . . . . 0.0 110.363 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.686 HG22 ' H ' ' A' ' 329' ' ' GLU . 2.7 mt -76.23 -175.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 121.532 -0.73 . . . . 0.0 109.14 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.686 ' H ' HG22 ' A' ' 328' ' ' ILE . 3.4 mt-10 -171.45 110.96 0.32 Allowed 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.315 -0.866 . . . . 0.0 111.241 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.778 ' C ' ' HE2' ' A' ' 298' ' ' MET . 29.7 m -144.44 149.95 16.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 O-C-N 121.583 -0.698 . . . . 0.0 110.092 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.7 OUTLIER -68.69 98.25 0.88 Allowed 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.73 ' HB2' HG23 ' A' ' 330' ' ' VAL . 4.8 ttp -144.76 159.72 42.4 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.76 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.754 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 0.9 OUTLIER -101.88 117.02 62.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.483 ' O ' ' HE2' ' A' ' 338' ' ' LYS . 33.8 Cg_endo -54.74 -31.59 72.38 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.458 1.241 . . . . 0.0 111.429 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.754 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 6.6 mt -69.86 -69.75 0.33 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.888 -1.133 . . . . 0.0 110.428 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 335' ' ' LEU . 23.8 m -43.28 -60.36 1.72 Allowed 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.675 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.631 HD11 ' CE1' ' A' ' 416' ' ' HIS . 8.5 mm -55.41 -35.02 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.228 -0.92 . . . . 0.0 110.676 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 1.3 mtmm -56.11 -47.39 78.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.9 -1.125 . . . . 0.0 109.11 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -37.51 76.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.805 -0.559 . . . . 0.0 110.227 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.829 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -66.56 -23.87 66.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 1.057 ' CG1' HG11 ' A' ' 308' ' ' VAL . 72.6 t -89.98 -28.13 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.804 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.924 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -73.94 -30.24 62.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.371 -0.831 . . . . 0.0 109.937 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -69.23 -23.37 63.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.904 . . . . 0.0 109.913 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.489 ' HG2' HG13 ' A' ' 432' ' ' ILE . 0.3 OUTLIER -90.55 -25.19 20.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.824 . . . . 0.0 110.613 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 90.2 t -90.45 -23.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.098 -1.001 . . . . 0.0 111.107 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 342' ' ' ALA . 97.0 t -68.2 -20.11 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.984 -1.072 . . . . 0.0 110.405 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 351' ' ' TYR . 2.1 m120 -63.49 -51.78 64.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.464 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 373' ' ' ASP . . . -90.84 -19.07 23.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.402 -0.811 . . . . 0.0 111.029 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.65 -81.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.967 -1.083 . . . . 0.0 110.883 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.476 ' CG ' ' N ' ' A' ' 351' ' ' TYR . 27.7 ptt180 -92.01 -44.92 8.59 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.218 -0.926 . . . . 0.0 111.392 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' TYR . . . . . 0.476 ' N ' ' CG ' ' A' ' 350' ' ' ARG . 9.0 t80 -64.11 -40.45 96.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.209 -0.932 . . . . 0.0 110.729 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 348' ' ' ALA . . . -109.6 173.71 17.21 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -159.21 28.64 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -1.039 . . . . 0.0 109.85 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -89.29 -59.85 1.52 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.573 ' CH2' ' HB2' ' A' ' 357' ' ' LYS . 19.9 t90 -176.15 132.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -1.135 . . . . 0.0 110.132 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.83 HD12 HG13 ' A' ' 319' ' ' ILE . 5.9 mt -102.0 158.53 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.422 -0.799 . . . . 0.0 109.209 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.573 ' HB2' ' CH2' ' A' ' 355' ' ' TRP . 0.5 OUTLIER -144.09 104.93 4.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.027 -1.045 . . . . 0.0 110.654 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.68 HG23 HG23 ' A' ' 319' ' ' ILE . 41.2 t -107.94 89.88 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 108.86 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.0 t -121.01 138.4 54.18 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.387 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.559 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.1 t -120.97 145.12 48.08 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -141.45 -172.42 13.24 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -159.85 172.07 18.3 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.196 -1.179 . . . . 0.0 110.585 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.471 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -145.34 175.57 2.68 Favored Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.526 -0.734 . . . . 0.0 109.643 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 41.5 Cg_endo -68.15 111.34 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.699 1.368 . . . . 0.0 111.133 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 3.9 t-20 72.75 29.24 1.97 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.531 -0.731 . . . . 0.0 111.118 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 19.7 ptt-85 171.64 116.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.325 -0.859 . . . . 0.0 110.773 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.641 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.4 179.98 4.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.102 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.618 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 36.8 p-90 -170.55 143.93 2.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.619 -1.301 . . . . 0.0 110.309 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.634 ' HB3' HD13 ' A' ' 301' ' ' LEU . 31.8 p90 -114.16 140.28 48.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.286 -0.884 . . . . 0.0 109.257 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 432' ' ' ILE . 27.0 tt0 -130.95 149.95 52.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 111.979 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 37.7 t -128.78 150.66 34.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 357' ' ' LYS . 29.3 tt0 -150.12 140.43 22.28 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.992 -1.067 . . . . 0.0 109.692 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 348' ' ' ALA . 1.7 p30 -161.12 168.95 23.32 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.976 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.3 151.89 20.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.428 -0.795 . . . . 0.0 110.32 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 162.81 -156.46 28.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.52 ' O ' ' N7 ' ' A' ' 451' ' ' ANP . 49.9 Cg_endo -74.53 137.75 23.29 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.961 1.506 . . . . 0.0 110.614 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -92.03 -174.04 42.33 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.589 HG12 ' N9 ' ' A' ' 451' ' ' ANP . 3.2 mt -110.69 97.88 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.005 -1.291 . . . . 0.0 109.891 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.957 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -68.56 178.83 0.76 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.28 -0.888 . . . . 0.0 110.547 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.957 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 43.0 Cg_endo -70.8 -19.75 30.81 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.165 1.613 . . . . 0.0 110.012 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.46 -30.67 17.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 109.579 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.573 ' HB3' " O2'" ' A' ' 451' ' ' ANP . 3.5 mt-30 -85.0 -19.22 32.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.465 -0.772 . . . . 0.0 109.829 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.487 ' O ' ' OE1' ' A' ' 388' ' ' GLN . 36.0 ttm-85 -54.25 -52.03 62.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.395 -0.815 . . . . 0.0 110.521 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.552 ' HA ' ' OE1' ' A' ' 388' ' ' GLN . 7.7 mmtt -44.03 -18.57 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.692 -0.63 . . . . 0.0 111.828 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.608 ' O ' HD12 ' A' ' 386' ' ' LEU . 0.2 OUTLIER -111.55 42.08 1.77 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.814 -1.179 . . . . 0.0 111.642 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.608 HD12 ' O ' ' A' ' 385' ' ' HIS . 0.2 OUTLIER -169.08 104.08 0.39 Allowed 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.158 -1.589 . . . . 0.0 114.322 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.567 ' CE2' HD13 ' A' ' 422' ' ' LEU . 39.2 m-85 62.61 78.3 0.3 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.552 ' OE1' ' HA ' ' A' ' 384' ' ' LYS . 13.6 pt20 -172.8 69.46 0.39 Allowed Pre-proline 0 C--N 1.294 -1.814 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.974 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -80.75 99.75 1.16 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.98 1.516 . . . . 0.0 110.558 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' PHE . . . . . 0.52 ' C ' HG23 ' A' ' 391' ' ' VAL . 2.2 t80 -178.66 62.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.092 -1.005 . . . . 0.0 110.289 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.52 HG23 ' C ' ' A' ' 390' ' ' PHE . 4.8 t -151.37 64.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.454 -0.779 . . . . 0.0 110.547 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.0 157.05 26.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.88 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 177.01 154.37 11.91 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.71 92.56 4.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -1.105 . . . . 0.0 110.061 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 396' ' ' ALA . 10.1 t -164.12 179.69 6.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.228 -0.92 . . . . 0.0 110.289 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 395' ' ' SER . . . 60.57 112.93 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.262 -0.899 . . . . 0.0 110.074 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 398' ' ' THR . 11.0 tpt180 -110.44 159.83 17.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.466 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 397' ' ' ARG . 4.5 p 43.93 -170.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.367 -0.833 . . . . 0.0 110.581 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.483 HG13 ' N ' ' A' ' 400' ' ' SER . 2.9 tp -51.49 155.37 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.346 -0.846 . . . . 0.0 110.095 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.483 ' N ' HG13 ' A' ' 399' ' ' ILE . 3.2 m -102.44 -43.87 5.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.206 -0.934 . . . . 0.0 110.475 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 77.43 66.41 1.79 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 53.7 m -133.33 -51.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.225 -1.162 . . . . 0.0 110.156 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 146.24 77.08 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 1.2 mp -124.12 170.44 10.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.225 -1.162 . . . . 0.0 110.267 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.494 ' H ' HD23 ' A' ' 406' ' ' LEU . . . 132.28 43.8 0.16 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 405' ' ' GLY . 0.6 OUTLIER -121.92 61.87 0.95 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.254 -1.144 . . . . 0.0 110.004 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -104.12 34.6 2.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.292 -0.88 . . . . 0.0 110.725 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.665 ' O ' HG12 ' A' ' 409' ' ' VAL . 0.0 OUTLIER -110.61 159.47 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.783 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.742 ' HA ' HD13 ' A' ' 412' ' ' ILE . 0.4 OUTLIER 79.76 -35.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 121.605 -0.684 . . . . 0.0 110.47 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -69.84 -54.06 15.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.0 -1.062 . . . . 0.0 110.079 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.87 -21.11 41.26 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.28 -0.887 . . . . 0.0 110.013 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.829 HG12 ' HB2' ' A' ' 340' ' ' ALA . 1.0 OUTLIER -66.86 -59.1 4.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.822 HG11 ' HB2' ' A' ' 420' ' ' LEU . 21.2 t -67.94 -22.31 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.523 -0.736 . . . . 0.0 110.031 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -82.44 -23.45 34.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.551 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.51 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 58.8 m-20 -83.31 -21.91 33.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.517 -0.739 . . . . 0.0 109.203 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.631 ' CE1' HD11 ' A' ' 337' ' ' ILE . 37.7 m80 -92.77 -37.2 12.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.701 . . . . 0.0 109.894 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.1 OUTLIER 81.95 29.64 0.13 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.798 -0.564 . . . . 0.0 111.015 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.589 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -98.39 -90.66 1.96 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.53 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.6 tpp -175.89 161.57 2.5 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.278 -1.131 . . . . 0.0 111.168 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.822 ' HB2' HG11 ' A' ' 413' ' ' VAL . 27.0 tp -152.66 108.12 3.29 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.353 -0.842 . . . . 0.0 109.312 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.61 138.14 48.68 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.782 -1.199 . . . . 0.0 111.738 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.567 HD13 ' CE2' ' A' ' 387' ' ' PHE . 0.2 OUTLIER -90.57 130.5 36.6 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -122.56 114.84 2.56 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 119.577 -1.296 . . . . 0.0 110.006 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.0 m -66.0 102.12 0.76 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.406 -1.055 . . . . 0.0 108.651 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.53 ' CB ' ' HG3' ' A' ' 427' ' ' ARG . 33.2 t -53.63 137.29 37.44 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.274 -0.891 . . . . 0.0 110.368 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 425' ' ' SER . 6.4 pt-20 -39.23 -27.51 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.527 0.68 . . . . 0.0 109.72 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.598 ' HD3' ' N ' ' A' ' 429' ' ' GLY . 0.3 OUTLIER -74.34 24.45 0.08 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.522 -0.736 . . . . 0.0 111.381 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 53.56 38.72 58.92 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.738 ' C ' HD22 ' A' ' 430' ' ' LEU . . . -132.74 -154.14 7.47 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.738 HD22 ' C ' ' A' ' 429' ' ' GLY . 2.4 mm? -130.18 152.21 49.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.885 -1.362 . . . . 0.0 113.308 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 11.3 p -142.34 113.18 7.43 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.489 HG13 ' HG2' ' A' ' 344' ' ' MET . 21.6 mm -87.09 118.15 32.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.837 -1.165 . . . . 0.0 111.112 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' ARG . . . . . 0.412 ' HD2' ' HE1' ' A' ' 435' ' ' TRP . 2.6 ttm180 -105.52 95.29 5.71 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.62 ' HB3' ' CE2' ' A' ' 369' ' ' PHE . . . -98.82 137.52 37.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.323 -0.86 . . . . 0.0 110.998 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.618 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 92.1 m95 -109.01 155.05 21.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.848 . . . . 0.0 111.24 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 1.051 HD12 HD11 ' A' ' 301' ' ' LEU . 53.7 mt -145.63 101.05 4.32 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.589 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 39.8 Cg_endo -63.88 136.98 55.7 Favored 'Trans proline' 0 C--N 1.297 -2.142 0 O-C-N 124.069 1.562 . . . . 0.0 111.836 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.641 HG13 ' HD2' ' A' ' 439' ' ' PRO . 89.7 t -81.99 146.23 55.07 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.72 -0.612 . . . . 0.0 110.158 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.641 ' HD2' HG13 ' A' ' 438' ' ' VAL . 56.5 Cg_endo -76.53 -163.5 0.21 Allowed 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 124.196 1.629 . . . . 0.0 110.121 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.95 59.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 O-C-N 121.738 -0.601 . . . . 0.0 109.992 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 59.2 p -92.48 -32.17 14.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -0.873 . . . . 0.0 110.468 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -147.2 124.08 11.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.953 . . . . 0.0 110.313 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -94.9 140.26 30.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.097 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -144.36 154.59 43.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 131.49 102.24 0.89 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 35.0 p -140.72 152.83 45.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -1.107 . . . . 0.0 110.252 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 448' ' ' LYS . 67.8 p -100.36 -32.66 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 110.123 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 447' ' ' THR . 0.0 OUTLIER 37.7 -153.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.63 -0.669 . . . . 0.0 110.59 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.26 -68.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 110.321 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 CA-C-O 117.93 -1.483 . . . . 0.0 109.582 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.62 ' C5 ' ' HG ' ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 290' ' ' THR . 5.2 t . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.222 0.534 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 292' ' ' GLN . . . -96.94 -162.8 32.23 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLN . . . . . 0.446 ' CB ' ' O ' ' A' ' 291' ' ' GLY . 0.1 OUTLIER 66.83 32.12 6.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.174 -1.192 . . . . 0.0 110.126 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.43 62.22 0.55 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 109.723 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.587 ' CB ' ' CD ' ' A' ' 295' ' ' PRO . 1.0 OUTLIER -79.69 -172.04 0.31 Allowed Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.377 -0.827 . . . . 0.0 109.811 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 294' ' ' MET . 43.3 Cg_endo -83.21 64.77 7.82 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 O-C-N 124.026 1.54 . . . . 0.0 110.998 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.565 ' HE2' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -88.37 102.92 15.35 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.435 -0.79 . . . . 0.0 109.747 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.0 mt-10 -118.53 -167.59 1.39 Allowed 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.584 -0.697 . . . . 0.0 109.347 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 1.8 mmt -88.19 124.92 34.32 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.886 -1.134 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.686 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -143.33 150.32 39.01 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.441 0.638 . . . . 0.0 111.163 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.534 ' HB3' ' CB ' ' A' ' 303' ' ' ALA . 46.9 t0 -84.44 118.81 24.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.899 HD11 HD12 ' A' ' 436' ' ' LEU . 7.1 mt -64.46 -22.56 67.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.968 -1.082 . . . . 0.0 109.726 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.795 ' HA ' HD23 ' A' ' 323' ' ' LEU . 48.2 m-20 -81.24 -19.78 42.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 0.0 108.735 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -84.61 -35.9 22.4 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.695 -0.628 . . . . 0.0 109.485 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.805 ' O ' HG23 ' A' ' 308' ' ' VAL . 21.5 t -77.25 -34.6 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.494 -0.754 . . . . 0.0 109.267 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 91.9 mt -77.23 -28.65 53.77 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.505 -0.747 . . . . 0.0 109.68 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -63.63 -42.1 98.87 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.62 -30.46 61.67 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.477 -1.014 . . . . 0.0 109.065 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 304' ' ' VAL . 74.4 t -75.22 -21.29 16.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 1.017 ' CG1' HG11 ' A' ' 358' ' ' VAL . 3.2 mt -77.38 -41.36 29.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -64.07 -17.66 63.61 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -83.31 -43.91 15.48 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.351 0.596 . . . . 0.0 109.866 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.727 ' OE2' HG21 ' A' ' 358' ' ' VAL . 6.7 pt-20 -81.67 10.88 5.34 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.359 -0.838 . . . . 0.0 110.306 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 314' ' ' GLY . 60.5 p -117.64 69.64 0.78 Allowed 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 313' ' ' SER . . . -42.59 -30.15 0.85 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 313' ' ' SER . 28.6 t80 -162.69 36.21 0.11 Allowed 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.788 -0.831 . . . . 0.0 109.984 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.34 56.32 8.11 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.092 -1.005 . . . . 0.0 108.538 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -68.31 -55.34 12.46 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-O 121.372 0.606 . . . . 0.0 110.746 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' A' ' 355' ' ' TRP . 7.4 pt-20 -170.59 58.56 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.862 0 C-N-CA 119.471 -0.892 . . . . 0.0 112.087 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.88 HG13 HD12 ' A' ' 356' ' ' ILE . 2.2 mp -106.9 125.38 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.788 -1.195 . . . . 0.0 110.225 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.19 116.77 29.18 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 7.6 p -95.25 129.91 42.2 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.418 -0.802 . . . . 0.0 111.173 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.76 79.17 1.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.479 -0.763 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.795 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.7 mp -95.06 160.95 14.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.444 -0.785 . . . . 0.0 110.525 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.597 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 83.9 t80 -50.42 129.06 25.16 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.171 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.05 71.76 6.87 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.767 1.404 . . . . 0.0 110.695 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -179.72 28.19 0.05 OUTLIER Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.36 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 326' ' ' GLY . 29.3 m 46.59 99.12 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.079 -1.248 . . . . 0.0 110.209 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.535 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 3.0 mt -69.23 174.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 121.431 -0.793 . . . . 0.0 110.099 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 4.9 mt-10 -168.14 105.44 0.48 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.793 0.806 . . . . 0.0 110.714 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.91 HG11 ' HB3' ' A' ' 367' ' ' ALA . 9.9 m -133.42 171.45 18.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 O-C-N 121.749 -0.594 . . . . 0.0 109.751 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -87.25 90.9 8.53 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.981 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.952 ' CE ' HG21 ' A' ' 337' ' ' ILE . 16.6 ptm -142.58 162.17 36.16 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 111.15 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 23.6 t-160 -91.56 114.21 61.1 Favored Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 36.3 Cg_endo -58.35 -18.76 39.79 Favored 'Trans proline' 0 C--N 1.295 -2.243 0 O-C-N 123.388 1.204 . . . . 0.0 109.87 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.615 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -84.19 -70.62 0.56 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.392 -0.817 . . . . 0.0 110.735 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.578 ' HB3' ' CE1' ' A' ' 416' ' ' HIS . 10.6 t -51.65 -36.43 46.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 110.569 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.952 HG21 ' CE ' ' A' ' 332' ' ' MET . 37.3 mm -70.62 -43.04 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 110.091 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 4.7 tppt? -52.28 -35.03 49.11 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 120.911 -1.118 . . . . 0.0 108.866 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.15 -36.33 35.31 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.535 0.683 . . . . 0.0 109.824 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 1.089 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -56.0 -48.66 75.49 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.586 -0.697 . . . . 0.0 110.5 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.793 ' CG1' HG11 ' A' ' 308' ' ' VAL . 70.2 t -75.21 -38.33 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.513 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.752 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -50.42 -53.99 25.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.325 -0.86 . . . . 0.0 110.748 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -19.81 61.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.103 -0.998 . . . . 0.0 110.512 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 0.5 OUTLIER -69.46 -45.17 69.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.121 -0.987 . . . . 0.0 110.529 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 84.4 t -80.09 -20.59 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.431 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 342' ' ' ALA . 25.4 t -60.02 -20.59 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.124 -0.985 . . . . 0.0 110.074 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 0.6 OUTLIER -69.08 -41.88 76.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.314 -0.866 . . . . 0.0 110.475 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.694 ' HB1' ' CB ' ' A' ' 373' ' ' ASP . . . -90.29 -20.39 22.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.92 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -78.3 -52.12 9.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 110.219 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -90.43 -45.61 8.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 110.482 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 347' ' ' ASN . 1.9 m-85 -89.8 -25.88 20.85 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.231 -0.918 . . . . 0.0 110.557 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -63.96 -135.18 0.01 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -133.83 -48.83 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.205 -1.173 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' GLY . . . . . 0.479 ' O ' HG13 ' A' ' 356' ' ' ILE . . . -171.48 -87.33 0.07 OUTLIER Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.213 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.448 ' HA ' ' CG ' ' A' ' 318' ' ' GLU . 37.3 t90 -42.83 132.6 3.81 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.23 -1.159 . . . . 0.0 112.469 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.88 HD12 HG13 ' A' ' 319' ' ' ILE . 2.8 mt -125.26 145.66 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.516 ' HD3' ' HB3' ' A' ' 372' ' ' GLU . 5.9 tttt -125.54 110.67 14.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.564 -1.335 . . . . 0.0 110.372 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 1.017 HG11 ' CG1' ' A' ' 309' ' ' ILE . 22.1 t -106.24 101.74 12.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 109.266 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 33.8 m -130.02 152.49 49.42 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.562 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.2 OUTLIER -147.07 153.22 39.71 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.63 -0.669 . . . . 0.0 109.697 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -144.27 -160.67 8.59 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 108.394 -1.883 . . . . 0.0 108.394 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.2 OUTLIER -173.0 178.87 2.41 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.893 -1.357 . . . . 0.0 111.302 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.561 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 3.5 mt-10 -160.89 -178.52 0.89 Allowed Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 38.0 Cg_endo -64.41 135.34 45.72 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.245 1.129 . . . . 0.0 110.341 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.533 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 15.2 p30 39.71 33.71 0.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.764 -0.585 . . . . 0.0 110.562 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER -174.17 94.0 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.258 -0.901 . . . . 0.0 111.421 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.91 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -103.27 151.35 22.79 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.673 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 30.7 p-90 -144.68 174.07 11.29 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.362 -1.461 . . . . 0.0 111.247 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 369' ' ' PHE . 9.2 p90 -148.92 139.33 22.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.671 -0.643 . . . . 0.0 109.408 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 432' ' ' ILE . 50.1 tt0 -130.72 163.94 26.16 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.252 -0.905 . . . . 0.0 111.648 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.442 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 32.0 t -132.17 156.05 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.607 -0.683 . . . . 0.0 110.01 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 357' ' ' LYS . 10.2 tt0 -149.83 131.46 14.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.074 -1.016 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.694 ' CB ' ' HB1' ' A' ' 348' ' ' ALA . 35.9 m-20 -136.99 162.74 32.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.003 -1.061 . . . . 0.0 110.88 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -87.96 142.17 28.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.963 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 157.63 -168.4 34.31 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.46 -176.66 2.86 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 O-C-N 124.053 1.554 . . . . 0.0 110.692 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' GLY . . . . . 0.574 ' O ' ' N3 ' ' A' ' 451' ' ' ANP . . . -90.49 -131.47 4.78 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.774 HD11 HD21 ' A' ' 430' ' ' LEU . 3.1 mm -103.29 145.03 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.041 -1.27 . . . . 0.0 109.93 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.871 ' HB3' ' HB3' ' A' ' 382' ' ' GLN . . . -39.79 160.11 0.11 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.506 -0.746 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.28 -54.23 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.055 1.555 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -75.33 -23.19 57.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.82 . . . . 0.0 110.165 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.871 ' HB3' ' HB3' ' A' ' 379' ' ' ALA . 1.1 tt0 -82.92 -23.25 33.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.953 . . . . 0.0 109.682 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.18 -22.31 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.398 -0.814 . . . . 0.0 110.091 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -87.51 -35.11 18.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 0.0 110.053 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.505 ' N ' ' ND1' ' A' ' 385' ' ' HIS . 2.3 m-70 -80.52 -69.67 0.58 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.218 -0.926 . . . . 0.0 110.647 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 1.062 ' CD1' HD13 ' A' ' 422' ' ' LEU . 0.3 OUTLIER 63.86 99.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.949 ' CE2' HD21 ' A' ' 420' ' ' LEU . 2.0 m-85 62.38 35.13 15.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 386' ' ' LEU . 29.7 mt-30 -145.97 60.99 6.92 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.024 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.496 ' O ' ' CG ' ' A' ' 390' ' ' PHE . 42.0 Cg_endo -69.3 84.27 0.59 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 124.126 1.593 . . . . 0.0 110.346 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' PHE . . . . . 0.496 ' CG ' ' O ' ' A' ' 389' ' ' PRO . 12.5 m-85 -162.96 108.79 1.15 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 109.801 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 3.2 t -106.33 144.79 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.95 . . . . 0.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.02 58.24 4.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.262 -0.898 . . . . 0.0 109.907 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -88.38 37.35 3.29 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.75 -176.7 5.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -1.139 . . . . 0.0 110.215 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 396' ' ' ALA . 8.6 t -97.1 31.39 2.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 0.0 110.339 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 395' ' ' SER . . . 57.45 99.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.131 -0.981 . . . . 0.0 110.366 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.9 ttt85 -120.68 -68.75 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 0.0 110.002 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -179.93 2.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.252 -0.905 . . . . 0.0 110.148 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 18.2 tt -48.75 155.5 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.877 . . . . 0.0 110.278 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 83.1 p -123.8 80.46 1.81 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.17 -0.956 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -150.24 -85.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.414 ' O ' ' CZ ' ' A' ' 390' ' ' PHE . 0.7 OUTLIER -106.46 -94.19 0.37 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -1.166 . . . . 0.0 110.596 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 404' ' ' LEU . . . 94.28 -167.74 27.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 403' ' ' GLY . 0.3 OUTLIER 176.71 162.19 0.41 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.186 -1.185 . . . . 0.0 110.338 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -140.67 -48.33 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -165.59 24.34 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -1.207 . . . . 0.0 110.25 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -109.89 125.43 52.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.189 -0.944 . . . . 0.0 110.355 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.778 HG23 HG23 ' A' ' 409' ' ' VAL . 1.0 OUTLIER -113.04 -166.59 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 109.805 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.778 HG23 HG23 ' A' ' 408' ' ' ILE . 3.7 t 79.22 -27.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.662 0 O-C-N 121.718 -0.614 . . . . 0.0 110.699 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 19.4 tt0 -57.92 -57.53 12.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.89 -1.131 . . . . 0.0 110.139 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -63.53 -34.91 78.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 110.659 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 1.089 HG21 ' HB2' ' A' ' 340' ' ' ALA . 1.4 mp -56.37 -73.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.936 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.82 HG22 HD21 ' A' ' 417' ' ' ASN . 85.7 t -50.92 -34.54 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.457 -0.777 . . . . 0.0 110.321 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 0.1 OUTLIER -59.28 -39.39 82.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.206 -0.934 . . . . 0.0 110.138 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.536 ' O ' ' CE ' ' A' ' 296' ' ' MET . 22.5 m-80 -110.61 7.23 22.32 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.406 -0.809 . . . . 0.0 110.304 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.77 ' CG ' HD11 ' A' ' 337' ' ' ILE . 8.9 m80 -115.98 -56.95 2.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 111.577 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 1.098 ' HA ' HD23 ' A' ' 436' ' ' LEU . 0.0 OUTLIER -98.77 -87.7 0.34 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.986 -1.071 . . . . 0.0 110.944 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 149.74 -37.15 0.97 Allowed Glycine 0 C--N 1.263 -3.488 0 C-N-CA 117.791 -2.147 . . . . 0.0 109.824 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.612 ' HB3' ' HB2' ' A' ' 435' ' ' TRP . 2.7 ttp -117.08 145.6 43.65 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.139 -1.212 . . . . 0.0 111.354 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.949 HD21 ' CE2' ' A' ' 387' ' ' PHE . 23.0 tp -151.91 87.13 1.33 Allowed 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -107.94 158.51 17.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.2 -0.937 . . . . 0.0 111.3 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 1.062 HD13 ' CD1' ' A' ' 386' ' ' LEU . 0.3 OUTLIER -108.35 131.86 54.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.59 -0.694 . . . . 0.0 110.785 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 424' ' ' THR . . . -130.66 -177.88 15.13 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 429' ' ' GLY . 5.4 m 65.5 155.83 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.152 -1.205 . . . . 0.0 111.079 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.543 ' HA ' ' CD2' ' A' ' 430' ' ' LEU . 0.2 OUTLIER -178.33 -143.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.57 -0.706 . . . . 0.0 109.635 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -61.55 -13.22 19.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.088 -1.008 . . . . 0.0 109.548 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.551 ' HG2' ' N ' ' A' ' 428' ' ' GLY . 0.0 OUTLIER -72.39 -27.06 62.13 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.422 -0.799 . . . . 0.0 110.433 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.551 ' N ' ' HG2' ' A' ' 427' ' ' ARG . . . -176.94 47.76 0.1 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.738 ' O ' HG22 ' A' ' 424' ' ' THR . . . 85.16 -146.19 21.78 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 121.142 -1.211 . . . . 0.0 110.393 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.774 HD21 HD11 ' A' ' 378' ' ' ILE . 0.2 OUTLIER -141.24 160.38 40.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.55 -0.971 . . . . 0.0 109.737 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.705 ' H ' HD13 ' A' ' 430' ' ' LEU . 5.1 p -156.48 151.29 25.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.327 -0.858 . . . . 0.0 109.66 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.476 ' O ' ' HG3' ' A' ' 370' ' ' GLN . 12.8 mt -120.35 121.94 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 110.258 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' ARG . . . . . 0.455 ' HG2' ' CD ' ' A' ' 370' ' ' GLN . 12.0 mtm180 -99.42 122.88 43.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 110.113 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -122.11 133.08 54.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.673 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 86.0 m95 -110.55 135.91 50.49 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.898 -1.126 . . . . 0.0 112.888 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 1.098 HD23 ' HA ' ' A' ' 417' ' ' ASN . 6.9 mt -115.28 87.68 16.8 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 417' ' ' ASN . 47.1 Cg_endo -83.56 121.11 2.9 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 O-C-N 124.041 1.548 . . . . 0.0 111.617 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 438' ' ' VAL . 2.8 t -74.16 112.31 16.33 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.037 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 52.1 Cg_endo -71.65 -177.02 2.25 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.84 1.442 . . . . 0.0 110.995 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 37.9 t -44.0 157.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 121.682 -0.636 . . . . 0.0 110.201 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 1.6 t -134.93 -20.55 1.72 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.218 -0.926 . . . . 0.0 111.159 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -170.36 1.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.924 -1.11 . . . . 0.0 110.933 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 444' ' ' GLN . . . -129.66 93.54 3.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.449 -0.782 . . . . 0.0 110.054 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 443' ' ' ALA . 6.1 pt20 -177.73 156.54 1.13 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 169.14 -36.62 0.2 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 446' ' ' THR . 3.9 t -111.44 107.17 16.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 110.05 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.01 174.33 11.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 110.135 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.98 95.18 5.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -170.23 106.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 110.434 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.498 179.929 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.655 " O4'" HG23 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.205 0.526 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -122.1 48.9 0.92 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -134.68 100.49 4.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -1.133 . . . . 0.0 110.512 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -133.04 40.2 3.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.307 -0.871 . . . . 0.0 109.817 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.437 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 8.4 tpt -79.8 134.2 57.47 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.432 -0.792 . . . . 0.0 110.571 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 294' ' ' MET . 50.6 Cg_endo -90.36 40.61 0.41 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.849 1.447 . . . . 0.0 110.094 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.608 ' HE2' ' NE2' ' A' ' 416' ' ' HIS . 1.0 OUTLIER -114.23 105.34 13.05 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.617 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 47.0 mt-10 -136.25 -154.06 0.54 Allowed 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.454 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.683 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 1.6 mmt -87.12 132.67 33.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.921 . . . . 0.0 110.699 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.726 ' HB3' ' CG ' ' A' ' 332' ' ' MET . . . -148.05 158.2 43.93 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.088 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.7 OUTLIER -90.51 119.46 30.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.759 . . . . 0.0 109.705 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.831 HD11 HD12 ' A' ' 436' ' ' LEU . 8.4 mt -65.77 -19.9 66.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.039 -1.038 . . . . 0.0 109.645 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.801 ' HA ' HD23 ' A' ' 323' ' ' LEU . 52.0 t-20 -84.69 -19.98 31.94 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.111 -0.993 . . . . 0.0 108.913 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.9 -36.03 21.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.598 -0.689 . . . . 0.0 109.322 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.743 ' O ' HG23 ' A' ' 308' ' ' VAL . 22.3 t -78.16 -38.46 23.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.526 -0.734 . . . . 0.0 109.214 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 88.5 mt -76.92 -28.21 55.19 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.424 -0.798 . . . . 0.0 109.991 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.83 -25.24 75.36 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.832 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 3.8 mt-10 -83.85 -33.17 24.9 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.46 -1.023 . . . . 0.0 109.272 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 1.049 HG11 ' CG1' ' A' ' 341' ' ' VAL . 40.2 t -72.45 -28.73 29.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.459 -0.776 . . . . 0.0 109.118 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.6 HG13 HG11 ' A' ' 358' ' ' VAL . 4.6 mt -72.58 -57.08 7.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.77 -16.5 64.3 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.82 0.819 . . . . 0.0 109.014 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.832 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -65.94 -66.42 0.55 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.763 -0.586 . . . . 0.0 111.047 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.421 ' HG2' ' C ' ' A' ' 311' ' ' ALA . 4.5 mm-40 -127.47 42.8 3.25 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.871 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.557 ' CB ' HD13 ' A' ' 319' ' ' ILE . 7.0 p -86.11 32.1 0.62 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.878 -1.139 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 51.68 23.15 9.56 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.548 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 0.2 OUTLIER 70.59 43.65 0.74 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.844 -0.797 . . . . 0.0 110.249 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 74.58 52.02 0.09 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.486 -0.759 . . . . 0.0 110.725 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.459 ' HG3' ' HA3' ' A' ' 314' ' ' GLY . 12.8 mmm180 -68.27 -83.05 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 122.019 0.914 . . . . 0.0 109.144 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -145.82 50.03 1.2 Allowed 'General case' 0 C--N 1.268 -2.971 0 CA-C-O 122.011 0.91 . . . . 0.0 109.886 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.647 HG13 HD12 ' A' ' 356' ' ' ILE . 5.2 mt -99.46 135.8 33.28 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.24 102.93 14.33 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.32 -0.863 . . . . 0.0 109.43 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.566 ' CG2' HD13 ' A' ' 309' ' ' ILE . 19.0 p -91.63 129.1 37.66 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.409 -0.807 . . . . 0.0 111.293 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.38 78.5 1.38 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.801 HD23 ' HA ' ' A' ' 302' ' ' ASN . 6.5 mp -95.12 154.46 17.17 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.442 -0.786 . . . . 0.0 110.277 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.585 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 20.7 t80 -40.36 120.13 1.58 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.695 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -79.18 69.42 7.93 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.878 1.462 . . . . 0.0 111.366 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . -172.23 -76.46 0.05 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.6 OUTLIER 167.52 108.96 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.525 -0.985 . . . . 0.0 109.359 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 329' ' ' GLU . 3.8 mt -87.66 178.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 O-C-N 121.468 -0.77 . . . . 0.0 109.995 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.632 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.5 mt-10 -171.58 102.26 0.19 Allowed 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.566 0.698 . . . . 0.0 110.297 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 1.153 HG12 HG22 ' A' ' 438' ' ' VAL . 21.3 m -133.86 158.54 42.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.943 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.3 OUTLIER -79.41 98.81 6.9 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.726 ' CG ' ' HB3' ' A' ' 299' ' ' ALA . 4.9 ppp? -139.93 172.7 12.4 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.188 -0.945 . . . . 0.0 112.194 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.5 ' NE2' ' HB3' ' A' ' 335' ' ' LEU . 21.9 t-160 -106.92 114.62 61.4 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 37.7 Cg_endo -61.17 -21.14 70.76 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.405 1.213 . . . . 0.0 111.04 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.5 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 1.9 tp -87.78 -54.62 4.16 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.984 -1.072 . . . . 0.0 110.141 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.753 ' O ' HD12 ' A' ' 412' ' ' ILE . 0.4 OUTLIER -63.83 -25.13 68.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.286 -0.884 . . . . 0.0 110.661 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 1.042 HD11 ' CE1' ' A' ' 416' ' ' HIS . 32.0 mm -85.34 -42.56 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.633 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 11.9 mtmt -57.86 -34.91 70.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 108.06 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -72.43 -43.77 63.35 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.526 0.679 . . . . 0.0 109.991 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 1.039 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -60.89 -30.66 70.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.505 -0.747 . . . . 0.0 110.973 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 1.049 ' CG1' HG11 ' A' ' 308' ' ' VAL . 98.7 t -78.62 -40.18 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.069 -1.019 . . . . 0.0 110.541 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.94 98.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -0.898 . . . . 0.0 110.828 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ASN . . . . . 0.717 ' O ' HG12 ' A' ' 346' ' ' VAL . 1.3 t30 -58.71 -20.35 48.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.258 -0.901 . . . . 0.0 110.981 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.8 mtt -84.53 -57.64 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.054 -1.029 . . . . 0.0 110.504 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.488 HG23 HG21 ' A' ' 356' ' ' ILE . 5.4 p -63.73 -19.49 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.303 -0.873 . . . . 0.0 110.756 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 343' ' ' ASN . 9.5 p -64.64 -19.99 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.083 -1.011 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -74.07 -55.86 5.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.101 -0.999 . . . . 0.0 110.415 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -76.19 -19.56 58.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 110.623 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.12 -50.72 30.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 0.0 109.992 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 346' ' ' VAL . 6.7 mmm180 -53.6 -69.18 0.13 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -0.936 . . . . 0.0 109.715 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.57 -53.92 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 109.888 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 86.13 65.3 1.43 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -64.57 -48.89 73.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -1.204 . . . . 0.0 110.099 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . 150.92 -7.52 0.66 Allowed Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.302 -1.428 . . . . 0.0 111.205 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.549 ' CZ3' ' NH1' ' A' ' 427' ' ' ARG . 40.6 t90 -162.83 138.22 6.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.374 -1.662 . . . . 0.0 112.658 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.647 HD12 HG13 ' A' ' 319' ' ' ILE . 3.1 mt -128.3 164.87 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 372' ' ' GLU . 2.8 tttt -147.06 134.86 21.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.477 -1.389 . . . . 0.0 111.389 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.6 HG11 HG13 ' A' ' 309' ' ' ILE . 11.0 t -133.77 82.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 55.9 p -116.27 136.15 53.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.289 -0.882 . . . . 0.0 110.536 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 323' ' ' LEU . 0.8 OUTLIER -137.38 158.69 43.85 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.622 -0.673 . . . . 0.0 109.914 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -146.74 -150.26 5.15 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -165.55 177.46 7.38 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.21 -1.171 . . . . 0.0 110.077 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -152.88 175.89 2.71 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 110.165 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.7 Cg_endo -70.18 117.24 4.99 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.895 1.471 . . . . 0.0 110.892 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 48.0 t30 71.99 19.54 4.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.381 -0.824 . . . . 0.0 110.972 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 6.5 ptt180 173.73 127.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.431 -0.793 . . . . 0.0 110.834 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.727 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -114.45 -179.55 3.66 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.611 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 28.0 p-90 -169.23 162.39 10.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.449 -1.407 . . . . 0.0 110.968 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 37.9 p90 -131.6 158.66 40.44 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.512 ' CG ' ' HA ' ' A' ' 433' ' ' ARG . 2.1 mt-30 -144.89 151.35 38.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.858 -1.151 . . . . 0.0 112.228 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 57.2 t -129.88 155.03 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 357' ' ' LYS . 5.3 mt-10 -145.05 159.43 42.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.944 -1.098 . . . . 0.0 109.987 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.448 ' OD2' HD12 ' A' ' 430' ' ' LEU . 2.5 p30 -147.09 153.04 39.48 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.019 -1.05 . . . . 0.0 110.886 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.22 135.83 51.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.343 -0.848 . . . . 0.0 110.095 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 144.17 173.02 15.24 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.28 -166.83 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.846 1.445 . . . . 0.0 110.38 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -92.65 175.01 36.82 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.72 HG23 " O2'" ' A' ' 451' ' ' ANP . 3.4 mt -70.07 144.23 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -1.107 . . . . 0.0 110.138 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.707 ' HB3' ' HG3' ' A' ' 382' ' ' GLN . . . -74.13 153.94 88.48 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.141 -0.974 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.68 -21.75 21.5 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.861 1.453 . . . . 0.0 110.25 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -90.65 -30.96 16.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.266 -0.897 . . . . 0.0 110.605 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.707 ' HG3' ' HB3' ' A' ' 379' ' ' ALA . 1.2 mt-30 -90.16 -18.83 25.06 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.31 -0.869 . . . . 0.0 110.806 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 379' ' ' ALA . 45.7 ttp85 -52.72 -54.59 31.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.217 -0.927 . . . . 0.0 110.769 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -19.97 8.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.129 -0.982 . . . . 0.0 110.407 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -91.51 28.43 1.72 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.275 -0.891 . . . . 0.0 111.049 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.686 HD11 " O4'" ' A' ' 451' ' ' ANP . 0.2 OUTLIER -128.5 77.14 1.75 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.934 -1.104 . . . . 0.0 110.728 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.564 ' CG ' ' C ' ' A' ' 386' ' ' LEU . 17.5 p90 38.14 49.24 1.22 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.515 -0.741 . . . . 0.0 110.61 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.508 ' HB2' ' HD2' ' A' ' 389' ' ' PRO . 3.3 pt20 -60.06 166.77 3.4 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.592 -0.693 . . . . 0.0 109.756 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 388' ' ' GLN . 44.2 Cg_endo -71.3 175.96 8.6 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.829 1.436 . . . . 0.0 110.572 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' PHE . . . . . 0.558 ' C ' HG23 ' A' ' 391' ' ' VAL . 22.4 p90 -131.28 124.99 31.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 110.156 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.558 HG23 ' C ' ' A' ' 390' ' ' PHE . 19.9 t -153.45 44.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.589 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 393' ' ' GLY . 13.0 tpp180 -44.71 160.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.086 -1.009 . . . . 0.0 109.981 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 392' ' ' ARG . . . -57.91 -119.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 394' ' ' ASP . 28.3 p-10 -48.02 141.19 6.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.119 -1.224 . . . . 0.0 110.37 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.9 m -164.09 46.05 0.11 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 110.298 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -53.84 -89.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 0.0 109.806 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.549 ' CZ ' ' CB ' ' A' ' 397' ' ' ARG . 0.1 OUTLIER -108.69 54.09 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.892 . . . . 0.0 110.152 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 7.7 p -114.29 100.9 8.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.261 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.4 mp -106.64 -35.48 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.436 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 2.1 m 52.29 -172.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -115.13 59.63 0.41 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 26.2 m -80.64 88.18 5.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -1.142 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -172.41 75.54 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 405' ' ' GLY . 0.4 OUTLIER -79.4 96.27 5.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.265 -1.138 . . . . 0.0 110.222 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 404' ' ' LEU . . . -43.73 103.84 0.05 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 3.3 tp -153.85 -61.85 0.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.235 -1.156 . . . . 0.0 110.279 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -101.12 -165.31 1.19 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.241 -0.912 . . . . 0.0 110.263 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.787 ' O ' HG23 ' A' ' 408' ' ' ILE . 9.1 tp -168.11 88.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.122 -0.986 . . . . 0.0 110.681 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 408' ' ' ILE . 9.1 t -160.87 -37.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.183 -0.948 . . . . 0.0 109.863 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 59.4 tt0 -67.9 -57.43 6.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.128 -0.982 . . . . 0.0 109.687 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.572 ' O ' ' ND2' ' A' ' 415' ' ' ASN . 0.4 OUTLIER -56.11 -18.73 10.65 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.245 -0.909 . . . . 0.0 110.297 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 1.039 HG21 ' HB2' ' A' ' 340' ' ' ALA . 18.1 mm -63.47 -71.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.113 -0.992 . . . . 0.0 109.538 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 420' ' ' LEU . 10.8 t -64.36 -21.3 28.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 109.23 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 4.8 t0 -81.22 -20.41 41.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.512 -0.743 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 411' ' ' ARG . 1.2 m-80 -77.5 -23.73 50.24 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 1.042 ' CE1' HD11 ' A' ' 337' ' ' ILE . 55.2 m80 -91.24 -17.14 26.49 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.703 -0.623 . . . . 0.0 109.367 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.567 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 34.4 m120 67.82 10.49 7.83 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.327 0.584 . . . . 0.0 110.317 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 435' ' ' TRP . . . -69.86 -87.55 0.11 Allowed Glycine 0 N--CA 1.482 1.726 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.577 ' O ' HG11 ' A' ' 413' ' ' VAL . 0.3 OUTLIER 178.02 166.08 0.73 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 111.208 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 413' ' ' VAL . 42.5 tp -151.56 118.81 5.94 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 109.324 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -129.03 147.86 50.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.969 -1.082 . . . . 0.0 111.356 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.95 127.3 45.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.433 -0.792 . . . . 0.0 109.311 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -176.85 -176.18 44.78 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.807 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.668 HG23 ' N ' ' A' ' 429' ' ' GLY . 74.6 m -90.07 136.28 33.14 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.379 -1.071 . . . . 0.0 110.387 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.586 ' HB3' ' CB ' ' A' ' 431' ' ' SER . 8.5 t -108.45 178.62 4.44 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.358 -0.838 . . . . 0.0 109.763 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 428' ' ' GLY . 2.9 pp20? -44.57 -20.14 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.032 0.444 . . . . 0.0 111.041 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.549 ' NH1' ' CZ3' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -67.45 5.26 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.004 -1.06 . . . . 0.0 110.264 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 426' ' ' GLU . . . 64.78 36.99 93.77 Favored Glycine 0 C--O 1.216 -0.976 0 N-CA-C 108.806 -1.717 . . . . 0.0 108.806 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 424' ' ' THR . . . 170.74 -165.71 38.92 Favored Glycine 0 N--CA 1.505 3.244 0 C-N-CA 117.623 -2.227 . . . . 0.0 113.224 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.668 HD13 ' N ' ' A' ' 431' ' ' SER . 0.2 OUTLIER -35.19 123.21 0.6 Allowed 'General case' 0 N--CA 1.515 2.777 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.668 ' N ' HD13 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -153.76 115.22 4.18 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.645 HD11 ' N1 ' ' A' ' 451' ' ' ANP . 31.8 mt -97.55 145.59 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 110.722 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' ARG . . . . . 0.512 ' HA ' ' CG ' ' A' ' 370' ' ' GLN . 20.2 mtp180 -126.76 144.11 51.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 109.87 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -139.77 132.68 29.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.615 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.611 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 87.5 m95 -111.46 157.98 19.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.044 -1.035 . . . . 0.0 112.082 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.831 HD12 HD11 ' A' ' 301' ' ' LEU . 75.4 mt -147.26 127.62 6.84 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.446 ' C ' ' HD3' ' A' ' 439' ' ' PRO . 43.1 Cg_endo -70.13 141.41 43.68 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.522 1.275 . . . . 0.0 111.845 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 1.153 HG22 HG12 ' A' ' 330' ' ' VAL . 53.7 t -110.67 74.05 0.88 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.577 -0.702 . . . . 0.0 110.416 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.558 ' O ' HG23 ' A' ' 440' ' ' VAL . 49.1 Cg_endo -75.37 75.14 3.96 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.829 1.436 . . . . 0.0 110.979 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.571 HG21 ' SD ' ' A' ' 298' ' ' MET . 11.0 t -154.17 -55.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.048 -1.033 . . . . 0.0 110.506 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 10.0 t -48.15 -28.83 3.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.328 -0.857 . . . . 0.0 111.058 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 443' ' ' ALA . 0.0 OUTLIER -103.9 -176.45 3.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.988 -1.07 . . . . 0.0 110.448 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 443' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 442' ' ' ARG . . . -178.71 39.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.24 -0.912 . . . . 0.0 110.2 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' GLN . . . . . 0.401 ' OE1' ' HD2' ' A' ' 442' ' ' ARG . 33.2 mt-30 -84.07 -68.94 0.68 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.212 -0.93 . . . . 0.0 110.417 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 172.17 -62.07 0.15 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 15.0 t -134.77 177.06 8.09 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.208 -1.172 . . . . 0.0 110.24 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 38.3 p -132.03 44.36 2.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.371 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -138.78 88.83 2.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.94 . . . . 0.0 110.237 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -154.71 156.24 36.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.234 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.568 -179.981 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.72 " O2'" HG23 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 290' ' ' THR . 10.0 t . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.235 0.54 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -162.31 -166.83 21.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.92 69.64 1.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -1.091 . . . . 0.0 110.021 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -131.41 35.49 3.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 0.0 110.598 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.555 ' HB3' ' CD ' ' A' ' 295' ' ' PRO . 0.0 OUTLIER -90.15 -178.23 0.93 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.28 -0.887 . . . . 0.0 109.622 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.595 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 46.3 Cg_endo -89.19 45.85 0.88 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.77 1.405 . . . . 0.0 109.871 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.471 ' HE2' ' NE2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -109.49 109.26 20.03 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.4 OUTLIER -148.14 -146.93 0.21 Allowed 'General case' 0 C--N 1.273 -2.737 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.521 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -88.04 144.86 26.28 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.227 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.98 162.84 40.83 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.358 -0.839 . . . . 0.0 111.201 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.714 ' O ' HG23 ' A' ' 304' ' ' VAL . 71.4 m-20 -94.32 118.76 32.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.543 -0.723 . . . . 0.0 109.363 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.907 HD11 HD12 ' A' ' 436' ' ' LEU . 5.5 mt -69.82 -21.46 63.38 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.949 -1.095 . . . . 0.0 109.765 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.713 ' OD1' HD23 ' A' ' 323' ' ' LEU . 55.9 t-20 -84.99 -20.04 31.13 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.092 -1.005 . . . . 0.0 108.86 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.598 ' HB3' ' HB2' ' A' ' 300' ' ' ASP . . . -87.32 -34.63 18.8 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.546 0.689 . . . . 0.0 109.506 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 300' ' ' ASP . 18.0 t -80.42 -31.43 12.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.411 -0.805 . . . . 0.0 109.245 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.534 ' CD2' HG21 ' A' ' 341' ' ' VAL . 62.9 mt -80.52 -30.68 37.2 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.433 -0.792 . . . . 0.0 109.969 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -69.52 -32.48 71.38 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.841 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 1.2 mt-10 -78.1 -34.29 50.19 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.405 -1.056 . . . . 0.0 109.043 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 1.057 HG11 ' HB ' ' A' ' 341' ' ' VAL . 88.2 t -78.87 -19.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 121.664 0.745 . . . . 0.0 109.531 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.997 HD11 ' CG1' ' A' ' 358' ' ' VAL . 0.0 OUTLIER -75.79 -44.09 39.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 122.052 0.93 . . . . 0.0 108.617 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.473 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -91.06 -16.55 27.69 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.282 -0.886 . . . . 0.0 109.735 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -60.42 -62.38 1.9 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.668 -0.645 . . . . 0.0 110.838 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.725 ' CD ' ' HB1' ' A' ' 342' ' ' ALA . 2.7 pt-20 -145.99 38.06 1.08 Allowed 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.94 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.997 ' O ' HD11 ' A' ' 319' ' ' ILE . 6.9 m -91.4 31.41 1.16 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 109.339 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 94.36 21.23 27.66 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 3.0 m-85 62.46 45.55 6.34 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.674 -0.898 . . . . 0.0 109.735 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 1.9 mt-10 59.44 43.24 16.6 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.562 ' CG ' ' N ' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -69.07 -84.98 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.571 0.701 . . . . 0.0 110.041 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.562 ' N ' ' CG ' ' A' ' 317' ' ' ARG . 38.8 mt-10 -136.35 67.81 1.45 Allowed 'General case' 0 C--N 1.275 -2.653 0 CA-C-O 121.608 0.718 . . . . 0.0 111.027 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.997 HD11 ' O ' ' A' ' 313' ' ' SER . 2.6 mp -113.13 129.08 69.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.712 -0.618 . . . . 0.0 109.632 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 358' ' ' VAL . 1.5 tt0 -89.1 100.73 13.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.072 -1.018 . . . . 0.0 109.321 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 19.9 p -92.17 130.31 37.92 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.781 0.801 . . . . 0.0 111.697 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.12 78.61 1.34 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.713 HD23 ' OD1' ' A' ' 302' ' ' ASN . 0.9 OUTLIER -89.34 160.51 16.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 111.002 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 50.8 t80 -59.49 119.4 39.45 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.548 -0.72 . . . . 0.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.22 73.0 5.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.889 1.468 . . . . 0.0 110.573 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -172.06 27.48 0.1 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 326' ' ' GLY . 0.8 OUTLIER 47.12 96.79 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.186 -1.185 . . . . 0.0 110.145 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.663 HG22 ' H ' ' A' ' 329' ' ' GLU . 3.1 mt -73.06 -179.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.658 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.663 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.2 mt-10 -169.48 107.66 0.4 Allowed 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.91 0.862 . . . . 0.0 111.128 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.811 HG11 ' HB3' ' A' ' 367' ' ' ALA . 31.6 m -141.38 153.13 19.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 5.3 tptt -67.55 97.87 0.63 Allowed 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 118.359 -1.336 . . . . 0.0 107.9 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.84 ' SD ' HD13 ' A' ' 436' ' ' LEU . 4.9 ttp -139.69 173.6 11.37 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.469 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.614 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 23.7 t-160 -117.11 113.26 39.45 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 37.5 Cg_endo -59.9 -20.08 58.07 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.553 1.291 . . . . 0.0 110.634 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.614 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -79.24 -63.01 1.52 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.305 -0.872 . . . . 0.0 110.212 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 412' ' ' ILE . 27.1 p -55.77 -46.93 77.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.108 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.741 HD11 ' CE1' ' A' ' 416' ' ' HIS . 23.6 mm -63.34 -32.35 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.386 -0.821 . . . . 0.0 110.05 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 10.3 mttt -59.27 -45.7 90.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.041 -1.037 . . . . 0.0 109.5 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -31.82 63.59 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.843 -0.536 . . . . 0.0 110.745 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.979 ' HA ' HG12 ' A' ' 409' ' ' VAL . . . -65.03 -45.24 86.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.155 -0.965 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 1.057 ' HB ' HG11 ' A' ' 308' ' ' VAL . 16.0 t -81.1 -22.21 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 110.291 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.725 ' HB1' ' CD ' ' A' ' 312' ' ' GLU . . . -71.37 -34.73 70.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.325 -0.859 . . . . 0.0 110.682 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -83.27 -19.72 35.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.204 -0.935 . . . . 0.0 110.559 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.529 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 0.1 OUTLIER -75.36 -31.32 60.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.179 -0.951 . . . . 0.0 111.063 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.745 HG13 HG21 ' A' ' 356' ' ' ILE . 9.6 t -90.66 -20.26 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.956 -1.09 . . . . 0.0 110.608 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 342' ' ' ALA . 47.9 t -77.25 -20.95 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 0.0 110.908 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 344' ' ' MET . 2.8 p30 -78.11 -38.81 43.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.97 -1.081 . . . . 0.0 110.715 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 347' ' ' ASN . . . -90.24 -20.74 22.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.123 -0.986 . . . . 0.0 110.464 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -78.1 -26.66 48.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.132 -0.98 . . . . 0.0 110.68 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -89.05 -71.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -0.962 . . . . 0.0 110.694 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -75.69 -32.26 60.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 110.52 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.507 ' HA2' ' HA2' ' A' ' 375' ' ' GLY . . . -65.87 172.04 25.52 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -67.82 0.37 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -1.116 . . . . 0.0 110.052 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 318' ' ' GLU . . . 163.26 40.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -140.37 120.98 14.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.062 -1.258 . . . . 0.0 110.866 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.745 HG21 HG13 ' A' ' 345' ' ' VAL . 1.8 mp -123.37 124.21 69.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.647 -0.658 . . . . 0.0 109.339 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 372' ' ' GLU . 0.0 OUTLIER -89.46 105.08 17.56 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.981 -1.075 . . . . 0.0 109.895 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.997 ' CG1' HD11 ' A' ' 309' ' ' ILE . 74.8 t -102.5 120.28 52.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.316 -0.865 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.429 ' OG ' ' HD3' ' A' ' 357' ' ' LYS . 0.9 OUTLIER -145.84 140.34 27.0 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.214 -0.929 . . . . 0.0 110.206 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 369' ' ' PHE . 8.9 t -132.49 135.5 46.06 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.466 -0.771 . . . . 0.0 109.99 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.474 ' C ' HG22 ' A' ' 362' ' ' THR . . . -130.88 -160.71 10.05 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.64 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -173.51 165.39 4.63 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.913 -1.346 . . . . 0.0 111.336 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.483 ' HB2' ' CD ' ' A' ' 366' ' ' ARG . 1.0 OUTLIER -147.94 178.12 1.56 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.6 Cg_endo -71.71 110.85 2.99 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.713 1.375 . . . . 0.0 110.599 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 438' ' ' VAL . 0.1 OUTLIER 74.96 27.15 1.2 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.383 -0.823 . . . . 0.0 110.99 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 437' ' ' PRO . 0.2 OUTLIER 179.13 97.39 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.257 -0.902 . . . . 0.0 111.667 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.811 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -99.62 166.84 10.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.149 -0.97 . . . . 0.0 108.396 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.688 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 40.9 p-90 -164.89 174.41 10.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.437 -1.414 . . . . 0.0 111.862 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.547 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 51.8 p90 -150.11 129.36 12.82 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -112.24 155.23 24.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.146 -0.972 . . . . 0.0 111.236 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 432' ' ' ILE . 0.7 OUTLIER -138.07 126.48 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.598 -0.689 . . . . 0.0 109.877 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 357' ' ' LYS . 18.9 tt0 -128.31 106.14 8.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.249 -0.907 . . . . 0.0 109.79 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.493 ' HB3' ' HA ' ' A' ' 356' ' ' ILE . 15.7 p30 -120.02 167.65 11.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.957 -1.089 . . . . 0.0 110.421 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -108.06 101.21 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.385 -0.822 . . . . 0.0 110.501 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' GLY . . . . . 0.507 ' HA2' ' HA2' ' A' ' 352' ' ' GLY . . . -116.12 -138.97 6.5 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.77 -60.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.017 1.535 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' A' ' 430' ' ' LEU . . . 119.69 -179.56 16.6 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 430' ' ' LEU . 1.4 mm -110.59 93.94 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.279 . . . . 0.0 109.998 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -44.38 167.11 0.1 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 42.1 Cg_endo -68.19 -28.24 34.27 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.564 1.297 . . . . 0.0 110.666 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -90.88 -19.91 22.84 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.111 -0.993 . . . . 0.0 111.655 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.638 ' HB3' " O2'" ' A' ' 451' ' ' ANP . 6.1 mt-30 -80.86 -20.01 43.24 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.84 -1.162 . . . . 0.0 111.542 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.55 -24.27 20.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.91 -1.119 . . . . 0.0 110.746 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -75.52 -33.77 60.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.005 -1.059 . . . . 0.0 110.25 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.63 ' O ' HD12 ' A' ' 386' ' ' LEU . 2.6 m-70 -88.32 54.4 3.05 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.176 -0.953 . . . . 0.0 110.2 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.662 HD11 " O4'" ' A' ' 451' ' ' ANP . 0.1 OUTLIER -151.77 103.05 2.9 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.019 -1.05 . . . . 0.0 111.095 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 386' ' ' LEU . 30.1 m-85 65.9 75.01 0.35 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.609 0.719 . . . . 0.0 111.291 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -117.78 62.75 4.09 Favored Pre-proline 0 C--N 1.296 -1.743 0 O-C-N 121.627 -0.67 . . . . 0.0 109.553 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.565 ' O ' ' CD1' ' A' ' 390' ' ' PHE . 44.9 Cg_endo -71.38 114.48 3.94 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.975 1.513 . . . . 0.0 110.407 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 389' ' ' PRO . 49.3 m-85 -153.06 -165.81 2.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 110.062 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.39 132.54 33.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 110.211 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.55 -52.9 1.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.902 . . . . 0.0 110.355 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 116.51 172.39 16.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 394' ' ' ASP . 17.4 p30 -130.06 157.75 41.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -1.174 . . . . 0.0 110.304 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 396' ' ' ALA . 3.3 m -70.7 104.03 2.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.322 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 397' ' ' ARG . . . 55.16 -99.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.438 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 396' ' ' ALA . 0.2 OUTLIER 171.63 70.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.028 -1.045 . . . . 0.0 110.169 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 398' ' ' THR . 5.4 t -76.52 162.28 27.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.187 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 399' ' ' ILE . 2.1 mp -74.32 135.65 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 110.092 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 399' ' ' ILE . 0.4 OUTLIER 61.46 122.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.257 -0.902 . . . . 0.0 110.279 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 113.7 42.5 0.87 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 18.0 p -69.62 -49.44 53.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.332 -1.099 . . . . 0.0 110.203 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.458 ' O ' HD22 ' A' ' 404' ' ' LEU . . . -117.73 173.14 14.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 403' ' ' GLY . 0.4 OUTLIER -127.31 156.68 41.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -1.134 . . . . 0.0 110.201 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -138.27 114.62 1.08 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.82 -13.62 13.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.305 -1.115 . . . . 0.0 110.252 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 410' ' ' GLN . . . -75.89 144.82 40.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.423 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.699 ' O ' HD13 ' A' ' 412' ' ' ILE . 2.9 mp -99.19 -10.85 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.979 HG12 ' HA ' ' A' ' 340' ' ' ALA . 27.4 m -122.36 -7.94 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.319 -0.863 . . . . 0.0 109.859 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 407' ' ' ALA . 48.2 tt0 -74.47 -50.07 19.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.196 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -20.99 66.17 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.427 -0.796 . . . . 0.0 110.157 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.699 HD13 ' O ' ' A' ' 408' ' ' ILE . 1.1 mp -71.19 -63.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.269 -0.894 . . . . 0.0 108.726 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 420' ' ' LEU . 15.5 t -64.14 -21.71 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.638 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 1.9 m-20 -79.23 -32.7 43.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.408 -0.808 . . . . 0.0 109.814 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -78.72 -28.33 45.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 109.33 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.741 ' CE1' HD11 ' A' ' 337' ' ' ILE . 30.2 m80 -81.62 -38.8 25.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.414 -0.804 . . . . 0.0 109.391 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 1.0 OUTLIER 82.24 45.24 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 CA-C-O 121.364 0.602 . . . . 0.0 110.943 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.589 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -112.28 -88.62 1.78 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.593 ' HE1' ' NE1' ' A' ' 435' ' ' TRP . 28.5 ttp -178.66 157.82 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -1.205 . . . . 0.0 112.254 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.666 ' HB2' HG11 ' A' ' 413' ' ' VAL . 57.0 tp -153.02 95.6 1.99 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 0.5 OUTLIER -115.86 155.89 27.1 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.759 -1.213 . . . . 0.0 112.786 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.862 HD12 HG12 ' A' ' 432' ' ' ILE . 2.7 tp -106.15 140.21 39.47 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -141.81 83.01 0.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 430' ' ' LEU . 20.5 m -84.52 121.51 27.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.254 -1.145 . . . . 0.0 110.85 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 426' ' ' GLU . 0.5 OUTLIER -75.38 100.3 4.39 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 425' ' ' SER . 19.9 tt0 37.64 62.22 0.91 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.123 0.487 . . . . 0.0 110.601 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.486 ' HB3' ' NH1' ' A' ' 427' ' ' ARG . 0.0 OUTLIER 41.32 49.81 3.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 110.221 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -139.61 -49.42 0.05 OUTLIER Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -123.49 88.77 0.4 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.286 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.76 HD11 HD11 ' A' ' 378' ' ' ILE . 0.2 OUTLIER -70.5 121.46 17.84 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.12 -1.224 . . . . 0.0 110.151 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.54 ' O ' ' CG1' ' A' ' 432' ' ' ILE . 3.0 t -122.23 177.03 5.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.943 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.862 HG12 HD12 ' A' ' 422' ' ' LEU . 10.1 mt -156.92 114.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.254 -0.904 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -90.57 100.69 13.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.346 -0.846 . . . . 0.0 110.334 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.547 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -94.65 132.04 39.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.134 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.688 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.5 m95 -116.38 156.74 26.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.784 -1.198 . . . . 0.0 113.098 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.907 HD12 HD11 ' A' ' 301' ' ' LEU . 67.8 mt -146.34 100.81 4.11 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.589 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 44.9 Cg_endo -71.53 143.82 43.49 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 123.961 1.506 . . . . 0.0 112.441 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.636 HG23 ' HA ' ' A' ' 330' ' ' VAL . 5.9 p -117.5 122.78 30.51 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.58 -163.85 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.77 1.405 . . . . 0.0 110.657 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.08 103.54 15.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.388 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 442' ' ' ARG . 28.7 p -110.19 163.05 13.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.387 -0.821 . . . . 0.0 109.964 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' A' ' 443' ' ' ALA . 0.3 OUTLIER 67.36 136.86 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.143 -0.973 . . . . 0.0 110.173 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 443' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 442' ' ' ARG . . . 61.39 177.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.194 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -128.33 5.09 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.877 . . . . 0.0 110.261 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 176.69 -69.15 0.08 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 4.4 t -174.65 139.86 0.57 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -1.145 . . . . 0.0 110.196 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 29.4 p -90.0 45.92 1.31 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.168 -0.957 . . . . 0.0 110.265 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 107.78 11.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.331 -0.856 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -103.57 138.98 39.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.304 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.756 " H1'" HD12 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.276 0.56 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.54 55.81 1.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 293' ' ' GLU . 1.0 OUTLIER -173.33 77.23 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -1.14 . . . . 0.0 110.0 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 292' ' ' GLN . 2.3 mt-10 -157.29 46.22 0.39 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 110.255 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.476 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 10.0 ptm -146.62 132.82 9.58 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.943 . . . . 0.0 110.412 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.581 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 48.5 Cg_endo -85.69 52.38 3.09 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.916 1.482 . . . . 0.0 110.164 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.634 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -93.41 110.17 21.73 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.076 0.941 . . . . 0.0 108.9 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.4 mt-10 -133.27 -172.4 2.94 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.824 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -87.48 140.35 29.62 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.759 0.79 . . . . 0.0 109.958 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -157.36 169.31 25.02 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.435 0.636 . . . . 0.0 110.037 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 304' ' ' VAL . 57.4 m-20 -96.14 119.51 34.75 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.561 -0.712 . . . . 0.0 109.171 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.812 HD21 ' SD ' ' A' ' 332' ' ' MET . 8.1 mt -62.24 -25.6 67.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.997 -1.064 . . . . 0.0 109.299 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.89 ' HA ' HD23 ' A' ' 323' ' ' LEU . 55.1 t-20 -76.19 -23.24 54.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.977 -1.077 . . . . 0.0 108.503 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -82.92 -33.48 26.83 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 308' ' ' VAL . 47.8 t -74.94 -38.34 43.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.616 0.722 . . . . 0.0 109.161 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.593 HD13 ' OG ' ' A' ' 360' ' ' SER . 92.2 mt -75.13 -27.06 59.64 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.466 -0.772 . . . . 0.0 109.982 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.43 -35.9 92.52 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.52 -34.31 54.07 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.417 -1.049 . . . . 0.0 108.673 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.859 HG11 ' HB ' ' A' ' 341' ' ' VAL . 50.7 t -75.68 -18.6 15.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 121.554 0.692 . . . . 0.0 109.148 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.527 ' HA ' ' HG2' ' A' ' 312' ' ' GLU . 1.4 mt -78.77 -45.0 25.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.5 -18.27 65.19 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -91.19 -34.08 15.15 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.766 -0.584 . . . . 0.0 111.144 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.906 ' OE2' HG21 ' A' ' 358' ' ' VAL . 18.9 pt-20 -86.15 16.95 3.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.083 -1.011 . . . . 0.0 110.723 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.5 m -122.57 67.66 0.95 Allowed 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -56.67 -42.63 91.16 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.443 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 0.3 OUTLIER -136.79 24.01 3.1 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.307 -1.114 . . . . 0.0 111.004 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 2.5 mt-10 60.96 57.46 2.56 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.915 -1.116 . . . . 0.0 108.441 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -66.51 -76.08 0.08 Allowed 'General case' 0 C--N 1.278 -2.526 0 CA-C-O 121.616 0.722 . . . . 0.0 109.722 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 355' ' ' TRP . 7.1 pt-20 -170.52 56.67 0.03 OUTLIER 'General case' 0 C--N 1.265 -3.086 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.863 HG13 HD12 ' A' ' 356' ' ' ILE . 1.8 mp -91.28 129.76 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.444 -0.903 . . . . 0.0 109.974 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -104.3 111.05 23.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.232 -0.918 . . . . 0.0 109.673 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.404 HG22 ' CD1' ' A' ' 309' ' ' ILE . 17.7 p -89.01 126.9 35.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.3 -0.875 . . . . 0.0 110.702 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ALA . . . . . 0.441 ' HB3' ' OG ' ' A' ' 359' ' ' SER . . . -149.36 79.54 1.4 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.576 -0.702 . . . . 0.0 109.341 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.89 HD23 ' HA ' ' A' ' 302' ' ' ASN . 4.7 mp -95.33 150.22 20.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.488 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.574 ' HB2' ' HA2' ' A' ' 361' ' ' GLY . 89.6 t80 -37.33 129.88 0.82 Allowed Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.576 -0.703 . . . . 0.0 110.678 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.39 82.66 1.35 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.924 1.486 . . . . 0.0 109.515 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . 162.56 -11.13 0.1 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.682 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.2 OUTLIER 79.85 120.55 0.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.329 -1.101 . . . . 0.0 109.951 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 329' ' ' GLU . 1.6 mm -72.29 -176.02 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 CA-C-O 121.704 0.764 . . . . 0.0 109.93 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 328' ' ' ILE . 3.2 mt-10 -170.19 105.19 0.3 Allowed 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.561 0.696 . . . . 0.0 109.953 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 298' ' ' MET . 2.7 m -150.52 169.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-O 121.541 0.686 . . . . 0.0 110.653 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -96.63 94.02 7.09 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.812 ' SD ' HD21 ' A' ' 301' ' ' LEU . 0.0 OUTLIER -148.44 133.65 18.37 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.764 0.792 . . . . 0.0 110.027 -179.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.582 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 19.1 t-160 -55.48 113.17 5.12 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.722 -0.611 . . . . 0.0 109.913 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 40.6 Cg_endo -66.5 -19.56 54.75 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.816 1.429 . . . . 0.0 110.096 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.582 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -74.59 -68.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 0.0 109.835 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.765 ' O ' HD12 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -47.56 -40.9 20.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.557 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.724 HD11 ' CE1' ' A' ' 416' ' ' HIS . 11.9 mm -64.15 -46.83 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 109.316 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.556 ' HG3' HG22 ' A' ' 308' ' ' VAL . 0.0 OUTLIER -43.72 -47.67 7.88 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.355 -0.841 . . . . 0.0 109.555 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -70.67 -35.45 72.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.569 -0.707 . . . . 0.0 110.641 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.601 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -58.66 -32.34 69.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.414 -0.804 . . . . 0.0 111.089 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.859 ' HB ' HG11 ' A' ' 308' ' ' VAL . 32.3 t -90.24 -28.24 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.97 -1.081 . . . . 0.0 111.009 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.73 -19.68 57.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.976 -1.078 . . . . 0.0 110.753 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.3 -19.74 23.72 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.116 -0.99 . . . . 0.0 110.992 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.478 ' SD ' ' HB ' ' A' ' 432' ' ' ILE . 6.3 mtt -82.23 -23.76 35.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.09 -1.006 . . . . 0.0 111.357 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.504 HG11 ' OE1' ' A' ' 312' ' ' GLU . 28.0 m -90.7 -23.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.044 -1.035 . . . . 0.0 111.395 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.88 -29.96 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.914 -1.116 . . . . 0.0 110.533 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 66.3 t30 -65.77 -34.16 77.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.179 -0.951 . . . . 0.0 110.438 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -89.72 -22.97 21.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 110.507 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.31 -51.44 60.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.108 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 351' ' ' TYR . 4.1 mmt180 -90.5 -65.28 1.03 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.299 -0.876 . . . . 0.0 110.872 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 347' ' ' ASN . 0.9 OUTLIER -38.54 -72.0 0.07 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.381 -0.824 . . . . 0.0 110.74 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -129.5 100.6 0.5 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.585 ' O ' ' ND2' ' A' ' 353' ' ' ASN . 2.0 p-10 -86.38 86.42 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -1.151 . . . . 0.0 109.789 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' GLY . . . . . 0.451 ' O ' ' OE1' ' A' ' 318' ' ' GLU . . . -123.16 -35.35 0.72 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.584 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 14.3 t90 179.81 124.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.031 -1.276 . . . . 0.0 110.863 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.863 HD12 HG13 ' A' ' 319' ' ' ILE . 1.5 mt -105.98 143.71 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.584 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 13.4 tttt -134.43 106.44 7.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.827 -1.171 . . . . 0.0 111.359 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.906 HG21 ' OE2' ' A' ' 312' ' ' GLU . 88.8 t -98.52 83.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 370' ' ' GLN . 30.2 t -116.39 141.36 48.27 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.357 -0.839 . . . . 0.0 111.272 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.593 ' OG ' HD13 ' A' ' 305' ' ' LEU . 3.9 m -134.23 168.29 19.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 109.124 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -161.77 -159.47 10.18 Favored Glycine 0 C--N 1.292 -1.868 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -177.18 164.39 2.2 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.369 -1.077 . . . . 0.0 110.032 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.507 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 3.9 mt-10 -141.72 -179.83 1.06 Allowed Pre-proline 0 C--N 1.29 -2.0 0 O-C-N 121.636 -0.665 . . . . 0.0 109.522 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 44.3 Cg_endo -71.63 116.8 4.85 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.682 1.359 . . . . 0.0 111.191 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 5.4 m-20 80.01 25.41 0.37 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.874 -0.517 . . . . 0.0 111.509 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.586 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 167.34 111.67 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.319 -0.863 . . . . 0.0 111.473 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -104.41 174.65 5.78 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.194 -0.941 . . . . 0.0 108.876 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.629 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 47.8 p-90 -170.84 174.76 4.73 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.402 -1.436 . . . . 0.0 111.475 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.572 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 34.2 p90 -144.21 134.72 24.71 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.52 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 5.3 tt0 -127.54 149.76 50.0 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.938 -1.101 . . . . 0.0 112.432 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.52 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 98.4 t -125.23 135.04 65.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -130.03 147.16 51.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 109.946 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.569 ' OD2' ' N6 ' ' A' ' 451' ' ' ANP . 40.6 p30 -143.51 157.99 44.0 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 375' ' ' GLY . 0.8 OUTLIER -91.67 159.54 15.81 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 110.077 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 375' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 374' ' ' ASP . . . 135.3 -159.4 24.05 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.508 ' O ' ' C2 ' ' A' ' 451' ' ' ANP . 46.5 Cg_endo -73.65 157.48 48.37 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.894 1.471 . . . . 0.0 110.397 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' GLY . . . . . 0.756 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -87.59 -144.76 9.38 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.851 HD11 ' HG ' ' A' ' 430' ' ' LEU . 0.7 OUTLIER -106.2 98.03 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.144 -1.21 . . . . 0.0 109.486 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -52.33 171.75 0.2 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.524 -0.735 . . . . 0.0 110.99 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 44.8 Cg_endo -72.55 -47.38 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 124.134 1.597 . . . . 0.0 109.458 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -25.07 68.2 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.408 -0.807 . . . . 0.0 109.094 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 0.3 OUTLIER -86.58 -20.62 27.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.506 -0.746 . . . . 0.0 109.556 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 386' ' ' LEU . 0.2 OUTLIER -60.85 -32.88 72.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.467 -0.771 . . . . 0.0 109.709 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -24.29 51.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 109.599 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 385' ' ' HIS . 1.8 m-70 -100.3 49.31 0.91 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.399 -0.813 . . . . 0.0 109.656 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.519 ' HA ' HD12 ' A' ' 386' ' ' LEU . 1.5 tp -126.18 85.44 2.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.307 -0.871 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 388' ' ' GLN . 15.6 m-85 67.95 14.98 9.49 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.407 0.622 . . . . 0.0 110.398 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.507 ' O ' ' O ' ' A' ' 387' ' ' PHE . 6.2 mt-30 51.44 116.47 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.899 -0.501 . . . . 0.0 111.72 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 390' ' ' PHE . 48.4 Cg_endo -74.39 166.66 28.96 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.629 1.331 . . . . 0.0 109.975 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER -43.08 137.06 2.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 110.436 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.783 HG22 ' H ' ' A' ' 392' ' ' ARG . 4.8 p -128.87 -166.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.596 -0.69 . . . . 0.0 109.786 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' ARG . . . . . 0.783 ' H ' HG22 ' A' ' 391' ' ' VAL . 0.9 OUTLIER -40.51 149.04 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.047 -1.033 . . . . 0.0 110.417 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 160.33 59.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -150.66 116.43 5.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.228 -1.16 . . . . 0.0 110.365 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 26.2 t -152.51 -81.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 110.082 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' A' ' 397' ' ' ARG . . . -159.57 19.41 0.17 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.309 -0.87 . . . . 0.0 110.287 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 396' ' ' ALA . 0.0 OUTLIER -141.35 179.81 6.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.272 -0.893 . . . . 0.0 110.259 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.568 ' O ' ' C ' ' A' ' 399' ' ' ILE . 0.2 OUTLIER -91.79 -29.07 16.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.11 -0.994 . . . . 0.0 110.599 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 399' ' ' ILE . 11.2 tp -2.99 105.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 CA-C-O 121.533 0.682 . . . . 0.0 112.4 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 42.4 m -137.01 158.62 44.04 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.14 -0.975 . . . . 0.0 110.336 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 402' ' ' THR . . . 83.68 -162.18 39.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.502 ' CB ' ' O ' ' A' ' 401' ' ' GLY . 0.2 OUTLIER 69.76 105.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.335 -1.097 . . . . 0.0 110.169 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -145.24 136.03 6.32 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 84.9 mt -116.53 42.85 2.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.202 -1.175 . . . . 0.0 110.343 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -61.13 -19.57 57.15 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 46.79 78.31 0.07 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.25 -1.147 . . . . 0.0 110.21 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.534 ' CB ' ' HG3' ' A' ' 410' ' ' GLN . . . -108.9 -141.91 0.38 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.28 -0.887 . . . . 0.0 110.354 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.64 -88.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.057 -1.027 . . . . 0.0 110.567 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 340' ' ' ALA . 10.9 m -53.58 -22.13 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.14 -0.975 . . . . 0.0 110.461 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.534 ' HG3' ' CB ' ' A' ' 407' ' ' ALA . 0.1 OUTLIER -64.52 -47.43 78.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.215 -0.928 . . . . 0.0 109.88 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.515 ' HA ' ' HB2' ' A' ' 414' ' ' ASP . 0.0 OUTLIER -66.75 -27.76 67.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -0.873 . . . . 0.0 109.683 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.765 HD12 ' O ' ' A' ' 336' ' ' SER . 31.0 mm -63.67 -60.37 2.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.91 HG21 HD13 ' A' ' 420' ' ' LEU . 45.7 t -65.8 -23.08 31.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.182 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.515 ' HB2' ' HA ' ' A' ' 411' ' ' ARG . 0.5 OUTLIER -75.19 -25.87 58.58 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.416 ' OD1' ' HE3' ' A' ' 296' ' ' MET . 0.9 OUTLIER -80.47 -19.55 45.74 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.724 ' CE1' HD11 ' A' ' 337' ' ' ILE . 32.8 m80 -96.28 -76.18 0.51 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.807 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.635 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 4.3 m-20 127.29 26.81 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.596 0 C-N-CA 123.948 0.899 . . . . 0.0 109.297 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 435' ' ' TRP . . . -86.4 -103.41 0.77 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.583 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 18.4 ttm -165.74 161.85 18.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -1.143 . . . . 0.0 110.638 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 413' ' ' VAL . 4.8 tp -151.86 96.32 2.21 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.983 -1.073 . . . . 0.0 109.223 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.12 155.73 43.96 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.978 -1.076 . . . . 0.0 111.603 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.457 HD11 H5'2 ' A' ' 451' ' ' ANP . 0.1 OUTLIER -91.6 146.28 23.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.556 -0.715 . . . . 0.0 110.354 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -133.5 99.88 0.38 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 429' ' ' GLY . 17.6 m -74.56 122.58 23.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.186 -1.185 . . . . 0.0 110.735 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.503 ' HB3' ' CG ' ' A' ' 427' ' ' ARG . 26.6 t -90.75 147.42 23.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.309 -0.87 . . . . 0.0 109.46 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -45.81 -20.76 0.09 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.801 -0.562 . . . . 0.0 111.308 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.514 ' CB ' ' CZ ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -59.25 -5.11 0.66 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.191 -0.943 . . . . 0.0 111.599 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 90.09 21.89 37.29 Favored Glycine 0 N--CA 1.476 1.352 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.615 ' O ' HG23 ' A' ' 424' ' ' THR . . . -144.66 -137.9 3.24 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.851 ' HG ' HD11 ' A' ' 378' ' ' ILE . 0.0 OUTLIER -175.33 -173.25 0.64 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.169 -1.195 . . . . 0.0 111.786 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.666 ' N ' HD22 ' A' ' 430' ' ' LEU . 24.9 p -154.28 150.16 27.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.478 ' HB ' ' SD ' ' A' ' 344' ' ' MET . 24.2 mm -90.52 121.01 40.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 120.717 -1.24 . . . . 0.0 111.149 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -98.3 96.15 7.86 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.551 -0.718 . . . . 0.0 109.323 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.572 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -97.0 143.71 27.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.613 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.629 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 88.0 m95 -120.08 157.72 28.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.264 -0.897 . . . . 0.0 112.136 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.572 HD13 ' SD ' ' A' ' 332' ' ' MET . 38.1 mt -145.44 125.26 7.01 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.9 139.69 43.96 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 123.59 1.31 . . . . 0.0 111.358 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.641 HG23 ' HD2' ' A' ' 439' ' ' PRO . 7.2 p -99.16 146.79 32.31 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.535 -0.728 . . . . 0.0 110.404 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.641 ' HD2' HG23 ' A' ' 438' ' ' VAL . 50.3 Cg_endo -72.35 143.63 39.52 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.979 1.515 . . . . 0.0 109.773 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.79 HG12 ' O ' ' A' ' 440' ' ' VAL . 72.1 t -153.3 44.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.956 -1.09 . . . . 0.0 110.645 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 14.0 p -145.82 -40.63 0.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 110.092 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.699 ' O ' ' HB3' ' A' ' 443' ' ' ALA . 0.9 OUTLIER -136.9 -179.95 6.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 443' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 442' ' ' ARG . . . 67.79 104.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 443' ' ' ALA . 0.0 OUTLIER 53.7 105.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.763 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -87.85 136.64 13.97 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 23.1 p -92.41 128.95 38.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -1.231 . . . . 0.0 110.565 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 81.5 p -86.64 82.57 7.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.867 . . . . 0.0 110.149 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -126.36 72.75 1.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.046 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.43 -56.05 3.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.883 . . . . 0.0 110.36 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 CA-C-O 117.948 -1.473 . . . . 0.0 109.589 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.738 ' C6 ' HD11 ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.354 0.597 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -134.49 -116.61 1.67 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -143.75 13.6 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -1.182 . . . . 0.0 110.082 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.483 ' HG3' ' HG2' ' A' ' 294' ' ' MET . 5.2 pt-20 -124.82 13.3 8.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.203 -0.936 . . . . 0.0 109.991 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.483 ' HG2' ' HG3' ' A' ' 293' ' ' GLU . 11.4 mmt -142.7 61.88 11.74 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.51 79.0 0.89 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.292 1.68 . . . . 0.0 112.12 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.583 ' HE3' ' NE2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -71.9 105.84 3.99 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 5.1 mt-10 -115.95 -169.97 1.7 Allowed 'General case' 0 C--N 1.28 -2.428 0 O-C-N 121.683 -0.636 . . . . 0.0 110.228 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.631 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.2 OUTLIER -88.28 128.86 35.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 111.193 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.565 ' HB3' ' SD ' ' A' ' 332' ' ' MET . . . -156.48 159.22 38.43 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.66 -0.65 . . . . 0.0 111.057 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.808 ' O ' HG23 ' A' ' 304' ' ' VAL . 5.9 t0 -84.08 121.37 27.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.514 -0.741 . . . . 0.0 110.13 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 8.0 mt -68.54 -25.2 64.8 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.138 -0.976 . . . . 0.0 109.76 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.696 ' HA ' HD23 ' A' ' 323' ' ' LEU . 22.7 p30 -79.3 -21.21 46.3 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.089 -1.007 . . . . 0.0 108.871 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -85.44 -29.65 24.17 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.761 0.791 . . . . 0.0 108.968 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 308' ' ' VAL . 42.2 t -74.92 -38.46 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.55 0.69 . . . . 0.0 109.278 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.603 ' CD2' HG21 ' A' ' 341' ' ' VAL . 86.2 mt -73.61 -40.75 63.58 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.306 -0.871 . . . . 0.0 110.142 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -58.71 -29.42 64.27 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.846 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 6.0 mt-10 -79.03 -31.16 44.51 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.394 -1.062 . . . . 0.0 108.997 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 304' ' ' VAL . 52.3 t -75.48 -21.83 16.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.667 0.746 . . . . 0.0 109.154 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.556 ' CD1' HG22 ' A' ' 321' ' ' THR . 0.7 OUTLIER -76.19 -49.68 24.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.403 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -80.2 -16.72 54.17 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.815 0.816 . . . . 0.0 109.194 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.846 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -65.14 -63.04 1.2 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.696 -0.627 . . . . 0.0 110.709 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.28 37.91 0.7 Allowed 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.715 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.629 ' O ' HD11 ' A' ' 319' ' ' ILE . 1.2 t -87.55 43.1 1.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.892 -1.13 . . . . 0.0 109.098 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 315' ' ' TYR . . . 73.66 25.22 72.77 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.511 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 51.4 t80 63.71 44.19 5.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.657 -0.908 . . . . 0.0 110.258 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 4.2 tt0 68.24 46.57 1.09 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.235 -0.916 . . . . 0.0 109.781 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.496 ' CG ' ' N ' ' A' ' 318' ' ' GLU . 0.3 OUTLIER -68.59 -88.04 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.304 0 O-C-N 121.608 -0.683 . . . . 0.0 109.844 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.496 ' N ' ' CG ' ' A' ' 317' ' ' ARG . 16.9 mt-10 -140.93 66.12 1.38 Allowed 'General case' 0 C--N 1.277 -2.574 0 O-C-N 121.399 -0.813 . . . . 0.0 111.287 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.697 HG23 HG23 ' A' ' 358' ' ' VAL . 2.7 mp -104.43 134.09 46.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 O-C-N 121.598 -0.689 . . . . 0.0 110.129 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -91.36 107.23 19.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.763 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.556 HG22 ' CD1' ' A' ' 309' ' ' ILE . 12.5 p -89.84 124.66 34.87 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 111.519 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ALA . . . . . 0.589 ' HB3' ' OG ' ' A' ' 359' ' ' SER . . . -149.81 78.63 1.36 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 302' ' ' ASN . 2.7 mp -94.62 169.52 10.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.453 -0.779 . . . . 0.0 110.879 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.476 ' HB2' ' HA2' ' A' ' 361' ' ' GLY . 93.8 t80 -62.11 112.39 6.24 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.764 . . . . 0.0 109.756 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.86 79.29 1.98 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.878 1.462 . . . . 0.0 110.487 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 179.73 29.65 0.05 OUTLIER Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.773 -1.203 . . . . 0.0 110.11 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 326' ' ' GLY . 1.0 OUTLIER 47.81 98.2 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.11 -1.23 . . . . 0.0 110.509 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.632 HG23 HG21 ' A' ' 362' ' ' THR . 1.1 mt -82.11 -176.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.495 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.575 ' H ' HG22 ' A' ' 328' ' ' ILE . 0.6 OUTLIER -178.14 105.43 0.05 OUTLIER 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.416 0.627 . . . . 0.0 110.376 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 1.021 HG11 ' HB3' ' A' ' 367' ' ' ALA . 5.3 m -136.05 171.57 16.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-O 121.749 0.785 . . . . 0.0 110.5 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.2 OUTLIER -91.22 89.62 7.41 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.573 ' CG ' HG23 ' A' ' 330' ' ' VAL . 4.0 ppp? -140.26 148.34 41.31 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.439 -0.788 . . . . 0.0 109.894 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 21.0 t-160 -75.97 110.82 12.03 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.481 ' O ' ' HD3' ' A' ' 338' ' ' LYS . 36.7 Cg_endo -58.74 -19.33 45.68 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.476 1.251 . . . . 0.0 109.152 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.593 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -82.57 -63.9 1.28 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.529 0.681 . . . . 0.0 109.805 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.507 ' OG ' HG13 ' A' ' 412' ' ' ILE . 26.8 t -49.39 -50.54 39.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.538 -0.726 . . . . 0.0 110.132 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.554 HG13 ' CE ' ' A' ' 332' ' ' MET . 21.7 mm -59.91 -45.68 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.565 ' HD3' HG13 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -46.81 -49.03 20.6 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.7 -1.25 . . . . 0.0 109.377 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -60.97 -38.88 87.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.491 -0.756 . . . . 0.0 110.302 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -58.94 -53.25 60.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 0.0 110.83 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.791 ' CG1' HG11 ' A' ' 308' ' ' VAL . 55.2 t -70.31 -21.08 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 110.057 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -81.65 -19.73 41.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.397 -0.815 . . . . 0.0 110.779 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -84.64 -44.67 13.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.088 -1.008 . . . . 0.0 110.777 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 6.1 mtm -69.15 -20.14 64.02 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.16 -0.962 . . . . 0.0 110.546 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 342' ' ' ALA . 8.7 p -87.86 -27.48 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.104 -0.997 . . . . 0.0 110.506 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 342' ' ' ALA . 53.5 t -76.85 -28.02 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 110.373 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 17.4 m120 -75.13 -32.04 61.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.105 -0.997 . . . . 0.0 110.281 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.686 ' HB2' ' OD1' ' A' ' 373' ' ' ASP . . . -90.58 -18.63 24.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.123 -0.986 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -77.05 -81.21 0.09 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.033 -1.042 . . . . 0.0 111.856 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -48.41 64.95 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.381 -0.824 . . . . 0.0 112.34 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 347' ' ' ASN . 36.6 m-85 -74.79 -58.93 2.98 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.855 -1.153 . . . . 0.0 111.561 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 348' ' ' ALA . . . -108.12 59.55 0.36 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.189 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.23 93.1 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.235 . . . . 0.0 109.886 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -147.7 -67.06 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -150.13 139.19 21.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.119 -1.224 . . . . 0.0 110.657 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.619 HD12 HG13 ' A' ' 319' ' ' ILE . 20.3 mt -123.66 162.08 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.459 -0.776 . . . . 0.0 109.832 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 372' ' ' GLU . 1.1 ttpt -136.83 111.36 8.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.069 -1.019 . . . . 0.0 110.331 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.697 HG23 HG23 ' A' ' 319' ' ' ILE . 65.1 t -110.17 88.41 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 110.034 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.589 ' OG ' ' HB3' ' A' ' 322' ' ' ALA . 1.0 OUTLIER -112.55 148.95 33.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 110.436 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.542 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -144.65 142.14 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.403 -0.81 . . . . 0.0 110.016 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -135.08 -165.9 10.92 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.7 OUTLIER -174.52 179.17 1.81 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.775 -1.426 . . . . 0.0 111.547 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 8.2 mt-10 -156.32 173.18 5.18 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.527 ' O ' ' HB2' ' A' ' 365' ' ' ASN . 39.6 Cg_endo -66.38 119.01 5.99 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.422 1.222 . . . . 0.0 110.469 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' A' ' 364' ' ' PRO . 4.1 m120 62.88 37.3 12.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.934 -0.479 . . . . 0.0 110.969 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 10.7 ptm180 169.31 106.32 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.455 -0.778 . . . . 0.0 110.399 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 1.021 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -116.49 168.11 10.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.176 -0.952 . . . . 0.0 109.835 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.64 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 25.8 p-90 -154.74 169.05 24.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.86 -1.15 . . . . 0.0 110.811 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.519 ' CE1' HD11 ' A' ' 436' ' ' LEU . 32.9 p90 -144.4 136.29 26.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.456 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.517 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 9.7 tt0 -121.07 153.84 36.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.101 -0.999 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.517 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 40.6 t -137.06 143.92 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 110.181 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 2.0 mt-10 -137.29 134.45 36.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.355 -0.841 . . . . 0.0 109.779 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.686 ' OD1' ' HB2' ' A' ' 348' ' ' ALA . 3.6 p30 -151.1 163.18 39.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.894 -1.129 . . . . 0.0 110.864 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -110.04 134.13 52.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 352' ' ' GLY . . . 159.54 -136.05 4.43 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.496 ' HG3' ' CB ' ' A' ' 351' ' ' TYR . 47.0 Cg_endo -72.65 106.16 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.991 1.521 . . . . 0.0 110.349 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 427' ' ' ARG . . . -78.35 -157.78 10.7 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 1.013 HG23 " O2'" ' A' ' 451' ' ' ANP . 9.7 mt -119.04 172.67 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.496 -1.003 . . . . 0.0 110.12 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -120.91 175.0 2.6 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.867 -1.146 . . . . 0.0 110.675 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 51.3 Cg_endo -79.94 -33.07 1.25 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 124.059 1.557 . . . . 0.0 111.349 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -89.65 -19.76 24.49 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.907 -1.121 . . . . 0.0 111.312 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.604 ' HG3' ' HB3' ' A' ' 379' ' ' ALA . 41.6 mt-30 -85.91 -26.67 25.44 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.95 -1.094 . . . . 0.0 108.846 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 385' ' ' HIS . 0.2 OUTLIER -66.97 -25.38 66.29 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.082 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 383' ' ' ARG . 32.5 mmtm -46.94 -35.69 6.81 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 383' ' ' ARG . 0.5 OUTLIER -100.74 -139.26 0.33 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.695 ' O ' ' CG ' ' A' ' 387' ' ' PHE . 0.0 OUTLIER -66.2 -68.23 0.39 Allowed 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.962 ' CD1' HG21 ' A' ' 378' ' ' ILE . 37.0 m-85 -170.7 23.38 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 112.13 -2.305 . . . . 0.0 108.814 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 382' ' ' GLN . 0.6 OUTLIER 9.73 111.29 0.0 OUTLIER Pre-proline 0 N--CA 1.518 2.947 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.99 -163.38 0.2 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.514 1.271 . . . . 0.0 110.42 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' PHE . . . . . 0.581 ' C ' HG23 ' A' ' 391' ' ' VAL . 5.6 t80 -94.66 108.52 20.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.084 -1.01 . . . . 0.0 110.683 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.581 HG23 ' C ' ' A' ' 390' ' ' PHE . 31.6 t -153.9 133.3 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 110.223 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 393' ' ' GLY . 0.2 OUTLIER -112.98 155.2 25.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.955 . . . . 0.0 110.007 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 392' ' ' ARG . . . 50.93 97.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.2 80.39 1.61 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.193 -1.181 . . . . 0.0 110.298 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.2 m -105.82 -46.02 4.23 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -0.929 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 397' ' ' ARG . . . -69.16 -90.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.078 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 397' ' ' ARG . 0.5 OUTLIER 178.15 122.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.199 -0.938 . . . . 0.0 110.016 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.7 m -136.19 10.2 3.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.126 -0.984 . . . . 0.0 110.677 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.984 HD13 ' O ' ' A' ' 399' ' ' ILE . 0.0 OUTLIER -107.08 -0.31 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.141 -0.974 . . . . 0.0 110.087 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 399' ' ' ILE . 0.7 OUTLIER 71.19 94.06 0.08 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.254 -0.904 . . . . 0.0 110.347 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 402' ' ' THR . . . -102.2 137.47 13.37 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.694 HG22 ' O ' ' A' ' 402' ' ' THR . 97.9 m 55.7 41.36 30.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.345 -1.091 . . . . 0.0 110.572 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -76.35 -72.99 1.04 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 12.5 mt -138.71 -35.33 0.58 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.25 -1.147 . . . . 0.0 110.289 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 406' ' ' LEU . . . -145.91 138.61 7.65 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.68 HD13 HG22 ' A' ' 408' ' ' ILE . 3.3 pp -42.09 133.73 2.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -1.126 . . . . 0.0 110.227 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -99.44 74.96 1.94 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.075 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.68 HG22 HD13 ' A' ' 406' ' ' LEU . 9.7 tp -155.67 155.9 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 0.0 110.774 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 410' ' ' GLN . 13.2 p -120.05 -42.08 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.479 -0.763 . . . . 0.0 109.926 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.592 ' N ' HG13 ' A' ' 409' ' ' VAL . 2.6 pt20 -51.72 -29.34 18.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.433 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.478 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.4 OUTLIER -76.51 -35.88 58.08 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.827 HG21 ' HB2' ' A' ' 340' ' ' ALA . 0.6 OUTLIER -56.84 -44.7 82.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' A' ' 420' ' ' LEU . 92.9 t -73.93 -22.66 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 35.2 t70 -80.02 -19.58 47.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.699 -0.626 . . . . 0.0 109.603 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -85.77 -26.83 25.58 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.382 -0.824 . . . . 0.0 109.142 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.716 ' CB ' HD23 ' A' ' 436' ' ' LEU . 30.6 m80 -89.78 -31.57 17.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.766 . . . . 0.0 109.083 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.4 OUTLIER 77.27 42.96 0.12 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.395 0.617 . . . . 0.0 110.6 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.614 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -106.8 -85.14 1.76 Allowed Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.565 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.0 OUTLIER -179.2 164.23 1.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.113 . . . . 0.0 111.331 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.557 ' HB2' HG11 ' A' ' 413' ' ' VAL . 19.1 tp -151.3 92.59 1.8 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.163 -0.961 . . . . 0.0 109.258 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.537 ' HB2' ' HG3' ' A' ' 433' ' ' ARG . 0.3 OUTLIER -92.28 139.93 30.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.975 -1.078 . . . . 0.0 110.443 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.704 HD22 HG12 ' A' ' 432' ' ' ILE . 0.3 OUTLIER -114.98 145.7 41.98 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.43 -0.794 . . . . 0.0 111.275 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 430' ' ' LEU . . . -145.53 145.52 14.78 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.532 HG21 ' H ' ' A' ' 378' ' ' ILE . 7.8 m -158.6 131.23 7.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.838 -1.39 . . . . 0.0 111.041 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.72 96.97 7.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 426' ' ' GLU . 41.8 tt0 52.7 49.67 19.81 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.606 -0.684 . . . . 0.0 109.959 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.511 ' HA ' ' HA3' ' A' ' 377' ' ' GLY . 0.9 OUTLIER 50.85 44.63 28.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 110.234 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -143.46 -59.08 0.02 OUTLIER Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -87.83 82.44 1.57 Allowed Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.628 HD21 ' C5 ' ' A' ' 451' ' ' ANP . 18.4 tp -90.59 108.78 20.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -1.132 . . . . 0.0 110.852 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 66.5 m -118.07 132.98 56.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.608 -0.682 . . . . 0.0 109.368 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.872 HD13 ' N1 ' ' A' ' 451' ' ' ANP . 4.4 mt -136.7 142.26 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.935 -1.103 . . . . 0.0 111.031 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' ARG . . . . . 0.537 ' HG3' ' HB2' ' A' ' 421' ' ' GLU . 0.0 OUTLIER -122.2 117.02 25.2 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.445 -0.785 . . . . 0.0 109.598 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 369' ' ' PHE . . . -102.6 140.0 37.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.165 -0.959 . . . . 0.0 111.049 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.64 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 79.8 m95 -114.6 154.44 28.34 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.288 -0.883 . . . . 0.0 111.271 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.716 HD23 ' CB ' ' A' ' 416' ' ' HIS . 12.7 mt -145.87 111.08 4.46 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.614 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 49.5 Cg_endo -85.9 130.57 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.691 1.364 . . . . 0.0 110.823 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.772 HG22 ' HB ' ' A' ' 330' ' ' VAL . 60.6 t -82.79 110.08 20.5 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.408 -0.808 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.646 ' O ' HG23 ' A' ' 440' ' ' VAL . 57.3 Cg_endo -78.44 169.29 20.2 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.938 1.494 . . . . 0.0 109.987 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 439' ' ' PRO . 48.7 t -157.05 94.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.137 -0.977 . . . . 0.0 110.802 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.569 HG22 ' C ' ' A' ' 440' ' ' VAL . 3.1 t 34.48 76.37 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.623 -0.673 . . . . 0.0 110.75 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.744 ' O ' ' HB2' ' A' ' 443' ' ' ALA . 0.0 OUTLIER 46.84 -175.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 443' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 442' ' ' ARG . . . 166.63 47.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' GLN . . . . . 0.49 ' HG3' ' N ' ' A' ' 445' ' ' GLY . 47.2 tp60 -159.08 154.11 25.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 110.358 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' GLY . . . . . 0.49 ' N ' ' HG3' ' A' ' 444' ' ' GLN . . . 146.19 46.93 0.03 OUTLIER Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 59.7 p -107.02 -142.68 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -1.161 . . . . 0.0 110.207 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 448' ' ' LYS . 72.2 p -101.77 -136.69 0.33 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.836 . . . . 0.0 110.233 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 447' ' ' THR . 13.2 mttm 56.9 169.82 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.194 -0.941 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 448' ' ' LYS . 7.4 mm-40 -42.95 144.15 0.64 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.516 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 1.013 " O2'" HG23 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.299 0.571 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -69.46 -101.29 0.04 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -80.47 -168.93 1.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.197 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.5 78.16 9.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.267 -0.896 . . . . 0.0 109.939 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.487 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 0.0 OUTLIER -75.06 128.63 84.58 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.352 -0.842 . . . . 0.0 110.855 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.759 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 51.4 Cg_endo -94.18 -157.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.687 1.592 . . . . 0.0 109.362 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.548 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 43.36 87.68 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 122.323 1.058 . . . . 0.0 109.99 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 1.1 mt-10 -143.06 -156.6 0.7 Allowed 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.278 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.535 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -88.25 131.61 34.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.937 -1.102 . . . . 0.0 110.589 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -150.04 160.07 43.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.443 -0.786 . . . . 0.0 110.709 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.82 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.9 OUTLIER -102.57 120.38 40.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 110.083 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.526 HD11 ' CD1' ' A' ' 436' ' ' LEU . 15.3 mt -63.37 -21.27 66.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 109.751 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.666 ' HA ' HD23 ' A' ' 323' ' ' LEU . 0.2 OUTLIER -83.41 -21.58 32.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.064 -1.022 . . . . 0.0 108.754 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 307' ' ' GLU . . . -88.15 -26.79 22.26 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.728 0.775 . . . . 0.0 109.144 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 300' ' ' ASP . 18.3 t -83.8 -38.38 14.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.634 ' CD2' HG21 ' A' ' 341' ' ' VAL . 91.0 mt -78.41 -28.42 46.86 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.408 -0.807 . . . . 0.0 110.113 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.65 -32.66 82.09 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 303' ' ' ALA . 3.1 mm-40 -79.6 -35.26 39.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -1.141 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.715 HG11 ' CG1' ' A' ' 341' ' ' VAL . 65.4 t -77.81 -19.29 13.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.642 0.734 . . . . 0.0 109.673 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.579 ' CD1' HG22 ' A' ' 321' ' ' THR . 0.3 OUTLIER -79.81 -43.12 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.492 -0.755 . . . . 0.0 109.25 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -80.2 -17.18 53.08 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.638 0.732 . . . . 0.0 109.969 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.33 -53.96 4.22 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.586 -0.696 . . . . 0.0 112.034 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.442 ' O ' HG11 ' A' ' 345' ' ' VAL . 76.1 mm-40 -112.26 45.2 1.31 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.252 -0.905 . . . . 0.0 111.227 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 309' ' ' ILE . 0.3 OUTLIER -80.65 28.56 0.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.238 -0.914 . . . . 0.0 110.79 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 53.41 42.84 65.56 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 22.2 m-85 61.69 33.07 18.23 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.681 -0.894 . . . . 0.0 110.051 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 2.8 tt0 65.31 43.94 3.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 109.378 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.584 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.8 OUTLIER -68.76 -83.18 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.606 0.717 . . . . 0.0 110.436 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.584 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.7 pt-20 -159.23 64.1 0.39 Allowed 'General case' 0 C--N 1.273 -2.754 0 O-C-N 121.672 -0.642 . . . . 0.0 110.69 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.874 HG13 HD12 ' A' ' 356' ' ' ILE . 2.2 mp -96.51 126.75 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 109.511 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.46 103.66 16.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.705 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.579 HG22 ' CD1' ' A' ' 309' ' ' ILE . 19.0 p -89.68 125.68 35.35 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.502 -0.749 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.36 78.97 1.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.478 -0.764 . . . . 0.0 109.249 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.666 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.3 mp -89.48 149.23 23.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.384 -0.823 . . . . 0.0 110.528 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.599 ' CD1' ' HD2' ' A' ' 325' ' ' PRO . 60.4 t80 -38.37 147.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.737 -0.602 . . . . 0.0 110.321 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.599 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.8 Cg_endo -81.83 64.12 8.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.948 1.499 . . . . 0.0 110.44 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . 172.87 8.38 0.02 OUTLIER Glycine 0 N--CA 1.498 2.767 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.697 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 1.2 p 66.07 119.92 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.473 -1.604 . . . . 0.0 109.728 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.65 ' N ' HD13 ' A' ' 328' ' ' ILE . 1.6 mm -74.58 -178.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.864 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.586 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.6 mt-10 -170.56 103.72 0.26 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 121.688 0.756 . . . . 0.0 109.97 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.535 ' C ' ' HE2' ' A' ' 298' ' ' MET . 4.0 m -140.17 172.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.378 0 CA-C-O 121.646 0.736 . . . . 0.0 110.556 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.2 tptp -91.0 89.69 7.54 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.591 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 2.2 tmm? -143.79 157.3 44.47 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.401 -0.812 . . . . 0.0 110.609 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.777 ' CD2' ' HB2' ' A' ' 335' ' ' LEU . 17.4 t60 -78.54 117.68 67.85 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 38.4 Cg_endo -62.11 -21.88 73.24 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.776 1.409 . . . . 0.0 110.341 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.777 ' HB2' ' CD2' ' A' ' 333' ' ' HIS . 12.1 mt -76.95 -63.6 1.32 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.107 0.956 . . . . 0.0 110.258 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.488 ' HB3' HG13 ' A' ' 412' ' ' ILE . 17.4 m -45.8 -53.08 10.17 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.554 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.757 HD11 ' CE1' ' A' ' 416' ' ' HIS . 16.7 mm -57.16 -43.84 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.999 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 0.2 OUTLIER -48.8 -41.19 31.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.887 -1.133 . . . . 0.0 108.344 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 336' ' ' SER . 6.8 mtt180 -67.46 -47.71 69.32 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.488 0.661 . . . . 0.0 109.909 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.43 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -51.82 -36.2 47.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 110.641 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.715 ' CG1' HG11 ' A' ' 308' ' ' VAL . 33.6 t -89.99 -21.05 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -0.935 . . . . 0.0 110.281 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.59 -56.69 9.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.868 . . . . 0.0 110.846 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ASN . . . . . 0.556 ' O ' HG12 ' A' ' 346' ' ' VAL . 76.1 m-20 -75.68 -19.72 58.94 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.212 -0.93 . . . . 0.0 110.724 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.667 ' CE ' HG21 ' A' ' 432' ' ' ILE . 2.0 mtt -67.48 -32.66 73.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.287 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.807 ' O ' ' HB2' ' A' ' 349' ' ' ALA . 55.9 t -90.44 -19.05 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.351 -0.843 . . . . 0.0 111.236 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 343' ' ' ASN . 0.6 OUTLIER -70.93 -30.31 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.939 -1.101 . . . . 0.0 110.685 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -60.9 -55.76 29.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.144 -0.972 . . . . 0.0 110.636 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.488 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -85.1 -19.23 32.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.173 -0.954 . . . . 0.0 110.403 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.807 ' HB2' ' O ' ' A' ' 345' ' ' VAL . . . -43.34 -72.8 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.381 -0.824 . . . . 0.0 110.811 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 61.0 mtt85 -87.0 -69.22 0.69 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.084 -1.01 . . . . 0.0 110.744 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' TYR . . . . . 0.492 ' O ' ' N ' ' A' ' 353' ' ' ASN . 2.3 t80 -49.03 -72.61 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.301 -0.874 . . . . 0.0 110.829 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -52.85 88.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 351' ' ' TYR . 6.3 p-10 -96.2 51.48 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.184 -1.186 . . . . 0.0 109.801 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -121.1 -66.93 0.26 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.575 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 2.0 t90 -176.28 140.36 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -1.182 . . . . 0.0 110.219 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.874 HD12 HG13 ' A' ' 319' ' ' ILE . 2.8 mt -110.41 158.96 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.651 -0.656 . . . . 0.0 109.909 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 11.8 ttpt -142.15 105.58 4.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.74 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.648 HG23 HG23 ' A' ' 319' ' ' ILE . 68.9 t -107.73 84.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.327 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 69.5 p -116.67 140.73 49.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.006 -1.059 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.505 ' HB3' ' HG ' ' A' ' 323' ' ' LEU . 1.9 t -125.72 158.66 34.28 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.543 ' C ' HG22 ' A' ' 362' ' ' THR . . . -159.07 -152.62 6.51 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -179.26 174.18 1.05 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.215 -1.168 . . . . 0.0 110.525 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.561 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 1.9 mt-10 -151.81 -175.13 0.45 Allowed Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.468 -0.77 . . . . 0.0 109.504 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 40.7 Cg_endo -69.7 116.96 4.8 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.582 1.306 . . . . 0.0 111.353 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.563 ' O ' ' HG3' ' A' ' 366' ' ' ARG . 1.9 m-20 69.65 6.09 5.53 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.679 -0.638 . . . . 0.0 111.844 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 365' ' ' ASN . 59.7 mtp85 -155.7 104.92 2.37 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.098 -1.001 . . . . 0.0 111.834 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -101.01 167.59 10.15 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 52.7 p-90 -170.9 178.79 3.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.189 -1.569 . . . . 0.0 111.905 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 27.5 p90 -147.76 141.62 25.79 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.544 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 1.0 OUTLIER -134.15 149.44 51.05 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.871 -1.143 . . . . 0.0 112.325 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.544 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 33.6 t -127.22 134.05 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.454 ' HG3' ' OG ' ' A' ' 431' ' ' SER . 0.7 OUTLIER -128.96 145.88 51.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.778 -1.201 . . . . 0.0 109.897 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 373' ' ' ASP . 8.0 p30 -149.92 145.98 26.81 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.69 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.33 137.36 38.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.392 -0.817 . . . . 0.0 109.917 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 169.8 -164.15 37.59 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.008 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.53 -161.63 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.156 1.608 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 424' ' ' THR . . . -146.83 166.24 28.37 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.972 HD11 HD21 ' A' ' 422' ' ' LEU . 5.5 mt -72.6 169.81 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.236 . . . . 0.0 109.787 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.995 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -95.25 177.8 1.68 Allowed Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.96 -1.088 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.872 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 45.9 Cg_endo -73.32 -46.43 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.036 1.545 . . . . 0.0 110.78 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -90.77 -30.22 17.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.959 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.995 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -64.45 -20.18 66.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.079 -1.013 . . . . 0.0 110.338 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 382' ' ' GLN . 16.8 ttt180 -44.81 -29.22 0.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.162 -0.961 . . . . 0.0 109.872 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.475 ' HD3' ' OE1' ' A' ' 388' ' ' GLN . 20.0 mttt -89.95 -33.15 16.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.352 -0.843 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 382' ' ' GLN . 5.0 m170 -40.94 -59.18 1.51 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.314 -0.866 . . . . 0.0 110.036 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 386' ' ' LEU . 0.9 OUTLIER -113.91 64.04 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.481 ' O ' ' HG2' ' A' ' 388' ' ' GLN . 0.8 OUTLIER 176.14 62.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.33 -0.856 . . . . 0.0 110.253 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 387' ' ' PHE . 2.2 mt-30 -152.99 126.35 4.21 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.04 -1.037 . . . . 0.0 110.363 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.65 88.27 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.923 1.486 . . . . 0.0 110.544 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.05 138.57 37.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.153 -0.967 . . . . 0.0 110.146 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.468 ' H ' HG22 ' A' ' 391' ' ' VAL . 35.4 m -83.94 47.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.257 -0.902 . . . . 0.0 110.666 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -113.03 138.59 49.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 394' ' ' ASP . . . 165.36 -102.72 0.2 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 393' ' ' GLY . 0.4 OUTLIER 65.47 145.76 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -1.168 . . . . 0.0 110.121 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 m -111.71 43.47 1.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.198 -0.939 . . . . 0.0 110.08 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -100.58 -0.71 37.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 52.32 89.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.163 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 2.9 m -124.24 -129.1 0.25 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 110.078 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 399' ' ' ILE . 7.8 tp -116.82 54.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.053 -1.029 . . . . 0.0 110.215 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.9 t -128.11 -169.94 2.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.408 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -110.14 -176.69 20.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.4 p -131.76 -38.44 1.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -1.149 . . . . 0.0 110.248 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 102.07 -46.87 1.21 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 13.5 tp 45.17 82.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.263 -1.139 . . . . 0.0 110.126 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -141.79 -169.65 12.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.8 60.34 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.332 -1.099 . . . . 0.0 110.114 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.84 86.48 5.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.85 ' O ' HD13 ' A' ' 412' ' ' ILE . 27.3 mm -119.78 35.18 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.267 -0.896 . . . . 0.0 110.175 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 410' ' ' GLN . 7.0 p -129.47 -34.03 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.183 -0.948 . . . . 0.0 110.269 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 31.0 tt0 -66.4 -42.14 88.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 110.502 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.488 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.0 OUTLIER -69.57 -32.31 71.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.173 -0.954 . . . . 0.0 110.033 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 408' ' ' ILE . 1.1 mp -59.64 -63.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.147 -0.971 . . . . 0.0 108.58 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 1.047 HG21 HD13 ' A' ' 420' ' ' LEU . 35.5 t -63.32 -28.22 44.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.321 -0.862 . . . . 0.0 109.823 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.488 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 29.7 t70 -73.24 -20.54 60.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.511 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.548 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.1 m-80 -95.27 -14.31 24.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.473 -0.767 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.757 ' CE1' HD11 ' A' ' 337' ' ' ILE . 37.3 m80 -93.03 -34.1 13.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.451 -0.781 . . . . 0.0 109.865 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 4.1 m120 72.95 47.43 0.2 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.488 0.661 . . . . 0.0 110.431 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.575 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -121.28 -87.16 0.92 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.593 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.2 OUTLIER -171.12 161.74 6.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.397 -1.061 . . . . 0.0 110.615 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 1.047 HD13 HG21 ' A' ' 413' ' ' VAL . 14.1 tp -150.36 90.68 1.68 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 109.989 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 433' ' ' ARG . 63.0 mm-40 -89.81 154.03 20.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.235 -0.915 . . . . 0.0 110.046 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.972 HD21 HD11 ' A' ' 378' ' ' ILE . 7.2 tt -138.31 130.64 28.9 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.983 -1.073 . . . . 0.0 111.149 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.546 ' C ' ' HA ' ' A' ' 430' ' ' LEU . . . -90.33 163.04 29.91 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.773 ' HA ' ' HG ' ' A' ' 430' ' ' LEU 0.258 12.9 t -140.7 -38.48 0.43 Allowed 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.836 1.318 . . . . 0.0 112.397 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.683 ' N ' HG23 ' A' ' 424' ' ' THR . 1.4 p 155.38 -62.19 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.19 -48.02 72.03 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.589 ' HD2' ' CG2' ' A' ' 424' ' ' THR . 0.8 OUTLIER -61.57 -29.55 70.09 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 429' ' ' GLY . . . 139.86 86.65 0.13 Allowed Glycine 0 C--O 1.215 -1.04 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' A' ' 424' ' ' THR . . . 44.55 -167.0 0.03 OUTLIER Glycine 0 N--CA 1.499 2.862 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.783 HD22 ' N6 ' ' A' ' 451' ' ' ANP . 0.7 OUTLIER -110.93 131.93 54.64 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.579 1.69 . . . . 0.0 110.354 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.5 ' N ' HD23 ' A' ' 430' ' ' LEU . 4.0 m -143.26 -177.75 5.52 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.919 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.667 HG21 ' CE ' ' A' ' 344' ' ' MET . 9.1 mm -149.94 92.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.687 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' ARG . . . . . 0.534 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.1 mtt180 -88.59 134.84 33.76 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.859 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -128.98 129.35 45.29 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.05 -1.031 . . . . 0.0 109.679 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 84.0 m95 -111.28 145.57 38.56 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.139 -0.975 . . . . 0.0 111.908 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.526 ' CD1' HD11 ' A' ' 301' ' ' LEU . 5.9 mt -134.35 106.69 11.11 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.575 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 42.8 Cg_endo -68.78 138.82 42.1 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 O-C-N 123.911 1.479 . . . . 0.0 111.382 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.545 ' CG2' ' HD2' ' A' ' 439' ' ' PRO . 4.9 p -86.17 145.63 40.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.567 -0.708 . . . . 0.0 109.557 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 438' ' ' VAL . 47.4 Cg_endo -69.23 -167.74 0.22 Allowed 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.802 1.422 . . . . 0.0 110.423 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 441' ' ' THR . 12.4 t -63.36 154.3 6.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.731 -0.606 . . . . 0.0 110.474 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 440' ' ' VAL . 9.8 p -150.82 -91.98 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.971 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -118.35 -134.42 0.33 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.08 -1.013 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -151.38 129.33 11.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.044 -1.035 . . . . 0.0 110.097 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -138.05 91.55 2.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.323 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -49.4 156.41 1.71 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 20.7 p -98.52 103.28 15.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.205 -1.173 . . . . 0.0 110.17 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 60.6 p -76.03 127.2 32.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.227 -0.92 . . . . 0.0 110.176 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.44 133.06 47.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.198 -0.938 . . . . 0.0 110.389 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -74.32 -61.68 1.78 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 110.13 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.561 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.783 ' N6 ' HD22 ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.205 0.526 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.98 176.22 19.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -74.12 93.63 2.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -1.159 . . . . 0.0 109.974 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.535 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 42.3 tt0 -111.92 87.34 2.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.065 -1.022 . . . . 0.0 110.73 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.89 107.34 16.89 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.445 -0.784 . . . . 0.0 109.069 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.623 ' HB3' ' CD2' ' A' ' 333' ' ' HIS . 49.4 Cg_endo -97.83 -177.27 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.421 1.414 . . . . 0.0 111.252 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.508 ' C ' ' O ' ' A' ' 295' ' ' PRO . 0.0 OUTLIER 27.99 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.193 0.997 . . . . 0.0 111.104 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 18.6 pt-20 -164.25 -159.98 0.51 Allowed 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.502 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.0 OUTLIER -88.22 127.75 35.45 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.926 -1.109 . . . . 0.0 110.146 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -147.55 163.86 35.25 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.181 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.586 ' O ' HG23 ' A' ' 304' ' ' VAL . 16.3 t0 -100.12 116.42 32.11 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.664 -0.647 . . . . 0.0 109.759 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.648 HD12 HG21 ' A' ' 328' ' ' ILE . 12.0 mt -60.53 -27.45 67.65 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.299 -0.875 . . . . 0.0 109.778 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.818 ' HA ' HD23 ' A' ' 323' ' ' LEU . 56.7 t-20 -76.19 -22.68 55.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.056 . . . . 0.0 108.963 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -85.56 -31.46 22.66 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.459 0.647 . . . . 0.0 109.552 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 300' ' ' ASP . 33.2 t -79.58 -34.31 15.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.499 -0.75 . . . . 0.0 109.542 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.774 ' O ' HD12 ' A' ' 309' ' ' ILE . 82.6 mt -79.92 -26.77 40.04 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.401 -0.812 . . . . 0.0 109.991 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.56 -33.86 88.36 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.81 -32.92 25.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.305 -1.115 . . . . 0.0 109.417 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.843 HG11 ' CG1' ' A' ' 341' ' ' VAL . 51.0 t -75.39 -19.24 15.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.389 -0.819 . . . . 0.0 109.189 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.818 HD11 ' CG1' ' A' ' 358' ' ' VAL . 1.0 OUTLIER -83.26 -46.01 18.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.08 -17.58 61.99 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.277 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.58 -53.57 4.37 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.97 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -100.86 35.0 2.3 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 111.045 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 309' ' ' ILE . 0.1 OUTLIER -86.18 32.15 0.63 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.082 -1.012 . . . . 0.0 110.365 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 45.24 33.2 3.93 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.686 -2.165 . . . . 0.0 107.686 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 39.8 m-85 61.86 52.07 3.57 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 122.096 -0.65 . . . . 0.0 109.95 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 16.1 mt-10 59.28 35.52 23.36 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.597 -0.689 . . . . 0.0 110.256 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.3 OUTLIER -68.84 -74.13 0.13 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.509 -0.744 . . . . 0.0 109.46 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 9.3 mt-10 -160.42 80.85 0.67 Allowed 'General case' 0 C--N 1.274 -2.7 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.542 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.984 HG13 HD12 ' A' ' 356' ' ' ILE . 2.7 mp -122.62 142.21 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.508 ' HB3' ' CG ' ' A' ' 357' ' ' LYS . 26.3 tt0 -109.7 103.89 12.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.446 -0.784 . . . . 0.0 109.547 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 20.0 p -90.53 123.71 34.42 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.245 -0.91 . . . . 0.0 111.411 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -144.33 78.69 1.59 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.818 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.7 mp -91.07 152.31 20.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.561 -0.712 . . . . 0.0 110.999 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.573 ' HB3' ' CD1' ' A' ' 328' ' ' ILE . 19.9 t80 -41.19 136.15 1.72 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.593 -0.692 . . . . 0.0 110.058 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 324' ' ' TYR . 51.8 Cg_endo -83.67 57.28 5.55 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 124.027 1.54 . . . . 0.0 110.276 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -167.58 21.13 0.1 OUTLIER Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.747 -1.215 . . . . 0.0 110.505 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 326' ' ' GLY . 68.5 m 56.44 111.56 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.019 -1.283 . . . . 0.0 110.215 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.648 HG21 HD12 ' A' ' 301' ' ' LEU . 3.5 mm -69.12 -179.34 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.579 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.635 ' H ' HG22 ' A' ' 328' ' ' ILE . 1.7 mt-10 -174.84 101.28 0.09 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.64 -0.663 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 1.016 HG11 ' HB3' ' A' ' 367' ' ' ALA . 8.4 m -143.41 174.17 5.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 121.62 0.724 . . . . 0.0 110.469 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.1 OUTLIER -95.05 93.63 7.49 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.624 ' HG2' HG23 ' A' ' 330' ' ' VAL . 11.2 ptm -136.47 164.76 27.41 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.973 0.892 . . . . 0.0 112.597 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.623 ' CD2' ' HB3' ' A' ' 295' ' ' PRO . 23.4 t-160 -88.06 116.44 66.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 39.3 Cg_endo -62.47 -30.23 79.75 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.637 1.335 . . . . 0.0 112.542 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.597 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 3.9 tp -82.23 -49.2 10.36 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.623 -1.298 . . . . 0.0 110.589 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.542 ' HB2' ' ND1' ' A' ' 333' ' ' HIS . 0.5 OUTLIER -60.6 -42.26 96.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.915 -1.115 . . . . 0.0 109.869 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.933 HD11 ' CE1' ' A' ' 416' ' ' HIS . 18.5 mm -65.37 -46.99 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.601 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 0.7 OUTLIER -51.54 -32.93 29.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.83 -1.169 . . . . 0.0 107.873 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.477 ' NH1' ' OD1' ' A' ' 343' ' ' ASN . 0.0 OUTLIER -77.45 -34.65 54.41 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.991 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 344' ' ' MET . . . -67.55 -29.57 68.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.454 -0.779 . . . . 0.0 110.449 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.843 ' CG1' HG11 ' A' ' 308' ' ' VAL . 52.8 t -90.28 -25.49 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 110.423 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 346' ' ' VAL . . . -83.3 -19.95 35.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.578 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ASN . . . . . 0.477 ' OD1' ' NH1' ' A' ' 339' ' ' ARG . 0.3 OUTLIER -83.78 -21.08 32.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -0.916 . . . . 0.0 110.779 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 3.2 mtt -90.69 -51.3 5.45 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.138 -0.976 . . . . 0.0 111.221 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 341' ' ' VAL . 27.4 m -68.22 -19.69 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -0.943 . . . . 0.0 111.505 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 347' ' ' ASN . 14.5 p -61.53 -39.64 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.843 -1.161 . . . . 0.0 110.72 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.52 ' N ' HG13 ' A' ' 346' ' ' VAL . 10.9 t30 -63.2 -49.78 72.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.126 -0.984 . . . . 0.0 110.806 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.488 ' O ' ' HA2' ' A' ' 352' ' ' GLY . . . -72.73 -19.91 61.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.219 -0.926 . . . . 0.0 110.612 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.09 -73.18 0.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.025 -1.047 . . . . 0.0 110.253 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -55.35 -51.63 66.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.298 -0.876 . . . . 0.0 110.453 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -59.54 2.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.215 -0.928 . . . . 0.0 110.379 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 348' ' ' ALA . . . 68.09 -104.11 1.12 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 1.5 t30 55.0 17.35 1.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -1.145 . . . . 0.0 110.207 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 374' ' ' ASP . . . -168.37 -98.25 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.067 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.612 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -179.78 148.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -1.166 . . . . 0.0 109.881 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.984 HD12 HG13 ' A' ' 319' ' ' ILE . 0.8 OUTLIER -106.49 159.52 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.309 -0.869 . . . . 0.0 110.024 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.612 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 1.4 ttmt -150.41 112.72 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 110.692 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.818 ' CG1' HD11 ' A' ' 309' ' ' ILE . 21.9 t -103.07 88.81 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 370' ' ' GLN . 6.8 p -115.04 151.14 34.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -0.896 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.536 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.6 OUTLIER -140.14 163.53 32.47 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.533 ' C ' HG22 ' A' ' 362' ' ' THR . . . -155.23 -164.32 12.95 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.545 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.1 OUTLIER -176.36 144.05 0.53 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.716 -1.461 . . . . 0.0 112.048 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 39.0 mt-10 -109.03 175.61 1.89 Allowed Pre-proline 0 C--N 1.287 -2.146 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.304 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 40.1 Cg_endo -66.07 127.0 16.77 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.245 1.129 . . . . 0.0 110.087 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.552 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 6.6 m120 60.52 22.25 11.97 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.519 -0.738 . . . . 0.0 110.243 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 42.1 mtm180 -163.63 145.06 9.22 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 1.016 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -143.17 151.16 40.36 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.11 -0.994 . . . . 0.0 109.159 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.603 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 37.7 p-90 -151.67 170.38 19.85 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.905 -1.122 . . . . 0.0 110.682 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 369' ' ' PHE . 36.4 p90 -139.5 130.42 26.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.44 -0.787 . . . . 0.0 109.582 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 359' ' ' SER . 0.8 OUTLIER -116.1 150.48 37.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -0.933 . . . . 0.0 111.381 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.29 143.86 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.497 -0.752 . . . . 0.0 109.348 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 357' ' ' LYS . 1.8 tt0 -126.36 145.51 50.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.013 -1.054 . . . . 0.0 110.198 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 355' ' ' TRP . 11.1 t70 -156.65 143.66 18.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.841 . . . . 0.0 110.331 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 374' ' ' ASP . 27.6 t0 -98.39 64.47 1.59 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.37 -0.831 . . . . 0.0 110.016 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -86.88 -148.01 12.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.15 -40.59 3.15 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.008 1.531 . . . . 0.0 110.482 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' GLY . . . . . 0.593 ' C ' HD13 ' A' ' 378' ' ' ILE . . . 103.6 -174.85 23.06 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.768 HD11 HD11 ' A' ' 430' ' ' LEU . 1.9 mm -99.72 176.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.065 -1.256 . . . . 0.0 110.102 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.902 ' HB3' ' CB ' ' A' ' 382' ' ' GLN . . . -109.91 165.61 12.35 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.248 -0.908 . . . . 0.0 109.752 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 43.2 Cg_endo -70.07 -49.26 0.53 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.842 1.443 . . . . 0.0 110.229 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -89.53 -19.69 24.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.12 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.902 ' CB ' ' HB3' ' A' ' 379' ' ' ALA . 4.5 tt0 -82.82 -19.78 36.98 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.275 -0.89 . . . . 0.0 110.86 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 382' ' ' GLN . 2.2 ttt85 -42.32 -37.97 1.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.024 -1.047 . . . . 0.0 110.021 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.84 -27.89 19.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.203 -0.936 . . . . 0.0 110.404 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -51.81 -18.23 1.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.107 -0.996 . . . . 0.0 110.747 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.633 HD11 " O2'" ' A' ' 451' ' ' ANP . 50.4 mt -86.59 23.22 1.7 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.92 -1.113 . . . . 0.0 110.731 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 57.3 m-85 -159.7 35.2 0.19 Allowed 'General case' 0 C--N 1.293 -1.87 0 O-C-N 121.483 -0.761 . . . . 0.0 109.984 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -104.49 136.75 19.13 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 110.568 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.63 147.49 35.72 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.841 1.442 . . . . 0.0 109.888 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' PHE . . . . . 0.435 ' HB2' ' OE1' ' A' ' 388' ' ' GLN . 53.7 t80 -172.89 107.23 0.16 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.031 -1.043 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 392' ' ' ARG . 2.5 t -137.06 170.07 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.259 -0.9 . . . . 0.0 109.694 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 391' ' ' VAL . 0.1 OUTLIER 44.25 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.033 -1.042 . . . . 0.0 109.964 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 150.56 58.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -145.1 139.2 27.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -1.163 . . . . 0.0 110.204 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 t -156.66 -40.81 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.911 . . . . 0.0 110.15 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -108.23 -90.26 0.45 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.903 . . . . 0.0 110.082 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -79.05 147.22 32.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -0.972 . . . . 0.0 110.166 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 4.1 m -159.96 127.91 4.75 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.114 -0.991 . . . . 0.0 110.344 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.555 HD12 ' C ' ' A' ' 399' ' ' ILE . 2.0 pp -85.54 -29.33 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.402 ' N ' HD12 ' A' ' 399' ' ' ILE . 9.6 t -110.79 135.87 50.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.329 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 125.11 101.7 1.35 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 402' ' ' THR . 53.1 m -132.03 13.94 4.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.211 -1.17 . . . . 0.0 109.955 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 165.26 -117.42 0.75 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 45.7 tp -89.57 -73.54 0.51 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.173 -1.192 . . . . 0.0 109.995 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -164.23 55.6 0.28 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.95 170.2 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -1.124 . . . . 0.0 110.529 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -106.48 160.15 15.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 109.664 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.589 HG22 HG12 ' A' ' 409' ' ' VAL . 14.2 mt -130.01 169.47 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.042 -1.036 . . . . 0.0 110.48 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 408' ' ' ILE . 10.6 p -48.83 -22.51 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.954 . . . . 0.0 110.176 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 48.3 tt0 -62.9 -55.94 21.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.23 -0.919 . . . . 0.0 110.609 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.4 OUTLIER -59.02 -32.19 69.5 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.311 -0.868 . . . . 0.0 110.684 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 340' ' ' ALA . 1.0 OUTLIER -64.03 -58.37 7.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.092 -1.005 . . . . 0.0 109.143 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.653 HG11 ' HB2' ' A' ' 420' ' ' LEU . 30.4 t -65.51 -21.41 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.249 -0.907 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 0.1 OUTLIER -82.41 -25.83 33.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 109.515 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 2.2 t-20 -86.41 -17.82 33.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.933 ' CE1' HD11 ' A' ' 337' ' ' ILE . 22.7 m80 -92.87 -41.2 10.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.539 -0.726 . . . . 0.0 109.664 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.1 OUTLIER 79.59 36.04 0.15 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.437 0.637 . . . . 0.0 109.949 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.635 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -101.86 -90.03 2.1 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.565 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.7 OUTLIER -173.0 163.45 4.79 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.349 -1.089 . . . . 0.0 111.222 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.653 ' HB2' HG11 ' A' ' 413' ' ' VAL . 14.3 tp -151.45 97.93 2.46 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.57 152.17 34.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.001 -1.062 . . . . 0.0 111.541 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.602 ' O ' HD12 ' A' ' 422' ' ' LEU . 2.9 pp -132.47 121.13 22.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.404 -0.81 . . . . 0.0 109.273 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -141.8 132.04 5.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.702 HG21 ' HA ' ' A' ' 427' ' ' ARG . 3.5 t -128.45 155.1 45.32 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.254 -1.145 . . . . 0.0 110.703 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 2.6 p -85.74 112.67 21.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.309 -0.869 . . . . 0.0 109.359 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 53.02 49.3 20.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.59 -0.694 . . . . 0.0 110.038 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.702 ' HA ' HG21 ' A' ' 424' ' ' THR . 13.9 mmt180 45.13 46.64 9.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 110.02 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -143.68 -66.51 0.02 OUTLIER Glycine 0 N--CA 1.484 1.853 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -77.88 77.03 1.68 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.768 HD11 HD11 ' A' ' 378' ' ' ILE . 0.3 OUTLIER -76.44 135.77 39.42 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.138 -1.213 . . . . 0.0 111.777 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 40.2 t -144.76 114.24 7.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.689 -0.632 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 432' ' ' ILE . 1.5 tt -94.46 131.91 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.145 -0.972 . . . . 0.0 110.368 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -111.79 103.04 11.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.94 . . . . 0.0 110.407 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 368' ' ' TRP . . . -91.96 130.39 37.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.325 -0.86 . . . . 0.0 109.518 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.603 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.3 m95 -107.66 157.24 18.25 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.822 -1.174 . . . . 0.0 112.438 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.505 HD12 HD11 ' A' ' 301' ' ' LEU . 19.8 mt -142.68 114.12 6.04 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.635 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 51.4 Cg_endo -78.45 129.53 9.44 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.534 1.281 . . . . 0.0 112.161 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.799 HG21 HG12 ' A' ' 330' ' ' VAL . 6.8 t -109.32 69.0 0.42 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.539 -0.725 . . . . 0.0 110.02 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.483 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 57.7 Cg_endo -75.01 -170.5 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.681 1.358 . . . . 0.0 110.558 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 440' ' ' VAL 0.255 9.5 p -141.2 29.65 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 O-C-N 121.907 -0.496 . . . . 0.0 110.752 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 66.2 p -51.77 111.83 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.063 -1.023 . . . . 0.0 110.398 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -116.49 -49.67 2.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.304 -0.873 . . . . 0.0 110.023 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -108.56 121.01 44.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.222 -0.923 . . . . 0.0 110.259 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -163.51 -175.83 4.39 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.246 -0.909 . . . . 0.0 110.092 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' GLY . . . . . 0.451 ' C ' HG23 ' A' ' 446' ' ' THR . . . -172.1 -63.2 0.04 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 445' ' ' GLY . 48.5 p -149.8 110.81 4.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -1.149 . . . . 0.0 110.177 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 30.7 p -47.05 169.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -76.25 -87.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.266 -0.896 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.11 138.11 20.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.276 -0.89 . . . . 0.0 110.176 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 CA-C-O 118.019 -1.434 . . . . 0.0 109.546 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.757 " C1'" HD12 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 290' ' ' THR . 41.7 m . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.258 0.552 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -150.08 -149.96 5.14 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 292' ' ' GLN . 1.5 tm0? -80.28 6.78 11.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -1.119 . . . . 0.0 110.268 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.68 92.42 5.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 0.0 110.465 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 67.4 mtp -104.13 109.4 62.4 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.289 -0.882 . . . . 0.0 109.937 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.442 ' HG2' ' NE2' ' A' ' 333' ' ' HIS . 54.2 Cg_endo -83.79 48.74 2.67 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.874 1.46 . . . . 0.0 111.283 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.04 107.74 15.84 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 15.5 mt-10 -128.81 -162.02 1.16 Allowed 'General case' 0 C--N 1.283 -2.287 0 O-C-N 121.637 -0.664 . . . . 0.0 109.913 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.468 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -88.33 133.51 34.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.048 -1.033 . . . . 0.0 110.271 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.584 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -149.68 160.7 43.31 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.447 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.903 ' O ' HG23 ' A' ' 304' ' ' VAL . 4.3 t0 -90.77 121.32 32.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.801 -0.562 . . . . 0.0 109.891 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.776 HD11 HD12 ' A' ' 436' ' ' LEU . 9.5 mt -72.18 -21.15 61.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 109.718 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.645 ' OD1' HD23 ' A' ' 323' ' ' LEU . 8.9 t30 -83.45 -23.97 32.04 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 109.138 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.682 ' HB3' ' HB3' ' A' ' 300' ' ' ASP . . . -84.0 -31.59 25.4 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.515 -0.74 . . . . 0.0 109.584 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 300' ' ' ASP . 11.4 t -78.41 -35.88 19.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.401 -0.812 . . . . 0.0 109.705 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.509 ' CD2' HG21 ' A' ' 341' ' ' VAL . 71.1 mt -76.08 -29.56 58.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.26 -0.9 . . . . 0.0 110.924 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLY . . . . . 0.473 ' HA2' HD12 ' A' ' 309' ' ' ILE . . . -65.58 -39.78 95.69 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -75.84 -32.56 59.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.203 -1.174 . . . . 0.0 109.59 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 1.006 HG11 ' HB ' ' A' ' 341' ' ' VAL . 41.0 t -78.27 -19.96 13.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 109.339 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.989 ' CG1' HG11 ' A' ' 358' ' ' VAL . 1.4 mt -71.15 -50.48 41.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.79 -15.08 61.64 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.823 0.821 . . . . 0.0 108.879 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 308' ' ' VAL . . . -61.62 -63.17 1.36 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.857 -0.527 . . . . 0.0 111.817 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 311' ' ' ALA . 13.3 mt-10 -143.41 38.92 1.4 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.525 -1.27 . . . . 0.0 113.047 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.949 ' OG ' HD12 ' A' ' 319' ' ' ILE . 5.9 t -85.77 10.37 13.8 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.616 -1.303 . . . . 0.0 109.53 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 317' ' ' ARG . . . 111.39 43.33 0.99 Allowed Glycine 0 C--N 1.291 -1.945 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.536 ' O ' ' HG3' ' A' ' 316' ' ' GLU . 23.7 m-85 59.43 41.6 19.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.918 . . . . 0.0 110.094 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 53.59 32.67 14.8 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.342 1.068 . . . . 0.0 109.096 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 0.2 OUTLIER -69.81 -81.59 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.98 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.634 ' C ' HD13 ' A' ' 319' ' ' ILE . 14.3 pt-20 -126.89 72.15 1.34 Allowed 'General case' 0 C--N 1.277 -2.545 0 O-C-N 121.669 -0.644 . . . . 0.0 111.974 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.949 HD12 ' OG ' ' A' ' 313' ' ' SER . 1.8 mm -104.52 123.2 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 358' ' ' VAL . 7.5 tt0 -88.98 98.15 11.6 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.59 HG22 HD13 ' A' ' 309' ' ' ILE . 20.6 p -89.46 129.22 35.99 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.893 0.854 . . . . 0.0 111.832 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.46 77.85 1.31 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.645 HD23 ' OD1' ' A' ' 302' ' ' ASN . 0.8 OUTLIER -96.46 158.51 15.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.47 -0.768 . . . . 0.0 110.644 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.605 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 15.3 t80 -54.31 116.03 9.74 Favored Pre-proline 0 C--N 1.299 -1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.49 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -80.97 64.64 8.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.022 1.538 . . . . 0.0 110.322 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.451 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -162.52 23.04 0.2 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 4.3 p 60.26 106.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -1.136 . . . . 0.0 110.646 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.557 HG22 ' N ' ' A' ' 329' ' ' GLU . 4.0 mt -84.8 175.48 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 O-C-N 121.723 -0.611 . . . . 0.0 109.646 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.557 ' N ' HG22 ' A' ' 328' ' ' ILE . 2.7 mt-10 -169.47 109.89 0.45 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.391 -0.818 . . . . 0.0 111.352 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 1.124 HG11 ' HB3' ' A' ' 367' ' ' ALA . 12.7 m -145.03 160.68 13.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.517 0.675 . . . . 0.0 109.936 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.0 OUTLIER -82.94 95.89 8.12 Favored 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.518 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.584 ' HG3' ' HB3' ' A' ' 299' ' ' ALA . 19.2 ptm -140.37 -178.21 5.39 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 110.975 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.774 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 0.8 OUTLIER -115.13 112.23 44.39 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.506 ' HB2' ' HE3' ' A' ' 338' ' ' LYS . 36.6 Cg_endo -58.74 -19.66 47.36 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.721 1.379 . . . . 0.0 110.447 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.774 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 2.9 tm? -78.95 -63.89 1.31 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.382 -0.824 . . . . 0.0 110.123 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.47 ' O ' HG12 ' A' ' 412' ' ' ILE . 0.0 OUTLIER -54.22 -49.97 68.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.305 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.562 HD13 ' CG2' ' A' ' 412' ' ' ILE . 17.3 mm -62.91 -31.78 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 110.346 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.506 ' HE3' ' HB2' ' A' ' 334' ' ' PRO . 0.4 OUTLIER -61.03 -57.86 10.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.906 -1.121 . . . . 0.0 109.772 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.401 ' HD2' ' C ' ' A' ' 339' ' ' ARG . 4.1 tmm_? -69.45 -21.35 63.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.466 -0.771 . . . . 0.0 110.356 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.432 ' HB2' ' CG1' ' A' ' 412' ' ' ILE . . . -69.6 -44.69 70.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.014 . . . . 0.0 110.307 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 1.006 ' HB ' HG11 ' A' ' 308' ' ' VAL . 46.3 t -80.42 -22.16 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.337 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -70.62 -62.24 1.46 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.137 -0.977 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ASN . . . . . 0.923 ' O ' HG12 ' A' ' 346' ' ' VAL . 0.7 OUTLIER -59.25 -43.48 92.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.074 -1.016 . . . . 0.0 110.73 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.539 ' CE ' HG21 ' A' ' 432' ' ' ILE . 2.9 ttm -57.7 -19.05 24.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.274 -0.891 . . . . 0.0 110.976 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 341' ' ' VAL . 78.0 t -88.68 -22.26 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.094 -1.004 . . . . 0.0 111.587 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.923 HG12 ' O ' ' A' ' 343' ' ' ASN . 9.0 p -64.82 -19.5 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.951 -1.093 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -66.26 -42.63 88.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.052 -1.03 . . . . 0.0 111.536 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.495 ' HB2' ' CG ' ' A' ' 373' ' ' ASP . . . -89.3 -19.86 24.79 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.938 -1.101 . . . . 0.0 111.369 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -89.41 -69.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.959 -1.088 . . . . 0.0 110.822 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -65.8 -41.92 91.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.125 -0.984 . . . . 0.0 110.744 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.82 -35.73 16.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.175 -0.953 . . . . 0.0 110.56 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -97.34 156.27 20.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.97 53.94 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -1.12 . . . . 0.0 109.959 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 355' ' ' TRP . . . -128.04 -59.58 0.12 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.587 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.3 OUTLIER 171.78 150.25 0.05 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.151 -1.205 . . . . 0.0 109.841 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' A' ' 313' ' ' SER . 26.6 mt -116.49 164.21 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.251 -0.905 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 18.4 tttm -142.27 97.6 3.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.561 -0.712 . . . . 0.0 109.752 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.989 HG11 ' CG1' ' A' ' 309' ' ' ILE . 26.0 t -93.01 139.57 17.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.8 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.56 ' HA ' ' CD1' ' A' ' 323' ' ' LEU . 60.3 p -160.13 169.91 22.33 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.087 -1.008 . . . . 0.0 111.458 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.517 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 34.2 t -155.21 150.28 26.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.635 -0.665 . . . . 0.0 109.762 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.513 ' HA3' ' CZ2' ' A' ' 368' ' ' TRP . . . -139.1 -169.92 11.7 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.605 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.5 OUTLIER -178.21 166.16 1.91 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.926 -1.338 . . . . 0.0 111.834 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.571 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 5.1 mm-40 -128.35 -174.91 0.4 Allowed Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 45.8 Cg_endo -86.71 36.46 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.495 1.261 . . . . 0.0 110.446 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 2.8 m-20 161.29 36.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.533 ' HG2' ' HB3' ' A' ' 437' ' ' PRO . 0.2 OUTLIER 166.14 103.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.821 . . . . 0.0 109.718 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 1.124 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -103.91 157.52 17.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.023 -1.048 . . . . 0.0 110.205 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.596 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 30.2 p-90 -150.51 166.46 30.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 110.323 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 434' ' ' ALA . 36.0 p90 -133.77 147.26 51.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -0.83 . . . . 0.0 109.499 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.542 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 24.5 tt0 -139.08 155.9 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 111.538 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.542 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 6.3 t -140.03 144.15 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 431' ' ' SER . 26.2 tt0 -142.62 147.65 36.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.824 -1.172 . . . . 0.0 110.099 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.495 ' CG ' ' HB2' ' A' ' 348' ' ' ALA . 1.5 p30 -161.4 169.68 21.5 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.068 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -79.54 166.69 21.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.388 -0.82 . . . . 0.0 110.026 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 428' ' ' GLY . . . 124.58 -164.12 18.16 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.89 127.08 11.17 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.042 1.549 . . . . 0.0 110.622 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' GLY . . . . . 0.644 ' HA2' HD12 ' A' ' 430' ' ' LEU . . . -94.24 -169.62 37.73 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.711 HG22 ' H ' ' A' ' 379' ' ' ALA . 3.2 mm -76.97 -172.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.942 -1.328 . . . . 0.0 110.145 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.961 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -155.59 160.36 30.9 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.235 -0.915 . . . . 0.0 110.101 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.84 -38.1 4.47 Favored 'Trans proline' 0 C--N 1.298 -2.101 0 O-C-N 124.087 1.572 . . . . 0.0 110.367 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -90.1 -20.91 22.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.199 -0.938 . . . . 0.0 110.284 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.961 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 5.3 tp60 -76.92 -23.57 52.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.204 -0.935 . . . . 0.0 110.343 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' A' ' 387' ' ' PHE . 2.2 ttt180 -52.53 -26.36 12.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.223 -0.923 . . . . 0.0 110.351 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -79.67 -32.62 41.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.308 -0.87 . . . . 0.0 110.066 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -59.0 -71.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.032 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.551 ' O ' ' CD2' ' A' ' 387' ' ' PHE . 0.5 OUTLIER -100.28 50.15 0.9 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 0.0 110.552 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 386' ' ' LEU . 0.2 OUTLIER 176.02 68.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.195 -0.94 . . . . 0.0 110.155 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.538 ' O ' ' HG3' ' A' ' 388' ' ' GLN . 25.9 pt20 -141.22 132.39 13.5 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.219 -0.925 . . . . 0.0 110.454 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -83.69 51.23 3.42 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.749 1.394 . . . . 0.0 110.183 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.9 149.01 49.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.93 171.22 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.33 -0.856 . . . . 0.0 110.803 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.41 -56.65 1.23 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.415 -0.803 . . . . 0.0 109.789 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 139.88 -122.71 2.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -144.31 78.03 1.56 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -1.136 . . . . 0.0 110.131 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.26 36.94 4.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.905 . . . . 0.0 110.35 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -54.94 154.95 4.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.489 ' C ' HG23 ' A' ' 398' ' ' THR . 5.8 ttm-85 -92.94 84.79 4.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.295 -0.878 . . . . 0.0 110.349 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.489 HG23 ' C ' ' A' ' 397' ' ' ARG . 2.0 p 58.5 133.29 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.509 -0.744 . . . . 0.0 110.388 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 399' ' ' ILE . 19.8 tt -116.93 128.43 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.323 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.4 p -102.45 20.96 16.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 110.017 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 96.75 39.09 4.22 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 4.5 t -125.67 141.32 52.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -1.15 . . . . 0.0 110.233 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -108.14 -60.95 0.55 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.74 55.99 5.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.32 -1.106 . . . . 0.0 110.187 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -143.33 108.57 0.52 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 406' ' ' LEU . 14.3 tp -163.38 130.76 3.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -1.145 . . . . 0.0 110.287 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 410' ' ' GLN . . . -87.02 -30.35 21.27 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.891 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 412' ' ' ILE . 10.7 mt 64.59 -125.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.287 -0.883 . . . . 0.0 110.869 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.502 ' HA ' HD13 ' A' ' 412' ' ' ILE . 13.6 p -46.91 -19.88 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.052 -1.03 . . . . 0.0 111.744 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.863 ' HB3' ' HB1' ' A' ' 407' ' ' ALA . 0.7 OUTLIER -58.53 -67.08 0.39 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.012 -1.055 . . . . 0.0 111.589 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.52 ' HG2' ' NH2' ' A' ' 411' ' ' ARG . 0.0 OUTLIER -60.31 -26.09 66.27 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.193 -0.942 . . . . 0.0 111.956 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.732 HD12 ' O ' ' A' ' 408' ' ' ILE . 1.3 mp -64.79 -61.69 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 120.473 -1.392 . . . . 0.0 109.332 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.568 HG21 HD13 ' A' ' 420' ' ' LEU . 25.5 t -66.23 -25.14 34.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.093 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 9.1 m-20 -78.38 -23.29 46.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 109.823 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 16.6 t-20 -82.95 -15.31 51.79 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.318 -0.864 . . . . 0.0 109.285 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.579 ' O ' ' CB ' ' A' ' 417' ' ' ASN . 34.1 m80 -90.89 -30.09 17.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.515 -0.74 . . . . 0.0 110.062 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 3.4 t-20 81.52 17.57 0.45 Allowed 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.814 -0.554 . . . . 0.0 110.464 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.577 ' HA2' ' CD ' ' A' ' 437' ' ' PRO . . . -84.81 -91.7 0.79 Allowed Glycine 0 N--CA 1.481 1.678 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.585 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.8 ttp -174.52 167.12 3.91 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.205 -1.174 . . . . 0.0 111.042 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.568 HD13 HG21 ' A' ' 413' ' ' VAL . 19.1 tp -150.83 112.48 4.46 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.597 -0.69 . . . . 0.0 109.181 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -123.54 133.29 54.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.893 -1.129 . . . . 0.0 111.936 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.541 ' CD2' HD12 ' A' ' 432' ' ' ILE . 10.8 mt -108.96 127.59 54.2 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 430' ' ' LEU . . . -136.59 136.83 8.62 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.073 -1.537 . . . . 0.0 110.762 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 429' ' ' GLY . 5.9 m -90.11 123.98 34.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.436 -1.038 . . . . 0.0 109.674 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.573 ' HB2' ' CG ' ' A' ' 427' ' ' ARG . 41.8 m -85.47 144.73 27.79 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.137 -0.977 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.55 -20.26 0.24 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.213 0.53 . . . . 0.0 110.532 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.573 ' CG ' ' HB2' ' A' ' 425' ' ' SER . 0.2 OUTLIER -57.02 -8.17 0.6 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.32 -0.862 . . . . 0.0 111.3 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 375' ' ' GLY . . . 93.53 21.26 29.64 Favored Glycine 0 N--CA 1.479 1.563 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.636 ' O ' HG23 ' A' ' 424' ' ' THR . . . -147.41 -136.7 2.84 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.927 HD22 ' N ' ' A' ' 431' ' ' SER . 0.0 OUTLIER -175.42 -175.71 0.83 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.038 -1.272 . . . . 0.0 112.11 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.927 ' N ' HD22 ' A' ' 430' ' ' LEU . 0.9 OUTLIER -153.05 -178.98 7.27 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.203 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.541 HD12 ' CD2' ' A' ' 422' ' ' LEU . 0.6 OUTLIER -137.02 133.9 47.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.043 -1.035 . . . . 0.0 110.631 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -111.63 97.8 6.98 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.47 -0.769 . . . . 0.0 109.111 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.592 ' HB3' ' CE2' ' A' ' 369' ' ' PHE . . . -90.63 133.07 35.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.402 -0.811 . . . . 0.0 110.474 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.596 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.7 m95 -105.64 151.92 23.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.097 -1.002 . . . . 0.0 111.586 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.776 HD12 HD11 ' A' ' 301' ' ' LEU . 36.8 mt -144.41 83.91 9.61 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.577 ' CD ' ' HA2' ' A' ' 418' ' ' GLY . 41.7 Cg_endo -69.35 137.0 35.57 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 123.92 1.484 . . . . 0.0 111.443 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 330' ' ' VAL . 40.8 t -79.35 142.96 59.19 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.78 -0.575 . . . . 0.0 109.947 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 331' ' ' LYS . 47.3 Cg_endo -74.17 167.4 27.28 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.742 1.39 . . . . 0.0 110.425 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 443' ' ' ALA . 13.2 p -45.53 160.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 0.0 110.171 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 3.8 t -115.64 36.0 4.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.122 -0.987 . . . . 0.0 110.211 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -135.8 -44.88 0.66 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.2 -0.937 . . . . 0.0 110.31 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' ALA . . . . . 0.417 ' O ' HG11 ' A' ' 440' ' ' VAL . . . -155.87 129.5 8.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.326 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -71.35 -30.63 66.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 110.046 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -170.46 173.61 44.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 15.3 p -58.28 158.01 7.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.235 -1.156 . . . . 0.0 110.233 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.411 ' H ' HG22 ' A' ' 447' ' ' THR . 3.3 t -105.11 57.78 0.68 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.228 -0.92 . . . . 0.0 110.289 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.09 159.92 14.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.271 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.28 72.1 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.332 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 CA-C-O 117.974 -1.459 . . . . 0.0 109.57 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.906 ' C6 ' HD21 ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.31 0.576 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 112.62 -67.79 0.24 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -55.26 141.58 34.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.282 -1.128 . . . . 0.0 110.36 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -150.61 39.14 0.71 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.899 . . . . 0.0 110.038 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.481 ' HE2' ' HB3' ' A' ' 294' ' ' MET . 10.2 ptp -168.55 116.24 0.59 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.992 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.546 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 49.9 Cg_endo -78.89 67.1 8.63 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 124.112 1.585 . . . . 0.0 111.305 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.681 ' HE3' ' NE2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -80.82 108.86 14.84 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.471 -0.892 . . . . 0.0 108.937 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.617 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 52.8 mt-10 -123.47 -161.96 1.01 Allowed 'General case' 0 C--N 1.274 -2.686 0 O-C-N 121.825 -0.547 . . . . 0.0 109.748 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.424 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -88.01 130.01 35.1 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 110.381 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.811 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -149.26 158.65 44.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.526 -0.734 . . . . 0.0 110.852 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.783 ' O ' HG23 ' A' ' 304' ' ' VAL . 7.4 m-20 -98.65 117.32 32.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.566 -0.709 . . . . 0.0 110.206 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.598 HD12 HG21 ' A' ' 328' ' ' ILE . 13.4 mt -62.27 -23.85 66.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.169 -0.957 . . . . 0.0 109.845 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.495 ' OD1' HD23 ' A' ' 323' ' ' LEU . 44.0 t-20 -81.63 -22.27 37.71 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.177 -0.952 . . . . 0.0 109.114 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.403 ' O ' ' OE1' ' A' ' 307' ' ' GLU . . . -84.4 -30.31 25.48 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.629 -0.669 . . . . 0.0 109.664 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 300' ' ' ASP . 4.4 t -80.92 -34.46 13.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 109.608 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 79.2 mt -78.71 -27.48 44.94 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.398 -0.814 . . . . 0.0 110.623 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.4 -37.15 85.58 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.741 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 1.5 mp0 -76.21 -34.46 59.25 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.271 -1.135 . . . . 0.0 109.315 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.522 HG11 ' HB ' ' A' ' 341' ' ' VAL . 95.6 t -78.71 -19.59 13.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.534 -0.729 . . . . 0.0 109.443 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.534 HG13 HG11 ' A' ' 358' ' ' VAL . 0.1 OUTLIER -73.67 -43.51 54.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.422 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -90.44 -16.02 29.79 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.665 0.745 . . . . 0.0 109.139 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -53.9 -61.82 2.06 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.736 -0.603 . . . . 0.0 110.503 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -150.74 37.23 0.64 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.741 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.628 ' HB3' HD13 ' A' ' 319' ' ' ILE . 11.3 m -89.5 43.65 1.16 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.121 -0.987 . . . . 0.0 108.948 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 317' ' ' ARG . . . 63.18 44.35 97.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.484 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 19.7 m-30 48.82 38.0 11.04 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.0 -1.294 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 2.1 mt-10 69.38 56.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.329 -0.857 . . . . 0.0 110.006 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 314' ' ' GLY . 3.1 mmt180 -68.7 -92.11 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.787 0.803 . . . . 0.0 109.869 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 318' ' ' GLU . 15.6 pt-20 -126.55 58.05 1.41 Allowed 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.544 0.688 . . . . 0.0 109.741 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.774 HG23 HG23 ' A' ' 358' ' ' VAL . 3.5 mt -104.73 130.66 55.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 121.613 -0.679 . . . . 0.0 110.2 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -89.46 103.38 16.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 19.6 p -93.6 123.07 36.68 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 111.291 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.59 78.03 1.49 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 360' ' ' SER . 3.4 mp -90.47 144.84 25.41 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.517 -0.74 . . . . 0.0 110.5 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' LEU . 7.4 t80 -40.7 137.85 1.34 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.574 -0.704 . . . . 0.0 109.634 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -82.7 47.6 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.892 1.469 . . . . 0.0 110.791 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.464 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -159.8 13.59 0.19 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 3.3 p 60.05 116.33 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.997 -1.296 . . . . 0.0 109.638 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.598 HG21 HD12 ' A' ' 301' ' ' LEU . 2.7 mm -67.77 -179.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.737 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.562 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.8 mt-10 -171.25 105.76 0.23 Allowed 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.632 0.73 . . . . 0.0 110.644 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.945 HG12 HG22 ' A' ' 438' ' ' VAL . 12.1 m -149.98 163.95 3.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-O 121.597 0.713 . . . . 0.0 110.343 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.2 tptm -79.59 91.44 5.2 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.811 ' HG3' ' HB3' ' A' ' 299' ' ' ALA . 11.1 ptm -140.56 158.9 43.31 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 110.613 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.547 ' NE2' ' HB2' ' A' ' 335' ' ' LEU . 18.1 t-160 -88.96 113.29 55.44 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 40.0 Cg_endo -64.19 -19.4 65.91 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.59 1.31 . . . . 0.0 109.894 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.547 ' HB2' ' NE2' ' A' ' 333' ' ' HIS . 0.2 OUTLIER -78.14 -53.65 7.14 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 109.995 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 60.3 p -64.72 -36.25 83.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 0.0 109.937 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.748 HD11 ' CE1' ' A' ' 416' ' ' HIS . 10.1 mm -75.1 -35.99 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.114 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 0.4 OUTLIER -57.04 -50.57 72.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.971 -1.081 . . . . 0.0 108.984 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -27.29 61.14 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.636 -0.665 . . . . 0.0 109.747 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 1.06 ' HB2' HD13 ' A' ' 412' ' ' ILE . . . -60.25 -49.58 77.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.149 -0.97 . . . . 0.0 110.183 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.522 ' HB ' HG11 ' A' ' 308' ' ' VAL . 21.5 t -77.47 -35.4 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.0 109.952 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.429 ' O ' ' HB ' ' A' ' 346' ' ' VAL . . . -59.32 -27.05 65.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.848 . . . . 0.0 110.299 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ASN . . . . . 0.506 ' O ' HG12 ' A' ' 346' ' ' VAL . 0.5 OUTLIER -85.37 -19.94 30.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.477 ' SD ' HG21 ' A' ' 432' ' ' ILE . 0.8 OUTLIER -84.88 -33.09 22.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 7.9 p -87.75 -24.2 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.224 -0.922 . . . . 0.0 110.322 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 343' ' ' ASN . 7.6 p -65.01 -20.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.154 -0.966 . . . . 0.0 110.234 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.12 -58.84 4.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -69.05 -31.16 69.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 110.175 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.94 66.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 109.985 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.32 -41.25 49.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -62.45 1.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.217 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 111.92 -41.71 2.16 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -88.65 83.59 6.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -1.17 . . . . 0.0 110.225 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 374' ' ' ASP . . . 177.57 101.86 0.15 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.588 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.2 OUTLIER -51.56 139.41 20.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.225 -1.161 . . . . 0.0 110.355 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.719 HD12 HG13 ' A' ' 319' ' ' ILE . 17.0 mt -111.75 167.84 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.749 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.588 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 39.9 tttt -148.56 114.97 5.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.951 -1.093 . . . . 0.0 111.12 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.774 HG23 HG23 ' A' ' 319' ' ' ILE . 21.7 t -119.24 78.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 109.25 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 95.5 p -110.68 135.24 51.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 110.357 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.511 ' HB3' ' HG ' ' A' ' 323' ' ' LEU . 0.0 OUTLIER -121.33 149.13 43.4 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 109.794 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.526 ' C ' HG22 ' A' ' 362' ' ' THR . . . -147.48 -165.07 11.6 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -175.81 162.64 2.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.961 -1.317 . . . . 0.0 111.32 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 1.2 mt-10 -126.63 174.21 4.4 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 50.5 Cg_endo -77.63 31.11 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.453 1.239 . . . . 0.0 111.488 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.557 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 11.9 p-10 177.88 26.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.069 -1.02 . . . . 0.0 110.766 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 24.4 ptt180 160.61 115.15 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 121.224 0.535 . . . . 0.0 109.861 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.587 ' H ' HG23 ' A' ' 438' ' ' VAL . . . -96.23 166.47 11.72 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.145 -0.972 . . . . 0.0 109.26 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 61.9 p-90 -161.09 148.62 15.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.736 -1.228 . . . . 0.0 111.147 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.554 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 30.2 p90 -122.84 136.33 54.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.42 -0.8 . . . . 0.0 109.732 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.5 ' HG3' ' HA ' ' A' ' 433' ' ' ARG . 1.9 tt0 -112.23 137.42 50.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.375 -0.828 . . . . 0.0 111.481 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 54.3 t -131.93 107.51 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -109.71 158.22 18.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.071 -1.018 . . . . 0.0 110.664 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 5.5 p-10 -168.97 132.33 1.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.374 -0.829 . . . . 0.0 110.15 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.486 ' O ' ' HA3' ' A' ' 354' ' ' GLY . 5.9 m-20 -107.93 154.38 21.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 110.361 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -169.77 -115.09 0.32 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.47 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.789 1.415 . . . . 0.0 110.427 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 172.21 -161.86 33.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.89 HG23 " O2'" ' A' ' 451' ' ' ANP . 16.1 mt -131.17 154.67 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -1.205 . . . . 0.0 111.219 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.82 150.38 88.4 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.534 -0.729 . . . . 0.0 109.081 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.38 -22.76 28.78 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 O-C-N 123.84 1.442 . . . . 0.0 110.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -91.09 -26.77 18.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.3 -0.875 . . . . 0.0 111.363 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -88.81 -29.36 19.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.052 -1.03 . . . . 0.0 110.761 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -19.43 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.049 -1.032 . . . . 0.0 110.394 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 385' ' ' HIS . 12.2 mmtt -82.48 -34.44 28.04 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.377 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.571 ' N ' ' ND1' ' A' ' 385' ' ' HIS . 0.1 OUTLIER -107.24 -74.03 0.67 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.243 -0.91 . . . . 0.0 110.743 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.633 HD11 " H1'" ' A' ' 451' ' ' ANP . 0.6 OUTLIER 31.88 49.56 0.13 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.806 -0.559 . . . . 0.0 111.51 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.891 ' CE2' HD12 ' A' ' 422' ' ' LEU . 0.2 OUTLIER -155.82 34.65 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.137 -0.977 . . . . 0.0 109.931 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -171.07 154.91 4.27 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.565 -0.709 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.15 96.94 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.798 1.42 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -52.44 158.14 1.31 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.15 -0.969 . . . . 0.0 110.342 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.574 ' O ' HG12 ' A' ' 391' ' ' VAL . 45.4 t -90.22 46.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -0.896 . . . . 0.0 110.28 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 391' ' ' VAL . 0.1 OUTLIER -178.95 48.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 110.195 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -131.67 -74.39 0.11 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -132.0 80.11 1.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.211 -1.17 . . . . 0.0 110.103 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.645 ' O ' ' HB3' ' A' ' 396' ' ' ALA . 42.6 p -166.66 -171.25 1.81 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 395' ' ' SER . . . 64.87 65.45 0.61 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 110.238 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.39 83.1 1.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.448 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 399' ' ' ILE . 52.3 m 53.28 -97.92 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.269 -0.895 . . . . 0.0 110.242 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.566 ' N ' HG22 ' A' ' 398' ' ' THR . 6.8 tp -122.15 159.12 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.065 -1.022 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.9 t -48.72 153.54 0.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -131.51 -74.29 0.11 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 94.0 m -73.42 131.68 42.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.33 -1.1 . . . . 0.0 110.713 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 404' ' ' LEU . . . -121.16 140.95 14.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 403' ' ' GLY . 1.7 tt 44.63 92.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.136 -1.214 . . . . 0.0 110.031 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 406' ' ' LEU . . . 146.59 73.18 0.02 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 405' ' ' GLY . 1.7 tp -177.12 67.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.325 -1.103 . . . . 0.0 110.201 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -95.58 130.41 42.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 110.281 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.482 HG21 ' OE1' ' A' ' 410' ' ' GLN . 23.6 mm -96.73 155.58 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.062 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.638 ' HA ' HD12 ' A' ' 412' ' ' ILE . 17.4 t -39.51 -56.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.259 -0.901 . . . . 0.0 111.196 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.564 ' O ' ' CB ' ' A' ' 414' ' ' ASP . 7.8 pt20 -48.7 -52.04 25.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.14 -0.975 . . . . 0.0 111.688 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.2 OUTLIER -68.8 -20.72 64.34 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.75 -1.219 . . . . 0.0 111.274 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 1.06 HD13 ' HB2' ' A' ' 340' ' ' ALA . 16.9 mt -73.94 -75.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.88 -1.138 . . . . 0.0 108.679 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 419' ' ' MET . 21.4 t -54.29 -21.07 5.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.488 -0.757 . . . . 0.0 109.661 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 21.0 t0 -77.34 -40.32 44.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.143 -0.973 . . . . 0.0 109.864 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 0.8 OUTLIER -68.36 -20.36 64.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.284 -0.885 . . . . 0.0 109.65 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.748 ' CE1' HD11 ' A' ' 337' ' ' ILE . 25.5 m80 -80.36 -26.38 38.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.379 -0.826 . . . . 0.0 110.01 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 2.1 t30 79.43 47.97 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.544 0.688 . . . . 0.0 110.445 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.555 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -118.23 -86.45 1.11 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.572 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.2 OUTLIER 179.14 161.75 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.358 -1.084 . . . . 0.0 111.259 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 410' ' ' GLN . 13.3 tp -152.55 101.53 2.65 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.338 -0.851 . . . . 0.0 108.82 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -111.46 136.41 50.66 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 120.839 -1.163 . . . . 0.0 112.405 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.891 HD12 ' CE2' ' A' ' 387' ' ' PHE . 0.8 OUTLIER -99.46 93.42 5.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.711 0.767 . . . . 0.0 109.317 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 430' ' ' LEU . . . -60.73 141.96 48.17 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 54.7 m -137.14 109.48 7.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.389 -1.065 . . . . 0.0 110.396 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.549 ' O ' ' HG3' ' A' ' 426' ' ' GLU . 0.3 OUTLIER -101.88 106.1 17.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.896 . . . . 0.0 110.367 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 425' ' ' SER . 11.3 pt-20 41.81 -111.06 0.14 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.523 -0.735 . . . . 0.0 111.276 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.484 ' HD3' ' C ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -34.39 -30.77 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.872 0 O-C-N 121.011 -1.056 . . . . 0.0 111.556 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.581 ' O ' HD13 ' A' ' 430' ' ' LEU . . . 132.56 27.16 0.62 Allowed Glycine 0 C--N 1.293 -1.832 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -44.92 119.04 2.97 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.848 HD11 HD11 ' A' ' 378' ' ' ILE . 2.7 mp -99.49 110.62 23.07 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.947 -1.325 . . . . 0.0 113.129 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.454 ' OG ' ' HA3' ' A' ' 423' ' ' GLY . 0.1 OUTLIER -113.43 111.64 22.29 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.495 ' O ' ' CG ' ' A' ' 370' ' ' GLN . 21.4 mm -87.52 125.78 41.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 120.723 -1.236 . . . . 0.0 112.9 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' ARG . . . . . 0.5 ' HA ' ' HG3' ' A' ' 370' ' ' GLN . 0.0 OUTLIER -118.8 85.9 2.45 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.554 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.95 131.9 35.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.471 -0.768 . . . . 0.0 110.703 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 81.3 m95 -112.79 154.04 26.85 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.245 1.021 . . . . 0.0 111.959 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 416' ' ' HIS . 17.8 mt -143.46 117.0 6.01 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.555 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 42.2 Cg_endo -68.41 143.99 59.93 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 O-C-N 123.549 1.289 . . . . 0.0 111.284 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.945 HG22 HG12 ' A' ' 330' ' ' VAL . 76.3 t -103.98 90.37 2.95 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.659 -0.651 . . . . 0.0 110.35 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 47.2 Cg_endo -73.32 77.11 2.54 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.961 1.506 . . . . 0.0 110.09 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.888 HG23 HG12 ' A' ' 438' ' ' VAL . 24.4 t -115.65 152.69 17.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.158 -0.964 . . . . 0.0 110.117 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 441' ' ' THR . 1.3 t -44.27 113.36 0.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.218 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -50.55 -35.57 30.37 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.217 -0.927 . . . . 0.0 110.118 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -99.07 175.66 5.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 110.013 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -125.17 167.35 14.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -168.18 -130.74 1.21 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 446' ' ' THR . 9.0 t -123.89 74.55 1.29 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.293 -1.122 . . . . 0.0 110.209 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' A' ' 448' ' ' LYS . 8.4 t -69.16 -174.48 0.64 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.219 -0.926 . . . . 0.0 110.168 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 447' ' ' THR . 0.1 OUTLIER 70.52 91.47 0.09 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.199 -0.938 . . . . 0.0 110.184 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -133.57 87.39 2.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.259 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.89 " O2'" HG23 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.217 0.532 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 292' ' ' GLN . . . -105.27 -42.44 1.76 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 291' ' ' GLY . 6.1 tp-100 58.5 128.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.479 -1.012 . . . . 0.0 110.355 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.98 79.84 1.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 110.473 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.32 81.54 37.94 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.779 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.632 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 52.6 Cg_endo -84.45 50.02 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.156 1.608 . . . . 0.0 110.522 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.625 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.4 OUTLIER -94.69 107.65 19.65 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 122.152 0.977 . . . . 0.0 108.37 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.639 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.2 mm-40 -123.37 -159.73 0.87 Allowed 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.835 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.62 137.37 32.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 0.0 110.918 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -156.44 153.26 28.56 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.411 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 304' ' ' VAL . 5.2 m-20 -88.22 114.67 25.07 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.921 HD11 ' CD1' ' A' ' 436' ' ' LEU . 4.8 mt -64.09 -24.88 67.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 0.0 110.599 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.625 ' CA ' HD23 ' A' ' 323' ' ' LEU . 48.5 p-10 -81.0 -19.9 42.99 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.706 -1.246 . . . . 0.0 109.033 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.513 ' N ' ' OD1' ' A' ' 302' ' ' ASN . . . -87.96 -27.75 21.9 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.577 0.703 . . . . 0.0 109.225 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.806 ' O ' HG23 ' A' ' 308' ' ' VAL . 90.4 t -78.85 -36.95 19.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.554 -0.716 . . . . 0.0 109.623 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 84.4 mt -76.34 -35.38 58.76 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.404 -0.81 . . . . 0.0 110.321 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -65.29 -26.59 71.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 2.8 mt-10 -84.14 -32.85 24.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.235 -1.156 . . . . 0.0 109.713 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.854 HG11 HG12 ' A' ' 341' ' ' VAL . 48.0 t -75.75 -21.4 15.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.385 -0.822 . . . . 0.0 109.121 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 1.074 HD11 ' CG1' ' A' ' 358' ' ' VAL . 17.1 mt -78.74 -53.49 13.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 122.109 0.957 . . . . 0.0 108.673 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 315' ' ' TYR . . . -68.21 -15.67 63.67 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.214 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -78.32 -59.17 2.89 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.753 -0.592 . . . . 0.0 111.931 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -118.36 32.84 5.93 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.022 -1.071 . . . . 0.0 112.348 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.561 ' HB3' ' CD1' ' A' ' 319' ' ' ILE . 1.0 OUTLIER -129.04 44.34 2.99 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.923 -1.111 . . . . 0.0 109.777 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 59.13 22.32 55.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 310' ' ' ALA . 0.3 OUTLIER 60.32 55.18 3.65 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.392 -1.064 . . . . 0.0 109.989 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.525 ' OE1' ' CA ' ' A' ' 316' ' ' GLU . 0.5 OUTLIER 66.7 35.77 5.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.122 -0.986 . . . . 0.0 109.741 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -48.18 62.58 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.899 0.857 . . . . 0.0 109.917 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -150.28 57.05 0.95 Allowed 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 121.51 0.671 . . . . 0.0 110.213 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 1.001 HG13 HD12 ' A' ' 356' ' ' ILE . 2.7 mp -127.47 131.43 70.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 109.795 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -90.24 105.41 17.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.077 -1.014 . . . . 0.0 109.595 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.747 HG22 HD13 ' A' ' 309' ' ' ILE . 17.3 p -90.03 120.51 31.29 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.393 -0.817 . . . . 0.0 110.721 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -140.34 77.45 1.61 Allowed 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.467 -0.77 . . . . 0.0 108.974 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.625 HD23 ' CA ' ' A' ' 302' ' ' ASN . 1.1 mp -92.0 163.18 14.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.618 -0.676 . . . . 0.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 5.4 t80 -49.01 131.77 15.2 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.224 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 324' ' ' TYR . 50.9 Cg_endo -84.74 52.79 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.951 1.501 . . . . 0.0 110.186 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -162.97 22.42 0.18 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 326' ' ' GLY . 15.6 p 53.04 104.65 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.338 -1.095 . . . . 0.0 110.15 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.769 HG23 HG21 ' A' ' 362' ' ' THR . 1.3 mt -74.6 -178.17 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.45 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.622 ' H ' HG22 ' A' ' 328' ' ' ILE . 5.1 mt-10 -169.8 103.12 0.32 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.611 0.72 . . . . 0.0 110.77 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.721 HG11 ' HB3' ' A' ' 367' ' ' ALA . 31.1 m -137.2 153.53 29.3 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.127 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -73.31 97.73 2.54 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.756 ' SD ' HD21 ' A' ' 301' ' ' LEU . 5.9 ttp -137.27 166.12 24.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.13 -0.981 . . . . 0.0 112.105 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.632 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 22.4 t-160 -103.26 113.86 65.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.523 ' O ' ' CG ' ' A' ' 338' ' ' LYS . 38.3 Cg_endo -63.11 -22.43 73.17 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.635 1.334 . . . . 0.0 111.904 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.674 ' C ' HD12 ' A' ' 335' ' ' LEU . 0.7 OUTLIER -83.54 -56.61 3.64 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.664 -1.273 . . . . 0.0 110.601 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 51.5 p -61.96 -38.15 87.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.134 -0.979 . . . . 0.0 110.636 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.793 HD11 ' CE1' ' A' ' 416' ' ' HIS . 23.1 mm -76.24 -33.93 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.11 -0.994 . . . . 0.0 110.157 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 334' ' ' PRO . 4.7 mttt -59.89 -36.25 76.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -42.93 60.26 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.032 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.816 ' CB ' HG21 ' A' ' 412' ' ' ILE . . . -61.54 -35.11 76.83 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.359 -0.838 . . . . 0.0 110.616 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.854 HG12 HG11 ' A' ' 308' ' ' VAL . 50.7 t -76.12 -34.13 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.207 -0.933 . . . . 0.0 109.646 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.755 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -70.66 -22.38 62.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 0.0 109.805 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -80.29 -23.75 40.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 109.969 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.556 ' SD ' HG21 ' A' ' 432' ' ' ILE . 7.8 mtt -85.0 -41.61 15.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.406 -0.809 . . . . 0.0 110.215 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.46 -22.79 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.885 . . . . 0.0 110.509 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 342' ' ' ALA . 65.3 t -74.16 -24.84 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.101 -0.999 . . . . 0.0 110.16 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -81.63 -31.06 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 110.248 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -89.54 -24.93 21.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 110.197 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -74.53 -39.43 62.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 110.031 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.534 ' O ' ' ND2' ' A' ' 353' ' ' ASN . 0.0 OUTLIER -88.71 -70.15 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -48.66 -59.08 3.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -87.45 142.56 18.08 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 350' ' ' ARG . 24.5 m-80 -139.79 81.27 1.81 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -1.103 . . . . 0.0 110.187 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -159.59 -48.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.57 ' CH2' ' HB2' ' A' ' 357' ' ' LYS . 1.4 t90 -178.65 141.9 0.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.25 . . . . 0.0 110.232 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 1.001 HD12 HG13 ' A' ' 319' ' ' ILE . 3.5 mt -107.23 163.16 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.73 . . . . 0.0 109.746 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.57 ' HB2' ' CH2' ' A' ' 355' ' ' TRP . 0.1 OUTLIER -140.73 93.69 2.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 0.0 109.957 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 1.074 ' CG1' HD11 ' A' ' 309' ' ' ILE . 37.7 t -97.15 105.01 16.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.139 -0.976 . . . . 0.0 109.784 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.2 t -124.88 160.1 29.6 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 110.992 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.55 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.4 t -142.92 130.47 21.26 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.602 -0.686 . . . . 0.0 109.212 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.567 ' C ' HG22 ' A' ' 362' ' ' THR . . . -123.76 -174.36 14.16 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.769 HG21 HG23 ' A' ' 328' ' ' ILE . 0.1 OUTLIER 170.13 163.74 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -1.106 . . . . 0.0 110.801 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.569 ' HB3' ' CD ' ' A' ' 364' ' ' PRO . 3.0 mt-10 -136.64 -168.87 0.2 Allowed Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.569 ' CD ' ' HB3' ' A' ' 363' ' ' GLU . 48.2 Cg_endo -84.79 31.04 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.21 1.11 . . . . 0.0 110.742 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 366' ' ' ARG . 57.3 t-20 -178.64 27.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 0.0 110.795 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.7 OUTLIER 165.63 107.1 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.156 -0.965 . . . . 0.0 111.149 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.721 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -106.63 137.89 43.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.277 -0.889 . . . . 0.0 109.214 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.687 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 64.6 p-90 -140.55 154.78 46.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.876 -1.14 . . . . 0.0 110.655 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.417 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 53.4 p90 -127.28 138.75 53.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.328 -0.857 . . . . 0.0 109.457 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 432' ' ' ILE . 8.1 pt20 -126.99 165.38 19.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.178 -0.951 . . . . 0.0 111.673 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 431' ' ' SER . 3.1 t -141.66 125.78 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.461 ' HG2' ' N ' ' A' ' 373' ' ' ASP . 30.0 tt0 -124.33 155.2 39.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.752 -1.217 . . . . 0.0 110.598 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.461 ' N ' ' HG2' ' A' ' 372' ' ' GLU . 2.4 p30 -148.14 148.26 30.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.407 -0.808 . . . . 0.0 110.492 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -86.5 95.15 9.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.2 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 168.86 162.94 22.02 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.07 124.59 10.17 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.014 1.534 . . . . 0.0 110.02 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -114.14 -90.86 1.81 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.867 HG13 HD11 ' A' ' 430' ' ' LEU . 65.7 mt -66.5 165.85 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.234 -1.156 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.957 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -128.97 178.91 1.45 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.253 -0.904 . . . . 0.0 110.003 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.957 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 43.1 Cg_endo -71.05 -48.92 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.94 1.495 . . . . 0.0 109.653 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' GLU . . . . . 0.427 ' OE2' ' HG2' ' A' ' 380' ' ' PRO . 1.4 mp0 -91.04 -19.87 22.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.423 -0.798 . . . . 0.0 110.393 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.785 ' HB3' ' HB3' ' A' ' 379' ' ' ALA . 59.0 tt0 -81.16 -19.44 43.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.34 -0.85 . . . . 0.0 110.919 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.494 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 0.2 OUTLIER -56.95 -27.69 61.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.067 -1.02 . . . . 0.0 110.646 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -86.81 -19.07 29.54 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.13 -0.981 . . . . 0.0 110.546 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 382' ' ' GLN . 1.5 m80 -48.18 -56.88 6.8 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.287 -0.883 . . . . 0.0 111.492 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.506 ' O ' ' CG ' ' A' ' 387' ' ' PHE . 0.5 OUTLIER -115.34 38.87 3.1 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.96 -1.087 . . . . 0.0 111.342 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.506 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 8.9 m-85 -160.63 43.78 0.19 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.175 -0.953 . . . . 0.0 110.11 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.02 140.85 86.83 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.312 -0.868 . . . . 0.0 109.911 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.82 -158.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.044 1.549 . . . . 0.0 110.31 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 390' ' ' PHE . 14.7 p90 -112.26 99.15 7.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.426 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 391' ' ' VAL . 14.9 p -110.79 37.32 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.411 0.624 . . . . 0.0 109.904 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? 58.76 68.54 0.81 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 110.355 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -94.99 -95.54 1.68 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.59 120.45 40.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.318 -1.107 . . . . 0.0 110.161 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 396' ' ' ALA . 15.3 m -71.56 162.52 29.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 396' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 395' ' ' SER . . . 56.5 159.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 396' ' ' ALA . 0.1 OUTLIER -176.51 34.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.231 -0.918 . . . . 0.0 110.141 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 4.4 m -162.25 26.05 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.189 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 tp -123.08 -13.12 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 110.317 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 9.7 p -159.98 43.91 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.182 -0.949 . . . . 0.0 110.282 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -101.99 139.79 14.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.7 t -120.7 -2.92 9.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.266 -1.137 . . . . 0.0 110.269 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -71.57 152.83 49.82 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 4.9 tt -128.67 -61.63 1.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -1.123 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 65.15 134.51 0.02 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 1.3 mt -93.32 -17.75 23.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.226 -1.161 . . . . 0.0 110.263 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.903 ' O ' HG23 ' A' ' 408' ' ' ILE . . . -110.05 115.2 29.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.903 HG23 ' O ' ' A' ' 407' ' ' ALA . 1.3 pt -168.96 93.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.226 -0.921 . . . . 0.0 110.701 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.401 ' O ' ' HB ' ' A' ' 412' ' ' ILE . 41.0 t -65.7 -18.43 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.395 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -62.34 -61.53 2.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.479 -0.763 . . . . 0.0 110.097 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.485 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.3 OUTLIER -54.23 -23.63 15.49 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.351 -0.843 . . . . 0.0 110.559 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.816 HG21 ' CB ' ' A' ' 340' ' ' ALA . 29.6 mm -68.18 -59.93 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.237 -0.914 . . . . 0.0 108.718 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 420' ' ' LEU . 38.2 t -67.55 -19.15 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.458 -0.776 . . . . 0.0 109.43 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.485 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 7.1 t70 -84.24 -25.33 29.52 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.52 -0.738 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.52 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.4 m120 -75.3 -23.63 57.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.793 ' CE1' HD11 ' A' ' 337' ' ' ILE . 45.1 m80 -95.75 -36.84 11.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.268 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 2.5 t-20 80.04 57.1 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 121.435 0.636 . . . . 0.0 110.838 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.56 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -123.53 -84.66 0.66 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.549 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.7 OUTLIER -179.3 165.99 1.46 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.133 . . . . 0.0 111.556 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.528 ' HB2' HG11 ' A' ' 413' ' ' VAL . 15.1 tp -152.22 83.2 1.26 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.437 ' OE1' ' HA ' ' A' ' 421' ' ' GLU . 4.1 mm-40 -101.0 166.51 10.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.915 -1.116 . . . . 0.0 111.643 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.7 HD23 HD11 ' A' ' 378' ' ' ILE . 1.0 OUTLIER -123.85 123.63 40.88 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.57 0.7 . . . . 0.0 110.231 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.437 ' O ' ' OG1' ' A' ' 424' ' ' THR . . . -125.98 151.66 17.89 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 91.8 m -164.83 124.55 1.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.874 -1.368 . . . . 0.0 111.715 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 427' ' ' ARG . 3.4 p -62.42 121.72 13.93 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 49.58 -96.46 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 425' ' ' SER . 12.5 tpp85 -161.68 24.19 0.12 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.077 -1.014 . . . . 0.0 109.301 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -124.36 -15.66 3.32 Favored Glycine 0 N--CA 1.48 1.597 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -117.64 78.11 0.29 Allowed Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.266 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 1.048 HD22 ' N6 ' ' A' ' 451' ' ' ANP . 1.7 tt -76.79 152.78 35.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.031 -1.276 . . . . 0.0 110.287 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.688 ' N ' HD23 ' A' ' 430' ' ' LEU . 53.4 p -159.7 127.27 4.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.572 -0.705 . . . . 0.0 110.126 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.706 HD11 ' C2 ' ' A' ' 451' ' ' ANP . 18.1 mm -90.1 134.89 27.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 85.96 2.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.483 -0.761 . . . . 0.0 109.522 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.417 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -88.68 138.43 31.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.265 -0.897 . . . . 0.0 109.87 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.687 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.4 m95 -117.81 154.6 31.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 122.458 1.123 . . . . 0.0 113.067 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.921 ' CD1' HD11 ' A' ' 301' ' ' LEU . 7.9 mt -142.08 114.9 6.46 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.56 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 47.5 Cg_endo -71.07 138.77 34.34 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 O-C-N 123.572 1.301 . . . . 0.0 112.628 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.632 HG22 HG12 ' A' ' 330' ' ' VAL . 7.0 t -112.25 64.75 0.73 Allowed Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 42.2 Cg_endo -67.34 92.52 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.924 1.486 . . . . 0.0 110.934 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 98.8 t -132.52 -76.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.422 -0.799 . . . . 0.0 109.96 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 35.6 p -87.39 150.97 23.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.905 . . . . 0.0 109.901 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 50.34 48.6 22.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.77 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 444' ' ' GLN . . . -92.19 130.32 37.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.34 -0.85 . . . . 0.0 110.579 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 443' ' ' ALA . 13.3 mt-30 54.97 162.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.857 . . . . 0.0 110.496 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -144.16 43.03 1.01 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 446' ' ' THR . 3.2 t -103.29 75.42 1.35 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.352 -1.087 . . . . 0.0 110.219 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -144.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 0.0 110.286 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -133.24 165.04 25.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.34 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -79.96 133.63 36.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 110.22 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 CA-C-O 117.954 -1.47 . . . . 0.0 109.541 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 1.048 ' N6 ' HD22 ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 151.95 54.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -103.19 174.41 5.88 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.28 -1.13 . . . . 0.0 110.137 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.95 79.13 6.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.263 -0.898 . . . . 0.0 110.348 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 43.3 mtm -119.52 106.87 41.67 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.226 -0.921 . . . . 0.0 110.415 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.539 ' HG2' ' CD2' ' A' ' 333' ' ' HIS . 48.9 Cg_endo -86.9 54.55 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.948 1.499 . . . . 0.0 110.633 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.602 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -96.58 108.62 21.24 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.602 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.1 mt-10 -138.09 -152.55 0.43 Allowed 'General case' 0 C--N 1.276 -2.621 0 O-C-N 121.818 -0.551 . . . . 0.0 109.604 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.678 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 1.5 mmt -88.4 141.12 28.8 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 110.594 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.594 ' HB3' ' HE3' ' A' ' 332' ' ' MET . . . -154.15 157.82 39.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.396 -0.815 . . . . 0.0 110.985 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.918 ' O ' HG23 ' A' ' 304' ' ' VAL . 3.1 m-20 -90.85 117.23 29.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.41 -0.807 . . . . 0.0 110.059 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.526 HD11 ' CD1' ' A' ' 436' ' ' LEU . 8.4 mt -67.19 -24.17 65.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 110.015 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.607 ' OD1' HD23 ' A' ' 323' ' ' LEU . 9.0 t30 -84.77 -22.94 29.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.871 -1.143 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -83.72 -29.78 27.25 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.43 -0.794 . . . . 0.0 109.334 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 300' ' ' ASP . 19.3 t -78.7 -40.06 23.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.573 -0.705 . . . . 0.0 109.309 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.606 ' CD2' HG21 ' A' ' 341' ' ' VAL . 81.4 mt -72.62 -30.14 64.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.49 -0.756 . . . . 0.0 110.594 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 309' ' ' ILE . . . -61.03 -36.0 91.63 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -33.7 57.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.323 -1.104 . . . . 0.0 109.419 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.816 HG11 HG12 ' A' ' 341' ' ' VAL . 74.5 t -75.0 -18.93 16.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.505 -0.747 . . . . 0.0 109.244 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 1.068 ' CG1' HG11 ' A' ' 358' ' ' VAL . 5.0 mt -77.16 -46.16 29.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.96 -16.65 63.79 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.626 0.727 . . . . 0.0 109.482 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -74.92 -58.74 3.09 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.677 -0.639 . . . . 0.0 110.542 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.535 ' HB2' ' CG1' ' A' ' 345' ' ' VAL . 2.5 mm-40 -111.12 46.13 1.11 Allowed 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.753 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.643 ' HA ' ' CD1' ' A' ' 319' ' ' ILE . 0.6 OUTLIER -79.1 18.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.331 -0.855 . . . . 0.0 111.302 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 53.34 53.51 34.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 22.5 m-30 46.66 43.07 12.3 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.37 -1.076 . . . . 0.0 110.222 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.3 OUTLIER 65.12 35.92 7.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.906 -1.121 . . . . 0.0 109.667 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.576 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -69.06 -73.24 0.16 Allowed 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.552 -0.718 . . . . 0.0 109.786 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.576 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.2 mt-10 -167.91 78.63 0.16 Allowed 'General case' 0 C--N 1.27 -2.88 0 CA-C-O 121.548 0.689 . . . . 0.0 111.235 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.721 ' CG2' HG23 ' A' ' 358' ' ' VAL . 4.2 mm -97.05 121.99 48.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.764 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.486 ' HB3' ' HG3' ' A' ' 357' ' ' LYS . 0.4 OUTLIER -88.73 101.41 13.98 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 108.462 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 16.7 p -90.28 128.28 36.38 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.779 0.8 . . . . 0.0 111.951 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.98 78.15 1.34 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.607 HD23 ' OD1' ' A' ' 302' ' ' ASN . 5.0 mp -96.94 170.91 8.83 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.462 -0.774 . . . . 0.0 110.334 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.661 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 27.8 t80 -63.22 126.1 88.47 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.321 -0.862 . . . . 0.0 109.925 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.402 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.9 Cg_endo -78.71 71.06 7.1 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.938 1.494 . . . . 0.0 110.7 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 172.73 30.35 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.446 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 326' ' ' GLY . 1.7 p 45.99 100.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.162 -1.199 . . . . 0.0 110.499 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.637 HG22 ' H ' ' A' ' 329' ' ' GLU . 1.7 mt -71.12 -177.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 O-C-N 121.507 -0.746 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.637 ' H ' HG22 ' A' ' 328' ' ' ILE . 4.9 mt-10 -167.34 107.65 0.6 Allowed 'General case' 0 C--N 1.289 -2.034 0 O-C-N 121.391 -0.818 . . . . 0.0 111.259 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.678 ' C ' ' HE2' ' A' ' 298' ' ' MET . 7.7 m -137.49 157.45 34.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-O 121.494 0.664 . . . . 0.0 109.97 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 11.2 tptt -78.04 92.5 4.37 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.594 ' HE3' ' HB3' ' A' ' 299' ' ' ALA . 3.0 tmm? -150.03 158.74 44.47 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 110.761 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.732 ' CD2' ' HB2' ' A' ' 335' ' ' LEU . 5.9 t60 -91.07 126.6 54.66 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.454 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 39.1 Cg_endo -61.87 -19.83 67.11 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 123.527 1.277 . . . . 0.0 109.95 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.732 ' HB2' ' CD2' ' A' ' 333' ' ' HIS . 4.4 mt -75.73 -57.85 3.64 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.375 -0.828 . . . . 0.0 109.886 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.401 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 25.3 p -52.91 -47.67 67.81 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.588 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.529 ' CG1' ' HG3' ' A' ' 332' ' ' MET . 24.1 mm -63.44 -32.15 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.069 -1.02 . . . . 0.0 110.473 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 43.2 mttt -60.69 -40.31 91.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.12 -0.987 . . . . 0.0 109.546 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -42.12 65.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.802 -0.561 . . . . 0.0 111.223 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.736 ' HA ' HG12 ' A' ' 409' ' ' VAL . . . -67.2 -30.9 70.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.229 -0.92 . . . . 0.0 111.088 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.816 HG12 HG11 ' A' ' 308' ' ' VAL . 43.0 t -90.31 -25.4 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.525 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.67 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -82.99 -20.22 35.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 110.469 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -88.49 -19.4 26.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.144 -0.973 . . . . 0.0 110.613 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.745 ' SD ' HG21 ' A' ' 432' ' ' ILE . 58.2 mtt -78.21 -36.6 46.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.224 -0.923 . . . . 0.0 110.56 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 312' ' ' GLU . 12.2 p -88.57 -23.58 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.314 -0.866 . . . . 0.0 111.045 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 342' ' ' ALA . 12.1 t -66.19 -19.57 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.997 -1.065 . . . . 0.0 110.348 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -79.74 -33.73 40.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.452 ' O ' ' HA3' ' A' ' 352' ' ' GLY . . . -88.41 -27.79 21.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.083 -1.011 . . . . 0.0 110.751 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.31 -29.61 65.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.154 -0.966 . . . . 0.0 111.329 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 15.7 mtt-85 -77.83 -66.91 0.78 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.995 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 351' ' ' TYR . 13.4 m-30 -90.22 -19.85 23.7 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.149 -0.969 . . . . 0.0 111.129 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 353' ' ' ASN . . . -76.76 -98.15 0.17 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.33 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 352' ' ' GLY . 2.1 t30 76.56 46.7 0.08 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.459 -1.024 . . . . 0.0 109.92 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -130.49 -78.0 0.18 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -137.36 127.8 26.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -1.096 . . . . 0.0 109.687 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.543 ' HB ' HD13 ' A' ' 319' ' ' ILE . 44.9 mt -115.11 159.11 15.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 108.816 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.517 ' CD ' ' HB2' ' A' ' 372' ' ' GLU . 4.2 tttp -148.0 117.51 7.0 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.838 -1.164 . . . . 0.0 111.338 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 1.068 HG11 ' CG1' ' A' ' 309' ' ' ILE . 20.8 t -109.78 135.13 49.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.505 ' HA ' HD12 ' A' ' 323' ' ' LEU . 43.4 t -157.59 164.1 37.63 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.746 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -164.56 132.55 3.35 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -136.15 -163.72 10.0 Favored Glycine 0 C--N 1.29 -2.017 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.661 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.2 OUTLIER -160.02 166.47 29.91 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.277 -1.131 . . . . 0.0 110.417 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.578 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -146.24 -175.88 0.51 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 39.1 Cg_endo -64.93 111.03 1.61 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.449 1.236 . . . . 0.0 110.501 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.544 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 16.9 m120 59.34 40.72 20.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.732 -0.605 . . . . 0.0 110.795 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 1.4 mtt85 -176.83 98.42 0.05 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.156 -0.965 . . . . 0.0 111.192 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -97.53 171.6 8.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.135 -0.978 . . . . 0.0 108.391 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.608 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 22.7 p-90 -171.35 160.8 6.26 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.343 -1.473 . . . . 0.0 111.373 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 53.7 p90 -137.85 132.61 32.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.517 -0.74 . . . . 0.0 109.24 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.603 ' HG3' ' CZ3' ' A' ' 368' ' ' TRP . 22.9 mt-30 -121.53 168.78 11.34 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.06 -1.025 . . . . 0.0 112.353 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.471 ' HB ' HG22 ' A' ' 432' ' ' ILE . 65.2 t -140.08 148.92 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.517 ' HB2' ' CD ' ' A' ' 357' ' ' LYS . 9.1 mt-10 -147.05 148.15 31.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.061 -1.024 . . . . 0.0 110.429 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.66 ' OD1' ' N1 ' ' A' ' 451' ' ' ANP . 0.5 OUTLIER -165.28 163.65 20.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.287 -0.883 . . . . 0.0 110.239 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 428' ' ' GLY . 36.6 t0 -107.92 62.69 0.61 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.214 -0.928 . . . . 0.0 110.428 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -87.46 -148.5 14.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.29 -43.52 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.051 1.553 . . . . 0.0 110.211 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 112.05 -176.69 18.22 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.696 ' CD1' HD21 ' A' ' 430' ' ' LEU . 0.8 OUTLIER -99.14 134.68 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.115 -1.227 . . . . 0.0 109.551 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' A' ' 382' ' ' GLN . . . -50.11 165.3 0.33 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.454 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 47.1 Cg_endo -72.67 -38.9 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.079 1.568 . . . . 0.0 111.456 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.33 -45.13 9.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.028 -1.045 . . . . 0.0 110.662 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.645 ' HB3' ' HB3' ' A' ' 379' ' ' ALA . 16.6 tt0 -56.52 -18.43 11.58 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -50.44 -33.04 19.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.131 -0.98 . . . . 0.0 109.802 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -90.22 -20.07 23.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.324 -0.86 . . . . 0.0 109.692 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.405 ' ND1' ' N ' ' A' ' 385' ' ' HIS . 0.2 OUTLIER -96.05 25.15 4.99 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.747 HD11 " C5'" ' A' ' 451' ' ' ANP . 0.8 OUTLIER -91.38 19.51 6.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.592 -0.692 . . . . 0.0 111.611 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 29.5 m-85 -160.68 51.16 0.28 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.363 -0.836 . . . . 0.0 110.385 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -138.33 105.69 7.84 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.18 -0.95 . . . . 0.0 110.149 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 390' ' ' PHE . 46.9 Cg_endo -79.01 164.6 24.84 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.941 1.495 . . . . 0.0 110.405 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 389' ' ' PRO . 2.1 t80 -178.72 95.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.683 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 391' ' ' VAL . 17.9 m -69.84 122.09 20.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.245 -0.909 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -161.08 0.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.307 -0.87 . . . . 0.0 109.259 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 394' ' ' ASP . . . -130.81 138.21 10.02 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.072 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 393' ' ' GLY . 12.2 t70 56.52 160.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.496 -1.003 . . . . 0.0 110.916 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 396' ' ' ALA . 0.1 OUTLIER -135.32 -46.73 0.7 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.43 -0.794 . . . . 0.0 110.064 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 396' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 395' ' ' SER . . . 55.35 28.44 11.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.361 -0.837 . . . . 0.0 110.71 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -138.29 -89.38 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.085 -1.01 . . . . 0.0 110.213 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 398' ' ' THR . 13.1 t -151.97 120.19 6.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.417 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 399' ' ' ILE . 3.4 tp -98.71 122.87 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.806 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.1 m -107.48 151.69 25.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.192 -0.942 . . . . 0.0 110.326 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 95.67 175.73 36.92 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 61.0 m -81.24 104.91 12.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -1.134 . . . . 0.0 110.086 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 76.86 -102.95 1.71 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 405' ' ' GLY . 0.8 OUTLIER -114.62 81.84 1.62 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.27 -1.136 . . . . 0.0 110.492 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 406' ' ' LEU . . . -62.39 -121.2 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.427 ' CB ' ' O ' ' A' ' 405' ' ' GLY . 0.2 OUTLIER 65.21 38.33 6.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -1.157 . . . . 0.0 110.611 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.416 ' O ' ' HB ' ' A' ' 408' ' ' ILE . . . -69.34 -168.27 0.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.138 -0.976 . . . . 0.0 109.852 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.554 ' CD1' ' HG3' ' A' ' 410' ' ' GLN . 21.1 tt -175.0 153.11 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 0.0 110.54 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.736 HG12 ' HA ' ' A' ' 340' ' ' ALA . 32.8 m -56.36 -25.03 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.398 -0.814 . . . . 0.0 110.501 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.554 ' HG3' ' CD1' ' A' ' 408' ' ' ILE . 2.7 mt-30 -51.41 -43.52 62.0 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.192 -0.942 . . . . 0.0 109.761 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -28.8 66.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.476 -0.765 . . . . 0.0 110.301 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.661 HG12 ' HB2' ' A' ' 340' ' ' ALA . 1.5 mp -70.11 -63.04 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.194 -0.941 . . . . 0.0 108.802 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.899 HG11 ' HB2' ' A' ' 420' ' ' LEU . 59.5 t -62.6 -23.55 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 23.1 t70 -80.33 -29.95 38.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -80.84 -28.33 36.17 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.451 -0.781 . . . . 0.0 109.5 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.602 ' CD2' ' CE ' ' A' ' 296' ' ' MET . 39.1 m80 -86.95 -34.81 19.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.525 -0.735 . . . . 0.0 109.726 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 1.3 t-20 75.42 31.57 0.77 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.558 -0.714 . . . . 0.0 111.096 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.536 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -95.9 -83.51 1.65 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.584 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.4 OUTLIER -178.86 161.02 1.17 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -1.053 . . . . 0.0 110.671 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.899 ' HB2' HG11 ' A' ' 413' ' ' VAL . 67.2 tp -150.87 93.86 2.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.985 -1.072 . . . . 0.0 109.976 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.557 ' O ' ' CG ' ' A' ' 433' ' ' ARG . 37.3 mt-10 -125.0 140.47 52.89 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.081 -1.012 . . . . 0.0 109.973 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.792 HD13 HD11 ' A' ' 430' ' ' LEU . 0.6 OUTLIER -121.91 150.68 41.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.908 -1.12 . . . . 0.0 111.569 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 424' ' ' THR . . . -135.24 -165.82 10.87 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.769 HG22 ' C ' ' A' ' 429' ' ' GLY . 7.3 m 58.48 154.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.584 -1.539 . . . . 0.0 109.888 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.568 ' N ' ' HD3' ' A' ' 427' ' ' ARG . 60.1 p 179.35 -145.14 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.439 -0.788 . . . . 0.0 109.932 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 427' ' ' ARG . 6.6 pt-20 -50.74 -23.7 2.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.338 -0.851 . . . . 0.0 109.763 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.568 ' HD3' ' N ' ' A' ' 425' ' ' SER . 0.2 OUTLIER -51.26 -44.29 61.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.43 -0.794 . . . . 0.0 110.345 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.416 ' O ' ' OD1' ' A' ' 374' ' ' ASP . . . -155.84 -37.06 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.769 ' C ' HG22 ' A' ' 424' ' ' THR . . . -178.72 -131.54 1.59 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 422' ' ' LEU . 0.2 OUTLIER -153.52 149.4 27.65 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.084 -1.244 . . . . 0.0 109.397 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.649 ' H ' HD13 ' A' ' 430' ' ' LEU . 35.2 t -149.05 102.72 3.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.992 -1.068 . . . . 0.0 109.826 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.745 HG21 ' SD ' ' A' ' 344' ' ' MET . 9.6 tp -89.82 150.23 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 110.877 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' ARG . . . . . 0.557 ' CG ' ' O ' ' A' ' 421' ' ' GLU . 0.1 OUTLIER -133.98 106.06 7.05 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.646 -0.659 . . . . 0.0 109.67 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -96.57 146.3 24.95 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.413 -0.805 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.608 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 93.0 m95 -121.07 153.87 36.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.134 -0.979 . . . . 0.0 111.593 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.561 HD23 ' HB3' ' A' ' 416' ' ' HIS . 7.7 mt -141.12 124.73 10.09 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.536 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 43.5 Cg_endo -68.4 135.71 34.68 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.557 1.293 . . . . 0.0 111.266 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.458 HG22 HG12 ' A' ' 330' ' ' VAL . 3.2 t -104.13 106.91 55.51 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.931 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.48 57.03 5.96 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.216 1.64 . . . . 0.0 109.945 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 6.7 p -115.11 138.22 46.11 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 O-C-N 121.442 -0.786 . . . . 0.0 110.641 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 23.3 p -76.85 169.05 19.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.461 -0.775 . . . . 0.0 110.583 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.537 ' O ' ' HB3' ' A' ' 443' ' ' ALA . 17.2 tpp180 -159.09 72.43 0.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.39 -0.819 . . . . 0.0 109.92 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 442' ' ' ARG . . . 60.47 137.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.305 -0.872 . . . . 0.0 110.308 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -127.28 77.76 1.76 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.341 -0.849 . . . . 0.0 109.989 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' GLY . . . . . 0.421 ' O ' ' OG1' ' A' ' 446' ' ' THR . . . -72.28 -16.91 77.22 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 445' ' ' GLY . 59.7 p 43.7 -142.51 0.16 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.32 -1.106 . . . . 0.0 110.26 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 67.6 p -110.78 121.89 46.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.166 -0.959 . . . . 0.0 110.306 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -155.52 152.37 28.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.327 -0.858 . . . . 0.0 110.313 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -111.31 110.84 21.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.337 -0.852 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 CA-C-O 117.995 -1.447 . . . . 0.0 109.487 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.747 " C5'" HD11 ' A' ' 386' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.253 0.549 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -82.68 148.16 25.89 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 64.1 129.77 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.245 -1.15 . . . . 0.0 110.413 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -69.17 87.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 110.418 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 5.3 mtt -68.91 130.32 91.67 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.309 -0.869 . . . . 0.0 109.952 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.559 ' HG2' ' NE2' ' A' ' 333' ' ' HIS . 51.3 Cg_endo -83.42 61.12 7.03 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.994 1.523 . . . . 0.0 111.071 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.532 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -89.03 109.24 20.1 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.611 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 24.2 mt-10 -135.93 -157.13 0.77 Allowed 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.993 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.54 ' CG ' ' HE3' ' A' ' 331' ' ' LYS . 0.1 OUTLIER -87.64 141.91 28.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 0.0 110.624 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.564 ' HB3' ' HE3' ' A' ' 332' ' ' MET . . . -155.95 163.98 39.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.64 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.883 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.5 OUTLIER -101.58 114.65 28.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.339 -0.851 . . . . 0.0 110.471 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.624 HD12 HG21 ' A' ' 328' ' ' ILE . 14.3 mt -61.23 -25.03 66.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.84 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.73 ' OD1' HD23 ' A' ' 323' ' ' LEU . 40.4 t-20 -80.7 -23.7 39.35 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.197 -0.939 . . . . 0.0 109.365 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.76 -25.59 26.31 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 300' ' ' ASP . 5.5 t -83.69 -34.68 10.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.427 -0.795 . . . . 0.0 109.484 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 309' ' ' ILE . 59.3 mt -79.43 -28.37 41.7 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.346 -0.846 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.14 -35.85 91.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.785 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 4.3 mt-10 -80.67 -33.63 35.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.294 -1.121 . . . . 0.0 109.79 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 304' ' ' VAL . 27.7 t -77.29 -19.99 14.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.785 HD11 ' CG1' ' A' ' 358' ' ' VAL . 0.9 OUTLIER -76.11 -51.41 20.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.419 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -77.41 -15.41 59.37 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.404 -0.81 . . . . 0.0 109.456 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.785 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -70.72 -62.49 1.37 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.401 ' OE2' ' O ' ' A' ' 311' ' ' ALA . 9.8 mm-40 -123.05 31.08 6.13 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.586 -1.246 . . . . 0.0 113.351 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.662 ' O ' HD11 ' A' ' 319' ' ' ILE . 2.6 m -111.26 44.31 1.34 Allowed 'General case' 0 C--N 1.289 -2.052 0 O-C-N 120.641 -1.287 . . . . 0.0 108.964 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 69.8 26.52 74.3 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.496 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 4.8 m-85 59.24 47.7 11.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -1.046 . . . . 0.0 110.322 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 68.42 35.61 3.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.107 -0.996 . . . . 0.0 109.621 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 14.3 tpp85 -69.06 -81.36 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.642 0.734 . . . . 0.0 110.625 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 318' ' ' GLU . 4.3 pt-20 -126.58 72.93 1.36 Allowed 'General case' 0 C--N 1.275 -2.633 0 O-C-N 121.615 -0.678 . . . . 0.0 111.149 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.904 HG13 HD12 ' A' ' 356' ' ' ILE . 2.6 mp -132.6 138.19 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.002 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -99.48 103.88 15.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.846 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.513 HG22 HD13 ' A' ' 309' ' ' ILE . 35.7 p -89.73 122.04 32.45 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.257 -0.902 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -138.81 79.39 1.73 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.73 HD23 ' OD1' ' A' ' 302' ' ' ASN . 1.2 mp -88.66 150.28 23.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.478 -0.764 . . . . 0.0 110.386 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.572 ' HB3' ' CD1' ' A' ' 328' ' ' ILE . 36.6 t80 -37.21 145.3 0.27 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.599 -0.688 . . . . 0.0 109.928 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.547 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 51.7 Cg_endo -83.0 59.03 6.56 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 O-C-N 123.966 1.508 . . . . 0.0 110.444 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . 179.74 17.1 0.03 OUTLIER Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.738 -1.22 . . . . 0.0 111.242 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 2.0 m 58.47 115.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.666 -1.49 . . . . 0.0 110.018 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.624 HG21 HD12 ' A' ' 301' ' ' LEU . 2.0 mm -69.48 178.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.542 ' H ' HG22 ' A' ' 328' ' ' ILE . 4.9 mt-10 -170.87 106.09 0.26 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.609 0.719 . . . . 0.0 109.971 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.722 HG12 HG22 ' A' ' 438' ' ' VAL . 7.8 m -148.16 168.46 3.89 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-O 121.648 0.737 . . . . 0.0 110.539 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -85.09 94.26 8.81 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.576 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 4.7 tmm? -145.17 157.51 44.06 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 110.592 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.616 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 22.2 t-160 -82.79 111.65 31.26 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.449 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 37.9 Cg_endo -62.16 -19.3 66.14 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.717 1.377 . . . . 0.0 110.058 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.616 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -81.3 -47.21 13.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.937 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -65.06 -41.33 95.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.448 -0.782 . . . . 0.0 109.982 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.58 HD11 ' CE1' ' A' ' 416' ' ' HIS . 19.6 mm -71.3 -33.67 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.909 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.527 ' HG3' HG13 ' A' ' 304' ' ' VAL . 7.4 mttm -59.06 -60.94 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.706 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -37.15 86.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.482 -0.761 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.551 ' CB ' HG21 ' A' ' 412' ' ' ILE . . . -58.71 -35.56 72.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.92 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.553 HG12 ' CG1' ' A' ' 308' ' ' VAL . 48.2 t -88.33 -21.23 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 111.136 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 308' ' ' VAL . . . -77.61 -28.74 51.59 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.092 -1.005 . . . . 0.0 111.993 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ASN . . . . . 0.428 HD21 ' HA ' ' A' ' 340' ' ' ALA . 21.9 p30 -89.7 -18.67 25.97 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.786 -1.196 . . . . 0.0 111.793 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.535 ' HG2' ' HA ' ' A' ' 341' ' ' VAL . 3.6 ptp -88.57 -20.93 24.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.73 -1.231 . . . . 0.0 111.077 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.432 ' N ' ' HG3' ' A' ' 344' ' ' MET . 8.2 p -90.6 -20.6 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.086 -1.009 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 342' ' ' ALA . 40.4 t -69.43 -20.16 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.047 -1.033 . . . . 0.0 110.994 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -63.83 -31.28 72.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.12 -0.987 . . . . 0.0 110.516 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.557 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -89.73 -21.3 22.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 110.738 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -82.26 -68.72 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.075 -1.015 . . . . 0.0 110.656 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -57.11 -66.9 0.38 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.191 -0.943 . . . . 0.0 110.702 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.53 -39.88 36.61 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.165 -0.959 . . . . 0.0 110.491 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -71.53 163.95 54.1 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -164.38 38.18 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.34 -1.094 . . . . 0.0 109.855 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -123.11 -67.14 0.22 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.6 OUTLIER -173.0 137.26 0.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.164 -1.197 . . . . 0.0 110.386 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.904 HD12 HG13 ' A' ' 319' ' ' ILE . 5.3 mt -107.52 167.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -0.76 . . . . 0.0 109.274 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 2.2 tttp -148.93 116.5 6.21 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.027 -1.045 . . . . 0.0 110.822 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.785 ' CG1' HD11 ' A' ' 309' ' ' ILE . 17.5 t -115.51 75.94 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 108.974 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.3 p -104.69 132.06 51.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.818 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.443 ' H ' HD12 ' A' ' 323' ' ' LEU . 28.8 t -122.0 163.58 19.11 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.55 -0.719 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.573 ' C ' HG22 ' A' ' 362' ' ' THR . . . -159.45 -153.37 6.82 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.573 HG22 ' C ' ' A' ' 361' ' ' GLY . 0.0 OUTLIER -179.65 171.38 1.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.43 -1.041 . . . . 0.0 109.901 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.568 ' CB ' ' CD ' ' A' ' 364' ' ' PRO . 3.8 mt-10 -131.91 -169.54 0.21 Allowed Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.193 -0.942 . . . . 0.0 109.809 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 363' ' ' GLU . 48.3 Cg_endo -84.74 30.0 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.447 0 O-C-N 123.582 1.306 . . . . 0.0 110.963 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 366' ' ' ARG . 3.8 p30 167.86 34.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.31 -0.869 . . . . 0.0 110.18 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 166.75 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.383 -0.823 . . . . 0.0 109.9 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.672 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -97.74 162.35 13.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.164 -0.96 . . . . 0.0 109.313 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.674 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 45.3 p-90 -167.31 171.65 10.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.706 -1.246 . . . . 0.0 111.005 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.6 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 20.3 p90 -141.8 143.3 33.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.226 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 0.1 OUTLIER -132.88 145.62 51.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.133 -0.979 . . . . 0.0 111.725 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 21.1 t -127.11 132.62 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -123.11 158.56 30.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.945 -1.097 . . . . 0.0 110.39 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 11.2 p-10 -150.88 140.25 21.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.366 -0.834 . . . . 0.0 110.215 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.41 177.38 9.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.335 -0.853 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 107.23 -158.6 14.99 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.17 163.0 40.04 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.947 1.499 . . . . 0.0 110.987 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' GLY . . . . . 0.434 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -105.52 -153.13 21.2 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.68 HD12 ' N9 ' ' A' ' 451' ' ' ANP . 1.6 mm -89.87 93.25 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.138 -1.213 . . . . 0.0 110.112 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.763 ' HB3' ' NE2' ' A' ' 382' ' ' GLN . . . -46.61 165.9 0.19 Allowed Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.808 -1.182 . . . . 0.0 109.233 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.489 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 46.6 Cg_endo -73.1 -19.55 22.72 Favored 'Trans proline' 0 C--N 1.294 -2.301 0 O-C-N 123.482 1.254 . . . . 0.0 110.231 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -84.4 -43.67 14.47 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.306 -0.871 . . . . 0.0 111.331 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.763 ' NE2' ' HB3' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -83.89 -34.69 24.49 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.087 -1.008 . . . . 0.0 111.189 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.623 ' CB ' HG22 ' A' ' 378' ' ' ILE . 0.0 OUTLIER -60.07 -19.61 53.91 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.684 -1.26 . . . . 0.0 109.572 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.475 ' HG2' ' HD2' ' A' ' 383' ' ' ARG . 33.2 mmtt -86.86 -23.64 25.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.554 -0.716 . . . . 0.0 110.61 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.657 ' CE1' ' HA ' ' A' ' 382' ' ' GLN . 0.0 OUTLIER -118.45 29.95 7.48 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.983 -1.073 . . . . 0.0 111.49 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.598 HD11 " C4'" ' A' ' 451' ' ' ANP . 13.1 tp -75.92 -123.27 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.027 -1.046 . . . . 0.0 108.713 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.83 32.91 2.46 Favored 'General case' 0 C--N 1.282 -2.355 0 O-C-N 121.068 -1.02 . . . . 0.0 109.731 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -52.06 128.52 38.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.6 -0.687 . . . . 0.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.61 160.07 44.77 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.992 1.522 . . . . 0.0 110.062 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.05 -157.93 0.71 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.08 -1.013 . . . . 0.0 110.468 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 391' ' ' VAL . 91.8 t -131.52 39.29 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 110.495 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.67 -73.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.164 -0.96 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 394' ' ' ASP . . . 137.17 -132.22 5.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 394' ' ' ASP . 5.0 p-10 36.63 84.86 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.69 -0.888 . . . . 0.0 110.724 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.2 72.16 0.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.882 . . . . 0.0 110.351 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -96.99 -164.58 1.16 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 110.143 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.26 -113.2 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.99 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 399' ' ' ILE . 10.5 t -144.18 150.63 38.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.862 -1.148 . . . . 0.0 110.093 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 400' ' ' SER . 20.2 mt 42.61 -103.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.149 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.47 ' N ' HG22 ' A' ' 399' ' ' ILE . 37.1 t -134.94 96.76 3.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.915 -1.115 . . . . 0.0 110.068 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -122.85 -4.8 8.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 90.8 m -129.54 158.02 40.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.134 -1.215 . . . . 0.0 110.258 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 129.11 -4.95 6.39 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 404' ' ' LEU . 1.7 pp -121.52 18.53 11.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -1.107 . . . . 0.0 109.944 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 162.61 126.89 0.84 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 19.1 mt -129.29 82.37 2.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.184 -1.186 . . . . 0.0 110.373 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.404 ' HB3' ' O3G' ' A' ' 451' ' ' ANP . . . -62.29 95.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 109.926 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 412' ' ' ILE . 7.1 tp -116.6 132.48 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.157 -0.964 . . . . 0.0 110.757 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.645 ' HA ' HD13 ' A' ' 412' ' ' ILE . 10.4 t -138.44 5.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 109.485 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 414' ' ' ASP . 16.6 mt-30 -90.08 -48.51 7.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.416 -0.802 . . . . 0.0 109.608 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -66.4 -20.98 66.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.444 -0.785 . . . . 0.0 109.738 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.645 HD13 ' HA ' ' A' ' 409' ' ' VAL . 1.1 mp -68.57 -72.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.248 -0.908 . . . . 0.0 108.726 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 419' ' ' MET . 12.6 t -60.35 -23.22 27.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 21.5 t0 -75.9 -30.18 58.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.459 -0.775 . . . . 0.0 109.728 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.509 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 2.5 m-20 -77.18 -19.93 56.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.207 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.58 ' CE1' HD11 ' A' ' 337' ' ' ILE . 44.0 m80 -89.79 -28.56 19.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.557 -0.714 . . . . 0.0 109.756 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.5 OUTLIER 78.14 4.6 2.77 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.677 -0.639 . . . . 0.0 110.002 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.566 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -66.52 -91.36 0.05 OUTLIER Glycine 0 N--CA 1.482 1.727 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.565 ' O ' HG11 ' A' ' 413' ' ' VAL . 1.4 ttp 178.96 166.31 0.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -1.101 . . . . 0.0 111.413 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.464 ' HB2' HG11 ' A' ' 413' ' ' VAL . 25.1 tp -151.96 90.96 1.57 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.396 -0.815 . . . . 0.0 108.904 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -112.24 143.12 43.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.941 -1.099 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.713 HD21 ' C2 ' ' A' ' 451' ' ' ANP . 0.2 OUTLIER -105.72 111.65 24.41 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 109.747 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.461 ' O ' ' OG1' ' A' ' 424' ' ' THR . . . -98.3 162.78 20.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 427' ' ' ARG . 4.6 m -165.15 116.83 1.15 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -1.229 . . . . 0.0 110.674 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 23.0 t -75.07 98.9 3.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 426' ' ' GLU . 25.7 tt0 55.48 45.84 24.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.363 -0.836 . . . . 0.0 110.111 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.518 ' HG3' ' NH1' ' A' ' 427' ' ' ARG . 10.7 mmt85 46.64 32.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.94 . . . . 0.0 109.958 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -125.02 -46.45 0.24 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -107.11 82.41 0.31 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.626 ' CD2' ' C6 ' ' A' ' 451' ' ' ANP . 0.5 OUTLIER -78.62 135.46 37.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -1.209 . . . . 0.0 110.949 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 28.6 m -148.5 122.14 9.21 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.506 HD12 ' HG ' ' A' ' 422' ' ' LEU . 1.1 tt -89.39 128.02 41.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.062 -1.024 . . . . 0.0 110.609 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' ARG . . . . . 0.464 ' HG3' ' HG3' ' A' ' 370' ' ' GLN . 0.5 OUTLIER -107.13 99.67 9.21 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.44 -0.788 . . . . 0.0 110.059 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.6 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -90.32 138.5 31.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.674 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 89.4 m95 -114.97 159.32 20.89 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.284 1.04 . . . . 0.0 113.088 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.529 ' CD1' HD11 ' A' ' 301' ' ' LEU . 32.0 mt -146.33 123.11 5.85 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.566 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 44.4 Cg_endo -74.17 141.83 29.82 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 123.479 1.252 . . . . 0.0 112.18 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.722 HG22 HG12 ' A' ' 330' ' ' VAL . 55.0 t -101.8 134.25 20.27 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.758 -0.588 . . . . 0.0 109.862 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.98 108.73 2.38 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.803 1.422 . . . . 0.0 109.955 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 438' ' ' VAL . 21.3 t -128.99 127.19 65.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.205 -0.935 . . . . 0.0 110.736 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 442' ' ' ARG . 1.2 t -140.21 66.19 1.4 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 0.0 109.774 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 441' ' ' THR . 0.3 OUTLIER 68.03 -83.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.292 -0.88 . . . . 0.0 109.842 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 443' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 442' ' ' ARG . . . 39.84 90.06 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.273 -0.892 . . . . 0.0 110.553 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -109.7 33.9 4.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.152 -0.967 . . . . 0.0 110.115 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 446' ' ' THR . . . -167.08 31.77 0.2 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 445' ' ' GLY . 30.7 p -156.47 73.91 0.8 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.223 -1.163 . . . . 0.0 110.34 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 54.7 p -83.12 -49.08 9.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -81.61 95.63 7.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.172 -0.955 . . . . 0.0 110.255 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.88 -165.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.167 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 117.955 -1.469 . . . . 0.0 109.494 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.713 ' C2 ' HD21 ' A' ' 422' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.296 0.57 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -171.05 166.0 39.16 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.33 87.35 4.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -1.17 . . . . 0.0 110.234 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -123.04 42.66 3.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -0.937 . . . . 0.0 110.026 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.462 ' HG2' ' HG3' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -70.85 121.17 83.14 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.336 -0.853 . . . . 0.0 110.06 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.685 ' HB3' ' CD2' ' A' ' 333' ' ' HIS . 48.1 Cg_endo -76.09 176.3 10.21 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.912 1.48 . . . . 0.0 111.078 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.617 ' HE1' ' HB3' ' A' ' 415' ' ' ASN . 0.8 OUTLIER 35.78 51.69 0.73 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.699 1.238 . . . . 0.0 110.16 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.654 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.4 OUTLIER -126.5 -156.98 0.77 Allowed 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.24 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.452 ' SD ' ' OE1' ' A' ' 329' ' ' GLU . 0.7 OUTLIER -86.81 125.17 33.77 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.414 -1.429 . . . . 0.0 110.626 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -137.99 158.55 44.1 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.586 0.708 . . . . 0.0 111.572 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.835 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.9 OUTLIER -102.19 112.75 25.55 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.573 ' CD2' ' HE1' ' A' ' 332' ' ' MET . 14.1 mt -60.34 -24.87 65.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.092 -1.005 . . . . 0.0 110.472 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.965 ' HA ' HD23 ' A' ' 323' ' ' LEU . 7.7 m-20 -79.52 -23.39 42.94 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.829 -1.17 . . . . 0.0 109.107 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -83.12 -30.37 27.96 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.479 0.657 . . . . 0.0 109.678 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 300' ' ' ASP . 2.9 t -79.02 -31.87 15.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.44 -0.787 . . . . 0.0 109.69 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 309' ' ' ILE . 97.9 mt -77.64 -31.78 52.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 110.869 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.21 -38.36 95.81 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.471 -1.347 . . . . 0.0 109.897 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 48.4 mt-10 -76.32 -34.73 59.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -1.15 . . . . 0.0 109.7 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.787 HG11 ' CG1' ' A' ' 341' ' ' VAL . 63.6 t -77.48 -19.13 14.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.687 0.756 . . . . 0.0 109.701 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.778 ' CD1' HG11 ' A' ' 358' ' ' VAL . 0.0 OUTLIER -75.09 -43.85 44.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -90.37 -16.8 28.44 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.506 0.669 . . . . 0.0 110.377 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -73.25 -41.95 63.09 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.586 -0.696 . . . . 0.0 112.261 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 312' ' ' GLU . 1.4 pp20? -115.82 17.24 16.14 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.753 -1.179 . . . . 0.0 112.354 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.563 ' HB2' HD11 ' A' ' 319' ' ' ILE . 15.4 t -102.99 -39.47 6.9 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.391 1.091 . . . . 0.0 109.621 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 118.12 -40.29 2.35 Favored Glycine 0 C--N 1.263 -3.491 0 N-CA-C 107.326 -2.31 . . . . 0.0 107.326 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 5.8 t80 174.65 37.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 0.2 OUTLIER 58.8 47.59 12.47 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.488 ' O ' ' HG3' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -67.75 -39.7 84.15 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.449 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 317' ' ' ARG . 39.0 mt-10 -154.97 51.74 0.61 Allowed 'General case' 0 C--N 1.273 -2.751 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.437 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.798 HG23 HG23 ' A' ' 358' ' ' VAL . 5.5 mt -118.9 129.34 75.24 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.949 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.542 ' HB3' ' HD3' ' A' ' 357' ' ' LYS . 37.1 tt0 -97.19 103.53 15.47 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.593 HG22 ' CD1' ' A' ' 309' ' ' ILE . 24.2 p -89.12 128.3 35.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 111.871 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.57 78.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.965 HD23 ' HA ' ' A' ' 302' ' ' ASN . 1.9 mp -95.53 159.91 14.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.471 -0.768 . . . . 0.0 111.148 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.637 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 83.5 t80 -47.94 121.44 8.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.622 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.64 78.96 1.96 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.903 1.475 . . . . 0.0 110.718 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 173.15 29.29 0.03 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.524 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 326' ' ' GLY . 2.1 p 44.28 98.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.069 -1.253 . . . . 0.0 110.001 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.561 HG22 ' H ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -72.43 -179.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.463 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.561 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.3 mt-10 -171.39 105.66 0.22 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.68 0.752 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 1.004 HG11 ' HB3' ' A' ' 367' ' ' ALA . 31.0 m -137.06 158.35 36.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 O-C-N 121.67 -0.644 . . . . 0.0 109.626 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.1 OUTLIER -72.36 91.81 1.37 Allowed 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.831 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.71 ' SD ' HD13 ' A' ' 436' ' ' LEU . 3.8 ttp -134.81 168.15 19.57 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 111.255 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.685 ' CD2' ' HB3' ' A' ' 295' ' ' PRO . 19.0 t-160 -101.85 118.09 60.2 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 37.2 Cg_endo -59.66 -21.72 64.05 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.41 1.216 . . . . 0.0 110.37 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.619 ' HB2' ' NE2' ' A' ' 333' ' ' HIS . 0.3 OUTLIER -83.4 -68.2 0.73 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.461 -0.774 . . . . 0.0 110.355 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 333' ' ' HIS . 0.4 OUTLIER -46.55 -44.51 17.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.484 -0.76 . . . . 0.0 110.007 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.836 HD11 ' CE1' ' A' ' 416' ' ' HIS . 37.9 mm -65.16 -46.23 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.393 -0.817 . . . . 0.0 109.53 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 337' ' ' ILE . 0.0 OUTLIER -47.04 -41.98 17.62 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.083 -1.011 . . . . 0.0 108.492 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 343' ' ' ASN . 17.2 mtt180 -73.03 -34.93 66.63 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.433 0.635 . . . . 0.0 110.314 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.816 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -62.23 -32.62 73.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.763 . . . . 0.0 110.849 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.787 ' CG1' HG11 ' A' ' 308' ' ' VAL . 44.7 t -85.19 -63.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.127 -0.983 . . . . 0.0 110.063 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.593 ' HA ' ' CG2' ' A' ' 345' ' ' VAL . . . -51.39 -19.45 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 110.687 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ASN . . . . . 0.574 ' O ' HG12 ' A' ' 346' ' ' VAL . 16.8 t-20 -76.2 -42.48 46.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.137 -0.977 . . . . 0.0 111.412 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.1 mtt -79.57 -24.89 41.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.975 -1.078 . . . . 0.0 111.413 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 341' ' ' VAL . 16.7 m -88.56 -19.74 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.906 -1.121 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 343' ' ' ASN . 4.7 p -58.72 -36.16 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.916 -1.115 . . . . 0.0 110.544 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.476 ' OD1' ' O2A' ' A' ' 451' ' ' ANP . 0.9 OUTLIER -65.3 -54.38 29.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.897 . . . . 0.0 110.357 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.489 ' O ' ' CA ' ' A' ' 352' ' ' GLY . . . -66.55 -19.82 65.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.891 . . . . 0.0 110.503 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -74.76 -50.32 17.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 110.485 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.08 -73.19 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.915 . . . . 0.0 110.682 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' TYR . . . . . 0.444 ' O ' ' O ' ' A' ' 352' ' ' GLY . 12.1 m-85 -82.54 -44.6 15.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.225 -0.922 . . . . 0.0 110.828 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 348' ' ' ALA . . . 55.59 103.58 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 353' ' ' ASN . 26.6 t-20 -113.24 24.74 11.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -1.194 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 355' ' ' TRP . . . 178.64 -73.56 0.07 OUTLIER Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.642 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER 178.36 164.81 0.76 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.14 -1.212 . . . . 0.0 109.78 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.543 HD12 HG13 ' A' ' 319' ' ' ILE . 0.9 OUTLIER -112.45 163.01 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.279 -0.888 . . . . 0.0 111.183 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.642 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -142.23 124.08 15.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.825 . . . . 0.0 110.002 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.798 HG23 HG23 ' A' ' 319' ' ' ILE . 21.7 t -119.92 83.15 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.406 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.534 ' HA ' HD12 ' A' ' 323' ' ' LEU . 47.2 t -113.53 166.56 11.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.319 -0.863 . . . . 0.0 110.528 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.552 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.6 t -156.77 160.07 38.89 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.52 -0.737 . . . . 0.0 109.849 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -149.22 -162.52 10.4 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.637 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -170.62 174.89 4.85 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.905 -1.35 . . . . 0.0 110.782 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.556 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 2.6 mt-10 -160.41 -178.65 0.92 Allowed Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 38.4 Cg_endo -64.11 135.31 46.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.475 1.25 . . . . 0.0 109.908 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.553 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 5.0 p-10 38.74 33.65 0.07 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.614 -0.678 . . . . 0.0 110.699 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.553 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 3.6 mtt180 -172.67 99.93 0.14 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.393 -0.817 . . . . 0.0 111.265 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 1.004 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -110.32 154.8 22.99 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.1 -1.0 . . . . 0.0 108.659 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.621 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 45.9 p-90 -153.4 177.49 10.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.548 -1.345 . . . . 0.0 111.649 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.783 ' HE2' HD11 ' A' ' 436' ' ' LEU . 32.7 p90 -150.44 153.56 36.14 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -145.85 152.87 40.19 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.853 -1.154 . . . . 0.0 111.673 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.564 ' O ' HG22 ' A' ' 432' ' ' ILE . 88.0 t -122.73 141.31 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.529 ' HB2' ' HG2' ' A' ' 357' ' ' LYS . 0.8 OUTLIER -121.62 154.93 36.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.061 -1.024 . . . . 0.0 110.732 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -155.0 140.04 17.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -107.72 109.36 20.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 0.0 110.385 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -177.37 -107.32 0.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.13 -172.03 0.8 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.829 1.436 . . . . 0.0 110.671 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 430' ' ' LEU . . . -144.09 -150.76 5.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.564 HG23 " H1'" ' A' ' 451' ' ' ANP . 11.3 mt -118.55 161.25 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.179 -1.189 . . . . 0.0 110.076 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.842 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -112.02 176.47 1.49 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.094 -1.004 . . . . 0.0 110.555 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.842 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 47.2 Cg_endo -75.64 -45.04 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.092 1.575 . . . . 0.0 110.643 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -81.34 -35.73 30.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 110.514 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.831 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 5.2 mp0 -61.29 -21.49 63.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.268 -0.895 . . . . 0.0 110.307 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -59.58 -30.79 68.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.879 . . . . 0.0 109.987 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 388' ' ' GLN . 0.1 OUTLIER -79.56 -35.39 39.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 385' ' ' HIS . 2.8 m-70 -67.19 -25.73 66.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.203 -0.936 . . . . 0.0 110.417 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.613 ' O ' ' CG ' ' A' ' 387' ' ' PHE . 12.4 mt -88.89 1.45 55.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -0.997 . . . . 0.0 110.21 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 90.4 m-85 -160.74 52.37 0.29 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.714 -0.616 . . . . 0.0 110.389 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 384' ' ' LYS . 3.4 mt-30 -104.81 136.63 19.14 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.019 -1.05 . . . . 0.0 110.559 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.53 124.96 8.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.877 1.461 . . . . 0.0 109.887 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -90.57 139.92 30.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 57.9 t -139.06 152.26 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.236 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -100.43 145.32 28.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 110.381 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 113.39 -12.9 23.5 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -88.78 115.8 26.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.335 -1.097 . . . . 0.0 110.086 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.55 87.13 2.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.283 -0.886 . . . . 0.0 110.113 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -82.67 -171.41 3.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.939 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -148.11 59.86 1.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.112 -0.993 . . . . 0.0 110.286 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 8.9 m -154.75 20.84 0.46 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.882 . . . . 0.0 110.046 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.2 mt -136.46 -66.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 110.357 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 9.1 m 57.13 56.75 5.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.961 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -91.54 -160.87 36.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.39 178.06 5.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.26 -1.141 . . . . 0.0 110.405 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -52.19 106.29 0.33 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 24.8 mt -97.68 164.82 12.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 110.425 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 118.45 33.6 1.19 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.767 ' H ' HD13 ' A' ' 406' ' ' LEU . 0.0 OUTLIER -90.56 174.56 7.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.34 -1.094 . . . . 0.0 110.806 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.434 ' C ' HG23 ' A' ' 408' ' ' ILE . . . -109.47 133.58 52.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.638 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.878 HD12 HG12 ' A' ' 409' ' ' VAL . 1.7 pp -146.95 -156.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 109.933 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.878 HG12 HD12 ' A' ' 408' ' ' ILE . 1.4 p -37.73 -33.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.326 -0.859 . . . . 0.0 110.923 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 408' ' ' ILE . 1.3 mm100 -65.9 -55.7 15.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.042 -1.036 . . . . 0.0 109.739 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.504 ' HD3' ' ND2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -56.57 -20.77 22.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.816 HG21 ' HB2' ' A' ' 340' ' ' ALA . 25.4 mm -72.11 -65.91 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 108.569 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.907 HG21 HD13 ' A' ' 420' ' ' LEU . 86.5 t -59.99 -19.87 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.538 -0.726 . . . . 0.0 109.703 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -82.22 -32.83 29.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.867 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.617 ' HB3' ' HE1' ' A' ' 296' ' ' MET . 1.4 m-20 -78.7 -28.06 45.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.481 -0.762 . . . . 0.0 109.378 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.836 ' CE1' HD11 ' A' ' 337' ' ' ILE . 41.1 m80 -86.34 -39.03 16.86 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.881 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 1.0 OUTLIER 79.88 45.44 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.393 0.616 . . . . 0.0 110.543 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 419' ' ' MET . . . -107.85 -85.81 1.78 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.57 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.4 ttp 177.99 169.88 0.72 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.321 -1.105 . . . . 0.0 111.019 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.907 HD13 HG21 ' A' ' 413' ' ' VAL . 16.1 tp -151.46 89.34 1.49 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.769 . . . . 0.0 109.133 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.38 159.47 15.11 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.095 -1.003 . . . . 0.0 111.525 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 422' ' ' LEU . 3.0 pp -134.05 119.45 18.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.606 -0.684 . . . . 0.0 109.535 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 430' ' ' LEU . . . -131.14 170.72 21.27 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.536 ' OG1' ' CD2' ' A' ' 430' ' ' LEU . 88.0 m -165.05 106.9 0.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.057 -1.261 . . . . 0.0 110.448 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 426' ' ' GLU . 1.6 m -41.92 105.54 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.854 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 425' ' ' SER . 7.3 tt0 59.64 -87.04 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 425' ' ' SER . 0.0 OUTLIER -162.76 35.71 0.1 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.127 -0.983 . . . . 0.0 109.424 179.769 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -144.75 -36.55 0.07 OUTLIER Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -85.75 57.98 4.84 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.652 ' CD1' ' N7 ' ' A' ' 451' ' ' ANP . 0.2 OUTLIER -68.06 114.89 6.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.185 -1.185 . . . . 0.0 110.298 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.525 ' HB2' ' CG ' ' A' ' 372' ' ' GLU . 14.6 t -128.32 120.87 27.93 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.429 -0.794 . . . . 0.0 110.312 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 371' ' ' VAL . 1.2 tt -91.73 130.68 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.52 129.46 56.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.999 -1.063 . . . . 0.0 110.771 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -120.07 128.68 53.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.273 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.621 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.8 m95 -102.44 155.62 18.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.94 -1.1 . . . . 0.0 111.591 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.783 HD11 ' HE2' ' A' ' 369' ' ' PHE . 14.6 mt -145.59 129.04 8.41 Favored Pre-proline 0 N--CA 1.485 1.276 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.02 142.23 41.91 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.721 1.38 . . . . 0.0 110.069 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.616 HG22 HG12 ' A' ' 330' ' ' VAL . 2.6 t -73.35 -47.35 7.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.152 -0.967 . . . . 0.0 110.498 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 438' ' ' VAL . 58.0 Cg_endo -89.63 -170.73 0.46 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.51 1.269 . . . . 0.0 110.333 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 440' ' ' VAL . 12.0 p -100.5 157.71 4.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.627 -0.671 . . . . 0.0 109.926 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 4.0 p -117.38 140.2 49.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.914 -1.116 . . . . 0.0 110.096 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.13 107.9 18.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.159 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.07 125.11 24.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 110.178 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.77 149.38 49.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 110.131 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 166.15 -161.38 35.01 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 1.9 t -164.23 73.14 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -1.182 . . . . 0.0 110.207 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 1.6 t -147.89 125.01 11.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.038 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -107.7 -143.1 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.885 . . . . 0.0 110.298 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -74.59 131.18 40.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.88 . . . . 0.0 110.178 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 CA-C-O 117.995 -1.447 . . . . 0.0 109.504 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.652 ' N7 ' ' CD1' ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.274 0.559 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -147.75 -147.04 4.45 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -144.07 119.34 10.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -1.159 . . . . 0.0 110.017 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.46 82.82 1.96 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.0 110.483 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.507 ' N ' ' HD3' ' A' ' 295' ' ' PRO . 34.1 mtp -146.39 67.59 11.8 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.154 -0.966 . . . . 0.0 110.385 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.581 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 53.3 Cg_endo -99.45 -163.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 121.948 1.765 . . . . 0.0 111.283 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.688 ' HE3' ' NE2' ' A' ' 416' ' ' HIS . 0.3 OUTLIER 28.83 80.57 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.416 1.103 . . . . 0.0 112.015 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 14.2 mt-10 -148.63 -149.06 0.28 Allowed 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.507 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -87.64 128.81 35.28 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.74 -1.225 . . . . 0.0 109.527 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . -136.01 158.29 44.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.404 -0.81 . . . . 0.0 111.67 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 304' ' ' VAL . 4.3 m-20 -95.12 117.51 30.33 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.564 HD11 HD12 ' A' ' 436' ' ' LEU . 6.7 mt -63.86 -23.64 67.43 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.05 -1.031 . . . . 0.0 110.191 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.852 ' HA ' HD23 ' A' ' 323' ' ' LEU . 29.9 m-20 -79.94 -19.57 47.69 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.904 -1.123 . . . . 0.0 108.569 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.94 -37.21 19.29 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.433 0.635 . . . . 0.0 109.463 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.814 ' O ' HG23 ' A' ' 308' ' ' VAL . 22.0 t -74.94 -30.79 24.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.528 -0.732 . . . . 0.0 109.514 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 25.2 mt -78.65 -36.38 43.96 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.285 -0.884 . . . . 0.0 110.428 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -62.06 -39.1 97.16 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.683 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 1.0 OUTLIER -71.88 -33.66 68.54 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.231 -1.158 . . . . 0.0 108.599 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 304' ' ' VAL . 93.5 t -75.57 -18.77 15.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.811 0.815 . . . . 0.0 108.9 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.665 HG13 HG21 ' A' ' 321' ' ' THR . 0.3 OUTLIER -72.71 -45.1 58.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 122.021 0.915 . . . . 0.0 108.648 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.428 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -90.95 -15.86 29.03 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 121.4 -0.813 . . . . 0.0 109.795 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -61.61 -64.81 0.82 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.658 -0.651 . . . . 0.0 111.297 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.434 ' HG3' ' C ' ' A' ' 311' ' ' ALA . 94.9 mt-10 -142.98 39.2 1.47 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.088 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.642 ' O ' HD11 ' A' ' 319' ' ' ILE . 19.4 m -88.31 42.74 1.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.892 -1.13 . . . . 0.0 109.161 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' A' ' 315' ' ' TYR . . . 74.07 13.87 80.77 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.58 ' CB ' ' O ' ' A' ' 314' ' ' GLY . 4.0 t80 78.88 63.3 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.893 -0.769 . . . . 0.0 108.926 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.576 ' CG ' ' O ' ' A' ' 315' ' ' TYR . 6.2 pt-20 41.74 45.73 3.11 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.126 0.965 . . . . 0.0 109.907 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.58 ' CG ' ' O ' ' A' ' 314' ' ' GLY . 6.4 mmt180 -68.36 -89.74 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 121.771 0.796 . . . . 0.0 109.808 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.25 65.55 1.41 Allowed 'General case' 0 C--N 1.272 -2.778 0 CA-C-O 121.583 0.706 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.644 ' CG2' HG23 ' A' ' 358' ' ' VAL . 2.6 mp -101.27 148.37 7.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 121.52 -0.737 . . . . 0.0 110.113 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -114.28 105.46 13.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.164 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.772 HG22 ' HB ' ' A' ' 358' ' ' VAL . 28.2 p -90.55 122.04 33.02 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 111.38 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -129.69 78.36 1.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.852 HD23 ' HA ' ' A' ' 302' ' ' ASN . 1.8 mp -93.78 174.18 7.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 111.215 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.629 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 20.8 t80 -61.23 137.84 94.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.651 -0.656 . . . . 0.0 109.906 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.569 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 53.1 Cg_endo -82.46 61.97 7.78 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.963 1.507 . . . . 0.0 110.547 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 178.82 22.2 0.03 OUTLIER Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.777 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 326' ' ' GLY . 2.1 m 55.12 107.3 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.891 -1.358 . . . . 0.0 110.281 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.546 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -81.63 -177.51 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.122 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 1.9 mt-10 -170.92 108.79 0.31 Allowed 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.841 0.829 . . . . 0.0 111.107 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 436' ' ' LEU . 25.3 m -131.3 159.17 43.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 O-C-N 121.72 -0.613 . . . . 0.0 109.463 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 3.3 tptt -76.4 93.57 3.51 Favored 'General case' 0 C--N 1.288 -2.104 0 C-N-CA 118.681 -1.208 . . . . 0.0 108.909 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.733 ' HE1' HG21 ' A' ' 337' ' ' ILE . 0.0 OUTLIER -134.73 -174.46 3.59 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.818 0.818 . . . . 0.0 111.326 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.601 ' CB ' ' NE2' ' A' ' 416' ' ' HIS . 18.6 t-160 -113.82 117.56 44.07 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 37.1 Cg_endo -59.24 -26.58 82.32 Favored 'Trans proline' 0 C--N 1.289 -2.563 0 O-C-N 123.105 1.055 . . . . 0.0 110.391 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.637 HD12 ' C ' ' A' ' 335' ' ' LEU . 0.5 OUTLIER -83.09 -66.47 0.89 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.273 -0.892 . . . . 0.0 110.819 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.546 ' N ' ' HG ' ' A' ' 335' ' ' LEU . 3.5 m -52.88 -42.76 65.6 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.941 -1.099 . . . . 0.0 110.624 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.768 HD11 ' CG ' ' A' ' 416' ' ' HIS . 29.6 mm -64.17 -44.45 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.591 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 0.7 OUTLIER -50.72 -46.77 59.18 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.707 -1.246 . . . . 0.0 109.284 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -43.17 93.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 0.0 110.121 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 1.023 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -47.29 -40.99 18.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.514 -0.741 . . . . 0.0 110.576 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.621 ' CG1' HG11 ' A' ' 308' ' ' VAL . 40.2 t -80.04 -32.14 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 110.47 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.969 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -66.78 -23.65 66.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.26 -0.9 . . . . 0.0 110.364 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ASN . . . . . 0.554 ' HB2' ' HB1' ' A' ' 407' ' ' ALA . 0.2 OUTLIER -66.99 -29.88 69.84 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.147 -0.971 . . . . 0.0 110.489 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 42.0 mtt -82.04 -42.9 18.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.208 -0.933 . . . . 0.0 110.498 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.569 HG21 ' HA ' ' A' ' 313' ' ' SER . 3.7 p -67.86 -19.6 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.474 -0.766 . . . . 0.0 110.776 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 342' ' ' ALA . 53.0 t -67.99 -20.08 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.14 -0.975 . . . . 0.0 110.657 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.2 -57.38 4.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 110.366 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.422 ' O ' ' HA2' ' A' ' 352' ' ' GLY . . . -79.72 -19.97 47.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.46 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 345' ' ' VAL . . . -74.06 -25.11 59.65 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 110.413 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -73.71 -67.94 0.55 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.204 -0.935 . . . . 0.0 110.295 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -30.45 51.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 110.217 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 348' ' ' ALA . . . 82.95 106.5 0.48 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 374' ' ' ASP . 10.5 m120 -97.5 -57.4 2.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.285 -1.127 . . . . 0.0 110.466 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . 150.99 -17.38 0.93 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.607 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 37.7 t90 -154.37 130.87 10.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.842 -1.387 . . . . 0.0 111.666 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 319' ' ' ILE . 82.1 mt -124.05 158.98 30.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.559 ' HB3' ' CB ' ' A' ' 372' ' ' GLU . 5.9 tttp -136.4 137.95 41.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.628 -1.295 . . . . 0.0 111.672 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.772 ' HB ' HG22 ' A' ' 321' ' ' THR . 26.0 t -132.85 81.19 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.44 ' HB3' ' HE3' ' A' ' 357' ' ' LYS . 89.1 p -112.14 160.77 17.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.161 -0.962 . . . . 0.0 111.256 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 369' ' ' PHE . 47.2 t -162.16 130.44 4.11 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -118.1 -161.47 11.95 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.8 OUTLIER -171.36 177.58 3.5 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.748 -1.442 . . . . 0.0 112.014 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.563 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 1.0 OUTLIER -156.29 175.26 3.3 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 38.0 Cg_endo -64.29 116.32 3.67 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.158 1.083 . . . . 0.0 111.289 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.517 ' C ' ' HG3' ' A' ' 366' ' ' ARG . 6.2 m-20 63.07 18.38 10.88 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.743 -0.598 . . . . 0.0 111.147 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.517 ' HG3' ' C ' ' A' ' 365' ' ' ASN . 26.9 mtp180 -160.23 108.02 1.64 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.437 -0.789 . . . . 0.0 110.377 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.68 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -112.7 179.19 4.04 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.864 -1.147 . . . . 0.0 108.708 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.654 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 11.5 p-90 -171.44 149.04 2.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.825 -1.172 . . . . 0.0 110.11 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 369' ' ' PHE . 4.7 p90 -138.46 142.8 39.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.963 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.534 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 11.9 tt0 -133.31 155.09 50.06 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 110.42 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.534 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 36.7 t -118.78 151.74 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.428 -0.795 . . . . 0.0 110.179 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.559 ' CB ' ' HB3' ' A' ' 357' ' ' LYS . 4.4 tt0 -139.19 117.24 11.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.269 -0.895 . . . . 0.0 109.746 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 20.4 p-10 -145.88 143.48 29.61 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.04 -1.038 . . . . 0.0 110.201 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 353' ' ' ASN . 12.4 t0 -74.83 140.76 44.15 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.406 -0.809 . . . . 0.0 109.817 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -179.51 -150.29 8.96 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.07 -162.24 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.975 1.513 . . . . 0.0 110.512 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -140.22 -172.75 12.99 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.599 HG12 ' N9 ' ' A' ' 451' ' ' ANP . 26.0 mt -110.39 140.16 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -1.174 . . . . 0.0 110.568 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -82.56 164.4 47.49 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.407 -0.808 . . . . 0.0 109.872 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 46.6 Cg_endo -73.83 -30.25 9.54 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 124.087 1.572 . . . . 0.0 110.732 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -90.39 -21.29 22.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.0 110.483 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.766 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 0.1 OUTLIER -78.88 -21.65 47.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.177 -0.952 . . . . 0.0 110.466 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -49.97 -21.42 1.2 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.151 -0.968 . . . . 0.0 110.467 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.54 -32.19 16.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.24 -0.912 . . . . 0.0 110.482 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.432 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 5.4 m-70 -80.35 -10.88 59.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.319 -0.863 . . . . 0.0 110.893 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.808 HD21 ' N3 ' ' A' ' 451' ' ' ANP . 22.1 tp -82.77 8.05 13.33 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.036 -1.04 . . . . 0.0 111.445 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.609 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 31.2 m-85 -162.53 27.21 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.496 -0.752 . . . . 0.0 110.606 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 387' ' ' PHE . 24.7 mt-30 53.89 162.83 0.05 OUTLIER Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 121.46 -0.775 . . . . 0.0 110.536 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 390' ' ' PHE . 50.5 Cg_endo -82.58 41.66 1.16 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.76 1.4 . . . . 0.0 110.549 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 389' ' ' PRO . 93.7 m-85 59.41 137.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.356 -0.84 . . . . 0.0 110.329 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 42.6 t -84.95 148.97 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.976 . . . . 0.0 110.084 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -130.12 -3.79 4.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.217 -0.927 . . . . 0.0 110.48 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 117.95 -41.28 2.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -143.35 110.64 5.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -1.175 . . . . 0.0 110.517 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.1 t -121.47 -89.34 0.6 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.15 -0.969 . . . . 0.0 110.107 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -151.45 -72.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 109.965 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.3 155.83 10.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 109.883 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.67 138.62 54.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 110.475 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 399' ' ' ILE . 0.0 OUTLIER -115.73 120.54 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 110.169 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.49 -141.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.107 -0.996 . . . . 0.0 110.11 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -70.51 -66.93 2.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 32.6 p -108.89 157.87 18.21 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.285 -1.126 . . . . 0.0 110.108 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -120.07 -171.49 14.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 404' ' ' LEU . 5.7 tp -104.4 74.33 1.17 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.375 -1.074 . . . . 0.0 110.173 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -114.72 164.37 12.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.05 -56.11 1.27 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.211 -1.17 . . . . 0.0 110.214 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' A' ' 343' ' ' ASN . . . -105.82 -51.78 2.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.902 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.76 ' O ' HG23 ' A' ' 408' ' ' ILE . 1.1 tp 23.1 98.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.622 0 CA-C-O 121.292 0.568 . . . . 0.0 111.605 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 409' ' ' VAL . 93.6 t -79.83 1.91 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 1.3 mm100 -74.25 -55.3 6.2 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 110.237 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 1.9 mmt180 -67.8 -31.49 71.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.323 -0.861 . . . . 0.0 109.898 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 1.023 HG21 ' HB2' ' A' ' 340' ' ' ALA . 8.7 mm -67.21 -66.28 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.894 HG21 HD13 ' A' ' 420' ' ' LEU . 35.4 t -57.11 -23.24 18.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.424 -0.797 . . . . 0.0 109.699 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 29.5 m-20 -78.09 -30.72 49.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.221 -0.925 . . . . 0.0 109.535 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.51 ' HB3' ' HE1' ' A' ' 296' ' ' MET . 1.2 m-20 -109.31 7.29 25.11 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.65 -0.657 . . . . 0.0 109.625 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.768 ' CG ' HD11 ' A' ' 337' ' ' ILE . 47.1 m80 -134.64 -62.92 0.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 111.968 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.956 ' HA ' HD23 ' A' ' 436' ' ' LEU . 2.4 m-20 -74.73 -99.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.808 0.814 . . . . 0.0 111.61 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 149.11 -35.04 1.08 Allowed Glycine 0 C--N 1.262 -3.551 0 N-CA-C 106.432 -2.667 . . . . 0.0 106.432 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.669 ' HB3' ' HB2' ' A' ' 435' ' ' TRP . 36.4 ttm -123.14 145.69 48.38 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.658 -0.907 . . . . 0.0 109.601 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.894 HD13 HG21 ' A' ' 413' ' ' VAL . 19.7 tp -150.84 92.71 1.86 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.114 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -107.6 128.8 54.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.372 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.511 HD13 HD13 ' A' ' 378' ' ' ILE . 2.0 pp -89.81 138.58 31.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.869 . . . . 0.0 109.547 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.488 ' O ' ' HG ' ' A' ' 430' ' ' LEU . . . -149.26 -168.66 15.02 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.555 -1.307 . . . . 0.0 109.903 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.853 HG22 ' O ' ' A' ' 429' ' ' GLY . 0.2 OUTLIER 50.09 173.2 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.577 -0.955 . . . . 0.0 111.185 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.801 ' OG ' HD12 ' A' ' 430' ' ' LEU . 0.2 OUTLIER 172.06 -143.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -58.13 -34.18 69.97 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.36 -0.837 . . . . 0.0 109.893 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.562 ' HG2' ' N ' ' A' ' 428' ' ' GLY . 0.0 OUTLIER -44.65 -27.57 0.5 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.118 -0.989 . . . . 0.0 109.897 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.562 ' N ' ' HG2' ' A' ' 427' ' ' ARG . . . 178.87 54.07 0.08 OUTLIER Glycine 0 N--CA 1.484 1.9 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.853 ' O ' HG22 ' A' ' 424' ' ' THR . . . 69.39 144.65 0.18 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.801 HD12 ' OG ' ' A' ' 425' ' ' SER . 0.3 OUTLIER -88.68 165.23 14.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.882 -1.364 . . . . 0.0 109.876 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.541 ' N ' ' HB ' ' A' ' 424' ' ' THR . 1.7 p -146.52 162.86 37.42 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.964 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.628 HD11 ' N1 ' ' A' ' 451' ' ' ANP . 13.3 mm -123.8 121.84 63.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -98.99 100.98 12.22 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.833 ' HB1' HD22 ' A' ' 417' ' ' ASN . . . -110.35 135.05 51.67 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 111.066 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.669 ' HB2' ' HB3' ' A' ' 419' ' ' MET . 88.0 m95 -110.14 138.35 46.64 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 121.064 -1.023 . . . . 0.0 111.255 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.956 HD23 ' HA ' ' A' ' 417' ' ' ASN . 9.7 mt -113.46 75.79 2.57 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 417' ' ' ASN . 37.5 Cg_endo -63.05 115.08 2.74 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 O-C-N 124.665 1.876 . . . . 0.0 110.494 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.513 ' CG1' ' HD2' ' A' ' 439' ' ' PRO . 4.6 t -69.66 143.91 93.19 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.384 -0.823 . . . . 0.0 109.682 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.513 ' HD2' ' CG1' ' A' ' 438' ' ' VAL . 53.6 Cg_endo -71.23 -164.26 0.15 Allowed 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.0 1.526 . . . . 0.0 110.418 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.33 39.11 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 121.314 0.578 . . . . 0.0 110.289 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 442' ' ' ARG . 14.4 t -84.53 171.54 12.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -0.892 . . . . 0.0 110.164 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 441' ' ' THR . 5.0 mmt180 54.79 94.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.108 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -151.51 -74.13 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 110.179 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.71 81.52 3.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.963 . . . . 0.0 110.292 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -125.88 84.17 0.35 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 1.8 t -55.96 167.33 0.61 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -1.115 . . . . 0.0 110.275 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 8.9 p -86.11 -48.17 8.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 110.081 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 448' ' ' LYS . 0.0 OUTLIER -150.03 131.36 14.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.906 . . . . 0.0 110.036 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.68 -17.03 61.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 0.0 110.382 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 CA-C-O 118.028 -1.429 . . . . 0.0 109.573 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.808 ' N3 ' HD21 ' A' ' 386' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.276 0.56 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -149.12 -152.63 5.78 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.22 -32.89 4.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.31 -1.112 . . . . 0.0 110.198 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.425 ' C ' ' HD3' ' A' ' 295' ' ' PRO . 4.2 mt-10 -135.32 77.87 1.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.774 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -116.14 67.72 3.34 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.229 -0.919 . . . . 0.0 111.257 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 297' ' ' GLU . 47.0 Cg_endo -73.98 179.18 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.912 1.48 . . . . 0.0 109.542 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.541 ' HE3' ' HB3' ' A' ' 415' ' ' ASN . 0.1 OUTLIER 40.38 48.37 2.39 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.85 1.309 . . . . 0.0 109.304 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.701 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 4.3 mm-40 -127.84 -149.91 0.43 Allowed 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.193 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.488 ' HE2' ' N ' ' A' ' 330' ' ' VAL . 2.1 mmt -84.74 117.49 23.85 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 120.286 -1.508 . . . . 0.0 110.7 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.527 ' HB3' ' HE3' ' A' ' 332' ' ' MET . . . -134.09 162.01 33.29 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.528 0.68 . . . . 0.0 111.129 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 304' ' ' VAL . 4.1 m-20 -95.97 119.01 33.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.654 -0.654 . . . . 0.0 109.867 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.653 HD11 HD12 ' A' ' 436' ' ' LEU . 6.1 mt -65.51 -23.45 66.89 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.091 -1.006 . . . . 0.0 109.654 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.692 ' HA ' HD23 ' A' ' 323' ' ' LEU . 4.5 m-20 -75.68 -19.99 58.74 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.957 -1.09 . . . . 0.0 108.351 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.07 -37.24 19.08 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.524 0.678 . . . . 0.0 109.601 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.877 ' O ' HG23 ' A' ' 308' ' ' VAL . 2.5 t -78.8 -28.62 14.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.415 -0.803 . . . . 0.0 109.554 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 309' ' ' ILE . 72.4 mt -82.85 -31.38 28.04 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.62 -31.99 82.72 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -83.82 -30.82 26.21 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.268 -1.136 . . . . 0.0 109.251 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 304' ' ' VAL . 88.7 t -72.58 -26.88 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.305 -0.872 . . . . 0.0 109.32 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 305' ' ' LEU . 1.0 OUTLIER -75.79 -50.2 24.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.08 -16.7 64.5 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.861 0.839 . . . . 0.0 108.762 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -67.01 -68.03 0.41 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.453 0.644 . . . . 0.0 110.79 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.82 49.35 2.23 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.553 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.988 ' HB2' HD13 ' A' ' 319' ' ' ILE . 6.2 p -82.32 40.46 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.001 -1.062 . . . . 0.0 109.994 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.542 ' C ' ' CD2' ' A' ' 315' ' ' TYR . . . 53.16 38.15 55.83 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.542 ' CD2' ' C ' ' A' ' 314' ' ' GLY . 3.6 m-85 67.89 34.65 4.16 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.629 -0.924 . . . . 0.0 109.279 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 4.9 mm-40 57.52 41.71 25.48 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.241 -0.912 . . . . 0.0 108.614 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.575 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 1.6 tpp180 -68.71 -86.89 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.432 0.634 . . . . 0.0 110.784 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.575 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 5.4 mt-10 -127.04 66.15 1.29 Allowed 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.637 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.988 HD13 ' HB2' ' A' ' 313' ' ' SER . 1.5 mp -111.48 120.77 62.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 358' ' ' VAL . 24.0 tt0 -88.33 100.45 13.03 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.343 -0.848 . . . . 0.0 109.79 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 20.7 p -88.46 122.98 32.53 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.52 0.676 . . . . 0.0 110.903 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -144.55 78.94 1.59 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' ' 302' ' ' ASN . 1.7 mp -90.29 164.77 14.24 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 110.125 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 323' ' ' LEU . 5.2 t80 -43.24 136.76 2.95 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.631 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -83.14 51.57 3.68 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.94 1.495 . . . . 0.0 111.232 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -165.73 -87.77 0.07 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.3 m -178.54 105.26 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.613 -0.933 . . . . 0.0 108.98 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 329' ' ' GLU . 2.0 mt -74.17 -179.69 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 O-C-N 121.404 -0.81 . . . . 0.0 110.006 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.656 ' H ' HG22 ' A' ' 328' ' ' ILE . 3.2 mt-10 -170.82 105.63 0.26 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.585 0.707 . . . . 0.0 110.601 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.983 HG11 ' HB3' ' A' ' 367' ' ' ALA . 25.4 m -139.23 154.24 25.13 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.302 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.6 OUTLIER -71.7 92.35 1.18 Allowed 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.698 ' HE1' HG21 ' A' ' 304' ' ' VAL . 10.0 tmm? -143.07 158.24 43.78 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.108 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.617 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 9.9 t-160 -100.42 121.24 53.95 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 38.6 Cg_endo -64.77 -18.81 63.62 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.628 1.33 . . . . 0.0 109.697 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.617 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 0.6 OUTLIER -81.23 -80.01 0.15 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.618 -0.676 . . . . 0.0 110.692 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 96.9 p -44.37 -43.06 7.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.39 -0.819 . . . . 0.0 110.178 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.601 HD11 ' CE1' ' A' ' 416' ' ' HIS . 1.2 mm -66.32 -40.95 88.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.811 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 0.0 OUTLIER -45.45 -38.4 6.08 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -44.39 67.79 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.108 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.911 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -54.63 -47.99 72.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.61 -0.681 . . . . 0.0 111.089 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.806 ' CG1' HG11 ' A' ' 308' ' ' VAL . 33.3 t -75.62 -28.08 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.132 -0.98 . . . . 0.0 110.403 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.54 -19.89 63.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 110.117 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -88.85 -19.83 25.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.311 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.4 mtt -82.59 -44.78 15.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.243 -0.911 . . . . 0.0 110.373 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 346' ' ' VAL . 6.9 p -69.84 -42.82 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.555 ' N ' HG13 ' A' ' 345' ' ' VAL . 19.4 t -52.05 -19.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.102 -0.999 . . . . 0.0 110.569 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -67.12 -46.4 74.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.193 -0.942 . . . . 0.0 110.635 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 356' ' ' ILE . . . -88.78 -19.72 25.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.212 -0.93 . . . . 0.0 110.656 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.3 -27.16 65.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.159 -0.963 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 350' ' ' ARG . 0.0 OUTLIER -83.3 -37.09 23.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 110.123 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.85 -67.44 0.84 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 65.34 52.98 35.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -106.3 -1.94 22.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -1.153 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -145.08 -84.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.643 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -172.7 148.81 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -1.11 . . . . 0.0 109.875 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.528 HD12 HG13 ' A' ' 319' ' ' ILE . 1.0 OUTLIER -109.8 153.34 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.869 . . . . 0.0 109.528 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.643 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.1 OUTLIER -144.5 114.69 7.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.986 . . . . 0.0 110.745 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.719 HG23 HG23 ' A' ' 319' ' ' ILE . 55.3 t -109.72 138.64 36.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.553 ' HA ' HD12 ' A' ' 323' ' ' LEU . 97.7 p -161.18 173.96 14.35 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 120.502 -1.374 . . . . 0.0 111.507 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.524 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 6.4 p -155.04 131.3 10.33 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.488 0.661 . . . . 0.0 109.826 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.503 ' O ' ' HB ' ' A' ' 362' ' ' THR . . . -129.91 -172.47 13.16 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 107.986 -2.046 . . . . 0.0 107.986 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.652 HG21 HG23 ' A' ' 328' ' ' ILE . 0.6 OUTLIER 175.96 176.26 0.25 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.867 -1.372 . . . . 0.0 111.546 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.532 ' OE1' ' CD ' ' A' ' 364' ' ' PRO . 33.3 mm-40 -141.54 175.24 3.14 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.532 ' CD ' ' OE1' ' A' ' 363' ' ' GLU . 47.3 Cg_endo -77.25 26.01 0.46 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.336 1.177 . . . . 0.0 111.388 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 21.3 p-10 -170.19 24.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.065 -1.022 . . . . 0.0 110.202 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.542 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 8.1 ptt180 162.46 109.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.789 -0.569 . . . . 0.0 110.248 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.983 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -100.45 168.9 9.45 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.194 -0.941 . . . . 0.0 109.085 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.688 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 34.8 p-90 -170.98 153.16 3.73 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.587 -1.321 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 434' ' ' ALA . 54.4 p90 -121.81 157.15 31.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.175 -0.953 . . . . 0.0 108.638 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.542 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 5.8 tt0 -141.8 159.39 42.33 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.829 -1.17 . . . . 0.0 111.835 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.542 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 96.8 t -137.83 135.73 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.526 ' HB3' ' NH1' ' A' ' 427' ' ' ARG . 18.1 mt-10 -131.21 158.08 41.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.835 -1.165 . . . . 0.0 111.041 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 430' ' ' LEU . 27.1 t0 -150.58 142.81 24.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.436 -0.79 . . . . 0.0 109.782 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.65 2.0 20.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.219 -0.926 . . . . 0.0 110.297 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' GLY . . . . . 0.421 ' O ' ' HA3' ' A' ' 429' ' ' GLY . . . -65.53 -175.15 5.28 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.09 145.69 44.98 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.942 1.496 . . . . 0.0 110.642 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' GLY . . . . . 0.813 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -63.67 -140.34 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.813 HD13 ' C ' ' A' ' 377' ' ' GLY . 0.0 OUTLIER -116.75 118.95 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.147 -1.208 . . . . 0.0 109.957 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -43.26 161.64 0.19 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.281 -0.887 . . . . 0.0 110.296 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.38 -24.14 16.8 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.939 1.494 . . . . 0.0 110.028 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -88.67 -21.49 23.91 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.392 -0.818 . . . . 0.0 109.876 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.524 ' OE1' " O2'" ' A' ' 451' ' ' ANP . 0.0 OUTLIER -86.17 -30.33 22.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -22.21 66.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.612 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -20.84 63.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.603 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -92.42 21.02 5.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.472 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 1.031 HD22 HD21 ' A' ' 422' ' ' LEU . 8.5 mt -137.06 95.87 3.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.582 ' CB ' ' O ' ' A' ' 386' ' ' LEU . 13.5 m-85 86.73 72.51 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.769 0.795 . . . . 0.0 109.332 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -40.74 98.57 0.18 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.731 -0.606 . . . . 0.0 111.286 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 387' ' ' PHE . 48.2 Cg_endo -91.1 148.45 3.73 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.995 1.524 . . . . 0.0 109.851 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.85 -173.87 3.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.017 -1.052 . . . . 0.0 110.406 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.547 HG12 ' N ' ' A' ' 392' ' ' ARG . 39.0 t -94.07 172.72 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.278 -0.889 . . . . 0.0 111.022 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' ARG . . . . . 0.547 ' N ' HG12 ' A' ' 391' ' ' VAL . 0.0 OUTLIER -46.46 -68.41 0.2 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.38 -0.825 . . . . 0.0 110.148 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 394' ' ' ASP . . . 174.8 156.71 14.61 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 393' ' ' GLY . 12.9 m-20 -156.6 179.82 8.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.25 -1.147 . . . . 0.0 110.433 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 396' ' ' ALA . 1.4 m -72.61 148.81 44.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.305 -0.872 . . . . 0.0 110.268 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 395' ' ' SER . . . 54.91 106.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.314 -0.867 . . . . 0.0 110.047 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.42 138.76 29.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.259 -0.901 . . . . 0.0 110.393 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.47 ' O ' ' HB ' ' A' ' 399' ' ' ILE . 11.6 m -95.1 -10.81 29.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.308 -0.87 . . . . 0.0 110.04 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 398' ' ' THR . 31.1 mt 58.79 146.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 110.175 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.94 122.77 48.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.067 -1.021 . . . . 0.0 110.42 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -85.04 -158.99 30.4 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.0 m -69.29 154.16 42.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -1.195 . . . . 0.0 109.832 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -119.0 155.62 15.98 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.26 114.65 3.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -1.16 . . . . 0.0 110.339 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -140.54 -36.78 0.11 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -171.07 28.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -1.18 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.623 ' O ' HD13 ' A' ' 408' ' ' ILE . . . -74.3 129.77 38.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.168 -0.957 . . . . 0.0 110.367 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 407' ' ' ALA . 21.7 mm -124.35 -8.46 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.34 -0.85 . . . . 0.0 109.779 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.547 ' HA ' HG13 ' A' ' 412' ' ' ILE . 14.7 p -116.45 -9.46 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.53 -0.731 . . . . 0.0 109.989 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 44.6 tt0 -68.53 -62.39 1.41 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.297 -0.877 . . . . 0.0 110.315 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -19.99 6.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.241 -0.912 . . . . 0.0 110.497 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.911 HG21 ' HB2' ' A' ' 340' ' ' ALA . 24.7 mm -66.0 -69.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.105 -0.997 . . . . 0.0 108.984 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 420' ' ' LEU . 69.6 t -62.18 -20.72 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 109.437 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 2.8 t70 -79.14 -26.48 42.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.469 -0.769 . . . . 0.0 109.85 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.541 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 22.7 m-20 -84.0 -22.93 31.19 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.313 -0.867 . . . . 0.0 109.292 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.601 ' CE1' HD11 ' A' ' 337' ' ' ILE . 41.4 m80 -93.18 -26.16 17.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.504 -0.747 . . . . 0.0 109.686 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.57 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 4.2 m120 66.03 59.27 0.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.687 0.756 . . . . 0.0 110.889 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.559 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -128.29 -84.04 0.42 Allowed Glycine 0 N--CA 1.481 1.656 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.569 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.1 OUTLIER -179.07 155.98 0.76 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -1.129 . . . . 0.0 112.011 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.826 ' HB2' HG21 ' A' ' 413' ' ' VAL . 15.7 tp -152.76 92.83 1.69 Allowed 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.458 -0.776 . . . . 0.0 108.995 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 432' ' ' ILE . 0.2 OUTLIER -115.22 123.43 48.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.007 -1.058 . . . . 0.0 110.969 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 1.031 HD21 HD22 ' A' ' 386' ' ' LEU . 0.8 OUTLIER -126.5 140.01 52.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.154 -0.966 . . . . 0.0 110.098 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.43 ' HA2' HG13 ' A' ' 378' ' ' ILE . . . 175.46 -169.76 42.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 44.3 m -78.97 154.95 29.16 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.297 -1.119 . . . . 0.0 110.003 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.569 ' HB2' ' CB ' ' A' ' 431' ' ' SER . 1.8 m -133.42 170.41 15.52 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -49.42 -39.67 33.59 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 120.853 0.358 . . . . 0.0 110.714 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 427' ' ' ARG . 6.8 ptp180 -39.69 -33.19 0.17 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.909 0.861 . . . . 0.0 109.334 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 426' ' ' GLU . . . 106.07 39.78 2.08 Favored Glycine 0 C--N 1.293 -1.822 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . 174.91 -145.85 8.13 Favored Glycine 0 N--CA 1.503 3.109 0 C-N-CA 118.014 -2.041 . . . . 0.0 112.54 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.996 HD13 ' N ' ' A' ' 431' ' ' SER . 0.9 OUTLIER -66.98 140.06 57.71 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 121.914 0.864 . . . . 0.0 113.008 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.996 ' N ' HD13 ' A' ' 430' ' ' LEU . 29.4 t -167.02 112.18 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.492 HG13 ' CA ' ' A' ' 422' ' ' LEU . 15.6 tt -125.83 157.33 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.162 -0.961 . . . . 0.0 110.567 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.73 127.35 18.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.405 -0.81 . . . . 0.0 109.928 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 369' ' ' PHE . . . -109.69 147.27 33.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.271 -0.893 . . . . 0.0 110.129 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.688 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.3 m95 -124.22 155.91 37.73 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.398 1.094 . . . . 0.0 113.246 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.653 HD12 HD11 ' A' ' 301' ' ' LEU . 19.0 mt -145.38 94.8 5.14 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.559 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 42.6 Cg_endo -67.19 146.17 75.21 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.966 1.509 . . . . 0.0 112.896 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 10.8 t -107.3 98.0 21.18 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.836 -0.54 . . . . 0.0 110.379 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 440' ' ' VAL . 49.6 Cg_endo -89.18 -172.02 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.78 1.411 . . . . 0.0 111.577 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.692 ' O ' HG13 ' A' ' 440' ' ' VAL . 4.6 p 29.07 111.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 441' ' ' THR . 14.7 t -176.09 48.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 443' ' ' ALA . 0.2 OUTLIER -132.68 -49.78 0.9 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.913 -1.117 . . . . 0.0 110.903 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 443' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 444' ' ' GLN . . . -44.26 170.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.074 -1.016 . . . . 0.0 110.815 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 443' ' ' ALA . 14.2 mm100 59.66 78.71 0.26 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.559 -0.713 . . . . 0.0 110.54 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' GLY . . . . . 0.932 ' O ' HG22 ' A' ' 446' ' ' THR . . . -126.56 -32.84 0.69 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.932 HG22 ' O ' ' A' ' 445' ' ' GLY . 1.4 t 53.61 141.08 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.688 0.756 . . . . 0.0 111.181 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 446' ' ' THR . 2.0 t 178.1 55.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.216 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -77.84 -29.7 50.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.296 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 450' ' ' GLY . 4.6 tt0 -159.91 -37.13 0.05 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.321 -0.862 . . . . 0.0 110.246 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 449' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.404 0 CA-C-O 118.027 -1.429 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.607 " O5'" HD21 ' A' ' 386' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.19 0.519 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 86.97 -57.68 4.61 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -114.62 174.88 5.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -1.069 . . . . 0.0 109.765 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.4 54.52 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.055 -1.028 . . . . 0.0 110.647 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.553 ' N ' ' HD3' ' A' ' 295' ' ' PRO . 3.3 mtt -145.95 62.51 8.35 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.039 . . . . 0.0 110.827 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.643 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 54.7 Cg_endo -89.89 58.44 1.78 Allowed 'Trans proline' 0 C--N 1.3 -1.974 0 O-C-N 124.095 1.576 . . . . 0.0 110.188 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.642 ' HE3' ' HB3' ' A' ' 415' ' ' ASN . 0.2 OUTLIER -81.84 108.79 15.65 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 122.216 1.008 . . . . 0.0 109.239 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.646 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 20.3 mt-10 -133.71 -155.71 0.69 Allowed 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.221 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.06 139.06 30.89 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 111.037 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.812 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -155.69 160.09 40.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.576 -0.703 . . . . 0.0 110.523 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.668 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.6 OUTLIER -103.86 114.84 29.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.382 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.645 HD11 HD12 ' A' ' 436' ' ' LEU . 7.5 mt -59.92 -25.13 64.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.265 -0.897 . . . . 0.0 109.831 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.688 ' HA ' HD23 ' A' ' 323' ' ' LEU . 42.3 t-20 -82.18 -21.53 36.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.939 -1.1 . . . . 0.0 109.356 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.52 -27.54 22.56 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.604 0.716 . . . . 0.0 109.474 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 300' ' ' ASP . 28.5 t -82.89 -37.05 13.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 121.582 0.706 . . . . 0.0 109.168 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.552 ' CD2' HG21 ' A' ' 341' ' ' VAL . 86.1 mt -79.72 -31.11 41.09 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.475 -0.766 . . . . 0.0 110.117 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.95 -26.73 73.23 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -84.44 -33.52 23.65 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.419 -1.048 . . . . 0.0 109.782 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.949 HG11 ' CG1' ' A' ' 341' ' ' VAL . 78.6 t -75.2 -25.42 18.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.395 -0.816 . . . . 0.0 109.469 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.976 HD11 ' CG1' ' A' ' 358' ' ' VAL . 1.6 mt -79.56 -43.45 23.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.734 0.778 . . . . 0.0 108.941 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.2 -17.3 62.52 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.73 0.776 . . . . 0.0 109.048 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -85.7 -45.62 11.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.657 -0.652 . . . . 0.0 110.67 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 342' ' ' ALA . 8.6 mt-10 -99.34 28.68 4.38 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.115 -0.991 . . . . 0.0 110.599 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.474 ' O ' ' OG ' ' A' ' 313' ' ' SER . 1.6 t -97.48 38.08 1.3 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.254 -0.904 . . . . 0.0 109.93 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -99.18 -74.77 1.16 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.45 ' O ' ' CG ' ' A' ' 316' ' ' GLU . 2.7 t80 -93.32 25.78 3.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -1.094 . . . . 0.0 108.689 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.641 ' O ' HD11 ' A' ' 319' ' ' ILE . 48.5 mm-40 -160.03 38.21 0.18 Allowed 'General case' 0 C--O 1.192 -1.966 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.471 ' HA ' ' CD1' ' A' ' 319' ' ' ILE . 0.1 OUTLIER -69.52 -0.99 7.46 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 121.422 0.63 . . . . 0.0 110.002 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.05 33.92 0.45 Allowed 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.918 0.866 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.726 ' CG2' HG23 ' A' ' 358' ' ' VAL . 0.7 OUTLIER -89.15 134.86 27.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.484 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -95.87 110.32 22.52 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.012 -1.055 . . . . 0.0 109.119 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.928 HG22 HD13 ' A' ' 309' ' ' ILE . 10.8 p -89.52 123.28 33.48 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.351 -0.843 . . . . 0.0 111.675 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.84 78.41 1.49 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.688 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.2 mp -93.93 154.85 17.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.78 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.595 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 79.0 t80 -46.75 132.26 8.43 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.425 -0.797 . . . . 0.0 110.215 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.478 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 46.5 Cg_endo -72.71 78.91 1.99 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.952 1.501 . . . . 0.0 110.318 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . 167.66 7.89 0.03 OUTLIER Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.804 -1.189 . . . . 0.0 111.177 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 0.5 OUTLIER 63.38 116.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 O-C-N 120.555 -1.556 . . . . 0.0 109.57 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 329' ' ' GLU . 4.1 mm -69.23 179.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.734 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.63 ' H ' HG22 ' A' ' 328' ' ' ILE . 1.9 mt-10 -175.49 104.47 0.08 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.609 0.719 . . . . 0.0 110.674 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.839 HG23 ' HG2' ' A' ' 332' ' ' MET . 13.7 m -150.09 172.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 O-C-N 121.702 -0.624 . . . . 0.0 110.323 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.646 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -86.22 93.58 9.09 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 119.384 -0.927 . . . . 0.0 108.664 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.839 ' HG2' HG23 ' A' ' 330' ' ' VAL . 11.7 ptm -144.58 166.27 25.64 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.356 -0.84 . . . . 0.0 110.568 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.643 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 19.1 t-160 -92.18 112.22 54.03 Favored Pre-proline 0 C--N 1.297 -1.698 0 O-C-N 121.523 -0.736 . . . . 0.0 109.46 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 41.4 Cg_endo -66.39 -23.62 50.89 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.825 1.434 . . . . 0.0 111.128 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.584 HD12 ' C ' ' A' ' 335' ' ' LEU . 1.1 tp -81.99 -62.16 1.71 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.951 -1.093 . . . . 0.0 109.817 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.509 ' OG ' HG13 ' A' ' 412' ' ' ILE . 14.7 t -53.65 -42.94 68.37 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.109 -0.995 . . . . 0.0 109.374 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.868 HD11 ' CE1' ' A' ' 416' ' ' HIS . 20.5 mm -60.34 -45.71 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.195 -0.941 . . . . 0.0 109.121 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.538 ' HG3' HG13 ' A' ' 304' ' ' VAL . 20.8 mttm -46.19 -50.25 15.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.0 108.611 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.05 -44.15 78.57 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.544 0.688 . . . . 0.0 110.056 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.572 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -54.34 -29.18 47.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.407 -0.808 . . . . 0.0 111.022 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.949 ' CG1' HG11 ' A' ' 308' ' ' VAL . 66.3 t -88.76 -43.9 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.079 -1.013 . . . . 0.0 111.24 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.832 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -54.4 -38.93 66.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.125 -0.984 . . . . 0.0 110.844 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.88 -34.6 29.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -0.965 . . . . 0.0 110.666 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 340' ' ' ALA . 0.0 OUTLIER -65.73 -28.17 68.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 342' ' ' ALA . 7.7 p -88.53 -22.89 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.013 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 342' ' ' ALA . 89.3 t -76.31 -22.03 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.161 -0.962 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.458 ' CG ' ' O2A' ' A' ' 451' ' ' ANP . 12.1 t30 -69.72 -41.21 75.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.158 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 352' ' ' GLY . . . -79.7 -19.9 47.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.36 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.28 -34.43 25.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.486 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -80.2 -63.7 1.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.625 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -21.72 33.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.13 -0.981 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 353' ' ' ASN . . . -109.46 176.24 19.4 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.067 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 352' ' ' GLY . 27.1 p-10 -178.62 42.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.537 -0.978 . . . . 0.0 109.808 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 355' ' ' TRP . . . -131.38 78.32 0.38 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.465 ' HB3' ' O ' ' A' ' 354' ' ' GLY . 9.9 t90 58.49 138.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -1.076 . . . . 0.0 111.043 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.526 ' CD1' ' OE1' ' A' ' 316' ' ' GLU . 6.5 mt -126.3 164.44 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.484 ' HG2' ' HB3' ' A' ' 320' ' ' GLU . 11.9 tttt -144.38 132.5 21.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.586 -1.321 . . . . 0.0 112.351 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.976 ' CG1' HD11 ' A' ' 309' ' ' ILE . 98.9 t -125.54 93.14 2.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 12.8 t -120.84 160.38 23.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 111.145 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.557 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 1.0 OUTLIER -141.68 157.16 45.41 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.569 -0.707 . . . . 0.0 109.469 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -146.75 -164.54 11.11 Favored Glycine 0 C--N 1.293 -1.841 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.1 OUTLIER -171.14 178.96 3.18 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.871 -1.37 . . . . 0.0 111.233 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 366' ' ' ARG . 6.2 mt-10 -154.23 177.69 1.9 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.587 -0.695 . . . . 0.0 109.823 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 40.9 Cg_endo -67.74 107.87 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.707 1.372 . . . . 0.0 110.763 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 4.8 t-20 68.77 31.16 4.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.409 -0.807 . . . . 0.0 110.531 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 3.6 mtt180 -176.31 109.4 0.09 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.55 -0.719 . . . . 0.0 109.787 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.792 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -113.06 161.12 17.44 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.954 -1.091 . . . . 0.0 110.096 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.6 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 22.3 p-90 -153.74 171.56 18.68 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.927 -1.108 . . . . 0.0 110.886 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.438 ' HB3' HD13 ' A' ' 301' ' ' LEU . 14.4 p90 -150.54 144.65 25.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.529 -0.732 . . . . 0.0 109.225 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -142.38 163.56 32.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.908 -1.12 . . . . 0.0 111.344 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.471 ' O ' ' HG3' ' A' ' 372' ' ' GLU . 17.6 t -128.6 152.83 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.55 -0.719 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 371' ' ' VAL . 1.6 mt-10 -140.23 130.69 25.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.403 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -141.26 150.73 42.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.038 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.69 120.83 43.61 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.198 -0.939 . . . . 0.0 110.762 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -175.59 -107.37 0.21 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.34 -171.08 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.938 1.494 . . . . 0.0 111.186 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' GLY . . . . . 0.687 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -155.62 -178.8 30.18 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.866 HG23 " H1'" ' A' ' 451' ' ' ANP . 0.7 OUTLIER -107.31 -154.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.039 -1.271 . . . . 0.0 110.691 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 383' ' ' ARG . . . -155.8 161.11 30.17 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.85 -20.72 22.11 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 O-C-N 123.704 1.37 . . . . 0.0 110.963 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.94 -36.75 13.26 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.948 -1.095 . . . . 0.0 111.738 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.638 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 15.3 pt20 -89.65 -30.34 18.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.019 -1.051 . . . . 0.0 111.824 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 379' ' ' ALA . 19.9 ttt-85 -56.12 -18.87 11.1 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.756 -1.215 . . . . 0.0 109.841 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.97 -31.02 39.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.288 -0.883 . . . . 0.0 110.941 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.638 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 5.2 p80 -112.47 1.31 15.86 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.97 -1.081 . . . . 0.0 111.201 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 386' ' ' LEU . 2.1 tt -95.86 15.07 21.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.158 -0.964 . . . . 0.0 110.173 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 386' ' ' LEU . 0.2 OUTLIER -172.61 47.75 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.417 -0.802 . . . . 0.0 109.949 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -99.52 142.48 24.69 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.407 -0.808 . . . . 0.0 110.011 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 390' ' ' PHE . 48.2 Cg_endo -76.98 -175.4 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.021 1.537 . . . . 0.0 110.735 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 389' ' ' PRO . 1.1 t80 60.4 131.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.429 -0.794 . . . . 0.0 110.82 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.414 ' H ' HG12 ' A' ' 391' ' ' VAL . 3.2 p -73.82 137.98 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.954 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.98 129.36 55.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.144 -0.973 . . . . 0.0 110.441 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 175.45 84.02 0.06 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.74 82.59 6.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.201 -1.176 . . . . 0.0 110.114 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 397' ' ' ARG . 0.7 OUTLIER -143.72 172.87 12.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.329 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 396' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 397' ' ' ARG . . . 42.75 -94.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 110.343 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 395' ' ' SER . 0.2 OUTLIER 41.32 79.03 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.223 -0.923 . . . . 0.0 110.505 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.577 HG23 ' N ' ' A' ' 399' ' ' ILE . 6.0 t -155.2 -43.57 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.942 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.577 ' N ' HG23 ' A' ' 398' ' ' THR . 19.2 mm -128.07 -69.38 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.383 -0.823 . . . . 0.0 110.107 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.57 ' OG ' HG22 ' A' ' 399' ' ' ILE . 2.8 p -161.85 92.48 0.86 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.206 -0.934 . . . . 0.0 110.082 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -94.57 -141.05 11.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.03 -63.18 0.17 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.302 -1.116 . . . . 0.0 110.049 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 66.96 92.56 0.04 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 34.0 mt -124.56 -166.32 1.5 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.414 -1.05 . . . . 0.0 109.666 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -168.18 -172.85 35.58 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.493 -1.337 . . . . 0.0 109.931 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 18.7 mt -115.27 34.51 4.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.472 -1.017 . . . . 0.0 109.963 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -81.89 94.45 7.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.598 ' O ' HD12 ' A' ' 408' ' ' ILE . 1.9 pp -102.82 30.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.309 -0.87 . . . . 0.0 109.84 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 412' ' ' ILE . 6.0 p -143.04 -36.32 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 109.809 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.441 ' N ' HG13 ' A' ' 409' ' ' VAL . 14.8 tt0 -69.8 -51.55 32.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.093 -1.004 . . . . 0.0 109.707 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.471 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 29.1 mmt180 -56.17 -19.06 11.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.297 -0.877 . . . . 0.0 109.88 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.719 HG22 ' N ' ' A' ' 413' ' ' VAL . 0.8 OUTLIER -65.42 -63.31 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.948 . . . . 0.0 108.817 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.779 HG11 ' HB2' ' A' ' 420' ' ' LEU . 7.0 t -67.13 -22.04 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.15 -0.969 . . . . 0.0 109.196 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 8.3 t70 -76.26 -27.93 56.88 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.671 -0.643 . . . . 0.0 109.648 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.642 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 0.3 OUTLIER -79.67 -12.36 59.82 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.386 -0.821 . . . . 0.0 109.322 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.868 ' CE1' HD11 ' A' ' 337' ' ' ILE . 30.1 m80 -97.2 -29.42 13.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.544 -0.722 . . . . 0.0 109.649 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.1 t-20 77.93 13.77 1.67 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.69 -0.631 . . . . 0.0 110.483 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.575 ' HA2' ' CD ' ' A' ' 437' ' ' PRO . . . -82.48 -87.87 0.72 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.684 ' O ' HG11 ' A' ' 413' ' ' VAL . 37.2 ttm -176.94 158.57 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -1.194 . . . . 0.0 111.338 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.779 ' HB2' HG11 ' A' ' 413' ' ' VAL . 27.4 tp -152.57 98.79 2.4 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.181 -0.949 . . . . 0.0 109.059 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -126.31 167.8 15.01 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.75 -1.219 . . . . 0.0 112.511 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.682 HD21 ' H2 ' ' A' ' 451' ' ' ANP . 35.0 mt -89.95 141.24 28.84 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.226 0.536 . . . . 0.0 109.962 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 431' ' ' SER . . . -108.38 163.92 12.76 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' THR . . . . . 1.001 HG23 ' HA2' ' A' ' 428' ' ' GLY . 20.8 m -138.27 131.36 30.03 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.293 -1.122 . . . . 0.0 109.948 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.447 ' H ' ' N ' ' A' ' 429' ' ' GLY . 2.6 m -116.4 96.85 5.72 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.903 . . . . 0.0 110.27 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 428' ' ' GLY . 20.7 tt0 52.63 -106.82 0.31 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.222 -0.924 . . . . 0.0 109.991 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.475 ' HD3' ' N ' ' A' ' 428' ' ' GLY . 0.0 OUTLIER -42.4 -27.52 0.16 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.823 -1.173 . . . . 0.0 109.926 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 1.001 ' HA2' HG23 ' A' ' 424' ' ' THR . . . 126.79 26.85 1.09 Allowed Glycine 0 C--N 1.291 -1.928 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.447 ' N ' ' H ' ' A' ' 425' ' ' SER . . . -40.78 142.73 0.74 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.762 HD12 ' C6 ' ' A' ' 451' ' ' ANP . 3.5 mm? -86.17 111.05 20.02 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.301 -1.117 . . . . 0.0 110.653 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 423' ' ' GLY . 17.7 m -125.49 102.24 7.3 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.89 122.46 40.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.966 -1.083 . . . . 0.0 111.208 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -107.75 116.1 31.34 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.535 0.683 . . . . 0.0 110.276 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.407 ' HB3' ' CE2' ' A' ' 369' ' ' PHE . . . -108.0 129.27 55.13 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.6 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 82.5 m95 -103.12 153.75 20.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.882 -1.136 . . . . 0.0 112.064 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.645 HD12 HD11 ' A' ' 301' ' ' LEU . 14.7 mt -143.91 81.84 11.52 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.575 ' CD ' ' HA2' ' A' ' 418' ' ' GLY . 45.6 Cg_endo -70.55 133.6 24.48 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 O-C-N 124.02 1.537 . . . . 0.0 111.737 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.514 HG22 ' HB ' ' A' ' 330' ' ' VAL . 5.8 t -92.4 120.94 67.26 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.587 -0.695 . . . . 0.0 109.903 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.46 -168.6 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.742 1.391 . . . . 0.0 109.903 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 440' ' ' VAL . 6.5 p -130.61 132.31 64.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 O-C-N 121.665 -0.647 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 442' ' ' ARG . 17.0 p -122.84 126.58 47.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.283 -0.885 . . . . 0.0 110.052 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 441' ' ' THR . 0.1 OUTLIER 168.91 38.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.206 -0.933 . . . . 0.0 110.217 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -94.92 -44.02 7.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.134 -0.979 . . . . 0.0 110.246 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -146.75 158.03 43.82 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.202 -0.937 . . . . 0.0 110.323 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -163.56 111.14 0.46 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.0 p -126.06 172.43 9.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -1.19 . . . . 0.0 110.014 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 447' ' ' THR . 7.9 t -151.26 98.29 2.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.207 -0.933 . . . . 0.0 110.286 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -127.34 -54.27 1.36 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.396 -0.815 . . . . 0.0 110.105 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -47.07 111.98 0.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.418 -0.801 . . . . 0.0 110.422 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.866 " H1'" HG23 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 290' ' ' THR . 13.9 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.316 0.579 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -163.91 36.37 0.3 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -122.79 140.06 53.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.419 -1.048 . . . . 0.0 110.448 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -84.99 84.3 7.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.898 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.03 166.09 31.74 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.307 -0.871 . . . . 0.0 110.279 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.606 ' HB2' ' CD2' ' A' ' 333' ' ' HIS . 47.6 Cg_endo -90.08 -158.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.087 1.572 . . . . 0.0 109.887 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.55 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 43.6 79.94 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 122.638 1.209 . . . . 0.0 109.479 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.708 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.7 OUTLIER -146.31 -147.53 0.22 Allowed 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.836 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.518 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -85.87 127.76 34.66 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.07 -1.019 . . . . 0.0 110.716 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -143.32 159.32 42.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.466 0.65 . . . . 0.0 110.996 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.652 ' HB2' ' HB3' ' A' ' 303' ' ' ALA . 7.6 m-20 -91.13 108.55 19.95 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.935 HD11 HD12 ' A' ' 436' ' ' LEU . 2.5 mt -57.83 -30.25 65.59 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.276 -0.89 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 303' ' ' ALA . 53.1 p-10 -79.53 -19.87 48.51 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.845 -1.159 . . . . 0.0 109.883 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.652 ' HB3' ' HB2' ' A' ' 300' ' ' ASP . . . -84.12 -27.95 27.81 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.377 -0.827 . . . . 0.0 109.103 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.535 HG13 ' HD3' ' A' ' 338' ' ' LYS . 62.3 t -81.04 -38.51 16.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.786 0.803 . . . . 0.0 109.352 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.728 HD22 HG11 ' A' ' 341' ' ' VAL . 71.2 mt -77.1 -26.43 53.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 110.385 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -65.82 -31.16 78.87 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -83.0 -33.13 26.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -1.153 . . . . 0.0 109.628 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.504 HG11 ' HB ' ' A' ' 341' ' ' VAL . 58.9 t -78.32 -19.29 13.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.439 -0.788 . . . . 0.0 109.667 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.686 HD11 ' CG1' ' A' ' 358' ' ' VAL . 0.9 OUTLIER -83.57 -42.98 17.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.674 0.749 . . . . 0.0 109.259 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.84 -18.5 60.93 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.705 0.764 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.536 ' HB3' ' OE1' ' A' ' 312' ' ' GLU . . . -90.54 -55.1 3.71 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.753 0.787 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.536 ' OE1' ' HB3' ' A' ' 311' ' ' ALA . 58.1 mp0 -104.48 50.65 0.79 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.721 0.772 . . . . 0.0 109.206 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.584 ' HA ' HD13 ' A' ' 319' ' ' ILE . 0.3 OUTLIER -76.03 32.94 0.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.77 -0.581 . . . . 0.0 111.545 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 53.76 48.46 61.62 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 1.7 t80 53.82 37.03 25.51 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.444 -1.033 . . . . 0.0 110.079 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 5.5 mt-10 61.09 37.33 17.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.792 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 19.7 tpp180 -69.05 -85.2 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.575 0.703 . . . . 0.0 109.667 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.2 pt-20 -169.2 67.21 0.06 Allowed 'General case' 0 C--N 1.273 -2.718 0 O-C-N 121.538 -0.726 . . . . 0.0 110.526 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.692 HG23 HG23 ' A' ' 358' ' ' VAL . 1.8 mp -90.95 129.89 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 109.707 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -89.08 103.12 15.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.663 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 18.3 p -88.81 123.81 33.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.419 -0.801 . . . . 0.0 111.094 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' ALA . . . . . 0.459 ' HB3' ' CB ' ' A' ' 359' ' ' SER . . . -146.55 79.09 1.52 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.539 HD12 ' H ' ' A' ' 360' ' ' SER . 5.8 mp -88.41 157.08 18.8 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.379 -0.825 . . . . 0.0 110.322 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.433 ' CD1' ' HD2' ' A' ' 325' ' ' PRO . 21.7 t80 -40.39 141.99 0.8 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.504 -0.747 . . . . 0.0 110.422 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.433 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.0 Cg_endo -83.07 60.32 7.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.04 1.547 . . . . 0.0 111.205 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . -176.92 -75.25 0.05 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.5 OUTLIER 165.05 116.57 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.581 -0.952 . . . . 0.0 108.932 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.536 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 2.7 mm -69.27 178.17 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.061 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.5 mt-10 -173.65 101.44 0.11 Allowed 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 121.469 0.652 . . . . 0.0 110.697 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 1.015 HG12 HG22 ' A' ' 438' ' ' VAL . 16.5 m -143.65 161.26 16.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.094 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -81.13 92.4 6.27 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.596 ' SD ' HD12 ' A' ' 337' ' ' ILE . 22.0 ttp -144.79 153.99 42.23 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.712 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.606 ' CD2' ' HB2' ' A' ' 295' ' ' PRO . 7.3 t-160 -78.73 119.84 78.73 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.778 -0.577 . . . . 0.0 109.682 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.458 ' O ' ' HD3' ' A' ' 338' ' ' LYS . 43.5 Cg_endo -70.75 -21.16 29.24 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.662 1.348 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.742 HD12 ' C ' ' A' ' 335' ' ' LEU . 0.1 OUTLIER -84.52 -63.01 1.41 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.235 -0.916 . . . . 0.0 110.188 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 335' ' ' LEU . 3.1 m -52.78 -35.4 56.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.903 -1.123 . . . . 0.0 110.096 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.734 HD11 ' CE1' ' A' ' 416' ' ' HIS . 3.1 mm -73.93 -45.88 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.221 -0.924 . . . . 0.0 110.032 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.535 ' HD3' HG13 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -43.33 -44.32 5.47 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.13 -0.981 . . . . 0.0 109.197 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -49.9 59.77 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.522 0.677 . . . . 0.0 110.315 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.623 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -52.23 -30.91 29.7 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.301 -0.874 . . . . 0.0 111.674 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.728 HG11 HD22 ' A' ' 305' ' ' LEU . 40.9 t -89.94 -23.73 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.913 -1.117 . . . . 0.0 111.424 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.51 -24.81 60.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.002 -1.061 . . . . 0.0 111.137 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -90.16 -19.0 24.76 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.024 -1.047 . . . . 0.0 111.673 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.6 ttm -82.28 -25.42 34.04 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.917 -1.114 . . . . 0.0 112.196 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.448 HG22 ' H ' ' A' ' 345' ' ' VAL . 23.3 m -90.39 -32.39 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.685 -1.259 . . . . 0.0 111.869 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 312' ' ' GLU . 73.4 t -74.28 -21.14 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 120.971 -1.08 . . . . 0.0 110.79 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -79.95 -19.97 46.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.041 -1.037 . . . . 0.0 110.421 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.493 ' O ' ' HA3' ' A' ' 352' ' ' GLY . . . -89.92 -20.09 23.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 0.0 110.511 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -80.79 -21.31 41.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.096 -1.002 . . . . 0.0 110.773 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 346' ' ' VAL . 4.9 mmt180 -87.76 -70.09 0.65 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.091 -1.005 . . . . 0.0 110.535 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' TYR . . . . . 0.437 ' O ' ' C ' ' A' ' 352' ' ' GLY . 0.2 OUTLIER -77.43 -35.11 54.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 110.377 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 348' ' ' ALA . . . -42.41 -51.65 5.4 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 352' ' ' GLY . 36.4 m-20 43.27 50.1 5.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.296 -1.12 . . . . 0.0 110.356 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -162.02 -80.74 0.04 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.044 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.1 OUTLIER -165.69 149.66 8.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.145 -1.209 . . . . 0.0 109.854 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.603 HD12 HG13 ' A' ' 319' ' ' ILE . 8.3 mt -114.41 165.67 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.218 -0.926 . . . . 0.0 110.73 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.4 OUTLIER -148.4 101.32 3.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.189 -0.944 . . . . 0.0 110.391 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.692 HG23 HG23 ' A' ' 319' ' ' ILE . 99.0 t -104.45 88.08 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.108 -0.995 . . . . 0.0 109.803 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 322' ' ' ALA . 53.2 p -115.01 134.99 54.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.086 -1.008 . . . . 0.0 110.932 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.539 ' H ' HD12 ' A' ' 323' ' ' LEU . 1.8 t -117.39 144.39 45.0 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.482 -0.761 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.599 ' C ' HG22 ' A' ' 362' ' ' THR . . . -140.66 -161.14 8.58 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.599 HG22 ' C ' ' A' ' 361' ' ' GLY . 0.0 OUTLIER 171.12 176.9 0.06 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.14 -1.212 . . . . 0.0 110.962 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.562 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 2.4 mt-10 -147.65 178.19 1.53 Allowed Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 46.0 Cg_endo -81.45 50.28 3.47 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.636 1.335 . . . . 0.0 109.791 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 365' ' ' ASN . 10.2 p-10 165.59 -3.7 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.795 -0.566 . . . . 0.0 111.266 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 14.2 mtm-85 -166.18 109.37 0.77 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.118 -0.989 . . . . 0.0 110.976 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.715 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -103.19 162.08 13.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.103 -0.998 . . . . 0.0 108.765 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.66 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 31.3 p-90 -170.31 162.92 8.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.715 -1.24 . . . . 0.0 111.131 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 39.8 p90 -133.54 133.82 42.6 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -122.84 152.13 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 111.986 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 15.5 t -132.09 122.05 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.558 ' CG ' ' HB2' ' A' ' 431' ' ' SER . 2.3 mt-10 -116.75 139.34 50.68 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 110.395 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 373' ' ' ASP . 3.3 p30 -141.0 145.82 36.45 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.263 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -104.04 114.55 28.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.323 -0.861 . . . . 0.0 110.346 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -172.55 -109.84 0.23 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.1 -168.32 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.93 1.49 . . . . 0.0 110.532 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -141.72 -160.24 8.24 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 0.595 HG23 " H1'" ' A' ' 451' ' ' ANP . 3.0 mt -111.88 159.04 12.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.24 -1.153 . . . . 0.0 109.842 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -91.01 161.24 35.93 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.931 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 46.3 Cg_endo -72.77 -46.1 0.45 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.087 1.572 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' GLU . . . . . 0.518 ' O ' ' CE1' ' A' ' 385' ' ' HIS . 0.0 OUTLIER -73.17 -53.33 11.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.833 . . . . 0.0 110.082 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.592 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 0.0 OUTLIER -56.08 -33.33 64.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.259 -0.9 . . . . 0.0 109.808 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -40.33 13.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.679 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -71.21 -41.3 70.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.501 -0.749 . . . . 0.0 109.422 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' HIS . . . . . 0.592 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 1.2 p-80 -120.05 74.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.602 -0.686 . . . . 0.0 109.804 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.844 HD11 " O4'" ' A' ' 451' ' ' ANP . 0.4 OUTLIER -86.96 9.55 19.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.109 -0.994 . . . . 0.0 110.386 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 70.8 m-85 -161.35 21.67 0.12 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.296 0.569 . . . . 0.0 109.908 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.5 ' HA ' ' CD2' ' A' ' 404' ' ' LEU . 10.7 pt20 178.19 68.36 0.11 Allowed Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.433 -0.792 . . . . 0.0 110.408 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' PRO . . . . . 0.696 ' HD2' HD23 ' A' ' 404' ' ' LEU . 44.0 Cg_endo -71.49 105.49 1.76 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 O-C-N 124.021 1.537 . . . . 0.0 110.515 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' PHE . . . . . 0.527 ' C ' HG23 ' A' ' 391' ' ' VAL . 90.4 m-85 -67.08 -175.08 0.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 110.415 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.527 HG23 ' C ' ' A' ' 390' ' ' PHE . 41.6 t -150.2 92.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 110.103 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 8.9 mmt-85 42.67 85.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.326 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 58.25 -135.8 51.53 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.77 86.29 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -1.155 . . . . 0.0 110.244 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 19.7 t -139.68 71.76 1.38 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.327 -0.858 . . . . 0.0 110.093 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -131.67 115.63 16.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 110.417 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 9.3 mtp85 -74.72 130.23 39.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.154 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' THR . . . . . 0.443 ' O ' ' HB ' ' A' ' 399' ' ' ILE . 1.8 p -53.8 169.63 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 0.0 110.149 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.502 HG22 ' N ' ' A' ' 400' ' ' SER . 3.6 mt 56.15 -93.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 110.245 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.502 ' N ' HG22 ' A' ' 399' ' ' ILE . 61.5 m 55.24 -170.24 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 0.0 110.254 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -74.59 -44.75 25.44 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 48.6 m -155.45 147.36 23.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.247 -1.149 . . . . 0.0 110.274 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -105.76 -73.39 0.88 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' LEU . . . . . 0.696 HD23 ' HD2' ' A' ' 389' ' ' PRO . 1.4 mt -126.87 -46.81 1.54 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.156 -1.202 . . . . 0.0 110.215 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 133.42 -178.23 18.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.2 103.92 15.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -1.208 . . . . 0.0 110.352 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -109.32 156.38 20.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 109.989 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.72 ' O ' HD13 ' A' ' 412' ' ' ILE . 3.8 tp -155.4 27.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.584 ' HA ' HD13 ' A' ' 412' ' ' ILE . 8.8 p -126.73 -2.69 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.3 -0.875 . . . . 0.0 110.079 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 1.8 mm100 -82.34 -53.33 6.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 109.91 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.433 ' HA ' ' HB2' ' A' ' 414' ' ' ASP . 0.0 OUTLIER -61.52 -19.91 62.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.381 -0.824 . . . . 0.0 109.772 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.72 HD13 ' O ' ' A' ' 408' ' ' ILE . 1.0 OUTLIER -69.24 -73.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.653 ' N ' HG22 ' A' ' 412' ' ' ILE . 91.8 t -57.77 -20.13 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.363 -0.835 . . . . 0.0 109.763 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 1.8 m-20 -78.74 -33.19 46.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.371 -0.83 . . . . 0.0 109.966 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.55 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 5.0 m-20 -74.24 -19.86 60.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.038 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.734 ' CE1' HD11 ' A' ' 337' ' ' ILE . 41.3 m80 -92.75 -35.94 13.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.57 -0.706 . . . . 0.0 109.597 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.1 t30 80.71 32.39 0.15 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.641 -0.662 . . . . 0.0 110.608 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.565 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -95.71 -89.61 1.77 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.546 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.1 OUTLIER -177.79 162.88 1.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -1.218 . . . . 0.0 112.079 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 13.8 tp -152.63 102.7 2.73 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 0.3 OUTLIER -119.37 164.28 15.94 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.685 -1.259 . . . . 0.0 113.128 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.411 HD22 ' H2 ' ' A' ' 451' ' ' ANP . 23.3 mt -107.07 136.93 46.08 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 431' ' ' SER . . . -97.97 154.79 20.29 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.883 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.804 HG23 ' HA2' ' A' ' 428' ' ' GLY . 87.0 m -144.08 92.78 2.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -1.04 . . . . 0.0 110.01 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 425' ' ' SER . . . . . 0.539 ' C ' ' CG ' ' A' ' 426' ' ' GLU . 4.4 m -91.6 108.82 20.17 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.0 -1.062 . . . . 0.0 111.368 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.539 ' CG ' ' C ' ' A' ' 425' ' ' SER . 0.1 OUTLIER 53.71 -93.58 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.356 -0.84 . . . . 0.0 110.574 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.482 ' C ' ' HD3' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -63.92 -28.55 69.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.416 -1.427 . . . . 0.0 109.87 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.804 ' HA2' HG23 ' A' ' 424' ' ' THR . . . 136.89 26.08 0.41 Allowed Glycine 0 C--N 1.292 -1.882 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 428' ' ' GLY . . . -39.73 100.19 0.01 OUTLIER Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.806 HD13 ' C5 ' ' A' ' 451' ' ' ANP . 12.4 mt -60.38 114.01 2.7 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.18 0.991 . . . . 0.0 111.948 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.558 ' HB2' ' CG ' ' A' ' 372' ' ' GLU . 0.3 OUTLIER -123.53 100.05 6.61 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.913 HD11 ' N1 ' ' A' ' 451' ' ' ANP . 73.1 mt -89.31 122.53 40.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.914 -1.116 . . . . 0.0 111.496 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.76 100.17 9.58 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.686 -0.634 . . . . 0.0 109.646 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.5 128.81 36.03 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.66 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 86.9 m95 -110.36 159.23 17.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.804 -1.185 . . . . 0.0 113.382 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.935 HD12 HD11 ' A' ' 301' ' ' LEU . 51.5 mt -148.33 109.09 3.64 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.565 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 39.9 Cg_endo -64.35 139.91 67.69 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.778 1.409 . . . . 0.0 112.488 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 1.015 HG22 HG12 ' A' ' 330' ' ' VAL . 22.0 t -113.12 102.23 54.51 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.99 82.33 0.47 Allowed 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.83 1.437 . . . . 0.0 110.57 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.678 ' O ' HG23 ' A' ' 441' ' ' THR . 42.3 t -135.76 0.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 110.542 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 440' ' ' VAL . 17.1 p -158.84 132.21 7.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.187 -0.946 . . . . 0.0 110.593 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 441' ' ' THR . 3.2 mmm-85 38.94 58.64 1.75 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.444 -0.785 . . . . 0.0 110.56 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -103.13 125.67 49.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.45 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -112.54 -97.05 0.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' GLY . . . . . 0.535 ' C ' HG22 ' A' ' 446' ' ' THR . . . 155.04 118.77 0.65 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.535 HG22 ' C ' ' A' ' 445' ' ' GLY . 1.6 t 33.81 96.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.813 -0.816 . . . . 0.0 111.046 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 31.1 p -137.05 163.37 30.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.277 -0.89 . . . . 0.0 110.22 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -144.47 -144.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 110.489 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -134.26 -45.78 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.517 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.913 ' N1 ' HD11 ' A' ' 432' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 46.8 p . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.251 0.548 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 292' ' ' GLN . . . 138.31 -89.61 0.2 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 291' ' ' GLY . 0.0 OUTLIER 64.85 147.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.307 -1.114 . . . . 0.0 110.25 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.489 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 9.5 pt-20 -151.21 74.28 1.14 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.973 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.544 ' O ' ' HG3' ' A' ' 294' ' ' MET . 8.0 ptt? -68.82 107.41 2.02 Favored Pre-proline 0 N--CA 1.5 2.075 0 O-C-N 121.426 -0.796 . . . . 0.0 110.819 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.654 ' CB ' ' CD2' ' A' ' 333' ' ' HIS . 53.4 Cg_endo -102.2 -156.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.309 2.006 . . . . 0.0 109.475 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' MET . . . . . 0.498 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 41.25 94.98 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 122.16 0.981 . . . . 0.0 110.851 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.0 mt-10 -144.67 -164.26 1.88 Allowed 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' MET . . . . . 0.446 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.0 OUTLIER -88.7 129.36 35.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 110.108 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.671 ' HB3' ' SD ' ' A' ' 332' ' ' MET . . . -149.77 167.19 27.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.323 -0.861 . . . . 0.0 111.316 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.675 ' O ' HG23 ' A' ' 304' ' ' VAL . 26.3 t70 -96.36 117.89 31.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.735 . . . . 0.0 109.551 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.669 HD11 HD12 ' A' ' 436' ' ' LEU . 20.3 mt -65.36 -22.37 66.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.094 -1.004 . . . . 0.0 110.015 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.773 ' HA ' HD23 ' A' ' 323' ' ' LEU . 43.7 t-20 -80.77 -22.28 40.29 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.996 -1.065 . . . . 0.0 108.755 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.485 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -84.17 -32.51 24.58 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.589 0.709 . . . . 0.0 109.454 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 300' ' ' ASP . 21.8 t -77.29 -37.72 25.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.587 -0.695 . . . . 0.0 109.529 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 88.4 mt -76.86 -26.64 54.49 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.69 -38.24 95.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -76.39 -35.59 58.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -1.118 . . . . 0.0 109.336 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.99 HG11 HG12 ' A' ' 341' ' ' VAL . 92.8 t -75.24 -18.8 16.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.55 0.691 . . . . 0.0 109.441 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.574 ' CD1' HG22 ' A' ' 321' ' ' THR . 0.0 OUTLIER -77.6 -43.77 29.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.783 0.801 . . . . 0.0 109.123 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.452 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -75.17 -17.7 60.33 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.539 0.685 . . . . 0.0 109.866 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -88.11 -45.22 10.32 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 111.155 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -98.47 31.32 2.88 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.211 -0.93 . . . . 0.0 111.25 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.654 ' OG ' HD13 ' A' ' 319' ' ' ILE . 1.0 OUTLIER -82.84 -7.53 59.65 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.06 -1.025 . . . . 0.0 109.974 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 87.56 -53.95 4.38 Favored Glycine 0 C--N 1.286 -2.198 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 19.3 t80 174.54 36.16 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 1.6 tm-20 70.02 36.17 2.02 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 317' ' ' ARG . 0.0 OUTLIER -67.86 -90.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.337 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 317' ' ' ARG . 20.5 mt-10 -152.17 73.77 1.06 Allowed 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.233 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.675 ' CG2' HG23 ' A' ' 358' ' ' VAL . 3.3 mp -105.1 134.3 46.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.297 -0.877 . . . . 0.0 109.182 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' GLU . . . . . 0.507 ' HB3' ' CG ' ' A' ' 357' ' ' LYS . 3.1 tt0 -99.55 108.6 21.06 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.035 -1.041 . . . . 0.0 110.121 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.574 HG22 ' CD1' ' A' ' 309' ' ' ILE . 15.3 p -93.97 126.5 39.22 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 110.744 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -147.81 78.23 1.44 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.374 -0.829 . . . . 0.0 109.414 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.773 HD23 ' HA ' ' A' ' 302' ' ' ASN . 4.2 mp -91.0 156.35 18.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.393 -0.817 . . . . 0.0 110.462 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' TYR . . . . . 0.605 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 69.2 t80 -45.8 125.62 6.61 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.893 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.51 68.93 8.16 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.885 1.466 . . . . 0.0 110.217 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -173.31 24.38 0.07 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 326' ' ' GLY . 0.0 OUTLIER 50.41 101.62 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 O-C-N 121.017 -1.284 . . . . 0.0 110.432 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 329' ' ' GLU . 1.1 mt -78.52 -176.61 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.35 -0.843 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -176.54 111.26 0.09 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.791 0.805 . . . . 0.0 110.87 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.864 HG12 HG22 ' A' ' 438' ' ' VAL . 8.5 m -142.48 162.12 18.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-O 121.391 0.615 . . . . 0.0 109.955 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.3 OUTLIER -78.28 91.0 4.36 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 332' ' ' MET . . . . . 0.759 ' CE ' HG21 ' A' ' 337' ' ' ILE . 4.4 ppp? -135.83 135.36 39.76 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.643 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' HIS . . . . . 0.654 ' CD2' ' CB ' ' A' ' 295' ' ' PRO . 10.3 t-80 -67.34 116.44 36.73 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.461 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 41.0 Cg_endo -65.32 -19.53 61.88 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.62 1.326 . . . . 0.0 110.07 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.641 ' CB ' ' CE1' ' A' ' 333' ' ' HIS . 0.5 OUTLIER -81.14 -46.08 15.44 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.426 -0.797 . . . . 0.0 110.899 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.503 ' O ' HD12 ' A' ' 412' ' ' ILE . 2.2 m -72.73 -37.47 67.73 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.143 -0.973 . . . . 0.0 110.117 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.847 HD11 ' CE1' ' A' ' 416' ' ' HIS . 32.5 mm -71.82 -30.47 37.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.402 -0.812 . . . . 0.0 109.521 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 3.8 mttt -68.29 -43.22 78.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 108.7 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 335' ' ' LEU . 75.5 mtt-85 -72.24 -31.77 66.11 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.474 0.654 . . . . 0.0 110.723 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -73.58 -35.88 65.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 111.035 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.99 HG12 HG11 ' A' ' 308' ' ' VAL . 59.4 t -80.46 -27.85 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 110.552 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.797 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -79.36 -28.29 41.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.183 -0.948 . . . . 0.0 110.182 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -89.77 -24.2 21.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.305 -0.872 . . . . 0.0 110.321 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 347' ' ' ASN . 1.9 mtm -71.65 -47.15 56.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.875 . . . . 0.0 110.386 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.8 t -65.43 -28.36 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 342' ' ' ALA . 71.6 t -56.34 -25.61 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.274 -0.891 . . . . 0.0 110.329 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 344' ' ' MET . 0.1 OUTLIER -56.18 -53.59 55.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.947 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ALA . . . . . 0.551 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -85.53 -19.13 31.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.861 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.488 ' HB3' ' HA ' ' A' ' 346' ' ' VAL . . . -68.2 -59.66 3.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.319 -0.863 . . . . 0.0 111.668 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.518 ' HG3' ' N ' ' A' ' 351' ' ' TYR . 4.4 ptt-85 -86.5 -41.11 14.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.935 -1.103 . . . . 0.0 111.876 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 351' ' ' TYR . . . . . 0.518 ' N ' ' HG3' ' A' ' 350' ' ' ARG . 0.3 OUTLIER -90.2 -42.44 11.03 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.762 -1.211 . . . . 0.0 110.495 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -85.27 173.54 48.31 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -168.48 72.76 0.1 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.278 -1.131 . . . . 0.0 109.873 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' GLY . . . . . 0.523 ' CA ' ' HB2' ' A' ' 374' ' ' ASP . . . -161.65 67.68 0.24 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.591 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 11.1 t90 59.77 145.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -1.04 . . . . 0.0 111.242 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.417 HD12 HG13 ' A' ' 319' ' ' ILE . 6.0 mt -123.75 162.33 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.591 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 16.6 tttt -150.44 117.73 6.03 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.782 -1.199 . . . . 0.0 111.253 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.675 HG23 ' CG2' ' A' ' 319' ' ' ILE . 3.4 t -106.25 89.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 370' ' ' GLN . 4.4 t -113.44 139.44 48.92 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.273 -0.892 . . . . 0.0 111.229 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' SER . . . . . 0.487 ' HB2' ' HG ' ' A' ' 323' ' ' LEU . 3.7 m -138.33 158.11 44.93 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.384 -0.823 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.559 ' C ' HG22 ' A' ' 362' ' ' THR . . . -148.3 -154.69 6.37 Favored Glycine 0 C--N 1.295 -1.713 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.605 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER 175.02 169.25 0.29 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.03 -1.276 . . . . 0.0 110.71 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 362' ' ' THR . 3.1 mm-40 -149.39 172.23 5.44 Favored Pre-proline 0 C--N 1.293 -1.887 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 364' ' ' PRO . . . . . 0.534 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 40.2 Cg_endo -66.24 116.28 3.94 Favored 'Trans proline' 0 C--N 1.299 -2.075 0 O-C-N 123.682 1.359 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 44.2 t30 74.25 34.72 0.8 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.655 -0.653 . . . . 0.0 111.009 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.1 OUTLIER 165.81 97.51 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.305 -0.872 . . . . 0.0 111.214 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.41 171.34 7.42 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.158 -0.963 . . . . 0.0 109.039 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' TRP . . . . . 0.64 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 39.2 p-90 -170.96 165.37 7.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.445 -1.41 . . . . 0.0 110.813 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 35.1 p90 -139.28 131.33 27.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.485 -0.759 . . . . 0.0 109.336 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' GLN . . . . . 0.523 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 20.5 tt0 -116.08 151.33 35.78 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.246 -0.909 . . . . 0.0 111.773 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.523 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 89.0 t -127.05 142.4 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.564 -0.71 . . . . 0.0 109.636 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.43 ' HG3' ' C ' ' A' ' 371' ' ' VAL . 55.4 mt-10 -137.81 129.58 28.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.4 -0.812 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -159.55 161.55 35.25 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.536 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.523 ' HB2' ' CA ' ' A' ' 354' ' ' GLY . 0.5 OUTLIER -80.46 152.64 28.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 110.494 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 375' ' ' GLY . . . . . 0.468 ' HA2' ' HA2' ' A' ' 352' ' ' GLY . . . 164.64 -146.33 11.23 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.616 ' O ' HD23 ' A' ' 430' ' ' LEU . 42.4 Cg_endo -72.89 -169.48 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.053 1.554 . . . . 0.0 110.554 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' GLY . . . . . 0.472 ' CA ' ' HA3' ' A' ' 428' ' ' GLY . . . -145.22 139.4 8.34 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' ILE . . . . . 1.049 HD11 HD12 ' A' ' 422' ' ' LEU . 3.9 mt -81.08 170.81 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.102 -1.234 . . . . 0.0 109.923 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.947 ' HB3' ' HG2' ' A' ' 382' ' ' GLN . . . -151.32 175.99 2.58 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.252 -0.905 . . . . 0.0 110.324 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.879 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 49.5 Cg_endo -71.96 -34.25 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.061 1.558 . . . . 0.0 110.236 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.71 -21.73 30.01 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.849 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' GLN . . . . . 0.947 ' HG2' ' HB3' ' A' ' 379' ' ' ALA . 1.6 mm-40 -90.75 -18.27 25.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.129 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 1.6 tpp85 -60.25 -19.75 55.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.126 -0.984 . . . . 0.0 110.095 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.49 ' HD3' ' OE1' ' A' ' 388' ' ' GLN . 0.2 OUTLIER -86.95 -20.71 26.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.868 . . . . 0.0 110.618 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -63.05 -46.63 86.6 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.147 -0.971 . . . . 0.0 111.222 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.58 ' O ' ' CG ' ' A' ' 387' ' ' PHE . 1.0 OUTLIER -128.11 49.84 2.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.034 -1.041 . . . . 0.0 110.94 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 1.7 m-85 -175.0 51.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.177 -0.952 . . . . 0.0 111.078 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.506 ' O ' ' HG3' ' A' ' 388' ' ' GLN . 21.7 pt20 -153.74 134.76 8.43 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.033 -1.042 . . . . 0.0 110.44 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -81.9 114.55 2.61 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.793 1.418 . . . . 0.0 110.032 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -104.78 146.87 28.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 0.0 110.206 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.92 160.78 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.402 -0.811 . . . . 0.0 110.375 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' ARG . . . . . 0.413 ' HA ' ' HD2' ' A' ' 392' ' ' ARG . 33.2 tpt85 -79.82 -57.14 3.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -0.875 . . . . 0.0 110.208 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -158.87 -48.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -133.75 -58.54 0.87 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -1.195 . . . . 0.0 110.149 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.432 ' OG ' ' HG2' ' A' ' 397' ' ' ARG . 1.3 t -154.48 -75.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.204 -0.935 . . . . 0.0 109.941 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . 53.41 45.13 28.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.432 ' HG2' ' OG ' ' A' ' 395' ' ' SER . 2.6 ptp85 -127.59 108.11 10.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 0.0 110.127 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 68.7 p -60.67 145.86 47.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 110.12 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 399' ' ' ILE . 6.4 tp -103.1 71.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.23 -0.919 . . . . 0.0 110.463 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -48.12 24.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.251 -0.906 . . . . 0.0 110.052 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -160.1 -117.65 0.47 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.7 m -145.18 78.43 1.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -1.157 . . . . 0.0 110.237 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 170.78 94.44 0.09 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 2.5 tt -108.77 -67.33 0.98 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -1.203 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -111.98 92.29 0.64 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.722 HD23 ' HG3' ' A' ' 411' ' ' ARG . 5.7 mt -92.52 114.91 27.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -1.164 . . . . 0.0 110.258 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -78.67 -162.44 0.37 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -0.905 . . . . 0.0 110.097 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' ILE . . . . . 0.796 HG23 HG23 ' A' ' 409' ' ' VAL . 6.3 tt -115.29 -17.02 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.108 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.796 HG23 HG23 ' A' ' 408' ' ' ILE . 99.5 t -128.24 -31.91 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 109.868 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 2.3 mt-30 -69.42 -49.56 53.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.257 -0.902 . . . . 0.0 109.888 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.722 ' HG3' HD23 ' A' ' 406' ' ' LEU . 0.6 OUTLIER -65.88 -20.93 66.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.269 -0.894 . . . . 0.0 109.827 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.896 HG21 ' HB2' ' A' ' 340' ' ' ALA . 18.5 mm -68.12 -69.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 108.934 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.795 HG11 ' HB2' ' A' ' 420' ' ' LEU . 87.1 t -62.76 -21.15 26.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.368 -0.833 . . . . 0.0 109.015 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 8.4 t70 -75.24 -31.71 60.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.588 -0.695 . . . . 0.0 109.403 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.498 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.1 m-20 -76.97 -14.74 59.81 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.405 -0.81 . . . . 0.0 109.12 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' HIS . . . . . 0.847 ' CE1' HD11 ' A' ' 337' ' ' ILE . 38.9 m80 -92.51 -34.47 14.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.579 -0.7 . . . . 0.0 109.861 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 4.7 m-20 80.58 19.89 0.51 Allowed 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.374 0.607 . . . . 0.0 110.281 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' GLY . . . . . 0.564 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -90.03 -92.01 1.23 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' MET . . . . . 0.567 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 31.6 ttm -176.9 162.01 2.04 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.189 -1.183 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.795 ' HB2' HG11 ' A' ' 413' ' ' VAL . 21.2 tp -151.32 104.91 3.14 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.387 -0.82 . . . . 0.0 108.832 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.487 ' O ' HG23 ' A' ' 432' ' ' ILE . 0.5 OUTLIER -112.98 143.31 44.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.974 -1.079 . . . . 0.0 111.902 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 1.049 HD12 HD11 ' A' ' 378' ' ' ILE . 3.5 mm? -99.42 80.69 2.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.485 -0.759 . . . . 0.0 109.402 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 429' ' ' GLY . . . -50.98 104.51 0.14 Allowed Glycine 0 C--N 1.28 -2.532 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.912 HG23 ' HA2' ' A' ' 428' ' ' GLY . 30.4 m -107.97 106.14 16.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.255 -1.144 . . . . 0.0 109.09 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.89 99.46 12.49 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.057 -1.027 . . . . 0.0 111.713 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 428' ' ' GLY . 4.2 tt0 53.03 -112.27 0.68 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.184 -0.948 . . . . 0.0 110.673 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.47 ' C ' ' HD3' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -40.86 -29.24 0.09 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.101 -1.0 . . . . 0.0 109.994 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 428' ' ' GLY . . . . . 0.912 ' HA2' HG23 ' A' ' 424' ' ' THR . . . 131.48 35.32 0.37 Allowed Glycine 0 C--N 1.296 -1.646 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 429' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 423' ' ' GLY . . . -43.53 98.78 0.01 OUTLIER Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 428' ' ' GLY . 2.7 mm? -65.82 106.37 1.51 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.196 0.998 . . . . 0.0 111.831 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' SER . . . . . 0.455 ' O ' ' HA3' ' A' ' 423' ' ' GLY . 0.0 OUTLIER -145.76 100.72 3.46 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 432' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 421' ' ' GLU . 80.6 mt -92.0 151.9 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.067 -1.021 . . . . 0.0 112.864 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -124.45 94.86 4.33 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.23 139.83 30.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.786 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' TRP . . . . . 0.64 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 84.9 m95 -120.28 153.12 36.83 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.102 0.953 . . . . 0.0 111.707 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.669 HD12 HD11 ' A' ' 301' ' ' LEU . 86.0 mt -140.72 115.15 7.32 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.564 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 43.9 Cg_endo -70.69 134.24 25.59 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.834 1.439 . . . . 0.0 111.418 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.864 HG22 HG12 ' A' ' 330' ' ' VAL . 21.4 t -94.11 144.16 27.61 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.622 -0.674 . . . . 0.0 110.161 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' PRO . . . . . 0.495 ' HD2' ' CG1' ' A' ' 438' ' ' VAL . 50.8 Cg_endo -73.71 101.87 1.43 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.993 1.523 . . . . 0.0 110.457 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 441' ' ' THR . 40.7 t -137.47 179.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.144 -0.973 . . . . 0.0 109.985 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.559 ' H ' HG12 ' A' ' 440' ' ' VAL . 2.8 p 59.58 83.15 0.14 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.333 -0.854 . . . . 0.0 110.145 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 443' ' ' ALA . 0.6 OUTLIER -169.23 63.91 0.05 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 443' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 442' ' ' ARG . . . -51.03 -179.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.166 -0.959 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -76.41 -155.63 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.148 -0.97 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -100.65 -76.34 1.21 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' THR . . . . . 0.553 ' C ' HG22 ' A' ' 447' ' ' THR . 7.4 t -126.49 -7.84 6.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.235 -1.156 . . . . 0.0 110.204 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.553 HG22 ' C ' ' A' ' 446' ' ' THR . 2.0 t 34.55 90.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.288 0.566 . . . . 0.0 110.755 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -49.81 -48.01 51.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 0.0 109.953 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.49 147.41 45.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 110.081 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 CA-C-O 118.005 -1.442 . . . . 0.0 109.545 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 451' ' ' ANP . . . . . 0.604 ' C5 ' HD11 ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.606 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 55.4 Cg_endo . . . . . 0 C--O 1.213 -0.76 0 N-CA-C 109.954 -0.825 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.596 ' HE3' ' HB3' ' A' ' 415' ' ' ASN . 0.1 OUTLIER 23.68 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 122.358 1.075 . . . . 0.0 111.576 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.677 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.9 mm-40 -144.42 -159.51 1.0 Allowed 'General case' 0 C--N 1.267 -3.02 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.217 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.667 ' HA ' ' HA ' ' A' ' 331' ' ' LYS . 2.1 mmt -85.2 117.06 23.91 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.109 0.957 . . . . 0.0 110.797 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.732 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -141.18 150.61 42.97 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.061 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.745 ' O ' HG23 ' A' ' 304' ' ' VAL . 13.8 m-20 -85.15 136.57 33.48 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.488 -0.758 . . . . 0.0 109.205 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.691 HD21 ' CE ' ' A' ' 332' ' ' MET . 6.8 mt -73.68 -23.82 59.87 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.955 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 303' ' ' ALA . 47.0 p30 -83.93 -18.96 35.58 Favored 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.856 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.511 ' N ' ' OD1' ' A' ' 302' ' ' ASN . . . -82.3 -36.34 27.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 300' ' ' ASP . 16.2 t -74.15 -39.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.542 -0.724 . . . . 0.0 109.584 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 62.7 mt -69.55 -33.47 72.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.406 -0.809 . . . . 0.0 110.052 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -67.72 -22.35 73.53 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.99 -38.47 27.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.311 -1.111 . . . . 0.0 108.52 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.468 HG11 ' HB ' ' A' ' 341' ' ' VAL . 88.8 t -77.4 -18.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.641 HD12 ' CG2' ' A' ' 321' ' ' THR . 1.3 mm -78.31 -45.71 26.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.654 0.74 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.99 -18.39 63.33 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.692 0.758 . . . . 0.0 109.067 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.61 -36.67 14.28 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.163 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.589 ' O ' ' CD ' ' A' ' 317' ' ' ARG . 15.3 mm-40 -91.59 8.33 37.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 110.399 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 309' ' ' ILE . 78.2 p -115.67 66.36 0.7 Allowed 'General case' 0 C--N 1.274 -2.703 0 O-C-N 120.898 -1.126 . . . . 0.0 108.187 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.59 ' O ' ' CG ' ' A' ' 315' ' ' TYR . . . -113.71 -32.06 2.18 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.294 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.607 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 90.1 m-85 -155.26 74.43 0.9 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 120.111 1.956 . . . . 0.0 114.408 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.607 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 1.4 tp10 91.5 12.8 0.04 OUTLIER 'General case' 0 CA--C 1.452 -2.804 0 O-C-N 121.732 -0.605 . . . . 0.0 111.901 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.589 ' CD ' ' O ' ' A' ' 312' ' ' GLU . 0.0 OUTLIER -81.68 87.93 6.27 Favored 'General case' 0 C--N 1.259 -3.328 0 N-CA-C 101.034 -3.691 . . . . 0.0 101.034 179.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.713 ' N ' HD12 ' A' ' 356' ' ' ILE . 0.5 OUTLIER -65.74 73.14 0.06 Allowed 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.549 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.707 HG23 HG23 ' A' ' 358' ' ' VAL . 42.6 mt -99.14 116.52 42.42 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.744 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.21 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.433 ' H ' ' HA ' ' A' ' 357' ' ' LYS . 1.5 tp10 -89.6 110.78 21.61 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.641 ' CG2' HD12 ' A' ' 309' ' ' ILE . 12.8 p -88.25 130.13 35.17 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.195 -0.941 . . . . 0.0 112.284 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.73 77.73 1.29 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.566 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 4.1 mp -93.3 167.18 11.91 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.443 -0.786 . . . . 0.0 110.884 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CD2' HG21 ' A' ' 362' ' ' THR . 57.9 t80 -58.94 112.44 5.06 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 121.44 -0.787 . . . . 0.0 109.193 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 324' ' ' TYR . 44.3 Cg_endo -70.3 79.06 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.969 1.51 . . . . 0.0 111.057 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.459 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -175.81 -82.82 0.06 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 0.8 OUTLIER 171.35 107.97 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.453 -1.028 . . . . 0.0 109.443 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 329' ' ' GLU . 5.2 mt -85.43 -179.54 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 O-C-N 121.533 -0.729 . . . . 0.0 109.352 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.607 ' H ' HG22 ' A' ' 328' ' ' ILE . 0.8 OUTLIER -173.98 103.95 0.11 Allowed 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.211 -0.996 . . . . 0.0 112.505 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.56 HG23 ' HG2' ' A' ' 332' ' ' MET . 5.6 m -142.79 142.18 26.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -83.72 101.19 11.38 Favored 'General case' 0 C--N 1.257 -3.44 0 C-N-CA 118.512 -1.275 . . . . 0.0 108.015 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.732 ' HG3' ' HB3' ' A' ' 299' ' ' ALA 0.252 0.0 OUTLIER -135.46 -173.23 3.28 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.707 0.765 . . . . 0.0 111.515 -179.585 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.758 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 6.7 t-80 -109.24 112.27 59.6 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 37.5 Cg_endo -59.87 -18.98 52.51 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.719 1.378 . . . . 0.0 110.407 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.758 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 1.6 mt -76.3 -73.92 0.25 Allowed 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.397 -0.815 . . . . 0.0 109.674 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.432 ' HB3' HG23 ' A' ' 412' ' ' ILE . 0.4 OUTLIER -45.7 -49.78 14.27 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.702 -0.623 . . . . 0.0 110.441 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.669 HD11 ' CE1' ' A' ' 416' ' ' HIS . 6.7 mm -60.19 -40.89 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.084 -1.01 . . . . 0.0 109.999 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 6.1 mtmt -55.46 -48.39 74.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 109.17 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -28.77 67.19 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.415 0.626 . . . . 0.0 110.327 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -67.1 -37.26 83.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.748 . . . . 0.0 110.6 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' A' ' 305' ' ' LEU . 92.8 t -78.69 -35.0 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.125 -0.984 . . . . 0.0 110.207 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.714 ' O ' HG12 ' A' ' 345' ' ' VAL . . . -64.35 -68.75 0.33 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.554 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . 0.916 ' O ' HG22 ' A' ' 346' ' ' VAL . 24.7 m120 -47.52 -19.28 0.17 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.296 -0.877 . . . . 0.0 111.203 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 3.4 mtt -74.92 -42.43 57.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.603 -1.31 . . . . 0.0 110.18 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.736 HG23 HG21 ' A' ' 356' ' ' ILE . 14.7 p -81.16 -18.69 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.844 . . . . 0.0 111.136 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.916 HG22 ' O ' ' A' ' 343' ' ' ASN . 17.9 m -60.02 -20.98 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.046 -1.034 . . . . 0.0 110.465 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -84.48 -30.87 24.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 110.666 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 352' ' ' GLY . . . -90.5 -19.1 24.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.946 . . . . 0.0 110.824 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -82.73 -53.58 5.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 110.451 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -72.56 0.14 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 110.365 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -70.02 -47.4 62.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 110.203 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 348' ' ' ALA . . . -79.9 162.34 46.62 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 353' ' ' ASN . 21.5 t-20 -171.68 29.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.454 -1.027 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 355' ' ' TRP . . . -110.56 -33.05 2.56 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 17.0 t90 178.46 129.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.899 -1.354 . . . . 0.0 111.851 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.736 HG21 HG23 ' A' ' 345' ' ' VAL . 1.7 mt -117.01 146.97 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 372' ' ' GLU . 6.9 tttt -140.42 128.2 21.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.487 -1.383 . . . . 0.0 112.087 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.707 HG23 HG23 ' A' ' 319' ' ' ILE . 71.9 t -120.3 108.85 24.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 39.0 t -127.35 160.03 32.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.087 -1.008 . . . . 0.0 111.366 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.566 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -144.49 142.28 30.14 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.596 -0.69 . . . . 0.0 109.679 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -134.87 -166.12 11.03 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.64 HG21 ' CD2' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -173.16 173.11 3.7 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.019 -1.283 . . . . 0.0 111.285 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 4.5 mt-10 -153.08 176.65 2.3 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.675 -0.641 . . . . 0.0 109.524 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.561 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.8 Cg_endo -70.28 105.41 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.684 1.36 . . . . 0.0 110.782 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.586 ' HA ' ' CG1' ' A' ' 438' ' ' VAL . 8.4 t-20 80.49 34.02 0.14 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.868 -0.52 . . . . 0.0 110.631 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 172.5 105.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.837 . . . . 0.0 111.206 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -105.79 169.08 8.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.094 -1.003 . . . . 0.0 108.504 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 37.6 p-90 -168.43 172.4 8.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.603 -1.311 . . . . 0.0 110.615 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.628 ' CE1' ' HB3' ' A' ' 434' ' ' ALA . 37.6 p90 -143.78 140.94 30.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.37 -0.832 . . . . 0.0 109.923 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 12.4 tt0 -127.0 153.98 45.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.293 -0.879 . . . . 0.0 110.741 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.553 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 88.5 t -124.39 164.37 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.437 -0.79 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 357' ' ' LYS . 45.7 mt-10 -150.52 135.33 17.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.957 . . . . 0.0 109.764 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -148.67 148.63 30.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.077 -1.014 . . . . 0.0 110.594 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -82.29 158.67 23.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.332 -0.855 . . . . 0.0 110.144 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 153.96 -167.87 32.29 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.23 -26.4 14.72 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.982 1.517 . . . . 0.0 110.589 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 88.63 -171.85 40.15 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.572 HD11 HD11 ' A' ' 430' ' ' LEU . 54.5 mt -74.91 151.62 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.293 -1.122 . . . . 0.0 110.036 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.671 ' HB3' ' HG3' ' A' ' 382' ' ' GLN . . . -73.76 169.16 19.86 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.136 -0.978 . . . . 0.0 110.011 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.653 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 47.6 Cg_endo -73.19 -38.04 2.99 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.946 1.498 . . . . 0.0 110.291 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . 0.603 ' O ' ' CD2' ' A' ' 385' ' ' HIS . 0.9 OUTLIER -90.45 -37.51 13.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.314 -0.866 . . . . 0.0 110.765 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.671 ' HG3' ' HB3' ' A' ' 379' ' ' ALA . 45.5 mt-30 -62.25 -28.47 69.73 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.259 -0.901 . . . . 0.0 110.299 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -21.51 3.98 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.955 -1.09 . . . . 0.0 109.164 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -31.6 16.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.504 -0.748 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 381' ' ' GLU . 2.1 p80 -117.47 68.95 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.878 -1.139 . . . . 0.0 111.025 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.488 ' HA ' HD13 ' A' ' 386' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 1.028 HG12 HG23 ' A' ' 409' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 1.028 HG23 HG12 ' A' ' 408' ' ' ILE . 4.3 t 80.52 -59.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.947 -0.47 . . . . 0.0 110.42 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 42.0 tt0 -54.78 -58.84 5.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.99 -1.069 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -59.22 -19.56 46.63 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.293 -0.88 . . . . 0.0 110.685 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.532 HG21 ' HB2' ' A' ' 340' ' ' ALA . 11.0 mm -67.29 -70.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.156 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 1.04 HG21 HD13 ' A' ' 420' ' ' LEU . 22.5 t -60.89 -21.09 23.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.347 -0.846 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 5.0 t70 -77.54 -29.41 52.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -0.847 . . . . 0.0 109.841 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.596 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 0.9 OUTLIER -81.37 -14.78 56.82 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.209 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.669 ' CE1' HD11 ' A' ' 337' ' ' ILE . 31.6 m80 -93.36 -37.46 11.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.576 -0.702 . . . . 0.0 109.785 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 13.9 t-20 81.43 42.91 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 121.377 0.608 . . . . 0.0 110.455 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.578 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -111.8 -89.26 1.86 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.564 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 2.6 ttp -173.36 159.76 3.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.159 -1.2 . . . . 0.0 111.464 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 1.04 HD13 HG21 ' A' ' 413' ' ' VAL . 14.0 tp -151.02 109.08 3.72 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.373 -0.83 . . . . 0.0 109.387 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -130.07 161.32 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.923 -1.11 . . . . 0.0 111.083 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.765 HD23 ' CD1' ' A' ' 432' ' ' ILE . 2.9 mt -126.78 138.61 53.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.384 -0.823 . . . . 0.0 110.169 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.639 ' O ' HD12 ' A' ' 430' ' ' LEU . . . -135.88 161.88 24.89 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.513 ' OG1' HD12 ' A' ' 430' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.207 -1.172 . . . . 0.0 110.631 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 423' ' ' GLY . 15.6 tp -78.4 139.92 38.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -1.169 . . . . 0.0 110.636 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 371' ' ' VAL . 23.3 t -139.3 132.39 29.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.56 -0.713 . . . . 0.0 109.857 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.765 ' CD1' HD23 ' A' ' 422' ' ' LEU . 29.1 mm -92.68 140.64 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.196 -0.94 . . . . 0.0 110.648 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -119.92 97.16 5.48 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.321 -0.862 . . . . 0.0 110.407 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.628 ' HB3' ' CE1' ' A' ' 369' ' ' PHE . . . -103.25 137.4 41.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 110.236 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 88.9 m95 -118.93 153.14 35.08 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.1 -1.0 . . . . 0.0 111.839 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.589 HD12 HD11 ' A' ' 301' ' ' LEU . 24.6 mt -145.35 100.15 4.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.578 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 41.4 Cg_endo -65.75 138.04 52.05 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.967 1.509 . . . . 0.0 111.592 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.798 HG23 ' HD2' ' A' ' 439' ' ' PRO . 2.9 p -93.24 151.2 40.19 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.706 -0.621 . . . . 0.0 109.928 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.798 ' HD2' HG23 ' A' ' 438' ' ' VAL . 39.5 Cg_endo . . . . . 0 C--N 1.312 -1.375 0 O-C-N 123.642 1.338 . . . . 0.0 110.205 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.624 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 51.4 Cg_endo . . . . . 0 C--O 1.214 -0.705 0 CA-C-O 121.347 0.478 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.594 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -90.82 109.41 20.61 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.938 0.875 . . . . 0.0 108.98 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.2 mt-10 -134.53 -156.33 0.72 Allowed 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.73 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.778 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.7 OUTLIER -87.4 131.89 34.15 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.048 -1.033 . . . . 0.0 110.239 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -142.34 147.83 36.94 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 110.972 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 304' ' ' VAL . 1.1 m-20 -89.61 119.8 30.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.427 -0.796 . . . . 0.0 109.454 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 1.051 HD11 HD12 ' A' ' 436' ' ' LEU . 6.5 mt -62.31 -21.12 65.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.008 -1.057 . . . . 0.0 109.801 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.676 ' HA ' HD23 ' A' ' 323' ' ' LEU . 51.4 t-20 -84.25 -22.1 30.91 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.084 -1.01 . . . . 0.0 109.029 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.9 -33.38 22.77 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.714 -0.616 . . . . 0.0 109.823 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.625 ' O ' HG23 ' A' ' 308' ' ' VAL . 22.7 t -79.55 -34.72 16.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.342 -0.849 . . . . 0.0 109.407 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 94.3 mt -75.28 -31.29 60.69 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.408 -0.808 . . . . 0.0 110.161 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -63.39 -31.0 79.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -80.17 -34.07 37.86 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.39 -1.065 . . . . 0.0 109.362 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 1.057 HG11 ' CG1' ' A' ' 341' ' ' VAL . 97.7 t -74.76 -20.38 16.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.64 0.733 . . . . 0.0 109.103 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.648 HG13 HG11 ' A' ' 358' ' ' VAL . 1.1 mt -75.88 -50.87 21.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.59 -16.43 63.4 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.83 0.824 . . . . 0.0 108.929 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -62.98 -66.35 0.55 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.7 -0.625 . . . . 0.0 110.765 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.93 44.54 2.88 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.884 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.554 ' CB ' ' CD1' ' A' ' 319' ' ' ILE . 3.3 p -86.63 27.12 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.866 -1.146 . . . . 0.0 110.358 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.494 ' O ' ' HG2' ' A' ' 317' ' ' ARG . . . 43.55 42.74 6.03 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 12.7 m-85 58.86 49.37 9.91 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.702 -0.881 . . . . 0.0 109.608 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 0.7 OUTLIER 59.93 62.24 1.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.61 0.719 . . . . 0.0 110.834 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 314' ' ' GLY . 16.2 mmm180 -71.66 -82.79 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.907 0.861 . . . . 0.0 109.092 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -147.14 55.9 1.11 Allowed 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.83 HG13 HD12 ' A' ' 356' ' ' ILE . 19.6 mt -97.47 131.9 43.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.75 -0.594 . . . . 0.0 110.627 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.484 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 1.1 tp10 -91.52 107.06 18.95 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 16.9 p -94.36 122.85 37.34 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 111.133 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.1 77.06 1.48 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 302' ' ' ASN . 6.1 mp -95.47 140.6 30.1 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.373 -0.83 . . . . 0.0 109.977 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 9.8 t80 -42.68 121.84 2.81 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.447 -0.783 . . . . 0.0 109.826 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.14 59.88 7.21 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.974 1.513 . . . . 0.0 110.194 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . -158.74 20.4 0.31 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 53.8 m 55.29 100.12 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.253 -1.145 . . . . 0.0 110.363 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.686 HG22 ' H ' ' A' ' 329' ' ' GLU . 2.7 mt -76.23 -175.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 121.532 -0.73 . . . . 0.0 109.14 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.686 ' H ' HG22 ' A' ' 328' ' ' ILE . 3.4 mt-10 -171.45 110.96 0.32 Allowed 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.315 -0.866 . . . . 0.0 111.241 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.778 ' C ' ' HE2' ' A' ' 298' ' ' MET . 29.7 m -144.44 149.95 16.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 O-C-N 121.583 -0.698 . . . . 0.0 110.092 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.7 OUTLIER -68.69 98.25 0.88 Allowed 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.73 ' HB2' HG23 ' A' ' 330' ' ' VAL . 4.8 ttp -144.76 159.72 42.4 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.76 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.633 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 19.5 t-160 -101.88 117.02 62.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.483 ' O ' ' HE2' ' A' ' 338' ' ' LYS . 33.8 Cg_endo -54.74 -31.59 72.38 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.458 1.241 . . . . 0.0 111.429 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.633 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 6.6 mt -69.86 -69.75 0.33 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.888 -1.133 . . . . 0.0 110.428 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 335' ' ' LEU . 23.8 m -43.28 -60.36 1.72 Allowed 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.675 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.631 HD11 ' CE1' ' A' ' 416' ' ' HIS . 8.5 mm -55.41 -35.02 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.228 -0.92 . . . . 0.0 110.676 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 1.3 mtmm -56.11 -47.39 78.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.9 -1.125 . . . . 0.0 109.11 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -37.51 76.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.805 -0.559 . . . . 0.0 110.227 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.829 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -66.56 -23.87 66.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 1.057 ' CG1' HG11 ' A' ' 308' ' ' VAL . 72.6 t -89.98 -28.13 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.804 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.924 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -73.94 -30.24 62.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.371 -0.831 . . . . 0.0 109.937 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -69.23 -23.37 63.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.904 . . . . 0.0 109.913 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.489 ' HG2' HG13 ' A' ' 432' ' ' ILE . 0.3 OUTLIER -90.55 -25.19 20.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.824 . . . . 0.0 110.613 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 90.2 t -90.45 -23.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.098 -1.001 . . . . 0.0 111.107 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 342' ' ' ALA . 97.0 t -68.2 -20.11 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.984 -1.072 . . . . 0.0 110.405 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 351' ' ' TYR . 2.1 m120 -63.49 -51.78 64.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.464 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 373' ' ' ASP . . . -90.84 -19.07 23.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.402 -0.811 . . . . 0.0 111.029 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.65 -81.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.967 -1.083 . . . . 0.0 110.883 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.476 ' CG ' ' N ' ' A' ' 351' ' ' TYR . 27.7 ptt180 -92.01 -44.92 8.59 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.218 -0.926 . . . . 0.0 111.392 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . 0.476 ' N ' ' CG ' ' A' ' 350' ' ' ARG . 9.0 t80 -64.11 -40.45 96.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.209 -0.932 . . . . 0.0 110.729 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 348' ' ' ALA . . . -109.6 173.71 17.21 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -159.21 28.64 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -1.039 . . . . 0.0 109.85 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -89.29 -59.85 1.52 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.573 ' CH2' ' HB2' ' A' ' 357' ' ' LYS . 19.9 t90 -176.15 132.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -1.135 . . . . 0.0 110.132 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.83 HD12 HG13 ' A' ' 319' ' ' ILE . 5.9 mt -102.0 158.53 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.422 -0.799 . . . . 0.0 109.209 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.573 ' HB2' ' CH2' ' A' ' 355' ' ' TRP . 0.5 OUTLIER -144.09 104.93 4.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.027 -1.045 . . . . 0.0 110.654 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.68 HG23 HG23 ' A' ' 319' ' ' ILE . 41.2 t -107.94 89.88 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 108.86 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.0 t -121.01 138.4 54.18 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.387 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.559 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.1 t -120.97 145.12 48.08 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -141.45 -172.42 13.24 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -159.85 172.07 18.3 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.196 -1.179 . . . . 0.0 110.585 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.471 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -145.34 175.57 2.68 Favored Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.526 -0.734 . . . . 0.0 109.643 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 41.5 Cg_endo -68.15 111.34 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.699 1.368 . . . . 0.0 111.133 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 3.9 t-20 72.75 29.24 1.97 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.531 -0.731 . . . . 0.0 111.118 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 19.7 ptt-85 171.64 116.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.325 -0.859 . . . . 0.0 110.773 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.641 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.4 179.98 4.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.102 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.618 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 36.8 p-90 -170.55 143.93 2.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.619 -1.301 . . . . 0.0 110.309 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.634 ' HB3' HD13 ' A' ' 301' ' ' LEU . 31.8 p90 -114.16 140.28 48.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.286 -0.884 . . . . 0.0 109.257 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 432' ' ' ILE . 27.0 tt0 -130.95 149.95 52.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 111.979 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 37.7 t -128.78 150.66 34.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 357' ' ' LYS . 29.3 tt0 -150.12 140.43 22.28 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.992 -1.067 . . . . 0.0 109.692 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 348' ' ' ALA . 1.7 p30 -161.12 168.95 23.32 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.976 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.3 151.89 20.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.428 -0.795 . . . . 0.0 110.32 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 162.81 -156.46 28.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.53 137.75 23.29 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.961 1.506 . . . . 0.0 110.614 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -92.03 -174.04 42.33 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.572 HG13 HD21 ' A' ' 430' ' ' LEU . 3.2 mt -110.69 97.88 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.005 -1.291 . . . . 0.0 109.891 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.957 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -68.56 178.83 0.76 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.28 -0.888 . . . . 0.0 110.547 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.957 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 43.0 Cg_endo -70.8 -19.75 30.81 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.165 1.613 . . . . 0.0 110.012 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.46 -30.67 17.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 109.579 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -85.0 -19.22 32.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.465 -0.772 . . . . 0.0 109.829 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 385' ' ' HIS . 36.0 ttm-85 -54.25 -52.03 62.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.395 -0.815 . . . . 0.0 110.521 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -44.03 -18.57 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.692 -0.63 . . . . 0.0 111.828 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' A' ' 385' ' ' HIS . 0.6 OUTLIER -111.55 42.08 1.77 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.814 -1.179 . . . . 0.0 111.642 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.608 HD12 ' O ' ' A' ' 385' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 O-C-N 120.158 -1.589 . . . . 0.0 114.322 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.665 ' O ' HG12 ' A' ' 409' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.742 ' HA ' HD13 ' A' ' 412' ' ' ILE . 0.4 OUTLIER 79.76 -35.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 121.605 -0.684 . . . . 0.0 110.47 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -69.84 -54.06 15.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.0 -1.062 . . . . 0.0 110.079 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.87 -21.11 41.26 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.28 -0.887 . . . . 0.0 110.013 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.829 HG12 ' HB2' ' A' ' 340' ' ' ALA . 1.0 OUTLIER -66.86 -59.1 4.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.822 HG11 ' HB2' ' A' ' 420' ' ' LEU . 21.2 t -67.94 -22.31 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.523 -0.736 . . . . 0.0 110.031 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -82.44 -23.45 34.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.551 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.51 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 58.8 m-20 -83.31 -21.91 33.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.517 -0.739 . . . . 0.0 109.203 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.631 ' CE1' HD11 ' A' ' 337' ' ' ILE . 37.7 m80 -92.77 -37.2 12.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.701 . . . . 0.0 109.894 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.5 t-20 81.95 29.64 0.13 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.798 -0.564 . . . . 0.0 111.015 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.589 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -98.39 -90.66 1.96 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.53 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.6 tpp -175.89 161.57 2.5 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.278 -1.131 . . . . 0.0 111.168 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.822 ' HB2' HG11 ' A' ' 413' ' ' VAL . 27.0 tp -152.66 108.12 3.29 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.353 -0.842 . . . . 0.0 109.312 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.61 138.14 48.68 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.782 -1.199 . . . . 0.0 111.738 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.493 HD23 HD11 ' A' ' 378' ' ' ILE . 0.2 OUTLIER -90.57 130.5 36.6 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -122.56 114.84 2.56 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 119.577 -1.296 . . . . 0.0 110.006 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 C--N 1.305 -1.345 0 O-C-N 121.406 -1.055 . . . . 0.0 108.651 179.801 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.738 ' C ' HD22 ' A' ' 430' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.738 HD22 ' C ' ' A' ' 429' ' ' GLY . 2.4 mm? -130.18 152.21 49.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.885 -1.362 . . . . 0.0 113.308 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 11.3 p -142.34 113.18 7.43 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.489 HG13 ' HG2' ' A' ' 344' ' ' MET . 21.6 mm -87.09 118.15 32.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.837 -1.165 . . . . 0.0 111.112 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . 0.412 ' HD2' ' HE1' ' A' ' 435' ' ' TRP . 2.6 ttm180 -105.52 95.29 5.71 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.62 ' HB3' ' CE2' ' A' ' 369' ' ' PHE . . . -98.82 137.52 37.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.323 -0.86 . . . . 0.0 110.998 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.618 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 92.1 m95 -109.01 155.05 21.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.848 . . . . 0.0 111.24 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 1.051 HD12 HD11 ' A' ' 301' ' ' LEU . 53.7 mt -145.63 101.05 4.32 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.589 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 39.8 Cg_endo -63.88 136.98 55.7 Favored 'Trans proline' 0 C--N 1.297 -2.142 0 O-C-N 124.069 1.562 . . . . 0.0 111.836 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.641 HG13 ' HD2' ' A' ' 439' ' ' PRO . 89.7 t -81.99 146.23 55.07 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.72 -0.612 . . . . 0.0 110.158 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.641 ' HD2' HG13 ' A' ' 438' ' ' VAL . 56.5 Cg_endo . . . . . 0 C--N 1.3 -1.994 0 O-C-N 124.196 1.629 . . . . 0.0 110.121 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.475 ' HG2' ' ND1' ' A' ' 333' ' ' HIS . 43.3 Cg_endo . . . . . 0 C--O 1.215 -0.646 0 CA-C-O 121.432 0.513 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.565 ' HE2' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -88.37 102.92 15.35 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.435 -0.79 . . . . 0.0 109.747 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.0 mt-10 -118.53 -167.59 1.39 Allowed 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.584 -0.697 . . . . 0.0 109.347 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 1.8 mmt -88.19 124.92 34.32 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.886 -1.134 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.686 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -143.33 150.32 39.01 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.441 0.638 . . . . 0.0 111.163 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.534 ' HB3' ' CB ' ' A' ' 303' ' ' ALA . 46.9 t0 -84.44 118.81 24.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.899 HD11 HD12 ' A' ' 436' ' ' LEU . 7.1 mt -64.46 -22.56 67.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.968 -1.082 . . . . 0.0 109.726 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.795 ' HA ' HD23 ' A' ' 323' ' ' LEU . 48.2 m-20 -81.24 -19.78 42.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 0.0 108.735 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -84.61 -35.9 22.4 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.695 -0.628 . . . . 0.0 109.485 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.805 ' O ' HG23 ' A' ' 308' ' ' VAL . 21.5 t -77.25 -34.6 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.494 -0.754 . . . . 0.0 109.267 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 91.9 mt -77.23 -28.65 53.77 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.505 -0.747 . . . . 0.0 109.68 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -63.63 -42.1 98.87 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.62 -30.46 61.67 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.477 -1.014 . . . . 0.0 109.065 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 304' ' ' VAL . 74.4 t -75.22 -21.29 16.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 1.017 ' CG1' HG11 ' A' ' 358' ' ' VAL . 3.2 mt -77.38 -41.36 29.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -64.07 -17.66 63.61 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -83.31 -43.91 15.48 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.351 0.596 . . . . 0.0 109.866 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.727 ' OE2' HG21 ' A' ' 358' ' ' VAL . 6.7 pt-20 -81.67 10.88 5.34 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.359 -0.838 . . . . 0.0 110.306 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 314' ' ' GLY . 60.5 p -117.64 69.64 0.78 Allowed 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 313' ' ' SER . . . -42.59 -30.15 0.85 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 313' ' ' SER . 28.6 t80 -162.69 36.21 0.11 Allowed 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.788 -0.831 . . . . 0.0 109.984 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.34 56.32 8.11 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.092 -1.005 . . . . 0.0 108.538 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -68.31 -55.34 12.46 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-O 121.372 0.606 . . . . 0.0 110.746 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' A' ' 355' ' ' TRP . 7.4 pt-20 -170.59 58.56 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.862 0 C-N-CA 119.471 -0.892 . . . . 0.0 112.087 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.88 HG13 HD12 ' A' ' 356' ' ' ILE . 2.2 mp -106.9 125.38 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.788 -1.195 . . . . 0.0 110.225 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.19 116.77 29.18 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 7.6 p -95.25 129.91 42.2 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.418 -0.802 . . . . 0.0 111.173 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.76 79.17 1.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.479 -0.763 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.795 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.7 mp -95.06 160.95 14.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.444 -0.785 . . . . 0.0 110.525 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.597 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 83.9 t80 -50.42 129.06 25.16 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.171 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.05 71.76 6.87 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.767 1.404 . . . . 0.0 110.695 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -179.72 28.19 0.05 OUTLIER Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.36 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 326' ' ' GLY . 29.3 m 46.59 99.12 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.079 -1.248 . . . . 0.0 110.209 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.535 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 3.0 mt -69.23 174.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 121.431 -0.793 . . . . 0.0 110.099 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 4.9 mt-10 -168.14 105.44 0.48 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.793 0.806 . . . . 0.0 110.714 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.91 HG11 ' HB3' ' A' ' 367' ' ' ALA . 9.9 m -133.42 171.45 18.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 O-C-N 121.749 -0.594 . . . . 0.0 109.751 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -87.25 90.9 8.53 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.981 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.952 ' CE ' HG21 ' A' ' 337' ' ' ILE . 16.6 ptm -142.58 162.17 36.16 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 111.15 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 23.6 t-160 -91.56 114.21 61.1 Favored Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 36.3 Cg_endo -58.35 -18.76 39.79 Favored 'Trans proline' 0 C--N 1.295 -2.243 0 O-C-N 123.388 1.204 . . . . 0.0 109.87 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.615 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -84.19 -70.62 0.56 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.392 -0.817 . . . . 0.0 110.735 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.578 ' HB3' ' CE1' ' A' ' 416' ' ' HIS . 10.6 t -51.65 -36.43 46.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 110.569 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.952 HG21 ' CE ' ' A' ' 332' ' ' MET . 37.3 mm -70.62 -43.04 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 110.091 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 4.7 tppt? -52.28 -35.03 49.11 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 120.911 -1.118 . . . . 0.0 108.866 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.15 -36.33 35.31 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.535 0.683 . . . . 0.0 109.824 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 1.089 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -56.0 -48.66 75.49 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.586 -0.697 . . . . 0.0 110.5 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.793 ' CG1' HG11 ' A' ' 308' ' ' VAL . 70.2 t -75.21 -38.33 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.513 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.752 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -50.42 -53.99 25.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.325 -0.86 . . . . 0.0 110.748 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -19.81 61.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.103 -0.998 . . . . 0.0 110.512 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 0.5 OUTLIER -69.46 -45.17 69.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.121 -0.987 . . . . 0.0 110.529 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 84.4 t -80.09 -20.59 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.431 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 342' ' ' ALA . 25.4 t -60.02 -20.59 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.124 -0.985 . . . . 0.0 110.074 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 0.6 OUTLIER -69.08 -41.88 76.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.314 -0.866 . . . . 0.0 110.475 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.694 ' HB1' ' CB ' ' A' ' 373' ' ' ASP . . . -90.29 -20.39 22.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.92 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -78.3 -52.12 9.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 110.219 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -90.43 -45.61 8.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 110.482 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 347' ' ' ASN . 1.9 m-85 -89.8 -25.88 20.85 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.231 -0.918 . . . . 0.0 110.557 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -63.96 -135.18 0.01 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -133.83 -48.83 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.205 -1.173 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . 0.479 ' O ' HG13 ' A' ' 356' ' ' ILE . . . -171.48 -87.33 0.07 OUTLIER Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.213 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.448 ' HA ' ' CG ' ' A' ' 318' ' ' GLU . 37.3 t90 -42.83 132.6 3.81 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.23 -1.159 . . . . 0.0 112.469 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.88 HD12 HG13 ' A' ' 319' ' ' ILE . 2.8 mt -125.26 145.66 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.516 ' HD3' ' HB3' ' A' ' 372' ' ' GLU . 5.9 tttt -125.54 110.67 14.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.564 -1.335 . . . . 0.0 110.372 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 1.017 HG11 ' CG1' ' A' ' 309' ' ' ILE . 22.1 t -106.24 101.74 12.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 109.266 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 33.8 m -130.02 152.49 49.42 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.562 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.2 OUTLIER -147.07 153.22 39.71 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.63 -0.669 . . . . 0.0 109.697 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -144.27 -160.67 8.59 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 108.394 -1.883 . . . . 0.0 108.394 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.2 OUTLIER -173.0 178.87 2.41 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.893 -1.357 . . . . 0.0 111.302 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.561 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 3.5 mt-10 -160.89 -178.52 0.89 Allowed Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 38.0 Cg_endo -64.41 135.34 45.72 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.245 1.129 . . . . 0.0 110.341 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.533 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 15.2 p30 39.71 33.71 0.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.764 -0.585 . . . . 0.0 110.562 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER -174.17 94.0 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.258 -0.901 . . . . 0.0 111.421 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.91 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -103.27 151.35 22.79 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.673 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 30.7 p-90 -144.68 174.07 11.29 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.362 -1.461 . . . . 0.0 111.247 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 369' ' ' PHE . 9.2 p90 -148.92 139.33 22.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.671 -0.643 . . . . 0.0 109.408 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 432' ' ' ILE . 50.1 tt0 -130.72 163.94 26.16 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.252 -0.905 . . . . 0.0 111.648 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.442 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 32.0 t -132.17 156.05 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.607 -0.683 . . . . 0.0 110.01 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 357' ' ' LYS . 10.2 tt0 -149.83 131.46 14.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.074 -1.016 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.694 ' CB ' ' HB1' ' A' ' 348' ' ' ALA . 35.9 m-20 -136.99 162.74 32.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.003 -1.061 . . . . 0.0 110.88 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -87.96 142.17 28.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.963 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 157.63 -168.4 34.31 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.46 -176.66 2.86 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 O-C-N 124.053 1.554 . . . . 0.0 110.692 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' A' ' 430' ' ' LEU . . . -90.49 -131.47 4.78 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.774 HD11 HD21 ' A' ' 430' ' ' LEU . 3.1 mm -103.29 145.03 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.041 -1.27 . . . . 0.0 109.93 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.871 ' HB3' ' HB3' ' A' ' 382' ' ' GLN . . . -39.79 160.11 0.11 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.506 -0.746 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.28 -54.23 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.055 1.555 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -75.33 -23.19 57.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.82 . . . . 0.0 110.165 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.871 ' HB3' ' HB3' ' A' ' 379' ' ' ALA . 1.1 tt0 -82.92 -23.25 33.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.953 . . . . 0.0 109.682 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.18 -22.31 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.398 -0.814 . . . . 0.0 110.091 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -87.51 -35.11 18.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 0.0 110.053 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.505 ' N ' ' ND1' ' A' ' 385' ' ' HIS . 2.3 m-70 -80.52 -69.67 0.58 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.218 -0.926 . . . . 0.0 110.647 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 1.062 ' CD1' HD13 ' A' ' 422' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.778 HG23 HG23 ' A' ' 409' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.778 HG23 HG23 ' A' ' 408' ' ' ILE . 3.7 t 79.22 -27.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.662 0 O-C-N 121.718 -0.614 . . . . 0.0 110.699 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 19.4 tt0 -57.92 -57.53 12.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.89 -1.131 . . . . 0.0 110.139 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -63.53 -34.91 78.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 110.659 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 1.089 HG21 ' HB2' ' A' ' 340' ' ' ALA . 1.4 mp -56.37 -73.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.936 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.82 HG22 HD21 ' A' ' 417' ' ' ASN . 85.7 t -50.92 -34.54 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.457 -0.777 . . . . 0.0 110.321 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 0.1 OUTLIER -59.28 -39.39 82.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.206 -0.934 . . . . 0.0 110.138 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.536 ' O ' ' CE ' ' A' ' 296' ' ' MET . 22.5 m-80 -110.61 7.23 22.32 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.406 -0.809 . . . . 0.0 110.304 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.77 ' CG ' HD11 ' A' ' 337' ' ' ILE . 8.9 m80 -115.98 -56.95 2.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 111.577 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 1.098 ' HA ' HD23 ' A' ' 436' ' ' LEU . 0.0 OUTLIER -98.77 -87.7 0.34 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.986 -1.071 . . . . 0.0 110.944 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 149.74 -37.15 0.97 Allowed Glycine 0 C--N 1.263 -3.488 0 C-N-CA 117.791 -2.147 . . . . 0.0 109.824 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.612 ' HB3' ' HB2' ' A' ' 435' ' ' TRP . 2.7 ttp -117.08 145.6 43.65 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.139 -1.212 . . . . 0.0 111.354 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.48 ' O ' ' HG ' ' A' ' 420' ' ' LEU . 23.0 tp -151.91 87.13 1.33 Allowed 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -107.94 158.51 17.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.2 -0.937 . . . . 0.0 111.3 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 1.062 HD13 ' CD1' ' A' ' 386' ' ' LEU . 0.3 OUTLIER -108.35 131.86 54.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.59 -0.694 . . . . 0.0 110.785 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 424' ' ' THR . . . -130.66 -177.88 15.13 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 429' ' ' GLY . 5.4 m . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.152 -1.205 . . . . 0.0 111.079 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.738 ' O ' HG22 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.497 2.732 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.774 HD21 HD11 ' A' ' 378' ' ' ILE . 0.2 OUTLIER -141.24 160.38 40.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.55 -0.971 . . . . 0.0 109.737 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.705 ' H ' HD13 ' A' ' 430' ' ' LEU . 5.1 p -156.48 151.29 25.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.327 -0.858 . . . . 0.0 109.66 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.476 ' O ' ' HG3' ' A' ' 370' ' ' GLN . 12.8 mt -120.35 121.94 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 110.258 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . 0.455 ' HG2' ' CD ' ' A' ' 370' ' ' GLN . 12.0 mtm180 -99.42 122.88 43.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 110.113 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -122.11 133.08 54.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.673 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 86.0 m95 -110.55 135.91 50.49 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.898 -1.126 . . . . 0.0 112.888 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 1.098 HD23 ' HA ' ' A' ' 417' ' ' ASN . 6.9 mt -115.28 87.68 16.8 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 417' ' ' ASN . 47.1 Cg_endo -83.56 121.11 2.9 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 O-C-N 124.041 1.548 . . . . 0.0 111.617 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 438' ' ' VAL . 2.8 t -74.16 112.31 16.33 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.037 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 52.1 Cg_endo . . . . . 0 C--N 1.307 -1.641 0 O-C-N 123.84 1.442 . . . . 0.0 110.995 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo . . . . . 0 C--O 1.215 -0.657 0 N-CA-C 110.094 -0.772 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.608 ' HE2' ' NE2' ' A' ' 416' ' ' HIS . 1.0 OUTLIER -114.23 105.34 13.05 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.617 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 47.0 mt-10 -136.25 -154.06 0.54 Allowed 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.454 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.683 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 1.6 mmt -87.12 132.67 33.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.921 . . . . 0.0 110.699 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.726 ' HB3' ' CG ' ' A' ' 332' ' ' MET . . . -148.05 158.2 43.93 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.088 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.7 OUTLIER -90.51 119.46 30.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.759 . . . . 0.0 109.705 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.831 HD11 HD12 ' A' ' 436' ' ' LEU . 8.4 mt -65.77 -19.9 66.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.039 -1.038 . . . . 0.0 109.645 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.801 ' HA ' HD23 ' A' ' 323' ' ' LEU . 52.0 t-20 -84.69 -19.98 31.94 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.111 -0.993 . . . . 0.0 108.913 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.9 -36.03 21.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.598 -0.689 . . . . 0.0 109.322 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.743 ' O ' HG23 ' A' ' 308' ' ' VAL . 22.3 t -78.16 -38.46 23.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.526 -0.734 . . . . 0.0 109.214 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 88.5 mt -76.92 -28.21 55.19 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.424 -0.798 . . . . 0.0 109.991 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.83 -25.24 75.36 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.832 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 3.8 mt-10 -83.85 -33.17 24.9 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.46 -1.023 . . . . 0.0 109.272 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 1.049 HG11 ' CG1' ' A' ' 341' ' ' VAL . 40.2 t -72.45 -28.73 29.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.459 -0.776 . . . . 0.0 109.118 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.6 HG13 HG11 ' A' ' 358' ' ' VAL . 4.6 mt -72.58 -57.08 7.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.77 -16.5 64.3 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.82 0.819 . . . . 0.0 109.014 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.832 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -65.94 -66.42 0.55 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.763 -0.586 . . . . 0.0 111.047 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.421 ' HG2' ' C ' ' A' ' 311' ' ' ALA . 4.5 mm-40 -127.47 42.8 3.25 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.871 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.557 ' CB ' HD13 ' A' ' 319' ' ' ILE . 7.0 p -86.11 32.1 0.62 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.878 -1.139 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 51.68 23.15 9.56 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.548 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 0.2 OUTLIER 70.59 43.65 0.74 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.844 -0.797 . . . . 0.0 110.249 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 74.58 52.02 0.09 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.486 -0.759 . . . . 0.0 110.725 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.459 ' HG3' ' HA3' ' A' ' 314' ' ' GLY . 12.8 mmm180 -68.27 -83.05 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 122.019 0.914 . . . . 0.0 109.144 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -145.82 50.03 1.2 Allowed 'General case' 0 C--N 1.268 -2.971 0 CA-C-O 122.011 0.91 . . . . 0.0 109.886 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.647 HG13 HD12 ' A' ' 356' ' ' ILE . 5.2 mt -99.46 135.8 33.28 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.24 102.93 14.33 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.32 -0.863 . . . . 0.0 109.43 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.566 ' CG2' HD13 ' A' ' 309' ' ' ILE . 19.0 p -91.63 129.1 37.66 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.409 -0.807 . . . . 0.0 111.293 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.38 78.5 1.38 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.801 HD23 ' HA ' ' A' ' 302' ' ' ASN . 6.5 mp -95.12 154.46 17.17 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.442 -0.786 . . . . 0.0 110.277 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.585 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 20.7 t80 -40.36 120.13 1.58 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.695 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -79.18 69.42 7.93 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.878 1.462 . . . . 0.0 111.366 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . -172.23 -76.46 0.05 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.6 OUTLIER 167.52 108.96 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.525 -0.985 . . . . 0.0 109.359 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 329' ' ' GLU . 3.8 mt -87.66 178.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 O-C-N 121.468 -0.77 . . . . 0.0 109.995 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.632 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.5 mt-10 -171.58 102.26 0.19 Allowed 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.566 0.698 . . . . 0.0 110.297 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 1.153 HG12 HG22 ' A' ' 438' ' ' VAL . 21.3 m -133.86 158.54 42.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.943 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.3 OUTLIER -79.41 98.81 6.9 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.726 ' CG ' ' HB3' ' A' ' 299' ' ' ALA . 4.9 ppp? -139.93 172.7 12.4 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.188 -0.945 . . . . 0.0 112.194 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.5 ' NE2' ' HB3' ' A' ' 335' ' ' LEU . 21.9 t-160 -106.92 114.62 61.4 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 37.7 Cg_endo -61.17 -21.14 70.76 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.405 1.213 . . . . 0.0 111.04 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.5 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 1.9 tp -87.78 -54.62 4.16 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.984 -1.072 . . . . 0.0 110.141 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.753 ' O ' HD12 ' A' ' 412' ' ' ILE . 0.4 OUTLIER -63.83 -25.13 68.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.286 -0.884 . . . . 0.0 110.661 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 1.042 HD11 ' CE1' ' A' ' 416' ' ' HIS . 32.0 mm -85.34 -42.56 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.633 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 11.9 mtmt -57.86 -34.91 70.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 108.06 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -72.43 -43.77 63.35 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.526 0.679 . . . . 0.0 109.991 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 1.039 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -60.89 -30.66 70.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.505 -0.747 . . . . 0.0 110.973 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 1.049 ' CG1' HG11 ' A' ' 308' ' ' VAL . 98.7 t -78.62 -40.18 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.069 -1.019 . . . . 0.0 110.541 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.94 98.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -0.898 . . . . 0.0 110.828 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . 0.717 ' O ' HG12 ' A' ' 346' ' ' VAL . 1.3 t30 -58.71 -20.35 48.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.258 -0.901 . . . . 0.0 110.981 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.8 mtt -84.53 -57.64 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.054 -1.029 . . . . 0.0 110.504 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.488 HG23 HG21 ' A' ' 356' ' ' ILE . 5.4 p -63.73 -19.49 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.303 -0.873 . . . . 0.0 110.756 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 343' ' ' ASN . 9.5 p -64.64 -19.99 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.083 -1.011 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -74.07 -55.86 5.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.101 -0.999 . . . . 0.0 110.415 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -76.19 -19.56 58.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 110.623 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.12 -50.72 30.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 0.0 109.992 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 346' ' ' VAL . 6.7 mmm180 -53.6 -69.18 0.13 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -0.936 . . . . 0.0 109.715 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.57 -53.92 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 109.888 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 86.13 65.3 1.43 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -64.57 -48.89 73.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -1.204 . . . . 0.0 110.099 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . 150.92 -7.52 0.66 Allowed Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.302 -1.428 . . . . 0.0 111.205 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.426 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 40.6 t90 -162.83 138.22 6.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.374 -1.662 . . . . 0.0 112.658 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.647 HD12 HG13 ' A' ' 319' ' ' ILE . 3.1 mt -128.3 164.87 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 372' ' ' GLU . 2.8 tttt -147.06 134.86 21.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.477 -1.389 . . . . 0.0 111.389 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.6 HG11 HG13 ' A' ' 309' ' ' ILE . 11.0 t -133.77 82.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 55.9 p -116.27 136.15 53.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.289 -0.882 . . . . 0.0 110.536 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 323' ' ' LEU . 0.8 OUTLIER -137.38 158.69 43.85 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.622 -0.673 . . . . 0.0 109.914 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -146.74 -150.26 5.15 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -165.55 177.46 7.38 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.21 -1.171 . . . . 0.0 110.077 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -152.88 175.89 2.71 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 110.165 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.7 Cg_endo -70.18 117.24 4.99 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.895 1.471 . . . . 0.0 110.892 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 48.0 t30 71.99 19.54 4.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.381 -0.824 . . . . 0.0 110.972 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 6.5 ptt180 173.73 127.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.431 -0.793 . . . . 0.0 110.834 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.727 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -114.45 -179.55 3.66 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.611 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 28.0 p-90 -169.23 162.39 10.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.449 -1.407 . . . . 0.0 110.968 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 37.9 p90 -131.6 158.66 40.44 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.542 ' NE2' ' HG2' ' A' ' 433' ' ' ARG . 4.1 mt-30 -144.89 151.35 38.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.858 -1.151 . . . . 0.0 112.228 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 57.2 t -129.88 155.03 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 357' ' ' LYS . 5.3 mt-10 -145.05 159.43 42.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.944 -1.098 . . . . 0.0 109.987 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.448 ' OD2' HD12 ' A' ' 430' ' ' LEU . 2.5 p30 -147.09 153.04 39.48 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.019 -1.05 . . . . 0.0 110.886 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.22 135.83 51.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.343 -0.848 . . . . 0.0 110.095 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 144.17 173.02 15.24 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.28 -166.83 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.846 1.445 . . . . 0.0 110.38 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -92.65 175.01 36.82 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.559 HG13 ' CD2' ' A' ' 430' ' ' LEU . 3.4 mt -70.07 144.23 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -1.107 . . . . 0.0 110.138 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.707 ' HB3' ' HG3' ' A' ' 382' ' ' GLN . . . -74.13 153.94 88.48 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.141 -0.974 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.68 -21.75 21.5 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.861 1.453 . . . . 0.0 110.25 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . 0.414 ' O ' ' CD2' ' A' ' 385' ' ' HIS . 10.8 tt0 -90.65 -30.96 16.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.266 -0.897 . . . . 0.0 110.605 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.707 ' HG3' ' HB3' ' A' ' 379' ' ' ALA . 1.2 mt-30 -90.16 -18.83 25.06 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.31 -0.869 . . . . 0.0 110.806 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 379' ' ' ALA . 45.7 ttp85 -52.72 -54.59 31.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.217 -0.927 . . . . 0.0 110.769 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -19.97 8.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.129 -0.982 . . . . 0.0 110.407 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 385' ' ' HIS . 8.4 m-70 -91.51 28.43 1.72 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.275 -0.891 . . . . 0.0 111.049 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 382' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 O-C-N 120.934 -1.104 . . . . 0.0 110.728 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.787 HG23 ' O ' ' A' ' 408' ' ' ILE . 9.1 tp . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.315 0.578 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 408' ' ' ILE . 9.1 t -160.87 -37.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.183 -0.948 . . . . 0.0 109.863 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 59.4 tt0 -67.9 -57.43 6.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.128 -0.982 . . . . 0.0 109.687 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.454 ' O ' ' OD1' ' A' ' 415' ' ' ASN . 0.4 OUTLIER -56.11 -18.73 10.65 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.245 -0.909 . . . . 0.0 110.297 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 1.039 HG21 ' HB2' ' A' ' 340' ' ' ALA . 18.1 mm -63.47 -71.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.113 -0.992 . . . . 0.0 109.538 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 420' ' ' LEU . 10.8 t -64.36 -21.3 28.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 109.23 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 4.8 t0 -81.22 -20.41 41.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.512 -0.743 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 411' ' ' ARG . 1.4 m120 -77.5 -23.73 50.24 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 1.042 ' CE1' HD11 ' A' ' 337' ' ' ILE . 55.2 m80 -91.24 -17.14 26.49 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.703 -0.623 . . . . 0.0 109.367 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.567 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 34.4 m120 67.82 10.49 7.83 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.327 0.584 . . . . 0.0 110.317 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 435' ' ' TRP . . . -69.86 -87.55 0.11 Allowed Glycine 0 N--CA 1.482 1.726 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.577 ' O ' HG11 ' A' ' 413' ' ' VAL . 0.3 OUTLIER 178.02 166.08 0.73 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 111.208 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 413' ' ' VAL . 42.5 tp -151.56 118.81 5.94 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 109.324 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -129.03 147.86 50.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.969 -1.082 . . . . 0.0 111.356 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.95 127.3 45.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.433 -0.792 . . . . 0.0 109.311 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -176.85 -176.18 44.78 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.807 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.668 HG23 ' N ' ' A' ' 429' ' ' GLY . 74.6 m . . . . . 0 C--N 1.299 -1.607 0 O-C-N 121.379 -1.071 . . . . 0.0 110.387 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.505 3.244 0 CA-C-O 122.426 1.015 . . . . 0.0 113.224 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.668 HD13 ' N ' ' A' ' 431' ' ' SER . 0.2 OUTLIER -35.19 123.21 0.6 Allowed 'General case' 0 N--CA 1.515 2.777 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.668 ' N ' HD13 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -153.76 115.22 4.18 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.412 ' C ' ' HG3' ' A' ' 433' ' ' ARG . 31.8 mt -97.55 145.59 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 110.722 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . 0.542 ' HG2' ' NE2' ' A' ' 370' ' ' GLN . 20.2 mtp180 -126.76 144.11 51.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 109.87 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -139.77 132.68 29.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.615 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.611 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 87.5 m95 -111.46 157.98 19.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.044 -1.035 . . . . 0.0 112.082 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.831 HD12 HD11 ' A' ' 301' ' ' LEU . 75.4 mt -147.26 127.62 6.84 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.446 ' C ' ' HD3' ' A' ' 439' ' ' PRO . 43.1 Cg_endo -70.13 141.41 43.68 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.522 1.275 . . . . 0.0 111.845 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 1.153 HG22 HG12 ' A' ' 330' ' ' VAL . 53.7 t -110.67 74.05 0.88 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.577 -0.702 . . . . 0.0 110.416 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.446 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 49.1 Cg_endo . . . . . 0 C--N 1.305 -1.742 0 O-C-N 123.829 1.436 . . . . 0.0 110.979 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.595 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 46.3 Cg_endo . . . . . 0 CA--C 1.508 -0.804 0 N-CA-C 109.871 -0.857 . . . . 0.0 109.871 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.471 ' HE2' ' NE2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -109.49 109.26 20.03 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.4 OUTLIER -148.14 -146.93 0.21 Allowed 'General case' 0 C--N 1.273 -2.737 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.521 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -88.04 144.86 26.28 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.227 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.98 162.84 40.83 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.358 -0.839 . . . . 0.0 111.201 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.714 ' O ' HG23 ' A' ' 304' ' ' VAL . 71.4 m-20 -94.32 118.76 32.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.543 -0.723 . . . . 0.0 109.363 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.907 HD11 HD12 ' A' ' 436' ' ' LEU . 5.5 mt -69.82 -21.46 63.38 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.949 -1.095 . . . . 0.0 109.765 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.713 ' OD1' HD23 ' A' ' 323' ' ' LEU . 55.9 t-20 -84.99 -20.04 31.13 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.092 -1.005 . . . . 0.0 108.86 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.598 ' HB3' ' HB2' ' A' ' 300' ' ' ASP . . . -87.32 -34.63 18.8 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.546 0.689 . . . . 0.0 109.506 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 300' ' ' ASP . 18.0 t -80.42 -31.43 12.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.411 -0.805 . . . . 0.0 109.245 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.534 ' CD2' HG21 ' A' ' 341' ' ' VAL . 62.9 mt -80.52 -30.68 37.2 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.433 -0.792 . . . . 0.0 109.969 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -69.52 -32.48 71.38 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.841 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 1.2 mt-10 -78.1 -34.29 50.19 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.405 -1.056 . . . . 0.0 109.043 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 1.057 HG11 ' HB ' ' A' ' 341' ' ' VAL . 88.2 t -78.87 -19.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 121.664 0.745 . . . . 0.0 109.531 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.997 HD11 ' CG1' ' A' ' 358' ' ' VAL . 0.0 OUTLIER -75.79 -44.09 39.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 122.052 0.93 . . . . 0.0 108.617 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.473 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -91.06 -16.55 27.69 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.282 -0.886 . . . . 0.0 109.735 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -60.42 -62.38 1.9 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.668 -0.645 . . . . 0.0 110.838 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.725 ' CD ' ' HB1' ' A' ' 342' ' ' ALA . 2.7 pt-20 -145.99 38.06 1.08 Allowed 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.94 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.997 ' O ' HD11 ' A' ' 319' ' ' ILE . 6.9 m -91.4 31.41 1.16 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 109.339 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 94.36 21.23 27.66 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 3.0 m-85 62.46 45.55 6.34 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.674 -0.898 . . . . 0.0 109.735 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 1.9 mt-10 59.44 43.24 16.6 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.562 ' CG ' ' N ' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -69.07 -84.98 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.571 0.701 . . . . 0.0 110.041 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.562 ' N ' ' CG ' ' A' ' 317' ' ' ARG . 38.8 mt-10 -136.35 67.81 1.45 Allowed 'General case' 0 C--N 1.275 -2.653 0 CA-C-O 121.608 0.718 . . . . 0.0 111.027 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.997 HD11 ' O ' ' A' ' 313' ' ' SER . 2.6 mp -113.13 129.08 69.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.712 -0.618 . . . . 0.0 109.632 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 358' ' ' VAL . 1.5 tt0 -89.1 100.73 13.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.072 -1.018 . . . . 0.0 109.321 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 19.9 p -92.17 130.31 37.92 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.781 0.801 . . . . 0.0 111.697 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.12 78.61 1.34 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.713 HD23 ' OD1' ' A' ' 302' ' ' ASN . 0.9 OUTLIER -89.34 160.51 16.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 111.002 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 50.8 t80 -59.49 119.4 39.45 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.548 -0.72 . . . . 0.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.22 73.0 5.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.889 1.468 . . . . 0.0 110.573 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -172.06 27.48 0.1 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 326' ' ' GLY . 0.8 OUTLIER 47.12 96.79 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.186 -1.185 . . . . 0.0 110.145 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.663 HG22 ' H ' ' A' ' 329' ' ' GLU . 3.1 mt -73.06 -179.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.658 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.663 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.2 mt-10 -169.48 107.66 0.4 Allowed 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.91 0.862 . . . . 0.0 111.128 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.811 HG11 ' HB3' ' A' ' 367' ' ' ALA . 31.6 m -141.38 153.13 19.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 5.3 tptt -67.55 97.87 0.63 Allowed 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 118.359 -1.336 . . . . 0.0 107.9 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.84 ' SD ' HD13 ' A' ' 436' ' ' LEU . 4.9 ttp -139.69 173.6 11.37 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.469 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.614 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 23.7 t-160 -117.11 113.26 39.45 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 37.5 Cg_endo -59.9 -20.08 58.07 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.553 1.291 . . . . 0.0 110.634 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.614 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -79.24 -63.01 1.52 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.305 -0.872 . . . . 0.0 110.212 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 412' ' ' ILE . 27.1 p -55.77 -46.93 77.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.108 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.741 HD11 ' CE1' ' A' ' 416' ' ' HIS . 23.6 mm -63.34 -32.35 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.386 -0.821 . . . . 0.0 110.05 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 10.3 mttt -59.27 -45.7 90.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.041 -1.037 . . . . 0.0 109.5 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -31.82 63.59 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.843 -0.536 . . . . 0.0 110.745 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.979 ' HA ' HG12 ' A' ' 409' ' ' VAL . . . -65.03 -45.24 86.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.155 -0.965 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 1.057 ' HB ' HG11 ' A' ' 308' ' ' VAL . 16.0 t -81.1 -22.21 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 110.291 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.725 ' HB1' ' CD ' ' A' ' 312' ' ' GLU . . . -71.37 -34.73 70.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.325 -0.859 . . . . 0.0 110.682 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -83.27 -19.72 35.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.204 -0.935 . . . . 0.0 110.559 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.529 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 0.1 OUTLIER -75.36 -31.32 60.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.179 -0.951 . . . . 0.0 111.063 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.745 HG13 HG21 ' A' ' 356' ' ' ILE . 9.6 t -90.66 -20.26 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.956 -1.09 . . . . 0.0 110.608 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 342' ' ' ALA . 47.9 t -77.25 -20.95 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 0.0 110.908 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 344' ' ' MET . 2.8 p30 -78.11 -38.81 43.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.97 -1.081 . . . . 0.0 110.715 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 347' ' ' ASN . . . -90.24 -20.74 22.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.123 -0.986 . . . . 0.0 110.464 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -78.1 -26.66 48.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.132 -0.98 . . . . 0.0 110.68 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -89.05 -71.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -0.962 . . . . 0.0 110.694 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -75.69 -32.26 60.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 110.52 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.507 ' HA2' ' HA2' ' A' ' 375' ' ' GLY . . . -65.87 172.04 25.52 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -67.82 0.37 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -1.116 . . . . 0.0 110.052 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 318' ' ' GLU . . . 163.26 40.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -140.37 120.98 14.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.062 -1.258 . . . . 0.0 110.866 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.745 HG21 HG13 ' A' ' 345' ' ' VAL . 1.8 mp -123.37 124.21 69.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.647 -0.658 . . . . 0.0 109.339 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 372' ' ' GLU . 0.0 OUTLIER -89.46 105.08 17.56 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.981 -1.075 . . . . 0.0 109.895 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.997 ' CG1' HD11 ' A' ' 309' ' ' ILE . 74.8 t -102.5 120.28 52.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.316 -0.865 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.429 ' OG ' ' HD3' ' A' ' 357' ' ' LYS . 0.9 OUTLIER -145.84 140.34 27.0 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.214 -0.929 . . . . 0.0 110.206 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 369' ' ' PHE . 8.9 t -132.49 135.5 46.06 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.466 -0.771 . . . . 0.0 109.99 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.474 ' C ' HG22 ' A' ' 362' ' ' THR . . . -130.88 -160.71 10.05 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.64 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -173.51 165.39 4.63 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.913 -1.346 . . . . 0.0 111.336 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.483 ' HB2' ' CD ' ' A' ' 366' ' ' ARG . 1.0 OUTLIER -147.94 178.12 1.56 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.6 Cg_endo -71.71 110.85 2.99 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.713 1.375 . . . . 0.0 110.599 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.532 ' HA ' ' CG1' ' A' ' 438' ' ' VAL . 1.4 t-20 74.96 27.15 1.2 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.383 -0.823 . . . . 0.0 110.99 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 437' ' ' PRO . 0.2 OUTLIER 179.13 97.39 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.257 -0.902 . . . . 0.0 111.667 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.811 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -99.62 166.84 10.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.149 -0.97 . . . . 0.0 108.396 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.688 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 40.9 p-90 -164.89 174.41 10.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.437 -1.414 . . . . 0.0 111.862 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.547 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 51.8 p90 -150.11 129.36 12.82 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -112.24 155.23 24.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.146 -0.972 . . . . 0.0 111.236 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 432' ' ' ILE . 0.7 OUTLIER -138.07 126.48 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.598 -0.689 . . . . 0.0 109.877 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 357' ' ' LYS . 18.9 tt0 -128.31 106.14 8.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.249 -0.907 . . . . 0.0 109.79 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.493 ' HB3' ' HA ' ' A' ' 356' ' ' ILE . 15.7 p30 -120.02 167.65 11.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.957 -1.089 . . . . 0.0 110.421 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -108.06 101.21 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.385 -0.822 . . . . 0.0 110.501 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . 0.507 ' HA2' ' HA2' ' A' ' 352' ' ' GLY . . . -116.12 -138.97 6.5 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.77 -60.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.017 1.535 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' A' ' 430' ' ' LEU . . . 119.69 -179.56 16.6 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 430' ' ' LEU . 1.4 mm -110.59 93.94 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.279 . . . . 0.0 109.998 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -44.38 167.11 0.1 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 42.1 Cg_endo -68.19 -28.24 34.27 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.564 1.297 . . . . 0.0 110.666 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -90.88 -19.91 22.84 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.111 -0.993 . . . . 0.0 111.655 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.492 ' HG3' ' HB3' ' A' ' 379' ' ' ALA . 2.5 mt-30 -80.86 -20.01 43.24 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.84 -1.162 . . . . 0.0 111.542 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.55 -24.27 20.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.91 -1.119 . . . . 0.0 110.746 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -75.52 -33.77 60.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.005 -1.059 . . . . 0.0 110.25 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.63 ' O ' HD12 ' A' ' 386' ' ' LEU . 2.6 m-70 -88.32 54.4 3.05 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.176 -0.953 . . . . 0.0 110.2 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.63 HD12 ' O ' ' A' ' 385' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.307 -1.273 0 O-C-N 121.019 -1.05 . . . . 0.0 111.095 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.699 ' O ' HD13 ' A' ' 412' ' ' ILE . 2.9 mp . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.335 0.588 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.979 HG12 ' HA ' ' A' ' 340' ' ' ALA . 27.4 m -122.36 -7.94 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.319 -0.863 . . . . 0.0 109.859 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 48.2 tt0 -74.47 -50.07 19.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.196 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -20.99 66.17 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.427 -0.796 . . . . 0.0 110.157 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.699 HD13 ' O ' ' A' ' 408' ' ' ILE . 1.1 mp -71.19 -63.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.269 -0.894 . . . . 0.0 108.726 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 420' ' ' LEU . 15.5 t -64.14 -21.71 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.638 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 1.9 m-20 -79.23 -32.7 43.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.408 -0.808 . . . . 0.0 109.814 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -78.72 -28.33 45.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 109.33 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.741 ' CE1' HD11 ' A' ' 337' ' ' ILE . 30.2 m80 -81.62 -38.8 25.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.414 -0.804 . . . . 0.0 109.391 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 1.0 OUTLIER 82.24 45.24 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 CA-C-O 121.364 0.602 . . . . 0.0 110.943 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.589 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -112.28 -88.62 1.78 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.593 ' HE1' ' NE1' ' A' ' 435' ' ' TRP . 28.5 ttp -178.66 157.82 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -1.205 . . . . 0.0 112.254 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.666 ' HB2' HG11 ' A' ' 413' ' ' VAL . 57.0 tp -153.02 95.6 1.99 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 0.5 OUTLIER -115.86 155.89 27.1 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.759 -1.213 . . . . 0.0 112.786 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.862 HD12 HG12 ' A' ' 432' ' ' ILE . 2.7 tp -106.15 140.21 39.47 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -141.81 83.01 0.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 430' ' ' LEU . 20.5 m . . . . . 0 C--N 1.302 -1.47 0 O-C-N 121.254 -1.145 . . . . 0.0 110.85 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.579 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.76 HD11 HD11 ' A' ' 378' ' ' ILE . 0.2 OUTLIER -70.5 121.46 17.84 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.12 -1.224 . . . . 0.0 110.151 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.54 ' O ' ' CG1' ' A' ' 432' ' ' ILE . 3.0 t -122.23 177.03 5.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.943 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.862 HG12 HD12 ' A' ' 422' ' ' LEU . 10.1 mt -156.92 114.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.254 -0.904 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -90.57 100.69 13.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.346 -0.846 . . . . 0.0 110.334 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.547 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -94.65 132.04 39.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.134 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.688 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.5 m95 -116.38 156.74 26.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.784 -1.198 . . . . 0.0 113.098 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.907 HD12 HD11 ' A' ' 301' ' ' LEU . 67.8 mt -146.34 100.81 4.11 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.589 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 44.9 Cg_endo -71.53 143.82 43.49 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 123.961 1.506 . . . . 0.0 112.441 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.636 HG23 ' HA ' ' A' ' 330' ' ' VAL . 5.9 p -117.5 122.78 30.51 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.304 -1.798 0 O-C-N 123.77 1.405 . . . . 0.0 110.657 -179.922 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.581 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 48.5 Cg_endo . . . . . 0 CA--C 1.51 -0.718 0 N-CA-C 110.164 -0.745 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.634 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -93.41 110.17 21.73 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.076 0.941 . . . . 0.0 108.9 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.4 mt-10 -133.27 -172.4 2.94 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.824 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -87.48 140.35 29.62 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.759 0.79 . . . . 0.0 109.958 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -157.36 169.31 25.02 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.435 0.636 . . . . 0.0 110.037 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 304' ' ' VAL . 57.4 m-20 -96.14 119.51 34.75 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.561 -0.712 . . . . 0.0 109.171 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.812 HD21 ' SD ' ' A' ' 332' ' ' MET . 8.1 mt -62.24 -25.6 67.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.997 -1.064 . . . . 0.0 109.299 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.89 ' HA ' HD23 ' A' ' 323' ' ' LEU . 55.1 t-20 -76.19 -23.24 54.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.977 -1.077 . . . . 0.0 108.503 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -82.92 -33.48 26.83 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 308' ' ' VAL . 47.8 t -74.94 -38.34 43.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.616 0.722 . . . . 0.0 109.161 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.593 HD13 ' OG ' ' A' ' 360' ' ' SER . 92.2 mt -75.13 -27.06 59.64 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.466 -0.772 . . . . 0.0 109.982 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.43 -35.9 92.52 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.52 -34.31 54.07 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.417 -1.049 . . . . 0.0 108.673 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.859 HG11 ' HB ' ' A' ' 341' ' ' VAL . 50.7 t -75.68 -18.6 15.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 121.554 0.692 . . . . 0.0 109.148 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.527 ' HA ' ' HG2' ' A' ' 312' ' ' GLU . 1.4 mt -78.77 -45.0 25.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.5 -18.27 65.19 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -91.19 -34.08 15.15 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.766 -0.584 . . . . 0.0 111.144 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.906 ' OE2' HG21 ' A' ' 358' ' ' VAL . 18.9 pt-20 -86.15 16.95 3.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.083 -1.011 . . . . 0.0 110.723 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.5 m -122.57 67.66 0.95 Allowed 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -56.67 -42.63 91.16 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.443 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 0.3 OUTLIER -136.79 24.01 3.1 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.307 -1.114 . . . . 0.0 111.004 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 2.5 mt-10 60.96 57.46 2.56 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.915 -1.116 . . . . 0.0 108.441 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -66.51 -76.08 0.08 Allowed 'General case' 0 C--N 1.278 -2.526 0 CA-C-O 121.616 0.722 . . . . 0.0 109.722 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 355' ' ' TRP . 7.1 pt-20 -170.52 56.67 0.03 OUTLIER 'General case' 0 C--N 1.265 -3.086 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.863 HG13 HD12 ' A' ' 356' ' ' ILE . 1.8 mp -91.28 129.76 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.444 -0.903 . . . . 0.0 109.974 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -104.3 111.05 23.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.232 -0.918 . . . . 0.0 109.673 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.404 HG22 ' CD1' ' A' ' 309' ' ' ILE . 17.7 p -89.01 126.9 35.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.3 -0.875 . . . . 0.0 110.702 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . 0.441 ' HB3' ' OG ' ' A' ' 359' ' ' SER . . . -149.36 79.54 1.4 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.576 -0.702 . . . . 0.0 109.341 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.89 HD23 ' HA ' ' A' ' 302' ' ' ASN . 4.7 mp -95.33 150.22 20.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.488 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.574 ' HB2' ' HA2' ' A' ' 361' ' ' GLY . 89.6 t80 -37.33 129.88 0.82 Allowed Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.576 -0.703 . . . . 0.0 110.678 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.39 82.66 1.35 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.924 1.486 . . . . 0.0 109.515 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . 162.56 -11.13 0.1 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.682 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.2 OUTLIER 79.85 120.55 0.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.329 -1.101 . . . . 0.0 109.951 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 329' ' ' GLU . 1.6 mm -72.29 -176.02 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 CA-C-O 121.704 0.764 . . . . 0.0 109.93 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 328' ' ' ILE . 3.2 mt-10 -170.19 105.19 0.3 Allowed 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.561 0.696 . . . . 0.0 109.953 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 298' ' ' MET . 2.7 m -150.52 169.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-O 121.541 0.686 . . . . 0.0 110.653 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -96.63 94.02 7.09 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.812 ' SD ' HD21 ' A' ' 301' ' ' LEU . 0.0 OUTLIER -148.44 133.65 18.37 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.764 0.792 . . . . 0.0 110.027 -179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.582 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 19.1 t-160 -55.48 113.17 5.12 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.722 -0.611 . . . . 0.0 109.913 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 40.6 Cg_endo -66.5 -19.56 54.75 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.816 1.429 . . . . 0.0 110.096 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.582 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -74.59 -68.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 0.0 109.835 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.765 ' O ' HD12 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -47.56 -40.9 20.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.557 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.724 HD11 ' CE1' ' A' ' 416' ' ' HIS . 11.9 mm -64.15 -46.83 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 109.316 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.556 ' HG3' HG22 ' A' ' 308' ' ' VAL . 0.0 OUTLIER -43.72 -47.67 7.88 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.355 -0.841 . . . . 0.0 109.555 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -70.67 -35.45 72.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.569 -0.707 . . . . 0.0 110.641 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.601 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -58.66 -32.34 69.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.414 -0.804 . . . . 0.0 111.089 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.859 ' HB ' HG11 ' A' ' 308' ' ' VAL . 32.3 t -90.24 -28.24 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.97 -1.081 . . . . 0.0 111.009 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.73 -19.68 57.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.976 -1.078 . . . . 0.0 110.753 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.3 -19.74 23.72 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.116 -0.99 . . . . 0.0 110.992 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.478 ' SD ' ' HB ' ' A' ' 432' ' ' ILE . 6.3 mtt -82.23 -23.76 35.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.09 -1.006 . . . . 0.0 111.357 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.504 HG11 ' OE1' ' A' ' 312' ' ' GLU . 28.0 m -90.7 -23.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.044 -1.035 . . . . 0.0 111.395 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.88 -29.96 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.914 -1.116 . . . . 0.0 110.533 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 66.3 t30 -65.77 -34.16 77.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.179 -0.951 . . . . 0.0 110.438 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -89.72 -22.97 21.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 110.507 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.31 -51.44 60.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.108 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 351' ' ' TYR . 4.1 mmt180 -90.5 -65.28 1.03 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.299 -0.876 . . . . 0.0 110.872 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 347' ' ' ASN . 0.9 OUTLIER -38.54 -72.0 0.07 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.381 -0.824 . . . . 0.0 110.74 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -129.5 100.6 0.5 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.426 ' H ' ' ND2' ' A' ' 353' ' ' ASN . 6.3 p30 -86.38 86.42 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -1.151 . . . . 0.0 109.789 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . 0.451 ' O ' ' OE1' ' A' ' 318' ' ' GLU . . . -123.16 -35.35 0.72 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.584 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 14.3 t90 179.81 124.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.031 -1.276 . . . . 0.0 110.863 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.863 HD12 HG13 ' A' ' 319' ' ' ILE . 1.5 mt -105.98 143.71 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.584 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 13.4 tttt -134.43 106.44 7.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.827 -1.171 . . . . 0.0 111.359 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.906 HG21 ' OE2' ' A' ' 312' ' ' GLU . 88.8 t -98.52 83.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 370' ' ' GLN . 30.2 t -116.39 141.36 48.27 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.357 -0.839 . . . . 0.0 111.272 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.593 ' OG ' HD13 ' A' ' 305' ' ' LEU . 3.9 m -134.23 168.29 19.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 109.124 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -161.77 -159.47 10.18 Favored Glycine 0 C--N 1.292 -1.868 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -177.18 164.39 2.2 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.369 -1.077 . . . . 0.0 110.032 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.507 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 3.9 mt-10 -141.72 -179.83 1.06 Allowed Pre-proline 0 C--N 1.29 -2.0 0 O-C-N 121.636 -0.665 . . . . 0.0 109.522 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 44.3 Cg_endo -71.63 116.8 4.85 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.682 1.359 . . . . 0.0 111.191 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 2.2 m120 80.01 25.41 0.37 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.874 -0.517 . . . . 0.0 111.509 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.586 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 167.34 111.67 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.319 -0.863 . . . . 0.0 111.473 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -104.41 174.65 5.78 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.194 -0.941 . . . . 0.0 108.876 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.629 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 47.8 p-90 -170.84 174.76 4.73 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.402 -1.436 . . . . 0.0 111.475 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.572 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 34.2 p90 -144.21 134.72 24.71 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.52 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 14.3 tt0 -127.54 149.76 50.0 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.938 -1.101 . . . . 0.0 112.432 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.52 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 98.4 t -125.23 135.04 65.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -130.03 147.16 51.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 109.946 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 373' ' ' ASP . 40.6 p30 -143.51 157.99 44.0 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 375' ' ' GLY . 0.8 OUTLIER -91.67 159.54 15.81 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 110.077 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 374' ' ' ASP . . . 135.3 -159.4 24.05 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.65 157.48 48.37 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.894 1.471 . . . . 0.0 110.397 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . 0.756 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -87.59 -144.76 9.38 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.851 HD11 ' HG ' ' A' ' 430' ' ' LEU . 0.7 OUTLIER -106.2 98.03 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.144 -1.21 . . . . 0.0 109.486 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -52.33 171.75 0.2 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.524 -0.735 . . . . 0.0 110.99 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 44.8 Cg_endo -72.55 -47.38 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 124.134 1.597 . . . . 0.0 109.458 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -25.07 68.2 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.408 -0.807 . . . . 0.0 109.094 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -86.58 -20.62 27.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.506 -0.746 . . . . 0.0 109.556 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 386' ' ' LEU . 0.2 OUTLIER -60.85 -32.88 72.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.467 -0.771 . . . . 0.0 109.709 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -24.29 51.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 109.599 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 385' ' ' HIS . 1.8 m-70 -100.3 49.31 0.91 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.399 -0.813 . . . . 0.0 109.656 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 386' ' ' LEU . 1.5 tp . . . . . 0 C--N 1.304 -1.412 0 O-C-N 121.307 -0.871 . . . . 0.0 109.451 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.061 0.457 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 340' ' ' ALA . 10.9 m -53.58 -22.13 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.14 -0.975 . . . . 0.0 110.461 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 0.1 OUTLIER -64.52 -47.43 78.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.215 -0.928 . . . . 0.0 109.88 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.515 ' HA ' ' HB2' ' A' ' 414' ' ' ASP . 0.0 OUTLIER -66.75 -27.76 67.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -0.873 . . . . 0.0 109.683 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.765 HD12 ' O ' ' A' ' 336' ' ' SER . 31.0 mm -63.67 -60.37 2.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.91 HG21 HD13 ' A' ' 420' ' ' LEU . 45.7 t -65.8 -23.08 31.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.182 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.515 ' HB2' ' HA ' ' A' ' 411' ' ' ARG . 0.5 OUTLIER -75.19 -25.87 58.58 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.416 ' OD1' ' HE3' ' A' ' 296' ' ' MET . 0.9 OUTLIER -80.47 -19.55 45.74 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.724 ' CE1' HD11 ' A' ' 337' ' ' ILE . 32.8 m80 -96.28 -76.18 0.51 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.807 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.635 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 4.3 m-20 127.29 26.81 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.596 0 C-N-CA 123.948 0.899 . . . . 0.0 109.297 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 435' ' ' TRP . . . -86.4 -103.41 0.77 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.583 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 18.4 ttm -165.74 161.85 18.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -1.143 . . . . 0.0 110.638 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 413' ' ' VAL . 4.8 tp -151.86 96.32 2.21 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.983 -1.073 . . . . 0.0 109.223 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.12 155.73 43.96 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.978 -1.076 . . . . 0.0 111.603 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.6 146.28 23.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.556 -0.715 . . . . 0.0 110.354 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -133.5 99.88 0.38 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 429' ' ' GLY . 17.6 m . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.186 -1.185 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.615 ' O ' HG23 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.486 2.009 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.851 ' HG ' HD11 ' A' ' 378' ' ' ILE . 0.0 OUTLIER -175.33 -173.25 0.64 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.169 -1.195 . . . . 0.0 111.786 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.666 ' N ' HD22 ' A' ' 430' ' ' LEU . 24.9 p -154.28 150.16 27.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.478 ' HB ' ' SD ' ' A' ' 344' ' ' MET . 24.2 mm -90.52 121.01 40.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 120.717 -1.24 . . . . 0.0 111.149 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -98.3 96.15 7.86 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.551 -0.718 . . . . 0.0 109.323 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.572 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -97.0 143.71 27.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.613 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.629 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 88.0 m95 -120.08 157.72 28.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.264 -0.897 . . . . 0.0 112.136 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.572 HD13 ' SD ' ' A' ' 332' ' ' MET . 38.1 mt -145.44 125.26 7.01 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.9 139.69 43.96 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 123.59 1.31 . . . . 0.0 111.358 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.641 HG23 ' HD2' ' A' ' 439' ' ' PRO . 7.2 p -99.16 146.79 32.31 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.535 -0.728 . . . . 0.0 110.404 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.641 ' HD2' HG23 ' A' ' 438' ' ' VAL . 50.3 Cg_endo . . . . . 0 C--N 1.306 -1.679 0 O-C-N 123.979 1.515 . . . . 0.0 109.773 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.485 0.971 0 CA-C-O 121.244 0.435 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.583 ' HE3' ' NE2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -71.9 105.84 3.99 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 5.1 mt-10 -115.95 -169.97 1.7 Allowed 'General case' 0 C--N 1.28 -2.428 0 O-C-N 121.683 -0.636 . . . . 0.0 110.228 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.631 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.2 OUTLIER -88.28 128.86 35.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 111.193 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.565 ' HB3' ' SD ' ' A' ' 332' ' ' MET . . . -156.48 159.22 38.43 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.66 -0.65 . . . . 0.0 111.057 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.808 ' O ' HG23 ' A' ' 304' ' ' VAL . 5.9 t0 -84.08 121.37 27.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.514 -0.741 . . . . 0.0 110.13 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 8.0 mt -68.54 -25.2 64.8 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.138 -0.976 . . . . 0.0 109.76 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.696 ' HA ' HD23 ' A' ' 323' ' ' LEU . 22.7 p30 -79.3 -21.21 46.3 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.089 -1.007 . . . . 0.0 108.871 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -85.44 -29.65 24.17 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.761 0.791 . . . . 0.0 108.968 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 308' ' ' VAL . 42.2 t -74.92 -38.46 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.55 0.69 . . . . 0.0 109.278 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.603 ' CD2' HG21 ' A' ' 341' ' ' VAL . 86.2 mt -73.61 -40.75 63.58 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.306 -0.871 . . . . 0.0 110.142 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -58.71 -29.42 64.27 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.846 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 6.0 mt-10 -79.03 -31.16 44.51 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.394 -1.062 . . . . 0.0 108.997 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 304' ' ' VAL . 52.3 t -75.48 -21.83 16.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.667 0.746 . . . . 0.0 109.154 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.556 ' CD1' HG22 ' A' ' 321' ' ' THR . 0.7 OUTLIER -76.19 -49.68 24.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.403 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -80.2 -16.72 54.17 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.815 0.816 . . . . 0.0 109.194 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.846 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -65.14 -63.04 1.2 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.696 -0.627 . . . . 0.0 110.709 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.28 37.91 0.7 Allowed 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.715 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.629 ' O ' HD11 ' A' ' 319' ' ' ILE . 1.2 t -87.55 43.1 1.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.892 -1.13 . . . . 0.0 109.098 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 315' ' ' TYR . . . 73.66 25.22 72.77 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.511 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 51.4 t80 63.71 44.19 5.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.657 -0.908 . . . . 0.0 110.258 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 4.2 tt0 68.24 46.57 1.09 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.235 -0.916 . . . . 0.0 109.781 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.496 ' CG ' ' N ' ' A' ' 318' ' ' GLU . 0.3 OUTLIER -68.59 -88.04 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.304 0 O-C-N 121.608 -0.683 . . . . 0.0 109.844 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.496 ' N ' ' CG ' ' A' ' 317' ' ' ARG . 16.9 mt-10 -140.93 66.12 1.38 Allowed 'General case' 0 C--N 1.277 -2.574 0 O-C-N 121.399 -0.813 . . . . 0.0 111.287 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.697 HG23 HG23 ' A' ' 358' ' ' VAL . 2.7 mp -104.43 134.09 46.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 O-C-N 121.598 -0.689 . . . . 0.0 110.129 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -91.36 107.23 19.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.763 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.556 HG22 ' CD1' ' A' ' 309' ' ' ILE . 12.5 p -89.84 124.66 34.87 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 111.519 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . 0.589 ' HB3' ' OG ' ' A' ' 359' ' ' SER . . . -149.81 78.63 1.36 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 302' ' ' ASN . 2.7 mp -94.62 169.52 10.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.453 -0.779 . . . . 0.0 110.879 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.476 ' HB2' ' HA2' ' A' ' 361' ' ' GLY . 93.8 t80 -62.11 112.39 6.24 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.764 . . . . 0.0 109.756 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.86 79.29 1.98 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.878 1.462 . . . . 0.0 110.487 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 179.73 29.65 0.05 OUTLIER Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.773 -1.203 . . . . 0.0 110.11 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 326' ' ' GLY . 1.0 OUTLIER 47.81 98.2 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.11 -1.23 . . . . 0.0 110.509 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.632 HG23 HG21 ' A' ' 362' ' ' THR . 1.1 mt -82.11 -176.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.495 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.575 ' H ' HG22 ' A' ' 328' ' ' ILE . 0.6 OUTLIER -178.14 105.43 0.05 OUTLIER 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.416 0.627 . . . . 0.0 110.376 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 1.021 HG11 ' HB3' ' A' ' 367' ' ' ALA . 5.3 m -136.05 171.57 16.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-O 121.749 0.785 . . . . 0.0 110.5 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.2 OUTLIER -91.22 89.62 7.41 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.573 ' CG ' HG23 ' A' ' 330' ' ' VAL . 4.0 ppp? -140.26 148.34 41.31 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.439 -0.788 . . . . 0.0 109.894 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 21.0 t-160 -75.97 110.82 12.03 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.481 ' O ' ' HD3' ' A' ' 338' ' ' LYS . 36.7 Cg_endo -58.74 -19.33 45.68 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.476 1.251 . . . . 0.0 109.152 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.593 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -82.57 -63.9 1.28 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.529 0.681 . . . . 0.0 109.805 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.507 ' OG ' HG13 ' A' ' 412' ' ' ILE . 26.8 t -49.39 -50.54 39.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.538 -0.726 . . . . 0.0 110.132 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.554 HG13 ' CE ' ' A' ' 332' ' ' MET . 21.7 mm -59.91 -45.68 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.565 ' HD3' HG13 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -46.81 -49.03 20.6 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.7 -1.25 . . . . 0.0 109.377 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -60.97 -38.88 87.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.491 -0.756 . . . . 0.0 110.302 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -58.94 -53.25 60.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 0.0 110.83 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.791 ' CG1' HG11 ' A' ' 308' ' ' VAL . 55.2 t -70.31 -21.08 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 110.057 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -81.65 -19.73 41.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.397 -0.815 . . . . 0.0 110.779 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -84.64 -44.67 13.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.088 -1.008 . . . . 0.0 110.777 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 6.1 mtm -69.15 -20.14 64.02 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.16 -0.962 . . . . 0.0 110.546 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 342' ' ' ALA . 8.7 p -87.86 -27.48 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.104 -0.997 . . . . 0.0 110.506 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 342' ' ' ALA . 53.5 t -76.85 -28.02 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 110.373 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 17.4 m120 -75.13 -32.04 61.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.105 -0.997 . . . . 0.0 110.281 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.686 ' HB2' ' OD1' ' A' ' 373' ' ' ASP . . . -90.58 -18.63 24.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.123 -0.986 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -77.05 -81.21 0.09 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.033 -1.042 . . . . 0.0 111.856 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -48.41 64.95 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.381 -0.824 . . . . 0.0 112.34 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 347' ' ' ASN . 36.6 m-85 -74.79 -58.93 2.98 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.855 -1.153 . . . . 0.0 111.561 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 348' ' ' ALA . . . -108.12 59.55 0.36 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.189 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.23 93.1 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.235 . . . . 0.0 109.886 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -147.7 -67.06 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -150.13 139.19 21.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.119 -1.224 . . . . 0.0 110.657 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.619 HD12 HG13 ' A' ' 319' ' ' ILE . 20.3 mt -123.66 162.08 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.459 -0.776 . . . . 0.0 109.832 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 372' ' ' GLU . 1.1 ttpt -136.83 111.36 8.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.069 -1.019 . . . . 0.0 110.331 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.697 HG23 HG23 ' A' ' 319' ' ' ILE . 65.1 t -110.17 88.41 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 110.034 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.589 ' OG ' ' HB3' ' A' ' 322' ' ' ALA . 1.0 OUTLIER -112.55 148.95 33.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 110.436 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.542 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -144.65 142.14 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.403 -0.81 . . . . 0.0 110.016 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -135.08 -165.9 10.92 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.7 OUTLIER -174.52 179.17 1.81 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.775 -1.426 . . . . 0.0 111.547 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 8.2 mt-10 -156.32 173.18 5.18 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.527 ' O ' ' HB2' ' A' ' 365' ' ' ASN . 39.6 Cg_endo -66.38 119.01 5.99 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.422 1.222 . . . . 0.0 110.469 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' A' ' 364' ' ' PRO . 2.3 m-80 62.88 37.3 12.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.934 -0.479 . . . . 0.0 110.969 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 10.7 ptm180 169.31 106.32 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.455 -0.778 . . . . 0.0 110.399 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 1.021 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -116.49 168.11 10.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.176 -0.952 . . . . 0.0 109.835 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.64 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 25.8 p-90 -154.74 169.05 24.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.86 -1.15 . . . . 0.0 110.811 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.519 ' CE1' HD11 ' A' ' 436' ' ' LEU . 32.9 p90 -144.4 136.29 26.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.456 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.517 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 9.7 tt0 -121.07 153.84 36.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.101 -0.999 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.517 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 40.6 t -137.06 143.92 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 110.181 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 2.0 mt-10 -137.29 134.45 36.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.355 -0.841 . . . . 0.0 109.779 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.686 ' OD1' ' HB2' ' A' ' 348' ' ' ALA . 3.6 p30 -151.1 163.18 39.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.894 -1.129 . . . . 0.0 110.864 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -110.04 134.13 52.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 352' ' ' GLY . . . 159.54 -136.05 4.43 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.496 ' HG3' ' CB ' ' A' ' 351' ' ' TYR . 47.0 Cg_endo -72.65 106.16 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.991 1.521 . . . . 0.0 110.349 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -78.35 -157.78 10.7 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.607 HD12 HD12 ' A' ' 422' ' ' LEU . 9.7 mt -119.04 172.67 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.496 -1.003 . . . . 0.0 110.12 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -120.91 175.0 2.6 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.867 -1.146 . . . . 0.0 110.675 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 51.3 Cg_endo -79.94 -33.07 1.25 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 124.059 1.557 . . . . 0.0 111.349 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -89.65 -19.76 24.49 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.907 -1.121 . . . . 0.0 111.312 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.604 ' HG3' ' HB3' ' A' ' 379' ' ' ALA . 41.6 mt-30 -85.91 -26.67 25.44 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.95 -1.094 . . . . 0.0 108.846 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 385' ' ' HIS . 0.2 OUTLIER -66.97 -25.38 66.29 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.082 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 383' ' ' ARG . 32.5 mmtm -46.94 -35.69 6.81 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.505 ' CD2' ' H ' ' A' ' 385' ' ' HIS . 1.4 m-70 -100.74 -139.26 0.33 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.481 -1.691 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.552 ' O ' HD13 ' A' ' 412' ' ' ILE . 9.7 tp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.265 0.555 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 410' ' ' GLN . 13.2 p -120.05 -42.08 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.479 -0.763 . . . . 0.0 109.926 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.592 ' N ' HG13 ' A' ' 409' ' ' VAL . 2.6 pt20 -51.72 -29.34 18.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.433 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.478 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.4 OUTLIER -76.51 -35.88 58.08 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.827 HG21 ' HB2' ' A' ' 340' ' ' ALA . 0.6 OUTLIER -56.84 -44.7 82.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' A' ' 420' ' ' LEU . 92.9 t -73.93 -22.66 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 35.2 t70 -80.02 -19.58 47.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.699 -0.626 . . . . 0.0 109.603 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -85.77 -26.83 25.58 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.382 -0.824 . . . . 0.0 109.142 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.716 ' CB ' HD23 ' A' ' 436' ' ' LEU . 30.6 m80 -89.78 -31.57 17.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.766 . . . . 0.0 109.083 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.4 OUTLIER 77.27 42.96 0.12 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.395 0.617 . . . . 0.0 110.6 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.614 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -106.8 -85.14 1.76 Allowed Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.565 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.0 OUTLIER -179.2 164.23 1.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.113 . . . . 0.0 111.331 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.557 ' HB2' HG11 ' A' ' 413' ' ' VAL . 19.1 tp -151.3 92.59 1.8 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.163 -0.961 . . . . 0.0 109.258 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.537 ' HB2' ' HG3' ' A' ' 433' ' ' ARG . 0.3 OUTLIER -92.28 139.93 30.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.975 -1.078 . . . . 0.0 110.443 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.704 HD22 HG12 ' A' ' 432' ' ' ILE . 0.3 OUTLIER -114.98 145.7 41.98 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.43 -0.794 . . . . 0.0 111.275 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 430' ' ' LEU . . . -145.53 145.52 14.78 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.532 HG21 ' H ' ' A' ' 378' ' ' ILE . 7.8 m . . . . . 0 N--CA 1.49 1.57 0 O-C-N 120.838 -1.39 . . . . 0.0 111.041 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.494 2.533 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.601 ' CD1' HG13 ' A' ' 378' ' ' ILE . 18.4 tp -90.59 108.78 20.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -1.132 . . . . 0.0 110.852 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 66.5 m -118.07 132.98 56.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.608 -0.682 . . . . 0.0 109.368 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.704 HG12 HD22 ' A' ' 422' ' ' LEU . 4.4 mt -136.7 142.26 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.935 -1.103 . . . . 0.0 111.031 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . 0.537 ' HG3' ' HB2' ' A' ' 421' ' ' GLU . 0.0 OUTLIER -122.2 117.02 25.2 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.445 -0.785 . . . . 0.0 109.598 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 369' ' ' PHE . . . -102.6 140.0 37.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.165 -0.959 . . . . 0.0 111.049 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.64 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 79.8 m95 -114.6 154.44 28.34 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.288 -0.883 . . . . 0.0 111.271 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.716 HD23 ' CB ' ' A' ' 416' ' ' HIS . 12.7 mt -145.87 111.08 4.46 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.614 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 49.5 Cg_endo -85.9 130.57 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.691 1.364 . . . . 0.0 110.823 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.772 HG22 ' HB ' ' A' ' 330' ' ' VAL . 60.6 t -82.79 110.08 20.5 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.408 -0.808 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 57.3 Cg_endo . . . . . 0 C--N 1.311 -1.403 0 O-C-N 123.938 1.494 . . . . 0.0 109.987 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.656 ' CB ' ' CD2' ' A' ' 333' ' ' HIS . 51.4 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 N-CA-C 109.362 -1.053 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.548 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 43.36 87.68 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 122.323 1.058 . . . . 0.0 109.99 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 1.1 mt-10 -143.06 -156.6 0.7 Allowed 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.278 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.535 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -88.25 131.61 34.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.937 -1.102 . . . . 0.0 110.589 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -150.04 160.07 43.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.443 -0.786 . . . . 0.0 110.709 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.82 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.9 OUTLIER -102.57 120.38 40.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 110.083 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.526 HD11 ' CD1' ' A' ' 436' ' ' LEU . 15.3 mt -63.37 -21.27 66.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 109.751 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.666 ' HA ' HD23 ' A' ' 323' ' ' LEU . 26.0 t-20 -83.41 -21.58 32.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.064 -1.022 . . . . 0.0 108.754 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 307' ' ' GLU . . . -88.15 -26.79 22.26 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.728 0.775 . . . . 0.0 109.144 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 300' ' ' ASP . 18.3 t -83.8 -38.38 14.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.634 ' CD2' HG21 ' A' ' 341' ' ' VAL . 91.0 mt -78.41 -28.42 46.86 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.408 -0.807 . . . . 0.0 110.113 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.65 -32.66 82.09 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 303' ' ' ALA . 3.1 mm-40 -79.6 -35.26 39.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -1.141 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.715 HG11 ' CG1' ' A' ' 341' ' ' VAL . 65.4 t -77.81 -19.29 13.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.642 0.734 . . . . 0.0 109.673 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.579 ' CD1' HG22 ' A' ' 321' ' ' THR . 0.3 OUTLIER -79.81 -43.12 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.492 -0.755 . . . . 0.0 109.25 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -80.2 -17.18 53.08 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.638 0.732 . . . . 0.0 109.969 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.33 -53.96 4.22 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.586 -0.696 . . . . 0.0 112.034 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.442 ' O ' HG11 ' A' ' 345' ' ' VAL . 76.1 mm-40 -112.26 45.2 1.31 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.252 -0.905 . . . . 0.0 111.227 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 309' ' ' ILE . 0.3 OUTLIER -80.65 28.56 0.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.238 -0.914 . . . . 0.0 110.79 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 53.41 42.84 65.56 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 22.2 m-85 61.69 33.07 18.23 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.681 -0.894 . . . . 0.0 110.051 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 2.8 tt0 65.31 43.94 3.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 109.378 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.584 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.8 OUTLIER -68.76 -83.18 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.606 0.717 . . . . 0.0 110.436 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.584 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.7 pt-20 -159.23 64.1 0.39 Allowed 'General case' 0 C--N 1.273 -2.754 0 O-C-N 121.672 -0.642 . . . . 0.0 110.69 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.874 HG13 HD12 ' A' ' 356' ' ' ILE . 2.2 mp -96.51 126.75 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 109.511 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.46 103.66 16.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.705 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.579 HG22 ' CD1' ' A' ' 309' ' ' ILE . 19.0 p -89.68 125.68 35.35 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.502 -0.749 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.36 78.97 1.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.478 -0.764 . . . . 0.0 109.249 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.666 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.3 mp -89.48 149.23 23.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.384 -0.823 . . . . 0.0 110.528 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.599 ' CD1' ' HD2' ' A' ' 325' ' ' PRO . 60.4 t80 -38.37 147.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.737 -0.602 . . . . 0.0 110.321 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.599 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.8 Cg_endo -81.83 64.12 8.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.948 1.499 . . . . 0.0 110.44 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . 172.87 8.38 0.02 OUTLIER Glycine 0 N--CA 1.498 2.767 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.697 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 1.2 p 66.07 119.92 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.473 -1.604 . . . . 0.0 109.728 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.65 HD13 ' N ' ' A' ' 328' ' ' ILE . 1.6 mm -74.58 -178.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.864 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.586 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.6 mt-10 -170.56 103.72 0.26 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 121.688 0.756 . . . . 0.0 109.97 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.535 ' C ' ' HE2' ' A' ' 298' ' ' MET . 4.0 m -140.17 172.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.378 0 CA-C-O 121.646 0.736 . . . . 0.0 110.556 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.2 tptp -91.0 89.69 7.54 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.591 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 2.2 tmm? -143.79 157.3 44.47 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.401 -0.812 . . . . 0.0 110.609 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.656 ' CD2' ' CB ' ' A' ' 295' ' ' PRO . 3.3 t-80 -78.54 117.68 67.85 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 38.4 Cg_endo -62.11 -21.88 73.24 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.776 1.409 . . . . 0.0 110.341 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.575 ' HB2' ' ND1' ' A' ' 333' ' ' HIS . 12.1 mt -76.95 -63.6 1.32 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.107 0.956 . . . . 0.0 110.258 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.488 ' HB3' HG13 ' A' ' 412' ' ' ILE . 17.4 m -45.8 -53.08 10.17 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.554 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.757 HD11 ' CE1' ' A' ' 416' ' ' HIS . 16.7 mm -57.16 -43.84 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.999 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 0.2 OUTLIER -48.8 -41.19 31.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.887 -1.133 . . . . 0.0 108.344 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 336' ' ' SER . 6.8 mtt180 -67.46 -47.71 69.32 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.488 0.661 . . . . 0.0 109.909 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.43 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -51.82 -36.2 47.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 110.641 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.715 ' CG1' HG11 ' A' ' 308' ' ' VAL . 33.6 t -89.99 -21.05 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -0.935 . . . . 0.0 110.281 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.59 -56.69 9.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.868 . . . . 0.0 110.846 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . 0.556 ' O ' HG12 ' A' ' 346' ' ' VAL . 76.1 m-20 -75.68 -19.72 58.94 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.212 -0.93 . . . . 0.0 110.724 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.667 ' CE ' HG21 ' A' ' 432' ' ' ILE . 2.0 mtt -67.48 -32.66 73.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.287 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.807 ' O ' ' HB2' ' A' ' 349' ' ' ALA . 55.9 t -90.44 -19.05 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.351 -0.843 . . . . 0.0 111.236 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 343' ' ' ASN . 0.6 OUTLIER -70.93 -30.31 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.939 -1.101 . . . . 0.0 110.685 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -60.9 -55.76 29.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.144 -0.972 . . . . 0.0 110.636 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.488 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -85.1 -19.23 32.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.173 -0.954 . . . . 0.0 110.403 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.807 ' HB2' ' O ' ' A' ' 345' ' ' VAL . . . -43.34 -72.8 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.381 -0.824 . . . . 0.0 110.811 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 61.0 mtt85 -87.0 -69.22 0.69 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.084 -1.01 . . . . 0.0 110.744 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . 0.492 ' O ' ' N ' ' A' ' 353' ' ' ASN . 2.3 t80 -49.03 -72.61 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.301 -0.874 . . . . 0.0 110.829 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -52.85 88.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 351' ' ' TYR . 6.3 p-10 -96.2 51.48 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.184 -1.186 . . . . 0.0 109.801 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -121.1 -66.93 0.26 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.575 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 2.0 t90 -176.28 140.36 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -1.182 . . . . 0.0 110.219 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.874 HD12 HG13 ' A' ' 319' ' ' ILE . 2.8 mt -110.41 158.96 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.651 -0.656 . . . . 0.0 109.909 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 11.8 ttpt -142.15 105.58 4.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.74 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.648 HG23 HG23 ' A' ' 319' ' ' ILE . 68.9 t -107.73 84.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.327 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 69.5 p -116.67 140.73 49.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.006 -1.059 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.505 ' HB3' ' HG ' ' A' ' 323' ' ' LEU . 1.9 t -125.72 158.66 34.28 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.543 ' C ' HG22 ' A' ' 362' ' ' THR . . . -159.07 -152.62 6.51 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -179.26 174.18 1.05 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.215 -1.168 . . . . 0.0 110.525 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.561 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 1.9 mt-10 -151.81 -175.13 0.45 Allowed Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.468 -0.77 . . . . 0.0 109.504 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 40.7 Cg_endo -69.7 116.96 4.8 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.582 1.306 . . . . 0.0 111.353 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.563 ' O ' ' HG3' ' A' ' 366' ' ' ARG . 1.9 m-20 69.65 6.09 5.53 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.679 -0.638 . . . . 0.0 111.844 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 365' ' ' ASN . 59.7 mtp85 -155.7 104.92 2.37 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.098 -1.001 . . . . 0.0 111.834 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -101.01 167.59 10.15 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 52.7 p-90 -170.9 178.79 3.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.189 -1.569 . . . . 0.0 111.905 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 27.5 p90 -147.76 141.62 25.79 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.544 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 8.8 tt0 -134.15 149.44 51.05 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.871 -1.143 . . . . 0.0 112.325 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.544 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 33.6 t -127.22 134.05 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.454 ' HG3' ' OG ' ' A' ' 431' ' ' SER . 0.7 OUTLIER -128.96 145.88 51.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.778 -1.201 . . . . 0.0 109.897 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 373' ' ' ASP . 8.0 p30 -149.92 145.98 26.81 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.69 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.33 137.36 38.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.392 -0.817 . . . . 0.0 109.917 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 169.8 -164.15 37.59 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.008 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.53 -161.63 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.156 1.608 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 424' ' ' THR . . . -146.83 166.24 28.37 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.972 HD11 HD21 ' A' ' 422' ' ' LEU . 5.5 mt -72.6 169.81 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.236 . . . . 0.0 109.787 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.995 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -95.25 177.8 1.68 Allowed Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.96 -1.088 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.872 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 45.9 Cg_endo -73.32 -46.43 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.036 1.545 . . . . 0.0 110.78 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -90.77 -30.22 17.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.959 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.995 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -64.45 -20.18 66.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.079 -1.013 . . . . 0.0 110.338 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 382' ' ' GLN . 16.8 ttt180 -44.81 -29.22 0.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.162 -0.961 . . . . 0.0 109.872 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 385' ' ' HIS . 20.0 mttt -89.95 -33.15 16.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.352 -0.843 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 382' ' ' GLN . 5.0 m170 -40.94 -59.18 1.51 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.314 -0.866 . . . . 0.0 110.036 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 386' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.85 ' O ' HD13 ' A' ' 412' ' ' ILE . 27.3 mm . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.328 0.585 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 410' ' ' GLN . 7.0 p -129.47 -34.03 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.183 -0.948 . . . . 0.0 110.269 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 31.0 tt0 -66.4 -42.14 88.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 110.502 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.488 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.0 OUTLIER -69.57 -32.31 71.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.173 -0.954 . . . . 0.0 110.033 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 408' ' ' ILE . 1.1 mp -59.64 -63.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.147 -0.971 . . . . 0.0 108.58 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 1.047 HG21 HD13 ' A' ' 420' ' ' LEU . 35.5 t -63.32 -28.22 44.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.321 -0.862 . . . . 0.0 109.823 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.488 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 29.7 t70 -73.24 -20.54 60.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.511 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.548 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.1 m-80 -95.27 -14.31 24.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.473 -0.767 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.757 ' CE1' HD11 ' A' ' 337' ' ' ILE . 37.3 m80 -93.03 -34.1 13.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.451 -0.781 . . . . 0.0 109.865 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 4.1 m120 72.95 47.43 0.2 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.488 0.661 . . . . 0.0 110.431 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.575 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -121.28 -87.16 0.92 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.593 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.2 OUTLIER -171.12 161.74 6.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.397 -1.061 . . . . 0.0 110.615 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 1.047 HD13 HG21 ' A' ' 413' ' ' VAL . 14.1 tp -150.36 90.68 1.68 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 109.989 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 433' ' ' ARG . 63.0 mm-40 -89.81 154.03 20.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.235 -0.915 . . . . 0.0 110.046 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.972 HD21 HD11 ' A' ' 378' ' ' ILE . 7.2 tt -138.31 130.64 28.9 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.983 -1.073 . . . . 0.0 111.149 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.546 ' C ' ' HA ' ' A' ' 430' ' ' LEU . . . -90.33 163.04 29.91 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.773 ' HA ' ' HG ' ' A' ' 430' ' ' LEU 0.258 12.9 t . . . . . 0 N--CA 1.506 2.334 0 CA-C-N 118.836 1.318 . . . . 0.0 112.397 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.499 2.862 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.773 ' HG ' ' HA ' ' A' ' 424' ' ' THR . 0.7 OUTLIER -110.93 131.93 54.64 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.579 1.69 . . . . 0.0 110.354 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.5 ' N ' HD23 ' A' ' 430' ' ' LEU . 4.0 m -143.26 -177.75 5.52 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.919 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.667 HG21 ' CE ' ' A' ' 344' ' ' MET . 9.1 mm -149.94 92.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.687 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . 0.534 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.1 mtt180 -88.59 134.84 33.76 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.859 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -128.98 129.35 45.29 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.05 -1.031 . . . . 0.0 109.679 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 84.0 m95 -111.28 145.57 38.56 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.139 -0.975 . . . . 0.0 111.908 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.526 ' CD1' HD11 ' A' ' 301' ' ' LEU . 5.9 mt -134.35 106.69 11.11 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.575 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 42.8 Cg_endo -68.78 138.82 42.1 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 O-C-N 123.911 1.479 . . . . 0.0 111.382 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.545 ' CG2' ' HD2' ' A' ' 439' ' ' PRO . 4.9 p -86.17 145.63 40.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.567 -0.708 . . . . 0.0 109.557 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 438' ' ' VAL . 47.4 Cg_endo . . . . . 0 C--N 1.303 -1.852 0 O-C-N 123.802 1.422 . . . . 0.0 110.423 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.623 ' HB3' ' CD2' ' A' ' 333' ' ' HIS . 49.4 Cg_endo . . . . . 0 C--O 1.214 -0.718 0 CA-C-O 121.24 0.433 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.508 ' C ' ' O ' ' A' ' 295' ' ' PRO . 0.0 OUTLIER 27.99 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.193 0.997 . . . . 0.0 111.104 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 18.6 pt-20 -164.25 -159.98 0.51 Allowed 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.502 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.0 OUTLIER -88.22 127.75 35.45 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.926 -1.109 . . . . 0.0 110.146 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -147.55 163.86 35.25 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.181 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.586 ' O ' HG23 ' A' ' 304' ' ' VAL . 16.3 t0 -100.12 116.42 32.11 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.664 -0.647 . . . . 0.0 109.759 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.648 HD12 HG21 ' A' ' 328' ' ' ILE . 12.0 mt -60.53 -27.45 67.65 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.299 -0.875 . . . . 0.0 109.778 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.818 ' HA ' HD23 ' A' ' 323' ' ' LEU . 56.7 t-20 -76.19 -22.68 55.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.056 . . . . 0.0 108.963 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -85.56 -31.46 22.66 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.459 0.647 . . . . 0.0 109.552 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 300' ' ' ASP . 33.2 t -79.58 -34.31 15.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.499 -0.75 . . . . 0.0 109.542 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.774 ' O ' HD12 ' A' ' 309' ' ' ILE . 82.6 mt -79.92 -26.77 40.04 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.401 -0.812 . . . . 0.0 109.991 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.56 -33.86 88.36 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.81 -32.92 25.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.305 -1.115 . . . . 0.0 109.417 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.843 HG11 ' CG1' ' A' ' 341' ' ' VAL . 51.0 t -75.39 -19.24 15.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.389 -0.819 . . . . 0.0 109.189 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.818 HD11 ' CG1' ' A' ' 358' ' ' VAL . 1.0 OUTLIER -83.26 -46.01 18.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.08 -17.58 61.99 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.277 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.58 -53.57 4.37 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.97 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -100.86 35.0 2.3 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 111.045 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 309' ' ' ILE . 0.1 OUTLIER -86.18 32.15 0.63 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.082 -1.012 . . . . 0.0 110.365 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 45.24 33.2 3.93 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.686 -2.165 . . . . 0.0 107.686 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 39.8 m-85 61.86 52.07 3.57 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 122.096 -0.65 . . . . 0.0 109.95 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 16.1 mt-10 59.28 35.52 23.36 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.597 -0.689 . . . . 0.0 110.256 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.3 OUTLIER -68.84 -74.13 0.13 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.509 -0.744 . . . . 0.0 109.46 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 9.3 mt-10 -160.42 80.85 0.67 Allowed 'General case' 0 C--N 1.274 -2.7 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.542 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.984 HG13 HD12 ' A' ' 356' ' ' ILE . 2.7 mp -122.62 142.21 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.508 ' HB3' ' CG ' ' A' ' 357' ' ' LYS . 26.3 tt0 -109.7 103.89 12.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.446 -0.784 . . . . 0.0 109.547 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 20.0 p -90.53 123.71 34.42 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.245 -0.91 . . . . 0.0 111.411 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -144.33 78.69 1.59 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.818 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.7 mp -91.07 152.31 20.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.561 -0.712 . . . . 0.0 110.999 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.573 ' HB3' ' CD1' ' A' ' 328' ' ' ILE . 19.9 t80 -41.19 136.15 1.72 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.593 -0.692 . . . . 0.0 110.058 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 324' ' ' TYR . 51.8 Cg_endo -83.67 57.28 5.55 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 124.027 1.54 . . . . 0.0 110.276 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -167.58 21.13 0.1 OUTLIER Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.747 -1.215 . . . . 0.0 110.505 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 326' ' ' GLY . 68.5 m 56.44 111.56 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.019 -1.283 . . . . 0.0 110.215 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.648 HG21 HD12 ' A' ' 301' ' ' LEU . 3.5 mm -69.12 -179.34 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.579 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.635 ' H ' HG22 ' A' ' 328' ' ' ILE . 1.7 mt-10 -174.84 101.28 0.09 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.64 -0.663 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 1.016 HG11 ' HB3' ' A' ' 367' ' ' ALA . 8.4 m -143.41 174.17 5.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 121.62 0.724 . . . . 0.0 110.469 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.1 OUTLIER -95.05 93.63 7.49 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.624 ' HG2' HG23 ' A' ' 330' ' ' VAL . 11.2 ptm -136.47 164.76 27.41 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.973 0.892 . . . . 0.0 112.597 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.623 ' CD2' ' HB3' ' A' ' 295' ' ' PRO . 23.4 t-160 -88.06 116.44 66.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 39.3 Cg_endo -62.47 -30.23 79.75 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.637 1.335 . . . . 0.0 112.542 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.597 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 3.9 tp -82.23 -49.2 10.36 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.623 -1.298 . . . . 0.0 110.589 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.542 ' HB2' ' ND1' ' A' ' 333' ' ' HIS . 0.5 OUTLIER -60.6 -42.26 96.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.915 -1.115 . . . . 0.0 109.869 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.933 HD11 ' CE1' ' A' ' 416' ' ' HIS . 18.5 mm -65.37 -46.99 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.601 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 0.7 OUTLIER -51.54 -32.93 29.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.83 -1.169 . . . . 0.0 107.873 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.477 ' NH1' ' OD1' ' A' ' 343' ' ' ASN . 0.0 OUTLIER -77.45 -34.65 54.41 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.991 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 344' ' ' MET . . . -67.55 -29.57 68.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.454 -0.779 . . . . 0.0 110.449 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.843 ' CG1' HG11 ' A' ' 308' ' ' VAL . 52.8 t -90.28 -25.49 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 110.423 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 346' ' ' VAL . . . -83.3 -19.95 35.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.578 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . 0.477 ' OD1' ' NH1' ' A' ' 339' ' ' ARG . 0.3 OUTLIER -83.78 -21.08 32.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -0.916 . . . . 0.0 110.779 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 3.2 mtt -90.69 -51.3 5.45 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.138 -0.976 . . . . 0.0 111.221 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 341' ' ' VAL . 27.4 m -68.22 -19.69 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -0.943 . . . . 0.0 111.505 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 347' ' ' ASN . 14.5 p -61.53 -39.64 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.843 -1.161 . . . . 0.0 110.72 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.52 ' N ' HG13 ' A' ' 346' ' ' VAL . 10.9 t30 -63.2 -49.78 72.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.126 -0.984 . . . . 0.0 110.806 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.488 ' O ' ' HA2' ' A' ' 352' ' ' GLY . . . -72.73 -19.91 61.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.219 -0.926 . . . . 0.0 110.612 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.09 -73.18 0.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.025 -1.047 . . . . 0.0 110.253 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -55.35 -51.63 66.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.298 -0.876 . . . . 0.0 110.453 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -59.54 2.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.215 -0.928 . . . . 0.0 110.379 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 348' ' ' ALA . . . 68.09 -104.11 1.12 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 1.5 t30 55.0 17.35 1.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -1.145 . . . . 0.0 110.207 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 374' ' ' ASP . . . -168.37 -98.25 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.067 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.612 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -179.78 148.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -1.166 . . . . 0.0 109.881 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.984 HD12 HG13 ' A' ' 319' ' ' ILE . 0.8 OUTLIER -106.49 159.52 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.309 -0.869 . . . . 0.0 110.024 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.612 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 1.4 ttmt -150.41 112.72 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 110.692 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.818 ' CG1' HD11 ' A' ' 309' ' ' ILE . 21.9 t -103.07 88.81 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 370' ' ' GLN . 6.8 p -115.04 151.14 34.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -0.896 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.536 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.6 OUTLIER -140.14 163.53 32.47 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.533 ' C ' HG22 ' A' ' 362' ' ' THR . . . -155.23 -164.32 12.95 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.545 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.1 OUTLIER -176.36 144.05 0.53 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.716 -1.461 . . . . 0.0 112.048 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 39.0 mt-10 -109.03 175.61 1.89 Allowed Pre-proline 0 C--N 1.287 -2.146 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.304 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 40.1 Cg_endo -66.07 127.0 16.77 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.245 1.129 . . . . 0.0 110.087 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.552 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 6.6 m120 60.52 22.25 11.97 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.519 -0.738 . . . . 0.0 110.243 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 42.1 mtm180 -163.63 145.06 9.22 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 1.016 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -143.17 151.16 40.36 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.11 -0.994 . . . . 0.0 109.159 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.603 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 37.7 p-90 -151.67 170.38 19.85 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.905 -1.122 . . . . 0.0 110.682 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 369' ' ' PHE . 36.4 p90 -139.5 130.42 26.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.44 -0.787 . . . . 0.0 109.582 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 359' ' ' SER . 0.8 OUTLIER -116.1 150.48 37.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -0.933 . . . . 0.0 111.381 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.29 143.86 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.497 -0.752 . . . . 0.0 109.348 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 357' ' ' LYS . 1.8 tt0 -126.36 145.51 50.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.013 -1.054 . . . . 0.0 110.198 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.451 ' OD1' ' HB1' ' A' ' 348' ' ' ALA . 11.1 t70 -156.65 143.66 18.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.841 . . . . 0.0 110.331 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 374' ' ' ASP . 27.6 t0 -98.39 64.47 1.59 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.37 -0.831 . . . . 0.0 110.016 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -86.88 -148.01 12.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.15 -40.59 3.15 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.008 1.531 . . . . 0.0 110.482 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . 0.593 ' C ' HD13 ' A' ' 378' ' ' ILE . . . 103.6 -174.85 23.06 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.768 HD11 HD11 ' A' ' 430' ' ' LEU . 1.9 mm -99.72 176.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.065 -1.256 . . . . 0.0 110.102 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.902 ' HB3' ' CB ' ' A' ' 382' ' ' GLN . . . -109.91 165.61 12.35 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.248 -0.908 . . . . 0.0 109.752 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 43.2 Cg_endo -70.07 -49.26 0.53 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.842 1.443 . . . . 0.0 110.229 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -89.53 -19.69 24.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.12 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.902 ' CB ' ' HB3' ' A' ' 379' ' ' ALA . 4.5 tt0 -82.82 -19.78 36.98 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.275 -0.89 . . . . 0.0 110.86 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 382' ' ' GLN . 2.2 ttt85 -42.32 -37.97 1.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.024 -1.047 . . . . 0.0 110.021 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.84 -27.89 19.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.203 -0.936 . . . . 0.0 110.404 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -51.81 -18.23 1.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.107 -0.996 . . . . 0.0 110.747 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 50.4 mt . . . . . 0 N--CA 1.501 2.119 0 O-C-N 120.92 -1.113 . . . . 0.0 110.731 179.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.589 HG22 HG12 ' A' ' 409' ' ' VAL . 14.2 mt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.268 0.556 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 408' ' ' ILE . 10.6 p -48.83 -22.51 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.954 . . . . 0.0 110.176 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 48.3 tt0 -62.9 -55.94 21.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.23 -0.919 . . . . 0.0 110.609 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.4 OUTLIER -59.02 -32.19 69.5 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.311 -0.868 . . . . 0.0 110.684 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 340' ' ' ALA . 1.0 OUTLIER -64.03 -58.37 7.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.092 -1.005 . . . . 0.0 109.143 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.653 HG11 ' HB2' ' A' ' 420' ' ' LEU . 30.4 t -65.51 -21.41 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.249 -0.907 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 0.1 OUTLIER -82.41 -25.83 33.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 109.515 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 2.2 t-20 -86.41 -17.82 33.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.933 ' CE1' HD11 ' A' ' 337' ' ' ILE . 22.7 m80 -92.87 -41.2 10.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.539 -0.726 . . . . 0.0 109.664 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 6.0 t-20 79.59 36.04 0.15 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.437 0.637 . . . . 0.0 109.949 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.635 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -101.86 -90.03 2.1 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.565 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.7 OUTLIER -173.0 163.45 4.79 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.349 -1.089 . . . . 0.0 111.222 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.653 ' HB2' HG11 ' A' ' 413' ' ' VAL . 14.3 tp -151.45 97.93 2.46 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.57 152.17 34.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.001 -1.062 . . . . 0.0 111.541 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.602 ' O ' HD12 ' A' ' 422' ' ' LEU . 2.9 pp -132.47 121.13 22.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.404 -0.81 . . . . 0.0 109.273 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -141.8 132.04 5.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 3.5 t . . . . . 0 C--N 1.304 -1.396 0 O-C-N 121.254 -1.145 . . . . 0.0 110.703 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.498 2.822 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.768 HD11 HD11 ' A' ' 378' ' ' ILE . 0.3 OUTLIER -76.44 135.77 39.42 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.138 -1.213 . . . . 0.0 111.777 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 40.2 t -144.76 114.24 7.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.689 -0.632 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 432' ' ' ILE . 1.5 tt -94.46 131.91 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.145 -0.972 . . . . 0.0 110.368 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -111.79 103.04 11.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.94 . . . . 0.0 110.407 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 368' ' ' TRP . . . -91.96 130.39 37.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.325 -0.86 . . . . 0.0 109.518 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.603 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.3 m95 -107.66 157.24 18.25 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.822 -1.174 . . . . 0.0 112.438 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.505 HD12 HD11 ' A' ' 301' ' ' LEU . 19.8 mt -142.68 114.12 6.04 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.635 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 51.4 Cg_endo -78.45 129.53 9.44 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.534 1.281 . . . . 0.0 112.161 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.799 HG21 HG12 ' A' ' 330' ' ' VAL . 6.8 t -109.32 69.0 0.42 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.539 -0.725 . . . . 0.0 110.02 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.483 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 57.7 Cg_endo . . . . . 0 C--N 1.308 -1.574 0 O-C-N 123.681 1.358 . . . . 0.0 110.558 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.642 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 54.2 Cg_endo . . . . . 0 C--O 1.216 -0.609 0 CA-C-O 121.361 0.484 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.04 107.74 15.84 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 15.5 mt-10 -128.81 -162.02 1.16 Allowed 'General case' 0 C--N 1.283 -2.287 0 O-C-N 121.637 -0.664 . . . . 0.0 109.913 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.468 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -88.33 133.51 34.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.048 -1.033 . . . . 0.0 110.271 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.584 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -149.68 160.7 43.31 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.447 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.903 ' O ' HG23 ' A' ' 304' ' ' VAL . 4.3 t0 -90.77 121.32 32.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.801 -0.562 . . . . 0.0 109.891 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.776 HD11 HD12 ' A' ' 436' ' ' LEU . 9.5 mt -72.18 -21.15 61.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 109.718 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.645 ' OD1' HD23 ' A' ' 323' ' ' LEU . 8.9 t30 -83.45 -23.97 32.04 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 109.138 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.682 ' HB3' ' HB3' ' A' ' 300' ' ' ASP . . . -84.0 -31.59 25.4 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.515 -0.74 . . . . 0.0 109.584 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 300' ' ' ASP . 11.4 t -78.41 -35.88 19.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.401 -0.812 . . . . 0.0 109.705 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.509 ' CD2' HG21 ' A' ' 341' ' ' VAL . 71.1 mt -76.08 -29.56 58.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.26 -0.9 . . . . 0.0 110.924 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . 0.473 ' HA2' HD12 ' A' ' 309' ' ' ILE . . . -65.58 -39.78 95.69 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -75.84 -32.56 59.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.203 -1.174 . . . . 0.0 109.59 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 1.006 HG11 ' HB ' ' A' ' 341' ' ' VAL . 41.0 t -78.27 -19.96 13.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 109.339 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.989 ' CG1' HG11 ' A' ' 358' ' ' VAL . 1.4 mt -71.15 -50.48 41.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.79 -15.08 61.64 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.823 0.821 . . . . 0.0 108.879 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 308' ' ' VAL . . . -61.62 -63.17 1.36 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.857 -0.527 . . . . 0.0 111.817 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 311' ' ' ALA . 13.3 mt-10 -143.41 38.92 1.4 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.525 -1.27 . . . . 0.0 113.047 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.949 ' OG ' HD12 ' A' ' 319' ' ' ILE . 5.9 t -85.77 10.37 13.8 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.616 -1.303 . . . . 0.0 109.53 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 317' ' ' ARG . . . 111.39 43.33 0.99 Allowed Glycine 0 C--N 1.291 -1.945 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.536 ' O ' ' HG3' ' A' ' 316' ' ' GLU . 23.7 m-85 59.43 41.6 19.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.918 . . . . 0.0 110.094 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 53.59 32.67 14.8 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.342 1.068 . . . . 0.0 109.096 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 0.2 OUTLIER -69.81 -81.59 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.98 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.634 ' C ' HD13 ' A' ' 319' ' ' ILE . 14.3 pt-20 -126.89 72.15 1.34 Allowed 'General case' 0 C--N 1.277 -2.545 0 O-C-N 121.669 -0.644 . . . . 0.0 111.974 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.949 HD12 ' OG ' ' A' ' 313' ' ' SER . 1.8 mm -104.52 123.2 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 358' ' ' VAL . 7.5 tt0 -88.98 98.15 11.6 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.59 HG22 HD13 ' A' ' 309' ' ' ILE . 20.6 p -89.46 129.22 35.99 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.893 0.854 . . . . 0.0 111.832 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.46 77.85 1.31 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.645 HD23 ' OD1' ' A' ' 302' ' ' ASN . 0.8 OUTLIER -96.46 158.51 15.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.47 -0.768 . . . . 0.0 110.644 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.605 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 15.3 t80 -54.31 116.03 9.74 Favored Pre-proline 0 C--N 1.299 -1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.49 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -80.97 64.64 8.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.022 1.538 . . . . 0.0 110.322 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.451 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -162.52 23.04 0.2 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 4.3 p 60.26 106.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -1.136 . . . . 0.0 110.646 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.557 HG22 ' N ' ' A' ' 329' ' ' GLU . 4.0 mt -84.8 175.48 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 O-C-N 121.723 -0.611 . . . . 0.0 109.646 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.557 ' N ' HG22 ' A' ' 328' ' ' ILE . 2.7 mt-10 -169.47 109.89 0.45 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.391 -0.818 . . . . 0.0 111.352 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 1.124 HG11 ' HB3' ' A' ' 367' ' ' ALA . 12.7 m -145.03 160.68 13.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.517 0.675 . . . . 0.0 109.936 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.0 OUTLIER -82.94 95.89 8.12 Favored 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.518 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.584 ' HG3' ' HB3' ' A' ' 299' ' ' ALA . 19.2 ptm -140.37 -178.21 5.39 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 110.975 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.642 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 18.1 t-160 -115.13 112.23 44.39 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.506 ' HB2' ' HE3' ' A' ' 338' ' ' LYS . 36.6 Cg_endo -58.74 -19.66 47.36 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.721 1.379 . . . . 0.0 110.447 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.684 ' C ' HD13 ' A' ' 335' ' ' LEU . 2.9 tm? -78.95 -63.89 1.31 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.382 -0.824 . . . . 0.0 110.123 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.47 ' O ' HG12 ' A' ' 412' ' ' ILE . 0.0 OUTLIER -54.22 -49.97 68.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.305 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.562 HD13 ' CG2' ' A' ' 412' ' ' ILE . 17.3 mm -62.91 -31.78 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 110.346 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.506 ' HE3' ' HB2' ' A' ' 334' ' ' PRO . 0.4 OUTLIER -61.03 -57.86 10.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.906 -1.121 . . . . 0.0 109.772 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.401 ' HD2' ' C ' ' A' ' 339' ' ' ARG . 4.1 tmm_? -69.45 -21.35 63.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.466 -0.771 . . . . 0.0 110.356 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.432 ' HB2' ' CG1' ' A' ' 412' ' ' ILE . . . -69.6 -44.69 70.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.014 . . . . 0.0 110.307 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 1.006 ' HB ' HG11 ' A' ' 308' ' ' VAL . 46.3 t -80.42 -22.16 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.337 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -70.62 -62.24 1.46 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.137 -0.977 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . 0.923 ' O ' HG12 ' A' ' 346' ' ' VAL . 1.8 t30 -59.25 -43.48 92.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.074 -1.016 . . . . 0.0 110.73 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.539 ' CE ' HG21 ' A' ' 432' ' ' ILE . 2.9 ttm -57.7 -19.05 24.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.274 -0.891 . . . . 0.0 110.976 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 341' ' ' VAL . 78.0 t -88.68 -22.26 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.094 -1.004 . . . . 0.0 111.587 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.923 HG12 ' O ' ' A' ' 343' ' ' ASN . 9.0 p -64.82 -19.5 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.951 -1.093 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -66.26 -42.63 88.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.052 -1.03 . . . . 0.0 111.536 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.495 ' HB2' ' CG ' ' A' ' 373' ' ' ASP . . . -89.3 -19.86 24.79 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.938 -1.101 . . . . 0.0 111.369 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -89.41 -69.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.959 -1.088 . . . . 0.0 110.822 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -65.8 -41.92 91.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.125 -0.984 . . . . 0.0 110.744 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.82 -35.73 16.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.175 -0.953 . . . . 0.0 110.56 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -97.34 156.27 20.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -141.97 53.94 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -1.12 . . . . 0.0 109.959 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 355' ' ' TRP . . . -128.04 -59.58 0.12 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.587 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.3 OUTLIER 171.78 150.25 0.05 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.151 -1.205 . . . . 0.0 109.841 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' A' ' 313' ' ' SER . 26.6 mt -116.49 164.21 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.251 -0.905 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 18.4 tttm -142.27 97.6 3.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.561 -0.712 . . . . 0.0 109.752 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.989 HG11 ' CG1' ' A' ' 309' ' ' ILE . 26.0 t -93.01 139.57 17.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.8 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.56 ' HA ' ' CD1' ' A' ' 323' ' ' LEU . 60.3 p -160.13 169.91 22.33 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.087 -1.008 . . . . 0.0 111.458 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.517 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 34.2 t -155.21 150.28 26.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.635 -0.665 . . . . 0.0 109.762 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.513 ' HA3' ' CZ2' ' A' ' 368' ' ' TRP . . . -139.1 -169.92 11.7 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.605 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.5 OUTLIER -178.21 166.16 1.91 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.926 -1.338 . . . . 0.0 111.834 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.571 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 5.1 mm-40 -128.35 -174.91 0.4 Allowed Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 45.8 Cg_endo -86.71 36.46 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.495 1.261 . . . . 0.0 110.446 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 2.8 m-20 161.29 36.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.533 ' HG2' ' HB3' ' A' ' 437' ' ' PRO . 0.2 OUTLIER 166.14 103.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.821 . . . . 0.0 109.718 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 1.124 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -103.91 157.52 17.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.023 -1.048 . . . . 0.0 110.205 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.596 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 30.2 p-90 -150.51 166.46 30.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 110.323 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 434' ' ' ALA . 36.0 p90 -133.77 147.26 51.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -0.83 . . . . 0.0 109.499 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.542 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 24.5 tt0 -139.08 155.9 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 111.538 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.542 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 6.3 t -140.03 144.15 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 431' ' ' SER . 26.2 tt0 -142.62 147.65 36.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.824 -1.172 . . . . 0.0 110.099 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.495 ' CG ' ' HB2' ' A' ' 348' ' ' ALA . 1.5 p30 -161.4 169.68 21.5 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.068 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -79.54 166.69 21.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.388 -0.82 . . . . 0.0 110.026 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 124.58 -164.12 18.16 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.89 127.08 11.17 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.042 1.549 . . . . 0.0 110.622 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . 0.644 ' HA2' HD12 ' A' ' 430' ' ' LEU . . . -94.24 -169.62 37.73 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.711 HG22 ' H ' ' A' ' 379' ' ' ALA . 3.2 mm -76.97 -172.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.942 -1.328 . . . . 0.0 110.145 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.961 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -155.59 160.36 30.9 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.235 -0.915 . . . . 0.0 110.101 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.84 -38.1 4.47 Favored 'Trans proline' 0 C--N 1.298 -2.101 0 O-C-N 124.087 1.572 . . . . 0.0 110.367 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -90.1 -20.91 22.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.199 -0.938 . . . . 0.0 110.284 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.961 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 5.3 tp60 -76.92 -23.57 52.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.204 -0.935 . . . . 0.0 110.343 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -52.53 -26.36 12.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.223 -0.923 . . . . 0.0 110.351 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -79.67 -32.62 41.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.308 -0.87 . . . . 0.0 110.066 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -59.0 -71.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.032 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 0.0 110.552 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 412' ' ' ILE . 10.7 mt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 120.936 0.398 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.502 ' HA ' HD13 ' A' ' 412' ' ' ILE . 13.6 p -46.91 -19.88 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.052 -1.03 . . . . 0.0 111.744 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 0.7 OUTLIER -58.53 -67.08 0.39 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.012 -1.055 . . . . 0.0 111.589 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.52 ' HG2' ' NH2' ' A' ' 411' ' ' ARG . 0.0 OUTLIER -60.31 -26.09 66.27 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.193 -0.942 . . . . 0.0 111.956 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.732 HD12 ' O ' ' A' ' 408' ' ' ILE . 1.3 mp -64.79 -61.69 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 120.473 -1.392 . . . . 0.0 109.332 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.568 HG21 HD13 ' A' ' 420' ' ' LEU . 25.5 t -66.23 -25.14 34.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.093 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 9.1 m-20 -78.38 -23.29 46.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 109.823 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 16.6 t-20 -82.95 -15.31 51.79 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.318 -0.864 . . . . 0.0 109.285 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.579 ' O ' ' CB ' ' A' ' 417' ' ' ASN . 34.1 m80 -90.89 -30.09 17.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.515 -0.74 . . . . 0.0 110.062 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 3.4 t-20 81.52 17.57 0.45 Allowed 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.814 -0.554 . . . . 0.0 110.464 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.577 ' HA2' ' CD ' ' A' ' 437' ' ' PRO . . . -84.81 -91.7 0.79 Allowed Glycine 0 N--CA 1.481 1.678 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.585 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.8 ttp -174.52 167.12 3.91 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.205 -1.174 . . . . 0.0 111.042 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.568 HD13 HG21 ' A' ' 413' ' ' VAL . 19.1 tp -150.83 112.48 4.46 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.597 -0.69 . . . . 0.0 109.181 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -123.54 133.29 54.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.893 -1.129 . . . . 0.0 111.936 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.541 ' CD2' HD12 ' A' ' 432' ' ' ILE . 10.8 mt -108.96 127.59 54.2 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 430' ' ' LEU . . . -136.59 136.83 8.62 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.073 -1.537 . . . . 0.0 110.762 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 429' ' ' GLY . 5.9 m . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.436 -1.038 . . . . 0.0 109.674 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.636 ' O ' HG23 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.927 HD22 ' N ' ' A' ' 431' ' ' SER . 0.0 OUTLIER -175.42 -175.71 0.83 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.038 -1.272 . . . . 0.0 112.11 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.927 ' N ' HD22 ' A' ' 430' ' ' LEU . 0.9 OUTLIER -153.05 -178.98 7.27 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.203 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.541 HD12 ' CD2' ' A' ' 422' ' ' LEU . 0.6 OUTLIER -137.02 133.9 47.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.043 -1.035 . . . . 0.0 110.631 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -111.63 97.8 6.98 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.47 -0.769 . . . . 0.0 109.111 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.592 ' HB3' ' CE2' ' A' ' 369' ' ' PHE . . . -90.63 133.07 35.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.402 -0.811 . . . . 0.0 110.474 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.596 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.7 m95 -105.64 151.92 23.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.097 -1.002 . . . . 0.0 111.586 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.776 HD12 HD11 ' A' ' 301' ' ' LEU . 36.8 mt -144.41 83.91 9.61 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.577 ' CD ' ' HA2' ' A' ' 418' ' ' GLY . 41.7 Cg_endo -69.35 137.0 35.57 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 123.92 1.484 . . . . 0.0 111.443 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 330' ' ' VAL . 40.8 t -79.35 142.96 59.19 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.78 -0.575 . . . . 0.0 109.947 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 331' ' ' LYS . 47.3 Cg_endo . . . . . 0 C--N 1.313 -1.321 0 O-C-N 123.742 1.39 . . . . 0.0 110.425 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.546 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 49.9 Cg_endo . . . . . 0 N--CA 1.479 0.674 0 CA-C-O 121.205 0.419 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.681 ' HE3' ' NE2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -80.82 108.86 14.84 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.471 -0.892 . . . . 0.0 108.937 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.617 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 52.8 mt-10 -123.47 -161.96 1.01 Allowed 'General case' 0 C--N 1.274 -2.686 0 O-C-N 121.825 -0.547 . . . . 0.0 109.748 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.424 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -88.01 130.01 35.1 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 110.381 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.811 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -149.26 158.65 44.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.526 -0.734 . . . . 0.0 110.852 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.783 ' O ' HG23 ' A' ' 304' ' ' VAL . 7.4 m-20 -98.65 117.32 32.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.566 -0.709 . . . . 0.0 110.206 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.598 HD12 HG21 ' A' ' 328' ' ' ILE . 13.4 mt -62.27 -23.85 66.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.169 -0.957 . . . . 0.0 109.845 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.495 ' OD1' HD23 ' A' ' 323' ' ' LEU . 44.0 t-20 -81.63 -22.27 37.71 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.177 -0.952 . . . . 0.0 109.114 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.403 ' O ' ' OE1' ' A' ' 307' ' ' GLU . . . -84.4 -30.31 25.48 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.629 -0.669 . . . . 0.0 109.664 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 300' ' ' ASP . 4.4 t -80.92 -34.46 13.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 109.608 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 79.2 mt -78.71 -27.48 44.94 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.398 -0.814 . . . . 0.0 110.623 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.4 -37.15 85.58 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.741 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 1.5 mp0 -76.21 -34.46 59.25 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.271 -1.135 . . . . 0.0 109.315 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.522 HG11 ' HB ' ' A' ' 341' ' ' VAL . 95.6 t -78.71 -19.59 13.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.534 -0.729 . . . . 0.0 109.443 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.534 HG13 HG11 ' A' ' 358' ' ' VAL . 0.1 OUTLIER -73.67 -43.51 54.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.422 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -90.44 -16.02 29.79 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.665 0.745 . . . . 0.0 109.139 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -53.9 -61.82 2.06 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.736 -0.603 . . . . 0.0 110.503 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -150.74 37.23 0.64 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.741 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.628 ' HB3' HD13 ' A' ' 319' ' ' ILE . 11.3 m -89.5 43.65 1.16 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.121 -0.987 . . . . 0.0 108.948 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 317' ' ' ARG . . . 63.18 44.35 97.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.484 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 19.7 m-30 48.82 38.0 11.04 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.0 -1.294 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 2.1 mt-10 69.38 56.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.329 -0.857 . . . . 0.0 110.006 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 314' ' ' GLY . 3.1 mmt180 -68.7 -92.11 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.787 0.803 . . . . 0.0 109.869 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 318' ' ' GLU . 15.6 pt-20 -126.55 58.05 1.41 Allowed 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.544 0.688 . . . . 0.0 109.741 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.774 HG23 HG23 ' A' ' 358' ' ' VAL . 3.5 mt -104.73 130.66 55.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 121.613 -0.679 . . . . 0.0 110.2 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -89.46 103.38 16.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 19.6 p -93.6 123.07 36.68 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 111.291 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.59 78.03 1.49 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 360' ' ' SER . 3.4 mp -90.47 144.84 25.41 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.517 -0.74 . . . . 0.0 110.5 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' LEU . 7.4 t80 -40.7 137.85 1.34 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.574 -0.704 . . . . 0.0 109.634 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -82.7 47.6 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.892 1.469 . . . . 0.0 110.791 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.464 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -159.8 13.59 0.19 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 3.3 p 60.05 116.33 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.997 -1.296 . . . . 0.0 109.638 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.598 HG21 HD12 ' A' ' 301' ' ' LEU . 2.7 mm -67.77 -179.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.737 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.562 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.8 mt-10 -171.25 105.76 0.23 Allowed 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.632 0.73 . . . . 0.0 110.644 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.945 HG12 HG22 ' A' ' 438' ' ' VAL . 12.1 m -149.98 163.95 3.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-O 121.597 0.713 . . . . 0.0 110.343 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.2 tptm -79.59 91.44 5.2 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.811 ' HG3' ' HB3' ' A' ' 299' ' ' ALA . 11.1 ptm -140.56 158.9 43.31 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 110.613 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.547 ' NE2' ' HB2' ' A' ' 335' ' ' LEU . 18.1 t-160 -88.96 113.29 55.44 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 40.0 Cg_endo -64.19 -19.4 65.91 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.59 1.31 . . . . 0.0 109.894 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.547 ' HB2' ' NE2' ' A' ' 333' ' ' HIS . 0.2 OUTLIER -78.14 -53.65 7.14 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 109.995 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 60.3 p -64.72 -36.25 83.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 0.0 109.937 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.748 HD11 ' CE1' ' A' ' 416' ' ' HIS . 10.1 mm -75.1 -35.99 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.114 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 0.4 OUTLIER -57.04 -50.57 72.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.971 -1.081 . . . . 0.0 108.984 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -27.29 61.14 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.636 -0.665 . . . . 0.0 109.747 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 1.06 ' HB2' HD13 ' A' ' 412' ' ' ILE . . . -60.25 -49.58 77.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.149 -0.97 . . . . 0.0 110.183 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.522 ' HB ' HG11 ' A' ' 308' ' ' VAL . 21.5 t -77.47 -35.4 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.0 109.952 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.429 ' O ' ' HB ' ' A' ' 346' ' ' VAL . . . -59.32 -27.05 65.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.848 . . . . 0.0 110.299 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . 0.506 ' O ' HG12 ' A' ' 346' ' ' VAL . 0.5 OUTLIER -85.37 -19.94 30.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.477 ' SD ' HG21 ' A' ' 432' ' ' ILE . 0.8 OUTLIER -84.88 -33.09 22.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 7.9 p -87.75 -24.2 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.224 -0.922 . . . . 0.0 110.322 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 343' ' ' ASN . 7.6 p -65.01 -20.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.154 -0.966 . . . . 0.0 110.234 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.12 -58.84 4.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -69.05 -31.16 69.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 110.175 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.94 66.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 109.985 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.32 -41.25 49.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -62.45 1.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.217 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 111.92 -41.71 2.16 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -88.65 83.59 6.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -1.17 . . . . 0.0 110.225 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 374' ' ' ASP . . . 177.57 101.86 0.15 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.588 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.2 OUTLIER -51.56 139.41 20.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.225 -1.161 . . . . 0.0 110.355 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.719 HD12 HG13 ' A' ' 319' ' ' ILE . 17.0 mt -111.75 167.84 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.749 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.588 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 39.9 tttt -148.56 114.97 5.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.951 -1.093 . . . . 0.0 111.12 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.774 HG23 HG23 ' A' ' 319' ' ' ILE . 21.7 t -119.24 78.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 109.25 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 95.5 p -110.68 135.24 51.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 110.357 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.511 ' HB3' ' HG ' ' A' ' 323' ' ' LEU . 0.0 OUTLIER -121.33 149.13 43.4 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 109.794 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.526 ' C ' HG22 ' A' ' 362' ' ' THR . . . -147.48 -165.07 11.6 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -175.81 162.64 2.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.961 -1.317 . . . . 0.0 111.32 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 1.2 mt-10 -126.63 174.21 4.4 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 50.5 Cg_endo -77.63 31.11 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.453 1.239 . . . . 0.0 111.488 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.557 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 11.9 p-10 177.88 26.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.069 -1.02 . . . . 0.0 110.766 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 24.4 ptt180 160.61 115.15 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 121.224 0.535 . . . . 0.0 109.861 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.587 ' H ' HG23 ' A' ' 438' ' ' VAL . . . -96.23 166.47 11.72 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.145 -0.972 . . . . 0.0 109.26 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 61.9 p-90 -161.09 148.62 15.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.736 -1.228 . . . . 0.0 111.147 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.554 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 30.2 p90 -122.84 136.33 54.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.42 -0.8 . . . . 0.0 109.732 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.5 ' HG3' ' HA ' ' A' ' 433' ' ' ARG . 1.9 tt0 -112.23 137.42 50.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.375 -0.828 . . . . 0.0 111.481 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 54.3 t -131.93 107.51 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -109.71 158.22 18.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.071 -1.018 . . . . 0.0 110.664 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 5.5 p-10 -168.97 132.33 1.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.374 -0.829 . . . . 0.0 110.15 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.486 ' O ' ' HA3' ' A' ' 354' ' ' GLY . 5.9 m-20 -107.93 154.38 21.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 110.361 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -169.77 -115.09 0.32 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.47 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.789 1.415 . . . . 0.0 110.427 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 172.21 -161.86 33.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.848 HD11 HD11 ' A' ' 430' ' ' LEU . 16.1 mt -131.17 154.67 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -1.205 . . . . 0.0 111.219 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.82 150.38 88.4 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.534 -0.729 . . . . 0.0 109.081 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.38 -22.76 28.78 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 O-C-N 123.84 1.442 . . . . 0.0 110.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -91.09 -26.77 18.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.3 -0.875 . . . . 0.0 111.363 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -88.81 -29.36 19.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.052 -1.03 . . . . 0.0 110.761 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -19.43 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.049 -1.032 . . . . 0.0 110.394 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 385' ' ' HIS . 12.2 mmtt -82.48 -34.44 28.04 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.377 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.571 ' N ' ' ND1' ' A' ' 385' ' ' HIS . 0.1 OUTLIER -107.24 -74.03 0.67 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.243 -0.91 . . . . 0.0 110.743 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' A' ' 385' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.498 1.958 0 O-C-N 121.806 -0.559 . . . . 0.0 111.51 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.482 HG21 ' OE1' ' A' ' 410' ' ' GLN . 23.6 mm . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.252 0.548 . . . . 0.0 110.062 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.638 ' HA ' HD12 ' A' ' 412' ' ' ILE . 17.4 t -39.51 -56.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.259 -0.901 . . . . 0.0 111.196 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.564 ' O ' ' CB ' ' A' ' 414' ' ' ASP . 7.8 pt20 -48.7 -52.04 25.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.14 -0.975 . . . . 0.0 111.688 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.2 OUTLIER -68.8 -20.72 64.34 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.75 -1.219 . . . . 0.0 111.274 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 1.06 HD13 ' HB2' ' A' ' 340' ' ' ALA . 16.9 mt -73.94 -75.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.88 -1.138 . . . . 0.0 108.679 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 419' ' ' MET . 21.4 t -54.29 -21.07 5.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.488 -0.757 . . . . 0.0 109.661 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 21.0 t0 -77.34 -40.32 44.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.143 -0.973 . . . . 0.0 109.864 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 0.8 OUTLIER -68.36 -20.36 64.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.284 -0.885 . . . . 0.0 109.65 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.748 ' CE1' HD11 ' A' ' 337' ' ' ILE . 25.5 m80 -80.36 -26.38 38.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.379 -0.826 . . . . 0.0 110.01 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 2.1 t30 79.43 47.97 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.544 0.688 . . . . 0.0 110.445 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.555 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -118.23 -86.45 1.11 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.572 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.2 OUTLIER 179.14 161.75 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.358 -1.084 . . . . 0.0 111.259 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 410' ' ' GLN . 13.3 tp -152.55 101.53 2.65 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.338 -0.851 . . . . 0.0 108.82 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -111.46 136.41 50.66 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 120.839 -1.163 . . . . 0.0 112.405 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.46 93.42 5.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.711 0.767 . . . . 0.0 109.317 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 430' ' ' LEU . . . -60.73 141.96 48.17 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 54.7 m . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.389 -1.065 . . . . 0.0 110.396 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.848 HD11 HD11 ' A' ' 378' ' ' ILE . 2.7 mp -99.49 110.62 23.07 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.947 -1.325 . . . . 0.0 113.129 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.454 ' OG ' ' HA3' ' A' ' 423' ' ' GLY . 0.1 OUTLIER -113.43 111.64 22.29 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.495 ' O ' ' CG ' ' A' ' 370' ' ' GLN . 21.4 mm -87.52 125.78 41.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 120.723 -1.236 . . . . 0.0 112.9 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . 0.5 ' HA ' ' HG3' ' A' ' 370' ' ' GLN . 0.0 OUTLIER -118.8 85.9 2.45 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.554 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.95 131.9 35.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.471 -0.768 . . . . 0.0 110.703 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 81.3 m95 -112.79 154.04 26.85 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.245 1.021 . . . . 0.0 111.959 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 416' ' ' HIS . 17.8 mt -143.46 117.0 6.01 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.555 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 42.2 Cg_endo -68.41 143.99 59.93 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 O-C-N 123.549 1.289 . . . . 0.0 111.284 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.945 HG22 HG12 ' A' ' 330' ' ' VAL . 76.3 t -103.98 90.37 2.95 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.659 -0.651 . . . . 0.0 110.35 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 47.2 Cg_endo . . . . . 0 C--N 1.307 -1.62 0 O-C-N 123.961 1.506 . . . . 0.0 110.09 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.632 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 52.6 Cg_endo . . . . . 0 C--O 1.215 -0.631 0 N-CA-C 110.522 -0.607 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.625 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.4 OUTLIER -94.69 107.65 19.65 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 122.152 0.977 . . . . 0.0 108.37 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.639 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.2 mm-40 -123.37 -159.73 0.87 Allowed 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.835 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.62 137.37 32.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 0.0 110.918 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -156.44 153.26 28.56 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.411 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 304' ' ' VAL . 5.2 m-20 -88.22 114.67 25.07 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.921 HD11 ' CD1' ' A' ' 436' ' ' LEU . 4.8 mt -64.09 -24.88 67.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 0.0 110.599 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.625 ' CA ' HD23 ' A' ' 323' ' ' LEU . 48.5 p-10 -81.0 -19.9 42.99 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.706 -1.246 . . . . 0.0 109.033 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.513 ' N ' ' OD1' ' A' ' 302' ' ' ASN . . . -87.96 -27.75 21.9 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.577 0.703 . . . . 0.0 109.225 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.806 ' O ' HG23 ' A' ' 308' ' ' VAL . 90.4 t -78.85 -36.95 19.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.554 -0.716 . . . . 0.0 109.623 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 84.4 mt -76.34 -35.38 58.76 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.404 -0.81 . . . . 0.0 110.321 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -65.29 -26.59 71.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 2.8 mt-10 -84.14 -32.85 24.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.235 -1.156 . . . . 0.0 109.713 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.854 HG11 HG12 ' A' ' 341' ' ' VAL . 48.0 t -75.75 -21.4 15.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.385 -0.822 . . . . 0.0 109.121 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 1.074 HD11 ' CG1' ' A' ' 358' ' ' VAL . 17.1 mt -78.74 -53.49 13.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 122.109 0.957 . . . . 0.0 108.673 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 315' ' ' TYR . . . -68.21 -15.67 63.67 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.214 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -78.32 -59.17 2.89 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.753 -0.592 . . . . 0.0 111.931 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -118.36 32.84 5.93 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.022 -1.071 . . . . 0.0 112.348 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.561 ' HB3' ' CD1' ' A' ' 319' ' ' ILE . 1.0 OUTLIER -129.04 44.34 2.99 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.923 -1.111 . . . . 0.0 109.777 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 59.13 22.32 55.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 310' ' ' ALA . 0.3 OUTLIER 60.32 55.18 3.65 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.392 -1.064 . . . . 0.0 109.989 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.525 ' OE1' ' CA ' ' A' ' 316' ' ' GLU . 0.5 OUTLIER 66.7 35.77 5.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.122 -0.986 . . . . 0.0 109.741 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -48.18 62.58 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.899 0.857 . . . . 0.0 109.917 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -150.28 57.05 0.95 Allowed 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 121.51 0.671 . . . . 0.0 110.213 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 1.001 HG13 HD12 ' A' ' 356' ' ' ILE . 2.7 mp -127.47 131.43 70.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 109.795 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -90.24 105.41 17.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.077 -1.014 . . . . 0.0 109.595 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.747 HG22 HD13 ' A' ' 309' ' ' ILE . 17.3 p -90.03 120.51 31.29 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.393 -0.817 . . . . 0.0 110.721 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -140.34 77.45 1.61 Allowed 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.467 -0.77 . . . . 0.0 108.974 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.625 HD23 ' CA ' ' A' ' 302' ' ' ASN . 1.1 mp -92.0 163.18 14.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.618 -0.676 . . . . 0.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 5.4 t80 -49.01 131.77 15.2 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.224 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 324' ' ' TYR . 50.9 Cg_endo -84.74 52.79 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.951 1.501 . . . . 0.0 110.186 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -162.97 22.42 0.18 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 326' ' ' GLY . 15.6 p 53.04 104.65 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.338 -1.095 . . . . 0.0 110.15 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.769 HG23 HG21 ' A' ' 362' ' ' THR . 1.3 mt -74.6 -178.17 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.45 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.622 ' H ' HG22 ' A' ' 328' ' ' ILE . 5.1 mt-10 -169.8 103.12 0.32 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.611 0.72 . . . . 0.0 110.77 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.721 HG11 ' HB3' ' A' ' 367' ' ' ALA . 31.1 m -137.2 153.53 29.3 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.127 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -73.31 97.73 2.54 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.756 ' SD ' HD21 ' A' ' 301' ' ' LEU . 5.9 ttp -137.27 166.12 24.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.13 -0.981 . . . . 0.0 112.105 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.632 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 22.4 t-160 -103.26 113.86 65.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.523 ' O ' ' CG ' ' A' ' 338' ' ' LYS . 38.3 Cg_endo -63.11 -22.43 73.17 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.635 1.334 . . . . 0.0 111.904 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.674 ' C ' HD12 ' A' ' 335' ' ' LEU . 0.7 OUTLIER -83.54 -56.61 3.64 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.664 -1.273 . . . . 0.0 110.601 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 51.5 p -61.96 -38.15 87.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.134 -0.979 . . . . 0.0 110.636 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.793 HD11 ' CE1' ' A' ' 416' ' ' HIS . 23.1 mm -76.24 -33.93 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.11 -0.994 . . . . 0.0 110.157 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 334' ' ' PRO . 4.7 mttt -59.89 -36.25 76.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -42.93 60.26 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.032 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.816 ' CB ' HG21 ' A' ' 412' ' ' ILE . . . -61.54 -35.11 76.83 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.359 -0.838 . . . . 0.0 110.616 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.854 HG12 HG11 ' A' ' 308' ' ' VAL . 50.7 t -76.12 -34.13 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.207 -0.933 . . . . 0.0 109.646 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.755 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -70.66 -22.38 62.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 0.0 109.805 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -80.29 -23.75 40.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 109.969 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.556 ' SD ' HG21 ' A' ' 432' ' ' ILE . 7.8 mtt -85.0 -41.61 15.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.406 -0.809 . . . . 0.0 110.215 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.46 -22.79 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.885 . . . . 0.0 110.509 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 342' ' ' ALA . 65.3 t -74.16 -24.84 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.101 -0.999 . . . . 0.0 110.16 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -81.63 -31.06 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 110.248 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -89.54 -24.93 21.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 110.197 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -74.53 -39.43 62.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 110.031 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.71 -70.15 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -48.66 -59.08 3.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -87.45 142.56 18.08 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -139.79 81.27 1.81 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -1.103 . . . . 0.0 110.187 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -159.59 -48.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.57 ' CH2' ' HB2' ' A' ' 357' ' ' LYS . 1.4 t90 -178.65 141.9 0.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.25 . . . . 0.0 110.232 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 1.001 HD12 HG13 ' A' ' 319' ' ' ILE . 3.5 mt -107.23 163.16 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.73 . . . . 0.0 109.746 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.57 ' HB2' ' CH2' ' A' ' 355' ' ' TRP . 0.1 OUTLIER -140.73 93.69 2.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 0.0 109.957 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 1.074 ' CG1' HD11 ' A' ' 309' ' ' ILE . 37.7 t -97.15 105.01 16.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.139 -0.976 . . . . 0.0 109.784 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.2 t -124.88 160.1 29.6 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 110.992 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.55 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.4 t -142.92 130.47 21.26 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.602 -0.686 . . . . 0.0 109.212 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.567 ' C ' HG22 ' A' ' 362' ' ' THR . . . -123.76 -174.36 14.16 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.769 HG21 HG23 ' A' ' 328' ' ' ILE . 0.1 OUTLIER 170.13 163.74 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -1.106 . . . . 0.0 110.801 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.569 ' HB3' ' CD ' ' A' ' 364' ' ' PRO . 3.0 mt-10 -136.64 -168.87 0.2 Allowed Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.569 ' CD ' ' HB3' ' A' ' 363' ' ' GLU . 48.2 Cg_endo -84.79 31.04 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.21 1.11 . . . . 0.0 110.742 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 366' ' ' ARG . 57.3 t-20 -178.64 27.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 0.0 110.795 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.7 OUTLIER 165.63 107.1 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.156 -0.965 . . . . 0.0 111.149 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.721 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -106.63 137.89 43.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.277 -0.889 . . . . 0.0 109.214 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.687 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 64.6 p-90 -140.55 154.78 46.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.876 -1.14 . . . . 0.0 110.655 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.417 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 53.4 p90 -127.28 138.75 53.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.328 -0.857 . . . . 0.0 109.457 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 432' ' ' ILE . 2.9 pt20 -126.99 165.38 19.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.178 -0.951 . . . . 0.0 111.673 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 431' ' ' SER . 3.1 t -141.66 125.78 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.461 ' HG2' ' N ' ' A' ' 373' ' ' ASP . 30.0 tt0 -124.33 155.2 39.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.752 -1.217 . . . . 0.0 110.598 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.461 ' N ' ' HG2' ' A' ' 372' ' ' GLU . 2.4 p30 -148.14 148.26 30.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.407 -0.808 . . . . 0.0 110.492 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -86.5 95.15 9.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.2 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 168.86 162.94 22.02 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.07 124.59 10.17 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.014 1.534 . . . . 0.0 110.02 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -114.14 -90.86 1.81 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.867 HG13 HD11 ' A' ' 430' ' ' LEU . 65.7 mt -66.5 165.85 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.234 -1.156 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.957 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -128.97 178.91 1.45 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.253 -0.904 . . . . 0.0 110.003 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.957 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 43.1 Cg_endo -71.05 -48.92 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.94 1.495 . . . . 0.0 109.653 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . 0.427 ' OE2' ' HG2' ' A' ' 380' ' ' PRO . 1.4 mp0 -91.04 -19.87 22.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.423 -0.798 . . . . 0.0 110.393 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.785 ' HB3' ' HB3' ' A' ' 379' ' ' ALA . 59.0 tt0 -81.16 -19.44 43.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.34 -0.85 . . . . 0.0 110.919 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -27.69 61.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.067 -1.02 . . . . 0.0 110.646 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -86.81 -19.07 29.54 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.13 -0.981 . . . . 0.0 110.546 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.594 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 8.4 m170 -48.18 -56.88 6.8 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.287 -0.883 . . . . 0.0 111.492 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.008 0 O-C-N 120.96 -1.087 . . . . 0.0 111.342 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.438 ' O ' HG12 ' A' ' 412' ' ' ILE . 1.3 pt . . . . . 0 N--CA 1.498 1.95 0 CA-C-O 121.05 0.452 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.401 ' O ' ' HB ' ' A' ' 412' ' ' ILE . 41.0 t -65.7 -18.43 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.395 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -62.34 -61.53 2.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.479 -0.763 . . . . 0.0 110.097 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.485 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.3 OUTLIER -54.23 -23.63 15.49 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.351 -0.843 . . . . 0.0 110.559 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.816 HG21 ' CB ' ' A' ' 340' ' ' ALA . 29.6 mm -68.18 -59.93 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.237 -0.914 . . . . 0.0 108.718 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 420' ' ' LEU . 38.2 t -67.55 -19.15 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.458 -0.776 . . . . 0.0 109.43 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.485 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 7.1 t70 -84.24 -25.33 29.52 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.52 -0.738 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.52 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.4 m120 -75.3 -23.63 57.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.793 ' CE1' HD11 ' A' ' 337' ' ' ILE . 45.1 m80 -95.75 -36.84 11.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.268 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.1 OUTLIER 80.04 57.1 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 121.435 0.636 . . . . 0.0 110.838 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.56 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -123.53 -84.66 0.66 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.549 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.7 OUTLIER -179.3 165.99 1.46 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.133 . . . . 0.0 111.556 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.528 ' HB2' HG11 ' A' ' 413' ' ' VAL . 15.1 tp -152.22 83.2 1.26 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.437 ' OE1' ' HA ' ' A' ' 421' ' ' GLU . 4.1 mm-40 -101.0 166.51 10.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.915 -1.116 . . . . 0.0 111.643 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.7 HD23 HD11 ' A' ' 378' ' ' ILE . 1.0 OUTLIER -123.85 123.63 40.88 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.57 0.7 . . . . 0.0 110.231 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.437 ' O ' ' OG1' ' A' ' 424' ' ' THR . . . -125.98 151.66 17.89 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 91.8 m . . . . . 0 N--CA 1.49 1.56 0 O-C-N 120.874 -1.368 . . . . 0.0 111.715 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.495 2.599 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.867 HD11 HG13 ' A' ' 378' ' ' ILE . 1.7 tt -76.79 152.78 35.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.031 -1.276 . . . . 0.0 110.287 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.688 ' N ' HD23 ' A' ' 430' ' ' LEU . 53.4 p -159.7 127.27 4.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.572 -0.705 . . . . 0.0 110.126 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.556 HG21 ' SD ' ' A' ' 344' ' ' MET . 18.1 mm -90.1 134.89 27.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 85.96 2.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.483 -0.761 . . . . 0.0 109.522 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.417 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -88.68 138.43 31.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.265 -0.897 . . . . 0.0 109.87 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.687 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.4 m95 -117.81 154.6 31.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 122.458 1.123 . . . . 0.0 113.067 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.921 ' CD1' HD11 ' A' ' 301' ' ' LEU . 7.9 mt -142.08 114.9 6.46 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.56 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 47.5 Cg_endo -71.07 138.77 34.34 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 O-C-N 123.572 1.301 . . . . 0.0 112.628 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.632 HG22 HG12 ' A' ' 330' ' ' VAL . 7.0 t -112.25 64.75 0.73 Allowed Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 42.2 Cg_endo . . . . . 0 C--N 1.308 -1.604 0 O-C-N 123.924 1.486 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.618 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 48.9 Cg_endo . . . . . 0 C--O 1.215 -0.673 0 N-CA-C 110.633 -0.564 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.602 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -96.58 108.62 21.24 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.602 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.1 mt-10 -138.09 -152.55 0.43 Allowed 'General case' 0 C--N 1.276 -2.621 0 O-C-N 121.818 -0.551 . . . . 0.0 109.604 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.678 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 1.5 mmt -88.4 141.12 28.8 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 110.594 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.594 ' HB3' ' HE3' ' A' ' 332' ' ' MET . . . -154.15 157.82 39.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.396 -0.815 . . . . 0.0 110.985 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.918 ' O ' HG23 ' A' ' 304' ' ' VAL . 3.1 m-20 -90.85 117.23 29.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.41 -0.807 . . . . 0.0 110.059 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.526 HD11 ' CD1' ' A' ' 436' ' ' LEU . 8.4 mt -67.19 -24.17 65.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 110.015 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.607 ' OD1' HD23 ' A' ' 323' ' ' LEU . 9.0 t30 -84.77 -22.94 29.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.871 -1.143 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -83.72 -29.78 27.25 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.43 -0.794 . . . . 0.0 109.334 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 300' ' ' ASP . 19.3 t -78.7 -40.06 23.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.573 -0.705 . . . . 0.0 109.309 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.606 ' CD2' HG21 ' A' ' 341' ' ' VAL . 81.4 mt -72.62 -30.14 64.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.49 -0.756 . . . . 0.0 110.594 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 309' ' ' ILE . . . -61.03 -36.0 91.63 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -33.7 57.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.323 -1.104 . . . . 0.0 109.419 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.816 HG11 HG12 ' A' ' 341' ' ' VAL . 74.5 t -75.0 -18.93 16.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.505 -0.747 . . . . 0.0 109.244 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 1.068 ' CG1' HG11 ' A' ' 358' ' ' VAL . 5.0 mt -77.16 -46.16 29.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.96 -16.65 63.79 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.626 0.727 . . . . 0.0 109.482 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -74.92 -58.74 3.09 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.677 -0.639 . . . . 0.0 110.542 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.535 ' HB2' ' CG1' ' A' ' 345' ' ' VAL . 2.5 mm-40 -111.12 46.13 1.11 Allowed 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.753 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.643 ' HA ' ' CD1' ' A' ' 319' ' ' ILE . 0.6 OUTLIER -79.1 18.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.331 -0.855 . . . . 0.0 111.302 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 53.34 53.51 34.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 22.5 m-30 46.66 43.07 12.3 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.37 -1.076 . . . . 0.0 110.222 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.3 OUTLIER 65.12 35.92 7.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.906 -1.121 . . . . 0.0 109.667 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.576 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -69.06 -73.24 0.16 Allowed 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.552 -0.718 . . . . 0.0 109.786 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.576 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.2 mt-10 -167.91 78.63 0.16 Allowed 'General case' 0 C--N 1.27 -2.88 0 CA-C-O 121.548 0.689 . . . . 0.0 111.235 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.721 ' CG2' HG23 ' A' ' 358' ' ' VAL . 4.2 mm -97.05 121.99 48.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.764 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.486 ' HB3' ' HG3' ' A' ' 357' ' ' LYS . 0.4 OUTLIER -88.73 101.41 13.98 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 108.462 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 16.7 p -90.28 128.28 36.38 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.779 0.8 . . . . 0.0 111.951 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.98 78.15 1.34 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.607 HD23 ' OD1' ' A' ' 302' ' ' ASN . 5.0 mp -96.94 170.91 8.83 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.462 -0.774 . . . . 0.0 110.334 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.661 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 27.8 t80 -63.22 126.1 88.47 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.321 -0.862 . . . . 0.0 109.925 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.402 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.9 Cg_endo -78.71 71.06 7.1 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.938 1.494 . . . . 0.0 110.7 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 172.73 30.35 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.446 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 326' ' ' GLY . 1.7 p 45.99 100.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.162 -1.199 . . . . 0.0 110.499 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.637 HG22 ' H ' ' A' ' 329' ' ' GLU . 1.7 mt -71.12 -177.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 O-C-N 121.507 -0.746 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.637 ' H ' HG22 ' A' ' 328' ' ' ILE . 4.9 mt-10 -167.34 107.65 0.6 Allowed 'General case' 0 C--N 1.289 -2.034 0 O-C-N 121.391 -0.818 . . . . 0.0 111.259 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.678 ' C ' ' HE2' ' A' ' 298' ' ' MET . 7.7 m -137.49 157.45 34.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-O 121.494 0.664 . . . . 0.0 109.97 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 11.2 tptt -78.04 92.5 4.37 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.594 ' HE3' ' HB3' ' A' ' 299' ' ' ALA . 3.0 tmm? -150.03 158.74 44.47 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 110.761 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.625 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 6.5 t-160 -91.07 126.6 54.66 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.566 ' HD2' ' CD2' ' A' ' 333' ' ' HIS . 39.1 Cg_endo -61.87 -19.83 67.11 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 123.527 1.277 . . . . 0.0 109.95 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.625 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 4.4 mt -75.73 -57.85 3.64 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.375 -0.828 . . . . 0.0 109.886 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.401 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 25.3 p -52.91 -47.67 67.81 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.588 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.529 ' CG1' ' HG3' ' A' ' 332' ' ' MET . 24.1 mm -63.44 -32.15 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.069 -1.02 . . . . 0.0 110.473 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 43.2 mttt -60.69 -40.31 91.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.12 -0.987 . . . . 0.0 109.546 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -42.12 65.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.802 -0.561 . . . . 0.0 111.223 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.736 ' HA ' HG12 ' A' ' 409' ' ' VAL . . . -67.2 -30.9 70.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.229 -0.92 . . . . 0.0 111.088 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.816 HG12 HG11 ' A' ' 308' ' ' VAL . 43.0 t -90.31 -25.4 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.525 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.67 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -82.99 -20.22 35.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 110.469 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -88.49 -19.4 26.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.144 -0.973 . . . . 0.0 110.613 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.745 ' SD ' HG21 ' A' ' 432' ' ' ILE . 58.2 mtt -78.21 -36.6 46.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.224 -0.923 . . . . 0.0 110.56 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 312' ' ' GLU . 12.2 p -88.57 -23.58 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.314 -0.866 . . . . 0.0 111.045 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 342' ' ' ALA . 12.1 t -66.19 -19.57 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.997 -1.065 . . . . 0.0 110.348 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -79.74 -33.73 40.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.452 ' O ' ' HA3' ' A' ' 352' ' ' GLY . . . -88.41 -27.79 21.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.083 -1.011 . . . . 0.0 110.751 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.31 -29.61 65.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.154 -0.966 . . . . 0.0 111.329 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 15.7 mtt-85 -77.83 -66.91 0.78 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.995 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 351' ' ' TYR . 13.4 m-30 -90.22 -19.85 23.7 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.149 -0.969 . . . . 0.0 111.129 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 353' ' ' ASN . . . -76.76 -98.15 0.17 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.33 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 352' ' ' GLY . 2.1 t30 76.56 46.7 0.08 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.459 -1.024 . . . . 0.0 109.92 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -130.49 -78.0 0.18 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -137.36 127.8 26.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -1.096 . . . . 0.0 109.687 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.543 ' HB ' HD13 ' A' ' 319' ' ' ILE . 44.9 mt -115.11 159.11 15.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 108.816 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.517 ' CD ' ' HB2' ' A' ' 372' ' ' GLU . 4.2 tttp -148.0 117.51 7.0 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.838 -1.164 . . . . 0.0 111.338 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 1.068 HG11 ' CG1' ' A' ' 309' ' ' ILE . 20.8 t -109.78 135.13 49.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.505 ' HA ' HD12 ' A' ' 323' ' ' LEU . 43.4 t -157.59 164.1 37.63 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.746 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -164.56 132.55 3.35 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -136.15 -163.72 10.0 Favored Glycine 0 C--N 1.29 -2.017 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.661 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.2 OUTLIER -160.02 166.47 29.91 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.277 -1.131 . . . . 0.0 110.417 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.578 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -146.24 -175.88 0.51 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 39.1 Cg_endo -64.93 111.03 1.61 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.449 1.236 . . . . 0.0 110.501 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.544 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 16.9 m120 59.34 40.72 20.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.732 -0.605 . . . . 0.0 110.795 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 1.4 mtt85 -176.83 98.42 0.05 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.156 -0.965 . . . . 0.0 111.192 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -97.53 171.6 8.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.135 -0.978 . . . . 0.0 108.391 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.608 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 22.7 p-90 -171.35 160.8 6.26 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.343 -1.473 . . . . 0.0 111.373 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 53.7 p90 -137.85 132.61 32.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.517 -0.74 . . . . 0.0 109.24 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.603 ' HG3' ' CZ3' ' A' ' 368' ' ' TRP . 22.9 mt-30 -121.53 168.78 11.34 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.06 -1.025 . . . . 0.0 112.353 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.471 ' HB ' HG22 ' A' ' 432' ' ' ILE . 65.2 t -140.08 148.92 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.517 ' HB2' ' CD ' ' A' ' 357' ' ' LYS . 9.1 mt-10 -147.05 148.15 31.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.061 -1.024 . . . . 0.0 110.429 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 0.5 OUTLIER -165.28 163.65 20.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.287 -0.883 . . . . 0.0 110.239 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -107.92 62.69 0.61 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.214 -0.928 . . . . 0.0 110.428 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -87.46 -148.5 14.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.29 -43.52 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.051 1.553 . . . . 0.0 110.211 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 112.05 -176.69 18.22 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.696 ' CD1' HD21 ' A' ' 430' ' ' LEU . 0.8 OUTLIER -99.14 134.68 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.115 -1.227 . . . . 0.0 109.551 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' A' ' 382' ' ' GLN . . . -50.11 165.3 0.33 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.454 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 47.1 Cg_endo -72.67 -38.9 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.079 1.568 . . . . 0.0 111.456 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . 0.475 ' O ' ' CD2' ' A' ' 385' ' ' HIS . 0.7 OUTLIER -89.33 -45.13 9.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.028 -1.045 . . . . 0.0 110.662 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.645 ' HB3' ' HB3' ' A' ' 379' ' ' ALA . 16.6 tt0 -56.52 -18.43 11.58 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -50.44 -33.04 19.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.131 -0.98 . . . . 0.0 109.802 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -90.22 -20.07 23.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.324 -0.86 . . . . 0.0 109.692 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.627 ' CD2' ' N ' ' A' ' 385' ' ' HIS . 1.4 m170 -96.05 25.15 4.99 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.66 HD13 HG21 ' A' ' 378' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.49 0 O-C-N 121.592 -0.692 . . . . 0.0 111.611 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.554 ' CD1' ' HG3' ' A' ' 410' ' ' GLN . 21.1 tt . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.331 0.586 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.736 HG12 ' HA ' ' A' ' 340' ' ' ALA . 32.8 m -56.36 -25.03 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.398 -0.814 . . . . 0.0 110.501 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.554 ' HG3' ' CD1' ' A' ' 408' ' ' ILE . 2.7 mt-30 -51.41 -43.52 62.0 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.192 -0.942 . . . . 0.0 109.761 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -28.8 66.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.476 -0.765 . . . . 0.0 110.301 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.661 HG12 ' HB2' ' A' ' 340' ' ' ALA . 1.5 mp -70.11 -63.04 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.194 -0.941 . . . . 0.0 108.802 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.899 HG11 ' HB2' ' A' ' 420' ' ' LEU . 59.5 t -62.6 -23.55 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 23.1 t70 -80.33 -29.95 38.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -80.84 -28.33 36.17 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.451 -0.781 . . . . 0.0 109.5 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.602 ' CD2' ' CE ' ' A' ' 296' ' ' MET . 39.1 m80 -86.95 -34.81 19.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.525 -0.735 . . . . 0.0 109.726 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.0 OUTLIER 75.42 31.57 0.77 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.558 -0.714 . . . . 0.0 111.096 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.536 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -95.9 -83.51 1.65 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.584 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.4 OUTLIER -178.86 161.02 1.17 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -1.053 . . . . 0.0 110.671 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.899 ' HB2' HG11 ' A' ' 413' ' ' VAL . 67.2 tp -150.87 93.86 2.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.985 -1.072 . . . . 0.0 109.976 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.557 ' O ' ' CG ' ' A' ' 433' ' ' ARG . 37.3 mt-10 -125.0 140.47 52.89 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.081 -1.012 . . . . 0.0 109.973 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.792 HD13 HD11 ' A' ' 430' ' ' LEU . 0.6 OUTLIER -121.91 150.68 41.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.908 -1.12 . . . . 0.0 111.569 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 424' ' ' THR . . . -135.24 -165.82 10.87 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.769 HG22 ' C ' ' A' ' 429' ' ' GLY . 7.3 m . . . . . 0 N--CA 1.49 1.562 0 O-C-N 120.584 -1.539 . . . . 0.0 109.888 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.769 ' C ' HG22 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.492 2.383 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 422' ' ' LEU . 0.2 OUTLIER -153.52 149.4 27.65 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.084 -1.244 . . . . 0.0 109.397 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.649 ' H ' HD13 ' A' ' 430' ' ' LEU . 35.2 t -149.05 102.72 3.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.992 -1.068 . . . . 0.0 109.826 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.745 HG21 ' SD ' ' A' ' 344' ' ' MET . 9.6 tp -89.82 150.23 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 110.877 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . 0.557 ' CG ' ' O ' ' A' ' 421' ' ' GLU . 0.1 OUTLIER -133.98 106.06 7.05 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.646 -0.659 . . . . 0.0 109.67 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -96.57 146.3 24.95 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.413 -0.805 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.608 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 93.0 m95 -121.07 153.87 36.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.134 -0.979 . . . . 0.0 111.593 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.561 HD23 ' HB3' ' A' ' 416' ' ' HIS . 7.7 mt -141.12 124.73 10.09 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.536 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 43.5 Cg_endo -68.4 135.71 34.68 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.557 1.293 . . . . 0.0 111.266 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.458 HG22 HG12 ' A' ' 330' ' ' VAL . 3.2 t -104.13 106.91 55.51 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.931 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.306 -1.69 0 O-C-N 124.216 1.64 . . . . 0.0 109.945 -179.938 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.559 ' HG2' ' NE2' ' A' ' 333' ' ' HIS . 51.3 Cg_endo . . . . . 0 C--O 1.215 -0.643 0 CA-C-O 121.35 0.479 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.532 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -89.03 109.24 20.1 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.611 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 24.2 mt-10 -135.93 -157.13 0.77 Allowed 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.993 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.54 ' CG ' ' HE3' ' A' ' 331' ' ' LYS . 0.1 OUTLIER -87.64 141.91 28.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 0.0 110.624 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.564 ' HB3' ' HE3' ' A' ' 332' ' ' MET . . . -155.95 163.98 39.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.64 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.883 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.5 OUTLIER -101.58 114.65 28.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.339 -0.851 . . . . 0.0 110.471 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.624 HD12 HG21 ' A' ' 328' ' ' ILE . 14.3 mt -61.23 -25.03 66.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.84 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.73 ' OD1' HD23 ' A' ' 323' ' ' LEU . 40.4 t-20 -80.7 -23.7 39.35 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.197 -0.939 . . . . 0.0 109.365 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.76 -25.59 26.31 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 300' ' ' ASP . 5.5 t -83.69 -34.68 10.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.427 -0.795 . . . . 0.0 109.484 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 309' ' ' ILE . 59.3 mt -79.43 -28.37 41.7 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.346 -0.846 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.14 -35.85 91.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.785 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 4.3 mt-10 -80.67 -33.63 35.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.294 -1.121 . . . . 0.0 109.79 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 304' ' ' VAL . 27.7 t -77.29 -19.99 14.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.785 HD11 ' CG1' ' A' ' 358' ' ' VAL . 0.9 OUTLIER -76.11 -51.41 20.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.419 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -77.41 -15.41 59.37 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.404 -0.81 . . . . 0.0 109.456 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.785 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -70.72 -62.49 1.37 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.401 ' OE2' ' O ' ' A' ' 311' ' ' ALA . 9.8 mm-40 -123.05 31.08 6.13 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.586 -1.246 . . . . 0.0 113.351 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.662 ' O ' HD11 ' A' ' 319' ' ' ILE . 2.6 m -111.26 44.31 1.34 Allowed 'General case' 0 C--N 1.289 -2.052 0 O-C-N 120.641 -1.287 . . . . 0.0 108.964 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 69.8 26.52 74.3 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.496 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 4.8 m-85 59.24 47.7 11.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -1.046 . . . . 0.0 110.322 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 68.42 35.61 3.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.107 -0.996 . . . . 0.0 109.621 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 14.3 tpp85 -69.06 -81.36 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.642 0.734 . . . . 0.0 110.625 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 318' ' ' GLU . 4.3 pt-20 -126.58 72.93 1.36 Allowed 'General case' 0 C--N 1.275 -2.633 0 O-C-N 121.615 -0.678 . . . . 0.0 111.149 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.904 HG13 HD12 ' A' ' 356' ' ' ILE . 2.6 mp -132.6 138.19 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.002 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -99.48 103.88 15.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.846 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.513 HG22 HD13 ' A' ' 309' ' ' ILE . 35.7 p -89.73 122.04 32.45 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.257 -0.902 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -138.81 79.39 1.73 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.73 HD23 ' OD1' ' A' ' 302' ' ' ASN . 1.2 mp -88.66 150.28 23.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.478 -0.764 . . . . 0.0 110.386 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.572 ' HB3' ' CD1' ' A' ' 328' ' ' ILE . 36.6 t80 -37.21 145.3 0.27 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.599 -0.688 . . . . 0.0 109.928 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.547 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 51.7 Cg_endo -83.0 59.03 6.56 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 O-C-N 123.966 1.508 . . . . 0.0 110.444 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . 179.74 17.1 0.03 OUTLIER Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.738 -1.22 . . . . 0.0 111.242 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 2.0 m 58.47 115.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.666 -1.49 . . . . 0.0 110.018 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.624 HG21 HD12 ' A' ' 301' ' ' LEU . 2.0 mm -69.48 178.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.542 ' H ' HG22 ' A' ' 328' ' ' ILE . 4.9 mt-10 -170.87 106.09 0.26 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.609 0.719 . . . . 0.0 109.971 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.722 HG12 HG22 ' A' ' 438' ' ' VAL . 7.8 m -148.16 168.46 3.89 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-O 121.648 0.737 . . . . 0.0 110.539 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -85.09 94.26 8.81 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.576 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 4.7 tmm? -145.17 157.51 44.06 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 110.592 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.616 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 22.2 t-160 -82.79 111.65 31.26 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.449 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 37.9 Cg_endo -62.16 -19.3 66.14 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.717 1.377 . . . . 0.0 110.058 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.616 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -81.3 -47.21 13.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.937 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -65.06 -41.33 95.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.448 -0.782 . . . . 0.0 109.982 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.58 HD11 ' CE1' ' A' ' 416' ' ' HIS . 19.6 mm -71.3 -33.67 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.909 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.527 ' HG3' HG13 ' A' ' 304' ' ' VAL . 7.4 mttm -59.06 -60.94 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.706 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -37.15 86.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.482 -0.761 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.551 ' CB ' HG21 ' A' ' 412' ' ' ILE . . . -58.71 -35.56 72.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.92 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.553 HG12 ' CG1' ' A' ' 308' ' ' VAL . 48.2 t -88.33 -21.23 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 111.136 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 308' ' ' VAL . . . -77.61 -28.74 51.59 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.092 -1.005 . . . . 0.0 111.993 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . 0.428 HD21 ' HA ' ' A' ' 340' ' ' ALA . 21.9 p30 -89.7 -18.67 25.97 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.786 -1.196 . . . . 0.0 111.793 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.535 ' HG2' ' HA ' ' A' ' 341' ' ' VAL . 3.6 ptp -88.57 -20.93 24.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.73 -1.231 . . . . 0.0 111.077 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.432 ' N ' ' HG3' ' A' ' 344' ' ' MET . 8.2 p -90.6 -20.6 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.086 -1.009 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 342' ' ' ALA . 40.4 t -69.43 -20.16 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.047 -1.033 . . . . 0.0 110.994 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -63.83 -31.28 72.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.12 -0.987 . . . . 0.0 110.516 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.557 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -89.73 -21.3 22.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 110.738 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -82.26 -68.72 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.075 -1.015 . . . . 0.0 110.656 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -57.11 -66.9 0.38 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.191 -0.943 . . . . 0.0 110.702 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.53 -39.88 36.61 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.165 -0.959 . . . . 0.0 110.491 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -71.53 163.95 54.1 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -164.38 38.18 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.34 -1.094 . . . . 0.0 109.855 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -123.11 -67.14 0.22 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.6 OUTLIER -173.0 137.26 0.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.164 -1.197 . . . . 0.0 110.386 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.904 HD12 HG13 ' A' ' 319' ' ' ILE . 5.3 mt -107.52 167.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -0.76 . . . . 0.0 109.274 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 2.2 tttp -148.93 116.5 6.21 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.027 -1.045 . . . . 0.0 110.822 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.785 ' CG1' HD11 ' A' ' 309' ' ' ILE . 17.5 t -115.51 75.94 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 108.974 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.3 p -104.69 132.06 51.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.818 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.443 ' H ' HD12 ' A' ' 323' ' ' LEU . 28.8 t -122.0 163.58 19.11 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.55 -0.719 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.573 ' C ' HG22 ' A' ' 362' ' ' THR . . . -159.45 -153.37 6.82 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.573 HG22 ' C ' ' A' ' 361' ' ' GLY . 0.0 OUTLIER -179.65 171.38 1.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.43 -1.041 . . . . 0.0 109.901 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.568 ' CB ' ' CD ' ' A' ' 364' ' ' PRO . 3.8 mt-10 -131.91 -169.54 0.21 Allowed Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.193 -0.942 . . . . 0.0 109.809 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 363' ' ' GLU . 48.3 Cg_endo -84.74 30.0 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.447 0 O-C-N 123.582 1.306 . . . . 0.0 110.963 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 366' ' ' ARG . 3.8 p30 167.86 34.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.31 -0.869 . . . . 0.0 110.18 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 166.75 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.383 -0.823 . . . . 0.0 109.9 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.672 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -97.74 162.35 13.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.164 -0.96 . . . . 0.0 109.313 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.674 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 45.3 p-90 -167.31 171.65 10.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.706 -1.246 . . . . 0.0 111.005 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.6 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 20.3 p90 -141.8 143.3 33.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.226 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 0.1 OUTLIER -132.88 145.62 51.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.133 -0.979 . . . . 0.0 111.725 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 21.1 t -127.11 132.62 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -123.11 158.56 30.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.945 -1.097 . . . . 0.0 110.39 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 11.2 p-10 -150.88 140.25 21.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.366 -0.834 . . . . 0.0 110.215 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.41 177.38 9.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.335 -0.853 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 107.23 -158.6 14.99 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.17 163.0 40.04 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.947 1.499 . . . . 0.0 110.987 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . 0.434 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -105.52 -153.13 21.2 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.68 ' N ' HD13 ' A' ' 378' ' ' ILE . 1.6 mm -89.87 93.25 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.138 -1.213 . . . . 0.0 110.112 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.763 ' HB3' ' NE2' ' A' ' 382' ' ' GLN . . . -46.61 165.9 0.19 Allowed Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.808 -1.182 . . . . 0.0 109.233 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.489 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 46.6 Cg_endo -73.1 -19.55 22.72 Favored 'Trans proline' 0 C--N 1.294 -2.301 0 O-C-N 123.482 1.254 . . . . 0.0 110.231 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -84.4 -43.67 14.47 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.306 -0.871 . . . . 0.0 111.331 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.763 ' NE2' ' HB3' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -83.89 -34.69 24.49 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.087 -1.008 . . . . 0.0 111.189 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.623 ' CB ' HG22 ' A' ' 378' ' ' ILE . 0.0 OUTLIER -60.07 -19.61 53.91 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.684 -1.26 . . . . 0.0 109.572 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.475 ' HG2' ' HD2' ' A' ' 383' ' ' ARG . 33.2 mmtt -86.86 -23.64 25.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.554 -0.716 . . . . 0.0 110.61 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.627 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 0.3 OUTLIER -118.45 29.95 7.48 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.983 -1.073 . . . . 0.0 111.49 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 13.1 tp . . . . . 0 C--N 1.303 -1.43 0 O-C-N 121.027 -1.046 . . . . 0.0 108.713 -179.98 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 412' ' ' ILE . 7.1 tp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.367 0.603 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.645 ' HA ' HD13 ' A' ' 412' ' ' ILE . 10.4 t -138.44 5.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 109.485 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 414' ' ' ASP . 16.6 mt-30 -90.08 -48.51 7.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.416 -0.802 . . . . 0.0 109.608 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -66.4 -20.98 66.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.444 -0.785 . . . . 0.0 109.738 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.645 HD13 ' HA ' ' A' ' 409' ' ' VAL . 1.1 mp -68.57 -72.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.248 -0.908 . . . . 0.0 108.726 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 419' ' ' MET . 12.6 t -60.35 -23.22 27.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 21.5 t0 -75.9 -30.18 58.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.459 -0.775 . . . . 0.0 109.728 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.509 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 2.5 m-20 -77.18 -19.93 56.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.207 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.58 ' CE1' HD11 ' A' ' 337' ' ' ILE . 44.0 m80 -89.79 -28.56 19.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.557 -0.714 . . . . 0.0 109.756 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.5 OUTLIER 78.14 4.6 2.77 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.677 -0.639 . . . . 0.0 110.002 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.566 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -66.52 -91.36 0.05 OUTLIER Glycine 0 N--CA 1.482 1.727 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.565 ' O ' HG11 ' A' ' 413' ' ' VAL . 1.4 ttp 178.96 166.31 0.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -1.101 . . . . 0.0 111.413 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.464 ' HB2' HG11 ' A' ' 413' ' ' VAL . 25.1 tp -151.96 90.96 1.57 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.396 -0.815 . . . . 0.0 108.904 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -112.24 143.12 43.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.941 -1.099 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.506 ' HG ' HD12 ' A' ' 432' ' ' ILE . 0.2 OUTLIER -105.72 111.65 24.41 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 109.747 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.461 ' O ' ' OG1' ' A' ' 424' ' ' THR . . . -98.3 162.78 20.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 423' ' ' GLY . 4.6 m . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.11 -1.229 . . . . 0.0 110.674 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.549 ' CD1' HG12 ' A' ' 378' ' ' ILE . 0.5 OUTLIER -78.62 135.46 37.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -1.209 . . . . 0.0 110.949 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 28.6 m -148.5 122.14 9.21 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.506 HD12 ' HG ' ' A' ' 422' ' ' LEU . 1.1 tt -89.39 128.02 41.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.062 -1.024 . . . . 0.0 110.609 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . 0.464 ' HG3' ' HG3' ' A' ' 370' ' ' GLN . 0.5 OUTLIER -107.13 99.67 9.21 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.44 -0.788 . . . . 0.0 110.059 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.6 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -90.32 138.5 31.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.674 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 89.4 m95 -114.97 159.32 20.89 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.284 1.04 . . . . 0.0 113.088 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.529 ' CD1' HD11 ' A' ' 301' ' ' LEU . 32.0 mt -146.33 123.11 5.85 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.566 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 44.4 Cg_endo -74.17 141.83 29.82 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 123.479 1.252 . . . . 0.0 112.18 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.722 HG22 HG12 ' A' ' 330' ' ' VAL . 55.0 t -101.8 134.25 20.27 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.758 -0.588 . . . . 0.0 109.862 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 C--N 1.307 -1.637 0 O-C-N 123.803 1.422 . . . . 0.0 109.955 179.95 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.685 ' HB3' ' CD2' ' A' ' 333' ' ' HIS . 48.1 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 CA-C-O 121.323 0.468 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.617 ' HE1' ' HB3' ' A' ' 415' ' ' ASN . 0.8 OUTLIER 35.78 51.69 0.73 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.699 1.238 . . . . 0.0 110.16 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.654 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.4 OUTLIER -126.5 -156.98 0.77 Allowed 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.24 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.452 ' SD ' ' OE1' ' A' ' 329' ' ' GLU . 0.7 OUTLIER -86.81 125.17 33.77 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.414 -1.429 . . . . 0.0 110.626 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -137.99 158.55 44.1 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.586 0.708 . . . . 0.0 111.572 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.835 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.9 OUTLIER -102.19 112.75 25.55 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.573 ' CD2' ' HE1' ' A' ' 332' ' ' MET . 14.1 mt -60.34 -24.87 65.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.092 -1.005 . . . . 0.0 110.472 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.965 ' HA ' HD23 ' A' ' 323' ' ' LEU . 7.7 m-20 -79.52 -23.39 42.94 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.829 -1.17 . . . . 0.0 109.107 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -83.12 -30.37 27.96 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.479 0.657 . . . . 0.0 109.678 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 300' ' ' ASP . 2.9 t -79.02 -31.87 15.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.44 -0.787 . . . . 0.0 109.69 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 309' ' ' ILE . 97.9 mt -77.64 -31.78 52.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 110.869 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.21 -38.36 95.81 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.471 -1.347 . . . . 0.0 109.897 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 48.4 mt-10 -76.32 -34.73 59.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -1.15 . . . . 0.0 109.7 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.787 HG11 ' CG1' ' A' ' 341' ' ' VAL . 63.6 t -77.48 -19.13 14.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.687 0.756 . . . . 0.0 109.701 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.778 ' CD1' HG11 ' A' ' 358' ' ' VAL . 0.0 OUTLIER -75.09 -43.85 44.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -90.37 -16.8 28.44 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.506 0.669 . . . . 0.0 110.377 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -73.25 -41.95 63.09 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.586 -0.696 . . . . 0.0 112.261 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 312' ' ' GLU . 1.4 pp20? -115.82 17.24 16.14 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.753 -1.179 . . . . 0.0 112.354 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.563 ' HB2' HD11 ' A' ' 319' ' ' ILE . 15.4 t -102.99 -39.47 6.9 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.391 1.091 . . . . 0.0 109.621 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 118.12 -40.29 2.35 Favored Glycine 0 C--N 1.263 -3.491 0 N-CA-C 107.326 -2.31 . . . . 0.0 107.326 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 5.8 t80 174.65 37.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 0.2 OUTLIER 58.8 47.59 12.47 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.488 ' O ' ' HG3' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -67.75 -39.7 84.15 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.449 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 317' ' ' ARG . 39.0 mt-10 -154.97 51.74 0.61 Allowed 'General case' 0 C--N 1.273 -2.751 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.437 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.798 HG23 HG23 ' A' ' 358' ' ' VAL . 5.5 mt -118.9 129.34 75.24 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.949 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.542 ' HB3' ' HD3' ' A' ' 357' ' ' LYS . 37.1 tt0 -97.19 103.53 15.47 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.593 HG22 ' CD1' ' A' ' 309' ' ' ILE . 24.2 p -89.12 128.3 35.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 111.871 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.57 78.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.965 HD23 ' HA ' ' A' ' 302' ' ' ASN . 1.9 mp -95.53 159.91 14.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.471 -0.768 . . . . 0.0 111.148 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.637 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 83.5 t80 -47.94 121.44 8.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.622 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.64 78.96 1.96 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.903 1.475 . . . . 0.0 110.718 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 173.15 29.29 0.03 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.524 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 326' ' ' GLY . 2.1 p 44.28 98.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.069 -1.253 . . . . 0.0 110.001 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.561 HG22 ' H ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -72.43 -179.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.463 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.561 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.3 mt-10 -171.39 105.66 0.22 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.68 0.752 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 1.004 HG11 ' HB3' ' A' ' 367' ' ' ALA . 31.0 m -137.06 158.35 36.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 O-C-N 121.67 -0.644 . . . . 0.0 109.626 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.1 OUTLIER -72.36 91.81 1.37 Allowed 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.831 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.71 ' SD ' HD13 ' A' ' 436' ' ' LEU . 3.8 ttp -134.81 168.15 19.57 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 111.255 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.685 ' CD2' ' HB3' ' A' ' 295' ' ' PRO . 19.0 t-160 -101.85 118.09 60.2 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 37.2 Cg_endo -59.66 -21.72 64.05 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.41 1.216 . . . . 0.0 110.37 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.619 ' HB2' ' NE2' ' A' ' 333' ' ' HIS . 0.3 OUTLIER -83.4 -68.2 0.73 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.461 -0.774 . . . . 0.0 110.355 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 333' ' ' HIS . 0.4 OUTLIER -46.55 -44.51 17.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.484 -0.76 . . . . 0.0 110.007 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.836 HD11 ' CE1' ' A' ' 416' ' ' HIS . 37.9 mm -65.16 -46.23 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.393 -0.817 . . . . 0.0 109.53 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 337' ' ' ILE . 0.0 OUTLIER -47.04 -41.98 17.62 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.083 -1.011 . . . . 0.0 108.492 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 343' ' ' ASN . 17.2 mtt180 -73.03 -34.93 66.63 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.433 0.635 . . . . 0.0 110.314 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.816 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -62.23 -32.62 73.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.763 . . . . 0.0 110.849 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.787 ' CG1' HG11 ' A' ' 308' ' ' VAL . 44.7 t -85.19 -63.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.127 -0.983 . . . . 0.0 110.063 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.593 ' HA ' ' CG2' ' A' ' 345' ' ' VAL . . . -51.39 -19.45 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 110.687 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . 0.574 ' O ' HG12 ' A' ' 346' ' ' VAL . 2.0 t30 -76.2 -42.48 46.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.137 -0.977 . . . . 0.0 111.412 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.1 mtt -79.57 -24.89 41.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.975 -1.078 . . . . 0.0 111.413 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 341' ' ' VAL . 16.7 m -88.56 -19.74 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.906 -1.121 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 343' ' ' ASN . 4.7 p -58.72 -36.16 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.916 -1.115 . . . . 0.0 110.544 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.437 ' N ' ' CG1' ' A' ' 346' ' ' VAL . 0.9 OUTLIER -65.3 -54.38 29.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.897 . . . . 0.0 110.357 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.489 ' O ' ' CA ' ' A' ' 352' ' ' GLY . . . -66.55 -19.82 65.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.891 . . . . 0.0 110.503 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -74.76 -50.32 17.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 110.485 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.08 -73.19 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.915 . . . . 0.0 110.682 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . 0.444 ' O ' ' O ' ' A' ' 352' ' ' GLY . 12.1 m-85 -82.54 -44.6 15.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.225 -0.922 . . . . 0.0 110.828 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 348' ' ' ALA . . . 55.59 103.58 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 353' ' ' ASN . 26.6 t-20 -113.24 24.74 11.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -1.194 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 355' ' ' TRP . . . 178.64 -73.56 0.07 OUTLIER Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.642 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER 178.36 164.81 0.76 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.14 -1.212 . . . . 0.0 109.78 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.543 HD12 HG13 ' A' ' 319' ' ' ILE . 0.9 OUTLIER -112.45 163.01 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.279 -0.888 . . . . 0.0 111.183 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.642 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -142.23 124.08 15.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.825 . . . . 0.0 110.002 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.798 HG23 HG23 ' A' ' 319' ' ' ILE . 21.7 t -119.92 83.15 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.406 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.534 ' HA ' HD12 ' A' ' 323' ' ' LEU . 47.2 t -113.53 166.56 11.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.319 -0.863 . . . . 0.0 110.528 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.552 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.6 t -156.77 160.07 38.89 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.52 -0.737 . . . . 0.0 109.849 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -149.22 -162.52 10.4 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.637 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -170.62 174.89 4.85 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.905 -1.35 . . . . 0.0 110.782 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.556 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 2.6 mt-10 -160.41 -178.65 0.92 Allowed Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 38.4 Cg_endo -64.11 135.31 46.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.475 1.25 . . . . 0.0 109.908 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.553 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 5.0 p-10 38.74 33.65 0.07 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.614 -0.678 . . . . 0.0 110.699 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.553 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 3.6 mtt180 -172.67 99.93 0.14 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.393 -0.817 . . . . 0.0 111.265 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 1.004 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -110.32 154.8 22.99 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.1 -1.0 . . . . 0.0 108.659 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.621 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 45.9 p-90 -153.4 177.49 10.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.548 -1.345 . . . . 0.0 111.649 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.783 ' HE2' HD11 ' A' ' 436' ' ' LEU . 32.7 p90 -150.44 153.56 36.14 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -145.85 152.87 40.19 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.853 -1.154 . . . . 0.0 111.673 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.564 ' O ' HG22 ' A' ' 432' ' ' ILE . 88.0 t -122.73 141.31 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.529 ' HB2' ' HG2' ' A' ' 357' ' ' LYS . 0.8 OUTLIER -121.62 154.93 36.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.061 -1.024 . . . . 0.0 110.732 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -155.0 140.04 17.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -107.72 109.36 20.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 0.0 110.385 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -177.37 -107.32 0.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.13 -172.03 0.8 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.829 1.436 . . . . 0.0 110.671 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 430' ' ' LEU . . . -144.09 -150.76 5.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.454 HD11 HD21 ' A' ' 430' ' ' LEU . 11.3 mt -118.55 161.25 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.179 -1.189 . . . . 0.0 110.076 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.842 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -112.02 176.47 1.49 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.094 -1.004 . . . . 0.0 110.555 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.842 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 47.2 Cg_endo -75.64 -45.04 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.092 1.575 . . . . 0.0 110.643 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -81.34 -35.73 30.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 110.514 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.831 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 5.2 mp0 -61.29 -21.49 63.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.268 -0.895 . . . . 0.0 110.307 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -59.58 -30.79 68.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.879 . . . . 0.0 109.987 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.56 -35.39 39.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 385' ' ' HIS . 2.8 m-70 -67.19 -25.73 66.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.203 -0.936 . . . . 0.0 110.417 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.105 -0.997 . . . . 0.0 110.21 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.878 HD12 HG12 ' A' ' 409' ' ' VAL . 1.7 pp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.878 HG12 HD12 ' A' ' 408' ' ' ILE . 1.4 p -37.73 -33.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.326 -0.859 . . . . 0.0 110.923 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 408' ' ' ILE . 1.3 mm100 -65.9 -55.7 15.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.042 -1.036 . . . . 0.0 109.739 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.504 ' HD3' ' ND2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -56.57 -20.77 22.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.816 HG21 ' HB2' ' A' ' 340' ' ' ALA . 25.4 mm -72.11 -65.91 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 108.569 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.907 HG21 HD13 ' A' ' 420' ' ' LEU . 86.5 t -59.99 -19.87 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.538 -0.726 . . . . 0.0 109.703 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -82.22 -32.83 29.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.867 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.617 ' HB3' ' HE1' ' A' ' 296' ' ' MET . 1.4 m-20 -78.7 -28.06 45.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.481 -0.762 . . . . 0.0 109.378 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.836 ' CE1' HD11 ' A' ' 337' ' ' ILE . 41.1 m80 -86.34 -39.03 16.86 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.881 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 1.0 OUTLIER 79.88 45.44 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.393 0.616 . . . . 0.0 110.543 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 419' ' ' MET . . . -107.85 -85.81 1.78 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.57 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.4 ttp 177.99 169.88 0.72 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.321 -1.105 . . . . 0.0 111.019 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.907 HD13 HG21 ' A' ' 413' ' ' VAL . 16.1 tp -151.46 89.34 1.49 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.769 . . . . 0.0 109.133 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.38 159.47 15.11 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.095 -1.003 . . . . 0.0 111.525 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 422' ' ' LEU . 3.0 pp -134.05 119.45 18.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.606 -0.684 . . . . 0.0 109.535 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 430' ' ' LEU . . . -131.14 170.72 21.27 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.536 ' OG1' ' CD2' ' A' ' 430' ' ' LEU . 88.0 m . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.057 -1.261 . . . . 0.0 110.448 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 423' ' ' GLY . 0.2 OUTLIER -68.06 114.89 6.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.185 -1.185 . . . . 0.0 110.298 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.525 ' HB2' ' CG ' ' A' ' 372' ' ' GLU . 14.6 t -128.32 120.87 27.93 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.429 -0.794 . . . . 0.0 110.312 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 371' ' ' VAL . 1.2 tt -91.73 130.68 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.52 129.46 56.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.999 -1.063 . . . . 0.0 110.771 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -120.07 128.68 53.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.273 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.621 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.8 m95 -102.44 155.62 18.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.94 -1.1 . . . . 0.0 111.591 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.783 HD11 ' HE2' ' A' ' 369' ' ' PHE . 14.6 mt -145.59 129.04 8.41 Favored Pre-proline 0 N--CA 1.485 1.276 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.02 142.23 41.91 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.721 1.38 . . . . 0.0 110.069 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.616 HG22 HG12 ' A' ' 330' ' ' VAL . 2.6 t -73.35 -47.35 7.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.152 -0.967 . . . . 0.0 110.498 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 438' ' ' VAL . 58.0 Cg_endo . . . . . 0 C--N 1.314 -1.289 0 O-C-N 123.51 1.269 . . . . 0.0 110.333 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.581 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 53.3 Cg_endo . . . . . 0 C--O 1.214 -0.714 0 CA-C-O 121.778 0.657 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.688 ' HE3' ' NE2' ' A' ' 416' ' ' HIS . 0.3 OUTLIER 28.83 80.57 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.416 1.103 . . . . 0.0 112.015 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 14.2 mt-10 -148.63 -149.06 0.28 Allowed 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.507 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -87.64 128.81 35.28 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.74 -1.225 . . . . 0.0 109.527 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . -136.01 158.29 44.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.404 -0.81 . . . . 0.0 111.67 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 304' ' ' VAL . 4.3 m-20 -95.12 117.51 30.33 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.564 HD11 HD12 ' A' ' 436' ' ' LEU . 6.7 mt -63.86 -23.64 67.43 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.05 -1.031 . . . . 0.0 110.191 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.852 ' HA ' HD23 ' A' ' 323' ' ' LEU . 29.9 m-20 -79.94 -19.57 47.69 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.904 -1.123 . . . . 0.0 108.569 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.94 -37.21 19.29 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.433 0.635 . . . . 0.0 109.463 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.814 ' O ' HG23 ' A' ' 308' ' ' VAL . 22.0 t -74.94 -30.79 24.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.528 -0.732 . . . . 0.0 109.514 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 25.2 mt -78.65 -36.38 43.96 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.285 -0.884 . . . . 0.0 110.428 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -62.06 -39.1 97.16 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.683 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 1.0 OUTLIER -71.88 -33.66 68.54 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.231 -1.158 . . . . 0.0 108.599 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 304' ' ' VAL . 93.5 t -75.57 -18.77 15.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.811 0.815 . . . . 0.0 108.9 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.665 HG13 HG21 ' A' ' 321' ' ' THR . 0.3 OUTLIER -72.71 -45.1 58.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 122.021 0.915 . . . . 0.0 108.648 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.428 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -90.95 -15.86 29.03 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 121.4 -0.813 . . . . 0.0 109.795 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -61.61 -64.81 0.82 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.658 -0.651 . . . . 0.0 111.297 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.434 ' HG3' ' C ' ' A' ' 311' ' ' ALA . 94.9 mt-10 -142.98 39.2 1.47 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.088 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.642 ' O ' HD11 ' A' ' 319' ' ' ILE . 19.4 m -88.31 42.74 1.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.892 -1.13 . . . . 0.0 109.161 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.58 ' O ' ' CG ' ' A' ' 317' ' ' ARG . . . 74.07 13.87 80.77 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.58 ' CB ' ' O ' ' A' ' 314' ' ' GLY . 4.0 t80 78.88 63.3 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.893 -0.769 . . . . 0.0 108.926 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.576 ' CG ' ' O ' ' A' ' 315' ' ' TYR . 6.2 pt-20 41.74 45.73 3.11 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.126 0.965 . . . . 0.0 109.907 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.58 ' CG ' ' O ' ' A' ' 314' ' ' GLY . 6.4 mmt180 -68.36 -89.74 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 121.771 0.796 . . . . 0.0 109.808 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.25 65.55 1.41 Allowed 'General case' 0 C--N 1.272 -2.778 0 CA-C-O 121.583 0.706 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.644 ' CG2' HG23 ' A' ' 358' ' ' VAL . 2.6 mp -101.27 148.37 7.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 121.52 -0.737 . . . . 0.0 110.113 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -114.28 105.46 13.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.164 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.772 HG22 ' HB ' ' A' ' 358' ' ' VAL . 28.2 p -90.55 122.04 33.02 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 111.38 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -129.69 78.36 1.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.852 HD23 ' HA ' ' A' ' 302' ' ' ASN . 1.8 mp -93.78 174.18 7.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 111.215 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.629 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 20.8 t80 -61.23 137.84 94.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.651 -0.656 . . . . 0.0 109.906 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.569 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 53.1 Cg_endo -82.46 61.97 7.78 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.963 1.507 . . . . 0.0 110.547 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 178.82 22.2 0.03 OUTLIER Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.777 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 326' ' ' GLY . 2.1 m 55.12 107.3 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.891 -1.358 . . . . 0.0 110.281 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.546 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -81.63 -177.51 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.122 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 1.9 mt-10 -170.92 108.79 0.31 Allowed 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.841 0.829 . . . . 0.0 111.107 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 436' ' ' LEU . 25.3 m -131.3 159.17 43.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 O-C-N 121.72 -0.613 . . . . 0.0 109.463 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 3.3 tptt -76.4 93.57 3.51 Favored 'General case' 0 C--N 1.288 -2.104 0 C-N-CA 118.681 -1.208 . . . . 0.0 108.909 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.733 ' HE1' HG21 ' A' ' 337' ' ' ILE . 0.0 OUTLIER -134.73 -174.46 3.59 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.818 0.818 . . . . 0.0 111.326 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.601 ' CB ' ' NE2' ' A' ' 416' ' ' HIS . 18.6 t-160 -113.82 117.56 44.07 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 37.1 Cg_endo -59.24 -26.58 82.32 Favored 'Trans proline' 0 C--N 1.289 -2.563 0 O-C-N 123.105 1.055 . . . . 0.0 110.391 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.637 ' C ' HD12 ' A' ' 335' ' ' LEU . 0.5 OUTLIER -83.09 -66.47 0.89 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.273 -0.892 . . . . 0.0 110.819 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.546 ' N ' ' HG ' ' A' ' 335' ' ' LEU . 3.5 m -52.88 -42.76 65.6 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.941 -1.099 . . . . 0.0 110.624 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.768 HD11 ' CG ' ' A' ' 416' ' ' HIS . 29.6 mm -64.17 -44.45 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.591 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 0.7 OUTLIER -50.72 -46.77 59.18 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.707 -1.246 . . . . 0.0 109.284 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -43.17 93.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 0.0 110.121 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 1.023 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -47.29 -40.99 18.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.514 -0.741 . . . . 0.0 110.576 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.621 ' CG1' HG11 ' A' ' 308' ' ' VAL . 40.2 t -80.04 -32.14 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 110.47 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.969 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -66.78 -23.65 66.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.26 -0.9 . . . . 0.0 110.364 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -66.99 -29.88 69.84 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.147 -0.971 . . . . 0.0 110.489 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 42.0 mtt -82.04 -42.9 18.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.208 -0.933 . . . . 0.0 110.498 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.569 HG21 ' HA ' ' A' ' 313' ' ' SER . 3.7 p -67.86 -19.6 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.474 -0.766 . . . . 0.0 110.776 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 342' ' ' ALA . 53.0 t -67.99 -20.08 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.14 -0.975 . . . . 0.0 110.657 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.2 -57.38 4.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 110.366 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.422 ' O ' ' HA2' ' A' ' 352' ' ' GLY . . . -79.72 -19.97 47.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.46 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 345' ' ' VAL . . . -74.06 -25.11 59.65 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 110.413 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -73.71 -67.94 0.55 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.204 -0.935 . . . . 0.0 110.295 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -30.45 51.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 110.217 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 348' ' ' ALA . . . 82.95 106.5 0.48 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 374' ' ' ASP . 10.5 m120 -97.5 -57.4 2.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.285 -1.127 . . . . 0.0 110.466 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . 150.99 -17.38 0.93 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.607 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 37.7 t90 -154.37 130.87 10.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.842 -1.387 . . . . 0.0 111.666 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 319' ' ' ILE . 82.1 mt -124.05 158.98 30.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.559 ' HB3' ' CB ' ' A' ' 372' ' ' GLU . 5.9 tttp -136.4 137.95 41.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.628 -1.295 . . . . 0.0 111.672 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.772 ' HB ' HG22 ' A' ' 321' ' ' THR . 26.0 t -132.85 81.19 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.44 ' HB3' ' HE3' ' A' ' 357' ' ' LYS . 89.1 p -112.14 160.77 17.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.161 -0.962 . . . . 0.0 111.256 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 369' ' ' PHE . 47.2 t -162.16 130.44 4.11 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -118.1 -161.47 11.95 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.8 OUTLIER -171.36 177.58 3.5 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.748 -1.442 . . . . 0.0 112.014 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.563 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 1.0 OUTLIER -156.29 175.26 3.3 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 38.0 Cg_endo -64.29 116.32 3.67 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.158 1.083 . . . . 0.0 111.289 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.517 ' C ' ' HG3' ' A' ' 366' ' ' ARG . 6.2 m-20 63.07 18.38 10.88 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.743 -0.598 . . . . 0.0 111.147 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.517 ' HG3' ' C ' ' A' ' 365' ' ' ASN . 26.9 mtp180 -160.23 108.02 1.64 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.437 -0.789 . . . . 0.0 110.377 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.68 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -112.7 179.19 4.04 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.864 -1.147 . . . . 0.0 108.708 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.654 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 11.5 p-90 -171.44 149.04 2.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.825 -1.172 . . . . 0.0 110.11 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 369' ' ' PHE . 4.7 p90 -138.46 142.8 39.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.963 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.534 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 11.9 tt0 -133.31 155.09 50.06 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 110.42 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.534 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 36.7 t -118.78 151.74 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.428 -0.795 . . . . 0.0 110.179 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.559 ' CB ' ' HB3' ' A' ' 357' ' ' LYS . 4.4 tt0 -139.19 117.24 11.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.269 -0.895 . . . . 0.0 109.746 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 20.4 p-10 -145.88 143.48 29.61 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.04 -1.038 . . . . 0.0 110.201 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 353' ' ' ASN . 12.4 t0 -74.83 140.76 44.15 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.406 -0.809 . . . . 0.0 109.817 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -179.51 -150.29 8.96 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.07 -162.24 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.975 1.513 . . . . 0.0 110.512 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -140.22 -172.75 12.99 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.511 HD13 HD13 ' A' ' 422' ' ' LEU . 26.0 mt -110.39 140.16 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -1.174 . . . . 0.0 110.568 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -82.56 164.4 47.49 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.407 -0.808 . . . . 0.0 109.872 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 46.6 Cg_endo -73.83 -30.25 9.54 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 124.087 1.572 . . . . 0.0 110.732 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -90.39 -21.29 22.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.0 110.483 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.766 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 0.1 OUTLIER -78.88 -21.65 47.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.177 -0.952 . . . . 0.0 110.466 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -49.97 -21.42 1.2 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.151 -0.968 . . . . 0.0 110.467 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.54 -32.19 16.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.24 -0.912 . . . . 0.0 110.482 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.432 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 5.4 m-70 -80.35 -10.88 59.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.319 -0.863 . . . . 0.0 110.893 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 386' ' ' LEU . 22.1 tp . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.036 -1.04 . . . . 0.0 111.445 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.76 HG23 ' O ' ' A' ' 408' ' ' ILE . 1.1 tp . . . . . 0 N--CA 1.511 2.622 0 CA-C-O 121.292 0.568 . . . . 0.0 111.605 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 409' ' ' VAL . 93.6 t -79.83 1.91 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 1.3 mm100 -74.25 -55.3 6.2 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 110.237 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 1.9 mmt180 -67.8 -31.49 71.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.323 -0.861 . . . . 0.0 109.898 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 1.023 HG21 ' HB2' ' A' ' 340' ' ' ALA . 8.7 mm -67.21 -66.28 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.894 HG21 HD13 ' A' ' 420' ' ' LEU . 35.4 t -57.11 -23.24 18.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.424 -0.797 . . . . 0.0 109.699 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 29.5 m-20 -78.09 -30.72 49.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.221 -0.925 . . . . 0.0 109.535 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.51 ' HB3' ' HE1' ' A' ' 296' ' ' MET . 1.2 m-20 -109.31 7.29 25.11 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.65 -0.657 . . . . 0.0 109.625 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.768 ' CG ' HD11 ' A' ' 337' ' ' ILE . 47.1 m80 -134.64 -62.92 0.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 111.968 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.956 ' HA ' HD23 ' A' ' 436' ' ' LEU . 2.4 m-20 -74.73 -99.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.808 0.814 . . . . 0.0 111.61 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 149.11 -35.04 1.08 Allowed Glycine 0 C--N 1.262 -3.551 0 N-CA-C 106.432 -2.667 . . . . 0.0 106.432 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.669 ' HB3' ' HB2' ' A' ' 435' ' ' TRP . 36.4 ttm -123.14 145.69 48.38 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.658 -0.907 . . . . 0.0 109.601 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.894 HD13 HG21 ' A' ' 413' ' ' VAL . 19.7 tp -150.84 92.71 1.86 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.114 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -107.6 128.8 54.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.372 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.511 HD13 HD13 ' A' ' 378' ' ' ILE . 2.0 pp -89.81 138.58 31.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.869 . . . . 0.0 109.547 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.488 ' O ' ' HG ' ' A' ' 430' ' ' LEU . . . -149.26 -168.66 15.02 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.555 -1.307 . . . . 0.0 109.903 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.853 HG22 ' O ' ' A' ' 429' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 O-C-N 121.577 -0.955 . . . . 0.0 111.185 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.853 ' O ' HG22 ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.571 ' HA ' ' HB ' ' A' ' 424' ' ' THR . 0.3 OUTLIER -88.68 165.23 14.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.882 -1.364 . . . . 0.0 109.876 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.541 ' N ' ' HB ' ' A' ' 424' ' ' THR . 1.7 p -146.52 162.86 37.42 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.964 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 370' ' ' GLN . 13.3 mm -123.8 121.84 63.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -98.99 100.98 12.22 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.833 ' HB1' HD22 ' A' ' 417' ' ' ASN . . . -110.35 135.05 51.67 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 111.066 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.669 ' HB2' ' HB3' ' A' ' 419' ' ' MET . 88.0 m95 -110.14 138.35 46.64 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 121.064 -1.023 . . . . 0.0 111.255 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.956 HD23 ' HA ' ' A' ' 417' ' ' ASN . 9.7 mt -113.46 75.79 2.57 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 417' ' ' ASN . 37.5 Cg_endo -63.05 115.08 2.74 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 O-C-N 124.665 1.876 . . . . 0.0 110.494 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.513 ' CG1' ' HD2' ' A' ' 439' ' ' PRO . 4.6 t -69.66 143.91 93.19 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.384 -0.823 . . . . 0.0 109.682 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.513 ' HD2' ' CG1' ' A' ' 438' ' ' VAL . 53.6 Cg_endo . . . . . 0 C--N 1.301 -1.935 0 O-C-N 124.0 1.526 . . . . 0.0 110.418 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 297' ' ' GLU . 47.0 Cg_endo . . . . . 0 C--O 1.214 -0.702 0 N-CA-C 109.542 -0.984 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.541 ' HE3' ' HB3' ' A' ' 415' ' ' ASN . 0.1 OUTLIER 40.38 48.37 2.39 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.85 1.309 . . . . 0.0 109.304 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.701 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 4.3 mm-40 -127.84 -149.91 0.43 Allowed 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.193 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.488 ' HE2' ' N ' ' A' ' 330' ' ' VAL . 2.1 mmt -84.74 117.49 23.85 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 120.286 -1.508 . . . . 0.0 110.7 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.527 ' HB3' ' HE3' ' A' ' 332' ' ' MET . . . -134.09 162.01 33.29 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.528 0.68 . . . . 0.0 111.129 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 304' ' ' VAL . 4.1 m-20 -95.97 119.01 33.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.654 -0.654 . . . . 0.0 109.867 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.653 HD11 HD12 ' A' ' 436' ' ' LEU . 6.1 mt -65.51 -23.45 66.89 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.091 -1.006 . . . . 0.0 109.654 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.692 ' HA ' HD23 ' A' ' 323' ' ' LEU . 4.5 m-20 -75.68 -19.99 58.74 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.957 -1.09 . . . . 0.0 108.351 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.07 -37.24 19.08 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.524 0.678 . . . . 0.0 109.601 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.877 ' O ' HG23 ' A' ' 308' ' ' VAL . 2.5 t -78.8 -28.62 14.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.415 -0.803 . . . . 0.0 109.554 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 309' ' ' ILE . 72.4 mt -82.85 -31.38 28.04 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.62 -31.99 82.72 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -83.82 -30.82 26.21 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.268 -1.136 . . . . 0.0 109.251 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 304' ' ' VAL . 88.7 t -72.58 -26.88 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.305 -0.872 . . . . 0.0 109.32 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 305' ' ' LEU . 1.0 OUTLIER -75.79 -50.2 24.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.08 -16.7 64.5 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.861 0.839 . . . . 0.0 108.762 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -67.01 -68.03 0.41 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.453 0.644 . . . . 0.0 110.79 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.82 49.35 2.23 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.553 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.988 ' HB2' HD13 ' A' ' 319' ' ' ILE . 6.2 p -82.32 40.46 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.001 -1.062 . . . . 0.0 109.994 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.542 ' C ' ' CD2' ' A' ' 315' ' ' TYR . . . 53.16 38.15 55.83 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.542 ' CD2' ' C ' ' A' ' 314' ' ' GLY . 3.6 m-85 67.89 34.65 4.16 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.629 -0.924 . . . . 0.0 109.279 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 4.9 mm-40 57.52 41.71 25.48 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.241 -0.912 . . . . 0.0 108.614 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.575 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 1.6 tpp180 -68.71 -86.89 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.432 0.634 . . . . 0.0 110.784 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.575 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 5.4 mt-10 -127.04 66.15 1.29 Allowed 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.637 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.988 HD13 ' HB2' ' A' ' 313' ' ' SER . 1.5 mp -111.48 120.77 62.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 358' ' ' VAL . 24.0 tt0 -88.33 100.45 13.03 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.343 -0.848 . . . . 0.0 109.79 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 20.7 p -88.46 122.98 32.53 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.52 0.676 . . . . 0.0 110.903 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -144.55 78.94 1.59 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' ' 302' ' ' ASN . 1.7 mp -90.29 164.77 14.24 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 110.125 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 323' ' ' LEU . 5.2 t80 -43.24 136.76 2.95 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.631 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -83.14 51.57 3.68 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.94 1.495 . . . . 0.0 111.232 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -165.73 -87.77 0.07 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.3 m -178.54 105.26 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.613 -0.933 . . . . 0.0 108.98 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 329' ' ' GLU . 2.0 mt -74.17 -179.69 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 O-C-N 121.404 -0.81 . . . . 0.0 110.006 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.656 ' H ' HG22 ' A' ' 328' ' ' ILE . 3.2 mt-10 -170.82 105.63 0.26 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.585 0.707 . . . . 0.0 110.601 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.983 HG11 ' HB3' ' A' ' 367' ' ' ALA . 25.4 m -139.23 154.24 25.13 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.302 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.6 OUTLIER -71.7 92.35 1.18 Allowed 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.698 ' HE1' HG21 ' A' ' 304' ' ' VAL . 10.0 tmm? -143.07 158.24 43.78 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.108 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.617 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 9.9 t-160 -100.42 121.24 53.95 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 38.6 Cg_endo -64.77 -18.81 63.62 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.628 1.33 . . . . 0.0 109.697 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.617 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 0.6 OUTLIER -81.23 -80.01 0.15 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.618 -0.676 . . . . 0.0 110.692 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 96.9 p -44.37 -43.06 7.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.39 -0.819 . . . . 0.0 110.178 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.601 HD11 ' CE1' ' A' ' 416' ' ' HIS . 1.2 mm -66.32 -40.95 88.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.811 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 0.0 OUTLIER -45.45 -38.4 6.08 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -44.39 67.79 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.108 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.911 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -54.63 -47.99 72.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.61 -0.681 . . . . 0.0 111.089 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.806 ' CG1' HG11 ' A' ' 308' ' ' VAL . 33.3 t -75.62 -28.08 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.132 -0.98 . . . . 0.0 110.403 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.54 -19.89 63.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 110.117 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -88.85 -19.83 25.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.311 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.4 mtt -82.59 -44.78 15.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.243 -0.911 . . . . 0.0 110.373 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 346' ' ' VAL . 6.9 p -69.84 -42.82 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.555 ' N ' HG13 ' A' ' 345' ' ' VAL . 19.4 t -52.05 -19.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.102 -0.999 . . . . 0.0 110.569 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -67.12 -46.4 74.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.193 -0.942 . . . . 0.0 110.635 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 356' ' ' ILE . . . -88.78 -19.72 25.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.212 -0.93 . . . . 0.0 110.656 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.3 -27.16 65.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.159 -0.963 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 350' ' ' ARG . 0.0 OUTLIER -83.3 -37.09 23.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 110.123 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.85 -67.44 0.84 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 65.34 52.98 35.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -106.3 -1.94 22.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -1.153 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -145.08 -84.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.643 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -172.7 148.81 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -1.11 . . . . 0.0 109.875 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.528 HD12 HG13 ' A' ' 319' ' ' ILE . 1.0 OUTLIER -109.8 153.34 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.869 . . . . 0.0 109.528 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.643 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.1 OUTLIER -144.5 114.69 7.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.986 . . . . 0.0 110.745 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.719 HG23 HG23 ' A' ' 319' ' ' ILE . 55.3 t -109.72 138.64 36.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.553 ' HA ' ' CD1' ' A' ' 323' ' ' LEU . 97.7 p -161.18 173.96 14.35 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 120.502 -1.374 . . . . 0.0 111.507 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.524 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 6.4 p -155.04 131.3 10.33 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.488 0.661 . . . . 0.0 109.826 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.503 ' O ' ' HB ' ' A' ' 362' ' ' THR . . . -129.91 -172.47 13.16 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 107.986 -2.046 . . . . 0.0 107.986 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.652 HG21 HG23 ' A' ' 328' ' ' ILE . 0.6 OUTLIER 175.96 176.26 0.25 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.867 -1.372 . . . . 0.0 111.546 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.532 ' OE1' ' CD ' ' A' ' 364' ' ' PRO . 33.3 mm-40 -141.54 175.24 3.14 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.532 ' CD ' ' OE1' ' A' ' 363' ' ' GLU . 47.3 Cg_endo -77.25 26.01 0.46 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.336 1.177 . . . . 0.0 111.388 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 21.3 p-10 -170.19 24.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.065 -1.022 . . . . 0.0 110.202 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.542 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 8.1 ptt180 162.46 109.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.789 -0.569 . . . . 0.0 110.248 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.983 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -100.45 168.9 9.45 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.194 -0.941 . . . . 0.0 109.085 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.688 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 34.8 p-90 -170.98 153.16 3.73 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.587 -1.321 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 434' ' ' ALA . 54.4 p90 -121.81 157.15 31.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.175 -0.953 . . . . 0.0 108.638 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.542 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 5.8 tt0 -141.8 159.39 42.33 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.829 -1.17 . . . . 0.0 111.835 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.542 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 96.8 t -137.83 135.73 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.403 ' OE2' ' CD ' ' A' ' 370' ' ' GLN . 18.1 mt-10 -131.21 158.08 41.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.835 -1.165 . . . . 0.0 111.041 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 430' ' ' LEU . 27.1 t0 -150.58 142.81 24.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.436 -0.79 . . . . 0.0 109.782 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.65 2.0 20.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.219 -0.926 . . . . 0.0 110.297 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . 0.421 ' O ' ' HA3' ' A' ' 429' ' ' GLY . . . -65.53 -175.15 5.28 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.09 145.69 44.98 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.942 1.496 . . . . 0.0 110.642 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . 0.813 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -63.67 -140.34 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.813 HD13 ' C ' ' A' ' 377' ' ' GLY . 0.0 OUTLIER -116.75 118.95 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.147 -1.208 . . . . 0.0 109.957 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -43.26 161.64 0.19 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.281 -0.887 . . . . 0.0 110.296 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.38 -24.14 16.8 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.939 1.494 . . . . 0.0 110.028 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -88.67 -21.49 23.91 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.392 -0.818 . . . . 0.0 109.876 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -86.17 -30.33 22.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -22.21 66.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.612 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -20.84 63.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.603 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -92.42 21.02 5.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.472 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 1.031 HD22 HD21 ' A' ' 422' ' ' LEU . 8.5 mt . . . . . 0 C--N 1.302 -1.488 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . . . . . . . . . 21.7 mm . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.326 0.584 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.547 ' HA ' HG13 ' A' ' 412' ' ' ILE . 14.7 p -116.45 -9.46 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.53 -0.731 . . . . 0.0 109.989 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 7.3 tt0 -68.53 -62.39 1.41 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.297 -0.877 . . . . 0.0 110.315 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -19.99 6.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.241 -0.912 . . . . 0.0 110.497 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.911 HG21 ' HB2' ' A' ' 340' ' ' ALA . 24.7 mm -66.0 -69.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.105 -0.997 . . . . 0.0 108.984 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 420' ' ' LEU . 69.6 t -62.18 -20.72 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 109.437 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 2.8 t70 -79.14 -26.48 42.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.469 -0.769 . . . . 0.0 109.85 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.541 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 22.7 m-20 -84.0 -22.93 31.19 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.313 -0.867 . . . . 0.0 109.292 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.601 ' CE1' HD11 ' A' ' 337' ' ' ILE . 41.4 m80 -93.18 -26.16 17.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.504 -0.747 . . . . 0.0 109.686 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.57 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 4.2 m120 66.03 59.27 0.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.687 0.756 . . . . 0.0 110.889 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.559 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -128.29 -84.04 0.42 Allowed Glycine 0 N--CA 1.481 1.656 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.569 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.1 OUTLIER -179.07 155.98 0.76 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -1.129 . . . . 0.0 112.011 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.826 ' HB2' HG21 ' A' ' 413' ' ' VAL . 15.7 tp -152.76 92.83 1.69 Allowed 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.458 -0.776 . . . . 0.0 108.995 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 432' ' ' ILE . 0.2 OUTLIER -115.22 123.43 48.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.007 -1.058 . . . . 0.0 110.969 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 1.031 HD21 HD22 ' A' ' 386' ' ' LEU . 0.8 OUTLIER -126.5 140.01 52.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.154 -0.966 . . . . 0.0 110.098 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.43 ' HA2' HG13 ' A' ' 378' ' ' ILE . . . 175.46 -169.76 42.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 44.3 m . . . . . 0 N--CA 1.487 1.414 0 O-C-N 121.297 -1.119 . . . . 0.0 110.003 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.503 3.109 0 CA-C-O 121.827 0.682 . . . . 0.0 112.54 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.996 HD13 ' N ' ' A' ' 431' ' ' SER . 0.9 OUTLIER -66.98 140.06 57.71 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 121.914 0.864 . . . . 0.0 113.008 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.996 ' N ' HD13 ' A' ' 430' ' ' LEU . 29.4 t -167.02 112.18 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.492 HG13 ' CA ' ' A' ' 422' ' ' LEU . 15.6 tt -125.83 157.33 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.162 -0.961 . . . . 0.0 110.567 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.73 127.35 18.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.405 -0.81 . . . . 0.0 109.928 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 369' ' ' PHE . . . -109.69 147.27 33.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.271 -0.893 . . . . 0.0 110.129 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.688 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.3 m95 -124.22 155.91 37.73 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.398 1.094 . . . . 0.0 113.246 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.653 HD12 HD11 ' A' ' 301' ' ' LEU . 19.0 mt -145.38 94.8 5.14 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.559 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 42.6 Cg_endo -67.19 146.17 75.21 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.966 1.509 . . . . 0.0 112.896 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 10.8 t -107.3 98.0 21.18 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.836 -0.54 . . . . 0.0 110.379 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 49.6 Cg_endo . . . . . 0 C--N 1.309 -1.5 0 O-C-N 123.78 1.411 . . . . 0.0 111.577 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.643 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 54.7 Cg_endo . . . . . 0 C--O 1.215 -0.665 0 N-CA-C 110.188 -0.735 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.642 ' HE3' ' HB3' ' A' ' 415' ' ' ASN . 0.2 OUTLIER -81.84 108.79 15.65 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 122.216 1.008 . . . . 0.0 109.239 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.646 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 20.3 mt-10 -133.71 -155.71 0.69 Allowed 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.221 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.06 139.06 30.89 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 111.037 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.812 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -155.69 160.09 40.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.576 -0.703 . . . . 0.0 110.523 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.668 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.6 OUTLIER -103.86 114.84 29.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.382 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.645 HD11 HD12 ' A' ' 436' ' ' LEU . 7.5 mt -59.92 -25.13 64.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.265 -0.897 . . . . 0.0 109.831 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.688 ' HA ' HD23 ' A' ' 323' ' ' LEU . 42.3 t-20 -82.18 -21.53 36.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.939 -1.1 . . . . 0.0 109.356 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.52 -27.54 22.56 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.604 0.716 . . . . 0.0 109.474 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 300' ' ' ASP . 28.5 t -82.89 -37.05 13.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 121.582 0.706 . . . . 0.0 109.168 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.552 ' CD2' HG21 ' A' ' 341' ' ' VAL . 86.1 mt -79.72 -31.11 41.09 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.475 -0.766 . . . . 0.0 110.117 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.95 -26.73 73.23 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -84.44 -33.52 23.65 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.419 -1.048 . . . . 0.0 109.782 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.949 HG11 ' CG1' ' A' ' 341' ' ' VAL . 78.6 t -75.2 -25.42 18.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.395 -0.816 . . . . 0.0 109.469 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.976 HD11 ' CG1' ' A' ' 358' ' ' VAL . 1.6 mt -79.56 -43.45 23.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.734 0.778 . . . . 0.0 108.941 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.2 -17.3 62.52 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.73 0.776 . . . . 0.0 109.048 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -85.7 -45.62 11.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.657 -0.652 . . . . 0.0 110.67 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 342' ' ' ALA . 8.6 mt-10 -99.34 28.68 4.38 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.115 -0.991 . . . . 0.0 110.599 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.474 ' O ' ' OG ' ' A' ' 313' ' ' SER . 1.6 t -97.48 38.08 1.3 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.254 -0.904 . . . . 0.0 109.93 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -99.18 -74.77 1.16 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.45 ' O ' ' CG ' ' A' ' 316' ' ' GLU . 2.7 t80 -93.32 25.78 3.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -1.094 . . . . 0.0 108.689 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.641 ' O ' HD11 ' A' ' 319' ' ' ILE . 48.5 mm-40 -160.03 38.21 0.18 Allowed 'General case' 0 C--O 1.192 -1.966 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.471 ' HA ' ' CD1' ' A' ' 319' ' ' ILE . 0.1 OUTLIER -69.52 -0.99 7.46 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 121.422 0.63 . . . . 0.0 110.002 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.05 33.92 0.45 Allowed 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.918 0.866 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.726 ' CG2' HG23 ' A' ' 358' ' ' VAL . 0.7 OUTLIER -89.15 134.86 27.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.484 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -95.87 110.32 22.52 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.012 -1.055 . . . . 0.0 109.119 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.928 HG22 HD13 ' A' ' 309' ' ' ILE . 10.8 p -89.52 123.28 33.48 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.351 -0.843 . . . . 0.0 111.675 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.84 78.41 1.49 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.688 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.2 mp -93.93 154.85 17.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.78 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.595 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 79.0 t80 -46.75 132.26 8.43 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.425 -0.797 . . . . 0.0 110.215 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.478 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 46.5 Cg_endo -72.71 78.91 1.99 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.952 1.501 . . . . 0.0 110.318 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . 167.66 7.89 0.03 OUTLIER Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.804 -1.189 . . . . 0.0 111.177 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 0.5 OUTLIER 63.38 116.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 O-C-N 120.555 -1.556 . . . . 0.0 109.57 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 329' ' ' GLU . 4.1 mm -69.23 179.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.734 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.63 ' H ' HG22 ' A' ' 328' ' ' ILE . 1.9 mt-10 -175.49 104.47 0.08 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.609 0.719 . . . . 0.0 110.674 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.839 HG23 ' HG2' ' A' ' 332' ' ' MET . 13.7 m -150.09 172.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 O-C-N 121.702 -0.624 . . . . 0.0 110.323 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.646 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -86.22 93.58 9.09 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 119.384 -0.927 . . . . 0.0 108.664 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.839 ' HG2' HG23 ' A' ' 330' ' ' VAL . 11.7 ptm -144.58 166.27 25.64 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.356 -0.84 . . . . 0.0 110.568 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.643 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 19.1 t-160 -92.18 112.22 54.03 Favored Pre-proline 0 C--N 1.297 -1.698 0 O-C-N 121.523 -0.736 . . . . 0.0 109.46 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 41.4 Cg_endo -66.39 -23.62 50.89 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.825 1.434 . . . . 0.0 111.128 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.584 ' C ' HD12 ' A' ' 335' ' ' LEU . 1.1 tp -81.99 -62.16 1.71 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.951 -1.093 . . . . 0.0 109.817 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.509 ' OG ' HG13 ' A' ' 412' ' ' ILE . 14.7 t -53.65 -42.94 68.37 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.109 -0.995 . . . . 0.0 109.374 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.868 HD11 ' CE1' ' A' ' 416' ' ' HIS . 20.5 mm -60.34 -45.71 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.195 -0.941 . . . . 0.0 109.121 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.538 ' HG3' HG13 ' A' ' 304' ' ' VAL . 20.8 mttm -46.19 -50.25 15.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.0 108.611 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.05 -44.15 78.57 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.544 0.688 . . . . 0.0 110.056 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.572 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -54.34 -29.18 47.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.407 -0.808 . . . . 0.0 111.022 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.949 ' CG1' HG11 ' A' ' 308' ' ' VAL . 66.3 t -88.76 -43.9 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.079 -1.013 . . . . 0.0 111.24 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.832 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -54.4 -38.93 66.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.125 -0.984 . . . . 0.0 110.844 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . 0.483 ' ND2' HD11 ' A' ' 408' ' ' ILE . 0.8 OUTLIER -81.88 -34.6 29.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -0.965 . . . . 0.0 110.666 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 340' ' ' ALA . 0.0 OUTLIER -65.73 -28.17 68.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 342' ' ' ALA . 7.7 p -88.53 -22.89 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.013 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 342' ' ' ALA . 89.3 t -76.31 -22.03 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.161 -0.962 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -69.72 -41.21 75.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.158 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 352' ' ' GLY . . . -79.7 -19.9 47.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.36 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.28 -34.43 25.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.486 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -80.2 -63.7 1.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.625 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -21.72 33.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.13 -0.981 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 353' ' ' ASN . . . -109.46 176.24 19.4 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.067 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 352' ' ' GLY . 27.1 p-10 -178.62 42.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.537 -0.978 . . . . 0.0 109.808 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 355' ' ' TRP . . . -131.38 78.32 0.38 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.465 ' HB3' ' O ' ' A' ' 354' ' ' GLY . 9.9 t90 58.49 138.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -1.076 . . . . 0.0 111.043 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.526 ' CD1' ' OE1' ' A' ' 316' ' ' GLU . 6.5 mt -126.3 164.44 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.484 ' HG2' ' HB3' ' A' ' 320' ' ' GLU . 11.9 tttt -144.38 132.5 21.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.586 -1.321 . . . . 0.0 112.351 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.976 ' CG1' HD11 ' A' ' 309' ' ' ILE . 98.9 t -125.54 93.14 2.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 12.8 t -120.84 160.38 23.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 111.145 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.557 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 1.0 OUTLIER -141.68 157.16 45.41 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.569 -0.707 . . . . 0.0 109.469 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -146.75 -164.54 11.11 Favored Glycine 0 C--N 1.293 -1.841 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.1 OUTLIER -171.14 178.96 3.18 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.871 -1.37 . . . . 0.0 111.233 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 366' ' ' ARG . 6.2 mt-10 -154.23 177.69 1.9 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.587 -0.695 . . . . 0.0 109.823 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 40.9 Cg_endo -67.74 107.87 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.707 1.372 . . . . 0.0 110.763 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 4.8 t-20 68.77 31.16 4.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.409 -0.807 . . . . 0.0 110.531 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 3.6 mtt180 -176.31 109.4 0.09 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.55 -0.719 . . . . 0.0 109.787 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.792 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -113.06 161.12 17.44 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.954 -1.091 . . . . 0.0 110.096 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.6 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 22.3 p-90 -153.74 171.56 18.68 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.927 -1.108 . . . . 0.0 110.886 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.438 ' HB3' HD13 ' A' ' 301' ' ' LEU . 14.4 p90 -150.54 144.65 25.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.529 -0.732 . . . . 0.0 109.225 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.465 ' NE2' ' HG2' ' A' ' 433' ' ' ARG . 5.2 pt20 -142.38 163.56 32.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.908 -1.12 . . . . 0.0 111.344 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.471 ' O ' ' HG3' ' A' ' 372' ' ' GLU . 17.6 t -128.6 152.83 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.55 -0.719 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 371' ' ' VAL . 1.6 mt-10 -140.23 130.69 25.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.403 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -141.26 150.73 42.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.038 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.69 120.83 43.61 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.198 -0.939 . . . . 0.0 110.762 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -175.59 -107.37 0.21 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.34 -171.08 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.938 1.494 . . . . 0.0 111.186 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . 0.687 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -155.62 -178.8 30.18 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.687 HD13 ' C ' ' A' ' 377' ' ' GLY . 0.7 OUTLIER -107.31 -154.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.039 -1.271 . . . . 0.0 110.691 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 383' ' ' ARG . . . -155.8 161.11 30.17 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.85 -20.72 22.11 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 O-C-N 123.704 1.37 . . . . 0.0 110.963 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.94 -36.75 13.26 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.948 -1.095 . . . . 0.0 111.738 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.638 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 15.3 pt20 -89.65 -30.34 18.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.019 -1.051 . . . . 0.0 111.824 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 379' ' ' ALA . 19.9 ttt-85 -56.12 -18.87 11.1 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.756 -1.215 . . . . 0.0 109.841 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.97 -31.02 39.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.288 -0.883 . . . . 0.0 110.941 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.638 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 5.2 p80 -112.47 1.31 15.86 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.97 -1.081 . . . . 0.0 111.201 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 386' ' ' LEU . 2.1 tt . . . . . 0 C--N 1.303 -1.446 0 O-C-N 121.158 -0.964 . . . . 0.0 110.173 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.598 ' O ' HD12 ' A' ' 408' ' ' ILE . 1.9 pp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.489 0.661 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 412' ' ' ILE . 6.0 p -143.04 -36.32 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 109.809 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.441 ' N ' HG13 ' A' ' 409' ' ' VAL . 14.8 tt0 -69.8 -51.55 32.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.093 -1.004 . . . . 0.0 109.707 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.471 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 29.1 mmt180 -56.17 -19.06 11.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.297 -0.877 . . . . 0.0 109.88 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.719 HG22 ' N ' ' A' ' 413' ' ' VAL . 0.8 OUTLIER -65.42 -63.31 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.948 . . . . 0.0 108.817 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.779 HG11 ' HB2' ' A' ' 420' ' ' LEU . 7.0 t -67.13 -22.04 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.15 -0.969 . . . . 0.0 109.196 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 8.3 t70 -76.26 -27.93 56.88 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.671 -0.643 . . . . 0.0 109.648 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.642 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 0.3 OUTLIER -79.67 -12.36 59.82 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.386 -0.821 . . . . 0.0 109.322 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.868 ' CE1' HD11 ' A' ' 337' ' ' ILE . 30.1 m80 -97.2 -29.42 13.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.544 -0.722 . . . . 0.0 109.649 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.1 t-20 77.93 13.77 1.67 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.69 -0.631 . . . . 0.0 110.483 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.575 ' HA2' ' CD ' ' A' ' 437' ' ' PRO . . . -82.48 -87.87 0.72 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.684 ' O ' HG11 ' A' ' 413' ' ' VAL . 37.2 ttm -176.94 158.57 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -1.194 . . . . 0.0 111.338 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.779 ' HB2' HG11 ' A' ' 413' ' ' VAL . 27.4 tp -152.57 98.79 2.4 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.181 -0.949 . . . . 0.0 109.059 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -126.31 167.8 15.01 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.75 -1.219 . . . . 0.0 112.511 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 35.0 mt -89.95 141.24 28.84 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.226 0.536 . . . . 0.0 109.962 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 431' ' ' SER . . . -108.38 163.92 12.76 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 20.8 m . . . . . 0 C--N 1.295 -1.796 0 O-C-N 121.293 -1.122 . . . . 0.0 109.948 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . . . . . . 0 N--CA 1.485 1.949 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 378' ' ' ILE . 3.5 mm? -86.17 111.05 20.02 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.301 -1.117 . . . . 0.0 110.653 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 423' ' ' GLY . 17.7 m -125.49 102.24 7.3 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.89 122.46 40.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.966 -1.083 . . . . 0.0 111.208 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . 0.465 ' HG2' ' NE2' ' A' ' 370' ' ' GLN . 12.2 mtt180 -107.75 116.1 31.34 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.535 0.683 . . . . 0.0 110.276 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.407 ' HB3' ' CE2' ' A' ' 369' ' ' PHE . . . -108.0 129.27 55.13 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.6 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 82.5 m95 -103.12 153.75 20.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.882 -1.136 . . . . 0.0 112.064 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.645 HD12 HD11 ' A' ' 301' ' ' LEU . 14.7 mt -143.91 81.84 11.52 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.575 ' CD ' ' HA2' ' A' ' 418' ' ' GLY . 45.6 Cg_endo -70.55 133.6 24.48 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 O-C-N 124.02 1.537 . . . . 0.0 111.737 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.514 HG22 ' HB ' ' A' ' 330' ' ' VAL . 5.8 t -92.4 120.94 67.26 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.587 -0.695 . . . . 0.0 109.903 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.304 -1.804 0 O-C-N 123.742 1.391 . . . . 0.0 109.903 179.983 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.606 ' HB2' ' CD2' ' A' ' 333' ' ' HIS . 47.6 Cg_endo . . . . . 0 C--O 1.216 -0.605 0 N-CA-C 109.887 -0.851 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.55 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 43.6 79.94 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 122.638 1.209 . . . . 0.0 109.479 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.708 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.7 OUTLIER -146.31 -147.53 0.22 Allowed 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.836 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.518 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -85.87 127.76 34.66 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.07 -1.019 . . . . 0.0 110.716 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -143.32 159.32 42.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.466 0.65 . . . . 0.0 110.996 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.652 ' HB2' ' HB3' ' A' ' 303' ' ' ALA . 7.6 m-20 -91.13 108.55 19.95 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.935 HD11 HD12 ' A' ' 436' ' ' LEU . 2.5 mt -57.83 -30.25 65.59 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.276 -0.89 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 303' ' ' ALA . 53.1 p-10 -79.53 -19.87 48.51 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.845 -1.159 . . . . 0.0 109.883 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.652 ' HB3' ' HB2' ' A' ' 300' ' ' ASP . . . -84.12 -27.95 27.81 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.377 -0.827 . . . . 0.0 109.103 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.535 HG13 ' HD3' ' A' ' 338' ' ' LYS . 62.3 t -81.04 -38.51 16.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.786 0.803 . . . . 0.0 109.352 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.728 HD22 HG11 ' A' ' 341' ' ' VAL . 71.2 mt -77.1 -26.43 53.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 110.385 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -65.82 -31.16 78.87 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -83.0 -33.13 26.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -1.153 . . . . 0.0 109.628 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.504 HG11 ' HB ' ' A' ' 341' ' ' VAL . 58.9 t -78.32 -19.29 13.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.439 -0.788 . . . . 0.0 109.667 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.686 HD11 ' CG1' ' A' ' 358' ' ' VAL . 0.9 OUTLIER -83.57 -42.98 17.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.674 0.749 . . . . 0.0 109.259 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.84 -18.5 60.93 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.705 0.764 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.536 ' HB3' ' OE1' ' A' ' 312' ' ' GLU . . . -90.54 -55.1 3.71 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.753 0.787 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.536 ' OE1' ' HB3' ' A' ' 311' ' ' ALA . 58.1 mp0 -104.48 50.65 0.79 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.721 0.772 . . . . 0.0 109.206 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.584 ' HA ' HD13 ' A' ' 319' ' ' ILE . 0.3 OUTLIER -76.03 32.94 0.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.77 -0.581 . . . . 0.0 111.545 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 53.76 48.46 61.62 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 1.7 t80 53.82 37.03 25.51 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.444 -1.033 . . . . 0.0 110.079 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 5.5 mt-10 61.09 37.33 17.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.792 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 19.7 tpp180 -69.05 -85.2 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.575 0.703 . . . . 0.0 109.667 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.2 pt-20 -169.2 67.21 0.06 Allowed 'General case' 0 C--N 1.273 -2.718 0 O-C-N 121.538 -0.726 . . . . 0.0 110.526 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.692 HG23 HG23 ' A' ' 358' ' ' VAL . 1.8 mp -90.95 129.89 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 109.707 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -89.08 103.12 15.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.663 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 18.3 p -88.81 123.81 33.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.419 -0.801 . . . . 0.0 111.094 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . 0.459 ' HB3' ' CB ' ' A' ' 359' ' ' SER . . . -146.55 79.09 1.52 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.539 HD12 ' H ' ' A' ' 360' ' ' SER . 5.8 mp -88.41 157.08 18.8 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.379 -0.825 . . . . 0.0 110.322 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.433 ' CD1' ' HD2' ' A' ' 325' ' ' PRO . 21.7 t80 -40.39 141.99 0.8 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.504 -0.747 . . . . 0.0 110.422 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.433 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.0 Cg_endo -83.07 60.32 7.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.04 1.547 . . . . 0.0 111.205 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . -176.92 -75.25 0.05 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.5 OUTLIER 165.05 116.57 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.581 -0.952 . . . . 0.0 108.932 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.536 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 2.7 mm -69.27 178.17 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.061 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.5 mt-10 -173.65 101.44 0.11 Allowed 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 121.469 0.652 . . . . 0.0 110.697 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 1.015 HG12 HG22 ' A' ' 438' ' ' VAL . 16.5 m -143.65 161.26 16.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.094 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -81.13 92.4 6.27 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.596 ' SD ' HD12 ' A' ' 337' ' ' ILE . 22.0 ttp -144.79 153.99 42.23 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.712 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.606 ' CD2' ' HB2' ' A' ' 295' ' ' PRO . 7.3 t-160 -78.73 119.84 78.73 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.778 -0.577 . . . . 0.0 109.682 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 43.5 Cg_endo -70.75 -21.16 29.24 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.662 1.348 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.742 ' C ' HD12 ' A' ' 335' ' ' LEU . 0.1 OUTLIER -84.52 -63.01 1.41 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.235 -0.916 . . . . 0.0 110.188 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 335' ' ' LEU . 3.1 m -52.78 -35.4 56.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.903 -1.123 . . . . 0.0 110.096 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.734 HD11 ' CE1' ' A' ' 416' ' ' HIS . 3.1 mm -73.93 -45.88 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.221 -0.924 . . . . 0.0 110.032 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.535 ' HD3' HG13 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -43.33 -44.32 5.47 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.13 -0.981 . . . . 0.0 109.197 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -49.9 59.77 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.522 0.677 . . . . 0.0 110.315 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.623 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -52.23 -30.91 29.7 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.301 -0.874 . . . . 0.0 111.674 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.728 HG11 HD22 ' A' ' 305' ' ' LEU . 40.9 t -89.94 -23.73 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.913 -1.117 . . . . 0.0 111.424 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.51 -24.81 60.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.002 -1.061 . . . . 0.0 111.137 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -90.16 -19.0 24.76 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.024 -1.047 . . . . 0.0 111.673 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.6 ttm -82.28 -25.42 34.04 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.917 -1.114 . . . . 0.0 112.196 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.448 ' H ' HG22 ' A' ' 345' ' ' VAL . 23.3 m -90.39 -32.39 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.685 -1.259 . . . . 0.0 111.869 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 312' ' ' GLU . 73.4 t -74.28 -21.14 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 120.971 -1.08 . . . . 0.0 110.79 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -79.95 -19.97 46.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.041 -1.037 . . . . 0.0 110.421 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.493 ' O ' ' HA3' ' A' ' 352' ' ' GLY . . . -89.92 -20.09 23.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 0.0 110.511 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -80.79 -21.31 41.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.096 -1.002 . . . . 0.0 110.773 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 346' ' ' VAL . 4.9 mmt180 -87.76 -70.09 0.65 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.091 -1.005 . . . . 0.0 110.535 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . 0.437 ' O ' ' C ' ' A' ' 352' ' ' GLY . 0.2 OUTLIER -77.43 -35.11 54.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 110.377 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 348' ' ' ALA . . . -42.41 -51.65 5.4 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 352' ' ' GLY . 36.4 m-20 43.27 50.1 5.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.296 -1.12 . . . . 0.0 110.356 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -162.02 -80.74 0.04 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.044 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.1 OUTLIER -165.69 149.66 8.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.145 -1.209 . . . . 0.0 109.854 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.603 HD12 HG13 ' A' ' 319' ' ' ILE . 8.3 mt -114.41 165.67 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.218 -0.926 . . . . 0.0 110.73 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.4 OUTLIER -148.4 101.32 3.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.189 -0.944 . . . . 0.0 110.391 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.692 HG23 HG23 ' A' ' 319' ' ' ILE . 99.0 t -104.45 88.08 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.108 -0.995 . . . . 0.0 109.803 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 322' ' ' ALA . 53.2 p -115.01 134.99 54.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.086 -1.008 . . . . 0.0 110.932 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.539 ' H ' HD12 ' A' ' 323' ' ' LEU . 1.8 t -117.39 144.39 45.0 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.482 -0.761 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.599 ' C ' HG22 ' A' ' 362' ' ' THR . . . -140.66 -161.14 8.58 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.599 HG22 ' C ' ' A' ' 361' ' ' GLY . 0.0 OUTLIER 171.12 176.9 0.06 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.14 -1.212 . . . . 0.0 110.962 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.562 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 2.4 mt-10 -147.65 178.19 1.53 Allowed Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 46.0 Cg_endo -81.45 50.28 3.47 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.636 1.335 . . . . 0.0 109.791 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 365' ' ' ASN . 10.2 p-10 165.59 -3.7 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.795 -0.566 . . . . 0.0 111.266 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 14.2 mtm-85 -166.18 109.37 0.77 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.118 -0.989 . . . . 0.0 110.976 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.715 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -103.19 162.08 13.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.103 -0.998 . . . . 0.0 108.765 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.66 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 31.3 p-90 -170.31 162.92 8.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.715 -1.24 . . . . 0.0 111.131 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 39.8 p90 -133.54 133.82 42.6 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -122.84 152.13 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 111.986 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 15.5 t -132.09 122.05 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.558 ' CG ' ' HB2' ' A' ' 431' ' ' SER . 2.3 mt-10 -116.75 139.34 50.68 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 110.395 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 373' ' ' ASP . 3.3 p30 -141.0 145.82 36.45 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.263 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -104.04 114.55 28.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.323 -0.861 . . . . 0.0 110.346 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -172.55 -109.84 0.23 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.1 -168.32 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.93 1.49 . . . . 0.0 110.532 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -141.72 -160.24 8.24 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 0.554 ' CG1' HD21 ' A' ' 430' ' ' LEU . 3.0 mt -111.88 159.04 12.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.24 -1.153 . . . . 0.0 109.842 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 382' ' ' GLN . . . -91.01 161.24 35.93 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.931 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 46.3 Cg_endo -72.77 -46.1 0.45 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.087 1.572 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . 0.518 ' O ' ' CE1' ' A' ' 385' ' ' HIS . 0.0 OUTLIER -73.17 -53.33 11.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.833 . . . . 0.0 110.082 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.592 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 0.0 OUTLIER -56.08 -33.33 64.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.259 -0.9 . . . . 0.0 109.808 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -40.33 13.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.679 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -71.21 -41.3 70.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.501 -0.749 . . . . 0.0 109.422 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.592 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 1.2 p-80 -120.05 74.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.602 -0.686 . . . . 0.0 109.804 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.76 ' O ' HD13 ' A' ' 386' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.109 -0.994 . . . . 0.0 110.386 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.72 ' O ' HD13 ' A' ' 412' ' ' ILE . 3.8 tp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.312 0.577 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.584 ' HA ' HD13 ' A' ' 412' ' ' ILE . 8.8 p -126.73 -2.69 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.3 -0.875 . . . . 0.0 110.079 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 1.8 mm100 -82.34 -53.33 6.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 109.91 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.433 ' HA ' ' HB2' ' A' ' 414' ' ' ASP . 0.0 OUTLIER -61.52 -19.91 62.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.381 -0.824 . . . . 0.0 109.772 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.72 HD13 ' O ' ' A' ' 408' ' ' ILE . 1.0 OUTLIER -69.24 -73.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.653 ' N ' HG22 ' A' ' 412' ' ' ILE . 91.8 t -57.77 -20.13 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.363 -0.835 . . . . 0.0 109.763 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 1.8 m-20 -78.74 -33.19 46.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.371 -0.83 . . . . 0.0 109.966 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.55 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 0.8 OUTLIER -74.24 -19.86 60.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.038 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.734 ' CE1' HD11 ' A' ' 337' ' ' ILE . 41.3 m80 -92.75 -35.94 13.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.57 -0.706 . . . . 0.0 109.597 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.1 t30 80.71 32.39 0.15 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.641 -0.662 . . . . 0.0 110.608 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.565 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -95.71 -89.61 1.77 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.546 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.1 OUTLIER -177.79 162.88 1.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -1.218 . . . . 0.0 112.079 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 13.8 tp -152.63 102.7 2.73 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 0.3 OUTLIER -119.37 164.28 15.94 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.685 -1.259 . . . . 0.0 113.128 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 23.3 mt -107.07 136.93 46.08 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 431' ' ' SER . . . -97.97 154.79 20.29 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.883 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 87.0 m . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.432 -1.04 . . . . 0.0 110.01 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.666 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.554 HD21 ' CG1' ' A' ' 378' ' ' ILE . 12.4 mt -60.38 114.01 2.7 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.18 0.991 . . . . 0.0 111.948 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.558 ' HB2' ' CG ' ' A' ' 372' ' ' GLU . 0.3 OUTLIER -123.53 100.05 6.61 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 73.1 mt -89.31 122.53 40.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.914 -1.116 . . . . 0.0 111.496 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.76 100.17 9.58 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.686 -0.634 . . . . 0.0 109.646 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.5 128.81 36.03 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.66 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 86.9 m95 -110.36 159.23 17.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.804 -1.185 . . . . 0.0 113.382 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.935 HD12 HD11 ' A' ' 301' ' ' LEU . 51.5 mt -148.33 109.09 3.64 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.565 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 39.9 Cg_endo -64.35 139.91 67.69 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.778 1.409 . . . . 0.0 112.488 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 1.015 HG22 HG12 ' A' ' 330' ' ' VAL . 22.0 t -113.12 102.23 54.51 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 C--N 1.301 -1.935 0 O-C-N 123.83 1.437 . . . . 0.0 110.57 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.654 ' CB ' ' CD2' ' A' ' 333' ' ' HIS . 53.4 Cg_endo . . . . . 0 N--CA 1.452 -0.941 0 N-CA-C 109.475 -1.01 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' MET . . . . . 0.498 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 41.25 94.98 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 122.16 0.981 . . . . 0.0 110.851 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.0 mt-10 -144.67 -164.26 1.88 Allowed 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' MET . . . . . 0.446 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.0 OUTLIER -88.7 129.36 35.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 110.108 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.671 ' HB3' ' SD ' ' A' ' 332' ' ' MET . . . -149.77 167.19 27.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.323 -0.861 . . . . 0.0 111.316 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.675 ' O ' HG23 ' A' ' 304' ' ' VAL . 26.3 t70 -96.36 117.89 31.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.735 . . . . 0.0 109.551 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.669 HD11 HD12 ' A' ' 436' ' ' LEU . 20.3 mt -65.36 -22.37 66.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.094 -1.004 . . . . 0.0 110.015 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.773 ' HA ' HD23 ' A' ' 323' ' ' LEU . 43.7 t-20 -80.77 -22.28 40.29 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.996 -1.065 . . . . 0.0 108.755 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.485 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -84.17 -32.51 24.58 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.589 0.709 . . . . 0.0 109.454 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 300' ' ' ASP . 21.8 t -77.29 -37.72 25.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.587 -0.695 . . . . 0.0 109.529 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 88.4 mt -76.86 -26.64 54.49 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.69 -38.24 95.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -76.39 -35.59 58.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -1.118 . . . . 0.0 109.336 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.99 HG11 HG12 ' A' ' 341' ' ' VAL . 92.8 t -75.24 -18.8 16.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.55 0.691 . . . . 0.0 109.441 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.574 ' CD1' HG22 ' A' ' 321' ' ' THR . 0.0 OUTLIER -77.6 -43.77 29.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.783 0.801 . . . . 0.0 109.123 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . 0.452 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -75.17 -17.7 60.33 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.539 0.685 . . . . 0.0 109.866 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -88.11 -45.22 10.32 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 111.155 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -98.47 31.32 2.88 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.211 -0.93 . . . . 0.0 111.25 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.654 ' OG ' HD13 ' A' ' 319' ' ' ILE . 1.0 OUTLIER -82.84 -7.53 59.65 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.06 -1.025 . . . . 0.0 109.974 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 87.56 -53.95 4.38 Favored Glycine 0 C--N 1.286 -2.198 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 19.3 t80 174.54 36.16 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 1.6 tm-20 70.02 36.17 2.02 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 317' ' ' ARG . 0.0 OUTLIER -67.86 -90.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.337 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 317' ' ' ARG . 20.5 mt-10 -152.17 73.77 1.06 Allowed 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.233 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.675 ' CG2' HG23 ' A' ' 358' ' ' VAL . 3.3 mp -105.1 134.3 46.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.297 -0.877 . . . . 0.0 109.182 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' GLU . . . . . 0.507 ' HB3' ' CG ' ' A' ' 357' ' ' LYS . 3.1 tt0 -99.55 108.6 21.06 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.035 -1.041 . . . . 0.0 110.121 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.574 HG22 ' CD1' ' A' ' 309' ' ' ILE . 15.3 p -93.97 126.5 39.22 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 110.744 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -147.81 78.23 1.44 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.374 -0.829 . . . . 0.0 109.414 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' LEU . . . . . 0.773 HD23 ' HA ' ' A' ' 302' ' ' ASN . 4.2 mp -91.0 156.35 18.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.393 -0.817 . . . . 0.0 110.462 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' TYR . . . . . 0.605 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 69.2 t80 -45.8 125.62 6.61 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.893 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.51 68.93 8.16 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.885 1.466 . . . . 0.0 110.217 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -173.31 24.38 0.07 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 326' ' ' GLY . 0.0 OUTLIER 50.41 101.62 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 O-C-N 121.017 -1.284 . . . . 0.0 110.432 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 329' ' ' GLU . 1.1 mt -78.52 -176.61 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.35 -0.843 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -176.54 111.26 0.09 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.791 0.805 . . . . 0.0 110.87 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.864 HG12 HG22 ' A' ' 438' ' ' VAL . 8.5 m -142.48 162.12 18.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-O 121.391 0.615 . . . . 0.0 109.955 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.3 OUTLIER -78.28 91.0 4.36 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' MET . . . . . 0.759 ' CE ' HG21 ' A' ' 337' ' ' ILE . 4.4 ppp? -135.83 135.36 39.76 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.643 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' HIS . . . . . 0.654 ' CD2' ' CB ' ' A' ' 295' ' ' PRO . 10.3 t-80 -67.34 116.44 36.73 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.461 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 41.0 Cg_endo -65.32 -19.53 61.88 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.62 1.326 . . . . 0.0 110.07 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.641 ' CB ' ' CE1' ' A' ' 333' ' ' HIS . 0.5 OUTLIER -81.14 -46.08 15.44 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.426 -0.797 . . . . 0.0 110.899 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.503 ' O ' HD12 ' A' ' 412' ' ' ILE . 2.2 m -72.73 -37.47 67.73 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.143 -0.973 . . . . 0.0 110.117 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.847 HD11 ' CE1' ' A' ' 416' ' ' HIS . 32.5 mm -71.82 -30.47 37.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.402 -0.812 . . . . 0.0 109.521 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 3.8 mttt -68.29 -43.22 78.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 108.7 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 335' ' ' LEU . 75.5 mtt-85 -72.24 -31.77 66.11 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.474 0.654 . . . . 0.0 110.723 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -73.58 -35.88 65.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 111.035 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.99 HG12 HG11 ' A' ' 308' ' ' VAL . 59.4 t -80.46 -27.85 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 110.552 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.797 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -79.36 -28.29 41.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.183 -0.948 . . . . 0.0 110.182 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -89.77 -24.2 21.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.305 -0.872 . . . . 0.0 110.321 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 347' ' ' ASN . 1.9 mtm -71.65 -47.15 56.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.875 . . . . 0.0 110.386 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.8 t -65.43 -28.36 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 342' ' ' ALA . 71.6 t -56.34 -25.61 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.274 -0.891 . . . . 0.0 110.329 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 344' ' ' MET . 1.0 OUTLIER -56.18 -53.59 55.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.947 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' ALA . . . . . 0.551 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -85.53 -19.13 31.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.861 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.488 ' HB3' ' HA ' ' A' ' 346' ' ' VAL . . . -68.2 -59.66 3.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.319 -0.863 . . . . 0.0 111.668 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.518 ' HG3' ' N ' ' A' ' 351' ' ' TYR . 4.4 ptt-85 -86.5 -41.11 14.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.935 -1.103 . . . . 0.0 111.876 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' TYR . . . . . 0.518 ' N ' ' HG3' ' A' ' 350' ' ' ARG . 0.3 OUTLIER -90.2 -42.44 11.03 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.762 -1.211 . . . . 0.0 110.495 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -85.27 173.54 48.31 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -168.48 72.76 0.1 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.278 -1.131 . . . . 0.0 109.873 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' GLY . . . . . 0.523 ' CA ' ' HB2' ' A' ' 374' ' ' ASP . . . -161.65 67.68 0.24 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.591 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 11.1 t90 59.77 145.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -1.04 . . . . 0.0 111.242 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.417 HD12 HG13 ' A' ' 319' ' ' ILE . 6.0 mt -123.75 162.33 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.591 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 16.6 tttt -150.44 117.73 6.03 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.782 -1.199 . . . . 0.0 111.253 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.675 HG23 ' CG2' ' A' ' 319' ' ' ILE . 3.4 t -106.25 89.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 370' ' ' GLN . 4.4 t -113.44 139.44 48.92 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.273 -0.892 . . . . 0.0 111.229 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . 0.487 ' HB2' ' HG ' ' A' ' 323' ' ' LEU . 3.7 m -138.33 158.11 44.93 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.384 -0.823 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.559 ' C ' HG22 ' A' ' 362' ' ' THR . . . -148.3 -154.69 6.37 Favored Glycine 0 C--N 1.295 -1.713 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' THR . . . . . 0.605 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER 175.02 169.25 0.29 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.03 -1.276 . . . . 0.0 110.71 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.468 ' CD ' ' HD2' ' A' ' 364' ' ' PRO . 3.1 mm-40 -149.39 172.23 5.44 Favored Pre-proline 0 C--N 1.293 -1.887 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' PRO . . . . . 0.534 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 40.2 Cg_endo -66.24 116.28 3.94 Favored 'Trans proline' 0 C--N 1.299 -2.075 0 O-C-N 123.682 1.359 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 4.4 t-20 74.25 34.72 0.8 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.655 -0.653 . . . . 0.0 111.009 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.1 OUTLIER 165.81 97.51 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.305 -0.872 . . . . 0.0 111.214 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.41 171.34 7.42 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.158 -0.963 . . . . 0.0 109.039 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' TRP . . . . . 0.64 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 39.2 p-90 -170.96 165.37 7.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.445 -1.41 . . . . 0.0 110.813 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 35.1 p90 -139.28 131.33 27.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.485 -0.759 . . . . 0.0 109.336 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' GLN . . . . . 0.523 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 20.5 tt0 -116.08 151.33 35.78 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.246 -0.909 . . . . 0.0 111.773 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.523 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 89.0 t -127.05 142.4 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.564 -0.71 . . . . 0.0 109.636 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.43 ' HG3' ' C ' ' A' ' 371' ' ' VAL . 55.4 mt-10 -137.81 129.58 28.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.4 -0.812 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -159.55 161.55 35.25 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.536 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' ASP . . . . . 0.523 ' HB2' ' CA ' ' A' ' 354' ' ' GLY . 0.5 OUTLIER -80.46 152.64 28.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 110.494 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . 0.468 ' HA2' ' HA2' ' A' ' 352' ' ' GLY . . . 164.64 -146.33 11.23 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.616 ' O ' HD23 ' A' ' 430' ' ' LEU . 42.4 Cg_endo -72.89 -169.48 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.053 1.554 . . . . 0.0 110.554 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -145.22 139.4 8.34 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' ILE . . . . . 1.049 HD11 HD12 ' A' ' 422' ' ' LEU . 3.9 mt -81.08 170.81 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.102 -1.234 . . . . 0.0 109.923 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.947 ' HB3' ' HG2' ' A' ' 382' ' ' GLN . . . -151.32 175.99 2.58 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.252 -0.905 . . . . 0.0 110.324 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.879 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 49.5 Cg_endo -71.96 -34.25 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.061 1.558 . . . . 0.0 110.236 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.71 -21.73 30.01 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.849 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' GLN . . . . . 0.947 ' HG2' ' HB3' ' A' ' 379' ' ' ALA . 1.6 mm-40 -90.75 -18.27 25.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.129 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 1.6 tpp85 -60.25 -19.75 55.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.126 -0.984 . . . . 0.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -20.71 26.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.868 . . . . 0.0 110.618 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' HIS . . . . . 0.583 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 20.6 m-70 -63.05 -46.63 86.6 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.147 -0.971 . . . . 0.0 111.222 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 386' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.034 -1.041 . . . . 0.0 110.94 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' ILE . . . . . 0.796 HG23 HG23 ' A' ' 409' ' ' VAL . 6.3 tt . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.291 0.567 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.796 HG23 HG23 ' A' ' 408' ' ' ILE . 99.5 t -128.24 -31.91 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 109.868 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 2.3 mt-30 -69.42 -49.56 53.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.257 -0.902 . . . . 0.0 109.888 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.56 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.6 OUTLIER -65.88 -20.93 66.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.269 -0.894 . . . . 0.0 109.827 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.896 HG21 ' HB2' ' A' ' 340' ' ' ALA . 18.5 mm -68.12 -69.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 108.934 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.795 HG11 ' HB2' ' A' ' 420' ' ' LEU . 87.1 t -62.76 -21.15 26.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.368 -0.833 . . . . 0.0 109.015 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 8.4 t70 -75.24 -31.71 60.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.588 -0.695 . . . . 0.0 109.403 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' ASN . . . . . 0.498 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.1 m-20 -76.97 -14.74 59.81 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.405 -0.81 . . . . 0.0 109.12 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.847 ' CE1' HD11 ' A' ' 337' ' ' ILE . 38.9 m80 -92.51 -34.47 14.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.579 -0.7 . . . . 0.0 109.861 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 4.7 m-20 80.58 19.89 0.51 Allowed 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.374 0.607 . . . . 0.0 110.281 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . 0.564 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -90.03 -92.01 1.23 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' MET . . . . . 0.567 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 31.6 ttm -176.9 162.01 2.04 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.189 -1.183 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.795 ' HB2' HG11 ' A' ' 413' ' ' VAL . 21.2 tp -151.32 104.91 3.14 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.387 -0.82 . . . . 0.0 108.832 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.487 ' O ' HG23 ' A' ' 432' ' ' ILE . 0.5 OUTLIER -112.98 143.31 44.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.974 -1.079 . . . . 0.0 111.902 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 1.049 HD12 HD11 ' A' ' 378' ' ' ILE . 3.5 mm? -99.42 80.69 2.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.485 -0.759 . . . . 0.0 109.402 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 429' ' ' GLY . . . -50.98 104.51 0.14 Allowed Glycine 0 C--N 1.28 -2.532 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.255 -1.144 . . . . 0.0 109.09 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 423' ' ' GLY . . . . . . . . 0 N--CA 1.494 2.507 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 376' ' ' PRO . 2.7 mm? -65.82 106.37 1.51 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.196 0.998 . . . . 0.0 111.831 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' SER . . . . . 0.455 ' O ' ' HA3' ' A' ' 423' ' ' GLY . 0.0 OUTLIER -145.76 100.72 3.46 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 421' ' ' GLU . 80.6 mt -92.0 151.9 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.067 -1.021 . . . . 0.0 112.864 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -124.45 94.86 4.33 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.23 139.83 30.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.786 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' TRP . . . . . 0.64 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 84.9 m95 -120.28 153.12 36.83 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.102 0.953 . . . . 0.0 111.707 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.669 HD12 HD11 ' A' ' 301' ' ' LEU . 86.0 mt -140.72 115.15 7.32 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.564 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 43.9 Cg_endo -70.69 134.24 25.59 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.834 1.439 . . . . 0.0 111.418 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.864 HG22 HG12 ' A' ' 330' ' ' VAL . 21.4 t -94.11 144.16 27.61 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.622 -0.674 . . . . 0.0 110.161 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' PRO . . . . . 0.495 ' HD2' ' CG1' ' A' ' 438' ' ' VAL . 50.8 Cg_endo . . . . . 0 C--N 1.303 -1.828 0 O-C-N 123.993 1.523 . . . . 0.0 110.457 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.281 0.563 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 292' ' ' GLN . . . 151.79 70.05 0.01 OUTLIER Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 291' ' ' GLY . 11.9 mt-30 54.86 166.63 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.268 -1.137 . . . . 0.0 110.085 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.447 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 0.8 OUTLIER -165.19 40.88 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.076 -1.015 . . . . 0.0 110.714 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 6.1 mtt -73.4 111.98 14.06 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.213 -0.93 . . . . 0.0 110.201 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.606 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 55.4 Cg_endo -93.83 -163.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.972 1.512 . . . . 0.0 109.954 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.596 ' HE3' ' HB3' ' A' ' 415' ' ' ASN . 0.1 OUTLIER 23.68 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 122.358 1.075 . . . . 0.0 111.576 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.677 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.9 mm-40 -144.42 -159.51 1.0 Allowed 'General case' 0 C--N 1.267 -3.02 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.217 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.667 ' HA ' ' HA ' ' A' ' 331' ' ' LYS . 2.1 mmt -85.2 117.06 23.91 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.109 0.957 . . . . 0.0 110.797 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.732 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -141.18 150.61 42.97 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.061 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.745 ' O ' HG23 ' A' ' 304' ' ' VAL . 13.8 m-20 -85.15 136.57 33.48 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.488 -0.758 . . . . 0.0 109.205 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.691 HD21 ' CE ' ' A' ' 332' ' ' MET . 6.8 mt -73.68 -23.82 59.87 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.955 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 303' ' ' ALA . 47.0 p30 -83.93 -18.96 35.58 Favored 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 118.973 -1.091 . . . . 0.0 108.856 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.511 ' N ' ' OD1' ' A' ' 302' ' ' ASN . . . -82.3 -36.34 27.08 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 300' ' ' ASP . 16.2 t -74.15 -39.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.542 -0.724 . . . . 0.0 109.584 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 62.7 mt -69.55 -33.47 72.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.406 -0.809 . . . . 0.0 110.052 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -67.72 -22.35 73.53 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.99 -38.47 27.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.311 -1.111 . . . . 0.0 108.52 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.468 HG11 ' HB ' ' A' ' 341' ' ' VAL . 88.8 t -77.4 -18.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.641 HD12 ' CG2' ' A' ' 321' ' ' THR . 1.3 mm -78.31 -45.71 26.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.654 0.74 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.99 -18.39 63.33 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.692 0.758 . . . . 0.0 109.067 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.61 -36.67 14.28 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.163 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.589 ' O ' ' CD ' ' A' ' 317' ' ' ARG . 15.3 mm-40 -91.59 8.33 37.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 110.399 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 309' ' ' ILE . 78.2 p -115.67 66.36 0.7 Allowed 'General case' 0 C--N 1.274 -2.703 0 O-C-N 120.898 -1.126 . . . . 0.0 108.187 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.59 ' O ' ' CG ' ' A' ' 315' ' ' TYR . . . -113.71 -32.06 2.18 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.294 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.607 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 90.1 m-85 -155.26 74.43 0.9 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 120.111 1.956 . . . . 0.0 114.408 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.607 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 1.4 tp10 91.5 12.8 0.04 OUTLIER 'General case' 0 CA--C 1.452 -2.804 0 O-C-N 121.732 -0.605 . . . . 0.0 111.901 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.589 ' CD ' ' O ' ' A' ' 312' ' ' GLU . 0.0 OUTLIER -81.68 87.93 6.27 Favored 'General case' 0 C--N 1.259 -3.328 0 N-CA-C 101.034 -3.691 . . . . 0.0 101.034 179.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.713 ' N ' HD12 ' A' ' 356' ' ' ILE . 0.5 OUTLIER -65.74 73.14 0.06 Allowed 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.549 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.707 HG23 HG23 ' A' ' 358' ' ' VAL . 42.6 mt -99.14 116.52 42.42 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.744 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.21 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.433 ' H ' ' HA ' ' A' ' 357' ' ' LYS . 1.5 tp10 -89.6 110.78 21.61 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.641 ' CG2' HD12 ' A' ' 309' ' ' ILE . 12.8 p -88.25 130.13 35.17 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.195 -0.941 . . . . 0.0 112.284 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.73 77.73 1.29 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.566 ' HG ' ' CB ' ' A' ' 360' ' ' SER . 4.1 mp -93.3 167.18 11.91 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.443 -0.786 . . . . 0.0 110.884 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CD2' HG21 ' A' ' 362' ' ' THR . 57.9 t80 -58.94 112.44 5.06 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 121.44 -0.787 . . . . 0.0 109.193 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 324' ' ' TYR . 44.3 Cg_endo -70.3 79.06 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.969 1.51 . . . . 0.0 111.057 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.459 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -175.81 -82.82 0.06 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 0.8 OUTLIER 171.35 107.97 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.453 -1.028 . . . . 0.0 109.443 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.607 HG22 ' H ' ' A' ' 329' ' ' GLU . 5.2 mt -85.43 -179.54 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 O-C-N 121.533 -0.729 . . . . 0.0 109.352 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.607 ' H ' HG22 ' A' ' 328' ' ' ILE . 0.8 OUTLIER -173.98 103.95 0.11 Allowed 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.211 -0.996 . . . . 0.0 112.505 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.56 HG23 ' HG2' ' A' ' 332' ' ' MET . 5.6 m -142.79 142.18 26.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -83.72 101.19 11.38 Favored 'General case' 0 C--N 1.257 -3.44 0 C-N-CA 118.512 -1.275 . . . . 0.0 108.015 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.732 ' HG3' ' HB3' ' A' ' 299' ' ' ALA 0.252 0.0 OUTLIER -135.46 -173.23 3.28 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.707 0.765 . . . . 0.0 111.515 -179.585 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.758 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 6.7 t-80 -109.24 112.27 59.6 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 37.5 Cg_endo -59.87 -18.98 52.51 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 123.719 1.378 . . . . 0.0 110.407 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.758 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 1.6 mt -76.3 -73.92 0.25 Allowed 'General case' 0 C--N 1.292 -1.892 0 O-C-N 121.397 -0.815 . . . . 0.0 109.674 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.432 ' HB3' HG23 ' A' ' 412' ' ' ILE . 0.4 OUTLIER -45.7 -49.78 14.27 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.702 -0.623 . . . . 0.0 110.441 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.669 HD11 ' CE1' ' A' ' 416' ' ' HIS . 6.7 mm -60.19 -40.89 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.084 -1.01 . . . . 0.0 109.999 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 6.1 mtmt -55.46 -48.39 74.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 109.17 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -28.77 67.19 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.415 0.626 . . . . 0.0 110.327 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -67.1 -37.26 83.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.748 . . . . 0.0 110.6 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' A' ' 305' ' ' LEU . 92.8 t -78.69 -35.0 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.125 -0.984 . . . . 0.0 110.207 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.714 ' O ' HG12 ' A' ' 345' ' ' VAL . . . -64.35 -68.75 0.33 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.554 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . 0.916 ' O ' HG22 ' A' ' 346' ' ' VAL . 24.7 m120 -47.52 -19.28 0.17 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.296 -0.877 . . . . 0.0 111.203 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 3.4 mtt -74.92 -42.43 57.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.603 -1.31 . . . . 0.0 110.18 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.736 HG23 HG21 ' A' ' 356' ' ' ILE . 14.7 p -81.16 -18.69 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.844 . . . . 0.0 111.136 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.916 HG22 ' O ' ' A' ' 343' ' ' ASN . 17.9 m -60.02 -20.98 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 O-C-N 121.046 -1.034 . . . . 0.0 110.465 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -84.48 -30.87 24.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 110.666 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 352' ' ' GLY . . . -90.5 -19.1 24.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.946 . . . . 0.0 110.824 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -82.73 -53.58 5.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 110.451 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -72.56 0.14 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 0.0 110.365 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -70.02 -47.4 62.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 110.203 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 348' ' ' ALA . . . -79.9 162.34 46.62 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 353' ' ' ASN . 21.5 t-20 -171.68 29.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.454 -1.027 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 355' ' ' TRP . . . -110.56 -33.05 2.56 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 17.0 t90 178.46 129.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.899 -1.354 . . . . 0.0 111.851 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.736 HG21 HG23 ' A' ' 345' ' ' VAL . 1.7 mt -117.01 146.97 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 372' ' ' GLU . 6.9 tttt -140.42 128.2 21.8 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.487 -1.383 . . . . 0.0 112.087 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.707 HG23 HG23 ' A' ' 319' ' ' ILE . 71.9 t -120.3 108.85 24.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 39.0 t -127.35 160.03 32.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.087 -1.008 . . . . 0.0 111.366 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.566 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -144.49 142.28 30.14 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.596 -0.69 . . . . 0.0 109.679 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -134.87 -166.12 11.03 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.64 HG21 ' CD2' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -173.16 173.11 3.7 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.019 -1.283 . . . . 0.0 111.285 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 4.5 mt-10 -153.08 176.65 2.3 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.675 -0.641 . . . . 0.0 109.524 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.561 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.8 Cg_endo -70.28 105.41 1.56 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.684 1.36 . . . . 0.0 110.782 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.586 ' HA ' ' CG1' ' A' ' 438' ' ' VAL . 8.4 t-20 80.49 34.02 0.14 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.868 -0.52 . . . . 0.0 110.631 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 172.5 105.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.837 . . . . 0.0 111.206 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -105.79 169.08 8.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.094 -1.003 . . . . 0.0 108.504 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 37.6 p-90 -168.43 172.4 8.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.603 -1.311 . . . . 0.0 110.615 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.628 ' CE1' ' HB3' ' A' ' 434' ' ' ALA . 37.6 p90 -143.78 140.94 30.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.37 -0.832 . . . . 0.0 109.923 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 12.4 tt0 -127.0 153.98 45.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.293 -0.879 . . . . 0.0 110.741 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.553 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 88.5 t -124.39 164.37 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.437 -0.79 . . . . 0.0 110.012 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 357' ' ' LYS . 45.7 mt-10 -150.52 135.33 17.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.957 . . . . 0.0 109.764 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -148.67 148.63 30.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.077 -1.014 . . . . 0.0 110.594 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -82.29 158.67 23.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.332 -0.855 . . . . 0.0 110.144 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 153.96 -167.87 32.29 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 427' ' ' ARG . 45.4 Cg_endo -73.23 -26.4 14.72 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.982 1.517 . . . . 0.0 110.589 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 88.63 -171.85 40.15 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.709 HG23 " O2'" ' A' ' 451' ' ' ANP . 54.5 mt -74.91 151.62 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.293 -1.122 . . . . 0.0 110.036 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.671 ' HB3' ' HG3' ' A' ' 382' ' ' GLN . . . -73.76 169.16 19.86 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.136 -0.978 . . . . 0.0 110.011 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.653 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 47.6 Cg_endo -73.19 -38.04 2.99 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.946 1.498 . . . . 0.0 110.291 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . 0.603 ' O ' ' CD2' ' A' ' 385' ' ' HIS . 0.9 OUTLIER -90.45 -37.51 13.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.314 -0.866 . . . . 0.0 110.765 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.671 ' HG3' ' HB3' ' A' ' 379' ' ' ALA . 45.5 mt-30 -62.25 -28.47 69.73 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.259 -0.901 . . . . 0.0 110.299 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.6 -21.51 3.98 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.955 -1.09 . . . . 0.0 109.164 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -31.6 16.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.504 -0.748 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 381' ' ' GLU . 2.1 p80 -117.47 68.95 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.878 -1.139 . . . . 0.0 111.025 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 1.128 HD11 " O4'" ' A' ' 451' ' ' ANP . 0.1 OUTLIER -109.5 71.74 0.78 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.806 ' CE2' HD12 ' A' ' 386' ' ' LEU . 48.7 p90 44.88 45.3 8.46 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-O 121.787 0.803 . . . . 0.0 110.237 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -78.15 133.52 64.65 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.181 -0.949 . . . . 0.0 110.429 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 390' ' ' PHE . 49.4 Cg_endo -79.35 174.57 11.78 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.877 1.462 . . . . 0.0 110.831 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 389' ' ' PRO . 0.3 OUTLIER 61.04 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.376 -0.828 . . . . 0.0 110.865 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 392' ' ' ARG . 11.7 p -124.49 170.91 14.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.52 -0.738 . . . . 0.0 110.097 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . 0.535 ' N ' HG22 ' A' ' 391' ' ' VAL . 0.0 OUTLIER -145.05 98.42 3.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.926 . . . . 0.0 110.25 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 175.43 169.44 37.17 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.25 -5.07 22.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.286 -1.126 . . . . 0.0 110.03 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 47.0 m -145.33 140.93 28.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 110.054 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 397' ' ' ARG . . . -96.61 -31.48 12.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.916 . . . . 0.0 110.181 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 396' ' ' ALA . 5.4 ttt180 60.7 49.68 6.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 88.6 m -75.02 118.67 18.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 110.22 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.602 HG23 ' N ' ' A' ' 400' ' ' SER . 6.9 tt -87.89 -42.88 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.602 ' N ' HG23 ' A' ' 399' ' ' ILE . 8.7 t -171.23 -175.76 1.75 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 110.082 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 115.96 48.8 0.48 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 402' ' ' THR . 8.3 t -94.41 142.17 27.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.203 -1.175 . . . . 0.0 110.257 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 165.62 -137.44 4.69 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.84 167.4 10.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -1.167 . . . . 0.0 110.155 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -120.17 81.57 0.33 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 3.4 mp -91.17 71.12 6.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -1.115 . . . . 0.0 110.115 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 408' ' ' ILE . . . -90.73 44.29 1.19 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.295 -0.878 . . . . 0.0 110.441 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 1.028 HG12 HG23 ' A' ' 409' ' ' VAL . 0.2 OUTLIER -43.5 164.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.275 -0.89 . . . . 0.0 109.916 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 1.028 HG23 HG12 ' A' ' 408' ' ' ILE . 4.3 t 80.52 -59.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 O-C-N 121.947 -0.47 . . . . 0.0 110.42 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 42.0 tt0 -54.78 -58.84 5.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.99 -1.069 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -59.22 -19.56 46.63 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.293 -0.88 . . . . 0.0 110.685 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.532 HG21 ' HB2' ' A' ' 340' ' ' ALA . 11.0 mm -67.29 -70.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.156 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 1.04 HG21 HD13 ' A' ' 420' ' ' LEU . 22.5 t -60.89 -21.09 23.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.347 -0.846 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 5.0 t70 -77.54 -29.41 52.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -0.847 . . . . 0.0 109.841 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.596 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 0.9 OUTLIER -81.37 -14.78 56.82 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.209 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.669 ' CE1' HD11 ' A' ' 337' ' ' ILE . 31.6 m80 -93.36 -37.46 11.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.576 -0.702 . . . . 0.0 109.785 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 13.9 t-20 81.43 42.91 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 121.377 0.608 . . . . 0.0 110.455 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.578 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -111.8 -89.26 1.86 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.564 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 2.6 ttp -173.36 159.76 3.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.159 -1.2 . . . . 0.0 111.464 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 1.04 HD13 HG21 ' A' ' 413' ' ' VAL . 14.0 tp -151.02 109.08 3.72 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.373 -0.83 . . . . 0.0 109.387 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -130.07 161.32 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.923 -1.11 . . . . 0.0 111.083 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.765 HD23 ' CD1' ' A' ' 432' ' ' ILE . 2.9 mt -126.78 138.61 53.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.384 -0.823 . . . . 0.0 110.169 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.639 ' O ' HD12 ' A' ' 430' ' ' LEU . . . -135.88 161.88 24.89 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.513 ' OG1' HD12 ' A' ' 430' ' ' LEU . 0.8 OUTLIER -154.95 129.89 9.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.207 -1.172 . . . . 0.0 110.631 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 426' ' ' GLU . 5.5 t -88.85 98.97 12.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.308 -0.87 . . . . 0.0 109.142 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 425' ' ' SER . 23.5 tt0 59.36 39.4 22.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.351 -0.843 . . . . 0.0 109.733 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 376' ' ' PRO . 64.9 mmt-85 46.93 35.95 3.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.276 -0.89 . . . . 0.0 109.471 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -129.18 -44.52 0.2 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -113.09 84.44 0.36 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 423' ' ' GLY . 15.6 tp -78.4 139.92 38.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -1.169 . . . . 0.0 110.636 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 371' ' ' VAL . 23.3 t -139.3 132.39 29.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.56 -0.713 . . . . 0.0 109.857 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.765 ' CD1' HD23 ' A' ' 422' ' ' LEU . 29.1 mm -92.68 140.64 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.196 -0.94 . . . . 0.0 110.648 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -119.92 97.16 5.48 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.321 -0.862 . . . . 0.0 110.407 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.628 ' HB3' ' CE1' ' A' ' 369' ' ' PHE . . . -103.25 137.4 41.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 110.236 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 88.9 m95 -118.93 153.14 35.08 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.1 -1.0 . . . . 0.0 111.839 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.589 HD12 HD11 ' A' ' 301' ' ' LEU . 24.6 mt -145.35 100.15 4.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.578 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 41.4 Cg_endo -65.75 138.04 52.05 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.967 1.509 . . . . 0.0 111.592 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.798 HG23 ' HD2' ' A' ' 439' ' ' PRO . 2.9 p -93.24 151.2 40.19 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.706 -0.621 . . . . 0.0 109.928 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.813 ' O ' HG23 ' A' ' 441' ' ' THR . 39.5 Cg_endo -64.22 161.32 34.55 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.642 1.338 . . . . 0.0 110.205 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 439' ' ' PRO . 10.3 p -39.26 143.3 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.376 -0.828 . . . . 0.0 110.597 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.813 HG23 ' O ' ' A' ' 439' ' ' PRO . 40.5 p -143.64 -163.03 1.57 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.377 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 5.2 mmt-85 -139.45 82.92 1.91 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 109.989 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -131.3 109.58 10.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.371 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -107.44 -47.97 3.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.224 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 101.73 -170.02 20.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 15.0 t -89.47 140.03 29.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.314 -1.109 . . . . 0.0 110.315 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 447' ' ' THR . 4.0 t -155.72 111.94 3.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -82.56 161.34 22.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -98.08 -41.7 7.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 1.128 " O4'" HD11 ' A' ' 386' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.21 0.528 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -84.67 105.45 2.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.91 105.97 1.22 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.301 -1.117 . . . . 0.0 110.148 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 294' ' ' MET . 0.3 OUTLIER -174.25 38.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.123 -0.986 . . . . 0.0 110.509 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 293' ' ' GLU . 19.5 mtt -154.2 119.62 2.73 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.216 -0.928 . . . . 0.0 110.113 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.624 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 51.4 Cg_endo -85.84 69.26 5.03 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.875 1.46 . . . . 0.0 111.062 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.594 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -90.82 109.41 20.61 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.938 0.875 . . . . 0.0 108.98 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.2 mt-10 -134.53 -156.33 0.72 Allowed 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.73 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.778 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.7 OUTLIER -87.4 131.89 34.15 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.048 -1.033 . . . . 0.0 110.239 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -142.34 147.83 36.94 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 110.972 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 304' ' ' VAL . 1.1 m-20 -89.61 119.8 30.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.427 -0.796 . . . . 0.0 109.454 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 1.051 HD11 HD12 ' A' ' 436' ' ' LEU . 6.5 mt -62.31 -21.12 65.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.008 -1.057 . . . . 0.0 109.801 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.676 ' HA ' HD23 ' A' ' 323' ' ' LEU . 51.4 t-20 -84.25 -22.1 30.91 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.084 -1.01 . . . . 0.0 109.029 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.9 -33.38 22.77 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.714 -0.616 . . . . 0.0 109.823 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.625 ' O ' HG23 ' A' ' 308' ' ' VAL . 22.7 t -79.55 -34.72 16.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.342 -0.849 . . . . 0.0 109.407 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 94.3 mt -75.28 -31.29 60.69 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.408 -0.808 . . . . 0.0 110.161 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -63.39 -31.0 79.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -80.17 -34.07 37.86 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.39 -1.065 . . . . 0.0 109.362 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 1.057 HG11 ' CG1' ' A' ' 341' ' ' VAL . 97.7 t -74.76 -20.38 16.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.64 0.733 . . . . 0.0 109.103 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.648 HG13 HG11 ' A' ' 358' ' ' VAL . 1.1 mt -75.88 -50.87 21.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.59 -16.43 63.4 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.83 0.824 . . . . 0.0 108.929 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -62.98 -66.35 0.55 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.7 -0.625 . . . . 0.0 110.765 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.93 44.54 2.88 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.868 -1.133 . . . . 0.0 111.884 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.554 ' CB ' ' CD1' ' A' ' 319' ' ' ILE . 3.3 p -86.63 27.12 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.866 -1.146 . . . . 0.0 110.358 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.494 ' O ' ' HG2' ' A' ' 317' ' ' ARG . . . 43.55 42.74 6.03 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 12.7 m-85 58.86 49.37 9.91 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.702 -0.881 . . . . 0.0 109.608 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 0.7 OUTLIER 59.93 62.24 1.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.61 0.719 . . . . 0.0 110.834 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 314' ' ' GLY . 16.2 mmm180 -71.66 -82.79 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.907 0.861 . . . . 0.0 109.092 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -147.14 55.9 1.11 Allowed 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.83 HG13 HD12 ' A' ' 356' ' ' ILE . 19.6 mt -97.47 131.9 43.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.75 -0.594 . . . . 0.0 110.627 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.484 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 1.1 tp10 -91.52 107.06 18.95 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 16.9 p -94.36 122.85 37.34 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 111.133 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.1 77.06 1.48 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.676 HD23 ' HA ' ' A' ' 302' ' ' ASN . 6.1 mp -95.47 140.6 30.1 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.373 -0.83 . . . . 0.0 109.977 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 9.8 t80 -42.68 121.84 2.81 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.447 -0.783 . . . . 0.0 109.826 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.14 59.88 7.21 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.974 1.513 . . . . 0.0 110.194 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . -158.74 20.4 0.31 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 53.8 m 55.29 100.12 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.253 -1.145 . . . . 0.0 110.363 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.686 HG22 ' H ' ' A' ' 329' ' ' GLU . 2.7 mt -76.23 -175.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 121.532 -0.73 . . . . 0.0 109.14 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.686 ' H ' HG22 ' A' ' 328' ' ' ILE . 3.4 mt-10 -171.45 110.96 0.32 Allowed 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.315 -0.866 . . . . 0.0 111.241 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.778 ' C ' ' HE2' ' A' ' 298' ' ' MET . 29.7 m -144.44 149.95 16.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 O-C-N 121.583 -0.698 . . . . 0.0 110.092 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.7 OUTLIER -68.69 98.25 0.88 Allowed 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.73 ' HB2' HG23 ' A' ' 330' ' ' VAL . 4.8 ttp -144.76 159.72 42.4 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.76 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.633 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 19.5 t-160 -101.88 117.02 62.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.483 ' O ' ' HE2' ' A' ' 338' ' ' LYS . 33.8 Cg_endo -54.74 -31.59 72.38 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.458 1.241 . . . . 0.0 111.429 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.633 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 6.6 mt -69.86 -69.75 0.33 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.888 -1.133 . . . . 0.0 110.428 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 335' ' ' LEU . 23.8 m -43.28 -60.36 1.72 Allowed 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.675 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.631 HD11 ' CE1' ' A' ' 416' ' ' HIS . 8.5 mm -55.41 -35.02 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.228 -0.92 . . . . 0.0 110.676 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 1.3 mtmm -56.11 -47.39 78.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.9 -1.125 . . . . 0.0 109.11 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -37.51 76.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.805 -0.559 . . . . 0.0 110.227 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.829 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -66.56 -23.87 66.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 1.057 ' CG1' HG11 ' A' ' 308' ' ' VAL . 72.6 t -89.98 -28.13 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.804 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.924 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -73.94 -30.24 62.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.371 -0.831 . . . . 0.0 109.937 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -69.23 -23.37 63.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.904 . . . . 0.0 109.913 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.489 ' HG2' HG13 ' A' ' 432' ' ' ILE . 0.3 OUTLIER -90.55 -25.19 20.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.824 . . . . 0.0 110.613 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 90.2 t -90.45 -23.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.098 -1.001 . . . . 0.0 111.107 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 342' ' ' ALA . 97.0 t -68.2 -20.11 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.984 -1.072 . . . . 0.0 110.405 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 351' ' ' TYR . 2.1 m120 -63.49 -51.78 64.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.464 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' A' ' 373' ' ' ASP . . . -90.84 -19.07 23.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.402 -0.811 . . . . 0.0 111.029 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.65 -81.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.967 -1.083 . . . . 0.0 110.883 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.476 ' CG ' ' N ' ' A' ' 351' ' ' TYR . 27.7 ptt180 -92.01 -44.92 8.59 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.218 -0.926 . . . . 0.0 111.392 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . 0.476 ' N ' ' CG ' ' A' ' 350' ' ' ARG . 9.0 t80 -64.11 -40.45 96.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.209 -0.932 . . . . 0.0 110.729 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 348' ' ' ALA . . . -109.6 173.71 17.21 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -159.21 28.64 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -1.039 . . . . 0.0 109.85 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -89.29 -59.85 1.52 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.573 ' CH2' ' HB2' ' A' ' 357' ' ' LYS . 19.9 t90 -176.15 132.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -1.135 . . . . 0.0 110.132 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.83 HD12 HG13 ' A' ' 319' ' ' ILE . 5.9 mt -102.0 158.53 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.422 -0.799 . . . . 0.0 109.209 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.573 ' HB2' ' CH2' ' A' ' 355' ' ' TRP . 0.5 OUTLIER -144.09 104.93 4.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.027 -1.045 . . . . 0.0 110.654 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.68 HG23 HG23 ' A' ' 319' ' ' ILE . 41.2 t -107.94 89.88 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 108.86 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 4.0 t -121.01 138.4 54.18 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.387 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.559 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.1 t -120.97 145.12 48.08 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -141.45 -172.42 13.24 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -159.85 172.07 18.3 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.196 -1.179 . . . . 0.0 110.585 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.471 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -145.34 175.57 2.68 Favored Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.526 -0.734 . . . . 0.0 109.643 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 41.5 Cg_endo -68.15 111.34 2.44 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.699 1.368 . . . . 0.0 111.133 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 3.9 t-20 72.75 29.24 1.97 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.531 -0.731 . . . . 0.0 111.118 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 19.7 ptt-85 171.64 116.73 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.325 -0.859 . . . . 0.0 110.773 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.641 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.4 179.98 4.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.102 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.618 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 36.8 p-90 -170.55 143.93 2.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.619 -1.301 . . . . 0.0 110.309 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.634 ' HB3' HD13 ' A' ' 301' ' ' LEU . 31.8 p90 -114.16 140.28 48.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.286 -0.884 . . . . 0.0 109.257 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 432' ' ' ILE . 27.0 tt0 -130.95 149.95 52.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 111.979 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 37.7 t -128.78 150.66 34.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 357' ' ' LYS . 29.3 tt0 -150.12 140.43 22.28 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.992 -1.067 . . . . 0.0 109.692 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 348' ' ' ALA . 1.7 p30 -161.12 168.95 23.32 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.976 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.3 151.89 20.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.428 -0.795 . . . . 0.0 110.32 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 162.81 -156.46 28.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.52 ' O ' ' N7 ' ' A' ' 451' ' ' ANP . 49.9 Cg_endo -74.53 137.75 23.29 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.961 1.506 . . . . 0.0 110.614 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -92.03 -174.04 42.33 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.589 HG12 ' N9 ' ' A' ' 451' ' ' ANP . 3.2 mt -110.69 97.88 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.005 -1.291 . . . . 0.0 109.891 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.957 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -68.56 178.83 0.76 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.28 -0.888 . . . . 0.0 110.547 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.957 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 43.0 Cg_endo -70.8 -19.75 30.81 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.165 1.613 . . . . 0.0 110.012 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.46 -30.67 17.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 109.579 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.573 ' HB3' " O2'" ' A' ' 451' ' ' ANP . 3.5 mt-30 -85.0 -19.22 32.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.465 -0.772 . . . . 0.0 109.829 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.487 ' O ' ' OE1' ' A' ' 388' ' ' GLN . 36.0 ttm-85 -54.25 -52.03 62.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.395 -0.815 . . . . 0.0 110.521 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.552 ' HA ' ' OE1' ' A' ' 388' ' ' GLN . 7.7 mmtt -44.03 -18.57 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.692 -0.63 . . . . 0.0 111.828 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' A' ' 385' ' ' HIS . 0.6 OUTLIER -111.55 42.08 1.77 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.814 -1.179 . . . . 0.0 111.642 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.608 HD12 ' O ' ' A' ' 385' ' ' HIS . 0.2 OUTLIER -169.08 104.08 0.39 Allowed 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.158 -1.589 . . . . 0.0 114.322 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.567 ' CE2' HD13 ' A' ' 422' ' ' LEU . 39.2 m-85 62.61 78.3 0.3 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.552 ' OE1' ' HA ' ' A' ' 384' ' ' LYS . 13.6 pt20 -172.8 69.46 0.39 Allowed Pre-proline 0 C--N 1.294 -1.814 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.974 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -80.75 99.75 1.16 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.98 1.516 . . . . 0.0 110.558 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . 0.52 ' C ' HG23 ' A' ' 391' ' ' VAL . 2.2 t80 -178.66 62.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.092 -1.005 . . . . 0.0 110.289 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.52 HG23 ' C ' ' A' ' 390' ' ' PHE . 4.8 t -151.37 64.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.454 -0.779 . . . . 0.0 110.547 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.0 157.05 26.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.88 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 177.01 154.37 11.91 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.71 92.56 4.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -1.105 . . . . 0.0 110.061 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.562 ' O ' ' HB3' ' A' ' 396' ' ' ALA . 10.1 t -164.12 179.69 6.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.228 -0.92 . . . . 0.0 110.289 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 395' ' ' SER . . . 60.57 112.93 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.262 -0.899 . . . . 0.0 110.074 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 398' ' ' THR . 11.0 tpt180 -110.44 159.83 17.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.225 -0.922 . . . . 0.0 110.466 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 397' ' ' ARG . 4.5 p 43.93 -170.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.367 -0.833 . . . . 0.0 110.581 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.483 HG13 ' N ' ' A' ' 400' ' ' SER . 2.9 tp -51.49 155.37 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.346 -0.846 . . . . 0.0 110.095 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.483 ' N ' HG13 ' A' ' 399' ' ' ILE . 3.2 m -102.44 -43.87 5.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.206 -0.934 . . . . 0.0 110.475 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 77.43 66.41 1.79 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 53.7 m -133.33 -51.9 0.88 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.225 -1.162 . . . . 0.0 110.156 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 146.24 77.08 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 1.2 mp -124.12 170.44 10.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.225 -1.162 . . . . 0.0 110.267 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.494 ' H ' HD23 ' A' ' 406' ' ' LEU . . . 132.28 43.8 0.16 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 405' ' ' GLY . 0.6 OUTLIER -121.92 61.87 0.95 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.254 -1.144 . . . . 0.0 110.004 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -104.12 34.6 2.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.292 -0.88 . . . . 0.0 110.725 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.665 ' O ' HG12 ' A' ' 409' ' ' VAL . 0.0 OUTLIER -110.61 159.47 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.783 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.742 ' HA ' HD13 ' A' ' 412' ' ' ILE . 0.4 OUTLIER 79.76 -35.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 121.605 -0.684 . . . . 0.0 110.47 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -69.84 -54.06 15.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.0 -1.062 . . . . 0.0 110.079 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.87 -21.11 41.26 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.28 -0.887 . . . . 0.0 110.013 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.829 HG12 ' HB2' ' A' ' 340' ' ' ALA . 1.0 OUTLIER -66.86 -59.1 4.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.822 HG11 ' HB2' ' A' ' 420' ' ' LEU . 21.2 t -67.94 -22.31 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.523 -0.736 . . . . 0.0 110.031 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -82.44 -23.45 34.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.551 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.51 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 58.8 m-20 -83.31 -21.91 33.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.517 -0.739 . . . . 0.0 109.203 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.631 ' CE1' HD11 ' A' ' 337' ' ' ILE . 37.7 m80 -92.77 -37.2 12.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.579 -0.701 . . . . 0.0 109.894 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.5 t-20 81.95 29.64 0.13 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.798 -0.564 . . . . 0.0 111.015 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.589 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -98.39 -90.66 1.96 Allowed Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.53 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.6 tpp -175.89 161.57 2.5 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.278 -1.131 . . . . 0.0 111.168 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.822 ' HB2' HG11 ' A' ' 413' ' ' VAL . 27.0 tp -152.66 108.12 3.29 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.353 -0.842 . . . . 0.0 109.312 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.61 138.14 48.68 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.782 -1.199 . . . . 0.0 111.738 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.567 HD13 ' CE2' ' A' ' 387' ' ' PHE . 0.2 OUTLIER -90.57 130.5 36.6 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -122.56 114.84 2.56 Favored Glycine 0 C--N 1.291 -1.964 0 C-N-CA 119.577 -1.296 . . . . 0.0 110.006 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.0 m -66.0 102.12 0.76 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.406 -1.055 . . . . 0.0 108.651 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.53 ' CB ' ' HG3' ' A' ' 427' ' ' ARG . 33.2 t -53.63 137.29 37.44 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.274 -0.891 . . . . 0.0 110.368 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 425' ' ' SER . 6.4 pt-20 -39.23 -27.51 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.527 0.68 . . . . 0.0 109.72 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.598 ' HD3' ' N ' ' A' ' 429' ' ' GLY . 0.3 OUTLIER -74.34 24.45 0.08 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.522 -0.736 . . . . 0.0 111.381 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 53.56 38.72 58.92 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.738 ' C ' HD22 ' A' ' 430' ' ' LEU . . . -132.74 -154.14 7.47 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.738 HD22 ' C ' ' A' ' 429' ' ' GLY . 2.4 mm? -130.18 152.21 49.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.885 -1.362 . . . . 0.0 113.308 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 11.3 p -142.34 113.18 7.43 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.489 HG13 ' HG2' ' A' ' 344' ' ' MET . 21.6 mm -87.09 118.15 32.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.837 -1.165 . . . . 0.0 111.112 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . 0.412 ' HD2' ' HE1' ' A' ' 435' ' ' TRP . 2.6 ttm180 -105.52 95.29 5.71 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.62 ' HB3' ' CE2' ' A' ' 369' ' ' PHE . . . -98.82 137.52 37.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.323 -0.86 . . . . 0.0 110.998 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.618 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 92.1 m95 -109.01 155.05 21.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.848 . . . . 0.0 111.24 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 1.051 HD12 HD11 ' A' ' 301' ' ' LEU . 53.7 mt -145.63 101.05 4.32 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.589 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 39.8 Cg_endo -63.88 136.98 55.7 Favored 'Trans proline' 0 C--N 1.297 -2.142 0 O-C-N 124.069 1.562 . . . . 0.0 111.836 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.641 HG13 ' HD2' ' A' ' 439' ' ' PRO . 89.7 t -81.99 146.23 55.07 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.72 -0.612 . . . . 0.0 110.158 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.641 ' HD2' HG13 ' A' ' 438' ' ' VAL . 56.5 Cg_endo -76.53 -163.5 0.21 Allowed 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 124.196 1.629 . . . . 0.0 110.121 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.95 59.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 O-C-N 121.738 -0.601 . . . . 0.0 109.992 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 59.2 p -92.48 -32.17 14.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -0.873 . . . . 0.0 110.468 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -147.2 124.08 11.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.953 . . . . 0.0 110.313 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -94.9 140.26 30.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.097 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -144.36 154.59 43.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 131.49 102.24 0.89 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 35.0 p -140.72 152.83 45.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -1.107 . . . . 0.0 110.252 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 448' ' ' LYS . 67.8 p -100.36 -32.66 10.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 110.123 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 447' ' ' THR . 0.0 OUTLIER 37.7 -153.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.63 -0.669 . . . . 0.0 110.59 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.26 -68.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 110.321 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 CA-C-O 117.93 -1.483 . . . . 0.0 109.582 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.62 ' C5 ' ' HG ' ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 290' ' ' THR . 5.2 t . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.222 0.534 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 292' ' ' GLN . . . -96.94 -162.8 32.23 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . 0.446 ' CB ' ' O ' ' A' ' 291' ' ' GLY . 0.1 OUTLIER 66.83 32.12 6.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.174 -1.192 . . . . 0.0 110.126 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.43 62.22 0.55 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 109.723 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.587 ' CB ' ' CD ' ' A' ' 295' ' ' PRO . 1.0 OUTLIER -79.69 -172.04 0.31 Allowed Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.377 -0.827 . . . . 0.0 109.811 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 294' ' ' MET . 43.3 Cg_endo -83.21 64.77 7.82 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 O-C-N 124.026 1.54 . . . . 0.0 110.998 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.565 ' HE2' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -88.37 102.92 15.35 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.435 -0.79 . . . . 0.0 109.747 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.0 mt-10 -118.53 -167.59 1.39 Allowed 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.584 -0.697 . . . . 0.0 109.347 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 1.8 mmt -88.19 124.92 34.32 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.886 -1.134 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.686 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -143.33 150.32 39.01 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.441 0.638 . . . . 0.0 111.163 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.534 ' HB3' ' CB ' ' A' ' 303' ' ' ALA . 46.9 t0 -84.44 118.81 24.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.899 HD11 HD12 ' A' ' 436' ' ' LEU . 7.1 mt -64.46 -22.56 67.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.968 -1.082 . . . . 0.0 109.726 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.795 ' HA ' HD23 ' A' ' 323' ' ' LEU . 48.2 m-20 -81.24 -19.78 42.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.967 -1.083 . . . . 0.0 108.735 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -84.61 -35.9 22.4 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.695 -0.628 . . . . 0.0 109.485 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.805 ' O ' HG23 ' A' ' 308' ' ' VAL . 21.5 t -77.25 -34.6 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.494 -0.754 . . . . 0.0 109.267 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 91.9 mt -77.23 -28.65 53.77 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.505 -0.747 . . . . 0.0 109.68 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -63.63 -42.1 98.87 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.62 -30.46 61.67 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.477 -1.014 . . . . 0.0 109.065 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 304' ' ' VAL . 74.4 t -75.22 -21.29 16.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 1.017 ' CG1' HG11 ' A' ' 358' ' ' VAL . 3.2 mt -77.38 -41.36 29.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -64.07 -17.66 63.61 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -83.31 -43.91 15.48 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.351 0.596 . . . . 0.0 109.866 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.727 ' OE2' HG21 ' A' ' 358' ' ' VAL . 6.7 pt-20 -81.67 10.88 5.34 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.359 -0.838 . . . . 0.0 110.306 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 314' ' ' GLY . 60.5 p -117.64 69.64 0.78 Allowed 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 313' ' ' SER . . . -42.59 -30.15 0.85 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 313' ' ' SER . 28.6 t80 -162.69 36.21 0.11 Allowed 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.788 -0.831 . . . . 0.0 109.984 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.34 56.32 8.11 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.092 -1.005 . . . . 0.0 108.538 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -68.31 -55.34 12.46 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-O 121.372 0.606 . . . . 0.0 110.746 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' A' ' 355' ' ' TRP . 7.4 pt-20 -170.59 58.56 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.862 0 C-N-CA 119.471 -0.892 . . . . 0.0 112.087 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.88 HG13 HD12 ' A' ' 356' ' ' ILE . 2.2 mp -106.9 125.38 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.788 -1.195 . . . . 0.0 110.225 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.19 116.77 29.18 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 7.6 p -95.25 129.91 42.2 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.418 -0.802 . . . . 0.0 111.173 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.76 79.17 1.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.479 -0.763 . . . . 0.0 109.393 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.795 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.7 mp -95.06 160.95 14.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.444 -0.785 . . . . 0.0 110.525 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.597 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 83.9 t80 -50.42 129.06 25.16 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.171 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.05 71.76 6.87 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.767 1.404 . . . . 0.0 110.695 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -179.72 28.19 0.05 OUTLIER Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.36 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 326' ' ' GLY . 29.3 m 46.59 99.12 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.079 -1.248 . . . . 0.0 110.209 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.535 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 3.0 mt -69.23 174.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 121.431 -0.793 . . . . 0.0 110.099 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 4.9 mt-10 -168.14 105.44 0.48 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.793 0.806 . . . . 0.0 110.714 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.91 HG11 ' HB3' ' A' ' 367' ' ' ALA . 9.9 m -133.42 171.45 18.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 O-C-N 121.749 -0.594 . . . . 0.0 109.751 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -87.25 90.9 8.53 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.981 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.952 ' CE ' HG21 ' A' ' 337' ' ' ILE . 16.6 ptm -142.58 162.17 36.16 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 111.15 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 23.6 t-160 -91.56 114.21 61.1 Favored Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 36.3 Cg_endo -58.35 -18.76 39.79 Favored 'Trans proline' 0 C--N 1.295 -2.243 0 O-C-N 123.388 1.204 . . . . 0.0 109.87 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.615 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -84.19 -70.62 0.56 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.392 -0.817 . . . . 0.0 110.735 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.578 ' HB3' ' CE1' ' A' ' 416' ' ' HIS . 10.6 t -51.65 -36.43 46.12 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.29 -0.881 . . . . 0.0 110.569 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.952 HG21 ' CE ' ' A' ' 332' ' ' MET . 37.3 mm -70.62 -43.04 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 110.091 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 4.7 tppt? -52.28 -35.03 49.11 Favored 'General case' 0 C--N 1.312 -1.045 0 O-C-N 120.911 -1.118 . . . . 0.0 108.866 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.15 -36.33 35.31 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.535 0.683 . . . . 0.0 109.824 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 1.089 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -56.0 -48.66 75.49 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.586 -0.697 . . . . 0.0 110.5 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.793 ' CG1' HG11 ' A' ' 308' ' ' VAL . 70.2 t -75.21 -38.33 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.513 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.752 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -50.42 -53.99 25.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.325 -0.86 . . . . 0.0 110.748 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -19.81 61.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.103 -0.998 . . . . 0.0 110.512 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 0.5 OUTLIER -69.46 -45.17 69.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.121 -0.987 . . . . 0.0 110.529 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 84.4 t -80.09 -20.59 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.431 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 342' ' ' ALA . 25.4 t -60.02 -20.59 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.124 -0.985 . . . . 0.0 110.074 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 0.6 OUTLIER -69.08 -41.88 76.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.314 -0.866 . . . . 0.0 110.475 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.694 ' HB1' ' CB ' ' A' ' 373' ' ' ASP . . . -90.29 -20.39 22.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.188 -0.945 . . . . 0.0 110.92 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -78.3 -52.12 9.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 110.219 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -90.43 -45.61 8.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 110.482 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 347' ' ' ASN . 1.9 m-85 -89.8 -25.88 20.85 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.231 -0.918 . . . . 0.0 110.557 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -63.96 -135.18 0.01 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -133.83 -48.83 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.205 -1.173 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . 0.479 ' O ' HG13 ' A' ' 356' ' ' ILE . . . -171.48 -87.33 0.07 OUTLIER Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.213 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.448 ' HA ' ' CG ' ' A' ' 318' ' ' GLU . 37.3 t90 -42.83 132.6 3.81 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.23 -1.159 . . . . 0.0 112.469 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.88 HD12 HG13 ' A' ' 319' ' ' ILE . 2.8 mt -125.26 145.66 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.516 ' HD3' ' HB3' ' A' ' 372' ' ' GLU . 5.9 tttt -125.54 110.67 14.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.564 -1.335 . . . . 0.0 110.372 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 1.017 HG11 ' CG1' ' A' ' 309' ' ' ILE . 22.1 t -106.24 101.74 12.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 109.266 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 33.8 m -130.02 152.49 49.42 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.562 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.2 OUTLIER -147.07 153.22 39.71 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.63 -0.669 . . . . 0.0 109.697 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -144.27 -160.67 8.59 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 108.394 -1.883 . . . . 0.0 108.394 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.2 OUTLIER -173.0 178.87 2.41 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.893 -1.357 . . . . 0.0 111.302 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.561 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 3.5 mt-10 -160.89 -178.52 0.89 Allowed Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 38.0 Cg_endo -64.41 135.34 45.72 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.245 1.129 . . . . 0.0 110.341 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.533 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 15.2 p30 39.71 33.71 0.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.764 -0.585 . . . . 0.0 110.562 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER -174.17 94.0 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.258 -0.901 . . . . 0.0 111.421 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.91 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -103.27 151.35 22.79 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.673 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 30.7 p-90 -144.68 174.07 11.29 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.362 -1.461 . . . . 0.0 111.247 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 369' ' ' PHE . 9.2 p90 -148.92 139.33 22.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.671 -0.643 . . . . 0.0 109.408 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 432' ' ' ILE . 50.1 tt0 -130.72 163.94 26.16 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.252 -0.905 . . . . 0.0 111.648 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.442 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 32.0 t -132.17 156.05 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.607 -0.683 . . . . 0.0 110.01 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 357' ' ' LYS . 10.2 tt0 -149.83 131.46 14.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.074 -1.016 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.694 ' CB ' ' HB1' ' A' ' 348' ' ' ALA . 35.9 m-20 -136.99 162.74 32.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.003 -1.061 . . . . 0.0 110.88 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -87.96 142.17 28.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.963 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 157.63 -168.4 34.31 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.46 -176.66 2.86 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 O-C-N 124.053 1.554 . . . . 0.0 110.692 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . 0.574 ' O ' ' N3 ' ' A' ' 451' ' ' ANP . . . -90.49 -131.47 4.78 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.774 HD11 HD21 ' A' ' 430' ' ' LEU . 3.1 mm -103.29 145.03 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.041 -1.27 . . . . 0.0 109.93 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.871 ' HB3' ' HB3' ' A' ' 382' ' ' GLN . . . -39.79 160.11 0.11 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.506 -0.746 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.28 -54.23 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.055 1.555 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -75.33 -23.19 57.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.82 . . . . 0.0 110.165 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.871 ' HB3' ' HB3' ' A' ' 379' ' ' ALA . 1.1 tt0 -82.92 -23.25 33.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.953 . . . . 0.0 109.682 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.18 -22.31 0.97 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.398 -0.814 . . . . 0.0 110.091 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -87.51 -35.11 18.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 0.0 110.053 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.505 ' N ' ' ND1' ' A' ' 385' ' ' HIS . 2.3 m-70 -80.52 -69.67 0.58 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.218 -0.926 . . . . 0.0 110.647 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 1.062 ' CD1' HD13 ' A' ' 422' ' ' LEU . 0.3 OUTLIER 63.86 99.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.949 ' CE2' HD21 ' A' ' 420' ' ' LEU . 2.0 m-85 62.38 35.13 15.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 386' ' ' LEU . 29.7 mt-30 -145.97 60.99 6.92 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.024 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.496 ' O ' ' CG ' ' A' ' 390' ' ' PHE . 42.0 Cg_endo -69.3 84.27 0.59 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 124.126 1.593 . . . . 0.0 110.346 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . 0.496 ' CG ' ' O ' ' A' ' 389' ' ' PRO . 12.5 m-85 -162.96 108.79 1.15 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 109.801 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 3.2 t -106.33 144.79 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.95 . . . . 0.0 110.334 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.02 58.24 4.09 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.262 -0.898 . . . . 0.0 109.907 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -88.38 37.35 3.29 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.75 -176.7 5.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -1.139 . . . . 0.0 110.215 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 396' ' ' ALA . 8.6 t -97.1 31.39 2.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 0.0 110.339 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 395' ' ' SER . . . 57.45 99.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.131 -0.981 . . . . 0.0 110.366 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.9 ttt85 -120.68 -68.75 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 0.0 110.002 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -179.93 2.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.252 -0.905 . . . . 0.0 110.148 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 18.2 tt -48.75 155.5 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.877 . . . . 0.0 110.278 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 83.1 p -123.8 80.46 1.81 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.17 -0.956 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -150.24 -85.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.414 ' O ' ' CZ ' ' A' ' 390' ' ' PHE . 0.7 OUTLIER -106.46 -94.19 0.37 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -1.166 . . . . 0.0 110.596 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 404' ' ' LEU . . . 94.28 -167.74 27.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 403' ' ' GLY . 0.3 OUTLIER 176.71 162.19 0.41 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.186 -1.185 . . . . 0.0 110.338 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -140.67 -48.33 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -165.59 24.34 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -1.207 . . . . 0.0 110.25 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -109.89 125.43 52.79 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.189 -0.944 . . . . 0.0 110.355 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.778 HG23 HG23 ' A' ' 409' ' ' VAL . 1.0 OUTLIER -113.04 -166.59 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 109.805 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.778 HG23 HG23 ' A' ' 408' ' ' ILE . 3.7 t 79.22 -27.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.662 0 O-C-N 121.718 -0.614 . . . . 0.0 110.699 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 19.4 tt0 -57.92 -57.53 12.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.89 -1.131 . . . . 0.0 110.139 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -63.53 -34.91 78.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 110.659 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 1.089 HG21 ' HB2' ' A' ' 340' ' ' ALA . 1.4 mp -56.37 -73.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.936 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.82 HG22 HD21 ' A' ' 417' ' ' ASN . 85.7 t -50.92 -34.54 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.457 -0.777 . . . . 0.0 110.321 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 0.1 OUTLIER -59.28 -39.39 82.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.206 -0.934 . . . . 0.0 110.138 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.536 ' O ' ' CE ' ' A' ' 296' ' ' MET . 22.5 m-80 -110.61 7.23 22.32 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.406 -0.809 . . . . 0.0 110.304 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.77 ' CG ' HD11 ' A' ' 337' ' ' ILE . 8.9 m80 -115.98 -56.95 2.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 111.577 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 1.098 ' HA ' HD23 ' A' ' 436' ' ' LEU . 0.0 OUTLIER -98.77 -87.7 0.34 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.986 -1.071 . . . . 0.0 110.944 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 149.74 -37.15 0.97 Allowed Glycine 0 C--N 1.263 -3.488 0 C-N-CA 117.791 -2.147 . . . . 0.0 109.824 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.612 ' HB3' ' HB2' ' A' ' 435' ' ' TRP . 2.7 ttp -117.08 145.6 43.65 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.139 -1.212 . . . . 0.0 111.354 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.949 HD21 ' CE2' ' A' ' 387' ' ' PHE . 23.0 tp -151.91 87.13 1.33 Allowed 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -107.94 158.51 17.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.2 -0.937 . . . . 0.0 111.3 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 1.062 HD13 ' CD1' ' A' ' 386' ' ' LEU . 0.3 OUTLIER -108.35 131.86 54.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.59 -0.694 . . . . 0.0 110.785 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 424' ' ' THR . . . -130.66 -177.88 15.13 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 429' ' ' GLY . 5.4 m 65.5 155.83 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.152 -1.205 . . . . 0.0 111.079 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.543 ' HA ' ' CD2' ' A' ' 430' ' ' LEU . 0.2 OUTLIER -178.33 -143.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.57 -0.706 . . . . 0.0 109.635 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -61.55 -13.22 19.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.088 -1.008 . . . . 0.0 109.548 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.551 ' HG2' ' N ' ' A' ' 428' ' ' GLY . 0.0 OUTLIER -72.39 -27.06 62.13 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.422 -0.799 . . . . 0.0 110.433 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.551 ' N ' ' HG2' ' A' ' 427' ' ' ARG . . . -176.94 47.76 0.1 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.738 ' O ' HG22 ' A' ' 424' ' ' THR . . . 85.16 -146.19 21.78 Favored Glycine 0 N--CA 1.497 2.732 0 O-C-N 121.142 -1.211 . . . . 0.0 110.393 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.774 HD21 HD11 ' A' ' 378' ' ' ILE . 0.2 OUTLIER -141.24 160.38 40.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.55 -0.971 . . . . 0.0 109.737 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.705 ' H ' HD13 ' A' ' 430' ' ' LEU . 5.1 p -156.48 151.29 25.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.327 -0.858 . . . . 0.0 109.66 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.476 ' O ' ' HG3' ' A' ' 370' ' ' GLN . 12.8 mt -120.35 121.94 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 110.258 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . 0.455 ' HG2' ' CD ' ' A' ' 370' ' ' GLN . 12.0 mtm180 -99.42 122.88 43.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 110.113 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -122.11 133.08 54.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.673 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 86.0 m95 -110.55 135.91 50.49 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 120.898 -1.126 . . . . 0.0 112.888 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 1.098 HD23 ' HA ' ' A' ' 417' ' ' ASN . 6.9 mt -115.28 87.68 16.8 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 417' ' ' ASN . 47.1 Cg_endo -83.56 121.11 2.9 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 O-C-N 124.041 1.548 . . . . 0.0 111.617 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 438' ' ' VAL . 2.8 t -74.16 112.31 16.33 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.319 -0.863 . . . . 0.0 109.037 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 52.1 Cg_endo -71.65 -177.02 2.25 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.84 1.442 . . . . 0.0 110.995 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 37.9 t -44.0 157.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 121.682 -0.636 . . . . 0.0 110.201 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 1.6 t -134.93 -20.55 1.72 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.218 -0.926 . . . . 0.0 111.159 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -170.36 1.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.924 -1.11 . . . . 0.0 110.933 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 444' ' ' GLN . . . -129.66 93.54 3.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.449 -0.782 . . . . 0.0 110.054 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 443' ' ' ALA . 6.1 pt20 -177.73 156.54 1.13 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 169.14 -36.62 0.2 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 446' ' ' THR . 3.9 t -111.44 107.17 16.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 110.05 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.01 174.33 11.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 110.135 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.98 95.18 5.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -170.23 106.94 0.33 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 110.434 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.498 179.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.655 " O4'" HG23 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.205 0.526 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -122.1 48.9 0.92 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -134.68 100.49 4.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -1.133 . . . . 0.0 110.512 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -133.04 40.2 3.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.307 -0.871 . . . . 0.0 109.817 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.437 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 8.4 tpt -79.8 134.2 57.47 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.432 -0.792 . . . . 0.0 110.571 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 294' ' ' MET . 50.6 Cg_endo -90.36 40.61 0.41 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.849 1.447 . . . . 0.0 110.094 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.608 ' HE2' ' NE2' ' A' ' 416' ' ' HIS . 1.0 OUTLIER -114.23 105.34 13.05 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.617 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 47.0 mt-10 -136.25 -154.06 0.54 Allowed 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.454 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.683 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 1.6 mmt -87.12 132.67 33.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.921 . . . . 0.0 110.699 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.726 ' HB3' ' CG ' ' A' ' 332' ' ' MET . . . -148.05 158.2 43.93 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.088 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.7 OUTLIER -90.51 119.46 30.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.485 -0.759 . . . . 0.0 109.705 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.831 HD11 HD12 ' A' ' 436' ' ' LEU . 8.4 mt -65.77 -19.9 66.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.039 -1.038 . . . . 0.0 109.645 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.801 ' HA ' HD23 ' A' ' 323' ' ' LEU . 52.0 t-20 -84.69 -19.98 31.94 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.111 -0.993 . . . . 0.0 108.913 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.9 -36.03 21.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.598 -0.689 . . . . 0.0 109.322 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.743 ' O ' HG23 ' A' ' 308' ' ' VAL . 22.3 t -78.16 -38.46 23.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.526 -0.734 . . . . 0.0 109.214 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 88.5 mt -76.92 -28.21 55.19 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.424 -0.798 . . . . 0.0 109.991 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.83 -25.24 75.36 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.832 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 3.8 mt-10 -83.85 -33.17 24.9 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.46 -1.023 . . . . 0.0 109.272 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 1.049 HG11 ' CG1' ' A' ' 341' ' ' VAL . 40.2 t -72.45 -28.73 29.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.459 -0.776 . . . . 0.0 109.118 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.6 HG13 HG11 ' A' ' 358' ' ' VAL . 4.6 mt -72.58 -57.08 7.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.77 -16.5 64.3 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.82 0.819 . . . . 0.0 109.014 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.832 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -65.94 -66.42 0.55 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.763 -0.586 . . . . 0.0 111.047 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.421 ' HG2' ' C ' ' A' ' 311' ' ' ALA . 4.5 mm-40 -127.47 42.8 3.25 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.871 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.557 ' CB ' HD13 ' A' ' 319' ' ' ILE . 7.0 p -86.11 32.1 0.62 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.878 -1.139 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 51.68 23.15 9.56 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.548 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 0.2 OUTLIER 70.59 43.65 0.74 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.844 -0.797 . . . . 0.0 110.249 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 74.58 52.02 0.09 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.486 -0.759 . . . . 0.0 110.725 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.459 ' HG3' ' HA3' ' A' ' 314' ' ' GLY . 12.8 mmm180 -68.27 -83.05 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 122.019 0.914 . . . . 0.0 109.144 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -145.82 50.03 1.2 Allowed 'General case' 0 C--N 1.268 -2.971 0 CA-C-O 122.011 0.91 . . . . 0.0 109.886 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.647 HG13 HD12 ' A' ' 356' ' ' ILE . 5.2 mt -99.46 135.8 33.28 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.24 102.93 14.33 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.32 -0.863 . . . . 0.0 109.43 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.566 ' CG2' HD13 ' A' ' 309' ' ' ILE . 19.0 p -91.63 129.1 37.66 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.409 -0.807 . . . . 0.0 111.293 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.38 78.5 1.38 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.801 HD23 ' HA ' ' A' ' 302' ' ' ASN . 6.5 mp -95.12 154.46 17.17 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.442 -0.786 . . . . 0.0 110.277 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.585 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 20.7 t80 -40.36 120.13 1.58 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.695 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -79.18 69.42 7.93 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.878 1.462 . . . . 0.0 111.366 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . -172.23 -76.46 0.05 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.6 OUTLIER 167.52 108.96 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.525 -0.985 . . . . 0.0 109.359 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 329' ' ' GLU . 3.8 mt -87.66 178.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 O-C-N 121.468 -0.77 . . . . 0.0 109.995 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.632 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.5 mt-10 -171.58 102.26 0.19 Allowed 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.566 0.698 . . . . 0.0 110.297 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 1.153 HG12 HG22 ' A' ' 438' ' ' VAL . 21.3 m -133.86 158.54 42.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.943 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.3 OUTLIER -79.41 98.81 6.9 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.726 ' CG ' ' HB3' ' A' ' 299' ' ' ALA . 4.9 ppp? -139.93 172.7 12.4 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.188 -0.945 . . . . 0.0 112.194 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.5 ' NE2' ' HB3' ' A' ' 335' ' ' LEU . 21.9 t-160 -106.92 114.62 61.4 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 37.7 Cg_endo -61.17 -21.14 70.76 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.405 1.213 . . . . 0.0 111.04 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.5 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 1.9 tp -87.78 -54.62 4.16 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.984 -1.072 . . . . 0.0 110.141 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.753 ' O ' HD12 ' A' ' 412' ' ' ILE . 0.4 OUTLIER -63.83 -25.13 68.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.286 -0.884 . . . . 0.0 110.661 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 1.042 HD11 ' CE1' ' A' ' 416' ' ' HIS . 32.0 mm -85.34 -42.56 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.633 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 11.9 mtmt -57.86 -34.91 70.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 108.06 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -72.43 -43.77 63.35 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.526 0.679 . . . . 0.0 109.991 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 1.039 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -60.89 -30.66 70.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.505 -0.747 . . . . 0.0 110.973 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 1.049 ' CG1' HG11 ' A' ' 308' ' ' VAL . 98.7 t -78.62 -40.18 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.069 -1.019 . . . . 0.0 110.541 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.94 98.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -0.898 . . . . 0.0 110.828 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . 0.717 ' O ' HG12 ' A' ' 346' ' ' VAL . 1.3 t30 -58.71 -20.35 48.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.258 -0.901 . . . . 0.0 110.981 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.8 mtt -84.53 -57.64 3.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.054 -1.029 . . . . 0.0 110.504 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.488 HG23 HG21 ' A' ' 356' ' ' ILE . 5.4 p -63.73 -19.49 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.303 -0.873 . . . . 0.0 110.756 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 343' ' ' ASN . 9.5 p -64.64 -19.99 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.083 -1.011 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -74.07 -55.86 5.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.101 -0.999 . . . . 0.0 110.415 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -76.19 -19.56 58.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 110.623 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.12 -50.72 30.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 0.0 109.992 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 346' ' ' VAL . 6.7 mmm180 -53.6 -69.18 0.13 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -0.936 . . . . 0.0 109.715 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.57 -53.92 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 109.888 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 86.13 65.3 1.43 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -64.57 -48.89 73.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.152 -1.204 . . . . 0.0 110.099 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . 150.92 -7.52 0.66 Allowed Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.302 -1.428 . . . . 0.0 111.205 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.549 ' CZ3' ' NH1' ' A' ' 427' ' ' ARG . 40.6 t90 -162.83 138.22 6.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.374 -1.662 . . . . 0.0 112.658 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.647 HD12 HG13 ' A' ' 319' ' ' ILE . 3.1 mt -128.3 164.87 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 372' ' ' GLU . 2.8 tttt -147.06 134.86 21.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.477 -1.389 . . . . 0.0 111.389 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.6 HG11 HG13 ' A' ' 309' ' ' ILE . 11.0 t -133.77 82.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 55.9 p -116.27 136.15 53.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.289 -0.882 . . . . 0.0 110.536 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 323' ' ' LEU . 0.8 OUTLIER -137.38 158.69 43.85 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.622 -0.673 . . . . 0.0 109.914 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -146.74 -150.26 5.15 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -165.55 177.46 7.38 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.21 -1.171 . . . . 0.0 110.077 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -152.88 175.89 2.71 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 110.165 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.7 Cg_endo -70.18 117.24 4.99 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.895 1.471 . . . . 0.0 110.892 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 48.0 t30 71.99 19.54 4.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.381 -0.824 . . . . 0.0 110.972 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 6.5 ptt180 173.73 127.46 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.431 -0.793 . . . . 0.0 110.834 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.727 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -114.45 -179.55 3.66 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.611 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 28.0 p-90 -169.23 162.39 10.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.449 -1.407 . . . . 0.0 110.968 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 37.9 p90 -131.6 158.66 40.44 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.542 ' NE2' ' HG2' ' A' ' 433' ' ' ARG . 4.1 mt-30 -144.89 151.35 38.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.858 -1.151 . . . . 0.0 112.228 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 57.2 t -129.88 155.03 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 357' ' ' LYS . 5.3 mt-10 -145.05 159.43 42.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.944 -1.098 . . . . 0.0 109.987 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.448 ' OD2' HD12 ' A' ' 430' ' ' LEU . 2.5 p30 -147.09 153.04 39.48 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.019 -1.05 . . . . 0.0 110.886 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.22 135.83 51.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.343 -0.848 . . . . 0.0 110.095 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 144.17 173.02 15.24 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.28 -166.83 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.846 1.445 . . . . 0.0 110.38 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -92.65 175.01 36.82 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.72 HG23 " O2'" ' A' ' 451' ' ' ANP . 3.4 mt -70.07 144.23 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -1.107 . . . . 0.0 110.138 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.707 ' HB3' ' HG3' ' A' ' 382' ' ' GLN . . . -74.13 153.94 88.48 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.141 -0.974 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.68 -21.75 21.5 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.861 1.453 . . . . 0.0 110.25 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . 0.414 ' O ' ' CD2' ' A' ' 385' ' ' HIS . 10.8 tt0 -90.65 -30.96 16.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.266 -0.897 . . . . 0.0 110.605 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.707 ' HG3' ' HB3' ' A' ' 379' ' ' ALA . 1.2 mt-30 -90.16 -18.83 25.06 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.31 -0.869 . . . . 0.0 110.806 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 379' ' ' ALA . 45.7 ttp85 -52.72 -54.59 31.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.217 -0.927 . . . . 0.0 110.769 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -19.97 8.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.129 -0.982 . . . . 0.0 110.407 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 385' ' ' HIS . 8.4 m-70 -91.51 28.43 1.72 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.275 -0.891 . . . . 0.0 111.049 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.686 HD11 " O4'" ' A' ' 451' ' ' ANP . 0.2 OUTLIER -128.5 77.14 1.75 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.934 -1.104 . . . . 0.0 110.728 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.564 ' CG ' ' C ' ' A' ' 386' ' ' LEU . 17.5 p90 38.14 49.24 1.22 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.515 -0.741 . . . . 0.0 110.61 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.508 ' HB2' ' HD2' ' A' ' 389' ' ' PRO . 3.3 pt20 -60.06 166.77 3.4 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.592 -0.693 . . . . 0.0 109.756 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 388' ' ' GLN . 44.2 Cg_endo -71.3 175.96 8.6 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.829 1.436 . . . . 0.0 110.572 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . 0.558 ' C ' HG23 ' A' ' 391' ' ' VAL . 22.4 p90 -131.28 124.99 31.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 110.156 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.558 HG23 ' C ' ' A' ' 390' ' ' PHE . 19.9 t -153.45 44.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 110.589 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' A' ' 393' ' ' GLY . 13.0 tpp180 -44.71 160.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.086 -1.009 . . . . 0.0 109.981 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 392' ' ' ARG . . . -57.91 -119.33 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 394' ' ' ASP . 28.3 p-10 -48.02 141.19 6.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.119 -1.224 . . . . 0.0 110.37 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.9 m -164.09 46.05 0.11 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 110.298 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -53.84 -89.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 0.0 109.806 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.549 ' CZ ' ' CB ' ' A' ' 397' ' ' ARG . 0.1 OUTLIER -108.69 54.09 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.892 . . . . 0.0 110.152 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 7.7 p -114.29 100.9 8.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.261 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.4 mp -106.64 -35.48 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 110.436 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 2.1 m 52.29 -172.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -115.13 59.63 0.41 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 26.2 m -80.64 88.18 5.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -1.142 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -172.41 75.54 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 405' ' ' GLY . 0.4 OUTLIER -79.4 96.27 5.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.265 -1.138 . . . . 0.0 110.222 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 404' ' ' LEU . . . -43.73 103.84 0.05 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 3.3 tp -153.85 -61.85 0.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.235 -1.156 . . . . 0.0 110.279 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -101.12 -165.31 1.19 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.241 -0.912 . . . . 0.0 110.263 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.787 ' O ' HG23 ' A' ' 408' ' ' ILE . 9.1 tp -168.11 88.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.122 -0.986 . . . . 0.0 110.681 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 408' ' ' ILE . 9.1 t -160.87 -37.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.183 -0.948 . . . . 0.0 109.863 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 59.4 tt0 -67.9 -57.43 6.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.128 -0.982 . . . . 0.0 109.687 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.454 ' O ' ' OD1' ' A' ' 415' ' ' ASN . 0.4 OUTLIER -56.11 -18.73 10.65 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.245 -0.909 . . . . 0.0 110.297 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 1.039 HG21 ' HB2' ' A' ' 340' ' ' ALA . 18.1 mm -63.47 -71.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.113 -0.992 . . . . 0.0 109.538 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.597 HG21 HD13 ' A' ' 420' ' ' LEU . 10.8 t -64.36 -21.3 28.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 109.23 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 4.8 t0 -81.22 -20.41 41.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.512 -0.743 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 411' ' ' ARG . 1.4 m120 -77.5 -23.73 50.24 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 1.042 ' CE1' HD11 ' A' ' 337' ' ' ILE . 55.2 m80 -91.24 -17.14 26.49 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.703 -0.623 . . . . 0.0 109.367 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.567 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 34.4 m120 67.82 10.49 7.83 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.327 0.584 . . . . 0.0 110.317 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 435' ' ' TRP . . . -69.86 -87.55 0.11 Allowed Glycine 0 N--CA 1.482 1.726 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.577 ' O ' HG11 ' A' ' 413' ' ' VAL . 0.3 OUTLIER 178.02 166.08 0.73 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 111.208 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 413' ' ' VAL . 42.5 tp -151.56 118.81 5.94 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.289 -0.882 . . . . 0.0 109.324 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -129.03 147.86 50.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.969 -1.082 . . . . 0.0 111.356 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.95 127.3 45.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.433 -0.792 . . . . 0.0 109.311 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -176.85 -176.18 44.78 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.807 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.668 HG23 ' N ' ' A' ' 429' ' ' GLY . 74.6 m -90.07 136.28 33.14 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.379 -1.071 . . . . 0.0 110.387 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.586 ' HB3' ' CB ' ' A' ' 431' ' ' SER . 8.5 t -108.45 178.62 4.44 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.358 -0.838 . . . . 0.0 109.763 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 428' ' ' GLY . 2.9 pp20? -44.57 -20.14 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.032 0.444 . . . . 0.0 111.041 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.549 ' NH1' ' CZ3' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -67.45 5.26 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.004 -1.06 . . . . 0.0 110.264 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 426' ' ' GLU . . . 64.78 36.99 93.77 Favored Glycine 0 C--O 1.216 -0.976 0 N-CA-C 108.806 -1.717 . . . . 0.0 108.806 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 424' ' ' THR . . . 170.74 -165.71 38.92 Favored Glycine 0 N--CA 1.505 3.244 0 C-N-CA 117.623 -2.227 . . . . 0.0 113.224 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.668 HD13 ' N ' ' A' ' 431' ' ' SER . 0.2 OUTLIER -35.19 123.21 0.6 Allowed 'General case' 0 N--CA 1.515 2.777 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.668 ' N ' HD13 ' A' ' 430' ' ' LEU . 1.0 OUTLIER -153.76 115.22 4.18 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.645 HD11 ' N1 ' ' A' ' 451' ' ' ANP . 31.8 mt -97.55 145.59 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 110.722 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . 0.542 ' HG2' ' NE2' ' A' ' 370' ' ' GLN . 20.2 mtp180 -126.76 144.11 51.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 109.87 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -139.77 132.68 29.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.615 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.611 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 87.5 m95 -111.46 157.98 19.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.044 -1.035 . . . . 0.0 112.082 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.831 HD12 HD11 ' A' ' 301' ' ' LEU . 75.4 mt -147.26 127.62 6.84 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.446 ' C ' ' HD3' ' A' ' 439' ' ' PRO . 43.1 Cg_endo -70.13 141.41 43.68 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.522 1.275 . . . . 0.0 111.845 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 1.153 HG22 HG12 ' A' ' 330' ' ' VAL . 53.7 t -110.67 74.05 0.88 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.577 -0.702 . . . . 0.0 110.416 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.558 ' O ' HG23 ' A' ' 440' ' ' VAL . 49.1 Cg_endo -75.37 75.14 3.96 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.829 1.436 . . . . 0.0 110.979 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.571 HG21 ' SD ' ' A' ' 298' ' ' MET . 11.0 t -154.17 -55.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.048 -1.033 . . . . 0.0 110.506 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 10.0 t -48.15 -28.83 3.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.328 -0.857 . . . . 0.0 111.058 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 443' ' ' ALA . 0.0 OUTLIER -103.9 -176.45 3.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.988 -1.07 . . . . 0.0 110.448 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 442' ' ' ARG . . . -178.71 39.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.24 -0.912 . . . . 0.0 110.2 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . 0.401 ' OE1' ' HD2' ' A' ' 442' ' ' ARG . 33.2 mt-30 -84.07 -68.94 0.68 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.212 -0.93 . . . . 0.0 110.417 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 172.17 -62.07 0.15 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 15.0 t -134.77 177.06 8.09 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.208 -1.172 . . . . 0.0 110.24 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 38.3 p -132.03 44.36 2.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.371 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -138.78 88.83 2.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.94 . . . . 0.0 110.237 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -154.71 156.24 36.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 110.234 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.568 -179.981 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.72 " O2'" HG23 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 290' ' ' THR . 10.0 t . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.235 0.54 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -162.31 -166.83 21.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.92 69.64 1.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -1.091 . . . . 0.0 110.021 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -131.41 35.49 3.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 0.0 110.598 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.555 ' HB3' ' CD ' ' A' ' 295' ' ' PRO . 0.0 OUTLIER -90.15 -178.23 0.93 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.28 -0.887 . . . . 0.0 109.622 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.595 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 46.3 Cg_endo -89.19 45.85 0.88 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.77 1.405 . . . . 0.0 109.871 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.471 ' HE2' ' NE2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -109.49 109.26 20.03 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.4 OUTLIER -148.14 -146.93 0.21 Allowed 'General case' 0 C--N 1.273 -2.737 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.521 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -88.04 144.86 26.28 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.227 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -152.98 162.84 40.83 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.358 -0.839 . . . . 0.0 111.201 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.714 ' O ' HG23 ' A' ' 304' ' ' VAL . 71.4 m-20 -94.32 118.76 32.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.543 -0.723 . . . . 0.0 109.363 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.907 HD11 HD12 ' A' ' 436' ' ' LEU . 5.5 mt -69.82 -21.46 63.38 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.949 -1.095 . . . . 0.0 109.765 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.713 ' OD1' HD23 ' A' ' 323' ' ' LEU . 55.9 t-20 -84.99 -20.04 31.13 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.092 -1.005 . . . . 0.0 108.86 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.598 ' HB3' ' HB2' ' A' ' 300' ' ' ASP . . . -87.32 -34.63 18.8 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.546 0.689 . . . . 0.0 109.506 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 300' ' ' ASP . 18.0 t -80.42 -31.43 12.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.411 -0.805 . . . . 0.0 109.245 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.534 ' CD2' HG21 ' A' ' 341' ' ' VAL . 62.9 mt -80.52 -30.68 37.2 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.433 -0.792 . . . . 0.0 109.969 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -69.52 -32.48 71.38 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.841 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 1.2 mt-10 -78.1 -34.29 50.19 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.405 -1.056 . . . . 0.0 109.043 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 1.057 HG11 ' HB ' ' A' ' 341' ' ' VAL . 88.2 t -78.87 -19.78 12.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 121.664 0.745 . . . . 0.0 109.531 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.997 HD11 ' CG1' ' A' ' 358' ' ' VAL . 0.0 OUTLIER -75.79 -44.09 39.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 122.052 0.93 . . . . 0.0 108.617 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.473 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -91.06 -16.55 27.69 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.282 -0.886 . . . . 0.0 109.735 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -60.42 -62.38 1.9 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.668 -0.645 . . . . 0.0 110.838 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.725 ' CD ' ' HB1' ' A' ' 342' ' ' ALA . 2.7 pt-20 -145.99 38.06 1.08 Allowed 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.94 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.997 ' O ' HD11 ' A' ' 319' ' ' ILE . 6.9 m -91.4 31.41 1.16 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 109.339 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 94.36 21.23 27.66 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 3.0 m-85 62.46 45.55 6.34 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.674 -0.898 . . . . 0.0 109.735 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 1.9 mt-10 59.44 43.24 16.6 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.562 ' CG ' ' N ' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -69.07 -84.98 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.571 0.701 . . . . 0.0 110.041 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.562 ' N ' ' CG ' ' A' ' 317' ' ' ARG . 38.8 mt-10 -136.35 67.81 1.45 Allowed 'General case' 0 C--N 1.275 -2.653 0 CA-C-O 121.608 0.718 . . . . 0.0 111.027 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.997 HD11 ' O ' ' A' ' 313' ' ' SER . 2.6 mp -113.13 129.08 69.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.712 -0.618 . . . . 0.0 109.632 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 358' ' ' VAL . 1.5 tt0 -89.1 100.73 13.45 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.072 -1.018 . . . . 0.0 109.321 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 19.9 p -92.17 130.31 37.92 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.781 0.801 . . . . 0.0 111.697 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.12 78.61 1.34 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.713 HD23 ' OD1' ' A' ' 302' ' ' ASN . 0.9 OUTLIER -89.34 160.51 16.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 111.002 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.64 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 50.8 t80 -59.49 119.4 39.45 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.548 -0.72 . . . . 0.0 110.087 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.22 73.0 5.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.889 1.468 . . . . 0.0 110.573 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -172.06 27.48 0.1 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 326' ' ' GLY . 0.8 OUTLIER 47.12 96.79 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.186 -1.185 . . . . 0.0 110.145 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.663 HG22 ' H ' ' A' ' 329' ' ' GLU . 3.1 mt -73.06 -179.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.658 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.663 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.2 mt-10 -169.48 107.66 0.4 Allowed 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.91 0.862 . . . . 0.0 111.128 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.811 HG11 ' HB3' ' A' ' 367' ' ' ALA . 31.6 m -141.38 153.13 19.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 5.3 tptt -67.55 97.87 0.63 Allowed 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 118.359 -1.336 . . . . 0.0 107.9 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.84 ' SD ' HD13 ' A' ' 436' ' ' LEU . 4.9 ttp -139.69 173.6 11.37 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.469 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.614 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 23.7 t-160 -117.11 113.26 39.45 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.475 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 37.5 Cg_endo -59.9 -20.08 58.07 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.553 1.291 . . . . 0.0 110.634 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.614 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -79.24 -63.01 1.52 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.305 -0.872 . . . . 0.0 110.212 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 412' ' ' ILE . 27.1 p -55.77 -46.93 77.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.108 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.741 HD11 ' CE1' ' A' ' 416' ' ' HIS . 23.6 mm -63.34 -32.35 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.386 -0.821 . . . . 0.0 110.05 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 10.3 mttt -59.27 -45.7 90.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.041 -1.037 . . . . 0.0 109.5 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -31.82 63.59 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.843 -0.536 . . . . 0.0 110.745 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.979 ' HA ' HG12 ' A' ' 409' ' ' VAL . . . -65.03 -45.24 86.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.155 -0.965 . . . . 0.0 110.762 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 1.057 ' HB ' HG11 ' A' ' 308' ' ' VAL . 16.0 t -81.1 -22.21 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 110.291 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.725 ' HB1' ' CD ' ' A' ' 312' ' ' GLU . . . -71.37 -34.73 70.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.325 -0.859 . . . . 0.0 110.682 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -83.27 -19.72 35.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.204 -0.935 . . . . 0.0 110.559 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.529 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 0.1 OUTLIER -75.36 -31.32 60.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.179 -0.951 . . . . 0.0 111.063 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.745 HG13 HG21 ' A' ' 356' ' ' ILE . 9.6 t -90.66 -20.26 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.956 -1.09 . . . . 0.0 110.608 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 342' ' ' ALA . 47.9 t -77.25 -20.95 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 0.0 110.908 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 344' ' ' MET . 2.8 p30 -78.11 -38.81 43.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.97 -1.081 . . . . 0.0 110.715 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 347' ' ' ASN . . . -90.24 -20.74 22.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.123 -0.986 . . . . 0.0 110.464 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -78.1 -26.66 48.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.132 -0.98 . . . . 0.0 110.68 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -89.05 -71.71 0.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -0.962 . . . . 0.0 110.694 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -75.69 -32.26 60.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 110.52 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.507 ' HA2' ' HA2' ' A' ' 375' ' ' GLY . . . -65.87 172.04 25.52 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -67.82 0.37 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.302 -1.116 . . . . 0.0 110.052 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 318' ' ' GLU . . . 163.26 40.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -140.37 120.98 14.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.062 -1.258 . . . . 0.0 110.866 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.745 HG21 HG13 ' A' ' 345' ' ' VAL . 1.8 mp -123.37 124.21 69.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.647 -0.658 . . . . 0.0 109.339 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 372' ' ' GLU . 0.0 OUTLIER -89.46 105.08 17.56 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.981 -1.075 . . . . 0.0 109.895 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.997 ' CG1' HD11 ' A' ' 309' ' ' ILE . 74.8 t -102.5 120.28 52.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.316 -0.865 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.429 ' OG ' ' HD3' ' A' ' 357' ' ' LYS . 0.9 OUTLIER -145.84 140.34 27.0 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.214 -0.929 . . . . 0.0 110.206 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 369' ' ' PHE . 8.9 t -132.49 135.5 46.06 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.466 -0.771 . . . . 0.0 109.99 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.474 ' C ' HG22 ' A' ' 362' ' ' THR . . . -130.88 -160.71 10.05 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.64 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -173.51 165.39 4.63 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.913 -1.346 . . . . 0.0 111.336 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.483 ' HB2' ' CD ' ' A' ' 366' ' ' ARG . 1.0 OUTLIER -147.94 178.12 1.56 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 43.6 Cg_endo -71.71 110.85 2.99 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.713 1.375 . . . . 0.0 110.599 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.532 ' HA ' ' CG1' ' A' ' 438' ' ' VAL . 1.4 t-20 74.96 27.15 1.2 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.383 -0.823 . . . . 0.0 110.99 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 437' ' ' PRO . 0.2 OUTLIER 179.13 97.39 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.257 -0.902 . . . . 0.0 111.667 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.811 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -99.62 166.84 10.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.149 -0.97 . . . . 0.0 108.396 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.688 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 40.9 p-90 -164.89 174.41 10.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.437 -1.414 . . . . 0.0 111.862 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.547 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 51.8 p90 -150.11 129.36 12.82 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -112.24 155.23 24.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.146 -0.972 . . . . 0.0 111.236 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 432' ' ' ILE . 0.7 OUTLIER -138.07 126.48 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.598 -0.689 . . . . 0.0 109.877 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 357' ' ' LYS . 18.9 tt0 -128.31 106.14 8.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.249 -0.907 . . . . 0.0 109.79 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.493 ' HB3' ' HA ' ' A' ' 356' ' ' ILE . 15.7 p30 -120.02 167.65 11.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.957 -1.089 . . . . 0.0 110.421 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -108.06 101.21 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.385 -0.822 . . . . 0.0 110.501 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . 0.507 ' HA2' ' HA2' ' A' ' 352' ' ' GLY . . . -116.12 -138.97 6.5 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.77 -60.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.017 1.535 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' A' ' 430' ' ' LEU . . . 119.69 -179.56 16.6 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 430' ' ' LEU . 1.4 mm -110.59 93.94 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.279 . . . . 0.0 109.998 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -44.38 167.11 0.1 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 42.1 Cg_endo -68.19 -28.24 34.27 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.564 1.297 . . . . 0.0 110.666 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -90.88 -19.91 22.84 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.111 -0.993 . . . . 0.0 111.655 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.638 ' HB3' " O2'" ' A' ' 451' ' ' ANP . 2.5 mt-30 -80.86 -20.01 43.24 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.84 -1.162 . . . . 0.0 111.542 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.55 -24.27 20.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.91 -1.119 . . . . 0.0 110.746 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -75.52 -33.77 60.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.005 -1.059 . . . . 0.0 110.25 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.63 ' O ' HD12 ' A' ' 386' ' ' LEU . 2.6 m-70 -88.32 54.4 3.05 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.176 -0.953 . . . . 0.0 110.2 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.662 HD11 " O4'" ' A' ' 451' ' ' ANP . 0.1 OUTLIER -151.77 103.05 2.9 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.019 -1.05 . . . . 0.0 111.095 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 386' ' ' LEU . 30.1 m-85 65.9 75.01 0.35 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.609 0.719 . . . . 0.0 111.291 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -117.78 62.75 4.09 Favored Pre-proline 0 C--N 1.296 -1.743 0 O-C-N 121.627 -0.67 . . . . 0.0 109.553 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.565 ' O ' ' CD1' ' A' ' 390' ' ' PHE . 44.9 Cg_endo -71.38 114.48 3.94 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.975 1.513 . . . . 0.0 110.407 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 389' ' ' PRO . 49.3 m-85 -153.06 -165.81 2.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 110.062 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.39 132.54 33.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 110.211 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.55 -52.9 1.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.902 . . . . 0.0 110.355 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 116.51 172.39 16.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 394' ' ' ASP . 17.4 p30 -130.06 157.75 41.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -1.174 . . . . 0.0 110.304 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 396' ' ' ALA . 3.3 m -70.7 104.03 2.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.322 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 397' ' ' ARG . . . 55.16 -99.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.438 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 396' ' ' ALA . 0.2 OUTLIER 171.63 70.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.028 -1.045 . . . . 0.0 110.169 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 398' ' ' THR . 5.4 t -76.52 162.28 27.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.187 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 399' ' ' ILE . 2.1 mp -74.32 135.65 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.271 -0.893 . . . . 0.0 110.092 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 399' ' ' ILE . 0.4 OUTLIER 61.46 122.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.257 -0.902 . . . . 0.0 110.279 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 113.7 42.5 0.87 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 18.0 p -69.62 -49.44 53.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.332 -1.099 . . . . 0.0 110.203 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.458 ' O ' HD22 ' A' ' 404' ' ' LEU . . . -117.73 173.14 14.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 403' ' ' GLY . 0.4 OUTLIER -127.31 156.68 41.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -1.134 . . . . 0.0 110.201 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -138.27 114.62 1.08 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.82 -13.62 13.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.305 -1.115 . . . . 0.0 110.252 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 410' ' ' GLN . . . -75.89 144.82 40.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.423 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.699 ' O ' HD13 ' A' ' 412' ' ' ILE . 2.9 mp -99.19 -10.85 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.151 -0.968 . . . . 0.0 110.157 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.979 HG12 ' HA ' ' A' ' 340' ' ' ALA . 27.4 m -122.36 -7.94 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.319 -0.863 . . . . 0.0 109.859 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 407' ' ' ALA . 48.2 tt0 -74.47 -50.07 19.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.196 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -20.99 66.17 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.427 -0.796 . . . . 0.0 110.157 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.699 HD13 ' O ' ' A' ' 408' ' ' ILE . 1.1 mp -71.19 -63.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.269 -0.894 . . . . 0.0 108.726 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 420' ' ' LEU . 15.5 t -64.14 -21.71 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.638 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 1.9 m-20 -79.23 -32.7 43.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.408 -0.808 . . . . 0.0 109.814 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -78.72 -28.33 45.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 109.33 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.741 ' CE1' HD11 ' A' ' 337' ' ' ILE . 30.2 m80 -81.62 -38.8 25.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.414 -0.804 . . . . 0.0 109.391 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 1.0 OUTLIER 82.24 45.24 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 CA-C-O 121.364 0.602 . . . . 0.0 110.943 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.589 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -112.28 -88.62 1.78 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.593 ' HE1' ' NE1' ' A' ' 435' ' ' TRP . 28.5 ttp -178.66 157.82 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.152 -1.205 . . . . 0.0 112.254 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.666 ' HB2' HG11 ' A' ' 413' ' ' VAL . 57.0 tp -153.02 95.6 1.99 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 0.5 OUTLIER -115.86 155.89 27.1 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.759 -1.213 . . . . 0.0 112.786 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.862 HD12 HG12 ' A' ' 432' ' ' ILE . 2.7 tp -106.15 140.21 39.47 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -141.81 83.01 0.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 430' ' ' LEU . 20.5 m -84.52 121.51 27.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.254 -1.145 . . . . 0.0 110.85 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 426' ' ' GLU . 0.5 OUTLIER -75.38 100.3 4.39 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 425' ' ' SER . 19.9 tt0 37.64 62.22 0.91 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.123 0.487 . . . . 0.0 110.601 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.486 ' HB3' ' NH1' ' A' ' 427' ' ' ARG . 0.0 OUTLIER 41.32 49.81 3.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 110.221 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -139.61 -49.42 0.05 OUTLIER Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -123.49 88.77 0.4 Allowed Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.286 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.76 HD11 HD11 ' A' ' 378' ' ' ILE . 0.2 OUTLIER -70.5 121.46 17.84 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.12 -1.224 . . . . 0.0 110.151 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.54 ' O ' ' CG1' ' A' ' 432' ' ' ILE . 3.0 t -122.23 177.03 5.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.943 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.862 HG12 HD12 ' A' ' 422' ' ' LEU . 10.1 mt -156.92 114.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.254 -0.904 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -90.57 100.69 13.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.346 -0.846 . . . . 0.0 110.334 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.547 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -94.65 132.04 39.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.134 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.688 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.5 m95 -116.38 156.74 26.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.784 -1.198 . . . . 0.0 113.098 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.907 HD12 HD11 ' A' ' 301' ' ' LEU . 67.8 mt -146.34 100.81 4.11 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.589 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 44.9 Cg_endo -71.53 143.82 43.49 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 123.961 1.506 . . . . 0.0 112.441 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.636 HG23 ' HA ' ' A' ' 330' ' ' VAL . 5.9 p -117.5 122.78 30.51 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.58 -163.85 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.77 1.405 . . . . 0.0 110.657 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.08 103.54 15.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.388 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 442' ' ' ARG . 28.7 p -110.19 163.05 13.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.387 -0.821 . . . . 0.0 109.964 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' A' ' 443' ' ' ALA . 0.3 OUTLIER 67.36 136.86 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.143 -0.973 . . . . 0.0 110.173 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 442' ' ' ARG . . . 61.39 177.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.194 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -128.33 5.09 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.877 . . . . 0.0 110.261 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 176.69 -69.15 0.08 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 4.4 t -174.65 139.86 0.57 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -1.145 . . . . 0.0 110.196 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 29.4 p -90.0 45.92 1.31 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.168 -0.957 . . . . 0.0 110.265 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 107.78 11.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.331 -0.856 . . . . 0.0 110.172 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -103.57 138.98 39.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.304 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.756 " H1'" HD12 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.276 0.56 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 97.54 55.81 1.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 293' ' ' GLU . 1.0 OUTLIER -173.33 77.23 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -1.14 . . . . 0.0 110.0 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 292' ' ' GLN . 2.3 mt-10 -157.29 46.22 0.39 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.281 -0.887 . . . . 0.0 110.255 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.476 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 10.0 ptm -146.62 132.82 9.58 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.943 . . . . 0.0 110.412 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.581 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 48.5 Cg_endo -85.69 52.38 3.09 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.916 1.482 . . . . 0.0 110.164 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.634 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -93.41 110.17 21.73 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.076 0.941 . . . . 0.0 108.9 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.4 mt-10 -133.27 -172.4 2.94 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.824 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -87.48 140.35 29.62 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.759 0.79 . . . . 0.0 109.958 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -157.36 169.31 25.02 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.435 0.636 . . . . 0.0 110.037 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 304' ' ' VAL . 57.4 m-20 -96.14 119.51 34.75 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.561 -0.712 . . . . 0.0 109.171 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.812 HD21 ' SD ' ' A' ' 332' ' ' MET . 8.1 mt -62.24 -25.6 67.91 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.997 -1.064 . . . . 0.0 109.299 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.89 ' HA ' HD23 ' A' ' 323' ' ' LEU . 55.1 t-20 -76.19 -23.24 54.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.977 -1.077 . . . . 0.0 108.503 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -82.92 -33.48 26.83 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 308' ' ' VAL . 47.8 t -74.94 -38.34 43.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.616 0.722 . . . . 0.0 109.161 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.593 HD13 ' OG ' ' A' ' 360' ' ' SER . 92.2 mt -75.13 -27.06 59.64 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.466 -0.772 . . . . 0.0 109.982 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.43 -35.9 92.52 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.52 -34.31 54.07 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.417 -1.049 . . . . 0.0 108.673 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.859 HG11 ' HB ' ' A' ' 341' ' ' VAL . 50.7 t -75.68 -18.6 15.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 121.554 0.692 . . . . 0.0 109.148 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.527 ' HA ' ' HG2' ' A' ' 312' ' ' GLU . 1.4 mt -78.77 -45.0 25.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -65.5 -18.27 65.19 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -91.19 -34.08 15.15 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.766 -0.584 . . . . 0.0 111.144 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.906 ' OE2' HG21 ' A' ' 358' ' ' VAL . 18.9 pt-20 -86.15 16.95 3.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.083 -1.011 . . . . 0.0 110.723 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.5 m -122.57 67.66 0.95 Allowed 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -56.67 -42.63 91.16 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.443 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 0.3 OUTLIER -136.79 24.01 3.1 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.307 -1.114 . . . . 0.0 111.004 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 2.5 mt-10 60.96 57.46 2.56 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.915 -1.116 . . . . 0.0 108.441 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -66.51 -76.08 0.08 Allowed 'General case' 0 C--N 1.278 -2.526 0 CA-C-O 121.616 0.722 . . . . 0.0 109.722 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 355' ' ' TRP . 7.1 pt-20 -170.52 56.67 0.03 OUTLIER 'General case' 0 C--N 1.265 -3.086 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.863 HG13 HD12 ' A' ' 356' ' ' ILE . 1.8 mp -91.28 129.76 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 119.444 -0.903 . . . . 0.0 109.974 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -104.3 111.05 23.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.232 -0.918 . . . . 0.0 109.673 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.404 HG22 ' CD1' ' A' ' 309' ' ' ILE . 17.7 p -89.01 126.9 35.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.3 -0.875 . . . . 0.0 110.702 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . 0.441 ' HB3' ' OG ' ' A' ' 359' ' ' SER . . . -149.36 79.54 1.4 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.576 -0.702 . . . . 0.0 109.341 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.89 HD23 ' HA ' ' A' ' 302' ' ' ASN . 4.7 mp -95.33 150.22 20.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.488 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.574 ' HB2' ' HA2' ' A' ' 361' ' ' GLY . 89.6 t80 -37.33 129.88 0.82 Allowed Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.576 -0.703 . . . . 0.0 110.678 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.39 82.66 1.35 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.924 1.486 . . . . 0.0 109.515 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . 162.56 -11.13 0.1 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.682 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.2 OUTLIER 79.85 120.55 0.05 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.329 -1.101 . . . . 0.0 109.951 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 329' ' ' GLU . 1.6 mm -72.29 -176.02 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 CA-C-O 121.704 0.764 . . . . 0.0 109.93 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 328' ' ' ILE . 3.2 mt-10 -170.19 105.19 0.3 Allowed 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.561 0.696 . . . . 0.0 109.953 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 298' ' ' MET . 2.7 m -150.52 169.31 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-O 121.541 0.686 . . . . 0.0 110.653 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -96.63 94.02 7.09 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.812 ' SD ' HD21 ' A' ' 301' ' ' LEU . 0.0 OUTLIER -148.44 133.65 18.37 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.764 0.792 . . . . 0.0 110.027 -179.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.582 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 19.1 t-160 -55.48 113.17 5.12 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.722 -0.611 . . . . 0.0 109.913 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 40.6 Cg_endo -66.5 -19.56 54.75 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.816 1.429 . . . . 0.0 110.096 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.582 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -74.59 -68.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 0.0 109.835 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.765 ' O ' HD12 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -47.56 -40.9 20.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.398 -0.814 . . . . 0.0 109.557 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.724 HD11 ' CE1' ' A' ' 416' ' ' HIS . 11.9 mm -64.15 -46.83 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 109.316 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.556 ' HG3' HG22 ' A' ' 308' ' ' VAL . 0.0 OUTLIER -43.72 -47.67 7.88 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.355 -0.841 . . . . 0.0 109.555 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -70.67 -35.45 72.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.569 -0.707 . . . . 0.0 110.641 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.601 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -58.66 -32.34 69.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.414 -0.804 . . . . 0.0 111.089 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.859 ' HB ' HG11 ' A' ' 308' ' ' VAL . 32.3 t -90.24 -28.24 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.97 -1.081 . . . . 0.0 111.009 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.73 -19.68 57.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.976 -1.078 . . . . 0.0 110.753 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.3 -19.74 23.72 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.116 -0.99 . . . . 0.0 110.992 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.478 ' SD ' ' HB ' ' A' ' 432' ' ' ILE . 6.3 mtt -82.23 -23.76 35.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.09 -1.006 . . . . 0.0 111.357 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.504 HG11 ' OE1' ' A' ' 312' ' ' GLU . 28.0 m -90.7 -23.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.044 -1.035 . . . . 0.0 111.395 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.88 -29.96 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.914 -1.116 . . . . 0.0 110.533 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 66.3 t30 -65.77 -34.16 77.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.179 -0.951 . . . . 0.0 110.438 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -89.72 -22.97 21.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 110.507 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.31 -51.44 60.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.108 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 351' ' ' TYR . 4.1 mmt180 -90.5 -65.28 1.03 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.299 -0.876 . . . . 0.0 110.872 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 347' ' ' ASN . 0.9 OUTLIER -38.54 -72.0 0.07 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.381 -0.824 . . . . 0.0 110.74 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -129.5 100.6 0.5 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.426 ' H ' ' ND2' ' A' ' 353' ' ' ASN . 6.3 p30 -86.38 86.42 7.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -1.151 . . . . 0.0 109.789 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . 0.451 ' O ' ' OE1' ' A' ' 318' ' ' GLU . . . -123.16 -35.35 0.72 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.584 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 14.3 t90 179.81 124.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.031 -1.276 . . . . 0.0 110.863 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.863 HD12 HG13 ' A' ' 319' ' ' ILE . 1.5 mt -105.98 143.71 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.584 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 13.4 tttt -134.43 106.44 7.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.827 -1.171 . . . . 0.0 111.359 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.906 HG21 ' OE2' ' A' ' 312' ' ' GLU . 88.8 t -98.52 83.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 370' ' ' GLN . 30.2 t -116.39 141.36 48.27 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.357 -0.839 . . . . 0.0 111.272 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.593 ' OG ' HD13 ' A' ' 305' ' ' LEU . 3.9 m -134.23 168.29 19.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 109.124 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -161.77 -159.47 10.18 Favored Glycine 0 C--N 1.292 -1.868 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -177.18 164.39 2.2 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.369 -1.077 . . . . 0.0 110.032 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.507 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 3.9 mt-10 -141.72 -179.83 1.06 Allowed Pre-proline 0 C--N 1.29 -2.0 0 O-C-N 121.636 -0.665 . . . . 0.0 109.522 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 44.3 Cg_endo -71.63 116.8 4.85 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.682 1.359 . . . . 0.0 111.191 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 2.2 m120 80.01 25.41 0.37 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.874 -0.517 . . . . 0.0 111.509 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.586 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 167.34 111.67 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.319 -0.863 . . . . 0.0 111.473 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -104.41 174.65 5.78 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.194 -0.941 . . . . 0.0 108.876 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.629 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 47.8 p-90 -170.84 174.76 4.73 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.402 -1.436 . . . . 0.0 111.475 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.572 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 34.2 p90 -144.21 134.72 24.71 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.52 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 14.3 tt0 -127.54 149.76 50.0 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.938 -1.101 . . . . 0.0 112.432 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.52 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 98.4 t -125.23 135.04 65.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -130.03 147.16 51.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 109.946 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.569 ' OD2' ' N6 ' ' A' ' 451' ' ' ANP . 40.6 p30 -143.51 157.99 44.0 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 375' ' ' GLY . 0.8 OUTLIER -91.67 159.54 15.81 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 110.077 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 374' ' ' ASP . . . 135.3 -159.4 24.05 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.508 ' O ' ' C2 ' ' A' ' 451' ' ' ANP . 46.5 Cg_endo -73.65 157.48 48.37 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.894 1.471 . . . . 0.0 110.397 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . 0.756 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -87.59 -144.76 9.38 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.851 HD11 ' HG ' ' A' ' 430' ' ' LEU . 0.7 OUTLIER -106.2 98.03 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.144 -1.21 . . . . 0.0 109.486 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -52.33 171.75 0.2 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.524 -0.735 . . . . 0.0 110.99 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 44.8 Cg_endo -72.55 -47.38 0.38 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 124.134 1.597 . . . . 0.0 109.458 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -25.07 68.2 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.408 -0.807 . . . . 0.0 109.094 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -86.58 -20.62 27.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.506 -0.746 . . . . 0.0 109.556 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 386' ' ' LEU . 0.2 OUTLIER -60.85 -32.88 72.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.467 -0.771 . . . . 0.0 109.709 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -24.29 51.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 109.599 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 385' ' ' HIS . 1.8 m-70 -100.3 49.31 0.91 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.399 -0.813 . . . . 0.0 109.656 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.519 ' HA ' HD12 ' A' ' 386' ' ' LEU . 1.5 tp -126.18 85.44 2.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.307 -0.871 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 388' ' ' GLN . 15.6 m-85 67.95 14.98 9.49 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.407 0.622 . . . . 0.0 110.398 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.507 ' O ' ' O ' ' A' ' 387' ' ' PHE . 6.2 mt-30 51.44 116.47 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.899 -0.501 . . . . 0.0 111.72 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 390' ' ' PHE . 48.4 Cg_endo -74.39 166.66 28.96 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.629 1.331 . . . . 0.0 109.975 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 389' ' ' PRO . 0.2 OUTLIER -43.08 137.06 2.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 110.436 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.783 HG22 ' H ' ' A' ' 392' ' ' ARG . 4.8 p -128.87 -166.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.596 -0.69 . . . . 0.0 109.786 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . 0.783 ' H ' HG22 ' A' ' 391' ' ' VAL . 0.9 OUTLIER -40.51 149.04 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.047 -1.033 . . . . 0.0 110.417 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 160.33 59.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -150.66 116.43 5.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.228 -1.16 . . . . 0.0 110.365 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 26.2 t -152.51 -81.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 110.082 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' A' ' 397' ' ' ARG . . . -159.57 19.41 0.17 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.309 -0.87 . . . . 0.0 110.287 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 396' ' ' ALA . 0.0 OUTLIER -141.35 179.81 6.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.272 -0.893 . . . . 0.0 110.259 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.568 ' O ' ' C ' ' A' ' 399' ' ' ILE . 0.2 OUTLIER -91.79 -29.07 16.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.11 -0.994 . . . . 0.0 110.599 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 399' ' ' ILE . 11.2 tp -2.99 105.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.827 0 CA-C-O 121.533 0.682 . . . . 0.0 112.4 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 42.4 m -137.01 158.62 44.04 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.14 -0.975 . . . . 0.0 110.336 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 402' ' ' THR . . . 83.68 -162.18 39.24 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.502 ' CB ' ' O ' ' A' ' 401' ' ' GLY . 0.2 OUTLIER 69.76 105.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.335 -1.097 . . . . 0.0 110.169 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -145.24 136.03 6.32 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 84.9 mt -116.53 42.85 2.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.202 -1.175 . . . . 0.0 110.343 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -61.13 -19.57 57.15 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 46.79 78.31 0.07 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.25 -1.147 . . . . 0.0 110.21 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.534 ' CB ' ' HG3' ' A' ' 410' ' ' GLN . . . -108.9 -141.91 0.38 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.28 -0.887 . . . . 0.0 110.354 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.64 -88.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.057 -1.027 . . . . 0.0 110.567 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 340' ' ' ALA . 10.9 m -53.58 -22.13 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.14 -0.975 . . . . 0.0 110.461 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.534 ' HG3' ' CB ' ' A' ' 407' ' ' ALA . 0.1 OUTLIER -64.52 -47.43 78.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.215 -0.928 . . . . 0.0 109.88 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.515 ' HA ' ' HB2' ' A' ' 414' ' ' ASP . 0.0 OUTLIER -66.75 -27.76 67.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -0.873 . . . . 0.0 109.683 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.765 HD12 ' O ' ' A' ' 336' ' ' SER . 31.0 mm -63.67 -60.37 2.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.91 HG21 HD13 ' A' ' 420' ' ' LEU . 45.7 t -65.8 -23.08 31.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.182 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.515 ' HB2' ' HA ' ' A' ' 411' ' ' ARG . 0.5 OUTLIER -75.19 -25.87 58.58 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.416 ' OD1' ' HE3' ' A' ' 296' ' ' MET . 0.9 OUTLIER -80.47 -19.55 45.74 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.724 ' CE1' HD11 ' A' ' 337' ' ' ILE . 32.8 m80 -96.28 -76.18 0.51 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.807 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.635 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 4.3 m-20 127.29 26.81 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.596 0 C-N-CA 123.948 0.899 . . . . 0.0 109.297 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 435' ' ' TRP . . . -86.4 -103.41 0.77 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.583 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 18.4 ttm -165.74 161.85 18.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -1.143 . . . . 0.0 110.638 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 413' ' ' VAL . 4.8 tp -151.86 96.32 2.21 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.983 -1.073 . . . . 0.0 109.223 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.12 155.73 43.96 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.978 -1.076 . . . . 0.0 111.603 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.457 HD11 H5'2 ' A' ' 451' ' ' ANP . 0.1 OUTLIER -91.6 146.28 23.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.556 -0.715 . . . . 0.0 110.354 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -133.5 99.88 0.38 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 429' ' ' GLY . 17.6 m -74.56 122.58 23.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.186 -1.185 . . . . 0.0 110.735 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.503 ' HB3' ' CG ' ' A' ' 427' ' ' ARG . 26.6 t -90.75 147.42 23.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.309 -0.87 . . . . 0.0 109.46 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -45.81 -20.76 0.09 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.801 -0.562 . . . . 0.0 111.308 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.514 ' CB ' ' CZ ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -59.25 -5.11 0.66 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.191 -0.943 . . . . 0.0 111.599 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . 90.09 21.89 37.29 Favored Glycine 0 N--CA 1.476 1.352 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.615 ' O ' HG23 ' A' ' 424' ' ' THR . . . -144.66 -137.9 3.24 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.851 ' HG ' HD11 ' A' ' 378' ' ' ILE . 0.0 OUTLIER -175.33 -173.25 0.64 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.169 -1.195 . . . . 0.0 111.786 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.666 ' N ' HD22 ' A' ' 430' ' ' LEU . 24.9 p -154.28 150.16 27.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.478 ' HB ' ' SD ' ' A' ' 344' ' ' MET . 24.2 mm -90.52 121.01 40.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 120.717 -1.24 . . . . 0.0 111.149 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -98.3 96.15 7.86 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.551 -0.718 . . . . 0.0 109.323 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.572 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -97.0 143.71 27.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.613 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.629 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 88.0 m95 -120.08 157.72 28.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.264 -0.897 . . . . 0.0 112.136 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.572 HD13 ' SD ' ' A' ' 332' ' ' MET . 38.1 mt -145.44 125.26 7.01 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.9 139.69 43.96 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 123.59 1.31 . . . . 0.0 111.358 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.641 HG23 ' HD2' ' A' ' 439' ' ' PRO . 7.2 p -99.16 146.79 32.31 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.535 -0.728 . . . . 0.0 110.404 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.641 ' HD2' HG23 ' A' ' 438' ' ' VAL . 50.3 Cg_endo -72.35 143.63 39.52 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.979 1.515 . . . . 0.0 109.773 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.79 HG12 ' O ' ' A' ' 440' ' ' VAL . 72.1 t -153.3 44.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.956 -1.09 . . . . 0.0 110.645 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 14.0 p -145.82 -40.63 0.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 110.092 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.699 ' O ' ' HB3' ' A' ' 443' ' ' ALA . 0.9 OUTLIER -136.9 -179.95 6.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 442' ' ' ARG . . . 67.79 104.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 443' ' ' ALA . 0.0 OUTLIER 53.7 105.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.763 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -87.85 136.64 13.97 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 23.1 p -92.41 128.95 38.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.108 -1.231 . . . . 0.0 110.565 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 81.5 p -86.64 82.57 7.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.867 . . . . 0.0 110.149 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -126.36 72.75 1.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.046 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.43 -56.05 3.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.883 . . . . 0.0 110.36 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 CA-C-O 117.948 -1.473 . . . . 0.0 109.589 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.738 ' C6 ' HD11 ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.354 0.597 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -134.49 -116.61 1.67 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -143.75 13.6 1.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -1.182 . . . . 0.0 110.082 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.483 ' HG3' ' HG2' ' A' ' 294' ' ' MET . 5.2 pt-20 -124.82 13.3 8.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.203 -0.936 . . . . 0.0 109.991 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.483 ' HG2' ' HG3' ' A' ' 293' ' ' GLU . 11.4 mmt -142.7 61.88 11.74 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.51 79.0 0.89 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.292 1.68 . . . . 0.0 112.12 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.583 ' HE3' ' NE2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -71.9 105.84 3.99 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 5.1 mt-10 -115.95 -169.97 1.7 Allowed 'General case' 0 C--N 1.28 -2.428 0 O-C-N 121.683 -0.636 . . . . 0.0 110.228 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.631 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.2 OUTLIER -88.28 128.86 35.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 111.193 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.565 ' HB3' ' SD ' ' A' ' 332' ' ' MET . . . -156.48 159.22 38.43 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.66 -0.65 . . . . 0.0 111.057 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.808 ' O ' HG23 ' A' ' 304' ' ' VAL . 5.9 t0 -84.08 121.37 27.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.514 -0.741 . . . . 0.0 110.13 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 8.0 mt -68.54 -25.2 64.8 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.138 -0.976 . . . . 0.0 109.76 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.696 ' HA ' HD23 ' A' ' 323' ' ' LEU . 22.7 p30 -79.3 -21.21 46.3 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.089 -1.007 . . . . 0.0 108.871 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -85.44 -29.65 24.17 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.761 0.791 . . . . 0.0 108.968 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 308' ' ' VAL . 42.2 t -74.92 -38.46 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.55 0.69 . . . . 0.0 109.278 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.603 ' CD2' HG21 ' A' ' 341' ' ' VAL . 86.2 mt -73.61 -40.75 63.58 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.306 -0.871 . . . . 0.0 110.142 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -58.71 -29.42 64.27 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.846 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 6.0 mt-10 -79.03 -31.16 44.51 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.394 -1.062 . . . . 0.0 108.997 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 304' ' ' VAL . 52.3 t -75.48 -21.83 16.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.667 0.746 . . . . 0.0 109.154 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.556 ' CD1' HG22 ' A' ' 321' ' ' THR . 0.7 OUTLIER -76.19 -49.68 24.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.403 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -80.2 -16.72 54.17 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.815 0.816 . . . . 0.0 109.194 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.846 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -65.14 -63.04 1.2 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.696 -0.627 . . . . 0.0 110.709 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.28 37.91 0.7 Allowed 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.715 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.629 ' O ' HD11 ' A' ' 319' ' ' ILE . 1.2 t -87.55 43.1 1.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.892 -1.13 . . . . 0.0 109.098 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 315' ' ' TYR . . . 73.66 25.22 72.77 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.511 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 51.4 t80 63.71 44.19 5.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.657 -0.908 . . . . 0.0 110.258 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 4.2 tt0 68.24 46.57 1.09 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.235 -0.916 . . . . 0.0 109.781 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.496 ' CG ' ' N ' ' A' ' 318' ' ' GLU . 0.3 OUTLIER -68.59 -88.04 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.304 0 O-C-N 121.608 -0.683 . . . . 0.0 109.844 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.496 ' N ' ' CG ' ' A' ' 317' ' ' ARG . 16.9 mt-10 -140.93 66.12 1.38 Allowed 'General case' 0 C--N 1.277 -2.574 0 O-C-N 121.399 -0.813 . . . . 0.0 111.287 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.697 HG23 HG23 ' A' ' 358' ' ' VAL . 2.7 mp -104.43 134.09 46.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 O-C-N 121.598 -0.689 . . . . 0.0 110.129 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -91.36 107.23 19.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.763 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.556 HG22 ' CD1' ' A' ' 309' ' ' ILE . 12.5 p -89.84 124.66 34.87 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 111.519 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . 0.589 ' HB3' ' OG ' ' A' ' 359' ' ' SER . . . -149.81 78.63 1.36 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 302' ' ' ASN . 2.7 mp -94.62 169.52 10.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.453 -0.779 . . . . 0.0 110.879 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.476 ' HB2' ' HA2' ' A' ' 361' ' ' GLY . 93.8 t80 -62.11 112.39 6.24 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.478 -0.764 . . . . 0.0 109.756 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.86 79.29 1.98 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.878 1.462 . . . . 0.0 110.487 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 179.73 29.65 0.05 OUTLIER Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.773 -1.203 . . . . 0.0 110.11 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 326' ' ' GLY . 1.0 OUTLIER 47.81 98.2 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.11 -1.23 . . . . 0.0 110.509 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.632 HG23 HG21 ' A' ' 362' ' ' THR . 1.1 mt -82.11 -176.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.495 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.575 ' H ' HG22 ' A' ' 328' ' ' ILE . 0.6 OUTLIER -178.14 105.43 0.05 OUTLIER 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.416 0.627 . . . . 0.0 110.376 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 1.021 HG11 ' HB3' ' A' ' 367' ' ' ALA . 5.3 m -136.05 171.57 16.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-O 121.749 0.785 . . . . 0.0 110.5 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.2 OUTLIER -91.22 89.62 7.41 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.573 ' CG ' HG23 ' A' ' 330' ' ' VAL . 4.0 ppp? -140.26 148.34 41.31 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.439 -0.788 . . . . 0.0 109.894 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 21.0 t-160 -75.97 110.82 12.03 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.481 ' O ' ' HD3' ' A' ' 338' ' ' LYS . 36.7 Cg_endo -58.74 -19.33 45.68 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.476 1.251 . . . . 0.0 109.152 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.593 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -82.57 -63.9 1.28 Allowed 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.529 0.681 . . . . 0.0 109.805 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.507 ' OG ' HG13 ' A' ' 412' ' ' ILE . 26.8 t -49.39 -50.54 39.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.538 -0.726 . . . . 0.0 110.132 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.554 HG13 ' CE ' ' A' ' 332' ' ' MET . 21.7 mm -59.91 -45.68 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.565 ' HD3' HG13 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -46.81 -49.03 20.6 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.7 -1.25 . . . . 0.0 109.377 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -60.97 -38.88 87.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.491 -0.756 . . . . 0.0 110.302 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -58.94 -53.25 60.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 0.0 110.83 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.791 ' CG1' HG11 ' A' ' 308' ' ' VAL . 55.2 t -70.31 -21.08 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 110.057 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -81.65 -19.73 41.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.397 -0.815 . . . . 0.0 110.779 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -84.64 -44.67 13.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.088 -1.008 . . . . 0.0 110.777 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 6.1 mtm -69.15 -20.14 64.02 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.16 -0.962 . . . . 0.0 110.546 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 342' ' ' ALA . 8.7 p -87.86 -27.48 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.104 -0.997 . . . . 0.0 110.506 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 342' ' ' ALA . 53.5 t -76.85 -28.02 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.143 -0.973 . . . . 0.0 110.373 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 351' ' ' TYR . 17.4 m120 -75.13 -32.04 61.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.105 -0.997 . . . . 0.0 110.281 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.686 ' HB2' ' OD1' ' A' ' 373' ' ' ASP . . . -90.58 -18.63 24.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.123 -0.986 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -77.05 -81.21 0.09 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.033 -1.042 . . . . 0.0 111.856 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -48.41 64.95 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.381 -0.824 . . . . 0.0 112.34 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 347' ' ' ASN . 36.6 m-85 -74.79 -58.93 2.98 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.855 -1.153 . . . . 0.0 111.561 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 348' ' ' ALA . . . -108.12 59.55 0.36 Allowed Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.189 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.23 93.1 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.235 . . . . 0.0 109.886 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -147.7 -67.06 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -150.13 139.19 21.09 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.119 -1.224 . . . . 0.0 110.657 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.619 HD12 HG13 ' A' ' 319' ' ' ILE . 20.3 mt -123.66 162.08 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.459 -0.776 . . . . 0.0 109.832 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 372' ' ' GLU . 1.1 ttpt -136.83 111.36 8.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.069 -1.019 . . . . 0.0 110.331 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.697 HG23 HG23 ' A' ' 319' ' ' ILE . 65.1 t -110.17 88.41 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 110.034 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.589 ' OG ' ' HB3' ' A' ' 322' ' ' ALA . 1.0 OUTLIER -112.55 148.95 33.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 110.436 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.542 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -144.65 142.14 29.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.403 -0.81 . . . . 0.0 110.016 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -135.08 -165.9 10.92 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.7 OUTLIER -174.52 179.17 1.81 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.775 -1.426 . . . . 0.0 111.547 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 8.2 mt-10 -156.32 173.18 5.18 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.527 ' O ' ' HB2' ' A' ' 365' ' ' ASN . 39.6 Cg_endo -66.38 119.01 5.99 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.422 1.222 . . . . 0.0 110.469 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' A' ' 364' ' ' PRO . 2.3 m-80 62.88 37.3 12.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.934 -0.479 . . . . 0.0 110.969 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 10.7 ptm180 169.31 106.32 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.455 -0.778 . . . . 0.0 110.399 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 1.021 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -116.49 168.11 10.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.176 -0.952 . . . . 0.0 109.835 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.64 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 25.8 p-90 -154.74 169.05 24.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.86 -1.15 . . . . 0.0 110.811 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.519 ' CE1' HD11 ' A' ' 436' ' ' LEU . 32.9 p90 -144.4 136.29 26.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.456 -0.778 . . . . 0.0 109.456 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.517 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 9.7 tt0 -121.07 153.84 36.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.101 -0.999 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.517 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 40.6 t -137.06 143.92 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 110.181 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 2.0 mt-10 -137.29 134.45 36.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.355 -0.841 . . . . 0.0 109.779 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.686 ' OD1' ' HB2' ' A' ' 348' ' ' ALA . 3.6 p30 -151.1 163.18 39.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.894 -1.129 . . . . 0.0 110.864 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -110.04 134.13 52.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . 0.439 ' HA3' ' HA3' ' A' ' 352' ' ' GLY . . . 159.54 -136.05 4.43 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.496 ' HG3' ' CB ' ' A' ' 351' ' ' TYR . 47.0 Cg_endo -72.65 106.16 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.991 1.521 . . . . 0.0 110.349 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 427' ' ' ARG . . . -78.35 -157.78 10.7 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 1.013 HG23 " O2'" ' A' ' 451' ' ' ANP . 9.7 mt -119.04 172.67 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.496 -1.003 . . . . 0.0 110.12 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -120.91 175.0 2.6 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.867 -1.146 . . . . 0.0 110.675 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 51.3 Cg_endo -79.94 -33.07 1.25 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 124.059 1.557 . . . . 0.0 111.349 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -89.65 -19.76 24.49 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.907 -1.121 . . . . 0.0 111.312 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.604 ' HG3' ' HB3' ' A' ' 379' ' ' ALA . 41.6 mt-30 -85.91 -26.67 25.44 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.95 -1.094 . . . . 0.0 108.846 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 385' ' ' HIS . 0.2 OUTLIER -66.97 -25.38 66.29 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.082 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 383' ' ' ARG . 32.5 mmtm -46.94 -35.69 6.81 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.505 ' H ' ' CD2' ' A' ' 385' ' ' HIS . 1.4 m-70 -100.74 -139.26 0.33 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.695 ' O ' ' CG ' ' A' ' 387' ' ' PHE . 0.0 OUTLIER -66.2 -68.23 0.39 Allowed 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.962 ' CD1' HG21 ' A' ' 378' ' ' ILE . 37.0 m-85 -170.7 23.38 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 112.13 -2.305 . . . . 0.0 108.814 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 382' ' ' GLN . 0.6 OUTLIER 9.73 111.29 0.0 OUTLIER Pre-proline 0 N--CA 1.518 2.947 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.99 -163.38 0.2 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.514 1.271 . . . . 0.0 110.42 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . 0.581 ' C ' HG23 ' A' ' 391' ' ' VAL . 5.6 t80 -94.66 108.52 20.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.084 -1.01 . . . . 0.0 110.683 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.581 HG23 ' C ' ' A' ' 390' ' ' PHE . 31.6 t -153.9 133.3 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.443 -0.786 . . . . 0.0 110.223 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 393' ' ' GLY . 0.2 OUTLIER -112.98 155.2 25.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.955 . . . . 0.0 110.007 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 392' ' ' ARG . . . 50.93 97.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.2 80.39 1.61 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.193 -1.181 . . . . 0.0 110.298 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.2 m -105.82 -46.02 4.23 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -0.929 . . . . 0.0 110.302 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 397' ' ' ARG . . . -69.16 -90.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.078 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 397' ' ' ARG . 0.5 OUTLIER 178.15 122.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.199 -0.938 . . . . 0.0 110.016 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 1.7 m -136.19 10.2 3.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.126 -0.984 . . . . 0.0 110.677 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.984 HD13 ' O ' ' A' ' 399' ' ' ILE . 0.0 OUTLIER -107.08 -0.31 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.141 -0.974 . . . . 0.0 110.087 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 399' ' ' ILE . 0.7 OUTLIER 71.19 94.06 0.08 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.254 -0.904 . . . . 0.0 110.347 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 402' ' ' THR . . . -102.2 137.47 13.37 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.694 HG22 ' O ' ' A' ' 402' ' ' THR . 97.9 m 55.7 41.36 30.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.345 -1.091 . . . . 0.0 110.572 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -76.35 -72.99 1.04 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 12.5 mt -138.71 -35.33 0.58 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.25 -1.147 . . . . 0.0 110.289 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 406' ' ' LEU . . . -145.91 138.61 7.65 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.68 HD13 HG22 ' A' ' 408' ' ' ILE . 3.3 pp -42.09 133.73 2.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -1.126 . . . . 0.0 110.227 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -99.44 74.96 1.94 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.075 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.68 HG22 HD13 ' A' ' 406' ' ' LEU . 9.7 tp -155.67 155.9 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 0.0 110.774 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 410' ' ' GLN . 13.2 p -120.05 -42.08 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.479 -0.763 . . . . 0.0 109.926 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.592 ' N ' HG13 ' A' ' 409' ' ' VAL . 2.6 pt20 -51.72 -29.34 18.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.433 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.478 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.4 OUTLIER -76.51 -35.88 58.08 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.827 HG21 ' HB2' ' A' ' 340' ' ' ALA . 0.6 OUTLIER -56.84 -44.7 82.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' A' ' 420' ' ' LEU . 92.9 t -73.93 -22.66 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 35.2 t70 -80.02 -19.58 47.39 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.699 -0.626 . . . . 0.0 109.603 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -85.77 -26.83 25.58 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.382 -0.824 . . . . 0.0 109.142 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.716 ' CB ' HD23 ' A' ' 436' ' ' LEU . 30.6 m80 -89.78 -31.57 17.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.475 -0.766 . . . . 0.0 109.083 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.4 OUTLIER 77.27 42.96 0.12 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.395 0.617 . . . . 0.0 110.6 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.614 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -106.8 -85.14 1.76 Allowed Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.565 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.0 OUTLIER -179.2 164.23 1.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -1.113 . . . . 0.0 111.331 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.557 ' HB2' HG11 ' A' ' 413' ' ' VAL . 19.1 tp -151.3 92.59 1.8 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.163 -0.961 . . . . 0.0 109.258 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.537 ' HB2' ' HG3' ' A' ' 433' ' ' ARG . 0.3 OUTLIER -92.28 139.93 30.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.975 -1.078 . . . . 0.0 110.443 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.704 HD22 HG12 ' A' ' 432' ' ' ILE . 0.3 OUTLIER -114.98 145.7 41.98 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.43 -0.794 . . . . 0.0 111.275 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 430' ' ' LEU . . . -145.53 145.52 14.78 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.532 HG21 ' H ' ' A' ' 378' ' ' ILE . 7.8 m -158.6 131.23 7.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.838 -1.39 . . . . 0.0 111.041 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.72 96.97 7.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 426' ' ' GLU . 41.8 tt0 52.7 49.67 19.81 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.606 -0.684 . . . . 0.0 109.959 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.511 ' HA ' ' HA3' ' A' ' 377' ' ' GLY . 0.9 OUTLIER 50.85 44.63 28.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 110.234 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -143.46 -59.08 0.02 OUTLIER Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -87.83 82.44 1.57 Allowed Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.628 HD21 ' C5 ' ' A' ' 451' ' ' ANP . 18.4 tp -90.59 108.78 20.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -1.132 . . . . 0.0 110.852 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 66.5 m -118.07 132.98 56.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.608 -0.682 . . . . 0.0 109.368 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.872 HD13 ' N1 ' ' A' ' 451' ' ' ANP . 4.4 mt -136.7 142.26 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.935 -1.103 . . . . 0.0 111.031 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . 0.537 ' HG3' ' HB2' ' A' ' 421' ' ' GLU . 0.0 OUTLIER -122.2 117.02 25.2 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.445 -0.785 . . . . 0.0 109.598 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 369' ' ' PHE . . . -102.6 140.0 37.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.165 -0.959 . . . . 0.0 111.049 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.64 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 79.8 m95 -114.6 154.44 28.34 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.288 -0.883 . . . . 0.0 111.271 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.716 HD23 ' CB ' ' A' ' 416' ' ' HIS . 12.7 mt -145.87 111.08 4.46 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.614 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 49.5 Cg_endo -85.9 130.57 3.64 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.691 1.364 . . . . 0.0 110.823 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.772 HG22 ' HB ' ' A' ' 330' ' ' VAL . 60.6 t -82.79 110.08 20.5 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.408 -0.808 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.646 ' O ' HG23 ' A' ' 440' ' ' VAL . 57.3 Cg_endo -78.44 169.29 20.2 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.938 1.494 . . . . 0.0 109.987 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 439' ' ' PRO . 48.7 t -157.05 94.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.137 -0.977 . . . . 0.0 110.802 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.569 HG22 ' C ' ' A' ' 440' ' ' VAL . 3.1 t 34.48 76.37 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.623 -0.673 . . . . 0.0 110.75 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.744 ' O ' ' HB2' ' A' ' 443' ' ' ALA . 0.0 OUTLIER 46.84 -175.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 442' ' ' ARG . . . 166.63 47.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . 0.49 ' HG3' ' N ' ' A' ' 445' ' ' GLY . 47.2 tp60 -159.08 154.11 25.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 110.358 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . 0.49 ' N ' ' HG3' ' A' ' 444' ' ' GLN . . . 146.19 46.93 0.03 OUTLIER Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 59.7 p -107.02 -142.68 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.226 -1.161 . . . . 0.0 110.207 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 448' ' ' LYS . 72.2 p -101.77 -136.69 0.33 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.836 . . . . 0.0 110.233 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 447' ' ' THR . 13.2 mttm 56.9 169.82 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.194 -0.941 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 448' ' ' LYS . 7.4 mm-40 -42.95 144.15 0.64 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.516 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 1.013 " O2'" HG23 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.299 0.571 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -69.46 -101.29 0.04 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -80.47 -168.93 1.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.197 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.5 78.16 9.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.267 -0.896 . . . . 0.0 109.939 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.487 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 0.0 OUTLIER -75.06 128.63 84.58 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.352 -0.842 . . . . 0.0 110.855 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.656 ' CB ' ' CD2' ' A' ' 333' ' ' HIS . 51.4 Cg_endo -94.18 -157.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.687 1.592 . . . . 0.0 109.362 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.548 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 43.36 87.68 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 122.323 1.058 . . . . 0.0 109.99 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 1.1 mt-10 -143.06 -156.6 0.7 Allowed 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.278 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.535 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.1 OUTLIER -88.25 131.61 34.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.937 -1.102 . . . . 0.0 110.589 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -150.04 160.07 43.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.443 -0.786 . . . . 0.0 110.709 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.82 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.9 OUTLIER -102.57 120.38 40.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 110.083 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.526 HD11 ' CD1' ' A' ' 436' ' ' LEU . 15.3 mt -63.37 -21.27 66.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 109.751 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.666 ' HA ' HD23 ' A' ' 323' ' ' LEU . 26.0 t-20 -83.41 -21.58 32.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.064 -1.022 . . . . 0.0 108.754 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 307' ' ' GLU . . . -88.15 -26.79 22.26 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.728 0.775 . . . . 0.0 109.144 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 300' ' ' ASP . 18.3 t -83.8 -38.38 14.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.634 ' CD2' HG21 ' A' ' 341' ' ' VAL . 91.0 mt -78.41 -28.42 46.86 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.408 -0.807 . . . . 0.0 110.113 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.65 -32.66 82.09 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 303' ' ' ALA . 3.1 mm-40 -79.6 -35.26 39.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -1.141 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.715 HG11 ' CG1' ' A' ' 341' ' ' VAL . 65.4 t -77.81 -19.29 13.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.642 0.734 . . . . 0.0 109.673 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.579 ' CD1' HG22 ' A' ' 321' ' ' THR . 0.3 OUTLIER -79.81 -43.12 22.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.492 -0.755 . . . . 0.0 109.25 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -80.2 -17.18 53.08 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.638 0.732 . . . . 0.0 109.969 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.33 -53.96 4.22 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.586 -0.696 . . . . 0.0 112.034 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.442 ' O ' HG11 ' A' ' 345' ' ' VAL . 76.1 mm-40 -112.26 45.2 1.31 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.252 -0.905 . . . . 0.0 111.227 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 309' ' ' ILE . 0.3 OUTLIER -80.65 28.56 0.33 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.238 -0.914 . . . . 0.0 110.79 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 53.41 42.84 65.56 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 22.2 m-85 61.69 33.07 18.23 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.681 -0.894 . . . . 0.0 110.051 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 2.8 tt0 65.31 43.94 3.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 109.378 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.584 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.8 OUTLIER -68.76 -83.18 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.606 0.717 . . . . 0.0 110.436 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.584 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.7 pt-20 -159.23 64.1 0.39 Allowed 'General case' 0 C--N 1.273 -2.754 0 O-C-N 121.672 -0.642 . . . . 0.0 110.69 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.874 HG13 HD12 ' A' ' 356' ' ' ILE . 2.2 mp -96.51 126.75 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 0.0 109.511 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.46 103.66 16.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.705 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.579 HG22 ' CD1' ' A' ' 309' ' ' ILE . 19.0 p -89.68 125.68 35.35 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.502 -0.749 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.36 78.97 1.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.478 -0.764 . . . . 0.0 109.249 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.666 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.3 mp -89.48 149.23 23.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.384 -0.823 . . . . 0.0 110.528 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.599 ' CD1' ' HD2' ' A' ' 325' ' ' PRO . 60.4 t80 -38.37 147.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.737 -0.602 . . . . 0.0 110.321 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.599 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.8 Cg_endo -81.83 64.12 8.48 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.948 1.499 . . . . 0.0 110.44 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . 172.87 8.38 0.02 OUTLIER Glycine 0 N--CA 1.498 2.767 0 C-N-CA 119.658 -1.258 . . . . 0.0 111.697 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 1.2 p 66.07 119.92 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.473 -1.604 . . . . 0.0 109.728 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.65 ' N ' HD13 ' A' ' 328' ' ' ILE . 1.6 mm -74.58 -178.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.864 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.586 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.6 mt-10 -170.56 103.72 0.26 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 121.688 0.756 . . . . 0.0 109.97 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.535 ' C ' ' HE2' ' A' ' 298' ' ' MET . 4.0 m -140.17 172.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.378 0 CA-C-O 121.646 0.736 . . . . 0.0 110.556 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.2 tptp -91.0 89.69 7.54 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.591 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 2.2 tmm? -143.79 157.3 44.47 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.401 -0.812 . . . . 0.0 110.609 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.656 ' CD2' ' CB ' ' A' ' 295' ' ' PRO . 3.3 t-80 -78.54 117.68 67.85 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 38.4 Cg_endo -62.11 -21.88 73.24 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.776 1.409 . . . . 0.0 110.341 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.575 ' HB2' ' ND1' ' A' ' 333' ' ' HIS . 12.1 mt -76.95 -63.6 1.32 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.107 0.956 . . . . 0.0 110.258 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.488 ' HB3' HG13 ' A' ' 412' ' ' ILE . 17.4 m -45.8 -53.08 10.17 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.554 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.757 HD11 ' CE1' ' A' ' 416' ' ' HIS . 16.7 mm -57.16 -43.84 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.999 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 0.2 OUTLIER -48.8 -41.19 31.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.887 -1.133 . . . . 0.0 108.344 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 336' ' ' SER . 6.8 mtt180 -67.46 -47.71 69.32 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.488 0.661 . . . . 0.0 109.909 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.43 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -51.82 -36.2 47.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 110.641 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.715 ' CG1' HG11 ' A' ' 308' ' ' VAL . 33.6 t -89.99 -21.05 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.204 -0.935 . . . . 0.0 110.281 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.59 -56.69 9.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.868 . . . . 0.0 110.846 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . 0.556 ' O ' HG12 ' A' ' 346' ' ' VAL . 76.1 m-20 -75.68 -19.72 58.94 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.212 -0.93 . . . . 0.0 110.724 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.667 ' CE ' HG21 ' A' ' 432' ' ' ILE . 2.0 mtt -67.48 -32.66 73.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.287 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.807 ' O ' ' HB2' ' A' ' 349' ' ' ALA . 55.9 t -90.44 -19.05 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.351 -0.843 . . . . 0.0 111.236 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 343' ' ' ASN . 0.6 OUTLIER -70.93 -30.31 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.939 -1.101 . . . . 0.0 110.685 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -60.9 -55.76 29.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.144 -0.972 . . . . 0.0 110.636 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.488 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -85.1 -19.23 32.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.173 -0.954 . . . . 0.0 110.403 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.807 ' HB2' ' O ' ' A' ' 345' ' ' VAL . . . -43.34 -72.8 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.381 -0.824 . . . . 0.0 110.811 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 61.0 mtt85 -87.0 -69.22 0.69 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.084 -1.01 . . . . 0.0 110.744 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . 0.492 ' O ' ' N ' ' A' ' 353' ' ' ASN . 2.3 t80 -49.03 -72.61 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.301 -0.874 . . . . 0.0 110.829 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -52.85 88.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 351' ' ' TYR . 6.3 p-10 -96.2 51.48 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.184 -1.186 . . . . 0.0 109.801 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -121.1 -66.93 0.26 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.575 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 2.0 t90 -176.28 140.36 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -1.182 . . . . 0.0 110.219 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.874 HD12 HG13 ' A' ' 319' ' ' ILE . 2.8 mt -110.41 158.96 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.651 -0.656 . . . . 0.0 109.909 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 11.8 ttpt -142.15 105.58 4.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.113 -0.992 . . . . 0.0 110.74 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.648 HG23 HG23 ' A' ' 319' ' ' ILE . 68.9 t -107.73 84.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.327 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 69.5 p -116.67 140.73 49.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.006 -1.059 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.505 ' HB3' ' HG ' ' A' ' 323' ' ' LEU . 1.9 t -125.72 158.66 34.28 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.543 ' C ' HG22 ' A' ' 362' ' ' THR . . . -159.07 -152.62 6.51 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -179.26 174.18 1.05 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.215 -1.168 . . . . 0.0 110.525 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.561 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 1.9 mt-10 -151.81 -175.13 0.45 Allowed Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.468 -0.77 . . . . 0.0 109.504 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 40.7 Cg_endo -69.7 116.96 4.8 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.582 1.306 . . . . 0.0 111.353 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.563 ' O ' ' HG3' ' A' ' 366' ' ' ARG . 1.9 m-20 69.65 6.09 5.53 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.679 -0.638 . . . . 0.0 111.844 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 365' ' ' ASN . 59.7 mtp85 -155.7 104.92 2.37 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.098 -1.001 . . . . 0.0 111.834 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -101.01 167.59 10.15 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 52.7 p-90 -170.9 178.79 3.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.189 -1.569 . . . . 0.0 111.905 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.636 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 27.5 p90 -147.76 141.62 25.79 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.544 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 8.8 tt0 -134.15 149.44 51.05 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.871 -1.143 . . . . 0.0 112.325 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.544 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 33.6 t -127.22 134.05 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.454 ' HG3' ' OG ' ' A' ' 431' ' ' SER . 0.7 OUTLIER -128.96 145.88 51.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.778 -1.201 . . . . 0.0 109.897 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 373' ' ' ASP . 8.0 p30 -149.92 145.98 26.81 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.69 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.33 137.36 38.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.392 -0.817 . . . . 0.0 109.917 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 169.8 -164.15 37.59 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.008 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.53 -161.63 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.156 1.608 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 424' ' ' THR . . . -146.83 166.24 28.37 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.972 HD11 HD21 ' A' ' 422' ' ' LEU . 5.5 mt -72.6 169.81 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.236 . . . . 0.0 109.787 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.995 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -95.25 177.8 1.68 Allowed Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 120.96 -1.088 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.872 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 45.9 Cg_endo -73.32 -46.43 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.036 1.545 . . . . 0.0 110.78 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -90.77 -30.22 17.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.959 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.995 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -64.45 -20.18 66.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.079 -1.013 . . . . 0.0 110.338 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 382' ' ' GLN . 16.8 ttt180 -44.81 -29.22 0.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.162 -0.961 . . . . 0.0 109.872 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.475 ' HD3' ' OE1' ' A' ' 388' ' ' GLN . 20.0 mttt -89.95 -33.15 16.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.352 -0.843 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 382' ' ' GLN . 5.0 m170 -40.94 -59.18 1.51 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.314 -0.866 . . . . 0.0 110.036 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 386' ' ' LEU . 0.9 OUTLIER -113.91 64.04 0.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.112 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.481 ' O ' ' HG2' ' A' ' 388' ' ' GLN . 0.8 OUTLIER 176.14 62.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.33 -0.856 . . . . 0.0 110.253 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 387' ' ' PHE . 2.2 mt-30 -152.99 126.35 4.21 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.04 -1.037 . . . . 0.0 110.363 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.65 88.27 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.923 1.486 . . . . 0.0 110.544 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.05 138.57 37.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.153 -0.967 . . . . 0.0 110.146 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.468 ' H ' HG22 ' A' ' 391' ' ' VAL . 35.4 m -83.94 47.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.257 -0.902 . . . . 0.0 110.666 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -113.03 138.59 49.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 394' ' ' ASP . . . 165.36 -102.72 0.2 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 393' ' ' GLY . 0.4 OUTLIER 65.47 145.76 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -1.168 . . . . 0.0 110.121 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 m -111.71 43.47 1.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.198 -0.939 . . . . 0.0 110.08 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -100.58 -0.71 37.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 52.32 89.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.163 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 2.9 m -124.24 -129.1 0.25 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 110.078 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 399' ' ' ILE . 7.8 tp -116.82 54.66 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.053 -1.029 . . . . 0.0 110.215 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.9 t -128.11 -169.94 2.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.408 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -110.14 -176.69 20.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.4 p -131.76 -38.44 1.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -1.149 . . . . 0.0 110.248 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 102.07 -46.87 1.21 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 13.5 tp 45.17 82.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.263 -1.139 . . . . 0.0 110.126 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -141.79 -169.65 12.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.8 60.34 0.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.332 -1.099 . . . . 0.0 110.114 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.84 86.48 5.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.85 ' O ' HD13 ' A' ' 412' ' ' ILE . 27.3 mm -119.78 35.18 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.267 -0.896 . . . . 0.0 110.175 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 410' ' ' GLN . 7.0 p -129.47 -34.03 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.183 -0.948 . . . . 0.0 110.269 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 31.0 tt0 -66.4 -42.14 88.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 110.502 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.488 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.0 OUTLIER -69.57 -32.31 71.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.173 -0.954 . . . . 0.0 110.033 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 408' ' ' ILE . 1.1 mp -59.64 -63.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.147 -0.971 . . . . 0.0 108.58 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 1.047 HG21 HD13 ' A' ' 420' ' ' LEU . 35.5 t -63.32 -28.22 44.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.321 -0.862 . . . . 0.0 109.823 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.488 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 29.7 t70 -73.24 -20.54 60.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.511 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.548 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.1 m-80 -95.27 -14.31 24.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.473 -0.767 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.757 ' CE1' HD11 ' A' ' 337' ' ' ILE . 37.3 m80 -93.03 -34.1 13.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.451 -0.781 . . . . 0.0 109.865 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 4.1 m120 72.95 47.43 0.2 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.488 0.661 . . . . 0.0 110.431 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.575 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -121.28 -87.16 0.92 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.593 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.2 OUTLIER -171.12 161.74 6.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.397 -1.061 . . . . 0.0 110.615 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 1.047 HD13 HG21 ' A' ' 413' ' ' VAL . 14.1 tp -150.36 90.68 1.68 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 109.989 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 433' ' ' ARG . 63.0 mm-40 -89.81 154.03 20.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.235 -0.915 . . . . 0.0 110.046 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.972 HD21 HD11 ' A' ' 378' ' ' ILE . 7.2 tt -138.31 130.64 28.9 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.983 -1.073 . . . . 0.0 111.149 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.546 ' C ' ' HA ' ' A' ' 430' ' ' LEU . . . -90.33 163.04 29.91 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.773 ' HA ' ' HG ' ' A' ' 430' ' ' LEU 0.258 12.9 t -140.7 -38.48 0.43 Allowed 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 118.836 1.318 . . . . 0.0 112.397 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.683 ' N ' HG23 ' A' ' 424' ' ' THR . 1.4 p 155.38 -62.19 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.19 -48.02 72.03 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.589 ' HD2' ' CG2' ' A' ' 424' ' ' THR . 0.8 OUTLIER -61.57 -29.55 70.09 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 429' ' ' GLY . . . 139.86 86.65 0.13 Allowed Glycine 0 C--O 1.215 -1.04 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' A' ' 424' ' ' THR . . . 44.55 -167.0 0.03 OUTLIER Glycine 0 N--CA 1.499 2.862 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.783 HD22 ' N6 ' ' A' ' 451' ' ' ANP . 0.7 OUTLIER -110.93 131.93 54.64 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.579 1.69 . . . . 0.0 110.354 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.5 ' N ' HD23 ' A' ' 430' ' ' LEU . 4.0 m -143.26 -177.75 5.52 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.919 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.667 HG21 ' CE ' ' A' ' 344' ' ' MET . 9.1 mm -149.94 92.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.687 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . 0.534 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.1 mtt180 -88.59 134.84 33.76 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.859 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.636 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -128.98 129.35 45.29 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.05 -1.031 . . . . 0.0 109.679 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 84.0 m95 -111.28 145.57 38.56 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.139 -0.975 . . . . 0.0 111.908 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.526 ' CD1' HD11 ' A' ' 301' ' ' LEU . 5.9 mt -134.35 106.69 11.11 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.575 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 42.8 Cg_endo -68.78 138.82 42.1 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 O-C-N 123.911 1.479 . . . . 0.0 111.382 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.545 ' CG2' ' HD2' ' A' ' 439' ' ' PRO . 4.9 p -86.17 145.63 40.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.567 -0.708 . . . . 0.0 109.557 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 438' ' ' VAL . 47.4 Cg_endo -69.23 -167.74 0.22 Allowed 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.802 1.422 . . . . 0.0 110.423 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 441' ' ' THR . 12.4 t -63.36 154.3 6.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 O-C-N 121.731 -0.606 . . . . 0.0 110.474 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 440' ' ' VAL . 9.8 p -150.82 -91.98 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.971 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -118.35 -134.42 0.33 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.08 -1.013 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -151.38 129.33 11.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.044 -1.035 . . . . 0.0 110.097 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -138.05 91.55 2.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.323 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -49.4 156.41 1.71 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 20.7 p -98.52 103.28 15.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.205 -1.173 . . . . 0.0 110.17 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 60.6 p -76.03 127.2 32.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.227 -0.92 . . . . 0.0 110.176 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.44 133.06 47.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.198 -0.938 . . . . 0.0 110.389 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -74.32 -61.68 1.78 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 110.13 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.561 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.783 ' N6 ' HD22 ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.205 0.526 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.98 176.22 19.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -74.12 93.63 2.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -1.159 . . . . 0.0 109.974 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.535 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 42.3 tt0 -111.92 87.34 2.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.065 -1.022 . . . . 0.0 110.73 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.89 107.34 16.89 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.445 -0.784 . . . . 0.0 109.069 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.623 ' HB3' ' CD2' ' A' ' 333' ' ' HIS . 49.4 Cg_endo -97.83 -177.27 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.421 1.414 . . . . 0.0 111.252 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.508 ' C ' ' O ' ' A' ' 295' ' ' PRO . 0.0 OUTLIER 27.99 91.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.193 0.997 . . . . 0.0 111.104 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 18.6 pt-20 -164.25 -159.98 0.51 Allowed 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.502 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.0 OUTLIER -88.22 127.75 35.45 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.926 -1.109 . . . . 0.0 110.146 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -147.55 163.86 35.25 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.181 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.586 ' O ' HG23 ' A' ' 304' ' ' VAL . 16.3 t0 -100.12 116.42 32.11 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.664 -0.647 . . . . 0.0 109.759 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.648 HD12 HG21 ' A' ' 328' ' ' ILE . 12.0 mt -60.53 -27.45 67.65 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.299 -0.875 . . . . 0.0 109.778 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.818 ' HA ' HD23 ' A' ' 323' ' ' LEU . 56.7 t-20 -76.19 -22.68 55.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.056 . . . . 0.0 108.963 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -85.56 -31.46 22.66 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.459 0.647 . . . . 0.0 109.552 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 300' ' ' ASP . 33.2 t -79.58 -34.31 15.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.499 -0.75 . . . . 0.0 109.542 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.774 ' O ' HD12 ' A' ' 309' ' ' ILE . 82.6 mt -79.92 -26.77 40.04 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.401 -0.812 . . . . 0.0 109.991 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.56 -33.86 88.36 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.81 -32.92 25.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.305 -1.115 . . . . 0.0 109.417 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.843 HG11 ' CG1' ' A' ' 341' ' ' VAL . 51.0 t -75.39 -19.24 15.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.389 -0.819 . . . . 0.0 109.189 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.818 HD11 ' CG1' ' A' ' 358' ' ' VAL . 1.0 OUTLIER -83.26 -46.01 18.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.08 -17.58 61.99 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.277 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -90.58 -53.57 4.37 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.97 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -100.86 35.0 2.3 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 111.045 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 309' ' ' ILE . 0.1 OUTLIER -86.18 32.15 0.63 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.082 -1.012 . . . . 0.0 110.365 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 45.24 33.2 3.93 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.686 -2.165 . . . . 0.0 107.686 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 39.8 m-85 61.86 52.07 3.57 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 122.096 -0.65 . . . . 0.0 109.95 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 16.1 mt-10 59.28 35.52 23.36 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.597 -0.689 . . . . 0.0 110.256 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.3 OUTLIER -68.84 -74.13 0.13 Allowed 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.509 -0.744 . . . . 0.0 109.46 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 9.3 mt-10 -160.42 80.85 0.67 Allowed 'General case' 0 C--N 1.274 -2.7 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.542 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.984 HG13 HD12 ' A' ' 356' ' ' ILE . 2.7 mp -122.62 142.21 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.508 ' HB3' ' CG ' ' A' ' 357' ' ' LYS . 26.3 tt0 -109.7 103.89 12.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.446 -0.784 . . . . 0.0 109.547 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 20.0 p -90.53 123.71 34.42 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.245 -0.91 . . . . 0.0 111.411 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -144.33 78.69 1.59 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.818 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.7 mp -91.07 152.31 20.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.561 -0.712 . . . . 0.0 110.999 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.573 ' HB3' ' CD1' ' A' ' 328' ' ' ILE . 19.9 t80 -41.19 136.15 1.72 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.593 -0.692 . . . . 0.0 110.058 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 324' ' ' TYR . 51.8 Cg_endo -83.67 57.28 5.55 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 124.027 1.54 . . . . 0.0 110.276 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -167.58 21.13 0.1 OUTLIER Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.747 -1.215 . . . . 0.0 110.505 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 326' ' ' GLY . 68.5 m 56.44 111.56 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.019 -1.283 . . . . 0.0 110.215 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.648 HG21 HD12 ' A' ' 301' ' ' LEU . 3.5 mm -69.12 -179.34 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.579 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.635 ' H ' HG22 ' A' ' 328' ' ' ILE . 1.7 mt-10 -174.84 101.28 0.09 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.64 -0.663 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 1.016 HG11 ' HB3' ' A' ' 367' ' ' ALA . 8.4 m -143.41 174.17 5.03 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 CA-C-O 121.62 0.724 . . . . 0.0 110.469 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.1 OUTLIER -95.05 93.63 7.49 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.624 ' HG2' HG23 ' A' ' 330' ' ' VAL . 11.2 ptm -136.47 164.76 27.41 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.973 0.892 . . . . 0.0 112.597 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.623 ' CD2' ' HB3' ' A' ' 295' ' ' PRO . 23.4 t-160 -88.06 116.44 66.2 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 39.3 Cg_endo -62.47 -30.23 79.75 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.637 1.335 . . . . 0.0 112.542 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.597 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 3.9 tp -82.23 -49.2 10.36 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.623 -1.298 . . . . 0.0 110.589 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.542 ' HB2' ' ND1' ' A' ' 333' ' ' HIS . 0.5 OUTLIER -60.6 -42.26 96.42 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.915 -1.115 . . . . 0.0 109.869 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.933 HD11 ' CE1' ' A' ' 416' ' ' HIS . 18.5 mm -65.37 -46.99 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.601 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 0.7 OUTLIER -51.54 -32.93 29.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.83 -1.169 . . . . 0.0 107.873 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.477 ' NH1' ' OD1' ' A' ' 343' ' ' ASN . 0.0 OUTLIER -77.45 -34.65 54.41 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.991 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 344' ' ' MET . . . -67.55 -29.57 68.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.454 -0.779 . . . . 0.0 110.449 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.843 ' CG1' HG11 ' A' ' 308' ' ' VAL . 52.8 t -90.28 -25.49 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 110.423 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 346' ' ' VAL . . . -83.3 -19.95 35.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.578 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . 0.477 ' OD1' ' NH1' ' A' ' 339' ' ' ARG . 0.3 OUTLIER -83.78 -21.08 32.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -0.916 . . . . 0.0 110.779 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 340' ' ' ALA . 3.2 mtt -90.69 -51.3 5.45 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.138 -0.976 . . . . 0.0 111.221 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 341' ' ' VAL . 27.4 m -68.22 -19.69 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.191 -0.943 . . . . 0.0 111.505 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 347' ' ' ASN . 14.5 p -61.53 -39.64 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.843 -1.161 . . . . 0.0 110.72 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.52 ' N ' HG13 ' A' ' 346' ' ' VAL . 10.9 t30 -63.2 -49.78 72.87 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.126 -0.984 . . . . 0.0 110.806 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.488 ' O ' ' HA2' ' A' ' 352' ' ' GLY . . . -72.73 -19.91 61.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.219 -0.926 . . . . 0.0 110.612 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -67.09 -73.18 0.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.025 -1.047 . . . . 0.0 110.253 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -55.35 -51.63 66.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.298 -0.876 . . . . 0.0 110.453 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -59.54 2.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.215 -0.928 . . . . 0.0 110.379 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 348' ' ' ALA . . . 68.09 -104.11 1.12 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 1.5 t30 55.0 17.35 1.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -1.145 . . . . 0.0 110.207 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 374' ' ' ASP . . . -168.37 -98.25 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.067 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.612 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -179.78 148.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -1.166 . . . . 0.0 109.881 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.984 HD12 HG13 ' A' ' 319' ' ' ILE . 0.8 OUTLIER -106.49 159.52 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.309 -0.869 . . . . 0.0 110.024 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.612 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 1.4 ttmt -150.41 112.72 4.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 110.692 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.818 ' CG1' HD11 ' A' ' 309' ' ' ILE . 21.9 t -103.07 88.81 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 370' ' ' GLN . 6.8 p -115.04 151.14 34.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -0.896 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.536 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 0.6 OUTLIER -140.14 163.53 32.47 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.495 -0.753 . . . . 0.0 109.666 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.533 ' C ' HG22 ' A' ' 362' ' ' THR . . . -155.23 -164.32 12.95 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.545 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.1 OUTLIER -176.36 144.05 0.53 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.716 -1.461 . . . . 0.0 112.048 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 39.0 mt-10 -109.03 175.61 1.89 Allowed Pre-proline 0 C--N 1.287 -2.146 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.304 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 40.1 Cg_endo -66.07 127.0 16.77 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.245 1.129 . . . . 0.0 110.087 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.552 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 6.6 m120 60.52 22.25 11.97 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.519 -0.738 . . . . 0.0 110.243 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 42.1 mtm180 -163.63 145.06 9.22 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 1.016 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -143.17 151.16 40.36 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.11 -0.994 . . . . 0.0 109.159 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.603 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 37.7 p-90 -151.67 170.38 19.85 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.905 -1.122 . . . . 0.0 110.682 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 369' ' ' PHE . 36.4 p90 -139.5 130.42 26.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.44 -0.787 . . . . 0.0 109.582 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 359' ' ' SER . 0.8 OUTLIER -116.1 150.48 37.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -0.933 . . . . 0.0 111.381 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.29 143.86 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.497 -0.752 . . . . 0.0 109.348 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 357' ' ' LYS . 1.8 tt0 -126.36 145.51 50.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.013 -1.054 . . . . 0.0 110.198 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 355' ' ' TRP . 11.1 t70 -156.65 143.66 18.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.841 . . . . 0.0 110.331 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 374' ' ' ASP . 27.6 t0 -98.39 64.47 1.59 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.37 -0.831 . . . . 0.0 110.016 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -86.88 -148.01 12.23 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.15 -40.59 3.15 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.008 1.531 . . . . 0.0 110.482 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . 0.593 ' C ' HD13 ' A' ' 378' ' ' ILE . . . 103.6 -174.85 23.06 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.768 HD11 HD11 ' A' ' 430' ' ' LEU . 1.9 mm -99.72 176.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.065 -1.256 . . . . 0.0 110.102 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.902 ' HB3' ' CB ' ' A' ' 382' ' ' GLN . . . -109.91 165.61 12.35 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.248 -0.908 . . . . 0.0 109.752 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 43.2 Cg_endo -70.07 -49.26 0.53 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.842 1.443 . . . . 0.0 110.229 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -89.53 -19.69 24.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.12 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.902 ' CB ' ' HB3' ' A' ' 379' ' ' ALA . 4.5 tt0 -82.82 -19.78 36.98 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.275 -0.89 . . . . 0.0 110.86 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 382' ' ' GLN . 2.2 ttt85 -42.32 -37.97 1.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.024 -1.047 . . . . 0.0 110.021 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.84 -27.89 19.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.203 -0.936 . . . . 0.0 110.404 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -51.81 -18.23 1.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.107 -0.996 . . . . 0.0 110.747 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.633 HD11 " O2'" ' A' ' 451' ' ' ANP . 50.4 mt -86.59 23.22 1.7 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.92 -1.113 . . . . 0.0 110.731 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 57.3 m-85 -159.7 35.2 0.19 Allowed 'General case' 0 C--N 1.293 -1.87 0 O-C-N 121.483 -0.761 . . . . 0.0 109.984 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 388' ' ' GLN . 0.0 OUTLIER -104.49 136.75 19.13 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 110.568 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.63 147.49 35.72 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.841 1.442 . . . . 0.0 109.888 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . 0.435 ' HB2' ' OE1' ' A' ' 388' ' ' GLN . 53.7 t80 -172.89 107.23 0.16 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.031 -1.043 . . . . 0.0 110.583 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 392' ' ' ARG . 2.5 t -137.06 170.07 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.259 -0.9 . . . . 0.0 109.694 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 391' ' ' VAL . 0.1 OUTLIER 44.25 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.033 -1.042 . . . . 0.0 109.964 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 150.56 58.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -145.1 139.2 27.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -1.163 . . . . 0.0 110.204 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 t -156.66 -40.81 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.911 . . . . 0.0 110.15 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -108.23 -90.26 0.45 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.903 . . . . 0.0 110.082 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -79.05 147.22 32.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -0.972 . . . . 0.0 110.166 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 4.1 m -159.96 127.91 4.75 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.114 -0.991 . . . . 0.0 110.344 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.555 HD12 ' C ' ' A' ' 399' ' ' ILE . 2.0 pp -85.54 -29.33 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.402 ' N ' HD12 ' A' ' 399' ' ' ILE . 9.6 t -110.79 135.87 50.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.329 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 125.11 101.7 1.35 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 402' ' ' THR . 53.1 m -132.03 13.94 4.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.211 -1.17 . . . . 0.0 109.955 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 165.26 -117.42 0.75 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 45.7 tp -89.57 -73.54 0.51 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.173 -1.192 . . . . 0.0 109.995 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -164.23 55.6 0.28 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.95 170.2 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.289 -1.124 . . . . 0.0 110.529 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -106.48 160.15 15.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.363 -0.836 . . . . 0.0 109.664 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.589 HG22 HG12 ' A' ' 409' ' ' VAL . 14.2 mt -130.01 169.47 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.042 -1.036 . . . . 0.0 110.48 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 408' ' ' ILE . 10.6 p -48.83 -22.51 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.174 -0.954 . . . . 0.0 110.176 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 48.3 tt0 -62.9 -55.94 21.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.23 -0.919 . . . . 0.0 110.609 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.4 OUTLIER -59.02 -32.19 69.5 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.311 -0.868 . . . . 0.0 110.684 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 340' ' ' ALA . 1.0 OUTLIER -64.03 -58.37 7.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.092 -1.005 . . . . 0.0 109.143 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.653 HG11 ' HB2' ' A' ' 420' ' ' LEU . 30.4 t -65.51 -21.41 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.249 -0.907 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 0.1 OUTLIER -82.41 -25.83 33.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 109.515 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 2.2 t-20 -86.41 -17.82 33.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.933 ' CE1' HD11 ' A' ' 337' ' ' ILE . 22.7 m80 -92.87 -41.2 10.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.539 -0.726 . . . . 0.0 109.664 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 6.0 t-20 79.59 36.04 0.15 Allowed 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.437 0.637 . . . . 0.0 109.949 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.635 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -101.86 -90.03 2.1 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.565 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.7 OUTLIER -173.0 163.45 4.79 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.349 -1.089 . . . . 0.0 111.222 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.653 ' HB2' HG11 ' A' ' 413' ' ' VAL . 14.3 tp -151.45 97.93 2.46 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.57 152.17 34.7 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.001 -1.062 . . . . 0.0 111.541 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.602 ' O ' HD12 ' A' ' 422' ' ' LEU . 2.9 pp -132.47 121.13 22.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.404 -0.81 . . . . 0.0 109.273 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -141.8 132.04 5.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.702 HG21 ' HA ' ' A' ' 427' ' ' ARG . 3.5 t -128.45 155.1 45.32 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.254 -1.145 . . . . 0.0 110.703 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 2.6 p -85.74 112.67 21.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.309 -0.869 . . . . 0.0 109.359 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 53.02 49.3 20.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.59 -0.694 . . . . 0.0 110.038 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.702 ' HA ' HG21 ' A' ' 424' ' ' THR . 13.9 mmt180 45.13 46.64 9.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 110.02 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -143.68 -66.51 0.02 OUTLIER Glycine 0 N--CA 1.484 1.853 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -77.88 77.03 1.68 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.768 HD11 HD11 ' A' ' 378' ' ' ILE . 0.3 OUTLIER -76.44 135.77 39.42 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.138 -1.213 . . . . 0.0 111.777 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 40.2 t -144.76 114.24 7.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.689 -0.632 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 432' ' ' ILE . 1.5 tt -94.46 131.91 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.145 -0.972 . . . . 0.0 110.368 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -111.79 103.04 11.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.94 . . . . 0.0 110.407 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 368' ' ' TRP . . . -91.96 130.39 37.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.325 -0.86 . . . . 0.0 109.518 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.603 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.3 m95 -107.66 157.24 18.25 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.822 -1.174 . . . . 0.0 112.438 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.505 HD12 HD11 ' A' ' 301' ' ' LEU . 19.8 mt -142.68 114.12 6.04 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.635 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 51.4 Cg_endo -78.45 129.53 9.44 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.534 1.281 . . . . 0.0 112.161 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.799 HG21 HG12 ' A' ' 330' ' ' VAL . 6.8 t -109.32 69.0 0.42 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.539 -0.725 . . . . 0.0 110.02 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.483 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 57.7 Cg_endo -75.01 -170.5 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.681 1.358 . . . . 0.0 110.558 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 440' ' ' VAL 0.255 9.5 p -141.2 29.65 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 O-C-N 121.907 -0.496 . . . . 0.0 110.752 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 66.2 p -51.77 111.83 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.063 -1.023 . . . . 0.0 110.398 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -116.49 -49.67 2.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.304 -0.873 . . . . 0.0 110.023 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -108.56 121.01 44.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.222 -0.923 . . . . 0.0 110.259 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -163.51 -175.83 4.39 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.246 -0.909 . . . . 0.0 110.092 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . 0.451 ' C ' HG23 ' A' ' 446' ' ' THR . . . -172.1 -63.2 0.04 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 445' ' ' GLY . 48.5 p -149.8 110.81 4.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -1.149 . . . . 0.0 110.177 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 30.7 p -47.05 169.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -76.25 -87.17 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.266 -0.896 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.11 138.11 20.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.276 -0.89 . . . . 0.0 110.176 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 CA-C-O 118.019 -1.434 . . . . 0.0 109.546 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.757 " C1'" HD12 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 290' ' ' THR . 41.7 m . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.258 0.552 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -150.08 -149.96 5.14 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 292' ' ' GLN . 1.5 tm0? -80.28 6.78 11.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -1.119 . . . . 0.0 110.268 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.68 92.42 5.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.223 -0.923 . . . . 0.0 110.465 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 67.4 mtp -104.13 109.4 62.4 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.289 -0.882 . . . . 0.0 109.937 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.642 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 54.2 Cg_endo -83.79 48.74 2.67 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.874 1.46 . . . . 0.0 111.283 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.04 107.74 15.84 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 15.5 mt-10 -128.81 -162.02 1.16 Allowed 'General case' 0 C--N 1.283 -2.287 0 O-C-N 121.637 -0.664 . . . . 0.0 109.913 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.468 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.3 OUTLIER -88.33 133.51 34.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.048 -1.033 . . . . 0.0 110.271 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.584 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -149.68 160.7 43.31 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.447 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.903 ' O ' HG23 ' A' ' 304' ' ' VAL . 4.3 t0 -90.77 121.32 32.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.801 -0.562 . . . . 0.0 109.891 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.776 HD11 HD12 ' A' ' 436' ' ' LEU . 9.5 mt -72.18 -21.15 61.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 109.718 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.645 ' OD1' HD23 ' A' ' 323' ' ' LEU . 8.9 t30 -83.45 -23.97 32.04 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 109.138 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.682 ' HB3' ' HB3' ' A' ' 300' ' ' ASP . . . -84.0 -31.59 25.4 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.515 -0.74 . . . . 0.0 109.584 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 300' ' ' ASP . 11.4 t -78.41 -35.88 19.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.401 -0.812 . . . . 0.0 109.705 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.509 ' CD2' HG21 ' A' ' 341' ' ' VAL . 71.1 mt -76.08 -29.56 58.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.26 -0.9 . . . . 0.0 110.924 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . 0.473 ' HA2' HD12 ' A' ' 309' ' ' ILE . . . -65.58 -39.78 95.69 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -75.84 -32.56 59.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.203 -1.174 . . . . 0.0 109.59 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 1.006 HG11 ' HB ' ' A' ' 341' ' ' VAL . 41.0 t -78.27 -19.96 13.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 109.339 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.989 ' CG1' HG11 ' A' ' 358' ' ' VAL . 1.4 mt -71.15 -50.48 41.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.79 -15.08 61.64 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.823 0.821 . . . . 0.0 108.879 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 308' ' ' VAL . . . -61.62 -63.17 1.36 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.857 -0.527 . . . . 0.0 111.817 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 311' ' ' ALA . 13.3 mt-10 -143.41 38.92 1.4 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.525 -1.27 . . . . 0.0 113.047 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.949 ' OG ' HD12 ' A' ' 319' ' ' ILE . 5.9 t -85.77 10.37 13.8 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.616 -1.303 . . . . 0.0 109.53 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 317' ' ' ARG . . . 111.39 43.33 0.99 Allowed Glycine 0 C--N 1.291 -1.945 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.536 ' O ' ' HG3' ' A' ' 316' ' ' GLU . 23.7 m-85 59.43 41.6 19.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.639 -0.918 . . . . 0.0 110.094 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 53.59 32.67 14.8 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.342 1.068 . . . . 0.0 109.096 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 0.2 OUTLIER -69.81 -81.59 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.98 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.634 ' C ' HD13 ' A' ' 319' ' ' ILE . 14.3 pt-20 -126.89 72.15 1.34 Allowed 'General case' 0 C--N 1.277 -2.545 0 O-C-N 121.669 -0.644 . . . . 0.0 111.974 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.949 HD12 ' OG ' ' A' ' 313' ' ' SER . 1.8 mm -104.52 123.2 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 358' ' ' VAL . 7.5 tt0 -88.98 98.15 11.6 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.59 HG22 HD13 ' A' ' 309' ' ' ILE . 20.6 p -89.46 129.22 35.99 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.893 0.854 . . . . 0.0 111.832 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.46 77.85 1.31 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.645 HD23 ' OD1' ' A' ' 302' ' ' ASN . 0.8 OUTLIER -96.46 158.51 15.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.47 -0.768 . . . . 0.0 110.644 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.605 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 15.3 t80 -54.31 116.03 9.74 Favored Pre-proline 0 C--N 1.299 -1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.49 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -80.97 64.64 8.92 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 124.022 1.538 . . . . 0.0 110.322 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.451 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -162.52 23.04 0.2 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 4.3 p 60.26 106.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -1.136 . . . . 0.0 110.646 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.557 HG22 ' N ' ' A' ' 329' ' ' GLU . 4.0 mt -84.8 175.48 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 O-C-N 121.723 -0.611 . . . . 0.0 109.646 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.557 ' N ' HG22 ' A' ' 328' ' ' ILE . 2.7 mt-10 -169.47 109.89 0.45 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.391 -0.818 . . . . 0.0 111.352 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 1.124 HG11 ' HB3' ' A' ' 367' ' ' ALA . 12.7 m -145.03 160.68 13.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.517 0.675 . . . . 0.0 109.936 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.0 OUTLIER -82.94 95.89 8.12 Favored 'General case' 0 C--N 1.282 -2.338 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.518 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.584 ' HG3' ' HB3' ' A' ' 299' ' ' ALA . 19.2 ptm -140.37 -178.21 5.39 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 110.975 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.642 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 18.1 t-160 -115.13 112.23 44.39 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.506 ' HB2' ' HE3' ' A' ' 338' ' ' LYS . 36.6 Cg_endo -58.74 -19.66 47.36 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.721 1.379 . . . . 0.0 110.447 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.684 ' C ' HD13 ' A' ' 335' ' ' LEU . 2.9 tm? -78.95 -63.89 1.31 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.382 -0.824 . . . . 0.0 110.123 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.47 ' O ' HG12 ' A' ' 412' ' ' ILE . 0.0 OUTLIER -54.22 -49.97 68.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.305 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.562 HD13 ' CG2' ' A' ' 412' ' ' ILE . 17.3 mm -62.91 -31.78 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 110.346 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.506 ' HE3' ' HB2' ' A' ' 334' ' ' PRO . 0.4 OUTLIER -61.03 -57.86 10.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.906 -1.121 . . . . 0.0 109.772 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.401 ' HD2' ' C ' ' A' ' 339' ' ' ARG . 4.1 tmm_? -69.45 -21.35 63.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.466 -0.771 . . . . 0.0 110.356 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.432 ' HB2' ' CG1' ' A' ' 412' ' ' ILE . . . -69.6 -44.69 70.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.077 -1.014 . . . . 0.0 110.307 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 1.006 ' HB ' HG11 ' A' ' 308' ' ' VAL . 46.3 t -80.42 -22.16 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.337 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -70.62 -62.24 1.46 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.137 -0.977 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . 0.923 ' O ' HG12 ' A' ' 346' ' ' VAL . 1.8 t30 -59.25 -43.48 92.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.074 -1.016 . . . . 0.0 110.73 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.539 ' CE ' HG21 ' A' ' 432' ' ' ILE . 2.9 ttm -57.7 -19.05 24.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.274 -0.891 . . . . 0.0 110.976 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 341' ' ' VAL . 78.0 t -88.68 -22.26 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.094 -1.004 . . . . 0.0 111.587 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.923 HG12 ' O ' ' A' ' 343' ' ' ASN . 9.0 p -64.82 -19.5 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.951 -1.093 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -66.26 -42.63 88.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.052 -1.03 . . . . 0.0 111.536 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.495 ' HB2' ' CG ' ' A' ' 373' ' ' ASP . . . -89.3 -19.86 24.79 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.938 -1.101 . . . . 0.0 111.369 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -89.41 -69.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.959 -1.088 . . . . 0.0 110.822 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -65.8 -41.92 91.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.125 -0.984 . . . . 0.0 110.744 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.82 -35.73 16.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.175 -0.953 . . . . 0.0 110.56 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -97.34 156.27 20.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -141.97 53.94 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -1.12 . . . . 0.0 109.959 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 355' ' ' TRP . . . -128.04 -59.58 0.12 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.587 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.3 OUTLIER 171.78 150.25 0.05 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.151 -1.205 . . . . 0.0 109.841 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' A' ' 313' ' ' SER . 26.6 mt -116.49 164.21 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.251 -0.905 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 18.4 tttm -142.27 97.6 3.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.561 -0.712 . . . . 0.0 109.752 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.989 HG11 ' CG1' ' A' ' 309' ' ' ILE . 26.0 t -93.01 139.57 17.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.8 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.56 ' HA ' ' CD1' ' A' ' 323' ' ' LEU . 60.3 p -160.13 169.91 22.33 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.087 -1.008 . . . . 0.0 111.458 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.517 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 34.2 t -155.21 150.28 26.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.635 -0.665 . . . . 0.0 109.762 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.513 ' HA3' ' CZ2' ' A' ' 368' ' ' TRP . . . -139.1 -169.92 11.7 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.605 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.5 OUTLIER -178.21 166.16 1.91 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.926 -1.338 . . . . 0.0 111.834 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.571 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 5.1 mm-40 -128.35 -174.91 0.4 Allowed Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 45.8 Cg_endo -86.71 36.46 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.495 1.261 . . . . 0.0 110.446 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 2.8 m-20 161.29 36.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.533 ' HG2' ' HB3' ' A' ' 437' ' ' PRO . 0.2 OUTLIER 166.14 103.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.387 -0.821 . . . . 0.0 109.718 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 1.124 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -103.91 157.52 17.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.023 -1.048 . . . . 0.0 110.205 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.596 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 30.2 p-90 -150.51 166.46 30.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.254 -0.904 . . . . 0.0 110.323 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 434' ' ' ALA . 36.0 p90 -133.77 147.26 51.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -0.83 . . . . 0.0 109.499 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.542 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 24.5 tt0 -139.08 155.9 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 111.538 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.542 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 6.3 t -140.03 144.15 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 431' ' ' SER . 26.2 tt0 -142.62 147.65 36.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.824 -1.172 . . . . 0.0 110.099 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.495 ' CG ' ' HB2' ' A' ' 348' ' ' ALA . 1.5 p30 -161.4 169.68 21.5 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.068 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -79.54 166.69 21.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.388 -0.82 . . . . 0.0 110.026 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 428' ' ' GLY . . . 124.58 -164.12 18.16 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.89 127.08 11.17 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.042 1.549 . . . . 0.0 110.622 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . 0.644 ' HA2' HD12 ' A' ' 430' ' ' LEU . . . -94.24 -169.62 37.73 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.711 HG22 ' H ' ' A' ' 379' ' ' ALA . 3.2 mm -76.97 -172.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.942 -1.328 . . . . 0.0 110.145 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.961 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -155.59 160.36 30.9 Favored Pre-proline 0 C--N 1.304 -1.413 0 O-C-N 121.235 -0.915 . . . . 0.0 110.101 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.84 -38.1 4.47 Favored 'Trans proline' 0 C--N 1.298 -2.101 0 O-C-N 124.087 1.572 . . . . 0.0 110.367 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -90.1 -20.91 22.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.199 -0.938 . . . . 0.0 110.284 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.961 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 5.3 tp60 -76.92 -23.57 52.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.204 -0.935 . . . . 0.0 110.343 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' A' ' 387' ' ' PHE . 2.2 ttt180 -52.53 -26.36 12.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.223 -0.923 . . . . 0.0 110.351 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -79.67 -32.62 41.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.308 -0.87 . . . . 0.0 110.066 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -59.0 -71.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.032 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.551 ' O ' ' CD2' ' A' ' 387' ' ' PHE . 0.5 OUTLIER -100.28 50.15 0.9 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.401 -0.812 . . . . 0.0 110.552 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 386' ' ' LEU . 0.2 OUTLIER 176.02 68.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.195 -0.94 . . . . 0.0 110.155 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.538 ' O ' ' HG3' ' A' ' 388' ' ' GLN . 25.9 pt20 -141.22 132.39 13.5 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.219 -0.925 . . . . 0.0 110.454 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -83.69 51.23 3.42 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.749 1.394 . . . . 0.0 110.183 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.9 149.01 49.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.93 171.22 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.33 -0.856 . . . . 0.0 110.803 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.41 -56.65 1.23 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.415 -0.803 . . . . 0.0 109.789 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 139.88 -122.71 2.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -144.31 78.03 1.56 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -1.136 . . . . 0.0 110.131 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.26 36.94 4.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.905 . . . . 0.0 110.35 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -54.94 154.95 4.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.489 ' C ' HG23 ' A' ' 398' ' ' THR . 5.8 ttm-85 -92.94 84.79 4.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.295 -0.878 . . . . 0.0 110.349 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.489 HG23 ' C ' ' A' ' 397' ' ' ARG . 2.0 p 58.5 133.29 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.509 -0.744 . . . . 0.0 110.388 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 399' ' ' ILE . 19.8 tt -116.93 128.43 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.323 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.4 p -102.45 20.96 16.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 110.017 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 96.75 39.09 4.22 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 4.5 t -125.67 141.32 52.08 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.246 -1.15 . . . . 0.0 110.233 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -108.14 -60.95 0.55 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.74 55.99 5.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.32 -1.106 . . . . 0.0 110.187 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -143.33 108.57 0.52 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 406' ' ' LEU . 14.3 tp -163.38 130.76 3.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -1.145 . . . . 0.0 110.287 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 410' ' ' GLN . . . -87.02 -30.35 21.27 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.891 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 412' ' ' ILE . 10.7 mt 64.59 -125.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.287 -0.883 . . . . 0.0 110.869 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.502 ' HA ' HD13 ' A' ' 412' ' ' ILE . 13.6 p -46.91 -19.88 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.052 -1.03 . . . . 0.0 111.744 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.863 ' HB3' ' HB1' ' A' ' 407' ' ' ALA . 0.7 OUTLIER -58.53 -67.08 0.39 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.012 -1.055 . . . . 0.0 111.589 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.52 ' HG2' ' NH2' ' A' ' 411' ' ' ARG . 0.0 OUTLIER -60.31 -26.09 66.27 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.193 -0.942 . . . . 0.0 111.956 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.732 HD12 ' O ' ' A' ' 408' ' ' ILE . 1.3 mp -64.79 -61.69 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 120.473 -1.392 . . . . 0.0 109.332 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.568 HG21 HD13 ' A' ' 420' ' ' LEU . 25.5 t -66.23 -25.14 34.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 110.093 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 9.1 m-20 -78.38 -23.29 46.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 109.823 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 16.6 t-20 -82.95 -15.31 51.79 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.318 -0.864 . . . . 0.0 109.285 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.579 ' O ' ' CB ' ' A' ' 417' ' ' ASN . 34.1 m80 -90.89 -30.09 17.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.515 -0.74 . . . . 0.0 110.062 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.579 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 3.4 t-20 81.52 17.57 0.45 Allowed 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.814 -0.554 . . . . 0.0 110.464 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.577 ' HA2' ' CD ' ' A' ' 437' ' ' PRO . . . -84.81 -91.7 0.79 Allowed Glycine 0 N--CA 1.481 1.678 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.585 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.8 ttp -174.52 167.12 3.91 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.205 -1.174 . . . . 0.0 111.042 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.568 HD13 HG21 ' A' ' 413' ' ' VAL . 19.1 tp -150.83 112.48 4.46 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.597 -0.69 . . . . 0.0 109.181 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -123.54 133.29 54.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.893 -1.129 . . . . 0.0 111.936 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.541 ' CD2' HD12 ' A' ' 432' ' ' ILE . 10.8 mt -108.96 127.59 54.2 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 430' ' ' LEU . . . -136.59 136.83 8.62 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.073 -1.537 . . . . 0.0 110.762 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 429' ' ' GLY . 5.9 m -90.11 123.98 34.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.436 -1.038 . . . . 0.0 109.674 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.573 ' HB2' ' CG ' ' A' ' 427' ' ' ARG . 41.8 m -85.47 144.73 27.79 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.137 -0.977 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.55 -20.26 0.24 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.213 0.53 . . . . 0.0 110.532 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.573 ' CG ' ' HB2' ' A' ' 425' ' ' SER . 0.2 OUTLIER -57.02 -8.17 0.6 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.32 -0.862 . . . . 0.0 111.3 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 375' ' ' GLY . . . 93.53 21.26 29.64 Favored Glycine 0 N--CA 1.479 1.563 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.636 ' O ' HG23 ' A' ' 424' ' ' THR . . . -147.41 -136.7 2.84 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.927 HD22 ' N ' ' A' ' 431' ' ' SER . 0.0 OUTLIER -175.42 -175.71 0.83 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.038 -1.272 . . . . 0.0 112.11 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.927 ' N ' HD22 ' A' ' 430' ' ' LEU . 0.9 OUTLIER -153.05 -178.98 7.27 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.203 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.541 HD12 ' CD2' ' A' ' 422' ' ' LEU . 0.6 OUTLIER -137.02 133.9 47.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.043 -1.035 . . . . 0.0 110.631 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -111.63 97.8 6.98 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.47 -0.769 . . . . 0.0 109.111 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.592 ' HB3' ' CE2' ' A' ' 369' ' ' PHE . . . -90.63 133.07 35.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.402 -0.811 . . . . 0.0 110.474 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.596 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.7 m95 -105.64 151.92 23.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.097 -1.002 . . . . 0.0 111.586 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.776 HD12 HD11 ' A' ' 301' ' ' LEU . 36.8 mt -144.41 83.91 9.61 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.577 ' CD ' ' HA2' ' A' ' 418' ' ' GLY . 41.7 Cg_endo -69.35 137.0 35.57 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 123.92 1.484 . . . . 0.0 111.443 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 330' ' ' VAL . 40.8 t -79.35 142.96 59.19 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.78 -0.575 . . . . 0.0 109.947 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 331' ' ' LYS . 47.3 Cg_endo -74.17 167.4 27.28 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.742 1.39 . . . . 0.0 110.425 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 443' ' ' ALA . 13.2 p -45.53 160.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.18 -0.95 . . . . 0.0 110.171 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 3.8 t -115.64 36.0 4.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.122 -0.987 . . . . 0.0 110.211 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -135.8 -44.88 0.66 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.2 -0.937 . . . . 0.0 110.31 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . 0.417 ' O ' HG11 ' A' ' 440' ' ' VAL . . . -155.87 129.5 8.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.326 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -71.35 -30.63 66.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 110.046 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -170.46 173.61 44.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 15.3 p -58.28 158.01 7.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.235 -1.156 . . . . 0.0 110.233 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.411 ' H ' HG22 ' A' ' 447' ' ' THR . 3.3 t -105.11 57.78 0.68 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.228 -0.92 . . . . 0.0 110.289 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.09 159.92 14.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.271 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.28 72.1 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.332 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 CA-C-O 117.974 -1.459 . . . . 0.0 109.57 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.906 ' C6 ' HD21 ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.31 0.576 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 112.62 -67.79 0.24 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -55.26 141.58 34.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.282 -1.128 . . . . 0.0 110.36 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -150.61 39.14 0.71 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.899 . . . . 0.0 110.038 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.481 ' HE2' ' HB3' ' A' ' 294' ' ' MET . 10.2 ptp -168.55 116.24 0.59 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.992 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.546 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 49.9 Cg_endo -78.89 67.1 8.63 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 124.112 1.585 . . . . 0.0 111.305 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.681 ' HE3' ' NE2' ' A' ' 416' ' ' HIS . 0.0 OUTLIER -80.82 108.86 14.84 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.471 -0.892 . . . . 0.0 108.937 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.617 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 52.8 mt-10 -123.47 -161.96 1.01 Allowed 'General case' 0 C--N 1.274 -2.686 0 O-C-N 121.825 -0.547 . . . . 0.0 109.748 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.424 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -88.01 130.01 35.1 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 110.381 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.811 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -149.26 158.65 44.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.526 -0.734 . . . . 0.0 110.852 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.783 ' O ' HG23 ' A' ' 304' ' ' VAL . 7.4 m-20 -98.65 117.32 32.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.566 -0.709 . . . . 0.0 110.206 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.598 HD12 HG21 ' A' ' 328' ' ' ILE . 13.4 mt -62.27 -23.85 66.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.169 -0.957 . . . . 0.0 109.845 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.495 ' OD1' HD23 ' A' ' 323' ' ' LEU . 44.0 t-20 -81.63 -22.27 37.71 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.177 -0.952 . . . . 0.0 109.114 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.403 ' O ' ' OE1' ' A' ' 307' ' ' GLU . . . -84.4 -30.31 25.48 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.629 -0.669 . . . . 0.0 109.664 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 300' ' ' ASP . 4.4 t -80.92 -34.46 13.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 109.608 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 79.2 mt -78.71 -27.48 44.94 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.398 -0.814 . . . . 0.0 110.623 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -68.4 -37.15 85.58 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.741 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 1.5 mp0 -76.21 -34.46 59.25 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.271 -1.135 . . . . 0.0 109.315 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.522 HG11 ' HB ' ' A' ' 341' ' ' VAL . 95.6 t -78.71 -19.59 13.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.534 -0.729 . . . . 0.0 109.443 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.534 HG13 HG11 ' A' ' 358' ' ' VAL . 0.1 OUTLIER -73.67 -43.51 54.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.422 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -90.44 -16.02 29.79 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.665 0.745 . . . . 0.0 109.139 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -53.9 -61.82 2.06 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.736 -0.603 . . . . 0.0 110.503 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -150.74 37.23 0.64 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.741 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.628 ' HB3' HD13 ' A' ' 319' ' ' ILE . 11.3 m -89.5 43.65 1.16 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.121 -0.987 . . . . 0.0 108.948 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 317' ' ' ARG . . . 63.18 44.35 97.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.484 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 19.7 m-30 48.82 38.0 11.04 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.0 -1.294 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 2.1 mt-10 69.38 56.36 0.37 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.329 -0.857 . . . . 0.0 110.006 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 314' ' ' GLY . 3.1 mmt180 -68.7 -92.11 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.787 0.803 . . . . 0.0 109.869 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 318' ' ' GLU . 15.6 pt-20 -126.55 58.05 1.41 Allowed 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.544 0.688 . . . . 0.0 109.741 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.774 HG23 HG23 ' A' ' 358' ' ' VAL . 3.5 mt -104.73 130.66 55.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 121.613 -0.679 . . . . 0.0 110.2 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -89.46 103.38 16.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 19.6 p -93.6 123.07 36.68 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 111.291 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.59 78.03 1.49 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 360' ' ' SER . 3.4 mp -90.47 144.84 25.41 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.517 -0.74 . . . . 0.0 110.5 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' LEU . 7.4 t80 -40.7 137.85 1.34 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.574 -0.704 . . . . 0.0 109.634 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -82.7 47.6 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.892 1.469 . . . . 0.0 110.791 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.464 ' O ' ' OG ' ' A' ' 327' ' ' SER . . . -159.8 13.59 0.19 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 326' ' ' GLY . 3.3 p 60.05 116.33 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.997 -1.296 . . . . 0.0 109.638 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.598 HG21 HD12 ' A' ' 301' ' ' LEU . 2.7 mm -67.77 -179.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.737 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.562 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.8 mt-10 -171.25 105.76 0.23 Allowed 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.632 0.73 . . . . 0.0 110.644 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.945 HG12 HG22 ' A' ' 438' ' ' VAL . 12.1 m -149.98 163.95 3.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-O 121.597 0.713 . . . . 0.0 110.343 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 1.2 tptm -79.59 91.44 5.2 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.811 ' HG3' ' HB3' ' A' ' 299' ' ' ALA . 11.1 ptm -140.56 158.9 43.31 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 110.613 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.547 ' NE2' ' HB2' ' A' ' 335' ' ' LEU . 18.1 t-160 -88.96 113.29 55.44 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 40.0 Cg_endo -64.19 -19.4 65.91 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.59 1.31 . . . . 0.0 109.894 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.547 ' HB2' ' NE2' ' A' ' 333' ' ' HIS . 0.2 OUTLIER -78.14 -53.65 7.14 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.515 -0.741 . . . . 0.0 109.995 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.431 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 60.3 p -64.72 -36.25 83.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.439 -0.788 . . . . 0.0 109.937 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.748 HD11 ' CE1' ' A' ' 416' ' ' HIS . 10.1 mm -75.1 -35.99 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 110.114 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 0.4 OUTLIER -57.04 -50.57 72.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.971 -1.081 . . . . 0.0 108.984 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -27.29 61.14 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.636 -0.665 . . . . 0.0 109.747 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 1.06 ' HB2' HD13 ' A' ' 412' ' ' ILE . . . -60.25 -49.58 77.05 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.149 -0.97 . . . . 0.0 110.183 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.522 ' HB ' HG11 ' A' ' 308' ' ' VAL . 21.5 t -77.47 -35.4 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.0 109.952 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.429 ' O ' ' HB ' ' A' ' 346' ' ' VAL . . . -59.32 -27.05 65.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.848 . . . . 0.0 110.299 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . 0.506 ' O ' HG12 ' A' ' 346' ' ' VAL . 0.5 OUTLIER -85.37 -19.94 30.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.477 ' SD ' HG21 ' A' ' 432' ' ' ILE . 0.8 OUTLIER -84.88 -33.09 22.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.255 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 7.9 p -87.75 -24.2 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.224 -0.922 . . . . 0.0 110.322 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 343' ' ' ASN . 7.6 p -65.01 -20.26 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.154 -0.966 . . . . 0.0 110.234 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -67.12 -58.84 4.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.288 -0.883 . . . . 0.0 110.148 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -69.05 -31.16 69.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 110.175 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.94 66.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 109.985 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.32 -41.25 49.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.271 -0.893 . . . . 0.0 110.156 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -62.45 1.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.217 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 111.92 -41.71 2.16 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -88.65 83.59 6.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -1.17 . . . . 0.0 110.225 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 374' ' ' ASP . . . 177.57 101.86 0.15 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.588 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.2 OUTLIER -51.56 139.41 20.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.225 -1.161 . . . . 0.0 110.355 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.719 HD12 HG13 ' A' ' 319' ' ' ILE . 17.0 mt -111.75 167.84 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.749 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.588 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 39.9 tttt -148.56 114.97 5.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.951 -1.093 . . . . 0.0 111.12 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.774 HG23 HG23 ' A' ' 319' ' ' ILE . 21.7 t -119.24 78.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 109.25 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 95.5 p -110.68 135.24 51.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 110.357 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.511 ' HB3' ' HG ' ' A' ' 323' ' ' LEU . 0.0 OUTLIER -121.33 149.13 43.4 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 109.794 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.526 ' C ' HG22 ' A' ' 362' ' ' THR . . . -147.48 -165.07 11.6 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.0 OUTLIER -175.81 162.64 2.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.961 -1.317 . . . . 0.0 111.32 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 1.2 mt-10 -126.63 174.21 4.4 Favored Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 50.5 Cg_endo -77.63 31.11 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.453 1.239 . . . . 0.0 111.488 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.557 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 11.9 p-10 177.88 26.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.069 -1.02 . . . . 0.0 110.766 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 24.4 ptt180 160.61 115.15 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.528 0 CA-C-O 121.224 0.535 . . . . 0.0 109.861 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.587 ' H ' HG23 ' A' ' 438' ' ' VAL . . . -96.23 166.47 11.72 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.145 -0.972 . . . . 0.0 109.26 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.691 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 61.9 p-90 -161.09 148.62 15.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.736 -1.228 . . . . 0.0 111.147 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.554 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 30.2 p90 -122.84 136.33 54.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.42 -0.8 . . . . 0.0 109.732 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.5 ' HG3' ' HA ' ' A' ' 433' ' ' ARG . 1.9 tt0 -112.23 137.42 50.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.375 -0.828 . . . . 0.0 111.481 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 54.3 t -131.93 107.51 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -109.71 158.22 18.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.071 -1.018 . . . . 0.0 110.664 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 5.5 p-10 -168.97 132.33 1.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.374 -0.829 . . . . 0.0 110.15 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.486 ' O ' ' HA3' ' A' ' 354' ' ' GLY . 5.9 m-20 -107.93 154.38 21.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.241 -0.912 . . . . 0.0 110.361 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -169.77 -115.09 0.32 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.47 -90.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.789 1.415 . . . . 0.0 110.427 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 172.21 -161.86 33.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.89 HG23 " O2'" ' A' ' 451' ' ' ANP . 16.1 mt -131.17 154.67 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -1.205 . . . . 0.0 111.219 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.82 150.38 88.4 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.534 -0.729 . . . . 0.0 109.081 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.38 -22.76 28.78 Favored 'Trans proline' 0 C--N 1.295 -2.26 0 O-C-N 123.84 1.442 . . . . 0.0 110.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -91.09 -26.77 18.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.3 -0.875 . . . . 0.0 111.363 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -88.81 -29.36 19.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.052 -1.03 . . . . 0.0 110.761 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -19.43 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.049 -1.032 . . . . 0.0 110.394 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 385' ' ' HIS . 12.2 mmtt -82.48 -34.44 28.04 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.377 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.571 ' N ' ' ND1' ' A' ' 385' ' ' HIS . 0.1 OUTLIER -107.24 -74.03 0.67 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.243 -0.91 . . . . 0.0 110.743 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.633 HD11 " H1'" ' A' ' 451' ' ' ANP . 0.6 OUTLIER 31.88 49.56 0.13 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.806 -0.559 . . . . 0.0 111.51 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.891 ' CE2' HD12 ' A' ' 422' ' ' LEU . 0.2 OUTLIER -155.82 34.65 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.137 -0.977 . . . . 0.0 109.931 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -171.07 154.91 4.27 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.565 -0.709 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.15 96.94 0.97 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.798 1.42 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -52.44 158.14 1.31 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.15 -0.969 . . . . 0.0 110.342 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.574 ' O ' HG12 ' A' ' 391' ' ' VAL . 45.4 t -90.22 46.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -0.896 . . . . 0.0 110.28 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 391' ' ' VAL . 0.1 OUTLIER -178.95 48.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 110.195 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -131.67 -74.39 0.11 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -132.0 80.11 1.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.211 -1.17 . . . . 0.0 110.103 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.645 ' O ' ' HB3' ' A' ' 396' ' ' ALA . 42.6 p -166.66 -171.25 1.81 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 395' ' ' SER . . . 64.87 65.45 0.61 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 110.238 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.39 83.1 1.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.448 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 399' ' ' ILE . 52.3 m 53.28 -97.92 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.269 -0.895 . . . . 0.0 110.242 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.566 ' N ' HG22 ' A' ' 398' ' ' THR . 6.8 tp -122.15 159.12 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.065 -1.022 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.9 t -48.72 153.54 0.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -131.51 -74.29 0.11 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 94.0 m -73.42 131.68 42.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.33 -1.1 . . . . 0.0 110.713 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 404' ' ' LEU . . . -121.16 140.95 14.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 403' ' ' GLY . 1.7 tt 44.63 92.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.136 -1.214 . . . . 0.0 110.031 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 406' ' ' LEU . . . 146.59 73.18 0.02 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 405' ' ' GLY . 1.7 tp -177.12 67.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.325 -1.103 . . . . 0.0 110.201 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -95.58 130.41 42.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 110.281 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.482 HG21 ' OE1' ' A' ' 410' ' ' GLN . 23.6 mm -96.73 155.58 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.062 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.638 ' HA ' HD12 ' A' ' 412' ' ' ILE . 17.4 t -39.51 -56.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.259 -0.901 . . . . 0.0 111.196 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.564 ' O ' ' CB ' ' A' ' 414' ' ' ASP . 7.8 pt20 -48.7 -52.04 25.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.14 -0.975 . . . . 0.0 111.688 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.2 OUTLIER -68.8 -20.72 64.34 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.75 -1.219 . . . . 0.0 111.274 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 1.06 HD13 ' HB2' ' A' ' 340' ' ' ALA . 16.9 mt -73.94 -75.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 O-C-N 120.88 -1.138 . . . . 0.0 108.679 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 419' ' ' MET . 21.4 t -54.29 -21.07 5.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.488 -0.757 . . . . 0.0 109.661 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.564 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 21.0 t0 -77.34 -40.32 44.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.143 -0.973 . . . . 0.0 109.864 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 411' ' ' ARG . 0.8 OUTLIER -68.36 -20.36 64.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.284 -0.885 . . . . 0.0 109.65 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.748 ' CE1' HD11 ' A' ' 337' ' ' ILE . 25.5 m80 -80.36 -26.38 38.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.379 -0.826 . . . . 0.0 110.01 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 2.1 t30 79.43 47.97 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.544 0.688 . . . . 0.0 110.445 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.555 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -118.23 -86.45 1.11 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.572 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.2 OUTLIER 179.14 161.75 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.358 -1.084 . . . . 0.0 111.259 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 410' ' ' GLN . 13.3 tp -152.55 101.53 2.65 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.338 -0.851 . . . . 0.0 108.82 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -111.46 136.41 50.66 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 120.839 -1.163 . . . . 0.0 112.405 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.891 HD12 ' CE2' ' A' ' 387' ' ' PHE . 0.8 OUTLIER -99.46 93.42 5.88 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.711 0.767 . . . . 0.0 109.317 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 430' ' ' LEU . . . -60.73 141.96 48.17 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 54.7 m -137.14 109.48 7.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.389 -1.065 . . . . 0.0 110.396 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.549 ' O ' ' HG3' ' A' ' 426' ' ' GLU . 0.3 OUTLIER -101.88 106.1 17.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.896 . . . . 0.0 110.367 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 425' ' ' SER . 11.3 pt-20 41.81 -111.06 0.14 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.523 -0.735 . . . . 0.0 111.276 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.484 ' HD3' ' C ' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -34.39 -30.77 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.872 0 O-C-N 121.011 -1.056 . . . . 0.0 111.556 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.581 ' O ' HD13 ' A' ' 430' ' ' LEU . . . 132.56 27.16 0.62 Allowed Glycine 0 C--N 1.293 -1.832 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -44.92 119.04 2.97 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.848 HD11 HD11 ' A' ' 378' ' ' ILE . 2.7 mp -99.49 110.62 23.07 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.947 -1.325 . . . . 0.0 113.129 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.454 ' OG ' ' HA3' ' A' ' 423' ' ' GLY . 0.1 OUTLIER -113.43 111.64 22.29 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.495 ' O ' ' CG ' ' A' ' 370' ' ' GLN . 21.4 mm -87.52 125.78 41.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 120.723 -1.236 . . . . 0.0 112.9 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . 0.5 ' HA ' ' HG3' ' A' ' 370' ' ' GLN . 0.0 OUTLIER -118.8 85.9 2.45 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.554 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.95 131.9 35.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.471 -0.768 . . . . 0.0 110.703 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.691 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 81.3 m95 -112.79 154.04 26.85 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.245 1.021 . . . . 0.0 111.959 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 416' ' ' HIS . 17.8 mt -143.46 117.0 6.01 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.555 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 42.2 Cg_endo -68.41 143.99 59.93 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 O-C-N 123.549 1.289 . . . . 0.0 111.284 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.945 HG22 HG12 ' A' ' 330' ' ' VAL . 76.3 t -103.98 90.37 2.95 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.659 -0.651 . . . . 0.0 110.35 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 437' ' ' PRO . 47.2 Cg_endo -73.32 77.11 2.54 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.961 1.506 . . . . 0.0 110.09 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.888 HG23 HG12 ' A' ' 438' ' ' VAL . 24.4 t -115.65 152.69 17.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.158 -0.964 . . . . 0.0 110.117 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 441' ' ' THR . 1.3 t -44.27 113.36 0.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.218 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -50.55 -35.57 30.37 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.217 -0.927 . . . . 0.0 110.118 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -99.07 175.66 5.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 110.013 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -125.17 167.35 14.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -168.18 -130.74 1.21 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 446' ' ' THR . 9.0 t -123.89 74.55 1.29 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.293 -1.122 . . . . 0.0 110.209 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' A' ' 448' ' ' LYS . 8.4 t -69.16 -174.48 0.64 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.219 -0.926 . . . . 0.0 110.168 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 447' ' ' THR . 0.1 OUTLIER 70.52 91.47 0.09 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.199 -0.938 . . . . 0.0 110.184 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -133.57 87.39 2.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.259 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.89 " O2'" HG23 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.217 0.532 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 292' ' ' GLN . . . -105.27 -42.44 1.76 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 291' ' ' GLY . 6.1 tp-100 58.5 128.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.479 -1.012 . . . . 0.0 110.355 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.98 79.84 1.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 110.473 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.32 81.54 37.94 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.779 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.632 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 52.6 Cg_endo -84.45 50.02 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 124.156 1.608 . . . . 0.0 110.522 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.625 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.4 OUTLIER -94.69 107.65 19.65 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 122.152 0.977 . . . . 0.0 108.37 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.639 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.2 mm-40 -123.37 -159.73 0.87 Allowed 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.835 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.62 137.37 32.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.159 -0.963 . . . . 0.0 110.918 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -156.44 153.26 28.56 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.768 -0.773 . . . . 0.0 111.411 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 304' ' ' VAL . 5.2 m-20 -88.22 114.67 25.07 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.921 HD11 ' CD1' ' A' ' 436' ' ' LEU . 4.8 mt -64.09 -24.88 67.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 0.0 110.599 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.625 ' CA ' HD23 ' A' ' 323' ' ' LEU . 48.5 p-10 -81.0 -19.9 42.99 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.706 -1.246 . . . . 0.0 109.033 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.513 ' N ' ' OD1' ' A' ' 302' ' ' ASN . . . -87.96 -27.75 21.9 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.577 0.703 . . . . 0.0 109.225 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.806 ' O ' HG23 ' A' ' 308' ' ' VAL . 90.4 t -78.85 -36.95 19.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.554 -0.716 . . . . 0.0 109.623 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 84.4 mt -76.34 -35.38 58.76 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.404 -0.81 . . . . 0.0 110.321 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -65.29 -26.59 71.73 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 2.8 mt-10 -84.14 -32.85 24.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.235 -1.156 . . . . 0.0 109.713 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.854 HG11 HG12 ' A' ' 341' ' ' VAL . 48.0 t -75.75 -21.4 15.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.385 -0.822 . . . . 0.0 109.121 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 1.074 HD11 ' CG1' ' A' ' 358' ' ' VAL . 17.1 mt -78.74 -53.49 13.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 122.109 0.957 . . . . 0.0 108.673 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 315' ' ' TYR . . . -68.21 -15.67 63.67 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.214 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -78.32 -59.17 2.89 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.753 -0.592 . . . . 0.0 111.931 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -118.36 32.84 5.93 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.022 -1.071 . . . . 0.0 112.348 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.561 ' HB3' ' CD1' ' A' ' 319' ' ' ILE . 1.0 OUTLIER -129.04 44.34 2.99 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 120.923 -1.111 . . . . 0.0 109.777 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 59.13 22.32 55.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 310' ' ' ALA . 0.3 OUTLIER 60.32 55.18 3.65 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.392 -1.064 . . . . 0.0 109.989 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.525 ' OE1' ' CA ' ' A' ' 316' ' ' GLU . 0.5 OUTLIER 66.7 35.77 5.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.122 -0.986 . . . . 0.0 109.741 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -48.18 62.58 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.899 0.857 . . . . 0.0 109.917 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -150.28 57.05 0.95 Allowed 'General case' 0 C--N 1.271 -2.815 0 CA-C-O 121.51 0.671 . . . . 0.0 110.213 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 1.001 HG13 HD12 ' A' ' 356' ' ' ILE . 2.7 mp -127.47 131.43 70.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 109.795 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -90.24 105.41 17.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.077 -1.014 . . . . 0.0 109.595 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.747 HG22 HD13 ' A' ' 309' ' ' ILE . 17.3 p -90.03 120.51 31.29 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.393 -0.817 . . . . 0.0 110.721 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -140.34 77.45 1.61 Allowed 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.467 -0.77 . . . . 0.0 108.974 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.625 HD23 ' CA ' ' A' ' 302' ' ' ASN . 1.1 mp -92.0 163.18 14.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.618 -0.676 . . . . 0.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 5.4 t80 -49.01 131.77 15.2 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.224 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 324' ' ' TYR . 50.9 Cg_endo -84.74 52.79 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.951 1.501 . . . . 0.0 110.186 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -162.97 22.42 0.18 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 326' ' ' GLY . 15.6 p 53.04 104.65 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.338 -1.095 . . . . 0.0 110.15 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.769 HG23 HG21 ' A' ' 362' ' ' THR . 1.3 mt -74.6 -178.17 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.45 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.622 ' H ' HG22 ' A' ' 328' ' ' ILE . 5.1 mt-10 -169.8 103.12 0.32 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 121.611 0.72 . . . . 0.0 110.77 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.721 HG11 ' HB3' ' A' ' 367' ' ' ALA . 31.1 m -137.2 153.53 29.3 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.127 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -73.31 97.73 2.54 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.756 ' SD ' HD21 ' A' ' 301' ' ' LEU . 5.9 ttp -137.27 166.12 24.53 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.13 -0.981 . . . . 0.0 112.105 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.632 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 22.4 t-160 -103.26 113.86 65.45 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.523 ' O ' ' CG ' ' A' ' 338' ' ' LYS . 38.3 Cg_endo -63.11 -22.43 73.17 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.635 1.334 . . . . 0.0 111.904 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.674 ' C ' HD12 ' A' ' 335' ' ' LEU . 0.7 OUTLIER -83.54 -56.61 3.64 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.664 -1.273 . . . . 0.0 110.601 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 51.5 p -61.96 -38.15 87.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.134 -0.979 . . . . 0.0 110.636 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.793 HD11 ' CE1' ' A' ' 416' ' ' HIS . 23.1 mm -76.24 -33.93 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.11 -0.994 . . . . 0.0 110.157 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' A' ' 334' ' ' PRO . 4.7 mttt -59.89 -36.25 76.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -42.93 60.26 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.032 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.816 ' CB ' HG21 ' A' ' 412' ' ' ILE . . . -61.54 -35.11 76.83 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.359 -0.838 . . . . 0.0 110.616 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.854 HG12 HG11 ' A' ' 308' ' ' VAL . 50.7 t -76.12 -34.13 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.207 -0.933 . . . . 0.0 109.646 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.755 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -70.66 -22.38 62.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 0.0 109.805 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -80.29 -23.75 40.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.425 -0.797 . . . . 0.0 109.969 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.556 ' SD ' HG21 ' A' ' 432' ' ' ILE . 7.8 mtt -85.0 -41.61 15.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.406 -0.809 . . . . 0.0 110.215 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.46 -22.79 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.885 . . . . 0.0 110.509 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 342' ' ' ALA . 65.3 t -74.16 -24.84 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.101 -0.999 . . . . 0.0 110.16 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -81.63 -31.06 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 110.248 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -89.54 -24.93 21.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 110.197 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -74.53 -39.43 62.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.266 -0.896 . . . . 0.0 110.031 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.71 -70.15 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -48.66 -59.08 3.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -87.45 142.56 18.08 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -139.79 81.27 1.81 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.325 -1.103 . . . . 0.0 110.187 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -159.59 -48.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.57 ' CH2' ' HB2' ' A' ' 357' ' ' LYS . 1.4 t90 -178.65 141.9 0.21 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.25 . . . . 0.0 110.232 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 1.001 HD12 HG13 ' A' ' 319' ' ' ILE . 3.5 mt -107.23 163.16 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.73 . . . . 0.0 109.746 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.57 ' HB2' ' CH2' ' A' ' 355' ' ' TRP . 0.1 OUTLIER -140.73 93.69 2.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 0.0 109.957 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 1.074 ' CG1' HD11 ' A' ' 309' ' ' ILE . 37.7 t -97.15 105.01 16.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.139 -0.976 . . . . 0.0 109.784 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 1.2 t -124.88 160.1 29.6 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.391 -0.818 . . . . 0.0 110.992 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.55 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.4 t -142.92 130.47 21.26 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.602 -0.686 . . . . 0.0 109.212 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.567 ' C ' HG22 ' A' ' 362' ' ' THR . . . -123.76 -174.36 14.16 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.769 HG21 HG23 ' A' ' 328' ' ' ILE . 0.1 OUTLIER 170.13 163.74 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -1.106 . . . . 0.0 110.801 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.569 ' HB3' ' CD ' ' A' ' 364' ' ' PRO . 3.0 mt-10 -136.64 -168.87 0.2 Allowed Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.569 ' CD ' ' HB3' ' A' ' 363' ' ' GLU . 48.2 Cg_endo -84.79 31.04 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.21 1.11 . . . . 0.0 110.742 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 366' ' ' ARG . 57.3 t-20 -178.64 27.79 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 0.0 110.795 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.54 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.7 OUTLIER 165.63 107.1 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.156 -0.965 . . . . 0.0 111.149 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.721 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -106.63 137.89 43.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.277 -0.889 . . . . 0.0 109.214 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.687 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 64.6 p-90 -140.55 154.78 46.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.876 -1.14 . . . . 0.0 110.655 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.417 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 53.4 p90 -127.28 138.75 53.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.328 -0.857 . . . . 0.0 109.457 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 432' ' ' ILE . 2.9 pt20 -126.99 165.38 19.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.178 -0.951 . . . . 0.0 111.673 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 431' ' ' SER . 3.1 t -141.66 125.78 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.461 ' HG2' ' N ' ' A' ' 373' ' ' ASP . 30.0 tt0 -124.33 155.2 39.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.752 -1.217 . . . . 0.0 110.598 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.461 ' N ' ' HG2' ' A' ' 372' ' ' GLU . 2.4 p30 -148.14 148.26 30.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.407 -0.808 . . . . 0.0 110.492 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -86.5 95.15 9.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.2 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 168.86 162.94 22.02 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.07 124.59 10.17 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.014 1.534 . . . . 0.0 110.02 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -114.14 -90.86 1.81 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.867 HG13 HD11 ' A' ' 430' ' ' LEU . 65.7 mt -66.5 165.85 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.234 -1.156 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.957 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -128.97 178.91 1.45 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.253 -0.904 . . . . 0.0 110.003 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.957 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 43.1 Cg_endo -71.05 -48.92 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.94 1.495 . . . . 0.0 109.653 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . 0.427 ' OE2' ' HG2' ' A' ' 380' ' ' PRO . 1.4 mp0 -91.04 -19.87 22.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.423 -0.798 . . . . 0.0 110.393 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.785 ' HB3' ' HB3' ' A' ' 379' ' ' ALA . 59.0 tt0 -81.16 -19.44 43.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.34 -0.85 . . . . 0.0 110.919 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.494 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 0.2 OUTLIER -56.95 -27.69 61.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.067 -1.02 . . . . 0.0 110.646 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -86.81 -19.07 29.54 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.13 -0.981 . . . . 0.0 110.546 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.594 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 8.4 m170 -48.18 -56.88 6.8 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.287 -0.883 . . . . 0.0 111.492 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.506 ' O ' ' CG ' ' A' ' 387' ' ' PHE . 0.5 OUTLIER -115.34 38.87 3.1 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.96 -1.087 . . . . 0.0 111.342 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.506 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 8.9 m-85 -160.63 43.78 0.19 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.175 -0.953 . . . . 0.0 110.11 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.02 140.85 86.83 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.312 -0.868 . . . . 0.0 109.911 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.82 -158.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.044 1.549 . . . . 0.0 110.31 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 390' ' ' PHE . 14.7 p90 -112.26 99.15 7.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.426 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 391' ' ' VAL . 14.9 p -110.79 37.32 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.411 0.624 . . . . 0.0 109.904 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? 58.76 68.54 0.81 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 110.355 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -94.99 -95.54 1.68 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.59 120.45 40.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.318 -1.107 . . . . 0.0 110.161 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 396' ' ' ALA . 15.3 m -71.56 162.52 29.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 395' ' ' SER . . . 56.5 159.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 396' ' ' ALA . 0.1 OUTLIER -176.51 34.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.231 -0.918 . . . . 0.0 110.141 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 4.4 m -162.25 26.05 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.189 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 tp -123.08 -13.12 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 110.317 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 9.7 p -159.98 43.91 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.182 -0.949 . . . . 0.0 110.282 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -101.99 139.79 14.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.7 t -120.7 -2.92 9.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.266 -1.137 . . . . 0.0 110.269 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -71.57 152.83 49.82 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 4.9 tt -128.67 -61.63 1.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -1.123 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 65.15 134.51 0.02 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 1.3 mt -93.32 -17.75 23.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.226 -1.161 . . . . 0.0 110.263 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.903 ' O ' HG23 ' A' ' 408' ' ' ILE . . . -110.05 115.2 29.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.903 HG23 ' O ' ' A' ' 407' ' ' ALA . 1.3 pt -168.96 93.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.226 -0.921 . . . . 0.0 110.701 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.401 ' O ' ' HB ' ' A' ' 412' ' ' ILE . 41.0 t -65.7 -18.43 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.395 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -62.34 -61.53 2.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.479 -0.763 . . . . 0.0 110.097 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.485 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 0.3 OUTLIER -54.23 -23.63 15.49 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.351 -0.843 . . . . 0.0 110.559 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.816 HG21 ' CB ' ' A' ' 340' ' ' ALA . 29.6 mm -68.18 -59.93 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.237 -0.914 . . . . 0.0 108.718 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 420' ' ' LEU . 38.2 t -67.55 -19.15 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.458 -0.776 . . . . 0.0 109.43 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.485 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 7.1 t70 -84.24 -25.33 29.52 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.52 -0.738 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.52 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.4 m120 -75.3 -23.63 57.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.793 ' CE1' HD11 ' A' ' 337' ' ' ILE . 45.1 m80 -95.75 -36.84 11.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.268 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.1 OUTLIER 80.04 57.1 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 CA-C-O 121.435 0.636 . . . . 0.0 110.838 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.56 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -123.53 -84.66 0.66 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.549 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.7 OUTLIER -179.3 165.99 1.46 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -1.133 . . . . 0.0 111.556 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.528 ' HB2' HG11 ' A' ' 413' ' ' VAL . 15.1 tp -152.22 83.2 1.26 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.437 ' OE1' ' HA ' ' A' ' 421' ' ' GLU . 4.1 mm-40 -101.0 166.51 10.77 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.915 -1.116 . . . . 0.0 111.643 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.7 HD23 HD11 ' A' ' 378' ' ' ILE . 1.0 OUTLIER -123.85 123.63 40.88 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.57 0.7 . . . . 0.0 110.231 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.437 ' O ' ' OG1' ' A' ' 424' ' ' THR . . . -125.98 151.66 17.89 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 91.8 m -164.83 124.55 1.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.874 -1.368 . . . . 0.0 111.715 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 427' ' ' ARG . 3.4 p -62.42 121.72 13.93 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 49.58 -96.46 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 425' ' ' SER . 12.5 tpp85 -161.68 24.19 0.12 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.077 -1.014 . . . . 0.0 109.301 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -124.36 -15.66 3.32 Favored Glycine 0 N--CA 1.48 1.597 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -117.64 78.11 0.29 Allowed Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.266 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 1.048 HD22 ' N6 ' ' A' ' 451' ' ' ANP . 1.7 tt -76.79 152.78 35.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.031 -1.276 . . . . 0.0 110.287 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.688 ' N ' HD23 ' A' ' 430' ' ' LEU . 53.4 p -159.7 127.27 4.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.572 -0.705 . . . . 0.0 110.126 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.706 HD11 ' C2 ' ' A' ' 451' ' ' ANP . 18.1 mm -90.1 134.89 27.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 85.96 2.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.483 -0.761 . . . . 0.0 109.522 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.417 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -88.68 138.43 31.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.265 -0.897 . . . . 0.0 109.87 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.687 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.4 m95 -117.81 154.6 31.5 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 122.458 1.123 . . . . 0.0 113.067 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.921 ' CD1' HD11 ' A' ' 301' ' ' LEU . 7.9 mt -142.08 114.9 6.46 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.56 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 47.5 Cg_endo -71.07 138.77 34.34 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 O-C-N 123.572 1.301 . . . . 0.0 112.628 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.632 HG22 HG12 ' A' ' 330' ' ' VAL . 7.0 t -112.25 64.75 0.73 Allowed Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 437' ' ' PRO . 42.2 Cg_endo -67.34 92.52 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.924 1.486 . . . . 0.0 110.934 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 98.8 t -132.52 -76.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.422 -0.799 . . . . 0.0 109.96 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 35.6 p -87.39 150.97 23.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.905 . . . . 0.0 109.901 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 50.34 48.6 22.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.77 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 444' ' ' GLN . . . -92.19 130.32 37.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.34 -0.85 . . . . 0.0 110.579 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 443' ' ' ALA . 13.3 mt-30 54.97 162.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.857 . . . . 0.0 110.496 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -144.16 43.03 1.01 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 446' ' ' THR . 3.2 t -103.29 75.42 1.35 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.352 -1.087 . . . . 0.0 110.219 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -144.72 0.05 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.335 -0.853 . . . . 0.0 110.286 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -133.24 165.04 25.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.34 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -79.96 133.63 36.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 110.22 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 CA-C-O 117.954 -1.47 . . . . 0.0 109.541 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 1.048 ' N6 ' HD22 ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.148 0.499 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 151.95 54.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -103.19 174.41 5.88 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.28 -1.13 . . . . 0.0 110.137 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.95 79.13 6.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.263 -0.898 . . . . 0.0 110.348 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 43.3 mtm -119.52 106.87 41.67 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.226 -0.921 . . . . 0.0 110.415 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.618 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 48.9 Cg_endo -86.9 54.55 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.948 1.499 . . . . 0.0 110.633 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.602 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -96.58 108.62 21.24 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.602 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 2.1 mt-10 -138.09 -152.55 0.43 Allowed 'General case' 0 C--N 1.276 -2.621 0 O-C-N 121.818 -0.551 . . . . 0.0 109.604 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.678 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 1.5 mmt -88.4 141.12 28.8 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 110.594 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.594 ' HB3' ' HE3' ' A' ' 332' ' ' MET . . . -154.15 157.82 39.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.396 -0.815 . . . . 0.0 110.985 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.918 ' O ' HG23 ' A' ' 304' ' ' VAL . 3.1 m-20 -90.85 117.23 29.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.41 -0.807 . . . . 0.0 110.059 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.526 HD11 ' CD1' ' A' ' 436' ' ' LEU . 8.4 mt -67.19 -24.17 65.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 110.015 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.607 ' OD1' HD23 ' A' ' 323' ' ' LEU . 9.0 t30 -84.77 -22.94 29.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.871 -1.143 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -83.72 -29.78 27.25 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.43 -0.794 . . . . 0.0 109.334 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 300' ' ' ASP . 19.3 t -78.7 -40.06 23.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.573 -0.705 . . . . 0.0 109.309 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.606 ' CD2' HG21 ' A' ' 341' ' ' VAL . 81.4 mt -72.62 -30.14 64.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.49 -0.756 . . . . 0.0 110.594 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 309' ' ' ILE . . . -61.03 -36.0 91.63 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -33.7 57.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.323 -1.104 . . . . 0.0 109.419 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.816 HG11 HG12 ' A' ' 341' ' ' VAL . 74.5 t -75.0 -18.93 16.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.505 -0.747 . . . . 0.0 109.244 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 1.068 ' CG1' HG11 ' A' ' 358' ' ' VAL . 5.0 mt -77.16 -46.16 29.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.96 -16.65 63.79 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.626 0.727 . . . . 0.0 109.482 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -74.92 -58.74 3.09 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.677 -0.639 . . . . 0.0 110.542 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.535 ' HB2' ' CG1' ' A' ' 345' ' ' VAL . 2.5 mm-40 -111.12 46.13 1.11 Allowed 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.753 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.643 ' HA ' ' CD1' ' A' ' 319' ' ' ILE . 0.6 OUTLIER -79.1 18.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.331 -0.855 . . . . 0.0 111.302 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 53.34 53.51 34.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 22.5 m-30 46.66 43.07 12.3 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.37 -1.076 . . . . 0.0 110.222 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.465 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.3 OUTLIER 65.12 35.92 7.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.906 -1.121 . . . . 0.0 109.667 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.576 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -69.06 -73.24 0.16 Allowed 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.552 -0.718 . . . . 0.0 109.786 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.576 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.2 mt-10 -167.91 78.63 0.16 Allowed 'General case' 0 C--N 1.27 -2.88 0 CA-C-O 121.548 0.689 . . . . 0.0 111.235 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.721 ' CG2' HG23 ' A' ' 358' ' ' VAL . 4.2 mm -97.05 121.99 48.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.764 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.486 ' HB3' ' HG3' ' A' ' 357' ' ' LYS . 0.4 OUTLIER -88.73 101.41 13.98 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.065 -1.022 . . . . 0.0 108.462 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 16.7 p -90.28 128.28 36.38 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.779 0.8 . . . . 0.0 111.951 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -149.98 78.15 1.34 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.607 HD23 ' OD1' ' A' ' 302' ' ' ASN . 5.0 mp -96.94 170.91 8.83 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.462 -0.774 . . . . 0.0 110.334 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.661 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 27.8 t80 -63.22 126.1 88.47 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.321 -0.862 . . . . 0.0 109.925 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.402 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.9 Cg_endo -78.71 71.06 7.1 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.938 1.494 . . . . 0.0 110.7 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 172.73 30.35 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.446 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 326' ' ' GLY . 1.7 p 45.99 100.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.162 -1.199 . . . . 0.0 110.499 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.637 HG22 ' H ' ' A' ' 329' ' ' GLU . 1.7 mt -71.12 -177.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 O-C-N 121.507 -0.746 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.637 ' H ' HG22 ' A' ' 328' ' ' ILE . 4.9 mt-10 -167.34 107.65 0.6 Allowed 'General case' 0 C--N 1.289 -2.034 0 O-C-N 121.391 -0.818 . . . . 0.0 111.259 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.678 ' C ' ' HE2' ' A' ' 298' ' ' MET . 7.7 m -137.49 157.45 34.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 CA-C-O 121.494 0.664 . . . . 0.0 109.97 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 11.2 tptt -78.04 92.5 4.37 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.594 ' HE3' ' HB3' ' A' ' 299' ' ' ALA . 3.0 tmm? -150.03 158.74 44.47 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 110.761 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.625 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 6.5 t-160 -91.07 126.6 54.66 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.566 ' HD2' ' CD2' ' A' ' 333' ' ' HIS . 39.1 Cg_endo -61.87 -19.83 67.11 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 123.527 1.277 . . . . 0.0 109.95 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.625 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 4.4 mt -75.73 -57.85 3.64 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.375 -0.828 . . . . 0.0 109.886 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.401 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 25.3 p -52.91 -47.67 67.81 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.588 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.529 ' CG1' ' HG3' ' A' ' 332' ' ' MET . 24.1 mm -63.44 -32.15 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.069 -1.02 . . . . 0.0 110.473 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 43.2 mttt -60.69 -40.31 91.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.12 -0.987 . . . . 0.0 109.546 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -42.12 65.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.802 -0.561 . . . . 0.0 111.223 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.736 ' HA ' HG12 ' A' ' 409' ' ' VAL . . . -67.2 -30.9 70.97 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.229 -0.92 . . . . 0.0 111.088 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.816 HG12 HG11 ' A' ' 308' ' ' VAL . 43.0 t -90.31 -25.4 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.525 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.67 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -82.99 -20.22 35.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 110.469 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -88.49 -19.4 26.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.144 -0.973 . . . . 0.0 110.613 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.745 ' SD ' HG21 ' A' ' 432' ' ' ILE . 58.2 mtt -78.21 -36.6 46.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.224 -0.923 . . . . 0.0 110.56 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 312' ' ' GLU . 12.2 p -88.57 -23.58 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.314 -0.866 . . . . 0.0 111.045 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 342' ' ' ALA . 12.1 t -66.19 -19.57 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.997 -1.065 . . . . 0.0 110.348 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -79.74 -33.73 40.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.452 ' O ' ' HA3' ' A' ' 352' ' ' GLY . . . -88.41 -27.79 21.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.083 -1.011 . . . . 0.0 110.751 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.31 -29.61 65.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.154 -0.966 . . . . 0.0 111.329 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 15.7 mtt-85 -77.83 -66.91 0.78 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.995 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 351' ' ' TYR . 13.4 m-30 -90.22 -19.85 23.7 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.149 -0.969 . . . . 0.0 111.129 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 353' ' ' ASN . . . -76.76 -98.15 0.17 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.33 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 352' ' ' GLY . 2.1 t30 76.56 46.7 0.08 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.459 -1.024 . . . . 0.0 109.92 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -130.49 -78.0 0.18 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -137.36 127.8 26.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -1.096 . . . . 0.0 109.687 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.543 ' HB ' HD13 ' A' ' 319' ' ' ILE . 44.9 mt -115.11 159.11 15.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 108.816 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.517 ' CD ' ' HB2' ' A' ' 372' ' ' GLU . 4.2 tttp -148.0 117.51 7.0 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.838 -1.164 . . . . 0.0 111.338 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 1.068 HG11 ' CG1' ' A' ' 309' ' ' ILE . 20.8 t -109.78 135.13 49.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.505 ' HA ' HD12 ' A' ' 323' ' ' LEU . 43.4 t -157.59 164.1 37.63 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.746 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 323' ' ' LEU . 0.3 OUTLIER -164.56 132.55 3.35 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -136.15 -163.72 10.0 Favored Glycine 0 C--N 1.29 -2.017 0 C-N-CA 119.304 -1.427 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.661 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.2 OUTLIER -160.02 166.47 29.91 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.277 -1.131 . . . . 0.0 110.417 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.578 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 0.4 OUTLIER -146.24 -175.88 0.51 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 39.1 Cg_endo -64.93 111.03 1.61 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.449 1.236 . . . . 0.0 110.501 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.544 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 16.9 m120 59.34 40.72 20.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.732 -0.605 . . . . 0.0 110.795 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 1.4 mtt85 -176.83 98.42 0.05 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.156 -0.965 . . . . 0.0 111.192 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -97.53 171.6 8.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.135 -0.978 . . . . 0.0 108.391 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.608 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 22.7 p-90 -171.35 160.8 6.26 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.343 -1.473 . . . . 0.0 111.373 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 53.7 p90 -137.85 132.61 32.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.517 -0.74 . . . . 0.0 109.24 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.603 ' HG3' ' CZ3' ' A' ' 368' ' ' TRP . 22.9 mt-30 -121.53 168.78 11.34 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.06 -1.025 . . . . 0.0 112.353 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.471 ' HB ' HG22 ' A' ' 432' ' ' ILE . 65.2 t -140.08 148.92 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.517 ' HB2' ' CD ' ' A' ' 357' ' ' LYS . 9.1 mt-10 -147.05 148.15 31.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.061 -1.024 . . . . 0.0 110.429 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.66 ' OD1' ' N1 ' ' A' ' 451' ' ' ANP . 0.5 OUTLIER -165.28 163.65 20.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.287 -0.883 . . . . 0.0 110.239 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 428' ' ' GLY . 36.6 t0 -107.92 62.69 0.61 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.214 -0.928 . . . . 0.0 110.428 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -87.46 -148.5 14.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.29 -43.52 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.051 1.553 . . . . 0.0 110.211 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 112.05 -176.69 18.22 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.696 ' CD1' HD21 ' A' ' 430' ' ' LEU . 0.8 OUTLIER -99.14 134.68 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.115 -1.227 . . . . 0.0 109.551 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' A' ' 382' ' ' GLN . . . -50.11 165.3 0.33 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 0.0 110.454 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 47.1 Cg_endo -72.67 -38.9 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.079 1.568 . . . . 0.0 111.456 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . 0.475 ' O ' ' CD2' ' A' ' 385' ' ' HIS . 0.7 OUTLIER -89.33 -45.13 9.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.028 -1.045 . . . . 0.0 110.662 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.645 ' HB3' ' HB3' ' A' ' 379' ' ' ALA . 16.6 tt0 -56.52 -18.43 11.58 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.351 -0.843 . . . . 0.0 110.591 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -50.44 -33.04 19.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.131 -0.98 . . . . 0.0 109.802 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -90.22 -20.07 23.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.324 -0.86 . . . . 0.0 109.692 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.627 ' CD2' ' N ' ' A' ' 385' ' ' HIS . 1.4 m170 -96.05 25.15 4.99 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.747 HD11 " C5'" ' A' ' 451' ' ' ANP . 0.8 OUTLIER -91.38 19.51 6.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.592 -0.692 . . . . 0.0 111.611 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 29.5 m-85 -160.68 51.16 0.28 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.363 -0.836 . . . . 0.0 110.385 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -138.33 105.69 7.84 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.18 -0.95 . . . . 0.0 110.149 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 390' ' ' PHE . 46.9 Cg_endo -79.01 164.6 24.84 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.941 1.495 . . . . 0.0 110.405 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 389' ' ' PRO . 2.1 t80 -178.72 95.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.683 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 391' ' ' VAL . 17.9 m -69.84 122.09 20.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.245 -0.909 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -161.08 0.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.307 -0.87 . . . . 0.0 109.259 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 394' ' ' ASP . . . -130.81 138.21 10.02 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.072 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 393' ' ' GLY . 12.2 t70 56.52 160.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.496 -1.003 . . . . 0.0 110.916 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 396' ' ' ALA . 0.1 OUTLIER -135.32 -46.73 0.7 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.43 -0.794 . . . . 0.0 110.064 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 395' ' ' SER . . . 55.35 28.44 11.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.361 -0.837 . . . . 0.0 110.71 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -138.29 -89.38 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.085 -1.01 . . . . 0.0 110.213 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 398' ' ' THR . 13.1 t -151.97 120.19 6.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.417 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 399' ' ' ILE . 3.4 tp -98.71 122.87 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 0.0 109.806 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.1 m -107.48 151.69 25.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.192 -0.942 . . . . 0.0 110.326 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 95.67 175.73 36.92 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 61.0 m -81.24 104.91 12.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -1.134 . . . . 0.0 110.086 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 76.86 -102.95 1.71 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 405' ' ' GLY . 0.8 OUTLIER -114.62 81.84 1.62 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.27 -1.136 . . . . 0.0 110.492 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 406' ' ' LEU . . . -62.39 -121.2 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.427 ' CB ' ' O ' ' A' ' 405' ' ' GLY . 0.2 OUTLIER 65.21 38.33 6.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -1.157 . . . . 0.0 110.611 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.416 ' O ' ' HB ' ' A' ' 408' ' ' ILE . . . -69.34 -168.27 0.15 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.138 -0.976 . . . . 0.0 109.852 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.554 ' CD1' ' HG3' ' A' ' 410' ' ' GLN . 21.1 tt -175.0 153.11 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 0.0 110.54 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.736 HG12 ' HA ' ' A' ' 340' ' ' ALA . 32.8 m -56.36 -25.03 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.398 -0.814 . . . . 0.0 110.501 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.554 ' HG3' ' CD1' ' A' ' 408' ' ' ILE . 2.7 mt-30 -51.41 -43.52 62.0 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.192 -0.942 . . . . 0.0 109.761 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -28.8 66.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.476 -0.765 . . . . 0.0 110.301 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.661 HG12 ' HB2' ' A' ' 340' ' ' ALA . 1.5 mp -70.11 -63.04 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.194 -0.941 . . . . 0.0 108.802 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.899 HG11 ' HB2' ' A' ' 420' ' ' LEU . 59.5 t -62.6 -23.55 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.252 -0.905 . . . . 0.0 110.132 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 23.1 t70 -80.33 -29.95 38.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -80.84 -28.33 36.17 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.451 -0.781 . . . . 0.0 109.5 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.602 ' CD2' ' CE ' ' A' ' 296' ' ' MET . 39.1 m80 -86.95 -34.81 19.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.525 -0.735 . . . . 0.0 109.726 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.504 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.0 OUTLIER 75.42 31.57 0.77 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.558 -0.714 . . . . 0.0 111.096 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.536 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -95.9 -83.51 1.65 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.584 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 0.4 OUTLIER -178.86 161.02 1.17 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -1.053 . . . . 0.0 110.671 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.899 ' HB2' HG11 ' A' ' 413' ' ' VAL . 67.2 tp -150.87 93.86 2.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.985 -1.072 . . . . 0.0 109.976 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.557 ' O ' ' CG ' ' A' ' 433' ' ' ARG . 37.3 mt-10 -125.0 140.47 52.89 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.081 -1.012 . . . . 0.0 109.973 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.792 HD13 HD11 ' A' ' 430' ' ' LEU . 0.6 OUTLIER -121.91 150.68 41.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.908 -1.12 . . . . 0.0 111.569 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 424' ' ' THR . . . -135.24 -165.82 10.87 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.769 HG22 ' C ' ' A' ' 429' ' ' GLY . 7.3 m 58.48 154.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.584 -1.539 . . . . 0.0 109.888 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.568 ' N ' ' HD3' ' A' ' 427' ' ' ARG . 60.1 p 179.35 -145.14 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.439 -0.788 . . . . 0.0 109.932 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 427' ' ' ARG . 6.6 pt-20 -50.74 -23.7 2.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.338 -0.851 . . . . 0.0 109.763 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.568 ' HD3' ' N ' ' A' ' 425' ' ' SER . 0.2 OUTLIER -51.26 -44.29 61.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.43 -0.794 . . . . 0.0 110.345 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.416 ' O ' ' OD1' ' A' ' 374' ' ' ASP . . . -155.84 -37.06 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.769 ' C ' HG22 ' A' ' 424' ' ' THR . . . -178.72 -131.54 1.59 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 422' ' ' LEU . 0.2 OUTLIER -153.52 149.4 27.65 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.084 -1.244 . . . . 0.0 109.397 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.649 ' H ' HD13 ' A' ' 430' ' ' LEU . 35.2 t -149.05 102.72 3.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.992 -1.068 . . . . 0.0 109.826 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.745 HG21 ' SD ' ' A' ' 344' ' ' MET . 9.6 tp -89.82 150.23 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 110.877 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . 0.557 ' CG ' ' O ' ' A' ' 421' ' ' GLU . 0.1 OUTLIER -133.98 106.06 7.05 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.646 -0.659 . . . . 0.0 109.67 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -96.57 146.3 24.95 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.413 -0.805 . . . . 0.0 110.149 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.608 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 93.0 m95 -121.07 153.87 36.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.134 -0.979 . . . . 0.0 111.593 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.561 HD23 ' HB3' ' A' ' 416' ' ' HIS . 7.7 mt -141.12 124.73 10.09 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.536 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 43.5 Cg_endo -68.4 135.71 34.68 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.557 1.293 . . . . 0.0 111.266 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.458 HG22 HG12 ' A' ' 330' ' ' VAL . 3.2 t -104.13 106.91 55.51 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.931 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.48 57.03 5.96 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.216 1.64 . . . . 0.0 109.945 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 6.7 p -115.11 138.22 46.11 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 O-C-N 121.442 -0.786 . . . . 0.0 110.641 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 23.3 p -76.85 169.05 19.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.461 -0.775 . . . . 0.0 110.583 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.537 ' O ' ' HB3' ' A' ' 443' ' ' ALA . 17.2 tpp180 -159.09 72.43 0.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.39 -0.819 . . . . 0.0 109.92 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 442' ' ' ARG . . . 60.47 137.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.305 -0.872 . . . . 0.0 110.308 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -127.28 77.76 1.76 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.341 -0.849 . . . . 0.0 109.989 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . 0.421 ' O ' ' OG1' ' A' ' 446' ' ' THR . . . -72.28 -16.91 77.22 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 445' ' ' GLY . 59.7 p 43.7 -142.51 0.16 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.32 -1.106 . . . . 0.0 110.26 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 67.6 p -110.78 121.89 46.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.166 -0.959 . . . . 0.0 110.306 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -155.52 152.37 28.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.327 -0.858 . . . . 0.0 110.313 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -111.31 110.84 21.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.337 -0.852 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 CA-C-O 117.995 -1.447 . . . . 0.0 109.487 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.747 " C5'" HD11 ' A' ' 386' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.253 0.549 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -82.68 148.16 25.89 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.1 129.77 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.245 -1.15 . . . . 0.0 110.413 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -69.17 87.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 110.418 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 5.3 mtt -68.91 130.32 91.67 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.309 -0.869 . . . . 0.0 109.952 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.559 ' HG2' ' NE2' ' A' ' 333' ' ' HIS . 51.3 Cg_endo -83.42 61.12 7.03 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.994 1.523 . . . . 0.0 111.071 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.532 ' CE ' ' CD2' ' A' ' 416' ' ' HIS . 0.2 OUTLIER -89.03 109.24 20.1 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.611 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 24.2 mt-10 -135.93 -157.13 0.77 Allowed 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.993 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.54 ' CG ' ' HE3' ' A' ' 331' ' ' LYS . 0.1 OUTLIER -87.64 141.91 28.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 0.0 110.624 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.564 ' HB3' ' HE3' ' A' ' 332' ' ' MET . . . -155.95 163.98 39.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.64 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.883 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.5 OUTLIER -101.58 114.65 28.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.339 -0.851 . . . . 0.0 110.471 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.624 HD12 HG21 ' A' ' 328' ' ' ILE . 14.3 mt -61.23 -25.03 66.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.84 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.73 ' OD1' HD23 ' A' ' 323' ' ' LEU . 40.4 t-20 -80.7 -23.7 39.35 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.197 -0.939 . . . . 0.0 109.365 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.76 -25.59 26.31 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.576 -0.703 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 300' ' ' ASP . 5.5 t -83.69 -34.68 10.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.427 -0.795 . . . . 0.0 109.484 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 309' ' ' ILE . 59.3 mt -79.43 -28.37 41.7 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.346 -0.846 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.14 -35.85 91.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.785 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 4.3 mt-10 -80.67 -33.63 35.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.294 -1.121 . . . . 0.0 109.79 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 304' ' ' VAL . 27.7 t -77.29 -19.99 14.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.473 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.785 HD11 ' CG1' ' A' ' 358' ' ' VAL . 0.9 OUTLIER -76.11 -51.41 20.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.419 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -77.41 -15.41 59.37 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.404 -0.81 . . . . 0.0 109.456 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.785 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -70.72 -62.49 1.37 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.401 ' OE2' ' O ' ' A' ' 311' ' ' ALA . 9.8 mm-40 -123.05 31.08 6.13 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.586 -1.246 . . . . 0.0 113.351 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.662 ' O ' HD11 ' A' ' 319' ' ' ILE . 2.6 m -111.26 44.31 1.34 Allowed 'General case' 0 C--N 1.289 -2.052 0 O-C-N 120.641 -1.287 . . . . 0.0 108.964 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 69.8 26.52 74.3 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.496 ' O ' ' CB ' ' A' ' 316' ' ' GLU . 4.8 m-85 59.24 47.7 11.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -1.046 . . . . 0.0 110.322 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.496 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 0.0 OUTLIER 68.42 35.61 3.28 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.107 -0.996 . . . . 0.0 109.621 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 14.3 tpp85 -69.06 -81.36 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.642 0.734 . . . . 0.0 110.625 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 318' ' ' GLU . 4.3 pt-20 -126.58 72.93 1.36 Allowed 'General case' 0 C--N 1.275 -2.633 0 O-C-N 121.615 -0.678 . . . . 0.0 111.149 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.904 HG13 HD12 ' A' ' 356' ' ' ILE . 2.6 mp -132.6 138.19 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.096 -1.002 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -99.48 103.88 15.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.846 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.513 HG22 HD13 ' A' ' 309' ' ' ILE . 35.7 p -89.73 122.04 32.45 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.257 -0.902 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -138.81 79.39 1.73 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.73 HD23 ' OD1' ' A' ' 302' ' ' ASN . 1.2 mp -88.66 150.28 23.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.478 -0.764 . . . . 0.0 110.386 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.572 ' HB3' ' CD1' ' A' ' 328' ' ' ILE . 36.6 t80 -37.21 145.3 0.27 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.599 -0.688 . . . . 0.0 109.928 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.547 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 51.7 Cg_endo -83.0 59.03 6.56 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 O-C-N 123.966 1.508 . . . . 0.0 110.444 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . 179.74 17.1 0.03 OUTLIER Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.738 -1.22 . . . . 0.0 111.242 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 2.0 m 58.47 115.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 O-C-N 120.666 -1.49 . . . . 0.0 110.018 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.624 HG21 HD12 ' A' ' 301' ' ' LEU . 2.0 mm -69.48 178.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.306 -0.871 . . . . 0.0 109.508 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.542 ' H ' HG22 ' A' ' 328' ' ' ILE . 4.9 mt-10 -170.87 106.09 0.26 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.609 0.719 . . . . 0.0 109.971 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.722 HG12 HG22 ' A' ' 438' ' ' VAL . 7.8 m -148.16 168.46 3.89 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-O 121.648 0.737 . . . . 0.0 110.539 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -85.09 94.26 8.81 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.576 ' HG2' ' NE2' ' A' ' 416' ' ' HIS . 4.7 tmm? -145.17 157.51 44.06 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 110.592 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.616 ' CE1' ' HB3' ' A' ' 335' ' ' LEU . 22.2 t-160 -82.79 111.65 31.26 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.449 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 37.9 Cg_endo -62.16 -19.3 66.14 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.717 1.377 . . . . 0.0 110.058 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.616 ' HB3' ' CE1' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -81.3 -47.21 13.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 109.937 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 333' ' ' HIS . 0.1 OUTLIER -65.06 -41.33 95.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.448 -0.782 . . . . 0.0 109.982 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.58 HD11 ' CE1' ' A' ' 416' ' ' HIS . 19.6 mm -71.3 -33.67 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.909 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.527 ' HG3' HG13 ' A' ' 304' ' ' VAL . 7.4 mttm -59.06 -60.94 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.706 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -37.15 86.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.482 -0.761 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.551 ' CB ' HG21 ' A' ' 412' ' ' ILE . . . -58.71 -35.56 72.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.92 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.553 HG12 ' CG1' ' A' ' 308' ' ' VAL . 48.2 t -88.33 -21.23 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 111.136 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 308' ' ' VAL . . . -77.61 -28.74 51.59 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.092 -1.005 . . . . 0.0 111.993 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . 0.428 HD21 ' HA ' ' A' ' 340' ' ' ALA . 21.9 p30 -89.7 -18.67 25.97 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.786 -1.196 . . . . 0.0 111.793 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.535 ' HG2' ' HA ' ' A' ' 341' ' ' VAL . 3.6 ptp -88.57 -20.93 24.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.73 -1.231 . . . . 0.0 111.077 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.432 ' N ' ' HG3' ' A' ' 344' ' ' MET . 8.2 p -90.6 -20.6 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.086 -1.009 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 342' ' ' ALA . 40.4 t -69.43 -20.16 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.047 -1.033 . . . . 0.0 110.994 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -63.83 -31.28 72.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.12 -0.987 . . . . 0.0 110.516 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.557 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -89.73 -21.3 22.76 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 110.738 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -82.26 -68.72 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.075 -1.015 . . . . 0.0 110.656 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -57.11 -66.9 0.38 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.191 -0.943 . . . . 0.0 110.702 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.53 -39.88 36.61 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.165 -0.959 . . . . 0.0 110.491 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -71.53 163.95 54.1 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -164.38 38.18 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.34 -1.094 . . . . 0.0 109.855 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -123.11 -67.14 0.22 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.6 OUTLIER -173.0 137.26 0.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.164 -1.197 . . . . 0.0 110.386 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.904 HD12 HG13 ' A' ' 319' ' ' ILE . 5.3 mt -107.52 167.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -0.76 . . . . 0.0 109.274 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 2.2 tttp -148.93 116.5 6.21 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.027 -1.045 . . . . 0.0 110.822 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.785 ' CG1' HD11 ' A' ' 309' ' ' ILE . 17.5 t -115.51 75.94 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 108.974 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 14.3 p -104.69 132.06 51.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.818 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.443 ' H ' HD12 ' A' ' 323' ' ' LEU . 28.8 t -122.0 163.58 19.11 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.55 -0.719 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.573 ' C ' HG22 ' A' ' 362' ' ' THR . . . -159.45 -153.37 6.82 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.573 HG22 ' C ' ' A' ' 361' ' ' GLY . 0.0 OUTLIER -179.65 171.38 1.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.43 -1.041 . . . . 0.0 109.901 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.568 ' CB ' ' CD ' ' A' ' 364' ' ' PRO . 3.8 mt-10 -131.91 -169.54 0.21 Allowed Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.193 -0.942 . . . . 0.0 109.809 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 363' ' ' GLU . 48.3 Cg_endo -84.74 30.0 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.447 0 O-C-N 123.582 1.306 . . . . 0.0 110.963 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 366' ' ' ARG . 3.8 p30 167.86 34.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.31 -0.869 . . . . 0.0 110.18 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.0 OUTLIER 166.75 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.383 -0.823 . . . . 0.0 109.9 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.672 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -97.74 162.35 13.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.164 -0.96 . . . . 0.0 109.313 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.674 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 45.3 p-90 -167.31 171.65 10.48 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.706 -1.246 . . . . 0.0 111.005 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.6 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 20.3 p90 -141.8 143.3 33.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.564 -0.71 . . . . 0.0 109.226 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 0.1 OUTLIER -132.88 145.62 51.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.133 -0.979 . . . . 0.0 111.725 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 21.1 t -127.11 132.62 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -123.11 158.56 30.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.945 -1.097 . . . . 0.0 110.39 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 11.2 p-10 -150.88 140.25 21.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.366 -0.834 . . . . 0.0 110.215 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.41 177.38 9.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.335 -0.853 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 107.23 -158.6 14.99 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.17 163.0 40.04 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.947 1.499 . . . . 0.0 110.987 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . 0.434 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -105.52 -153.13 21.2 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.68 HD12 ' N9 ' ' A' ' 451' ' ' ANP . 1.6 mm -89.87 93.25 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.138 -1.213 . . . . 0.0 110.112 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.763 ' HB3' ' NE2' ' A' ' 382' ' ' GLN . . . -46.61 165.9 0.19 Allowed Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 120.808 -1.182 . . . . 0.0 109.233 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.489 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 46.6 Cg_endo -73.1 -19.55 22.72 Favored 'Trans proline' 0 C--N 1.294 -2.301 0 O-C-N 123.482 1.254 . . . . 0.0 110.231 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -84.4 -43.67 14.47 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.306 -0.871 . . . . 0.0 111.331 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.763 ' NE2' ' HB3' ' A' ' 379' ' ' ALA . 0.0 OUTLIER -83.89 -34.69 24.49 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.087 -1.008 . . . . 0.0 111.189 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.623 ' CB ' HG22 ' A' ' 378' ' ' ILE . 0.0 OUTLIER -60.07 -19.61 53.91 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.684 -1.26 . . . . 0.0 109.572 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.475 ' HG2' ' HD2' ' A' ' 383' ' ' ARG . 33.2 mmtt -86.86 -23.64 25.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.554 -0.716 . . . . 0.0 110.61 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.627 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 0.3 OUTLIER -118.45 29.95 7.48 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.983 -1.073 . . . . 0.0 111.49 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.598 HD11 " C4'" ' A' ' 451' ' ' ANP . 13.1 tp -75.92 -123.27 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.027 -1.046 . . . . 0.0 108.713 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.83 32.91 2.46 Favored 'General case' 0 C--N 1.282 -2.355 0 O-C-N 121.068 -1.02 . . . . 0.0 109.731 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -52.06 128.52 38.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.6 -0.687 . . . . 0.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.61 160.07 44.77 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.992 1.522 . . . . 0.0 110.062 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.05 -157.93 0.71 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.08 -1.013 . . . . 0.0 110.468 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 391' ' ' VAL . 91.8 t -131.52 39.29 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 110.495 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.67 -73.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.164 -0.96 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 394' ' ' ASP . . . 137.17 -132.22 5.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 394' ' ' ASP . 5.0 p-10 36.63 84.86 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.69 -0.888 . . . . 0.0 110.724 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.2 72.16 0.08 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.882 . . . . 0.0 110.351 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -96.99 -164.58 1.16 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 110.143 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.26 -113.2 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.99 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 399' ' ' ILE . 10.5 t -144.18 150.63 38.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.862 -1.148 . . . . 0.0 110.093 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.47 HG22 ' N ' ' A' ' 400' ' ' SER . 20.2 mt 42.61 -103.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.149 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.47 ' N ' HG22 ' A' ' 399' ' ' ILE . 37.1 t -134.94 96.76 3.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.915 -1.115 . . . . 0.0 110.068 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -122.85 -4.8 8.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 90.8 m -129.54 158.02 40.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.134 -1.215 . . . . 0.0 110.258 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 129.11 -4.95 6.39 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 404' ' ' LEU . 1.7 pp -121.52 18.53 11.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -1.107 . . . . 0.0 109.944 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 162.61 126.89 0.84 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 19.1 mt -129.29 82.37 2.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.184 -1.186 . . . . 0.0 110.373 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.404 ' HB3' ' O3G' ' A' ' 451' ' ' ANP . . . -62.29 95.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 109.926 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 412' ' ' ILE . 7.1 tp -116.6 132.48 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.157 -0.964 . . . . 0.0 110.757 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.645 ' HA ' HD13 ' A' ' 412' ' ' ILE . 10.4 t -138.44 5.52 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.582 -0.699 . . . . 0.0 109.485 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 414' ' ' ASP . 16.6 mt-30 -90.08 -48.51 7.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.416 -0.802 . . . . 0.0 109.608 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -66.4 -20.98 66.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.444 -0.785 . . . . 0.0 109.738 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.645 HD13 ' HA ' ' A' ' 409' ' ' VAL . 1.1 mp -68.57 -72.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.248 -0.908 . . . . 0.0 108.726 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 419' ' ' MET . 12.6 t -60.35 -23.22 27.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 410' ' ' GLN . 21.5 t0 -75.9 -30.18 58.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.459 -0.775 . . . . 0.0 109.728 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.509 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 2.5 m-20 -77.18 -19.93 56.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.207 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.58 ' CE1' HD11 ' A' ' 337' ' ' ILE . 44.0 m80 -89.79 -28.56 19.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.557 -0.714 . . . . 0.0 109.756 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 0.5 OUTLIER 78.14 4.6 2.77 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.677 -0.639 . . . . 0.0 110.002 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.566 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -66.52 -91.36 0.05 OUTLIER Glycine 0 N--CA 1.482 1.727 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.565 ' O ' HG11 ' A' ' 413' ' ' VAL . 1.4 ttp 178.96 166.31 0.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -1.101 . . . . 0.0 111.413 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.464 ' HB2' HG11 ' A' ' 413' ' ' VAL . 25.1 tp -151.96 90.96 1.57 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.396 -0.815 . . . . 0.0 108.904 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -112.24 143.12 43.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.941 -1.099 . . . . 0.0 111.055 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.713 HD21 ' C2 ' ' A' ' 451' ' ' ANP . 0.2 OUTLIER -105.72 111.65 24.41 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 109.747 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.461 ' O ' ' OG1' ' A' ' 424' ' ' THR . . . -98.3 162.78 20.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 427' ' ' ARG . 4.6 m -165.15 116.83 1.15 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -1.229 . . . . 0.0 110.674 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 23.0 t -75.07 98.9 3.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.556 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 426' ' ' GLU . 25.7 tt0 55.48 45.84 24.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.363 -0.836 . . . . 0.0 110.111 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.518 ' HG3' ' NH1' ' A' ' 427' ' ' ARG . 10.7 mmt85 46.64 32.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.94 . . . . 0.0 109.958 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -125.02 -46.45 0.24 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -107.11 82.41 0.31 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.626 ' CD2' ' C6 ' ' A' ' 451' ' ' ANP . 0.5 OUTLIER -78.62 135.46 37.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -1.209 . . . . 0.0 110.949 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . . . . . . . . . 28.6 m -148.5 122.14 9.21 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.506 HD12 ' HG ' ' A' ' 422' ' ' LEU . 1.1 tt -89.39 128.02 41.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.062 -1.024 . . . . 0.0 110.609 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . 0.464 ' HG3' ' HG3' ' A' ' 370' ' ' GLN . 0.5 OUTLIER -107.13 99.67 9.21 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.44 -0.788 . . . . 0.0 110.059 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.6 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -90.32 138.5 31.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.674 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 89.4 m95 -114.97 159.32 20.89 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.284 1.04 . . . . 0.0 113.088 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.529 ' CD1' HD11 ' A' ' 301' ' ' LEU . 32.0 mt -146.33 123.11 5.85 Favored Pre-proline 0 N--CA 1.488 1.452 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.566 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 44.4 Cg_endo -74.17 141.83 29.82 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 O-C-N 123.479 1.252 . . . . 0.0 112.18 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.722 HG22 HG12 ' A' ' 330' ' ' VAL . 55.0 t -101.8 134.25 20.27 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.758 -0.588 . . . . 0.0 109.862 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.98 108.73 2.38 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.803 1.422 . . . . 0.0 109.955 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 438' ' ' VAL . 21.3 t -128.99 127.19 65.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.205 -0.935 . . . . 0.0 110.736 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 442' ' ' ARG . 1.2 t -140.21 66.19 1.4 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 0.0 109.774 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 441' ' ' THR . 0.3 OUTLIER 68.03 -83.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.292 -0.88 . . . . 0.0 109.842 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 442' ' ' ARG . . . 39.84 90.06 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.273 -0.892 . . . . 0.0 110.553 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -109.7 33.9 4.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.152 -0.967 . . . . 0.0 110.115 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 446' ' ' THR . . . -167.08 31.77 0.2 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 445' ' ' GLY . 30.7 p -156.47 73.91 0.8 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.223 -1.163 . . . . 0.0 110.34 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 54.7 p -83.12 -49.08 9.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -81.61 95.63 7.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.172 -0.955 . . . . 0.0 110.255 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.88 -165.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.167 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 117.955 -1.469 . . . . 0.0 109.494 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.713 ' C2 ' HD21 ' A' ' 422' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.296 0.57 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -171.05 166.0 39.16 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.33 87.35 4.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -1.17 . . . . 0.0 110.234 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -123.04 42.66 3.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -0.937 . . . . 0.0 110.026 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.462 ' HG2' ' HG3' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -70.85 121.17 83.14 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.336 -0.853 . . . . 0.0 110.06 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.685 ' HB3' ' CD2' ' A' ' 333' ' ' HIS . 48.1 Cg_endo -76.09 176.3 10.21 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.912 1.48 . . . . 0.0 111.078 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.617 ' HE1' ' HB3' ' A' ' 415' ' ' ASN . 0.8 OUTLIER 35.78 51.69 0.73 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.699 1.238 . . . . 0.0 110.16 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.654 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.4 OUTLIER -126.5 -156.98 0.77 Allowed 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.24 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.452 ' SD ' ' OE1' ' A' ' 329' ' ' GLU . 0.7 OUTLIER -86.81 125.17 33.77 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.414 -1.429 . . . . 0.0 110.626 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -137.99 158.55 44.1 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.586 0.708 . . . . 0.0 111.572 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.835 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.9 OUTLIER -102.19 112.75 25.55 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.573 ' CD2' ' HE1' ' A' ' 332' ' ' MET . 14.1 mt -60.34 -24.87 65.4 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.092 -1.005 . . . . 0.0 110.472 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.965 ' HA ' HD23 ' A' ' 323' ' ' LEU . 7.7 m-20 -79.52 -23.39 42.94 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.829 -1.17 . . . . 0.0 109.107 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -83.12 -30.37 27.96 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.479 0.657 . . . . 0.0 109.678 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 300' ' ' ASP . 2.9 t -79.02 -31.87 15.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.44 -0.787 . . . . 0.0 109.69 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 309' ' ' ILE . 97.9 mt -77.64 -31.78 52.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 110.869 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.21 -38.36 95.81 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.471 -1.347 . . . . 0.0 109.897 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.69 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 48.4 mt-10 -76.32 -34.73 59.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -1.15 . . . . 0.0 109.7 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.787 HG11 ' CG1' ' A' ' 341' ' ' VAL . 63.6 t -77.48 -19.13 14.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.687 0.756 . . . . 0.0 109.701 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.778 ' CD1' HG11 ' A' ' 358' ' ' VAL . 0.0 OUTLIER -75.09 -43.85 44.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -90.37 -16.8 28.44 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.506 0.669 . . . . 0.0 110.377 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -73.25 -41.95 63.09 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.586 -0.696 . . . . 0.0 112.261 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 312' ' ' GLU . 1.4 pp20? -115.82 17.24 16.14 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.753 -1.179 . . . . 0.0 112.354 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.563 ' HB2' HD11 ' A' ' 319' ' ' ILE . 15.4 t -102.99 -39.47 6.9 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.391 1.091 . . . . 0.0 109.621 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 118.12 -40.29 2.35 Favored Glycine 0 C--N 1.263 -3.491 0 N-CA-C 107.326 -2.31 . . . . 0.0 107.326 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 5.8 t80 174.65 37.84 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 0.2 OUTLIER 58.8 47.59 12.47 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.488 ' O ' ' HG3' ' A' ' 318' ' ' GLU . 0.0 OUTLIER -67.75 -39.7 84.15 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.449 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 317' ' ' ARG . 39.0 mt-10 -154.97 51.74 0.61 Allowed 'General case' 0 C--N 1.273 -2.751 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.437 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.798 HG23 HG23 ' A' ' 358' ' ' VAL . 5.5 mt -118.9 129.34 75.24 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.949 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.542 ' HB3' ' HD3' ' A' ' 357' ' ' LYS . 37.1 tt0 -97.19 103.53 15.47 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.593 HG22 ' CD1' ' A' ' 309' ' ' ILE . 24.2 p -89.12 128.3 35.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 111.871 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -150.57 78.45 1.32 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.965 HD23 ' HA ' ' A' ' 302' ' ' ASN . 1.9 mp -95.53 159.91 14.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.471 -0.768 . . . . 0.0 111.148 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.637 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 83.5 t80 -47.94 121.44 8.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.622 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.64 78.96 1.96 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.903 1.475 . . . . 0.0 110.718 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 173.15 29.29 0.03 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.524 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 326' ' ' GLY . 2.1 p 44.28 98.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.069 -1.253 . . . . 0.0 110.001 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.561 HG22 ' H ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -72.43 -179.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.463 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.561 ' H ' HG22 ' A' ' 328' ' ' ILE . 2.3 mt-10 -171.39 105.66 0.22 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.68 0.752 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 1.004 HG11 ' HB3' ' A' ' 367' ' ' ALA . 31.0 m -137.06 158.35 36.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 O-C-N 121.67 -0.644 . . . . 0.0 109.626 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.1 OUTLIER -72.36 91.81 1.37 Allowed 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.831 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.71 ' SD ' HD13 ' A' ' 436' ' ' LEU . 3.8 ttp -134.81 168.15 19.57 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 111.255 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.685 ' CD2' ' HB3' ' A' ' 295' ' ' PRO . 19.0 t-160 -101.85 118.09 60.2 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 333' ' ' HIS . 37.2 Cg_endo -59.66 -21.72 64.05 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.41 1.216 . . . . 0.0 110.37 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.619 ' HB2' ' NE2' ' A' ' 333' ' ' HIS . 0.3 OUTLIER -83.4 -68.2 0.73 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.461 -0.774 . . . . 0.0 110.355 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 333' ' ' HIS . 0.4 OUTLIER -46.55 -44.51 17.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.484 -0.76 . . . . 0.0 110.007 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.836 HD11 ' CE1' ' A' ' 416' ' ' HIS . 37.9 mm -65.16 -46.23 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.393 -0.817 . . . . 0.0 109.53 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 337' ' ' ILE . 0.0 OUTLIER -47.04 -41.98 17.62 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.083 -1.011 . . . . 0.0 108.492 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 343' ' ' ASN . 17.2 mtt180 -73.03 -34.93 66.63 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.433 0.635 . . . . 0.0 110.314 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.816 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -62.23 -32.62 73.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.763 . . . . 0.0 110.849 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.787 ' CG1' HG11 ' A' ' 308' ' ' VAL . 44.7 t -85.19 -63.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.127 -0.983 . . . . 0.0 110.063 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.593 ' HA ' ' CG2' ' A' ' 345' ' ' VAL . . . -51.39 -19.45 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.47 -0.769 . . . . 0.0 110.687 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . 0.574 ' O ' HG12 ' A' ' 346' ' ' VAL . 2.0 t30 -76.2 -42.48 46.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.137 -0.977 . . . . 0.0 111.412 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.1 mtt -79.57 -24.89 41.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.975 -1.078 . . . . 0.0 111.413 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 341' ' ' VAL . 16.7 m -88.56 -19.74 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.906 -1.121 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 343' ' ' ASN . 4.7 p -58.72 -36.16 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.916 -1.115 . . . . 0.0 110.544 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.476 ' OD1' ' O2A' ' A' ' 451' ' ' ANP . 0.9 OUTLIER -65.3 -54.38 29.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.897 . . . . 0.0 110.357 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.489 ' O ' ' CA ' ' A' ' 352' ' ' GLY . . . -66.55 -19.82 65.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.275 -0.891 . . . . 0.0 110.503 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -74.76 -50.32 17.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 110.485 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.08 -73.19 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.915 . . . . 0.0 110.682 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . 0.444 ' O ' ' O ' ' A' ' 352' ' ' GLY . 12.1 m-85 -82.54 -44.6 15.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.225 -0.922 . . . . 0.0 110.828 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 348' ' ' ALA . . . 55.59 103.58 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' A' ' 353' ' ' ASN . 26.6 t-20 -113.24 24.74 11.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -1.194 . . . . 0.0 110.901 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 355' ' ' TRP . . . 178.64 -73.56 0.07 OUTLIER Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.642 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER 178.36 164.81 0.76 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.14 -1.212 . . . . 0.0 109.78 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.543 HD12 HG13 ' A' ' 319' ' ' ILE . 0.9 OUTLIER -112.45 163.01 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.279 -0.888 . . . . 0.0 111.183 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.642 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -142.23 124.08 15.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.825 . . . . 0.0 110.002 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.798 HG23 HG23 ' A' ' 319' ' ' ILE . 21.7 t -119.92 83.15 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.427 -0.796 . . . . 0.0 109.406 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.534 ' HA ' HD12 ' A' ' 323' ' ' LEU . 47.2 t -113.53 166.56 11.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.319 -0.863 . . . . 0.0 110.528 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.552 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 3.6 t -156.77 160.07 38.89 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.52 -0.737 . . . . 0.0 109.849 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -149.22 -162.52 10.4 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.637 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER -170.62 174.89 4.85 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.905 -1.35 . . . . 0.0 110.782 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.556 ' CB ' ' HD2' ' A' ' 364' ' ' PRO . 2.6 mt-10 -160.41 -178.65 0.92 Allowed Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 363' ' ' GLU . 38.4 Cg_endo -64.11 135.31 46.67 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.475 1.25 . . . . 0.0 109.908 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.553 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 5.0 p-10 38.74 33.65 0.07 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.614 -0.678 . . . . 0.0 110.699 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.553 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 3.6 mtt180 -172.67 99.93 0.14 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.393 -0.817 . . . . 0.0 111.265 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 1.004 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -110.32 154.8 22.99 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.1 -1.0 . . . . 0.0 108.659 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.621 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 45.9 p-90 -153.4 177.49 10.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.548 -1.345 . . . . 0.0 111.649 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.783 ' HE2' HD11 ' A' ' 436' ' ' LEU . 32.7 p90 -150.44 153.56 36.14 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -145.85 152.87 40.19 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.853 -1.154 . . . . 0.0 111.673 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.564 ' O ' HG22 ' A' ' 432' ' ' ILE . 88.0 t -122.73 141.31 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.529 ' HB2' ' HG2' ' A' ' 357' ' ' LYS . 0.8 OUTLIER -121.62 154.93 36.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.061 -1.024 . . . . 0.0 110.732 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -155.0 140.04 17.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -107.72 109.36 20.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 0.0 110.385 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -177.37 -107.32 0.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.13 -172.03 0.8 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.829 1.436 . . . . 0.0 110.671 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 430' ' ' LEU . . . -144.09 -150.76 5.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.564 HG23 " H1'" ' A' ' 451' ' ' ANP . 11.3 mt -118.55 161.25 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.179 -1.189 . . . . 0.0 110.076 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.842 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -112.02 176.47 1.49 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.094 -1.004 . . . . 0.0 110.555 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.842 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 47.2 Cg_endo -75.64 -45.04 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.092 1.575 . . . . 0.0 110.643 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -81.34 -35.73 30.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 110.514 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.831 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 5.2 mp0 -61.29 -21.49 63.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.268 -0.895 . . . . 0.0 110.307 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -59.58 -30.79 68.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.879 . . . . 0.0 109.987 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 388' ' ' GLN . 0.1 OUTLIER -79.56 -35.39 39.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 385' ' ' HIS . 2.8 m-70 -67.19 -25.73 66.27 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.203 -0.936 . . . . 0.0 110.417 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.613 ' O ' ' CG ' ' A' ' 387' ' ' PHE . 12.4 mt -88.89 1.45 55.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -0.997 . . . . 0.0 110.21 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 90.4 m-85 -160.74 52.37 0.29 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.714 -0.616 . . . . 0.0 110.389 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 384' ' ' LYS . 0.3 OUTLIER -104.81 136.63 19.14 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.019 -1.05 . . . . 0.0 110.559 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.53 124.96 8.66 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.877 1.461 . . . . 0.0 109.887 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -90.57 139.92 30.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 57.9 t -139.06 152.26 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.236 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -100.43 145.32 28.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 110.381 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 113.39 -12.9 23.5 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -88.78 115.8 26.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.335 -1.097 . . . . 0.0 110.086 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.55 87.13 2.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.283 -0.886 . . . . 0.0 110.113 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -82.67 -171.41 3.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.939 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -148.11 59.86 1.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.112 -0.993 . . . . 0.0 110.286 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 8.9 m -154.75 20.84 0.46 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.882 . . . . 0.0 110.046 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.2 mt -136.46 -66.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 110.357 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 9.1 m 57.13 56.75 5.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.961 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -91.54 -160.87 36.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.39 178.06 5.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.26 -1.141 . . . . 0.0 110.405 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -52.19 106.29 0.33 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 24.8 mt -97.68 164.82 12.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 110.425 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 118.45 33.6 1.19 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.767 ' H ' HD13 ' A' ' 406' ' ' LEU . 0.0 OUTLIER -90.56 174.56 7.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.34 -1.094 . . . . 0.0 110.806 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.434 ' C ' HG23 ' A' ' 408' ' ' ILE . . . -109.47 133.58 52.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.638 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.878 HD12 HG12 ' A' ' 409' ' ' VAL . 1.7 pp -146.95 -156.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 109.933 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.878 HG12 HD12 ' A' ' 408' ' ' ILE . 1.4 p -37.73 -33.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.326 -0.859 . . . . 0.0 110.923 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 408' ' ' ILE . 1.3 mm100 -65.9 -55.7 15.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.042 -1.036 . . . . 0.0 109.739 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.504 ' HD3' ' ND2' ' A' ' 415' ' ' ASN . 0.0 OUTLIER -56.57 -20.77 22.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.816 HG21 ' HB2' ' A' ' 340' ' ' ALA . 25.4 mm -72.11 -65.91 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 108.569 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.907 HG21 HD13 ' A' ' 420' ' ' LEU . 86.5 t -59.99 -19.87 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.538 -0.726 . . . . 0.0 109.703 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -82.22 -32.83 29.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.867 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.617 ' HB3' ' HE1' ' A' ' 296' ' ' MET . 1.4 m-20 -78.7 -28.06 45.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.481 -0.762 . . . . 0.0 109.378 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.836 ' CE1' HD11 ' A' ' 337' ' ' ILE . 41.1 m80 -86.34 -39.03 16.86 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.881 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 1.0 OUTLIER 79.88 45.44 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 CA-C-O 121.393 0.616 . . . . 0.0 110.543 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 419' ' ' MET . . . -107.85 -85.81 1.78 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.57 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 1.4 ttp 177.99 169.88 0.72 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.321 -1.105 . . . . 0.0 111.019 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.907 HD13 HG21 ' A' ' 413' ' ' VAL . 16.1 tp -151.46 89.34 1.49 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.769 . . . . 0.0 109.133 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.38 159.47 15.11 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.095 -1.003 . . . . 0.0 111.525 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 422' ' ' LEU . 3.0 pp -134.05 119.45 18.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.606 -0.684 . . . . 0.0 109.535 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 430' ' ' LEU . . . -131.14 170.72 21.27 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.536 ' OG1' ' CD2' ' A' ' 430' ' ' LEU . 88.0 m -165.05 106.9 0.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.057 -1.261 . . . . 0.0 110.448 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 426' ' ' GLU . 1.6 m -41.92 105.54 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.854 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 425' ' ' SER . 7.3 tt0 59.64 -87.04 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 425' ' ' SER . 0.0 OUTLIER -162.76 35.71 0.1 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.127 -0.983 . . . . 0.0 109.424 179.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . . . . . . . . . . . -144.75 -36.55 0.07 OUTLIER Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . -85.75 57.98 4.84 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.652 ' CD1' ' N7 ' ' A' ' 451' ' ' ANP . 0.2 OUTLIER -68.06 114.89 6.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.185 -1.185 . . . . 0.0 110.298 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.525 ' HB2' ' CG ' ' A' ' 372' ' ' GLU . 14.6 t -128.32 120.87 27.93 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.429 -0.794 . . . . 0.0 110.312 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 371' ' ' VAL . 1.2 tt -91.73 130.68 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.879 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.52 129.46 56.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.999 -1.063 . . . . 0.0 110.771 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -120.07 128.68 53.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.273 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.621 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 83.8 m95 -102.44 155.62 18.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.94 -1.1 . . . . 0.0 111.591 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.783 HD11 ' HE2' ' A' ' 369' ' ' PHE . 14.6 mt -145.59 129.04 8.41 Favored Pre-proline 0 N--CA 1.485 1.276 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.02 142.23 41.91 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.721 1.38 . . . . 0.0 110.069 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.616 HG22 HG12 ' A' ' 330' ' ' VAL . 2.6 t -73.35 -47.35 7.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.152 -0.967 . . . . 0.0 110.498 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 438' ' ' VAL . 58.0 Cg_endo -89.63 -170.73 0.46 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.51 1.269 . . . . 0.0 110.333 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 440' ' ' VAL . 12.0 p -100.5 157.71 4.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.627 -0.671 . . . . 0.0 109.926 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 4.0 p -117.38 140.2 49.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.914 -1.116 . . . . 0.0 110.096 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.13 107.9 18.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.159 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -67.07 125.11 24.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 110.178 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.77 149.38 49.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 110.131 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . 166.15 -161.38 35.01 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 1.9 t -164.23 73.14 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -1.182 . . . . 0.0 110.207 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 1.6 t -147.89 125.01 11.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.038 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -107.7 -143.1 0.38 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.885 . . . . 0.0 110.298 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -74.59 131.18 40.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.88 . . . . 0.0 110.178 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 CA-C-O 117.995 -1.447 . . . . 0.0 109.504 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.652 ' N7 ' ' CD1' ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.274 0.559 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -147.75 -147.04 4.45 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -144.07 119.34 10.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -1.159 . . . . 0.0 110.017 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.46 82.82 1.96 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.0 110.483 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.507 ' N ' ' HD3' ' A' ' 295' ' ' PRO . 34.1 mtp -146.39 67.59 11.8 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.154 -0.966 . . . . 0.0 110.385 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.581 ' HB3' ' NE2' ' A' ' 333' ' ' HIS . 53.3 Cg_endo -99.45 -163.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 121.948 1.765 . . . . 0.0 111.283 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.688 ' HE3' ' NE2' ' A' ' 416' ' ' HIS . 0.3 OUTLIER 28.83 80.57 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.416 1.103 . . . . 0.0 112.015 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 14.2 mt-10 -148.63 -149.06 0.28 Allowed 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.507 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -87.64 128.81 35.28 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.74 -1.225 . . . . 0.0 109.527 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . -136.01 158.29 44.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.404 -0.81 . . . . 0.0 111.67 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 304' ' ' VAL . 4.3 m-20 -95.12 117.51 30.33 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.564 HD11 HD12 ' A' ' 436' ' ' LEU . 6.7 mt -63.86 -23.64 67.43 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.05 -1.031 . . . . 0.0 110.191 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.852 ' HA ' HD23 ' A' ' 323' ' ' LEU . 29.9 m-20 -79.94 -19.57 47.69 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.904 -1.123 . . . . 0.0 108.569 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.94 -37.21 19.29 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.433 0.635 . . . . 0.0 109.463 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.814 ' O ' HG23 ' A' ' 308' ' ' VAL . 22.0 t -74.94 -30.79 24.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.528 -0.732 . . . . 0.0 109.514 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 25.2 mt -78.65 -36.38 43.96 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.285 -0.884 . . . . 0.0 110.428 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -62.06 -39.1 97.16 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.683 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 1.0 OUTLIER -71.88 -33.66 68.54 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.231 -1.158 . . . . 0.0 108.599 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 304' ' ' VAL . 93.5 t -75.57 -18.77 15.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.811 0.815 . . . . 0.0 108.9 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.665 HG13 HG21 ' A' ' 321' ' ' THR . 0.3 OUTLIER -72.71 -45.1 58.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 122.021 0.915 . . . . 0.0 108.648 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.428 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -90.95 -15.86 29.03 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 121.4 -0.813 . . . . 0.0 109.795 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -61.61 -64.81 0.82 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.658 -0.651 . . . . 0.0 111.297 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.434 ' HG3' ' C ' ' A' ' 311' ' ' ALA . 94.9 mt-10 -142.98 39.2 1.47 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.088 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.642 ' O ' HD11 ' A' ' 319' ' ' ILE . 19.4 m -88.31 42.74 1.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.892 -1.13 . . . . 0.0 109.161 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' A' ' 315' ' ' TYR . . . 74.07 13.87 80.77 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.58 ' CB ' ' O ' ' A' ' 314' ' ' GLY . 4.0 t80 78.88 63.3 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.893 -0.769 . . . . 0.0 108.926 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.576 ' CG ' ' O ' ' A' ' 315' ' ' TYR . 6.2 pt-20 41.74 45.73 3.11 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.126 0.965 . . . . 0.0 109.907 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.58 ' CG ' ' O ' ' A' ' 314' ' ' GLY . 6.4 mmt180 -68.36 -89.74 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 121.771 0.796 . . . . 0.0 109.808 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.25 65.55 1.41 Allowed 'General case' 0 C--N 1.272 -2.778 0 CA-C-O 121.583 0.706 . . . . 0.0 110.846 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.644 ' CG2' HG23 ' A' ' 358' ' ' VAL . 2.6 mp -101.27 148.37 7.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 121.52 -0.737 . . . . 0.0 110.113 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -114.28 105.46 13.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.164 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.772 HG22 ' HB ' ' A' ' 358' ' ' VAL . 28.2 p -90.55 122.04 33.02 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 111.38 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -129.69 78.36 1.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.852 HD23 ' HA ' ' A' ' 302' ' ' ASN . 1.8 mp -93.78 174.18 7.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 111.215 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.629 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 20.8 t80 -61.23 137.84 94.41 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.651 -0.656 . . . . 0.0 109.906 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.569 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 53.1 Cg_endo -82.46 61.97 7.78 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.963 1.507 . . . . 0.0 110.547 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 327' ' ' SER . . . 178.82 22.2 0.03 OUTLIER Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.777 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 326' ' ' GLY . 2.1 m 55.12 107.3 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 O-C-N 120.891 -1.358 . . . . 0.0 110.281 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.546 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -81.63 -177.51 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.122 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 1.9 mt-10 -170.92 108.79 0.31 Allowed 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.841 0.829 . . . . 0.0 111.107 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 436' ' ' LEU . 25.3 m -131.3 159.17 43.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 O-C-N 121.72 -0.613 . . . . 0.0 109.463 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 3.3 tptt -76.4 93.57 3.51 Favored 'General case' 0 C--N 1.288 -2.104 0 C-N-CA 118.681 -1.208 . . . . 0.0 108.909 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.733 ' HE1' HG21 ' A' ' 337' ' ' ILE . 0.0 OUTLIER -134.73 -174.46 3.59 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.818 0.818 . . . . 0.0 111.326 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.601 ' CB ' ' NE2' ' A' ' 416' ' ' HIS . 18.6 t-160 -113.82 117.56 44.07 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 37.1 Cg_endo -59.24 -26.58 82.32 Favored 'Trans proline' 0 C--N 1.289 -2.563 0 O-C-N 123.105 1.055 . . . . 0.0 110.391 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.637 HD12 ' C ' ' A' ' 335' ' ' LEU . 0.5 OUTLIER -83.09 -66.47 0.89 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.273 -0.892 . . . . 0.0 110.819 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.546 ' N ' ' HG ' ' A' ' 335' ' ' LEU . 3.5 m -52.88 -42.76 65.6 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.941 -1.099 . . . . 0.0 110.624 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.768 HD11 ' CG ' ' A' ' 416' ' ' HIS . 29.6 mm -64.17 -44.45 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.591 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 0.7 OUTLIER -50.72 -46.77 59.18 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.707 -1.246 . . . . 0.0 109.284 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -43.17 93.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 0.0 110.121 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 1.023 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -47.29 -40.99 18.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.514 -0.741 . . . . 0.0 110.576 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.621 ' CG1' HG11 ' A' ' 308' ' ' VAL . 40.2 t -80.04 -32.14 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 110.47 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.969 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -66.78 -23.65 66.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.26 -0.9 . . . . 0.0 110.364 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . 0.554 ' HB2' ' HB1' ' A' ' 407' ' ' ALA . 54.1 t-20 -66.99 -29.88 69.84 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.147 -0.971 . . . . 0.0 110.489 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 42.0 mtt -82.04 -42.9 18.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.208 -0.933 . . . . 0.0 110.498 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.569 HG21 ' HA ' ' A' ' 313' ' ' SER . 3.7 p -67.86 -19.6 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.474 -0.766 . . . . 0.0 110.776 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 342' ' ' ALA . 53.0 t -67.99 -20.08 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.14 -0.975 . . . . 0.0 110.657 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.2 -57.38 4.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 110.366 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.422 ' O ' ' HA2' ' A' ' 352' ' ' GLY . . . -79.72 -19.97 47.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 110.46 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 345' ' ' VAL . . . -74.06 -25.11 59.65 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 110.413 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -73.71 -67.94 0.55 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.204 -0.935 . . . . 0.0 110.295 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -30.45 51.8 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 110.217 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 348' ' ' ALA . . . 82.95 106.5 0.48 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 374' ' ' ASP . 10.5 m120 -97.5 -57.4 2.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.285 -1.127 . . . . 0.0 110.466 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . 150.99 -17.38 0.93 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.607 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . . . . . . . . . 37.7 t90 -154.37 130.87 10.58 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.842 -1.387 . . . . 0.0 111.666 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 319' ' ' ILE . 82.1 mt -124.05 158.98 30.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.559 ' HB3' ' CB ' ' A' ' 372' ' ' GLU . 5.9 tttp -136.4 137.95 41.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.628 -1.295 . . . . 0.0 111.672 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.772 ' HB ' HG22 ' A' ' 321' ' ' THR . 26.0 t -132.85 81.19 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.44 ' HB3' ' HE3' ' A' ' 357' ' ' LYS . 89.1 p -112.14 160.77 17.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.161 -0.962 . . . . 0.0 111.256 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 369' ' ' PHE . 47.2 t -162.16 130.44 4.11 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -118.1 -161.47 11.95 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.8 OUTLIER -171.36 177.58 3.5 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.748 -1.442 . . . . 0.0 112.014 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.563 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 1.0 OUTLIER -156.29 175.26 3.3 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 38.0 Cg_endo -64.29 116.32 3.67 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.158 1.083 . . . . 0.0 111.289 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.517 ' C ' ' HG3' ' A' ' 366' ' ' ARG . 6.2 m-20 63.07 18.38 10.88 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.743 -0.598 . . . . 0.0 111.147 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.517 ' HG3' ' C ' ' A' ' 365' ' ' ASN . 26.9 mtp180 -160.23 108.02 1.64 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.437 -0.789 . . . . 0.0 110.377 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.68 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -112.7 179.19 4.04 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.864 -1.147 . . . . 0.0 108.708 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.654 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 11.5 p-90 -171.44 149.04 2.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.825 -1.172 . . . . 0.0 110.11 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 369' ' ' PHE . 4.7 p90 -138.46 142.8 39.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.963 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.534 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 11.9 tt0 -133.31 155.09 50.06 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 110.42 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.534 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 36.7 t -118.78 151.74 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.428 -0.795 . . . . 0.0 110.179 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.559 ' CB ' ' HB3' ' A' ' 357' ' ' LYS . 4.4 tt0 -139.19 117.24 11.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.269 -0.895 . . . . 0.0 109.746 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 373' ' ' ASP . 20.4 p-10 -145.88 143.48 29.61 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.04 -1.038 . . . . 0.0 110.201 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 353' ' ' ASN . 12.4 t0 -74.83 140.76 44.15 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.406 -0.809 . . . . 0.0 109.817 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -179.51 -150.29 8.96 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.07 -162.24 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.975 1.513 . . . . 0.0 110.512 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -140.22 -172.75 12.99 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.599 HG12 ' N9 ' ' A' ' 451' ' ' ANP . 26.0 mt -110.39 140.16 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -1.174 . . . . 0.0 110.568 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -82.56 164.4 47.49 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.407 -0.808 . . . . 0.0 109.872 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 46.6 Cg_endo -73.83 -30.25 9.54 Favored 'Trans proline' 0 C--N 1.298 -2.082 0 O-C-N 124.087 1.572 . . . . 0.0 110.732 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -90.39 -21.29 22.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.196 -0.94 . . . . 0.0 110.483 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.766 ' HB2' ' HB3' ' A' ' 379' ' ' ALA . 0.1 OUTLIER -78.88 -21.65 47.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.177 -0.952 . . . . 0.0 110.466 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -49.97 -21.42 1.2 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.151 -0.968 . . . . 0.0 110.467 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.54 -32.19 16.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.24 -0.912 . . . . 0.0 110.482 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.432 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 5.4 m-70 -80.35 -10.88 59.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.319 -0.863 . . . . 0.0 110.893 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.808 HD21 ' N3 ' ' A' ' 451' ' ' ANP . 22.1 tp -82.77 8.05 13.33 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.036 -1.04 . . . . 0.0 111.445 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.609 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 31.2 m-85 -162.53 27.21 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.496 -0.752 . . . . 0.0 110.606 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 387' ' ' PHE . 24.7 mt-30 53.89 162.83 0.05 OUTLIER Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 121.46 -0.775 . . . . 0.0 110.536 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 390' ' ' PHE . 50.5 Cg_endo -82.58 41.66 1.16 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.76 1.4 . . . . 0.0 110.549 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 389' ' ' PRO . 93.7 m-85 59.41 137.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.356 -0.84 . . . . 0.0 110.329 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 42.6 t -84.95 148.97 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.976 . . . . 0.0 110.084 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -130.12 -3.79 4.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.217 -0.927 . . . . 0.0 110.48 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 117.95 -41.28 2.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -143.35 110.64 5.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -1.175 . . . . 0.0 110.517 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.1 t -121.47 -89.34 0.6 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.15 -0.969 . . . . 0.0 110.107 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -151.45 -72.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 109.965 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.3 155.83 10.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 109.883 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.67 138.62 54.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 110.475 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 399' ' ' ILE . 0.0 OUTLIER -115.73 120.54 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 110.169 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.49 -141.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.107 -0.996 . . . . 0.0 110.11 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -70.51 -66.93 2.04 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 32.6 p -108.89 157.87 18.21 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.285 -1.126 . . . . 0.0 110.108 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -120.07 -171.49 14.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 404' ' ' LEU . 5.7 tp -104.4 74.33 1.17 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.375 -1.074 . . . . 0.0 110.173 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -114.72 164.37 12.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.05 -56.11 1.27 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.211 -1.17 . . . . 0.0 110.214 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' A' ' 343' ' ' ASN . . . -105.82 -51.78 2.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.902 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.76 ' O ' HG23 ' A' ' 408' ' ' ILE . 1.1 tp 23.1 98.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.622 0 CA-C-O 121.292 0.568 . . . . 0.0 111.605 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 409' ' ' VAL . 93.6 t -79.83 1.91 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 1.3 mm100 -74.25 -55.3 6.2 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 110.237 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 415' ' ' ASN . 1.9 mmt180 -67.8 -31.49 71.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.323 -0.861 . . . . 0.0 109.898 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 1.023 HG21 ' HB2' ' A' ' 340' ' ' ALA . 8.7 mm -67.21 -66.28 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.894 HG21 HD13 ' A' ' 420' ' ' LEU . 35.4 t -57.11 -23.24 18.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.424 -0.797 . . . . 0.0 109.699 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 29.5 m-20 -78.09 -30.72 49.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.221 -0.925 . . . . 0.0 109.535 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.51 ' HB3' ' HE1' ' A' ' 296' ' ' MET . 1.2 m-20 -109.31 7.29 25.11 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.65 -0.657 . . . . 0.0 109.625 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.768 ' CG ' HD11 ' A' ' 337' ' ' ILE . 47.1 m80 -134.64 -62.92 0.72 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 111.968 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.956 ' HA ' HD23 ' A' ' 436' ' ' LEU . 2.4 m-20 -74.73 -99.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.808 0.814 . . . . 0.0 111.61 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 149.11 -35.04 1.08 Allowed Glycine 0 C--N 1.262 -3.551 0 N-CA-C 106.432 -2.667 . . . . 0.0 106.432 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.669 ' HB3' ' HB2' ' A' ' 435' ' ' TRP . 36.4 ttm -123.14 145.69 48.38 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.658 -0.907 . . . . 0.0 109.601 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.894 HD13 HG21 ' A' ' 413' ' ' VAL . 19.7 tp -150.84 92.71 1.86 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.114 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -107.6 128.8 54.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.372 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.511 HD13 HD13 ' A' ' 378' ' ' ILE . 2.0 pp -89.81 138.58 31.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.869 . . . . 0.0 109.547 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.488 ' O ' ' HG ' ' A' ' 430' ' ' LEU . . . -149.26 -168.66 15.02 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.555 -1.307 . . . . 0.0 109.903 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.853 HG22 ' O ' ' A' ' 429' ' ' GLY . 0.2 OUTLIER 50.09 173.2 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.577 -0.955 . . . . 0.0 111.185 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.801 ' OG ' HD12 ' A' ' 430' ' ' LEU . 0.2 OUTLIER 172.06 -143.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -58.13 -34.18 69.97 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.36 -0.837 . . . . 0.0 109.893 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.562 ' HG2' ' N ' ' A' ' 428' ' ' GLY . 0.0 OUTLIER -44.65 -27.57 0.5 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.118 -0.989 . . . . 0.0 109.897 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.562 ' N ' ' HG2' ' A' ' 427' ' ' ARG . . . 178.87 54.07 0.08 OUTLIER Glycine 0 N--CA 1.484 1.9 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.853 ' O ' HG22 ' A' ' 424' ' ' THR . . . 69.39 144.65 0.18 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.801 HD12 ' OG ' ' A' ' 425' ' ' SER . 0.3 OUTLIER -88.68 165.23 14.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.882 -1.364 . . . . 0.0 109.876 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.541 ' N ' ' HB ' ' A' ' 424' ' ' THR . 1.7 p -146.52 162.86 37.42 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.964 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.628 HD11 ' N1 ' ' A' ' 451' ' ' ANP . 13.3 mm -123.8 121.84 63.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -98.99 100.98 12.22 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.833 ' HB1' HD22 ' A' ' 417' ' ' ASN . . . -110.35 135.05 51.67 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 111.066 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.669 ' HB2' ' HB3' ' A' ' 419' ' ' MET . 88.0 m95 -110.14 138.35 46.64 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 121.064 -1.023 . . . . 0.0 111.255 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.956 HD23 ' HA ' ' A' ' 417' ' ' ASN . 9.7 mt -113.46 75.79 2.57 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 417' ' ' ASN . 37.5 Cg_endo -63.05 115.08 2.74 Favored 'Trans proline' 0 C--N 1.295 -2.287 0 O-C-N 124.665 1.876 . . . . 0.0 110.494 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.513 ' CG1' ' HD2' ' A' ' 439' ' ' PRO . 4.6 t -69.66 143.91 93.19 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.384 -0.823 . . . . 0.0 109.682 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.513 ' HD2' ' CG1' ' A' ' 438' ' ' VAL . 53.6 Cg_endo -71.23 -164.26 0.15 Allowed 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.0 1.526 . . . . 0.0 110.418 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.33 39.11 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 121.314 0.578 . . . . 0.0 110.289 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 442' ' ' ARG . 14.4 t -84.53 171.54 12.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.272 -0.892 . . . . 0.0 110.164 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 441' ' ' THR . 5.0 mmt180 54.79 94.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.108 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -151.51 -74.13 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 110.179 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.71 81.52 3.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.963 . . . . 0.0 110.292 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -125.88 84.17 0.35 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 1.8 t -55.96 167.33 0.61 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -1.115 . . . . 0.0 110.275 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 8.9 p -86.11 -48.17 8.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.878 . . . . 0.0 110.081 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 448' ' ' LYS . 0.0 OUTLIER -150.03 131.36 14.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.251 -0.906 . . . . 0.0 110.036 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.68 -17.03 61.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 0.0 110.382 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 CA-C-O 118.028 -1.429 . . . . 0.0 109.573 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.808 ' N3 ' HD21 ' A' ' 386' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.276 0.56 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -149.12 -152.63 5.78 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.22 -32.89 4.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.31 -1.112 . . . . 0.0 110.198 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.425 ' C ' ' HD3' ' A' ' 295' ' ' PRO . 4.2 mt-10 -135.32 77.87 1.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.774 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -116.14 67.72 3.34 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.229 -0.919 . . . . 0.0 111.257 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 297' ' ' GLU . 47.0 Cg_endo -73.98 179.18 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.912 1.48 . . . . 0.0 109.542 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.541 ' HE3' ' HB3' ' A' ' 415' ' ' ASN . 0.1 OUTLIER 40.38 48.37 2.39 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.85 1.309 . . . . 0.0 109.304 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.701 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 4.3 mm-40 -127.84 -149.91 0.43 Allowed 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.193 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.488 ' HE2' ' N ' ' A' ' 330' ' ' VAL . 2.1 mmt -84.74 117.49 23.85 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 120.286 -1.508 . . . . 0.0 110.7 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.527 ' HB3' ' HE3' ' A' ' 332' ' ' MET . . . -134.09 162.01 33.29 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.528 0.68 . . . . 0.0 111.129 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 304' ' ' VAL . 4.1 m-20 -95.97 119.01 33.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.654 -0.654 . . . . 0.0 109.867 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.653 HD11 HD12 ' A' ' 436' ' ' LEU . 6.1 mt -65.51 -23.45 66.89 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.091 -1.006 . . . . 0.0 109.654 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.692 ' HA ' HD23 ' A' ' 323' ' ' LEU . 4.5 m-20 -75.68 -19.99 58.74 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.957 -1.09 . . . . 0.0 108.351 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.07 -37.24 19.08 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.524 0.678 . . . . 0.0 109.601 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.877 ' O ' HG23 ' A' ' 308' ' ' VAL . 2.5 t -78.8 -28.62 14.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.415 -0.803 . . . . 0.0 109.554 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 309' ' ' ILE . 72.4 mt -82.85 -31.38 28.04 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.62 -31.99 82.72 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 311' ' ' ALA . 0.8 OUTLIER -83.82 -30.82 26.21 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.268 -1.136 . . . . 0.0 109.251 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 304' ' ' VAL . 88.7 t -72.58 -26.88 24.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.305 -0.872 . . . . 0.0 109.32 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.623 HD12 ' O ' ' A' ' 305' ' ' LEU . 1.0 OUTLIER -75.79 -50.2 24.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -67.08 -16.7 64.5 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.861 0.839 . . . . 0.0 108.762 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 307' ' ' GLU . . . -67.01 -68.03 0.41 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.453 0.644 . . . . 0.0 110.79 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.82 49.35 2.23 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.553 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.988 ' HB2' HD13 ' A' ' 319' ' ' ILE . 6.2 p -82.32 40.46 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.001 -1.062 . . . . 0.0 109.994 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.542 ' C ' ' CD2' ' A' ' 315' ' ' TYR . . . 53.16 38.15 55.83 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.542 ' CD2' ' C ' ' A' ' 314' ' ' GLY . 3.6 m-85 67.89 34.65 4.16 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.629 -0.924 . . . . 0.0 109.279 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 4.9 mm-40 57.52 41.71 25.48 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.241 -0.912 . . . . 0.0 108.614 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.575 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 1.6 tpp180 -68.71 -86.89 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.432 0.634 . . . . 0.0 110.784 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.575 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 5.4 mt-10 -127.04 66.15 1.29 Allowed 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.637 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.988 HD13 ' HB2' ' A' ' 313' ' ' SER . 1.5 mp -111.48 120.77 62.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 358' ' ' VAL . 24.0 tt0 -88.33 100.45 13.03 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.343 -0.848 . . . . 0.0 109.79 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 20.7 p -88.46 122.98 32.53 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.52 0.676 . . . . 0.0 110.903 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -144.55 78.94 1.59 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' ' 302' ' ' ASN . 1.7 mp -90.29 164.77 14.24 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 110.125 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 323' ' ' LEU . 5.2 t80 -43.24 136.76 2.95 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.631 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -83.14 51.57 3.68 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.94 1.495 . . . . 0.0 111.232 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . -165.73 -87.77 0.07 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.3 m -178.54 105.26 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.613 -0.933 . . . . 0.0 108.98 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 329' ' ' GLU . 2.0 mt -74.17 -179.69 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 O-C-N 121.404 -0.81 . . . . 0.0 110.006 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.656 ' H ' HG22 ' A' ' 328' ' ' ILE . 3.2 mt-10 -170.82 105.63 0.26 Allowed 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.585 0.707 . . . . 0.0 110.601 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.983 HG11 ' HB3' ' A' ' 367' ' ' ALA . 25.4 m -139.23 154.24 25.13 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.302 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.6 OUTLIER -71.7 92.35 1.18 Allowed 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.698 ' HE1' HG21 ' A' ' 304' ' ' VAL . 10.0 tmm? -143.07 158.24 43.78 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.108 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.617 ' CE1' ' HB2' ' A' ' 335' ' ' LEU . 9.9 t-160 -100.42 121.24 53.95 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 338' ' ' LYS . 38.6 Cg_endo -64.77 -18.81 63.62 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.628 1.33 . . . . 0.0 109.697 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.617 ' HB2' ' CE1' ' A' ' 333' ' ' HIS . 0.6 OUTLIER -81.23 -80.01 0.15 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.618 -0.676 . . . . 0.0 110.692 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 333' ' ' HIS . 96.9 p -44.37 -43.06 7.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.39 -0.819 . . . . 0.0 110.178 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.601 HD11 ' CE1' ' A' ' 416' ' ' HIS . 1.2 mm -66.32 -40.95 88.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.811 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 334' ' ' PRO . 0.0 OUTLIER -45.45 -38.4 6.08 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -44.39 67.79 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.108 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.911 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -54.63 -47.99 72.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.61 -0.681 . . . . 0.0 111.089 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.806 ' CG1' HG11 ' A' ' 308' ' ' VAL . 33.3 t -75.62 -28.08 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.132 -0.98 . . . . 0.0 110.403 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.54 -19.89 63.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 110.117 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -88.85 -19.83 25.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 110.311 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.4 mtt -82.59 -44.78 15.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.243 -0.911 . . . . 0.0 110.373 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 346' ' ' VAL . 6.9 p -69.84 -42.82 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.555 ' N ' HG13 ' A' ' 345' ' ' VAL . 19.4 t -52.05 -19.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.102 -0.999 . . . . 0.0 110.569 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -67.12 -46.4 74.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.193 -0.942 . . . . 0.0 110.635 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 356' ' ' ILE . . . -88.78 -19.72 25.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.212 -0.93 . . . . 0.0 110.656 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -69.3 -27.16 65.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.159 -0.963 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 350' ' ' ARG . 0.0 OUTLIER -83.3 -37.09 23.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 110.123 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.85 -67.44 0.84 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.878 . . . . 0.0 110.188 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 65.34 52.98 35.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -106.3 -1.94 22.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -1.153 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -145.08 -84.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.643 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -172.7 148.81 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -1.11 . . . . 0.0 109.875 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.528 HD12 HG13 ' A' ' 319' ' ' ILE . 1.0 OUTLIER -109.8 153.34 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.869 . . . . 0.0 109.528 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.643 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.1 OUTLIER -144.5 114.69 7.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.986 . . . . 0.0 110.745 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.719 HG23 HG23 ' A' ' 319' ' ' ILE . 55.3 t -109.72 138.64 36.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.553 ' HA ' HD12 ' A' ' 323' ' ' LEU . 97.7 p -161.18 173.96 14.35 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 120.502 -1.374 . . . . 0.0 111.507 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.524 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 6.4 p -155.04 131.3 10.33 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.488 0.661 . . . . 0.0 109.826 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.503 ' O ' ' HB ' ' A' ' 362' ' ' THR . . . -129.91 -172.47 13.16 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 107.986 -2.046 . . . . 0.0 107.986 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.652 HG21 HG23 ' A' ' 328' ' ' ILE . 0.6 OUTLIER 175.96 176.26 0.25 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.867 -1.372 . . . . 0.0 111.546 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.532 ' OE1' ' CD ' ' A' ' 364' ' ' PRO . 33.3 mm-40 -141.54 175.24 3.14 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.532 ' CD ' ' OE1' ' A' ' 363' ' ' GLU . 47.3 Cg_endo -77.25 26.01 0.46 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.336 1.177 . . . . 0.0 111.388 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 366' ' ' ARG . 21.3 p-10 -170.19 24.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.065 -1.022 . . . . 0.0 110.202 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.542 ' HB3' ' O ' ' A' ' 365' ' ' ASN . 8.1 ptt180 162.46 109.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.789 -0.569 . . . . 0.0 110.248 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.983 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -100.45 168.9 9.45 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.194 -0.941 . . . . 0.0 109.085 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.688 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 34.8 p-90 -170.98 153.16 3.73 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.587 -1.321 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 434' ' ' ALA . 54.4 p90 -121.81 157.15 31.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.175 -0.953 . . . . 0.0 108.638 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.542 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 5.8 tt0 -141.8 159.39 42.33 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.829 -1.17 . . . . 0.0 111.835 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.542 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 96.8 t -137.83 135.73 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.526 ' HB3' ' NH1' ' A' ' 427' ' ' ARG . 18.1 mt-10 -131.21 158.08 41.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.835 -1.165 . . . . 0.0 111.041 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 430' ' ' LEU . 27.1 t0 -150.58 142.81 24.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.436 -0.79 . . . . 0.0 109.782 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.65 2.0 20.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.219 -0.926 . . . . 0.0 110.297 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . 0.421 ' O ' ' HA3' ' A' ' 429' ' ' GLY . . . -65.53 -175.15 5.28 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.09 145.69 44.98 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.942 1.496 . . . . 0.0 110.642 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . 0.813 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -63.67 -140.34 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.813 HD13 ' C ' ' A' ' 377' ' ' GLY . 0.0 OUTLIER -116.75 118.95 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.147 -1.208 . . . . 0.0 109.957 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 382' ' ' GLN . . . -43.26 161.64 0.19 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.281 -0.887 . . . . 0.0 110.296 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.38 -24.14 16.8 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.939 1.494 . . . . 0.0 110.028 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -88.67 -21.49 23.91 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.392 -0.818 . . . . 0.0 109.876 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.524 ' OE1' " O2'" ' A' ' 451' ' ' ANP . 0.0 OUTLIER -86.17 -30.33 22.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -22.21 66.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.612 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.08 -20.84 63.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.603 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -92.42 21.02 5.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.472 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 1.031 HD22 HD21 ' A' ' 422' ' ' LEU . 8.5 mt -137.06 95.87 3.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.582 ' CB ' ' O ' ' A' ' 386' ' ' LEU . 13.5 m-85 86.73 72.51 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.769 0.795 . . . . 0.0 109.332 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -40.74 98.57 0.18 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.731 -0.606 . . . . 0.0 111.286 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 387' ' ' PHE . 48.2 Cg_endo -91.1 148.45 3.73 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.995 1.524 . . . . 0.0 109.851 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.85 -173.87 3.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.017 -1.052 . . . . 0.0 110.406 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.547 HG12 ' N ' ' A' ' 392' ' ' ARG . 39.0 t -94.07 172.72 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.278 -0.889 . . . . 0.0 111.022 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . 0.547 ' N ' HG12 ' A' ' 391' ' ' VAL . 0.0 OUTLIER -46.46 -68.41 0.2 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.38 -0.825 . . . . 0.0 110.148 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 394' ' ' ASP . . . 174.8 156.71 14.61 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.411 ' CG ' ' O ' ' A' ' 393' ' ' GLY . 12.9 m-20 -156.6 179.82 8.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.25 -1.147 . . . . 0.0 110.433 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 396' ' ' ALA . 1.4 m -72.61 148.81 44.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.305 -0.872 . . . . 0.0 110.268 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 395' ' ' SER . . . 54.91 106.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.314 -0.867 . . . . 0.0 110.047 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.42 138.76 29.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.259 -0.901 . . . . 0.0 110.393 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.47 ' O ' ' HB ' ' A' ' 399' ' ' ILE . 11.6 m -95.1 -10.81 29.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.308 -0.87 . . . . 0.0 110.04 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 398' ' ' THR . 31.1 mt 58.79 146.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 110.175 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.94 122.77 48.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.067 -1.021 . . . . 0.0 110.42 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -85.04 -158.99 30.4 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.0 m -69.29 154.16 42.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -1.195 . . . . 0.0 109.832 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -119.0 155.62 15.98 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.26 114.65 3.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -1.16 . . . . 0.0 110.339 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -140.54 -36.78 0.11 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -171.07 28.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -1.18 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.623 ' O ' HD13 ' A' ' 408' ' ' ILE . . . -74.3 129.77 38.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.168 -0.957 . . . . 0.0 110.367 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 407' ' ' ALA . 21.7 mm -124.35 -8.46 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.34 -0.85 . . . . 0.0 109.779 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.547 ' HA ' HG13 ' A' ' 412' ' ' ILE . 14.7 p -116.45 -9.46 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.53 -0.731 . . . . 0.0 109.989 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 7.3 tt0 -68.53 -62.39 1.41 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.297 -0.877 . . . . 0.0 110.315 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -19.99 6.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.241 -0.912 . . . . 0.0 110.497 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.911 HG21 ' HB2' ' A' ' 340' ' ' ALA . 24.7 mm -66.0 -69.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.105 -0.997 . . . . 0.0 108.984 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 420' ' ' LEU . 69.6 t -62.18 -20.72 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 109.437 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 2.8 t70 -79.14 -26.48 42.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.469 -0.769 . . . . 0.0 109.85 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.541 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 22.7 m-20 -84.0 -22.93 31.19 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.313 -0.867 . . . . 0.0 109.292 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.601 ' CE1' HD11 ' A' ' 337' ' ' ILE . 41.4 m80 -93.18 -26.16 17.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.504 -0.747 . . . . 0.0 109.686 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.57 ' HB2' ' O ' ' A' ' 416' ' ' HIS . 4.2 m120 66.03 59.27 0.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.687 0.756 . . . . 0.0 110.889 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.559 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -128.29 -84.04 0.42 Allowed Glycine 0 N--CA 1.481 1.656 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.569 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.1 OUTLIER -179.07 155.98 0.76 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -1.129 . . . . 0.0 112.011 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.826 ' HB2' HG21 ' A' ' 413' ' ' VAL . 15.7 tp -152.76 92.83 1.69 Allowed 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.458 -0.776 . . . . 0.0 108.995 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 432' ' ' ILE . 0.2 OUTLIER -115.22 123.43 48.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.007 -1.058 . . . . 0.0 110.969 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 1.031 HD21 HD22 ' A' ' 386' ' ' LEU . 0.8 OUTLIER -126.5 140.01 52.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.154 -0.966 . . . . 0.0 110.098 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.43 ' HA2' HG13 ' A' ' 378' ' ' ILE . . . 175.46 -169.76 42.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 429' ' ' GLY . 44.3 m -78.97 154.95 29.16 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.297 -1.119 . . . . 0.0 110.003 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.569 ' HB2' ' CB ' ' A' ' 431' ' ' SER . 1.8 m -133.42 170.41 15.52 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -49.42 -39.67 33.59 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 120.853 0.358 . . . . 0.0 110.714 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 427' ' ' ARG . 6.8 ptp180 -39.69 -33.19 0.17 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.909 0.861 . . . . 0.0 109.334 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 426' ' ' GLU . . . 106.07 39.78 2.08 Favored Glycine 0 C--N 1.293 -1.822 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 424' ' ' THR . . . 174.91 -145.85 8.13 Favored Glycine 0 N--CA 1.503 3.109 0 C-N-CA 118.014 -2.041 . . . . 0.0 112.54 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.996 HD13 ' N ' ' A' ' 431' ' ' SER . 0.9 OUTLIER -66.98 140.06 57.71 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 121.914 0.864 . . . . 0.0 113.008 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.996 ' N ' HD13 ' A' ' 430' ' ' LEU . 29.4 t -167.02 112.18 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.492 HG13 ' CA ' ' A' ' 422' ' ' LEU . 15.6 tt -125.83 157.33 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.162 -0.961 . . . . 0.0 110.567 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.73 127.35 18.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.405 -0.81 . . . . 0.0 109.928 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 369' ' ' PHE . . . -109.69 147.27 33.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.271 -0.893 . . . . 0.0 110.129 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.688 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 78.3 m95 -124.22 155.91 37.73 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.398 1.094 . . . . 0.0 113.246 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.653 HD12 HD11 ' A' ' 301' ' ' LEU . 19.0 mt -145.38 94.8 5.14 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.559 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 42.6 Cg_endo -67.19 146.17 75.21 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 123.966 1.509 . . . . 0.0 112.896 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 10.8 t -107.3 98.0 21.18 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.836 -0.54 . . . . 0.0 110.379 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 440' ' ' VAL . 49.6 Cg_endo -89.18 -172.02 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.78 1.411 . . . . 0.0 111.577 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.692 ' O ' HG13 ' A' ' 440' ' ' VAL . 4.6 p 29.07 111.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 441' ' ' THR . 14.7 t -176.09 48.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 443' ' ' ALA . 0.2 OUTLIER -132.68 -49.78 0.9 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.913 -1.117 . . . . 0.0 110.903 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 444' ' ' GLN . . . -44.26 170.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.074 -1.016 . . . . 0.0 110.815 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 443' ' ' ALA . 14.2 mm100 59.66 78.71 0.26 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.559 -0.713 . . . . 0.0 110.54 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . 0.932 ' O ' HG22 ' A' ' 446' ' ' THR . . . -126.56 -32.84 0.69 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.932 HG22 ' O ' ' A' ' 445' ' ' GLY . 1.4 t 53.61 141.08 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.688 0.756 . . . . 0.0 111.181 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 446' ' ' THR . 2.0 t 178.1 55.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.216 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -77.84 -29.7 50.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.296 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 450' ' ' GLY . 4.6 tt0 -159.91 -37.13 0.05 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.321 -0.862 . . . . 0.0 110.246 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 449' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.404 0 CA-C-O 118.027 -1.429 . . . . 0.0 109.593 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.607 " O5'" HD21 ' A' ' 386' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.19 0.519 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 86.97 -57.68 4.61 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -114.62 174.88 5.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.382 -1.069 . . . . 0.0 109.765 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.4 54.52 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.055 -1.028 . . . . 0.0 110.647 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.553 ' N ' ' HD3' ' A' ' 295' ' ' PRO . 3.3 mtt -145.95 62.51 8.35 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.039 . . . . 0.0 110.827 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.643 ' HG2' ' CE1' ' A' ' 333' ' ' HIS . 54.7 Cg_endo -89.89 58.44 1.78 Allowed 'Trans proline' 0 C--N 1.3 -1.974 0 O-C-N 124.095 1.576 . . . . 0.0 110.188 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.642 ' HE3' ' HB3' ' A' ' 415' ' ' ASN . 0.2 OUTLIER -81.84 108.79 15.65 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 122.216 1.008 . . . . 0.0 109.239 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.646 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 20.3 mt-10 -133.71 -155.71 0.69 Allowed 'General case' 0 C--N 1.275 -2.669 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.221 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.06 139.06 30.89 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 111.037 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.812 ' HB3' ' HG3' ' A' ' 332' ' ' MET . . . -155.69 160.09 40.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.576 -0.703 . . . . 0.0 110.523 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.668 ' O ' HG23 ' A' ' 304' ' ' VAL . 0.6 OUTLIER -103.86 114.84 29.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 110.382 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.645 HD11 HD12 ' A' ' 436' ' ' LEU . 7.5 mt -59.92 -25.13 64.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.265 -0.897 . . . . 0.0 109.831 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.688 ' HA ' HD23 ' A' ' 323' ' ' LEU . 42.3 t-20 -82.18 -21.53 36.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.939 -1.1 . . . . 0.0 109.356 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -87.52 -27.54 22.56 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.604 0.716 . . . . 0.0 109.474 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 300' ' ' ASP . 28.5 t -82.89 -37.05 13.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 121.582 0.706 . . . . 0.0 109.168 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.552 ' CD2' HG21 ' A' ' 341' ' ' VAL . 86.1 mt -79.72 -31.11 41.09 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.475 -0.766 . . . . 0.0 110.117 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -66.95 -26.73 73.23 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -84.44 -33.52 23.65 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.419 -1.048 . . . . 0.0 109.782 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.949 HG11 ' CG1' ' A' ' 341' ' ' VAL . 78.6 t -75.2 -25.42 18.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.395 -0.816 . . . . 0.0 109.469 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.976 HD11 ' CG1' ' A' ' 358' ' ' VAL . 1.6 mt -79.56 -43.45 23.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.734 0.778 . . . . 0.0 108.941 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.2 -17.3 62.52 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.73 0.776 . . . . 0.0 109.048 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -85.7 -45.62 11.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.657 -0.652 . . . . 0.0 110.67 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 342' ' ' ALA . 8.6 mt-10 -99.34 28.68 4.38 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.115 -0.991 . . . . 0.0 110.599 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.474 ' O ' ' OG ' ' A' ' 313' ' ' SER . 1.6 t -97.48 38.08 1.3 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.254 -0.904 . . . . 0.0 109.93 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . -99.18 -74.77 1.16 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.45 ' O ' ' CG ' ' A' ' 316' ' ' GLU . 2.7 t80 -93.32 25.78 3.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -1.094 . . . . 0.0 108.689 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.641 ' O ' HD11 ' A' ' 319' ' ' ILE . 48.5 mm-40 -160.03 38.21 0.18 Allowed 'General case' 0 C--O 1.192 -1.966 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.471 ' HA ' ' CD1' ' A' ' 319' ' ' ILE . 0.1 OUTLIER -69.52 -0.99 7.46 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 121.422 0.63 . . . . 0.0 110.002 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.05 33.92 0.45 Allowed 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.918 0.866 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.726 ' CG2' HG23 ' A' ' 358' ' ' VAL . 0.7 OUTLIER -89.15 134.86 27.35 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.484 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -95.87 110.32 22.52 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.012 -1.055 . . . . 0.0 109.119 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.928 HG22 HD13 ' A' ' 309' ' ' ILE . 10.8 p -89.52 123.28 33.48 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.351 -0.843 . . . . 0.0 111.675 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -146.84 78.41 1.49 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.688 HD23 ' HA ' ' A' ' 302' ' ' ASN . 5.2 mp -93.93 154.85 17.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.418 -0.801 . . . . 0.0 110.78 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.595 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 79.0 t80 -46.75 132.26 8.43 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.425 -0.797 . . . . 0.0 110.215 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.478 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 46.5 Cg_endo -72.71 78.91 1.99 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.952 1.501 . . . . 0.0 110.318 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 327' ' ' SER . . . 167.66 7.89 0.03 OUTLIER Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.804 -1.189 . . . . 0.0 111.177 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 326' ' ' GLY . 0.5 OUTLIER 63.38 116.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 O-C-N 120.555 -1.556 . . . . 0.0 109.57 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 329' ' ' GLU . 4.1 mm -69.23 179.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.734 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.63 ' H ' HG22 ' A' ' 328' ' ' ILE . 1.9 mt-10 -175.49 104.47 0.08 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.609 0.719 . . . . 0.0 110.674 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.839 HG23 ' HG2' ' A' ' 332' ' ' MET . 13.7 m -150.09 172.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 O-C-N 121.702 -0.624 . . . . 0.0 110.323 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.646 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -86.22 93.58 9.09 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 119.384 -0.927 . . . . 0.0 108.664 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.839 ' HG2' HG23 ' A' ' 330' ' ' VAL . 11.7 ptm -144.58 166.27 25.64 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.356 -0.84 . . . . 0.0 110.568 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.643 ' CE1' ' HG2' ' A' ' 295' ' ' PRO . 19.1 t-160 -92.18 112.22 54.03 Favored Pre-proline 0 C--N 1.297 -1.698 0 O-C-N 121.523 -0.736 . . . . 0.0 109.46 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 41.4 Cg_endo -66.39 -23.62 50.89 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.825 1.434 . . . . 0.0 111.128 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.584 HD12 ' C ' ' A' ' 335' ' ' LEU . 1.1 tp -81.99 -62.16 1.71 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.951 -1.093 . . . . 0.0 109.817 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.509 ' OG ' HG13 ' A' ' 412' ' ' ILE . 14.7 t -53.65 -42.94 68.37 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.109 -0.995 . . . . 0.0 109.374 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.868 HD11 ' CE1' ' A' ' 416' ' ' HIS . 20.5 mm -60.34 -45.71 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.195 -0.941 . . . . 0.0 109.121 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.538 ' HG3' HG13 ' A' ' 304' ' ' VAL . 20.8 mttm -46.19 -50.25 15.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.0 108.611 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.05 -44.15 78.57 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.544 0.688 . . . . 0.0 110.056 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.572 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -54.34 -29.18 47.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.407 -0.808 . . . . 0.0 111.022 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.949 ' CG1' HG11 ' A' ' 308' ' ' VAL . 66.3 t -88.76 -43.9 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.079 -1.013 . . . . 0.0 111.24 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.832 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -54.4 -38.93 66.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.125 -0.984 . . . . 0.0 110.844 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . 0.483 ' ND2' HD11 ' A' ' 408' ' ' ILE . 0.8 OUTLIER -81.88 -34.6 29.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -0.965 . . . . 0.0 110.666 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 340' ' ' ALA . 0.0 OUTLIER -65.73 -28.17 68.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 342' ' ' ALA . 7.7 p -88.53 -22.89 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.013 . . . . 0.0 110.606 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 342' ' ' ALA . 89.3 t -76.31 -22.03 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.161 -0.962 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.458 ' CG ' ' O2A' ' A' ' 451' ' ' ANP . 12.1 t30 -69.72 -41.21 75.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.158 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 352' ' ' GLY . . . -79.7 -19.9 47.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.36 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.28 -34.43 25.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.486 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -80.2 -63.7 1.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.625 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -21.72 33.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.13 -0.981 . . . . 0.0 110.894 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 353' ' ' ASN . . . -109.46 176.24 19.4 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.067 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 352' ' ' GLY . 27.1 p-10 -178.62 42.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.537 -0.978 . . . . 0.0 109.808 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 355' ' ' TRP . . . -131.38 78.32 0.38 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.465 ' HB3' ' O ' ' A' ' 354' ' ' GLY . 9.9 t90 58.49 138.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -1.076 . . . . 0.0 111.043 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.526 ' CD1' ' OE1' ' A' ' 316' ' ' GLU . 6.5 mt -126.3 164.44 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.484 ' HG2' ' HB3' ' A' ' 320' ' ' GLU . 11.9 tttt -144.38 132.5 21.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.586 -1.321 . . . . 0.0 112.351 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.976 ' CG1' HD11 ' A' ' 309' ' ' ILE . 98.9 t -125.54 93.14 2.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . . . . . . . . . 12.8 t -120.84 160.38 23.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 111.145 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.557 ' CB ' ' HG ' ' A' ' 323' ' ' LEU . 1.0 OUTLIER -141.68 157.16 45.41 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.569 -0.707 . . . . 0.0 109.469 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 324' ' ' TYR . . . -146.75 -164.54 11.11 Favored Glycine 0 C--N 1.293 -1.841 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 367' ' ' ALA . 0.1 OUTLIER -171.14 178.96 3.18 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.871 -1.37 . . . . 0.0 111.233 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 366' ' ' ARG . 6.2 mt-10 -154.23 177.69 1.9 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.587 -0.695 . . . . 0.0 109.823 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 40.9 Cg_endo -67.74 107.87 1.55 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.707 1.372 . . . . 0.0 110.763 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 366' ' ' ARG . 4.8 t-20 68.77 31.16 4.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.409 -0.807 . . . . 0.0 110.531 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 3.6 mtt180 -176.31 109.4 0.09 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.55 -0.719 . . . . 0.0 109.787 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.792 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -113.06 161.12 17.44 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.954 -1.091 . . . . 0.0 110.096 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.6 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 22.3 p-90 -153.74 171.56 18.68 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.927 -1.108 . . . . 0.0 110.886 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.438 ' HB3' HD13 ' A' ' 301' ' ' LEU . 14.4 p90 -150.54 144.65 25.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.529 -0.732 . . . . 0.0 109.225 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.465 ' NE2' ' HG2' ' A' ' 433' ' ' ARG . 5.2 pt20 -142.38 163.56 32.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.908 -1.12 . . . . 0.0 111.344 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.471 ' O ' ' HG3' ' A' ' 372' ' ' GLU . 17.6 t -128.6 152.83 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.55 -0.719 . . . . 0.0 109.802 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 371' ' ' VAL . 1.6 mt-10 -140.23 130.69 25.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.403 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -141.26 150.73 42.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.038 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.69 120.83 43.61 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.198 -0.939 . . . . 0.0 110.762 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -175.59 -107.37 0.21 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.34 -171.08 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.938 1.494 . . . . 0.0 111.186 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . 0.687 ' C ' HD13 ' A' ' 378' ' ' ILE . . . -155.62 -178.8 30.18 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.866 HG23 " H1'" ' A' ' 451' ' ' ANP . 0.7 OUTLIER -107.31 -154.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.039 -1.271 . . . . 0.0 110.691 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 383' ' ' ARG . . . -155.8 161.11 30.17 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.85 -20.72 22.11 Favored 'Trans proline' 0 C--N 1.289 -2.554 0 O-C-N 123.704 1.37 . . . . 0.0 110.963 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.94 -36.75 13.26 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.948 -1.095 . . . . 0.0 111.738 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.638 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 15.3 pt20 -89.65 -30.34 18.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.019 -1.051 . . . . 0.0 111.824 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 379' ' ' ALA . 19.9 ttt-85 -56.12 -18.87 11.1 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.756 -1.215 . . . . 0.0 109.841 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.97 -31.02 39.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.288 -0.883 . . . . 0.0 110.941 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.638 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 5.2 p80 -112.47 1.31 15.86 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.97 -1.081 . . . . 0.0 111.201 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 386' ' ' LEU . 2.1 tt -95.86 15.07 21.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.158 -0.964 . . . . 0.0 110.173 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 386' ' ' LEU . 0.2 OUTLIER -172.61 47.75 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.417 -0.802 . . . . 0.0 109.949 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -99.52 142.48 24.69 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.407 -0.808 . . . . 0.0 110.011 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 390' ' ' PHE . 48.2 Cg_endo -76.98 -175.4 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.021 1.537 . . . . 0.0 110.735 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 389' ' ' PRO . 1.1 t80 60.4 131.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.429 -0.794 . . . . 0.0 110.82 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.414 ' H ' HG12 ' A' ' 391' ' ' VAL . 3.2 p -73.82 137.98 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.954 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.98 129.36 55.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.144 -0.973 . . . . 0.0 110.441 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 175.45 84.02 0.06 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.74 82.59 6.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.201 -1.176 . . . . 0.0 110.114 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 397' ' ' ARG . 0.7 OUTLIER -143.72 172.87 12.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.329 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 397' ' ' ARG . . . 42.75 -94.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 110.343 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 395' ' ' SER . 0.2 OUTLIER 41.32 79.03 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.223 -0.923 . . . . 0.0 110.505 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.577 HG23 ' N ' ' A' ' 399' ' ' ILE . 6.0 t -155.2 -43.57 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.906 . . . . 0.0 109.942 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.577 ' N ' HG23 ' A' ' 398' ' ' THR . 19.2 mm -128.07 -69.38 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.383 -0.823 . . . . 0.0 110.107 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.57 ' OG ' HG22 ' A' ' 399' ' ' ILE . 2.8 p -161.85 92.48 0.86 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.206 -0.934 . . . . 0.0 110.082 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -94.57 -141.05 11.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.03 -63.18 0.17 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.302 -1.116 . . . . 0.0 110.049 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 66.96 92.56 0.04 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 34.0 mt -124.56 -166.32 1.5 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.414 -1.05 . . . . 0.0 109.666 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -168.18 -172.85 35.58 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.493 -1.337 . . . . 0.0 109.931 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 18.7 mt -115.27 34.51 4.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.472 -1.017 . . . . 0.0 109.963 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -81.89 94.45 7.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.481 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.598 ' O ' HD12 ' A' ' 408' ' ' ILE . 1.9 pp -102.82 30.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.309 -0.87 . . . . 0.0 109.84 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 412' ' ' ILE . 6.0 p -143.04 -36.32 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 109.809 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.441 ' N ' HG13 ' A' ' 409' ' ' VAL . 14.8 tt0 -69.8 -51.55 32.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.093 -1.004 . . . . 0.0 109.707 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.471 ' HA ' ' HB3' ' A' ' 414' ' ' ASP . 29.1 mmt180 -56.17 -19.06 11.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.297 -0.877 . . . . 0.0 109.88 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.719 HG22 ' N ' ' A' ' 413' ' ' VAL . 0.8 OUTLIER -65.42 -63.31 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.948 . . . . 0.0 108.817 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.779 HG11 ' HB2' ' A' ' 420' ' ' LEU . 7.0 t -67.13 -22.04 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.15 -0.969 . . . . 0.0 109.196 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 8.3 t70 -76.26 -27.93 56.88 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.671 -0.643 . . . . 0.0 109.648 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.642 ' HB3' ' HE3' ' A' ' 296' ' ' MET . 0.3 OUTLIER -79.67 -12.36 59.82 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.386 -0.821 . . . . 0.0 109.322 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.868 ' CE1' HD11 ' A' ' 337' ' ' ILE . 30.1 m80 -97.2 -29.42 13.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.544 -0.722 . . . . 0.0 109.649 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.1 t-20 77.93 13.77 1.67 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.69 -0.631 . . . . 0.0 110.483 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.575 ' HA2' ' CD ' ' A' ' 437' ' ' PRO . . . -82.48 -87.87 0.72 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.684 ' O ' HG11 ' A' ' 413' ' ' VAL . 37.2 ttm -176.94 158.57 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -1.194 . . . . 0.0 111.338 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.779 ' HB2' HG11 ' A' ' 413' ' ' VAL . 27.4 tp -152.57 98.79 2.4 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.181 -0.949 . . . . 0.0 109.059 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -126.31 167.8 15.01 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.75 -1.219 . . . . 0.0 112.511 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.682 HD21 ' H2 ' ' A' ' 451' ' ' ANP . 35.0 mt -89.95 141.24 28.84 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.226 0.536 . . . . 0.0 109.962 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 431' ' ' SER . . . -108.38 163.92 12.76 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 1.001 HG23 ' HA2' ' A' ' 428' ' ' GLY . 20.8 m -138.27 131.36 30.03 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.293 -1.122 . . . . 0.0 109.948 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.447 ' H ' ' N ' ' A' ' 429' ' ' GLY . 2.6 m -116.4 96.85 5.72 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.256 -0.903 . . . . 0.0 110.27 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 428' ' ' GLY . 20.7 tt0 52.63 -106.82 0.31 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.222 -0.924 . . . . 0.0 109.991 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.475 ' HD3' ' N ' ' A' ' 428' ' ' GLY . 0.0 OUTLIER -42.4 -27.52 0.16 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.823 -1.173 . . . . 0.0 109.926 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 1.001 ' HA2' HG23 ' A' ' 424' ' ' THR . . . 126.79 26.85 1.09 Allowed Glycine 0 C--N 1.291 -1.928 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.447 ' N ' ' H ' ' A' ' 425' ' ' SER . . . -40.78 142.73 0.74 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.762 HD12 ' C6 ' ' A' ' 451' ' ' ANP . 3.5 mm? -86.17 111.05 20.02 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.301 -1.117 . . . . 0.0 110.653 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 423' ' ' GLY . 17.7 m -125.49 102.24 7.3 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.89 122.46 40.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.966 -1.083 . . . . 0.0 111.208 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . 0.465 ' HG2' ' NE2' ' A' ' 370' ' ' GLN . 12.2 mtt180 -107.75 116.1 31.34 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.535 0.683 . . . . 0.0 110.276 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.407 ' HB3' ' CE2' ' A' ' 369' ' ' PHE . . . -108.0 129.27 55.13 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.6 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 82.5 m95 -103.12 153.75 20.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.882 -1.136 . . . . 0.0 112.064 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.645 HD12 HD11 ' A' ' 301' ' ' LEU . 14.7 mt -143.91 81.84 11.52 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.575 ' CD ' ' HA2' ' A' ' 418' ' ' GLY . 45.6 Cg_endo -70.55 133.6 24.48 Favored 'Trans proline' 0 C--N 1.298 -2.112 0 O-C-N 124.02 1.537 . . . . 0.0 111.737 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.514 HG22 ' HB ' ' A' ' 330' ' ' VAL . 5.8 t -92.4 120.94 67.26 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.587 -0.695 . . . . 0.0 109.903 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.46 -168.6 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.742 1.391 . . . . 0.0 109.903 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 440' ' ' VAL . 6.5 p -130.61 132.31 64.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 O-C-N 121.665 -0.647 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 442' ' ' ARG . 17.0 p -122.84 126.58 47.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.283 -0.885 . . . . 0.0 110.052 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 441' ' ' THR . 0.1 OUTLIER 168.91 38.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.206 -0.933 . . . . 0.0 110.217 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -94.92 -44.02 7.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.134 -0.979 . . . . 0.0 110.246 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -146.75 158.03 43.82 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.202 -0.937 . . . . 0.0 110.323 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -163.56 111.14 0.46 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . . . . . . . . . 30.0 p -126.06 172.43 9.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -1.19 . . . . 0.0 110.014 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 447' ' ' THR . 7.9 t -151.26 98.29 2.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.207 -0.933 . . . . 0.0 110.286 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -127.34 -54.27 1.36 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.396 -0.815 . . . . 0.0 110.105 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -47.07 111.98 0.47 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.418 -0.801 . . . . 0.0 110.422 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.866 " H1'" HG23 ' A' ' 378' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 290' ' ' THR . 13.9 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.316 0.579 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -163.91 36.37 0.3 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -122.79 140.06 53.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.419 -1.048 . . . . 0.0 110.448 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -84.99 84.3 7.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.898 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.03 166.09 31.74 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.307 -0.871 . . . . 0.0 110.279 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.606 ' HB2' ' CD2' ' A' ' 333' ' ' HIS . 47.6 Cg_endo -90.08 -158.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.087 1.572 . . . . 0.0 109.887 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.55 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 43.6 79.94 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 122.638 1.209 . . . . 0.0 109.479 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.708 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 0.7 OUTLIER -146.31 -147.53 0.22 Allowed 'General case' 0 C--N 1.264 -3.145 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.836 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.518 ' HE2' ' C ' ' A' ' 330' ' ' VAL . 0.4 OUTLIER -85.87 127.76 34.66 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.07 -1.019 . . . . 0.0 110.716 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -143.32 159.32 42.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.466 0.65 . . . . 0.0 110.996 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.652 ' HB2' ' HB3' ' A' ' 303' ' ' ALA . 7.6 m-20 -91.13 108.55 19.95 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.935 HD11 HD12 ' A' ' 436' ' ' LEU . 2.5 mt -57.83 -30.25 65.59 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.276 -0.89 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 303' ' ' ALA . 53.1 p-10 -79.53 -19.87 48.51 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.845 -1.159 . . . . 0.0 109.883 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.652 ' HB3' ' HB2' ' A' ' 300' ' ' ASP . . . -84.12 -27.95 27.81 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.377 -0.827 . . . . 0.0 109.103 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.535 HG13 ' HD3' ' A' ' 338' ' ' LYS . 62.3 t -81.04 -38.51 16.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.786 0.803 . . . . 0.0 109.352 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.728 HD22 HG11 ' A' ' 341' ' ' VAL . 71.2 mt -77.1 -26.43 53.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 110.385 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -65.82 -31.16 78.87 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -83.0 -33.13 26.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -1.153 . . . . 0.0 109.628 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.504 HG11 ' HB ' ' A' ' 341' ' ' VAL . 58.9 t -78.32 -19.29 13.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.439 -0.788 . . . . 0.0 109.667 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.686 HD11 ' CG1' ' A' ' 358' ' ' VAL . 0.9 OUTLIER -83.57 -42.98 17.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.674 0.749 . . . . 0.0 109.259 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.84 -18.5 60.93 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.705 0.764 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.536 ' HB3' ' OE1' ' A' ' 312' ' ' GLU . . . -90.54 -55.1 3.71 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.753 0.787 . . . . 0.0 110.51 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.536 ' OE1' ' HB3' ' A' ' 311' ' ' ALA . 58.1 mp0 -104.48 50.65 0.79 Allowed 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.721 0.772 . . . . 0.0 109.206 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.584 ' HA ' HD13 ' A' ' 319' ' ' ILE . 0.3 OUTLIER -76.03 32.94 0.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.77 -0.581 . . . . 0.0 111.545 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 53.76 48.46 61.62 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 316' ' ' GLU . 1.7 t80 53.82 37.03 25.51 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.444 -1.033 . . . . 0.0 110.079 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 315' ' ' TYR . 5.5 mt-10 61.09 37.33 17.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.792 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.559 ' HG3' ' N ' ' A' ' 318' ' ' GLU . 19.7 tpp180 -69.05 -85.2 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.575 0.703 . . . . 0.0 109.667 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 317' ' ' ARG . 4.2 pt-20 -169.2 67.21 0.06 Allowed 'General case' 0 C--N 1.273 -2.718 0 O-C-N 121.538 -0.726 . . . . 0.0 110.526 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.692 HG23 HG23 ' A' ' 358' ' ' VAL . 1.8 mp -90.95 129.89 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 109.707 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -89.08 103.12 15.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.663 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 358' ' ' VAL . 18.3 p -88.81 123.81 33.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.419 -0.801 . . . . 0.0 111.094 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . 0.459 ' HB3' ' CB ' ' A' ' 359' ' ' SER . . . -146.55 79.09 1.52 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.539 HD12 ' H ' ' A' ' 360' ' ' SER . 5.8 mp -88.41 157.08 18.8 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.379 -0.825 . . . . 0.0 110.322 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.433 ' CD1' ' HD2' ' A' ' 325' ' ' PRO . 21.7 t80 -40.39 141.99 0.8 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.504 -0.747 . . . . 0.0 110.422 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.433 ' HD2' ' CD1' ' A' ' 324' ' ' TYR . 50.0 Cg_endo -83.07 60.32 7.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.04 1.547 . . . . 0.0 111.205 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 327' ' ' SER . . . -176.92 -75.25 0.05 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 326' ' ' GLY . 0.5 OUTLIER 165.05 116.57 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.581 -0.952 . . . . 0.0 108.932 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.536 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 2.7 mm -69.27 178.17 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 C-N-CA 119.204 -0.999 . . . . 0.0 109.061 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 328' ' ' ILE . 2.5 mt-10 -173.65 101.44 0.11 Allowed 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 121.469 0.652 . . . . 0.0 110.697 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 1.015 HG12 HG22 ' A' ' 438' ' ' VAL . 16.5 m -143.65 161.26 16.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.094 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.0 OUTLIER -81.13 92.4 6.27 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.596 ' SD ' HD12 ' A' ' 337' ' ' ILE . 22.0 ttp -144.79 153.99 42.23 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.712 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.606 ' CD2' ' HB2' ' A' ' 295' ' ' PRO . 7.3 t-160 -78.73 119.84 78.73 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.778 -0.577 . . . . 0.0 109.682 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.458 ' O ' ' HD3' ' A' ' 338' ' ' LYS . 43.5 Cg_endo -70.75 -21.16 29.24 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.662 1.348 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.742 HD12 ' C ' ' A' ' 335' ' ' LEU . 0.1 OUTLIER -84.52 -63.01 1.41 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.235 -0.916 . . . . 0.0 110.188 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 335' ' ' LEU . 3.1 m -52.78 -35.4 56.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.903 -1.123 . . . . 0.0 110.096 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.734 HD11 ' CE1' ' A' ' 416' ' ' HIS . 3.1 mm -73.93 -45.88 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.221 -0.924 . . . . 0.0 110.032 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.535 ' HD3' HG13 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -43.33 -44.32 5.47 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.13 -0.981 . . . . 0.0 109.197 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -49.9 59.77 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.522 0.677 . . . . 0.0 110.315 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.623 ' HB2' HG12 ' A' ' 412' ' ' ILE . . . -52.23 -30.91 29.7 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.301 -0.874 . . . . 0.0 111.674 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.728 HG11 HD22 ' A' ' 305' ' ' LEU . 40.9 t -89.94 -23.73 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.913 -1.117 . . . . 0.0 111.424 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.51 -24.81 60.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.002 -1.061 . . . . 0.0 111.137 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -90.16 -19.0 24.76 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.024 -1.047 . . . . 0.0 111.673 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 5.6 ttm -82.28 -25.42 34.04 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.917 -1.114 . . . . 0.0 112.196 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.448 HG22 ' H ' ' A' ' 345' ' ' VAL . 23.3 m -90.39 -32.39 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 120.685 -1.259 . . . . 0.0 111.869 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 312' ' ' GLU . 73.4 t -74.28 -21.14 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 120.971 -1.08 . . . . 0.0 110.79 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -79.95 -19.97 46.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.041 -1.037 . . . . 0.0 110.421 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.493 ' O ' ' HA3' ' A' ' 352' ' ' GLY . . . -89.92 -20.09 23.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.2 -0.937 . . . . 0.0 110.511 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -80.79 -21.31 41.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.096 -1.002 . . . . 0.0 110.773 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 346' ' ' VAL . 4.9 mmt180 -87.76 -70.09 0.65 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.091 -1.005 . . . . 0.0 110.535 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . 0.437 ' O ' ' C ' ' A' ' 352' ' ' GLY . 0.2 OUTLIER -77.43 -35.11 54.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 110.377 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 348' ' ' ALA . . . -42.41 -51.65 5.4 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 352' ' ' GLY . 36.4 m-20 43.27 50.1 5.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.296 -1.12 . . . . 0.0 110.356 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . . . . . . . . . . . -162.02 -80.74 0.04 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.044 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 0.1 OUTLIER -165.69 149.66 8.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.145 -1.209 . . . . 0.0 109.854 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.603 HD12 HG13 ' A' ' 319' ' ' ILE . 8.3 mt -114.41 165.67 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.218 -0.926 . . . . 0.0 110.73 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 0.4 OUTLIER -148.4 101.32 3.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.189 -0.944 . . . . 0.0 110.391 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.692 HG23 HG23 ' A' ' 319' ' ' ILE . 99.0 t -104.45 88.08 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.108 -0.995 . . . . 0.0 109.803 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 322' ' ' ALA . 53.2 p -115.01 134.99 54.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.086 -1.008 . . . . 0.0 110.932 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.539 ' H ' HD12 ' A' ' 323' ' ' LEU . 1.8 t -117.39 144.39 45.0 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.482 -0.761 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.599 ' C ' HG22 ' A' ' 362' ' ' THR . . . -140.66 -161.14 8.58 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.599 HG22 ' C ' ' A' ' 361' ' ' GLY . 0.0 OUTLIER 171.12 176.9 0.06 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.14 -1.212 . . . . 0.0 110.962 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.562 ' HB3' ' HD2' ' A' ' 364' ' ' PRO . 2.4 mt-10 -147.65 178.19 1.53 Allowed Pre-proline 0 C--N 1.296 -1.733 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 363' ' ' GLU . 46.0 Cg_endo -81.45 50.28 3.47 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.636 1.335 . . . . 0.0 109.791 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 365' ' ' ASN . 10.2 p-10 165.59 -3.7 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.795 -0.566 . . . . 0.0 111.266 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 365' ' ' ASN . 14.2 mtm-85 -166.18 109.37 0.77 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.118 -0.989 . . . . 0.0 110.976 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.715 ' HB3' HG11 ' A' ' 330' ' ' VAL . . . -103.19 162.08 13.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.103 -0.998 . . . . 0.0 108.765 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.66 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 31.3 p-90 -170.31 162.92 8.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.715 -1.24 . . . . 0.0 111.131 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 39.8 p90 -133.54 133.82 42.6 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -122.84 152.13 41.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 111.986 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 15.5 t -132.09 122.05 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.558 ' CG ' ' HB2' ' A' ' 431' ' ' SER . 2.3 mt-10 -116.75 139.34 50.68 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.0 110.395 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 373' ' ' ASP . 3.3 p30 -141.0 145.82 36.45 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.263 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -104.04 114.55 28.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.323 -0.861 . . . . 0.0 110.346 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -172.55 -109.84 0.23 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -80.1 -168.32 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.93 1.49 . . . . 0.0 110.532 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -141.72 -160.24 8.24 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 0.595 HG23 " H1'" ' A' ' 451' ' ' ANP . 3.0 mt -111.88 159.04 12.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.24 -1.153 . . . . 0.0 109.842 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' A' ' 380' ' ' PRO . . . -91.01 161.24 35.93 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.931 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 46.3 Cg_endo -72.77 -46.1 0.45 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.087 1.572 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . 0.518 ' O ' ' CE1' ' A' ' 385' ' ' HIS . 0.0 OUTLIER -73.17 -53.33 11.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.368 -0.833 . . . . 0.0 110.082 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.592 ' HA ' ' CD2' ' A' ' 385' ' ' HIS . 0.0 OUTLIER -56.08 -33.33 64.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.259 -0.9 . . . . 0.0 109.808 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -40.33 13.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.679 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -71.21 -41.3 70.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.501 -0.749 . . . . 0.0 109.422 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.592 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 1.2 p-80 -120.05 74.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.602 -0.686 . . . . 0.0 109.804 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.844 HD11 " O4'" ' A' ' 451' ' ' ANP . 0.4 OUTLIER -86.96 9.55 19.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.109 -0.994 . . . . 0.0 110.386 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 70.8 m-85 -161.35 21.67 0.12 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.296 0.569 . . . . 0.0 109.908 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.5 ' HA ' ' CD2' ' A' ' 404' ' ' LEU . 10.7 pt20 178.19 68.36 0.11 Allowed Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.433 -0.792 . . . . 0.0 110.408 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . 0.696 ' HD2' HD23 ' A' ' 404' ' ' LEU . 44.0 Cg_endo -71.49 105.49 1.76 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 O-C-N 124.021 1.537 . . . . 0.0 110.515 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . 0.527 ' C ' HG23 ' A' ' 391' ' ' VAL . 90.4 m-85 -67.08 -175.08 0.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.308 -0.87 . . . . 0.0 110.415 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.527 HG23 ' C ' ' A' ' 390' ' ' PHE . 41.6 t -150.2 92.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 110.103 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . . . . . . . . . 8.9 mmt-85 42.67 85.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.326 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 58.25 -135.8 51.53 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.77 86.29 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -1.155 . . . . 0.0 110.244 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 19.7 t -139.68 71.76 1.38 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.327 -0.858 . . . . 0.0 110.093 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . -131.67 115.63 16.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 110.417 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 9.3 mtp85 -74.72 130.23 39.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.154 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . 0.443 ' O ' ' HB ' ' A' ' 399' ' ' ILE . 1.8 p -53.8 169.63 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 0.0 110.149 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.502 HG22 ' N ' ' A' ' 400' ' ' SER . 3.6 mt 56.15 -93.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 110.245 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.502 ' N ' HG22 ' A' ' 399' ' ' ILE . 61.5 m 55.24 -170.24 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 0.0 110.254 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -74.59 -44.75 25.44 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 48.6 m -155.45 147.36 23.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.247 -1.149 . . . . 0.0 110.274 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . -105.76 -73.39 0.88 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . 0.696 HD23 ' HD2' ' A' ' 389' ' ' PRO . 1.4 mt -126.87 -46.81 1.54 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.156 -1.202 . . . . 0.0 110.215 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 133.42 -178.23 18.39 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.2 103.92 15.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -1.208 . . . . 0.0 110.352 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -109.32 156.38 20.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 109.989 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.72 ' O ' HD13 ' A' ' 412' ' ' ILE . 3.8 tp -155.4 27.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.21 -0.931 . . . . 0.0 110.155 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.584 ' HA ' HD13 ' A' ' 412' ' ' ILE . 8.8 p -126.73 -2.69 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.3 -0.875 . . . . 0.0 110.079 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 1.8 mm100 -82.34 -53.33 6.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 109.91 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.433 ' HA ' ' HB2' ' A' ' 414' ' ' ASP . 0.0 OUTLIER -61.52 -19.91 62.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.381 -0.824 . . . . 0.0 109.772 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.72 HD13 ' O ' ' A' ' 408' ' ' ILE . 1.0 OUTLIER -69.24 -73.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.653 ' N ' HG22 ' A' ' 412' ' ' ILE . 91.8 t -57.77 -20.13 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.363 -0.835 . . . . 0.0 109.763 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 410' ' ' GLN . 1.8 m-20 -78.74 -33.19 46.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.371 -0.83 . . . . 0.0 109.966 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.55 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 0.8 OUTLIER -74.24 -19.86 60.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.038 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.734 ' CE1' HD11 ' A' ' 337' ' ' ILE . 41.3 m80 -92.75 -35.94 13.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.57 -0.706 . . . . 0.0 109.597 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 7.1 t30 80.71 32.39 0.15 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.641 -0.662 . . . . 0.0 110.608 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.565 ' HA2' ' HD3' ' A' ' 437' ' ' PRO . . . -95.71 -89.61 1.77 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.546 ' CB ' ' HB2' ' A' ' 435' ' ' TRP . 0.1 OUTLIER -177.79 162.88 1.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.129 -1.218 . . . . 0.0 112.079 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 13.8 tp -152.63 102.7 2.73 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 432' ' ' ILE . 0.3 OUTLIER -119.37 164.28 15.94 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.685 -1.259 . . . . 0.0 113.128 -179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.411 HD22 ' H2 ' ' A' ' 451' ' ' ANP . 23.3 mt -107.07 136.93 46.08 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 431' ' ' SER . . . -97.97 154.79 20.29 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.883 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.804 HG23 ' HA2' ' A' ' 428' ' ' GLY . 87.0 m -144.08 92.78 2.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.432 -1.04 . . . . 0.0 110.01 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . 0.539 ' C ' ' CG ' ' A' ' 426' ' ' GLU . 4.4 m -91.6 108.82 20.17 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.0 -1.062 . . . . 0.0 111.368 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.539 ' CG ' ' C ' ' A' ' 425' ' ' SER . 0.1 OUTLIER 53.71 -93.58 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 O-C-N 121.356 -0.84 . . . . 0.0 110.574 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.482 ' C ' ' HD3' ' A' ' 427' ' ' ARG . 0.0 OUTLIER -63.92 -28.55 69.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.416 -1.427 . . . . 0.0 109.87 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.804 ' HA2' HG23 ' A' ' 424' ' ' THR . . . 136.89 26.08 0.41 Allowed Glycine 0 C--N 1.292 -1.882 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 428' ' ' GLY . . . -39.73 100.19 0.01 OUTLIER Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.806 HD13 ' C5 ' ' A' ' 451' ' ' ANP . 12.4 mt -60.38 114.01 2.7 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.18 0.991 . . . . 0.0 111.948 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.558 ' HB2' ' CG ' ' A' ' 372' ' ' GLU . 0.3 OUTLIER -123.53 100.05 6.61 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.913 HD11 ' N1 ' ' A' ' 451' ' ' ANP . 73.1 mt -89.31 122.53 40.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.914 -1.116 . . . . 0.0 111.496 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.76 100.17 9.58 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.686 -0.634 . . . . 0.0 109.646 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.5 128.81 36.03 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.66 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 86.9 m95 -110.36 159.23 17.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.804 -1.185 . . . . 0.0 113.382 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.935 HD12 HD11 ' A' ' 301' ' ' LEU . 51.5 mt -148.33 109.09 3.64 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.565 ' HD3' ' HA2' ' A' ' 418' ' ' GLY . 39.9 Cg_endo -64.35 139.91 67.69 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.778 1.409 . . . . 0.0 112.488 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 1.015 HG22 HG12 ' A' ' 330' ' ' VAL . 22.0 t -113.12 102.23 54.51 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.99 82.33 0.47 Allowed 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.83 1.437 . . . . 0.0 110.57 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.678 ' O ' HG23 ' A' ' 441' ' ' THR . 42.3 t -135.76 0.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 110.542 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 440' ' ' VAL . 17.1 p -158.84 132.21 7.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.187 -0.946 . . . . 0.0 110.593 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 441' ' ' THR . 3.2 mmm-85 38.94 58.64 1.75 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.444 -0.785 . . . . 0.0 110.56 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . . . . . . . . . . . -103.13 125.67 49.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.45 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -112.54 -97.05 0.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . 0.535 ' C ' HG22 ' A' ' 446' ' ' THR . . . 155.04 118.77 0.65 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.535 HG22 ' C ' ' A' ' 445' ' ' GLY . 1.6 t 33.81 96.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.813 -0.816 . . . . 0.0 111.046 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . . . . . . . . . 31.1 p -137.05 163.37 30.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.277 -0.89 . . . . 0.0 110.22 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -144.47 -144.25 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 110.489 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -134.26 -45.78 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.517 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.913 ' N1 ' HD11 ' A' ' 432' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 46.8 p . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.251 0.548 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 292' ' ' GLN . . . 138.31 -89.61 0.2 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 291' ' ' GLY . 0.0 OUTLIER 64.85 147.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.307 -1.114 . . . . 0.0 110.25 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.489 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 9.5 pt-20 -151.21 74.28 1.14 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -0.86 . . . . 0.0 109.973 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.544 ' O ' ' HG3' ' A' ' 294' ' ' MET . 8.0 ptt? -68.82 107.41 2.02 Favored Pre-proline 0 N--CA 1.5 2.075 0 O-C-N 121.426 -0.796 . . . . 0.0 110.819 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.654 ' CB ' ' CD2' ' A' ' 333' ' ' HIS . 53.4 Cg_endo -102.2 -156.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.309 2.006 . . . . 0.0 109.475 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' MET . . . . . 0.498 ' CE ' ' HB3' ' A' ' 415' ' ' ASN . 0.0 OUTLIER 41.25 94.98 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 122.16 0.981 . . . . 0.0 110.851 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 331' ' ' LYS . 3.0 mt-10 -144.67 -164.26 1.88 Allowed 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' MET . . . . . 0.446 ' HG2' ' HD2' ' A' ' 331' ' ' LYS . 0.0 OUTLIER -88.7 129.36 35.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 110.108 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.671 ' HB3' ' SD ' ' A' ' 332' ' ' MET . . . -149.77 167.19 27.2 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.323 -0.861 . . . . 0.0 111.316 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.675 ' O ' HG23 ' A' ' 304' ' ' VAL . 26.3 t70 -96.36 117.89 31.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.735 . . . . 0.0 109.551 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.669 HD11 HD12 ' A' ' 436' ' ' LEU . 20.3 mt -65.36 -22.37 66.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.094 -1.004 . . . . 0.0 110.015 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.773 ' HA ' HD23 ' A' ' 323' ' ' LEU . 43.7 t-20 -80.77 -22.28 40.29 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.996 -1.065 . . . . 0.0 108.755 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.485 ' CB ' ' HB3' ' A' ' 300' ' ' ASP . . . -84.17 -32.51 24.58 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.589 0.709 . . . . 0.0 109.454 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 300' ' ' ASP . 21.8 t -77.29 -37.72 25.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.587 -0.695 . . . . 0.0 109.529 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 301' ' ' LEU . 88.4 mt -76.86 -26.64 54.49 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.342 -0.849 . . . . 0.0 110.515 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . -64.69 -38.24 95.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -76.39 -35.59 58.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -1.118 . . . . 0.0 109.336 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.99 HG11 HG12 ' A' ' 341' ' ' VAL . 92.8 t -75.24 -18.8 16.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.55 0.691 . . . . 0.0 109.441 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.574 ' CD1' HG22 ' A' ' 321' ' ' THR . 0.0 OUTLIER -77.6 -43.77 29.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.783 0.801 . . . . 0.0 109.123 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.452 ' N ' HG22 ' A' ' 309' ' ' ILE . . . -75.17 -17.7 60.33 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.539 0.685 . . . . 0.0 109.866 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -88.11 -45.22 10.32 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.505 -0.747 . . . . 0.0 111.155 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -98.47 31.32 2.88 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.211 -0.93 . . . . 0.0 111.25 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.654 ' OG ' HD13 ' A' ' 319' ' ' ILE . 1.0 OUTLIER -82.84 -7.53 59.65 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.06 -1.025 . . . . 0.0 109.974 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 315' ' ' TYR . . . 87.56 -53.95 4.38 Favored Glycine 0 C--N 1.286 -2.198 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 314' ' ' GLY . 19.3 t80 174.54 36.16 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 315' ' ' TYR . 1.6 tm-20 70.02 36.17 2.02 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 317' ' ' ARG . 0.0 OUTLIER -67.86 -90.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.337 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 317' ' ' ARG . 20.5 mt-10 -152.17 73.77 1.06 Allowed 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.233 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.675 ' CG2' HG23 ' A' ' 358' ' ' VAL . 3.3 mp -105.1 134.3 46.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.297 -0.877 . . . . 0.0 109.182 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' GLU . . . . . 0.507 ' HB3' ' CG ' ' A' ' 357' ' ' LYS . 3.1 tt0 -99.55 108.6 21.06 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.035 -1.041 . . . . 0.0 110.121 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.574 HG22 ' CD1' ' A' ' 309' ' ' ILE . 15.3 p -93.97 126.5 39.22 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 110.744 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' ALA . . . . . . . . . . . . . . . -147.81 78.23 1.44 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.374 -0.829 . . . . 0.0 109.414 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.773 HD23 ' HA ' ' A' ' 302' ' ' ASN . 4.2 mp -91.0 156.35 18.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.393 -0.817 . . . . 0.0 110.462 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' TYR . . . . . 0.605 ' CG ' ' CG2' ' A' ' 362' ' ' THR . 69.2 t80 -45.8 125.62 6.61 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.893 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -80.51 68.93 8.16 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.885 1.466 . . . . 0.0 110.217 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 327' ' ' SER . . . -173.31 24.38 0.07 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 326' ' ' GLY . 0.0 OUTLIER 50.41 101.62 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 O-C-N 121.017 -1.284 . . . . 0.0 110.432 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 329' ' ' GLU . 1.1 mt -78.52 -176.61 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.35 -0.843 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -176.54 111.26 0.09 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.791 0.805 . . . . 0.0 110.87 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.864 HG12 HG22 ' A' ' 438' ' ' VAL . 8.5 m -142.48 162.12 18.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-O 121.391 0.615 . . . . 0.0 109.955 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 297' ' ' GLU . 0.3 OUTLIER -78.28 91.0 4.36 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' MET . . . . . 0.759 ' CE ' HG21 ' A' ' 337' ' ' ILE . 4.4 ppp? -135.83 135.36 39.76 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.643 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' HIS . . . . . 0.654 ' CD2' ' CB ' ' A' ' 295' ' ' PRO . 10.3 t-80 -67.34 116.44 36.73 Favored Pre-proline 0 C--N 1.296 -1.755 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.461 ' O ' ' HG3' ' A' ' 338' ' ' LYS . 41.0 Cg_endo -65.32 -19.53 61.88 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.62 1.326 . . . . 0.0 110.07 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.641 ' CB ' ' CE1' ' A' ' 333' ' ' HIS . 0.5 OUTLIER -81.14 -46.08 15.44 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.426 -0.797 . . . . 0.0 110.899 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.503 ' O ' HD12 ' A' ' 412' ' ' ILE . 2.2 m -72.73 -37.47 67.73 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.143 -0.973 . . . . 0.0 110.117 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.847 HD11 ' CE1' ' A' ' 416' ' ' HIS . 32.5 mm -71.82 -30.47 37.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.402 -0.812 . . . . 0.0 109.521 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 334' ' ' PRO . 3.8 mttt -68.29 -43.22 78.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 108.7 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 335' ' ' LEU . 75.5 mtt-85 -72.24 -31.77 66.11 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.474 0.654 . . . . 0.0 110.723 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 412' ' ' ILE . . . -73.58 -35.88 65.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 111.035 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.99 HG12 HG11 ' A' ' 308' ' ' VAL . 59.4 t -80.46 -27.85 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 110.552 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.797 ' O ' HG23 ' A' ' 346' ' ' VAL . . . -79.36 -28.29 41.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.183 -0.948 . . . . 0.0 110.182 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -89.77 -24.2 21.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.305 -0.872 . . . . 0.0 110.321 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 347' ' ' ASN . 1.9 mtm -71.65 -47.15 56.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.875 . . . . 0.0 110.386 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.8 t -65.43 -28.36 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 342' ' ' ALA . 71.6 t -56.34 -25.61 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.274 -0.891 . . . . 0.0 110.329 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 344' ' ' MET . 1.0 OUTLIER -56.18 -53.59 55.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.947 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . 0.551 ' HA ' ' HA3' ' A' ' 352' ' ' GLY . . . -85.53 -19.13 31.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.861 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.488 ' HB3' ' HA ' ' A' ' 346' ' ' VAL . . . -68.2 -59.66 3.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.319 -0.863 . . . . 0.0 111.668 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.518 ' HG3' ' N ' ' A' ' 351' ' ' TYR . 4.4 ptt-85 -86.5 -41.11 14.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.935 -1.103 . . . . 0.0 111.876 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' TYR . . . . . 0.518 ' N ' ' HG3' ' A' ' 350' ' ' ARG . 0.3 OUTLIER -90.2 -42.44 11.03 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.762 -1.211 . . . . 0.0 110.495 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 348' ' ' ALA . . . -85.27 173.54 48.31 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -168.48 72.76 0.1 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.278 -1.131 . . . . 0.0 109.873 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' GLY . . . . . 0.523 ' CA ' ' HB2' ' A' ' 374' ' ' ASP . . . -161.65 67.68 0.24 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.591 ' CZ2' ' HB2' ' A' ' 357' ' ' LYS . 11.1 t90 59.77 145.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -1.04 . . . . 0.0 111.242 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.417 HD12 HG13 ' A' ' 319' ' ' ILE . 6.0 mt -123.75 162.33 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.591 ' HB2' ' CZ2' ' A' ' 355' ' ' TRP . 16.6 tttt -150.44 117.73 6.03 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.782 -1.199 . . . . 0.0 111.253 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.675 HG23 ' CG2' ' A' ' 319' ' ' ILE . 3.4 t -106.25 89.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 370' ' ' GLN . 4.4 t -113.44 139.44 48.92 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.273 -0.892 . . . . 0.0 111.229 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . 0.487 ' HB2' ' HG ' ' A' ' 323' ' ' LEU . 3.7 m -138.33 158.11 44.93 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.384 -0.823 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.559 ' C ' HG22 ' A' ' 362' ' ' THR . . . -148.3 -154.69 6.37 Favored Glycine 0 C--N 1.295 -1.713 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.605 ' CG2' ' CG ' ' A' ' 324' ' ' TYR . 0.0 OUTLIER 175.02 169.25 0.29 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.03 -1.276 . . . . 0.0 110.71 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 362' ' ' THR . 3.1 mm-40 -149.39 172.23 5.44 Favored Pre-proline 0 C--N 1.293 -1.887 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . 0.534 ' O ' ' CB ' ' A' ' 365' ' ' ASN . 40.2 Cg_endo -66.24 116.28 3.94 Favored 'Trans proline' 0 C--N 1.299 -2.075 0 O-C-N 123.682 1.359 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 364' ' ' PRO . 4.4 t-20 74.25 34.72 0.8 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.655 -0.653 . . . . 0.0 111.009 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 365' ' ' ASN . 0.1 OUTLIER 165.81 97.51 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.305 -0.872 . . . . 0.0 111.214 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 362' ' ' THR . . . -103.41 171.34 7.42 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.158 -0.963 . . . . 0.0 109.039 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' TRP . . . . . 0.64 ' CD1' ' CZ3' ' A' ' 435' ' ' TRP . 39.2 p-90 -170.96 165.37 7.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.445 -1.41 . . . . 0.0 110.813 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' PHE . . . . . 0.633 ' CZ ' ' CB ' ' A' ' 434' ' ' ALA . 35.1 p90 -139.28 131.33 27.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.485 -0.759 . . . . 0.0 109.336 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . 0.523 ' HG2' ' N ' ' A' ' 371' ' ' VAL . 20.5 tt0 -116.08 151.33 35.78 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.246 -0.909 . . . . 0.0 111.773 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.523 ' N ' ' HG2' ' A' ' 370' ' ' GLN . 89.0 t -127.05 142.4 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.564 -0.71 . . . . 0.0 109.636 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.43 ' HG3' ' C ' ' A' ' 371' ' ' VAL . 55.4 mt-10 -137.81 129.58 28.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.4 -0.812 . . . . 0.0 109.564 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -159.55 161.55 35.25 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.088 -1.045 . . . . 0.0 110.536 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.523 ' HB2' ' CA ' ' A' ' 354' ' ' GLY . 0.5 OUTLIER -80.46 152.64 28.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 110.494 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . 0.468 ' HA2' ' HA2' ' A' ' 352' ' ' GLY . . . 164.64 -146.33 11.23 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.616 ' O ' HD23 ' A' ' 430' ' ' LEU . 42.4 Cg_endo -72.89 -169.48 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.053 1.554 . . . . 0.0 110.554 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . 0.472 ' CA ' ' HA3' ' A' ' 428' ' ' GLY . . . -145.22 139.4 8.34 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' ILE . . . . . 1.049 HD11 HD12 ' A' ' 422' ' ' LEU . 3.9 mt -81.08 170.81 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.102 -1.234 . . . . 0.0 109.923 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.947 ' HB3' ' HG2' ' A' ' 382' ' ' GLN . . . -151.32 175.99 2.58 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.252 -0.905 . . . . 0.0 110.324 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.879 ' HD2' ' HB1' ' A' ' 379' ' ' ALA . 49.5 Cg_endo -71.96 -34.25 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 124.061 1.558 . . . . 0.0 110.236 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -84.71 -21.73 30.01 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.849 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . 0.947 ' HG2' ' HB3' ' A' ' 379' ' ' ALA . 1.6 mm-40 -90.75 -18.27 25.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 110.129 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 387' ' ' PHE . 1.6 tpp85 -60.25 -19.75 55.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.126 -0.984 . . . . 0.0 110.095 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.49 ' HD3' ' OE1' ' A' ' 388' ' ' GLN . 0.2 OUTLIER -86.95 -20.71 26.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.868 . . . . 0.0 110.618 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' HIS . . . . . 0.583 ' CD2' ' HA ' ' A' ' 382' ' ' GLN . 20.6 m-70 -63.05 -46.63 86.6 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.147 -0.971 . . . . 0.0 111.222 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.58 ' O ' ' CG ' ' A' ' 387' ' ' PHE . 1.0 OUTLIER -128.11 49.84 2.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.034 -1.041 . . . . 0.0 110.94 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' A' ' 386' ' ' LEU . 1.7 m-85 -175.0 51.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.177 -0.952 . . . . 0.0 111.078 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.506 ' O ' ' HG3' ' A' ' 388' ' ' GLN . 21.7 pt20 -153.74 134.76 8.43 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.033 -1.042 . . . . 0.0 110.44 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -81.9 114.55 2.61 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.793 1.418 . . . . 0.0 110.032 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -104.78 146.87 28.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 0.0 110.206 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.92 160.78 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.402 -0.811 . . . . 0.0 110.375 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' ARG . . . . . 0.413 ' HA ' ' HD2' ' A' ' 392' ' ' ARG . 33.2 tpt85 -79.82 -57.14 3.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.299 -0.875 . . . . 0.0 110.208 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -158.87 -48.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -133.75 -58.54 0.87 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -1.195 . . . . 0.0 110.149 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.432 ' OG ' ' HG2' ' A' ' 397' ' ' ARG . 1.3 t -154.48 -75.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.204 -0.935 . . . . 0.0 109.941 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' ALA . . . . . . . . . . . . . . . 53.41 45.13 28.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.432 ' HG2' ' OG ' ' A' ' 395' ' ' SER . 2.6 ptp85 -127.59 108.11 10.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 0.0 110.127 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' THR . . . . . . . . . . . . . 68.7 p -60.67 145.86 47.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 110.12 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 399' ' ' ILE . 6.4 tp -103.1 71.09 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.23 -0.919 . . . . 0.0 110.463 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -48.12 24.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.251 -0.906 . . . . 0.0 110.052 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -160.1 -117.65 0.47 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.7 m -145.18 78.43 1.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -1.157 . . . . 0.0 110.237 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 170.78 94.44 0.09 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 2.5 tt -108.77 -67.33 0.98 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -1.203 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -111.98 92.29 0.64 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.722 HD23 ' HG3' ' A' ' 411' ' ' ARG . 5.7 mt -92.52 114.91 27.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -1.164 . . . . 0.0 110.258 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -78.67 -162.44 0.37 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -0.905 . . . . 0.0 110.097 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' ILE . . . . . 0.796 HG23 HG23 ' A' ' 409' ' ' VAL . 6.3 tt -115.29 -17.02 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 0.0 110.108 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.796 HG23 HG23 ' A' ' 408' ' ' ILE . 99.5 t -128.24 -31.91 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.355 -0.841 . . . . 0.0 109.868 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 2.3 mt-30 -69.42 -49.56 53.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.257 -0.902 . . . . 0.0 109.888 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.722 ' HG3' HD23 ' A' ' 406' ' ' LEU . 0.6 OUTLIER -65.88 -20.93 66.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.269 -0.894 . . . . 0.0 109.827 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.896 HG21 ' HB2' ' A' ' 340' ' ' ALA . 18.5 mm -68.12 -69.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 108.934 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.795 HG11 ' HB2' ' A' ' 420' ' ' LEU . 87.1 t -62.76 -21.15 26.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.368 -0.833 . . . . 0.0 109.015 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 411' ' ' ARG . 8.4 t70 -75.24 -31.71 60.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.588 -0.695 . . . . 0.0 109.403 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.498 ' HB3' ' CE ' ' A' ' 296' ' ' MET . 1.1 m-20 -76.97 -14.74 59.81 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.405 -0.81 . . . . 0.0 109.12 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.847 ' CE1' HD11 ' A' ' 337' ' ' ILE . 38.9 m80 -92.51 -34.47 14.07 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.579 -0.7 . . . . 0.0 109.861 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 416' ' ' HIS . 4.7 m-20 80.58 19.89 0.51 Allowed 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.374 0.607 . . . . 0.0 110.281 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . 0.564 ' CA ' ' HD3' ' A' ' 437' ' ' PRO . . . -90.03 -92.01 1.23 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' MET . . . . . 0.567 ' HB3' ' CD1' ' A' ' 435' ' ' TRP . 31.6 ttm -176.9 162.01 2.04 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.189 -1.183 . . . . 0.0 111.212 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.795 ' HB2' HG11 ' A' ' 413' ' ' VAL . 21.2 tp -151.32 104.91 3.14 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.387 -0.82 . . . . 0.0 108.832 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.487 ' O ' HG23 ' A' ' 432' ' ' ILE . 0.5 OUTLIER -112.98 143.31 44.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.974 -1.079 . . . . 0.0 111.902 -179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 1.049 HD12 HD11 ' A' ' 378' ' ' ILE . 3.5 mm? -99.42 80.69 2.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.485 -0.759 . . . . 0.0 109.402 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 429' ' ' GLY . . . -50.98 104.51 0.14 Allowed Glycine 0 C--N 1.28 -2.532 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.912 HG23 ' HA2' ' A' ' 428' ' ' GLY . 30.4 m -107.97 106.14 16.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.255 -1.144 . . . . 0.0 109.09 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.89 99.46 12.49 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.057 -1.027 . . . . 0.0 111.713 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 428' ' ' GLY . 4.2 tt0 53.03 -112.27 0.68 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.184 -0.948 . . . . 0.0 110.673 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.47 ' C ' ' HD3' ' A' ' 427' ' ' ARG . 0.1 OUTLIER -40.86 -29.24 0.09 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.101 -1.0 . . . . 0.0 109.994 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' GLY . . . . . 0.912 ' HA2' HG23 ' A' ' 424' ' ' THR . . . 131.48 35.32 0.37 Allowed Glycine 0 C--N 1.296 -1.646 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 423' ' ' GLY . . . -43.53 98.78 0.01 OUTLIER Glycine 0 N--CA 1.494 2.507 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 428' ' ' GLY . 2.7 mm? -65.82 106.37 1.51 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.196 0.998 . . . . 0.0 111.831 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' SER . . . . . 0.455 ' O ' ' HA3' ' A' ' 423' ' ' GLY . 0.0 OUTLIER -145.76 100.72 3.46 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 421' ' ' GLU . 80.6 mt -92.0 151.9 3.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.067 -1.021 . . . . 0.0 112.864 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -124.45 94.86 4.33 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 369' ' ' PHE . . . -89.23 139.83 30.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.786 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' TRP . . . . . 0.64 ' CZ3' ' CD1' ' A' ' 368' ' ' TRP . 84.9 m95 -120.28 153.12 36.83 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.102 0.953 . . . . 0.0 111.707 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.669 HD12 HD11 ' A' ' 301' ' ' LEU . 86.0 mt -140.72 115.15 7.32 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.564 ' HD3' ' CA ' ' A' ' 418' ' ' GLY . 43.9 Cg_endo -70.69 134.24 25.59 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.834 1.439 . . . . 0.0 111.418 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.864 HG22 HG12 ' A' ' 330' ' ' VAL . 21.4 t -94.11 144.16 27.61 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.622 -0.674 . . . . 0.0 110.161 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' PRO . . . . . 0.495 ' HD2' ' CG1' ' A' ' 438' ' ' VAL . 50.8 Cg_endo -73.71 101.87 1.43 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.993 1.523 . . . . 0.0 110.457 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 441' ' ' THR . 40.7 t -137.47 179.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.144 -0.973 . . . . 0.0 109.985 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.559 ' H ' HG12 ' A' ' 440' ' ' VAL . 2.8 p 59.58 83.15 0.14 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.333 -0.854 . . . . 0.0 110.145 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 443' ' ' ALA . 0.6 OUTLIER -169.23 63.91 0.05 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 442' ' ' ARG . . . -51.03 -179.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.166 -0.959 . . . . 0.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -76.41 -155.63 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.148 -0.97 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -100.65 -76.34 1.21 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' THR . . . . . 0.553 ' C ' HG22 ' A' ' 447' ' ' THR . 7.4 t -126.49 -7.84 6.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.235 -1.156 . . . . 0.0 110.204 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.553 HG22 ' C ' ' A' ' 446' ' ' THR . 2.0 t 34.55 90.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.288 0.566 . . . . 0.0 110.755 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -49.81 -48.01 51.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 0.0 109.953 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.49 147.41 45.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 110.081 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 CA-C-O 118.005 -1.442 . . . . 0.0 109.545 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' ANP . . . . . 0.604 ' C5 ' HD11 ' A' ' 430' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_